Citrus Sinensis ID: 002342
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 934 | 2.2.26 [Sep-21-2011] | |||||||
| O48963 | 996 | Phototropin-1 OS=Arabidop | yes | no | 0.971 | 0.910 | 0.733 | 0.0 | |
| Q2QYY8 | 921 | Phototropin-1A OS=Oryza s | yes | no | 0.890 | 0.903 | 0.636 | 0.0 | |
| Q2RBR1 | 921 | Phototropin-1B OS=Oryza s | yes | no | 0.890 | 0.903 | 0.635 | 0.0 | |
| P93025 | 915 | Phototropin-2 OS=Arabidop | no | no | 0.820 | 0.837 | 0.625 | 0.0 | |
| Q9ST27 | 907 | Phototropin-2 OS=Oryza sa | no | no | 0.797 | 0.821 | 0.647 | 0.0 | |
| Q9LFA2 | 934 | Serine/threonine-protein | no | no | 0.307 | 0.307 | 0.434 | 1e-74 | |
| P15792 | 609 | Protein kinase PVPK-1 OS= | N/A | no | 0.307 | 0.471 | 0.434 | 5e-74 | |
| Q0DCT8 | 589 | Protein kinase G11A OS=Or | no | no | 0.341 | 0.541 | 0.416 | 5e-73 | |
| A2YBX5 | 589 | Protein kinase G11A OS=Or | N/A | no | 0.341 | 0.541 | 0.416 | 8e-73 | |
| O42626 | 623 | Serine/threonine-protein | N/A | no | 0.266 | 0.399 | 0.521 | 8e-72 |
| >sp|O48963|PHOT1_ARATH Phototropin-1 OS=Arabidopsis thaliana GN=PHOT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1350 bits (3495), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 691/942 (73%), Positives = 779/942 (82%), Gaps = 35/942 (3%)
Query: 5 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQP-TWQTWMEQRES---P 60
E + K S+K L RD+RGSLEVFNPST TRP NPVFRP+P WQ + R + P
Sbjct: 2 EPTEKPSTKPSSRTLPRDTRGSLEVFNPSTQLTRPDNPVFRPEPPAWQNLSDPRGTSPQP 61
Query: 61 EPEHAKLNSKSSRAEE----ITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGE 116
P+ S R+++ TSWMALKDP+P+ S +K+ ++
Sbjct: 62 RPQQEPAPSNPVRSDQEIAVTTSWMALKDPSPETIS------------KKTITAEKPQKS 109
Query: 117 AGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGG--DDPNGKPGTSRRNSNNSVRSSGEM 174
A AA QRAAEWGLVLKTDT+TGKPQ V R SGG +DPNGK TS+RNS NS RSSGEM
Sbjct: 110 AVAAEQRAAEWGLVLKTDTKTGKPQGVGVRNSGGTENDPNGKKTTSQRNSQNSCRSSGEM 169
Query: 175 SDEG--GKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV 232
SD G G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFF MTGYTSKEV
Sbjct: 170 SDGDVPGGRSGIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFNMTGYTSKEV 229
Query: 233 VGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGK 292
VGRNCRFLQG+GTD +++AKIRETL G +YCGR+LNYKKDGT FWNLLTIAPIKD+ GK
Sbjct: 230 VGRNCRFLQGSGTDADELAKIRETLAAGNNYCGRILNYKKDGTSFWNLLTIAPIKDESGK 289
Query: 293 VLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSL 352
VLKFIGMQVEVSKHTEGAK+K LRPNGLPESLIRYDARQK+MAT+SVTELV+A+K+PR+L
Sbjct: 290 VLKFIGMQVEVSKHTEGAKEKALRPNGLPESLIRYDARQKDMATNSVTELVEAVKRPRAL 349
Query: 353 SESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKK 412
SESTN P + KSE +E RR SENV P R + GGG R SMQRI+E+PEKK
Sbjct: 350 SESTNLHPFMTKSES---DELPKKPARRMSENVVPSGRRNSGGGRRNSMQRINEIPEKKS 406
Query: 413 QKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEG--DDDYESDDERPDSVDDKVRQKEMRK 470
+KS SFMG I +KS+S D+ S ++ I G DD+ DERP+SVDDKVRQKEMRK
Sbjct: 407 RKSSL-SFMG-IKKKSESLDE--SIDDGFIEYGEEDDEISDRDERPESVDDKVRQKEMRK 462
Query: 471 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDP 530
GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD
Sbjct: 463 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDL 522
Query: 531 ATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL 590
TV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQKGEVQYFIGVQLDGS+H+
Sbjct: 523 TTVKKIRNAIDNQTEVTVQLINYTKSGKKFWNIFHLQPMRDQKGEVQYFIGVQLDGSKHV 582
Query: 591 EPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDS 650
EP+RN I E +E E LVK+TA N++EAV+ELPDAN+TPEDLWANHSKVVH KPHRKDS
Sbjct: 583 EPVRNVIEETAVKEGEDLVKKTAVNIDEAVRELPDANMTPEDLWANHSKVVHCKPHRKDS 642
Query: 651 PPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 710
PPW AIQK+L+SGE I L+HF+P+KPLGSGDTGSVHLVEL G+ Q FAMKAMDK VMLNR
Sbjct: 643 PPWIAIQKVLESGEPIGLKHFKPVKPLGSGDTGSVHLVELVGTDQLFAMKAMDKAVMLNR 702
Query: 711 NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 770
NKVHRA AEREILD+LDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQP KVLKE
Sbjct: 703 NKVHRARAEREILDLLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQPRKVLKE 762
Query: 771 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830
DAVRFYAA+VVVALEYLHCQGIIYRDLKPENVL+QGNG +SL+DFDLSCLTSCKPQLL+P
Sbjct: 763 DAVRFYAAQVVVALEYLHCQGIIYRDLKPENVLIQGNGDISLSDFDLSCLTSCKPQLLIP 822
Query: 831 TTNE--KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888
+ +E KK++ K QQ P+FMAEPMRASNSFVGTEEYIAPEII+GAGHTSAVDWWALGIL+
Sbjct: 823 SIDEKKKKKQQKSQQTPIFMAEPMRASNSFVGTEEYIAPEIISGAGHTSAVDWWALGILM 882
Query: 889 YEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANV 930
YEMLYGYTPFRGKTRQKTF N+L KDLKFP+S P+S + +
Sbjct: 883 YEMLYGYTPFRGKTRQKTFTNVLQKDLKFPASIPASLQVKQL 924
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for photo-induced movements. Required for blue-light mediated mRNA destabilization. Mediates calcium spiking of extracellular origin in response to low rate of blue light. Mediates also rapid membrane depolarization and growth inhibition in response to blue light. Necessary for root phototropism. Involved in hypocotyl phototropism under low rate but not under high rate blue light. Contributes to the chloroplast accumulation but seems to be not required for chloroplast translocation. Regulates stomata opening and photomorphogenesis response of leaf tissue. Confers sensitivity to drought. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q2QYY8|PHT1A_ORYSJ Phototropin-1A OS=Oryza sativa subsp. japonica GN=PHOT1A PE=1 SV=2 | Back alignment and function description |
|---|
Score = 1169 bits (3023), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 591/928 (63%), Positives = 702/928 (75%), Gaps = 96/928 (10%)
Query: 5 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQRESPEPEH 64
E+ +Q + + P RDSRGSLEVFNPS+ S+ FR
Sbjct: 14 ERKEQQQQRGYQLP--RDSRGSLEVFNPSSASS------FR------------------- 46
Query: 65 AKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRA 124
+ ++ + + ++A+ D+E+ V Q QRA
Sbjct: 47 ----TAAAAPKSASPFLAIP------------------DREEDNVVAQ---------QRA 75
Query: 125 AEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKE-KG 183
AEWGLVL+TD TG PQ V AR S G S R+S E + + +
Sbjct: 76 AEWGLVLQTDHHTGLPQGVSARPSSG----------------SARTSSEDNPQQQQSAAA 119
Query: 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 243
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSAFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 244 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 304 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 363
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNN-TLKR 298
Query: 364 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 421
KS+ + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMTEVPSKRSSES--GSRRNSR-SGTRSSLQKINEVPDQGNRTRKSGLRAFM 355
Query: 422 GLIGRKSQSTDDHDSFENEIIMEGDDD--YESDDERPDSVDDKVRQKEMRKGIDLATTLE 479
G +G H S E ++ D+D +SDDERP+S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 539
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 540 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPE 599
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 600 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 659
A+E LVK+TA+N++EA KELPDANL PEDLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPEDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 660 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 719
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
K P+F AEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 822
Query: 900 GKTRQKTFANILHKDLKFPSSTPSSCKA 927
GKTRQ+TFANILHKD++FP+S S A
Sbjct: 823 GKTRQRTFANILHKDIRFPASISVSLAA 850
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RBR1|PHT1B_ORYSJ Phototropin-1B OS=Oryza sativa subsp. japonica GN=PHOT1B PE=1 SV=2 | Back alignment and function description |
|---|
Score = 1167 bits (3020), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 590/928 (63%), Positives = 703/928 (75%), Gaps = 96/928 (10%)
Query: 5 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQRESPEPEH 64
E+ +Q + + P RDSRGSLEVFNPS+ S+ FR
Sbjct: 14 ERKEQQQQRGYQLP--RDSRGSLEVFNPSSASS------FR------------------- 46
Query: 65 AKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRA 124
+ ++ + + ++A+ D+E+ V Q QRA
Sbjct: 47 ----TAAAAPKSASPFLAIP------------------DREEDNVVAQ---------QRA 75
Query: 125 AEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKE-KG 183
AEWGLVL+TD TG PQ V AR S G S R+S E + + +
Sbjct: 76 AEWGLVLQTDHHTGLPQGVSARPSSG----------------SARTSSEDNPQQQQSAAA 119
Query: 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 243
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSVFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 244 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 304 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 363
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNN-TLKR 298
Query: 364 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 421
KS+ + + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMSEVPSKRSSES--GSRRNSR-SGTRSSLQKINEVPDQVNRTRKSGLRAFM 355
Query: 422 GLIGRKSQSTDDHDSFENEIIMEGDDD--YESDDERPDSVDDKVRQKEMRKGIDLATTLE 479
G +G H S E ++ D+D +SDDERP+S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 539
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 540 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPE 599
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 600 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 659
A+E LVK+TA+N++EA KELPDANL P+DLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPKDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 660 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 719
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
K P+F AEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 822
Query: 900 GKTRQKTFANILHKDLKFPSSTPSSCKA 927
GKTRQ+TFANILHKD++FP+S S A
Sbjct: 823 GKTRQRTFANILHKDIRFPASISVSLAA 850
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93025|PHOT2_ARATH Phototropin-2 OS=Arabidopsis thaliana GN=PHOT2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 1012 bits (2616), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 508/812 (62%), Positives = 602/812 (74%), Gaps = 46/812 (5%)
Query: 116 EAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMS 175
++ +R AEWGL + V SG D + K + S N +
Sbjct: 62 DSAKITERTAEWGL------------SAVKPDSGDDGISFKLSSEVERSKN-MSRRSSEE 108
Query: 176 DEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR 235
+ PRVS +K ALST QQTFVVSDAT+P PI+YAS+GFF MTGY+SKE+VGR
Sbjct: 109 STSSESGAFPRVSQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGR 168
Query: 236 NCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLK 295
NCRFLQG TD +VAKIR+ ++NG+SYCGRLLNYKKDGTPFWNLLT+ PIKDD+G +K
Sbjct: 169 NCRFLQGPDTDKNEVAKIRDCVKNGKSYCGRLLNYKKDGTPFWNLLTVTPIKDDQGNTIK 228
Query: 296 FIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS-LSE 354
FIGMQVEVSK+TEG DK LRPNGL +SLIRYDARQKE A S+TE+VQ ++ +S + E
Sbjct: 229 FIGMQVEVSKYTEGVNDKALRPNGLSKSLIRYDARQKEKALDSITEVVQTIRHRKSQVQE 288
Query: 355 STNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQK 414
S + +++ S P P R + R S+ K +
Sbjct: 289 SVSNDTMVKPD----------------SSTTPTPGRQT----------RQSDEASKSFRT 322
Query: 415 SGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDE--RPDSVDDKVRQKEMRKGI 472
GR S G K +S+++ E+ + ME ++ S + + DS D R++++R+GI
Sbjct: 323 PGRVS--TPTGSKLKSSNNR--HEDLLRMEPEELMLSTEVIGQRDSWDLSDRERDIRQGI 378
Query: 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPAT 532
DLATTLERIEKNFVI+DPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD AT
Sbjct: 379 DLATTLERIEKNFVISDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDQAT 438
Query: 533 VRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 592
V+KIR AI +Q ++TVQLINYTKSGKKFWNLFHLQPMRDQKGE+QYFIGVQLDGS+H+EP
Sbjct: 439 VQKIRDAIRDQREITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHVEP 498
Query: 593 LRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPP 652
L+N + E T +S KLVK TA NV+EAV+ELPDAN PEDLWA HSK V+P PH K+S
Sbjct: 499 LQNRLSERTEMQSSKLVKATATNVDEAVRELPDANTRPEDLWAAHSKPVYPLPHNKESTS 558
Query: 653 WKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK 712
WKAI+KI SGE + L HF+PIKPLGSGDTGSVHLVEL G+G+ +AMKAM+K +MLNRNK
Sbjct: 559 WKAIKKIQASGETVGLHHFKPIKPLGSGDTGSVHLVELKGTGELYAMKAMEKTMMLNRNK 618
Query: 713 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
HRAC EREI+ +LDHPF+P LYASFQT THVCLITD+CPGGELF LLDRQP K+L ED+
Sbjct: 619 AHRACIEREIISLLDHPFLPTLYASFQTSTHVCLITDFCPGGELFALLDRQPMKILTEDS 678
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
RFYAAEVV+ LEYLHC GI+YRDLKPEN+LL+ +GH+ L DFDLS +T+C PQL++P
Sbjct: 679 ARFYAAEVVIGLEYLHCLGIVYRDLKPENILLKKDGHIVLADFDLSFMTTCTPQLIIPAA 738
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
K+RR K Q P F+AEP SNSFVGTEEYIAPEII GAGHTSA+DWWALGILLYEML
Sbjct: 739 PSKRRRSKSQPLPTFVAEPSTQSNSFVGTEEYIAPEIITGAGHTSAIDWWALGILLYEML 798
Query: 893 YGYTPFRGKTRQKTFANILHKDLKFPSSTPSS 924
YG TPFRGK RQKTFANILHKDL FPSS P S
Sbjct: 799 YGRTPFRGKNRQKTFANILHKDLTFPSSIPVS 830
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for photo-induced movements. Mediates calcium spiking of extra- and intracellular origins in response to blue light. Involved in hypocotyl phototropism. Contributes to the chloroplast accumulation in low blue light and mediates their translocation (avoidance response) at high fluence. Regulates stomata opening and photomorphogenesis response of leaf tissue. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ST27|PHOT2_ORYSJ Phototropin-2 OS=Oryza sativa subsp. japonica GN=PHOT2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 989 bits (2558), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/752 (64%), Positives = 573/752 (76%), Gaps = 7/752 (0%)
Query: 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 243
LPRVS +KDALS+ QQTFVVSDAT+PD PI+YAS GFF MTGY+ +EVVGRNCRFLQG
Sbjct: 86 LPRVSQELKDALSSLQQTFVVSDATRPDCPIIYASEGFFTMTGYSPREVVGRNCRFLQGP 145
Query: 244 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
TD +VAKIR+ +++G+S+CGRLLNY+KDG PFWNLLT+ PI+DD GKV+KFIGMQVEV
Sbjct: 146 DTDAAEVAKIRDAVKHGRSFCGRLLNYRKDGAPFWNLLTVTPIRDDNGKVIKFIGMQVEV 205
Query: 304 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTN----RP 359
SK+TEG DK +RPN LP SLIRYD RQK+ A SS+TE+VQ +K+PR + P
Sbjct: 206 SKYTEGLSDKRMRPNELPVSLIRYDERQKDKAMSSMTEVVQTVKQPRGARAPADAALLTP 265
Query: 360 PIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRS 419
P + ++ A G S + R+S + +K SGR S
Sbjct: 266 PKMSDADKMAAMSPVVAPGTPSGGGGGAGSFKSPLWDLKKEESRLSRLASGRK--SGRSS 323
Query: 420 FMGL-IGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTL 478
MG IG++S E ER DS + R+K++R+GIDLATTL
Sbjct: 324 LMGFKIGKRSSVGSREAPAVVEEPAPAPPPAPEVVERTDSWERAEREKDIRQGIDLATTL 383
Query: 479 ERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRA 538
ERIEKNFVITDPR+PDNPIIFASDSFLELTEY+REEILGRNCRFLQGPETD TV KIR
Sbjct: 384 ERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCRFLQGPETDQGTVDKIRE 443
Query: 539 AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIP 598
AI Q ++TVQLINYTKSGKKFWNLFHLQPMRDQKGE+QYFIGVQLDGS+H+EPLRN +
Sbjct: 444 AIREQKEITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHVEPLRNRLS 503
Query: 599 EATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQK 658
E T +S KLVK TAENV++AV+ELPDANL PEDLWA HS V PKPH++++P W AI+K
Sbjct: 504 ENTEIQSAKLVKATAENVDDAVRELPDANLRPEDLWAIHSMRVSPKPHKRNNPSWIAIEK 563
Query: 659 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA 718
+ GE+I L+HF+P+KPLG GDTGSVHLVEL GSG+ FAMKAMDK VMLNRNKVHRAC
Sbjct: 564 ATNLGEKIGLKHFKPVKPLGCGDTGSVHLVELQGSGELFAMKAMDKSVMLNRNKVHRACI 623
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
EREI +LDHPF+P LY SFQT THVCLITD+CPGGELF +LDRQP K+ +E+ RFYAA
Sbjct: 624 EREIYALLDHPFLPTLYTSFQTPTHVCLITDFCPGGELFAVLDRQPMKIFREECARFYAA 683
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
EVV+ LEYLHC GIIYRDLKPEN+LLQ +GH+ LTDFDLS LT+ KP ++ +T+ K+RR
Sbjct: 684 EVVIGLEYLHCLGIIYRDLKPENILLQADGHIVLTDFDLSFLTTSKPHVIKNSTSLKRRR 743
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ P F++EP SNSFVGTEEYIAPE+I GAGHTSA+DWWALGILLYEMLYG TPF
Sbjct: 744 SQEFLPPTFVSEPSTPSNSFVGTEEYIAPEVITGAGHTSAIDWWALGILLYEMLYGRTPF 803
Query: 899 RGKTRQKTFANILHKDLKFPSSTPSSCKAANV 930
RGK R+KTF NILHKDL FPSS P S A +
Sbjct: 804 RGKNRKKTFYNILHKDLTFPSSIPVSLAAKQL 835
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFA2|KIPK_ARATH Serine/threonine-protein kinase KIPK OS=Arabidopsis thaliana GN=KIPK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 281 bits (720), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 148/341 (43%), Positives = 196/341 (57%), Gaps = 54/341 (15%)
Query: 644 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 703
KPH W+AI+ I + L+HF +K LG GD G+V+L EL G+ FA+K MD
Sbjct: 511 KPHMSMDVRWEAIKHIKVQYGSLGLRHFNLLKKLGCGDIGTVYLAELIGTNCLFAIKVMD 570
Query: 704 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 763
+ R K RA AEREIL MLDHPF+P LYA F + CL+ +YCPGG+L +L +Q
Sbjct: 571 NEFLARRKKSPRAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQ 630
Query: 764 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS----- 818
+ E A RFY AE+++ALEYLH GIIYRDLKPEN+L++ +GH+ LTDFDLS
Sbjct: 631 LGRCFPEPAARFYVAEILLALEYLHMLGIIYRDLKPENILVREDGHIMLTDFDLSLRCAV 690
Query: 819 -------------------------------CLT--SCKPQLLLP--TTNEKKRR----- 838
C+T SC+ P ++N+++ R
Sbjct: 691 NPTLVRSNSPPGKDPARISGPYNTSNCIQPFCITEPSCQVSCFSPRLSSNQQQGRKPKRG 750
Query: 839 --------HKGQQNPVFMAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889
H + P +AEP A SNSFVGT EY+APEII G GH +AVDWW G+LLY
Sbjct: 751 DHLSKTQQHLSRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGVLLY 810
Query: 890 EMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANV 930
E+LYG TPF+G +T AN++ ++LKFP S S +A ++
Sbjct: 811 ELLYGKTPFKGYNNDETLANVVLQNLKFPDSPLVSFQAKDL 851
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15792|KPK1_PHAVU Protein kinase PVPK-1 OS=Phaseolus vulgaris PE=2 SV=1 | Back alignment and function description |
|---|
Score = 280 bits (715), Expect = 5e-74, Method: Compositional matrix adjust.
Identities = 146/336 (43%), Positives = 191/336 (56%), Gaps = 49/336 (14%)
Query: 644 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 703
KPH+ + W+AIQ + + ++HFR +K LG GD GSV+L EL G+ FAMK M+
Sbjct: 202 KPHKANDIRWEAIQAVRTRDGMLEMRHFRLLKKLGCGDIGSVYLAELSGTRTSFAMKVMN 261
Query: 704 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 763
K + NR K+ RA EREIL LDHPF+P LY F+T+ CL+ ++CPGG+L L RQ
Sbjct: 262 KTELANRKKLLRAQTEREILQSLDHPFLPTLYTHFETEIFSCLVMEFCPGGDLHALRQRQ 321
Query: 764 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
P K E AVRFY AEV+++LEYLH GIIYRDLKPENVL++ +GH+ L+DFDLS S
Sbjct: 322 PGKYFSEHAVRFYVAEVLLSLEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCSV 381
Query: 824 KPQLLLPTTNEKKRRH-------------------------------------------- 839
P L+ + N + +
Sbjct: 382 SPTLVKSSNNLQTKSSGYCVQPSCIEPTCVMQPDCIKPSCFTPRFLSGKSKKDKKSKPKN 441
Query: 840 --KGQQNPV--FMAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 894
Q P+ +AEP A S SFVGT EY+APEII G GH SAVDWW GI LYE+L+G
Sbjct: 442 DMHNQVTPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG 501
Query: 895 YTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANV 930
TPF+G + T N++ + L+FP S S A ++
Sbjct: 502 RTPFKGSANRATLFNVIGQPLRFPESPTVSFAARDL 537
|
Phaseolus vulgaris (taxid: 3885) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0DCT8|G11A_ORYSJ Protein kinase G11A OS=Oryza sativa subsp. japonica GN=Os06g0291600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (707), Expect = 5e-73, Method: Compositional matrix adjust.
Identities = 155/372 (41%), Positives = 205/372 (55%), Gaps = 53/372 (14%)
Query: 600 ATAEESEKLV--KQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQ 657
A+A S +LV +T E + + P + D A S KPH+ + W+AIQ
Sbjct: 122 ASASGSARLVGRSETGERGFSSSRCRPSTSSDVSDESACSSISSVTKPHKANDSRWEAIQ 181
Query: 658 KILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC 717
I + L HF+ +K LG GD GSV+L EL G+ YFAMK MDK + +R K+ RA
Sbjct: 182 MIRTRDGILGLSHFKLLKKLGCGDIGSVYLSELSGTKSYFAMKVMDKASLASRKKLLRAQ 241
Query: 718 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
E+EIL LDHPF+P LY F+T CL+ ++CPGG+L L RQ K E AV+FY
Sbjct: 242 TEKEILQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYV 301
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL--------- 828
AE+++A+EYLH GIIYRDLKPENVL++ +GH+ L+DFDLS + P L+
Sbjct: 302 AEILLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEA 361
Query: 829 --------------------------LPTT---------NEKKRRHKGQQN------PVF 847
PTT ++K R+ K + P
Sbjct: 362 LRKNNQAYCVQPACVEPSCMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVVNQVSPWPEL 421
Query: 848 MAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
+AEP A S SFVGT EY+APEII G GH SAVDWW GI LYE+L+G TPF+G + T
Sbjct: 422 IAEPSDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 481
Query: 907 FANILHKDLKFP 918
N++ + L+FP
Sbjct: 482 LFNVIGQPLRFP 493
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YBX5|G11A_ORYSI Protein kinase G11A OS=Oryza sativa subsp. indica GN=OsI_021818 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (705), Expect = 8e-73, Method: Compositional matrix adjust.
Identities = 155/372 (41%), Positives = 205/372 (55%), Gaps = 53/372 (14%)
Query: 600 ATAEESEKLV--KQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQ 657
A+A S +LV +T E + + P + D A S KPH+ + W+AIQ
Sbjct: 122 ASASGSARLVGRSETGERGFSSSRCRPSTSSDVSDESACSSISSVTKPHKANDSRWEAIQ 181
Query: 658 KILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC 717
I + L HF+ +K LG GD GSV+L EL G+ YFAMK MDK + +R K+ RA
Sbjct: 182 MIRTRDGILGLSHFKLLKKLGCGDIGSVYLSELNGTKSYFAMKVMDKASLASRKKLLRAQ 241
Query: 718 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
E+EIL LDHPF+P LY F+T CL+ ++CPGG+L L RQ K E AV+FY
Sbjct: 242 TEKEILQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYV 301
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL--------- 828
AE+++A+EYLH GIIYRDLKPENVL++ +GH+ L+DFDLS + P L+
Sbjct: 302 AEILLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEA 361
Query: 829 --------------------------LPTT---------NEKKRRHKGQQN------PVF 847
PTT ++K R+ K + P
Sbjct: 362 LRKNNQAYCVQPACVEPSCMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVVNQVSPWPEL 421
Query: 848 MAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
+AEP A S SFVGT EY+APEII G GH SAVDWW GI LYE+L+G TPF+G + T
Sbjct: 422 IAEPSDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 481
Query: 907 FANILHKDLKFP 918
N++ + L+FP
Sbjct: 482 LFNVIGQPLRFP 493
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O42626|NRC2_NEUCR Serine/threonine-protein kinase nrc-2 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) GN=nrc-2 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 272 bits (696), Expect = 8e-72, Method: Compositional matrix adjust.
Identities = 135/259 (52%), Positives = 171/259 (66%), Gaps = 10/259 (3%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ Q F IK +G GD G V+LV+ SG+ +AMK + K M+ RNK+ RA AE+EIL
Sbjct: 236 EVGPQSFDKIKLIGKGDVGKVYLVKEKKSGRLYAMKVLSKKEMIKRNKIKRALAEQEILA 295
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
+HPF+ LY SFQ++ ++ L +YC GGE F L +P K + ED RFYAAEV AL
Sbjct: 296 TSNHPFIVTLYHSFQSEDYLYLCMEYCSGGEFFRALQTRPGKCIPEDDARFYAAEVTAAL 355
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT--SCKPQLLLPTTNEKKRRHKGQ 842
EYLH G IYRDLKPEN+LL +GH+ L+DFDLS + KP +++ K
Sbjct: 356 EYLHLMGFIYRDLKPENILLHQSGHIMLSDFDLSKQSDPGGKPTMII-----GKNGTSTS 410
Query: 843 QNPVFMAEPMRA---SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
P + A +NSFVGTEEYIAPE+I G+GHTSAVDWW LGIL+YEMLYG TPF+
Sbjct: 411 SLPTIDTKSCIANFRTNSFVGTEEYIAPEVIKGSGHTSAVDWWTLGILIYEMLYGTTPFK 470
Query: 900 GKTRQKTFANILHKDLKFP 918
GK R TFANIL +D+ FP
Sbjct: 471 GKNRNATFANILREDIPFP 489
|
Controls entry of the cell into the asexual developmental program. Required to repress entry into the conidiation program. Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) (taxid: 367110) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 934 | ||||||
| 225435157 | 1004 | PREDICTED: phototropin-1-like [Vitis vin | 0.981 | 0.913 | 0.795 | 0.0 | |
| 297746173 | 958 | unnamed protein product [Vitis vinifera] | 0.941 | 0.917 | 0.783 | 0.0 | |
| 224055599 | 977 | predicted protein [Populus trichocarpa] | 0.961 | 0.919 | 0.781 | 0.0 | |
| 401782496 | 1028 | phototropin 1 [Fragaria x ananassa] | 0.968 | 0.880 | 0.757 | 0.0 | |
| 255582071 | 1006 | serine/threonine protein kinase, putativ | 0.975 | 0.905 | 0.765 | 0.0 | |
| 350535803 | 1018 | phototropin-1 [Solanum lycopersicum] gi| | 0.966 | 0.887 | 0.733 | 0.0 | |
| 449460993 | 952 | PREDICTED: phototropin-1-like [Cucumis s | 0.866 | 0.849 | 0.813 | 0.0 | |
| 60099454 | 976 | phototropin [Phaseolus vulgaris] | 0.955 | 0.913 | 0.734 | 0.0 | |
| 356542583 | 977 | PREDICTED: phototropin-1-like [Glycine m | 0.956 | 0.914 | 0.739 | 0.0 | |
| 15231245 | 996 | non-specific serine/threonine protein ki | 0.971 | 0.910 | 0.733 | 0.0 |
| >gi|225435157|ref|XP_002281752.1| PREDICTED: phototropin-1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1504 bits (3894), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 747/939 (79%), Positives = 824/939 (87%), Gaps = 22/939 (2%)
Query: 2 DQSEKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQRESPE 61
D S KSP + PL RDSRGSLEVFNPST+STRPTN FRPQPTW++W E R +PE
Sbjct: 5 DDSAKSP-----SLIPPLPRDSRGSLEVFNPSTYSTRPTNQAFRPQPTWKSWAEPRGTPE 59
Query: 62 PEHA-KLNSKSSR-AEEITSWMALKDPAPQ------KPSLPPLIQKMTNDQEKSTVTKQL 113
E + +L+SKS R A+EITSWMALK+P+P + S+ P + ++K T QL
Sbjct: 60 REGSPELSSKSGRSADEITSWMALKEPSPAPPLPLAQKSVSPAFNVQDDTRQKPTRKTQL 119
Query: 114 SGEAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGE 173
SGE AAQRAAEWGL+LKTDTETGKPQ V RTSGGD+PN K GTSRRNS NSVRSSGE
Sbjct: 120 SGEVDNAAQRAAEWGLMLKTDTETGKPQGVAVRTSGGDEPNYKTGTSRRNSGNSVRSSGE 179
Query: 174 MSDEGG--KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKE 231
MSDEGG K++ PRVS+ +KDALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGYTSKE
Sbjct: 180 MSDEGGAGKDRAFPRVSEDLKDALSTFQQTFVVSDATKPDYPILYASAGFFKMTGYTSKE 239
Query: 232 VVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEG 291
V+GRNCRFLQG+GTDPEDVAKIRE L G SYCGRLLNYKKDGTPFWNLLTI+PIKD+ G
Sbjct: 240 VIGRNCRFLQGSGTDPEDVAKIREALHAGNSYCGRLLNYKKDGTPFWNLLTISPIKDENG 299
Query: 292 KVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS 351
VLKFIGMQVEVSKHTEG+K+KM RPNGLPESLIRYDARQK+MAT+SV+ELVQA+KKPRS
Sbjct: 300 NVLKFIGMQVEVSKHTEGSKEKMTRPNGLPESLIRYDARQKDMATNSVSELVQAVKKPRS 359
Query: 352 LSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKK 411
LSES++RP +RKSE G E+ER A GRR SE+V PPRRNS G R SMQRISE+PEKK
Sbjct: 360 LSESSDRP-FMRKSEDG-EQERPEAPGRRNSESVAPPRRNSQSGR-RASMQRISELPEKK 416
Query: 412 KQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKG 471
+KS R SFM ++ RKSQ+ + F+ E++++ D DDERPDS+D+K RQ+EMR+G
Sbjct: 417 PRKSSRLSFMRIM-RKSQAHTEE--FDTEVLVD-DTSDSEDDERPDSIDNKTRQREMRRG 472
Query: 472 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPA 531
IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPA
Sbjct: 473 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPA 532
Query: 532 TVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 591
TVRKIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH+E
Sbjct: 533 TVRKIREAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHVE 592
Query: 592 PLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSP 651
PL N IPE+TA+ES KLVK+TAEN+++AV+ELPDANL PEDLW+NHSKVV PKPHRK+S
Sbjct: 593 PLHNCIPESTAKESAKLVKETAENIDDAVRELPDANLKPEDLWSNHSKVVLPKPHRKESS 652
Query: 652 PWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN 711
WKAIQKIL+ GEQI L+HFRP+KPLGSGDTGSVHLVELCG+G+YFAMKAMDK VMLNRN
Sbjct: 653 AWKAIQKILEDGEQIGLKHFRPVKPLGSGDTGSVHLVELCGTGEYFAMKAMDKNVMLNRN 712
Query: 712 KVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
KVHRACAEREILDMLDHPF+PALYASFQTKTH+CLITDYCPGGELFLLLDRQPTKVLKED
Sbjct: 713 KVHRACAEREILDMLDHPFLPALYASFQTKTHICLITDYCPGGELFLLLDRQPTKVLKED 772
Query: 772 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831
AVRFYAAEVVVALEYLHCQG+IYRDLKPENVLLQ +GHV+LTDFDLSCLTSCKPQLL+P
Sbjct: 773 AVRFYAAEVVVALEYLHCQGVIYRDLKPENVLLQSSGHVALTDFDLSCLTSCKPQLLMPN 832
Query: 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891
TNEKKR+HKGQQNP+FMAEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEM
Sbjct: 833 TNEKKRQHKGQQNPIFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEM 892
Query: 892 LYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANV 930
LYGYTPFRGKTRQKTFANILHKDLKFPSS S A +
Sbjct: 893 LYGYTPFRGKTRQKTFANILHKDLKFPSSISVSLNAKQL 931
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297746173|emb|CBI16229.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1464 bits (3790), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 729/931 (78%), Positives = 798/931 (85%), Gaps = 52/931 (5%)
Query: 2 DQSEKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQRESPE 61
D S KSP + PL RDSRGSLEVFNPST+STRPTN FRPQPTW++W E R S
Sbjct: 5 DDSAKSP-----SLIPPLPRDSRGSLEVFNPSTYSTRPTNQAFRPQPTWKSWAEPRRS-- 57
Query: 62 PEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAA 121
A+EITSWMALK+P+ +KS
Sbjct: 58 ------------ADEITSWMALKEPS---------PAPPLPLAQKS-------------- 82
Query: 122 QRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGG-- 179
RAAEWGL+LKTDTETGKPQ V RTSGGD+PN K GTSRRNS NSVRSSGEMSDEGG
Sbjct: 83 -RAAEWGLMLKTDTETGKPQGVAVRTSGGDEPNYKTGTSRRNSGNSVRSSGEMSDEGGAG 141
Query: 180 KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRF 239
K++ PRVS+ +KDALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGYTSKEV+GRNCRF
Sbjct: 142 KDRAFPRVSEDLKDALSTFQQTFVVSDATKPDYPILYASAGFFKMTGYTSKEVIGRNCRF 201
Query: 240 LQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGM 299
LQG+GTDPEDVAKIRE L G SYCGRLLNYKKDGTPFWNLLTI+PIKD+ G VLKFIGM
Sbjct: 202 LQGSGTDPEDVAKIREALHAGNSYCGRLLNYKKDGTPFWNLLTISPIKDENGNVLKFIGM 261
Query: 300 QVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRP 359
QVEVSKHTEG+K+KM RPNGLPESLIRYDARQK+MAT+SV+ELVQA+KKPRSLSES++RP
Sbjct: 262 QVEVSKHTEGSKEKMTRPNGLPESLIRYDARQKDMATNSVSELVQAVKKPRSLSESSDRP 321
Query: 360 PIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRS 419
+RKSE G E+ER A GRR SE+V PPRRNS G R SMQRISE+PEKK +KS R S
Sbjct: 322 -FMRKSEDG-EQERPEAPGRRNSESVAPPRRNSQSGR-RASMQRISELPEKKPRKSSRLS 378
Query: 420 FMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLE 479
FM ++ RKSQ+ + F+ E++++ D DDERPDS+D+K RQ+EMR+GIDLATTLE
Sbjct: 379 FMRIM-RKSQAHTEE--FDTEVLVD-DTSDSEDDERPDSIDNKTRQREMRRGIDLATTLE 434
Query: 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 539
RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR A
Sbjct: 435 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIREA 494
Query: 540 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPE 599
IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH+EPL N IPE
Sbjct: 495 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHVEPLHNCIPE 554
Query: 600 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 659
+TA+ES KLVK+TAEN+++AV+ELPDANL PEDLW+NHSKVV PKPHRK+S WKAIQKI
Sbjct: 555 STAKESAKLVKETAENIDDAVRELPDANLKPEDLWSNHSKVVLPKPHRKESSAWKAIQKI 614
Query: 660 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 719
L+ GEQI L+HFRP+KPLGSGDTGSVHLVELCG+G+YFAMKAMDK VMLNRNKVHRACAE
Sbjct: 615 LEDGEQIGLKHFRPVKPLGSGDTGSVHLVELCGTGEYFAMKAMDKNVMLNRNKVHRACAE 674
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
REILDMLDHPF+PALYASFQTKTH+CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE
Sbjct: 675 REILDMLDHPFLPALYASFQTKTHICLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 734
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
VVVALEYLHCQG+IYRDLKPENVLLQ +GHV+LTDFDLSCLTSCKPQLL+P TNEKKR+H
Sbjct: 735 VVVALEYLHCQGVIYRDLKPENVLLQSSGHVALTDFDLSCLTSCKPQLLMPNTNEKKRQH 794
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
KGQQNP+FMAEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 795 KGQQNPIFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 854
Query: 900 GKTRQKTFANILHKDLKFPSSTPSSCKAANV 930
GKTRQKTFANILHKDLKFPSS S A +
Sbjct: 855 GKTRQKTFANILHKDLKFPSSISVSLNAKQL 885
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224055599|ref|XP_002298559.1| predicted protein [Populus trichocarpa] gi|222845817|gb|EEE83364.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1448 bits (3748), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 732/937 (78%), Positives = 800/937 (85%), Gaps = 39/937 (4%)
Query: 1 MDQSEKSPKQSSKACESPLSRDSRGSLEVFNPST-FSTRPTNPVFRP-QPTWQTWMEQ-- 56
M+ ++KS KQSS PL RDSRGSLEVFNPS+ + RPTNP FR PTW++W++
Sbjct: 1 MEATDKSSKQSSGNV-PPLPRDSRGSLEVFNPSSAYLNRPTNPAFRSSNPTWKSWVDSSA 59
Query: 57 RESPEPEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGE 116
+ PEPE A + TSWMALKDP +KP +QLSGE
Sbjct: 60 KNEPEPEEAPIT---------TSWMALKDP--KKPK------------------QQLSGE 90
Query: 117 AGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSD 176
G A +RAAEWGLVLKTD ETGKPQ V RTSGGDDPN KPGTSRR+SNNSVR+SGE+SD
Sbjct: 91 IGVATKRAAEWGLVLKTDDETGKPQGVSVRTSGGDDPNAKPGTSRRDSNNSVRNSGELSD 150
Query: 177 EGG--KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVG 234
+GG +PRVS+ +++ALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGYTSKEV+G
Sbjct: 151 DGGTSNNSNIPRVSEDIRNALSTFQQTFVVSDATKPDYPILYASAGFFKMTGYTSKEVIG 210
Query: 235 RNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVL 294
RNCRFLQGAGTDPEDVAKIRE L+ +YCGRLLNYKKDG+PFWNLLTIAPIKDD GKVL
Sbjct: 211 RNCRFLQGAGTDPEDVAKIREALRGEGTYCGRLLNYKKDGSPFWNLLTIAPIKDDSGKVL 270
Query: 295 KFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSE 354
KFIGM VEVSKHTEG+KDK LRPNGLP SLIRYDARQKEMATSSVTELVQA+ +PR+LSE
Sbjct: 271 KFIGMLVEVSKHTEGSKDKTLRPNGLPGSLIRYDARQKEMATSSVTELVQAVNRPRALSE 330
Query: 355 STNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQK 414
STNRP ++RKSEGG E ER GA+GRR SENV P RRNS+ G R SMQRISE+PEKK +K
Sbjct: 331 STNRP-LMRKSEGGGEGERKGAIGRRNSENVAPNRRNSHRG-TRNSMQRISELPEKKPRK 388
Query: 415 SGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDL 474
S R SFMGL+ + + S D+ + + + D + DD R DS+DDKVR+KEMRKGIDL
Sbjct: 389 SSRLSFMGLMRKSTHSNDESFDVGITLDDDFESDDDDDDARLDSLDDKVRKKEMRKGIDL 448
Query: 475 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR 534
ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR
Sbjct: 449 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR 508
Query: 535 KIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLR 594
KIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH+EP
Sbjct: 509 KIREAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHVEPRT 568
Query: 595 NSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWK 654
NSIPEATA ESE+LVKQTAENV++A +ELPDAN+ PEDLWANHSKVV+PKPHRKDSP WK
Sbjct: 569 NSIPEATAIESEQLVKQTAENVDDAARELPDANMRPEDLWANHSKVVYPKPHRKDSPSWK 628
Query: 655 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 714
AIQKIL+SGEQ+ L+HFRP+KPLGSGDTGSVHLVEL G+GQ+FAMK MDK MLNRNKVH
Sbjct: 629 AIQKILESGEQLGLKHFRPVKPLGSGDTGSVHLVELYGTGQFFAMKTMDKAAMLNRNKVH 688
Query: 715 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVR 774
RACAEREILDMLDHPF+PALYASFQTKTH+CLITDYCPGGELFLLLDRQP KVLKEDAVR
Sbjct: 689 RACAEREILDMLDHPFLPALYASFQTKTHICLITDYCPGGELFLLLDRQPKKVLKEDAVR 748
Query: 775 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
FYAAEVV+ALEYLHCQGIIYRDLKPENVLLQ NGHV+LTDFDLSCLTSCKPQLL+P+TNE
Sbjct: 749 FYAAEVVIALEYLHCQGIIYRDLKPENVLLQSNGHVALTDFDLSCLTSCKPQLLIPSTNE 808
Query: 835 KKRRHKGQQN-PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 893
KKR K QQ PVFMAEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLY
Sbjct: 809 KKRHRKHQQAPPVFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLY 868
Query: 894 GYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANV 930
GYTPFRGKTRQKTFANILHKDLKFP S P S A +
Sbjct: 869 GYTPFRGKTRQKTFANILHKDLKFPGSIPVSLNAKQL 905
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|401782496|dbj|BAM36551.1| phototropin 1 [Fragaria x ananassa] | Back alignment and taxonomy information |
|---|
Score = 1413 bits (3658), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 718/948 (75%), Positives = 789/948 (83%), Gaps = 43/948 (4%)
Query: 18 PLSRDSRGSLEVFNPSTFSTRPTNPV-FRPQ--PTWQTWMEQRES-----PEPEHAKLNS 69
PL RDSRGSLE+FNPS STRP +P FR TW+TW++ R++ S
Sbjct: 16 PLPRDSRGSLEIFNPS--STRPASPPPFRQSKPATWKTWLDPRDTLNPKPDPSPPPIPAS 73
Query: 70 KSSRAE-EITSWMALKD----------PAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAG 118
KS R + ITSWMALKD P+ Q PP IQ+ + V + + E G
Sbjct: 74 KSGRDDGTITSWMALKDFPPTPPPPSKPSKQSQQAPPYIQQQQTIS--AAVNDKSTPEHG 131
Query: 119 AAAQRAAEWGLVLKTDTETGKPQAVVARTSGG-DDPNGKPGTSRRNSNNSVRSSGEMSDE 177
AAQRAAEWGLVLKTDTETGKPQ V R SGG +DP+ KPGTSRRNSNNSVRSSGE+SD+
Sbjct: 132 DAAQRAAEWGLVLKTDTETGKPQGVTTRNSGGPEDPSHKPGTSRRNSNNSVRSSGELSDD 191
Query: 178 GGKEKG----LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVV 233
GG G PRVS+ +K+ LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+
Sbjct: 192 GGGGGGIGKGFPRVSEDLKNVLSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVI 251
Query: 234 GRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKV 293
GRNCRFLQGA TDPEDVA++RE L SYCGRLLNYKKDGTPFWNLLTIAPIKD+ GKV
Sbjct: 252 GRNCRFLQGADTDPEDVAQLREALAKNTSYCGRLLNYKKDGTPFWNLLTIAPIKDETGKV 311
Query: 294 LKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLS 353
LKFIGMQVEVSKHTEG+KDKMLRPNGLPESLIRYDARQKE AT SVTELVQA+++PRSLS
Sbjct: 312 LKFIGMQVEVSKHTEGSKDKMLRPNGLPESLIRYDARQKEKATHSVTELVQAVRRPRSLS 371
Query: 354 ESTNRPPIIRKSEGGVEEER---------AGALGRRKSENVPPPRRNSYGGGCRTSMQRI 404
ESTNRP RKS GG E + +L RR SE+V PPRRNS G SM I
Sbjct: 372 ESTNRP--FRKSGGGGRGEEVIEAHARPSSESLPRRNSESVAPPRRNSLGD-ANFSMHSI 428
Query: 405 SEVPEKKKQKSGRRSFMGLIGRKSQSTD--DHDSFENEIIMEGDDDYESDDERPDSVDDK 462
EVPEKK++K RRSFMG++ +KSQ+ + D D+F+ E D +DERP S+DDK
Sbjct: 429 KEVPEKKQKKPRRRSFMGIM-KKSQTQNQLDDDTFDEFGASEDVRDDSDNDERPMSLDDK 487
Query: 463 VRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF 522
VR+KEMRKG+DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF
Sbjct: 488 VRKKEMRKGMDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF 547
Query: 523 LQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 582
LQGPETDPATV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQKGEVQYFIGV
Sbjct: 548 LQGPETDPATVKKIREAIDNQTEVTVQLINYTKSGKKFWNVFHLQPMRDQKGEVQYFIGV 607
Query: 583 QLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVH 642
QLDGS+H+EPL+NSIPE A+ESEKLVK+TA NV+EA +ELPDAN+ PEDLW NHSKVVH
Sbjct: 608 QLDGSQHIEPLQNSIPEVAAKESEKLVKETAVNVDEAARELPDANMKPEDLWMNHSKVVH 667
Query: 643 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 702
PKPHRKDSPPW AIQKILDSGEQI L+HF+PIKPLGSGDTGSVHLV+LCG+ QYFAMKAM
Sbjct: 668 PKPHRKDSPPWIAIQKILDSGEQIGLKHFKPIKPLGSGDTGSVHLVQLCGTDQYFAMKAM 727
Query: 703 DKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR 762
DK +MLNRNKVHRACAEREILDMLDHPF+PALYASFQTKTHVCLITDY PGGELFLLLD
Sbjct: 728 DKNIMLNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHVCLITDYYPGGELFLLLDT 787
Query: 763 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822
QPTKVLKE++VRFY AEVVVALEYLHCQGIIYRDLKPENVLLQ NGHV+LTDFDLSCLTS
Sbjct: 788 QPTKVLKENSVRFYVAEVVVALEYLHCQGIIYRDLKPENVLLQSNGHVTLTDFDLSCLTS 847
Query: 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882
CKPQLLLPT NEKKR HK Q +P+FMAEPMRASNSFVGTEEYIAPEII GAGH+SAVDWW
Sbjct: 848 CKPQLLLPTINEKKRHHKRQHDPIFMAEPMRASNSFVGTEEYIAPEIITGAGHSSAVDWW 907
Query: 883 ALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANV 930
ALGIL+YEMLYGYTPFRGKTRQKTFANILHKDLKFP S P+S +A +
Sbjct: 908 ALGILIYEMLYGYTPFRGKTRQKTFANILHKDLKFPGSIPASLQAKQL 955
|
Source: Fragaria x ananassa Species: Fragaria x ananassa Genus: Fragaria Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255582071|ref|XP_002531832.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223528528|gb|EEF30552.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1385 bits (3586), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 724/946 (76%), Positives = 804/946 (84%), Gaps = 35/946 (3%)
Query: 3 QSEKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPT-NPVFRPQPTWQTWMEQ-RESP 60
+S S KQS +PL RD RGSLEVFNPS+ S+ + N +RP W+TW+E+ + P
Sbjct: 6 RSSSSNKQSPPVI-TPLPRDPRGSLEVFNPSSTSSTRSTNLAYRPNTNWKTWVEKPHDGP 64
Query: 61 EPEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLI-----QKMTNDQEKSTVTKQLSG 115
+ KS RAEE T+WMA+KDPAP P+LP L Q + NDQ+K+ T +LSG
Sbjct: 65 NTQSP---PKSGRAEEATTWMAIKDPAPS-PTLPLLSSPSHSQLIGNDQDKNPAT-ELSG 119
Query: 116 EAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPN-GKPGTSRRNSNNSVRSSG-E 173
EA AA+RAAEWGLVLK +T+ GKPQ V R+SGGD+PN KPGTSRRNSNNSV+SSG +
Sbjct: 120 EAEMAARRAAEWGLVLKPETQEGKPQVGV-RSSGGDEPNSNKPGTSRRNSNNSVQSSGGD 178
Query: 174 MS-DEGGKE-KGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKE 231
+S D+GGKE KG+PRVS+ +K+ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKE
Sbjct: 179 LSEDDGGKENKGIPRVSEDIKNALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKE 238
Query: 232 VVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEG 291
V+GRNCRFLQGA TDPEDVAKIRE LQ+ SYCGRLLNYKKDGTPFWNLLTI+PIKD+ G
Sbjct: 239 VIGRNCRFLQGADTDPEDVAKIREALQSENSYCGRLLNYKKDGTPFWNLLTISPIKDESG 298
Query: 292 KVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS 351
KVLK+IGMQVEVSK TEG+KDKMLRPNGLPESLIRYDARQKEMATSSVTELVQA+K+PRS
Sbjct: 299 KVLKYIGMQVEVSKFTEGSKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAVKRPRS 358
Query: 352 LSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKK 411
LSE+T+RP ++RKSE G E+ER GALGRR SENVP RRNS GG R SMQ I+E+PEKK
Sbjct: 359 LSEATSRP-LMRKSESGGEDERKGALGRRNSENVPSNRRNSLGGA-RNSMQSINELPEKK 416
Query: 412 KQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDE------RPDSVDDKVRQ 465
+KS R SFMGL+ +KS + + DSF++ +I+ GDDD DDE RP+SVDDKVR+
Sbjct: 417 PRKSIRLSFMGLM-KKSSTQSNADSFDDALILNGDDDDVDDDEESEIDERPNSVDDKVRK 475
Query: 466 KEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQG 525
KEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQG
Sbjct: 476 KEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQG 535
Query: 526 PETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
PETDPATVRKIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD
Sbjct: 536 PETDPATVRKIREAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 595
Query: 586 GSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKP 645
GSEH+EP N IPE TA+ESEKLVKQTAENV+EAV+ELPDAN PEDLWANHSK VH KP
Sbjct: 596 GSEHVEPRSNCIPEETAQESEKLVKQTAENVDEAVRELPDANSKPEDLWANHSKAVHAKP 655
Query: 646 HRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 705
HRKD+P WKAIQKILD GE I L+HFRP+KPLGSGDTGSVHLVEL G+ +FAMKAMDK
Sbjct: 656 HRKDTPSWKAIQKILDDGEPIGLKHFRPVKPLGSGDTGSVHLVELSGTDHHFAMKAMDKN 715
Query: 706 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 765
VMLNRNKVHRACAEREILDMLDHPF+PALYASFQTKTH+CLITDYC GGELF+LLDRQPT
Sbjct: 716 VMLNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHICLITDYCSGGELFMLLDRQPT 775
Query: 766 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825
KVLKEDA RFYAAEVV+ALEYLHCQGIIYRDLKPENVLLQ +GHVSLTDFDLSCLTSCKP
Sbjct: 776 KVLKEDAARFYAAEVVIALEYLHCQGIIYRDLKPENVLLQSSGHVSLTDFDLSCLTSCKP 835
Query: 826 QLLLPTTNEKKR-RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 884
QLL+PT +EKK+ R QQ+P+FMAEPMRASNSFVGTEEYIAP +I +A
Sbjct: 836 QLLIPTVDEKKKHRKHHQQDPIFMAEPMRASNSFVGTEEYIAPVLIFHF-------IFAT 888
Query: 885 GILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANV 930
GILLYEMLYGYTPFRGKTRQKTFAN+LHKDLKFP S S A +
Sbjct: 889 GILLYEMLYGYTPFRGKTRQKTFANVLHKDLKFPRSRQVSLHAKQL 934
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350535803|ref|NP_001234214.1| phototropin-1 [Solanum lycopersicum] gi|151176133|gb|ABN42185.2| phototropin-1 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 1371 bits (3548), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 692/943 (73%), Positives = 769/943 (81%), Gaps = 40/943 (4%)
Query: 18 PLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWM-----------------EQRESP 60
PL RD RGSLEVFNPST+S+R TNPVFR QP+W+ W EQ P
Sbjct: 13 PLPRDPRGSLEVFNPSTYSSRSTNPVFRSQPSWKNWTAADPITRSTIPETEEKTEQIAIP 72
Query: 61 EPEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAA 120
+ K+N + W L+ Q+ L L++ + +K E GAA
Sbjct: 73 QIRVTKMNKSL-----LHGWQLLR---LQRNWLLRLLKNQLPVVRRFN-SKAAVDEVGAA 123
Query: 121 AQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEG-G 179
AQRAAEWGLVLKTD ETGK Q V RTSG DD NGK TSRR+S NS RSSGE SD+G G
Sbjct: 124 AQRAAEWGLVLKTDDETGKLQGVKVRTSG-DDTNGKTETSRRDSGNSGRSSGEFSDDGAG 182
Query: 180 KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRF 239
KE+G+PRVS+ ++DALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGYTSKEV+GRNCRF
Sbjct: 183 KERGIPRVSEDLRDALSTFQQTFVVSDATKPDYPILYASAGFFKMTGYTSKEVIGRNCRF 242
Query: 240 LQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGM 299
+QG+GTDPEDVA IRE LQ+G +YCGRLLNYKKDGTPFWNLLTIAPIKDD GKVLKFIGM
Sbjct: 243 MQGSGTDPEDVATIREALQSGSTYCGRLLNYKKDGTPFWNLLTIAPIKDDAGKVLKFIGM 302
Query: 300 QVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPR---SLSEST 356
QVEVSKHTEG+K+K +RPNGLPESLIRYD RQKEMA++SV EL++ +K PR +LSEST
Sbjct: 303 QVEVSKHTEGSKEKTVRPNGLPESLIRYDVRQKEMASNSVNELLEEIKNPRRARALSEST 362
Query: 357 N-RPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSM--QRISEVPEKKKQ 413
N RP +RKSEG E+ + N P RR+S+ G T+M ++I+EVPEKK +
Sbjct: 363 NNRPTFMRKSEGDQVEQDKQDTHKLNLVNKAPARRHSHAGTRTTTMKMEKINEVPEKKPK 422
Query: 414 KSGRRSFMGLIGRKSQSTDDHDS---FENEIIMEGDDDYESDDE---RPDSVDDKVRQKE 467
KS R SFMG++ +K ST FE + M+ DDD + + + RP SVDDKVR+KE
Sbjct: 423 KSARLSFMGIMKKKRSSTTMTTDDDDFEARMTMDNDDDDDDESDNDGRPVSVDDKVRKKE 482
Query: 468 MRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE 527
MRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE
Sbjct: 483 MRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE 542
Query: 528 TDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587
TDPATV+KIR AIDNQTDVTVQLINYTK+GKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS
Sbjct: 543 TDPATVKKIRQAIDNQTDVTVQLINYTKTGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 602
Query: 588 EHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHR 647
+H+EPL+NSIPE A ES KL+K+TA NV+EAV+ELPDAN PEDLW NHSKVV PKPHR
Sbjct: 603 QHVEPLQNSIPEDKATESAKLIKETAGNVDEAVRELPDANSKPEDLWRNHSKVVQPKPHR 662
Query: 648 KDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM 707
KDSP WKAIQKIL+SGE I L+HF+PIKPLGSGDTGSVHLVELCG+ Q+FAMKAMDK +M
Sbjct: 663 KDSPSWKAIQKILESGEPIGLKHFKPIKPLGSGDTGSVHLVELCGTDQHFAMKAMDKSIM 722
Query: 708 LNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 767
LNRNKVHRACAEREILDMLDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQ TKV
Sbjct: 723 LNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQQTKV 782
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827
LKEDA RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ GHVSLTDFDLSCLTSCKPQL
Sbjct: 783 LKEDAARFYAAEVVVALEYLHCQGIIYRDLKPENVLLQSGGHVSLTDFDLSCLTSCKPQL 842
Query: 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 887
L+P NEKK+ KGQ NP+FMAEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGIL
Sbjct: 843 LVPEINEKKKHQKGQHNPIFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGIL 902
Query: 888 LYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANV 930
LYEMLYGYTPFRGKTRQKTF+NILHKDLKFP S SS A +
Sbjct: 903 LYEMLYGYTPFRGKTRQKTFSNILHKDLKFPGSIQSSLHAKQL 945
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460993|ref|XP_004148228.1| PREDICTED: phototropin-1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1369 bits (3543), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 680/836 (81%), Positives = 730/836 (87%), Gaps = 27/836 (3%)
Query: 116 EAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSG-EM 174
E G+AA RAAEWGLVLKTDTETGKPQ V RTSGGD+PN K SRR SNNSVRSSG EM
Sbjct: 49 EVGSAALRAAEWGLVLKTDTETGKPQGVGVRTSGGDEPNTKQENSRRTSNNSVRSSGDEM 108
Query: 175 SDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVG 234
S+EGG+E+G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+G
Sbjct: 109 SEEGGRERGIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVIG 168
Query: 235 RNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVL 294
RNCRFLQGA TDPEDVAKIRE LQ G SYCGRLLNYKKDGTPFWNLLTI+PIKDD+GKVL
Sbjct: 169 RNCRFLQGADTDPEDVAKIREALQAGTSYCGRLLNYKKDGTPFWNLLTISPIKDDDGKVL 228
Query: 295 KFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSE 354
K IGMQVEVSKHTEG KDKM+RPNGLPESLIRYDARQKEMATSSVTELVQA+K+PRSLSE
Sbjct: 229 KLIGMQVEVSKHTEGFKDKMVRPNGLPESLIRYDARQKEMATSSVTELVQAVKRPRSLSE 288
Query: 355 --------STNRPPIIRKSEGGVEEERAG----------ALGRRKSENVPPPRRNSYGGG 396
S NR + RKS GG G + RRKSE+ P GG
Sbjct: 289 YRPRALSESMNRR-LFRKSGGGGGGGEGGGKDEKDKLEPTMVRRKSESAAAPAGRRSQGG 347
Query: 397 CRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDE-- 454
R SMQRI+EVP+KK +KS RSFMG++ RKSQS + +SF+ I EG DD D+
Sbjct: 348 SRRSMQRINEVPDKKPKKSSHRSFMGIM-RKSQSNVE-ESFD---IEEGSDDENESDDDV 402
Query: 455 RPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREE 514
RPDSVDDKVRQ+EMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREE
Sbjct: 403 RPDSVDDKVRQREMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREE 462
Query: 515 ILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKG 574
ILGRNCRFLQGPETD TV+KIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKG
Sbjct: 463 ILGRNCRFLQGPETDRTTVKKIRDAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKG 522
Query: 575 EVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLW 634
EVQYFIGVQLDGS+H+EPL N I E+TA+E EKL+K+TAENV+ A +ELPDANLTPEDLW
Sbjct: 523 EVQYFIGVQLDGSQHVEPLSNCIAESTAKEGEKLIKETAENVDLAARELPDANLTPEDLW 582
Query: 635 ANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSG 694
ANHSK+V PKPHRKDSP W+AIQKILD GEQI L+HF+P+KPLGSGDTGSVHLVELCG+
Sbjct: 583 ANHSKLVQPKPHRKDSPSWQAIQKILDGGEQIGLKHFKPVKPLGSGDTGSVHLVELCGTD 642
Query: 695 QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 754
QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF+PALYASFQTKTHVCLITDYCPGG
Sbjct: 643 QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHVCLITDYCPGG 702
Query: 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 814
ELFLLLDRQPTKV+KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ NGHV+LTD
Sbjct: 703 ELFLLLDRQPTKVIKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQSNGHVALTD 762
Query: 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 874
FDLSCLTSCKPQLLLP NEKK++ K QQ P+FMAEPMRASNSFVGTEEYIAPEII GAG
Sbjct: 763 FDLSCLTSCKPQLLLPAANEKKKQSKTQQTPIFMAEPMRASNSFVGTEEYIAPEIITGAG 822
Query: 875 HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANV 930
HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP S +S A +
Sbjct: 823 HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPRSISASLNAKQL 878
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|60099454|dbj|BAD89966.1| phototropin [Phaseolus vulgaris] | Back alignment and taxonomy information |
|---|
Score = 1366 bits (3536), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 674/918 (73%), Positives = 760/918 (82%), Gaps = 26/918 (2%)
Query: 21 RDSRGSLEVFNPSTFSTRPTNPVFRP---QPTWQTWMEQRESPEPEHAKLNSKSSRAEEI 77
RD RGSLEVFNPS+ S PV P Q TW+TW++ R +PE + + +E+
Sbjct: 6 RDQRGSLEVFNPSSSSYSNEKPVISPLRTQSTWKTWVDSRVEEQPEKQQ---RGGGPDEV 62
Query: 78 T--SWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRAAEWGLVLKTDT 135
T SWMALKD P PS Q + V + E G AA+RAAEWGLVLKTDT
Sbjct: 63 TATSWMALKDSTPPPPS-----------QTLAAVLGEPPAEVGNAAKRAAEWGLVLKTDT 111
Query: 136 ETGKPQAVVARTSGGDDPNGK-PGTSRRNSNNSVRSSGEMSDEGGKEKG-LPRVSDIVKD 193
ETGKPQ V +TSGG++P K G SRR+S NSVRSSGE SD+G + +G +PRVS+ ++D
Sbjct: 112 ETGKPQGVAVQTSGGEEPGVKVTGGSRRDSGNSVRSSGESSDDGREYRGGIPRVSEDLRD 171
Query: 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 253
ALS FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+GRNCRF+QGA TDP+DVAKI
Sbjct: 172 ALSAFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVIGRNCRFMQGADTDPDDVAKI 231
Query: 254 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDK 313
RE LQ GQ+YCGRLLNYKKDGTPFWNLLTIAPIKD +G+VLKFIGMQVEVSKHTEG K+
Sbjct: 232 REALQTGQTYCGRLLNYKKDGTPFWNLLTIAPIKDHDGRVLKFIGMQVEVSKHTEGNKEN 291
Query: 314 MLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIRKSEGGVEEER 373
MLRPNGLPESLIRYDARQKE A SSV+EL+ A+++PR+LSES RP I + + G ++++
Sbjct: 292 MLRPNGLPESLIRYDARQKEKANSSVSELLLAVRRPRALSESGGRPLIRKSASGDDDQDK 351
Query: 374 AGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDD 433
RRKSE+V RR S+ G RTSM++I+E+PE K + S RRSFMG I RK+QS
Sbjct: 352 PEKSSRRKSESVASFRRKSHAGD-RTSMEKITEIPENKHKTSRRRSFMGFI-RKNQSK-- 407
Query: 434 HDSFENEIIMEGDDDYESDD-ERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRL 492
SF +E ++EG + +D ER S D KV++KE RKG+DLATTLERIEKNFVITDPRL
Sbjct: 408 FGSFNDEAVIEGSSESSDEDGERSGSFDGKVQRKEKRKGLDLATTLERIEKNFVITDPRL 467
Query: 493 PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552
PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR AID QTDVTVQLIN
Sbjct: 468 PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIREAIDTQTDVTVQLIN 527
Query: 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQT 612
YTK+GKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS+H+EPL N I E TA+E EKLVK T
Sbjct: 528 YTKTGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSQHVEPLHNRIAENTAKEGEKLVKDT 587
Query: 613 AENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFR 672
AENV++A++ELPDANL PEDLW NHSKVVHPKPHR+D WKAIQKIL+SGEQI L HF+
Sbjct: 588 AENVDDALRELPDANLKPEDLWMNHSKVVHPKPHRRDEAAWKAIQKILESGEQIGLNHFK 647
Query: 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 732
P+KPLGSGDTGSV+LVEL +GQYFAMKAM+KG+MLNRNKVHRAC EREILDMLDHPF+P
Sbjct: 648 PVKPLGSGDTGSVYLVELGETGQYFAMKAMEKGIMLNRNKVHRACTEREILDMLDHPFLP 707
Query: 733 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
ALYASFQTKTHVCLITDYC GGELFLLLDRQP KVL+EDAVRFYAAEVVVALEYLHCQGI
Sbjct: 708 ALYASFQTKTHVCLITDYCSGGELFLLLDRQPAKVLREDAVRFYAAEVVVALEYLHCQGI 767
Query: 793 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
IYRDLKPENVLLQ +GHVSLTDFDLSCLTSCKPQLL+P+ NEKK+ KG Q P+FMAEPM
Sbjct: 768 IYRDLKPENVLLQSSGHVSLTDFDLSCLTSCKPQLLVPSINEKKKAQKGHQPPIFMAEPM 827
Query: 853 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 912
RASNSFVGTEEYIAPEII G+GH+SAVDWWALGILLYEM +GYTPFRGKTRQ+TF NILH
Sbjct: 828 RASNSFVGTEEYIAPEIITGSGHSSAVDWWALGILLYEMFFGYTPFRGKTRQRTFTNILH 887
Query: 913 KDLKFPSSTPSSCKAANV 930
KDLKFP S S A +
Sbjct: 888 KDLKFPKSKQVSFSAKQL 905
|
Source: Phaseolus vulgaris Species: Phaseolus vulgaris Genus: Phaseolus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542583|ref|XP_003539746.1| PREDICTED: phototropin-1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1362 bits (3524), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 678/917 (73%), Positives = 770/917 (83%), Gaps = 24/917 (2%)
Query: 21 RDSRGSLEVFNPST-FST-RPTNPVFRPQPTWQTWMEQRESPEPEHAKLNSKSSRAEEIT 78
RD RGSLEVFNPS+ +ST + N R Q TW+TW++ E PE + + ++ T
Sbjct: 6 RDQRGSLEVFNPSSSYSTEKSVNSPVRVQSTWKTWID--ELPEQQQQQQCGGTNEVT-AT 62
Query: 79 SWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRAAEWGLVLKTDTETG 138
SWMALKD AP P+L ++ + + GE G AA+RAAEWGLVLKTDTETG
Sbjct: 63 SWMALKDSAPPPPTLAAVLGESLS---------AAVGEVGNAAKRAAEWGLVLKTDTETG 113
Query: 139 KPQAVVARTSGGDDPNGK-PGTSRRNSNNSVRSSGEMSDEGGKEKG-LPRVSDIVKDALS 196
KPQ V RTSGG++P+ K G SRR+S+NSVRSSGE SD+G + +G +PRVS+ ++DALS
Sbjct: 114 KPQGVKVRTSGGEEPSAKVTGGSRRDSSNSVRSSGESSDDGREYRGGIPRVSEDLRDALS 173
Query: 197 TFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRET 256
FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+GRNCRF+QGA TDP+DVAKIRE
Sbjct: 174 AFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVIGRNCRFMQGADTDPDDVAKIREA 233
Query: 257 LQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLR 316
LQ+G +YCGRLLNYKKDGTPFWNLLTIAPIKDD+G+VLKFIGMQVEVSKHTEGAK+KMLR
Sbjct: 234 LQSGSTYCGRLLNYKKDGTPFWNLLTIAPIKDDDGRVLKFIGMQVEVSKHTEGAKEKMLR 293
Query: 317 PNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIRKSEGG--VEEERA 374
PNGLPESLIRYDARQKE A S+V+EL+ A+++PR+LSES RP +I+KS G +++
Sbjct: 294 PNGLPESLIRYDARQKEKANSTVSELLLAVRRPRALSESAGRP-MIKKSASGDDAQDKPP 352
Query: 375 GALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDH 434
RRKSE+V RR S+ G R+SM+RI+E+PEKK + S RRSFMG I RKSQS +
Sbjct: 353 EKSSRRKSESVASFRRKSHAGD-RSSMERITELPEKKHKSSRRRSFMGFI-RKSQS--NF 408
Query: 435 DSFENEIIMEGDDDYESDDE-RPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLP 493
SF +E ++E + +D+ RP+S D KV++KE RKG+DLATTLERIEKNFVITDPRLP
Sbjct: 409 GSFNDEAVVENSSESSDEDDERPESFDGKVQKKEKRKGLDLATTLERIEKNFVITDPRLP 468
Query: 494 DNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553
DNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR AIDNQTDVTVQLINY
Sbjct: 469 DNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIREAIDNQTDVTVQLINY 528
Query: 554 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTA 613
TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS+H+EPL N I + TA+E E+LVK TA
Sbjct: 529 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSQHVEPLHNRIADDTAKEGEQLVKDTA 588
Query: 614 ENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRP 673
ENV++A++ELPDAN+ PEDLW NHSKVVHPKPHR+D WKAIQ+IL+SGEQI L HFRP
Sbjct: 589 ENVDDALRELPDANMKPEDLWMNHSKVVHPKPHRRDEAAWKAIQQILNSGEQIGLNHFRP 648
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
+KPLGSGDTGSV+LVEL +G YFAMKAM+KGVMLNRNKVHRAC EREILDMLDHPF+PA
Sbjct: 649 VKPLGSGDTGSVYLVELGETGHYFAMKAMEKGVMLNRNKVHRACTEREILDMLDHPFLPA 708
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
LYASFQTKTHVCLITDYC GGELFLLLDRQP KVL+EDAVRFYAAEVVVALEYLHCQGII
Sbjct: 709 LYASFQTKTHVCLITDYCSGGELFLLLDRQPAKVLREDAVRFYAAEVVVALEYLHCQGII 768
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLKPENVLLQ +GHVSLTDFDLSCLTSCKPQLL+P NEKK+ KG P+FMAEPMR
Sbjct: 769 YRDLKPENVLLQSSGHVSLTDFDLSCLTSCKPQLLVPVINEKKKAQKGPHAPIFMAEPMR 828
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
ASNSFVGTEEYIAPEII G+GHTSAVDWWALGILLYEM YGYTPFRGKTRQ+TF NILHK
Sbjct: 829 ASNSFVGTEEYIAPEIITGSGHTSAVDWWALGILLYEMFYGYTPFRGKTRQRTFTNILHK 888
Query: 914 DLKFPSSTPSSCKAANV 930
DLKFP S S A +
Sbjct: 889 DLKFPKSKQVSFSAKQL 905
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15231245|ref|NP_190164.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] gi|79314333|ref|NP_001030814.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] gi|25090817|sp|O48963.1|PHOT1_ARATH RecName: Full=Phototropin-1; AltName: Full=Non-phototropic hypocotyl protein 1; AltName: Full=Root phototropism protein 1 gi|13430612|gb|AAK25928.1|AF360218_1 putative nonphototropic hypocotyl 1 protein [Arabidopsis thaliana] gi|2832241|gb|AAC01753.1| nonphototropic hypocotyl 1 [Arabidopsis thaliana] gi|7019644|emb|CAB75791.1| nonphototropic hypocotyl 1 [Arabidopsis thaliana] gi|14532876|gb|AAK64120.1| putative nonphototropic hypocotyl 1 protein [Arabidopsis thaliana] gi|332644551|gb|AEE78072.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] gi|332644552|gb|AEE78073.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1350 bits (3495), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 691/942 (73%), Positives = 779/942 (82%), Gaps = 35/942 (3%)
Query: 5 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQP-TWQTWMEQRES---P 60
E + K S+K L RD+RGSLEVFNPST TRP NPVFRP+P WQ + R + P
Sbjct: 2 EPTEKPSTKPSSRTLPRDTRGSLEVFNPSTQLTRPDNPVFRPEPPAWQNLSDPRGTSPQP 61
Query: 61 EPEHAKLNSKSSRAEE----ITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGE 116
P+ S R+++ TSWMALKDP+P+ S +K+ ++
Sbjct: 62 RPQQEPAPSNPVRSDQEIAVTTSWMALKDPSPETIS------------KKTITAEKPQKS 109
Query: 117 AGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGG--DDPNGKPGTSRRNSNNSVRSSGEM 174
A AA QRAAEWGLVLKTDT+TGKPQ V R SGG +DPNGK TS+RNS NS RSSGEM
Sbjct: 110 AVAAEQRAAEWGLVLKTDTKTGKPQGVGVRNSGGTENDPNGKKTTSQRNSQNSCRSSGEM 169
Query: 175 SDEG--GKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV 232
SD G G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFF MTGYTSKEV
Sbjct: 170 SDGDVPGGRSGIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFNMTGYTSKEV 229
Query: 233 VGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGK 292
VGRNCRFLQG+GTD +++AKIRETL G +YCGR+LNYKKDGT FWNLLTIAPIKD+ GK
Sbjct: 230 VGRNCRFLQGSGTDADELAKIRETLAAGNNYCGRILNYKKDGTSFWNLLTIAPIKDESGK 289
Query: 293 VLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSL 352
VLKFIGMQVEVSKHTEGAK+K LRPNGLPESLIRYDARQK+MAT+SVTELV+A+K+PR+L
Sbjct: 290 VLKFIGMQVEVSKHTEGAKEKALRPNGLPESLIRYDARQKDMATNSVTELVEAVKRPRAL 349
Query: 353 SESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKK 412
SESTN P + KSE +E RR SENV P R + GGG R SMQRI+E+PEKK
Sbjct: 350 SESTNLHPFMTKSES---DELPKKPARRMSENVVPSGRRNSGGGRRNSMQRINEIPEKKS 406
Query: 413 QKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEG--DDDYESDDERPDSVDDKVRQKEMRK 470
+KS SFMG I +KS+S D+ S ++ I G DD+ DERP+SVDDKVRQKEMRK
Sbjct: 407 RKSSL-SFMG-IKKKSESLDE--SIDDGFIEYGEEDDEISDRDERPESVDDKVRQKEMRK 462
Query: 471 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDP 530
GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD
Sbjct: 463 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDL 522
Query: 531 ATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL 590
TV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQKGEVQYFIGVQLDGS+H+
Sbjct: 523 TTVKKIRNAIDNQTEVTVQLINYTKSGKKFWNIFHLQPMRDQKGEVQYFIGVQLDGSKHV 582
Query: 591 EPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDS 650
EP+RN I E +E E LVK+TA N++EAV+ELPDAN+TPEDLWANHSKVVH KPHRKDS
Sbjct: 583 EPVRNVIEETAVKEGEDLVKKTAVNIDEAVRELPDANMTPEDLWANHSKVVHCKPHRKDS 642
Query: 651 PPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 710
PPW AIQK+L+SGE I L+HF+P+KPLGSGDTGSVHLVEL G+ Q FAMKAMDK VMLNR
Sbjct: 643 PPWIAIQKVLESGEPIGLKHFKPVKPLGSGDTGSVHLVELVGTDQLFAMKAMDKAVMLNR 702
Query: 711 NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 770
NKVHRA AEREILD+LDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQP KVLKE
Sbjct: 703 NKVHRARAEREILDLLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQPRKVLKE 762
Query: 771 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830
DAVRFYAA+VVVALEYLHCQGIIYRDLKPENVL+QGNG +SL+DFDLSCLTSCKPQLL+P
Sbjct: 763 DAVRFYAAQVVVALEYLHCQGIIYRDLKPENVLIQGNGDISLSDFDLSCLTSCKPQLLIP 822
Query: 831 TTNE--KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888
+ +E KK++ K QQ P+FMAEPMRASNSFVGTEEYIAPEII+GAGHTSAVDWWALGIL+
Sbjct: 823 SIDEKKKKKQQKSQQTPIFMAEPMRASNSFVGTEEYIAPEIISGAGHTSAVDWWALGILM 882
Query: 889 YEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANV 930
YEMLYGYTPFRGKTRQKTF N+L KDLKFP+S P+S + +
Sbjct: 883 YEMLYGYTPFRGKTRQKTFTNVLQKDLKFPASIPASLQVKQL 924
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 934 | ||||||
| TAIR|locus:2102674 | 996 | PHOT1 "phototropin 1" [Arabido | 0.963 | 0.903 | 0.720 | 0.0 | |
| UNIPROTKB|Q8H935 | 963 | Vfphot1a "Phototropin" [Vicia | 0.936 | 0.908 | 0.675 | 0.0 | |
| UNIPROTKB|Q2QYY8 | 921 | PHOT1A "Phototropin-1A" [Oryza | 0.778 | 0.789 | 0.713 | 3.2e-294 | |
| UNIPROTKB|Q2RBR1 | 921 | PHOT1B "Phototropin-1B" [Oryza | 0.778 | 0.789 | 0.712 | 6.7e-294 | |
| TAIR|locus:2155821 | 915 | PHOT2 "phototropin 2" [Arabido | 0.603 | 0.616 | 0.647 | 4.4e-267 | |
| UNIPROTKB|Q9ST27 | 907 | PHOT2 "Phototropin-2" [Oryza s | 0.802 | 0.826 | 0.634 | 1.2e-257 | |
| UNIPROTKB|Q5I6E9 | 700 | Adi3 "AvrPto-dependent Pto-int | 0.226 | 0.302 | 0.483 | 7.5e-76 | |
| TAIR|locus:2087785 | 577 | AGC1.5 "AGC kinase 1.5" [Arabi | 0.251 | 0.407 | 0.433 | 2.7e-73 | |
| TAIR|locus:2174885 | 499 | AT5G40030 [Arabidopsis thalian | 0.211 | 0.396 | 0.505 | 1.2e-72 | |
| TAIR|locus:2055017 | 765 | AT2G44830 [Arabidopsis thalian | 0.267 | 0.326 | 0.434 | 7.4e-72 |
| TAIR|locus:2102674 PHOT1 "phototropin 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3358 (1187.1 bits), Expect = 0., P = 0.
Identities = 675/937 (72%), Positives = 754/937 (80%)
Query: 5 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQP-TWQTWMEQRES---P 60
E + K S+K L RD+RGSLEVFNPST TRP NPVFRP+P WQ + R + P
Sbjct: 2 EPTEKPSTKPSSRTLPRDTRGSLEVFNPSTQLTRPDNPVFRPEPPAWQNLSDPRGTSPQP 61
Query: 61 EPEHAKLNSKSSRAE-EI---TSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSXX 116
P+ S R++ EI TSWMALKDP+P+ I K T EK Q S
Sbjct: 62 RPQQEPAPSNPVRSDQEIAVTTSWMALKDPSPET------ISKKTITAEKP----QKSAV 111
Query: 117 XXXXXXXXXXWGLVLKTDTETGKPQAVVARTSGG--DDPNGKPGTXXXXXXXXXXXXGEM 174
WGLVLKTDT+TGKPQ V R SGG +DPNGK T GEM
Sbjct: 112 AAEQRAAE--WGLVLKTDTKTGKPQGVGVRNSGGTENDPNGKKTTSQRNSQNSCRSSGEM 169
Query: 175 SD---EGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKE 231
SD GG+ G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFF MTGYTSKE
Sbjct: 170 SDGDVPGGRS-GIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFNMTGYTSKE 228
Query: 232 VVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEG 291
VVGRNCRFLQG+GTD +++AKIRETL G +YCGR+LNYKKDGT FWNLLTIAPIKD+ G
Sbjct: 229 VVGRNCRFLQGSGTDADELAKIRETLAAGNNYCGRILNYKKDGTSFWNLLTIAPIKDESG 288
Query: 292 KVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS 351
KVLKFIGMQVEVSKHTEGAK+K LRPNGLPESLIRYDARQK+MAT+SVTELV+A+K+PR+
Sbjct: 289 KVLKFIGMQVEVSKHTEGAKEKALRPNGLPESLIRYDARQKDMATNSVTELVEAVKRPRA 348
Query: 352 LSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKK 411
LSESTN P + KSE +E RR SENV P R + GGG R SMQRI+E+PEKK
Sbjct: 349 LSESTNLHPFMTKSES---DELPKKPARRMSENVVPSGRRNSGGGRRNSMQRINEIPEKK 405
Query: 412 KQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXX--SVDDKVRQKEMR 469
+KS SFMG I +KS+S D+ S ++ I SVDDKVRQKEMR
Sbjct: 406 SRKSSL-SFMG-IKKKSESLDE--SIDDGFIEYGEEDDEISDRDERPESVDDKVRQKEMR 461
Query: 470 KGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD 529
KGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD
Sbjct: 462 KGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD 521
Query: 530 PATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH 589
TV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQKGEVQYFIGVQLDGS+H
Sbjct: 522 LTTVKKIRNAIDNQTEVTVQLINYTKSGKKFWNIFHLQPMRDQKGEVQYFIGVQLDGSKH 581
Query: 590 LEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKD 649
+EP+RN I E +E E LVK+TA N++EAV+ELPDAN+TPEDLWANHSKVVH KPHRKD
Sbjct: 582 VEPVRNVIEETAVKEGEDLVKKTAVNIDEAVRELPDANMTPEDLWANHSKVVHCKPHRKD 641
Query: 650 SPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN 709
SPPW AIQK+L+SGE I L+HF+P+KPLGSGDTGSVHLVEL G+ Q FAMKAMDK VMLN
Sbjct: 642 SPPWIAIQKVLESGEPIGLKHFKPVKPLGSGDTGSVHLVELVGTDQLFAMKAMDKAVMLN 701
Query: 710 RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLK 769
RNKVHRA AEREILD+LDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQP KVLK
Sbjct: 702 RNKVHRARAEREILDLLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQPRKVLK 761
Query: 770 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829
EDAVRFYAA+VVVALEYLHCQGIIYRDLKPENVL+QGNG +SL+DFDLSCLTSCKPQLL+
Sbjct: 762 EDAVRFYAAQVVVALEYLHCQGIIYRDLKPENVLIQGNGDISLSDFDLSCLTSCKPQLLI 821
Query: 830 PTTNEKKRR--HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 887
P+ +EKK++ K QQ P+FMAEPMRASNSFVGTEEYIAPEII+GAGHTSAVDWWALGIL
Sbjct: 822 PSIDEKKKKKQQKSQQTPIFMAEPMRASNSFVGTEEYIAPEIISGAGHTSAVDWWALGIL 881
Query: 888 LYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSS 924
+YEMLYGYTPFRGKTRQKTF N+L KDLKFP+S P+S
Sbjct: 882 MYEMLYGYTPFRGKTRQKTFTNVLQKDLKFPASIPAS 918
|
|
| UNIPROTKB|Q8H935 Vfphot1a "Phototropin" [Vicia faba (taxid:3906)] | Back alignment and assigned GO terms |
|---|
Score = 3044 (1076.6 bits), Expect = 0., Sum P(2) = 0.
Identities = 612/906 (67%), Positives = 688/906 (75%)
Query: 32 PSTFSTRPTNPVFRPQPTWQTWMEQ-RESPEPEHAKLNSKSSRAEEITSWM--ALKDPAP 88
P T R + VF P + +P P ++ SSR E + D P
Sbjct: 3 PFTRDHRGSLEVFNPSSSETNGTPNPNPNPNPSNSWNTGTSSRGTEAPPLRDSIISDEVP 62
Query: 89 QKPSLPPLIQKMTNDQEKSTVTKQLSXXXXXXXXXXXXWGLVLKTDTETGKPQAVVARTS 148
S L K T KS + ++ WGLVLKTD+ETGKPQ V R S
Sbjct: 63 TATSWMAL--KETTPSPKSGESGSVAEQRAAE------WGLVLKTDSETGKPQGVGVRGS 114
Query: 149 GGDDPNGKPGTXXXXXXXXXXXXGEMSDEGGKE-KGLPRVSDIVKDALSTFQQTFVVSDA 207
GG G GE SD+G + +G+PRVS+ ++DALS FQQTFVVSDA
Sbjct: 115 GGG------GGSRRDSNNSVRSSGESSDDGREGGRGIPRVSEDLRDALSAFQQTFVVSDA 168
Query: 208 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 267
TKPDYPIMYASAGFF MTGYTSKEV+GRNCRF+QGA TDP DVAKIRE L G SYCGRL
Sbjct: 169 TKPDYPIMYASAGFFSMTGYTSKEVIGRNCRFMQGADTDPNDVAKIREALAAGTSYCGRL 228
Query: 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRY 327
LNYKKDGT FWNLLTIAPIKD+ GK+LK IGMQVEVSKHTEG K+KMLRPNGLPESLIRY
Sbjct: 229 LNYKKDGTTFWNLLTIAPIKDEHGKILKLIGMQVEVSKHTEGTKEKMLRPNGLPESLIRY 288
Query: 328 DARQKEMATSSVTELVQAM-KKPRSLSESTNRPPIIRKSEGGVEEE----RAGALGRRKS 382
DARQKE A SSVTELV+A+ K+PRSLSES NR P +K G + + + R+
Sbjct: 289 DARQKEKANSSVTELVEAVSKRPRSLSESANRLPFNKKPTNGSNDHATPPNSESSSRKSG 348
Query: 383 ENVPPPRRNSYGG-GCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEI 441
+ RR S+ G G SM I+E+PE KS RRSFMG + RKS S ++ F +E
Sbjct: 349 STLRSFRRKSHSGAGNSNSMHPITELPENNN-KSRRRSFMGFM-RKSLSNNER--FNHEQ 404
Query: 442 IMXXXXXXXXXXXXXXSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFAS 501
++ + +++E RKG DLATTLERIEKNFVITDPRLPDNPIIFAS
Sbjct: 405 VIDRNSSEDEDRLDSFDEQNIAQKREKRKGFDLATTLERIEKNFVITDPRLPDNPIIFAS 464
Query: 502 DSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFW 561
DSFLELTEYSREEILGRNCRFLQGPETDPATV+KIR AIDNQT+VTVQLINYTK+GKKFW
Sbjct: 465 DSFLELTEYSREEILGRNCRFLQGPETDPATVKKIRYAIDNQTEVTVQLINYTKTGKKFW 524
Query: 562 NLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVK 621
NLFHLQPMRDQKGEVQYFIGVQLDGS+H+EPL N I E TA+E E LVK+TAENV++A++
Sbjct: 525 NLFHLQPMRDQKGEVQYFIGVQLDGSQHVEPLHNGIAEDTAKEGENLVKKTAENVDDALR 584
Query: 622 ELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGD 681
ELPDAN+ PEDLW NHSKVVHPKPHR++ W+AIQKI++SGEQI L+HF+PIKPLGSGD
Sbjct: 585 ELPDANMKPEDLWMNHSKVVHPKPHRREDSAWRAIQKIMESGEQIGLKHFKPIKPLGSGD 644
Query: 682 TGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741
TGSVHLVELCG+ +FAMKAMDKGVM NRNKVHRAC EREILDMLDHPF+PALYASFQTK
Sbjct: 645 TGSVHLVELCGTDHHFAMKAMDKGVMPNRNKVHRACTEREILDMLDHPFLPALYASFQTK 704
Query: 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801
TH+CLITDYCPGGELF+LLDRQP KVLKEDAVRFYA EVVVALEYLHCQGIIYRDLKPEN
Sbjct: 705 THICLITDYCPGGELFMLLDRQPAKVLKEDAVRFYATEVVVALEYLHCQGIIYRDLKPEN 764
Query: 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGT 861
VLLQ GHVSLTDFDLSCLTSCKP+L++P+TN+KK KGQ P+FMAEPMRASNSFVGT
Sbjct: 765 VLLQSTGHVSLTDFDLSCLTSCKPELIVPSTNDKK---KGQHGPIFMAEPMRASNSFVGT 821
Query: 862 EEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSST 921
EEYIAPEII G+GHT AVDWWALGILLYEM YGYTPFRGK RQ+TFANILHKDLK P S
Sbjct: 822 EEYIAPEIITGSGHTCAVDWWALGILLYEMFYGYTPFRGKNRQRTFANILHKDLKLPKSK 881
Query: 922 PSSCKA 927
S A
Sbjct: 882 QVSLSA 887
|
|
| UNIPROTKB|Q2QYY8 PHOT1A "Phototropin-1A" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 2771 (980.5 bits), Expect = 3.2e-294, Sum P(2) = 3.2e-294
Identities = 534/748 (71%), Positives = 621/748 (83%)
Query: 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 243
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSAFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 244 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 304 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 363
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNNT-LKR 298
Query: 364 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 421
KS+ + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMTEVPSKRSSES--GSRRNSRSG-TRSSLQKINEVPDQGNRTRKSGLRAFM 355
Query: 422 GLIGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXX--SVDDKVRQKEMRKGIDLATTLE 479
G +G H S E ++ S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 539
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 540 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPE 599
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 600 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 659
A+E LVK+TA+N++EA KELPDANL PEDLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPEDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 660 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 719
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
K P+F AEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 822
Query: 900 GKTRQKTFANILHKDLKFPSSTPSSCKA 927
GKTRQ+TFANILHKD++FP+S S A
Sbjct: 823 GKTRQRTFANILHKDIRFPASISVSLAA 850
|
|
| UNIPROTKB|Q2RBR1 PHOT1B "Phototropin-1B" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 2768 (979.4 bits), Expect = 6.7e-294, Sum P(2) = 6.7e-294
Identities = 533/748 (71%), Positives = 622/748 (83%)
Query: 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 243
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSVFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 244 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 304 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 363
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNNT-LKR 298
Query: 364 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 421
KS+ + + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMSEVPSKRSSES--GSRRNSRSG-TRSSLQKINEVPDQVNRTRKSGLRAFM 355
Query: 422 GLIGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXX--SVDDKVRQKEMRKGIDLATTLE 479
G +G H S E ++ S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 539
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 540 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPE 599
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 600 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 659
A+E LVK+TA+N++EA KELPDANL P+DLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPKDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 660 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 719
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
K P+F AEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 822
Query: 900 GKTRQKTFANILHKDLKFPSSTPSSCKA 927
GKTRQ+TFANILHKD++FP+S S A
Sbjct: 823 GKTRQRTFANILHKDIRFPASISVSLAA 850
|
|
| TAIR|locus:2155821 PHOT2 "phototropin 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1906 (676.0 bits), Expect = 4.4e-267, Sum P(3) = 4.4e-267
Identities = 379/585 (64%), Positives = 443/585 (75%)
Query: 345 AMKKPRSLSESTNRPPIIRKSEGGVEEERAG-ALGRRKSENVPPPRRNSYGGGCRTSMQR 403
A +K ++L T IR + V+E + + + S P P R + R
Sbjct: 262 ARQKEKALDSITEVVQTIRHRKSQVQESVSNDTMVKPDSSTTPTPGRQT----------R 311
Query: 404 ISEVPEKKKQKSGRRSFMGLIGRKSQSTDD-HDSF---ENEIIMXXXXXXXXXXXXXXSV 459
S+ K + GR S G K +S+++ H+ E E +M S
Sbjct: 312 QSDEASKSFRTPGRVSTP--TGSKLKSSNNRHEDLLRMEPEELMLSTEVIGQRD----SW 365
Query: 460 DDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRN 519
D R++++R+GIDLATTLERIEKNFVI+DPRLPDNPIIFASDSFLELTEYSREEILGRN
Sbjct: 366 DLSDRERDIRQGIDLATTLERIEKNFVISDPRLPDNPIIFASDSFLELTEYSREEILGRN 425
Query: 520 CRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYF 579
CRFLQGPETD ATV+KIR AI +Q ++TVQLINYTKSGKKFWNLFHLQPMRDQKGE+QYF
Sbjct: 426 CRFLQGPETDQATVQKIRDAIRDQREITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYF 485
Query: 580 IGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSK 639
IGVQLDGS+H+EPL+N + E T +S KLVK TA NV+EAV+ELPDAN PEDLWA HSK
Sbjct: 486 IGVQLDGSDHVEPLQNRLSERTEMQSSKLVKATATNVDEAVRELPDANTRPEDLWAAHSK 545
Query: 640 VVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAM 699
V+P PH K+S WKAI+KI SGE + L HF+PIKPLGSGDTGSVHLVEL G+G+ +AM
Sbjct: 546 PVYPLPHNKESTSWKAIKKIQASGETVGLHHFKPIKPLGSGDTGSVHLVELKGTGELYAM 605
Query: 700 KAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 759
KAM+K +MLNRNK HRAC EREI+ +LDHPF+P LYASFQT THVCLITD+CPGGELF L
Sbjct: 606 KAMEKTMMLNRNKAHRACIEREIISLLDHPFLPTLYASFQTSTHVCLITDFCPGGELFAL 665
Query: 760 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819
LDRQP K+L ED+ RFYAAEVV+ LEYLHC GI+YRDLKPEN+LL+ +GH+ L DFDLS
Sbjct: 666 LDRQPMKILTEDSARFYAAEVVIGLEYLHCLGIVYRDLKPENILLKKDGHIVLADFDLSF 725
Query: 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 879
+T+C PQL++P K+RR K Q P F+AEP SNSFVGTEEYIAPEII GAGHTSA+
Sbjct: 726 MTTCTPQLIIPAAPSKRRRSKSQPLPTFVAEPSTQSNSFVGTEEYIAPEIITGAGHTSAI 785
Query: 880 DWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSS 924
DWWALGILLYEMLYG TPFRGK RQKTFANILHKDL FPSS P S
Sbjct: 786 DWWALGILLYEMLYGRTPFRGKNRQKTFANILHKDLTFPSSIPVS 830
|
|
| UNIPROTKB|Q9ST27 PHOT2 "Phototropin-2" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 2480 (878.1 bits), Expect = 1.2e-257, P = 1.2e-257
Identities = 488/769 (63%), Positives = 582/769 (75%)
Query: 172 GEMSDEGG----KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGY 227
G+ S +GG LPRVS +KDALS+ QQTFVVSDAT+PD PI+YAS GFF MTGY
Sbjct: 70 GKSSVDGGVGRASHDSLPRVSQELKDALSSLQQTFVVSDATRPDCPIIYASEGFFTMTGY 129
Query: 228 TSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIK 287
+ +EVVGRNCRFLQG TD +VAKIR+ +++G+S+CGRLLNY+KDG PFWNLLT+ PI+
Sbjct: 130 SPREVVGRNCRFLQGPDTDAAEVAKIRDAVKHGRSFCGRLLNYRKDGAPFWNLLTVTPIR 189
Query: 288 DDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMK 347
DD GKV+KFIGMQVEVSK+TEG DK +RPN LP SLIRYD RQK+ A SS+TE+VQ +K
Sbjct: 190 DDNGKVIKFIGMQVEVSKYTEGLSDKRMRPNELPVSLIRYDERQKDKAMSSMTEVVQTVK 249
Query: 348 KPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEV 407
+PR + + + ++ A+ S V P + GGG + + ++
Sbjct: 250 QPRGARAPADAALLTPPKMS--DADKMAAM----SPVVAPGTPSGGGGGAGSFKSPLWDL 303
Query: 408 PEKKKQ--------KSGRRSFMGL-IGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXXS 458
+++ + KSGR S MG IG++S E S
Sbjct: 304 KKEESRLSRLASGRKSGRSSLMGFKIGKRSSVGSREAPAVVEEPAPAPPPAPEVVERTDS 363
Query: 459 VDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGR 518
+ R+K++R+GIDLATTLERIEKNFVITDPR+PDNPIIFASDSFLELTEY+REEILGR
Sbjct: 364 WERAEREKDIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGR 423
Query: 519 NCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQY 578
NCRFLQGPETD TV KIR AI Q ++TVQLINYTKSGKKFWNLFHLQPMRDQKGE+QY
Sbjct: 424 NCRFLQGPETDQGTVDKIREAIREQKEITVQLINYTKSGKKFWNLFHLQPMRDQKGELQY 483
Query: 579 FIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHS 638
FIGVQLDGS+H+EPLRN + E T +S KLVK TAENV++AV+ELPDANL PEDLWA HS
Sbjct: 484 FIGVQLDGSDHVEPLRNRLSENTEIQSAKLVKATAENVDDAVRELPDANLRPEDLWAIHS 543
Query: 639 KVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFA 698
V PKPH++++P W AI+K + GE+I L+HF+P+KPLG GDTGSVHLVEL GSG+ FA
Sbjct: 544 MRVSPKPHKRNNPSWIAIEKATNLGEKIGLKHFKPVKPLGCGDTGSVHLVELQGSGELFA 603
Query: 699 MKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFL 758
MKAMDK VMLNRNKVHRAC EREI +LDHPF+P LY SFQT THVCLITD+CPGGELF
Sbjct: 604 MKAMDKSVMLNRNKVHRACIEREIYALLDHPFLPTLYTSFQTPTHVCLITDFCPGGELFA 663
Query: 759 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818
+LDRQP K+ +E+ RFYAAEVV+ LEYLHC GIIYRDLKPEN+LLQ +GH+ LTDFDLS
Sbjct: 664 VLDRQPMKIFREECARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQADGHIVLTDFDLS 723
Query: 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 878
LT+ KP ++ +T+ K+RR + P F++EP SNSFVGTEEYIAPE+I GAGHTSA
Sbjct: 724 FLTTSKPHVIKNSTSLKRRRSQEFLPPTFVSEPSTPSNSFVGTEEYIAPEVITGAGHTSA 783
Query: 879 VDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKA 927
+DWWALGILLYEMLYG TPFRGK R+KTF NILHKDL FPSS P S A
Sbjct: 784 IDWWALGILLYEMLYGRTPFRGKNRKKTFYNILHKDLTFPSSIPVSLAA 832
|
|
| UNIPROTKB|Q5I6E9 Adi3 "AvrPto-dependent Pto-interacting protein 3" [Solanum lycopersicum (taxid:4081)] | Back alignment and assigned GO terms |
|---|
Score = 533 (192.7 bits), Expect = 7.5e-76, Sum P(3) = 7.5e-76
Identities = 103/213 (48%), Positives = 142/213 (66%)
Query: 626 ANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSV 685
+ L+ + W+N + + KPH+ + P WKAI I + + HF+ +K LG GD GSV
Sbjct: 264 SGLSDDSNWSNITGSAN-KPHKGNDPRWKAILAIRARDGILGMSHFKLLKRLGCGDIGSV 322
Query: 686 HLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745
+L EL G+ YFAMK MDK + +R K+ RA EREIL +LDHPF+P LY F+T C
Sbjct: 323 YLSELSGTRCYFAMKVMDKASLASRKKLTRAQTEREILQLLDHPFLPTLYTHFETDRFSC 382
Query: 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ 805
L+ +YCPGG+L L RQP K E A RFYAAEV++ALEYLH G++YRDLKPENVL++
Sbjct: 383 LVMEYCPGGDLHTLRQRQPGKHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVR 442
Query: 806 GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+GH+ L+DFDLS + P L+ ++++ +R
Sbjct: 443 DDGHIMLSDFDLSLRCAVSPTLIRISSDDPSKR 475
|
|
| TAIR|locus:2087785 AGC1.5 "AGC kinase 1.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 505 (182.8 bits), Expect = 2.7e-73, Sum P(3) = 2.7e-73
Identities = 107/247 (43%), Positives = 147/247 (59%)
Query: 589 HLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDL--WANHSKVVHP--- 643
H +P + +P T+E +A N + + PD P +A +V P
Sbjct: 101 HYDP-KKIVPLTTSET----YSPSARNHHHHRTKSPDKKRAPRHNGDYAYGDNLVGPSAQ 155
Query: 644 --KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 701
KPH W AI I G QI L +FR +K LG GD GSV+L +L G+ FAMK
Sbjct: 156 PFKPHTGGDVRWDAINSIASKGPQIGLDNFRLLKRLGYGDIGSVYLADLRGTNAVFAMKV 215
Query: 702 MDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD 761
MDK + +RNK+ RA EREIL +LDHPF+P LY+ F+T CL+ ++C GG L L
Sbjct: 216 MDKASLASRNKLLRAQTEREILSLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQ 275
Query: 762 RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821
+QP++ E+A RFYA+EV++ALEYLH G++YRDLKPEN+L++ GH+ L+DFDLS
Sbjct: 276 KQPSRRFTEEAARFYASEVLLALEYLHMLGVVYRDLKPENILVRDEGHIMLSDFDLSLRC 335
Query: 822 SCKPQLL 828
+ P L+
Sbjct: 336 TFNPTLV 342
|
|
| TAIR|locus:2174885 AT5G40030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 520 (188.1 bits), Expect = 1.2e-72, Sum P(2) = 1.2e-72
Identities = 101/200 (50%), Positives = 138/200 (69%)
Query: 635 ANHSKVVHP-KPHRKDSPPWKAIQKILDS-GEQINLQHFRPIKPLGSGDTGSVHLVELCG 692
AN +V P KPH+ + W AIQ + S E + L HFR +K LG GD GSV+L EL
Sbjct: 76 ANFKRVFAPSKPHKGNDLRWDAIQNVKCSKNEDLGLGHFRLLKKLGCGDIGSVYLAELRE 135
Query: 693 SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 752
G +FAMK MDKG+++ R K+ RA EREIL +LDHPF+P LY+ F+T+ CL+ ++C
Sbjct: 136 MGCFFAMKVMDKGMLIGRKKLVRAQTEREILGLLDHPFLPTLYSHFETEKFSCLLMEFCS 195
Query: 753 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 812
GG+L +L +QP K E A RFYA+EV++ALEYLH G++YRDLKPENV+++ +GH+ L
Sbjct: 196 GGDLHILRQKQPGKHFSELAARFYASEVLLALEYLHMMGVVYRDLKPENVMVREDGHIML 255
Query: 813 TDFDLSCLTSCKPQLLLPTT 832
+DFDLS + P L+ T+
Sbjct: 256 SDFDLSLQSFVSPTLIQSTS 275
|
|
| TAIR|locus:2055017 AT2G44830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 537 (194.1 bits), Expect = 7.4e-72, Sum P(2) = 7.4e-72
Identities = 110/253 (43%), Positives = 156/253 (61%)
Query: 603 EESEKLVKQTAENVNEAVKELPDAN-LTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILD 661
+ S +V + E+ + D++ L+ E W+N + ++ KPH+ + P W AI I
Sbjct: 295 DRSISMVLDSFESTKTSASRASDSSGLSEESSWSNFTGSLN-KPHKGNDPWWNAILAIRT 353
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
+ + HF+ +K LG GD GSV+L EL G+ +FA+K MDK + +R K++RA ER+
Sbjct: 354 RDGILGMSHFKLLKRLGCGDIGSVYLAELSGTRCHFAVKVMDKASLEDRKKLNRAQTERD 413
Query: 722 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
IL +LDHPF+P LY F+T CL+ +YCPGG+L L RQP K E A RFYAAEV+
Sbjct: 414 ILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQPGKHFSEYAARFYAAEVL 473
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+ALEYLH G++YRDLKPENVL++ +GH+ L+DFDLS + P L+ ++ RR
Sbjct: 474 LALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAVSPTLIKTFDSDPSRRGAF 533
Query: 842 QQNPVFMAEPMRA 854
P M EP A
Sbjct: 534 CVQPACM-EPTSA 545
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q2QYY8 | PHT1A_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6368 | 0.8907 | 0.9033 | yes | no |
| Q2RBR1 | PHT1B_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6357 | 0.8907 | 0.9033 | yes | no |
| O48963 | PHOT1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7335 | 0.9710 | 0.9106 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| gw1.I.2683.1 | hypothetical protein (971 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 934 | |||
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-149 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-93 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-77 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-74 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-73 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-68 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-67 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-65 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-61 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-60 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-60 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-59 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-58 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-58 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-57 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-57 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-55 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-55 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-55 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-54 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-54 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-54 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-53 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-52 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-51 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-51 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-50 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-50 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-49 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-48 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-48 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-48 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-48 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-47 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-47 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-46 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-46 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-46 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-46 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-46 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-45 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-45 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-45 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-45 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-45 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-44 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-43 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-43 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-43 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-41 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-41 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-40 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-40 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-40 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-39 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-39 | |
| PRK13557 | 540 | PRK13557, PRK13557, histidine kinase; Provisional | 5e-39 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-38 | |
| PRK13559 | 361 | PRK13559, PRK13559, hypothetical protein; Provisio | 2e-38 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-37 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-37 | |
| PRK13559 | 361 | PRK13559, PRK13559, hypothetical protein; Provisio | 2e-36 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-36 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-36 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-35 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-34 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-33 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-33 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-33 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-31 | |
| PRK13558 | 665 | PRK13558, PRK13558, bacterio-opsin activator; Prov | 4e-31 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-31 | |
| PRK13558 | 665 | PRK13558, PRK13558, bacterio-opsin activator; Prov | 9e-31 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-30 | |
| PRK13557 | 540 | PRK13557, PRK13557, histidine kinase; Provisional | 2e-30 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-30 | |
| pfam13426 | 101 | pfam13426, PAS_9, PAS domain | 1e-29 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-26 | |
| pfam13426 | 101 | pfam13426, PAS_9, PAS domain | 2e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-23 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-22 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-22 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-21 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-21 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-19 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-19 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-19 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-18 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-16 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-12 | |
| TIGR02938 | 494 | TIGR02938, nifL_nitrog, nitrogen fixation negative | 1e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-12 | |
| cd00130 | 103 | cd00130, PAS, PAS domain; PAS motifs appear in arc | 1e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-09 | |
| cd00130 | 103 | cd00130, PAS, PAS domain; PAS motifs appear in arc | 5e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-08 | |
| pfam08447 | 90 | pfam08447, PAS_3, PAS fold | 2e-08 | |
| TIGR00229 | 124 | TIGR00229, sensory_box, PAS domain S-box | 2e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-08 | |
| smart00086 | 43 | smart00086, PAC, Motif C-terminal to PAS motifs (l | 9e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-07 | |
| COG2202 | 232 | COG2202, AtoS, FOG: PAS/PAC domain [Signal transdu | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-07 | |
| TIGR02938 | 494 | TIGR02938, nifL_nitrog, nitrogen fixation negative | 3e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-06 | |
| pfam00989 | 113 | pfam00989, PAS, PAS fold | 1e-06 | |
| COG2202 | 232 | COG2202, AtoS, FOG: PAS/PAC domain [Signal transdu | 2e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-06 | |
| pfam00989 | 113 | pfam00989, PAS, PAS fold | 3e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-06 | |
| TIGR00229 | 124 | TIGR00229, sensory_box, PAS domain S-box | 4e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-05 | |
| pfam08447 | 90 | pfam08447, PAS_3, PAS fold | 2e-05 | |
| smart00086 | 43 | smart00086, PAC, Motif C-terminal to PAS motifs (l | 2e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-04 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| smart00091 | 67 | smart00091, PAS, PAS domain | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.003 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.004 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 442 bits (1138), Expect = e-149
Identities = 152/262 (58%), Positives = 187/262 (71%), Gaps = 4/262 (1%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+HF+ IK LG GD G V LV L G+G+ FA+K +DK M+ RNKV R E+EIL LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
PF+P LYASFQT+T++CL+ DYCPGGELF LL RQP K L E+ RFYAAEV++ALEYLH
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT--TNEKKRRHKGQQNPV 846
GI+YRDLKPEN+LL +GH+ L+DFDLS + +P + ++ +
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
F EP SNSFVGTEEYIAPE+I+G GH SAVDWW LGILLYEMLYG TPF+G R +T
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240
Query: 907 FANILHKDLKFPSSTP--SSCK 926
F+NIL K++ FP S P SS +
Sbjct: 241 FSNILKKEVTFPGSPPVSSSAR 262
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 295 bits (758), Expect = 1e-93
Identities = 103/250 (41%), Positives = 142/250 (56%), Gaps = 29/250 (11%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V LV +G+ +AMK + K ++ R +V ER IL ++HPF+ L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
+FQT+ + L+ +Y PGGELF L ++ E+ RFYAAE+V+ALEYLH GIIYRD
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRD 118
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
LKPEN+LL +GH+ LTDF L+ +E R N
Sbjct: 119 LKPENILLDADGHIKLTDFGLAK--------------------------ELSSEGSRT-N 151
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 916
+F GT EY+APE++ G G+ AVDWW+LG+LLYEML G PF + R++ + IL L+
Sbjct: 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR 211
Query: 917 FPSSTPSSCK 926
FP +
Sbjct: 212 FPEFLSPEAR 221
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 252 bits (647), Expect = 2e-77
Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 33/254 (12%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+ ++ LG G G V+L +G+ A+K + K + + R E +IL L HP
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ LY F+ + + L+ +YC GG+LF LL ++ L ED RFY +++ ALEYLH +
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSK 116
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
GI++RDLKPEN+LL +GHV L DF L+ +
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLAR---------------------------QLDP 149
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK-TRQKTFAN 909
+ +FVGT EY+APE++ G G+ AVD W+LG++LYE+L G PF G + F
Sbjct: 150 GEKL-TTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKK 208
Query: 910 ILHKDLKFPSSTPS 923
I FP
Sbjct: 209 IGKPKPPFPPPEWD 222
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 245 bits (629), Expect = 2e-74
Identities = 102/251 (40%), Positives = 137/251 (54%), Gaps = 32/251 (12%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
F IK LG+G G V LV GSG+Y+A+K + K ++ +V E+ IL + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
PF+ LY SFQ +++ L+ +Y PGGELF L + + E RFYAA+VV+ALEYLH
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLH 118
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
I+YRDLKPEN+LL +G++ +TDF + KR
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFA-----------------KRVKGRTY----- 156
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908
+ GT EY+APEII G+ AVDWWALGIL+YEML GY PF + +
Sbjct: 157 --------TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE 208
Query: 909 NILHKDLKFPS 919
IL ++FPS
Sbjct: 209 KILEGKVRFPS 219
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 242 bits (621), Expect = 1e-73
Identities = 99/243 (40%), Positives = 142/243 (58%), Gaps = 21/243 (8%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
+ G G V L + +G +A+K + K M+ +N+V + ER+IL P+V LY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
SFQ K ++ L+ +Y PGG+L LL+ L ED R Y AE+V+ALEYLH GII+RD
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLEN--VGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
LKP+N+L+ NGH+ LTDF LS + + Q+ L ++ +R
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR------------------ 160
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 916
VGT +YIAPE+I G GH+ VDWW+LG +LYE L G PF G+T ++ F NIL+ ++
Sbjct: 161 -IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE 219
Query: 917 FPS 919
+P
Sbjct: 220 WPE 222
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 229 bits (587), Expect = 7e-68
Identities = 107/268 (39%), Positives = 152/268 (56%), Gaps = 20/268 (7%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F IK +G G G V LV +GQ +AMK + K M+ RN++ AER+IL D P+
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ LY SFQ + H+ L+ +Y PGG+L LL R+ V E+ RFY AE+V+AL+ +H
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL 120
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLS---------CLTSCKPQLLLPTTNEKKRRHKG 841
G I+RD+KP+N+L+ +GH+ L DF L LL N RR
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+Q V +NS VGT +YIAPE++ G + DWW+LG++LYEMLYG+ PF
Sbjct: 181 KQRRVR-------ANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233
Query: 902 TRQKTFANILH--KDLKFPSSTPSSCKA 927
T Q+T+ I++ + L+FP P S +A
Sbjct: 234 TLQETYNKIINWKESLRFPPDPPVSPEA 261
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 225 bits (577), Expect = 3e-67
Identities = 93/268 (34%), Positives = 140/268 (52%), Gaps = 25/268 (9%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HP 729
F+ K +G G +V L + + + +A+K +DK ++ KV E+E+L L+ HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+ LY +FQ + ++ + +Y P GEL + + + L E RFYAAE+++ALEYLH
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLHS 120
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCL---TSCKPQLLLPTTNEKKRRHKGQQNPV 846
+GII+RDLKPEN+LL + H+ +TDF + + S TN + K ++
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF- 179
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
SFVGT EY++PE++ + D WALG ++Y+ML G PFRG T
Sbjct: 180 ---------ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230
Query: 907 FANILHKDLKFPSSTPSSCKAANVPPVA 934
F IL + FP N PP A
Sbjct: 231 FQKILKLEYSFPP---------NFPPDA 249
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 8e-65
Identities = 89/258 (34%), Positives = 126/258 (48%), Gaps = 34/258 (13%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+ ++ LGSG G+V+ + G+G+ A+K + K K A E IL L HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPN 59
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ L +F+ K H+ L+ +YC GG+LF L R L ED + A +++ LEYLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLEYLHSN 117
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
GII+RDLKPEN+LL NG V + DF L+ L
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---------------------- 155
Query: 851 PMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR---QKT 906
+FVGT Y+APE++ G G+ VD W+LG++LYE+L G PF G+ +
Sbjct: 156 -----TTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQL 210
Query: 907 FANILHKDLKFPSSTPSS 924
IL L+F SS
Sbjct: 211 IRRILGPPLEFDEPKWSS 228
|
Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 209 bits (535), Expect = 1e-61
Identities = 94/248 (37%), Positives = 136/248 (54%), Gaps = 36/248 (14%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V LV++ + FA+K + K ++ + +E+EIL+ +HPF+ LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 737 SFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795
+F+ K ++ ++ +YC GGEL+ +L DR + E RFY A VV+A EYLH +GIIYR
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDR---GLFDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
DLKPEN+LL NG+V L DF + K K +
Sbjct: 118 DLKPENLLLDSNGYVKLVDFG--------------FAKKLKSGQK--------------T 149
Query: 856 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG--KTRQKTFANILH- 912
+F GT EY+APEII G+ +VD+W+LGILLYE+L G PF + + + +IL
Sbjct: 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG 209
Query: 913 -KDLKFPS 919
L+FP+
Sbjct: 210 NGKLEFPN 217
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 3e-60
Identities = 86/259 (33%), Positives = 135/259 (52%), Gaps = 33/259 (12%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
HF ++ +G G G V +V+ + + FAMK M+K + + V ER IL L+HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
F+ L+ SFQ + ++ L+ D GG+L L ++ E+ V+F+ E+V+ALEYLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS 118
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+GII+RD+KP+N+LL GHV +TDF+++
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIAT----------------------------KV 150
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT--- 906
P + S GT Y+APE++ G++ AVDWW+LG+ YE L G P+RG +R
Sbjct: 151 TPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210
Query: 907 FANILHKDLKFPSSTPSSC 925
A D+ +P++ +
Sbjct: 211 RAKQETADVLYPATWSTEA 229
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 5e-60
Identities = 94/254 (37%), Positives = 137/254 (53%), Gaps = 36/254 (14%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML--DHPFV 731
+KP+ G GSV+L + +G YFA+K + K M+ +N+V AER I+ M+ + P+V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIM-MIQGESPYV 59
Query: 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 791
LY SFQ+K ++ L+ +Y GG+ L+ + L ED + Y AEVV+ +E LH +G
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 792 IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEP 851
II+RD+KPEN+L+ GH+ LTDF LS G +N
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLS--------------------RNGLENK------ 151
Query: 852 MRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANIL 911
FVGT +Y+APE I G G DWW+LG +++E L+GY PF +T F NIL
Sbjct: 152 -----KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL 206
Query: 912 HKDLKFPSSTPSSC 925
+ + +P C
Sbjct: 207 SRRINWPEEVKEFC 220
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 7e-59
Identities = 102/254 (40%), Positives = 146/254 (57%), Gaps = 26/254 (10%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F IK + +G G+V+LV + Q FAMK ++K ++ RN++ + ER+IL ++PF
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V +++ SF+TK H+C++ +Y GG+ LL L D R Y AE V+ALEYLH
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA--LPVDMARMYFAETVLALEYLHNY 120
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN------EKKRRHKGQQN 844
GI++RDLKP+N+L+ GH+ LTDF LS K L+ TTN EK R
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLS-----KIGLMSLTTNLYEGHIEKDTRE----- 170
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
F+ GT EYIAPE+I G+ VDWWA+GI+LYE L G PF G T +
Sbjct: 171 --FL------DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 222
Query: 905 KTFANILHKDLKFP 918
+ F ++ D+++P
Sbjct: 223 ELFGQVISDDIEWP 236
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 1e-58
Identities = 93/247 (37%), Positives = 136/247 (55%), Gaps = 30/247 (12%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 733
K LG G G V L EL G+ + +A+K + K V+L + V E+ +L + HPF+
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
L++ FQTK + + +Y GG+L + R E RFYAAE+V+ L++LH +GII
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLK +NVLL GH+ + DF + CK +L T
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGM-----CKEGILGGVT--------------------- 152
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+++F GT +YIAPEI++ + AVDWWALG+LLYEML G +PF G + F +IL
Sbjct: 153 -TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED 211
Query: 914 DLKFPSS 920
++++P
Sbjct: 212 EVRYPRW 218
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 7e-58
Identities = 105/249 (42%), Positives = 141/249 (56%), Gaps = 33/249 (13%)
Query: 674 IKPLGSGDTGSVHLVE-LCGS--GQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDHP 729
+K LG G G V V + G+ G+ FAMK + K ++ N+ AER IL+ + HP
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
F+ L +FQT + LI +Y GGELF+ L+R+ + ED FY +E+ +ALE+LH
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQ 118
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
QGIIYRDLKPEN+LL GHV LTDF L CK + H+G
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGL-----CKESI-----------HEGT------- 155
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+++F GT EY+APEI+ +GH AVDWW+LG L+Y+ML G PF + R+KT
Sbjct: 156 ----VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211
Query: 910 ILHKDLKFP 918
IL L P
Sbjct: 212 ILKGKLNLP 220
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 199 bits (509), Expect = 3e-57
Identities = 92/251 (36%), Positives = 137/251 (54%), Gaps = 33/251 (13%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD--- 727
FR + LG G G V L E +G+ +A+KA+ KG ++ R++V E+ I + +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
HPF+ L+A FQT+ HVC + +Y GG+L + + V E FYAA VV+ L+YL
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYL 117
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H I+YRDLK +N+LL G V + DF L CK
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGL-----CKEG--------------------- 151
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907
M R S +F GT E++APE++ +T AVDWW LG+L+YEML G +PF G ++ F
Sbjct: 152 MGFGDRTS-TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210
Query: 908 ANILHKDLKFP 918
+I++ ++++P
Sbjct: 211 DSIVNDEVRYP 221
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 8e-57
Identities = 92/252 (36%), Positives = 127/252 (50%), Gaps = 32/252 (12%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
IK +G+G G VHLV S Y+A+K M ++ + E+ +L + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
PF+ L+ + + + ++ +Y PGGELF L + + FYA+E+V ALEYLH
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLH 118
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
+ I+YRDLKPEN+LL GH+ LTDF + KK R +
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFA----------------KKLRDR-------- 154
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908
+ + GT EY+APE+I GH AVDWWALGIL+YEML GY PF +
Sbjct: 155 ------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE 208
Query: 909 NILHKDLKFPSS 920
IL L+FP
Sbjct: 209 KILAGKLEFPRH 220
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 1e-55
Identities = 98/273 (35%), Positives = 138/273 (50%), Gaps = 45/273 (16%)
Query: 647 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV 706
+ D+ WK L F + LG+G G V + + G+G+Y+A+K + K
Sbjct: 9 KPDTSSWK-------------LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE 55
Query: 707 MLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK 766
+L +V E+ IL L HPF+ + SFQ + V + ++ GGELF L R+ +
Sbjct: 56 ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-RKAGR 114
Query: 767 VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826
D +FY AE+V+A EYLH + IIYRDLKPEN+LL GHV +TDF +
Sbjct: 115 -FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA-------- 165
Query: 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 886
KK + + + GT EY+APE+I GH AVDWW +G+
Sbjct: 166 --------KKVPDR--------------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGV 203
Query: 887 LLYEMLYGYTPFRGKTRQKTFANILHKDLKFPS 919
LLYE + GY PF T + + IL LKFP+
Sbjct: 204 LLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN 236
|
Length = 329 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 1e-55
Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 27/276 (9%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F IK +G G G V LV+ +G +AMK + K ML + +V AER+IL D+P+
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V LY SFQ + ++ LI +Y PGG++ LL ++ T E+ RFY AE ++A++ +H
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKL 120
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR---HKGQQNPVF 847
G I+RD+KP+N+LL GH+ L+DF L C L E R F
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGL-----CTG-LKKSHRTEFYRILSHALPSNFLDF 174
Query: 848 MAEPM----RASN----------SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 893
+++PM +A S VGT +YIAPE+ G+ DWW+LG+++YEML
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 894 GYTPFRGKTRQKTFANILH--KDLKFPSSTPSSCKA 927
GY PF Q+T+ I++ + L+FP P S +A
Sbjct: 235 GYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEA 270
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 193 bits (491), Expect = 7e-55
Identities = 96/253 (37%), Positives = 133/253 (52%), Gaps = 30/253 (11%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 733
K +G G G V L + G+++A+K + K +L + + AER +L + HPF+
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
L+ SFQT + + DY GGELF L R+ + E RFYAAE+ AL YLH II
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLKPEN+LL GHV LTDF L CK + E +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL-----CKEGI----------------------EHSK 151
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+++F GT EY+APE++ + VDWW LG +LYEMLYG PF + + + NIL+K
Sbjct: 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK 211
Query: 914 DLKFPSSTPSSCK 926
L+ + S +
Sbjct: 212 PLRLKPNISVSAR 224
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 2e-54
Identities = 102/248 (41%), Positives = 145/248 (58%), Gaps = 33/248 (13%)
Query: 674 IKPLGSGDTGSVHLV-ELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+K LG G G V LV ++ G +GQ +AMK + K + R++V R ER+IL ++HPF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV-RTKMERDILAEVNHPF 59
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ L+ +FQT+ + LI D+ GG+LF L ++ + E+ V+FY AE+ +AL++LH
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL 117
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
GIIYRDLKPEN+LL GH+ LTDF LS +EKK
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLS---------KESIDHEKK-------------- 154
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
+ SF GT EY+APE++ GHT + DWW+ G+L++EML G PF+GK R++T I
Sbjct: 155 ----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
Query: 911 LHKDLKFP 918
L L P
Sbjct: 211 LKAKLGMP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 2e-54
Identities = 93/245 (37%), Positives = 137/245 (55%), Gaps = 30/245 (12%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPA 733
K LG G G V L EL G+ ++FA+KA+ K V+L + V ER +L + +HPF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
L+ +FQTK H+ + +Y GG+L + Q + E RFYAAE++ L++LH +GII
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICGLQFLHKKGII 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLK +NVLL +GH+ + DF + CK +
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGM-----CKENMNGEGK--------------------- 152
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+++F GT +YIAPEI+ G + +VDWW+ G+LLYEML G +PF G+ + F +IL+
Sbjct: 153 -ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND 211
Query: 914 DLKFP 918
FP
Sbjct: 212 RPHFP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 190 bits (483), Expect = 8e-54
Identities = 95/253 (37%), Positives = 137/253 (54%), Gaps = 29/253 (11%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
K LG G G V LV +G+Y+AMK + K V++ +++V E +L HPF+ AL
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 794
SFQT +C + +Y GGELF L R+ +V ED RFY AE+V AL YLH ++Y
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 795 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 854
RDLK EN++L +GH+ +TDF L CK + T
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGL-----CKEGISDGAT---------------------- 151
Query: 855 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +K F IL ++
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211
Query: 915 LKFPSSTPSSCKA 927
++FP + K+
Sbjct: 212 IRFPRTLSPEAKS 224
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 6e-53
Identities = 101/262 (38%), Positives = 138/262 (52%), Gaps = 41/262 (15%)
Query: 671 FRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKV-HRACAEREILDML 726
F ++ LG+G G V LV G +G+ +AMK + K ++ + K ER++L+ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 727 DH-PFVPALYASFQTKTHVCLITDYCPGGELFL-LLDRQPTKVLKEDAVRFYAAEVVVAL 784
PF+ L+ +FQT T + LI DY GGELF L R+ E VR Y AE+V+AL
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLAL 118
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
++LH GIIYRD+K EN+LL GHV LTDF LS
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS-------------------------- 152
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFR--- 899
F+AE + SF GT EY+APE+I G GH AVDWW+LG+L +E+L G +PF
Sbjct: 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212
Query: 900 GKTRQKTFAN-ILHKDLKFPSS 920
+ Q + IL FP +
Sbjct: 213 EQNSQSEISRRILKSKPPFPKT 234
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 4e-52
Identities = 91/253 (35%), Positives = 141/253 (55%), Gaps = 29/253 (11%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
K LG G G V LV +G+Y+AMK + K V++ +++V E +L HPF+ AL
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 794
+FQT +C + +Y GGELF L R+ +V E+ RFY AE+V ALEYLH + ++Y
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVY 118
Query: 795 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 854
RD+K EN++L +GH+ +TDF L CK + ++ +
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGL-----CKEGI----SDGATMK---------------- 153
Query: 855 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + ++ F IL ++
Sbjct: 154 --TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211
Query: 915 LKFPSSTPSSCKA 927
++FP + K+
Sbjct: 212 IRFPRTLSPEAKS 224
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 184 bits (467), Expect = 1e-51
Identities = 101/253 (39%), Positives = 135/253 (53%), Gaps = 31/253 (12%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 733
K +G G G V L + G ++A+K + K +L + + + AER +L L HPF+
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
L+ SFQT + + DY GGELF L R+ + E RFYAAEV A+ YLH II
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLKPEN+LL GHV LTDF L CK + EP
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL-----CKEGV----------------------EPEE 151
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+++F GT EY+APE++ + VDWW LG +LYEMLYG PF + + + NILHK
Sbjct: 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK 211
Query: 914 DLKFP-SSTPSSC 925
L+ P T ++C
Sbjct: 212 PLQLPGGKTVAAC 224
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 1e-51
Identities = 99/253 (39%), Positives = 141/253 (55%), Gaps = 29/253 (11%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
K LG G G V LV SG+Y+AMK + K V++ +++V E +L HPF+ +L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 794
SFQTK +C + +Y GGELF L R+ +V ED RFY AE+V AL+YLH I+Y
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVY 118
Query: 795 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 854
RDLK EN++L +GH+ +TDF L CK + T +
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGL-----CKEGITDAATMK-------------------- 153
Query: 855 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +K F IL +D
Sbjct: 154 --TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED 211
Query: 915 LKFPSSTPSSCKA 927
+KFP + + K+
Sbjct: 212 IKFPRTLSADAKS 224
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 2e-50
Identities = 97/282 (34%), Positives = 140/282 (49%), Gaps = 48/282 (17%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
F IK +G G G V LV + +AMK + K +L RN+ AER+IL D+
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+V LY SFQ K ++ + DY PGG++ LL R + +ED RFY AE+ A+E +H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHK 119
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDL------------------------------SC 819
G I+RD+KP+N+L+ +GH+ LTDF L S
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 879
+ C+ + L +RR K Q ++S VGT YIAPE++ G+T
Sbjct: 180 IDRCRLKPL-------ERRRKRQHQRC-------LAHSLVGTPNYIAPEVLLRTGYTQLC 225
Query: 880 DWWALGILLYEMLYGYTPFRGKTRQKTFANILH--KDLKFPS 919
DWW++G++LYEML G PF T +T +++ L PS
Sbjct: 226 DWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPS 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 6e-50
Identities = 94/252 (37%), Positives = 138/252 (54%), Gaps = 33/252 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL---DMLDHPFVPA 733
+G G G V+ V + + +AMK + K ++ + +V ER IL + + PF+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
L SFQT + + L+TDY GGELF L Q ED +FY AE+V+ALE+LH I+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLKPEN+LL GH++L DF LS K L T N+
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLS-----KANL---TDNK------------------- 151
Query: 854 ASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 912
+N+F GT EY+APE++ G+T VD+W+LG+L++EM G++PF + Q+ + NI
Sbjct: 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211
Query: 913 KDLKFPSSTPSS 924
++FP + S
Sbjct: 212 GKVRFPKNVLSD 223
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-49
Identities = 85/254 (33%), Positives = 129/254 (50%), Gaps = 34/254 (13%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
F+ + +G G G V L + +G+ A+K M K ++ N+V ER+IL
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
++ L +FQ ++ L +Y PGG+ LL+ VL ED RFY AE+ A++ LH
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHE 119
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
G I+RDLKPEN L+ +GH+ LTDF LS
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLS------------------------------K 149
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+ +NS VG+ +Y+APE++ G G+ VD+W+LG +LYE L G+ PF G T +T+ N
Sbjct: 150 GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN 209
Query: 910 ILH--KDLKFPSST 921
+ + + L+ P
Sbjct: 210 LKYWKETLQRPVYD 223
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 74/217 (34%), Positives = 107/217 (49%), Gaps = 32/217 (14%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G+V+L +G+ A+K + K + + + E EIL L+HP + LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE--DSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
F+ + H+ L+ +YC GG L LL K L ED + +++ LEYLH GII+RD
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 797 LKPENVLLQ-GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
LKPEN+LL NG V L DF LS +
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSK---------------------------LLTSDKSLL 150
Query: 856 NSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEM 891
+ VGT Y+APE++ G G+ + D W+LG++LYE+
Sbjct: 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 1e-48
Identities = 89/245 (36%), Positives = 136/245 (55%), Gaps = 30/245 (12%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 733
K LG G G V L EL G+ Q+FA+KA+ K V+L + V E+ +L + +HPF+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
LY +FQTK ++ + +Y GG+L + Q FYAAE++ L++LH +GI+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLK +N+LL +GH+ + DF + CK +L + K
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGM-----CKENML----GDAK----------------- 152
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+ +F GT +YIAPEI+ G + ++VDWW+ G+LLYEML G +PF G ++ F +I
Sbjct: 153 -TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD 211
Query: 914 DLKFP 918
+ +P
Sbjct: 212 NPCYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 1e-48
Identities = 100/259 (38%), Positives = 142/259 (54%), Gaps = 34/259 (13%)
Query: 671 FRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNK-VHRACAEREILDML 726
F +K LG+G G V LV +G+ +AMK + K ++ + K V ER +L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 727 -DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
PF+ L+ +FQT+ + LI DY GGE+F L ++ ED VRFY+ E+++ALE
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALE 119
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
+LH GI+YRD+K EN+LL GHV LTDF LS
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLS--------------------------K 153
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
F++E + SF GT EY+APEII G GH AVDWW+LGIL++E+L G +PF + +
Sbjct: 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER 213
Query: 905 KTFANILHKDLKFPSSTPS 923
T + + + LK PS
Sbjct: 214 NTQSEVSRRILKCDPPFPS 232
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 2e-48
Identities = 96/254 (37%), Positives = 143/254 (56%), Gaps = 30/254 (11%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
K LG G G V LV+ +G+Y+AMK + K V++ +++V E +L HPF+ AL
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GII 793
SFQT +C + +Y GGELF L R+ +V ED RFY AE+V AL+YLH + ++
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVV 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLK EN++L +GH+ +TDF L CK +G ++ M
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGL-----CK---------------EGIKDGATM----- 153
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +K F IL +
Sbjct: 154 --KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211
Query: 914 DLKFPSSTPSSCKA 927
+++FP + K+
Sbjct: 212 EIRFPRTLSPEAKS 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 8e-48
Identities = 92/245 (37%), Positives = 129/245 (52%), Gaps = 30/245 (12%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPA 733
K LG G G V L EL G+ + +A+K + K V+L + V E+ IL + HPF+ A
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
L+ FQTK + + +Y GG+L + Q ++ E RFYAAEV +AL +LH G+I
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLK +N+LL GH L DF + CK +L
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGM-----CKEGIL----------------------NGV 151
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+ +F GT +YIAPEI+ + +VDWWALG+L+YEM+ G PF F +ILH
Sbjct: 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211
Query: 914 DLKFP 918
D+ +P
Sbjct: 212 DVLYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 1e-47
Identities = 97/242 (40%), Positives = 129/242 (53%), Gaps = 30/242 (12%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 733
K +G G G V L + G+ +A+K + K ++LNR + AER +L + HPF+
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
L+ SFQT + + D+ GGELF L R+ + E RFYAAE+ AL YLH I+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSINIV 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLKPEN+LL GHV LTDF L CK + T
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL-----CKEGIAQSDT--------------------- 152
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+ +F GT EY+APE+I + + VDWW LG +LYEMLYG PF + + + NILHK
Sbjct: 153 -TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211
Query: 914 DL 915
L
Sbjct: 212 PL 213
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 7e-47
Identities = 93/250 (37%), Positives = 133/250 (53%), Gaps = 29/250 (11%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
+G G G V V + + +A+K + K +++R++V AER +L ++ PF+ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
SFQ+ + L+ + GGELF L R+ RFY AE++ ALE LH +IYRD
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR--FDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
LKPEN+LL GH++L DF L CK L ++ K +N
Sbjct: 119 LKPENILLDYQGHIALCDFGL-----CK----LNMKDDDK------------------TN 151
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 916
+F GT EY+APE++ G G+T AVDWW LG+LLYEML G PF + + + IL + L+
Sbjct: 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR 211
Query: 917 FPSSTPSSCK 926
FP K
Sbjct: 212 FPDGFDRDAK 221
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 1e-46
Identities = 95/283 (33%), Positives = 148/283 (52%), Gaps = 26/283 (9%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F +K +G G G V LV+ +G+ +AMK + K M ++++ AER++L D P+
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V +LY SFQ ++ LI ++ PGG+L +L + T ED RFY AE V+A+E +H
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT--FSEDVTRFYMAECVLAIEAVHKL 120
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSC-----LTSCKPQLLLPTTNEKKRRHKGQQNP 845
G I+RD+KP+N+L+ GH+ L+DF LS S Q LL K R + +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL-QGKSNKNRIDNRNSV 179
Query: 846 VFMAEPMRASN----------------SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889
+ + S+ S VGT +YIAPEI G+ DWW+LG +++
Sbjct: 180 AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239
Query: 890 EMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPSSCKAANV 930
E L G+ PF + +T+ I++ + L FP S +A ++
Sbjct: 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDL 282
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 1e-46
Identities = 86/251 (34%), Positives = 129/251 (51%), Gaps = 30/251 (11%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP- 729
F + LG G G V L E G+ + +A+K + K V++ + V E+ +L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
F+ L++ FQT + + +Y GG+L + Q KE FYAAE+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGKFKEPHAVFYAAEIAIGLFFLHS 119
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+GIIYRDLK +NV+L GH+ + DF + CK + T
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGM-----CKENIFGGKT----------------- 157
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+ +F GT +YIAPEIIA + +VDWWA G+LLYEML G PF G+ + F +
Sbjct: 158 -----TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS 212
Query: 910 ILHKDLKFPSS 920
I+ ++ +P S
Sbjct: 213 IMEHNVSYPKS 223
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 5e-46
Identities = 89/262 (33%), Positives = 134/262 (51%), Gaps = 35/262 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
+G G G V +V +G +AMK M K V+L + V ER+IL + + P++P L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
+FQ K ++ L+ +Y PGG+L LL+R + ED +FY AE+V+A+ +H G ++RD
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAIHSVHQMGYVHRD 127
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
+KPENVL+ GH+ L DF + + A M S
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLT--------------------------ANKMVNSK 161
Query: 857 SFVGTEEYIAPEII------AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
VGT +YIAPE++ + DWW+LG++ YEM+YG +PF T KT+ NI
Sbjct: 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221
Query: 911 L-HKD-LKFPSSTPSSCKAANV 930
+ + LKFP S ++
Sbjct: 222 MNFQRFLKFPEDPKVSSDFLDL 243
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 169 bits (428), Expect = 5e-46
Identities = 101/276 (36%), Positives = 153/276 (55%), Gaps = 24/276 (8%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F +K +G G G V LV+ +G +AMK + K ML + +V AER+IL D +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V ++ SFQ K ++ LI ++ PGG++ LL ++ T L E+A +FY AE V+A++ +H
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQL 120
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSC-------------LTSCKPQ-LLLPTTNEKK 836
G I+RD+KP+N+LL GHV L+DF L LT P N K+
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT 896
+ ++N +A S VGT +YIAPE+ G+ DWW+LG+++YEML GY
Sbjct: 181 KAETWKKNRRQLAY------STVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 897 PFRGKTRQKTFANILH--KDLKFPSSTPSSCKAANV 930
PF +T Q+T+ +++ + L FP P S KA ++
Sbjct: 235 PFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 8e-46
Identities = 95/261 (36%), Positives = 143/261 (54%), Gaps = 38/261 (14%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC--AEREILDMLDH 728
F +K +G G G V +V++ +GQ +AMK ++K ML R + AC ER++L D
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAET--ACFREERDVLVNGDR 60
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
++ L+ +FQ + ++ L+ DY GG+L LL + + L ED RFY AE+V+A++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVLAIDSVH 119
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
G ++RD+KP+NVLL NGH+ L DF SCL +
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFG-SCLR-------------------------LL 153
Query: 849 AEPMRASNSFVGTEEYIAPEIIA----GAGHTSA-VDWWALGILLYEMLYGYTPFRGKTR 903
A+ SN VGT +YI+PEI+ G G DWW+LG+ +YEMLYG TPF ++
Sbjct: 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 904 QKTFANIL-HKD-LKFPSSTP 922
+T+ I+ HK+ +FP
Sbjct: 214 VETYGKIMNHKEHFQFPPDVT 234
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 1e-45
Identities = 99/278 (35%), Positives = 152/278 (54%), Gaps = 24/278 (8%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ F +K +G G G V LV+ +G +AMK + K ML + +V AER+IL D
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
+V ++ SFQ K ++ LI ++ PGG++ LL ++ T L E+ +FY AE V+A++ +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIH 118
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSC-------------LTSCKPQ-LLLPTTNE 834
G I+RD+KP+N+LL GHV L+DF L L P N
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 894
K++ ++N +A S VGT +YIAPE+ G+ DWW+LG+++YEML G
Sbjct: 179 KRKAETWKRNRRQLA------FSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 895 YTPFRGKTRQKTFANILH--KDLKFPSSTPSSCKAANV 930
Y PF +T Q+T+ +++ + L FP P S KA ++
Sbjct: 233 YPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 1e-45
Identities = 95/246 (38%), Positives = 138/246 (56%), Gaps = 32/246 (13%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 733
K LG G G V L EL G G+YFA+KA+ K V+L + V E+ +L + ++PF+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 734 LYASFQTKTHVCLITDYCPGGEL-FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
LY +FQTK H+ + ++ GG+L F + D+ + + FYAAE+V L++LH +GI
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYR---ATFYAAEIVCGLQFLHSKGI 117
Query: 793 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
IYRDLK +NV+L +GH+ + DF + CK + G
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGM-----CKENVF------------GDN--------- 151
Query: 853 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 912
RAS +F GT +YIAPEI+ G +T +VDWW+ G+LLYEML G +PF G + F +I
Sbjct: 152 RAS-TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV 210
Query: 913 KDLKFP 918
+P
Sbjct: 211 DTPHYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 3e-45
Identities = 92/253 (36%), Positives = 131/253 (51%), Gaps = 30/253 (11%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 733
K +G G G V L +++A+K + K +L + + +ER +L + HPF+
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
L+ SFQT + + DY GGELF L R+ + E RFYAAE+ AL YLH I+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIV 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLKPEN+LL GH+ LTDF L CK + E
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGL-----CKENI----------------------EHNG 151
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+++F GT EY+APE++ + VDWW LG +LYEMLYG PF + + + NIL+K
Sbjct: 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 211
Query: 914 DLKFPSSTPSSCK 926
L+ + +S +
Sbjct: 212 PLQLKPNITNSAR 224
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 3e-45
Identities = 89/244 (36%), Positives = 130/244 (53%), Gaps = 30/244 (12%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 735
LG G G V L L SG+ +A+K + K V+L + V E+ IL + +HPF+ LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 736 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795
FQT + + ++ GG+L + Q ++ E RFYAAE+ AL +LH +GIIYR
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
DLK +NVLL GH L DF + CK + G + +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGM-----CKEGI-----------FNG-----------KTT 153
Query: 856 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDL 915
++F GT +YIAPEI+ + +VDWWA+G+LLYEML G+ PF + F IL+ ++
Sbjct: 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 213
Query: 916 KFPS 919
+P+
Sbjct: 214 VYPT 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 164 bits (415), Expect = 4e-45
Identities = 99/254 (38%), Positives = 143/254 (56%), Gaps = 35/254 (13%)
Query: 670 HFRPIKPLGSGDTGSVHLV-ELCG--SGQYFAMKAMDKGVMLNRNKV-HRACAEREILDM 725
+F +K LG+G G V LV ++ G SG+ +AMK + K ++ + K ER++L+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 726 LDH-PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
+ PF+ L+ +FQT T + LI DY GGELF L ++ + KE V+ Y+ E+V+AL
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLAL 118
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
E+LH GIIYRD+K EN+LL NGHV LTDF LS
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS-------------------------- 152
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKT 902
F + + + SF GT EY+AP+I+ G GH AVDWW++G+L+YE+L G +PF
Sbjct: 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212
Query: 903 RQKTFANILHKDLK 916
+ + A I + LK
Sbjct: 213 EKNSQAEISRRILK 226
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 5e-45
Identities = 71/249 (28%), Positives = 118/249 (47%), Gaps = 34/249 (13%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLD 727
+ IK +G G G V+LV G+ + +K +D + N ++ R A E IL L+
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID---LSNMSEKEREDALNEVKILKKLN 57
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV--LKEDAVRFYAAEVVVALE 785
HP + Y SF+ K +C++ +Y GG+L + +Q + E+ + + ++ +AL+
Sbjct: 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YLH + I++RD+KP+N+ L NG V L DF +S K +
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFGIS---------------------KVLSST 156
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
V +A + VGT Y++PE+ + D W+LG +LYE+ PF G+ +
Sbjct: 157 VDLA------KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE 210
Query: 906 TFANILHKD 914
IL
Sbjct: 211 LALKILKGQ 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 5e-44
Identities = 91/283 (32%), Positives = 143/283 (50%), Gaps = 37/283 (13%)
Query: 654 KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 713
KA +KI ++ + F IK +G G G V LV S Q +AMK + K M+ R+
Sbjct: 30 KAAEKITKL--RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDS 87
Query: 714 HRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV 773
ER+I+ + ++ L+ +FQ ++ ++ +Y PGG+L L+ + E
Sbjct: 88 AFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD---IPEKWA 144
Query: 774 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
RFY AEVV+AL+ +H G I+RD+KP+N+LL +GH+ L DF +C+
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG-TCMK------------ 191
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS----AVDWWALGILLY 889
A M ++ VGT +YI+PE++ G DWW++G+ LY
Sbjct: 192 -------------MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238
Query: 890 EMLYGYTPFRGKTRQKTFANIL-HKD-LKFPSSTPSSCKAANV 930
EML G TPF + T++ I+ HK+ L FP S +A ++
Sbjct: 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDL 281
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 89/264 (33%), Positives = 140/264 (53%), Gaps = 41/264 (15%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 735
+G G V LVEL + + +AMK + K ++ + + E+ + + +HPF+ L+
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 736 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795
+ FQT++ + + ++ GG+L + RQ + L E+ RFY+AE+ +AL +LH +GIIYR
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
DLK +NVLL GH+ LTD+ + CK + P +
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGM-----CKEGI----------------------RPGDTT 153
Query: 856 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF---------RGKTRQKT 906
++F GT YIAPEI+ G + +VDWWALG+L++EM+ G +PF T
Sbjct: 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213
Query: 907 FANILHKDLKFPSSTPSSCKAANV 930
F IL K ++ P S S KA++V
Sbjct: 214 FQVILEKQIRIPRSL--SVKASSV 235
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 75/248 (30%), Positives = 119/248 (47%), Gaps = 28/248 (11%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V ++ +G+ +A K +DK + R A E++IL+ + F+ +L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
+F+TK +CL+ GG+L + E FYAA+++ LE+LH + I+YRD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
LKPENVLL +G+V ++D L+ KG +
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV------------------ELKGGKKI----------K 152
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 916
GT Y+APE++ G + +VDW+ALG LYEM+ G +PFR + + + + L+
Sbjct: 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212
Query: 917 FPSSTPSS 924
P
Sbjct: 213 MAVEYPDK 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 8e-43
Identities = 88/251 (35%), Positives = 131/251 (52%), Gaps = 30/251 (11%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP- 729
F + LG G G V L E G+ + +A+K + K V++ + V E+ +L + D P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
F+ L++ FQT + + +Y GG+L + Q KE FYAAE+ V L +LH
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGLFFLHR 119
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+GIIYRDLK +NV+L GH+ + DF + CK ++ T
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKEHMVDGVT----------------- 157
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+ +F GT +YIAPEIIA + +VDWWA G+LLYEML G PF G+ + F +
Sbjct: 158 -----TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS 212
Query: 910 ILHKDLKFPSS 920
I+ ++ +P S
Sbjct: 213 IMEHNVSYPKS 223
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 157 bits (397), Expect = 1e-41
Identities = 97/292 (33%), Positives = 147/292 (50%), Gaps = 44/292 (15%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F IK LG G G V L + +AMK + K +LNRN+V AER+IL D+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V LY SFQ K ++ + DY PGG++ LL R +V E RFY AE+ +A+E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM 120
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSC------------------------------L 820
G I+RD+KP+N+L+ +GH+ LTDF L +
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 880
++C+ L T ++ + Q+ +A +S VGT YIAPE++ G+T D
Sbjct: 181 SNCRCGDRLKTLEQRATK----QHQRCLA------HSLVGTPNYIAPEVLLRKGYTQLCD 230
Query: 881 WWALGILLYEMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPSSCKAANV 930
WW++G++L+EML G PF T +T +++ L P S +A ++
Sbjct: 231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDL 282
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 5e-41
Identities = 86/251 (34%), Positives = 129/251 (51%), Gaps = 30/251 (11%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP- 729
F + LG G G V L E G+ + +A+K + K V++ + V E+ +L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
F+ L++ FQT + + +Y GG+L + Q KE FYAAE+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI--QQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+GIIYRDLK +NV+L GH+ + DF + CK + T
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKENMWDGVT----------------- 157
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+ +F GT +YIAPEIIA + +VDWWA G+LLYEML G PF G+ + F +
Sbjct: 158 -----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 212
Query: 910 ILHKDLKFPSS 920
I+ ++ +P S
Sbjct: 213 IMEHNVAYPKS 223
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 1e-40
Identities = 89/282 (31%), Positives = 138/282 (48%), Gaps = 39/282 (13%)
Query: 647 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY--FAMKAMDK 704
+KDS K ++ ++ + F I+ LG+G G V L + + A+K +K
Sbjct: 12 KKDSDSTKEPKR----KNKMKYEDFNFIRTLGTGSFGRVILATY-KNEDFPPVAIKRFEK 66
Query: 705 GVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP 764
++ + +V +ER+IL+ ++HPF LY SF+ ++++ L+ ++ GGE F L R
Sbjct: 67 SKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN- 125
Query: 765 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824
K D FYAA++V+ EYL I+YRDLKPEN+LL +G + +TDF + + +
Sbjct: 126 -KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184
Query: 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 884
+ + GT EYIAPEI+ GH A DWW L
Sbjct: 185 ------------------------------TYTLCGTPEYIAPEILLNVGHGKAADWWTL 214
Query: 885 GILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCK 926
GI +YE+L G PF + IL + FP ++CK
Sbjct: 215 GIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCK 256
|
Length = 340 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 3e-40
Identities = 91/262 (34%), Positives = 138/262 (52%), Gaps = 39/262 (14%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALY 735
+G G V LV L + Q +AMK + K ++ + + E+ + + +PF+ L+
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 736 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795
+ FQT + + L+ +Y GG+L + RQ + L E+ RFYAAE+ +AL +LH +GIIYR
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
DLK +NVLL +GH+ LTD+ + CK L P +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGM-----CKEGL----------------------GPGDTT 153
Query: 856 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF-------RGKTRQKTFA 908
++F GT YIAPEI+ G + +VDWWALG+L++EM+ G +PF T F
Sbjct: 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213
Query: 909 NILHKDLKFPSSTPSSCKAANV 930
IL K ++ P S KA++V
Sbjct: 214 VILEKPIRIPRFL--SVKASHV 233
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 92/264 (34%), Positives = 139/264 (52%), Gaps = 41/264 (15%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 735
+G G V LV L + + +AMK + K ++ + + E+ + + +HPF+ L+
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 736 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795
+ FQT++ + + +Y GG+L + RQ + L E+ RFY+AE+ +AL YLH +GIIYR
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
DLK +NVLL GH+ LTD+ + CK L P +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGM-----CKEGL----------------------RPGDTT 153
Query: 856 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF---------RGKTRQKT 906
++F GT YIAPEI+ G + +VDWWALG+L++EM+ G +PF T
Sbjct: 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 213
Query: 907 FANILHKDLKFPSSTPSSCKAANV 930
F IL K ++ P S S KAA+V
Sbjct: 214 FQVILEKQIRIPRSL--SVKAASV 235
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 1e-39
Identities = 102/290 (35%), Positives = 147/290 (50%), Gaps = 40/290 (13%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F IK LG G G V L + +AMK + K +L RN+V AER+IL D+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V LY SFQ K ++ + DY PGG++ LL R + ED RFY AE+ A+E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM 120
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG----QQNPV 846
G I+RD+KP+N+L+ +GH+ LTDF L C T++ K G Q +
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGL-CTG-------FRWTHDSKYYQSGDHVRQDSMD 172
Query: 847 FMAE--------------PM--RA--------SNSFVGTEEYIAPEIIAGAGHTSAVDWW 882
F E P+ RA ++S VGT YIAPE++ G+T DWW
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232
Query: 883 ALGILLYEMLYGYTPFRGKTRQKTFANIL--HKDLKFPSSTPSSCKAANV 930
++G++LYEML G PF +T +T ++ L P S +A+++
Sbjct: 233 SVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDL 282
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 4e-39
Identities = 88/256 (34%), Positives = 136/256 (53%), Gaps = 34/256 (13%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F IK +G G G V +V++ + + +AMK ++K ML R + ER +L D +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ L+ +FQ + ++ L+ DY GG+L LL + + L ED RFY AE+V+A+ +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQL 121
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
++RD+KP+NVLL NGH+ L DF SCL +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFG-SCLK-------------------------MNQD 155
Query: 851 PMRASNSFVGTEEYIAPEIIA----GAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
S+ VGT +YI+PEI+ G G + DWW+LG+ +YEMLYG TPF ++ +
Sbjct: 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
Query: 906 TFANILHKD--LKFPS 919
T+ I++ + +FPS
Sbjct: 216 TYGKIMNHEERFQFPS 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|237425 PRK13557, PRK13557, histidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 5e-39
Identities = 60/144 (41%), Positives = 84/144 (58%), Gaps = 3/144 (2%)
Query: 446 DDDYESDDERPDSVDD--KVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDS 503
R SVD+ + R I A +E ++TDP PDNPI+FA+ +
Sbjct: 3 SPPEPRPHGRAPSVDESAAGDVSDHRSDIFFAA-VETTRMPMIVTDPNQPDNPIVFANRA 61
Query: 504 FLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNL 563
FLE+T Y+ EEI+G NCRFLQGPETD ATV ++R AI + ++ +++NY K G FWN
Sbjct: 62 FLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERREIATEILNYRKDGSSFWNA 121
Query: 564 FHLQPMRDQKGEVQYFIGVQLDGS 587
+ P+ + G++ YF G QLD S
Sbjct: 122 LFVSPVYNDAGDLVYFFGSQLDVS 145
|
Length = 540 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-38
Identities = 85/261 (32%), Positives = 128/261 (49%), Gaps = 30/261 (11%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+R ++ LG G G V+L + A+K + K + +V R E +IL L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 730 -FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVALEYL 787
+ LY FQ + + L+ +Y GG L LL + K L E F A+++ ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 788 HCQGIIYRDLKPENVLLQGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
H +GII+RD+KPEN+LL +G V L DF L+ L +P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP---------------------DPG 156
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYEMLYGYTPFRGKTR 903
+ ++ VGT Y+APE++ G +S+ D W+LGI LYE+L G PF G+
Sbjct: 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
Query: 904 QKTFANILHKDLKFPSSTPSS 924
+ L L+ P+ + +S
Sbjct: 217 SSATSQTLKIILELPTPSLAS 237
|
Length = 384 |
| >gnl|CDD|237427 PRK13559, PRK13559, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-38
Identities = 56/125 (44%), Positives = 76/125 (60%)
Query: 464 RQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFL 523
R G +E+ ITDP PD PI+ A+ +FL+LT Y+ EE++GRNCRFL
Sbjct: 35 RDFRGASGRLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFL 94
Query: 524 QGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQ 583
QG TDP V KIRAAI + ++ V+L+NY K G+ FWN HL P+ + G + YF G Q
Sbjct: 95 QGAATDPIAVAKIRAAIAAEREIVVELLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQ 154
Query: 584 LDGSE 588
D ++
Sbjct: 155 WDVTD 159
|
Length = 361 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 9e-38
Identities = 89/258 (34%), Positives = 142/258 (55%), Gaps = 34/258 (13%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ F +K +G G G V +V+L + + FAMK ++K ML R + ER++L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
++ L+ +FQ + ++ L+ DY GG+L LL + + L ED RFY AE+V+A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVH 119
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
++RD+KP+N+L+ NGH+ L DF SCL M
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFG-SCLK-------------------------LM 153
Query: 849 AEPMRASNSFVGTEEYIAPEIIA----GAG-HTSAVDWWALGILLYEMLYGYTPFRGKTR 903
+ S+ VGT +YI+PEI+ G G + DWW+LG+ +YEMLYG TPF ++
Sbjct: 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 904 QKTFANIL-HKD-LKFPS 919
+T+ I+ HK+ +FP+
Sbjct: 214 VETYGKIMNHKERFQFPA 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 70/256 (27%), Positives = 107/256 (41%), Gaps = 33/256 (12%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
F ++ +G G G V+ +G+ A+K + + K+ E +IL HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---EIQILKKCKHP 57
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+ Y S+ K + ++ ++C GG L LL + L E + + E++ LEYLH
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS 116
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
GII+RD+K N+LL +G V L DF LS QL
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSA------QL---------------------- 148
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+A N+ VGT ++APE+I G + D W+LGI E+ G P+ K
Sbjct: 149 SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK 208
Query: 910 ILHKDL-KFPSSTPSS 924
I + S
Sbjct: 209 IATNGPPGLRNPEKWS 224
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 65/233 (27%), Positives = 103/233 (44%), Gaps = 36/233 (15%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA---EREILDMLD 727
+ + LG G GSV+L +G+ A+K+++ L+ + A E IL L
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVE----LSGDSEEELEALEREIRILSSLQ 57
Query: 728 HPFVPALYASFQTKT--HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
HP + Y S + + + + +Y GG L LL + L E +R Y +++ L
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLA 115
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YLH GI++RD+K N+L+ +G V L DF + KR +
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDGVVKLADFGCA-----------------KRLGDIETGE 158
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ S GT ++APE+I G + A D W+LG + EM G P+
Sbjct: 159 --------GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-37
Identities = 90/283 (31%), Positives = 146/283 (51%), Gaps = 37/283 (13%)
Query: 654 KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 713
K ++KI Q+ + + +K +G G G V LV S + +AMK + K M+ R+
Sbjct: 30 KIVRKI--RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87
Query: 714 HRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV 773
ER+I+ + P+V L+ +FQ ++ ++ +Y PGG+L L+ + E
Sbjct: 88 AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWA 144
Query: 774 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
+FY AEVV+AL+ +H G+I+RD+KP+N+LL +GH+ L DF +C+
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG-TCM------------- 190
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLY 889
K G M ++ VGT +YI+PE++ G + DWW++G+ L+
Sbjct: 191 --KMDETG----------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 238
Query: 890 EMLYGYTPFRGKTRQKTFANIL-HKD-LKFPSSTPSSCKAANV 930
EML G TPF + T++ I+ HK+ L FP S A N+
Sbjct: 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNL 281
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|237427 PRK13559, PRK13559, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-36
Identities = 52/113 (46%), Positives = 72/113 (63%), Gaps = 3/113 (2%)
Query: 195 LSTFQQT---FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVA 251
+QT ++D +PD PI+ A+ F +TGY ++EVVGRNCRFLQGA TDP VA
Sbjct: 46 EQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVA 105
Query: 252 KIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
KIR + + LLNY+KDG PFWN L + P+ ++G++L F G Q +V+
Sbjct: 106 KIRAAIAAEREIVVELLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVT 158
|
Length = 361 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 82/258 (31%), Positives = 133/258 (51%), Gaps = 38/258 (14%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPA 733
+G G G V+ +G+ +AMK +DK + + A ER +L ++ D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
+ +F T + I D GG+L L + V E +RFYAAE+++ LE++H + ++
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLKP N+LL +GHV ++D L+C S KK+ H
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFS------------KKKPH-------------- 153
Query: 854 ASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRG-KTRQKTFAN-- 909
AS VGT Y+APE++ G + S+ DW++LG +L+++L G++PFR KT+ K +
Sbjct: 154 AS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210
Query: 910 ILHKDLKFPSSTPSSCKA 927
L ++ P S ++
Sbjct: 211 TLTMAVELPDSFSPELRS 228
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 2e-36
Identities = 91/281 (32%), Positives = 145/281 (51%), Gaps = 37/281 (13%)
Query: 656 IQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR 715
I KI D ++ + + +K +G G G V LV + + +AMK + K M+ R+
Sbjct: 32 INKIRDL--RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF 89
Query: 716 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
ER+I+ + P+V L+ +FQ ++ ++ +Y PGG+L L+ + E RF
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARF 146
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
Y AEVV+AL+ +H G I+RD+KP+N+LL +GH+ L DF +C+ K
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG-TCMKMNK----------- 194
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEM 891
E M ++ VGT +YI+PE++ G + DWW++G+ LYEM
Sbjct: 195 --------------EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
Query: 892 LYGYTPFRGKTRQKTFANIL-HKD-LKFPSSTPSSCKAANV 930
L G TPF + T++ I+ HK+ L FP S +A N+
Sbjct: 241 LVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 281
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 74/231 (32%), Positives = 116/231 (50%), Gaps = 28/231 (12%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
FR + LG G G V ++ +G+ +A K ++K + R A E++IL+ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V +L +++TK +CL+ GG+L + E+ FYAAE+ LE LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
I+YRDLKPEN+LL GH+ ++D L+ + E
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAV-------------------------EIPEGE 156
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+R VGT Y+APE++ +T + DWW LG L+YEM+ G +PFR +
Sbjct: 157 TIRGR---VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 73/234 (31%), Positives = 119/234 (50%), Gaps = 28/234 (11%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
FR + LG G G V ++ +G+ +A K ++K + R A E++IL+ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V L +++TK +CL+ GG+L + +E+ FYAAE++ LE LH +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
+YRDLKPEN+LL GH+ ++D L+ + +P + R
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA--------VKIPEGESIRGR------------ 161
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
VGT Y+APE++ +T + D+W LG L+YEM+ G +PFRG+ +
Sbjct: 162 --------VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 70/223 (31%), Positives = 115/223 (51%), Gaps = 28/223 (12%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V V++ +G+ +A K +DK + ++ A E+EIL+ ++ PF+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
+F++KTH+CL+ GG+L + + L+ + V Y+A++ + +LH I+YRD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
+KPENVLL G+ L+D L+ + L +R
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLA--------VELKDGKTITQR------------------ 154
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
GT Y+APEI+ ++ VDW+A+G +YEM+ G TPF+
Sbjct: 155 --AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 2e-33
Identities = 77/234 (32%), Positives = 123/234 (52%), Gaps = 36/234 (15%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPA 733
+G G G V+ +G+ +AMK +DK + + A ER +L ++ D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
+ +F T +C I D GG+L L + V E +RFYA E+++ LE++H + ++
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLKP N+LL +GHV ++D L+C S KK+ H
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFS------------KKKPHAS------------ 155
Query: 854 ASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLYGYTPFRG-KTRQK 905
VGT Y+APE++ G + S+ DW++LG +L+++L G++PFR KT+ K
Sbjct: 156 -----VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 76/234 (32%), Positives = 121/234 (51%), Gaps = 28/234 (11%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
FR + LG G G V ++ +G+ +A K ++K + R A E++IL+ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V +L +++TK +CL+ GG+L + +E FYAAE+ LE LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
I+YRDLKPEN+LL +GH+ ++D L+ + +P K R
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA--------VHVPEGQTIKGR------------ 161
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
VGT Y+APE++ +T + DWWALG LLYEM+ G +PF+ + ++
Sbjct: 162 --------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 77/258 (29%), Positives = 124/258 (48%), Gaps = 37/258 (14%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V ++ +G+ +A K ++K + R A E+ IL + F+ +L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 737 SFQTKTHVCLITDYCPGGEL----FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
+FQTKT +CL+ GG+L + + + P E FY A+++ LE+LH + I
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG--FPEPRACFYTAQIISGLEHLHQRRI 118
Query: 793 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
IYRDLKPENVLL +G+V ++D L+ V + +
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLA---------------------------VELKDGQ 151
Query: 853 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG---KTRQKTFAN 909
+ + GT ++APE++ G + +VD++ALG+ LYEM+ PFR K K
Sbjct: 152 SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ 211
Query: 910 -ILHKDLKFPSSTPSSCK 926
IL+ + +P + K
Sbjct: 212 RILNDSVTYPDKFSPASK 229
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|237426 PRK13558, PRK13558, bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 4e-31
Identities = 52/123 (42%), Positives = 73/123 (59%), Gaps = 5/123 (4%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 545
I D LPD P+I+ +D+F +T YS +E+LGRNCRFLQG +T+ V ++R AID +
Sbjct: 162 TIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERP 221
Query: 546 VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEES 605
+V+L NY K G FWN + P+RD+ G V +++G Q D +E R A E
Sbjct: 222 TSVELRNYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTE-----RKEAELALQRER 276
Query: 606 EKL 608
KL
Sbjct: 277 RKL 279
|
Length = 665 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 74/229 (32%), Positives = 113/229 (49%), Gaps = 28/229 (12%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
FR + LG G G V ++ +G+ +A K ++K + R A E+ IL+ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V +L +++TK +CL+ GG+L + E FYAAE+ LE L +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
I+YRDLKPEN+LL GH+ ++D L+ + +P + R
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA--------VQIPEGETVRGR------------ 161
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
VGT Y+APE+I +T + DWW LG L+YEM+ G +PFR
Sbjct: 162 --------VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|237426 PRK13558, PRK13558, bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 9e-31
Identities = 48/106 (45%), Positives = 73/106 (68%)
Query: 203 VVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS 262
++DAT PD P++Y + F ++TGY+ EV+GRNCRFLQG T+ E VA++RE + +
Sbjct: 162 TIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERP 221
Query: 263 YCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308
L NY+KDG+ FWN + IAPI+D++G V ++G Q +V++ E
Sbjct: 222 TSVELRNYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKE 267
|
Length = 665 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 68/236 (28%), Positives = 113/236 (47%), Gaps = 32/236 (13%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F+ +K LG G GSV+ V+ Q++A+K +D G M ++ + A E IL ++HP
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPN 60
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT--KVLKEDAVRFYAAEVVVALEYLH 788
+ + +F +C++ +Y P G+L + ++ K++ E + +++ L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
Q I++RDLK N+LL N V + D +S + KK K Q
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVL-------------KKNMAKTQ------ 161
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+GT Y+APE+ G ++ D W+LG LLYEM PF ++ Q
Sbjct: 162 ----------IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ 207
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|237425 PRK13557, PRK13557, histidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 49/118 (41%), Positives = 79/118 (66%)
Query: 188 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDP 247
SDI A+ T + +V+D +PD PI++A+ F +MTGY ++E++G NCRFLQG TD
Sbjct: 29 SDIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDR 88
Query: 248 EDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 305
VA++R+ + + +LNY+KDG+ FWN L ++P+ +D G ++ F G Q++VS+
Sbjct: 89 ATVAEVRDAIAERREIATEILNYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSR 146
|
Length = 540 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 71/226 (31%), Positives = 107/226 (47%), Gaps = 31/226 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA-EREILDMLDHPFVPALY 735
+G G G V+ +G+ A+K + + N K + A E ++L++L HP + Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIR--IQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 736 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795
+ V + +YC GG L LL+ ++L E +R Y +++ L YLH GI++R
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHR 123
Query: 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
D+KP N+ L NG + L DF C +L TT M E +
Sbjct: 124 DIKPANIFLDHNGVIKLGDF------GCAVKLKNNTTT--------------MGEEV--- 160
Query: 856 NSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEMLYGYTPF 898
S GT Y+APE+I G GH A D W+LG ++ EM G P+
Sbjct: 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|222120 pfam13426, PAS_9, PAS domain | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-29
Identities = 39/104 (37%), Positives = 60/104 (57%), Gaps = 3/104 (2%)
Query: 485 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 544
++ DP D I++A+D+ L L Y+REE+LG++ R L GP D V ++R A+ N
Sbjct: 1 ILVLDP---DGRIVYANDAALRLLGYTREELLGKSIRDLFGPGDDEEAVARLREALRNGG 57
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
+V V+L K G+ F L P+RD+ GEV +G+ D +E
Sbjct: 58 EVEVELELRRKDGEPFPVLVSASPVRDEDGEVVGIVGILRDITE 101
|
Length = 101 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-29
Identities = 60/154 (38%), Positives = 92/154 (59%), Gaps = 2/154 (1%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
++ F +KP+ G G V+L + + +A+K + K M+N+N VH+ AER+ L +
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
PF+ LY S Q+ +V L+ +Y GG++ LL E+ Y +EV +AL+YL
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLL--HIYGYFDEEMAVKYISEVALALDYL 120
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821
H GII+RDLKP+N+L+ GH+ LTDF LS +T
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 69/244 (28%), Positives = 114/244 (46%), Gaps = 34/244 (13%)
Query: 655 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 714
A++ I+ G+ L ++ ++ +G G +G V+ +G+ A+K M L +
Sbjct: 7 ALKDIVSEGDPREL--YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKE 60
Query: 715 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVR 774
E I+ HP + Y S+ + ++ +Y GG L ++ + + + E +
Sbjct: 61 LIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIA 119
Query: 775 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
+ EV+ LEYLH Q +I+RD+K +N+LL +G V L DF + QL T E
Sbjct: 120 YVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAA------QL----TKE 169
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 894
K +R NS VGT ++APE+I + VD W+LGI+ EM G
Sbjct: 170 KSKR-----------------NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
Query: 895 YTPF 898
P+
Sbjct: 213 EPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 66/251 (26%), Positives = 113/251 (45%), Gaps = 33/251 (13%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+K LG G +G V+ V +G+ +A+K + + + E + L + P
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI-HVDG-DEEFRKQLLRELKTLRSCESP 59
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+V Y +F + + ++ +Y GG L LL + + E + + A +++ L+YLH
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYLHT 117
Query: 790 Q-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
+ II+RD+KP N+L+ G V + DF +S +L T ++
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISK--------VLENTLDQC------------ 157
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908
N+FVGT Y++PE I G ++ A D W+LG+ L E G PF Q +F
Sbjct: 158 -------NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFL-PPGQPSFF 209
Query: 909 NILHKDLKFPS 919
++ P
Sbjct: 210 ELMQAICDGPP 220
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 32/223 (14%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC-AEREILDMLDHPFVPALY 735
+G G G V+ +G + A+K + + + + ++ E ++L L HP +
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQIS--LEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 736 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795
S +T + +I +Y G L ++ + E V Y +V+ L YLH QG+I+R
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHR 123
Query: 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
D+K N+L +G V L DF ++ + + +
Sbjct: 124 DIKAANILTTKDGVVKLADFGVA---------------------------TKLNDVSKDD 156
Query: 856 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
S VGT ++APE+I +G ++A D W+LG + E+L G P+
Sbjct: 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY 199
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|222120 pfam13426, PAS_9, PAS domain | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 37/104 (35%), Positives = 66/104 (63%), Gaps = 3/104 (2%)
Query: 202 FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ 261
+V D PD I+YA+ ++ GYT +E++G++ R L G G D E VA++RE L+NG
Sbjct: 1 ILVLD---PDGRIVYANDAALRLLGYTREELLGKSIRDLFGPGDDEEAVARLREALRNGG 57
Query: 262 SYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 305
L +KDG PF L++ +P++D++G+V+ +G+ ++++
Sbjct: 58 EVEVELELRRKDGEPFPVLVSASPVRDEDGEVVGIVGILRDITE 101
|
Length = 101 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 71/229 (31%), Positives = 104/229 (45%), Gaps = 36/229 (15%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 728
F ++ +G G G V+ + Q A+K +D L + ++EI L
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID----LEEAEDEIEDIQQEIQFLSQCRS 58
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
P++ Y SF + + +I +YC GG LL L E + F EV++ LEYLH
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGLEYLH 115
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
+G I+RD+K N+LL G V L DF +S QL T+ KR
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVS------GQL---TSTMSKR----------- 155
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897
N+FVGT ++APE+I +G+ D W+LGI E+ G P
Sbjct: 156 -------NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 59/238 (24%), Positives = 106/238 (44%), Gaps = 37/238 (15%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
++ +G G G+V V G+ K +D G M + K + +E IL L HP +
Sbjct: 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHPNIVR 63
Query: 734 LYASF--QTKTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHC 789
Y ++ + ++ +YC GG+L L+ + + K ++E+ + ++++AL H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 790 QG-----IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
+ +++RDLKP N+ L N +V L DF L+ +L +
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA--------KILGHDS----------- 164
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902
A ++VGT Y++PE + + D W+LG L+YE+ PF +
Sbjct: 165 --SFA------KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 33/231 (14%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ LG+G++G V V +G+ A+K + + K + E +IL +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK--QILRELDILHKCNS 58
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
P++ Y +F + + +Y GG L +L + E + A V+ L YLH
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEV-QGRIPERILGKIAVAVLKGLTYLH 117
Query: 789 CQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
+ II+RD+KP N+L+ G + L DF +S QL N
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS------GQL----VNSL------------ 155
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ +FVGT Y+APE I G ++ D W+LG+ L E+ G P+
Sbjct: 156 -------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 66/249 (26%), Positives = 101/249 (40%), Gaps = 31/249 (12%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LD 727
+ I+ +G G T V+ + + A+K +D L + + +E+ M +
Sbjct: 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRID----LEKCQTSVDELRKEVQAMSQCN 57
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEY 786
HP V Y SF + L+ Y GG L ++ P L E + EV+ LEY
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
LH G I+RD+K N+LL +G V + DF +S L +K R
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSAS------LADGGDRTRKVRK------- 164
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
+FVGT ++APE++ G+ D W+ GI E+ G P+ K
Sbjct: 165 ----------TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214
Query: 906 TFANILHKD 914
L D
Sbjct: 215 VLMLTLQND 223
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
+G G G V V + +AMK +D M NR + A E +L LD ++ Y
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV-RFYAAEVVVALEYLHCQGIIYR 795
SF K + ++ +Y G+L LL Q + L ED V RF+ ++++ L +LH + I++R
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF-IQILLGLAHLHSKKILHR 125
Query: 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
D+K N+ L +V + D ++ +LL TN +
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVA-------KLLSDNTN--------------------FA 158
Query: 856 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
N+ VGT Y++PE+ + D WALG++LYE G PF
Sbjct: 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 33/230 (14%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F ++ LG G GSV+ +GQ A+K V+ + E IL D P+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIK-----VVPVEEDLQEIIKEISILKQCDSPY 59
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ Y S+ T + ++ +YC G + ++ + K L E+ + + + LEYLH
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-KITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
I+RD+K N+LL G L DF +S GQ +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVS----------------------GQLT-----D 151
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
M N+ +GT ++APE+I G+ + D W+LGI EM G P+
Sbjct: 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 71/242 (29%), Positives = 107/242 (44%), Gaps = 43/242 (17%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR--NKVHR-ACAEREILDML 726
H+ PI+ LG G G L K ++ L R K R A E IL +L
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN----LTRLSEKERRDALNEIVILSLL 56
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
HP + A Y F + + +Y GG L+ + RQ ++ +E+ V +Y ++V A+ Y
Sbjct: 57 QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
+H GI++RD+K N+ L G + L DF +S K +
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS---------------------KILGSEY 155
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
MAE + VGT Y++PE+ G + D WALG +LYE+L T ++T
Sbjct: 156 SMAE------TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL---------TLKRT 200
Query: 907 FA 908
F
Sbjct: 201 FD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 35/231 (15%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFV 731
+ +G G G V+ +G+ A+K + ++ A REI L L+HP +
Sbjct: 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLR---FESEGIPKTALREIKLLKELNHPNI 60
Query: 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 791
L F+ K + L+ ++ L+ DRQ + L E ++ Y +++ L + H G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 792 IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEP 851
I++RDLKPEN+L+ G + L DF L+ +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH--------------------- 157
Query: 852 MRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGK 901
+V T Y APE++ G G+++ VD W++G + E+L F GK
Sbjct: 158 ------YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK 202
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 5e-23
Identities = 68/221 (30%), Positives = 111/221 (50%), Gaps = 36/221 (16%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPAL 734
LG G G+V+LV+ + +K + + + LN N+ +A E ++L LDHP +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
+ASF + C+IT+YC G +L L+ + K L E+ V + ++++ + Y+H + I
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 793 IYRDLKPENVLLQGNGHVSLTDFDLSCLT--SCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
++RDLK +N+ L+ N + + DF +S L SC L TT
Sbjct: 128 LHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCD----LATT------------------ 164
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891
F GT Y++PE + G+ S D W+LG +LYEM
Sbjct: 165 -------FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 39/228 (17%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA---EREI--LDMLDHPFV 731
LGSG GSV+ G +FA+K + + + + + E+EI L L HP +
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVS---LADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 791
+ + + ++ + + PGG L LL + E +R Y ++++ LEYLH +
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRN 122
Query: 792 IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEP 851
++RD+K N+L+ NG V L DF ++ K+
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMA----------------KQ------------VVE 154
Query: 852 MRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPF 898
+ SF G+ ++APE+IA G + A D W+LG + EM G P+
Sbjct: 155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW 202
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 5e-22
Identities = 71/247 (28%), Positives = 116/247 (46%), Gaps = 41/247 (16%)
Query: 655 AIQKILDSGEQ-INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 713
A+Q ++D G+ L +F I G G TG V + +G+ A+K MD R +
Sbjct: 7 ALQLVVDPGDPRSYLDNFVKI---GEGSTGIVCIATDKSTGRQVAVKKMDL-----RKQQ 58
Query: 714 HRACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
R E++ M D HP + +Y+S+ + ++ ++ GG L D + E+
Sbjct: 59 RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEE 115
Query: 772 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831
+ V+ AL +LH QG+I+RD+K +++LL +G V L+DF S
Sbjct: 116 QIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS--------- 166
Query: 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891
E RR S VGT ++APE+I+ + + VD W+LGI++ EM
Sbjct: 167 -KEVPRR-----------------KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 208
Query: 892 LYGYTPF 898
+ G P+
Sbjct: 209 VDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 7e-22
Identities = 63/234 (26%), Positives = 110/234 (47%), Gaps = 40/234 (17%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-----LDM 725
++ ++ +G G G+V+ + +G+ A+K ++ L+ + +RE+ L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIIN----LDTPDDDVSDIQREVALLSQLRQ 58
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
P + Y S+ + +I +Y GG + L+ P + E + EV+VAL+
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP---IAEKYISVIIREVLVALK 115
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
Y+H G+I+RD+K N+L+ G+V L DF ++ L N KR
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL---------NQNSSKR-------- 158
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPF 898
++FVGT ++APE+I G + + D W+LGI +YEM G P+
Sbjct: 159 ----------STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 65/231 (28%), Positives = 100/231 (43%), Gaps = 42/231 (18%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK--AMDKGVMLNRNKVHRACAEREILDM 725
+ + I+ +GSG G V+ +G+ A+K ++ G + E +L
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-----DDFEIIQQEISMLKE 56
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVA 783
HP + A + S+ + + ++ +YC GG L + R P L E + + E +
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKG 113
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
L YLH G I+RD+K N+LL +G V L DF +S QL T KR
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSA------QL---TATIAKR------ 158
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEM 891
SF+GT ++APE+ A G+ D WALGI E+
Sbjct: 159 ------------KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 9e-22
Identities = 58/229 (25%), Positives = 108/229 (47%), Gaps = 29/229 (12%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
++ +G G G LV+ S Q +AMK + + + + V + E +L + HP + A
Sbjct: 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIR--LPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
SF+ H+ ++ +YC GG+L + Q K+ ED + + ++ + ++++H + ++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVL 122
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
+RD+K +N+ L NG V L DF + L + P
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARL---------------------------LTSPGA 155
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902
+ ++VGT Y+ PEI + + D W+LG +LYE+ PF+ +
Sbjct: 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 62/208 (29%), Positives = 85/208 (40%), Gaps = 52/208 (25%)
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
M D+P LY S T LI DY G+LF LL ++ L E V+ ++V AL
Sbjct: 65 MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEAL 122
Query: 785 EYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
LH II+ D+K ENVL + + L D+ L CK G
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL-----CK--------------IIGTP 163
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG--- 900
+ + GT +Y +PE I G + + DWWA+G+L YE+L G PF+
Sbjct: 164 ------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211
Query: 901 --------KTRQKTFANILHKDLKFPSS 920
RQ K L F +
Sbjct: 212 EELDLESLLKRQ-------QKKLPFIKN 232
|
Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+ I+ +G G G VHL + +K + M +++ A E ++L +L HP
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPN 60
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ Y +F + ++ +Y PGG L + ++ +L ED + + ++++AL ++H +
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 791 GIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
I++RDLK +N+LL + H V + DF +S + S K
Sbjct: 121 LILHRDLKTQNILL--DKHKMVVKIGDFGISKILSSK----------------------- 155
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
+ + VGT YI+PE+ G + D WALG +LYE+
Sbjct: 156 -----SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 66/235 (28%), Positives = 106/235 (45%), Gaps = 29/235 (12%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
L +F+ K +G G V+ G+ A+K + M++ E ++L LD
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALE 785
HP V ASF + ++ + G+L ++ ++ +++ E + Y ++ ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
++H + I++RD+KP NV + G V L D L S K TT
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------TT------------- 161
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
A++S VGT Y++PE I G+ D W+LG LLYEM +PF G
Sbjct: 162 --------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 56/219 (25%), Positives = 107/219 (48%), Gaps = 28/219 (12%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
+K +G G G LV+ G+ + +K ++ M + + + E +L + HP +
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMKHPNIVQ 63
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
SF+ ++ ++ DYC GG+L+ ++ Q + ED + + ++ +AL+++H + I+
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
+RD+K +N+ L +G + L DF ++ +L +T E R
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIA--------RVLNSTVELAR---------------- 159
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
+ +GT Y++PEI + + D WALG +LYEM
Sbjct: 160 ---TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 36/220 (16%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V+ + +G + A K + + ++ E +IL HP + LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
++ + + ++ ++C GG L ++ + + L E +R+ +++ AL +LH +I+RD
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIML-ELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRD 128
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
LK N+LL +G V L DF +S + ++R
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAK----------NKSTLQKRD----------------- 161
Query: 857 SFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEM 891
+F+GT ++APE++A + D W+LGI L E+
Sbjct: 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 6e-21
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 29/228 (12%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMD-KGVMLNRNKVHRA---CAEREI--LDMLDHPF 730
+GSG GSV+L SG+ A+K ++ V + R+ REI L L H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ S H+ + +Y PGG + LL+ +E VR + +++ L YLH +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNR 125
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
GII+RD+K N+L+ G + ++DF +S +L + + K +
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGIS------KKLEANSLSTKTNGAR---------- 169
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
S G+ ++APE++ +T D W+LG L+ EML G PF
Sbjct: 170 -----PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 64/259 (24%), Positives = 107/259 (41%), Gaps = 40/259 (15%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVML-NRNKVHRACAEREILDMLDH 728
K LG G G V+ L G G A+K + + + R E I+ LDH
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLR---EARIMRKLDH 60
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
P + L + + ++ +Y PGG+L +L +P ++ D + F A ++ +EY
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSF-ALQIARGMEY 118
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
L + I+RDL N L+ N V ++DF LS ++ + KG + P+
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRD----------LYDDDYYKVKGGKLPI 168
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQK 905
++APE + TS D W+ G+LL+E+ G P+ G + +
Sbjct: 169 R----------------WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE 212
Query: 906 TFANILHKD-LKFPSSTPS 923
+ L P + P
Sbjct: 213 VLEYLKKGYRLPKPPNCPP 231
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 68/248 (27%), Positives = 106/248 (42%), Gaps = 57/248 (22%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI---LDML- 726
F ++ +G G G V+ +GQ A+K MD E EI ++L
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----------IIEDEEEEIKEEYNILR 57
Query: 727 ---DHPFVPALYASFQTKTHVC------LITDYCPGGELFLLLD--RQPTKVLKEDAVRF 775
+HP + Y +F K L+ + C GG + L+ R+ K LKE+ + +
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
E + L YLH +I+RD+K +N+LL N V L DF +S L +T +
Sbjct: 118 ILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--------QLDSTLGR 169
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYE 890
+ N+F+GT ++APE+IA A + + D W+LGI E
Sbjct: 170 R-------------------NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
Query: 891 MLYGYTPF 898
+ G P
Sbjct: 211 LADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-20
Identities = 60/243 (24%), Positives = 114/243 (46%), Gaps = 33/243 (13%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 728
+ IK +G G G ++L + ++ +K +D M + K +++E+ L + H
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK---EASKKEVILLAKMKH 58
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
P + +ASFQ + ++ +YC GG+L ++RQ + ED + + ++ + L+++H
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 789 CQGIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
+ I++RD+K +N+ L NG V+ L DF ++
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--------------------------- 151
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907
+ + M + + VGT Y++PEI + + D W+LG +LYE+ PF G +
Sbjct: 152 LNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV 211
Query: 908 ANI 910
I
Sbjct: 212 LKI 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 38/233 (16%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ I LG+G+ GSV V+ +G A K + G + K + E +I+
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK--QILRELQIMHECRS 62
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV--LKEDAVRFYAAEVVVALEY 786
P++ + Y +F + ++C+ ++ G L DR K + + + A VV L Y
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSL----DRIYKKGGPIPVEILGKIAVAVVEGLTY 118
Query: 787 LH-CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
L+ I++RD+KP N+L+ G + L DF +S +L+ N
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS------GELI---------------NS 157
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ +++FVGT Y++PE I G +T D W+LGI + E+ G PF
Sbjct: 158 I--------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 30/227 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
+G G G V + +G+ A+K + L ++A E + L HP+V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV-ALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
F + L+ +Y P +L D + + L E V+ Y ++ + Y+H GI++RD
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANGIMHRD 124
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
LKP N+L+ +G + + DF L+ L S E R +
Sbjct: 125 LKPANLLISADGVLKIADFGLARLFS--------------------------EEEPRLYS 158
Query: 857 SFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKT 902
V T Y APE++ GA VD WA+G + E+L G F G+
Sbjct: 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 2e-19
Identities = 54/189 (28%), Positives = 86/189 (45%), Gaps = 38/189 (20%)
Query: 720 REI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGE--LFLLLDRQPTKVLKEDAVRF 775
REI L L HP + L T+ + L+ +YC + L LD++P L + ++
Sbjct: 47 REISLLKELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGP-LSPNLIKS 102
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLPTTNE 834
+++ L Y H I++RDLKP+N+L+ +G + L DF L+
Sbjct: 103 IMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI------------ 150
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLY 893
P+R V T Y APEI+ G+ H ++AVD W++G + EM+
Sbjct: 151 ----------------PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT 194
Query: 894 GYTPFRGKT 902
G F G +
Sbjct: 195 GKPLFPGDS 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 70/247 (28%), Positives = 119/247 (48%), Gaps = 41/247 (16%)
Query: 655 AIQKILDSGE-QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 713
A++ ++D G+ + L+++ I G G TG V + SG+ A+K MD R +
Sbjct: 9 ALRMVVDQGDPRSLLENYIKI---GEGSTGIVCIAREKHSGRQVAVKMMDL-----RKQQ 60
Query: 714 HRACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
R E++ M D H V +Y S+ + ++ ++ GG L ++ + L E+
Sbjct: 61 RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR---LNEE 117
Query: 772 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831
+ V+ AL YLH QG+I+RD+K +++LL +G V L+DF S
Sbjct: 118 QIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS--------- 168
Query: 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891
+ KR+ S VGT ++APE+I+ + + VD W+LGI++ EM
Sbjct: 169 KDVPKRK------------------SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210
Query: 892 LYGYTPF 898
+ G P+
Sbjct: 211 VDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (219), Expect = 3e-19
Identities = 56/238 (23%), Positives = 92/238 (38%), Gaps = 41/238 (17%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV----MLNRNKVHRACAE--REILDM-- 725
K LG G G V+ G + L E E M
Sbjct: 4 GKKLGEGAFGEVYK------GTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKK 57
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
L HP + L + ++T+Y PGG+L L + K+ +D ++ A ++ +E
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQM-ALQIAKGME 116
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YL + ++RDL N L+ N V ++DF LS + + +KR + P
Sbjct: 117 YLESKNFVHRDLAARNCLVTENLVVKISDFGLS-------RDIYEDDYYRKRGGG--KLP 167
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 902
+ ++APE + TS D W+ G+LL+E+ G P+ G +
Sbjct: 168 IK----------------WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS 209
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 63/259 (24%), Positives = 107/259 (41%), Gaps = 41/259 (15%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVML-NRNKVHRACAEREILDMLDH 728
K LG G G V+ +L G G A+K + + + R E I+ LDH
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLR---EARIMRKLDH 60
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
P V L + + ++ +Y GG+L +L R+ L + +A ++ +EY
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEY 117
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
L + I+RDL N L+ N V ++DF LS ++ R +G + P+
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRD----------LYDDDYYRKRGGKLPI 167
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQK 905
++APE + TS D W+ G+LL+E+ G P+ G + ++
Sbjct: 168 R----------------WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 211
Query: 906 TFANILHKD-LKFPSSTPS 923
+ + L P + P
Sbjct: 212 VLEYLKNGYRLPQPPNCPP 230
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 66/235 (28%), Positives = 106/235 (45%), Gaps = 29/235 (12%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
L +FR K +G G V+ G A+K + +++ E ++L L+
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALE 785
HP V YASF + ++ + G+L ++ ++ +++ E V Y ++ ALE
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
++H + +++RD+KP NV + G V L D L S K TT
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------TT------------- 161
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
A++S VGT Y++PE I G+ D W+LG LLYEM +PF G
Sbjct: 162 --------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 44/214 (20%)
Query: 685 VHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTKT 742
V LV + Q F +K + K +R + L ++ H P + L+ ++
Sbjct: 9 VLLVMDTRTQQTFILKGLRKSSEYSRER----------LTIIPHCVPNMVCLHKYIVSED 58
Query: 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802
V L+ + GG+L+ + + + E+ V+ +AAE+VVAL+ LH +GI+ RDL P N+
Sbjct: 59 SVFLVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116
Query: 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 862
LL GH+ LT F + + V E +
Sbjct: 117 LLDDRGHIQLTYF-------------------------SRWSEV---EDSCDGEAV--EN 146
Query: 863 EYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT 896
Y APE+ + T A DWW+LG +L+E+L G T
Sbjct: 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKT 180
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 60/244 (24%), Positives = 102/244 (41%), Gaps = 50/244 (20%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA------CAEREI-- 722
+ I +G G G V+ +G+ A+K + ++ A REI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI---------RMENEKEGFPITAIREIKL 51
Query: 723 LDMLDHPFVPALY---ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
L L HP + L S + + ++ +Y +L LLD K E ++ Y +
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGS-IYMVFEYMDH-DLTGLLDSPEVK-FTESQIKCYMKQ 108
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
++ L+YLH GI++RD+K N+L+ +G + L DF L+ R +
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLA------------------RPY 150
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPF 898
+ + + + V T Y PE++ GA VD W++G +L E+ G F
Sbjct: 151 TKRNSADY--------TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202
Query: 899 RGKT 902
+G T
Sbjct: 203 QGST 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 72/247 (29%), Positives = 114/247 (46%), Gaps = 41/247 (16%)
Query: 655 AIQKILDSGE-QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 713
A+Q ++D G+ + L +F I G G TG V + + SG+ A+K MD R +
Sbjct: 8 ALQMVVDPGDPRTYLDNFIKI---GEGSTGIVCIATVKSSGKLVAVKKMDL-----RKQQ 59
Query: 714 HRACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
R E++ M D H V +Y S+ + ++ ++ GG L D + E+
Sbjct: 60 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEE 116
Query: 772 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831
+ V+ AL LH QG+I+RD+K +++LL +G V L+DF S
Sbjct: 117 QIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--------- 167
Query: 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891
E RR S VGT ++APE+I+ + VD W+LGI++ EM
Sbjct: 168 -KEVPRR-----------------KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209
Query: 892 LYGYTPF 898
+ G P+
Sbjct: 210 VDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 70/236 (29%), Positives = 98/236 (41%), Gaps = 55/236 (23%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
LG G GSV L +G FA+K + D L + + E EI P++
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR----ELEINKSCKSPYIVKY 64
Query: 735 YASF--QTKTHVCLITDYCPGGELFLLLDRQPTKVLK------EDAVRFYAAEVVVALEY 786
Y +F ++ + + + +YC GG L D KV K E + A V+ L Y
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSL----DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
LH + II+RD+KP N+LL G V L DF +S G+
Sbjct: 121 LHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS----------------------GE---- 154
Query: 847 FMAEPMRASNS----FVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
NS F GT Y+APE I G ++ D W+LG+ L E+ PF
Sbjct: 155 -------LVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 6e-18
Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 41/224 (18%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKA--MDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
LG G+ G+V+ + + A+K +D V L + + +E EIL D P++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIM----SELEILYKCDSPYIIGF 64
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 794
Y +F + + + T++ GG L + + P VL AV VV L YL I++
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY-RKIPEHVLGRIAV-----AVVKGLTYLWSLKILH 118
Query: 795 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 854
RD+KP N+L+ G V L DF +S QL+ N +
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVS------TQLV---------------NSI-------- 149
Query: 855 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ ++VGT Y+APE I+G + D W+LGI E+ G P+
Sbjct: 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 8e-18
Identities = 59/262 (22%), Positives = 107/262 (40%), Gaps = 41/262 (15%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 731
K LG G G V+ +L G A+K + + + + E ++ L HP V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKLGHPNV 58
Query: 732 PALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF-----YAAEVVVAL 784
L + + L+ +Y GG+L +L R ++ + +A ++ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
EYL + ++RDL N L+ + V ++DF LS + + +++ G+
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS--------RDVYDDDYYRKKTGGK-- 168
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 903
P+R ++APE + TS D W+ G+LL+E+ G TP+ G +
Sbjct: 169 -----LPIR----------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213
Query: 904 QKTFANILHKD--LKFPSSTPS 923
++ + K L P P
Sbjct: 214 EEVLEYL-RKGYRLPKPEYCPD 234
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 64/244 (26%), Positives = 107/244 (43%), Gaps = 50/244 (20%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDML 726
++ + P+GSG G V +G+ A+K + + ++ +H R E +L +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---QSAIHAKRTYRELRLLKHM 71
Query: 727 DHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
DH F PA +S + V L+T G +L ++ Q L +D ++F
Sbjct: 72 DHENVIGLLDVFTPA--SSLEDFQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVY 125
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+++ L+Y+H GII+RDLKP N+ + + + + DF L+ R
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-------------------R 166
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP 897
H + M +V T Y APEI+ H VD W++G ++ E+L G T
Sbjct: 167 HT--------DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTL 215
Query: 898 FRGK 901
F G
Sbjct: 216 FPGS 219
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 69/267 (25%), Positives = 115/267 (43%), Gaps = 43/267 (16%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLDHP 729
F + LG+G+ G V V SG A K + + RN++ R E ++L + P
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIR---ELKVLHECNSP 59
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLD---RQPTKVLKEDAVRFYAAEVVVALEY 786
++ Y +F + + + ++ GG L +L R P +L + ++ V+ L Y
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISI-----AVLRGLTY 114
Query: 787 LHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
L + I++RD+KP N+L+ G + L DF +S GQ
Sbjct: 115 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----------------------GQ--- 149
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
+ + M +NSFVGT Y++PE + G +T D W+LG+ L EM G P K
Sbjct: 150 --LIDSM--ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AK 204
Query: 906 TFANILHKDLKFPSSTPSSCKAANVPP 932
+ + + + S + PP
Sbjct: 205 ELEAMFGRPVSEGEAKESHRPVSGHPP 231
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 66/246 (26%), Positives = 112/246 (45%), Gaps = 39/246 (15%)
Query: 655 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 714
A+Q ++ G+ ++ +G G TG V + +G+ A+K MD R +
Sbjct: 10 ALQLVVSPGDP--REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQR 62
Query: 715 RACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
R E++ M D H V +Y S+ + ++ ++ GG L D + E+
Sbjct: 63 RELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEEQ 119
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
+ V+ AL YLH QG+I+RD+K +++LL +G + L+DF S
Sbjct: 120 IATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS---------- 169
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
E +R S VGT ++APE+I+ + + VD W+LGI++ EM+
Sbjct: 170 KEVPKR-----------------KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
Query: 893 YGYTPF 898
G P+
Sbjct: 213 DGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 28/220 (12%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLDHPFVP 732
K LG G G V+L +G+ A+K + D + +V+ E ++L L H +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 733 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
Y + + + +Y PGG + L + L E R Y +++ +EYLH I
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 793 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
++RD+K N+L G+V L DF S KR + M
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGAS-----------------KRLQTICSSGTGM---- 164
Query: 853 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
S GT +++PE+I+G G+ D W++G + EML
Sbjct: 165 ---KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-17
Identities = 64/226 (28%), Positives = 101/226 (44%), Gaps = 42/226 (18%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
I LG G G V+ + +G A K ++ + ++ E EIL +HP++
Sbjct: 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVK 73
Query: 734 LYASFQTKTHVCLITDYCPGGE---LFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
L +F + ++ ++CPGG + L LDR L E ++ +++ AL+YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHSM 129
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
II+RDLK NVLL +G + L DF +S +RR
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSA----------KNVKTLQRR------------ 167
Query: 851 PMRASNSFVGTEEYIAPEII-----AGAGHTSAVDWWALGILLYEM 891
+SF+GT ++APE++ + D W+LGI L EM
Sbjct: 168 -----DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 33/221 (14%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLDHPFV 731
++ +G G G V LV G+ + +K ++ + N ++ R AE+E +L L HP +
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLN---LRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 732 PALYASFQTKTHVCLIT-DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
A S++ + + I +C GG+L+ L Q K+L E+ V + ++ +AL+YLH +
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
I++RDLK +NV L + + D ++ + +N MA
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIA---------------------RVLENQCDMA- 159
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891
++ +GT Y++PE+ + + D WALG +YEM
Sbjct: 160 -----STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 5e-17
Identities = 62/234 (26%), Positives = 104/234 (44%), Gaps = 45/234 (19%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD------KGVMLNRNKVHRACAEREILD 724
+ + +G G +G+V+ +GQ A+K M+ K +++N V R I++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
LD S+ + ++ +Y GG L D + E + E + AL
Sbjct: 81 YLD---------SYLVGDELWVVMEYLAGGSL---TDVVTETCMDEGQIAAVCRECLQAL 128
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
E+LH +I+RD+K +N+LL +G V LTDF C T E+ +R
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF-CAQ---------ITPEQSKR------ 172
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
++ VGT ++APE++ + VD W+LGI+ EM+ G P+
Sbjct: 173 -----------STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 38/232 (16%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMK-------AMDKGVMLNRNKVHRACAEREILDMLDHP 729
+G G G V+L +G+ A+K + ++ V +E E L LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 730 FVPALYASFQTK-THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
+ Y F+T ++ + +Y PGG + L R + +E VRF+ +V+ L YLH
Sbjct: 69 NIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGR-FEEQLVRFFTEQVLEGLAYLH 125
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
+GI++RDLK +N+L+ +G ++DF +S K+ N
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGIS-----------------KKSDDIYDN---- 164
Query: 849 AEPMRASNSFVGTEEYIAPEII--AGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ S G+ ++APE+I G+++ VD W+LG ++ EM G P+
Sbjct: 165 ----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 77/261 (29%), Positives = 115/261 (44%), Gaps = 49/261 (18%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G+ GSV+ V +G AMK + + L+ +K ++ E +IL P++ Y
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIR--LELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 737 SFQTKTHVCLITDYCPGGELFLLLD-RQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIY 794
+F + V + +Y G L L T+ + ED +R VV L++L + II+
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126
Query: 795 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL--LPTTNEKKRRHKGQQNPVFMAEPM 852
RD+KP NVL+ GNG V L DF +S L+ L TN
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTN------------------- 161
Query: 853 RASNSFVGTEEYIAPEIIAGAG------HTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
+G + Y+APE I G +T D W+LG+ + EM G P+ +T
Sbjct: 162 ------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI 215
Query: 907 FAN---ILHKDLKFPSSTPSS 924
FA I+ D P + PS
Sbjct: 216 FAQLSAIVDGD---PPTLPSG 233
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 62/235 (26%), Positives = 104/235 (44%), Gaps = 29/235 (12%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
L +F+ K +G G V+ + A+K + M++ E ++L L+
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALE 785
HP V SF + ++ + G+L ++ ++ +++ E V Y ++ A+E
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
++H + +++RD+KP NV + G V L D L S K TT
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------TT------------- 161
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
A++S VGT Y++PE I G+ D W+LG LLYEM +PF G
Sbjct: 162 --------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 63/239 (26%), Positives = 99/239 (41%), Gaps = 49/239 (20%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-VHRACAEREI--LDMLD 727
+ K LG G V+ +G+ A+K + G ++ A REI L L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFT-ALREIKLLQELK 60
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV------- 780
HP + L F K+++ L+ ++ D + KV+K+ ++ A++
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-------DLE--KVIKDKSIVLTPADIKSYMLMT 111
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+ LEYLH I++RDLKP N+L+ +G + L DF L+
Sbjct: 112 LRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR--------------------- 150
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPF 898
P R V T Y APE++ GA H VD W++G + E+L PF
Sbjct: 151 ------SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR-VPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 9e-17
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE---ILDMLD 727
++ IK LG G GSV+L +G+ A+K M K RE + + +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF----YSWEECMNLREVKSLRKLNE 56
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
HP + L F+ + + +Y G L+ L+ + K E +R +++ L ++
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H G +RDLKPEN+L+ G V + DF L+ +P P T+
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP----PYTD-------------- 157
Query: 848 MAEPMRASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEM 891
+V T Y APEI+ ++S VD WALG ++ E+
Sbjct: 158 ----------YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 55/194 (28%), Positives = 86/194 (44%), Gaps = 31/194 (15%)
Query: 711 NKVHRACAEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVL 768
++ + A RE+ L L H + L +F+ K + L+ +Y L LL+ P L
Sbjct: 40 DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGG-L 97
Query: 769 KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828
DAVR Y +++ A+ Y H II+RD+KPEN+L+ +G + L DF + +P
Sbjct: 98 PPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155
Query: 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGIL 887
+V T Y APE++ G + VD WA+G +
Sbjct: 156 ------------------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCI 191
Query: 888 LYEMLYGYTPFRGK 901
+ E+L G F G
Sbjct: 192 MAELLDGEPLFPGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 66/240 (27%), Positives = 105/240 (43%), Gaps = 43/240 (17%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F ++ +G+G G V+ +GQ A+K MD + ++ E +L H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73
Query: 731 -VPALYASFQTKT------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
+ Y +F K+ + L+ ++C G + L+ LKED + + E++
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
L +LH +I+RD+K +NVLL N V L DF +S QL R G++
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------QL---------DRTVGRR 178
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV-----DWWALGILLYEMLYGYTPF 898
N+F+GT ++APE+IA + A D W+LGI EM G P
Sbjct: 179 ------------NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-16
Identities = 84/332 (25%), Positives = 146/332 (43%), Gaps = 50/332 (15%)
Query: 612 TAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRK--DSPPWKAIQKILDSGEQINLQ 669
+AE +N+ K P T E+ + + + P+ ++K D P + + + + E
Sbjct: 12 SAELLNQYAKYFPHVLFTSEEAFEKYCADLDPEAYKKCVDLPEGEEVPESNNPRE----- 66
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-VHRACAEREILDMLDH 728
H + L + + V GS K + K VMLN + A +E L DH
Sbjct: 67 HMYVLTTLVGRNPTTAAFVATRGSDP--KEKVVAKFVMLNDERQAAYARSELHCLAACDH 124
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED--------AVRFYAAEV 780
+ + F++ + LI +Y GG+L ++Q + LKE + FY ++
Sbjct: 125 FGIVKHFDDFKSDDKLLLIMEYGSGGDL----NKQIKQRLKEHLPFQEYEVGLLFY--QI 178
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
V+AL+ +H + +++RDLK N+ L G + L DF S K
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS---------------------K 217
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
+ V + ++SF GT Y+APE+ ++ D W+LG++LYE+L + PF+G
Sbjct: 218 QYSDSV----SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
Query: 901 KTRQKTFANILHKDLK-FPSSTPSSCKAANVP 931
++++ +L+ FP S KA P
Sbjct: 274 PSQREIMQQVLYGKYDPFPCPVSSGMKALLDP 305
|
Length = 478 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 39/228 (17%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD- 727
+ F I+ +GSG G V+ +G+ A+K V+ A ++EI+ M D
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIK-----VIKLEPGEDFAVVQQEIIMMKDC 63
Query: 728 -HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
H + A + S+ + + + ++C GG L + T L E + + + E + L Y
Sbjct: 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY--HVTGPLSESQIAYVSRETLQGLYY 121
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
LH +G ++RD+K N+LL NGHV L DF +S + T K++
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT--------ATIAKRK--------- 164
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEM 891
SF+GT ++APE+ A G+ D WA+GI E+
Sbjct: 165 ----------SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 5e-16
Identities = 58/179 (32%), Positives = 84/179 (46%), Gaps = 30/179 (16%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
E +L D P+V Y S+ T + +I +Y GG LL+ P L E +
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILR 108
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
E++ L+YLH + I+RD+K NVLL +G V L DF ++ QL T + KR
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA------GQL---TDTQIKR- 158
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897
N+FVGT ++APE+I + + S D W+LGI E+ G P
Sbjct: 159 -----------------NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 57/255 (22%), Positives = 105/255 (41%), Gaps = 62/255 (24%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-----LDMLDHPFV 731
+G G G+V+ +G++ A+K + V L+ + + REI L+ +HP +
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVR--VPLSEEGIPLSTL-REIALLKQLESFEHPNI 63
Query: 732 PALYASFQTK-----THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
L + L+ ++ +L L + P L + ++ +++ +++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDL-------SCLTSCKPQLLLPTTNEKKRRH 839
LH I++RDLKP+N+L+ +G V + DF L LTS
Sbjct: 123 LHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSV---------------- 166
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP-F 898
V T Y APE++ + + + VD W++G + E+ + P F
Sbjct: 167 -------------------VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL-FRRRPLF 206
Query: 899 RGKTRQKTFANILHK 913
RG + A+ L K
Sbjct: 207 RGTSE----ADQLDK 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 2e-15
Identities = 44/136 (32%), Positives = 68/136 (50%), Gaps = 23/136 (16%)
Query: 766 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825
+L++ R+ +++ AL+Y+H +I+RDLKP N+LL + V L DF L+ S
Sbjct: 102 NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161
Query: 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWAL 884
+ +NPV + + +V T Y APEI+ G+ T VD W++
Sbjct: 162 E--------------NPENPV-LTD-------YVATRWYRAPEILLGSTRYTKGVDMWSV 199
Query: 885 GILLYEMLYGYTPFRG 900
G +L EML G F G
Sbjct: 200 GCILGEMLLGKPLFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 32/228 (14%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F ++ +G G G V+ + + A+K +D + +++ E +L D P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ Y S+ T + +I +Y GG LL P L+E + E++ L+YLH +
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSE 120
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
I+RD+K NVLL G V L DF ++ QL T + KR
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVA------GQL---TDTQIKR------------- 158
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
N+FVGT ++APE+I + + D W+LGI E+ G P
Sbjct: 159 -----NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 57/179 (31%), Positives = 81/179 (45%), Gaps = 30/179 (16%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
E +L D P+V Y S+ T + +I +Y GG LL P E +
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLK 108
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
E++ L+YLH + I+RD+K NVLL G V L DF ++ QL T + KR
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVA------GQL---TDTQIKR- 158
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897
N+FVGT ++APE+I + + S D W+LGI E+ G P
Sbjct: 159 -----------------NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-15
Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 36/229 (15%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLDHP 729
F I LG+G+ G V V+ SG A K + + RN++ R E ++L + P
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECNSP 63
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
++ Y +F + + + ++ GG L +L + K + E+ + + V+ L YL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 790 Q-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
+ I++RD+KP N+L+ G + L DF +S GQ +
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----------------------GQ-----L 154
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897
+ M +NSFVGT Y++PE + G ++ D W++G+ L E+ G P
Sbjct: 155 IDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 63/235 (26%), Positives = 100/235 (42%), Gaps = 42/235 (17%)
Query: 677 LGSGDTGSVHLVELCGSGQ-YFAMK-------AMDKGVMLNRNKVHRACAEREIL-DMLD 727
LGSG G V+ V +GQ A+K A K + +E I+ + L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 728 HPFVPALYASFQTKTHVCLITDY---CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
HP + Y +F + ++ D P GE F L ++ + E+ + ++V+AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSL-KEKKQRFTEERIWNIFVQMVLAL 126
Query: 785 EYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
YLH + I++RDL P N++L + V++TDF L+ + K +
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA-------------------KQKQPE 167
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ + S VGT Y PEI+ + D WA G +LY+M PF
Sbjct: 168 SKL---------TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 47/236 (19%)
Query: 670 HFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNR--NKVHRACAER 720
H + IK LG G G V ELC +G+ A+K LN + HR+ ER
Sbjct: 5 HLKFIKQLGEGHFGKV---ELCRYDPLGDNTGEQVAVK------SLNHSGEEQHRSDFER 55
Query: 721 EILDM--LDHPFVPAL--YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFY 776
EI + LDH + + LI +Y P G L L R ++ + + F
Sbjct: 56 EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF- 114
Query: 777 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836
++++ ++YL Q I+RDL N+L++ V ++DF L+ +LP +
Sbjct: 115 SSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA--------KVLPEDKDYY 166
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
+ ++P+F + APE + + +SA D W+ G+ LYE+
Sbjct: 167 YVKEPGESPIF----------------WYAPECLRTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 8e-15
Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 45/228 (19%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMD------KGVMLNRNKVHRACAEREILDMLDHPF 730
+G G +G+V+ +GQ A++ M+ K +++N V R I++ LD
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 84
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
S+ + ++ +Y GG L D + E + E + ALE+LH
Sbjct: 85 ------SYLVGDELWVVMEYLAGGSL---TDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
+I+RD+K +N+LL +G V LTDF T E+ +R
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA----------QITPEQSKR------------ 173
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
++ VGT ++APE++ + VD W+LGI+ EM+ G P+
Sbjct: 174 -----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-14
Identities = 30/60 (50%), Positives = 43/60 (71%)
Query: 859 VGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP 918
+GT +Y+APE++ G H AVDWWALG+ L+E L G PF +T Q+ F NIL++D+ +P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 45/228 (19%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMD------KGVMLNRNKVHRACAEREILDMLDHPF 730
+G G +G+V+ +GQ A+K M+ K +++N V R I++ LD
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 83
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
S+ + ++ +Y GG L D + E + E + AL++LH
Sbjct: 84 ------SYLVGDELWVVMEYLAGGSL---TDVVTETCMDEGQIAAVCRECLQALDFLHSN 134
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
+I+RD+K +N+LL +G V LTDF T E+ +R
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCA----------QITPEQSKR------------ 172
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
++ VGT ++APE++ + VD W+LGI+ EM+ G P+
Sbjct: 173 -----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 1e-14
Identities = 58/251 (23%), Positives = 102/251 (40%), Gaps = 58/251 (23%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDMLD 727
+ +KP+GSG G V +G+ A+K K + + + R E ++L L
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK---KISNVFDDLIDAKRILREIKLLRHLR 57
Query: 728 HP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLD-----RQPTKVLKEDAVR 774
H P F V ++T+ + D + P + L +D ++
Sbjct: 58 HENIIGLLDILRPPSPEDFND---VYIVTEL-------METDLHKVIKSP-QPLTDDHIQ 106
Query: 775 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
++ +++ L+YLH +I+RDLKP N+L+ N + + DF L+
Sbjct: 107 YFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA---------------- 150
Query: 835 KKRRHKGQQ--NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEM 891
R F+ E +V T Y APE++ + T A+D W++G + E+
Sbjct: 151 ---RGVDPDEDEKGFLTE-------YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL 200
Query: 892 LYGYTPFRGKT 902
L F G+
Sbjct: 201 LTRKPLFPGRD 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 62/239 (25%), Positives = 106/239 (44%), Gaps = 36/239 (15%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG--VMLNRNKVHRACAEREILDMLDH 728
++PI+ +GSG G V SG+ A+K + V + R E +IL H
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR---ELKILRHFKH 63
Query: 729 PFVPALYASFQTK----THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
+ A+ + V ++ D ++ QP L E+ +R++ +++ L
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQP---LTEEHIRYFLYQLLRGL 120
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
+Y+H +I+RDLKP N+L+ + + + DF ++ S P E K
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT-------EHKY------- 166
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902
FM E +V T Y APE++ + +T+A+D W++G + EML F GK
Sbjct: 167 --FMTE-------YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 40/231 (17%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH----RACAEREILDML 726
+ P+ +G G G+V+ SG + A+K++ V N + + R A + L+
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VQTNEDGLPLSTVREVALLKRLEAF 59
Query: 727 DHPFVPALY---ASFQT--KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
DHP + L A+ +T +T V L+ ++ +L LD+ P L + ++ + +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
L++LH I++RDLKPEN+L+ G V L DF L+ + SC+ L
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL-------------- 164
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
PV V T Y APE++ + + + VD W++G + EM
Sbjct: 165 --TPV------------VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 70/278 (25%), Positives = 120/278 (43%), Gaps = 49/278 (17%)
Query: 643 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 702
P P S + +L + +GSG G+V+ V +G+ +A+K +
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI 107
Query: 703 ----DKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFL 758
+ V R ++ C E EIL ++HP V + F + ++ ++ GG L
Sbjct: 108 YGNHEDTV---RRQI---CREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-- 159
Query: 759 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818
+ T + E + A +++ + YLH + I++RD+KP N+L+ +V + DF +S
Sbjct: 160 ----EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVS 215
Query: 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII-----AGA 873
+ +A+ M NS VGT Y++PE I GA
Sbjct: 216 RI---------------------------LAQTMDPCNSSVGTIAYMSPERINTDLNHGA 248
Query: 874 GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANIL 911
A D W+LG+ + E G PF G RQ +A+++
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFPF-GVGRQGDWASLM 285
|
Length = 353 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-14
Identities = 72/254 (28%), Positives = 112/254 (44%), Gaps = 50/254 (19%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LGSG TG+V + G+ FA+K +D M + +RA AE L D + +
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 737 SFQTK--------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE-------VV 781
F K + L+ DY G+L RQ K + F E V+
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDL-----RQEIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+A+ ++H + +I+RD+K N+LL NG V L DF S + + T ++ R
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA-------TVSDDVGR--- 203
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+F GT Y+APEI ++ D ++LG+LLYE+L PF G+
Sbjct: 204 ---------------TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248
Query: 902 TRQKTFANILHKDL 915
++ ++HK L
Sbjct: 249 NMEE----VMHKTL 258
|
Length = 496 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 27/225 (12%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMK--AMDKGVMLNRNKVHRACAER-EILDMLDHPFVPA 733
LG G G+V+ L GQ A+K +D +L K + E ++L L H +
Sbjct: 8 LGKGAYGTVYC-GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
+ + + ++ PGG + +L+R L E Y +++ + YLH ++
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
+RD+K NV+L NG + L DF C +L + M + M
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDF------GCARRLAWVGLHGTHSN---------MLKSMH 169
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
GT ++APE+I +G+ D W++G ++EM G P
Sbjct: 170 ------GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 43/240 (17%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F ++ +G+G G V+ +GQ A+K MD + ++ E +L H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 731 -VPALYASFQTKT------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
+ Y +F K + L+ ++C G + L+ LKE+ + + E++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
L +LH +I+RD+K +NVLL N V L DF +S + R G++
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---------------QLDRTVGRR 168
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPF 898
N+F+GT ++APE+IA A + D W+LGI EM G P
Sbjct: 169 ------------NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 36/227 (15%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V+ + A+K + + +H E + L H +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSYLKHRNIVQYLG 72
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 794
S + + PGG L LL + P K E + FY +++ L+YLH I++
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKD-NEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 795 RDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
RD+K +NVL+ +G V ++DF S +R G NP
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTS------------------KRLAG-INPC------- 165
Query: 854 ASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPF 898
+ +F GT +Y+APE+I G+ + D W+LG + EM G PF
Sbjct: 166 -TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 7e-14
Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
+G G +G+V +GQ A+K ++ + + K E ++ L +P +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
SF + ++ +Y GG L D + E + E + ALE+LH +I+RD
Sbjct: 84 SFLVGDELFVVMEYLAGGSL---TDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRD 140
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
+K +NVLL +G V LTDF T E+ +R +
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCA----------QITPEQSKR-----------------S 173
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ VGT ++APE++ + VD W+LGI+ EM+ G P+
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 67/226 (29%), Positives = 102/226 (45%), Gaps = 42/226 (18%)
Query: 683 GSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFVPALYAS 737
GS +V C +GQ A+K K + +K+ + A REI L L H + L
Sbjct: 12 GSYGMVMKCKHKETGQIVAIK---KFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 738 FQTKTHVCLITDYCPGGELFLL--LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795
F+ K + L+ ++ + +L L++ P L E VR Y +++ +E+ H II+R
Sbjct: 69 FRRKKRLYLVFEFV---DHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCHSHNIIHR 124
Query: 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
D+KPEN+L+ +G V L DF + +A P
Sbjct: 125 DIKPENILVSQSGVVKLCDFGFA---------------------------RTLAAPGEVY 157
Query: 856 NSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 900
+V T Y APE++ G + AVD WA+G L+ EML G F G
Sbjct: 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 39/226 (17%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFV 731
+ +G G G V +GQ A+K K V + V + A REI L L HP +
Sbjct: 6 LSKIGEGSYGVVFKCRNRETGQIVAIK---KFVESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 732 PALYASFQTKTHVCLITDYCPGGELFLL--LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
L F+ K + L+ +YC + +L L++ P V E ++ + + A+ + H
Sbjct: 63 VNLIEVFRRKRKLHLVFEYC---DHTVLNELEKNPRGV-PEHLIKKIIWQTLQAVNFCHK 118
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
I+RD+KPEN+L+ G + L DF + ++L
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFA-------RILTG------------------- 152
Query: 850 EPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYG 894
P +V T Y APE++ G + VD WA+G + E+L G
Sbjct: 153 -PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
I LG G G V+ + +G A K +D + ++ E +IL DHP +
Sbjct: 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVK 66
Query: 734 LYASFQTKTHVCLITDYCPGGEL---FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
L +F + ++ ++ ++C GG + L L+R L E +R + + AL YLH
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTEPQIRVVCKQTLEALNYLHEN 122
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
II+RDLK N+L +G + L DF +S T +RR
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSA----------KNTRTIQRR------------ 160
Query: 851 PMRASNSFVGTEEYIAPEII-----AGAGHTSAVDWWALGILLYEM 891
+SF+GT ++APE++ + D W+LGI L EM
Sbjct: 161 -----DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 56/188 (29%), Positives = 82/188 (43%), Gaps = 34/188 (18%)
Query: 720 REI--LDMLDHPFVPALYASFQTK--THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
REI L L HP + L K + L+ +YC +L LLD PT E V+
Sbjct: 55 REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTP-FSESQVKC 112
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
+++ L+YLH II+RDLK N+LL G + + DF L+ + + P
Sbjct: 113 LMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK---- 168
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG 894
V T Y APE++ G +T+A+D WA+G +L E+L
Sbjct: 169 -----------------------VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
Query: 895 YTPFRGKT 902
GK+
Sbjct: 206 KPLLPGKS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 62/248 (25%), Positives = 99/248 (39%), Gaps = 34/248 (13%)
Query: 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LD 724
L+ + + LG G G V+ +G+ A+K K +M N A REI L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK---KILMHNEKDGFPITALREIKILK 62
Query: 725 MLDHPFVPAL------YASFQTKTHVC--LITDYCPGGELFLLLDRQPTKVLKEDAVRFY 776
L HP V L + ++T Y +L LL+ K L E ++ Y
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVK-LTESQIKCY 120
Query: 777 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL-TSCKPQLLLPTTNEK 835
+++ + YLH I++RD+K N+L+ G + + DF L+ P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP-------- 172
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG 894
+ R + V T Y PE++ G +T+AVD W +G + EM
Sbjct: 173 -------KGGGGGGT--RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
Query: 895 YTPFRGKT 902
+GK+
Sbjct: 224 RPILQGKS 231
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-13
Identities = 65/247 (26%), Positives = 109/247 (44%), Gaps = 18/247 (7%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
+Q + I+ +G G G V+L + A+K + + + N R E +I L
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAA------- 778
HP + +Y+ V Y G L LL Q + KE A +
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
++ +EY+H +G+++RDLKP+N+LL G V + D+ + + + LL ++
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE--- 177
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
M VGT +Y+APE + G + + D +ALG++LY+ML P+
Sbjct: 178 ------RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
Query: 899 RGKTRQK 905
R K +K
Sbjct: 232 RRKKGRK 238
|
Length = 932 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 42/232 (18%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLDHP 729
F I LG+G+ G V V SG A K + + RN++ R E ++L + P
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECNSP 63
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ---PTKVLKEDAVRFYAAEVVVALEY 786
++ Y +F + + + ++ GG L +L + P ++L + ++ V+ L Y
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI-----AVIKGLTY 118
Query: 787 LHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
L + I++RD+KP N+L+ G + L DF +S GQ
Sbjct: 119 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----------------------GQ--- 153
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897
+ + M +NSFVGT Y++PE + G ++ D W++G+ L EM G P
Sbjct: 154 --LIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 9e-13
Identities = 53/238 (22%), Positives = 98/238 (41%), Gaps = 29/238 (12%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMD--KGVMLNRNKVHRAC-AEREILDMLDHPFVPA 733
LG+G S + +G A+K + + + +V A E ++ L+HP +
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
+ + +H L ++ GG + LL + KE + Y +++ L YLH II
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQII 125
Query: 794 YRDLKPENVLLQGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
+RD+K N+L+ G + + DF + + L +GQ
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFG----AAAR----LAAKGTGAGEFQGQ---------- 167
Query: 853 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
+GT ++APE++ G + + D W++G ++ EM P+ + A I
Sbjct: 168 -----LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 30/232 (12%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLDH 728
+R K LG G G V+L +G+ A K + D +V E ++L L H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 729 PFVPALYASFQTKTH--VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
+ Y + + + + +Y PGG + L + L E R Y +++ + Y
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSY 121
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
LH I++RD+K N+L G+V L DF S K Q
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGAS---------------------KRLQTIC 160
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+R S GT +++PE+I+G G+ D W+LG + EML P+
Sbjct: 161 MSGTGIR---SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|131984 TIGR02938, nifL_nitrog, nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-12
Identities = 31/92 (33%), Positives = 56/92 (60%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
I+YA+ F ++TGYT +E++G+N L T PE + +L + + G+LLN +KD
Sbjct: 26 ILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNRRKD 85
Query: 274 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 305
G + LT+AP+ ++ G+ F+GM ++++
Sbjct: 86 GELYLAELTVAPVLNEAGETTHFLGMHRDITE 117
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes [Central intermediary metabolism, Nitrogen fixation, Regulatory functions, Protein interactions]. Length = 494 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 67/268 (25%), Positives = 108/268 (40%), Gaps = 53/268 (19%)
Query: 671 FRPIKPLGSGDTGSVH----LVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD-- 724
IK LGSG G+V+ + E A+K + R + A +EILD
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-------REETSPK-ANKEILDEA 60
Query: 725 ----MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAA 778
+DHP V L + LIT P G L LD R + + +
Sbjct: 61 YVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCL---LDYVRNHKDNIGSQYLLNWCV 116
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
++ + YL + +++RDL NVL++ HV +TDF L+ L +EK+
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD---------VDEKEYH 167
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTP 897
+G + P+ +++A E I +T D W+ G+ ++E M +G P
Sbjct: 168 AEGGKVPI----------------KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
Query: 898 FRGKTRQKTFANILHKDLKFPSSTPSSC 925
+ G ++L K + P P C
Sbjct: 212 YEGI-PAVEIPDLLEKGERLPQ--PPIC 236
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 65/266 (24%), Positives = 107/266 (40%), Gaps = 65/266 (24%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGS--GQYFAMK----AMDKGVMLNRNKVHRACAEREIL 723
+ IK LG G G V + + A+K K ++ R A RE+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR-------ALREL- 52
Query: 724 DMLDHPFVPALYASFQTKTH---VCL----ITDYCPGGELFL---LLDRQPTKVLK---- 769
L F + H CL I EL+L L++ ++++
Sbjct: 53 -KLLRHF----------RGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQP 101
Query: 770 -EDA-VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827
DA + + +++ L+Y+H +++RDLKP N+L+ + + + DF L+ S P
Sbjct: 102 LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP-- 159
Query: 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEI-IAGAGHTSAVDWWALGI 886
+N FM E +V T Y APEI ++ +T A+D W++G
Sbjct: 160 --------------GENAGFMTE-------YVATRWYRAPEIMLSFQSYTKAIDVWSVGC 198
Query: 887 LLYEMLYGYTPFRGKTRQKTFANILH 912
+L E+L F+GK IL
Sbjct: 199 ILAELLGRKPVFKGKDYVDQLNQILQ 224
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 42/231 (18%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
P +P+G G G V V G+ A+K M V N R E ++L H
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPN-VFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 731 V--------PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 782
V P F+ + ++T+ +++ QP L D V+ + +++
Sbjct: 61 VLSALDILQPPHIDPFE---EIYVVTELMQSDLHKIIVSPQP---LSSDHVKVFLYQILR 114
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
L+YLH GI++RD+KP N+L+ N + + DF L+ + +H Q
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA-----------RVEEPDESKHMTQ 163
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEML 892
+ V T+ Y APEI+ G+ H TSAVD W++G + E+L
Sbjct: 164 E---------------VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 58/227 (25%), Positives = 89/227 (39%), Gaps = 38/227 (16%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ F ++ +G G G+V+ + + A+K M + K E L L H
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYL 787
P + + L+ +YC G +L + ++P L+E + + L YL
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP---LQEVEIAAICHGALQGLAYL 131
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H I+RD+K N+LL G V L DF + L S
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS------------------------- 166
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAG--AGH-TSAVDWWALGILLYEM 891
+NSFVGT ++APE+I G VD W+LGI E+
Sbjct: 167 ------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-12
Identities = 63/240 (26%), Positives = 112/240 (46%), Gaps = 42/240 (17%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
L+ ++ +KP+GSG G V G A+K + + N+ RA E +L ++
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVN 78
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFL---LLDRQPTKV----LKEDAVRFYAAEV 780
H + +L F + + D ++L L+D +V L + + + ++
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQD------VYLVMELMDANLCQVIHMELDHERMSYLLYQM 132
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+ +++LH GII+RDLKP N++++ + + + DF L+ T+C TN
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAC--------TN------- 176
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
FM P +V T Y APE+I G G+ VD W++G ++ E++ G F+G
Sbjct: 177 ------FMMTP------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 25/138 (18%)
Query: 765 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824
T+ L D ++++ +++ L+Y+H +++RDLKP N+LL N + + DF L+ +
Sbjct: 100 TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD-- 157
Query: 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEI-IAGAGHTSAVDWWA 883
P + H G F+ E +V T Y APEI + G+T A+D W+
Sbjct: 158 -----PEHD-----HTG-----FLTE-------YVATRWYRAPEIMLNSKGYTKAIDIWS 195
Query: 884 LGILLYEMLYGYTPFRGK 901
+G +L EML F GK
Sbjct: 196 VGCILAEMLSNRPLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 40/240 (16%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-- 725
L+ ++ +KP+GSG G V + A+K + + +N+ H A RE++ M
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVLMKC 79
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKEDAVRFYAAEVV 781
++H + L F + + D EL +D +V L + + + +++
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL---MDANLCQVIQMELDHERMSYLLYQML 136
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+++LH GII+RDLKP N++++ + + + DF L+ R G
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-------------------RTAG 177
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
FM P +V T Y APE+I G G+ VD W++G ++ EM+ G F G
Sbjct: 178 TS---FMMTP------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 44/233 (18%)
Query: 667 NLQH-FRPIKPLGSGDTGSVHLVELCGSGQYFAMK--AMDKGVMLNRNKVHRACAEREIL 723
N QH + I+ +GSG G V+ +G+ A+K ++ G + ++EI
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF-------SLIQQEIF 58
Query: 724 DMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
+ + H + A + S+ ++ + + +YC GG L + T L E + + E +
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETL 116
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
L YLH +G ++RD+K N+LL NG V L DF ++ T KR+
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKI---------TATIAKRK--- 164
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEM 891
SF+GT ++APE+ A G+ D WA+GI E+
Sbjct: 165 ---------------SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 44/230 (19%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI--L 723
F+ ++ +G G G V+ +G+ A+K + +GV + A REI L
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV--------PSTAIREISLL 53
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
L+HP + L T+ + L+ ++ +L +D P + ++ Y +++
Sbjct: 54 KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
L + H +++RDLKP+N+L+ G + L DF L+ R G
Sbjct: 113 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-------------------RAFGV- 152
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEML 892
P+R V T Y APEI+ G +++AVD W+LG + EM+
Sbjct: 153 -------PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|238075 cd00130, PAS, PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-11
Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 3/101 (2%)
Query: 485 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 544
++ D D I++A+ + +L YS EE++G++ L PE ++ +
Sbjct: 5 VIVLDL---DGRILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGE 61
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
VT+++ K G W L L P+RD+ GEV +GV D
Sbjct: 62 PVTLEVRLRRKDGSVIWVLVSLTPIRDEGGEVIGLLGVVRD 102
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. Length = 103 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 30/233 (12%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLD 727
++R K LG G G V+L +G+ A+K + D +V+ E ++L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 728 HPFVPALYASFQ--TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
H + Y + + + + +Y PGG + L + L E+ R Y +++ +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVS 120
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YLH I++RD+K N+L G+V L DF S KR
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS-----------------KRIQT----- 158
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ M+ S GT +++PE+I+G G+ D W++ + EML P+
Sbjct: 159 ICMSGT--GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 58/245 (23%), Positives = 109/245 (44%), Gaps = 43/245 (17%)
Query: 669 QHFRPIKPLGSGDTGSVHLV-ELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI 722
Q + + +G G G V +L G++ A+K + ++G+ L+ R A
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS---TIREVAVLRH 57
Query: 723 LDMLDHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
L+ +HP V L+ + +T + L+ ++ +L LD+ P + + ++
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 116
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
+++ L++LH +++RDLKP+N+L+ +G + L DF L+ + S
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--------------- 161
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897
F A S V T Y APE++ + + + VD W++G + EM
Sbjct: 162 ---------FQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 208
Query: 898 FRGKT 902
FRG +
Sbjct: 209 FRGSS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 56/239 (23%), Positives = 106/239 (44%), Gaps = 33/239 (13%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
+K LGSG G VHL + G A+K + +G M + + A +++ L HP +
Sbjct: 9 LKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEA----KVMMKLSHPNLVQ 63
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
LY + + ++T+Y G L L + L + + ++V A+EYL G I
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
+RDL N L+ + V ++DF L+ + +L +++ +G + PV
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLA-------RYVL---DDQYTSSQGTKFPV------- 165
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANIL 911
++ PE+ + +S D W+ G+L++E+ G P+ + + ++
Sbjct: 166 ---------KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 68/245 (27%), Positives = 102/245 (41%), Gaps = 58/245 (23%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVP 732
I+ +G G G V+ V G A+K +D + AE IL L +HP V
Sbjct: 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDP----ISDVDEEIEAEYNILQSLPNHPNVV 82
Query: 733 ALYASFQTKTHVCLITDYCPGGELFLLLDR----QPTKVLK----------EDAVRFYAA 778
Y F D GG+L+L+L+ T+++K E + +
Sbjct: 83 KFYGMFYK-------ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
++ L++LH II+RD+K N+LL G V L DF +S QL T+ + RR
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA------QL----TSTRLRR 185
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLY 893
N+ VGT ++APE+IA + + D W+LGI E+
Sbjct: 186 -----------------NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD 228
Query: 894 GYTPF 898
G P
Sbjct: 229 GDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 63/246 (25%), Positives = 107/246 (43%), Gaps = 55/246 (22%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+ PIKP+G G G V + + + A+K + NR R E ++L LDH
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN-AFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 731 V--------PALYASFQTKTHVCLITDYCPGGELFLLLDR------QPTKVLKEDAVRFY 776
V P +F V ++ + L+D + ++ L +D +++
Sbjct: 66 VIAIKDIMPPPHREAFND---VYIVYE---------LMDTDLHQIIRSSQTLSDDHCQYF 113
Query: 777 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836
+++ L+Y+H +++RDLKP N+LL N + + DF L+ TS K
Sbjct: 114 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD---------- 163
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPE-IIAGAGHTSAVDWWALGILLYEMLYGY 895
FM E +V T Y APE ++ + +T+A+D W++G + E+L
Sbjct: 164 ----------FMTE-------YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
Query: 896 TPFRGK 901
F GK
Sbjct: 207 PLFPGK 212
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 43/234 (18%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELC------GSGQYFAMKAMDKGVMLNRNKVHRACAEREI 722
++ + I+ LG G G V L C G+G+ A+K + + + + + ++EI
Sbjct: 4 RYLKKIRVLGEGHFGKVSL--YCYDPANDGTGEMVAVKTLKREC----GQQNTSGWKKEI 57
Query: 723 --LDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
L L H + S Q + LI +Y P G L D P L + +A
Sbjct: 58 NILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL---RDYLPKHKLNLAQLLLFAQ 114
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
++ + YLH Q I+RDL NVLL + V + DF L+ +P +E R
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA--------KAVPEGHEYYRV 166
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
+ +PVF + A E + + A D W+ G+ LYE+L
Sbjct: 167 REDGDSPVF----------------WYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 58/225 (25%), Positives = 89/225 (39%), Gaps = 38/225 (16%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F ++ +G G G+V+ + + A+K M + K E L L HP
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+ + L+ +YC G LL + ++P + ++ AV A + L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ---GLAYLHS 133
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+I+RD+K N+LL G V L DF A
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFG-------------------------------SA 162
Query: 850 EPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEM 891
M +N FVGT ++APE+I + VD W+LGI E+
Sbjct: 163 SIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-11
Identities = 59/245 (24%), Positives = 102/245 (41%), Gaps = 45/245 (18%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+ ++PLG G G V + A+K K V+ + V A E +I+ LDH
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVK---KIVLTDPQSVKHALREIKIIRRLDHDN 63
Query: 731 VPALY-------------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
+ +Y T+ + I +L +L++ P L E+ R +
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP---LSEEHARLFM 120
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV-SLTDFDLSCLTSCKPQLLLPTTNEKK 836
+++ L+Y+H +++RDLKP NV + V + DF L+ + +
Sbjct: 121 YQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV------------DPH 168
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGY 895
HKG +++E + T+ Y +P ++ + T A+D WA G + EML G
Sbjct: 169 YSHKG-----YLSEGLV-------TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
Query: 896 TPFRG 900
F G
Sbjct: 217 PLFAG 221
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 38/225 (16%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F ++ +G G G+V+ + + A+K M + K E + L + HP
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+ + L+ +YC G LL + ++P + ++ A+ A + L YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ---GLAYLHS 143
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+I+RD+K N+LL G V L DF + + S
Sbjct: 144 HNMIHRDIKAGNILLTEPGQVKLADFGSASIAS--------------------------- 176
Query: 850 EPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEM 891
+NSFVGT ++APE+I + VD W+LGI E+
Sbjct: 177 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 5e-11
Identities = 61/240 (25%), Positives = 109/240 (45%), Gaps = 40/240 (16%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-- 725
L+ ++ +KP+GSG G V + A+K + + +N+ H A RE++ M
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKC 72
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKEDAVRFYAAEVV 781
++H + +L F + + D EL +D +V L + + + +++
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMEL---MDANLCQVIQMELDHERMSYLLYQML 129
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+++LH GII+RDLKP N++++ + + + DF L+ R G
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-------------------RTAG 170
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
FM P +V T Y APE+I G G+ VD W++G ++ EM+ F G+
Sbjct: 171 TS---FMMTP------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 60/241 (24%), Positives = 102/241 (42%), Gaps = 58/241 (24%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
+H + I+ LG G+ GSV ELC +G+ A+K + + R E E
Sbjct: 4 RHLKFIQQLGKGNFGSV---ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFER---EIE 57
Query: 722 ILDMLDHPFVPALYASFQTKTHVC---------LITDYCPGGELFLLLDRQPTKVLKEDA 772
IL L H + Y VC L+ +Y P G L L + ++ D
Sbjct: 58 ILKSLQHDNI-VKYKG------VCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL---DH 107
Query: 773 VRF--YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830
+ YA+++ +EYL + ++RDL N+L++ V + DF L+ +LP
Sbjct: 108 RKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT--------KVLP 159
Query: 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 890
E + + ++P+F + APE + + + A D W+ G++LYE
Sbjct: 160 QDKEYYKVREPGESPIF----------------WYAPESLTESKFSVASDVWSFGVVLYE 203
Query: 891 M 891
+
Sbjct: 204 L 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 56/248 (22%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-- 725
L+ ++ +KP+GSG G V +GQ A+K + + +N H A RE++ M
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKL 71
Query: 726 LDHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKEDAV 773
++H F P S + V L+ + L+D +V L + +
Sbjct: 72 VNHKNIIGLLNVFTPQ--KSLEEFQDVYLVME---------LMDANLCQVIQMDLDHERM 120
Query: 774 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
+ +++ +++LH GII+RDLKP N++++ + + + DF L+
Sbjct: 121 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------- 165
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 893
R G FM P +V T Y APE+I G G+ VD W++G ++ EM+
Sbjct: 166 ----RTAGTS---FMMTP------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 212
Query: 894 GYTPFRGK 901
G F G
Sbjct: 213 GTVLFPGT 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 68/262 (25%), Positives = 112/262 (42%), Gaps = 41/262 (15%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAEREILDML 726
F+ IK LGSG G+V+ G+ A+K + + NK E ++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 66
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVAL 784
D+P V L T T V LIT P G LLD R+ + + + ++ +
Sbjct: 67 DNPHVCRLLGICLTST-VQLITQLMPFG---CLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
YL + +++RDL NVL++ HV +TDF L+ L +EK+ +G +
Sbjct: 123 NYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---------GADEKEYHAEGGKV 173
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGKTR 903
P+ +++A E I +T D W+ G+ ++E M +G P+ G
Sbjct: 174 PI----------------KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IP 216
Query: 904 QKTFANILHKDLKFPSSTPSSC 925
++IL K + P P C
Sbjct: 217 ASEISSILEKGERLPQ--PPIC 236
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 9e-11
Identities = 56/245 (22%), Positives = 100/245 (40%), Gaps = 57/245 (23%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---D 727
++ + +G G V + +G+Y+A+K M K + + + REI +
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD----------RQPTKVLKEDAVRFYA 777
HP + L + L +F L+D ++P L E V+ Y
Sbjct: 57 HPNILRLIEVLFDRKTGRLAL-------VFELMDMNLYELIKGRKRP---LPEKRVKSYM 106
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
+++ +L+++H GI +RD+KPEN+L++ + + L DF KP P T
Sbjct: 107 YQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKP----PYT----- 156
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYT 896
++ T Y APE + G + +D WA+G + +E+L +
Sbjct: 157 -------------------EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197
Query: 897 PFRGK 901
F G
Sbjct: 198 LFPGT 202
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 9e-11
Identities = 48/173 (27%), Positives = 77/173 (44%), Gaps = 47/173 (27%)
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-VSLTDFDLSCLTSCKPQLLLPT 831
V+ Y+ ++ AL Y+H + I +RDLKP+N+L+ N H + L DF
Sbjct: 172 VKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF---------------- 215
Query: 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYE 890
K GQ+ S S++ + Y APE++ GA +T+ +D W+LG ++ E
Sbjct: 216 -GSAKNLLAGQR-----------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAE 263
Query: 891 MLYGYTPFRGKTRQKTFANIL-----------------HKDLKFPSSTPSSCK 926
M+ GY F G++ I+ + D+KFP P K
Sbjct: 264 MILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLK 316
|
Length = 440 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 57/229 (24%), Positives = 90/229 (39%), Gaps = 40/229 (17%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+ IK L G G V + G +K KG L E +L ++HP
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL---------IEAMLLQNVNHPS 118
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V + + + C++ + +L+ L ++ + + A+ ++ L YLH Q
Sbjct: 119 VIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ-ILEGLRYLHAQ 176
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
II+RD+K EN+ + V + D + Q PV
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDLGAA------------------------QFPV--VA 210
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 898
P GT E APE++A + S D W+ GI+L+EML Y T F
Sbjct: 211 PAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257
|
Length = 357 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 55/225 (24%), Positives = 91/225 (40%), Gaps = 31/225 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V+ A+K + + M +V E ++ + HP + L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
+ +IT++ G L L + + + + A ++ A+EYL + I+RD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
L N L+ N V + DF LS L T + H G + P+
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRL----------MTGDTYTAHAGAKFPI---------- 169
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM-LYGYTPFRG 900
++ APE +A + D WA G+LL+E+ YG +P+ G
Sbjct: 170 ------KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 53/231 (22%), Positives = 101/231 (43%), Gaps = 32/231 (13%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+ ++ LG G +V+ + +G+ A+K + + A E +L L H
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR--LQEEEGTPFTAIREASLLKGLKHAN 64
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ L+ TK + L+ +Y +L +D+ P L + V+ + +++ L Y+H +
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGG-LHPENVKLFLFQLLRGLSYIHQR 122
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
I++RDLKP+N+L+ G + L DF L+ S
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSV--------------------------- 155
Query: 851 PMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRG 900
P ++ V T Y P+++ G+ +++ +D W +G + EM+ G F G
Sbjct: 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 64/251 (25%), Positives = 100/251 (39%), Gaps = 51/251 (20%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 731
K LG G G V E SG A+K + + + E I+ LDH +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLK--EAAIMHSLDHENL 58
Query: 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF--------YAAEVVVA 783
LY T + ++T+ P G L LDR L++DA+ YA ++
Sbjct: 59 IRLYGVVLTHP-LMMVTELAPLGSL---LDR-----LRKDALGHFLISTLCDYAVQIANG 109
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
+ YL + I+RDL N+LL + V + DF L + + +
Sbjct: 110 MRYLESKRFIHRDLAARNILLASDDKVKIGDFGLM-----------------RALPQNED 152
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 902
+ V M E ++ + + APE + + A D W G+ L+EM YG P+ G +
Sbjct: 153 HYV-MEEHLKVPFA------WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS 205
Query: 903 RQKTFANILHK 913
+ IL K
Sbjct: 206 G----SQILKK 212
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 67/242 (27%), Positives = 104/242 (42%), Gaps = 52/242 (21%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH----RACAEREILDML-DH 728
I+ +G G G V V +G A+K +D +H AE IL L DH
Sbjct: 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDP--------IHDIDEEIEAEYNILKALSDH 74
Query: 729 PFVPALYASFQTKT-----HVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVV 781
P V Y + K + L+ + C GG + L+ + + ++E + + E +
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+ L++LH I+RD+K N+LL G V L DF +S QL T+ + RR
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA------QL----TSTRLRR--- 181
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYT 896
N+ VGT ++APE+IA + + + D W+LGI E+ G
Sbjct: 182 --------------NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
Query: 897 PF 898
P
Sbjct: 228 PL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 62/236 (26%), Positives = 100/236 (42%), Gaps = 40/236 (16%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+R +K +GSG G+V +G A+K + + + RA E +L + H
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHEN 75
Query: 731 VPALYASFQTKTHVCLITDY---CP--GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
V L F + D+ P G +L L+ + L ED ++F +++ L+
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK---LSEDRIQFLVYQMLKGLK 132
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
Y+H GII+RDLKP N+ + + + + DF L+ R +
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-------------------RQTDSE-- 171
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRG 900
+V T Y APE+I H T VD W++G ++ EML G F+G
Sbjct: 172 ---------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
E ++L L + L +F+ + + L+ +Y + LL+ P V + VR Y
Sbjct: 50 ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPP-EKVRSYIY 107
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+++ A+ + H I++RD+KPEN+L+ N + L DF + R
Sbjct: 108 QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFA-------------------R 148
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ + + E +V T Y +PE++ GA + AVD W++G +L E+ G F
Sbjct: 149 NLSEGSNANYTE-------YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
Query: 899 RGK-------TRQKTFANILHKDLKFPSSTP 922
G+ T QK + + +K S P
Sbjct: 202 PGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 55/245 (22%), Positives = 109/245 (44%), Gaps = 36/245 (14%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDH 728
F+ ++ LG G +V+ +G+ A+K + L+ + + A REI M L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKE----IHLDAEEGTPSTAIREISLMKELKH 57
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLD-RQPTKVLKEDAVRFYAAEVVVALEYL 787
+ L+ T+ + L+ +Y +L +D L + V+ + +++ + +
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H +++RDLKP+N+L+ G + L DF L+ R G
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLA-------------------RAFGI----- 152
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
P+ ++ V T Y AP+++ G+ +++++D W++G ++ EM+ G F G +
Sbjct: 153 ---PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ 209
Query: 907 FANIL 911
I
Sbjct: 210 LLKIF 214
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 57/225 (25%), Positives = 90/225 (40%), Gaps = 38/225 (16%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F + +G G G+V+ + + A+K M K E + L L HP
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+ + L+ +YC G LL + ++P + ++ A+ A + L YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ---GLAYLHS 139
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+I+RD+K N+LL G V L DF + +S
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--------------------------- 172
Query: 850 EPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEM 891
+NSFVGT ++APE+I + VD W+LGI E+
Sbjct: 173 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 63/241 (26%), Positives = 104/241 (43%), Gaps = 50/241 (20%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDMLDH 728
++ + P+GSG GSV +G A+K + + ++ +H R E +L + H
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKH 75
Query: 729 P--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
F PA S + V L+T + G +L ++ Q L +D V+F ++
Sbjct: 76 ENVIGLLDVFTPA--RSLEEFNDVYLVT-HLMGADLNNIVKCQK---LTDDHVQFLIYQI 129
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+ L+Y+H II+RDLKP N+ + + + + DF L+ RH
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA-------------------RHT 170
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR 899
+ +V T Y APEI+ H VD W++G ++ E+L G T F
Sbjct: 171 DDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219
Query: 900 G 900
G
Sbjct: 220 G 220
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 64/240 (26%), Positives = 99/240 (41%), Gaps = 33/240 (13%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
+K +GSG GSV +G+ A+K + + + RA E +L + H V
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIG 78
Query: 734 LYASFQTKTHVCLITD-YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
L F + D Y + L + L ED V++ +++ L+Y+H GI
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGI 138
Query: 793 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
I+RDLKP N+ + + + + DF L+ RH +
Sbjct: 139 IHRDLKPGNLAVNEDCELKILDFGLA-------------------RHADAE--------- 170
Query: 853 RASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANIL 911
+V T Y APE+I H VD W++G ++ EML G T F+GK IL
Sbjct: 171 --MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 35/142 (24%), Positives = 62/142 (43%), Gaps = 1/142 (0%)
Query: 678 GSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS 737
D VHL + + A+K ++ ++ + E L HP + S
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 738 FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 797
F + + +++ G LL + L E A+ F +V+ AL+Y+H +G I+R +
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSV 127
Query: 798 KPENVLLQGNGHVSLTDFDLSC 819
K ++LL G+G V L+ S
Sbjct: 128 KASHILLSGDGKVVLSGLRYSV 149
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 65/256 (25%), Positives = 106/256 (41%), Gaps = 36/256 (14%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
+K LG+G G V + A+K++ +G M AE ++ L HP +
Sbjct: 11 VKKLGAGQFGEVWM-GYYNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVR 65
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
LYA T+ + +IT+Y G L L L + + AA++ + ++ + I
Sbjct: 66 LYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
+RDL+ N+L+ + DF L+ L NE R +G + P+
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIE---------DNEYTAR-EGAKFPI------- 167
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH 912
++ APE I T D W+ GILL E++ YG P+ G T + N L
Sbjct: 168 ---------KWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-LE 217
Query: 913 KDLKFPSSTPSSCKAA 928
+ + P P +C
Sbjct: 218 RGYRMPR--PDNCPEE 231
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 44/230 (19%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMK-----AMDKGVMLNRNKVHRACAEREI--L 723
++ ++ +G G G V+ +G+ A+K D+GV + A REI L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGV--------PSTAIREISLL 52
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
L+HP + L ++ + L+ ++ +L +D P L ++ Y +++
Sbjct: 53 KELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
+ Y H +++RDLKP+N+L+ G + L DF L+ R G
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLA-------------------RAFGV- 151
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEML 892
P+R V T Y APEI+ G+ S VD W++G + EM+
Sbjct: 152 -------PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 34/240 (14%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
+I + + +K LG+G G V + S + A+K + G M V E ++
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM----SVQAFLEEANLMK 56
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVA 783
L H + LYA + + +IT+Y G L L KVL + F +A++
Sbjct: 57 TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF-SAQIAEG 115
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
+ Y+ + I+RDL+ NVL+ + + DF L+ + NE R +G +
Sbjct: 116 MAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE---------DNEYTAR-EGAK 165
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 902
P+ ++ APE I T D W+ GILLYE++ YG P+ G +
Sbjct: 166 FPI----------------KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-10
Identities = 50/183 (27%), Positives = 76/183 (41%), Gaps = 41/183 (22%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLI-----TD-YCPGGELFLLLDRQPTKVLKEDA 772
E IL ++HP + L +F CLI TD YC L ++ + A
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYC------YLAAKRNIAICDILA 186
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
+ V+ A++YLH II+RD+K EN+ + G V L DF +C P
Sbjct: 187 IE---RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAAC---------FPVD 234
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
+ + + GT APE++A + AVD W+ GI+L+EM
Sbjct: 235 INANKYY-----------------GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMA 277
Query: 893 YGY 895
+
Sbjct: 278 TCH 280
|
Length = 391 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 29/136 (21%)
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGH----VSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
+ YLH +++RDLKP N+L+ G G V + D L+ L + + L
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA---------- 170
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPF 898
+PV V T Y APE++ GA H T A+D WA+G + E+L F
Sbjct: 171 --DLDPV------------VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216
Query: 899 RGKTRQKTFANILHKD 914
+G+ + +N +D
Sbjct: 217 KGREAKIKKSNPFQRD 232
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 42/141 (29%), Positives = 62/141 (43%), Gaps = 33/141 (23%)
Query: 763 QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821
+ ED + A +V ALEYLH + +I+RD+KP NVL+ NG V L DF +S
Sbjct: 95 DKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS--- 151
Query: 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV-- 879
L + +A+ + A G + Y+APE I +
Sbjct: 152 ---GYL----VDS-------------VAKTIDA-----GCKPYMAPERINPELNQKGYDV 186
Query: 880 --DWWALGILLYEMLYGYTPF 898
D W+LGI + E+ G P+
Sbjct: 187 KSDVWSLGITMIELATGRFPY 207
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 30/233 (12%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLD 727
++R K LG G G V+L +G+ A+K + D +V+ E ++L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 728 HPFVPALYASFQ--TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
H + Y + + + + ++ PGG + L + L E+ R Y +++ +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVS 120
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YLH I++RD+K N+L G+V L DF S K Q
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGAS---------------------KRLQTI 159
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
M+ S GT +++PE+I+G G+ D W++G + EML P+
Sbjct: 160 CLSGTGMK---SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-10
Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 31/174 (17%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPG--GELFLLLDRQPTKVLKEDAVRFY 776
E +L L HP V AL CL+ P +L+ L + + L V
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVL---PKYRSDLYTYLGARL-RPLGLAQVTAV 265
Query: 777 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836
A +++ A++Y+H +GII+RD+K ENVL+ G + L DF +C
Sbjct: 266 ARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA--------------- 310
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 890
P GT + APE++AG +T +VD W+ G++++E
Sbjct: 311 --RGSWSTPFHYG--------IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 57/233 (24%), Positives = 94/233 (40%), Gaps = 35/233 (15%)
Query: 675 KPLGSGDTGSVHL-VELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 731
K LG G+ GSV V L SG+ A+K + + + K E ++ LDHP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLDHPCI 58
Query: 732 PALYASFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
L + + + L+ + P G L L R+ V ++ A +V + + YL +
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSD---LKELAHQVAMGMAYLESK 114
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
++RDL NVLL ++DF +S L ++ R + P+
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMS--------RALGAGSDYYRATTAGRWPL---- 162
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 902
++ APE I +S D W+ G+ L+E YG P+
Sbjct: 163 ------------KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-10
Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 48/235 (20%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 731
+ L G G V + G Q +KA+ G R E +IL + H +
Sbjct: 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR--------EIDILKTISHRAI 148
Query: 732 PALYASFQTKTHVCLITDY--CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
L +++ K+ VC++ C +LF +DR L++ ++ AL YLH
Sbjct: 149 INLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQ--AITIQRRLLEALAYLHG 203
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSC-LTSC--KPQLLLPTTNEKKRRHKGQQNPV 846
+GII+RD+K EN+ L + L DF +C L + PQ
Sbjct: 204 RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ-------------------- 243
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+ GT E +PE++A + + D W+ G++L+EM GK
Sbjct: 244 --------CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290
|
Length = 392 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 65/248 (26%), Positives = 101/248 (40%), Gaps = 43/248 (17%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPALY 735
+GSG G V+ + +G A+K M + N+ + R + +++ D P++ Y
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 736 ASFQTKTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYL-HCQGI 792
F T + V I L LL R P + ED + +V AL YL G+
Sbjct: 81 GYFITDSDV-FICMELMSTCLDKLLKRIQGP---IPEDILGKMTVAIVKALHYLKEKHGV 136
Query: 793 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
I+RD+KP N+LL +G+V L DF +S + +
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGISG---------------------------RLVDSK 169
Query: 853 RASNSFVGTEEYIAPEIIAGAGHTSA----VDWWALGILLYEMLYGYTPFRG-KTRQKTF 907
+ S G Y+APE I D W+LGI L E+ G P++ KT +
Sbjct: 170 AKTRS-AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL 228
Query: 908 ANILHKDL 915
IL ++
Sbjct: 229 TKILQEEP 236
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 51/215 (23%), Positives = 83/215 (38%), Gaps = 39/215 (18%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
E + L L H + +L+A V +IT+ G L L +VL ++ A
Sbjct: 52 EVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMAC 111
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+V + YL Q I+RDL N+L+ + + DF L+ L
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLI----------------- 154
Query: 839 HKGQQNPVFMAE----PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 893
+ V+++ P + + APE + ++ D W+ GILLYEM Y
Sbjct: 155 ----KEDVYLSSDKKIPYK----------WTAPEAASHGTFSTKSDVWSFGILLYEMFTY 200
Query: 894 GYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAA 928
G P+ G + + I + P P+ C
Sbjct: 201 GQVPYPGMNNHEVYDQIT-AGYRMPC--PAKCPQE 232
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 9e-10
Identities = 58/246 (23%), Positives = 96/246 (39%), Gaps = 31/246 (12%)
Query: 669 QHFRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRA----CA 718
+ + LG G G V +G+ A+K + V +R V
Sbjct: 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67
Query: 719 EREILDM--LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRF 775
RE+ M + H + L + + L+ D +L ++DR K+ L E V+
Sbjct: 68 LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDR---KIRLTESQVKC 123
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
+++ L LH ++RDL P N+ + G + DF L+ P T ++
Sbjct: 124 ILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPP--YSDTLSKD 181
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYG 894
+ + S V T Y APE++ GA + AVD W++G + E+L G
Sbjct: 182 ET-----------MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
Query: 895 YTPFRG 900
F G
Sbjct: 231 KPLFPG 236
|
Length = 335 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 27/189 (14%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
E EIL DHP + L K + ++ + PGG L L R+ L + +
Sbjct: 42 EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSL 100
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+ +EYL + I+RDL N L+ N + ++DF +S + + T +
Sbjct: 101 DAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMS-----REEEGGIYTVSDGLK 155
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTP 897
Q P+ ++ APE + +TS D W+ GILL+E G TP
Sbjct: 156 ----QIPI----------------KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTP 195
Query: 898 FRGKTRQKT 906
+ G + Q+T
Sbjct: 196 YPGMSNQQT 204
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 37/212 (17%)
Query: 716 ACAEREILDMLDHPFVPALYASF--QTKTHVCLITDYCPGGELFLLLDRQPTKV------ 767
AC E +L L HP V AL F + V L+ DY ++ + +K
Sbjct: 45 ACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQ 104
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDFDLSCLTSC 823
L V+ +++ + YLH +++RDLKP N+L+ G G V + D + L +
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN- 163
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWW 882
+P+ +P+ + V T Y APE++ GA H T A+D W
Sbjct: 164 --------------------SPL---KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 200
Query: 883 ALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914
A+G + E+L F + +N H D
Sbjct: 201 AIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD 232
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-09
Identities = 56/224 (25%), Positives = 87/224 (38%), Gaps = 51/224 (22%)
Query: 727 DHPFVPALYASFQTKTHVC-----------LITDYCPGGELFLLLDRQPTKVLKE----- 770
D P A F+ +T +C L + P G LF + + P + L+E
Sbjct: 14 DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAAD 73
Query: 771 ------DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCLT 821
+ R +V+ AL H QGI++RDLKP+N+++ G H + DF +
Sbjct: 74 GALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGT-- 130
Query: 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881
LLP + + + +GT Y APE + G T D
Sbjct: 131 ------LLPGVRDADVAT------------LTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 882 WALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK-FPSSTPSS 924
+A G++ E L G +G + A IL++ L S P
Sbjct: 173 YAWGLIFLECLTGQRVVQG----ASVAEILYQQLSPVDVSLPPW 212
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 61/239 (25%), Positives = 107/239 (44%), Gaps = 35/239 (14%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRACAEREILD 724
IN +K LGSG G VHL + Q A+KA+++G M + + A +++
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKW--RAQIKVAIKAINEGAMSEEDFIEEA----KVMM 54
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
L HP + LY + + ++T++ G L L RQ L +D + +V +
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGM 113
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
EYL I+RDL N L+ G V ++DF ++ + +L +++ G +
Sbjct: 114 EYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMT-------RYVL---DDEYTSSSGAKF 163
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 902
PV ++ PE+ + ++S D W+ G+L++E+ G PF K+
Sbjct: 164 PV----------------KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 45/230 (19%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI--L 723
+ I+ +G G G V+ +GQ AMK + ++GV + A REI L
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGV--------PSTAIREISLL 53
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVV 782
L HP + L ++ + LI ++ +L LD P + + + V+ Y +++
Sbjct: 54 KELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQ 112
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
+ + H + +++RDLKP+N+L+ G + L DF L+ R G
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA-------------------RAFGI 153
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA-VDWWALGILLYEM 891
P+R V T Y APE++ G+ S VD W++G + EM
Sbjct: 154 --------PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEM 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 71/262 (27%), Positives = 107/262 (40%), Gaps = 42/262 (16%)
Query: 675 KPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRA-CAEREILDMLDHPF 730
K +G+G+ G V L G+ A+K + G K R +E I+ DHP
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT---EKQRRDFLSEASIMGQFDHPN 66
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLL---DRQPTKVLKEDAVRFYAAEVVVALEYL 787
+ L V ++T+Y G L L D Q T + +R A+ ++YL
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIAS----GMKYL 122
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
G ++RDL N+L+ N ++DF LS + P+ T K
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI----------- 171
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGKTRQKT 906
P+R + APE IA TSA D W+ GI+++E M YG P+ + Q
Sbjct: 172 ---PIR----------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV 218
Query: 907 FANILHKDLKFPSSTPSSCKAA 928
I + + P+ P C AA
Sbjct: 219 IKAI-EEGYRLPA--PMDCPAA 237
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 62/243 (25%), Positives = 103/243 (42%), Gaps = 50/243 (20%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDML 726
+ ++ + P+GSG GSV Q A+K + + ++ +H R E +L +
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---QSLIHARRTYRELRLLKHM 71
Query: 727 DHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
H F PA S + V L+T+ G +L ++ Q L ++ V+F
Sbjct: 72 KHENVIGLLDVFTPA--TSIENFNEVYLVTNLM-GADLNNIVKCQK---LSDEHVQFLIY 125
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+++ L+Y+H GII+RDLKP NV + + + + DF L+
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD---------------- 169
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP 897
+ M +V T Y APEI+ H VD W++G ++ E+L G
Sbjct: 170 -----------DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKAL 215
Query: 898 FRG 900
F G
Sbjct: 216 FPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 60/236 (25%), Positives = 94/236 (39%), Gaps = 44/236 (18%)
Query: 681 DTGSVHLVELCGSGQY-------------FAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
D S+ L+ G+GQ+ A+K + G M AE +I+ L
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR 59
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
HP + LYA + + ++T+ G L L + LK + AA+V + YL
Sbjct: 60 HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
Q I+RDL NVL+ N + DF L+ + + + R G + P+
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARVIK---------EDIYEARE-GAKFPI- 168
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 902
++ APE + D W+ GILL E++ YG P+ G T
Sbjct: 169 ---------------KWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|238075 cd00130, PAS, PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-09
Identities = 27/94 (28%), Positives = 55/94 (58%), Gaps = 8/94 (8%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQN----GQSYCGRLLN 269
I+YA+ ++ GY+ +E++G++ L PED ++RE L+N G+ +
Sbjct: 14 ILYANPAAEQLLGYSPEELIGKSLLDL----IHPEDREELRERLENLLSGGEPVTLEVRL 69
Query: 270 YKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
+KDG+ W L+++ PI+D+ G+V+ +G+ ++
Sbjct: 70 RRKDGSVIWVLVSLTPIRDEGGEVIGLLGVVRDI 103
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. Length = 103 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 61/242 (25%), Positives = 106/242 (43%), Gaps = 41/242 (16%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDK--GVMLNRNKVHRACAEREILDMLDHPFV 731
++P+G G G V +GQ A+K + K + + +R E ++L L H +
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR---ELKLLKHLRHENI 71
Query: 732 PALYASF-QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+L F + +T+ G +L LL +P L++ ++++ +++ L+Y+H
Sbjct: 72 ISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRP---LEKQFIQYFLYQILRGLKYVHSA 127
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
G+++RDLKP N+L+ N + + DF L+ + PQ+
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARIQD--PQM----------------------- 162
Query: 851 PMRASNSFVGTEEYIAPEI-IAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+V T Y APEI + + VD W+ G + EML G F GK F+
Sbjct: 163 -----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI 217
Query: 910 IL 911
I
Sbjct: 218 IT 219
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 37/212 (17%)
Query: 716 ACAEREILDMLDHPFVPALYASF--QTKTHVCLITDYCPGGELFLLLDRQPTKV------ 767
AC E +L L HP V +L F V L+ DY ++ + +K
Sbjct: 45 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ 104
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDFDLSCLTSC 823
L V+ +++ + YLH +++RDLKP N+L+ G G V + D + L +
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN- 163
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWW 882
+P+ +P+ + V T Y APE++ GA H T A+D W
Sbjct: 164 --------------------SPL---KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 200
Query: 883 ALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914
A+G + E+L F + +N H D
Sbjct: 201 AIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 232
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 52/234 (22%), Positives = 92/234 (39%), Gaps = 37/234 (15%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
IN + + +G G+ G V L + GQ A+K + + AE ++
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKD----DSTAAQAFLAEASVMTT 56
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
L HP + L + ++T+Y G L L + V+ +A +V +E
Sbjct: 57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGME 116
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YL + ++RDL NVL+ + ++DF L+ E + + P
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA--------------KEASQGQDSGKLP 162
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 898
V ++ APE + ++ D W+ GILL+E+ +G P+
Sbjct: 163 V----------------KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 43/140 (30%), Positives = 60/140 (42%), Gaps = 34/140 (24%)
Query: 766 KVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824
V+ E+ + A V AL YL + II+RD+KP N+LL NG++ L DF +S
Sbjct: 102 SVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS------ 155
Query: 825 PQLLLPTTNEKKRRHKGQ-QNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVD 880
GQ + + A G Y+APE I G+ D
Sbjct: 156 ----------------GQLVDSI-------AKTRDAGCRPYMAPERIDPSARDGYDVRSD 192
Query: 881 WWALGILLYEMLYGYTPFRG 900
W+LGI LYE+ G P+
Sbjct: 193 VWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 64/285 (22%), Positives = 108/285 (37%), Gaps = 52/285 (18%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLN-RNKVHRACA 718
+I L R ++ LG G G V+ EL G S A+K + + + + +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ--- 57
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLL------------DRQP 764
E E++ L HP + L + C++ +Y G+L FL+ D
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 765 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824
L A ++ +EYL ++RDL N L+ V ++DF LS
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD---- 173
Query: 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 884
++ A+ R + + ++ PE I T+ D W+
Sbjct: 174 ---------------------IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212
Query: 885 GILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAA 928
G++L+E+ YG P+ G + Q+ I + L P P C A
Sbjct: 213 GVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL-LPC--PEDCPAR 254
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 57/243 (23%), Positives = 102/243 (41%), Gaps = 35/243 (14%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRACAEREILD 724
I+ + +K LG+G G V + GQY A+K + +G M + A +++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKW--RGQYDVAIKMIKEGSMSEDEFIEEA----KVMM 54
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
L H + LY + + ++T+Y G L L R+ K + + +V +
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGM 113
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
YL + I+RDL N L+ G V ++DF LS + +L +++ G +
Sbjct: 114 AYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLS-------RYVL---DDEYTSSVGSKF 163
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 903
PV + PE++ + +S D WA G+L++E+ G P+
Sbjct: 164 PV----------------RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN 207
Query: 904 QKT 906
+T
Sbjct: 208 SET 210
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAM----DKGVMLNRNKVHRACAEREILDMLDHP 729
++ LG G +V+ +GQ A+K + ++GV A E +L L H
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFT------AIREASLLKGLKHA 63
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+ L+ TK + + +Y +L + + P L VR + +++ L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGG-LHPYNVRLFMFQLLRGLAYIHG 121
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
Q I++RDLKP+N+L+ G + L DF L+ R K +
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLA-------------------RAK--------S 154
Query: 850 EPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRG 900
P + +S V T Y P+++ GA ++SA+D W G + EML G F G
Sbjct: 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 58/241 (24%), Positives = 94/241 (39%), Gaps = 44/241 (18%)
Query: 684 SVHLVELCGSGQY-------------FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
S+ L G+GQ+ A+K + G M E +I+ L H
Sbjct: 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDK 62
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ LYA + + ++T+Y G L L K L+ + AA++ + YL +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
I+RDL N+L+ N + DF L+ L +E R G + P+
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIE---------DDEYTARE-GAKFPI---- 168
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFAN 909
++ APE T D W+ GILL E++ YG P+ G T ++
Sbjct: 169 ------------KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ 216
Query: 910 I 910
+
Sbjct: 217 V 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|219844 pfam08447, PAS_3, PAS fold | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-08
Identities = 29/90 (32%), Positives = 43/90 (47%), Gaps = 7/90 (7%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ-----NGQSYCGRLL 268
I+Y S F ++ GYT +E+ +L PED ++R LQ G+ Y G
Sbjct: 1 IIYWSPRFEEILGYTPEELKSSYEGWLDL--VHPEDRERVRRALQEFSLKKGEPYSGEYR 58
Query: 269 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIG 298
+KDG W PI+D+ GK ++ IG
Sbjct: 59 IRRKDGEYRWVEARGRPIRDENGKPVRVIG 88
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 90 |
| >gnl|CDD|232884 TIGR00229, sensory_box, PAS domain S-box | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 22/96 (22%), Positives = 42/96 (43%), Gaps = 2/96 (2%)
Query: 497 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY-TK 555
I++ + +F E+ YS EE++GRN L E +I ++ + + + K
Sbjct: 25 ILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERRLEGEREPVSEERRVRRK 84
Query: 556 SGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 591
G + W + P+R G +G+ D +E +
Sbjct: 85 DGSEIWVEVSVSPIRTN-GGELGVVGIVRDITERKQ 119
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator [Regulatory functions, Small molecule interactions]. Length = 124 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 65/239 (27%), Positives = 103/239 (43%), Gaps = 42/239 (17%)
Query: 677 LGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
LG G+ GSV +L GS Q A+K M K + + + + E + DHP V
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVK-MLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 734 LYA-SFQTKTHVCL-----ITDYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEVVV 782
L S +++ L I + G+L FLL+ R +P + + VRF ++
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF-MIDIAS 124
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
+EYL + I+RDL N +L N V + DF LS KK
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS----------------KK------ 162
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRG 900
++ + R + +++A E +A +T+ D WA G+ ++E M G TP+ G
Sbjct: 163 ---IYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 55/249 (22%), Positives = 108/249 (43%), Gaps = 39/249 (15%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY---FAMKAMDKGVMLNRNKVHRACAEREI 722
I+ ++ +GSG G V L G A+K + +G M + + A ++
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWL----GYWLEKRKVAIKTIREGAMSEEDFIEEA----QV 52
Query: 723 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 782
+ L HP + LY ++ +CL+ ++ G L L Q K +E + +V
Sbjct: 53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQE-TLLGMCLDVCE 111
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
+ YL +I+RDL N L+ N V ++DF ++ + +L +++ G
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMT-------RFVL---DDQYTSSTGT 161
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901
+ PV ++ +PE+ + + ++S D W+ G+L++E+ G TP+ +
Sbjct: 162 KFPV----------------KWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205
Query: 902 TRQKTFANI 910
+ + I
Sbjct: 206 SNSEVVETI 214
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 30/188 (15%)
Query: 716 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
A E +L L H + L+ T+ + L+ +Y +L LD ++ V+
Sbjct: 50 AIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLD-NCGNLMSMHNVKI 107
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
+ +++ L Y H + I++RDLKP+N+L+ G + L DF L+ S
Sbjct: 108 FMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV------------ 155
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYG 894
P + ++ V T Y P+++ G+ +++ +D W +G +LYEM G
Sbjct: 156 ---------------PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200
Query: 895 YTPFRGKT 902
F G T
Sbjct: 201 RPMFPGST 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 67/264 (25%), Positives = 106/264 (40%), Gaps = 48/264 (18%)
Query: 677 LGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
+G+G+ G V L G + A+K + G + + +E I+ DHP +
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMGQFDHPNIIH 69
Query: 734 LYASFQTKTHVCLITDYCPGGEL--FLLL-DRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
L V +IT++ G L FL D Q T + +R AA ++YL
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAA----GMKYLSEM 125
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
++RDL N+L+ N ++DF LS + +P + +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLS-----------------RFLEDDTSDPTYTSS 168
Query: 851 -----PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGKTRQ 904
P+R + APE IA TSA D W+ GI+++E M YG P+ + Q
Sbjct: 169 LGGKIPIR----------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218
Query: 905 KTFANILHKDLKFPSSTPSSCKAA 928
N + +D + P P C A
Sbjct: 219 DVI-NAIEQDYRLPP--PMDCPTA 239
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 42/189 (22%), Positives = 82/189 (43%), Gaps = 28/189 (14%)
Query: 718 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
+E IL DHP + L + + ++ + PGG+ L ++ ++ + V+F A
Sbjct: 41 SEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF-A 99
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
+ + YL + I+RDL N L+ N + ++DF +S
Sbjct: 100 LDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMS------------------- 140
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 896
+ + + ++ + ++ ++ APE + ++S D W+ GILL+E G
Sbjct: 141 --RQEDDGIYSSSGLKQI-----PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVC 193
Query: 897 PFRGKTRQK 905
P+ G T Q+
Sbjct: 194 PYPGMTNQQ 202
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 46/195 (23%), Positives = 82/195 (42%), Gaps = 44/195 (22%)
Query: 716 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE----- 770
A E +L L H + L+ T+ + L+ +Y LD+ + L +
Sbjct: 51 AIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY---------LDKDLKQYLDDCGNSI 101
Query: 771 --DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828
V+ + +++ L Y H + +++RDLKP+N+L+ G + L DF L+ S
Sbjct: 102 NMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI----- 156
Query: 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGIL 887
P + ++ V T Y P+I+ G+ +++ +D W +G +
Sbjct: 157 ----------------------PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCI 194
Query: 888 LYEMLYGYTPFRGKT 902
YEM G F G T
Sbjct: 195 FYEMSTGRPLFPGST 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 60/260 (23%), Positives = 95/260 (36%), Gaps = 53/260 (20%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLDH 728
+ + +G G G V + Q A+K K +M N + A RE IL +L H
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALK---KVLMENEKEGFPITALREIKILQLLKH 70
Query: 729 PFVPALYASFQT--------KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
V L +T K L+ ++C + +L V+F +E+
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFC---------EHDLAGLLSNKNVKFTLSEI 121
Query: 781 -------VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
+ L Y+H I++RD+K N+L+ +G + L DF L+ S N
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLS-------KN 174
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEML 892
K R+ + V T Y PE++ G +D W G ++ EM
Sbjct: 175 SKPNRYTNR----------------VVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218
Query: 893 YGYTPFRGKTRQKTFANILH 912
+G T Q I
Sbjct: 219 TRSPIMQGNTEQHQLTLISQ 238
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 70/272 (25%), Positives = 113/272 (41%), Gaps = 57/272 (20%)
Query: 675 KPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 731
K LG G+ GSV +L GS A+K M K + +++ +E + DHP V
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 732 PALY------ASFQTKTHVCLITDYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEV 780
L +S Q +I + G+L FLL R P K+ + ++F ++
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF-MVDI 122
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK---- 836
+ +EYL + I+RDL N +L+ + V + DF LS KK
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS----------------KKIYSG 166
Query: 837 ---RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 892
R+ + + PV ++IA E +A +TS D WA G+ ++E+
Sbjct: 167 DYYRQGRIAKMPV----------------KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
Query: 893 YGYTPFRGKTRQKTFANILHKD-LKFPSSTPS 923
G TP+ G + + + H + LK P
Sbjct: 211 RGQTPYPGVENHEIYDYLRHGNRLKQPEDCLD 242
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|197509 smart00086, PAC, Motif C-terminal to PAS motifs (likely to contribute to PAS structural domain) | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 9e-08
Identities = 16/42 (38%), Positives = 22/42 (52%)
Query: 547 TVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
TV+ K G W L P+RD+ GEV+ +GV D +E
Sbjct: 1 TVEYRLRRKDGSYIWVLVSASPIRDEDGEVEGILGVVRDITE 42
|
PAC motif occurs C-terminal to a subset of all known PAS motifs. It is proposed to contribute to the PAS domain fold. Length = 43 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 56/237 (23%), Positives = 103/237 (43%), Gaps = 46/237 (19%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI--LDML 726
++ +G G G+V + + + A+K + D+GV + A REI L L
Sbjct: 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS--------ALREICLLKEL 56
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
H + LY + + L+ +YC +L D + + V+ + +++ L +
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDI-DPEIVKSFMFQLLKGLAF 114
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
H +++RDLKP+N+L+ NG + L DF L+ R G
Sbjct: 115 CHSHNVLHRDLKPQNLLINKNGELKLADFGLA-------------------RAFGI---- 151
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP-FRGK 901
P+R ++ V T Y P+++ GA +++++D W+ G + E+ P F G
Sbjct: 152 ----PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 56/235 (23%), Positives = 95/235 (40%), Gaps = 39/235 (16%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
+N++ + ++ +G G+ G V L G Y K K + N AE ++
Sbjct: 3 LNMKELKLLQTIGKGEFGDVML------GDYRGNKVAVKCIK-NDATAQAFLAEASVMTQ 55
Query: 726 LDHP-FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
L H V L + K + ++T+Y G L L + VL D + ++ +V A+
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
EYL ++RDL NVL+ + ++DF L T E +
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGL--------------TKEASSTQDTGKL 161
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 898
PV ++ APE + ++ D W+ GILL+E+ +G P+
Sbjct: 162 PV----------------KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 30/188 (15%)
Query: 716 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
A E +L L H + L+ TK + L+ +Y +L +D L VR
Sbjct: 50 AIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG-GLSMHNVRL 107
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
+ +++ L Y H + +++RDLKP+N+L+ G + L DF L+
Sbjct: 108 FLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLA----------------- 150
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG 894
R K + P + ++ V T Y P+++ G+ +++++D W +G + YEM G
Sbjct: 151 --RAK--------SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
Query: 895 YTPFRGKT 902
F G T
Sbjct: 201 RPLFPGST 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|225112 COG2202, AtoS, FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 52.9 bits (125), Expect = 2e-07
Identities = 32/119 (26%), Positives = 50/119 (42%), Gaps = 7/119 (5%)
Query: 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPAT 532
L LE + D D I++A+ + EL YS EE LGR L PE +
Sbjct: 113 RLRALLEASPDGIWVLDE---DGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERR 169
Query: 533 VRK--IRAAIDNQTDVTVQLINYTKSGKK-FWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
+ A + ++ K G++ W L + P+RD GE+ +G+ D +E
Sbjct: 170 ELELARALAEGRGGPLEIEYRVRRKDGERVRWILSRISPVRDD-GEIVGVVGIARDITE 227
|
Length = 232 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 38/149 (25%), Positives = 69/149 (46%), Gaps = 35/149 (23%)
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827
L + +F+ +++ AL+Y+H + +RDLKP+N+L + + + DF L+ +
Sbjct: 100 LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-----RVAF 154
Query: 828 L-LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWAL 884
PT +F + +V T Y APE+ + +T A+D W++
Sbjct: 155 NDTPTA-------------IFWTD-------YVATRWYRAPELCGSFFSKYTPAIDIWSI 194
Query: 885 GILLYEMLYGYTPFRGKTRQKTFANILHK 913
G + E+L G F GK N++H+
Sbjct: 195 GCIFAEVLTGKPLFPGK-------NVVHQ 216
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 33/114 (28%), Positives = 57/114 (50%), Gaps = 26/114 (22%)
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+++ A+EY+H + +I+RD+K EN+ L +G + L DF + +P E++
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA----------MPFEKEREAF 324
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
G +VGT +PEI+AG G+ D W+ G++L +ML
Sbjct: 325 DYG----------------WVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|131984 TIGR02938, nifL_nitrog, nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-07
Identities = 26/92 (28%), Positives = 51/92 (55%)
Query: 497 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKS 556
I++A+D+F +T Y++EEI+G+N L T P + + ++ Q +L+N K
Sbjct: 26 ILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNRRKD 85
Query: 557 GKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
G+ + + P+ ++ GE +F+G+ D +E
Sbjct: 86 GELYLAELTVAPVLNEAGETTHFLGMHRDITE 117
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes [Central intermediary metabolism, Nitrogen fixation, Regulatory functions, Protein interactions]. Length = 494 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 43/188 (22%), Positives = 81/188 (43%), Gaps = 30/188 (15%)
Query: 716 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
A E +L L H + L+ T + L+ +Y +L +D ++ V+
Sbjct: 51 AIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMD-DCGNIMSMHNVKI 108
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
+ +++ L Y H + +++RDLKP+N+L+ G + L DF L+ S
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV------------ 156
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYG 894
P + ++ V T Y P+++ G+ +++ +D W +G + +EM G
Sbjct: 157 ---------------PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG 201
Query: 895 YTPFRGKT 902
F G T
Sbjct: 202 RPLFPGST 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 63/275 (22%), Positives = 106/275 (38%), Gaps = 48/275 (17%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQY---FAMKAMDKGVMLNRNKVHRACAERE 721
+I+ H K +G+G+ G V L G+ A+K + G + +E
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEAS 58
Query: 722 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
I+ H + L +IT+Y G L K L++ F + ++V
Sbjct: 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGAL--------DKYLRDHDGEFSSYQLV 110
Query: 782 -------VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
++YL ++RDL N+L+ N ++DF LS + P+ T+
Sbjct: 111 GMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGG 170
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLY 893
K P+R + APE IA TSA D W+ GI+++E M +
Sbjct: 171 KI--------------PIR----------WTAPEAIAYRKFTSASDVWSFGIVMWEVMSF 206
Query: 894 GYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAA 928
G P+ + + I + + P P C +A
Sbjct: 207 GERPYWDMSNHEVMKAI-NDGFRLP--APMDCPSA 238
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 56/255 (21%), Positives = 93/255 (36%), Gaps = 56/255 (21%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK---AMDKGVML-----------NRNKVH 714
H + LG G G VHL E+ ++ + KG L N+N +
Sbjct: 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN 64
Query: 715 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FL----LLDRQ----- 763
E +IL L P + L + +C+IT+Y G+L FL L D++
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 764 ------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817
+ ++ A ++ ++YL ++RDL N L+ N + + DF
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADF-- 182
Query: 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 877
G ++ + R V ++A E I T+
Sbjct: 183 -----------------------GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT 219
Query: 878 AVDWWALGILLYEML 892
A D WA G+ L+E+L
Sbjct: 220 ASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 62/239 (25%), Positives = 103/239 (43%), Gaps = 35/239 (14%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
IK LG+G G V + G+ + A+K + G M + + A +I+ L H +
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEA----QIMKKLRHDKLVQ 65
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
LYA ++ + ++T+Y G L L + LK + AA+V + Y+ I
Sbjct: 66 LYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124
Query: 794 YRDLKPENVLLQGNGHV-SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
+RDL+ N+L+ G+G V + DF L+ L NE R +G + P+
Sbjct: 125 HRDLRSANILV-GDGLVCKIADFGLARLIE---------DNEYTAR-QGAKFPI------ 167
Query: 853 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANI 910
++ APE T D W+ GILL E++ G P+ G ++ +
Sbjct: 168 ----------KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 59/234 (25%), Positives = 98/234 (41%), Gaps = 36/234 (15%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA-----CAEREILDML-DH 728
K LG+G G V VE G + M V + + H + +E +I+ L +H
Sbjct: 41 KTLGAGAFGKV--VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
+ L + + +IT+YC G+L L R+ L + + ++ +V + +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 789 CQGIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
+ I+RDL NVLL +G + + DF L+ R N V
Sbjct: 159 SKNCIHRDLAARNVLLT-HGKIVKICDFGLA------------------RDIMNDSNYVV 199
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRG 900
N+ + +++APE I +T D W+ GILL+E+ G P+ G
Sbjct: 200 ------KGNARLPV-KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 58/239 (24%), Positives = 91/239 (38%), Gaps = 48/239 (20%)
Query: 677 LGSGDTGSVHLVELCGSGQY----FAMKAMDKGVMLNRNKVHRACA----------EREI 722
LG G G VHL E G ++ F++ +L K+ R A E +I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 723 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAV------- 773
+ L P + L A T +C+IT+Y G+L FL K D V
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 774 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
F A ++ ++YL ++RDL N L+ N + + DF +S
Sbjct: 133 IFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS--------------- 177
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
++ + R V +++ E I T+A D WA G+ L+E+L
Sbjct: 178 ----------RNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 43/213 (20%), Positives = 82/213 (38%), Gaps = 41/213 (19%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKV--------- 767
E ++ L HP + L + VC++ +Y G+L FL++ + V
Sbjct: 57 EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116
Query: 768 ----LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
L A ++ +EYL +++DL N+L+ HV ++D LS
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLS----- 171
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 883
++ A+ R + ++ PE I +S D W+
Sbjct: 172 --------------------REIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS 211
Query: 884 LGILLYEML-YGYTPFRGKTRQKTFANILHKDL 915
G++L+E+ +G P+ G + Q+ + + L
Sbjct: 212 FGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 59/229 (25%), Positives = 94/229 (41%), Gaps = 41/229 (17%)
Query: 674 IKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML 726
I+ LG G G V ELC +G+ A+K++ N + E EIL L
Sbjct: 9 IRDLGEGHFGKV---ELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL 63
Query: 727 DHPFVPALYASFQTK---THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
H + Y T+ + LI ++ P G L L R K+ + ++ YA ++
Sbjct: 64 YHENI-VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLK-YAVQICKG 121
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
++YL + ++RDL NVL++ V + DF L+ + T E
Sbjct: 122 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT--------KAIETDKEYYTVKDDLD 173
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
+PVF + APE + + A D W+ G+ LYE+L
Sbjct: 174 SPVF----------------WYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 61/265 (23%), Positives = 103/265 (38%), Gaps = 43/265 (16%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDML 726
R +K LGSG G+VH G + K + R + L
Sbjct: 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL 66
Query: 727 DHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
DH ++ L AS Q L+T P G L + RQ L + + ++
Sbjct: 67 DHAYIVRLLGICPGASLQ------LVTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQIA 119
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+ YL +++R+L N+LL+ + V + DF ++ LL P ++KK +
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA-------DLLYP--DDKKYFYSE 170
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRG 900
+ P+ +++A E I +T D W+ G+ ++EM+ YG P+ G
Sbjct: 171 HKTPI----------------KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214
Query: 901 KTRQKTFANILHKDLKFPSSTPSSC 925
R ++L K + P C
Sbjct: 215 -MRPHEVPDLLEKGERLAQ--PQIC 236
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 59/244 (24%), Positives = 100/244 (40%), Gaps = 43/244 (17%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
K LG+G G V + A+K M G M V AE ++ L H + L
Sbjct: 12 KKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL 66
Query: 735 YASFQTKTHVCLITDYCPGGELFLLL-----DRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+A TK + +IT++ G L L +QP L + ++A++ + ++
Sbjct: 67 HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID-----FSAQIAEGMAFIEQ 120
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+ I+RDL+ N+L+ + + DF L+ + NE R +G + P+
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIE---------DNEYTAR-EGAKFPI--- 167
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFA 908
++ APE I T D W+ GILL E++ YG P+ G + +
Sbjct: 168 -------------KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214
Query: 909 NILH 912
+
Sbjct: 215 ALER 218
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 50/246 (20%), Positives = 91/246 (36%), Gaps = 47/246 (19%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA---MDKGVML---------NRNKVHRA 716
Q R + LG G G VHL E G ++ A + V++ + +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 717 CAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP--TKVLKEDAVR 774
E +I+ L +P + L + +C+IT+Y G+L L ++ + + +
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 775 --------FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826
+ A ++ ++YL ++RDL N L+ + + + DF
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADF----------- 173
Query: 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 886
G ++ + R V ++A E I T+A D WA G+
Sbjct: 174 --------------GMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 887 LLYEML 892
L+EM
Sbjct: 220 TLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 31/141 (21%), Positives = 60/141 (42%), Gaps = 29/141 (20%)
Query: 762 RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV-SLTDFDLSCL 820
R P + L ++ + +++ + + H G+++RDLKP+N+L+ + + D L
Sbjct: 101 RGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160
Query: 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAV 879
S P+++ + T Y APE++ G+ H ++ V
Sbjct: 161 FSI---------------------------PVKSYTHEIVTLWYRAPEVLLGSTHYSTPV 193
Query: 880 DWWALGILLYEMLYGYTPFRG 900
D W++G + EM F G
Sbjct: 194 DIWSVGCIFAEMSRKQPLFPG 214
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 58/253 (22%), Positives = 102/253 (40%), Gaps = 36/253 (14%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V + G+ + A+K + G M + A +++ L H + LYA
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEA----QVMKKLRHEKLVQLYA 68
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
++ + ++T+Y G L L + K L+ + AA++ + Y+ ++RD
Sbjct: 69 VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
L+ N+L+ N + DF L+ L NE R +G + P+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIE---------DNEYTAR-QGAKFPI---------- 167
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDL 915
++ APE T D W+ GILL E+ G P+ G ++ + +
Sbjct: 168 ------KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGY 220
Query: 916 KFPSSTPSSCKAA 928
+ P P C +
Sbjct: 221 RMP--CPPECPES 231
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|216228 pfam00989, PAS, PAS fold | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 23/87 (26%), Positives = 46/87 (52%), Gaps = 1/87 (1%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYK-K 272
I+Y +A ++ G + +EV+G++ L D E +R+ L G+ G ++++
Sbjct: 23 ILYVNAAAEELLGLSREEVIGKSLLDLIPEDDDAEVAELLRQALLQGEESRGFEVSFRVP 82
Query: 273 DGTPFWNLLTIAPIKDDEGKVLKFIGM 299
DG P + +P++D G+V F+G+
Sbjct: 83 DGRPRHVEVRASPVRDAGGEVRGFLGV 109
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 113 |
| >gnl|CDD|225112 COG2202, AtoS, FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 49.5 bits (116), Expect = 2e-06
Identities = 19/97 (19%), Positives = 41/97 (42%), Gaps = 2/97 (2%)
Query: 210 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ--NGQSYCGRL 267
D I+YA+ ++ GY+ +E +GR L + ++ L G
Sbjct: 130 EDGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERRELELARALAEGRGGPLEIEY 189
Query: 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+KDG +L+ D+G+++ +G+ +++
Sbjct: 190 RVRRKDGERVRWILSRISPVRDDGEIVGVVGIARDIT 226
|
Length = 232 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 54/241 (22%), Positives = 87/241 (36%), Gaps = 45/241 (18%)
Query: 675 KPLGSGDTGSVHLVE---LCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+ LG G G V L E LC A+K + R HR E E+L L H
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR---EAELLTNLQHE 67
Query: 730 FVPALYASFQTKTHVCLITDYCPGGEL-----------FLLLDRQPTKVLKEDAVRFYAA 778
+ Y + ++ +Y G+L L+ + L + + A
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
++ + YL Q ++RDL N L+ N V + DF
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF----------------------- 164
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTP 897
G V+ + R + ++ PE I T+ D W+LG++L+E+ YG P
Sbjct: 165 --GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
Query: 898 F 898
+
Sbjct: 223 W 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 55/230 (23%), Positives = 99/230 (43%), Gaps = 39/230 (16%)
Query: 677 LGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRAC-----AEREILDMLDHPF 730
LGSG+ G V G Y K +D + + +N+ ++ E EI+ LD+P+
Sbjct: 3 LGSGNFGCVK------KGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPY 56
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ + + + + L+ + GG L L + ++ + V +V + ++YL +
Sbjct: 57 IVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMH-QVSMGMKYLEGK 114
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
++RDL NVLL + ++DF LS + L + K R G+
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLS-------KALGADDSYYKARSAGKW------- 160
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFR 899
P++ + APE I +S D W+ GI ++E YG P++
Sbjct: 161 PLK----------WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK 200
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 62/240 (25%), Positives = 100/240 (41%), Gaps = 41/240 (17%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 732
K LG G+ GSV +L A+K M K + R+++ +E + DHP V
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 733 ALYA-SFQTKTH-----VCLITDYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEVV 781
L QT +I + G+L FLL R P + + V+F ++
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF-MTDIA 122
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+EYL + I+RDL N +L N +V + DF LS + R+ +
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI---------YNGDYYRQGRI 173
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM-LYGYTPFRG 900
+ PV ++IA E +A +T+ D W+ G+ ++E+ G TP+ G
Sbjct: 174 AKMPV----------------KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 48/193 (24%), Positives = 71/193 (36%), Gaps = 35/193 (18%)
Query: 718 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
E I+ DHP + L V +IT+Y G L L K V
Sbjct: 54 TEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGM-L 112
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
+ ++YL ++RDL N+L+ N ++DF LS
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS------------------- 153
Query: 838 RHKGQQNPVFMAE----PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-ML 892
R + + P+R + APE IA TSA D W+ GI+++E M
Sbjct: 154 RRLEDSEATYTTKGGKIPIR----------WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
Query: 893 YGYTPFRGKTRQK 905
YG P+ + Q
Sbjct: 204 YGERPYWDMSNQD 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|216228 pfam00989, PAS, PAS fold | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-06
Identities = 23/90 (25%), Positives = 42/90 (46%), Gaps = 1/90 (1%)
Query: 497 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY-TK 555
I++ + + EL SREE++G++ L + D +R A+ + +++
Sbjct: 23 ILYVNAAAEELLGLSREEVIGKSLLDLIPEDDDAEVAELLRQALLQGEESRGFEVSFRVP 82
Query: 556 SGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
G+ P+RD GEV+ F+GV D
Sbjct: 83 DGRPRHVEVRASPVRDAGGEVRGFLGVLRD 112
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 113 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 62/261 (23%), Positives = 109/261 (41%), Gaps = 39/261 (14%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE----REILDML 726
+ +K LGSG G+V+ G+ + K +LN +A E I+ +
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIK--ILNETTGPKANVEFMDEALIMASM 66
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
DHP + L + T + L+T P G L + + + + + ++ + Y
Sbjct: 67 DHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN-WCVQIAKGMMY 124
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
L + +++RDL NVL++ HV +TDF L+ L +EK+ G + P+
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE---------GDEKEYNADGGKMPI 175
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRG-KTRQ 904
+++A E I T D W+ G+ ++E M +G P+ G TR+
Sbjct: 176 ----------------KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219
Query: 905 KTFANILHKDLKFPSSTPSSC 925
++L K + P P C
Sbjct: 220 --IPDLLEKGERLPQ--PPIC 236
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 57/275 (20%), Positives = 104/275 (37%), Gaps = 53/275 (19%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM---LNRNKVHRACAE-REILDM 725
+ + I LG G+ G V L + G + + V+ L + K +E R LDM
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGI----EEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 726 ---LDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDR--------QPTKVLKEDA 772
L H V L + +I +Y G+L FL + P ++ A
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
+ ++ + +++L ++RDL N L+ V +S L+ K
Sbjct: 122 L---CTQIALGMDHLSNARFVHRDLAARNCLVSSQREVK-----VSLLSLSK-------D 166
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
+K + + P+R ++APE + ++ D W+ G+L++E+
Sbjct: 167 VYNSEYYKLRNALI----PLR----------WLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212
Query: 893 -YGYTPFRGKTRQKTFANILHKDLKF--PSSTPSS 924
G PF G + ++ + L+ P PS
Sbjct: 213 TQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSR 247
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|232884 TIGR00229, sensory_box, PAS domain S-box | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 4e-06
Identities = 22/94 (23%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYK-K 272
I+Y + F ++ GY+++E++GRN L E +I L+ + + K
Sbjct: 25 ILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERRLEGEREPVSEERRVRRK 84
Query: 273 DGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306
DG+ W ++++PI G L +G+ ++++
Sbjct: 85 DGSEIWVEVSVSPI-RTNGGELGVVGIVRDITER 117
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator [Regulatory functions, Small molecule interactions]. Length = 124 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 6e-06
Identities = 33/120 (27%), Positives = 53/120 (44%), Gaps = 28/120 (23%)
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
+ +LH I++RDLK N+LL G + + DF L+ R +
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLA------------------REY--- 156
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGK 901
P++ V T Y APE++ GA ++A+D W++G + E+L F GK
Sbjct: 157 ------GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 63/262 (24%), Positives = 108/262 (41%), Gaps = 41/262 (15%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM----- 725
+ +K LGSG G+V+ G+ + K +L N +A +EILD
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIK--VLRENTSPKA--NKEILDEAYVMA 64
Query: 726 -LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
+ P+V L T T V L+T P G L + ++ +D + + ++ +
Sbjct: 65 GVGSPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLN-WCVQIAKGM 122
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
YL +++RDL NVL++ HV +TDF L+ L +E + G +
Sbjct: 123 SYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD---------IDETEYHADGGKV 173
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGKTR 903
P+ +++A E I T D W+ G+ ++E M +G P+ G
Sbjct: 174 PI----------------KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IP 216
Query: 904 QKTFANILHKDLKFPSSTPSSC 925
+ ++L K + P P C
Sbjct: 217 AREIPDLLEKGERLPQ--PPIC 236
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 7e-06
Identities = 66/256 (25%), Positives = 109/256 (42%), Gaps = 36/256 (14%)
Query: 661 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER 720
D GE L + IK +G+G G V LV+ + ++F KA+ + R K + E
Sbjct: 6 DDGES-RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK-SQLVIEV 63
Query: 721 EILDMLDHPFVPALYASFQTKTH--VCLITDYCPGGELFLLLDRQPTKVLK------EDA 772
++ L H + F K + + ++ ++C G+ L R K K E A
Sbjct: 64 NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGD----LSRNIQKCYKMFGKIEEHA 119
Query: 773 VRFYAAEVVVALEYLH-------CQGIIYRDLKPENVLLQ-GNGHVSLTDFDLSCLTSCK 824
+ +++ AL Y H + +++RDLKP+N+ L G H+ + L +
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG-R 178
Query: 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII--AGAGHTSAVDWW 882
P + K E M ++S VGT Y +PE++ + D W
Sbjct: 179 PIAKIGDFGLSKN---------IGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMW 227
Query: 883 ALGILLYEMLYGYTPF 898
ALG ++YE+ G TPF
Sbjct: 228 ALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 50/230 (21%), Positives = 86/230 (37%), Gaps = 51/230 (22%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-----QPTKVLKEDAV 773
E ++ DHP + L +CL+ +Y G+L L Q + +
Sbjct: 58 EAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSA 117
Query: 774 RFY---------------AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818
R A +V + YL + ++RDL N L+ N V + DF LS
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 878
+N ++ A+ +AS + ++ PE I +T+
Sbjct: 178 ------------------------RN-IYSADYYKASENDAIPIRWMPPESIFYNRYTTE 212
Query: 879 VDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD---LKFPSSTPSS 924
D WA G++L+E+ YG P+ G ++ + +D L P + P
Sbjct: 213 SDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV--RDGNVLSCPDNCPLE 260
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 59/250 (23%), Positives = 101/250 (40%), Gaps = 36/250 (14%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V + G+ + A+K + G M+ + A +I+ L H + LYA
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEA----QIMKKLRHDKLVPLYA 68
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
++ + ++T++ G L L K LK + AA++ + Y+ I+RD
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
L+ N+L+ N + DF L+ L NE R +G + P+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIE---------DNEYTAR-QGAKFPI---------- 167
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDL 915
++ APE T D W+ GILL E++ G P+ G ++ + +
Sbjct: 168 ------KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV---ER 218
Query: 916 KFPSSTPSSC 925
+ P C
Sbjct: 219 GYRMPCPQGC 228
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|219844 pfam08447, PAS_3, PAS fold | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 24/90 (26%), Positives = 39/90 (43%), Gaps = 5/90 (5%)
Query: 497 IIFASDSFLELTEYSREEILGRNCRFLQG--PETDPATVRKI--RAAIDNQTDVTVQLIN 552
II+ S F E+ Y+ EE+ +L PE D VR+ ++ + +
Sbjct: 1 IIYWSPRFEEILGYTPEELKSSYEGWLDLVHPE-DRERVRRALQEFSLKKGEPYSGEYRI 59
Query: 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 582
K G+ W +P+RD+ G+ IGV
Sbjct: 60 RRKDGEYRWVEARGRPIRDENGKPVRVIGV 89
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 90 |
| >gnl|CDD|197509 smart00086, PAC, Motif C-terminal to PAS motifs (likely to contribute to PAS structural domain) | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 2e-05
Identities = 11/36 (30%), Positives = 25/36 (69%)
Query: 269 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+KDG+ W L++ +PI+D++G+V +G+ +++
Sbjct: 6 LRRKDGSYIWVLVSASPIRDEDGEVEGILGVVRDIT 41
|
PAC motif occurs C-terminal to a subset of all known PAS motifs. It is proposed to contribute to the PAS domain fold. Length = 43 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 29/122 (23%)
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPT 831
++ Y +++ + Y H +++RDLKP+N+L+ + + L DF L+
Sbjct: 104 IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA------------- 150
Query: 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA-VDWWALGILLYE 890
R G P+R V T Y APEI+ G+ H S VD W++G + E
Sbjct: 151 ------RAFGI--------PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAE 196
Query: 891 ML 892
M+
Sbjct: 197 MV 198
|
Length = 294 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 50/184 (27%), Positives = 78/184 (42%), Gaps = 29/184 (15%)
Query: 718 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
E I+ DHP + L T+ V ++ + P GEL L L ++ Y+
Sbjct: 56 QEAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYS 113
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
++ AL YL + ++RD+ NVL+ V L DF LS + L + K
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS-------RYLEDESYYKAS 166
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 896
+ K P++ ++APE I TSA D W G+ ++E+L G
Sbjct: 167 KGK---------LPIK----------WMAPESINFRRFTSASDVWMFGVCMWEILMLGVK 207
Query: 897 PFRG 900
PF+G
Sbjct: 208 PFQG 211
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 55/235 (23%), Positives = 99/235 (42%), Gaps = 43/235 (18%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN--RNKVHRACAEREIL------DML 726
LGSG+ G+V + MK +K V + +N + + E+L L
Sbjct: 1 GELGSGNFGTV-------KKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL 53
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
D+P++ + + ++ + L+ + G L L Q K + E + +V + ++Y
Sbjct: 54 DNPYIVRMIGICEAESWM-LVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKY 110
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
L ++RDL NVLL + ++DF LS + L N K + G+
Sbjct: 111 LEETNFVHRDLAARNVLLVTQHYAKISDFGLS-------KALGADENYYKAKTHGKW--- 160
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRG 900
P++ + APE + +S D W+ G+L++E YG P++G
Sbjct: 161 ----PVK----------WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 58/261 (22%), Positives = 103/261 (39%), Gaps = 55/261 (21%)
Query: 675 KPLGSGDTGSV---HLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
K LG G+ G V L G Y A+K + + + +++ +E +L ++HP
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHP 63
Query: 730 FVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQ------------PTKVLKEDAVRF 775
V LY + + LI +Y G L FL R+ + L R
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 776 YAAEVVVALEYLHCQGIIY--------RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827
+++ + +G+ Y RDL NVL+ + ++DF LS +
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 887
+ +R KG+ PV +++A E + +T+ D W+ G+L
Sbjct: 184 V--------KRSKGRI-PV----------------KWMAIESLFDHIYTTQSDVWSFGVL 218
Query: 888 LYEML-YGYTPFRGKTRQKTF 907
L+E++ G P+ G ++ F
Sbjct: 219 LWEIVTLGGNPYPGIAPERLF 239
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 53/262 (20%), Positives = 97/262 (37%), Gaps = 58/262 (22%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-------- 726
KPLG G G V E + ++ + + E+++ D++
Sbjct: 18 KPLGEGAFGQVVKAE------AVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 727 --DHPFVPALYASFQTKTHVCLITDYCPGGEL--FL------------LLDRQPTKVLKE 770
H + L + + ++ +Y G L FL R P + L +
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 771 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV-SLTDFDLSCLTSCKPQLLL 829
+ +A +V +E+L + I+RDL NVL+ HV + DF L+
Sbjct: 132 KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV-TEDHVMKIADFGLARDIHH------ 184
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889
+ R+ + PV +++APE + +T D W+ G+LL+
Sbjct: 185 ---IDYYRKTTNGRLPV----------------KWMAPEALFDRVYTHQSDVWSFGVLLW 225
Query: 890 E-MLYGYTPFRGKTRQKTFANI 910
E G +P+ G ++ F +
Sbjct: 226 EIFTLGGSPYPGIPVEELFKLL 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 54/244 (22%), Positives = 89/244 (36%), Gaps = 48/244 (19%)
Query: 675 KPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+ LG G G V L E A+KA+ + R R E E+L L H
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQHE 67
Query: 730 FVPALYASFQTKTHVCLITDYCPGGEL-----------FLLLDRQPTKVLKE---DAVRF 775
+ Y + ++ +Y G+L +L+D QP + E +
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
A+++ + YL Q ++RDL N L+ N V + DF
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDF-------------------- 167
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG 894
G V+ + R + ++ PE I T+ D W+ G++L+E+ YG
Sbjct: 168 -----GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG 222
Query: 895 YTPF 898
P+
Sbjct: 223 KQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 31/123 (25%), Positives = 54/123 (43%), Gaps = 27/123 (21%)
Query: 770 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829
ED ++ + +++ L Y H + ++RD+K N+LL G + L DF L+ L
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL--------- 165
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILL 888
+ +E R + V T Y PE++ G + A+D W+ G +L
Sbjct: 166 -----------------YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 208
Query: 889 YEM 891
E+
Sbjct: 209 GEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 58/281 (20%), Positives = 106/281 (37%), Gaps = 50/281 (17%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAM-DKGVMLNRNKVHRACA 718
+INL R ++ LG G V+ L G+ Q A+K + DK R +
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLL------------DRQP 764
R L HP + L + + +I YC +L FL++ D+
Sbjct: 61 MRS---RLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 765 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824
L+ ++ +E+L ++++DL NVL+ +V ++D L
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLF------ 171
Query: 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 884
V+ A+ + + + +++PE I + D W+
Sbjct: 172 -------------------REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212
Query: 885 GILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPS 923
G++L+E+ YG P+ G + Q I ++ L P P+
Sbjct: 213 GVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPA 253
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 49/208 (23%)
Query: 714 HRACA-EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
HR A E E+L L HP + L + + + ++ L +Y P G L L + ++VL+ D
Sbjct: 51 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK--SRVLETD 108
Query: 772 ----------------AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815
+ +AA+V ++YL + I+RDL N+L+ N + DF
Sbjct: 109 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 168
Query: 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 875
LS +GQ+ V++ + M ++A E + + +
Sbjct: 169 GLS---------------------RGQE--VYVKKTMGRL-----PVRWMAIESLNYSVY 200
Query: 876 TSAVDWWALGILLYEML-YGYTPFRGKT 902
T+ D W+ G+LL+E++ G TP+ G T
Sbjct: 201 TTNSDVWSYGVLLWEIVSLGGTPYCGMT 228
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 9e-05
Identities = 50/235 (21%), Positives = 92/235 (39%), Gaps = 41/235 (17%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
+NLQ + +G G+ G+V E +GQ A+K + V E ++
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVT-----AQAFLEETAVMTK 55
Query: 726 LDHP-FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
L H V L ++ + + G L L + ++ + ++ +V +
Sbjct: 56 LHHKNLVRLLGVILHNGLYI--VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
EYL + +++RDL N+L+ +G ++DF L+
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA-------------------------- 147
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 898
M NS + ++ APE + +S D W+ G+LL+E+ YG P+
Sbjct: 148 ---RVGSMGVDNSKLPV-KWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 30/149 (20%), Positives = 58/149 (38%), Gaps = 15/149 (10%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFV 731
IK L G T V+L+ + +K R E IL +L V
Sbjct: 3 IKLLKGGLTNRVYLLGTKDED--YVLK--INPSREKGADRER---EVAILQLLARKGLPV 55
Query: 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 791
P + AS ++ L+ ++ G L + + + + ++ AE++ L L
Sbjct: 56 PKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ------LAELLAKLHQLPLLV 109
Query: 792 IIYRDLKPENVLLQGNGHVSLTDFDLSCL 820
+ + DL P N+L+ + + D++ +
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 53/244 (21%), Positives = 97/244 (39%), Gaps = 33/244 (13%)
Query: 684 SVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL--DMLDHPFVPALYASFQTK 741
SV+L +G ++ D + N + H + E++ HP + + F T
Sbjct: 15 SVYLARHTPTGTLVTVRITD---LENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG 71
Query: 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801
+ + +I+ + G LL + + E + + L YLH G I+R++K +
Sbjct: 72 SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASH 131
Query: 802 VLLQGNGHVSLTDFD-LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG 860
+L+ G+G VSL+ L L GQ+ V P
Sbjct: 132 ILISGDGLVSLSGLSHLYSLV-----------------RNGQKAKVVYDFP----QFSTS 170
Query: 861 TEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP 918
+++PE++ G+ D +++GI E+ G PF+ R + +L + LK P
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ----MLLQKLKGP 226
Query: 919 SSTP 922
+P
Sbjct: 227 PYSP 230
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 51/209 (24%)
Query: 714 HRACA-EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
HR A E E+L L HP + L + + + ++ + +Y P G L L + ++VL+ D
Sbjct: 46 HRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRK--SRVLETD 103
Query: 772 A-----------------VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 814
++F A++V ++YL + I+RDL NVL+ N + D
Sbjct: 104 PAFAKEHGTASTLTSQQLLQF-ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIAD 162
Query: 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 874
F LS +G++ V++ + M ++A E + +
Sbjct: 163 FGLS---------------------RGEE--VYVKKTMGRL-----PVRWMAIESLNYSV 194
Query: 875 HTSAVDWWALGILLYEML-YGYTPFRGKT 902
+T+ D W+ G+LL+E++ G TP+ G T
Sbjct: 195 YTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 47/224 (20%), Positives = 95/224 (42%), Gaps = 23/224 (10%)
Query: 678 GSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS 737
G D +V+L +G+Y ++ ++ N V E + + +HP + A+
Sbjct: 9 GFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRAT 67
Query: 738 FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 797
F + ++T + G L+ + E A+ + V+ AL+Y+H G ++R +
Sbjct: 68 FIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSV 127
Query: 798 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNS 857
K ++L+ +G V L+ +N H GQ+ V P +
Sbjct: 128 KASHILISVDGKVYLSGL---------------RSNLSMINH-GQRLRVVHDFPKYS--- 168
Query: 858 FVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFR 899
V +++PE++ G+ + D +++GI E+ G+ PF+
Sbjct: 169 -VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 42/189 (22%), Positives = 76/189 (40%), Gaps = 27/189 (14%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
E IL HP + L K + ++ + GG+ L + ++ ++ ++
Sbjct: 43 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM-VE 101
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+EYL + I+RDL N L+ + ++DF +S + + +T K
Sbjct: 102 NAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMS---REEEDGVYASTGGMK-- 156
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTP 897
Q PV ++ APE + ++S D W+ GILL+E G P
Sbjct: 157 ----QIPV----------------KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVP 196
Query: 898 FRGKTRQKT 906
+ + Q+T
Sbjct: 197 YANLSNQQT 205
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 53/247 (21%), Positives = 85/247 (34%), Gaps = 49/247 (19%)
Query: 674 IKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLN--RNKVHRACAEREILDML 726
+ LG G G V L E + A+K + K N R R E E+L
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFER---EAELLTNF 65
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGEL------------FLLLDRQPTKVLKEDAVR 774
H + Y ++ +Y G+L FL P L +
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 775 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
A ++ + YL Q ++RDL N L+ + V + DF +S
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS---------------- 169
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 893
V+ + R + ++ PE I T+ D W+ G++L+E+ Y
Sbjct: 170 ---------RDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTY 220
Query: 894 GYTPFRG 900
G P+ G
Sbjct: 221 GKQPWYG 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 51/209 (24%)
Query: 714 HRACA-EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
HR A E E+L L HP + L + + + ++ L +Y P G L L + ++VL+ D
Sbjct: 39 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK--SRVLETD 96
Query: 772 A-----------------VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 814
+ F AA+V ++YL + I+RDL N+L+ N + D
Sbjct: 97 PAFAIANSTASTLSSQQLLHF-AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 155
Query: 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 874
F LS +GQ+ V++ + M ++A E + +
Sbjct: 156 FGLS---------------------RGQE--VYVKKTMGRL-----PVRWMAIESLNYSV 187
Query: 875 HTSAVDWWALGILLYEML-YGYTPFRGKT 902
+T+ D W+ G+LL+E++ G TP+ G T
Sbjct: 188 YTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 7e-04
Identities = 52/268 (19%), Positives = 101/268 (37%), Gaps = 44/268 (16%)
Query: 674 IKPLGSGDTGSVH--LVELCGSGQYF---AMKAM-DKGVMLNRNKVHRACAEREILDMLD 727
I+ LG G G V+ L + G+ A+K + + M R + E ++ +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEF---LNEASVMKEFN 67
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLL------DRQPTKVLKEDAVRFY--AAE 779
V L T ++ + G+L L + +F AAE
Sbjct: 68 CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
+ + YL + ++RDL N ++ + V + DF ++ + T+ ++
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT--------RDIYETDYYRKGG 179
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 898
KG P+R ++APE + T+ D W+ G++L+EM P+
Sbjct: 180 KG-------LLPVR----------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222
Query: 899 RGKTRQKTFANILHKD-LKFPSSTPSSC 925
+G + ++ ++ L P + P
Sbjct: 223 QGLSNEEVLKFVIDGGHLDLPENCPDKL 250
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-04
Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 26/126 (20%)
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
Y+ +V +E+L + I+RDL N+LL N V + DF L+ P +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------- 231
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG 894
R + P+ +++APE I +T+ D W+ G+LL+E+ G
Sbjct: 232 --RKGSARLPL----------------KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 273
Query: 895 YTPFRG 900
+P+ G
Sbjct: 274 ASPYPG 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 60/254 (23%), Positives = 101/254 (39%), Gaps = 46/254 (18%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACA----EREILDML-DH 728
KPLG G G V + E G + +A+ V ML + + + E E++ M+ H
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----------- 775
+ L + + +I +Y G L +L R P D R
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 776 -YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
+V +EYL Q I+RDL NVL+ N + + DF L+ + +
Sbjct: 141 SCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA--------RDVNNIDY 192
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 893
K+ G+ PV +++APE + +T D W+ G+L++E+
Sbjct: 193 YKKTTNGRL-PV----------------KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235
Query: 894 GYTPFRGKTRQKTF 907
G +P+ G ++ F
Sbjct: 236 GGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 17/37 (45%), Positives = 26/37 (70%)
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815
+V+ L LH GI++RD+KPEN+L+ +G V + DF
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353
|
Length = 507 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 41/149 (27%), Positives = 62/149 (41%), Gaps = 49/149 (32%)
Query: 782 VALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
VAL+Y H + +++ DLKPEN+L++ S T D P TN R
Sbjct: 242 VALDYFHTELHLMHTDLKPENILME----TSDTVVD-------------PVTN----RA- 279
Query: 841 GQQNPVFMAEPMR--------------ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 886
+P R + + V T Y +PE++ G G + D W++G
Sbjct: 280 ------LPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGC 333
Query: 887 LLYEMLYGYTPFRGKTRQKTFANILHKDL 915
++YE+ YT GK T N+ H L
Sbjct: 334 IIYEL---YT---GKLLYDTHDNLEHLHL 356
|
Length = 467 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 33/126 (26%), Positives = 55/126 (43%), Gaps = 26/126 (20%)
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
Y+ +V +E+L + I+RDL N+LL N V + DF L+ P +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------- 236
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG 894
R + P+ +++APE I +T D W+ G+LL+E+ G
Sbjct: 237 --RKGDARLPL----------------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 278
Query: 895 YTPFRG 900
+P+ G
Sbjct: 279 ASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|214512 smart00091, PAS, PAS domain | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.002
Identities = 15/49 (30%), Positives = 28/49 (57%), Gaps = 4/49 (8%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS 262
I+YA+ ++ GY+ +E++G++ L PED +++E LQ S
Sbjct: 23 ILYANPAAEELLGYSPEELIGKSLLEL----IHPEDRERVQEALQRLLS 67
|
PAS motifs appear in archaea, eubacteria and eukarya. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. Length = 67 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 25/96 (26%), Positives = 45/96 (46%), Gaps = 11/96 (11%)
Query: 726 LDHPFVPALYA--SFQTKT----HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
+DH +P Y SF+ + L E+F + + K++K +
Sbjct: 80 IDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMK-----D 134
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815
++ LEY+H GI + D+KPEN+++ GN + D+
Sbjct: 135 MLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170
|
Length = 294 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 46/254 (18%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHR----ACAEREILDML-DH 728
KPLG G G V + E G + K + V ML + + +E E++ M+ H
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQP-------TKVLKEDAVRFY--- 776
+ L + + ++ +Y G L +L R P T L E+ + F
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 777 --AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
A +V +EYL Q I+RDL NVL+ + + + DF L+ + +
Sbjct: 138 SCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA--------RDVHNIDY 189
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 893
K+ G+ PV +++APE + +T D W+ G+LL+E+
Sbjct: 190 YKKTTNGRL-PV----------------KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 232
Query: 894 GYTPFRGKTRQKTF 907
G +P+ G ++ F
Sbjct: 233 GGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 43/200 (21%), Positives = 75/200 (37%), Gaps = 42/200 (21%)
Query: 735 YASFQTKTHVCLITDYCP----GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
YA ++ + Y P L++ P L + ++ +V +E+L +
Sbjct: 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESP--ALSYMDLVGFSYQVANGMEFLASK 258
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
++RDL NVL+ V + DF L+ +
Sbjct: 259 NCVHRDLAARNVLICEGKLVKICDFGLA------------------------------RD 288
Query: 851 PMRASN-----SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQ 904
MR SN S +++APE I +T+ D W+ GILL+E+ G TP+
Sbjct: 289 IMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348
Query: 905 KTFANILHKDLKFPSSTPSS 924
+ F N + + + +S
Sbjct: 349 EQFYNAIKRGYRMAKPAHAS 368
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 33/145 (22%), Positives = 60/145 (41%), Gaps = 45/145 (31%)
Query: 764 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS----- 818
P + + V A ++ + YLH +G+I++D+ N ++ V +TD LS
Sbjct: 111 PQALSTQQLVHM-AIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFP 169
Query: 819 ----CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 874
CL NE + P++ ++A E +
Sbjct: 170 MDYHCLGD----------NENR--------------PVK----------WMALESLVNKE 195
Query: 875 HTSAVDWWALGILLYEML-YGYTPF 898
++SA D W+ G+LL+E++ G TP+
Sbjct: 196 YSSASDVWSFGVLLWELMTLGQTPY 220
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 41/159 (25%), Positives = 67/159 (42%), Gaps = 26/159 (16%)
Query: 752 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 811
E+ LL ++ L + + +V +E+L + ++RDL NVLL V
Sbjct: 218 NDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVK 277
Query: 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA 871
+ DF L+ ++ KG F+ P++ ++APE I
Sbjct: 278 ICDFGLA----------RDIMHDSNYVSKGS---TFL--PVK----------WMAPESIF 312
Query: 872 GAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFAN 909
+T+ D W+ GILL+E+ G TP+ G TF N
Sbjct: 313 DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 934 | |||
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.98 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.98 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.98 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.98 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.98 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.98 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.98 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.98 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.98 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.98 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.93 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.93 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.93 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 99.92 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 99.85 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| PF13426 | 104 | PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_ | 99.63 | |
| PF13426 | 104 | PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_ | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.52 | |
| PF08448 | 110 | PAS_4: PAS fold; InterPro: IPR013656 The PAS fold | 99.5 | |
| PF08448 | 110 | PAS_4: PAS fold; InterPro: IPR013656 The PAS fold | 99.5 | |
| PF00989 | 113 | PAS: PAS fold; InterPro: IPR013767 PAS domains are | 99.5 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.48 | |
| PF00989 | 113 | PAS: PAS fold; InterPro: IPR013767 PAS domains are | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.44 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 99.42 | |
| PRK13557 | 540 | histidine kinase; Provisional | 99.41 | |
| PRK13559 | 361 | hypothetical protein; Provisional | 99.41 | |
| PRK11091 | 779 | aerobic respiration control sensor protein ArcB; P | 99.39 | |
| PRK11091 | 779 | aerobic respiration control sensor protein ArcB; P | 99.38 | |
| PRK13559 | 361 | hypothetical protein; Provisional | 99.37 | |
| PRK13557 | 540 | histidine kinase; Provisional | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.31 | |
| PRK13558 | 665 | bacterio-opsin activator; Provisional | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| PRK10060 | 663 | RNase II stability modulator; Provisional | 99.21 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 99.19 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.18 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.17 | |
| PRK13558 | 665 | bacterio-opsin activator; Provisional | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| TIGR00229 | 124 | sensory_box PAS domain S-box. The PAS domain was p | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| PRK10060 | 663 | RNase II stability modulator; Provisional | 99.13 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 99.1 | |
| PF08447 | 91 | PAS_3: PAS fold; InterPro: IPR013655 The PAS fold | 99.03 | |
| TIGR00229 | 124 | sensory_box PAS domain S-box. The PAS domain was p | 99.02 | |
| PF08447 | 91 | PAS_3: PAS fold; InterPro: IPR013655 The PAS fold | 99.02 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.0 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.99 | |
| COG3829 | 560 | RocR Transcriptional regulator containing PAS, AAA | 98.88 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| cd00130 | 103 | PAS PAS domain; PAS motifs appear in archaea, euba | 98.81 | |
| cd00130 | 103 | PAS PAS domain; PAS motifs appear in archaea, euba | 98.79 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.78 | |
| TIGR02966 | 333 | phoR_proteo phosphate regulon sensor kinase PhoR. | 98.76 | |
| PRK11073 | 348 | glnL nitrogen regulation protein NR(II); Provision | 98.74 | |
| PRK11073 | 348 | glnL nitrogen regulation protein NR(II); Provision | 98.72 | |
| PRK11360 | 607 | sensory histidine kinase AtoS; Provisional | 98.71 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.69 | |
| PRK11360 | 607 | sensory histidine kinase AtoS; Provisional | 98.69 | |
| PF13596 | 106 | PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D. | 98.63 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.61 | |
| TIGR02966 | 333 | phoR_proteo phosphate regulon sensor kinase PhoR. | 98.59 | |
| KOG0501 | 971 | consensus K+-channel KCNQ [Inorganic ion transport | 98.58 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.55 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.55 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.53 | |
| PF12860 | 115 | PAS_7: PAS fold | 98.53 | |
| PF13596 | 106 | PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D. | 98.53 | |
| PF12860 | 115 | PAS_7: PAS fold | 98.52 | |
| KOG0501 | 971 | consensus K+-channel KCNQ [Inorganic ion transport | 98.52 | |
| PRK11388 | 638 | DNA-binding transcriptional regulator DhaR; Provis | 98.51 |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=413.36 Aligned_cols=235 Identities=45% Similarity=0.769 Sum_probs=215.1
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
...++|++++.||+|+||+||+|+.+.+++.||+|+++|..+...........|..||..++||+||.++..|++...+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 45689999999999999999999999999999999999988888888889999999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
||+||+.||.|+.+|+++ +.|++..+++|+.+|+.||.|||++|||||||||+|||++.+|+++|+|||+|+..
T Consensus 102 lVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~---- 175 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED---- 175 (357)
T ss_pred EEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc----
Confidence 999999999999999876 55999999999999999999999999999999999999999999999999999642
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
......+.++|||+.|||||++.+.+|+..+|+||||+++|+|++|.+||.+.+...
T Consensus 176 -----------------------~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~ 232 (357)
T KOG0598|consen 176 -----------------------LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK 232 (357)
T ss_pred -----------------------ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH
Confidence 122335567899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 906 TFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 906 ~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
++++|+.+....|.. ..|..++||
T Consensus 233 ~~~~I~~~k~~~~p~-~ls~~ardl 256 (357)
T KOG0598|consen 233 MYDKILKGKLPLPPG-YLSEEARDL 256 (357)
T ss_pred HHHHHhcCcCCCCCc-cCCHHHHHH
Confidence 999999999655543 246666665
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=394.08 Aligned_cols=232 Identities=45% Similarity=0.820 Sum_probs=217.8
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
...++|++++.||.|+||.|.+|+++.+|..||+|++.+.......+.+...+|..||+.+.||+++++++.|.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 45789999999999999999999999999999999999987777788888999999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
|||||++||.|+.++++. +.|++..+++++.||+.||+|||+++|++|||||+||||+++|.+||+|||+|+...
T Consensus 121 mvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS--- 195 (355)
T ss_pred EEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence 999999999999999875 459999999999999999999999999999999999999999999999999996543
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
..+.+.||||.|+|||++..++|+.++|+|||||++|||+.|.+||.+.+...
T Consensus 196 ---------------------------~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~ 248 (355)
T KOG0616|consen 196 ---------------------------GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ 248 (355)
T ss_pred ---------------------------CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH
Confidence 23568899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCcccCCCC
Q 002342 906 TFANILHKDLKFPSSTPSSCKAANVP 931 (934)
Q Consensus 906 ~~~~i~~~~~~~p~~~~~s~~~k~l~ 931 (934)
++++|+++++.||+.. |.++|||.
T Consensus 249 iY~KI~~~~v~fP~~f--s~~~kdLl 272 (355)
T KOG0616|consen 249 IYEKILEGKVKFPSYF--SSDAKDLL 272 (355)
T ss_pred HHHHHHhCcccCCccc--CHHHHHHH
Confidence 9999999999999975 77777764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=405.22 Aligned_cols=290 Identities=50% Similarity=0.892 Sum_probs=251.6
Q ss_pred CCCCCCCCCCchhhhHhhc-ccccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHH
Q 002342 642 HPKPHRKDSPPWKAIQKIL-DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER 720 (934)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~ 720 (934)
..+||......|..+..+. .....+..++|++++.||.|.-|+||+|+...++..+|+|++.|..+..+.+..+...|.
T Consensus 49 ~~kph~~~d~~w~a~~~~~~~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~ 128 (459)
T KOG0610|consen 49 GNKPHKGNDVRWEAISSIRNSKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTER 128 (459)
T ss_pred cCCCCCCCchhhhhhccccccCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHH
Confidence 3567777777888877666 466788899999999999999999999999999999999999999888889999999999
Q ss_pred HHHHhCCCCCccceeEEEEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 002342 721 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPE 800 (934)
Q Consensus 721 ~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~ 800 (934)
+||+.++||+++.||..|+.+.+.|+|||||+||+|..++++|.++.|++..+++|+.+++.||+|||-.|||+|||||+
T Consensus 129 eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPE 208 (459)
T KOG0610|consen 129 EILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPE 208 (459)
T ss_pred HHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CEEEecCCcEEEEecccCcccCCCCCCCCCcch-------------------h---h-hcc---ccCC--CCcccc-ccc
Q 002342 801 NVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN-------------------E---K-KRR---HKGQ--QNPVFM-AEP 851 (934)
Q Consensus 801 NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~-------------------~---~-~~~---~~~~--~~~~~~-~~~ 851 (934)
||||.++|+|.|.||.++......+........ . . ++. .... ..+... ...
T Consensus 209 NILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~ 288 (459)
T KOG0610|consen 209 NILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPT 288 (459)
T ss_pred eeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCC
Confidence 999999999999999998765443332221100 0 0 000 0000 011121 233
Q ss_pred ccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccCCCC
Q 002342 852 MRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANVP 931 (934)
Q Consensus 852 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~k~l~ 931 (934)
...+++++||-.|+|||++.|.+++.++|+|+|||+||||++|..||.|.+..+++.+|+.+.+.||..+..|..+|||+
T Consensus 289 ~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLI 368 (459)
T KOG0610|consen 289 GARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLI 368 (459)
T ss_pred CccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHH
Confidence 47788999999999999999999999999999999999999999999999999999999999999999988999999986
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=413.96 Aligned_cols=265 Identities=39% Similarity=0.665 Sum_probs=225.7
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+..++|++++.||+|+||.||+|+.+.||..||+|+++|..+....++..+..|..||...++|+||+||..|++..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
||||||++||++..+|.+. ..|+++.+++|+.+++.|++.||+.|+|||||||+|+||+..|++||+|||+|......
T Consensus 217 YLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999999999875 56999999999999999999999999999999999999999999999999999654332
Q ss_pred CCCCCCc---chhhhc-cccCCCCc----------------ccccccccccccccCCCCccchhhhcCCCCCchhHHHHH
Q 002342 825 PQLLLPT---TNEKKR-RHKGQQNP----------------VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 884 (934)
Q Consensus 825 ~~~~~~~---~~~~~~-~~~~~~~~----------------~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSl 884 (934)
.....-. ...... .......+ .+.........+.+|||-|||||++.+.+|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 2211000 000000 00000000 011112233456799999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCCcccCCCC
Q 002342 885 GILLYEMLYGYTPFRGKTRQKTFANILHKD--LKFPSSTPSSCKAANVP 931 (934)
Q Consensus 885 G~iL~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~s~~~k~l~ 931 (934)
|||+|||+.|.|||.+.+..+++++|++-. +.||.....|.+|+||+
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI 423 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLI 423 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHH
Confidence 999999999999999999999999999855 89999999999999985
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=415.41 Aligned_cols=232 Identities=31% Similarity=0.539 Sum_probs=217.8
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
.+|+..+.||+|||+.||.+++..+|..||+|++.+..+......+.+.+|++|.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 57999999999999999999999999999999999988888888899999999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
|+|..++|..+++++ +.++|.+++.++.||+.||.|||+++|||||||..|++++.+.+|||+|||+|.....
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~----- 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY----- 170 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC-----
Confidence 999999999999864 5699999999999999999999999999999999999999999999999999965432
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
+.....++||||.|+|||++...++++.+||||+||+||.|+.|+|||...+-.+++.
T Consensus 171 ----------------------~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~ 228 (592)
T KOG0575|consen 171 ----------------------DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN 228 (592)
T ss_pred ----------------------cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH
Confidence 2234568899999999999999999999999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCCCCcccCCCC
Q 002342 909 NILHKDLKFPSSTPSSCKAANVP 931 (934)
Q Consensus 909 ~i~~~~~~~p~~~~~s~~~k~l~ 931 (934)
+|...++.+|+ .+|..|+||+
T Consensus 229 ~Ik~~~Y~~P~--~ls~~A~dLI 249 (592)
T KOG0575|consen 229 KIKLNEYSMPS--HLSAEAKDLI 249 (592)
T ss_pred HHHhcCccccc--ccCHHHHHHH
Confidence 99999999999 4699998875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=390.74 Aligned_cols=221 Identities=29% Similarity=0.504 Sum_probs=201.9
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|.+.+.||+|+|++||+++++.++..||||.+.+..+ .+...+.+..|+.||+.++|||||.|++++..++++|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999987644 566677889999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC------CcEEEEecccCccc
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN------GHVSLTDFDLSCLT 821 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~------~~vkl~DFG~a~~~ 821 (934)
||||+||+|.+|+++.+ .+++..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+..
T Consensus 88 MEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999999998864 59999999999999999999999999999999999999865 35899999999764
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
. +.....+.||+|.|||||++....|+.|+|+||+|++||+|++|++||...
T Consensus 166 ~----------------------------~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 166 Q----------------------------PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred C----------------------------chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 3 234456889999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHcCCCCCCC
Q 002342 902 TRQKTFANILHKDLKFPS 919 (934)
Q Consensus 902 ~~~~~~~~i~~~~~~~p~ 919 (934)
+..+.+..+..+.-..|.
T Consensus 218 t~~eL~~~~~k~~~~~~~ 235 (429)
T KOG0595|consen 218 TPKELLLYIKKGNEIVPV 235 (429)
T ss_pred CHHHHHHHHhccccccCc
Confidence 999999999888765554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=402.32 Aligned_cols=248 Identities=37% Similarity=0.611 Sum_probs=220.7
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 744 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 744 (934)
....+|.+.+.||+|+|++|++|+++.+++.||||++.|..+....+.+.+.+|..+|.+| +||.|++||..|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3467999999999999999999999999999999999998887888888899999999999 899999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+|+||+++|+|.+++++. +.|++..+++++.||+.||+|||++|||||||||+||||+.+|++||+|||.|+.+.+.
T Consensus 150 YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999999999886 55999999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
....- .+...........+++||-.|.+||+|.....++.+|+|+|||+||+|+.|.|||.+.+..
T Consensus 228 ~~~~~--------------~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney 293 (604)
T KOG0592|consen 228 QKSQE--------------NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY 293 (604)
T ss_pred hcccc--------------CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH
Confidence 33211 0111111112247899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCcccCCCC
Q 002342 905 KTFANILHKDLKFPSSTPSSCKAANVP 931 (934)
Q Consensus 905 ~~~~~i~~~~~~~p~~~~~s~~~k~l~ 931 (934)
.++++|+.-.+.||... +..++||+
T Consensus 294 liFqkI~~l~y~fp~~f--p~~a~dLv 318 (604)
T KOG0592|consen 294 LIFQKIQALDYEFPEGF--PEDARDLI 318 (604)
T ss_pred HHHHHHHHhcccCCCCC--CHHHHHHH
Confidence 99999999999999875 46666653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=390.79 Aligned_cols=234 Identities=32% Similarity=0.488 Sum_probs=204.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccC----hHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN----RNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~----~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
.+.|.+.+.||+|+||.|-+|..+.+|+.||||++++..... ........+|++||++|+|||||+++++|...++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 478999999999999999999999999999999999865433 2234456799999999999999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC---CcEEEEecccCcc
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSCL 820 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~---~~vkl~DFG~a~~ 820 (934)
.||||||+.||+|++.+-.+ +.+.++..+.+++||+.||.|||++||+||||||+|||++.+ -.+||+|||+|+.
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999999775 569999999999999999999999999999999999999876 5789999999976
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCC---chhHHHHHHHHHHHHHhCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT---SAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s---~~~DiwSlG~iL~elltG~~P 897 (934)
.+ ......++||||.|.|||++.+..+. .++|+|||||+||-+++|.+|
T Consensus 329 ~g----------------------------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pP 380 (475)
T KOG0615|consen 329 SG----------------------------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPP 380 (475)
T ss_pred cc----------------------------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCC
Confidence 43 12234688999999999999776543 378999999999999999999
Q ss_pred CCCCCHHH-HHHHHHcCCCCC--CCCCCCCcccCCCC
Q 002342 898 FRGKTRQK-TFANILHKDLKF--PSSTPSSCKAANVP 931 (934)
Q Consensus 898 f~~~~~~~-~~~~i~~~~~~~--p~~~~~s~~~k~l~ 931 (934)
|.+..... ..++|.+|.+.| |.|..+|.+++||+
T Consensus 381 FS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI 417 (475)
T KOG0615|consen 381 FSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLI 417 (475)
T ss_pred cccccCCccHHHHHhcCcccccChhhhhhhHHHHHHH
Confidence 99877766 899999999866 45677888888775
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=401.42 Aligned_cols=228 Identities=41% Similarity=0.804 Sum_probs=212.7
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCC
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKT 742 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~ 742 (934)
..+..++|.++++||+|+||+|+++..+.+++.||||+++|..+...+.++....|..|+.... ||+++.++.+|++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4678899999999999999999999999999999999999999999999999999999999885 999999999999999
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
++|+||||+.||++..+.+ .+.|++..+++|+..++.||.|||++||||||||.+|||++.+|++||+|||+|+..
T Consensus 443 ~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~- 518 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG- 518 (694)
T ss_pred eEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc-
Confidence 9999999999999555443 355999999999999999999999999999999999999999999999999999642
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
......++++||||.|||||++.+..|+.++|+|||||+||||+.|..||.|++
T Consensus 519 --------------------------m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd 572 (694)
T KOG0694|consen 519 --------------------------MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD 572 (694)
T ss_pred --------------------------CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 112346789999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 002342 903 RQKTFANILHKDLKFPSST 921 (934)
Q Consensus 903 ~~~~~~~i~~~~~~~p~~~ 921 (934)
..+++..|++.+..||.+.
T Consensus 573 Eee~FdsI~~d~~~yP~~l 591 (694)
T KOG0694|consen 573 EEEVFDSIVNDEVRYPRFL 591 (694)
T ss_pred HHHHHHHHhcCCCCCCCcc
Confidence 9999999999999999987
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=370.53 Aligned_cols=232 Identities=28% Similarity=0.479 Sum_probs=205.9
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC-e
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-H 743 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~ 743 (934)
.+..++.+.++.||+|..|+||+|+++.+++.||+|++.- ..+....+++.+|++|++.++|||||.+|+.|..+. .
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 3556789999999999999999999999999999999953 346677789999999999999999999999999988 5
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
++|+||||++|+|.+++... +.+++..+..++.++++||.|||. .+||||||||+|||++..|.|||||||.+....
T Consensus 153 isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 99999999999999999875 559999999999999999999996 899999999999999999999999999996542
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK- 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~- 901 (934)
. ...++++||..|||||.+.+..|+.++||||||++|+||++|+.||...
T Consensus 231 n-----------------------------S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~ 281 (364)
T KOG0581|consen 231 N-----------------------------SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN 281 (364)
T ss_pred h-----------------------------hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC
Confidence 1 1457889999999999999999999999999999999999999999885
Q ss_pred ----CHHHHHHHHHcCC-CCCCCCCCCCcccCCC
Q 002342 902 ----TRQKTFANILHKD-LKFPSSTPSSCKAANV 930 (934)
Q Consensus 902 ----~~~~~~~~i~~~~-~~~p~~~~~s~~~k~l 930 (934)
...+.+..|+.+. ..+|.. ..|.+.++|
T Consensus 282 ~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef~~F 314 (364)
T KOG0581|consen 282 PPYLDIFELLCAIVDEPPPRLPEG-EFSPEFRSF 314 (364)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCcc-cCCHHHHHH
Confidence 6678999999865 466664 346665554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=361.64 Aligned_cols=225 Identities=30% Similarity=0.518 Sum_probs=200.5
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeE-EEEeCCe-E
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA-SFQTKTH-V 744 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~-~~~~~~~-~ 744 (934)
...+|+++++||+|+||.||+|.+..+|..+|.|-+.-+. .+......+..|+.+|++|+|||||++++ .|..+.. +
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 3568999999999999999999999999999999988553 35566678889999999999999999998 6655555 8
Q ss_pred EEEEEccCCCCchhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHH--CC--CeecCCCCCCEEEecCCcEEEEecccC
Q 002342 745 CLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHC--QG--IIYRDLKPENVLLQGNGHVSLTDFDLS 818 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~yLH~--~g--iiHrDLKp~NILl~~~~~vkl~DFG~a 818 (934)
+||||||.+|+|..+++. +..+.+++..++.++.|+|.||..+|. .+ |+||||||.||+|+.+|.|||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999999874 345789999999999999999999999 45 999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
+.+.... ....+++|||.||+||.+.+.+|+++||||||||++|||+.=++||
T Consensus 176 r~l~s~~---------------------------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF 228 (375)
T KOG0591|consen 176 RFLSSKT---------------------------TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPF 228 (375)
T ss_pred hHhcchh---------------------------HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCc
Confidence 7654221 2345789999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCC-CCC
Q 002342 899 RGKTRQKTFANILHKDLK-FPS 919 (934)
Q Consensus 899 ~~~~~~~~~~~i~~~~~~-~p~ 919 (934)
.|.+..+.-++|.+|+++ +|.
T Consensus 229 ~g~n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 229 YGDNLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred ccccHHHHHHHHHcCCCCCCcH
Confidence 999999999999999875 673
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=364.32 Aligned_cols=241 Identities=32% Similarity=0.529 Sum_probs=203.5
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccC-----------hHHHHHHHHHHHHHHhCCCCCccce
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-----------RNKVHRACAEREILDMLDHPFVPAL 734 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~-----------~~~~~~~~~E~~il~~l~hp~Iv~l 734 (934)
..+++|++.+.||+|.||.|-+|++..+++.||||++.|..... ....+...+|+.||++|.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34679999999999999999999999999999999998753321 1224678899999999999999999
Q ss_pred eEEEEe--CCeEEEEEEccCCCCchhhhccCCCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEE
Q 002342 735 YASFQT--KTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 811 (934)
Q Consensus 735 ~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~-l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vk 811 (934)
+++..+ .+.+|||+|||..|.+...-.. +. +++.++++|+++++.||+|||.+|||||||||+|+||+++|+||
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d---~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD---KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCC---cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 999985 5789999999998887655332 33 99999999999999999999999999999999999999999999
Q ss_pred EEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC----CCchhHHHHHHHH
Q 002342 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGIL 887 (934)
Q Consensus 812 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~s~~~DiwSlG~i 887 (934)
|.|||.+........ ..........+|||.|||||++.++. -+++.||||+||+
T Consensus 251 IsDFGVs~~~~~~~~----------------------~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVT 308 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSD----------------------EGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVT 308 (576)
T ss_pred eeccceeeecccCCc----------------------cccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhh
Confidence 999999965422100 00001112258999999999997732 2458999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccCCCC
Q 002342 888 LYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANVP 931 (934)
Q Consensus 888 L~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~k~l~ 931 (934)
||+|+.|+.||.+....+++.+|++..+.||..+.++..+|||+
T Consensus 309 LYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli 352 (576)
T KOG0585|consen 309 LYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLI 352 (576)
T ss_pred HHHhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHH
Confidence 99999999999999999999999999999999987888888874
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=341.72 Aligned_cols=235 Identities=36% Similarity=0.587 Sum_probs=218.0
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
...++|++.+.||.|.||.||+++.++++..+|+|++.|..+......+.+.+|++|-+.|+||||+++|++|.+...+|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 44679999999999999999999999999999999999887766677788899999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
|++||..+|+|+..++.+....+++.....+..|++.||.|+|.+++|||||||+|+|++..|.+||+|||.+..
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~----- 173 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH----- 173 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee-----
Confidence 999999999999999977778899999999999999999999999999999999999999999999999999843
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
.+.....+.|||+-|++||+..+..++..+|+|++|++.||++.|.+||...+..+
T Consensus 174 ------------------------~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e 229 (281)
T KOG0580|consen 174 ------------------------APSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE 229 (281)
T ss_pred ------------------------cCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH
Confidence 22445568899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCcccCCCC
Q 002342 906 TFANILHKDLKFPSSTPSSCKAANVP 931 (934)
Q Consensus 906 ~~~~i~~~~~~~p~~~~~s~~~k~l~ 931 (934)
++++|.+-++.+|+. ++..++||+
T Consensus 230 tYkrI~k~~~~~p~~--is~~a~dlI 253 (281)
T KOG0580|consen 230 TYKRIRKVDLKFPST--ISGGAADLI 253 (281)
T ss_pred HHHHHHHccccCCcc--cChhHHHHH
Confidence 999999999999965 577777764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=369.97 Aligned_cols=223 Identities=33% Similarity=0.538 Sum_probs=204.3
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
+++|.+...||+|+||.||+++.+.+.+.||+|++.|.. .....++.+.+|++|++.++||||+.++++|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 368999999999999999999999999999999998753 3455678899999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
+|||.| +|+.++... +.++++.++.++.+++.||.|||+++|+|||+||.|||+..+|.+|+||||+|+.++..
T Consensus 80 te~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--- 153 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--- 153 (808)
T ss_pred ehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC---
Confidence 999955 999999764 56999999999999999999999999999999999999999999999999999776432
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
-...+++.|||.|||||++.+..|+..+|+|||||+||||++|+|||...+..+..
T Consensus 154 ------------------------t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv 209 (808)
T KOG0597|consen 154 ------------------------TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLV 209 (808)
T ss_pred ------------------------ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHH
Confidence 12345678999999999999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCC
Q 002342 908 ANILHKDLKFPSST 921 (934)
Q Consensus 908 ~~i~~~~~~~p~~~ 921 (934)
+.|+.....+|+..
T Consensus 210 ~~I~~d~v~~p~~~ 223 (808)
T KOG0597|consen 210 KSILKDPVKPPSTA 223 (808)
T ss_pred HHHhcCCCCCcccc
Confidence 99999999999854
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=373.32 Aligned_cols=235 Identities=34% Similarity=0.606 Sum_probs=208.3
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccCh--HHHHHHHHHHHHHHhCC-CCCccceeEEEEeCC
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR--NKVHRACAEREILDMLD-HPFVPALYASFQTKT 742 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~--~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~ 742 (934)
...+.|.+.+.||+|+||+|+++.+..++..||+|++.+...... .....+.+|+.+++.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 346799999999999999999999999999999998776432211 34456678999999998 999999999999999
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-CcEEEEecccCccc
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLT 821 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-~~vkl~DFG~a~~~ 821 (934)
.+|+|||||.||+|++++... +.+.+..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999999883 559999999999999999999999999999999999999999 99999999999654
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC-CC-chhHHHHHHHHHHHHHhCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HT-SAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~s-~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
. .......+.|||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||.
T Consensus 172 ~---------------------------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~ 224 (370)
T KOG0583|consen 172 P---------------------------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFD 224 (370)
T ss_pred C---------------------------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 1 1123456789999999999999977 75 69999999999999999999999
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 900 GKTRQKTFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 900 ~~~~~~~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
..+...++.+|.++.+.+|.+.. |+++++|
T Consensus 225 d~~~~~l~~ki~~~~~~~p~~~~-S~~~~~L 254 (370)
T KOG0583|consen 225 DSNVPNLYRKIRKGEFKIPSYLL-SPEARSL 254 (370)
T ss_pred CccHHHHHHHHhcCCccCCCCcC-CHHHHHH
Confidence 99999999999999999999975 6666654
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=345.18 Aligned_cols=235 Identities=40% Similarity=0.760 Sum_probs=217.7
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+-+++|..++.||+|.||+|-+++.+.+++.||+|+++|..+..++.+.....|-++|+..+||++..|..+|+..+.+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 45678999999999999999999999999999999999999988999988899999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+||||..||.|+-++.+. +.|+++.++++-..|+.||.|||+++||.||||.+|+|++.+|++||+|||+|+..
T Consensus 244 CFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--- 318 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE--- 318 (516)
T ss_pred EEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc---
Confidence 9999999999999999774 56999999999999999999999999999999999999999999999999999542
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
..-.....++||||.|+|||++....|+.++|+|.+|+++|||++|+.||...+..
T Consensus 319 ------------------------I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~ 374 (516)
T KOG0690|consen 319 ------------------------IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE 374 (516)
T ss_pred ------------------------ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence 11224567899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 905 KTFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 905 ~~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
..+..|+-+++.||... |+++|.|
T Consensus 375 kLFeLIl~ed~kFPr~l--s~eAktL 398 (516)
T KOG0690|consen 375 KLFELILMEDLKFPRTL--SPEAKTL 398 (516)
T ss_pred HHHHHHHhhhccCCccC--CHHHHHH
Confidence 99999999999999864 6666654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=352.98 Aligned_cols=224 Identities=30% Similarity=0.578 Sum_probs=209.3
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
..+|++.+.||.|.||+|-+|++...|+.||||.++|+.+.+.+.+-.+.+|++||..|+||||+.+|++|++.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 46899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||..+|.|++|+... +.+++.+++.+++||..|+.|+|+++++|||||.+|||++.++++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---- 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---- 205 (668)
T ss_pred EEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc----
Confidence 9999999999999876 4599999999999999999999999999999999999999999999999999855321
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
.....+|||+|.|.+||++.+.+| .+.+|.||||++||.|++|..||.|.+...+
T Consensus 206 ------------------------~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l 261 (668)
T KOG0611|consen 206 ------------------------KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL 261 (668)
T ss_pred ------------------------ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH
Confidence 223468999999999999999988 5689999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCC
Q 002342 907 FANILHKDLKFPSST 921 (934)
Q Consensus 907 ~~~i~~~~~~~p~~~ 921 (934)
.++|.+|.+.=|..+
T Consensus 262 vrQIs~GaYrEP~~P 276 (668)
T KOG0611|consen 262 VRQISRGAYREPETP 276 (668)
T ss_pred HHHhhcccccCCCCC
Confidence 999999999877754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=342.15 Aligned_cols=215 Identities=27% Similarity=0.444 Sum_probs=188.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
++.|+.+.++|+|+||.||+++++.||+.||||.+... ..++...+-..+|+++|++|.|||+|.|+++|.....++||
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 36899999999999999999999999999999998753 33455556668999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
+|||+.. +.+-+.+.+ ..++.+.++.|+.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+....
T Consensus 80 FE~~dhT-vL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~---- 153 (396)
T KOG0593|consen 80 FEYCDHT-VLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA---- 153 (396)
T ss_pred eeecchH-HHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC----
Confidence 9999554 444555543 3499999999999999999999999999999999999999999999999999976542
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
+....+..+.|.+|.|||.+.+ ..|...+|||++||++.||++|.+.|+|.+..++
T Consensus 154 -----------------------pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ 210 (396)
T KOG0593|consen 154 -----------------------PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ 210 (396)
T ss_pred -----------------------CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH
Confidence 2233455688999999999988 7899999999999999999999999999999988
Q ss_pred HHHHHc
Q 002342 907 FANILH 912 (934)
Q Consensus 907 ~~~i~~ 912 (934)
+..|..
T Consensus 211 Ly~I~k 216 (396)
T KOG0593|consen 211 LYLIRK 216 (396)
T ss_pred HHHHHH
Confidence 877754
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=372.03 Aligned_cols=231 Identities=30% Similarity=0.539 Sum_probs=210.6
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.+-|++.+.||.|+.|.|-+|++..||+..|||++.+...........+.+|+-||+.+.||||+.+|+++++..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 46789999999999999999999999999999999887555666677899999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
+||++||.|++++.++ +.+++.++..++.||+.|+.|+|..+|+||||||+|+||+..+++||+|||+|....
T Consensus 91 lEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~----- 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV----- 163 (786)
T ss_pred EEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc-----
Confidence 9999999999999886 459999999999999999999999999999999999999999999999999995421
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT-SAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s-~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
+.....+.||+|.|.|||++.|.+|. .++||||+|||||.|++|+.||.+.+...+
T Consensus 164 -----------------------~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~L 220 (786)
T KOG0588|consen 164 -----------------------PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVL 220 (786)
T ss_pred -----------------------CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHH
Confidence 23345677999999999999999884 699999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCCCcccCCC
Q 002342 907 FANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 907 ~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
+.++.+|.|.+|++. |.+++||
T Consensus 221 LlKV~~G~f~MPs~I--s~eaQdL 242 (786)
T KOG0588|consen 221 LLKVQRGVFEMPSNI--SSEAQDL 242 (786)
T ss_pred HHHHHcCcccCCCcC--CHHHHHH
Confidence 999999999999865 6776665
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=355.82 Aligned_cols=217 Identities=27% Similarity=0.427 Sum_probs=191.2
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC--CeE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THV 744 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~ 744 (934)
..+.|+.+.+||+|.||.||+|++..+|+.||||.+..+.. +........+||.||++|+||||++|.+...+. ..+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 45789999999999999999999999999999999987543 345556778999999999999999999998876 789
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|||+||| .-+|..++... .-.|++.+++.|++||+.||+|||.+||+|||||.+||||+.+|.+||+|||+|+.+...
T Consensus 194 YlVFeYM-dhDL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 194 YLVFEYM-DHDLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEecc-cchhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999999 66788887653 346999999999999999999999999999999999999999999999999999754322
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
. ....+..+-|++|.|||.|.| ..|+.++|+||+||||.||+.|++.|.|.+.
T Consensus 272 ~--------------------------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE 325 (560)
T KOG0600|consen 272 G--------------------------SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE 325 (560)
T ss_pred C--------------------------CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence 1 122345578999999999988 4789999999999999999999999999999
Q ss_pred HHHHHHHHc
Q 002342 904 QKTFANILH 912 (934)
Q Consensus 904 ~~~~~~i~~ 912 (934)
.+++.+|.+
T Consensus 326 veQl~kIfk 334 (560)
T KOG0600|consen 326 VEQLHKIFK 334 (560)
T ss_pred HHHHHHHHH
Confidence 999999965
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=331.92 Aligned_cols=235 Identities=29% Similarity=0.461 Sum_probs=209.4
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+..+.|.+...||+|.|+.||.+.+..+|+.||+|++....+... ..+.+.+|+.|-+.|+||||++|++.+......|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 345789999999999999999999999999999999886544333 5678999999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEEEEecccCcccC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTS 822 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~~vkl~DFG~a~~~~ 822 (934)
||+|+|.|++|..-+-.+ ..+++..+-.+++||+.+|.|+|.+||||||+||+|+|+-+ .--+||+|||+|...+
T Consensus 87 lvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999999998766544 45899999999999999999999999999999999999954 3359999999996543
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
.......++|||.|||||++...+|+..+|||+.|++||-|+.|.+||++.+
T Consensus 165 ----------------------------~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~ 216 (355)
T KOG0033|consen 165 ----------------------------DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 216 (355)
T ss_pred ----------------------------CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc
Confidence 1123446789999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCC--CCCCCcccCCCC
Q 002342 903 RQKTFANILHKDLKFPS--STPSSCKAANVP 931 (934)
Q Consensus 903 ~~~~~~~i~~~~~~~p~--~~~~s~~~k~l~ 931 (934)
...++++|..|.+.+|+ |..++.++|||+
T Consensus 217 ~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lv 247 (355)
T KOG0033|consen 217 QHRLYEQIKAGAYDYPSPEWDTVTPEAKSLI 247 (355)
T ss_pred HHHHHHHHhccccCCCCcccCcCCHHHHHHH
Confidence 99999999999998886 678999999874
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=360.91 Aligned_cols=261 Identities=36% Similarity=0.633 Sum_probs=207.9
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..++||||+++++++.+...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998754444455667888999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
|||+||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999999765 459999999999999999999999999999999999999999999999999986543211000
Q ss_pred CCcc-hhhhccccC--CCC-----cccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 829 LPTT-NEKKRRHKG--QQN-----PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 829 ~~~~-~~~~~~~~~--~~~-----~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.... ......... ... ..............+||+.|+|||++.+..++.++|||||||++|+|++|++||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 0000 000000000 000 00000011122456899999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHc--CCCCCCCCCCCCcccCCCC
Q 002342 901 KTRQKTFANILH--KDLKFPSSTPSSCKAANVP 931 (934)
Q Consensus 901 ~~~~~~~~~i~~--~~~~~p~~~~~s~~~k~l~ 931 (934)
.+..+.+.+|.. ..+.+|...+.|..+++|.
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li 271 (363)
T cd05628 239 ETPQETYKKVMNWKETLIFPPEVPISEKAKDLI 271 (363)
T ss_pred CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHH
Confidence 999999999986 4567887767777777653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=384.55 Aligned_cols=239 Identities=36% Similarity=0.641 Sum_probs=217.2
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+..++|.+++.||+|+||.|.+|+++.+++.||+|+++|-.+..+.....|..|..||...+++-|+.++..|+++.++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 46678999999999999999999999999999999999987666677778899999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|||||||+||+|..++.+.. .+++..+++|+..|+.||..||+.|+|||||||+||||+..|++||+|||.|-.+..+
T Consensus 151 YlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 99999999999999997753 6999999999999999999999999999999999999999999999999999655322
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-----CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
....+...+|||-|++||++.. +.|+..+|+||+||++|||++|..||+
T Consensus 229 --------------------------G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 229 --------------------------GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred --------------------------CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 1234556799999999999943 568889999999999999999999999
Q ss_pred CCCHHHHHHHHHcC--CCCCCCCCCCCcccCCCC
Q 002342 900 GKTRQKTFANILHK--DLKFPSSTPSSCKAANVP 931 (934)
Q Consensus 900 ~~~~~~~~~~i~~~--~~~~p~~~~~s~~~k~l~ 931 (934)
..+..++|-+|.+- .+.||....+|..+|||+
T Consensus 283 adslveTY~KIm~hk~~l~FP~~~~VSeeakdLI 316 (1317)
T KOG0612|consen 283 ADSLVETYGKIMNHKESLSFPDETDVSEEAKDLI 316 (1317)
T ss_pred HHHHHHHHHHHhchhhhcCCCcccccCHHHHHHH
Confidence 99999999999875 689997778999999885
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=337.16 Aligned_cols=233 Identities=25% Similarity=0.395 Sum_probs=207.0
Q ss_pred cccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
..+.++.+.|++...||.|..++||+|+...++..||||++.-.. .....+.+.+|+..|+.++||||++++.+|..+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEk--c~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEK--CNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhh--hhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 345577899999999999999999999999999999999998653 344578899999999999999999999999999
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
..+|+||.||.+|++.++++......+++..+..|+++++.||.|||++|.||||||+.||||+.+|.|||+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 99999999999999999998765566999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc--CCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA--GAGHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--~~~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
.... .......++++||++|||||++. ..+|++|+||||||++..||++|..||.
T Consensus 177 ~~~G-----------------------~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~ 233 (516)
T KOG0582|consen 177 FDSG-----------------------DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS 233 (516)
T ss_pred cccC-----------------------ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc
Confidence 4311 00011126889999999999974 3688999999999999999999999999
Q ss_pred CCCHHHHHHHHHcCCCCCCC
Q 002342 900 GKTRQKTFANILHKDLKFPS 919 (934)
Q Consensus 900 ~~~~~~~~~~i~~~~~~~p~ 919 (934)
...+.+++.+-+++.++.|.
T Consensus 234 k~pPmkvLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 234 KYPPMKVLLLTLQNDPPTLL 253 (516)
T ss_pred cCChHHHHHHHhcCCCCCcc
Confidence 99999999999999988776
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=347.57 Aligned_cols=223 Identities=26% Similarity=0.432 Sum_probs=194.3
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCC-e
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKT-H 743 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~-~ 743 (934)
..+++|+++++||.|+||.||+|..+.++..||||.+++... ..+.. .-.+|++.|++|+ ||||++|.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 346899999999999999999999999999999999987533 22221 2357999999998 999999999999887 9
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|+||||| ..+|+++++.+ .+.|++..++.|+.||+.||+|+|++|+.|||+||+|||+.....|||+|||+|+....
T Consensus 85 L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999999 89999999887 78899999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
.+ ..+..+.|.+|.|||+|. .+.|+.++|+|++||+++|+.+=++.|+|.+
T Consensus 163 kp----------------------------PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 163 KP----------------------------PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred CC----------------------------CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 21 123557899999999985 5678999999999999999999999999999
Q ss_pred HHHHHHHHHc--CCCCCCCC
Q 002342 903 RQKTFANILH--KDLKFPSS 920 (934)
Q Consensus 903 ~~~~~~~i~~--~~~~~p~~ 920 (934)
..+++.+|++ |.....+|
T Consensus 215 E~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 215 EIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred HHHHHHHHHHHhCCCccccc
Confidence 9999999976 55444333
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=315.36 Aligned_cols=214 Identities=26% Similarity=0.452 Sum_probs=190.5
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|...+.||+|.||.||+|++..+|+.||||.++.....+ .......+|++.|+.++|+||+.++++|...+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 57999999999999999999999999999999998764322 22345778999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||| ..+|...++.. ...++...++.|+.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+...+
T Consensus 81 Efm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~--- 155 (318)
T KOG0659|consen 81 EFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN--- 155 (318)
T ss_pred Eec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC---
Confidence 999 78999998765 4679999999999999999999999999999999999999999999999999997764322
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
......+-|.+|.|||.+.|. .|+..+|+||.||++.||+.|.|.|.|.+..+++
T Consensus 156 ------------------------~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL 211 (318)
T KOG0659|consen 156 ------------------------RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL 211 (318)
T ss_pred ------------------------cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH
Confidence 222333789999999999874 6889999999999999999999999999999999
Q ss_pred HHHHc
Q 002342 908 ANILH 912 (934)
Q Consensus 908 ~~i~~ 912 (934)
..|.+
T Consensus 212 ~~If~ 216 (318)
T KOG0659|consen 212 SKIFR 216 (318)
T ss_pred HHHHH
Confidence 99876
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=323.45 Aligned_cols=234 Identities=29% Similarity=0.502 Sum_probs=206.9
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccc-----cChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeC
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM-----LNRNKVHRACAEREILDML-DHPFVPALYASFQTK 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~-----~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~ 741 (934)
...|.-.+.||.|..+.|-.+.++.++..+|+|++..... ......+...+|+.||+++ .||||+++.++|+++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 5678899999999999999999999999999999864221 1223455667899999998 799999999999999
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
..+++|+|.|+.|.|++++... -.+++...+.|++|++.|+.|||.++||||||||+|||++++.++||+|||+|+..
T Consensus 96 sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 9999999999999999999764 56999999999999999999999999999999999999999999999999999654
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC------CCCCchhHHHHHHHHHHHHHhCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG------AGHTSAVDWWALGILLYEMLYGY 895 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~~s~~~DiwSlG~iL~elltG~ 895 (934)
. +.......||||+|+|||.+.. .+|+..+|+|++|+++|.|+.|.
T Consensus 174 ~----------------------------~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGc 225 (411)
T KOG0599|consen 174 E----------------------------PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGC 225 (411)
T ss_pred C----------------------------CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCC
Confidence 2 2334456799999999999954 47888999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCC--CCCCCcccCCCC
Q 002342 896 TPFRGKTRQKTFANILHKDLKFPS--STPSSCKAANVP 931 (934)
Q Consensus 896 ~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~s~~~k~l~ 931 (934)
+||+.....-++++|.+|+++|.+ |..+|..+|||+
T Consensus 226 pPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLI 263 (411)
T KOG0599|consen 226 PPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLI 263 (411)
T ss_pred CchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHH
Confidence 999999999999999999988754 678999999986
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=351.72 Aligned_cols=231 Identities=40% Similarity=0.757 Sum_probs=204.1
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
...++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++++..++.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 34679999999999999999999999999999999998654434445667889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-- 170 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-- 170 (329)
T ss_pred EEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC--
Confidence 999999999999999764 4589999999999999999999999999999999999999999999999999854211
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+
T Consensus 171 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 222 (329)
T PTZ00263 171 ----------------------------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR 222 (329)
T ss_pred ----------------------------CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH
Confidence 1123579999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 906 TFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 906 ~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
.+..+..+.+.+|.+. +..+++|
T Consensus 223 ~~~~i~~~~~~~p~~~--~~~~~~l 245 (329)
T PTZ00263 223 IYEKILAGRLKFPNWF--DGRARDL 245 (329)
T ss_pred HHHHHhcCCcCCCCCC--CHHHHHH
Confidence 9999999998888764 4444443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=327.36 Aligned_cols=216 Identities=23% Similarity=0.355 Sum_probs=189.2
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE--eCCeE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ--TKTHV 744 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~ 744 (934)
..+.|+.+.+|++|+||.||+|+++.++..||+|.++-... ....--...+|+.+|.+++|||||.+-++.. +-+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 45789999999999999999999999999999999875431 2222234578999999999999999999886 34679
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
||||||| .-+|..++...+ ..|...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.++.
T Consensus 153 y~VMe~~-EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs- 229 (419)
T KOG0663|consen 153 YIVMEYV-EHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS- 229 (419)
T ss_pred eeeHHHH-HhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC-
Confidence 9999999 668999988764 5699999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
+....+..+-|++|.|||.+.+. .|+.++|+||+|||+.||++++|.|.|.+.
T Consensus 230 --------------------------p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE 283 (419)
T KOG0663|consen 230 --------------------------PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE 283 (419)
T ss_pred --------------------------CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch
Confidence 23344567889999999999875 688999999999999999999999999999
Q ss_pred HHHHHHHHc
Q 002342 904 QKTFANILH 912 (934)
Q Consensus 904 ~~~~~~i~~ 912 (934)
.+++.+|.+
T Consensus 284 ~dQl~~If~ 292 (419)
T KOG0663|consen 284 IDQLDKIFK 292 (419)
T ss_pred HHHHHHHHH
Confidence 999999965
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=350.10 Aligned_cols=230 Identities=27% Similarity=0.435 Sum_probs=205.9
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
...|....+||+|+.|.||.++...+++.||+|.+.... ....+.+.+|+.+|+.++|+|||.+++.|-..+.+|.|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 357999999999999999999999999999999998653 34456688999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||||+||+|.+.+.. ..+++.++..|++++|.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+...
T Consensus 349 MEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~--- 422 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE--- 422 (550)
T ss_pred EeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc---
Confidence 999999999999876 34999999999999999999999999999999999999999999999999999654321
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
.....+.+|||.|||||++....|++++||||||++++||+-|+|||...+....+
T Consensus 423 ------------------------~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl 478 (550)
T KOG0578|consen 423 ------------------------QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 478 (550)
T ss_pred ------------------------cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH
Confidence 12445779999999999999999999999999999999999999999988888888
Q ss_pred HHHH-cCCCCCCCCCCCCcccCCC
Q 002342 908 ANIL-HKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 908 ~~i~-~~~~~~p~~~~~s~~~k~l 930 (934)
..|. +|...+......|...|||
T Consensus 479 yLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 479 YLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred HHHhhcCCCCcCCccccCHHHHHH
Confidence 8885 6778888777788887775
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=345.51 Aligned_cols=226 Identities=28% Similarity=0.473 Sum_probs=192.8
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeE-EEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~-vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
+.++.....+...||.|+||+||++.+. |.. +|+|++......... ...+.+|+.+|.+++|||||+|++++....
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4455667778888999999999999984 445 999999876544444 778999999999999999999999999877
Q ss_pred -eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCCCCEEEecCC-cEEEEecccCc
Q 002342 743 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG-IIYRDLKPENVLLQGNG-HVSLTDFDLSC 819 (934)
Q Consensus 743 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~g-iiHrDLKp~NILl~~~~-~vkl~DFG~a~ 819 (934)
..+|||||+++|+|..++.....+.++...+..++.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 7999999999999999998744567999999999999999999999999 99999999999999997 99999999996
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc--CCCCCchhHHHHHHHHHHHHHhCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA--GAGHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--~~~~s~~~DiwSlG~iL~elltG~~P 897 (934)
...... ...+...||+.|||||++. ...|+.++||||||++||||+||+.|
T Consensus 193 ~~~~~~---------------------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~P 245 (362)
T KOG0192|consen 193 EKVISK---------------------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIP 245 (362)
T ss_pred eecccc---------------------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCC
Confidence 532110 1223367999999999999 67999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCC--CCCC
Q 002342 898 FRGKTRQKTFANILHKDL--KFPS 919 (934)
Q Consensus 898 f~~~~~~~~~~~i~~~~~--~~p~ 919 (934)
|.+....++...+..+.. .+|.
T Consensus 246 f~~~~~~~~~~~v~~~~~Rp~~p~ 269 (362)
T KOG0192|consen 246 FEDLAPVQVASAVVVGGLRPPIPK 269 (362)
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCc
Confidence 999998777777765443 4444
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=355.21 Aligned_cols=260 Identities=36% Similarity=0.579 Sum_probs=204.2
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
.|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+++|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999987544455566778899999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99999999998764 4589999999999999999999999999999999999999999999999999854321110000
Q ss_pred Ccchhhhcc----------ccCC----------CCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHH
Q 002342 830 PTTNEKKRR----------HKGQ----------QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889 (934)
Q Consensus 830 ~~~~~~~~~----------~~~~----------~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ 889 (934)
......... .... ..............+.+||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 000000000 0000 00000000111234568999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCCCcccCCCC
Q 002342 890 EMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPSSCKAANVP 931 (934)
Q Consensus 890 elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~s~~~k~l~ 931 (934)
+|++|.+||.+.+..+....+.. ..+.+|.....+.++++|.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli 283 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLI 283 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHH
Confidence 99999999999888777777764 4566776666676666653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=342.77 Aligned_cols=228 Identities=39% Similarity=0.717 Sum_probs=200.8
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999987643333445567889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+++++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~----- 153 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----- 153 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----
Confidence 999999999999764 4589999999999999999999999999999999999999999999999999854210
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.++
T Consensus 154 -------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~ 208 (291)
T cd05612 154 -------------------------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE 208 (291)
T ss_pred -------------------------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1123479999999999999999999999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCCCCcccCCC
Q 002342 909 NILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 909 ~i~~~~~~~p~~~~~s~~~k~l 930 (934)
.+..+...+|... +..+++|
T Consensus 209 ~i~~~~~~~~~~~--~~~~~~l 228 (291)
T cd05612 209 KILAGKLEFPRHL--DLYAKDL 228 (291)
T ss_pred HHHhCCcCCCccC--CHHHHHH
Confidence 9999998888754 4444443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=355.16 Aligned_cols=259 Identities=36% Similarity=0.600 Sum_probs=203.2
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
.|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||++++++|.+.+++|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 68999999999999999999999999999999986544445556778899999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
||++|+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|...........
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 99999999998764 4589999999999999999999999999999999999999999999999999854321111000
Q ss_pred Ccchhhhcc------cc----CC----------CCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHH
Q 002342 830 PTTNEKKRR------HK----GQ----------QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889 (934)
Q Consensus 830 ~~~~~~~~~------~~----~~----------~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ 889 (934)
......... .. .. ..............+.+||+.|+|||++.+..++.++|||||||+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 000000000 00 00 00000000111234568999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCCCcccCCC
Q 002342 890 EMLYGYTPFRGKTRQKTFANILHK--DLKFPSSTPSSCKAANV 930 (934)
Q Consensus 890 elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~s~~~k~l 930 (934)
+|++|++||.+.+..+....+... .+.+|.....+.++++|
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~l 282 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDL 282 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHH
Confidence 999999999998888888777763 45666655566666654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=353.17 Aligned_cols=260 Identities=36% Similarity=0.650 Sum_probs=204.4
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++++.||.|+||.||++++..+++.||||++.+...........+.+|+.+|+.++||||++++++|.+.+++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998654444455667888999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
|||.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++..........
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999998764 359999999999999999999999999999999999999999999999999986543211100
Q ss_pred CCcchhhhccc-----------cCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCC
Q 002342 829 LPTTNEKKRRH-----------KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 829 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~P 897 (934)
........... .......+.........+.+||+.|+|||++.+..++.++|||||||++|+|++|.+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 00000000000 0000000000001122345899999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCC--CCCCCCCCCCcccCCC
Q 002342 898 FRGKTRQKTFANILHKD--LKFPSSTPSSCKAANV 930 (934)
Q Consensus 898 f~~~~~~~~~~~i~~~~--~~~p~~~~~s~~~k~l 930 (934)
|.+.+..+.+..+.... +.+|.....+..+++|
T Consensus 239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 273 (364)
T cd05599 239 FCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDL 273 (364)
T ss_pred CCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHH
Confidence 99999988888887643 5566655556666554
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=356.48 Aligned_cols=260 Identities=35% Similarity=0.632 Sum_probs=202.2
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++++.||+|+||.||++.+..+++.||||++.+...........+.+|+++++.++||||++++++|.+.+++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999987654334455677889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
|||+|++|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999998764 459999999999999999999999999999999999999999999999999986432111000
Q ss_pred C-----Ccchhhhc---cccCCCCc------------ccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHH
Q 002342 829 L-----PTTNEKKR---RHKGQQNP------------VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888 (934)
Q Consensus 829 ~-----~~~~~~~~---~~~~~~~~------------~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL 888 (934)
. ........ ........ .............+||+.|+|||++.+..++.++|||||||+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 0 00000000 00000000 0000000111246799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCCCcccCCC
Q 002342 889 YEMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 889 ~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~s~~~k~l 930 (934)
|+|++|.+||.+.+..+.+..|.. ..+.+|.....+..+++|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dl 282 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDL 282 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHH
Confidence 999999999999888888888875 446667654455555544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=348.01 Aligned_cols=234 Identities=32% Similarity=0.523 Sum_probs=211.8
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCCeEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVC 745 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~ 745 (934)
....|++.+.||.|.||.||++.++.+|+.||+|++.+...........+.+|+.||+++. |||||.+++.|++.+.++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3568999999999999999999999999999999999876655556678999999999998 999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC----CcEEEEecccCccc
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDFDLSCLT 821 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~----~~vkl~DFG~a~~~ 821 (934)
+|||+|.||.|++.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+... +.+|++|||++...
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 999999999999999876 39999999999999999999999999999999999999643 47999999999654
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
.. .......+||+.|+|||++....|+..+||||+|+++|.|+.|.+||.+.
T Consensus 190 ~~----------------------------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~ 241 (382)
T KOG0032|consen 190 KP----------------------------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE 241 (382)
T ss_pred cC----------------------------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC
Confidence 21 23456779999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHcCCCCCCC--CCCCCcccCCCC
Q 002342 902 TRQKTFANILHKDLKFPS--STPSSCKAANVP 931 (934)
Q Consensus 902 ~~~~~~~~i~~~~~~~p~--~~~~s~~~k~l~ 931 (934)
+....+.+|..+++.|+. |..+|..+|||+
T Consensus 242 ~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i 273 (382)
T KOG0032|consen 242 TEFEIFLAILRGDFDFTSEPWDDISESAKDFI 273 (382)
T ss_pred ChhHHHHHHHcCCCCCCCCCccccCHHHHHHH
Confidence 999999999999987764 577888888874
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=348.30 Aligned_cols=225 Identities=37% Similarity=0.720 Sum_probs=199.6
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCC-eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSG-QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~-~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
.+..++|++.+.||.|+||.||+|.+..++ ..||+|.+.+...........+.+|+.+++.++||||+++++++.+++.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 356779999999999999999999987665 7899999976544444556678899999999999999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|+||||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999765 4599999999999999999999999999999999999999999999999999854310
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
.....+||+.|||||++.+..++.++|||||||++|+|++|.+||.+.+.
T Consensus 184 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 184 ------------------------------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred ------------------------------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 11245799999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 002342 904 QKTFANILHKDLKFPSST 921 (934)
Q Consensus 904 ~~~~~~i~~~~~~~p~~~ 921 (934)
..+++.+..+...+|...
T Consensus 234 ~~~~~~i~~~~~~~p~~~ 251 (340)
T PTZ00426 234 LLIYQKILEGIIYFPKFL 251 (340)
T ss_pred HHHHHHHhcCCCCCCCCC
Confidence 999999999988888653
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=352.09 Aligned_cols=261 Identities=36% Similarity=0.645 Sum_probs=206.6
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..++||||++++++|.+.+++|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998654444455677888999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
|||+|++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..........
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999998764 459999999999999999999999999999999999999999999999999986432211000
Q ss_pred C-Cc---c--hhhhccccCCC--CcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 829 L-PT---T--NEKKRRHKGQQ--NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 829 ~-~~---~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
. .. . ........... ...............+||+.|+|||++.+..++.++|||||||++|+|++|++||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 0 00 0 00000000000 000000011123356899999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHc--CCCCCCCCCCCCcccCCCC
Q 002342 901 KTRQKTFANILH--KDLKFPSSTPSSCKAANVP 931 (934)
Q Consensus 901 ~~~~~~~~~i~~--~~~~~p~~~~~s~~~k~l~ 931 (934)
.+....+.++.. ..+.+|...+.+.++++|+
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li 271 (360)
T cd05627 239 ETPQETYRKVMNWKETLVFPPEVPISEKAKDLI 271 (360)
T ss_pred CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHH
Confidence 999999888876 3467777666777777653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=352.41 Aligned_cols=260 Identities=36% Similarity=0.599 Sum_probs=200.4
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++.|..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987643333445567788999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
|||++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..........
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999999764 458999999999999999999999999999999999999999999999999985432110000
Q ss_pred CCcchhhhcc---cc-------------CCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHH
Q 002342 829 LPTTNEKKRR---HK-------------GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892 (934)
Q Consensus 829 ~~~~~~~~~~---~~-------------~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ell 892 (934)
.......... .. ..................+||+.|||||++.+..++.++|||||||++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 0000000000 00 0000000000112233568999999999999999999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCCcccCCC
Q 002342 893 YGYTPFRGKTRQKTFANILHKD--LKFPSSTPSSCKAANV 930 (934)
Q Consensus 893 tG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~s~~~k~l 930 (934)
+|++||.+.+..+....+.... +.+|.....+..+++|
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 278 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDL 278 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHH
Confidence 9999999998888777776543 4455544455554443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=336.53 Aligned_cols=234 Identities=32% Similarity=0.478 Sum_probs=192.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC--eEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT--HVC 745 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~ 745 (934)
...|...+.||+|+||.||++.+..+|..+|+|.+... +....+.+.+|+.+|++++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~---~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE---DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc---cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 34688999999999999999999999999999998754 2222677899999999999999999999755444 689
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-CCcEEEEecccCcccCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-~~~vkl~DFG~a~~~~~~ 824 (934)
++|||+++|+|.+++.+.++ .+++..++.+.+||+.||.|||++|||||||||+|||++. ++.+||+|||++......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 99999999999999998765 6999999999999999999999999999999999999999 799999999998654310
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCC-CC
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRG-KT 902 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~-~~ 902 (934)
.........+.||+.|||||++..+ ...+++|||||||++.||+||++||.. ..
T Consensus 172 ------------------------~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~ 227 (313)
T KOG0198|consen 172 ------------------------GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE 227 (313)
T ss_pred ------------------------cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc
Confidence 0111233467899999999999853 334599999999999999999999987 44
Q ss_pred HHHHHHHHHcCC--CCCCCCCCCCcccCCCC
Q 002342 903 RQKTFANILHKD--LKFPSSTPSSCKAANVP 931 (934)
Q Consensus 903 ~~~~~~~i~~~~--~~~p~~~~~s~~~k~l~ 931 (934)
....+-.|.... ..+|.+ +|++++||.
T Consensus 228 ~~~~~~~ig~~~~~P~ip~~--ls~~a~~Fl 256 (313)
T KOG0198|consen 228 EAEALLLIGREDSLPEIPDS--LSDEAKDFL 256 (313)
T ss_pred hHHHHHHHhccCCCCCCCcc--cCHHHHHHH
Confidence 455455555444 345554 688887763
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=352.26 Aligned_cols=236 Identities=34% Similarity=0.644 Sum_probs=201.5
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+..++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++++|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999997644334444566788999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
+|||||++|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 999999999999998653 48999999999999999999999999999999999999999999999999985432100
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC----CCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
.....+.+||+.|||||++.+.. ++.++|+|||||+||+|++|++||.+.
T Consensus 197 --------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 197 --------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred --------------------------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 01123567999999999997643 778999999999999999999999999
Q ss_pred CHHHHHHHHHcCC--CCCCCCCCCCcccCCC
Q 002342 902 TRQKTFANILHKD--LKFPSSTPSSCKAANV 930 (934)
Q Consensus 902 ~~~~~~~~i~~~~--~~~p~~~~~s~~~k~l 930 (934)
+....+.+|.... +.+|.....+..+++|
T Consensus 251 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~l 281 (370)
T cd05621 251 SLVGTYSKIMDHKNSLNFPEDVEISKHAKNL 281 (370)
T ss_pred CHHHHHHHHHhCCcccCCCCcccCCHHHHHH
Confidence 9988999888744 6677665566666654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=343.96 Aligned_cols=217 Identities=42% Similarity=0.793 Sum_probs=192.5
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 754 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg 754 (934)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998754444555667788999999999999999999999999999999999999
Q ss_pred CchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchh
Q 002342 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834 (934)
Q Consensus 755 sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 834 (934)
+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~----------- 147 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS----------- 147 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-----------
Confidence 999998764 4599999999999999999999999999999999999999999999999999853210
Q ss_pred hhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Q 002342 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~~ 914 (934)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+..+.
T Consensus 148 ----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~ 211 (323)
T cd05571 148 ----------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211 (323)
T ss_pred ----------------CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 0111234579999999999999999999999999999999999999999999999999999888
Q ss_pred CCCCCC
Q 002342 915 LKFPSS 920 (934)
Q Consensus 915 ~~~p~~ 920 (934)
..+|..
T Consensus 212 ~~~p~~ 217 (323)
T cd05571 212 IRFPRT 217 (323)
T ss_pred CCCCCC
Confidence 888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=350.08 Aligned_cols=237 Identities=35% Similarity=0.647 Sum_probs=201.9
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++..++++
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45568999999999999999999999999999999999764333444455678899999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+|||||+|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 9999999999999998653 4899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC----CCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
........+||+.|||||++.+.. ++.++|||||||+||+|++|.+||.+
T Consensus 196 --------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 196 --------------------------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred --------------------------CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 011223567999999999997643 77899999999999999999999999
Q ss_pred CCHHHHHHHHHcCC--CCCCCCCCCCcccCCC
Q 002342 901 KTRQKTFANILHKD--LKFPSSTPSSCKAANV 930 (934)
Q Consensus 901 ~~~~~~~~~i~~~~--~~~p~~~~~s~~~k~l 930 (934)
.+....+.+|.... +.+|.....+..+++|
T Consensus 250 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 281 (371)
T cd05622 250 DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 281 (371)
T ss_pred CCHHHHHHHHHcCCCcccCCCcCCCCHHHHHH
Confidence 99999999998754 5677655566666554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=349.32 Aligned_cols=237 Identities=35% Similarity=0.612 Sum_probs=202.0
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+..++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 35567999999999999999999999999999999999764433444555677899999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+|||||+||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999998653 4899999999999999999999999999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC----CCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA----GHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~----~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
........+||+.|||||++.+. .++.++|||||||+||+|++|++||.+
T Consensus 196 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 249 (370)
T cd05596 196 --------------------------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (370)
T ss_pred --------------------------CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence 00112345799999999999754 378899999999999999999999999
Q ss_pred CCHHHHHHHHHcCC--CCCCCCCCCCcccCCC
Q 002342 901 KTRQKTFANILHKD--LKFPSSTPSSCKAANV 930 (934)
Q Consensus 901 ~~~~~~~~~i~~~~--~~~p~~~~~s~~~k~l 930 (934)
.+....+..|..+. +.+|.....|..+++|
T Consensus 250 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 281 (370)
T cd05596 250 DSLVGTYSKIMDHKNSLTFPDDIEISKQAKDL 281 (370)
T ss_pred CCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHH
Confidence 99999999998754 6677765566666654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=347.21 Aligned_cols=209 Identities=30% Similarity=0.509 Sum_probs=190.0
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-C-----CCccceeEEEEeCC
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-H-----PFVPALYASFQTKT 742 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-h-----p~Iv~l~~~~~~~~ 742 (934)
.+|.+++.||+|+||+|.+|.+.+|++.||||+++.. +........|+.||..|+ | -|||+++++|...+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 3899999999999999999999999999999999753 566677788999999997 4 38999999999999
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC--cEEEEecccCcc
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG--HVSLTDFDLSCL 820 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~--~vkl~DFG~a~~ 820 (934)
++|||+|.+ ..+|+++++.+....|+...++.++.||+.||.+||+.||||+||||+||||.+-+ .|||+|||+|+.
T Consensus 262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999999999 99999999998888899999999999999999999999999999999999997644 699999999965
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
... ..-+.+-+..|.|||++.|.+|+.+.||||||||+.||++|.|.|.|
T Consensus 341 ~~q------------------------------~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 341 ESQ------------------------------RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cCC------------------------------cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 321 11155788899999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHc
Q 002342 901 KTRQKTFANILH 912 (934)
Q Consensus 901 ~~~~~~~~~i~~ 912 (934)
.+..+++..|.+
T Consensus 391 ~ne~DQl~~I~e 402 (586)
T KOG0667|consen 391 DNEYDQLARIIE 402 (586)
T ss_pred CCHHHHHHHHHH
Confidence 999999999976
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=337.89 Aligned_cols=215 Identities=41% Similarity=0.740 Sum_probs=191.5
Q ss_pred cccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCCCc
Q 002342 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 756 (934)
Q Consensus 677 LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL 756 (934)
||+|+||.||++.+..+++.||+|++.+...........+.+|+.+|+.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999865444455667788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhh
Q 002342 757 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836 (934)
Q Consensus 757 ~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~ 836 (934)
.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~------------- 145 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK------------- 145 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc-------------
Confidence 9999764 4599999999999999999999999999999999999999999999999999853210
Q ss_pred ccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Q 002342 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 916 (934)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~~~~ 916 (934)
........+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.++.+..+.+.
T Consensus 146 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~ 211 (312)
T cd05585 146 --------------DDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR 211 (312)
T ss_pred --------------CCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCC
Confidence 011223457999999999999999999999999999999999999999999999999999998888
Q ss_pred CCCC
Q 002342 917 FPSS 920 (934)
Q Consensus 917 ~p~~ 920 (934)
+|..
T Consensus 212 ~~~~ 215 (312)
T cd05585 212 FPDG 215 (312)
T ss_pred CCCc
Confidence 8764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=329.25 Aligned_cols=228 Identities=36% Similarity=0.684 Sum_probs=210.2
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCe
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 743 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 743 (934)
.+...+|.++.+||.|+||+|.++..+.+...||||+++|+.+.+.+.++....|.++|... +-|++++++..|++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 45678999999999999999999999999999999999999988888888889999999887 46799999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|+||||+.||+|.-+++.- +.|.+..+.+|+.+|+-||-|||++|||+||||.+|||++.+|++||+|||+|+.-.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni- 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI- 501 (683)
T ss_pred eeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc-
Confidence 99999999999999998764 459999999999999999999999999999999999999999999999999995421
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
-....+.++||||.|+|||++.-.+|+.++|+||+|++||||+.|++||.|.+.
T Consensus 502 --------------------------~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 502 --------------------------FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred --------------------------cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 112345689999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 002342 904 QKTFANILHKDLKFPSST 921 (934)
Q Consensus 904 ~~~~~~i~~~~~~~p~~~ 921 (934)
.++++.|.+.+..||...
T Consensus 556 ~elF~aI~ehnvsyPKsl 573 (683)
T KOG0696|consen 556 DELFQAIMEHNVSYPKSL 573 (683)
T ss_pred HHHHHHHHHccCcCcccc
Confidence 999999999999999875
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=338.48 Aligned_cols=217 Identities=41% Similarity=0.801 Sum_probs=191.5
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 754 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg 754 (934)
+.||+|+||.||++++..+|+.||+|++.+...........+.+|+.+++.++||||++++++|...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998754444555667788999999999999999999999999999999999999
Q ss_pred CchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchh
Q 002342 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834 (934)
Q Consensus 755 sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 834 (934)
+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~---------- 148 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC----------
Confidence 999888764 45999999999999999999999999999999999999999999999999998432100
Q ss_pred hhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Q 002342 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~~ 914 (934)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+..+.
T Consensus 149 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~ 211 (323)
T cd05595 149 -----------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211 (323)
T ss_pred -----------------CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 011224579999999999999999999999999999999999999999999999999998888
Q ss_pred CCCCCC
Q 002342 915 LKFPSS 920 (934)
Q Consensus 915 ~~~p~~ 920 (934)
..+|..
T Consensus 212 ~~~p~~ 217 (323)
T cd05595 212 IRFPRT 217 (323)
T ss_pred CCCCCC
Confidence 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=342.28 Aligned_cols=224 Identities=26% Similarity=0.480 Sum_probs=202.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe-EEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH-VCL 746 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~-~~l 746 (934)
++.|.+++.+|.|+||.+++++++.+++.|++|.+.-.....+ ..+...+|+.+++++.|||||.++++|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 5789999999999999999999999999999999876544333 33477889999999999999999999998887 999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||+||+||+|.+.+.++.+..|++..+..|+.||+.||.|||+++|+|||||+.||+++.++.|||+|||+|+.+....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 9999999999999999888899999999999999999999999999999999999999999999999999998765322
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
....+.+||+.||+||.+.+.+|+.++|||||||++|||++=+++|.+.+....
T Consensus 161 --------------------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L 214 (426)
T KOG0589|consen 161 --------------------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL 214 (426)
T ss_pred --------------------------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH
Confidence 134577999999999999999999999999999999999999999999999999
Q ss_pred HHHHHcCC-CCCCC
Q 002342 907 FANILHKD-LKFPS 919 (934)
Q Consensus 907 ~~~i~~~~-~~~p~ 919 (934)
..+|.++. .+.|.
T Consensus 215 i~ki~~~~~~Plp~ 228 (426)
T KOG0589|consen 215 ILKINRGLYSPLPS 228 (426)
T ss_pred HHHHhhccCCCCCc
Confidence 99999887 34443
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=339.48 Aligned_cols=217 Identities=44% Similarity=0.810 Sum_probs=192.2
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 754 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg 754 (934)
+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998765445556677889999999999999999999999999999999999999
Q ss_pred CchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchh
Q 002342 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834 (934)
Q Consensus 755 sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 834 (934)
+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~---------- 148 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---------- 148 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc----------
Confidence 999888664 45999999999999999999999999999999999999999999999999998532100
Q ss_pred hhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Q 002342 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~~ 914 (934)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+..+.
T Consensus 149 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 211 (328)
T cd05593 149 -----------------AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED 211 (328)
T ss_pred -----------------ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC
Confidence 011234579999999999999999999999999999999999999999999888998998888
Q ss_pred CCCCCC
Q 002342 915 LKFPSS 920 (934)
Q Consensus 915 ~~~p~~ 920 (934)
+.+|..
T Consensus 212 ~~~p~~ 217 (328)
T cd05593 212 IKFPRT 217 (328)
T ss_pred ccCCCC
Confidence 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=320.21 Aligned_cols=216 Identities=27% Similarity=0.450 Sum_probs=188.6
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCC-ccceeEEEEeCC----
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF-VPALYASFQTKT---- 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~---- 742 (934)
...|..+++||+|+||+||+|+.+.+|+.||+|.+.-.... ...-....+|+.+|+.|+|+| |+.|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45799999999999999999999999999999998764321 123345678999999999999 999999999877
Q ss_pred --eEEEEEEccCCCCchhhhccCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccC
Q 002342 743 --HVCLITDYCPGGELFLLLDRQPT--KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (934)
Q Consensus 743 --~~~lV~E~~~ggsL~~~l~~~~~--~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a 818 (934)
.+++||||+ ..+|..++..... ..++...++.++.||+.||+|||++||+||||||.||||+.+|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 8899999987542 35788999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~P 897 (934)
+.... +....+..++|.+|.|||++.+. .|+..+||||+||+++||+++++.
T Consensus 168 ra~~i---------------------------p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~L 220 (323)
T KOG0594|consen 168 RAFSI---------------------------PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPL 220 (323)
T ss_pred HHhcC---------------------------CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCC
Confidence 64321 22234566899999999999987 789999999999999999999999
Q ss_pred CCCCCHHHHHHHHHc
Q 002342 898 FRGKTRQKTFANILH 912 (934)
Q Consensus 898 f~~~~~~~~~~~i~~ 912 (934)
|.|.+..+++.+|.+
T Consensus 221 FpG~se~~ql~~If~ 235 (323)
T KOG0594|consen 221 FPGDSEIDQLFRIFR 235 (323)
T ss_pred CCCCcHHHHHHHHHH
Confidence 999999999888864
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=340.03 Aligned_cols=213 Identities=39% Similarity=0.681 Sum_probs=191.1
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.++..++||||+++++++...+++||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998754444455667889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 999999999999764 4589999999999999999999999999999999999999999999999999853210
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+.
T Consensus 154 -------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~ 208 (333)
T cd05600 154 -------------------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE 208 (333)
T ss_pred -------------------------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH
Confidence 1234579999999999999999999999999999999999999999999888888
Q ss_pred HHHcC
Q 002342 909 NILHK 913 (934)
Q Consensus 909 ~i~~~ 913 (934)
.+...
T Consensus 209 ~i~~~ 213 (333)
T cd05600 209 NLKYW 213 (333)
T ss_pred HHHhc
Confidence 77653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=336.85 Aligned_cols=222 Identities=37% Similarity=0.713 Sum_probs=194.6
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCC-CccceeEEEEeCCeEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP-FVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp-~Iv~l~~~~~~~~~~~lV~ 748 (934)
+|++++.||+|+||.||+|.+..+++.||||++.+...........+..|..++..++|+ +|+.+++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876444445566788899999999765 6888999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~----- 153 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF----- 153 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC-----
Confidence 999999999998764 4589999999999999999999999999999999999999999999999999843110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
........+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+.
T Consensus 154 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~ 211 (324)
T cd05587 154 ----------------------GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ 211 (324)
T ss_pred ----------------------CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 0011234579999999999999999999999999999999999999999999999999
Q ss_pred HHHcCCCCCCCC
Q 002342 909 NILHKDLKFPSS 920 (934)
Q Consensus 909 ~i~~~~~~~p~~ 920 (934)
.+......+|..
T Consensus 212 ~i~~~~~~~~~~ 223 (324)
T cd05587 212 SIMEHNVSYPKS 223 (324)
T ss_pred HHHcCCCCCCCC
Confidence 999888888764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=337.11 Aligned_cols=223 Identities=37% Similarity=0.704 Sum_probs=195.4
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
+|.+.+.||+|+||.||++++..+++.||+|++.+..............|..++..+ .|++|+.+++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999999999999999999875444444556677788888877 5899999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+++|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~---- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---- 154 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC----
Confidence 999999999998764 45999999999999999999999999999999999999999999999999998532100
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
.......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+...+++
T Consensus 155 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~ 211 (323)
T cd05616 155 -----------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 211 (323)
T ss_pred -----------------------CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011234579999999999999999999999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCC
Q 002342 909 NILHKDLKFPSST 921 (934)
Q Consensus 909 ~i~~~~~~~p~~~ 921 (934)
.|..+...+|...
T Consensus 212 ~i~~~~~~~p~~~ 224 (323)
T cd05616 212 SIMEHNVAYPKSM 224 (323)
T ss_pred HHHhCCCCCCCcC
Confidence 9999888888643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=340.23 Aligned_cols=264 Identities=36% Similarity=0.592 Sum_probs=216.0
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.++..-|..++.||-|+||.|.+|+...|...||+|.+.|.....+..+.....|..||...+++-||+||.+|++.+++
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 45667899999999999999999999999999999999988777888888899999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+||+|++||++..+|-+. +.|.++.+++|+.++.+|+++.|..|+|||||||+||||+.+|+|||+|||+|.-+...
T Consensus 705 YFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999999999875 56999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCCCcchhhhc----------cccCCCCcccc-----cccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHH
Q 002342 825 PQLLLPTTNEKKR----------RHKGQQNPVFM-----AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889 (934)
Q Consensus 825 ~~~~~~~~~~~~~----------~~~~~~~~~~~-----~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ 889 (934)
.....-......+ .+.+.+..... ....-...+.+||+.|+|||++...+|+-.+|+||.||+||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 2211111111000 00000000000 00112234668999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCCCcccCCC
Q 002342 890 EMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 890 elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~s~~~k~l 930 (934)
||+.|++||.+.+..++-.+|++ ..+.||.....|.++.+|
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~l 905 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDL 905 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHH
Confidence 99999999999999888777764 556788777677766554
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=328.81 Aligned_cols=222 Identities=32% Similarity=0.580 Sum_probs=186.7
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
.|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++|+||+.+++++...+..|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37889999999999999999999999999999876544333444567789999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
||++++|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG----- 155 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-----
Confidence 999999998876544456999999999999999999999999999999999999999999999999998542110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH----H
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ----K 905 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~----~ 905 (934)
.......||+.|||||++.+..++.++|||||||++|+|++|++||.+.... .
T Consensus 156 -----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05631 156 -----------------------ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE 212 (285)
T ss_pred -----------------------CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH
Confidence 0112346999999999999999999999999999999999999999876543 2
Q ss_pred HHHHHHcCCCCCCC
Q 002342 906 TFANILHKDLKFPS 919 (934)
Q Consensus 906 ~~~~i~~~~~~~p~ 919 (934)
+...+......+|.
T Consensus 213 ~~~~~~~~~~~~~~ 226 (285)
T cd05631 213 VDRRVKEDQEEYSE 226 (285)
T ss_pred HHHHhhcccccCCc
Confidence 33344444444443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=329.78 Aligned_cols=230 Identities=31% Similarity=0.506 Sum_probs=206.4
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
+-|.+.+.||+|-|..|-+|++.-+|..||||++.|..+.+... ..+++|+..|+.++|||||+||++...+..+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st-~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLST-GHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhh-hHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 46999999999999999999999999999999999876644444 56888999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE-ecCCcEEEEecccCcccCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl-~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|+-++|+|++|+-+.. ..++++.+++|+.||+.|+.|+|+..+|||||||+||++ ..-|-|||+|||++..
T Consensus 97 ELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNk------- 168 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNK------- 168 (864)
T ss_pred EecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeecccccc-------
Confidence 9999999999998764 449999999999999999999999999999999999877 4568999999999843
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~-~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
..+....+++||++.|-|||++.+..|+. ++||||||||||-|++|++||...+..+.
T Consensus 169 ---------------------f~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET 227 (864)
T KOG4717|consen 169 ---------------------FQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET 227 (864)
T ss_pred ---------------------CCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh
Confidence 23455677899999999999999999874 89999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCCCcccCCC
Q 002342 907 FANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 907 ~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
+-+|+..++.+|+.. |.+-+||
T Consensus 228 LTmImDCKYtvPshv--S~eCrdL 249 (864)
T KOG4717|consen 228 LTMIMDCKYTVPSHV--SKECRDL 249 (864)
T ss_pred hhhhhcccccCchhh--hHHHHHH
Confidence 999999999999976 4444444
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=334.92 Aligned_cols=230 Identities=25% Similarity=0.398 Sum_probs=197.2
Q ss_pred ccccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe
Q 002342 661 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (934)
Q Consensus 661 ~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (934)
...+.+....+++++.||+|.||.||++.+.. ...||+|.++...+ ....+.+|++||++|+|++||+|++++..
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 34566777889999999999999999999933 33799999887533 23567799999999999999999999999
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
+..+|||||||+.|+|.++|+...+..+.......++.|||+||+||+++++|||||...|||++.+..|||+|||+|+.
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc
Confidence 88999999999999999999986667899999999999999999999999999999999999999999999999999974
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 899 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~ 899 (934)
...+. +... ....-...|.|||++....++.+||||||||+||||+| |+.||.
T Consensus 353 ~~d~~----------Y~~~----------------~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~ 406 (468)
T KOG0197|consen 353 IGDDE----------YTAS----------------EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP 406 (468)
T ss_pred cCCCc----------eeec----------------CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC
Confidence 32211 1111 11123568999999999999999999999999999997 999999
Q ss_pred CCCHHHHHHHHHcCC-CCCCCCC
Q 002342 900 GKTRQKTFANILHKD-LKFPSST 921 (934)
Q Consensus 900 ~~~~~~~~~~i~~~~-~~~p~~~ 921 (934)
+.+..+++..|.+|. ++-|...
T Consensus 407 ~msn~ev~~~le~GyRlp~P~~C 429 (468)
T KOG0197|consen 407 GMSNEEVLELLERGYRLPRPEGC 429 (468)
T ss_pred CCCHHHHHHHHhccCcCCCCCCC
Confidence 999999999998876 4556554
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=333.78 Aligned_cols=223 Identities=38% Similarity=0.701 Sum_probs=194.3
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCCeEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
+|++.+.||+|+||.||+|.++.+++.||+|++.+...........+..|..++..+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998754434445566778999998885 577889999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||++|++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~---- 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---- 154 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC----
Confidence 999999999998764 45999999999999999999999999999999999999999999999999998532100
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
.......+||+.|+|||++.+..++.++|+|||||++|+|++|.+||.+.+...+++
T Consensus 155 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~ 211 (323)
T cd05615 155 -----------------------GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ 211 (323)
T ss_pred -----------------------CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011234579999999999999999999999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCC
Q 002342 909 NILHKDLKFPSST 921 (934)
Q Consensus 909 ~i~~~~~~~p~~~ 921 (934)
.+..+...+|...
T Consensus 212 ~i~~~~~~~p~~~ 224 (323)
T cd05615 212 SIMEHNVSYPKSL 224 (323)
T ss_pred HHHhCCCCCCccC
Confidence 9999888888653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=342.37 Aligned_cols=260 Identities=39% Similarity=0.678 Sum_probs=206.1
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++++.++++.|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998754444455677889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999999775 459999999999999999999999999999999999999999999999999986543321000
Q ss_pred CCcchhhh--ccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 829 LPTTNEKK--RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 829 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
........ .......................||+.|+|||++.+..++.++|||||||+||+|++|++||.+.+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 00000000 0000000000000011223456799999999999999999999999999999999999999999998888
Q ss_pred HHHHHc--CCCCCCCCCCCCcccCCC
Q 002342 907 FANILH--KDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 907 ~~~i~~--~~~~~p~~~~~s~~~k~l 930 (934)
+.++.. ..+.+|.....+.++++|
T Consensus 239 ~~~i~~~~~~~~~p~~~~~~~~~~~l 264 (350)
T cd05573 239 YNKIINWKESLRFPPDPPVSPEAIDL 264 (350)
T ss_pred HHHHhccCCcccCCCCCCCCHHHHHH
Confidence 888887 667777665445544443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=334.06 Aligned_cols=218 Identities=39% Similarity=0.746 Sum_probs=191.0
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEEEEEEccCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 753 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~g 753 (934)
+.||+|+||.||+|+++.+++.||+|++.+...........+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999999999999999999865443444556777899998876 799999999999999999999999999
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~---------- 148 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF---------- 148 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc----------
Confidence 9999988764 4599999999999999999999999999999999999999999999999999853210
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~ 913 (934)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..+..+
T Consensus 149 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~ 211 (320)
T cd05590 149 -----------------NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211 (320)
T ss_pred -----------------CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC
Confidence 011123457999999999999999999999999999999999999999999999999999998
Q ss_pred CCCCCCCC
Q 002342 914 DLKFPSST 921 (934)
Q Consensus 914 ~~~~p~~~ 921 (934)
...+|.+.
T Consensus 212 ~~~~~~~~ 219 (320)
T cd05590 212 EVVYPTWL 219 (320)
T ss_pred CCCCCCCC
Confidence 88888753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=328.16 Aligned_cols=237 Identities=33% Similarity=0.584 Sum_probs=209.5
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
..+..+.|..-++||+|+||.||-++-+.||+.||+|.+.|+.++.+.......+|..||..++.++||.+-..|++.+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 34567789999999999999999999999999999999988777777777778899999999999999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|+||..|+||+|.-+|...+...|++..+++|+.+|++||++||..+||+|||||+|||+++.|+|.|.|+|+|..++.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999999999887777899999999999999999999999999999999999999999999999999965431
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK-- 901 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~-- 901 (934)
. .....-+||.+|||||++.+..|++..|+|||||+||+|+.|+.||...
T Consensus 340 g----------------------------~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 340 G----------------------------KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred C----------------------------CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 1 1112338999999999999999999999999999999999999999863
Q ss_pred --CHHHHHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 902 --TRQKTFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 902 --~~~~~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
..+++-+++++....+|.. .|.++|+|
T Consensus 392 Kvk~eEvdrr~~~~~~ey~~k--FS~eaksl 420 (591)
T KOG0986|consen 392 KVKREEVDRRTLEDPEEYSDK--FSEEAKSL 420 (591)
T ss_pred hhhHHHHHHHHhcchhhcccc--cCHHHHHH
Confidence 3357778888888888854 46666654
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=314.80 Aligned_cols=237 Identities=29% Similarity=0.468 Sum_probs=199.5
Q ss_pred cccc-cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEEEEE
Q 002342 671 FRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 671 y~i~-~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
|++. ..||+|+|+.|--+....++..||||++.|. ......++.+|++++.++ .|+||++|+++|++++.+||||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 4443 4689999999999999999999999999875 345567889999999999 6999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc---EEEEecccCcccCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKP 825 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~---vkl~DFG~a~~~~~~~ 825 (934)
|-|.||+|..+++++ +.|++.++..+.++|+.||.|||.+||.||||||+|||..+.++ ||||||.+...+....
T Consensus 156 EKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred ecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 999999999999886 56999999999999999999999999999999999999976654 7999999874322111
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhh-----cCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII-----AGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l-----~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.- + ...-....+.+|+..|||||+. ....|+.++|.||||++||-|+.|.+||.|
T Consensus 234 ~~--------s------------pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 234 DC--------S------------PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred CC--------C------------CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 10 0 0011233466899999999998 345788999999999999999999999986
Q ss_pred CCH---------------HHHHHHHHcCCCCCCC--CCCCCcccCCCCC
Q 002342 901 KTR---------------QKTFANILHKDLKFPS--STPSSCKAANVPP 932 (934)
Q Consensus 901 ~~~---------------~~~~~~i~~~~~~~p~--~~~~s~~~k~l~~ 932 (934)
... ...+..|.+|.+.||. |..+|+.+|||+.
T Consensus 294 ~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlis 342 (463)
T KOG0607|consen 294 HCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLIS 342 (463)
T ss_pred ccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHH
Confidence 432 4578899999999995 7789999999863
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=332.34 Aligned_cols=220 Identities=40% Similarity=0.766 Sum_probs=191.4
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHH---HhCCCCCccceeEEEEeCCeEEEE
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL---DMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il---~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
|++++.||+|+||.||++.+..+++.||||++.+...........+.+|+.++ +.++||||+++++++...++.|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999865433444556677777665 456799999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+++++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~---- 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG---- 153 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC----
Confidence 999999999988754 3599999999999999999999999999999999999999999999999999843210
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
........+|++.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+.+
T Consensus 154 -----------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~ 210 (324)
T cd05589 154 -----------------------FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210 (324)
T ss_pred -----------------------CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 011223567999999999999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCC
Q 002342 908 ANILHKDLKFPSS 920 (934)
Q Consensus 908 ~~i~~~~~~~p~~ 920 (934)
..+..+...+|..
T Consensus 211 ~~i~~~~~~~p~~ 223 (324)
T cd05589 211 DSIVNDEVRYPRF 223 (324)
T ss_pred HHHHhCCCCCCCC
Confidence 9999888877754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=336.10 Aligned_cols=217 Identities=42% Similarity=0.801 Sum_probs=191.0
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 754 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg 754 (934)
+.||+|+||.||++.+..+++.||+|++.+...........+..|+++++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998755444555667788999999999999999999999999999999999999
Q ss_pred CchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 755 sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
+|..++... +.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--------- 149 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--------- 149 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC---------
Confidence 999988664 459999999999999999999997 79999999999999999999999999998432100
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~ 913 (934)
.......+||+.|||||++.+..++.++|||||||+||+|++|..||.+.+....+..+..+
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~ 211 (325)
T cd05594 150 ------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211 (325)
T ss_pred ------------------CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC
Confidence 01122457999999999999999999999999999999999999999999999999999888
Q ss_pred CCCCCCC
Q 002342 914 DLKFPSS 920 (934)
Q Consensus 914 ~~~~p~~ 920 (934)
.+.+|..
T Consensus 212 ~~~~p~~ 218 (325)
T cd05594 212 EIRFPRT 218 (325)
T ss_pred CCCCCCC
Confidence 8888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=333.56 Aligned_cols=218 Identities=41% Similarity=0.753 Sum_probs=191.4
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEEEEEEccCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 753 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~g 753 (934)
+.||+|+||.||+|++..+++.||+|++.+...........+..|..++..+ +||||+.++++|...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4689999999999999999999999999875444445556677899999876 899999999999999999999999999
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~---------- 148 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL---------- 148 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc----------
Confidence 9999988764 4589999999999999999999999999999999999999999999999999853210
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~ 913 (934)
........+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+..+
T Consensus 149 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~ 211 (321)
T cd05591 149 -----------------NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211 (321)
T ss_pred -----------------CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 011123457999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 002342 914 DLKFPSST 921 (934)
Q Consensus 914 ~~~~p~~~ 921 (934)
...+|.+.
T Consensus 212 ~~~~p~~~ 219 (321)
T cd05591 212 DVLYPVWL 219 (321)
T ss_pred CCCCCCCC
Confidence 88888653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=331.63 Aligned_cols=217 Identities=41% Similarity=0.808 Sum_probs=187.8
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEEEEEEccCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 753 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~g 753 (934)
+.||+|+||.||+|.+..+++.||+|++++..............|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999999875443444555666777777754 899999999999999999999999999
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--------- 149 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC---------
Confidence 9999998764 35999999999999999999999999999999999999999999999999998532110
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~ 913 (934)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 211 (316)
T cd05592 150 ------------------EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND 211 (316)
T ss_pred ------------------CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 11223567999999999999999999999999999999999999999999999999888877
Q ss_pred CCCCCCC
Q 002342 914 DLKFPSS 920 (934)
Q Consensus 914 ~~~~p~~ 920 (934)
...+|..
T Consensus 212 ~~~~~~~ 218 (316)
T cd05592 212 RPHFPRW 218 (316)
T ss_pred CCCCCCC
Confidence 7666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.47 Aligned_cols=228 Identities=39% Similarity=0.697 Sum_probs=209.7
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
.++...+++++..||-|+||.|=+|........+|+|+++|..+.+..+.+.+..|.+||..+++|+||++|-.|.+..+
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 34556789999999999999999999877777799999999888888888899999999999999999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+||+||-|-||.|+..+..+ +.|.+..+++|+.-+++|++|||++|||+|||||+|++++.+|.+||.|||+|+...
T Consensus 495 vYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~- 571 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG- 571 (732)
T ss_pred hhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc-
Confidence 99999999999999999876 459999999999999999999999999999999999999999999999999996542
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
....+.++||||.|.|||++..++++.++|.||||+++|||++|.|||.+.++
T Consensus 572 ---------------------------~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 572 ---------------------------SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred ---------------------------cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 34567899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHcCC--CCCCCCC
Q 002342 904 QKTFANILHKD--LKFPSST 921 (934)
Q Consensus 904 ~~~~~~i~~~~--~~~p~~~ 921 (934)
..+|..|++|- +.||...
T Consensus 625 mktYn~ILkGid~i~~Pr~I 644 (732)
T KOG0614|consen 625 MKTYNLILKGIDKIEFPRRI 644 (732)
T ss_pred HHHHHHHHhhhhhhhccccc
Confidence 99999999976 5677543
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=333.23 Aligned_cols=224 Identities=38% Similarity=0.674 Sum_probs=191.1
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.++..++|+||+.++++|.+++++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998644334445566888999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||++|++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--- 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC---
Confidence 999999999998653 3459999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
.......+||+.|||||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 157 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~ 213 (331)
T cd05597 157 -----------------------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred -----------------------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH
Confidence 011123469999999999963 4567899999999999999999999999988
Q ss_pred HHHHHHHHcCC--CCCCC
Q 002342 904 QKTFANILHKD--LKFPS 919 (934)
Q Consensus 904 ~~~~~~i~~~~--~~~p~ 919 (934)
.+.+..+.... +.+|.
T Consensus 214 ~~~~~~i~~~~~~~~~~~ 231 (331)
T cd05597 214 VETYGKIMNHKEHFQFPP 231 (331)
T ss_pred HHHHHHHHcCCCcccCCC
Confidence 88888887654 34443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=335.39 Aligned_cols=234 Identities=36% Similarity=0.614 Sum_probs=195.9
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.++..++|+||+.+++++...++.|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997643334445566788999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+.||+|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--- 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC---
Confidence 9999999999997642 458999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
.......+||+.|||||++.+ ..++.++|+|||||+||+|++|+.||.+.+.
T Consensus 157 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 213 (331)
T cd05624 157 -----------------------TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred -----------------------ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH
Confidence 011223579999999999976 4678899999999999999999999999988
Q ss_pred HHHHHHHHcCC--CCCCCCC-CCCcccCC
Q 002342 904 QKTFANILHKD--LKFPSST-PSSCKAAN 929 (934)
Q Consensus 904 ~~~~~~i~~~~--~~~p~~~-~~s~~~k~ 929 (934)
.+.+..+.... +++|... ..+..+++
T Consensus 214 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~~ 242 (331)
T cd05624 214 VETYGKIMNHEERFQFPSHITDVSEEAKD 242 (331)
T ss_pred HHHHHHHHcCCCcccCCCccccCCHHHHH
Confidence 88888887654 4445432 23444444
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=331.73 Aligned_cols=217 Identities=42% Similarity=0.772 Sum_probs=186.9
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHH-HHHhCCCCCccceeEEEEeCCeEEEEEEccCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTKTHVCLITDYCPG 753 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 753 (934)
+.||+|+||+||++.+..+++.||+|++.+...........+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999999999999999998654333334445555655 46789999999999999999999999999999
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~---------- 148 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE---------- 148 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc----------
Confidence 9999998764 4599999999999999999999999999999999999999999999999999843210
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~ 913 (934)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+++..+..+
T Consensus 149 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 211 (323)
T cd05575 149 -----------------HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK 211 (323)
T ss_pred -----------------CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 011223457999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCCCC
Q 002342 914 DLKFPSS 920 (934)
Q Consensus 914 ~~~~p~~ 920 (934)
.+.++..
T Consensus 212 ~~~~~~~ 218 (323)
T cd05575 212 PLRLKPN 218 (323)
T ss_pred CCCCCCC
Confidence 8776654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=329.38 Aligned_cols=224 Identities=39% Similarity=0.746 Sum_probs=190.8
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEEEEEEccCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 753 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~g 753 (934)
+.||+|+||.||+|.++.++..||+|++.+..............|..++..+ +||||+++++++.+.+++|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4689999999999999999999999999875433334455677788888765 899999999999999999999999999
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~---------- 148 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF---------- 148 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc----------
Confidence 9999998764 4589999999999999999999999999999999999999999999999999843110
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~ 913 (934)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+..+
T Consensus 149 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~ 211 (316)
T cd05620 149 -----------------GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD 211 (316)
T ss_pred -----------------CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 001123467999999999999999999999999999999999999999999998889888887
Q ss_pred CCCCCCCCCCCcccCC
Q 002342 914 DLKFPSSTPSSCKAAN 929 (934)
Q Consensus 914 ~~~~p~~~~~s~~~k~ 929 (934)
...+|.+. +.++++
T Consensus 212 ~~~~~~~~--~~~~~~ 225 (316)
T cd05620 212 TPHYPRWI--TKESKD 225 (316)
T ss_pred CCCCCCCC--CHHHHH
Confidence 77777653 444443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=331.28 Aligned_cols=217 Identities=44% Similarity=0.798 Sum_probs=186.3
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHH-HHHhCCCCCccceeEEEEeCCeEEEEEEccCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTKTHVCLITDYCPG 753 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 753 (934)
+.||+|+||.||+|++..+++.||+|++.+...........+..|.. +++.++||||+++++++.+.+..|+|||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999998654333333444555554 67889999999999999999999999999999
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~---------- 148 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE---------- 148 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC----------
Confidence 9999888654 4589999999999999999999999999999999999999999999999999843210
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~ 913 (934)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+...++..+..+
T Consensus 149 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 211 (321)
T cd05603 149 -----------------PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK 211 (321)
T ss_pred -----------------CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC
Confidence 011223457999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCCCC
Q 002342 914 DLKFPSS 920 (934)
Q Consensus 914 ~~~~p~~ 920 (934)
...+|..
T Consensus 212 ~~~~~~~ 218 (321)
T cd05603 212 PLQLPGG 218 (321)
T ss_pred CCCCCCC
Confidence 8777754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=335.79 Aligned_cols=235 Identities=38% Similarity=0.690 Sum_probs=199.7
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|.+.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998764444455667889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~--- 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK--- 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC---
Confidence 9999999999997652 459999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA------GAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
........||+.|+|||++. ...++.++|||||||++|+|++|+.||.+.+
T Consensus 157 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 157 -----------------------MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred -----------------------ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 00112346899999999997 4567789999999999999999999999988
Q ss_pred HHHHHHHHHcCC--CCCCCCCCCCcccCCC
Q 002342 903 RQKTFANILHKD--LKFPSSTPSSCKAANV 930 (934)
Q Consensus 903 ~~~~~~~i~~~~--~~~p~~~~~s~~~k~l 930 (934)
....+.+|.+.. +.+|.....+..+++|
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 243 (330)
T cd05601 214 SAKTYNNIMNFQRFLKFPEDPKVSSDFLDL 243 (330)
T ss_pred HHHHHHHHHcCCCccCCCCCCCCCHHHHHH
Confidence 888888887643 4666655555555544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=331.32 Aligned_cols=217 Identities=41% Similarity=0.743 Sum_probs=184.7
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHH-HHHhCCCCCccceeEEEEeCCeEEEEEEccCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTKTHVCLITDYCPG 753 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 753 (934)
+.||+|+||.||+|++..+++.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46899999999999999999999999998643322233334444444 56889999999999999999999999999999
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~---------- 148 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE---------- 148 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc----------
Confidence 9999998764 4588999999999999999999999999999999999999999999999999853210
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~ 913 (934)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+..+
T Consensus 149 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 211 (325)
T cd05602 149 -----------------HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 211 (325)
T ss_pred -----------------CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC
Confidence 011223557999999999999999999999999999999999999999999999999999887
Q ss_pred CCCCCCC
Q 002342 914 DLKFPSS 920 (934)
Q Consensus 914 ~~~~p~~ 920 (934)
...++..
T Consensus 212 ~~~~~~~ 218 (325)
T cd05602 212 PLQLKPN 218 (325)
T ss_pred CcCCCCC
Confidence 7766543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=333.21 Aligned_cols=235 Identities=35% Similarity=0.614 Sum_probs=195.6
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||+|+||.||++.++.+++.||+|++.+...........+.+|+.++..++|++|+.+++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999987643333444556788999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~---- 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED---- 155 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC----
Confidence 9999999999997642 35899999999999999999999999999999999999999999999999998532110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
........+||+.|||||++. ...++.++|||||||+||+|++|++||.+.+.
T Consensus 156 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 156 ----------------------GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred ----------------------CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 001122357999999999996 34678899999999999999999999999999
Q ss_pred HHHHHHHHcCCC--CCCCCC-CCCcccCCC
Q 002342 904 QKTFANILHKDL--KFPSST-PSSCKAANV 930 (934)
Q Consensus 904 ~~~~~~i~~~~~--~~p~~~-~~s~~~k~l 930 (934)
.+.+.++..... .+|... ..+..+++|
T Consensus 214 ~~~~~~i~~~~~~~~~p~~~~~~s~~~~~l 243 (332)
T cd05623 214 VETYGKIMNHKERFQFPAQVTDVSEDAKDL 243 (332)
T ss_pred HHHHHHHhCCCccccCCCccccCCHHHHHH
Confidence 999999887653 444432 234444443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=330.26 Aligned_cols=219 Identities=46% Similarity=0.796 Sum_probs=188.8
Q ss_pred ccccccCCcEEEEEEEEe---cCCeEEEEEEeeccccc-ChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 674 IKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~---~~~~~vAlK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
++.||+|+||.||+|++. .+++.||+|++.+.... .......+.+|+.+|+.++||||++++++|..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999874 47889999999764321 22334567789999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~------ 152 (323)
T cd05584 81 YLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH------ 152 (323)
T ss_pred CCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc------
Confidence 99999999998764 4589999999999999999999999999999999999999999999999999843210
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~ 909 (934)
........+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....+..
T Consensus 153 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~ 211 (323)
T cd05584 153 ---------------------EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211 (323)
T ss_pred ---------------------CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 01112345799999999999998899999999999999999999999999999999999
Q ss_pred HHcCCCCCCCCC
Q 002342 910 ILHKDLKFPSST 921 (934)
Q Consensus 910 i~~~~~~~p~~~ 921 (934)
+..+.+.+|...
T Consensus 212 ~~~~~~~~~~~~ 223 (323)
T cd05584 212 ILKGKLNLPPYL 223 (323)
T ss_pred HHcCCCCCCCCC
Confidence 999988887653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=330.18 Aligned_cols=230 Identities=26% Similarity=0.418 Sum_probs=197.8
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
..|+.+..||+|+||.||++.+..+++.||+|++.-.. .......+.+|+.+|.+++++||.++|+.|-.+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 46888899999999999999999999999999997543 4556778999999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
|||.||++.+.++.. ..+.+..+..++++++.||.|||..+.+|||||+.|||+..+|.+||+|||++..+.
T Consensus 91 ey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~------ 162 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT------ 162 (467)
T ss_pred HHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee------
Confidence 999999999999763 446899999999999999999999999999999999999999999999999985432
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
.......+++|||.|||||++....|+.++||||||++.+||++|.|||....++.++.
T Consensus 163 ---------------------~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf 221 (467)
T KOG0201|consen 163 ---------------------NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF 221 (467)
T ss_pred ---------------------chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE
Confidence 11223478999999999999999999999999999999999999999999988877766
Q ss_pred HHHcCCCCCCCCCCCCcccCCC
Q 002342 909 NILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 909 ~i~~~~~~~p~~~~~s~~~k~l 930 (934)
.|-+..++.-.. ..|...|+|
T Consensus 222 lIpk~~PP~L~~-~~S~~~kEF 242 (467)
T KOG0201|consen 222 LIPKSAPPRLDG-DFSPPFKEF 242 (467)
T ss_pred eccCCCCCcccc-ccCHHHHHH
Confidence 665433322222 345555554
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=330.08 Aligned_cols=217 Identities=38% Similarity=0.733 Sum_probs=186.1
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEEEEEEccCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 753 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~g 753 (934)
+.||+|+||.||++.+..+++.||+|++++...........+..|..++..+ +||||++++++|.+.+.+|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999999999999999999876554555566788899999998 799999999999999999999999999
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---------- 148 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR---------- 148 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc----------
Confidence 9999888664 4599999999999999999999999999999999999999999999999999843110
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC---------CHH
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK---------TRQ 904 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~---------~~~ 904 (934)
........+||+.|+|||++.+..++.++|+|||||++|+|++|+.||... ...
T Consensus 149 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~ 211 (329)
T cd05588 149 -----------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTED 211 (329)
T ss_pred -----------------CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchH
Confidence 011223467999999999999999999999999999999999999999631 222
Q ss_pred HHHHHHHcCCCCCCCC
Q 002342 905 KTFANILHKDLKFPSS 920 (934)
Q Consensus 905 ~~~~~i~~~~~~~p~~ 920 (934)
..++.+..+.+.+|..
T Consensus 212 ~~~~~~~~~~~~~p~~ 227 (329)
T cd05588 212 YLFQVILEKQIRIPRS 227 (329)
T ss_pred HHHHHHHcCCCCCCCC
Confidence 3566777787787764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=326.78 Aligned_cols=217 Identities=39% Similarity=0.764 Sum_probs=186.7
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEEEEEEccCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 753 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~g 753 (934)
+.||+|+||.||+|++..+++.||+|++.+..............|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999999875432333445667788888764 999999999999999999999999999
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~---------- 148 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML---------- 148 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC----------
Confidence 9999998764 4589999999999999999999999999999999999999999999999999843110
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~ 913 (934)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++++.+..+
T Consensus 149 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~ 211 (316)
T cd05619 149 -----------------GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD 211 (316)
T ss_pred -----------------CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 001123457999999999999999999999999999999999999999999988888888877
Q ss_pred CCCCCCC
Q 002342 914 DLKFPSS 920 (934)
Q Consensus 914 ~~~~p~~ 920 (934)
...+|.+
T Consensus 212 ~~~~~~~ 218 (316)
T cd05619 212 NPCYPRW 218 (316)
T ss_pred CCCCCcc
Confidence 7767654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=307.71 Aligned_cols=231 Identities=37% Similarity=0.706 Sum_probs=207.7
Q ss_pred cccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEe
Q 002342 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT 740 (934)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~ 740 (934)
..+.+.+++|.++++||+|+|.+|.+++++++.+.||+|+++|....+...+.-...|..+..+. +||++|-++.+|++
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 34557789999999999999999999999999999999999998888888888888898888876 79999999999999
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
+..+++|.||++||+|.-+++++ +.++++.++++..+|+.||.|||++|||.||||.+|||++..|++||+|+|+|+.
T Consensus 323 esrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred cceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999999999998886 4599999999999999999999999999999999999999999999999999954
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
. ..+...++++||||.|+|||++.+..|.+.+|+|+||++++||+.|+.||.-
T Consensus 401 ~---------------------------l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 401 G---------------------------LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred C---------------------------CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 2 2234567789999999999999999999999999999999999999999962
Q ss_pred -------C-CHHHHHHHHHcCCCCCCCCC
Q 002342 901 -------K-TRQKTFANILHKDLKFPSST 921 (934)
Q Consensus 901 -------~-~~~~~~~~i~~~~~~~p~~~ 921 (934)
. +..=.++-|+++++.+|...
T Consensus 454 vgm~n~d~ntedylfqvilekqiriprsl 482 (593)
T KOG0695|consen 454 VGMDNPDMNTEDYLFQVILEKQIRIPRSL 482 (593)
T ss_pred ecCCCcccchhHHHHHHHhhhccccccee
Confidence 2 22335777889999999865
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=326.65 Aligned_cols=217 Identities=41% Similarity=0.771 Sum_probs=190.8
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEEEEEEccCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 753 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~g 753 (934)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999999876544455566778899999888 799999999999999999999999999
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~---------- 148 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL---------- 148 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc----------
Confidence 9999988764 3599999999999999999999999999999999999999999999999999843110
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~ 913 (934)
........+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+....+..+..+
T Consensus 149 -----------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~ 211 (318)
T cd05570 149 -----------------GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED 211 (318)
T ss_pred -----------------CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 011123457999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCCCC
Q 002342 914 DLKFPSS 920 (934)
Q Consensus 914 ~~~~p~~ 920 (934)
...+|..
T Consensus 212 ~~~~~~~ 218 (318)
T cd05570 212 EVRYPRW 218 (318)
T ss_pred CCCCCCc
Confidence 8887764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=327.50 Aligned_cols=216 Identities=44% Similarity=0.762 Sum_probs=186.0
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHH-HHHhCCCCCccceeEEEEeCCeEEEEEEccCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTKTHVCLITDYCPG 753 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 753 (934)
+.||+|+||+||++.+..+++.||+|++.+...........+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999999999999999998654333344455556655 46779999999999999999999999999999
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~---------- 148 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA---------- 148 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC----------
Confidence 9999888654 4599999999999999999999999999999999999999999999999999843210
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~ 913 (934)
........+||+.|||||++.+..++.++|||||||++|+|++|.+||.+.+..++++.+..+
T Consensus 149 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~ 211 (325)
T cd05604 149 -----------------QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211 (325)
T ss_pred -----------------CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 011123457999999999999999999999999999999999999999999999999999888
Q ss_pred CCCCCC
Q 002342 914 DLKFPS 919 (934)
Q Consensus 914 ~~~~p~ 919 (934)
...++.
T Consensus 212 ~~~~~~ 217 (325)
T cd05604 212 PLVLRP 217 (325)
T ss_pred CccCCC
Confidence 776654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=327.87 Aligned_cols=217 Identities=39% Similarity=0.735 Sum_probs=185.5
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEEEEEEccCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 753 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~g 753 (934)
+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999999876554555666788899998877 899999999999999999999999999
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~---------- 148 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR---------- 148 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC----------
Confidence 9999888664 4599999999999999999999999999999999999999999999999999843210
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC---------CCHH
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG---------KTRQ 904 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~---------~~~~ 904 (934)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.. ....
T Consensus 149 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~ 211 (329)
T cd05618 149 -----------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 211 (329)
T ss_pred -----------------CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHH
Confidence 01122346799999999999999999999999999999999999999952 2223
Q ss_pred HHHHHHHcCCCCCCCC
Q 002342 905 KTFANILHKDLKFPSS 920 (934)
Q Consensus 905 ~~~~~i~~~~~~~p~~ 920 (934)
.+.+.+..+...+|..
T Consensus 212 ~~~~~i~~~~~~~p~~ 227 (329)
T cd05618 212 YLFQVILEKQIRIPRS 227 (329)
T ss_pred HHHHHHhcCCCCCCCC
Confidence 4566777777777764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.19 Aligned_cols=216 Identities=27% Similarity=0.428 Sum_probs=189.0
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe-----CC
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-----KT 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~ 742 (934)
...|..++.||.|+||.|+.+.++.+|..||||.+.. .+...-..++..+|+++|+.++|+||+.+++++.. -+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3567778999999999999999999999999998764 24566677889999999999999999999999975 35
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
.+|+|+|+| +.+|...++.+ +.+++..++.++.||+.||.|+|+.||+||||||+|+|++.+..+||||||+|+...
T Consensus 100 DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 789999999 89999999875 449999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
.. ......+..+.|.+|.|||++. ...|+.++||||+||++.||++|++.|.|.
T Consensus 177 ~~-------------------------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~ 231 (359)
T KOG0660|consen 177 KF-------------------------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK 231 (359)
T ss_pred cc-------------------------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC
Confidence 21 0011224457899999999985 468899999999999999999999999999
Q ss_pred CHHHHHHHHHc
Q 002342 902 TRQKTFANILH 912 (934)
Q Consensus 902 ~~~~~~~~i~~ 912 (934)
+..++++.|..
T Consensus 232 d~v~Ql~lI~~ 242 (359)
T KOG0660|consen 232 DYVHQLQLILE 242 (359)
T ss_pred chHHHHHHHHH
Confidence 99999988875
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=325.69 Aligned_cols=217 Identities=39% Similarity=0.723 Sum_probs=185.7
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEEEEEEccCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 753 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~g 753 (934)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+.+++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876544555667788999999888 699999999999999999999999999
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
++|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~---------- 148 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG---------- 148 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC----------
Confidence 9999988664 4599999999999999999999999999999999999999999999999999843110
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC-------CCHHHH
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG-------KTRQKT 906 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~-------~~~~~~ 906 (934)
........+||+.|+|||++.+..++.++|||||||+||+|++|.+||.. ......
T Consensus 149 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~ 211 (327)
T cd05617 149 -----------------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL 211 (327)
T ss_pred -----------------CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH
Confidence 01122346799999999999999999999999999999999999999963 222345
Q ss_pred HHHHHcCCCCCCCC
Q 002342 907 FANILHKDLKFPSS 920 (934)
Q Consensus 907 ~~~i~~~~~~~p~~ 920 (934)
++.+..+...+|..
T Consensus 212 ~~~~~~~~~~~p~~ 225 (327)
T cd05617 212 FQVILEKPIRIPRF 225 (327)
T ss_pred HHHHHhCCCCCCCC
Confidence 66677777777764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=328.23 Aligned_cols=215 Identities=41% Similarity=0.739 Sum_probs=185.2
Q ss_pred cccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC---CCCCccceeEEEEeCCeEEEEEEccCC
Q 002342 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQTKTHVCLITDYCPG 753 (934)
Q Consensus 677 LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~~~~~~lV~E~~~g 753 (934)
||+|+||+||++++..+++.||+|++.+..............|..++..+ +||||+.++++|...+.+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765433334445556677777665 699999999999999999999999999
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~---------- 148 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT---------- 148 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC----------
Confidence 9999988764 4599999999999999999999999999999999999999999999999999853211
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 912 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~ 912 (934)
........+||+.|||||++.+. .++.++|||||||++|+|++|+.||.+.+..+.++.+..
T Consensus 149 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~ 211 (330)
T cd05586 149 -----------------DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211 (330)
T ss_pred -----------------CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc
Confidence 01122356799999999999764 478899999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 002342 913 KDLKFPSS 920 (934)
Q Consensus 913 ~~~~~p~~ 920 (934)
+...+|..
T Consensus 212 ~~~~~~~~ 219 (330)
T cd05586 212 GKVRFPKN 219 (330)
T ss_pred CCCCCCCc
Confidence 88888764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=328.11 Aligned_cols=231 Identities=30% Similarity=0.530 Sum_probs=207.9
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
.......|.+.+.||+|.|++|.++++.-++..||||++.|..... .....+.+|+++|+.|+|||||+++.+...+..
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 3455678999999999999999999999999999999999875544 444458999999999999999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|+||||+.+|.+++++.+.+ .+.+..++.++.|++.|++|||+++|||||||.+||||+.+.++||+|||++..+.
T Consensus 130 lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred eEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec-
Confidence 999999999999999998763 37779999999999999999999999999999999999999999999999995432
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
......++||++.|.|||++.+..| .+.+|+||||++||.|+.|..||.|.+
T Consensus 207 ---------------------------~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 207 ---------------------------YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred ---------------------------ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 3345668899999999999999877 469999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCc
Q 002342 903 RQKTFANILHKDLKFPSSTPSSC 925 (934)
Q Consensus 903 ~~~~~~~i~~~~~~~p~~~~~s~ 925 (934)
..+.-.+.+.|++.+|.++..+|
T Consensus 260 lk~Lr~rvl~gk~rIp~~ms~dc 282 (596)
T KOG0586|consen 260 LKELRPRVLRGKYRIPFYMSCDC 282 (596)
T ss_pred cccccchheeeeecccceeechh
Confidence 99999999999999999874444
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=315.23 Aligned_cols=214 Identities=25% Similarity=0.410 Sum_probs=182.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++.+.||.|+||.||++.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++..++..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 568999999999999999999999999999999987532 122234567899999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||++ ++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--- 156 (288)
T cd07871 82 FEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--- 156 (288)
T ss_pred EeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC---
Confidence 99995 5899888654 345899999999999999999999999999999999999999999999999998542110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
........|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.
T Consensus 157 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~ 212 (288)
T cd07871 157 ------------------------TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE 212 (288)
T ss_pred ------------------------CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 011123468999999999876 5688999999999999999999999999888877
Q ss_pred HHHHHc
Q 002342 907 FANILH 912 (934)
Q Consensus 907 ~~~i~~ 912 (934)
+..+..
T Consensus 213 ~~~~~~ 218 (288)
T cd07871 213 LHLIFR 218 (288)
T ss_pred HHHHHH
Confidence 766654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=313.82 Aligned_cols=208 Identities=35% Similarity=0.618 Sum_probs=181.1
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
.|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++++..++++|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999999999999999876544333444556789999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG----- 155 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-----
Confidence 999999998886654456999999999999999999999999999999999999999999999999998542110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
......+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.....
T Consensus 156 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~ 208 (285)
T cd05605 156 -----------------------ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV 208 (285)
T ss_pred -----------------------CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh
Confidence 01123478999999999999999999999999999999999999999876643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.02 Aligned_cols=207 Identities=25% Similarity=0.462 Sum_probs=176.9
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC--C---eE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--T---HV 744 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~---~~ 744 (934)
.|.-.+.+|+|+||.||++....++..+|||..-.+. +.-.+|+.||+.++|||||+|..+|... + +.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 5888899999999999999999999999999765431 2344699999999999999999888632 2 55
Q ss_pred EEEEEccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-CcEEEEecccCccc
Q 002342 745 CLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLT 821 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-~~vkl~DFG~a~~~ 821 (934)
.+||||| .-+|+++++.. ....++.-.++.++.||++||.|||+.||+||||||.|||++.+ |.+||||||+|+..
T Consensus 98 nlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 6899999 67899888731 23558999999999999999999999999999999999999976 99999999999765
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
... ....+...|..|.|||.+.+ ..|+.+.||||.||++.||+.|++.|.|
T Consensus 177 ~~~----------------------------epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG 228 (364)
T KOG0658|consen 177 VKG----------------------------EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG 228 (364)
T ss_pred ccC----------------------------CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence 321 12245578999999999987 4789999999999999999999999999
Q ss_pred CCHHHHHHHHHc
Q 002342 901 KTRQKTFANILH 912 (934)
Q Consensus 901 ~~~~~~~~~i~~ 912 (934)
++..+++..|.+
T Consensus 229 ~s~~dQL~eIik 240 (364)
T KOG0658|consen 229 DSSVDQLVEIIK 240 (364)
T ss_pred CCHHHHHHHHHH
Confidence 999998887765
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=313.63 Aligned_cols=215 Identities=25% Similarity=0.380 Sum_probs=182.3
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||+|+||.||++++..+++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999876422 2334566788999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||++++.|..+... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 154 (287)
T cd07848 80 EYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS--- 154 (287)
T ss_pred ecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc---
Confidence 99988766555432 2459999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
........||+.|+|||++.+..++.++|+|||||++|+|++|++||.+.+..+...
T Consensus 155 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~ 211 (287)
T cd07848 155 -----------------------NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211 (287)
T ss_pred -----------------------cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011223568999999999999899999999999999999999999999887766655
Q ss_pred HHHc
Q 002342 909 NILH 912 (934)
Q Consensus 909 ~i~~ 912 (934)
.+..
T Consensus 212 ~~~~ 215 (287)
T cd07848 212 TIQK 215 (287)
T ss_pred HHHH
Confidence 5443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=324.54 Aligned_cols=217 Identities=44% Similarity=0.785 Sum_probs=188.2
Q ss_pred ccccccCCcEEEEEEEEe---cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEc
Q 002342 674 IKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (934)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~---~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 750 (934)
++.||+|+||.||++++. .+++.||+|++.+... .......+.+|+.+|++++||||+++++++...+.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 367999999999999873 5789999999986432 222334567899999999999999999999999999999999
Q ss_pred cCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCC
Q 002342 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (934)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 830 (934)
+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~------ 151 (318)
T cd05582 80 LRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH------ 151 (318)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC------
Confidence 9999999998664 45999999999999999999999999999999999999999999999999998542110
Q ss_pred cchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 002342 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910 (934)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i 910 (934)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 152 ---------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i 210 (318)
T cd05582 152 ---------------------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210 (318)
T ss_pred ---------------------CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH
Confidence 01223457999999999999988999999999999999999999999999999999999
Q ss_pred HcCCCCCCCC
Q 002342 911 LHKDLKFPSS 920 (934)
Q Consensus 911 ~~~~~~~p~~ 920 (934)
..+.+.+|..
T Consensus 211 ~~~~~~~p~~ 220 (318)
T cd05582 211 LKAKLGMPQF 220 (318)
T ss_pred HcCCCCCCCC
Confidence 9888888764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=322.87 Aligned_cols=223 Identities=44% Similarity=0.761 Sum_probs=184.4
Q ss_pred CcccccccccCCcEEEEEEEEe---cCCeEEEEEEeeccccc-ChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 744 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAlK~~~~~~~~-~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 744 (934)
+|++++.||+|+||.||+|++. .+++.||+|++.+.... .......+..|+.+++.+ +||||+.+++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4899999999999999999874 47899999999764322 223445677899999999 599999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999998764 45999999999999999999999999999999999999999999999999998542110
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCC--
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGK-- 901 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~-- 901 (934)
........+||+.|||||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 159 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 212 (332)
T cd05614 159 --------------------------EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE 212 (332)
T ss_pred --------------------------CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCC
Confidence 01112345799999999999875 4788999999999999999999999743
Q ss_pred --CHHHHHHHHHcCCCCCCCC
Q 002342 902 --TRQKTFANILHKDLKFPSS 920 (934)
Q Consensus 902 --~~~~~~~~i~~~~~~~p~~ 920 (934)
....+...+......+|..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd05614 213 RNTQSEVSRRILKCDPPFPSF 233 (332)
T ss_pred CCCHHHHHHHHhcCCCCCCCC
Confidence 3345556666666666543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=324.31 Aligned_cols=223 Identities=25% Similarity=0.353 Sum_probs=179.3
Q ss_pred ccccCCcccccccccCCcEEEEEEEEe-----cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASF 738 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~ 738 (934)
.+..++|++.+.||.|+||.||+|.+. .++..||+|.+.... .......+.+|+.+|..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 455678999999999999999999853 345789999987532 233456788999999999 899999999988
Q ss_pred EeC-CeEEEEEEccCCCCchhhhccCC-----------------------------------------------------
Q 002342 739 QTK-THVCLITDYCPGGELFLLLDRQP----------------------------------------------------- 764 (934)
Q Consensus 739 ~~~-~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------- 764 (934)
... ..+|+||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 754 46899999999999999886531
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhc
Q 002342 765 -------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837 (934)
Q Consensus 765 -------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~ 837 (934)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~----------- 229 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----------- 229 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc-----------
Confidence 12477888999999999999999999999999999999999999999999999854321100
Q ss_pred cccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHcCC
Q 002342 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK-TFANILHKD 914 (934)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~-~~~~i~~~~ 914 (934)
........+++.|||||++.+..++.++|||||||+||+|++ |.+||.+....+ ....+..+.
T Consensus 230 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 294 (338)
T cd05102 230 --------------YVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT 294 (338)
T ss_pred --------------hhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC
Confidence 011123356789999999999999999999999999999996 999998866544 344444443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=335.75 Aligned_cols=221 Identities=24% Similarity=0.389 Sum_probs=190.7
Q ss_pred cCCcccccccccCCcEEEEEEEEecC-CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGS-GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~-~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+... .......+.+|+.+|+.++||||++++++|..++++||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34599999999999999999999887 788999976532 33445567789999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 747 ITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
||||++||+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999999887532 2345899999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
. ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 223 ~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~ 277 (478)
T PTZ00267 223 V-------------------------SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR 277 (478)
T ss_pred c-------------------------ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0 011234567999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCC
Q 002342 905 KTFANILHKDLK 916 (934)
Q Consensus 905 ~~~~~i~~~~~~ 916 (934)
+++..+..+...
T Consensus 278 ~~~~~~~~~~~~ 289 (478)
T PTZ00267 278 EIMQQVLYGKYD 289 (478)
T ss_pred HHHHHHHhCCCC
Confidence 999998887653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=324.53 Aligned_cols=224 Identities=23% Similarity=0.327 Sum_probs=193.3
Q ss_pred cccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
..|.+..+...+...||+|.||+||++++-++ ||||+++... ..++..+.|++|+.+|++.+|.||+-|.+++...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~-pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDD-PTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCC-CCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34566677888999999999999999999664 9999998753 4667899999999999999999999999999988
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
.. .||+.+|+|.+|+.+++... ..|.....+.|++||++||.|||.++|||||||..||++.++++|||+|||++...
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 77 99999999999999998765 45999999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC---CCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
.. + ..........|+..|||||++.. .+|++.+|||||||++|||++|..||
T Consensus 539 ~~-------------w------------~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPy 593 (678)
T KOG0193|consen 539 TR-------------W------------SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPY 593 (678)
T ss_pred ee-------------e------------ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence 11 0 11122234468999999999954 57899999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCC
Q 002342 899 RGKTRQKTFANILHKDLK 916 (934)
Q Consensus 899 ~~~~~~~~~~~i~~~~~~ 916 (934)
...+..+++.++=+|.+.
T Consensus 594 si~~~dqIifmVGrG~l~ 611 (678)
T KOG0193|consen 594 SIQNRDQIIFMVGRGYLM 611 (678)
T ss_pred CCCChhheEEEecccccC
Confidence 988888888888777553
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=320.47 Aligned_cols=229 Identities=29% Similarity=0.482 Sum_probs=198.3
Q ss_pred cccc--cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 671 FRPI--KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 671 y~i~--~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
|++. +.||+|.||+||-+.++++|+.||||++.|-.+..++. ..+.+|+.||+++.||.||.|...|++.+.++.||
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 4443 68999999999999999999999999999876655544 78899999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC---CcEEEEecccCcccCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~---~~vkl~DFG~a~~~~~~~ 825 (934)
|-+ .|+..+++.....+.+++...++++.||+.||.|||.+||+|+||||+|||+.+. -.+||||||+|++.+.+.
T Consensus 643 EKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 643 EKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 999 5666666666556779999999999999999999999999999999999999754 379999999998765322
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
. ..+.+|||.|+|||++..++|+..-|+||.|+++|--+.|..||. ..++
T Consensus 722 F----------------------------RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEd 771 (888)
T KOG4236|consen 722 F----------------------------RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDED 771 (888)
T ss_pred h----------------------------hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC--Cccc
Confidence 1 235689999999999999999999999999999999999999995 5567
Q ss_pred HHHHHHcCCCCCCCC--CCCCcccCCCC
Q 002342 906 TFANILHKDLKFPSS--TPSSCKAANVP 931 (934)
Q Consensus 906 ~~~~i~~~~~~~p~~--~~~s~~~k~l~ 931 (934)
+-.+|.+..|.||.. ..+|..+-||+
T Consensus 772 IndQIQNAaFMyPp~PW~eis~~AidlI 799 (888)
T KOG4236|consen 772 INDQIQNAAFMYPPNPWSEISPEAIDLI 799 (888)
T ss_pred hhHHhhccccccCCCchhhcCHHHHHHH
Confidence 788889999999964 56777766653
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=314.27 Aligned_cols=212 Identities=25% Similarity=0.437 Sum_probs=177.1
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++.+.||+|+||.||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 3689999999999999999999999999999999875421 22234567899999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 156 (303)
T cd07869 82 FEYV-HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--- 156 (303)
T ss_pred EECC-CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC---
Confidence 9999 578888776542 45899999999999999999999999999999999999999999999999998532110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-HH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR-QK 905 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~-~~ 905 (934)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+... .+
T Consensus 157 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 212 (303)
T cd07869 157 ------------------------SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD 212 (303)
T ss_pred ------------------------CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH
Confidence 011123468999999999875 4578899999999999999999999987544 34
Q ss_pred HHHHH
Q 002342 906 TFANI 910 (934)
Q Consensus 906 ~~~~i 910 (934)
.+..+
T Consensus 213 ~~~~~ 217 (303)
T cd07869 213 QLERI 217 (303)
T ss_pred HHHHH
Confidence 44443
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.56 Aligned_cols=216 Identities=33% Similarity=0.598 Sum_probs=179.9
Q ss_pred cccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCCCc
Q 002342 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 756 (934)
Q Consensus 677 LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL 756 (934)
||+|+||+||++.+..+++.||+|.+.+...........+..|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999998765443444456677899999999999999999999999999999999999999
Q ss_pred hhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchh
Q 002342 757 FLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834 (934)
Q Consensus 757 ~~~l~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 834 (934)
..++.. .....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~---------- 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG---------- 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC----------
Confidence 887743 22346999999999999999999999999999999999999999999999999998543210
Q ss_pred hhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Q 002342 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR----QKTFANI 910 (934)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~----~~~~~~i 910 (934)
........||+.|+|||++.+..++.++|+|||||++|+|++|+.||..... ......+
T Consensus 151 -----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 213 (280)
T cd05608 151 -----------------QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI 213 (280)
T ss_pred -----------------CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh
Confidence 0112245799999999999999999999999999999999999999986543 2344445
Q ss_pred HcCCCCCCC
Q 002342 911 LHKDLKFPS 919 (934)
Q Consensus 911 ~~~~~~~p~ 919 (934)
..+...+|.
T Consensus 214 ~~~~~~~~~ 222 (280)
T cd05608 214 LNDSVTYPD 222 (280)
T ss_pred cccCCCCcc
Confidence 555444443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=309.83 Aligned_cols=214 Identities=33% Similarity=0.591 Sum_probs=179.7
Q ss_pred cccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCCCc
Q 002342 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 756 (934)
Q Consensus 677 LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL 756 (934)
||+|+||.||++.++.+|+.||+|.+.+...........+..|+++++.++||||+++++++..+.+.|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999998764433333344556799999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhh
Q 002342 757 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836 (934)
Q Consensus 757 ~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~ 836 (934)
.+++.......+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~------------ 148 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG------------ 148 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC------------
Confidence 98886655556899999999999999999999999999999999999999999999999998543210
Q ss_pred ccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHc
Q 002342 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR----QKTFANILH 912 (934)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~----~~~~~~i~~ 912 (934)
.......|++.|+|||++.+..++.++|+|||||++|+|++|+.||.+... .++...+..
T Consensus 149 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 212 (277)
T cd05607 149 ----------------KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212 (277)
T ss_pred ----------------ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc
Confidence 011234689999999999998899999999999999999999999976432 345555555
Q ss_pred CCCCCC
Q 002342 913 KDLKFP 918 (934)
Q Consensus 913 ~~~~~p 918 (934)
+...++
T Consensus 213 ~~~~~~ 218 (277)
T cd05607 213 DEVKFE 218 (277)
T ss_pred cccccc
Confidence 555444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=312.57 Aligned_cols=261 Identities=59% Similarity=1.016 Sum_probs=207.7
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||.|+||.||+|.+..+++.||+|.+.+...........+..|+++++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998765444456677889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+.+++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999987655679999999999999999999999999999999999999999999999999986543221110
Q ss_pred CCcchhhhccc--cCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 829 LPTTNEKKRRH--KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 829 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
........... ....................||..|+|||++.+..++.++||||||+++|+|++|+.||.+.+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 00000000000 0000011111222334466899999999999999999999999999999999999999999998888
Q ss_pred HHHHHcCCCCCCCCCCCCcccCC
Q 002342 907 FANILHKDLKFPSSTPSSCKAAN 929 (934)
Q Consensus 907 ~~~i~~~~~~~p~~~~~s~~~k~ 929 (934)
+..+......+|.....+..+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~ 263 (316)
T cd05574 241 FSNILKKEVTFPGSPPVSSSARD 263 (316)
T ss_pred HHHHhcCCccCCCccccCHHHHH
Confidence 88888877777765444444443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=312.81 Aligned_cols=210 Identities=27% Similarity=0.456 Sum_probs=184.4
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+..++|++++.||+|+||.||++.+..++..||+|.+.... .......+.+|+++|+.++||||+++++++..++..+
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 44679999999999999999999999999999999987542 3344567889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 156 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 156 (331)
T ss_pred EEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc-
Confidence 999999999999999764 3489999999999999999999986 699999999999999999999999999853211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 157 ----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 208 (331)
T cd06649 157 ----------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208 (331)
T ss_pred ----------------------------cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0122457999999999999999999999999999999999999999877766
Q ss_pred HHHH
Q 002342 905 KTFA 908 (934)
Q Consensus 905 ~~~~ 908 (934)
++..
T Consensus 209 ~~~~ 212 (331)
T cd06649 209 ELEA 212 (331)
T ss_pred HHHH
Confidence 5443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=301.00 Aligned_cols=228 Identities=25% Similarity=0.398 Sum_probs=196.6
Q ss_pred cCCcccc-cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEe----C
Q 002342 668 LQHFRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT----K 741 (934)
Q Consensus 668 ~~~y~i~-~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~----~ 741 (934)
.++|.+. ++||-|-.|+|..+.++.++..||+|++... ....+|+++.=+. .|||||.++++|.+ .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 4677776 5689999999999999999999999987532 4566788875554 79999999999864 4
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC---CcEEEEecccC
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLS 818 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~---~~vkl~DFG~a 818 (934)
.++.+|||.|+||.|+..++.++...|++.++..|++||+.|+.|||+.+|.||||||+|+|++.. -.+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 678899999999999999999988899999999999999999999999999999999999999754 36899999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
+.... .....+.|-||.|.|||++-..+|+..+|+|||||++|-|+.|.|||
T Consensus 212 K~t~~----------------------------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPF 263 (400)
T KOG0604|consen 212 KETQE----------------------------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263 (400)
T ss_pred cccCC----------------------------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcc
Confidence 64211 12334568899999999999999999999999999999999999999
Q ss_pred CCCCH----HHHHHHHHcCCCCCCC--CCCCCcccCCCC
Q 002342 899 RGKTR----QKTFANILHKDLKFPS--STPSSCKAANVP 931 (934)
Q Consensus 899 ~~~~~----~~~~~~i~~~~~~~p~--~~~~s~~~k~l~ 931 (934)
..... ..+-.+|..|.+.||. |...|.++|||+
T Consensus 264 YS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlI 302 (400)
T KOG0604|consen 264 YSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLI 302 (400)
T ss_pred cccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHH
Confidence 87554 5678899999999986 678888888875
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=332.62 Aligned_cols=224 Identities=29% Similarity=0.423 Sum_probs=191.9
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC---
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT--- 742 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--- 742 (934)
...++|.+.+.||+|+||+||++++..+++.||||++..... .......+.+|+.++..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345799999999999999999999999999999999876533 3445567889999999999999999988875432
Q ss_pred -----eEEEEEEccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEec
Q 002342 743 -----HVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815 (934)
Q Consensus 743 -----~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DF 815 (934)
.+++||||+++|+|.+++... ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 368999999999999998643 2346999999999999999999999999999999999999999999999999
Q ss_pred ccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCC
Q 002342 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 895 (934)
Q Consensus 816 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~ 895 (934)
|+++...... ........+||+.|+|||++.+..++.++|||||||+||+|++|+
T Consensus 188 Gls~~~~~~~-------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~ 242 (496)
T PTZ00283 188 GFSKMYAATV-------------------------SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242 (496)
T ss_pred ccCeeccccc-------------------------cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 9986432110 011223568999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCC
Q 002342 896 TPFRGKTRQKTFANILHKDL 915 (934)
Q Consensus 896 ~Pf~~~~~~~~~~~i~~~~~ 915 (934)
.||.+.+..+++..+..+.+
T Consensus 243 ~Pf~~~~~~~~~~~~~~~~~ 262 (496)
T PTZ00283 243 RPFDGENMEEVMHKTLAGRY 262 (496)
T ss_pred CCCCCCCHHHHHHHHhcCCC
Confidence 99999999889888887765
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=337.33 Aligned_cols=242 Identities=28% Similarity=0.406 Sum_probs=198.3
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEE-Ee--
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASF-QT-- 740 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~-~~-- 740 (934)
.+...+++|.+.|.+|||+.||+|.+...+..||||.+-.. +...++.+.+|+.+|+.|. |+|||.|++.. ..
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 34566789999999999999999999888899999988643 7788899999999999995 99999999942 21
Q ss_pred ----CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEecCCcEEEEe
Q 002342 741 ----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTD 814 (934)
Q Consensus 741 ----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~~~~vkl~D 814 (934)
.-.++|+||||.||+|.+++..+....|++.++..|+.|+|+||.+||..+ |||||||-+||||+.+|+.||||
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence 135789999999999999998665556999999999999999999999997 99999999999999999999999
Q ss_pred cccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhh---cCCCCCchhHHHHHHHHHHHH
Q 002342 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII---AGAGHTSAVDWWALGILLYEM 891 (934)
Q Consensus 815 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l---~~~~~s~~~DiwSlG~iL~el 891 (934)
||.+........ ...+. .. ....-...-|+.|+|||++ .+...+.|+|||+|||+||-|
T Consensus 190 FGSatt~~~~~~----~~~e~----------~~----ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkL 251 (738)
T KOG1989|consen 190 FGSATTKILSPT----SAQEV----------NY----VEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKL 251 (738)
T ss_pred ccccccccCCCc----cHHHH----------HH----HHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHH
Confidence 999854321111 00000 00 0001122468999999998 567789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccCCCC
Q 002342 892 LYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANVP 931 (934)
Q Consensus 892 ltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~k~l~ 931 (934)
++...||.+.... .|+++.|.||..++.|...++|+
T Consensus 252 Cy~t~PFe~sg~l----aIlng~Y~~P~~p~ys~~l~~LI 287 (738)
T KOG1989|consen 252 CYFTTPFEESGKL----AILNGNYSFPPFPNYSDRLKDLI 287 (738)
T ss_pred HHhCCCcCcCcce----eEEeccccCCCCccHHHHHHHHH
Confidence 9999999765333 57899999999988888888875
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=321.66 Aligned_cols=197 Identities=26% Similarity=0.386 Sum_probs=172.5
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+...+|++++.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+|+.++||||++++++|......|
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 445789999999999999999999999999999996432 34678999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
+|||++ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 160 lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~- 235 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI- 235 (391)
T ss_pred EEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-
Confidence 999999 67898888664 34899999999999999999999999999999999999999999999999998532110
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
........+||+.|+|||++.+..++.++|||||||+||+|++|..||..
T Consensus 236 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 236 -------------------------NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred -------------------------cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 00112345799999999999999999999999999999999999988764
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=308.66 Aligned_cols=214 Identities=26% Similarity=0.445 Sum_probs=179.7
Q ss_pred CCcccccccccCCcEEEEEEEEec-CCeEEEEEEeecccccChHHHHHHHHHHHHHHhC---CCCCccceeEEEE-----
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCG-SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQ----- 739 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~-~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~----- 739 (934)
++|++++.||+|+||.||+|.+.. +++.||+|.+...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 4789999998754322 22233455677777765 6999999999885
Q ss_pred eCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 740 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
....+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 345789999999 5689999876655668999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|++||.
T Consensus 159 ~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 159 IYSFQ----------------------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred eccCC----------------------------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 43210 11234568999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHc
Q 002342 900 GKTRQKTFANILH 912 (934)
Q Consensus 900 ~~~~~~~~~~i~~ 912 (934)
+.+..+.+..|.+
T Consensus 211 ~~~~~~~~~~i~~ 223 (290)
T cd07862 211 GSSDVDQLGKILD 223 (290)
T ss_pred CCCHHHHHHHHHH
Confidence 9998888888865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=308.02 Aligned_cols=221 Identities=45% Similarity=0.819 Sum_probs=196.8
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||.|+||.||++.+..+++.||+|++.+...........+.+|+++++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997654444455677889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 999999999999765 45999999999999999999999999999999999999999999999999998543110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
....+|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.....+
T Consensus 155 --------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 208 (290)
T cd05580 155 --------------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE 208 (290)
T ss_pred --------------------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 223468999999999988888899999999999999999999999888888888
Q ss_pred HHHcCCCCCCCCC
Q 002342 909 NILHKDLKFPSST 921 (934)
Q Consensus 909 ~i~~~~~~~p~~~ 921 (934)
.+..+...+|...
T Consensus 209 ~~~~~~~~~~~~~ 221 (290)
T cd05580 209 KILEGKVRFPSFF 221 (290)
T ss_pred HHhcCCccCCccC
Confidence 8888888877653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=315.51 Aligned_cols=211 Identities=22% Similarity=0.395 Sum_probs=176.0
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC-----CeE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----THV 744 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~ 744 (934)
+|++.+.||+|+||.||++.+..++..||||.+.... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999987532 2233445678999999999999999999988543 358
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+||||| +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 80 YVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999999 67899888764 34999999999999999999999999999999999999999999999999998542111
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
.. ........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+
T Consensus 157 ~~------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 157 TP------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred cC------------------------ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 00 0011234579999999999976 678889999999999999999999998877
Q ss_pred HHHHHH
Q 002342 903 RQKTFA 908 (934)
Q Consensus 903 ~~~~~~ 908 (934)
....+.
T Consensus 213 ~~~~~~ 218 (338)
T cd07859 213 VVHQLD 218 (338)
T ss_pred hHHHHH
Confidence 655443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=307.04 Aligned_cols=221 Identities=18% Similarity=0.209 Sum_probs=185.5
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe----CCeEEEEEEc
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----KTHVCLITDY 750 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~~lV~E~ 750 (934)
..||+|+++.||++.+ +|+.||+|.+.+...........+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5689999999999988 789999999987544444446778899999999999999999999876 4578999999
Q ss_pred cCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|++|+|.+++... +.++......++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----- 176 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----- 176 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----
Confidence 9999999999764 4588999999999999999999985 9999999999999999999999999998543210
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+++
T Consensus 177 -------------------------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~ 231 (283)
T PHA02988 177 -------------------------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY 231 (283)
T ss_pred -------------------------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 113368899999999976 67899999999999999999999999999988888
Q ss_pred HHHHcCCCCCCCCCCCCcccCC
Q 002342 908 ANILHKDLKFPSSTPSSCKAAN 929 (934)
Q Consensus 908 ~~i~~~~~~~p~~~~~s~~~k~ 929 (934)
..+..+...++.....+..+++
T Consensus 232 ~~i~~~~~~~~~~~~~~~~l~~ 253 (283)
T PHA02988 232 DLIINKNNSLKLPLDCPLEIKC 253 (283)
T ss_pred HHHHhcCCCCCCCCcCcHHHHH
Confidence 8887665554433233444443
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=319.31 Aligned_cols=212 Identities=27% Similarity=0.418 Sum_probs=191.0
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
.|.-++.||.|+||-||.+++..+...||||.+.........++..+..|+..|+++.|||++.+.++|-.+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 47888999999999999999999999999999987666677888999999999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|| -|+-.+++... .+++.+-++..|+.+.+.||+|||+.+.||||||..|||++..|.|||+|||+|.++.
T Consensus 107 YC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------- 177 (948)
T KOG0577|consen 107 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------- 177 (948)
T ss_pred HH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-------
Confidence 99 77777877654 3569999999999999999999999999999999999999999999999999986543
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
..++|+|||.|||||++. .+.|+-++||||||++..||.-.+||+...+....
T Consensus 178 ------------------------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA 233 (948)
T KOG0577|consen 178 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 233 (948)
T ss_pred ------------------------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH
Confidence 346789999999999995 46889999999999999999999999998888877
Q ss_pred HHHHHcCC
Q 002342 907 FANILHKD 914 (934)
Q Consensus 907 ~~~i~~~~ 914 (934)
+.-|.+..
T Consensus 234 LYHIAQNe 241 (948)
T KOG0577|consen 234 LYHIAQNE 241 (948)
T ss_pred HHHHHhcC
Confidence 77775543
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=304.83 Aligned_cols=211 Identities=34% Similarity=0.602 Sum_probs=182.1
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
.|+..+.||.|+||+||++.+..+++.||+|.+.+...........+.+|+.+|+.++|+||+.+++++..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37788999999999999999999999999999876544334444567789999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+.+++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG----- 155 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-----
Confidence 999999998886654456999999999999999999999999999999999999999999999999988432110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
.......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+........
T Consensus 156 -----------------------~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~ 211 (285)
T cd05632 156 -----------------------ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE 211 (285)
T ss_pred -----------------------CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 01123468999999999999999999999999999999999999998876654333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=311.45 Aligned_cols=226 Identities=25% Similarity=0.442 Sum_probs=184.2
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCe
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 743 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 743 (934)
.++...|++++.||+||.+.||+|.. .+.+.||+|.+.. ...+.+.+..+.+|+..|.+| +|.+|++||+|-..+++
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~-~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVL-LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHH-hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 45678899999999999999999998 4445666665443 234677889999999999999 69999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+||||||- ..+|..+|++.. ..++.-.+++|+.||+.|+.++|+.||||.||||.|+|+. .|.+||+|||+|..+..
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred EEEEeecc-cccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 99999987 889999997753 3355459999999999999999999999999999999998 78999999999976654
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC-----------CCchhHHHHHHHHHHHHH
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-----------HTSAVDWWALGILLYEML 892 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-----------~s~~~DiwSlG~iL~ell 892 (934)
+...+ ...+-+||+.||+||++.... .+.++|||||||+||+|+
T Consensus 512 DTTsI-------------------------~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv 566 (677)
T KOG0596|consen 512 DTTSI-------------------------VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV 566 (677)
T ss_pred cccce-------------------------eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH
Confidence 43322 223558999999999995533 456899999999999999
Q ss_pred hCCCCCCCCC-HHHHHHHHHcCC--CCCCCC
Q 002342 893 YGYTPFRGKT-RQKTFANILHKD--LKFPSS 920 (934)
Q Consensus 893 tG~~Pf~~~~-~~~~~~~i~~~~--~~~p~~ 920 (934)
+|++||..-. ....+..|..-. +.||..
T Consensus 567 YgktPf~~~~n~~aKl~aI~~P~~~Iefp~~ 597 (677)
T KOG0596|consen 567 YGKTPFGQIINQIAKLHAITDPNHEIEFPDI 597 (677)
T ss_pred hcCCchHHHHHHHHHHHhhcCCCccccccCC
Confidence 9999996533 445566665543 466654
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=301.28 Aligned_cols=209 Identities=27% Similarity=0.465 Sum_probs=188.5
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
-|.++.+||+|+||.||++.++.+|+.+|||.+... ..+.++..|+.|++++++|+||++|++|.....+|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 488999999999999999999999999999987643 466789999999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
||..|++.+.+..+ .+.+++.++..+++.-+.||+|||...-||||||..|||++-+|.+||+|||.|..+.
T Consensus 109 YCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT------- 180 (502)
T KOG0574|consen 109 YCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT------- 180 (502)
T ss_pred hcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh-------
Confidence 99999999998765 4679999999999999999999999999999999999999999999999999985432
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~ 909 (934)
+.....++.+|||.|||||++..-+|+.++||||||++..||.-|+|||.+-.+...+-+
T Consensus 181 --------------------DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM 240 (502)
T KOG0574|consen 181 --------------------DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM 240 (502)
T ss_pred --------------------hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe
Confidence 233455788999999999999999999999999999999999999999988877766555
Q ss_pred HH
Q 002342 910 IL 911 (934)
Q Consensus 910 i~ 911 (934)
|-
T Consensus 241 IP 242 (502)
T KOG0574|consen 241 IP 242 (502)
T ss_pred cc
Confidence 53
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=302.65 Aligned_cols=220 Identities=19% Similarity=0.258 Sum_probs=185.6
Q ss_pred cccCCcccccccccCCcEEEEEEEEe---cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
++..+|++.+.||+|+||.||++.+. ..+..||+|.++... .......+.+|+.+++.++||||+++++++...+
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 34568999999999999999999875 456789999987542 2344567889999999999999999999999999
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
..|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999999987643 458999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~ 901 (934)
.. .........+++.|+|||.+.+..++.++|||||||++|++++ |.+||.+.
T Consensus 159 ~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 159 SE--------------------------AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred cc--------------------------chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 00 0001112345678999999999999999999999999999875 99999999
Q ss_pred CHHHHHHHHHcCC
Q 002342 902 TRQKTFANILHKD 914 (934)
Q Consensus 902 ~~~~~~~~i~~~~ 914 (934)
+..+.++.+.++.
T Consensus 213 ~~~~~~~~~~~~~ 225 (266)
T cd05064 213 SGQDVIKAVEDGF 225 (266)
T ss_pred CHHHHHHHHHCCC
Confidence 9888888886653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=309.58 Aligned_cols=209 Identities=27% Similarity=0.452 Sum_probs=182.8
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+..++|++.+.||.|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++||||++++++|...+++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 34679999999999999999999999999999999987542 3344567889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
+||||+.+++|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~- 156 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 156 (333)
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh-
Confidence 999999999999999764 3489999999999999999999985 799999999999999999999999999843211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
.......|++.|+|||++.+..++.++|+|||||++|+|++|+.||......
T Consensus 157 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 157 ----------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred ----------------------------hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 0112346899999999999999999999999999999999999999876665
Q ss_pred HHH
Q 002342 905 KTF 907 (934)
Q Consensus 905 ~~~ 907 (934)
+..
T Consensus 209 ~~~ 211 (333)
T cd06650 209 ELE 211 (333)
T ss_pred HHH
Confidence 443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=320.34 Aligned_cols=225 Identities=24% Similarity=0.374 Sum_probs=183.0
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCC-----eEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASF 738 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~-----~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~ 738 (934)
.+..++|++.+.||+|+||.||++.+...+ ..||+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 345668999999999999999999975443 579999987542 233456788999999999 899999999999
Q ss_pred EeCCeEEEEEEccCCCCchhhhccCC------------------------------------------------------
Q 002342 739 QTKTHVCLITDYCPGGELFLLLDRQP------------------------------------------------------ 764 (934)
Q Consensus 739 ~~~~~~~lV~E~~~ggsL~~~l~~~~------------------------------------------------------ 764 (934)
...+.+|+|||||++|+|.+++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999999999999885421
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCC
Q 002342 765 --------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (934)
Q Consensus 765 --------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 830 (934)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~----- 266 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS----- 266 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc-----
Confidence 1247888999999999999999999999999999999999999999999999985432100
Q ss_pred cchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 002342 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFAN 909 (934)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~~~~ 909 (934)
.........+++.|||||++.+..++.++|||||||++|+|++ |+.||........+..
T Consensus 267 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~ 326 (374)
T cd05106 267 --------------------NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326 (374)
T ss_pred --------------------ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH
Confidence 0011122345678999999999999999999999999999997 9999988766555555
Q ss_pred HHcCCCC
Q 002342 910 ILHKDLK 916 (934)
Q Consensus 910 i~~~~~~ 916 (934)
+....+.
T Consensus 327 ~~~~~~~ 333 (374)
T cd05106 327 MVKRGYQ 333 (374)
T ss_pred HHHcccC
Confidence 5554443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.80 Aligned_cols=216 Identities=28% Similarity=0.457 Sum_probs=191.0
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
+.|.|+..||.|+||+||++..+.++-..|-|++... ....++.+.-||.||..++||+||+|++.|..++.+||+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 5689999999999999999999999999999988643 5677888999999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
|||.||-....+..- ++.+++.++..+++|+|.||.|||+++|||||||..|||++-+|.++|+|||.+....
T Consensus 109 EFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~------ 181 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK------ 181 (1187)
T ss_pred eecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch------
Confidence 999888877666543 4679999999999999999999999999999999999999999999999999984311
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
.......+|+|||.|||||++.+ .+|++++||||||++|.+|.-+.||....+.
T Consensus 182 ---------------------~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp 240 (1187)
T KOG0579|consen 182 ---------------------STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP 240 (1187)
T ss_pred ---------------------hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence 11223457899999999999844 6899999999999999999999999999999
Q ss_pred HHHHHHHHcCCC
Q 002342 904 QKTFANILHKDL 915 (934)
Q Consensus 904 ~~~~~~i~~~~~ 915 (934)
..++-+|.....
T Consensus 241 MRVllKiaKSeP 252 (1187)
T KOG0579|consen 241 MRVLLKIAKSEP 252 (1187)
T ss_pred HHHHHHHhhcCC
Confidence 999988876543
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=333.56 Aligned_cols=230 Identities=27% Similarity=0.373 Sum_probs=184.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
+++|++.+.||+|+||.||+|.+..+++.||+|++............++.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999999765444445567788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccC
Q 002342 748 TDYCPGGELFLLLDRQP---------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~---------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a 818 (934)
|||++|++|.+++.... ...++...+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 99999999999886421 123556778889999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
............. .. ................+||+.|||||++.+..++.++|||||||++|+|++|.+||
T Consensus 161 k~i~~~~~~~~~l-------~~--~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF 231 (932)
T PRK13184 161 IFKKLEEEDLLDI-------DV--DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231 (932)
T ss_pred eeccccccccccc-------cc--ccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 6542111100000 00 00000011112234568999999999999999999999999999999999999999
Q ss_pred CCCCHHHH
Q 002342 899 RGKTRQKT 906 (934)
Q Consensus 899 ~~~~~~~~ 906 (934)
.......+
T Consensus 232 ~~~~~~ki 239 (932)
T PRK13184 232 RRKKGRKI 239 (932)
T ss_pred CCcchhhh
Confidence 87655433
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=314.44 Aligned_cols=208 Identities=26% Similarity=0.462 Sum_probs=176.3
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC-----
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 742 (934)
.++|++.+.||+|+||.||++.+..++..||+|.+.+.. ........+.+|+.+++.++||||++++++|...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 579999999999999999999999999999999987542 23344567788999999999999999999986543
Q ss_pred -eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 743 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 743 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
.+|+||||+. ++|...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 5799999995 567666543 3889999999999999999999999999999999999999999999999998532
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|++||.+.
T Consensus 174 ~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 174 CT----------------------------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred cc----------------------------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 11 01122347899999999999999999999999999999999999999987
Q ss_pred CHHHHHHH
Q 002342 902 TRQKTFAN 909 (934)
Q Consensus 902 ~~~~~~~~ 909 (934)
+....+..
T Consensus 226 ~~~~~~~~ 233 (359)
T cd07876 226 DHIDQWNK 233 (359)
T ss_pred CHHHHHHH
Confidence 76554433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=312.69 Aligned_cols=201 Identities=29% Similarity=0.455 Sum_probs=170.9
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
...++|++++.||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++...+.+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 44678999999999999999999999999999999986532 3344567889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
+|||||++++|.... ...+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 149 lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~- 221 (353)
T PLN00034 149 VLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT- 221 (353)
T ss_pred EEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc-
Confidence 999999999986532 3567888899999999999999999999999999999999999999999998543210
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-----CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.......+||+.|+|||++.. ...+.++|||||||++|+|++|+.||..
T Consensus 222 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 222 --------------------------MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred --------------------------cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 011234579999999999843 3345689999999999999999999974
Q ss_pred C
Q 002342 901 K 901 (934)
Q Consensus 901 ~ 901 (934)
.
T Consensus 276 ~ 276 (353)
T PLN00034 276 G 276 (353)
T ss_pred C
Confidence 3
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=321.79 Aligned_cols=209 Identities=25% Similarity=0.403 Sum_probs=173.6
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC------
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 741 (934)
..+|++.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+|+.++||||++++++|...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 468999999999999999999999999999999876431 2234699999999999999999887532
Q ss_pred --CeEEEEEEccCCCCchhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-cEEEEecc
Q 002342 742 --THVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFD 816 (934)
Q Consensus 742 --~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-~vkl~DFG 816 (934)
.++++||||++ ++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 25779999995 577776643 2235699999999999999999999999999999999999998664 79999999
Q ss_pred cCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCC
Q 002342 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGY 895 (934)
Q Consensus 817 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~ 895 (934)
+|+.... .......+||+.|||||++.+. .++.++|||||||+||+|++|.
T Consensus 217 la~~~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~ 268 (440)
T PTZ00036 217 SAKNLLA----------------------------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY 268 (440)
T ss_pred cchhccC----------------------------CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9954321 0112245789999999998764 6899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHc
Q 002342 896 TPFRGKTRQKTFANILH 912 (934)
Q Consensus 896 ~Pf~~~~~~~~~~~i~~ 912 (934)
+||.+.+..+.+.++.+
T Consensus 269 ~pf~~~~~~~~~~~i~~ 285 (440)
T PTZ00036 269 PIFSGQSSVDQLVRIIQ 285 (440)
T ss_pred CCCCCCChHHHHHHHHH
Confidence 99999888877776654
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=303.50 Aligned_cols=205 Identities=36% Similarity=0.636 Sum_probs=179.3
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
.|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++|++|+.+++++...+..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999876544444445567789999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+.|++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG----- 155 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-----
Confidence 999999999886654456999999999999999999999999999999999999999999999999988432110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
.......|++.|+|||++.+..++.++|+|||||++|+|++|++||.+..
T Consensus 156 -----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 156 -----------------------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred -----------------------ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 01123468999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=320.01 Aligned_cols=213 Identities=33% Similarity=0.467 Sum_probs=178.9
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC------Ce
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------TH 743 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------~~ 743 (934)
-|..-+.||.|+||.||+++++.+|+.||||.+++.. .....+...+|++||++|+|||||+++++-++. ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 4556678999999999999999999999999998643 344567788999999999999999999986643 35
Q ss_pred EEEEEEccCCCCchhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec--CCc--EEEEecccC
Q 002342 744 VCLITDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG--NGH--VSLTDFDLS 818 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~--~~~--vkl~DFG~a 818 (934)
..+|||||.||+|+..+.+- ....+++.++..++..+..||.|||++||+||||||.||++-. +|+ -||+|||+|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 68999999999999999752 2345999999999999999999999999999999999999953 343 599999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~P 897 (934)
+.... +....+++||+.|++||++.. +.|+.-+|.|||||++|+++||..|
T Consensus 172 rel~d----------------------------~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lP 223 (732)
T KOG4250|consen 172 RELDD----------------------------NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELP 223 (732)
T ss_pred ccCCC----------------------------CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCC
Confidence 76432 224568899999999999985 8889999999999999999999999
Q ss_pred CCCCCH----HHHHHHHHc
Q 002342 898 FRGKTR----QKTFANILH 912 (934)
Q Consensus 898 f~~~~~----~~~~~~i~~ 912 (934)
|..... .++...+..
T Consensus 224 F~p~~~pk~~~~~~~~~~t 242 (732)
T KOG4250|consen 224 FIPFGGPKNNKEIMWHIIT 242 (732)
T ss_pred CCcCCCccccchhhhhhhc
Confidence 975333 345555554
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=314.79 Aligned_cols=213 Identities=27% Similarity=0.418 Sum_probs=180.3
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC-----eE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-----HV 744 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~~ 744 (934)
+|++.+.||+|+||.||++.+..+++.||+|.+... .........+.+|+.+|+.++||||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc-ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 488999999999999999999999999999988653 223345567889999999999999999999998776 88
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+||||+ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~lv~e~~-~~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 80 YVVTELM-QSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEEeecc-ccCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999999 56888877653 45999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
. ........+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.
T Consensus 157 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 210 (372)
T cd07853 157 E--------------------------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210 (372)
T ss_pred c--------------------------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH
Confidence 0 0111234689999999999874 478899999999999999999999999888
Q ss_pred HHHHHHHHc
Q 002342 904 QKTFANILH 912 (934)
Q Consensus 904 ~~~~~~i~~ 912 (934)
.+.+..|.+
T Consensus 211 ~~~~~~i~~ 219 (372)
T cd07853 211 IQQLDLITD 219 (372)
T ss_pred HHHHHHHHH
Confidence 777666643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=297.01 Aligned_cols=218 Identities=27% Similarity=0.495 Sum_probs=190.9
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
+|++.+.||.|+||.||++.+..+++.||+|.+.... .....+.+.+|+.+++.++||||+++++++...+.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5889999999999999999999999999999986432 23455678889999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+++++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~----- 153 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP----- 153 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-----
Confidence 999999999987655567899999999999999999999999999999999999999999999999998543211
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~ 909 (934)
........|++.|+|||++.+..++.++|+||||+++|+|++|.+||...+....+..
T Consensus 154 ----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~ 211 (255)
T cd08219 154 ----------------------GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK 211 (255)
T ss_pred ----------------------ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH
Confidence 1112245689999999999998899999999999999999999999999888888888
Q ss_pred HHcCCCC
Q 002342 910 ILHKDLK 916 (934)
Q Consensus 910 i~~~~~~ 916 (934)
+..+.+.
T Consensus 212 ~~~~~~~ 218 (255)
T cd08219 212 VCQGSYK 218 (255)
T ss_pred HhcCCCC
Confidence 8776653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=312.80 Aligned_cols=211 Identities=25% Similarity=0.459 Sum_probs=180.6
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC------
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 741 (934)
.++|++.+.||+|+||.||++.+..+++.||||.+.+.. ........+.+|+.+++.++||||+.+++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 579999999999999999999999999999999987542 2334456778899999999999999999988643
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
..+|+||||+ +++|...+.. .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 102 ~~~~lv~e~~-~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 102 QDVYIVMELM-DANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred CeEEEEEeCC-CCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 3579999999 5577777643 3888999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 177 ~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 177 GTS----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CCC----------------------------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 110 1122457899999999999999999999999999999999999999998
Q ss_pred CHHHHHHHHHc
Q 002342 902 TRQKTFANILH 912 (934)
Q Consensus 902 ~~~~~~~~i~~ 912 (934)
+..+.+..++.
T Consensus 229 ~~~~~~~~~~~ 239 (364)
T cd07875 229 DHIDQWNKVIE 239 (364)
T ss_pred CHHHHHHHHHH
Confidence 88877777654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=316.15 Aligned_cols=223 Identities=22% Similarity=0.350 Sum_probs=181.4
Q ss_pred ccccCCcccccccccCCcEEEEEEEE-----ecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASF 738 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~-----~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~ 738 (934)
.+..++|++.+.||+|+||.||+|.+ ..++..||+|+++... .......+.+|+.+|+.+ +||||+++++++
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 34556899999999999999999975 3457789999987532 233446788999999999 899999999999
Q ss_pred EeCCeEEEEEEccCCCCchhhhccCC------------------------------------------------------
Q 002342 739 QTKTHVCLITDYCPGGELFLLLDRQP------------------------------------------------------ 764 (934)
Q Consensus 739 ~~~~~~~lV~E~~~ggsL~~~l~~~~------------------------------------------------------ 764 (934)
...+..|+|||||++|+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999886432
Q ss_pred -------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 765 -------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 765 -------------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 1247788899999999999999999999999999999999999999999999985432110
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 904 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~ 904 (934)
. ........+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+....
T Consensus 269 ~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~ 323 (375)
T cd05104 269 N-------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323 (375)
T ss_pred c-------------------------ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch
Confidence 0 001122345678999999999999999999999999999997 99999887655
Q ss_pred HHHHHHHcCC
Q 002342 905 KTFANILHKD 914 (934)
Q Consensus 905 ~~~~~i~~~~ 914 (934)
..+.+++...
T Consensus 324 ~~~~~~~~~~ 333 (375)
T cd05104 324 SKFYKMIKEG 333 (375)
T ss_pred HHHHHHHHhC
Confidence 4444444433
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=322.99 Aligned_cols=215 Identities=22% Similarity=0.370 Sum_probs=177.6
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC------CCccceeEEEEe
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH------PFVPALYASFQT 740 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~h------p~Iv~l~~~~~~ 740 (934)
..++|++++.||+|+||+||+|.+..+++.||||+++.. .........|+.+++.+.| ++++.++++|..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 357899999999999999999999999999999998642 1223445667777777654 458889998876
Q ss_pred C-CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCC----------
Q 002342 741 K-THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNG---------- 808 (934)
Q Consensus 741 ~-~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~---------- 808 (934)
+ .++|+||+++ |++|.+++.+. ..+++..++.++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 4 5789999999 88999888764 459999999999999999999998 5999999999999998765
Q ss_pred ------cEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHH
Q 002342 809 ------HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882 (934)
Q Consensus 809 ------~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Diw 882 (934)
.+||+|||.+.... ......+||+.|||||++.+..|+.++|||
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~------------------------------~~~~~~~gt~~Y~APE~~~~~~~~~~~Diw 329 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER------------------------------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMW 329 (467)
T ss_pred cCCCCceEEECCCCccccCc------------------------------cccccccCCccccCcHHhhcCCCCcHHHHH
Confidence 49999999873211 112356899999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q 002342 883 ALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP 918 (934)
Q Consensus 883 SlG~iL~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 918 (934)
||||+||||++|++||.+.+..+.+..|......+|
T Consensus 330 SlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p 365 (467)
T PTZ00284 330 SMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLP 365 (467)
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC
Confidence 999999999999999999888777776655333333
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=312.53 Aligned_cols=212 Identities=27% Similarity=0.488 Sum_probs=181.5
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
++..+...-+..||+|+-|-||+++. .++.||||.++. .-..+|+.|+.|+||||+.|.+++....++
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCcee
Confidence 34444455567899999999999998 677999996542 233588999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|||||||..|.|+.+|+.. +.+.......|..+|+.||.|||.+.|||||||.-||||+.+..|||+|||-++.....
T Consensus 188 CIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred EEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 9999999999999999874 55888999999999999999999999999999999999999999999999988654321
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
....+|+||..|||||++...+.+.++|||||||+||||+||..||..-+..
T Consensus 266 ----------------------------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss 317 (904)
T KOG4721|consen 266 ----------------------------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS 317 (904)
T ss_pred ----------------------------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh
Confidence 2335789999999999999999999999999999999999999999987777
Q ss_pred HHHHHHHcCCCCCC
Q 002342 905 KTFANILHKDLKFP 918 (934)
Q Consensus 905 ~~~~~i~~~~~~~p 918 (934)
.+++-+=..-+.+|
T Consensus 318 AIIwGVGsNsL~Lp 331 (904)
T KOG4721|consen 318 AIIWGVGSNSLHLP 331 (904)
T ss_pred eeEEeccCCccccc
Confidence 77766544444333
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.28 Aligned_cols=213 Identities=29% Similarity=0.474 Sum_probs=177.5
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC---CCCCccceeEEEEe-----C
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQT-----K 741 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~-----~ 741 (934)
+|++.+.||+|+||.||++.++.+++.||+|.+..... .........+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 58999999999999999999999999999999875422 122223455677776655 79999999998864 3
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
..++++|||+. ++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 56899999995 58988887655556999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
... .......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.
T Consensus 159 ~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 159 SCQ----------------------------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cCc----------------------------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 210 1112346899999999999999999999999999999999999999988
Q ss_pred CHHHHHHHHHc
Q 002342 902 TRQKTFANILH 912 (934)
Q Consensus 902 ~~~~~~~~i~~ 912 (934)
...+.+.++..
T Consensus 211 ~~~~~~~~~~~ 221 (288)
T cd07863 211 SEADQLGKIFD 221 (288)
T ss_pred CHHHHHHHHHH
Confidence 88777766654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=304.14 Aligned_cols=217 Identities=25% Similarity=0.371 Sum_probs=179.2
Q ss_pred ccCCcccccccccCCcEEEEEEEEec----------------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCC
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCG----------------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~----------------~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 730 (934)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|..++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 34689999999999999999998632 34579999987542 3445567889999999999999
Q ss_pred ccceeEEEEeCCeEEEEEEccCCCCchhhhccCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 002342 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQP-----------------TKVLKEDAVRFYAAEVVVALEYLHCQGII 793 (934)
Q Consensus 731 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------~~~l~~~~~~~i~~qil~aL~yLH~~gii 793 (934)
|+++++++...+..|+||||+.+++|.+++.... ...++...+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999885431 12467788999999999999999999999
Q ss_pred ecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC
Q 002342 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA 873 (934)
Q Consensus 794 HrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~ 873 (934)
||||||+|||++.++.+||+|||++...... ..........+++.|||||++.+.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~~~~~ 215 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAG-------------------------DYYRIQGRAVLPIRWMAWECILMG 215 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccC-------------------------ceeEecCcCCCCccccCHHHHhcC
Confidence 9999999999999999999999998543110 001112334568899999999988
Q ss_pred CCCchhHHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHH
Q 002342 874 GHTSAVDWWALGILLYEMLY--GYTPFRGKTRQKTFANI 910 (934)
Q Consensus 874 ~~s~~~DiwSlG~iL~ellt--G~~Pf~~~~~~~~~~~i 910 (934)
.++.++|||||||++|+|++ |..||.+.+..+.+..+
T Consensus 216 ~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~ 254 (304)
T cd05096 216 KFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENA 254 (304)
T ss_pred CCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHH
Confidence 99999999999999999986 67899887777666544
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=333.18 Aligned_cols=224 Identities=25% Similarity=0.438 Sum_probs=182.8
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe--CCe
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTH 743 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~ 743 (934)
...++|++++.||.|+||.||+|.+..++..||+|++..... .......+..|+.+|+.|+||||++++++|.. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 446799999999999999999999999999999999876433 33445678899999999999999999999864 457
Q ss_pred EEEEEEccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHC-------CCeecCCCCCCEEEecC-------
Q 002342 744 VCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQ-------GIIYRDLKPENVLLQGN------- 807 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~-------giiHrDLKp~NILl~~~------- 807 (934)
+|||||||++++|.+++... ....+++..++.|+.||+.||.|||+. +||||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999998653 224599999999999999999999984 49999999999999642
Q ss_pred ----------CcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC--CCC
Q 002342 808 ----------GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGH 875 (934)
Q Consensus 808 ----------~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~ 875 (934)
+.+||+|||++...... ......+||+.|+|||++.+ ..+
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~----------------------------s~~~s~vGTp~YmAPEvL~ge~~~~ 220 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIE----------------------------SMAHSCVGTPYYWSPELLLHETKSY 220 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccc----------------------------ccccccCCCccccCHHHHhccCCCC
Confidence 34899999998543210 11234579999999999964 457
Q ss_pred CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q 002342 876 TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP 918 (934)
Q Consensus 876 s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 918 (934)
+.++|||||||+||+|++|.+||........+..++.....+|
T Consensus 221 s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp 263 (1021)
T PTZ00266 221 DDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP 263 (1021)
T ss_pred CchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC
Confidence 8899999999999999999999987666555444444444444
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=304.29 Aligned_cols=213 Identities=23% Similarity=0.392 Sum_probs=179.9
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|.+.+.||+|+||.||++.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++..++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 5689999999999999999999999999999999875422 22234567899999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+. ++|.+++... ...++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 157 (309)
T cd07872 83 FEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--- 157 (309)
T ss_pred EeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC---
Confidence 99995 5888887654 245899999999999999999999999999999999999999999999999998542111
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
........+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.
T Consensus 158 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 213 (309)
T cd07872 158 ------------------------TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213 (309)
T ss_pred ------------------------ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 011123467899999999865 4678899999999999999999999998887766
Q ss_pred HHHHH
Q 002342 907 FANIL 911 (934)
Q Consensus 907 ~~~i~ 911 (934)
+..+.
T Consensus 214 ~~~~~ 218 (309)
T cd07872 214 LHLIF 218 (309)
T ss_pred HHHHH
Confidence 65554
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=293.92 Aligned_cols=218 Identities=29% Similarity=0.487 Sum_probs=191.4
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
+|.+.+.||+|++|.||++.+..+++.|++|.+..... .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 48889999999999999999999999999999875433 34455678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+++++|.+++.......++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~----- 154 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN----- 154 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc-----
Confidence 999999999998754567999999999999999999999999999999999999999999999999998543211
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~ 909 (934)
........|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......
T Consensus 155 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 212 (256)
T cd08529 155 ----------------------TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212 (256)
T ss_pred ----------------------cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0112244688999999999999899999999999999999999999999888888888
Q ss_pred HHcCCC
Q 002342 910 ILHKDL 915 (934)
Q Consensus 910 i~~~~~ 915 (934)
+..+.+
T Consensus 213 ~~~~~~ 218 (256)
T cd08529 213 IIRGVF 218 (256)
T ss_pred HHcCCC
Confidence 877654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=314.37 Aligned_cols=229 Identities=24% Similarity=0.362 Sum_probs=197.0
Q ss_pred cccccccCCcccccccccCCcEEEEEEEEecCCe---E-EEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEE
Q 002342 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---Y-FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS 737 (934)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~---~-vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 737 (934)
..|++..++-.+.++||+|+||.||++..+..+. . ||+|..+...........++.+|.++|++++|||||++||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4566777778888999999999999999876432 3 89999876444567888999999999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEeccc
Q 002342 738 FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817 (934)
Q Consensus 738 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~ 817 (934)
...+..+++|||+|.||+|.+++++.+. .++..+...++.+.+.||+|||++++|||||..+|+|++.++.+||+|||+
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc
Confidence 9999999999999999999999998753 699999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCCCCCcchhhhccccCCCCcccccccccccc-cccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CC
Q 002342 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN-SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GY 895 (934)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~ 895 (934)
|..... ..... ...-...|+|||.+....|++++|||||||++||+++ |.
T Consensus 309 s~~~~~----------------------------~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~ 360 (474)
T KOG0194|consen 309 SRAGSQ----------------------------YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGA 360 (474)
T ss_pred ccCCcc----------------------------eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCC
Confidence 854310 00001 1124578999999999999999999999999999997 89
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCC
Q 002342 896 TPFRGKTRQKTFANILHKDLKFPS 919 (934)
Q Consensus 896 ~Pf~~~~~~~~~~~i~~~~~~~p~ 919 (934)
.||.+....++..+|....+..|.
T Consensus 361 ~Py~g~~~~~v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 361 EPYPGMKNYEVKAKIVKNGYRMPI 384 (474)
T ss_pred CCCCCCCHHHHHHHHHhcCccCCC
Confidence 999999999999999766654444
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=295.91 Aligned_cols=218 Identities=23% Similarity=0.333 Sum_probs=187.8
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+...+|.+.+.||+|+||.||++.+..++..||+|.+.+. ......+.+|+.+++.++||||+++++++..++.++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 4556799999999999999999999999999999998653 233467888999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
++|||+++++|.+++.......++...++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999999976555568999999999999999999999999999999999999999999999999985432110
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 904 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~ 904 (934)
........+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 159 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 212 (263)
T cd05052 159 --------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 212 (263)
T ss_pred --------------------------eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 001112234678999999999999999999999999999998 99999998888
Q ss_pred HHHHHHHcC
Q 002342 905 KTFANILHK 913 (934)
Q Consensus 905 ~~~~~i~~~ 913 (934)
+....+..+
T Consensus 213 ~~~~~~~~~ 221 (263)
T cd05052 213 QVYELLEKG 221 (263)
T ss_pred HHHHHHHCC
Confidence 887777654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=296.56 Aligned_cols=223 Identities=24% Similarity=0.399 Sum_probs=188.5
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+..++|+++++||+|+||.||++.+ .++..||+|.+.... .....+.+|+.+++.++|+||+++++++...+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 35667999999999999999999986 456679999876532 2346788999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|++|||+++++|.+++.......++...+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 99999999999999997765566899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~ 903 (934)
. ........++..|+|||++.+..++.++|+|||||++|+|++ |..||.+...
T Consensus 157 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 210 (261)
T cd05072 157 E--------------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210 (261)
T ss_pred c--------------------------eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence 0 001122346778999999998889999999999999999998 9999999888
Q ss_pred HHHHHHHHcCCCCCCC
Q 002342 904 QKTFANILHKDLKFPS 919 (934)
Q Consensus 904 ~~~~~~i~~~~~~~p~ 919 (934)
......+..+ ..+|.
T Consensus 211 ~~~~~~~~~~-~~~~~ 225 (261)
T cd05072 211 SDVMSALQRG-YRMPR 225 (261)
T ss_pred HHHHHHHHcC-CCCCC
Confidence 8888777654 33443
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=317.45 Aligned_cols=222 Identities=27% Similarity=0.419 Sum_probs=184.6
Q ss_pred ccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCCC
Q 002342 676 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGE 755 (934)
Q Consensus 676 ~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggs 755 (934)
+||+|.||+||-++|..+...+|||.+... +......+..|+.+.+.|+|.|||++++++..++++-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 589999999999999999999999988643 45566778899999999999999999999999999999999999999
Q ss_pred chhhhccCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe-cCCcEEEEecccCcccCCCCCCCCCcc
Q 002342 756 LFLLLDRQPTKVL--KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-GNGHVSLTDFDLSCLTSCKPQLLLPTT 832 (934)
Q Consensus 756 L~~~l~~~~~~~l--~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~-~~~~vkl~DFG~a~~~~~~~~~~~~~~ 832 (934)
|.+++.... +++ ++..+-+|.+||++||.|||.+.|||||||-+|||++ ..|.+||.|||-++....
T Consensus 659 LSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--------- 728 (1226)
T KOG4279|consen 659 LSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--------- 728 (1226)
T ss_pred HHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc---------
Confidence 999998764 345 8899999999999999999999999999999999996 579999999998865421
Q ss_pred hhhhccccCCCCcccccccccccccccCCCCccchhhhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHH
Q 002342 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFRGKTRQK--TFA 908 (934)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~--~~~ 908 (934)
-+.-+.++.||+.|||||++..+ +|+.++|||||||++.||.||+|||.....++ +++
T Consensus 729 ------------------inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk 790 (1226)
T KOG4279|consen 729 ------------------INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK 790 (1226)
T ss_pred ------------------CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh
Confidence 12345688999999999999764 67889999999999999999999998544432 222
Q ss_pred H-HHcCCCCCCCCCCCCcccCCC
Q 002342 909 N-ILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 909 ~-i~~~~~~~p~~~~~s~~~k~l 930 (934)
- +.+...++|.. .|.++|+|
T Consensus 791 VGmyKvHP~iPee--lsaeak~F 811 (1226)
T KOG4279|consen 791 VGMYKVHPPIPEE--LSAEAKNF 811 (1226)
T ss_pred hcceecCCCCcHH--HHHHHHHH
Confidence 1 12334455554 35555554
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=301.84 Aligned_cols=238 Identities=40% Similarity=0.703 Sum_probs=197.0
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++++..++++|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999988754434455667889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999999999764 458999999999999999999999999999999999999999999999999985421110000
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
... ... .............|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+.+.
T Consensus 159 ~~~---------~~~---~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~ 226 (305)
T cd05609 159 LYE---------GHI---EKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226 (305)
T ss_pred ccc---------ccc---ccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 000 000 00000111223568899999999998889999999999999999999999999999888898
Q ss_pred HHHcCCCCCCCC
Q 002342 909 NILHKDLKFPSS 920 (934)
Q Consensus 909 ~i~~~~~~~p~~ 920 (934)
.+..+...+|..
T Consensus 227 ~~~~~~~~~~~~ 238 (305)
T cd05609 227 QVISDDIEWPEG 238 (305)
T ss_pred HHHhcccCCCCc
Confidence 888887777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=310.52 Aligned_cols=211 Identities=25% Similarity=0.449 Sum_probs=178.5
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC-----
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK----- 741 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~----- 741 (934)
..++|++.+.||+|+||.||++.+..+++.||+|.+.+.. ........+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3579999999999999999999999999999999987542 2334456778899999999999999999998643
Q ss_pred -CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 742 -THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 742 -~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
...|+||||++ ++|...+.. .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 35799999994 567776643 388999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 169 ~~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 169 AGTS----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred CCCc----------------------------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2110 112235789999999999999999999999999999999999999998
Q ss_pred CCHHHHHHHHH
Q 002342 901 KTRQKTFANIL 911 (934)
Q Consensus 901 ~~~~~~~~~i~ 911 (934)
.+..+.+..+.
T Consensus 221 ~~~~~~~~~~~ 231 (355)
T cd07874 221 RDYIDQWNKVI 231 (355)
T ss_pred CCHHHHHHHHH
Confidence 87766554443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=297.57 Aligned_cols=222 Identities=25% Similarity=0.407 Sum_probs=188.5
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCC-----eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~-----~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
..++|++++.||+|+||.||++.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 4568999999999999999999986655 789999886432 344556788999999999999999999999999
Q ss_pred CeEEEEEEccCCCCchhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC
Q 002342 742 THVCLITDYCPGGELFLLLDRQPT--------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 807 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~ 807 (934)
...|++|||+++++|.+++..... ..++...+..++.|++.||.|||++|++|+||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 999999999999999999875421 458889999999999999999999999999999999999999
Q ss_pred CcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHH
Q 002342 808 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 887 (934)
Q Consensus 808 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~i 887 (934)
+.++|+|||++....... .........+++.|+|||.+.+..++.++|||||||+
T Consensus 161 ~~~~L~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~i 215 (283)
T cd05048 161 LTVKISDFGLSRDIYSAD-------------------------YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVV 215 (283)
T ss_pred CcEEECCCcceeeccccc-------------------------cccccCCCcccccccCHHHhccCcCchhhhHHHHHHH
Confidence 999999999985432110 0111223457889999999998899999999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCC
Q 002342 888 LYEMLY-GYTPFRGKTRQKTFANILHKDL 915 (934)
Q Consensus 888 L~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 915 (934)
+|+|++ |..||.+.+..+....|..+..
T Consensus 216 l~el~~~g~~p~~~~~~~~~~~~i~~~~~ 244 (283)
T cd05048 216 LWEIFSYGLQPYYGFSNQEVIEMIRSRQL 244 (283)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 999997 9999999999888888876653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=293.91 Aligned_cols=220 Identities=26% Similarity=0.398 Sum_probs=186.4
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeeccccc--ChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
+.|.+.+.||+|++|.||++.+..+++.||+|.+...... .......+.+|+.+++.++||||+++++++..+..+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4699999999999999999999999999999998754322 12334578889999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||+|+||+++.++.++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999999998764 4589999999999999999999999999999999999999999999999999854321000
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
.........|+..|+|||++.+..++.++||||||+++|+|++|++||...+....
T Consensus 160 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 215 (263)
T cd06625 160 ------------------------SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA 215 (263)
T ss_pred ------------------------ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH
Confidence 00111234688999999999998899999999999999999999999988777766
Q ss_pred HHHHHcCC
Q 002342 907 FANILHKD 914 (934)
Q Consensus 907 ~~~i~~~~ 914 (934)
+.++....
T Consensus 216 ~~~~~~~~ 223 (263)
T cd06625 216 IFKIATQP 223 (263)
T ss_pred HHHHhccC
Confidence 66665543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=311.84 Aligned_cols=226 Identities=25% Similarity=0.324 Sum_probs=182.4
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecC-----CeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeE
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYA 736 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~ 736 (934)
.+....++|++.+.||+|+||.||++.+... +..||||++.+.. .......+.+|+++|+.+. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 3445678999999999999999999987433 3579999987542 2334467889999999996 999999999
Q ss_pred EEEeCCeEEEEEEccCCCCchhhhccCC----------------------------------------------------
Q 002342 737 SFQTKTHVCLITDYCPGGELFLLLDRQP---------------------------------------------------- 764 (934)
Q Consensus 737 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------- 764 (934)
++...+.+|||||||++|+|.+++..+.
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 9999999999999999999998875421
Q ss_pred ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 002342 765 ------------------------------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802 (934)
Q Consensus 765 ------------------------------------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NI 802 (934)
...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 12478888899999999999999999999999999999
Q ss_pred EEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHH
Q 002342 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882 (934)
Q Consensus 803 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Diw 882 (934)
|++.++.+||+|||++........ ........+++.|+|||++.+..++.++|||
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 323 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSN-------------------------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVW 323 (400)
T ss_pred EEeCCCEEEEEeCCcceecccccc-------------------------ccccCCcCCCcceEChhhhcCCCCCchhhHH
Confidence 999999999999999854321100 0112234578899999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC
Q 002342 883 ALGILLYEMLY-GYTPFRGKTRQKTFANILHKDL 915 (934)
Q Consensus 883 SlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 915 (934)
||||++|+|++ |..||.+......+........
T Consensus 324 SlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~ 357 (400)
T cd05105 324 SYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGY 357 (400)
T ss_pred HHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCC
Confidence 99999999996 9999987655444433333333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=308.30 Aligned_cols=210 Identities=28% Similarity=0.451 Sum_probs=178.9
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC------
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 741 (934)
.++|++++.||.|+||.||++.+..+++.||+|.+.+.. ........+.+|+.+|+.++||||++++++|...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 478999999999999999999999999999999987542 1223345677899999999999999999988643
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
...|++|+++ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 4579999998 8899888754 34999999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+
T Consensus 169 ~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 169 DD------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred CC------------------------------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 11 1123478999999999977 5688899999999999999999999998
Q ss_pred CCHHHHHHHHHc
Q 002342 901 KTRQKTFANILH 912 (934)
Q Consensus 901 ~~~~~~~~~i~~ 912 (934)
.+..+.+..+..
T Consensus 219 ~~~~~~~~~~~~ 230 (343)
T cd07878 219 NDYIDQLKRIME 230 (343)
T ss_pred CCHHHHHHHHHH
Confidence 877766666543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=296.47 Aligned_cols=225 Identities=21% Similarity=0.295 Sum_probs=189.7
Q ss_pred ccCCcccccccccCCcEEEEEEEEec-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
..++|.+.+.||.|+||.||++.+.. ++..||+|.+.... .......+.+|+++|+.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35689999999999999999998753 36789999987542 233456788999999999999999999999999
Q ss_pred CeEEEEEEccCCCCchhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc
Q 002342 742 THVCLITDYCPGGELFLLLDRQP------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 809 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~ 809 (934)
...|+||||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999986532 234788999999999999999999999999999999999999999
Q ss_pred EEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHH
Q 002342 810 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889 (934)
Q Consensus 810 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ 889 (934)
++|+|||++....... .........+++.|+|||++.+..++.++|||||||++|
T Consensus 161 ~kl~d~g~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 215 (280)
T cd05049 161 VKIGDFGMSRDVYTTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLW 215 (280)
T ss_pred EEECCcccceecccCc-------------------------ceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHH
Confidence 9999999985321100 001112334678999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCC
Q 002342 890 EMLY-GYTPFRGKTRQKTFANILHKDLKFP 918 (934)
Q Consensus 890 ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p 918 (934)
+|++ |..||.+.+..+....+.++.+..+
T Consensus 216 e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (280)
T cd05049 216 EIFTYGKQPWYGLSNEEVIECITQGRLLQR 245 (280)
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 9998 9999999888888888887766444
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=296.17 Aligned_cols=221 Identities=22% Similarity=0.336 Sum_probs=187.4
Q ss_pred ccCCcccccccccCCcEEEEEEEEe-----cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
+.++|.+.+.||+|+||.||++.+. .++..+|+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4568999999999999999999862 35667999988653 344566788999999999999999999999999
Q ss_pred CeEEEEEEccCCCCchhhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcE
Q 002342 742 THVCLITDYCPGGELFLLLDRQP-----------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV 810 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~-----------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~v 810 (934)
+..|+||||+++++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999986432 1248999999999999999999999999999999999999999999
Q ss_pred EEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHH
Q 002342 811 SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 890 (934)
Q Consensus 811 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~e 890 (934)
+|+|||++....... .........+++.|+|||++.+..++.++|+|||||++|+
T Consensus 160 kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~ 214 (288)
T cd05093 160 KIGDFGMSRDVYSTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE 214 (288)
T ss_pred EeccCCccccccCCc-------------------------eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHH
Confidence 999999985432110 0011123346788999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCC
Q 002342 891 MLY-GYTPFRGKTRQKTFANILHKDL 915 (934)
Q Consensus 891 llt-G~~Pf~~~~~~~~~~~i~~~~~ 915 (934)
|++ |.+||.+.+..+.+..+..+.+
T Consensus 215 l~t~g~~p~~~~~~~~~~~~i~~~~~ 240 (288)
T cd05093 215 IFTYGKQPWYQLSNNEVIECITQGRV 240 (288)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 998 9999999888888888887764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=293.36 Aligned_cols=214 Identities=26% Similarity=0.344 Sum_probs=186.6
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
.+|++++.||.|+||.||++.+.. +..+|+|.+... .......+..|+.+++.++||||+++++++......|+||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD---DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc---chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 579999999999999999999977 889999998754 2333456888999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+++++|.+++.......++...++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~--- 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--- 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc---
Confidence 99999999999987666679999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTF 907 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~~ 907 (934)
.......+++.|+|||++.+..++.++|+||||+++|+|++ |+.||.+.+..+++
T Consensus 159 ------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~ 214 (261)
T cd05148 159 ------------------------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY 214 (261)
T ss_pred ------------------------ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 01112345778999999998899999999999999999998 99999998888888
Q ss_pred HHHHcC
Q 002342 908 ANILHK 913 (934)
Q Consensus 908 ~~i~~~ 913 (934)
..+..+
T Consensus 215 ~~~~~~ 220 (261)
T cd05148 215 DQITAG 220 (261)
T ss_pred HHHHhC
Confidence 887754
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=288.28 Aligned_cols=218 Identities=27% Similarity=0.469 Sum_probs=188.0
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe-CCeEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KTHVCLIT 748 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lV~ 748 (934)
+|++.+.||.|++|.||++.+..+++.||+|.+..... .......+.+|+.+++.++|||++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999999875422 33445668889999999999999999998864 45689999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+++++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~---- 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ---- 155 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc----
Confidence 9999999999987654556899999999999999999999999999999999999999999999999998543210
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
........|++.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+......
T Consensus 156 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~ 212 (257)
T cd08223 156 -----------------------CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212 (257)
T ss_pred -----------------------CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 011234568999999999999999999999999999999999999999888877777
Q ss_pred HHHcCCC
Q 002342 909 NILHKDL 915 (934)
Q Consensus 909 ~i~~~~~ 915 (934)
.+..+.+
T Consensus 213 ~~~~~~~ 219 (257)
T cd08223 213 RIIEGKL 219 (257)
T ss_pred HHHhcCC
Confidence 7777665
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=292.69 Aligned_cols=219 Identities=26% Similarity=0.446 Sum_probs=184.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++.+.||.|+||.||+|.+..+++.||+|.+... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE---PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 46899999999999999999999999999999998754 223345677899999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+++++|.+++... +.+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06645 85 MEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--- 159 (267)
T ss_pred EeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc---
Confidence 9999999999998764 35999999999999999999999999999999999999999999999999998543210
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
........|++.|+|||++. ...++.++|+|||||++|+|++|.+||......
T Consensus 160 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~ 215 (267)
T cd06645 160 ------------------------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred ------------------------ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch
Confidence 01123446899999999984 456788999999999999999999999776655
Q ss_pred HHHHHHHcCCCCCC
Q 002342 905 KTFANILHKDLKFP 918 (934)
Q Consensus 905 ~~~~~i~~~~~~~p 918 (934)
.....+....+..|
T Consensus 216 ~~~~~~~~~~~~~~ 229 (267)
T cd06645 216 RALFLMTKSNFQPP 229 (267)
T ss_pred hhHHhhhccCCCCC
Confidence 55545544444433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=284.32 Aligned_cols=245 Identities=24% Similarity=0.310 Sum_probs=196.7
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe----
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT---- 740 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~---- 740 (934)
.++.++|++.+.||+|||+.||+|+...++..||+|.+... ..+..+...+|++..++++||||++++++...
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 36778999999999999999999999999999999998765 35667788999999999999999999887643
Q ss_pred -CCeEEEEEEccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEecCCcEEEEec
Q 002342 741 -KTHVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDF 815 (934)
Q Consensus 741 -~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~~~~vkl~DF 815 (934)
....||++.|+..|+|.+.+... ++..+++.++..|+.+|++||++||... +.||||||.|||+++++.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 34589999999999999998753 3446999999999999999999999998 999999999999999999999999
Q ss_pred ccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC---CCCchhHHHHHHHHHHHHH
Q 002342 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEML 892 (934)
Q Consensus 816 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~---~~s~~~DiwSlG~iL~ell 892 (934)
|++......-.. ...............|+.|.|||.+.-. ..+.++|||||||+||.|+
T Consensus 174 GS~~~a~i~i~~------------------~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~m 235 (302)
T KOG2345|consen 174 GSATQAPIQIEG------------------SRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMM 235 (302)
T ss_pred cCccccceEeec------------------hHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHH
Confidence 998653211000 0001111222334579999999999654 4467999999999999999
Q ss_pred hCCCCCCCC--CHHHHHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 893 YGYTPFRGK--TRQKTFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 893 tG~~Pf~~~--~~~~~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
+|.-||.-. ....+.-.+.++++.||...+.|....+|
T Consensus 236 f~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~l 275 (302)
T KOG2345|consen 236 FGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQL 275 (302)
T ss_pred HcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHH
Confidence 999999632 22233446678899999888777665544
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=292.63 Aligned_cols=217 Identities=28% Similarity=0.419 Sum_probs=184.1
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||+|+||.||++++..+++.||+|.+.............+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 58999999999999999999999999999999887644445555667889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 749 DYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 749 E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||+++++|.+++... ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~-- 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch--
Confidence 999999999887532 2245899999999999999999999999999999999999999999999999988543210
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--H
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR--Q 904 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~--~ 904 (934)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .
T Consensus 160 -------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~ 214 (267)
T cd08228 160 -------------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF 214 (267)
T ss_pred -------------------------hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH
Confidence 0011234688999999999988899999999999999999999999975432 3
Q ss_pred HHHHHHHc
Q 002342 905 KTFANILH 912 (934)
Q Consensus 905 ~~~~~i~~ 912 (934)
.....+..
T Consensus 215 ~~~~~~~~ 222 (267)
T cd08228 215 SLCQKIEQ 222 (267)
T ss_pred HHHHHHhc
Confidence 45555544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=293.99 Aligned_cols=218 Identities=25% Similarity=0.409 Sum_probs=182.7
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++.+.||+|+||.||++.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++..++..|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 468999999999999999999999999999999987532 23345677899999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06646 85 MEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--- 159 (267)
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc---
Confidence 9999999999988654 35899999999999999999999999999999999999999999999999998543110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
........|++.|+|||.+. ...++.++|+|||||++|+|++|.+||......
T Consensus 160 ------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~ 215 (267)
T cd06646 160 ------------------------IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred ------------------------ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 01122346889999999984 345778999999999999999999999766655
Q ss_pred HHHHHHHcCCCCC
Q 002342 905 KTFANILHKDLKF 917 (934)
Q Consensus 905 ~~~~~i~~~~~~~ 917 (934)
+....+....+..
T Consensus 216 ~~~~~~~~~~~~~ 228 (267)
T cd06646 216 RALFLMSKSNFQP 228 (267)
T ss_pred hhheeeecCCCCC
Confidence 5544444444443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=289.30 Aligned_cols=219 Identities=28% Similarity=0.495 Sum_probs=192.5
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
+|++++.||.|+||.||.+++..++..+++|.+..... .......+.+|+.++++++|+||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 58999999999999999999999999999999875432 23445678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+++++|.+++.......+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~---- 155 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY---- 155 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc----
Confidence 9999999999987645568999999999999999999999999999999999999999999999999985432110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~ 909 (934)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....
T Consensus 156 -----------------------~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08221 156 -----------------------SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK 212 (256)
T ss_pred -----------------------ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 012345689999999999988889999999999999999999999999888888888
Q ss_pred HHcCCCC
Q 002342 910 ILHKDLK 916 (934)
Q Consensus 910 i~~~~~~ 916 (934)
+..+.+.
T Consensus 213 ~~~~~~~ 219 (256)
T cd08221 213 IVQGNYT 219 (256)
T ss_pred HHcCCCC
Confidence 8877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=305.98 Aligned_cols=203 Identities=27% Similarity=0.348 Sum_probs=173.3
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC-eEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-HVCL 746 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~~~l 746 (934)
.++|.-...||+|+||.||++... ++..||||.+....... ..++.+|+.+|.+++|||+|+|++||.+.+ ..+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 467888899999999999999884 44899999876542211 455999999999999999999999999888 5999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG---IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~g---iiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
|+|||++|+|.+++.......+++.....|+.+++.||+|||... ||||||||+|||+|.++.+||+|||+|+..+.
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 999999999999998764326899999999999999999999863 99999999999999999999999999954321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccc-cCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSF-VGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
. . ....+. .||.+|+|||++..+..+.++||||||++|+||++|+.|....
T Consensus 230 ~-~--------------------------~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 230 G-D--------------------------TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred c-c--------------------------cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 0 0 000111 6999999999999999999999999999999999999888753
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=291.55 Aligned_cols=217 Identities=26% Similarity=0.361 Sum_probs=184.7
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+..++|++.+.||+|++|.||++.+. +++.||+|.+..... ....+.+|+.+++.++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 45678999999999999999999874 457899999875422 2456788999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
++|||+++++|.+++.......++...+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999999977654568999999999999999999999999999999999999999999999999986542100
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 904 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~ 904 (934)
........++..|+|||++.+..++.++|+||||+++|+|++ |+.||.+.+..
T Consensus 158 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 211 (261)
T cd05068 158 --------------------------YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA 211 (261)
T ss_pred --------------------------ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 000111223568999999999889999999999999999998 99999998888
Q ss_pred HHHHHHHcC
Q 002342 905 KTFANILHK 913 (934)
Q Consensus 905 ~~~~~i~~~ 913 (934)
..+..+..+
T Consensus 212 ~~~~~~~~~ 220 (261)
T cd05068 212 EVLQQVDQG 220 (261)
T ss_pred HHHHHHHcC
Confidence 888777654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=301.23 Aligned_cols=224 Identities=25% Similarity=0.356 Sum_probs=182.1
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~----~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
+...+|++.+.||+|+||.||++.+..++. .||+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 345689999999999999999999876665 4899988643 2334456788999999999999999999998764
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
..++++||+++|+|.+++.... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 5789999999999999987643 35889999999999999999999999999999999999999999999999999654
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~ 900 (934)
..... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 160 ~~~~~-------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 160 GADEK-------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred cCCCc-------------------------ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 21100 001112235678999999999999999999999999999997 9999988
Q ss_pred CCHHHHHHHHHcCCCCCCC
Q 002342 901 KTRQKTFANILHKDLKFPS 919 (934)
Q Consensus 901 ~~~~~~~~~i~~~~~~~p~ 919 (934)
....++.. +......+|.
T Consensus 215 ~~~~~~~~-~~~~~~~~~~ 232 (316)
T cd05108 215 IPASEISS-ILEKGERLPQ 232 (316)
T ss_pred CCHHHHHH-HHhCCCCCCC
Confidence 77766554 4444444443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=294.99 Aligned_cols=221 Identities=22% Similarity=0.362 Sum_probs=184.6
Q ss_pred ccCCcccccccccCCcEEEEEEEEe----cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELC----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~----~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
..++|++.+.||+|+||.||++.+. .++..+|+|.+... ........+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4568999999999999999999863 35678999998753 23445567889999999999999999999999999
Q ss_pred eEEEEEEccCCCCchhhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC
Q 002342 743 HVCLITDYCPGGELFLLLDRQP---------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 807 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~---------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~ 807 (934)
..|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 9999999999999999985321 1247888999999999999999999999999999999999999
Q ss_pred CcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHH
Q 002342 808 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 887 (934)
Q Consensus 808 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~i 887 (934)
+.+||+|||++....... .........++..|+|||++.+..++.++|+|||||+
T Consensus 161 ~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 215 (283)
T cd05090 161 LHVKISDLGLSREIYSAD-------------------------YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVV 215 (283)
T ss_pred CcEEeccccccccccCCc-------------------------ceecccCCCccceecChHHhccCCCCchhhhHHHHHH
Confidence 999999999985432110 0011233446788999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 002342 888 LYEMLY-GYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 888 L~ellt-G~~Pf~~~~~~~~~~~i~~~~ 914 (934)
+|+|++ |.+||.+.+...+...+..+.
T Consensus 216 l~el~~~g~~p~~~~~~~~~~~~~~~~~ 243 (283)
T cd05090 216 LWEIFSFGLQPYYGFSNQEVIEMVRKRQ 243 (283)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999998 999999888877777776544
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=299.57 Aligned_cols=218 Identities=24% Similarity=0.366 Sum_probs=182.0
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeE--EEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCC
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 742 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~--vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 742 (934)
+..++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++..+ +||||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 3456899999999999999999999877754 577765532 2344556788899999999 8999999999999999
Q ss_pred eEEEEEEccCCCCchhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC
Q 002342 743 HVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 808 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~ 808 (934)
..|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999986532 23588999999999999999999999999999999999999999
Q ss_pred cEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHH
Q 002342 809 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888 (934)
Q Consensus 809 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL 888 (934)
.+||+|||++..... ........+++.|+|||++.+..++.++|||||||++
T Consensus 162 ~~kl~dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 213 (303)
T cd05088 162 VAKIADFGLSRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213 (303)
T ss_pred cEEeCccccCcccch----------------------------hhhcccCCCcccccCHHHHhccCCcccccchhhhhHH
Confidence 999999998842100 0001112346789999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcC
Q 002342 889 YEMLY-GYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 889 ~ellt-G~~Pf~~~~~~~~~~~i~~~ 913 (934)
|+|++ |.+||.+.+..+.+..+..+
T Consensus 214 ~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 214 WEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred HHHHhcCCCCcccCChHHHHHHHhcC
Confidence 99998 99999988888888777554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-33 Score=280.31 Aligned_cols=229 Identities=28% Similarity=0.434 Sum_probs=189.2
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~ 745 (934)
+.++.+.+..||+|+.|+|++++.+.+|...|||.+.+. .+....+++...+.++... ++|+||+.++||..+..++
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 456677889999999999999999999999999999864 3566677888888887666 5999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
+.||.| +..+..++++. .+.+++..+-.+...++.||.||-.+ ||||||+||+|||++..|++||||||++..+.++
T Consensus 168 IcMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 168 ICMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence 999999 54555555443 46699999999999999999999987 8999999999999999999999999999654322
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCC-
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRG- 900 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~s~~~DiwSlG~iL~elltG~~Pf~~- 900 (934)
...+...|.+.|||||.+. ...|+.++||||||++|+||+||+.||.+
T Consensus 246 ----------------------------kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c 297 (391)
T KOG0983|consen 246 ----------------------------KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC 297 (391)
T ss_pred ----------------------------cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC
Confidence 2233446999999999995 45788899999999999999999999997
Q ss_pred CCHHHHHHHHHcCCC-CCCCCCCCCccc
Q 002342 901 KTRQKTFANILHKDL-KFPSSTPSSCKA 927 (934)
Q Consensus 901 ~~~~~~~~~i~~~~~-~~p~~~~~s~~~ 927 (934)
.+..+++.+|++... .+|.....|+..
T Consensus 298 ~tdFe~ltkvln~ePP~L~~~~gFSp~F 325 (391)
T KOG0983|consen 298 KTDFEVLTKVLNEEPPLLPGHMGFSPDF 325 (391)
T ss_pred CccHHHHHHHHhcCCCCCCcccCcCHHH
Confidence 667799999988544 333333344443
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=288.99 Aligned_cols=217 Identities=25% Similarity=0.395 Sum_probs=183.9
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
+.++|++.+.||+|+||.||++... ++..+|+|.+.+... ....+.+|+.+|+.++||||+++++++...+..|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 3467999999999999999999874 456799998765321 23567889999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~- 154 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE- 154 (256)
T ss_pred EEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-
Confidence 999999999999987543 358999999999999999999999999999999999999999999999999885431100
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK 905 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~ 905 (934)
........++..|+|||++.+..++.++|+||||+++|+|++ |++||...+..+
T Consensus 155 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~ 209 (256)
T cd05114 155 -------------------------YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209 (256)
T ss_pred -------------------------eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 001112245678999999998889999999999999999999 999999999999
Q ss_pred HHHHHHcCCC
Q 002342 906 TFANILHKDL 915 (934)
Q Consensus 906 ~~~~i~~~~~ 915 (934)
.+..+.++..
T Consensus 210 ~~~~i~~~~~ 219 (256)
T cd05114 210 VVEMISRGFR 219 (256)
T ss_pred HHHHHHCCCC
Confidence 9888887653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=294.01 Aligned_cols=195 Identities=29% Similarity=0.472 Sum_probs=172.1
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++++.||+|+||.||++.+..+++.||+|.+.+.. .......+.+|+.++++++||||+++++++...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36899999999999999999999999999999987542 2344567889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+++++|..+. .+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----- 147 (279)
T cd06619 79 EFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----- 147 (279)
T ss_pred ecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc-----
Confidence 999999986542 378889999999999999999999999999999999999999999999999853211
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
......+|++.|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 148 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 148 ------------------------SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred ------------------------ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 012245789999999999999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=296.73 Aligned_cols=214 Identities=25% Similarity=0.396 Sum_probs=180.4
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
..++|++.+.||.|+||.||++.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++..++..|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999875422 2223456789999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 82 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-- 157 (301)
T cd07873 82 VFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-- 157 (301)
T ss_pred EEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC--
Confidence 999995 6898888654 345899999999999999999999999999999999999999999999999998542110
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
........+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+
T Consensus 158 -------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~ 212 (301)
T cd07873 158 -------------------------TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212 (301)
T ss_pred -------------------------CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0111233578899999998764 57889999999999999999999999888776
Q ss_pred HHHHHH
Q 002342 906 TFANIL 911 (934)
Q Consensus 906 ~~~~i~ 911 (934)
.+..+.
T Consensus 213 ~~~~~~ 218 (301)
T cd07873 213 QLHFIF 218 (301)
T ss_pred HHHHHH
Confidence 665554
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=295.04 Aligned_cols=215 Identities=28% Similarity=0.467 Sum_probs=183.9
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.+.|++++.||.|+||.||++.+..+++.||+|.+... .......+.+|+.+++.++||||+++++++..++..|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 46799999999999999999999999999999998754 445567788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+++++|..++.... ..+++..+..++.|++.+|.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~---- 162 (292)
T cd06644 88 IEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK---- 162 (292)
T ss_pred EecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc----
Confidence 99999999988775432 4589999999999999999999999999999999999999999999999998743210
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
.........|++.|+|||++. ...++.++|+|||||++|+|++|.+||...+
T Consensus 163 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 163 -----------------------TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred -----------------------cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 011123446889999999985 3456779999999999999999999998887
Q ss_pred HHHHHHHHHcC
Q 002342 903 RQKTFANILHK 913 (934)
Q Consensus 903 ~~~~~~~i~~~ 913 (934)
....+.++...
T Consensus 220 ~~~~~~~~~~~ 230 (292)
T cd06644 220 PMRVLLKIAKS 230 (292)
T ss_pred HHHHHHHHhcC
Confidence 77666666544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=293.01 Aligned_cols=213 Identities=28% Similarity=0.460 Sum_probs=182.5
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
.|++.+.||.|+||.||++.+..++..+++|.+... .......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 378999999999999999999999999999998653 34456678889999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+++++|..++... ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~----- 156 (282)
T cd06643 83 FCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT----- 156 (282)
T ss_pred ecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-----
Confidence 99999998887543 245899999999999999999999999999999999999999999999999998542110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
........|++.|+|||++. +..++.++|+|||||++|+|++|++||...+..
T Consensus 157 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~ 214 (282)
T cd06643 157 ----------------------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM 214 (282)
T ss_pred ----------------------ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH
Confidence 01123456899999999984 445778999999999999999999999988877
Q ss_pred HHHHHHHcC
Q 002342 905 KTFANILHK 913 (934)
Q Consensus 905 ~~~~~i~~~ 913 (934)
+....+...
T Consensus 215 ~~~~~~~~~ 223 (282)
T cd06643 215 RVLLKIAKS 223 (282)
T ss_pred HHHHHHhhc
Confidence 776666554
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=289.95 Aligned_cols=217 Identities=26% Similarity=0.372 Sum_probs=181.6
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeeccc--ccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe--CCeE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV--MLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHV 744 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~--~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~ 744 (934)
.+|++.+.||+|+||.||++.+..+++.||+|.+.... .........+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999999999999999886432 1223445678899999999999999999999876 3578
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 8999999999999998764 34889999999999999999999999999999999999999999999999998543110
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
. ..........|+..|+|||++.+..++.++|+|||||++|+|++|+.||......
T Consensus 160 ~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 215 (265)
T cd06652 160 C------------------------LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM 215 (265)
T ss_pred c------------------------ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH
Confidence 0 0001122346899999999999888999999999999999999999999877666
Q ss_pred HHHHHHH
Q 002342 905 KTFANIL 911 (934)
Q Consensus 905 ~~~~~i~ 911 (934)
..+..+.
T Consensus 216 ~~~~~~~ 222 (265)
T cd06652 216 AAIFKIA 222 (265)
T ss_pred HHHHHHh
Confidence 5555544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=291.39 Aligned_cols=218 Identities=29% Similarity=0.442 Sum_probs=184.8
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||.|+||.||++.+..+++.||||.+.+...........+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999999999999887644444455567889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 749 DYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 749 E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||+++++|.+++... ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 999999999988632 23458999999999999999999999999999999999999999999999999885432110
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--H
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR--Q 904 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~--~ 904 (934)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||.+... .
T Consensus 161 --------------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08229 161 --------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred --------------------------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH
Confidence 011234689999999999998899999999999999999999999976543 3
Q ss_pred HHHHHHHcC
Q 002342 905 KTFANILHK 913 (934)
Q Consensus 905 ~~~~~i~~~ 913 (934)
...+.+...
T Consensus 215 ~~~~~~~~~ 223 (267)
T cd08229 215 SLCKKIEQC 223 (267)
T ss_pred HHhhhhhcC
Confidence 444555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=293.74 Aligned_cols=216 Identities=27% Similarity=0.481 Sum_probs=186.2
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++++.||.|+||.||++.+..++..+|+|++... .......+.+|+.+++.++||||+++++++..+...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 35799999999999999999999889999999998643 445566788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+++++|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--- 156 (280)
T cd06611 81 IEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--- 156 (280)
T ss_pred eeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc---
Confidence 9999999999998654 245999999999999999999999999999999999999999999999999987432110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
........|++.|+|||++. ...++.++|+|||||++|+|++|++||.+.+
T Consensus 157 ------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 157 ------------------------LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred ------------------------ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 11123456899999999985 3456779999999999999999999999888
Q ss_pred HHHHHHHHHcCC
Q 002342 903 RQKTFANILHKD 914 (934)
Q Consensus 903 ~~~~~~~i~~~~ 914 (934)
....+..+..+.
T Consensus 213 ~~~~~~~~~~~~ 224 (280)
T cd06611 213 PMRVLLKILKSE 224 (280)
T ss_pred HHHHHHHHhcCC
Confidence 877777776654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=293.08 Aligned_cols=223 Identities=18% Similarity=0.270 Sum_probs=186.9
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecC-----CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 739 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 739 (934)
.+..++|++.+.||.|+||.||++.+... +..||+|.+.... .......+.+|+.+|+.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 35667899999999999999999998654 3789999986532 2334456788999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCchhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEE
Q 002342 740 TKTHVCLITDYCPGGELFLLLDRQP--------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 811 (934)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vk 811 (934)
.....|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999999999999986532 12367889999999999999999999999999999999999999999
Q ss_pred EEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHH
Q 002342 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891 (934)
Q Consensus 812 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~el 891 (934)
|+|||+++...... .........++..|+|||.+.+..++.++|||||||++|+|
T Consensus 160 l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 214 (277)
T cd05032 160 IGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214 (277)
T ss_pred ECCcccchhhccCc-------------------------ccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHh
Confidence 99999985432110 01112334578899999999988899999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCC
Q 002342 892 LY-GYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 892 lt-G~~Pf~~~~~~~~~~~i~~~~ 914 (934)
++ |.+||.+.+..+..+.+..+.
T Consensus 215 ~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 215 ATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred hccCCCCCccCCHHHHHHHHhcCC
Confidence 98 999999988888888777543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-33 Score=311.30 Aligned_cols=213 Identities=25% Similarity=0.392 Sum_probs=184.3
Q ss_pred ccccccccCCcEEEEEEEEecCCeEEEEEEeec-ccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe--EEEEE
Q 002342 672 RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDK-GVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH--VCLIT 748 (934)
Q Consensus 672 ~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~-~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~--~~lV~ 748 (934)
+....||+|+|-+||+|.|..+|..||--.++. +.......+.++..|+.+|+.|+||||+++|+++.+... +-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 445679999999999999999998887544332 233456677899999999999999999999999987654 78999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CCeecCCCCCCEEEecC-CcEEEEecccCcccCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ--GIIYRDLKPENVLLQGN-GHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~--giiHrDLKp~NILl~~~-~~vkl~DFG~a~~~~~~~ 825 (934)
|++..|+|..|+++. +.++...++.|++||+.||.|||++ .|||||||++||+|+.+ |.|||+|+|+|..+..+
T Consensus 123 EL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred ecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 999999999999885 4589999999999999999999998 59999999999999865 89999999999764321
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCCHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR-GKTRQ 904 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~-~~~~~ 904 (934)
...+.+|||.|||||+.. ..|+..+||||||++++||+|+..||. +.+..
T Consensus 200 ----------------------------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A 250 (632)
T KOG0584|consen 200 ----------------------------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA 250 (632)
T ss_pred ----------------------------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH
Confidence 223478999999999998 779999999999999999999999998 68888
Q ss_pred HHHHHHHcCCCC
Q 002342 905 KTFANILHKDLK 916 (934)
Q Consensus 905 ~~~~~i~~~~~~ 916 (934)
++|+++.+|..+
T Consensus 251 QIYKKV~SGiKP 262 (632)
T KOG0584|consen 251 QIYKKVTSGIKP 262 (632)
T ss_pred HHHHHHHcCCCH
Confidence 999999998754
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=293.77 Aligned_cols=209 Identities=28% Similarity=0.449 Sum_probs=181.6
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++||||++++++|..++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999987532 2344566889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+|||++.++.++|+|||++.....
T Consensus 79 ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 152 (308)
T cd06615 79 EHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 152 (308)
T ss_pred eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----
Confidence 999999999999765 458999999999999999999998 5999999999999999999999999998743210
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
......+|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.....
T Consensus 153 -------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 207 (308)
T cd06615 153 -------------------------SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE 207 (308)
T ss_pred -------------------------cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH
Confidence 0123457899999999998888999999999999999999999999877655444
Q ss_pred HHH
Q 002342 908 ANI 910 (934)
Q Consensus 908 ~~i 910 (934)
..+
T Consensus 208 ~~~ 210 (308)
T cd06615 208 AMF 210 (308)
T ss_pred Hhh
Confidence 333
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=303.30 Aligned_cols=221 Identities=26% Similarity=0.383 Sum_probs=178.5
Q ss_pred cccccCCcccccccccCCcEEEEEEEEec-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEE
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS 737 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 737 (934)
|++..++|++.+.||.|+||.||+|.+.. +++.||+|.+.... .......+..|+.++..+ +|+||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 34556789999999999999999997543 45789999986432 233445678899999999 89999999998
Q ss_pred EEe-CCeEEEEEEccCCCCchhhhccCCC---------------------------------------------------
Q 002342 738 FQT-KTHVCLITDYCPGGELFLLLDRQPT--------------------------------------------------- 765 (934)
Q Consensus 738 ~~~-~~~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------- 765 (934)
+.. +..++++|||+++++|.+++.....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 764 4678999999999999998864321
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhc
Q 002342 766 --------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837 (934)
Q Consensus 766 --------~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~ 837 (934)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~----------- 228 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----------- 228 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-----------
Confidence 2578999999999999999999999999999999999999999999999999864321100
Q ss_pred cccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 002342 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANIL 911 (934)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~ 911 (934)
........+++.|+|||++.+..++.++|||||||+||+|++ |.+||.+....+.+....
T Consensus 229 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~ 289 (337)
T cd05054 229 --------------YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL 289 (337)
T ss_pred --------------hhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Confidence 011223456788999999999999999999999999999997 999998765544443333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=296.72 Aligned_cols=224 Identities=23% Similarity=0.350 Sum_probs=185.4
Q ss_pred ccccCCcccccccccCCcEEEEEEEEe-----cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASF 738 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~ 738 (934)
.+..++|.+.+.||.|+||.||++.+. .++..+|+|.+.+.. .......+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 355678999999999999999999863 345689999887532 234456788999999999 799999999999
Q ss_pred EeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccC
Q 002342 739 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (934)
Q Consensus 739 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a 818 (934)
...+..|+||||+.+++|.+++.......+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999999997654455899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTP 897 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~P 897 (934)
........ ........+++.|+|||++.+..++.++|||||||++|+|++ |.+|
T Consensus 189 ~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p 243 (302)
T cd05055 189 RDIMNDSN-------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243 (302)
T ss_pred ccccCCCc-------------------------eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 54321100 001123346789999999999999999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHcCCC
Q 002342 898 FRGKTRQKTFANILHKDL 915 (934)
Q Consensus 898 f~~~~~~~~~~~i~~~~~ 915 (934)
|.+......+..+.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~ 261 (302)
T cd05055 244 YPGMPVDSKFYKLIKEGY 261 (302)
T ss_pred cCCCCchHHHHHHHHcCC
Confidence 988776655555544433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=291.14 Aligned_cols=223 Identities=17% Similarity=0.260 Sum_probs=184.6
Q ss_pred cccCCcccccccccCCcEEEEEEEEec-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (934)
+..++|++.+.||+|+||.||++.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456789999999999999999998743 35689999886432 22344567899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCchhhhccCCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEE
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPT--------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 812 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~--------~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl 812 (934)
....++||||+++++|.+++..... ..++...+..++.|++.||.|||++|++||||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999999865321 23577888999999999999999999999999999999999999999
Q ss_pred EecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHH
Q 002342 813 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892 (934)
Q Consensus 813 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ell 892 (934)
+|||++........ ........+++.|||||++.+..++.++|+|||||++|+|+
T Consensus 161 ~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 215 (277)
T cd05062 161 GDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 215 (277)
T ss_pred CCCCCccccCCcce-------------------------eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHH
Confidence 99999854321100 00111234678899999999989999999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCC
Q 002342 893 Y-GYTPFRGKTRQKTFANILHKDL 915 (934)
Q Consensus 893 t-G~~Pf~~~~~~~~~~~i~~~~~ 915 (934)
+ |.+||.+.+..+.++.+..+.+
T Consensus 216 ~~~~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05062 216 TLAEQPYQGMSNEQVLRFVMEGGL 239 (277)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCc
Confidence 8 8999999988888887776654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=307.98 Aligned_cols=200 Identities=27% Similarity=0.427 Sum_probs=171.9
Q ss_pred ccCCcccccccccCCcEEEEEEEEe--cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~--~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
...+|.+++.||.|+||.||++... .+++.||+|.+... ....+|+.+|+.++||||++++++|......
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3468999999999999999999764 35678999987643 2345799999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+|||++ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 162 ~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 162 CMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999999 67888888543 45999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
. .........||+.|+|||++.+..++.++|||||||+||+|++|+.||.+..
T Consensus 239 ~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 239 P-------------------------DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred c-------------------------ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 0 0111234679999999999999999999999999999999999999998754
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=290.47 Aligned_cols=216 Identities=25% Similarity=0.361 Sum_probs=181.8
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+..++|++.++||+|+||.||+|.+..++ .||+|.+.+... ....+.+|+.+++.++||||+++++++. ....|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 44578999999999999999999886654 599999875321 2346788999999999999999998875 46689
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
+||||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999999976545568999999999999999999999999999999999999999999999999985432110
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 904 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~ 904 (934)
........++..|+|||++.+..++.++|+|||||++|+|++ |.+||.+....
T Consensus 157 --------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~ 210 (262)
T cd05071 157 --------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 210 (262)
T ss_pred --------------------------cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence 001112346788999999998899999999999999999999 99999988888
Q ss_pred HHHHHHHcC
Q 002342 905 KTFANILHK 913 (934)
Q Consensus 905 ~~~~~i~~~ 913 (934)
+.+..+..+
T Consensus 211 ~~~~~~~~~ 219 (262)
T cd05071 211 EVLDQVERG 219 (262)
T ss_pred HHHHHHhcC
Confidence 888777654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=289.89 Aligned_cols=217 Identities=25% Similarity=0.383 Sum_probs=182.8
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+..++|++.+.||+|+||.||++.+. ++..+|+|.+..... ....+.+|+.+++.++|||++++++++. ....
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI 75 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence 345678999999999999999999874 556799999876432 2346889999999999999999999875 4568
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|++|||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 99999999999999997655566899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~ 903 (934)
. ........++..|+|||++.+..++.++|+||||+++|+|++ |.+||.+.+.
T Consensus 156 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 209 (260)
T cd05070 156 E--------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209 (260)
T ss_pred c--------------------------cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 0 001112245678999999998889999999999999999999 9999999888
Q ss_pred HHHHHHHHcC
Q 002342 904 QKTFANILHK 913 (934)
Q Consensus 904 ~~~~~~i~~~ 913 (934)
.+....+..+
T Consensus 210 ~~~~~~~~~~ 219 (260)
T cd05070 210 REVLEQVERG 219 (260)
T ss_pred HHHHHHHHcC
Confidence 8888877654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=260.83 Aligned_cols=214 Identities=23% Similarity=0.402 Sum_probs=186.7
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
+.|..+++||+|.||+||++++..++..||+|.++-+.. +...-....+|+.+|+.+.|.|||+++++...+..+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 578899999999999999999999999999999886432 2333456788999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||| ..+|..+...- .+.++.+.++.++.|++.||.|+|+.++.||||||.|+||+.+|.+|++|||+++.++..
T Consensus 81 e~c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip---- 154 (292)
T KOG0662|consen 81 EFC-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP---- 154 (292)
T ss_pred HHh-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc----
Confidence 999 77888887664 356999999999999999999999999999999999999999999999999999765321
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHH-hCCCCCCCCCHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEML-YGYTPFRGKTRQKT 906 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~ell-tG~~Pf~~~~~~~~ 906 (934)
.+-.+..+-|.+|.+|.++.+. -|+...|+||.||++.|+. .|+|.|+|.+-.++
T Consensus 155 -----------------------vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq 211 (292)
T KOG0662|consen 155 -----------------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_pred -----------------------eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH
Confidence 1112334679999999999886 4688999999999999999 59999999999999
Q ss_pred HHHHHc
Q 002342 907 FANILH 912 (934)
Q Consensus 907 ~~~i~~ 912 (934)
+++|..
T Consensus 212 lkrif~ 217 (292)
T KOG0662|consen 212 LKRIFR 217 (292)
T ss_pred HHHHHH
Confidence 998864
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=291.10 Aligned_cols=213 Identities=29% Similarity=0.446 Sum_probs=179.8
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEe------C
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT------K 741 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~------~ 741 (934)
+.|++.+.||.|+||.||++.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 57999999999999999999999999999999987532 2335678899999998 79999999999875 2
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
..+|++|||+.+++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999999999999988655556999999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc-----CCCCCchhHHHHHHHHHHHHHhCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYT 896 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~~~DiwSlG~iL~elltG~~ 896 (934)
... ........|++.|+|||++. +..++.++|+|||||++|+|++|..
T Consensus 162 ~~~---------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~ 214 (272)
T cd06637 162 DRT---------------------------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214 (272)
T ss_pred ccc---------------------------cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 110 11223457999999999986 3467889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHc
Q 002342 897 PFRGKTRQKTFANILH 912 (934)
Q Consensus 897 Pf~~~~~~~~~~~i~~ 912 (934)
||...........+..
T Consensus 215 p~~~~~~~~~~~~~~~ 230 (272)
T cd06637 215 PLCDMHPMRALFLIPR 230 (272)
T ss_pred CccccCHHHHHHHHhc
Confidence 9987766655555444
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=288.51 Aligned_cols=202 Identities=40% Similarity=0.654 Sum_probs=176.6
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEc
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 750 (934)
|++.+.||+|+||+||++.+..+++.||+|++...... ........+|+.+++.++||||+++++++......++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-ccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999875322 22223345699999999999999999999999999999999
Q ss_pred cCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCC
Q 002342 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (934)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 830 (934)
+.+++|.+++... ..++...+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-------- 149 (260)
T PF00069_consen 80 CPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-------- 149 (260)
T ss_dssp ETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--------
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------
Confidence 9998999999843 459999999999999999999999999999999999999999999999999985421
Q ss_pred cchhhhccccCCCCcccccccccccccccCCCCccchhhhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
..........+++.|+|||++. +..++.++|+||||+++|+|++|..||....
T Consensus 150 -------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~ 203 (260)
T PF00069_consen 150 -------------------ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN 203 (260)
T ss_dssp -------------------STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS
T ss_pred -------------------cccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 0112234557899999999998 8888999999999999999999999999873
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=290.21 Aligned_cols=225 Identities=24% Similarity=0.353 Sum_probs=186.2
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCC---eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~---~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
+..+|++.+.||+|+||.||++.+..++ ..+|+|.+.... .......+.+|+.+++.++||||+++++++..++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 3468999999999999999999986544 479999886532 23345678889999999999999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|+||||+++++|.+++.... ..++...+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999999997653 4589999999999999999999999999999999999999999999999999865421
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~ 902 (934)
.... ........++..|+|||.+.+..++.++|+|||||++|++++ |..||.+.+
T Consensus 159 ~~~~------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 159 DPEA------------------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred ccce------------------------eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 1100 001112234568999999998889999999999999999886 999999888
Q ss_pred HHHHHHHHHcCCCCCCC
Q 002342 903 RQKTFANILHKDLKFPS 919 (934)
Q Consensus 903 ~~~~~~~i~~~~~~~p~ 919 (934)
..+....+.++ ..+|.
T Consensus 215 ~~~~~~~~~~~-~~~~~ 230 (267)
T cd05066 215 NQDVIKAIEEG-YRLPA 230 (267)
T ss_pred HHHHHHHHhCC-CcCCC
Confidence 88888777765 33443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=297.48 Aligned_cols=222 Identities=19% Similarity=0.311 Sum_probs=179.9
Q ss_pred ccccccccC--CcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 672 RPIKPLGSG--DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 672 ~i~~~LG~G--~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
++++.||+| +|++||++.++.+|+.||+|.+..... .......+.+|+.+++.++||||++++++|..++..|+|||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 356789999 789999999999999999999875432 23445667789999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+.........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~-- 157 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR-- 157 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc--
Confidence 999999999987654455899999999999999999999999999999999999999999999999876332110000
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
. ...........++..|+|||++.+ ..++.++|||||||++|+|++|+.||........+
T Consensus 158 --------------~----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 219 (327)
T cd08227 158 --------------L----RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 219 (327)
T ss_pred --------------c----cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH
Confidence 0 000001123357888999999976 46889999999999999999999999877666655
Q ss_pred HHHHcCC
Q 002342 908 ANILHKD 914 (934)
Q Consensus 908 ~~i~~~~ 914 (934)
.....+.
T Consensus 220 ~~~~~~~ 226 (327)
T cd08227 220 LEKLNGT 226 (327)
T ss_pred HHHhcCC
Confidence 5554443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=291.75 Aligned_cols=223 Identities=21% Similarity=0.343 Sum_probs=186.8
Q ss_pred cccCCcccccccccCCcEEEEEEEEecC-----CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (934)
++..+|.+.+.||.|+||.||++.+..+ +..||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3456799999999999999999988543 5789999987532 23344668889999999999999999999999
Q ss_pred CCeEEEEEEccCCCCchhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQ--------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 806 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~ 806 (934)
....++++||+.+++|.+++... ....++...+..++.|++.||.|||++||+||||||+||+++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 99999999999999999998532 1234788889999999999999999999999999999999999
Q ss_pred CCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHH
Q 002342 807 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 886 (934)
Q Consensus 807 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~ 886 (934)
++.+||+|||++....... .........+++.|+|||++.+..++.++|||||||
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 214 (283)
T cd05091 160 KLNVKISDLGLFREVYAAD-------------------------YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGV 214 (283)
T ss_pred CCceEecccccccccccch-------------------------heeeccCccCCccccCHHHHhcCCCCcchhHHHHHH
Confidence 9999999999985432110 001122335678999999999888999999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCC
Q 002342 887 LLYEMLY-GYTPFRGKTRQKTFANILHKDL 915 (934)
Q Consensus 887 iL~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 915 (934)
++|+|++ |.+||.+.+..+.+..+.++..
T Consensus 215 ~l~el~~~g~~p~~~~~~~~~~~~i~~~~~ 244 (283)
T cd05091 215 VLWEVFSYGLQPYCGYSNQDVIEMIRNRQV 244 (283)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999997 9999999988889988887664
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=290.34 Aligned_cols=214 Identities=30% Similarity=0.500 Sum_probs=186.9
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||.|++|.||++.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++..+..+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47999999999999999999999999999999987542 2344566789999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+++++|.+++... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 152 (274)
T cd06609 79 EYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--- 152 (274)
T ss_pred EeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc---
Confidence 999999999998753 58999999999999999999999999999999999999999999999999986542110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
.......|++.|+|||++.+..++.++|+|||||++|+|++|++||.+.+......
T Consensus 153 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~ 208 (274)
T cd06609 153 ------------------------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF 208 (274)
T ss_pred ------------------------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence 11234568899999999999889999999999999999999999998877766666
Q ss_pred HHHcCC
Q 002342 909 NILHKD 914 (934)
Q Consensus 909 ~i~~~~ 914 (934)
.+..+.
T Consensus 209 ~~~~~~ 214 (274)
T cd06609 209 LIPKNN 214 (274)
T ss_pred HhhhcC
Confidence 665543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=295.07 Aligned_cols=209 Identities=25% Similarity=0.448 Sum_probs=181.0
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
.+|++.+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++||||++++++|..+.+.|+||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC---cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 58999999999999999999999999999999987543 223466888999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+++++|.+++.. ..++...+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 97 e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~---- 169 (296)
T cd06654 97 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 169 (296)
T ss_pred cccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc----
Confidence 99999999999864 34889999999999999999999999999999999999999999999999988542110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
........|++.|+|||.+.+..++.++|+|||||++|+|++|++||...+......
T Consensus 170 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~ 226 (296)
T cd06654 170 -----------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (296)
T ss_pred -----------------------ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH
Confidence 011123468999999999999889999999999999999999999998877655443
Q ss_pred HH
Q 002342 909 NI 910 (934)
Q Consensus 909 ~i 910 (934)
.+
T Consensus 227 ~~ 228 (296)
T cd06654 227 LI 228 (296)
T ss_pred HH
Confidence 33
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=286.86 Aligned_cols=212 Identities=24% Similarity=0.419 Sum_probs=181.3
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE-eCCe
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ-TKTH 743 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~ 743 (934)
.++..+|++.+.||+|+||.||++.. .+..+|+|.+... .....+.+|+.+++.++|+|++++++++. ..+.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 74 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence 46678999999999999999999976 4778999988643 23456889999999999999999998754 5567
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
.|++|||+++++|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 89999999999999999776555689999999999999999999999999999999999999999999999998843210
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~ 902 (934)
......++..|+|||++.+..++.++|||||||++|+|++ |++||...+
T Consensus 155 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 155 ------------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ------------------------------cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 0112234678999999999889999999999999999997 999999888
Q ss_pred HHHHHHHHHcC
Q 002342 903 RQKTFANILHK 913 (934)
Q Consensus 903 ~~~~~~~i~~~ 913 (934)
..+....+..+
T Consensus 205 ~~~~~~~~~~~ 215 (256)
T cd05082 205 LKDVVPRVEKG 215 (256)
T ss_pred HHHHHHHHhcC
Confidence 87777777654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=287.32 Aligned_cols=214 Identities=24% Similarity=0.393 Sum_probs=180.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
..+|++.+.||+|+||.||++.+. ++..+|+|.+.+... ....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 457999999999999999999885 466899999875422 224577899999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-- 154 (256)
T cd05059 78 TEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-- 154 (256)
T ss_pred EecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc--
Confidence 99999999999987643 358999999999999999999999999999999999999999999999999885432100
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~ 906 (934)
........++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...+..+.
T Consensus 155 ------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 210 (256)
T cd05059 155 ------------------------YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV 210 (256)
T ss_pred ------------------------ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH
Confidence 000111224568999999999999999999999999999998 8999998888888
Q ss_pred HHHHHcC
Q 002342 907 FANILHK 913 (934)
Q Consensus 907 ~~~i~~~ 913 (934)
...+..+
T Consensus 211 ~~~~~~~ 217 (256)
T cd05059 211 VESVSAG 217 (256)
T ss_pred HHHHHcC
Confidence 8777654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=307.66 Aligned_cols=197 Identities=27% Similarity=0.378 Sum_probs=169.7
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
...+|.+.+.||+|+||.||++.+..+++.||||.... ..+.+|+.+|+.++||||+++++++..++..|+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 35689999999999999999999999999999996432 235679999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
|||++ .++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 238 v~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 238 VLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 99999 678988886542 4599999999999999999999999999999999999999999999999999864321100
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
.......+||+.|||||++.+..++.++|||||||+||||++|..|+.
T Consensus 316 -------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 316 -------------------------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred -------------------------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 011124579999999999999999999999999999999999876554
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=290.10 Aligned_cols=212 Identities=26% Similarity=0.412 Sum_probs=178.1
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
+|++.+.||+|++|.||++.+..++..||+|.+.... ........+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 5899999999999999999999999999999986532 222334567889999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 750 YCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
|+. ++|.+++.... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 154 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---- 154 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC----
Confidence 995 68888876533 256899999999999999999999999999999999999999999999999998543211
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
........+++.|+|||++.+. .++.++|+|||||++|+|++|++||.+.+.....
T Consensus 155 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~ 211 (285)
T cd07861 155 -----------------------VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL 211 (285)
T ss_pred -----------------------cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 0111233578999999998754 5688999999999999999999999987766554
Q ss_pred HHH
Q 002342 908 ANI 910 (934)
Q Consensus 908 ~~i 910 (934)
..+
T Consensus 212 ~~~ 214 (285)
T cd07861 212 FRI 214 (285)
T ss_pred HHH
Confidence 443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=287.43 Aligned_cols=219 Identities=30% Similarity=0.440 Sum_probs=186.2
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||.|+||.||++.+..+++.||+|.++............+.+|+.+++.++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999999899999999987644444555678889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 749 DYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 749 E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||+++++|..++... ....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-- 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence 999999999988642 2345899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--HH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT--RQ 904 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~--~~ 904 (934)
........|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.... ..
T Consensus 160 -------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08224 160 -------------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred -------------------------CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH
Confidence 011123468899999999999999999999999999999999999996543 34
Q ss_pred HHHHHHHcCC
Q 002342 905 KTFANILHKD 914 (934)
Q Consensus 905 ~~~~~i~~~~ 914 (934)
+....+..+.
T Consensus 215 ~~~~~~~~~~ 224 (267)
T cd08224 215 SLCKKIEKCD 224 (267)
T ss_pred HHHhhhhcCC
Confidence 4555555543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=286.82 Aligned_cols=218 Identities=26% Similarity=0.383 Sum_probs=182.7
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeeccc--ccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC--CeE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV--MLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THV 744 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~--~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~ 744 (934)
.+|.+.+.||+|+||.||++.+..+++.||+|.+.... .........+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999875421 12344566788999999999999999999998763 568
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 9999999999999998764 34889999999999999999999999999999999999999999999999998543110
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
. ..........|+..|+|||++.+..++.++|+|||||++|+|++|++||......
T Consensus 160 ~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 215 (264)
T cd06653 160 C------------------------MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM 215 (264)
T ss_pred c------------------------ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH
Confidence 0 0001112356899999999999888899999999999999999999999887766
Q ss_pred HHHHHHHc
Q 002342 905 KTFANILH 912 (934)
Q Consensus 905 ~~~~~i~~ 912 (934)
..+.++..
T Consensus 216 ~~~~~~~~ 223 (264)
T cd06653 216 AAIFKIAT 223 (264)
T ss_pred HHHHHHHc
Confidence 66655543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=288.16 Aligned_cols=216 Identities=25% Similarity=0.396 Sum_probs=183.1
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+..++|+++++||+|+||.||+|.. .+++.||+|.+..... ....+.+|+.+++.++||||+++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 4567899999999999999999986 4567899999875432 2356788999999999999999999874 46789
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
++|||+.+++|.+++.......++...+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999999999876655679999999999999999999999999999999999999999999999999985432100
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 904 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~ 904 (934)
........++..|+|||++.+..++.++|+||||+++|+|++ |++||.+.+..
T Consensus 157 --------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 210 (260)
T cd05067 157 --------------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP 210 (260)
T ss_pred --------------------------cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH
Confidence 001122346788999999998889999999999999999998 99999998888
Q ss_pred HHHHHHHcC
Q 002342 905 KTFANILHK 913 (934)
Q Consensus 905 ~~~~~i~~~ 913 (934)
+....+..+
T Consensus 211 ~~~~~~~~~ 219 (260)
T cd05067 211 EVIQNLERG 219 (260)
T ss_pred HHHHHHHcC
Confidence 887777554
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=284.39 Aligned_cols=217 Identities=27% Similarity=0.450 Sum_probs=187.0
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||.|+||.||++.+..+++.+++|++... .......+.+|+.+++.++||||+++++++...+.+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE---PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC---chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 5899999999999999999999999999999998754 2335677889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+.+++|.+++.... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~---- 154 (262)
T cd06613 80 EYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT---- 154 (262)
T ss_pred eCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh----
Confidence 9999999999887642 45999999999999999999999999999999999999999999999999998542110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~---~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
........|+..|+|||.+.+. .++.++|+|||||++|+|++|++||.+.+...
T Consensus 155 -----------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~ 211 (262)
T cd06613 155 -----------------------IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR 211 (262)
T ss_pred -----------------------hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0112345688899999999777 78889999999999999999999999887766
Q ss_pred HHHHHHcCCCC
Q 002342 906 TFANILHKDLK 916 (934)
Q Consensus 906 ~~~~i~~~~~~ 916 (934)
....+....+.
T Consensus 212 ~~~~~~~~~~~ 222 (262)
T cd06613 212 ALFLISKSNFP 222 (262)
T ss_pred HHHHHHhccCC
Confidence 66666555443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=295.08 Aligned_cols=223 Identities=23% Similarity=0.345 Sum_probs=183.7
Q ss_pred ccccCCcccccccccCCcEEEEEEEEec-------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 736 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~-------~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 736 (934)
.+..++|.+.+.||+|+||.||++.+.. +...+|+|.+.+.. .......+.+|+.+++.+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3445789999999999999999998753 23579999987542 233456788899999999 7999999999
Q ss_pred EEEeCCeEEEEEEccCCCCchhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 002342 737 SFQTKTHVCLITDYCPGGELFLLLDRQPT--------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802 (934)
Q Consensus 737 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NI 802 (934)
++...+..|+||||+++++|.+++..+.. ..++...+..++.|++.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 99999999999999999999999975421 3488899999999999999999999999999999999
Q ss_pred EEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHH
Q 002342 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882 (934)
Q Consensus 803 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Diw 882 (934)
+++.++.+||+|||++........ ........+++.|+|||++.+..++.++|+|
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 226 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDY-------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 226 (307)
T ss_pred EEcCCCcEEECCCcccccccccch-------------------------hhccccCCCccceeChHHhccCCCCcHHHHH
Confidence 999999999999999854321000 0011122345789999999998899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 002342 883 ALGILLYEMLY-GYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 883 SlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~ 914 (934)
||||++|+|++ |.+||.+....++...+..+.
T Consensus 227 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 259 (307)
T cd05098 227 SFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 259 (307)
T ss_pred HHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCC
Confidence 99999999998 999999888777777776554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=315.81 Aligned_cols=230 Identities=25% Similarity=0.407 Sum_probs=195.8
Q ss_pred cccCCcccccccccCCcEEEEEEEEec-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (934)
+...+-.+.+.||+|+||+||+++... +...||||.++... +.+...+|.+|+++|..++|||||+|++++..
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 445677888999999999999998854 34689999998653 45567889999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCchhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQP------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 808 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~ 808 (934)
++.+|||+|||..|+|.++|.... ...++..+...|+.||+.||+||-++.+|||||...|+||..+.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 999999999999999999997531 12388999999999999999999999999999999999999999
Q ss_pred cEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHH
Q 002342 809 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888 (934)
Q Consensus 809 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL 888 (934)
.|||+|||+++..... +.++ ......-..+|||||.++-++|+.+||||||||+|
T Consensus 641 ~VKIsDfGLsRdiYss---------DYYk----------------~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvL 695 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSS---------DYYK----------------VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVL 695 (774)
T ss_pred EEEecccccchhhhhh---------hhhc----------------ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhh
Confidence 9999999999654321 1111 11122346789999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCC
Q 002342 889 YEMLY-GYTPFRGKTRQKTFANILHKDL-KFPSSTP 922 (934)
Q Consensus 889 ~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~ 922 (934)
||+++ |+-||.+.+++++++.|.+|.+ +-|...|
T Consensus 696 WEIFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP 731 (774)
T KOG1026|consen 696 WEIFSYGKQPYYGLSNQEVIECIRAGQLLSCPENCP 731 (774)
T ss_pred hhhhccccCcccccchHHHHHHHHcCCcccCCCCCC
Confidence 99996 9999999999999999999886 5555443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=263.48 Aligned_cols=225 Identities=27% Similarity=0.415 Sum_probs=186.9
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCC
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 742 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 742 (934)
..+.-+....+..||+|+||.|-+.++..+|...|+|.+.... ..+..+++.+|+.+.... .+|++|.||+.+....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 4455567777889999999999999999999999999987543 344556778888886555 7999999999999999
Q ss_pred eEEEEEEccCCCCchhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 743 HVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
.+||.||.| ..||..+..+ ..++.+++..+-+|+..++.||.|||++ .+||||+||+||||+.+|+||+||||+|.
T Consensus 119 dvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999999 7777666443 2356799999999999999999999987 99999999999999999999999999996
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC----CCCCchhHHHHHHHHHHHHHhCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----AGHTSAVDWWALGILLYEMLYGY 895 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~----~~~s~~~DiwSlG~iL~elltG~ 895 (934)
.+..+- ..+...|...|||||.+.. ..|+.++||||||++++||.+++
T Consensus 198 ~L~dSi----------------------------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr 249 (282)
T KOG0984|consen 198 YLVDSI----------------------------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILR 249 (282)
T ss_pred eehhhh----------------------------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcc
Confidence 543221 1123468889999999843 47889999999999999999999
Q ss_pred CCCCC-CCHHHHHHHHHcCCC-CCCC
Q 002342 896 TPFRG-KTRQKTFANILHKDL-KFPS 919 (934)
Q Consensus 896 ~Pf~~-~~~~~~~~~i~~~~~-~~p~ 919 (934)
.||.. .++.+++++++...- ++|.
T Consensus 250 ~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 250 FPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred ccccccCCHHHHHHHHhcCCCCCCcc
Confidence 99984 777899999987553 4444
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=289.57 Aligned_cols=223 Identities=17% Similarity=0.265 Sum_probs=184.3
Q ss_pred ccccCCcccccccccCCcEEEEEEEEec-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 739 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 739 (934)
.++.++|++.+.||+|+||.||++.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4566899999999999999999997653 35689999876432 2233456778999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCchhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEE
Q 002342 740 TKTHVCLITDYCPGGELFLLLDRQP--------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 811 (934)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vk 811 (934)
..+..|+||||+++++|.+++.... ...++...+..++.|++.||.|||++||+||||||+||+++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999999996532 12356778889999999999999999999999999999999999999
Q ss_pred EEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHH
Q 002342 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891 (934)
Q Consensus 812 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~el 891 (934)
|+|||++........ ........++..|+|||.+.+..++.++|+|||||++|+|
T Consensus 160 L~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el 214 (288)
T cd05061 160 IGDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214 (288)
T ss_pred ECcCCcccccccccc-------------------------ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHH
Confidence 999999854321100 0111223467789999999998999999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCC
Q 002342 892 LY-GYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 892 lt-G~~Pf~~~~~~~~~~~i~~~~ 914 (934)
++ |.+||.+.+..+.++.+..+.
T Consensus 215 ~~~~~~p~~~~~~~~~~~~~~~~~ 238 (288)
T cd05061 215 TSLAEQPYQGLSNEQVLKFVMDGG 238 (288)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCC
Confidence 98 899999988888888777654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=293.16 Aligned_cols=226 Identities=23% Similarity=0.358 Sum_probs=188.6
Q ss_pred cccccccCCcccccccccCCcEEEEEEEEecC-----CeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcccee
Q 002342 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 735 (934)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~ 735 (934)
+...+..++|++.+.||+|+||.||++.+... ...+|+|.+.... .......+.+|+.+++.+ +||||++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 82 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 82 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 34556778999999999999999999998644 3789999987542 233446688999999999 899999999
Q ss_pred EEEEeCCeEEEEEEccCCCCchhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 002342 736 ASFQTKTHVCLITDYCPGGELFLLLDRQ--------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801 (934)
Q Consensus 736 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~N 801 (934)
+++...+.+|++|||+++++|..++... ....+++..+..++.|++.||.|||++||+||||||+|
T Consensus 83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N 162 (293)
T cd05053 83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN 162 (293)
T ss_pred EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence 9999999999999999999999998642 23568999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHH
Q 002342 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (934)
Q Consensus 802 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Di 881 (934)
|+++.++.+||+|||++........ ........+++.|+|||++.+..++.++||
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 217 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDY-------------------------YRKTTNGRLPVKWMAPEALFDRVYTHQSDV 217 (293)
T ss_pred EEEcCCCeEEeCccccccccccccc-------------------------eeccCCCCCCccccCHHHhccCCcCcccce
Confidence 9999999999999999864321100 001112235678999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 002342 882 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 882 wSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~ 914 (934)
|||||++|+|++ |..||.+....+.+..+..+.
T Consensus 218 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 251 (293)
T cd05053 218 WSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGY 251 (293)
T ss_pred eehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999999997 999999988888887776654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=292.29 Aligned_cols=216 Identities=24% Similarity=0.345 Sum_probs=180.9
Q ss_pred CCcccccccccCCcEEEEEEEEecCCe--EEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~--~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~ 745 (934)
++|++.+.||.|+||.||++.+..++. .+++|.++.. ........+.+|+.++.++ +||||+++++++...+..|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877764 4688877632 2334456788999999999 7999999999999999999
Q ss_pred EEEEccCCCCchhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEE
Q 002342 746 LITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 811 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vk 811 (934)
+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999986532 13488999999999999999999999999999999999999999999
Q ss_pred EEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHH
Q 002342 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891 (934)
Q Consensus 812 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~el 891 (934)
|+|||++..... .........+..|+|||++.+..++.++|||||||++|+|
T Consensus 160 l~dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 211 (297)
T cd05089 160 IADFGLSRGEEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211 (297)
T ss_pred ECCcCCCccccc----------------------------eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHH
Confidence 999998742100 0001111235679999999998899999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCC
Q 002342 892 LY-GYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 892 lt-G~~Pf~~~~~~~~~~~i~~~~ 914 (934)
++ |.+||.+.+..+.+..+..+.
T Consensus 212 ~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 212 VSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred HcCCCCCCCCCCHHHHHHHHhcCC
Confidence 97 999999998888888877653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=288.48 Aligned_cols=219 Identities=21% Similarity=0.324 Sum_probs=181.5
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~----~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
+..++|++.+.||.|+||.||++.+..++. .||+|.+.... .......+.+|+.+++.++||||+.+++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 456789999999999999999999877766 48999886532 34445678899999999999999999999875
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
...+++|||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||++...
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 45789999999999999987542 45999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~ 900 (934)
..... ........+++.|+|||.+.+..++.++|||||||++|||++ |.+||..
T Consensus 160 ~~~~~-------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 160 DIDET-------------------------EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred ccccc-------------------------eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 21100 000111235678999999999999999999999999999998 9999988
Q ss_pred CCHHHHHHHHHcC
Q 002342 901 KTRQKTFANILHK 913 (934)
Q Consensus 901 ~~~~~~~~~i~~~ 913 (934)
.........+..+
T Consensus 215 ~~~~~~~~~~~~~ 227 (279)
T cd05109 215 IPAREIPDLLEKG 227 (279)
T ss_pred CCHHHHHHHHHCC
Confidence 7777766665554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=284.95 Aligned_cols=225 Identities=21% Similarity=0.328 Sum_probs=182.1
Q ss_pred ccccCCcEEEEEEEE--ecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCC
Q 002342 676 PLGSGDTGSVHLVEL--CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 753 (934)
Q Consensus 676 ~LG~G~~g~Vy~a~~--~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 753 (934)
.||+|+||.||++.+ ..++..+|+|++... .........+.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND-NNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCC-CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 689999999999965 457889999998654 2344556778899999999999999999998764 567999999999
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~------ 151 (257)
T cd05116 80 GPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY------ 151 (257)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe------
Confidence 9999998754 45899999999999999999999999999999999999999999999999998553211100
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHc
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILH 912 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~ 912 (934)
........+++.|+|||.+....++.++|+|||||++|+|++ |.+||.+.+..+..+.+.+
T Consensus 152 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~ 213 (257)
T cd05116 152 ------------------YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES 213 (257)
T ss_pred ------------------eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC
Confidence 001112245689999999988889999999999999999997 9999998888888888876
Q ss_pred CCC-CCCCCCCCCcccCCC
Q 002342 913 KDL-KFPSSTPSSCKAANV 930 (934)
Q Consensus 913 ~~~-~~p~~~~~s~~~k~l 930 (934)
+.. ++|. ..+.++++|
T Consensus 214 ~~~~~~~~--~~~~~l~~l 230 (257)
T cd05116 214 GERMECPQ--RCPPEMYDL 230 (257)
T ss_pred CCCCCCCC--CCCHHHHHH
Confidence 553 3333 234444444
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=303.63 Aligned_cols=225 Identities=24% Similarity=0.329 Sum_probs=183.0
Q ss_pred cccccCCcccccccccCCcEEEEEEEEe-----cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEE
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYAS 737 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~ 737 (934)
+.+..++|.+.+.||+|+||.||++++. .+++.||+|++.... .......+.+|+.+|..+. ||||++++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 4466678999999999999999999964 345789999997542 2233456889999999997 9999999999
Q ss_pred EEeCCeEEEEEEccCCCCchhhhccCCC----------------------------------------------------
Q 002342 738 FQTKTHVCLITDYCPGGELFLLLDRQPT---------------------------------------------------- 765 (934)
Q Consensus 738 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------------------------------------- 765 (934)
+...+..|+|||||.+|+|.+++.+...
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 9999999999999999999999865321
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 002342 766 --------------------------------------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801 (934)
Q Consensus 766 --------------------------------------------~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~N 801 (934)
..++...+..++.||+.||.|||++||+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 246777888999999999999999999999999999
Q ss_pred EEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHH
Q 002342 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (934)
Q Consensus 802 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Di 881 (934)
||++.++.+||+|||++........ ........+++.|||||++.+..++.++||
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 324 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSN-------------------------YISKGSTFLPLKWMAPESIFNNLYTTLSDV 324 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccc-------------------------cccCCCcCCCCceeChHHhcCCCCCcHhHH
Confidence 9999999999999999854211000 011123457889999999999889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC
Q 002342 882 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDL 915 (934)
Q Consensus 882 wSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 915 (934)
|||||++|+|++ |..||......+.+...+.+..
T Consensus 325 wslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~ 359 (401)
T cd05107 325 WSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY 359 (401)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCC
Confidence 999999999998 9999987666665555444443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=287.38 Aligned_cols=220 Identities=39% Similarity=0.716 Sum_probs=188.2
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
+|++.+.||.|+||.||++.+..++..||+|++.+.........+.+.+|++++++++||||+++++++....+.|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 48999999999999999999998999999999987554454567788999999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+.|++|..++... ..+++..+..++.||+.||.|||.+|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~----- 153 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD----- 153 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC-----
Confidence 99999999998765 45999999999999999999999999999999999999999999999999998543211
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR---QKT 906 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~---~~~ 906 (934)
.......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+. ..+
T Consensus 154 -----------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 210 (258)
T cd05578 154 -----------------------TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210 (258)
T ss_pred -----------------------ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH
Confidence 011234688899999999988899999999999999999999999998774 344
Q ss_pred HHHHHcCCCCCCC
Q 002342 907 FANILHKDLKFPS 919 (934)
Q Consensus 907 ~~~i~~~~~~~p~ 919 (934)
...+......+|.
T Consensus 211 ~~~~~~~~~~~~~ 223 (258)
T cd05578 211 RAKQETADVLYPA 223 (258)
T ss_pred HHHhccccccCcc
Confidence 4333334444443
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=286.23 Aligned_cols=218 Identities=23% Similarity=0.291 Sum_probs=185.0
Q ss_pred cCCcccccccccCCcEEEEEEEEecC---CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.++|++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 46799999999999999999998654 4589999887542 334456688899999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|++|||+++++|.+++.... ..++...+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999987653 36899999999999999999999999999999999999999999999999998654211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~ 903 (934)
.. ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 160 ~~-------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~ 214 (266)
T cd05033 160 EA-------------------------TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214 (266)
T ss_pred cc-------------------------ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH
Confidence 00 001112235678999999998899999999999999999997 9999998888
Q ss_pred HHHHHHHHcC
Q 002342 904 QKTFANILHK 913 (934)
Q Consensus 904 ~~~~~~i~~~ 913 (934)
.+....+..+
T Consensus 215 ~~~~~~~~~~ 224 (266)
T cd05033 215 QDVIKAVEDG 224 (266)
T ss_pred HHHHHHHHcC
Confidence 8888877664
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=283.96 Aligned_cols=218 Identities=25% Similarity=0.374 Sum_probs=186.8
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+..++|++.+.||.|+||.||++.+. +++.+|+|.+..... ....+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 356789999999999999999999975 557899999875422 235688899999999999999999999998999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
++||||+++++|.+++.......++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999999998765567999999999999999999999999999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~ 903 (934)
. ........++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+.
T Consensus 157 ~--------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 210 (261)
T cd05034 157 E--------------------------YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210 (261)
T ss_pred h--------------------------hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 0 000112234678999999999889999999999999999998 9999999888
Q ss_pred HHHHHHHHcC
Q 002342 904 QKTFANILHK 913 (934)
Q Consensus 904 ~~~~~~i~~~ 913 (934)
...+..+..+
T Consensus 211 ~~~~~~~~~~ 220 (261)
T cd05034 211 REVLEQVERG 220 (261)
T ss_pred HHHHHHHHcC
Confidence 8888888664
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=285.48 Aligned_cols=218 Identities=23% Similarity=0.358 Sum_probs=183.7
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
+.++|++.+.||+|+||.||++.+.. +..+|+|.+..... ....+.+|+.+++.++||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 34679999999999999999998743 45699998875422 23567889999999999999999999999899999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||||+.+++|.+++.... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 77 v~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~- 154 (256)
T cd05113 77 VTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE- 154 (256)
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-
Confidence 999999999999987643 358999999999999999999999999999999999999999999999999885432110
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK 905 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~ 905 (934)
........++..|+|||++.+..++.++|+|||||++|+|++ |..||...+..+
T Consensus 155 -------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~ 209 (256)
T cd05113 155 -------------------------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE 209 (256)
T ss_pred -------------------------eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 001112245678999999998889999999999999999998 999999888888
Q ss_pred HHHHHHcCCCC
Q 002342 906 TFANILHKDLK 916 (934)
Q Consensus 906 ~~~~i~~~~~~ 916 (934)
....+.++...
T Consensus 210 ~~~~~~~~~~~ 220 (256)
T cd05113 210 TVEKVSQGLRL 220 (256)
T ss_pred HHHHHhcCCCC
Confidence 88888776543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=283.15 Aligned_cols=211 Identities=22% Similarity=0.332 Sum_probs=176.9
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 754 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg 754 (934)
+.||+|+||.||++.+..+++.||+|.+.+.. .......+.+|+.+++.++||||+++++++......|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999999999999999876432 3444567889999999999999999999999999999999999999
Q ss_pred CchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchh
Q 002342 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834 (934)
Q Consensus 755 sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 834 (934)
+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 79 ~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-------- 149 (252)
T cd05084 79 DFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-------- 149 (252)
T ss_pred cHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc--------
Confidence 9999986542 4589999999999999999999999999999999999999999999999999853211000
Q ss_pred hhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC
Q 002342 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~ 913 (934)
........++..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+.......+..+
T Consensus 150 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~ 212 (252)
T cd05084 150 -----------------ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG 212 (252)
T ss_pred -----------------cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC
Confidence 000011123567999999999889999999999999999997 99999888877776666553
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=296.14 Aligned_cols=199 Identities=28% Similarity=0.430 Sum_probs=161.6
Q ss_pred ccccccCCcEEEEEEEEe--cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe--CCeEEEEEE
Q 002342 674 IKPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVCLITD 749 (934)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~--~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~lV~E 749 (934)
.++||+|+||.||+|.++ .+++.||+|.+.... ....+.+|+.+|+.++||||++++++|.. +..+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 357999999999999975 467899999886532 12346789999999999999999999854 567899999
Q ss_pred ccCCCCchhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE----ecCCcEEEEecccC
Q 002342 750 YCPGGELFLLLDRQ-------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL----QGNGHVSLTDFDLS 818 (934)
Q Consensus 750 ~~~ggsL~~~l~~~-------~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl----~~~~~vkl~DFG~a 818 (934)
|+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 99 66888876532 12358999999999999999999999999999999999999 45678999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~P 897 (934)
....... .+.......+||+.|+|||++.+. .++.++|||||||++|+|++|++|
T Consensus 160 ~~~~~~~------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 215 (317)
T cd07868 160 RLFNSPL------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred eccCCCC------------------------ccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 6532110 011122345789999999999874 578899999999999999999999
Q ss_pred CCCCC
Q 002342 898 FRGKT 902 (934)
Q Consensus 898 f~~~~ 902 (934)
|.+..
T Consensus 216 f~~~~ 220 (317)
T cd07868 216 FHCRQ 220 (317)
T ss_pred ccCCc
Confidence 97543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=292.67 Aligned_cols=223 Identities=22% Similarity=0.342 Sum_probs=186.0
Q ss_pred ccccCCcccccccccCCcEEEEEEEEe-------cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 736 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~-------~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 736 (934)
.+..++|++.+.||+|+||.||++++. .++..+|+|.+.... .......+.+|+.+++.+ +||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 356788999999999999999999853 234589999886532 234456788999999999 8999999999
Q ss_pred EEEeCCeEEEEEEccCCCCchhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 002342 737 SFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802 (934)
Q Consensus 737 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NI 802 (934)
++......|++|||+.+++|.+++.... ...++...+..++.||+.||.|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 9999999999999999999999987542 13478888999999999999999999999999999999
Q ss_pred EEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHH
Q 002342 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882 (934)
Q Consensus 803 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Diw 882 (934)
+++.++.+||+|||++........ ........+++.|+|||++.+..++.++|||
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 223 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDY-------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 223 (304)
T ss_pred EEcCCCcEEECCCccceecccccc-------------------------cccccCCCCCceeeCchhhccCCCCchhhHH
Confidence 999999999999999864321100 0111223467789999999998899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 002342 883 ALGILLYEMLY-GYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 883 SlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~ 914 (934)
|||+++|+|++ |..||.+.+..+++..+..+.
T Consensus 224 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 256 (304)
T cd05101 224 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 256 (304)
T ss_pred HHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC
Confidence 99999999998 899999988888888876554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-33 Score=293.97 Aligned_cols=242 Identities=29% Similarity=0.470 Sum_probs=198.3
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccC----hHHHHHHHHHHHHHHhCCCCCccceeEEEE-eCC
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN----RNKVHRACAEREILDMLDHPFVPALYASFQ-TKT 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~----~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~ 742 (934)
.++|-++..||+|||+.||++.|....++||+|+-..+.... ....+...+|..|.+.|+||.||++|++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 478999999999999999999999999999999865332221 223455678999999999999999999997 567
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CCeecCCCCCCEEEec---CCcEEEEeccc
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ--GIIYRDLKPENVLLQG---NGHVSLTDFDL 817 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~--giiHrDLKp~NILl~~---~~~vkl~DFG~ 817 (934)
.+|-|+|||+|.+|.-+++.. +.+++.+++.|+.||+.||.||... .|||=||||.|||+.+ .|.+||+|||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 889999999999999998764 6699999999999999999999987 6999999999999964 46799999999
Q ss_pred CcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC----CCCchhHHHHHHHHHHHHHh
Q 002342 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA----GHTSAVDWWALGILLYEMLY 893 (934)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~----~~s~~~DiwSlG~iL~ellt 893 (934)
++++.+++... ......+....||.+|++||++.-+ +.+.++||||+||++|.+++
T Consensus 620 SKIMdddSy~~--------------------vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY 679 (775)
T KOG1151|consen 620 SKIMDDDSYNS--------------------VDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY 679 (775)
T ss_pred hhhccCCccCc--------------------ccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc
Confidence 99886554321 1122345677899999999998543 55779999999999999999
Q ss_pred CCCCCCCCCH-HHHHH--HHH-cCCCCCCCCCCCCcccCCCC
Q 002342 894 GYTPFRGKTR-QKTFA--NIL-HKDLKFPSSTPSSCKAANVP 931 (934)
Q Consensus 894 G~~Pf~~~~~-~~~~~--~i~-~~~~~~p~~~~~s~~~k~l~ 931 (934)
|+-||...-. +++++ -|+ ....+||.-+-.|..+|+|+
T Consensus 680 GrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFI 721 (775)
T KOG1151|consen 680 GRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFI 721 (775)
T ss_pred cCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHH
Confidence 9999975433 34433 343 45689999888888888774
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=283.97 Aligned_cols=220 Identities=29% Similarity=0.450 Sum_probs=184.7
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccC------hHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN------RNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~------~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
+|.+.+.||.|++|.||+|.+..+++.||+|.+....... ......+.+|+.+++.++||||+++++++...++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999998899999999887543322 1234567889999999999999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999999764 4589999999999999999999999999999999999999999999999999865431
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
.... ...........|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 159 ~~~~---------------------~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 217 (267)
T cd06628 159 NSLS---------------------TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217 (267)
T ss_pred cccc---------------------CCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH
Confidence 1100 0001112345689999999999998899999999999999999999999988777
Q ss_pred HHHHHHHHc
Q 002342 904 QKTFANILH 912 (934)
Q Consensus 904 ~~~~~~i~~ 912 (934)
...+..+..
T Consensus 218 ~~~~~~~~~ 226 (267)
T cd06628 218 LQAIFKIGE 226 (267)
T ss_pred HHHHHHHhc
Confidence 666655544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=286.98 Aligned_cols=220 Identities=21% Similarity=0.324 Sum_probs=180.1
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~----~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
+..++|++.+.||.|+||.||++.+..++. .+++|.+... ........+..|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~- 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG- 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence 345789999999999999999999977776 4666766432 123344567788889999999999999998754
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
...+++|||+++++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 56789999999999999997643 45899999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~ 900 (934)
..... ........|+..|+|||.+.+..++.++|||||||++|+|++ |..||.+
T Consensus 160 ~~~~~-------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 214 (279)
T cd05111 160 YPDDK-------------------------KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214 (279)
T ss_pred cCCCc-------------------------ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 21100 011123457788999999998899999999999999999998 9999998
Q ss_pred CCHHHHHHHHHcCC
Q 002342 901 KTRQKTFANILHKD 914 (934)
Q Consensus 901 ~~~~~~~~~i~~~~ 914 (934)
.......+.+..+.
T Consensus 215 ~~~~~~~~~~~~~~ 228 (279)
T cd05111 215 MRPHEVPDLLEKGE 228 (279)
T ss_pred CCHHHHHHHHHCCC
Confidence 88777666665544
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=286.87 Aligned_cols=220 Identities=23% Similarity=0.327 Sum_probs=183.3
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCe---EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~---~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
...|++.+.||.|+||.||+|.+..+++ .||+|.+.+.. .......+..|+.+++.++||||+++++++..+...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4579999999999999999999987664 69999987532 344557788999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
++||||+++++|.+++.... ..++...++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 81 MIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999999987643 45899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~ 903 (934)
... ..........++..|+|||++.+..++.++|||||||++|++++ |..||...+.
T Consensus 160 ~~~----------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~ 217 (269)
T cd05065 160 TSD----------------------PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217 (269)
T ss_pred ccc----------------------cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH
Confidence 100 00000011112467999999999999999999999999999886 9999999888
Q ss_pred HHHHHHHHc
Q 002342 904 QKTFANILH 912 (934)
Q Consensus 904 ~~~~~~i~~ 912 (934)
.+....+..
T Consensus 218 ~~~~~~i~~ 226 (269)
T cd05065 218 QDVINAIEQ 226 (269)
T ss_pred HHHHHHHHc
Confidence 888877754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=286.07 Aligned_cols=220 Identities=23% Similarity=0.317 Sum_probs=184.1
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCe---EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~---~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
..+.|+..+.||+|+||.||+|.++.++. .+|+|.+.... .......+.+|+++++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 34678999999999999999999976654 79999886532 23345678899999999999999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
.|+||||+++++|.+++.... ..++...+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999987543 4589999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~ 902 (934)
.... .........++.|+|||++.+..++.++|||||||++|+|++ |+.||...+
T Consensus 160 ~~~~------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 160 DPEG------------------------TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred cccc------------------------ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 1000 000111223567999999998889999999999999999997 999999988
Q ss_pred HHHHHHHHHcC
Q 002342 903 RQKTFANILHK 913 (934)
Q Consensus 903 ~~~~~~~i~~~ 913 (934)
..+....|..+
T Consensus 216 ~~~~~~~i~~~ 226 (268)
T cd05063 216 NHEVMKAINDG 226 (268)
T ss_pred HHHHHHHHhcC
Confidence 88888888654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=288.65 Aligned_cols=220 Identities=21% Similarity=0.305 Sum_probs=185.1
Q ss_pred ccCCcccccccccCCcEEEEEEEEe-----cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
+..+|.+.+.||+|+||.||++... .++..+|+|.+... .......+.+|+++++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 3467899999999999999999753 35678999987643 344556788999999999999999999999999
Q ss_pred CeEEEEEEccCCCCchhhhccCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC
Q 002342 742 THVCLITDYCPGGELFLLLDRQPT-------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 808 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~-------------~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~ 808 (934)
+..|++|||+++++|.+++..... ..+++..+..++.||+.||+|||++|++||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 999999999999999999875421 3488999999999999999999999999999999999999999
Q ss_pred cEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHH
Q 002342 809 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888 (934)
Q Consensus 809 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL 888 (934)
.+||+|||++....... .........+++.|+|||++.+..++.++|||||||++
T Consensus 160 ~~kL~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 214 (280)
T cd05092 160 VVKIGDFGMSRDIYSTD-------------------------YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVL 214 (280)
T ss_pred CEEECCCCceeEcCCCc-------------------------eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHH
Confidence 99999999985432110 00111233467889999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 002342 889 YEMLY-GYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 889 ~ellt-G~~Pf~~~~~~~~~~~i~~~~ 914 (934)
|+|++ |.+||......+.+..+..+.
T Consensus 215 ~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 215 WEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred HHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 99998 999999888888888777654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=285.37 Aligned_cols=216 Identities=25% Similarity=0.352 Sum_probs=181.0
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+..++|.+...||+|++|.||++.+..+ ..+|+|.+.... .....+.+|+.+++.++|||++++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 4456799999999999999999988555 468999876532 22356788999999999999999998875 46689
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
++|||+.+++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||++++++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999999999976555568999999999999999999999999999999999999999999999999985432100
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 904 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~ 904 (934)
........++..|+|||.+.+..++.++|+||||+++|+|++ |.+||.+....
T Consensus 157 --------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 210 (260)
T cd05069 157 --------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR 210 (260)
T ss_pred --------------------------ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 001112346778999999998889999999999999999999 99999998888
Q ss_pred HHHHHHHcC
Q 002342 905 KTFANILHK 913 (934)
Q Consensus 905 ~~~~~i~~~ 913 (934)
+....+..+
T Consensus 211 ~~~~~~~~~ 219 (260)
T cd05069 211 EVLEQVERG 219 (260)
T ss_pred HHHHHHHcC
Confidence 888777654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=284.62 Aligned_cols=214 Identities=42% Similarity=0.769 Sum_probs=185.0
Q ss_pred cccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCCCc
Q 002342 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 756 (934)
Q Consensus 677 LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL 756 (934)
||.|++|.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..+|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999989999999999876544445567789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhh
Q 002342 757 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836 (934)
Q Consensus 757 ~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~ 836 (934)
.+++.+. ..++...+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~------------ 146 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG------------ 146 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc------------
Confidence 9999764 34899999999999999999999999999999999999999999999999998543211
Q ss_pred ccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHc--
Q 002342 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT--RQKTFANILH-- 912 (934)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~--~~~~~~~i~~-- 912 (934)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+.+..+..
T Consensus 147 ----------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 210 (262)
T cd05572 147 ----------------QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN 210 (262)
T ss_pred ----------------cccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC
Confidence 01123468899999999998889999999999999999999999998877 6777777774
Q ss_pred CCCCCCCC
Q 002342 913 KDLKFPSS 920 (934)
Q Consensus 913 ~~~~~p~~ 920 (934)
....+|..
T Consensus 211 ~~~~~~~~ 218 (262)
T cd05572 211 GKLEFPNY 218 (262)
T ss_pred CCCCCCcc
Confidence 34455543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=282.79 Aligned_cols=218 Identities=25% Similarity=0.486 Sum_probs=189.9
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
+|++.+.||.|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...++.|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999875422 23345678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+.+++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~----- 154 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST----- 154 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc-----
Confidence 999999999987654456899999999999999999999999999999999999999999999999998543210
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~ 909 (934)
........|++.|+|||++.+..++.++|+|||||++|+|++|+.||......+.+..
T Consensus 155 ----------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08218 155 ----------------------VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK 212 (256)
T ss_pred ----------------------hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH
Confidence 0011234588899999999998899999999999999999999999998888888888
Q ss_pred HHcCCC
Q 002342 910 ILHKDL 915 (934)
Q Consensus 910 i~~~~~ 915 (934)
++.+.+
T Consensus 213 ~~~~~~ 218 (256)
T cd08218 213 IIRGSY 218 (256)
T ss_pred HhcCCC
Confidence 877665
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=291.24 Aligned_cols=211 Identities=27% Similarity=0.461 Sum_probs=183.3
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
.+|++.+.||.|+||.||++.+..+++.||+|.+... .......+.+|+.+++.++||||+.+++++...+.+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ---KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc---cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 5799999999999999999999999999999998653 2234467788999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+++++|..++.. ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 169 (296)
T cd06655 96 EYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--- 169 (296)
T ss_pred EecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc---
Confidence 99999999998864 348999999999999999999999999999999999999999999999999885432110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+......
T Consensus 170 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~ 225 (296)
T cd06655 170 ------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (296)
T ss_pred ------------------------ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 01123468899999999999889999999999999999999999999887766555
Q ss_pred HHHc
Q 002342 909 NILH 912 (934)
Q Consensus 909 ~i~~ 912 (934)
.+..
T Consensus 226 ~~~~ 229 (296)
T cd06655 226 LIAT 229 (296)
T ss_pred HHHh
Confidence 5543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=287.01 Aligned_cols=212 Identities=26% Similarity=0.417 Sum_probs=179.3
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||+|+||.||++.+..+++.||+|.+.+... .......+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999875421 2223345778999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||++++.|..++... ..+++..++.++.||+.+|.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (286)
T cd07847 80 EYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--- 154 (286)
T ss_pred eccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc---
Confidence 999988887776543 348999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
.......++..|+|||++.+ ..++.++|+||||+++|+|++|.+||.+.+..+..
T Consensus 155 ------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~ 210 (286)
T cd07847 155 ------------------------DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL 210 (286)
T ss_pred ------------------------ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 01123457889999999876 45788999999999999999999999988776655
Q ss_pred HHH
Q 002342 908 ANI 910 (934)
Q Consensus 908 ~~i 910 (934)
..+
T Consensus 211 ~~~ 213 (286)
T cd07847 211 YLI 213 (286)
T ss_pred HHH
Confidence 544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=289.83 Aligned_cols=219 Identities=25% Similarity=0.373 Sum_probs=184.5
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCC----------------eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCC
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSG----------------QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~----------------~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 730 (934)
..++|++++.||+|+||.||++.+...+ ..||+|.+.... .......+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCC
Confidence 3568999999999999999999886543 568999987643 2345667889999999999999
Q ss_pred ccceeEEEEeCCeEEEEEEccCCCCchhhhccCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 002342 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQP---------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801 (934)
Q Consensus 731 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~N 801 (934)
|+++++++..++..+++|||+.+++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999987643 1258999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHH
Q 002342 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (934)
Q Consensus 802 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Di 881 (934)
|+++.++.++|+|||++....... .........+++.|+|||++.+..++.++||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSD-------------------------YYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215 (296)
T ss_pred eeecCCCceEEccccceeecccCc-------------------------ceeecCcCCCCceecCHHHhhcCCCCccchh
Confidence 999999999999999985432110 0011224456789999999998889999999
Q ss_pred HHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHc
Q 002342 882 WALGILLYEMLY--GYTPFRGKTRQKTFANILH 912 (934)
Q Consensus 882 wSlG~iL~ellt--G~~Pf~~~~~~~~~~~i~~ 912 (934)
|||||++|+|++ |..||...+..+.+..+..
T Consensus 216 ~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~ 248 (296)
T cd05051 216 WAFGVTLWEILTLCREQPYEHLTDQQVIENAGH 248 (296)
T ss_pred hhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHh
Confidence 999999999997 8899988888777776654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=292.50 Aligned_cols=205 Identities=25% Similarity=0.450 Sum_probs=179.0
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
.+|++++.||.|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...++.|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 68999999999999999999999999999999987542 233456788999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+++++|.+++.. ..+++..+..++.|++.+|.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~---- 168 (297)
T cd06656 96 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 168 (297)
T ss_pred cccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC----
Confidence 99999999999865 34899999999999999999999999999999999999999999999999998543211
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
........|++.|+|||.+.+..++.++|+|||||++|+|++|.+||.+.+....
T Consensus 169 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~ 223 (297)
T cd06656 169 -----------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (297)
T ss_pred -----------------------ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh
Confidence 0111234688999999999999899999999999999999999999987665433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=289.97 Aligned_cols=205 Identities=28% Similarity=0.489 Sum_probs=179.4
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+..++|++++.||+|+||+||++.+..+++.||+|++.... .......+.+|+++++.++||||+++++++...+.+|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 34578999999999999999999999999999999987532 2344567889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
+||||+++++|.+++... +.+++..++.++.+++.+|.|||+ .|++||||||+||+++.++.++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~- 156 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN- 156 (284)
T ss_pred EEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh-
Confidence 999999999999988764 458999999999999999999997 5999999999999999999999999998743210
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
......+|+..|+|||++.+..++.++|+|||||++|+|++|..||.....
T Consensus 157 ----------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 157 ----------------------------SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred ----------------------------hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 011235689999999999888899999999999999999999999986554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=287.42 Aligned_cols=227 Identities=20% Similarity=0.324 Sum_probs=190.4
Q ss_pred ccCCcccccccccCCcEEEEEEEEec-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
..++|++++.||.|+||.||+++.+. +.+.+++|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 34689999999999999999999754 34679999876431 233456788999999999999999999999999
Q ss_pred CeEEEEEEccCCCCchhhhccCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEe
Q 002342 742 THVCLITDYCPGGELFLLLDRQPT-------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 814 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~-------~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~D 814 (934)
+..|+||||+++++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 999999999999999999976541 1589999999999999999999999999999999999999999999999
Q ss_pred cccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-
Q 002342 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY- 893 (934)
Q Consensus 815 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt- 893 (934)
||++...... .........+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 161 ~~~~~~~~~~--------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~ 214 (275)
T cd05046 161 LSLSKDVYNS--------------------------EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQ 214 (275)
T ss_pred cccccccCcc--------------------------cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhC
Confidence 9988432110 0111223356788999999988888999999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 002342 894 GYTPFRGKTRQKTFANILHKDLKFPSST 921 (934)
Q Consensus 894 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 921 (934)
|..||.+......+..+..+...++...
T Consensus 215 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (275)
T cd05046 215 GELPFYGLSDEEVLNRLQAGKLELPVPE 242 (275)
T ss_pred CCCCccccchHHHHHHHHcCCcCCCCCC
Confidence 8999998888888888888777666543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=283.89 Aligned_cols=217 Identities=23% Similarity=0.349 Sum_probs=183.4
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+..++|.+.+.||+|+||.||++.+. .+..+|+|.+... ......+.+|+.+++.++|+||+++++++.. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 456789999999999999999999864 5567999987653 2234678889999999999999999999887 788
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
+++|||+++++|.+++.......++...+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 99999999999999998765566889999999999999999999999999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~ 903 (934)
. ........++..|+|||++....++.++|+|||||++|++++ |++||.+.+.
T Consensus 156 ~--------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 156 E--------------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred C--------------------------cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 0 001112245678999999998889999999999999999998 9999999888
Q ss_pred HHHHHHHHcC
Q 002342 904 QKTFANILHK 913 (934)
Q Consensus 904 ~~~~~~i~~~ 913 (934)
......+..+
T Consensus 210 ~~~~~~~~~~ 219 (260)
T cd05073 210 PEVIRALERG 219 (260)
T ss_pred HHHHHHHhCC
Confidence 8777777654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=284.57 Aligned_cols=219 Identities=24% Similarity=0.328 Sum_probs=179.9
Q ss_pred cccccccccCCcEEEEEEEEecCCe--EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe------CC
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------KT 742 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~--~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------~~ 742 (934)
|.+.+.||+|+||.||++.+..++. .+|+|.+... .........+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA-ICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccC-cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4567899999999999999877765 6999988754 2344556778899999999999999999987642 23
Q ss_pred eEEEEEEccCCCCchhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQ----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a 818 (934)
..+++|||+.+++|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 578999999999999887421 2245899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTP 897 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~P 897 (934)
........ ........+++.|+|||++.+..++.++|||||||++|+|++ |++|
T Consensus 160 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p 214 (272)
T cd05075 160 KKIYNGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214 (272)
T ss_pred cccCcccc-------------------------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 65321100 011123346778999999999999999999999999999998 8999
Q ss_pred CCCCCHHHHHHHHHcCCC
Q 002342 898 FRGKTRQKTFANILHKDL 915 (934)
Q Consensus 898 f~~~~~~~~~~~i~~~~~ 915 (934)
|.+....+.+..+.++..
T Consensus 215 ~~~~~~~~~~~~~~~~~~ 232 (272)
T cd05075 215 YPGVENSEIYDYLRQGNR 232 (272)
T ss_pred CCCCCHHHHHHHHHcCCC
Confidence 999888888888877653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=292.48 Aligned_cols=224 Identities=22% Similarity=0.327 Sum_probs=185.3
Q ss_pred cccccCCcccccccccCCcEEEEEEEEec-------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcccee
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 735 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~-------~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~ 735 (934)
+.+..++|.+.+.||+|+||.||++.+.. ....+|+|.+.... .......+..|+.+++.+ +||||++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 34455789999999999999999998632 35579999987532 334456788899999999 699999999
Q ss_pred EEEEeCCeEEEEEEccCCCCchhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 002342 736 ASFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801 (934)
Q Consensus 736 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~N 801 (934)
+++...+..|++|||+++++|.+++.... ...++...+..++.||+.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 99999999999999999999999986532 2358889999999999999999999999999999999
Q ss_pred EEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHH
Q 002342 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (934)
Q Consensus 802 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Di 881 (934)
||++.++.+||+|||++........ ........+++.|||||++.+..++.++||
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDY-------------------------YKKTSNGRLPVKWMAPEALFDRVYTHQSDV 219 (314)
T ss_pred EEEcCCCcEEEcccccccccccccc-------------------------ccccccCCCCccccCHHHHccCCcCccchh
Confidence 9999999999999999854321100 001112234568999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 002342 882 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 882 wSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~ 914 (934)
|||||++|+|++ |..||.+.+..+.+..+..+.
T Consensus 220 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 253 (314)
T cd05099 220 WSFGILMWEIFTLGGSPYPGIPVEELFKLLREGH 253 (314)
T ss_pred hHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999999998 999999988888888877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=285.27 Aligned_cols=218 Identities=24% Similarity=0.338 Sum_probs=180.7
Q ss_pred cccccccccCCcEEEEEEEEecC---CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe----
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH---- 743 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~---~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~---- 743 (934)
|++.+.||+|+||.||++.+..+ +..||+|.+.... ........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67889999999999999998654 4789999987532 234456678899999999999999999998765443
Q ss_pred --EEEEEEccCCCCchhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEeccc
Q 002342 744 --VCLITDYCPGGELFLLLDRQ----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817 (934)
Q Consensus 744 --~~lV~E~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~ 817 (934)
.+++|||+++++|..++... ....+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999888542 223589999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCC
Q 002342 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYT 896 (934)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~ 896 (934)
+........ ........++..|+|||.+.+..++.++|||||||++|+|++ |.+
T Consensus 160 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~ 214 (273)
T cd05035 160 SKKIYSGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT 214 (273)
T ss_pred eeecccccc-------------------------ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 865321100 001112335678999999988889999999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHcCC
Q 002342 897 PFRGKTRQKTFANILHKD 914 (934)
Q Consensus 897 Pf~~~~~~~~~~~i~~~~ 914 (934)
||.+....+.+..+..+.
T Consensus 215 p~~~~~~~~~~~~~~~~~ 232 (273)
T cd05035 215 PYPGVENHEIYDYLRHGN 232 (273)
T ss_pred CCCCCCHHHHHHHHHcCC
Confidence 999988888888877654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=290.50 Aligned_cols=219 Identities=23% Similarity=0.372 Sum_probs=185.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC--C----CccceeEEEEeC
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--P----FVPALYASFQTK 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~h--p----~Iv~l~~~~~~~ 741 (934)
..+|++++.+|+|.||+|-.+.+..++..+|||+++.. ....+...-|+++|.++.+ | -++++.++|+..
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 68999999999999999999999999999999998642 2334556679999999942 3 378899999999
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC--------------
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-------------- 807 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-------------- 807 (934)
++.|||+|.+ |.|+++++..+....|+.+.++.+..|++.+++|||+++++|.||||+|||+.++
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999999 8999999999888899999999999999999999999999999999999999421
Q ss_pred ------CcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHH
Q 002342 808 ------GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (934)
Q Consensus 808 ------~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Di 881 (934)
-.|+|+|||.|..-. ....+.+.|..|.|||++.+-+++.++||
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~------------------------------e~hs~iVsTRHYRAPEViLgLGwS~pCDv 292 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDH------------------------------EHHSTIVSTRHYRAPEVILGLGWSQPCDV 292 (415)
T ss_pred eccCCCcceEEEecCCcceec------------------------------cCcceeeeccccCCchheeccCcCCccCc
Confidence 237899999985421 12256789999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 002342 882 WALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSST 921 (934)
Q Consensus 882 wSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 921 (934)
||+||||+||.+|...|++..+.+.+.++..-.-++|..+
T Consensus 293 WSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~m 332 (415)
T KOG0671|consen 293 WSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRM 332 (415)
T ss_pred eeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHH
Confidence 9999999999999999999887775444433223677653
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=286.59 Aligned_cols=199 Identities=36% Similarity=0.611 Sum_probs=172.8
Q ss_pred cccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCCCc
Q 002342 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 756 (934)
Q Consensus 677 LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL 756 (934)
||+|+||+||+|.+..+++.||+|.+.+...........+..|+++|+.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999998765433334445567899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhh
Q 002342 757 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836 (934)
Q Consensus 757 ~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~ 836 (934)
.+++.......+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~------------- 147 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------------- 147 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-------------
Confidence 9998776545699999999999999999999999999999999999999999999999998854311
Q ss_pred ccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
........|+..|+|||++.+..++.++|+|||||++|+|++|+.||.....
T Consensus 148 ---------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 148 ---------------GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred ---------------CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 0011233578899999999888899999999999999999999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=287.76 Aligned_cols=221 Identities=22% Similarity=0.313 Sum_probs=185.9
Q ss_pred cCCcccccccccCCcEEEEEEEEec-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
..+|.+.+.||+|+||.||++.+.. ++..+++|.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4579999999999999999998643 4567999987643 2344466889999999999999999999999999
Q ss_pred eEEEEEEccCCCCchhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC
Q 002342 743 HVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 808 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~ 808 (934)
..++||||+++++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+||+++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999986532 23488999999999999999999999999999999999999999
Q ss_pred cEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHH
Q 002342 809 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888 (934)
Q Consensus 809 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL 888 (934)
.++|+|||++........ ........|++.|+|||++.+..++.++|||||||++
T Consensus 161 ~~~l~dfg~a~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 215 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDY-------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 215 (291)
T ss_pred cEEECCCCcccccCCCce-------------------------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHH
Confidence 999999999854321100 0112234578899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCC
Q 002342 889 YEMLY-GYTPFRGKTRQKTFANILHKDLK 916 (934)
Q Consensus 889 ~ellt-G~~Pf~~~~~~~~~~~i~~~~~~ 916 (934)
|+|++ |.+||...+..+.+..+..+...
T Consensus 216 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 244 (291)
T cd05094 216 WEIFTYGKQPWFQLSNTEVIECITQGRVL 244 (291)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHhCCCCC
Confidence 99998 99999988888888877766543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=281.94 Aligned_cols=217 Identities=28% Similarity=0.485 Sum_probs=188.1
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
+|++.+.||.|+||.||++.+..+++.+|+|.+..... .......+.+|+.+|+.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999876533 33445778899999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-CcEEEEecccCcccCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-~~vkl~DFG~a~~~~~~~~~~ 828 (934)
|+++++|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---- 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---- 155 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC----
Confidence 9999999999977555568999999999999999999999999999999999999865 46899999998543211
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
.......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.+.+......
T Consensus 156 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 211 (256)
T cd08220 156 ------------------------SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211 (256)
T ss_pred ------------------------ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence 01123468899999999998888999999999999999999999999988887777
Q ss_pred HHHcCCC
Q 002342 909 NILHKDL 915 (934)
Q Consensus 909 ~i~~~~~ 915 (934)
.+..+..
T Consensus 212 ~~~~~~~ 218 (256)
T cd08220 212 KIMSGTF 218 (256)
T ss_pred HHHhcCC
Confidence 7766543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=282.21 Aligned_cols=213 Identities=24% Similarity=0.369 Sum_probs=180.3
Q ss_pred cccccCCcEEEEEEEEec-CC--eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEcc
Q 002342 675 KPLGSGDTGSVHLVELCG-SG--QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYC 751 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~-~~--~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~ 751 (934)
+.||+|++|.||++.+.. .+ ..||+|.+...... .....+.+|+.++++++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999999865 33 36999998865432 566788899999999999999999999988 8999999999
Q ss_pred CCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCc
Q 002342 752 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831 (934)
Q Consensus 752 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 831 (934)
++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~----- 152 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED----- 152 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc-----
Confidence 999999999775435689999999999999999999999999999999999999999999999999865421100
Q ss_pred chhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 002342 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANI 910 (934)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i 910 (934)
.........++..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..++++.+
T Consensus 153 -------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 213 (257)
T cd05040 153 -------------------HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213 (257)
T ss_pred -------------------ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 0011123457889999999999899999999999999999998 99999988888888877
Q ss_pred HcCC
Q 002342 911 LHKD 914 (934)
Q Consensus 911 ~~~~ 914 (934)
....
T Consensus 214 ~~~~ 217 (257)
T cd05040 214 DKEG 217 (257)
T ss_pred HhcC
Confidence 6533
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=283.54 Aligned_cols=217 Identities=27% Similarity=0.392 Sum_probs=180.9
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccc--cChHHHHHHHHHHHHHHhCCCCCccceeEEEEe--CCeE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHV 744 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~ 744 (934)
..|++.+.||+|+||.||++.+..++..||+|.+..... ........+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 369999999999999999999999999999998865422 123345678889999999999999999999875 4678
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
+++|||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 9999999999999998764 34899999999999999999999999999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
.. .........|+..|+|||++.+..++.++|+|||||++|+|++|++||......
T Consensus 160 ~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~ 215 (266)
T cd06651 160 CM------------------------SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM 215 (266)
T ss_pred cc------------------------cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH
Confidence 00 000112345889999999999988999999999999999999999999877665
Q ss_pred HHHHHHH
Q 002342 905 KTFANIL 911 (934)
Q Consensus 905 ~~~~~i~ 911 (934)
.....+.
T Consensus 216 ~~~~~~~ 222 (266)
T cd06651 216 AAIFKIA 222 (266)
T ss_pred HHHHHHh
Confidence 5554443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=285.38 Aligned_cols=220 Identities=22% Similarity=0.332 Sum_probs=182.8
Q ss_pred ccCCcccccccccCCcEEEEEEEEec-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
..+.|.+.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34679999999999999999999987 7789999987643 2233445688899999999999999999999998
Q ss_pred CeEEEEEEccCCCCchhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC---cEEEE
Q 002342 742 THVCLITDYCPGGELFLLLDRQPT-----KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLT 813 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~---~vkl~ 813 (934)
+..|+||||++|++|.+++..... ..+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 999999999999999999875421 2589999999999999999999999999999999999998755 58999
Q ss_pred ecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh
Q 002342 814 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 893 (934)
Q Consensus 814 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt 893 (934)
|||++........ ........+++.|+|||++.+..++.++|||||||++|+|++
T Consensus 162 dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 216 (277)
T cd05036 162 DFGMARDIYRASY-------------------------YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216 (277)
T ss_pred cCccccccCCccc-------------------------eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHc
Confidence 9999864321100 001112234568999999999999999999999999999996
Q ss_pred -CCCCCCCCCHHHHHHHHHcC
Q 002342 894 -GYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 894 -G~~Pf~~~~~~~~~~~i~~~ 913 (934)
|..||.+.+..+....+...
T Consensus 217 ~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 217 LGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHcC
Confidence 99999998888877766543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=287.12 Aligned_cols=213 Identities=34% Similarity=0.619 Sum_probs=171.5
Q ss_pred ccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHH---HHHHhCCCCCccceeEEEEeCCeEEEEEEccC
Q 002342 676 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER---EILDMLDHPFVPALYASFQTKTHVCLITDYCP 752 (934)
Q Consensus 676 ~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~---~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 752 (934)
.||+|+||.||++.+..+++.||+|.+.+..............|. .+++..+||+|+.+++++...+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999998765433222222233343 34455689999999999999999999999999
Q ss_pred CCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcc
Q 002342 753 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832 (934)
Q Consensus 753 ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 832 (934)
|++|..++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-------- 150 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------- 150 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--------
Confidence 99999988654 45999999999999999999999999999999999999999999999999998532110
Q ss_pred hhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCC---CHHHHHH
Q 002342 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGK---TRQKTFA 908 (934)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~---~~~~~~~ 908 (934)
.....+|+..|+|||++.+. .++.++|+|||||++|+|++|+.||.+. .......
T Consensus 151 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~ 209 (278)
T cd05606 151 ---------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209 (278)
T ss_pred ---------------------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH
Confidence 11234689999999999754 6888999999999999999999999876 3344444
Q ss_pred HHHcCCCCCCC
Q 002342 909 NILHKDLKFPS 919 (934)
Q Consensus 909 ~i~~~~~~~p~ 919 (934)
.+......+|.
T Consensus 210 ~~~~~~~~~~~ 220 (278)
T cd05606 210 MTLTMAVELPD 220 (278)
T ss_pred HhhccCCCCCC
Confidence 44444555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=287.44 Aligned_cols=209 Identities=33% Similarity=0.500 Sum_probs=177.2
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++++.||+|+||.||++.+..++..||+|.+... ........+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 4799999999999999999999999999999988653 13344567889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 749 DYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||+++++|..++.... ...+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 9999999998886531 2358999999999999999999997 5999999999999999999999999998843211
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC------CCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG------HTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~------~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.......|++.|+|||++.+.. ++.++|+|||||++|+|++|+.||..
T Consensus 156 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 156 --------------------------SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred --------------------------CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 0112345888999999986543 47799999999999999999999987
Q ss_pred CCHHHHHH
Q 002342 901 KTRQKTFA 908 (934)
Q Consensus 901 ~~~~~~~~ 908 (934)
......+.
T Consensus 210 ~~~~~~~~ 217 (286)
T cd06622 210 ETYANIFA 217 (286)
T ss_pred cchhhHHH
Confidence 65554443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=288.19 Aligned_cols=213 Identities=29% Similarity=0.453 Sum_probs=178.9
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEE------e
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ------T 740 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~------~ 740 (934)
.+.|++.+.||.|+||.||++.+..+++.+|+|++... ......+..|+.+++.+ +||||+++++++. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 46899999999999999999999999999999998653 23345678899999998 7999999999985 3
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
.+.+|++|||+.+++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 46889999999999999999776556689999999999999999999999999999999999999999999999999853
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc-----CCCCCchhHHHHHHHHHHHHHhCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGY 895 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~~~DiwSlG~iL~elltG~ 895 (934)
.... ........|++.|+|||++. ...++.++|+|||||++|+|++|.
T Consensus 171 ~~~~---------------------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~ 223 (282)
T cd06636 171 LDRT---------------------------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA 223 (282)
T ss_pred hhcc---------------------------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCC
Confidence 2100 01123456899999999986 356788999999999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 002342 896 TPFRGKTRQKTFANIL 911 (934)
Q Consensus 896 ~Pf~~~~~~~~~~~i~ 911 (934)
+||........+..+.
T Consensus 224 ~p~~~~~~~~~~~~~~ 239 (282)
T cd06636 224 PPLCDMHPMRALFLIP 239 (282)
T ss_pred CCccccCHHhhhhhHh
Confidence 9998766555444443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=321.57 Aligned_cols=407 Identities=10% Similarity=0.049 Sum_probs=299.5
Q ss_pred ceEEecccCCCCCCCCCCcccCCCCCceEEEecccccccccccccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchH
Q 002342 141 QAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAG 220 (934)
Q Consensus 141 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~dit~~~~~e~aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a 220 (934)
.|+........+.+|. ....+++.|||++|++|++|+++++.|+.++++++++++++|. +|+|+++|++
T Consensus 164 ~~~~~~~~~~~~~~g~--------~~~~g~~~DIT~rk~ae~~l~~~~~~l~~l~e~~~~~i~~~d~---~g~i~~~N~~ 232 (807)
T PRK13560 164 RFIDCCLRFERHAHAD--------DQVDGFAEDITERKRAEERIDEALHFLQQLLDNIADPAFWKDE---DAKVFGCNDA 232 (807)
T ss_pred cEEEEEeeeeecCCCc--------eEEEEEEEccchHHHHHHHHHHHHHHHHHHHhhCCCeEEEEcC---CCCEEEEhHH
Confidence 4665544444433332 2356777999999999999999999999999999999999998 7779999999
Q ss_pred HHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEe--eeeecCCCCEEEEEE
Q 002342 221 FFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTI--APIKDDEGKVLKFIG 298 (934)
Q Consensus 221 ~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~s~--~pi~d~~G~v~~~v~ 298 (934)
+++++||+.+|++|+++..+.++.............+..+.....+.+.+++||+.+|+.+.+ .|+.|.+|.+.++++
T Consensus 233 ~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~~~~~g~~~g~~~ 312 (807)
T PRK13560 233 ACLACGFRREEIIGMSIHDFAPAQPADDYQEADAAKFDADGSQIIEAEFQNKDGRTRPVDVIFNHAEFDDKENHCAGLVG 312 (807)
T ss_pred HHHHhCCCHHHHcCCcchhcCCcchhHHHHHHHHHHhccCCceEEEEEEEcCCCCEEEEEEEecceEEEcCCCCEEEEEE
Confidence 999999999999999988777666544444455556666777778888899999999776654 566789999999999
Q ss_pred EEecchhhHHHHHHhhcCCCCCchhhhHHHHHHHHHhHHHHHHHHHHcc-CCCCcccCCCCCcc-cccCCCCchhhhccc
Q 002342 299 MQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMK-KPRSLSESTNRPPI-IRKSEGGVEEERAGA 376 (934)
Q Consensus 299 ~~~DITerk~~e~~L~~~~~~l~~~l~~~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 376 (934)
+++|||++|++|++|+... +.+..+..+.. .....+.......+ +...+..+|+..+++
T Consensus 313 ~~~DITerk~~e~~L~~se-------------------~~l~~l~~~~~~~i~~~d~~g~i~~~nn~~~~~~~G~~~~e~ 373 (807)
T PRK13560 313 AITDISGRRAAERELLEKE-------------------DMLRAIIEAAPIAAIGLDADGNICFVNNNAAERMLGWSAAEV 373 (807)
T ss_pred EEEechHHHHHHHHHHHHH-------------------HHHHHHHHhCcccEEEEcCCCCEEEecCHHHHHHhCCCHHHH
Confidence 9999999999999987321 11122222222 23333444444444 344667899999999
Q ss_pred ccCCCCCCCCCCCCCC--CCCCc------------------ccccccccccchhcccccccccccccccccccCCCCCCC
Q 002342 377 LGRRKSENVPPPRRNS--YGGGC------------------RTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDS 436 (934)
Q Consensus 377 ~g~~~~~~~~~~~~~~--~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (934)
.|+......++..... ..... ......+.........++|...|+.....+..+.++...
T Consensus 374 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~p~~d~~g~~~ 453 (807)
T PRK13560 374 MGKPLPGMDPELNEEFWCGDFQEWYPDGRPMAFDACPMAKTIKGGKIFDGQEVLIEREDDGPADCSAYAEPLHDADGNII 453 (807)
T ss_pred cCCCccccChhhhhhhhhchhhhcCCcCCcchhhhhhHHHHHhcCCcccCceEEEEcCCCCeEEEEEEEeeeECCCCCEE
Confidence 9998776544311100 00000 111112223344455677777777777777766666544
Q ss_pred ccccccccCCCCCCCCCCCCCchhhHHHHHhhhhcccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhc
Q 002342 437 FENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEIL 516 (934)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~dv~~r~~~e~~l~~~~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEli 516 (934)
+... ...|||+|++.|++++. .+.++++++++++..+..+ +..+.+|.....++||++++++
T Consensus 454 ~~~~-------------~~~DITerk~~E~~L~~---~~~~~e~~~~~i~~~~~~~--~~~~~~~~~~~~~~G~~~~e~~ 515 (807)
T PRK13560 454 GAIA-------------LLVDITERKQVEEQLLL---ANLIVENSPLVLFRWKAEE--GWPVELVSKNITQFGYEPDEFI 515 (807)
T ss_pred EEEE-------------EeehhhhHHHHHHHHHH---HHHHHhcCCceEEEEecCC--CceEEEecchhhhcCCCHHHhh
Confidence 3333 36899999999999987 5788999999999887652 2255566666788999999998
Q ss_pred CC--CCcccCCCCCCHHHHHHHHHHHhcC-CcEEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccccc
Q 002342 517 GR--NCRFLQGPETDPATVRKIRAAIDNQ-TDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 593 (934)
Q Consensus 517 G~--~~~~l~~~~~~~~~~~~i~~~l~~~-~~~~~e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e 593 (934)
+. .+..+++|++.......+...+..+ ..+..|+++.+++|..+|+.....|++|.+|.+.+++|+++|||++|++|
T Consensus 516 ~~~~~~~~~~~p~d~~~~~~~~~~~~~~g~~~~~~e~r~~~~dG~~~w~~~~~~~~~d~~G~~~~~~g~~~DITerK~aE 595 (807)
T PRK13560 516 SGKRMFAAIIHPADLEQVAAEVAEFAAQGVDRFEQEYRILGKGGAVCWIDDQSAAERDEEGQISHFEGIVIDISERKHAE 595 (807)
T ss_pred cccchHhhhcChhhHHHHHHHHHHHHhcCCccceeEEEEEcCCCCEEEEEecceeeeCCCCCEEEEEEEEechHHHHHHH
Confidence 63 3556778888777776666666555 45788999999999999999999999999999999999999999999975
Q ss_pred cc
Q 002342 594 RN 595 (934)
Q Consensus 594 ~~ 595 (934)
.+
T Consensus 596 ~~ 597 (807)
T PRK13560 596 EK 597 (807)
T ss_pred HH
Confidence 43
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=295.75 Aligned_cols=221 Identities=25% Similarity=0.369 Sum_probs=176.5
Q ss_pred cccCCcccccccccCCcEEEEEEEE-----ecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ 739 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~-----~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~ 739 (934)
+..++|++.+.||.|+||.||+|.+ ..+++.||||.+.... .......+.+|+.+|..+ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 4557899999999999999999985 3467899999987542 233456788899999999 6899999999876
Q ss_pred e-CCeEEEEEEccCCCCchhhhccCC------------------------------------------------------
Q 002342 740 T-KTHVCLITDYCPGGELFLLLDRQP------------------------------------------------------ 764 (934)
Q Consensus 740 ~-~~~~~lV~E~~~ggsL~~~l~~~~------------------------------------------------------ 764 (934)
. +..+++|||||++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 5 456899999999999999886431
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 765 -----------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 765 -----------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
...++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~------- 234 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------- 234 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-------
Confidence 12367788889999999999999999999999999999999999999999999854321100
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHH
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK-TFANIL 911 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~-~~~~i~ 911 (934)
........+++.|+|||++.+..++.++||||||+++|+|++ |..||.+..... ....+.
T Consensus 235 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 296 (343)
T cd05103 235 ------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 296 (343)
T ss_pred ------------------hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh
Confidence 001122346678999999999999999999999999999996 999998765443 333443
Q ss_pred cC
Q 002342 912 HK 913 (934)
Q Consensus 912 ~~ 913 (934)
.+
T Consensus 297 ~~ 298 (343)
T cd05103 297 EG 298 (343)
T ss_pred cc
Confidence 33
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=286.37 Aligned_cols=217 Identities=22% Similarity=0.329 Sum_probs=179.6
Q ss_pred CcccccccccCCcEEEEEEEEec-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
+|++.+.||+|+||.||++.+.. ....+++|.+.... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 48899999999999999998753 23579999886542 234456788999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 002342 745 CLITDYCPGGELFLLLDRQ----------------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~----------------------~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NI 802 (934)
+++|||+.+++|.+++... ....++...+..++.|++.||.|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999987542 113478899999999999999999999999999999999
Q ss_pred EEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHH
Q 002342 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882 (934)
Q Consensus 803 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Diw 882 (934)
|+++++.+||+|||++........ ........++..|+|||++.+..++.++|||
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 213 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDS-------------------------YVKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213 (290)
T ss_pred EEcCCCcEEeccccccccccCccc-------------------------hhcccCCCCCccccCHHHHccCCcchHhHHH
Confidence 999999999999999854321100 0011223467789999999988899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC
Q 002342 883 ALGILLYEMLY-GYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 883 SlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~ 913 (934)
|||+++|+|++ |.+||.+....++...+..+
T Consensus 214 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 245 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAPERLFNLLKTG 245 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Confidence 99999999998 99999988887777666543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=285.90 Aligned_cols=196 Identities=37% Similarity=0.681 Sum_probs=163.0
Q ss_pred ccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHH---hCCCCCccceeEEEEeCCeEEEEEEccC
Q 002342 676 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD---MLDHPFVPALYASFQTKTHVCLITDYCP 752 (934)
Q Consensus 676 ~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~---~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 752 (934)
.||+|+||.||++.+..+++.||+|.+.+.............+|..+++ ..+||||+.+++++..++..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999987654333332233444544444 3479999999999999999999999999
Q ss_pred CCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcc
Q 002342 753 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832 (934)
Q Consensus 753 ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 832 (934)
+++|.+++..+ ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-------- 150 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------- 150 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--------
Confidence 99999988764 35999999999999999999999999999999999999999999999999998432110
Q ss_pred hhhhccccCCCCcccccccccccccccCCCCccchhhhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
......|++.|+|||.+. +..++.++|+|||||++|+|++|..||.+..
T Consensus 151 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 151 ---------------------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred ---------------------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 111236899999999986 4568899999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=280.12 Aligned_cols=213 Identities=42% Similarity=0.750 Sum_probs=181.1
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHH-HhCCCCCccceeEEEEeCCeEEEEEEccCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPALYASFQTKTHVCLITDYCPG 753 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il-~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 753 (934)
+.||.|+||.||+|.+..+++.||+|++.+...........+..|..++ ...+|||++++++++...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999998764332333334445555544 455899999999999999999999999999
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---------- 149 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---------- 149 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----------
Confidence 9999999764 3589999999999999999999999999999999999999999999999998743210
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~ 913 (934)
.....|++.|+|||.+.+..++.++||||||+++|+|++|.+||...+....+..+..+
T Consensus 150 ---------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 208 (260)
T cd05611 150 ---------------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR 208 (260)
T ss_pred ---------------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 12346889999999998888899999999999999999999999998888888888877
Q ss_pred CCCCCCC
Q 002342 914 DLKFPSS 920 (934)
Q Consensus 914 ~~~~p~~ 920 (934)
...+|..
T Consensus 209 ~~~~~~~ 215 (260)
T cd05611 209 RINWPEE 215 (260)
T ss_pred ccCCCCc
Confidence 7665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=282.70 Aligned_cols=224 Identities=44% Similarity=0.813 Sum_probs=190.9
Q ss_pred cccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCCCc
Q 002342 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 756 (934)
Q Consensus 677 LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL 756 (934)
||.|+||.||++.+..+++.|++|.+.+...........+.+|+.+++.++||||+++++.+......|++|||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999998765444445667888999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhh
Q 002342 757 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836 (934)
Q Consensus 757 ~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~ 836 (934)
.+++.+.. .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~------- 151 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL------- 151 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc-------
Confidence 99997653 589999999999999999999999999999999999999999999999999854321111000
Q ss_pred ccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Q 002342 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 916 (934)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~~~~ 916 (934)
...........++..|+|||.+....++.++|+||||+++|+|++|..||......+.+..+..+.+.
T Consensus 152 ------------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 219 (265)
T cd05579 152 ------------NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE 219 (265)
T ss_pred ------------ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcC
Confidence 00011223456888999999998888899999999999999999999999999999999888887777
Q ss_pred CCCCC
Q 002342 917 FPSST 921 (934)
Q Consensus 917 ~p~~~ 921 (934)
+|...
T Consensus 220 ~~~~~ 224 (265)
T cd05579 220 WPEDV 224 (265)
T ss_pred CCccc
Confidence 77654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=293.55 Aligned_cols=225 Identities=23% Similarity=0.336 Sum_probs=186.1
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecC-------CeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccce
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGS-------GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPAL 734 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~-------~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l 734 (934)
.+.+...+|++.+.||+|+||.||+|++... +..||+|.+... ........+.+|+.+++++ +||||+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 4556667899999999999999999987532 237899988743 2334456788999999999 89999999
Q ss_pred eEEEEeCCeEEEEEEccCCCCchhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 002342 735 YASFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPE 800 (934)
Q Consensus 735 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~ 800 (934)
++++...+.+|++|||+++++|.+++.... ...++...+..++.||+.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999987532 234778888999999999999999999999999999
Q ss_pred CEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhH
Q 002342 801 NVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 880 (934)
Q Consensus 801 NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~D 880 (934)
|||++.++.+||+|||++........ ........+++.|+|||++.+..++.++|
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 218 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDY-------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSD 218 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccc-------------------------cccccCCCcCceEcCHHHhccCCcCchhh
Confidence 99999999999999999854321100 00111223467899999999999999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 002342 881 WWALGILLYEMLY-GYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 881 iwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~ 914 (934)
||||||++|+|++ |..||.+.+..+.+..+..+.
T Consensus 219 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 253 (334)
T cd05100 219 VWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGH 253 (334)
T ss_pred hHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999999998 999999998888888876653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=315.33 Aligned_cols=151 Identities=39% Similarity=0.653 Sum_probs=139.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
+++|.+++.||+|+||.||++.+..+++.||||++.+...........+..|+.+++.++||||+++++++...+++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999875555556667888999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
|||+.|++|.+++... +.+++..++.|+.||+.||.|||.+|||||||||+|||++.++.+||+|||+++.
T Consensus 83 mEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 83 MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999998764 4589999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=282.38 Aligned_cols=212 Identities=29% Similarity=0.433 Sum_probs=183.3
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
..|+..+.||.|+||.||++.+..++..||+|++.... .......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46889999999999999999999999999999987532 2345577889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||++|++|.+++.. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~---- 154 (277)
T cd06640 82 EYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---- 154 (277)
T ss_pred ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC----
Confidence 99999999999865 34899999999999999999999999999999999999999999999999998543210
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
........++..|+|||++.+..++.++|+|||||++|+|++|.+||...+......
T Consensus 155 -----------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 211 (277)
T cd06640 155 -----------------------QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF 211 (277)
T ss_pred -----------------------ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh
Confidence 011123468889999999998889999999999999999999999998877766665
Q ss_pred HHHc
Q 002342 909 NILH 912 (934)
Q Consensus 909 ~i~~ 912 (934)
.+..
T Consensus 212 ~~~~ 215 (277)
T cd06640 212 LIPK 215 (277)
T ss_pred hhhc
Confidence 5533
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=278.41 Aligned_cols=212 Identities=24% Similarity=0.370 Sum_probs=184.1
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+..++|++.+.||.|+||.||++.. .++.||+|.+.... .....+.+|+.+++.++|+||+++++++.+.+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccch----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 4567899999999999999999987 47899999987542 24567889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
+||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~- 155 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG- 155 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc-
Confidence 9999999999999997765456999999999999999999999999999999999999999999999999998543100
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 904 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~ 904 (934)
.....++..|+|||++....++.++|+||||+++|+|++ |..||...+..
T Consensus 156 -----------------------------~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 206 (256)
T cd05039 156 -----------------------------QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 206 (256)
T ss_pred -----------------------------cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 011234567999999998889999999999999999997 99999988887
Q ss_pred HHHHHHHcC
Q 002342 905 KTFANILHK 913 (934)
Q Consensus 905 ~~~~~i~~~ 913 (934)
+....+..+
T Consensus 207 ~~~~~~~~~ 215 (256)
T cd05039 207 DVVPHVEKG 215 (256)
T ss_pred HHHHHHhcC
Confidence 777766554
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=288.14 Aligned_cols=212 Identities=23% Similarity=0.417 Sum_probs=175.6
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
+|++.+.||.|+||.||+|.+..+|..||+|.+..... .......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 58999999999999999999999999999999875422 22233456789999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~----- 152 (284)
T cd07839 80 YCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP----- 152 (284)
T ss_pred cCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC-----
Confidence 995 67888776542 45999999999999999999999999999999999999999999999999998543210
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCC-CCCCCHHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP-FRGKTRQKTF 907 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~P-f~~~~~~~~~ 907 (934)
........+++.|+|||++.+. .++.++|||||||++|+|++|..| |.+.+..+.+
T Consensus 153 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~ 210 (284)
T cd07839 153 ----------------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 210 (284)
T ss_pred ----------------------CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH
Confidence 0111233578899999998775 468899999999999999998777 5556655655
Q ss_pred HHHH
Q 002342 908 ANIL 911 (934)
Q Consensus 908 ~~i~ 911 (934)
+.+.
T Consensus 211 ~~~~ 214 (284)
T cd07839 211 KRIF 214 (284)
T ss_pred HHHH
Confidence 5553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=280.97 Aligned_cols=220 Identities=24% Similarity=0.375 Sum_probs=182.2
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccc---cChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM---LNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~---~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
+|++.+.||.|+||.||++.+ .+++.+|+|.+..... ........+.+|+.+|+.++|+||+++++++...+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999986 5788999998864321 122334568889999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
+|||+++++|.+++.+. ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999999764 3489999999999999999999999999999999999999999999999999854321100
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
. ...........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+....
T Consensus 158 ~---------------------~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~ 216 (265)
T cd06631 158 H---------------------GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA 216 (265)
T ss_pred c---------------------ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH
Confidence 0 0001112345689999999999999999999999999999999999999988776655
Q ss_pred HHHHHcC
Q 002342 907 FANILHK 913 (934)
Q Consensus 907 ~~~i~~~ 913 (934)
...+...
T Consensus 217 ~~~~~~~ 223 (265)
T cd06631 217 MFYIGAH 223 (265)
T ss_pred HHHhhhc
Confidence 5555444
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=279.70 Aligned_cols=212 Identities=25% Similarity=0.388 Sum_probs=183.7
Q ss_pred cccccCCcEEEEEEEEecC---CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEcc
Q 002342 675 KPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYC 751 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~---~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~ 751 (934)
+.||+|+||.||++.+... +..|++|.+..... ......+.+|+.+++.++|+||+++++++.....+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4689999999999999866 88999999876532 224678889999999999999999999999999999999999
Q ss_pred CCCCchhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 752 PGGELFLLLDRQP-------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 752 ~ggsL~~~l~~~~-------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
++++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999997641 256999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~ 903 (934)
.. ........+++.|+|||.+....++.++|+|||||++|+|++ |..||.+...
T Consensus 159 ~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 213 (262)
T cd00192 159 DY-------------------------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213 (262)
T ss_pred cc-------------------------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH
Confidence 10 112234467889999999998889999999999999999998 6999999988
Q ss_pred HHHHHHHHcC
Q 002342 904 QKTFANILHK 913 (934)
Q Consensus 904 ~~~~~~i~~~ 913 (934)
.+....+..+
T Consensus 214 ~~~~~~~~~~ 223 (262)
T cd00192 214 EEVLEYLRKG 223 (262)
T ss_pred HHHHHHHHcC
Confidence 8888888764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=288.93 Aligned_cols=217 Identities=24% Similarity=0.361 Sum_probs=179.5
Q ss_pred cCCcccccccccCCcEEEEEEEEecC--------------CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccc
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGS--------------GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~--------------~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~ 733 (934)
.++|++.+.||+|+||.||++.+..+ ...||+|.+.... .......+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 46899999999999999999987543 2358999987542 3344567889999999999999999
Q ss_pred eeEEEEeCCeEEEEEEccCCCCchhhhccCC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 002342 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQP----------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 803 (934)
Q Consensus 734 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NIL 803 (934)
+++++...+..|+||||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999885431 123688899999999999999999999999999999999
Q ss_pred EecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHH
Q 002342 804 LQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 883 (934)
Q Consensus 804 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwS 883 (934)
++.++.+||+|||++....... .........+++.|+|||++.+..++.++|+||
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS 216 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGD-------------------------YYRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216 (295)
T ss_pred EcCCCcEEecccccccccccCc-------------------------ceeccCcCcCceeecChhhhccCCcCchhhHHH
Confidence 9999999999999985432100 001122334678999999999989999999999
Q ss_pred HHHHHHHHHh--CCCCCCCCCHHHHHHHHH
Q 002342 884 LGILLYEMLY--GYTPFRGKTRQKTFANIL 911 (934)
Q Consensus 884 lG~iL~ellt--G~~Pf~~~~~~~~~~~i~ 911 (934)
|||++|+|++ |..||...+..+.+..+.
T Consensus 217 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~ 246 (295)
T cd05097 217 FGVTLWEMFTLCKEQPYSLLSDEQVIENTG 246 (295)
T ss_pred HHHHHHHHHHcCCCCCCcccChHHHHHHHH
Confidence 9999999987 788998887777665553
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=283.84 Aligned_cols=219 Identities=23% Similarity=0.321 Sum_probs=184.2
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~----~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
...+|++.+.||+|+||.||++.++.++. .+|+|.+.+.. .......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45789999999999999999999877664 68999876542 24455678899999999999999999999887 7
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
..++||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 8999999999999999987653 348999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~ 901 (934)
..... .......++..|+|||.+....++.++|+|||||++|++++ |+.||.+.
T Consensus 161 ~~~~~-------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 215 (279)
T cd05057 161 VDEKE-------------------------YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215 (279)
T ss_pred Ccccc-------------------------eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 11000 00011224678999999988889999999999999999998 99999998
Q ss_pred CHHHHHHHHHcCC
Q 002342 902 TRQKTFANILHKD 914 (934)
Q Consensus 902 ~~~~~~~~i~~~~ 914 (934)
...++...+..+.
T Consensus 216 ~~~~~~~~~~~~~ 228 (279)
T cd05057 216 PAVEIPDLLEKGE 228 (279)
T ss_pred CHHHHHHHHhCCC
Confidence 8888887776643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=281.43 Aligned_cols=220 Identities=27% Similarity=0.422 Sum_probs=188.4
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||.|+||.||++.+..++..+|+|++...... .....+.+|+.+|+.++|+||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 4799999999999999999999889999999998754322 25677889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||+++++|.+++..... ..+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999976432 46899999999999999999999999999999999999999999999999998654321110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
.........|+..|+|||++... .++.++|+|||||++|+|++|+.||...+....
T Consensus 159 -----------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~ 215 (267)
T cd06610 159 -----------------------TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV 215 (267)
T ss_pred -----------------------cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh
Confidence 00122345689999999999877 788899999999999999999999998887777
Q ss_pred HHHHHcC
Q 002342 907 FANILHK 913 (934)
Q Consensus 907 ~~~i~~~ 913 (934)
+..+..+
T Consensus 216 ~~~~~~~ 222 (267)
T cd06610 216 LMLTLQN 222 (267)
T ss_pred HHHHhcC
Confidence 7766654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=286.17 Aligned_cols=222 Identities=22% Similarity=0.331 Sum_probs=185.7
Q ss_pred ccCCcccccccccCCcEEEEEEEEec-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
..++|++.+.||.|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45689999999999999999999753 67899999987542 234456788899999999999999999999999
Q ss_pred CeEEEEEEccCCCCchhhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 002342 742 THVCLITDYCPGGELFLLLDRQP--------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~--------------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~N 801 (934)
...|++|||+++++|.+++.... ...+++..+..++.||+.||.|||.+|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999986421 1247888899999999999999999999999999999
Q ss_pred EEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHH
Q 002342 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (934)
Q Consensus 802 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Di 881 (934)
|+++.++.++|+|||++....... .........+++.|+|||.+.+..++.++||
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSAD-------------------------YYKASENDAIPIRWMPPESIFYNRYTTESDV 215 (288)
T ss_pred eEecCCCceEECccccceecccCc-------------------------cccccCCCccChhhcCHHHHhcCCCCchhHH
Confidence 999999999999999985321100 0011122235678999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC
Q 002342 882 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDL 915 (934)
Q Consensus 882 wSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 915 (934)
|||||++|+|++ |..||.+.+..+....+..+..
T Consensus 216 ~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~ 250 (288)
T cd05050 216 WAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV 250 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC
Confidence 999999999997 9999999888888888877654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=286.71 Aligned_cols=204 Identities=27% Similarity=0.426 Sum_probs=173.0
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.+.|++.+.||.|++|.||++.++.+++.||+|.+..... ......+.+|+.+++.++||||+++++++...++.|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 4689999999999999999999998999999999875422 11223466899999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+. ++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 156 (291)
T cd07844 82 FEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--- 156 (291)
T ss_pred EecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC---
Confidence 99996 58999887643 35899999999999999999999999999999999999999999999999998432100
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
........+++.|+|||++.+ ..++.++||||||+++|+|++|++||.+..
T Consensus 157 ------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 157 ------------------------SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ------------------------CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 001112346889999999876 457889999999999999999999998765
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=289.75 Aligned_cols=211 Identities=27% Similarity=0.481 Sum_probs=181.9
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
+.|.....||.|+||.||++.+..++..||||.+... .......+.+|+.+++.++||||+++++.+...++.|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 4566678899999999999999999999999988643 2344566889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 99 e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---- 171 (292)
T cd06658 99 EFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE---- 171 (292)
T ss_pred eCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc----
Confidence 99999999998754 34899999999999999999999999999999999999999999999999998532110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
........|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.+.+....+.
T Consensus 172 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~ 228 (292)
T cd06658 172 -----------------------VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR 228 (292)
T ss_pred -----------------------cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011223568999999999998889999999999999999999999999888777666
Q ss_pred HHHc
Q 002342 909 NILH 912 (934)
Q Consensus 909 ~i~~ 912 (934)
.+..
T Consensus 229 ~~~~ 232 (292)
T cd06658 229 RIRD 232 (292)
T ss_pred HHHh
Confidence 6554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=281.73 Aligned_cols=209 Identities=22% Similarity=0.368 Sum_probs=178.8
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
..++|++.+.||.|+||.||++.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++... ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 457899999999999999999874 78889999886431 235678899999999999999999998764 5799
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||||+.+++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~--- 152 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM--- 152 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc---
Confidence 99999999999999776555689999999999999999999999999999999999999999999999998843210
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK 905 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~ 905 (934)
.......+..|+|||.+.+..++.++|+|||||++|+|++ |++||.+.+..+
T Consensus 153 ---------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 205 (254)
T cd05083 153 ---------------------------GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205 (254)
T ss_pred ---------------------------cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence 0011234568999999998889999999999999999997 999999988888
Q ss_pred HHHHHHcC
Q 002342 906 TFANILHK 913 (934)
Q Consensus 906 ~~~~i~~~ 913 (934)
....+..+
T Consensus 206 ~~~~~~~~ 213 (254)
T cd05083 206 VKECVEKG 213 (254)
T ss_pred HHHHHhCC
Confidence 77777665
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=284.54 Aligned_cols=214 Identities=28% Similarity=0.471 Sum_probs=183.6
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
+|++.+.||.|+||.||+|.+..++..||+|.+..... .......+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999999999999999876432 23345678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+ +++|.+++.... ..+++..++.++.||+.+|.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~---- 153 (286)
T cd07832 80 YM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE---- 153 (286)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC----
Confidence 99 999999986543 559999999999999999999999999999999999999999999999999985432110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
........|+..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+....+.
T Consensus 154 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~ 211 (286)
T cd07832 154 ----------------------PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA 211 (286)
T ss_pred ----------------------CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH
Confidence 0112234689999999998654 45889999999999999999999999888877776
Q ss_pred HHHc
Q 002342 909 NILH 912 (934)
Q Consensus 909 ~i~~ 912 (934)
.+..
T Consensus 212 ~~~~ 215 (286)
T cd07832 212 IVFR 215 (286)
T ss_pred HHHH
Confidence 6654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=280.00 Aligned_cols=218 Identities=21% Similarity=0.339 Sum_probs=172.2
Q ss_pred cccccCCcEEEEEEEEec--CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccC
Q 002342 675 KPLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 752 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~--~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 752 (934)
+.||+|+||.||++.... ....+|+|.+.... .......+.+|+.+++.++||||+++++++......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999996533 34578888775432 33344567889999999999999999999999999999999999
Q ss_pred CCCchhhhccCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 753 GGELFLLLDRQPT---KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 753 ggsL~~~l~~~~~---~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
+++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--- 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh---
Confidence 9999999876432 2356788899999999999999999999999999999999999999999999843211000
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-------AGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~ 901 (934)
........+++.|+|||++.. ..++.++|||||||++|+|++ |.+||...
T Consensus 156 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 156 ----------------------YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ----------------------eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 001123346788999999853 356779999999999999998 89999888
Q ss_pred CHHHHHHHHHc-CCCCCCC
Q 002342 902 TRQKTFANILH-KDLKFPS 919 (934)
Q Consensus 902 ~~~~~~~~i~~-~~~~~p~ 919 (934)
...+.+..+.. +...+|.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05042 214 SDEQVLKQVVREQDIKLPK 232 (269)
T ss_pred CHHHHHHHHhhccCccCCC
Confidence 87777666554 3334443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=298.00 Aligned_cols=195 Identities=27% Similarity=0.423 Sum_probs=168.1
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
...+|++++.||+|+||.||++.+..++..||+|+..+. ....|+.+++.++||||+++++++......|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 345799999999999999999999999999999985543 23468999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||||+ .++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 135 v~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 135 VLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred EEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 99999 67888888654 345999999999999999999999999999999999999999999999999998532110
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~ 900 (934)
.......||+.|+|||++.+..++.++|||||||++|+|++ +.++|..
T Consensus 211 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 211 --------------------------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred --------------------------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 11123569999999999999999999999999999999997 5555543
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=284.04 Aligned_cols=214 Identities=22% Similarity=0.365 Sum_probs=179.1
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||.|++|.||++.+..+++.||+|.+..... .......+.+|+++++.++||||+++++++....+.|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999865422 2233456788999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-CCcEEEEecccCcccCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||+ +++|.+++.......+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++......
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--- 156 (294)
T PLN00009 81 EYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--- 156 (294)
T ss_pred ecc-cccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC---
Confidence 999 568888876655555788999999999999999999999999999999999985 567999999998543211
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
........|++.|+|||++.+. .++.++|||||||++|+|++|.+||...+..+.
T Consensus 157 ------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~ 212 (294)
T PLN00009 157 ------------------------VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE 212 (294)
T ss_pred ------------------------ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0111233578899999998764 578899999999999999999999998877766
Q ss_pred HHHHH
Q 002342 907 FANIL 911 (934)
Q Consensus 907 ~~~i~ 911 (934)
+.++.
T Consensus 213 ~~~~~ 217 (294)
T PLN00009 213 LFKIF 217 (294)
T ss_pred HHHHH
Confidence 65553
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=286.06 Aligned_cols=213 Identities=29% Similarity=0.422 Sum_probs=179.9
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||+|+||.||++.+..+++.||+|.+.+... .......+.+|+++++.++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 479999999999999999999998999999999876432 2234456788999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+++++|..+.... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~---- 153 (286)
T cd07846 80 EFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP---- 153 (286)
T ss_pred ecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC----
Confidence 999998888876543 34899999999999999999999999999999999999999999999999998543110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
........|+..|+|||++.+ ..++.++||||||+++|+|++|++||.+.+..+..
T Consensus 154 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~ 210 (286)
T cd07846 154 -----------------------GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL 210 (286)
T ss_pred -----------------------ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHH
Confidence 011123468899999999976 44678999999999999999999999887766655
Q ss_pred HHHH
Q 002342 908 ANIL 911 (934)
Q Consensus 908 ~~i~ 911 (934)
..+.
T Consensus 211 ~~~~ 214 (286)
T cd07846 211 YHII 214 (286)
T ss_pred HHHH
Confidence 5544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=279.22 Aligned_cols=211 Identities=23% Similarity=0.344 Sum_probs=175.8
Q ss_pred cccccCCcEEEEEEEEecCC---eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEcc
Q 002342 675 KPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYC 751 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~---~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~ 751 (934)
+.||+|+||.||++.+..++ ..||+|.+...... .....+.+|+.+++.++||||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999886655 78999998765332 44567889999999999999999999876 45689999999
Q ss_pred CCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCc
Q 002342 752 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831 (934)
Q Consensus 752 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 831 (934)
.+++|.+++.... .+++..+..++.|++.+|.|||.+|++|+||||+|||++.++.+||+|||++........
T Consensus 78 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~----- 150 (257)
T cd05060 78 PLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD----- 150 (257)
T ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc-----
Confidence 9999999997653 589999999999999999999999999999999999999999999999999864321100
Q ss_pred chhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 002342 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANI 910 (934)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i 910 (934)
.........++..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+..+....+
T Consensus 151 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~ 211 (257)
T cd05060 151 -------------------YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML 211 (257)
T ss_pred -------------------ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 0001111234578999999999999999999999999999997 99999988888887777
Q ss_pred HcCC
Q 002342 911 LHKD 914 (934)
Q Consensus 911 ~~~~ 914 (934)
..+.
T Consensus 212 ~~~~ 215 (257)
T cd05060 212 ESGE 215 (257)
T ss_pred HcCC
Confidence 6553
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=285.97 Aligned_cols=214 Identities=27% Similarity=0.404 Sum_probs=181.6
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeeccccc--ChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
+|++.+.||.|+||.||++.+..+++.||+|.+...... .......+..|+.+++.++|+||+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488999999999999999999999999999999865432 122345567899999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-- 156 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--
Confidence 9999 999999997653 369999999999999999999999999999999999999999999999999985432110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
.......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+..+.
T Consensus 157 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~ 211 (298)
T cd07841 157 -------------------------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ 211 (298)
T ss_pred -------------------------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH
Confidence 01122356888999999865 4578899999999999999999999998887777
Q ss_pred HHHHHc
Q 002342 907 FANILH 912 (934)
Q Consensus 907 ~~~i~~ 912 (934)
+.++..
T Consensus 212 ~~~~~~ 217 (298)
T cd07841 212 LGKIFE 217 (298)
T ss_pred HHHHHH
Confidence 666653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=286.82 Aligned_cols=212 Identities=28% Similarity=0.469 Sum_probs=181.8
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
..|.....||.|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 34566678999999999999999999999999986532 223456788999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+++++|..++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 98 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~---- 170 (297)
T cd06659 98 EFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---- 170 (297)
T ss_pred ecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc----
Confidence 99999999988754 34899999999999999999999999999999999999999999999999988432110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
.......+|++.|+|||++.+..++.++|+|||||++|+|++|++||...+..+.+.
T Consensus 171 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 227 (297)
T cd06659 171 -----------------------VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 227 (297)
T ss_pred -----------------------cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011224568999999999999899999999999999999999999999888777776
Q ss_pred HHHcC
Q 002342 909 NILHK 913 (934)
Q Consensus 909 ~i~~~ 913 (934)
.+...
T Consensus 228 ~~~~~ 232 (297)
T cd06659 228 RLRDS 232 (297)
T ss_pred HHhcc
Confidence 66543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=279.04 Aligned_cols=211 Identities=23% Similarity=0.345 Sum_probs=173.9
Q ss_pred ccccCCcEEEEEEEEe--cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCC
Q 002342 676 PLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 753 (934)
Q Consensus 676 ~LG~G~~g~Vy~a~~~--~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 753 (934)
.||+|+||.||++.+. ..+..||+|++.... .......+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999775 445679999987542 34445678899999999999999999998864 578999999999
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
++|.+++... ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.........
T Consensus 79 ~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~------ 151 (257)
T cd05115 79 GPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY------ 151 (257)
T ss_pred CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccc------
Confidence 9999998654 245899999999999999999999999999999999999999999999999998543211000
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHc
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILH 912 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~ 912 (934)
........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 152 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05115 152 ------------------YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213 (257)
T ss_pred ------------------eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC
Confidence 000111234678999999998889999999999999999996 9999999888888877766
Q ss_pred CC
Q 002342 913 KD 914 (934)
Q Consensus 913 ~~ 914 (934)
+.
T Consensus 214 ~~ 215 (257)
T cd05115 214 GK 215 (257)
T ss_pred CC
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=277.32 Aligned_cols=209 Identities=29% Similarity=0.479 Sum_probs=182.1
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||.|+||.||++.+..+++.|++|.+.... ....+.+|+.+++.++||||+++++++....+.|++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 58999999999999999999998889999999987532 2567889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~---- 152 (256)
T cd06612 78 EYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT---- 152 (256)
T ss_pred ecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC----
Confidence 9999999999986542 45899999999999999999999999999999999999999999999999998543211
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
........|+..|+|||++.+..++.++||||||+++|+|++|++||..........
T Consensus 153 -----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~ 209 (256)
T cd06612 153 -----------------------MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF 209 (256)
T ss_pred -----------------------ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh
Confidence 011223458889999999999999999999999999999999999998776655444
Q ss_pred HH
Q 002342 909 NI 910 (934)
Q Consensus 909 ~i 910 (934)
.+
T Consensus 210 ~~ 211 (256)
T cd06612 210 MI 211 (256)
T ss_pred hh
Confidence 43
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=293.30 Aligned_cols=210 Identities=27% Similarity=0.492 Sum_probs=178.9
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC------
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 741 (934)
.++|++.+.||+|+||.||++.+..+++.||+|.+.+.. ........+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 478999999999999999999999999999999986532 2334445677899999999999999999998643
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
...|+||||+ +++|.+.+... ++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 94 ~~~~lv~e~~-~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred CcEEEEEecc-CCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 3579999999 56888887542 899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 169 ~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 169 GTS----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred CCC----------------------------CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 210 0112346889999999999999999999999999999999999999988
Q ss_pred CHHHHHHHHH
Q 002342 902 TRQKTFANIL 911 (934)
Q Consensus 902 ~~~~~~~~i~ 911 (934)
+....+..+.
T Consensus 221 ~~~~~~~~~~ 230 (353)
T cd07850 221 DHIDQWNKII 230 (353)
T ss_pred CHHHHHHHHH
Confidence 7766665554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=314.35 Aligned_cols=230 Identities=23% Similarity=0.370 Sum_probs=194.1
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCC-----eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~-----~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (934)
+....-++.+.||+|.||.||.+...... ..||+|.+.+. .+.+....|.+|..+|+.++|||||++++++-+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 34567788899999999999999886532 34999988764 366778899999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCchhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEec
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQ-----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~-----~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DF 815 (934)
....+|++|||+||+|..+|+.. ....++......++.+|++|+.||+++++|||||..+|+|++....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999864 1345899999999999999999999999999999999999999999999999
Q ss_pred ccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-C
Q 002342 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-G 894 (934)
Q Consensus 816 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G 894 (934)
|+|+.+...... +......-...|||||.+..+.++.++|||||||+|||+++ |
T Consensus 847 GlArDiy~~~yy-------------------------r~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG 901 (1025)
T KOG1095|consen 847 GLARDIYDKDYY-------------------------RKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLG 901 (1025)
T ss_pred chhHhhhhchhe-------------------------eccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCC
Confidence 999743221110 00011123468999999999999999999999999999997 9
Q ss_pred CCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Q 002342 895 YTPFRGKTRQKTFANIL-HKDLKFPSSTP 922 (934)
Q Consensus 895 ~~Pf~~~~~~~~~~~i~-~~~~~~p~~~~ 922 (934)
..||.+.++.+++...+ .|.++.|.+.|
T Consensus 902 ~~PY~~~~n~~v~~~~~~ggRL~~P~~CP 930 (1025)
T KOG1095|consen 902 ATPYPSRSNFEVLLDVLEGGRLDPPSYCP 930 (1025)
T ss_pred CCCCCCcchHHHHHHHHhCCccCCCCCCC
Confidence 99999999999998555 56677777764
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=282.29 Aligned_cols=243 Identities=35% Similarity=0.612 Sum_probs=199.1
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCCeEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lV 747 (934)
++|.+.+.||.|+||.||++.+..+++.||+|++.+...........+.+|..+++.++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998754444555677889999999998 99999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+.+++|.+++... ..++...++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999999999775 35999999999999999999999999999999999999999999999999998654322211
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
....... ..................|+..|+|||++.+..++.++|+||||+++|++++|..||...+....+
T Consensus 159 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 231 (280)
T cd05581 159 ESNKGDA-------TNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231 (280)
T ss_pred ccCCCCC-------ccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 0000000 000000011123345567899999999999888899999999999999999999999988887888
Q ss_pred HHHHcCCCCCCCC
Q 002342 908 ANILHKDLKFPSS 920 (934)
Q Consensus 908 ~~i~~~~~~~p~~ 920 (934)
+.+......+|..
T Consensus 232 ~~~~~~~~~~~~~ 244 (280)
T cd05581 232 QKILKLEYSFPPN 244 (280)
T ss_pred HHHHhcCCCCCCc
Confidence 8887777666653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=286.15 Aligned_cols=216 Identities=26% Similarity=0.389 Sum_probs=178.1
Q ss_pred cCCcccccccccCCcEEEEEEEEec----------------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCc
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCG----------------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 731 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~----------------~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~I 731 (934)
.++|++.+.||+|+||.||++.+.. ++..+|+|.+.... .......+.+|+.+|+.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3579999999999999999986532 34579999987532 34445678899999999999999
Q ss_pred cceeEEEEeCCeEEEEEEccCCCCchhhhccCCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 002342 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPT---------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802 (934)
Q Consensus 732 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NI 802 (934)
+++++++...+..|+||||+++++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9999999999999999999999999999875321 2477889999999999999999999999999999999
Q ss_pred EEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHH
Q 002342 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882 (934)
Q Consensus 803 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Diw 882 (934)
|++.++.++|+|||++....... .........+++.|++||+..+..++.++|+|
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Diw 216 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGD-------------------------YYRIQGRAVLPIRWMSWESILLGKFTTASDVW 216 (296)
T ss_pred EEcCCCCEEeccCcccccccCCc-------------------------ceeccCcCcCccccCCHHHHhcCCccchhhhh
Confidence 99999999999999985432110 00111223456789999999888899999999
Q ss_pred HHHHHHHHHHh--CCCCCCCCCHHHHHHHH
Q 002342 883 ALGILLYEMLY--GYTPFRGKTRQKTFANI 910 (934)
Q Consensus 883 SlG~iL~ellt--G~~Pf~~~~~~~~~~~i 910 (934)
||||++|+|++ |..||...+..+.+...
T Consensus 217 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~ 246 (296)
T cd05095 217 AFGVTLWEILTLCKEQPYSQLSDEQVIENT 246 (296)
T ss_pred HHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 99999999998 88999887776665543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=280.76 Aligned_cols=209 Identities=25% Similarity=0.377 Sum_probs=174.8
Q ss_pred cccccCCcEEEEEEEEecCCe--EEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEEEEEEcc
Q 002342 675 KPLGSGDTGSVHLVELCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYC 751 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~--~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~ 751 (934)
+.||+|+||.||++.+..++. .+++|.+... ........+.+|+.++..+ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 358999999999999988775 4688887642 2344556788999999999 8999999999999999999999999
Q ss_pred CCCCchhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEeccc
Q 002342 752 PGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817 (934)
Q Consensus 752 ~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~ 817 (934)
++++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999986532 13478999999999999999999999999999999999999999999999998
Q ss_pred CcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCC
Q 002342 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYT 896 (934)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~ 896 (934)
+..... .........++.|+|||++....++.++|+|||||++|+|++ |..
T Consensus 159 ~~~~~~----------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~ 210 (270)
T cd05047 159 SRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 210 (270)
T ss_pred ccccch----------------------------hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 732100 000111234667999999998889999999999999999996 999
Q ss_pred CCCCCCHHHHHHHHHcC
Q 002342 897 PFRGKTRQKTFANILHK 913 (934)
Q Consensus 897 Pf~~~~~~~~~~~i~~~ 913 (934)
||.+.+..+.+..+..+
T Consensus 211 pf~~~~~~~~~~~~~~~ 227 (270)
T cd05047 211 PYCGMTCAELYEKLPQG 227 (270)
T ss_pred CccccCHHHHHHHHhCC
Confidence 99988888888777654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=277.15 Aligned_cols=213 Identities=29% Similarity=0.454 Sum_probs=182.0
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccc--cChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
+|+..+.||+|+||+||++.+..++..|++|.+..... ........+.+|+.+++.++||||+++++++.....+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47888999999999999999988999999999875322 1234556788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~--- 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF--- 155 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc---
Confidence 9999999999998764 34899999999999999999999999999999999999999999999999988543110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
.......|++.|+|||.+.... ++.++|+|||||++|+|++|++||........
T Consensus 156 -------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~ 210 (258)
T cd06632 156 -------------------------SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA 210 (258)
T ss_pred -------------------------ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH
Confidence 0123456889999999998776 88999999999999999999999987765555
Q ss_pred HHHHHc
Q 002342 907 FANILH 912 (934)
Q Consensus 907 ~~~i~~ 912 (934)
...+..
T Consensus 211 ~~~~~~ 216 (258)
T cd06632 211 VFKIGR 216 (258)
T ss_pred HHHHHh
Confidence 555443
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=326.75 Aligned_cols=235 Identities=27% Similarity=0.471 Sum_probs=197.7
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.-+++....||.|.||.||-+.+..+|...|+|-++.... .......+.+|..+|..++|||+|++|++-...+.++|.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~-~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS-DHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCcc-ccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 3467888899999999999999999999999998876433 355667788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||||.+|+|.+++.. ++..++...+.+..|++.|+.|||+.|||||||||.||+++.+|-+|++|||.|.........
T Consensus 1313 MEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 999999999999976 356889999999999999999999999999999999999999999999999999765432110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCH-
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEMLYGYTPFRGKTR- 903 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~---~~s~~~DiwSlG~iL~elltG~~Pf~~~~~- 903 (934)
. .+......||+.|||||++.+. +..-+.|||||||++.||+||+.||...+.
T Consensus 1391 ~-----------------------~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1391 M-----------------------PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred C-----------------------CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence 0 0233466899999999999764 456689999999999999999999986444
Q ss_pred HHHHHHHHcCC-CCCCCCCCCCcccCCC
Q 002342 904 QKTFANILHKD-LKFPSSTPSSCKAANV 930 (934)
Q Consensus 904 ~~~~~~i~~~~-~~~p~~~~~s~~~k~l 930 (934)
-.++-.+-.|. .++|.. .|...+||
T Consensus 1448 ~aIMy~V~~gh~Pq~P~~--ls~~g~dF 1473 (1509)
T KOG4645|consen 1448 WAIMYHVAAGHKPQIPER--LSSEGRDF 1473 (1509)
T ss_pred hHHHhHHhccCCCCCchh--hhHhHHHH
Confidence 46666665555 588876 57666665
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=283.00 Aligned_cols=212 Identities=28% Similarity=0.426 Sum_probs=182.1
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
..|+..+.||.|+||.||++.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 45888999999999999999998999999999987542 2334567889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+++++|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~---- 154 (277)
T cd06642 82 EYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---- 154 (277)
T ss_pred EccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc----
Confidence 99999999998864 34899999999999999999999999999999999999999999999999998543210
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
........|+..|+|||++.+..++.++|+|||||++|+|++|++||..........
T Consensus 155 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 211 (277)
T cd06642 155 -----------------------QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF 211 (277)
T ss_pred -----------------------chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh
Confidence 001123468899999999999999999999999999999999999998766665555
Q ss_pred HHHc
Q 002342 909 NILH 912 (934)
Q Consensus 909 ~i~~ 912 (934)
.+..
T Consensus 212 ~~~~ 215 (277)
T cd06642 212 LIPK 215 (277)
T ss_pred hhhc
Confidence 4433
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=286.79 Aligned_cols=213 Identities=27% Similarity=0.433 Sum_probs=182.2
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
.|...+.||+|+||.||++.+..++..+|+|.+.+...........+.+|+.+++.++|||++++++++..++..|+|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 48899999999999999999999999999999876544444556678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+. |+|.+++... ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....
T Consensus 106 ~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~------- 176 (317)
T cd06635 106 YCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS------- 176 (317)
T ss_pred CCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-------
Confidence 995 5777776543 2458999999999999999999999999999999999999999999999999874321
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
......|++.|+|||++. ...++.++|+|||||++|+|++|++||.+......
T Consensus 177 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 232 (317)
T cd06635 177 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 232 (317)
T ss_pred ------------------------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 112346889999999984 45678899999999999999999999988877777
Q ss_pred HHHHHcCCC
Q 002342 907 FANILHKDL 915 (934)
Q Consensus 907 ~~~i~~~~~ 915 (934)
+..+..+..
T Consensus 233 ~~~~~~~~~ 241 (317)
T cd06635 233 LYHIAQNES 241 (317)
T ss_pred HHHHHhccC
Confidence 777766543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=274.89 Aligned_cols=209 Identities=24% Similarity=0.390 Sum_probs=176.0
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 754 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg 754 (934)
+.||.|+||.||++.. .++..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 3689999999999986 468899999987542 2333456888999999999999999999999999999999999999
Q ss_pred CchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchh
Q 002342 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834 (934)
Q Consensus 755 sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 834 (934)
+|.+++.... ..+++..+..++.|++.+|.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 78 ~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--------- 147 (250)
T cd05085 78 DFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI--------- 147 (250)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc---------
Confidence 9999986543 458899999999999999999999999999999999999999999999999984321100
Q ss_pred hhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC
Q 002342 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~ 913 (934)
........+++.|+|||++.+..++.++|+||||+++|++++ |..||.+.........+..+
T Consensus 148 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~ 210 (250)
T cd05085 148 -----------------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG 210 (250)
T ss_pred -----------------cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 001112234678999999998889999999999999999998 99999998888877777654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=283.38 Aligned_cols=205 Identities=28% Similarity=0.400 Sum_probs=171.9
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|.+++.||+|+||.||++.+..++..||+|.+..... ......+.+|+.+++.++|+||+++++++..++..|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 3689999999999999999999999999999999875422 22233567899999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+ +++|.+++.... ..++...++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 156 (291)
T cd07870 82 FEYM-HTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP--- 156 (291)
T ss_pred Eecc-cCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC---
Confidence 9999 577777765443 34788899999999999999999999999999999999999999999999998542110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
........+++.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+.
T Consensus 157 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 157 ------------------------SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred ------------------------CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 0111233578999999998764 578899999999999999999999986554
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=281.09 Aligned_cols=215 Identities=30% Similarity=0.480 Sum_probs=180.6
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCC----
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT---- 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~---- 742 (934)
.++|++.+.||.|++|.||+|.+..+++.|++|++.... .....+.+|+.+++.+ +||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 368999999999999999999999999999999987542 2345688999999999 7999999999997544
Q ss_pred --eEEEEEEccCCCCchhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccC
Q 002342 743 --HVCLITDYCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (934)
Q Consensus 743 --~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a 818 (934)
.+|+||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 5899999999999999886532 456899999999999999999999999999999999999999999999999988
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-----CCCCchhHHHHHHHHHHHHHh
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLY 893 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~s~~~DiwSlG~iL~ellt 893 (934)
...... ........|++.|+|||++.. ..++.++|||||||+||+|++
T Consensus 161 ~~~~~~---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~ 213 (275)
T cd06608 161 AQLDST---------------------------LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD 213 (275)
T ss_pred eecccc---------------------------hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHh
Confidence 542110 011223468999999999854 346778999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcC
Q 002342 894 GYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 894 G~~Pf~~~~~~~~~~~i~~~ 913 (934)
|++||........+..+..+
T Consensus 214 g~~p~~~~~~~~~~~~~~~~ 233 (275)
T cd06608 214 GKPPLCDMHPMRALFKIPRN 233 (275)
T ss_pred CCCCccccchHHHHHHhhcc
Confidence 99999877766666666554
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=281.42 Aligned_cols=213 Identities=23% Similarity=0.412 Sum_probs=179.7
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
+|++.+.||.|++|.||++.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999876432 2233456789999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 750 YCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
|++ ++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~---- 153 (284)
T cd07836 79 YMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---- 153 (284)
T ss_pred cCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC----
Confidence 996 58888876542 245899999999999999999999999999999999999999999999999998543210
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
........+++.|+|||++.+. .++.++|+|||||++|+|++|++||.+.+..+.+
T Consensus 154 -----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 210 (284)
T cd07836 154 -----------------------VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL 210 (284)
T ss_pred -----------------------ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 0111233578899999998664 5688999999999999999999999988887776
Q ss_pred HHHHc
Q 002342 908 ANILH 912 (934)
Q Consensus 908 ~~i~~ 912 (934)
..+.+
T Consensus 211 ~~~~~ 215 (284)
T cd07836 211 LKIFR 215 (284)
T ss_pred HHHHH
Confidence 66543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=280.35 Aligned_cols=209 Identities=23% Similarity=0.402 Sum_probs=177.1
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeeccccc---ChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML---NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~---~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
+|+..+.||+|+||.||++.+..+++.||+|.+...... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 488889999999999999999999999999998753221 12345778899999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-cEEEEecccCcccCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-~vkl~DFG~a~~~~~~~ 825 (934)
||||+++++|.+++... +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999998764 4589999999999999999999999999999999999998776 59999999985542110
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
. ..........|+..|+|||.+.+..++.++|+|||||++|+|++|..||.....
T Consensus 159 ~-----------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 213 (268)
T cd06630 159 T-----------------------GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH 213 (268)
T ss_pred c-----------------------cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 0 000112345689999999999988899999999999999999999999975443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=287.35 Aligned_cols=208 Identities=26% Similarity=0.454 Sum_probs=179.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|.+.+.||+|+||.||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 36899999999999999999999889999999998643 223346678899999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~--- 168 (293)
T cd06647 95 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--- 168 (293)
T ss_pred EecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc---
Confidence 9999999999998653 4889999999999999999999999999999999999999999999999988543211
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
........|++.|+|||.+.+..++.++|+|||||++|++++|++||...+....+
T Consensus 169 ------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~ 224 (293)
T cd06647 169 ------------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224 (293)
T ss_pred ------------------------ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe
Confidence 01112346889999999999888999999999999999999999999877665444
Q ss_pred H
Q 002342 908 A 908 (934)
Q Consensus 908 ~ 908 (934)
.
T Consensus 225 ~ 225 (293)
T cd06647 225 Y 225 (293)
T ss_pred e
Confidence 3
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=283.51 Aligned_cols=213 Identities=26% Similarity=0.424 Sum_probs=179.6
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
+|++++.||.|++|.||++.+..+++.||||.+..... .......+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48899999999999999999999999999998875432 22233567889999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+ .++|..++.......+++..+..++.|++.||+|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~-~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~----- 153 (284)
T cd07860 80 FL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP----- 153 (284)
T ss_pred cc-ccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC-----
Confidence 99 468988887655566999999999999999999999999999999999999999999999999998543211
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
........+++.|+|||++.+.. ++.++|+|||||++|+|++|+.||.+.+....+.
T Consensus 154 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~ 211 (284)
T cd07860 154 ----------------------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 211 (284)
T ss_pred ----------------------ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 01112335788999999987654 5789999999999999999999999887766555
Q ss_pred HHH
Q 002342 909 NIL 911 (934)
Q Consensus 909 ~i~ 911 (934)
++.
T Consensus 212 ~~~ 214 (284)
T cd07860 212 RIF 214 (284)
T ss_pred HHH
Confidence 443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=282.09 Aligned_cols=212 Identities=27% Similarity=0.485 Sum_probs=182.8
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
.|...+.||.|++|.||++.+..+++.+++|.+... .......+.+|+.+++.++||||+++++++...++.|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 456667999999999999999999999999987642 23344567899999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+.+++|.+++.. ..++...+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||.+......
T Consensus 97 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~----- 168 (285)
T cd06648 97 FLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----- 168 (285)
T ss_pred ccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC-----
Confidence 9999999999876 34899999999999999999999999999999999999999999999999987432110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~ 909 (934)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+....+..
T Consensus 169 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~ 226 (285)
T cd06648 169 ----------------------VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR 226 (285)
T ss_pred ----------------------CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH
Confidence 0111234689999999999988899999999999999999999999998887777777
Q ss_pred HHcCC
Q 002342 910 ILHKD 914 (934)
Q Consensus 910 i~~~~ 914 (934)
+..+.
T Consensus 227 ~~~~~ 231 (285)
T cd06648 227 IRDNL 231 (285)
T ss_pred HHhcC
Confidence 76653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=277.69 Aligned_cols=226 Identities=28% Similarity=0.510 Sum_probs=186.0
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
+|++.+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++|+||+++++++...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 58999999999999999999988999999999876532 24567888999999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+++++|.+++... ..+++..++.++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~-- 155 (264)
T cd06626 80 YCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT-- 155 (264)
T ss_pred cCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc--
Confidence 99999999998764 34889999999999999999999999999999999999999999999999998654321110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCC-HHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---HTSAVDWWALGILLYEMLYGYTPFRGKT-RQK 905 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~---~s~~~DiwSlG~iL~elltG~~Pf~~~~-~~~ 905 (934)
.........+++.|+|||++.+.. ++.++||||||+++|++++|..||.... ...
T Consensus 156 ---------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~ 214 (264)
T cd06626 156 ---------------------MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ 214 (264)
T ss_pred ---------------------ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH
Confidence 000012346889999999998766 7889999999999999999999997653 333
Q ss_pred HHHHHHcC-CCCCCCCC
Q 002342 906 TFANILHK-DLKFPSST 921 (934)
Q Consensus 906 ~~~~i~~~-~~~~p~~~ 921 (934)
....+..+ ...+|...
T Consensus 215 ~~~~~~~~~~~~~~~~~ 231 (264)
T cd06626 215 IMFHVGAGHKPPIPDSL 231 (264)
T ss_pred HHHHHhcCCCCCCCccc
Confidence 33333332 23455443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=308.48 Aligned_cols=205 Identities=25% Similarity=0.339 Sum_probs=161.3
Q ss_pred cCCcccccccccCCcEEEEEEEEecCC-eEEEEE--------------EeecccccChHHHHHHHHHHHHHHhCCCCCcc
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSG-QYFAMK--------------AMDKGVMLNRNKVHRACAEREILDMLDHPFVP 732 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~-~~vAlK--------------~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv 732 (934)
.++|++++.||+|+||+||++..+... ...+.| .+.+...........+.+|+.+|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 578999999999999999998764432 222222 11111112233455678999999999999999
Q ss_pred ceeEEEEeCCeEEEEEEccCCCCchhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc
Q 002342 733 ALYASFQTKTHVCLITDYCPGGELFLLLDRQP---TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 809 (934)
Q Consensus 733 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~ 809 (934)
++++++...+..|+||+++ +++|..++.... ........++.++.||+.||.|||++|||||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999999 677877765321 122446678889999999999999999999999999999999999
Q ss_pred EEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHH
Q 002342 810 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889 (934)
Q Consensus 810 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ 889 (934)
+||+|||++....... .......+||+.|+|||++.+..++.++|||||||+||
T Consensus 306 vkL~DFGla~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 359 (501)
T PHA03210 306 IVLGDFGTAMPFEKER--------------------------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILL 359 (501)
T ss_pred EEEEeCCCceecCccc--------------------------ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHH
Confidence 9999999986532110 01123457999999999999999999999999999999
Q ss_pred HHHhCCCCCC
Q 002342 890 EMLYGYTPFR 899 (934)
Q Consensus 890 elltG~~Pf~ 899 (934)
+|++|..|+.
T Consensus 360 ell~~~~~p~ 369 (501)
T PHA03210 360 DMLSHDFCPI 369 (501)
T ss_pred HHHHCCCCCc
Confidence 9999875443
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=281.11 Aligned_cols=213 Identities=28% Similarity=0.487 Sum_probs=182.9
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||.|+||.||++.+..+++.+|+|.+.... .......+.+|+++++.++||||+++++++...+..|++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 46899999999999999999999999999999987653 2345567889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||+.+++|.+++.... ..+++..+..++.|++.+|+|||+ .|++|+||||+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~--- 154 (265)
T cd06605 79 EYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--- 154 (265)
T ss_pred EecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH---
Confidence 9999999999987643 568999999999999999999999 99999999999999999999999999988432100
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----C
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK-----T 902 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~-----~ 902 (934)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||... .
T Consensus 155 --------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 208 (265)
T cd06605 155 --------------------------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208 (265)
T ss_pred --------------------------HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc
Confidence 001156889999999999999999999999999999999999999754 3
Q ss_pred HHHHHHHHHcC
Q 002342 903 RQKTFANILHK 913 (934)
Q Consensus 903 ~~~~~~~i~~~ 913 (934)
..+.++.+..+
T Consensus 209 ~~~~~~~~~~~ 219 (265)
T cd06605 209 IFELLQYIVNE 219 (265)
T ss_pred HHHHHHHHhcC
Confidence 34455555443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=279.80 Aligned_cols=218 Identities=24% Similarity=0.343 Sum_probs=181.7
Q ss_pred ccCCcccccccccCCcEEEEEEEEecC---CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
..++|.+.+.||.|+||.||++.+... ...+|+|.+.... .....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 346799999999999999999987544 4579999886532 24455678899999999999999999998876 55
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
.|+||||+++++|.+++.... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 789999999999999997643 3589999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~ 902 (934)
.. ........+++.|+|||.+....++.++|+||||+++|+|++ |..||.+.+
T Consensus 160 ~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 160 ES--------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred cc--------------------------ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 10 001112235678999999988889999999999999999986 999999988
Q ss_pred HHHHHHHHHcCC
Q 002342 903 RQKTFANILHKD 914 (934)
Q Consensus 903 ~~~~~~~i~~~~ 914 (934)
..+....+..+.
T Consensus 214 ~~~~~~~~~~~~ 225 (270)
T cd05056 214 NNDVIGRIENGE 225 (270)
T ss_pred HHHHHHHHHcCC
Confidence 888877776654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=279.44 Aligned_cols=215 Identities=27% Similarity=0.432 Sum_probs=179.6
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeeccccc-------ChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-------NRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~-------~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
+|.+.+.||.|+||.||++.+..+++.+|+|.+...... .....+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588899999999999999999989999999988642111 1123456788999999999999999999999999
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999998765 458999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC--CCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~--~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
... .........|+..|+|||++.... ++.++|+||||+++|+|++|..||..
T Consensus 160 ~~~-------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 160 DIY-------------------------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred ccc-------------------------cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 100 001123456899999999997754 78899999999999999999999986
Q ss_pred CCHHHHHHHHH
Q 002342 901 KTRQKTFANIL 911 (934)
Q Consensus 901 ~~~~~~~~~i~ 911 (934)
......+..+.
T Consensus 215 ~~~~~~~~~~~ 225 (272)
T cd06629 215 EEAIAAMFKLG 225 (272)
T ss_pred cchHHHHHHhh
Confidence 66655554443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=288.06 Aligned_cols=198 Identities=28% Similarity=0.445 Sum_probs=160.2
Q ss_pred cccccCCcEEEEEEEEec--CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE--eCCeEEEEEEc
Q 002342 675 KPLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ--TKTHVCLITDY 750 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~--~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~~lV~E~ 750 (934)
.+||+|+||.||+|.+.. ++..||+|.+.... ....+.+|+.+|+.++||||+++++++. .+..+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999999754 56899999886532 2235678999999999999999999985 45678999999
Q ss_pred cCCCCchhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE----ecCCcEEEEecccCc
Q 002342 751 CPGGELFLLLDRQ-------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL----QGNGHVSLTDFDLSC 819 (934)
Q Consensus 751 ~~ggsL~~~l~~~-------~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl----~~~~~vkl~DFG~a~ 819 (934)
+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 A-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred e-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 9 56787776421 12358899999999999999999999999999999999999 456789999999996
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
....... .........||+.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 161 ~~~~~~~------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f 216 (317)
T cd07867 161 LFNSPLK------------------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ccCCCcc------------------------cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence 5321100 01112345789999999999774 5788999999999999999999999
Q ss_pred CCCC
Q 002342 899 RGKT 902 (934)
Q Consensus 899 ~~~~ 902 (934)
.+..
T Consensus 217 ~~~~ 220 (317)
T cd07867 217 HCRQ 220 (317)
T ss_pred cccc
Confidence 7543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=283.70 Aligned_cols=214 Identities=22% Similarity=0.350 Sum_probs=180.7
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC--CeEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVC 745 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~ 745 (934)
.++|++.+.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++... +..|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 46899999999999999999999999999999998754322 23334567899999999999999999999877 8999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
+||||+. ++|.+++.... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 83 lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999995 58988886643 359999999999999999999999999999999999999999999999999985432110
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
.......+++.|+|||.+.+.. ++.++|+||||+++|+|++|.+||.+.+..
T Consensus 161 ---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~ 213 (293)
T cd07843 161 ---------------------------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213 (293)
T ss_pred ---------------------------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 1112335788999999997654 588999999999999999999999988887
Q ss_pred HHHHHHH
Q 002342 905 KTFANIL 911 (934)
Q Consensus 905 ~~~~~i~ 911 (934)
..+.++.
T Consensus 214 ~~~~~~~ 220 (293)
T cd07843 214 DQLNKIF 220 (293)
T ss_pred HHHHHHH
Confidence 7776654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=284.47 Aligned_cols=218 Identities=22% Similarity=0.335 Sum_probs=178.0
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~----~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
+..++|++.+.||+|+||.||++.+..++. .+|+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 345689999999999999999999987775 57888876532 233344678899999999999999999998754
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
..++++||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 5679999999999999987643 35899999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~ 900 (934)
..... ........++..|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 160 ~~~~~-------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 160 EGDEK-------------------------EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred cCccc-------------------------ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21100 001122346778999999999999999999999999999997 9999988
Q ss_pred CCHHHHHHHHHc
Q 002342 901 KTRQKTFANILH 912 (934)
Q Consensus 901 ~~~~~~~~~i~~ 912 (934)
....+....+..
T Consensus 215 ~~~~~~~~~~~~ 226 (303)
T cd05110 215 IPTREIPDLLEK 226 (303)
T ss_pred CCHHHHHHHHHC
Confidence 776665554443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=285.03 Aligned_cols=211 Identities=28% Similarity=0.420 Sum_probs=180.1
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
..|.+.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++||||+++++++...+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56999999999999999999999999999999987544444455567889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+. ++|.+++.... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~----- 167 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP----- 167 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC-----
Confidence 9995 67777765432 3589999999999999999999999999999999999999999999999998843210
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
.....|++.|+|||++. ...++.++||||||+++|+|++|++||.+.+...
T Consensus 168 --------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~ 221 (307)
T cd06607 168 --------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (307)
T ss_pred --------------------------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH
Confidence 12346888999999984 3567889999999999999999999999887766
Q ss_pred HHHHHHc
Q 002342 906 TFANILH 912 (934)
Q Consensus 906 ~~~~i~~ 912 (934)
....+..
T Consensus 222 ~~~~~~~ 228 (307)
T cd06607 222 ALYHIAQ 228 (307)
T ss_pred HHHHHhc
Confidence 6555544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=282.23 Aligned_cols=214 Identities=29% Similarity=0.445 Sum_probs=181.3
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||.|+||.||++.+..+++.||+|.+..... .......+.+|+++++.++|+||+++++++...+..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 379999999999999999999999999999998875422 3334567889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||++++.|..+.... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-- 155 (288)
T cd07833 80 EYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155 (288)
T ss_pred ecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--
Confidence 999876666555443 3489999999999999999999999999999999999999999999999999854321110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
.......++..|+|||++.+. .++.++|+||||+++|+|++|++||.+.+..+.+
T Consensus 156 ------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 211 (288)
T cd07833 156 ------------------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL 211 (288)
T ss_pred ------------------------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 112235688999999999888 8889999999999999999999999988776665
Q ss_pred HHHH
Q 002342 908 ANIL 911 (934)
Q Consensus 908 ~~i~ 911 (934)
..+.
T Consensus 212 ~~~~ 215 (288)
T cd07833 212 YLIQ 215 (288)
T ss_pred HHHH
Confidence 5543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=275.89 Aligned_cols=218 Identities=26% Similarity=0.497 Sum_probs=186.8
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe--CCeEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVCLI 747 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~lV 747 (934)
+|++.+.||.|+||.||++.+..++..||+|.+..... .......+..|+.+++.++||||+++++++.. ....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58899999999999999999999999999999876433 34455678889999999999999999998753 4578999
Q ss_pred EEccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHH-----HCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 748 TDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLH-----CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH-----~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
|||+++++|.+++... ....+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999998653 2346899999999999999999999 88999999999999999999999999999854
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
..... .......|++.|+|||++.+..++.++|+||||+++|+|++|+.||..
T Consensus 160 ~~~~~---------------------------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 160 LGHDS---------------------------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred ccCCc---------------------------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 32110 011234689999999999998899999999999999999999999999
Q ss_pred CCHHHHHHHHHcCCC
Q 002342 901 KTRQKTFANILHKDL 915 (934)
Q Consensus 901 ~~~~~~~~~i~~~~~ 915 (934)
.+.....+.+..+.+
T Consensus 213 ~~~~~~~~~~~~~~~ 227 (265)
T cd08217 213 RNQLQLASKIKEGKF 227 (265)
T ss_pred cCHHHHHHHHhcCCC
Confidence 887777777777654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=280.94 Aligned_cols=209 Identities=28% Similarity=0.506 Sum_probs=178.8
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC---CCCccceeEEEEeCCeEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD---HPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~~~~~~l 746 (934)
.|++.+.||.|+||.||++.+..+++.||+|.+.... .......+.+|+.+++.+. |||++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5889999999999999999999999999999987542 2334566788999999996 9999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||||+++++|.+++... .+++..+..++.|++.+|.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-- 154 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN-- 154 (277)
T ss_pred EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC--
Confidence 99999999999998653 5899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
........|++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.....
T Consensus 155 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~ 209 (277)
T cd06917 155 -------------------------SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209 (277)
T ss_pred -------------------------ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 011223468999999999865 456889999999999999999999998877665
Q ss_pred HHHHH
Q 002342 906 TFANI 910 (934)
Q Consensus 906 ~~~~i 910 (934)
....+
T Consensus 210 ~~~~~ 214 (277)
T cd06917 210 AMMLI 214 (277)
T ss_pred hhhcc
Confidence 55443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=276.77 Aligned_cols=218 Identities=26% Similarity=0.470 Sum_probs=186.1
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
+|++.+.||.|+||.||++.+..++..+|+|.+..... .......+.+|+.+++.++|+||+++++++......|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58899999999999999999999999999999876432 22344567889999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-cEEEEecccCcccCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-~vkl~DFG~a~~~~~~~~~~ 828 (934)
|+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--- 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc---
Confidence 99999999999775555689999999999999999999999999999999999999876 46999999885432110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+...
T Consensus 157 ------------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 212 (257)
T cd08225 157 ------------------------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212 (257)
T ss_pred ------------------------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 01122358999999999988889999999999999999999999999888777777
Q ss_pred HHHcCCC
Q 002342 909 NILHKDL 915 (934)
Q Consensus 909 ~i~~~~~ 915 (934)
.+..+.+
T Consensus 213 ~~~~~~~ 219 (257)
T cd08225 213 KICQGYF 219 (257)
T ss_pred HHhcccC
Confidence 7665543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=281.42 Aligned_cols=213 Identities=29% Similarity=0.413 Sum_probs=176.3
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEE-----eC
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ-----TK 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~-----~~ 741 (934)
.++|++++.||+|+||.||+|.+..+++.||+|++.+.. .....+.+|+.+++.+ +||||+++++++. .+
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 578999999999999999999999999999999876421 2234577899999999 7999999999873 45
Q ss_pred CeEEEEEEccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 742 THVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
+.+|+||||+++++|.+++... ....+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 6799999999999999887532 23458999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-----CCCCchhHHHHHHHHHHHHHhC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYG 894 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~s~~~DiwSlG~iL~elltG 894 (934)
..... ........|++.|+|||++.. ..++.++|||||||++|+|++|
T Consensus 173 ~~~~~---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g 225 (286)
T cd06638 173 QLTST---------------------------RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225 (286)
T ss_pred ecccC---------------------------CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcC
Confidence 43210 011123468999999999853 4578899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHH
Q 002342 895 YTPFRGKTRQKTFANIL 911 (934)
Q Consensus 895 ~~Pf~~~~~~~~~~~i~ 911 (934)
++||........+..+.
T Consensus 226 ~~p~~~~~~~~~~~~~~ 242 (286)
T cd06638 226 DPPLADLHPMRALFKIP 242 (286)
T ss_pred CCCCCCCchhHHHhhcc
Confidence 99998876655554443
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=284.66 Aligned_cols=216 Identities=29% Similarity=0.418 Sum_probs=180.5
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC--CeE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THV 744 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~ 744 (934)
..++|++.+.||.|+||.||++.+..++..||+|.+..... .......+.+|+.++++++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 46789999999999999999999999999999999875422 122223456799999999999999999998754 568
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~-~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 84 FLVMEYC-EQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEecC-CCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999999 458888876542 45899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
. .......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.
T Consensus 162 ~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 162 A---------------------------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred c---------------------------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 0 01112245788999999876 4578899999999999999999999999998
Q ss_pred HHHHHHHHc
Q 002342 904 QKTFANILH 912 (934)
Q Consensus 904 ~~~~~~i~~ 912 (934)
.+.+..+.+
T Consensus 215 ~~~~~~~~~ 223 (309)
T cd07845 215 IEQLDLIIQ 223 (309)
T ss_pred HHHHHHHHH
Confidence 888877765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=276.32 Aligned_cols=213 Identities=29% Similarity=0.500 Sum_probs=185.2
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++.+.||.|++|.||++.+..+++.|++|.+..... ......+.+|+.++..++||||+++++++......++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 368999999999999999999999999999999876532 245677889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||+++++|.+++... ..+++..+..++.|++.+|.|||+ +|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~-- 154 (264)
T cd06623 79 EYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL-- 154 (264)
T ss_pred EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--
Confidence 999999999999764 459999999999999999999999 999999999999999999999999999985432110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC---CHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK---TRQ 904 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~---~~~ 904 (934)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||... ...
T Consensus 155 -------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~ 209 (264)
T cd06623 155 -------------------------DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF 209 (264)
T ss_pred -------------------------CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHH
Confidence 1112346889999999999998999999999999999999999999877 445
Q ss_pred HHHHHHHc
Q 002342 905 KTFANILH 912 (934)
Q Consensus 905 ~~~~~i~~ 912 (934)
+..+.+..
T Consensus 210 ~~~~~~~~ 217 (264)
T cd06623 210 ELMQAICD 217 (264)
T ss_pred HHHHHHhc
Confidence 56666654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=274.70 Aligned_cols=215 Identities=22% Similarity=0.376 Sum_probs=181.9
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
..+|++.+.||.|+||.||++.+. ++..+|+|.+..... ....+.+|+++++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 457999999999999999999885 467899998875432 234578899999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+++++|.+++.... ..+++..++.++.|++.+|.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc--
Confidence 99999999999987543 358899999999999999999999999999999999999999999999999885421100
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~ 906 (934)
........++..|+|||++.+..++.++|+||||+++|+|++ |.+||........
T Consensus 155 ------------------------~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 210 (256)
T cd05112 155 ------------------------YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210 (256)
T ss_pred ------------------------ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 001112235678999999998889999999999999999998 9999998888888
Q ss_pred HHHHHcCC
Q 002342 907 FANILHKD 914 (934)
Q Consensus 907 ~~~i~~~~ 914 (934)
.+.+..+.
T Consensus 211 ~~~~~~~~ 218 (256)
T cd05112 211 VETINAGF 218 (256)
T ss_pred HHHHhCCC
Confidence 88876653
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=282.73 Aligned_cols=212 Identities=28% Similarity=0.427 Sum_probs=180.6
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
.|...+.||+|+||.||++.+..++..|++|.+.............+.+|+.+++.++|||++++++++.+....|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 37778889999999999999999999999999876544444555678889999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+ .++|.+++... ...+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 102 ~~-~~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------- 172 (313)
T cd06633 102 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------- 172 (313)
T ss_pred cC-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-------
Confidence 99 56787777554 2458999999999999999999999999999999999999999999999999873211
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
......|+..|+|||++. ...++.++|+|||||++|+|++|.+||...+....
T Consensus 173 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~ 228 (313)
T cd06633 173 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 228 (313)
T ss_pred ------------------------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 112346889999999984 45678899999999999999999999988877666
Q ss_pred HHHHHcCC
Q 002342 907 FANILHKD 914 (934)
Q Consensus 907 ~~~i~~~~ 914 (934)
...+....
T Consensus 229 ~~~~~~~~ 236 (313)
T cd06633 229 LYHIAQND 236 (313)
T ss_pred HHHHHhcC
Confidence 66665443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=278.24 Aligned_cols=217 Identities=31% Similarity=0.463 Sum_probs=180.8
Q ss_pred ccccccccCCcEEEEEEEEe----cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 672 RPIKPLGSGDTGSVHLVELC----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 672 ~i~~~LG~G~~g~Vy~a~~~----~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
++.+.||.|.||.||+|... ..+..|+||.+... ........+.+|++++++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 35678999999999999997 45678999999542 3444578899999999999999999999999988889999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||||++|+|.+++.......++......++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~-- 157 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS-- 157 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--
Confidence 999999999999988645669999999999999999999999999999999999999999999999999985531100
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~ 906 (934)
.........+...|+|||.+....++.++||||||+++|||++ |+.||...+..++
T Consensus 158 -----------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~ 214 (259)
T PF07714_consen 158 -----------------------KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI 214 (259)
T ss_dssp -----------------------SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH
T ss_pred -----------------------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 0011223356789999999998889999999999999999999 7899999999998
Q ss_pred HHHHHcCCC
Q 002342 907 FANILHKDL 915 (934)
Q Consensus 907 ~~~i~~~~~ 915 (934)
..++.++..
T Consensus 215 ~~~~~~~~~ 223 (259)
T PF07714_consen 215 IEKLKQGQR 223 (259)
T ss_dssp HHHHHTTEE
T ss_pred ccccccccc
Confidence 888865543
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=280.82 Aligned_cols=214 Identities=19% Similarity=0.198 Sum_probs=162.5
Q ss_pred cccCCcccccccccCCcEEEEEEEEecC---CeEEEEEEeecccccChHH--------HHHHHHHHHHHHhCCCCCccce
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNK--------VHRACAEREILDMLDHPFVPAL 734 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vAlK~~~~~~~~~~~~--------~~~~~~E~~il~~l~hp~Iv~l 734 (934)
+..++|++.+.||+|+||.||+|.+..+ +..+|+|+........... ......+...+..++|++|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4457899999999999999999999877 6778888644221100000 0112233344566789999999
Q ss_pred eEEEEeCC----eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcE
Q 002342 735 YASFQTKT----HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV 810 (934)
Q Consensus 735 ~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~v 810 (934)
++++.... ..+++|+++ ..++.+.+... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 98776543 457889988 55676666543 336788899999999999999999999999999999999999999
Q ss_pred EEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHH
Q 002342 811 SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 890 (934)
Q Consensus 811 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~e 890 (934)
+|+|||+|.......... ...........||+.|+|||++.+..++.++|||||||+||+
T Consensus 166 ~l~DFGla~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~e 225 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHI--------------------EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225 (294)
T ss_pred EEEEcCCceeeccCCccc--------------------ccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 999999996543211100 000112234579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCC
Q 002342 891 MLYGYTPFRGKT 902 (934)
Q Consensus 891 lltG~~Pf~~~~ 902 (934)
|++|++||.+..
T Consensus 226 l~~g~~P~~~~~ 237 (294)
T PHA02882 226 WAGIKLPWKGFG 237 (294)
T ss_pred HHhCCCCCCccc
Confidence 999999998763
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=274.82 Aligned_cols=217 Identities=25% Similarity=0.380 Sum_probs=185.1
Q ss_pred cccccccccCCcEEEEEEEEecCC----eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSG----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~----~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
+++.+.||.|+||.||++.+...+ ..+|+|.+.... .......+..|+.+++.++|+||+++++++...+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467789999999999999998766 899999986542 22255678899999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
+|||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999999765433389999999999999999999999999999999999999999999999999854321100
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK 905 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~ 905 (934)
.......+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||...+...
T Consensus 159 --------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~ 212 (258)
T smart00219 159 --------------------------YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE 212 (258)
T ss_pred --------------------------cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 00001226789999999988889999999999999999998 899999988888
Q ss_pred HHHHHHcCCC
Q 002342 906 TFANILHKDL 915 (934)
Q Consensus 906 ~~~~i~~~~~ 915 (934)
.++.+..+..
T Consensus 213 ~~~~~~~~~~ 222 (258)
T smart00219 213 VLEYLKKGYR 222 (258)
T ss_pred HHHHHhcCCC
Confidence 8888877654
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=279.00 Aligned_cols=221 Identities=20% Similarity=0.239 Sum_probs=183.7
Q ss_pred cccCCcccccccccCCcEEEEEEEEec----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe-
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCG----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT- 740 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~----~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~- 740 (934)
+..++|++.+.||+|+||.||++.+.. ++..+++|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 456789999999999999999999876 3578999987643 244556778899999999999999999998765
Q ss_pred CCeEEEEEEccCCCCchhhhccCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEe
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPT------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 814 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~------~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~D 814 (934)
....+++++|+++++|.+++..... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 5778999999999999999865422 4589999999999999999999999999999999999999999999999
Q ss_pred cccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-
Q 002342 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY- 893 (934)
Q Consensus 815 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt- 893 (934)
||+++.+...... .......++..|+|||++.+..++.++|||||||++|++++
T Consensus 161 ~g~~~~~~~~~~~-------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~ 215 (280)
T cd05043 161 NALSRDLFPMDYH-------------------------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTL 215 (280)
T ss_pred CCCcccccCCceE-------------------------EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcC
Confidence 9998643211100 00112245778999999999889999999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHHcC
Q 002342 894 GYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 894 G~~Pf~~~~~~~~~~~i~~~ 913 (934)
|++||...+..+....+..+
T Consensus 216 g~~p~~~~~~~~~~~~~~~~ 235 (280)
T cd05043 216 GQTPYVEIDPFEMAAYLKDG 235 (280)
T ss_pred CCCCcCcCCHHHHHHHHHcC
Confidence 99999988877777666554
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=280.97 Aligned_cols=215 Identities=21% Similarity=0.370 Sum_probs=177.0
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCCe----
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTH---- 743 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~---- 743 (934)
++|++.+.||+|+||.||++.+..+++.||+|.+.... ........+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 46999999999999999999999999999999886542 22223456788999999995 6999999999987665
Q ss_pred -EEEEEEccCCCCchhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-CCcEEEEecccC
Q 002342 744 -VCLITDYCPGGELFLLLDRQP---TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLS 818 (934)
Q Consensus 744 -~~lV~E~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-~~~vkl~DFG~a 818 (934)
.|+||||+.+ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999964 8888876432 245899999999999999999999999999999999999998 889999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~P 897 (934)
...... ........+++.|+|||++.+ ..++.++|+||||+++|+|++|.+|
T Consensus 159 ~~~~~~---------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 211 (295)
T cd07837 159 RAFSIP---------------------------VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211 (295)
T ss_pred eecCCC---------------------------ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCC
Confidence 543210 011122357889999999865 4578899999999999999999999
Q ss_pred CCCCCHHHHHHHHHc
Q 002342 898 FRGKTRQKTFANILH 912 (934)
Q Consensus 898 f~~~~~~~~~~~i~~ 912 (934)
|.+.+....+..+..
T Consensus 212 ~~~~~~~~~~~~~~~ 226 (295)
T cd07837 212 FPGDSELQQLLHIFK 226 (295)
T ss_pred CCCCCHHHHHHHHHH
Confidence 999888776665543
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=280.11 Aligned_cols=203 Identities=26% Similarity=0.369 Sum_probs=167.8
Q ss_pred CCc-ccccccccCCcEEEEEEEE----ecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe--C
Q 002342 669 QHF-RPIKPLGSGDTGSVHLVEL----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--K 741 (934)
Q Consensus 669 ~~y-~i~~~LG~G~~g~Vy~a~~----~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~ 741 (934)
++| ++++.||.|+||+||++.. ..++..||+|.+.... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 345 9999999999999988753 3567899999987542 22344667889999999999999999998765 3
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
..+|++|||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 4689999999999999998653 3999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
..... .........++..|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 158 ~~~~~------------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 158 PEGHE------------------------YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred CCcch------------------------hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 21100 00011122456779999999988899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=281.18 Aligned_cols=213 Identities=28% Similarity=0.441 Sum_probs=171.8
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHH-HHhCCCCCccceeEEEEeCCeEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-LDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
++|++.+.||+|+||.||++.+..+|+.||+|.+.+... .. ....+..|+.+ ++.++||||+++++++..++.+|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 479999999999999999999999999999999876432 12 22345556665 6677999999999999999999999
Q ss_pred EEccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 748 TDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|||+ .++|.+++... ....+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhh-cccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999 57887776542 234699999999999999999999998 9999999999999999999999999998542110
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC----CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~----~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||..
T Consensus 158 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 158 ----------------------------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ----------------------------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 01122458889999999865 4567899999999999999999999975
Q ss_pred C-CHHHHHHHHHc
Q 002342 901 K-TRQKTFANILH 912 (934)
Q Consensus 901 ~-~~~~~~~~i~~ 912 (934)
. ...+.+..+..
T Consensus 210 ~~~~~~~~~~~~~ 222 (283)
T cd06617 210 WKTPFQQLKQVVE 222 (283)
T ss_pred cccCHHHHHHHHh
Confidence 3 33344444444
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=285.09 Aligned_cols=209 Identities=27% Similarity=0.428 Sum_probs=173.7
Q ss_pred CcccccccccCCcEEEEEEEEec--CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC--CeEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVC 745 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~--~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~ 745 (934)
+|.+.+.||+|+||.||++.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58899999999999999999988 8999999999874323334456678899999999999999999999988 8899
Q ss_pred EEEEccCCCCchhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec----CCcEEEEecccC
Q 002342 746 LITDYCPGGELFLLLDRQ---PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG----NGHVSLTDFDLS 818 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~---~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~----~~~vkl~DFG~a 818 (934)
+||||++ ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999995 5777766432 1236899999999999999999999999999999999999999 899999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~P 897 (934)
........ ........++++.|+|||++.+. .++.++|+|||||++|+|++|++|
T Consensus 160 ~~~~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~ 215 (316)
T cd07842 160 RLFNAPLK------------------------PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215 (316)
T ss_pred cccCCCcc------------------------cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence 65321110 01122345689999999998764 578899999999999999999999
Q ss_pred CCCCCH
Q 002342 898 FRGKTR 903 (934)
Q Consensus 898 f~~~~~ 903 (934)
|.+...
T Consensus 216 ~~~~~~ 221 (316)
T cd07842 216 FKGREA 221 (316)
T ss_pred CcCCcc
Confidence 987554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=273.75 Aligned_cols=223 Identities=25% Similarity=0.378 Sum_probs=182.8
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHH-HHhCCCCCccceeEEEEeCCeE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-LDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
+..++.+-+..||.|+||+|++..++.+|+..|||.+..... .....++..|.+. ++.-+.||||++|+..-.++..
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc 138 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC 138 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence 445566777889999999999999999999999999986543 3344566667665 5556899999999999999999
Q ss_pred EEEEEccCCCCchhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 745 CLITDYCPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~---~~~~~l~~~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
||.||+| ..||..+.+. .....+++..+-.|..-.+.||.||-.. .||||||||+|||++..|.|||||||+|..
T Consensus 139 WiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 139 WICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence 9999999 7777655432 2234599999999999999999999976 899999999999999999999999999954
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc--CCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA--GAGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--~~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
+..+ -..+...|...|||||.+. +.+|+.+||+||||++|||+.||..||
T Consensus 218 Lv~S----------------------------iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPy 269 (361)
T KOG1006|consen 218 LVDS----------------------------IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPY 269 (361)
T ss_pred HHHH----------------------------HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCc
Confidence 3211 1223447999999999994 456899999999999999999999999
Q ss_pred CCCC-HHHHHHHHHcCCCCCCC
Q 002342 899 RGKT-RQKTFANILHKDLKFPS 919 (934)
Q Consensus 899 ~~~~-~~~~~~~i~~~~~~~p~ 919 (934)
.+-+ ..+++.++..|++++-.
T Consensus 270 r~w~svfeql~~Vv~gdpp~l~ 291 (361)
T KOG1006|consen 270 RKWDSVFEQLCQVVIGDPPILL 291 (361)
T ss_pred chHHHHHHHHHHHHcCCCCeec
Confidence 9854 46888899999876544
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=277.06 Aligned_cols=212 Identities=29% Similarity=0.449 Sum_probs=182.7
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
-|++++.||.|+||.||++.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 4888999999999999999998899999999876432 23345678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+++++|..++.. ..++...+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~----- 154 (277)
T cd06641 83 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT----- 154 (277)
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc-----
Confidence 9999999998864 34899999999999999999999999999999999999999999999999988543110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~ 909 (934)
........|+..|+|||.+.+..++.++|+|||||++|+|++|.+||...+.......
T Consensus 155 ----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 212 (277)
T cd06641 155 ----------------------QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL 212 (277)
T ss_pred ----------------------hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH
Confidence 0011234688899999999988889999999999999999999999988777766666
Q ss_pred HHcC
Q 002342 910 ILHK 913 (934)
Q Consensus 910 i~~~ 913 (934)
+..+
T Consensus 213 ~~~~ 216 (277)
T cd06641 213 IPKN 216 (277)
T ss_pred HhcC
Confidence 6544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=310.20 Aligned_cols=237 Identities=27% Similarity=0.413 Sum_probs=185.2
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe------
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------ 740 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------ 740 (934)
...+|+.+..||+||||.||+|+++-+|+.||||.+.... .......+.+|+..|.+|+|||||++|..+..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 3568999999999999999999999999999999987643 56667788999999999999999998764300
Q ss_pred --------------------------------------------------------------------------------
Q 002342 741 -------------------------------------------------------------------------------- 740 (934)
Q Consensus 741 -------------------------------------------------------------------------------- 740 (934)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 002342 741 -------------------------K--------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787 (934)
Q Consensus 741 -------------------------~--------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yL 787 (934)
+ ..+||-||||+...|.+++..+... -.....+.+++||++||.|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHH
Confidence 0 1278999999999999988775321 15788999999999999999
Q ss_pred HHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccch
Q 002342 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 867 (934)
Q Consensus 788 H~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aP 867 (934)
|++|||||||||.||+++.++.|||+|||+|+......... .............+....++.+||..|+||
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~---------d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESI---------DQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhH---------hhccCccccccCCCCcccccccceeeeecH
Confidence 99999999999999999999999999999996521100000 000000011111223355678999999999
Q ss_pred hhhcCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCC
Q 002342 868 EIIAGA---GHTSAVDWWALGILLYEMLYGYTPFRGKT-RQKTFANILHKDLKFP 918 (934)
Q Consensus 868 E~l~~~---~~s~~~DiwSlG~iL~elltG~~Pf~~~~-~~~~~~~i~~~~~~~p 918 (934)
|++.+. +|+.++|+||||++||||+ .||.... ...++..+.++.+++|
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~ 836 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEP 836 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCC
Confidence 999765 4999999999999999999 4687543 4577888888888887
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=278.34 Aligned_cols=205 Identities=24% Similarity=0.401 Sum_probs=169.6
Q ss_pred cCCcccccccccCCcEEEEEEEE----ecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe--C
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVEL----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--K 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~----~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~ 741 (934)
..+|++++.||+|+||.||++.. ..++..||+|.+... .......+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 35899999999999999999974 457889999998653 34455678899999999999999999998753 4
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
..+|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 57899999999999999987542 34899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
...... ........++..|+|||++.+..++.++|+|||||++|+|++|..|+..
T Consensus 159 ~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 159 PQDKEY------------------------YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred cCCCcc------------------------eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 211100 0001112345569999999998999999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=273.16 Aligned_cols=208 Identities=29% Similarity=0.466 Sum_probs=175.2
Q ss_pred cCCcccccccccCCcEEEEEEEEecCC----eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe-CC
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSG----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KT 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~----~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~ 742 (934)
...|++.+.||+|.||.||+|..+.++ +.||||.++-... .........+|+.+++.++||||+.|..+|-. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 568999999999999999999665543 3789998875422 22334567899999999999999999999876 88
Q ss_pred eEEEEEEccCCCCchhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC----CcEEEEec
Q 002342 743 HVCLITDYCPGGELFLLLDRQ---PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDF 815 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~---~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~----~~vkl~DF 815 (934)
.++|++||. .-+|+..++.. ..+.++...++.|+.||+.|+.|||++-|+||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999999 66898888643 23579999999999999999999999999999999999999988 89999999
Q ss_pred ccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhC
Q 002342 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG 894 (934)
Q Consensus 816 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG 894 (934)
|+++.+... ..+.......+-|.+|.|||.+.|. .|+.++|+|+.||++.||++-
T Consensus 181 GlaR~~~~p------------------------lkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl 236 (438)
T KOG0666|consen 181 GLARLFNNP------------------------LKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTL 236 (438)
T ss_pred cHHHHhhcc------------------------ccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHcc
Confidence 999775421 2334455667889999999999885 678899999999999999999
Q ss_pred CCCCCCC
Q 002342 895 YTPFRGK 901 (934)
Q Consensus 895 ~~Pf~~~ 901 (934)
+|.|.+.
T Consensus 237 ~PlF~g~ 243 (438)
T KOG0666|consen 237 EPLFKGR 243 (438)
T ss_pred Cccccch
Confidence 9999874
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=270.82 Aligned_cols=215 Identities=47% Similarity=0.868 Sum_probs=189.7
Q ss_pred cccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCCCc
Q 002342 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 756 (934)
Q Consensus 677 LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL 756 (934)
||.|+||.||++.+..+++.||+|++.+...........+..|+.+++.++||||+++++++..+...|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999999876655555677889999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhh
Q 002342 757 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836 (934)
Q Consensus 757 ~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~ 836 (934)
.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----------- 147 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----------- 147 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-----------
Confidence 9999765 358999999999999999999999999999999999999999999999999985432110
Q ss_pred ccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Q 002342 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 916 (934)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~~~~ 916 (934)
.......|+..|+|||.+.+...+.++|+||||+++|+|++|..||........++.+....+.
T Consensus 148 ----------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 211 (250)
T cd05123 148 ----------------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR 211 (250)
T ss_pred ----------------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 1223456889999999999888899999999999999999999999988888888888887777
Q ss_pred CCCC
Q 002342 917 FPSS 920 (934)
Q Consensus 917 ~p~~ 920 (934)
+|..
T Consensus 212 ~~~~ 215 (250)
T cd05123 212 FPEF 215 (250)
T ss_pred CCCC
Confidence 6665
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=279.11 Aligned_cols=212 Identities=23% Similarity=0.321 Sum_probs=176.0
Q ss_pred cccccCCcEEEEEEEEecCC------eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 675 KPLGSGDTGSVHLVELCGSG------QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~------~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
+.||.|+||.||++.+.... ..+|+|.+.+.. .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999986544 789999886542 2234567888999999999999999999999999999999
Q ss_pred EccCCCCchhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-----cEEEEecccC
Q 002342 749 DYCPGGELFLLLDRQ-----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-----HVSLTDFDLS 818 (934)
Q Consensus 749 E~~~ggsL~~~l~~~-----~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-----~vkl~DFG~a 818 (934)
||+++++|.+++... ....+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999998653 223478899999999999999999999999999999999999877 8999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTP 897 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~P 897 (934)
....... .........++..|+|||++.+..++.++|||||||++|+|++ |+.|
T Consensus 159 ~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p 213 (269)
T cd05044 159 RDIYKSD-------------------------YYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213 (269)
T ss_pred ccccccc-------------------------ccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCC
Confidence 5432110 0011122346788999999999999999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHcC
Q 002342 898 FRGKTRQKTFANILHK 913 (934)
Q Consensus 898 f~~~~~~~~~~~i~~~ 913 (934)
|...+..+....+..+
T Consensus 214 ~~~~~~~~~~~~~~~~ 229 (269)
T cd05044 214 YPALNNQEVLQHVTAG 229 (269)
T ss_pred CcccCHHHHHHHHhcC
Confidence 9988888877777654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=278.64 Aligned_cols=215 Identities=30% Similarity=0.416 Sum_probs=179.0
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeC-----
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK----- 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~----- 741 (934)
.++|.+.+.||.|+||.||++.+..+++.+|+|++.... .....+.+|+.+++.+ +|||++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 478999999999999999999999999999999986531 2234567899999998 899999999998753
Q ss_pred CeEEEEEEccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 742 THVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
+..|+||||+++++|.+++... ....+++..++.++.|++.||+|||+.||+|+||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 4689999999999999987632 23468999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-----CCCchhHHHHHHHHHHHHHhC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-----GHTSAVDWWALGILLYEMLYG 894 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----~~s~~~DiwSlG~iL~elltG 894 (934)
...... .......|+..|+|||++... .++.++|+|||||++|+|++|
T Consensus 177 ~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g 229 (291)
T cd06639 177 QLTSTR---------------------------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229 (291)
T ss_pred hccccc---------------------------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhC
Confidence 432100 011234688999999998653 357899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcC
Q 002342 895 YTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 895 ~~Pf~~~~~~~~~~~i~~~ 913 (934)
++||........+..+..+
T Consensus 230 ~~p~~~~~~~~~~~~~~~~ 248 (291)
T cd06639 230 DPPLFDMHPVKTLFKIPRN 248 (291)
T ss_pred CCCCCCCcHHHHHHHHhcC
Confidence 9999988776666666544
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=272.84 Aligned_cols=210 Identities=26% Similarity=0.374 Sum_probs=176.6
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCC
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 754 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg 754 (934)
+.||.|+||.||++.+.. ++.||+|.+..... ......+.+|++++++++||||+++++++......|+||||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 468999999999999977 99999998875432 235567889999999999999999999999999999999999999
Q ss_pred CchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchh
Q 002342 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834 (934)
Q Consensus 755 sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 834 (934)
+|.+++.... ..++...+..++.+++.+|.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 78 ~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-------- 148 (251)
T cd05041 78 SLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-------- 148 (251)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc--------
Confidence 9999986543 3588999999999999999999999999999999999999999999999999854211000
Q ss_pred hhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC
Q 002342 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~ 913 (934)
........++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.........+..+
T Consensus 149 -----------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~ 211 (251)
T cd05041 149 -----------------TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG 211 (251)
T ss_pred -----------------eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC
Confidence 000012234667999999998899999999999999999998 99999888877777666553
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=278.73 Aligned_cols=222 Identities=43% Similarity=0.755 Sum_probs=180.2
Q ss_pred CcccccccccCCcEEEEEEEEe---cCCeEEEEEEeeccccc-ChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 744 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAlK~~~~~~~~-~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 744 (934)
.|++.+.||.|+||.||+|.+. .+|..||+|++.+.... .......+.+|+.+++.+ +|+||+.++++|..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999985 47899999998754322 223345678899999999 699999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999998764 34899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
. ........|+..|+|||.+.+. .++.++||||||+++|+|++|..||....
T Consensus 159 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 212 (290)
T cd05613 159 E--------------------------VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212 (290)
T ss_pred c--------------------------ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC
Confidence 0 0112245689999999999753 46778999999999999999999997432
Q ss_pred ----HHHHHHHHHcCCCCCCC
Q 002342 903 ----RQKTFANILHKDLKFPS 919 (934)
Q Consensus 903 ----~~~~~~~i~~~~~~~p~ 919 (934)
...+.+.+......+|.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~ 233 (290)
T cd05613 213 EKNSQAEISRRILKSEPPYPQ 233 (290)
T ss_pred ccccHHHHHHHhhccCCCCCc
Confidence 34445555555444443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=279.87 Aligned_cols=204 Identities=24% Similarity=0.365 Sum_probs=170.7
Q ss_pred CCcccccccccCCcEEEEEEEE----ecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC--C
Q 002342 669 QHFRPIKPLGSGDTGSVHLVEL----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--T 742 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~----~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~ 742 (934)
..|++++.||+|+||.||++.. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 4689999999999999999985 4578899999986532 344456788999999999999999999998764 6
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
..++||||++|++|.+++.... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 7899999999999999986543 358999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
.... .........|+..|+|||++.+..++.++|||||||++|+|+++..|+.
T Consensus 161 ~~~~------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 161 TDKE------------------------YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred cCcc------------------------ceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 1100 0011123457788999999998889999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=278.98 Aligned_cols=214 Identities=28% Similarity=0.460 Sum_probs=185.6
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.+.|++.+.||.|++|.||++.+..++..|++|++..... ....+.+|+.+++.++|+||+++++++...+..|++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4579999999999999999999988899999999875422 456788899999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+++++|.+++.... ..++...+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~--- 169 (286)
T cd06614 94 MEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--- 169 (286)
T ss_pred EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc---
Confidence 99999999999998753 36999999999999999999999999999999999999999999999999987432110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
........+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.....
T Consensus 170 ------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~ 225 (286)
T cd06614 170 ------------------------KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225 (286)
T ss_pred ------------------------hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 00112345788999999999888999999999999999999999999988777666
Q ss_pred HHHHcC
Q 002342 908 ANILHK 913 (934)
Q Consensus 908 ~~i~~~ 913 (934)
..+..+
T Consensus 226 ~~~~~~ 231 (286)
T cd06614 226 FLITTK 231 (286)
T ss_pred HHHHhc
Confidence 666543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=277.89 Aligned_cols=195 Identities=31% Similarity=0.506 Sum_probs=165.6
Q ss_pred CCccccccc--ccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEE
Q 002342 669 QHFRPIKPL--GSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 669 ~~y~i~~~L--G~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~ 745 (934)
+.|.+.+.+ |.|+||.||++.++.++..+|+|.+.+..... .|+.+...+ +||||++++++|...+..|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 467777776 99999999999999999999999987542111 123333323 7999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-cEEEEecccCcccCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCK 824 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-~vkl~DFG~a~~~~~~ 824 (934)
+||||+++++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 9999999999999997653 699999999999999999999999999999999999999988 999999998854321
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||......
T Consensus 163 ------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 212 (267)
T PHA03390 163 ------------------------------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE 212 (267)
T ss_pred ------------------------------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 11235889999999999999999999999999999999999999865443
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=278.20 Aligned_cols=213 Identities=24% Similarity=0.416 Sum_probs=179.6
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEc
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 750 (934)
|++.+.||.|++|.||++.+..+|..||+|.+..... .......+.+|+.+++.++|||++++++++.+.+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 7888999999999999999999999999999875422 222335677899999999999999999999999999999999
Q ss_pred cCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCC
Q 002342 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (934)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 830 (934)
+ +++|.+++.......+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~------ 152 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP------ 152 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC------
Confidence 9 578999987765446999999999999999999999999999999999999999999999999998543210
Q ss_pred cchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 002342 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (934)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~ 909 (934)
........+++.|+|||++.+. .++.++|+||||+++|+|++|++||.+.+....+..
T Consensus 153 ---------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 211 (283)
T cd07835 153 ---------------------VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR 211 (283)
T ss_pred ---------------------ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0011223568899999988764 568899999999999999999999998877666555
Q ss_pred HHc
Q 002342 910 ILH 912 (934)
Q Consensus 910 i~~ 912 (934)
+.+
T Consensus 212 ~~~ 214 (283)
T cd07835 212 IFR 214 (283)
T ss_pred HHH
Confidence 543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=274.69 Aligned_cols=210 Identities=21% Similarity=0.308 Sum_probs=168.4
Q ss_pred cccccCCcEEEEEEEEe--cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccC
Q 002342 675 KPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 752 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~--~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 752 (934)
+.||+|+||.||++... .++..+|+|.+.... .......+.+|+.+++.++||||+++++++......|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999864 355789999876542 22334567889999999999999999999999999999999999
Q ss_pred CCCchhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 753 GGELFLLLDRQP---TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 753 ggsL~~~l~~~~---~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
+++|.+++.... ...++...+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~---- 154 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED---- 154 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc----
Confidence 999999986532 2246677888899999999999999999999999999999999999999999984321100
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-------CCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-------GHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-------~~s~~~DiwSlG~iL~ellt-G~~Pf~~~ 901 (934)
.........|++.|+|||++.+. .++.++|+||||+++|+|++ |..||...
T Consensus 155 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 155 ---------------------YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred ---------------------eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 00112234678899999998643 35779999999999999996 99999887
Q ss_pred CHHHHHHHHH
Q 002342 902 TRQKTFANIL 911 (934)
Q Consensus 902 ~~~~~~~~i~ 911 (934)
...+......
T Consensus 214 ~~~~~~~~~~ 223 (269)
T cd05087 214 SDEQVLTYTV 223 (269)
T ss_pred ChHHHHHHHh
Confidence 7766554433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=286.63 Aligned_cols=213 Identities=25% Similarity=0.424 Sum_probs=175.2
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC-----C
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----T 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~ 742 (934)
.++|++.+.||+|+||.||++.+..+++.||+|.+... ........+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 46899999999999999999999999999999998642 2233456677899999999999999999887643 3
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
.+|+||||+ +++|..++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 82 DVYIVQELM-ETDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred eEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 589999999 5688877754 349999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
.... ........+|++.|+|||.+.+ ..++.++|||||||++|+|++|++||.+.
T Consensus 158 ~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 158 PEHD------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred cccc------------------------ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1100 0011123578999999998755 56888999999999999999999999887
Q ss_pred CHHHHHHHH
Q 002342 902 TRQKTFANI 910 (934)
Q Consensus 902 ~~~~~~~~i 910 (934)
+....+..+
T Consensus 214 ~~~~~~~~~ 222 (336)
T cd07849 214 DYLHQLNLI 222 (336)
T ss_pred CHHHHHHHH
Confidence 665544433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=278.51 Aligned_cols=209 Identities=20% Similarity=0.312 Sum_probs=169.0
Q ss_pred cccccCCcEEEEEEEEecCCe-------EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 675 KPLGSGDTGSVHLVELCGSGQ-------YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~-------~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
+.||.|+||.||++.+...+. .+|+|.+... .....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999999866543 3888877543 234456778899999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc--------EEEEecccCc
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--------VSLTDFDLSC 819 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~--------vkl~DFG~a~ 819 (934)
|||+.+++|..++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||++.
T Consensus 78 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999997653 35899999999999999999999999999999999999987765 6899999874
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhC-CCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG-YTP 897 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG-~~P 897 (934)
... ......+++.|+|||++.+. .++.++|+|||||++|+|++| .+|
T Consensus 157 ~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~ 205 (258)
T cd05078 157 TVL-------------------------------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP 205 (258)
T ss_pred ccC-------------------------------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 321 11234688899999999864 578899999999999999998 577
Q ss_pred CCCCCHHHHHHHHHcCCCCCCC
Q 002342 898 FRGKTRQKTFANILHKDLKFPS 919 (934)
Q Consensus 898 f~~~~~~~~~~~i~~~~~~~p~ 919 (934)
|...+...... +......+|.
T Consensus 206 ~~~~~~~~~~~-~~~~~~~~~~ 226 (258)
T cd05078 206 LSALDSQKKLQ-FYEDRHQLPA 226 (258)
T ss_pred hhhccHHHHHH-HHHccccCCC
Confidence 76665554433 3344445554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=280.66 Aligned_cols=219 Identities=24% Similarity=0.325 Sum_probs=177.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC------
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 741 (934)
.++|++.+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 5689999999999999999999999999999998865322 122233456799999999999999999988654
Q ss_pred --CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 742 --THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 742 --~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
...|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus 90 ~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 90 YKGSFYLVFEFC-EHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCceEEEEEcCC-CcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 3469999999 568888876542 358999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
........ .........+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||
T Consensus 168 ~~~~~~~~-----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~ 224 (310)
T cd07865 168 AFSLSKNS-----------------------KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM 224 (310)
T ss_pred cccCCccc-----------------------CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC
Confidence 54221100 00111234678999999998765 4688999999999999999999999
Q ss_pred CCCCHHHHHHHHHc
Q 002342 899 RGKTRQKTFANILH 912 (934)
Q Consensus 899 ~~~~~~~~~~~i~~ 912 (934)
.+.+.......+..
T Consensus 225 ~~~~~~~~~~~~~~ 238 (310)
T cd07865 225 QGNTEQHQLTLISQ 238 (310)
T ss_pred CCCCHHHHHHHHHH
Confidence 98877665554443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=284.93 Aligned_cols=211 Identities=29% Similarity=0.466 Sum_probs=179.2
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC-----
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 742 (934)
.++|++++.||.|+||.||++.+..++..||+|.+.+.. ........+.+|+.+|+.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 578999999999999999999999999999999986532 23334456788999999999999999999987543
Q ss_pred -eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 743 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 743 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
..|+||||+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 468999999 8899888764 34899999999999999999999999999999999999999999999999998532
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.. ......+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+
T Consensus 169 ~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 169 DS------------------------------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred cc------------------------------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11 1123357889999999976 4578899999999999999999999998
Q ss_pred CCHHHHHHHHHcC
Q 002342 901 KTRQKTFANILHK 913 (934)
Q Consensus 901 ~~~~~~~~~i~~~ 913 (934)
.+....+..+...
T Consensus 219 ~~~~~~~~~~~~~ 231 (343)
T cd07880 219 HDHLDQLMEIMKV 231 (343)
T ss_pred CCHHHHHHHHHHh
Confidence 8877776666553
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=275.50 Aligned_cols=219 Identities=26% Similarity=0.399 Sum_probs=183.8
Q ss_pred CcccccccccCCcEEEEEEEEec-CCeEEEEEEeecccc-------cChHHHHHHHHHHHHHHh-CCCCCccceeEEEEe
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCG-SGQYFAMKAMDKGVM-------LNRNKVHRACAEREILDM-LDHPFVPALYASFQT 740 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~-~~~~vAlK~~~~~~~-------~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~ 740 (934)
+|++.+.||+|+||.||++.+.. +++.+|+|.+..... ........+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48999999999999999999987 688999998864321 123345567788888875 799999999999999
Q ss_pred CCeEEEEEEccCCCCchhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEeccc
Q 002342 741 KTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDL 817 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFG~ 817 (934)
.++.|++|||+++++|.+++.. .....+++..++.++.|++.+|.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988753 223459999999999999999999996 6899999999999999999999999999
Q ss_pred CcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCC
Q 002342 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~P 897 (934)
+...... .......|++.|+|||++.+..++.++|+||||+++|+|++|++|
T Consensus 161 ~~~~~~~----------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p 212 (269)
T cd08528 161 AKQKQPE----------------------------SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212 (269)
T ss_pred eeecccc----------------------------cccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCc
Confidence 8542210 012244689999999999998899999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCC
Q 002342 898 FRGKTRQKTFANILHKDLK 916 (934)
Q Consensus 898 f~~~~~~~~~~~i~~~~~~ 916 (934)
|...........+..+.+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 213 FYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred ccccCHHHHHHHHhhccCC
Confidence 9988887777777765543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=275.11 Aligned_cols=213 Identities=30% Similarity=0.493 Sum_probs=179.1
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe--CCeEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVCL 746 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~l 746 (934)
++|...+.||.|++|.||++.+..+++.||+|.+.... .......+.+|+++++.++||||++++++|.. .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 46889999999999999999999999999999987542 23455678899999999999999999999865 347899
Q ss_pred EEEccCCCCchhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 747 ITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
||||+++++|.+++.. .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999888653 22355899999999999999999999999999999999999999999999999998432110
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC---
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK--- 901 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~--- 901 (934)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus 159 -----------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 209 (287)
T cd06621 159 -----------------------------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP 209 (287)
T ss_pred -----------------------------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC
Confidence 011345788999999999999999999999999999999999999865
Q ss_pred --CHHHHHHHHHc
Q 002342 902 --TRQKTFANILH 912 (934)
Q Consensus 902 --~~~~~~~~i~~ 912 (934)
...+....+..
T Consensus 210 ~~~~~~~~~~~~~ 222 (287)
T cd06621 210 PLGPIELLSYIVN 222 (287)
T ss_pred CCChHHHHHHHhc
Confidence 23444444444
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=282.49 Aligned_cols=223 Identities=21% Similarity=0.294 Sum_probs=178.4
Q ss_pred cccccC--CcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccC
Q 002342 675 KPLGSG--DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 752 (934)
Q Consensus 675 ~~LG~G--~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 752 (934)
..||.| +||+||++.+..+++.||+|++..... .....+.+.+|+.+++.++||||++++++|..++..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 999999999999999999999875432 23445778899999999999999999999999999999999999
Q ss_pred CCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcc
Q 002342 753 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832 (934)
Q Consensus 753 ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 832 (934)
+++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~----- 157 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK----- 157 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc-----
Confidence 999999987654456999999999999999999999999999999999999999999999999865322110000
Q ss_pred hhhhccccCCCCcccccccccccccccCCCCccchhhhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 002342 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910 (934)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i 910 (934)
... .........++..|||||++.+. .++.++|||||||++|+|++|++||.+......+..+
T Consensus 158 -----------~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 222 (328)
T cd08226 158 -----------AKV----VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK 222 (328)
T ss_pred -----------ccc----cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHH
Confidence 000 00001122356779999999764 4678999999999999999999999988777666666
Q ss_pred HcCCCCCC
Q 002342 911 LHKDLKFP 918 (934)
Q Consensus 911 ~~~~~~~p 918 (934)
+.+....|
T Consensus 223 ~~~~~~~~ 230 (328)
T cd08226 223 LKGPPYSP 230 (328)
T ss_pred hcCCCCCC
Confidence 65544333
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=284.37 Aligned_cols=210 Identities=29% Similarity=0.459 Sum_probs=177.3
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC------
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 741 (934)
.++|++.+.||+|+||.||++.+..+++.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 4789999999999999999999999999999999875422 223345677899999999999999999988643
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
...|++++++ +++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3578899988 8899888754 24899999999999999999999999999999999999999999999999998432
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.. ......|++.|+|||.+.+ ..++.++|||||||++|+|++|++||.+
T Consensus 171 ~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 171 DD------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred cc------------------------------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 10 1123467889999999876 5678899999999999999999999998
Q ss_pred CCHHHHHHHHHc
Q 002342 901 KTRQKTFANILH 912 (934)
Q Consensus 901 ~~~~~~~~~i~~ 912 (934)
.+....+..+..
T Consensus 221 ~~~~~~~~~~~~ 232 (345)
T cd07877 221 TDHIDQLKLILR 232 (345)
T ss_pred CCHHHHHHHHHH
Confidence 877766666544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=281.11 Aligned_cols=214 Identities=27% Similarity=0.419 Sum_probs=180.1
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
..|...+.||.|+||.||++++..++..+|+|.+.............+.+|+.+++.++|+|++++++++...+..|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45889999999999999999999999999999987543334445567788999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+. ++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 95 e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~------ 166 (308)
T cd06634 95 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------ 166 (308)
T ss_pred EccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec------
Confidence 9995 6787776543 2458999999999999999999999999999999999999999999999999884321
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
......|++.|+|||.+. ...++.++|||||||++|+|++|..||.......
T Consensus 167 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 221 (308)
T cd06634 167 -------------------------PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (308)
T ss_pred -------------------------CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH
Confidence 112346889999999985 3457889999999999999999999998876666
Q ss_pred HHHHHHcCCC
Q 002342 906 TFANILHKDL 915 (934)
Q Consensus 906 ~~~~i~~~~~ 915 (934)
....+..+..
T Consensus 222 ~~~~~~~~~~ 231 (308)
T cd06634 222 ALYHIAQNES 231 (308)
T ss_pred HHHHHhhcCC
Confidence 6555555443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=284.13 Aligned_cols=226 Identities=23% Similarity=0.366 Sum_probs=193.5
Q ss_pred ccCCcccccccccCCcEEEEEEEEecC----CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGS----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~----~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
.....++.+.||.|.||.||++..... .--||||..+.++ +.+..+.|.+|.-+|++++||||++|++++.. .
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 334456678899999999999988433 3469999988754 45567889999999999999999999999976 5
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
..|||||+++-|.|..+++.+. ..++......++.||+.||.|||+.++|||||...|||+.+..-|||+|||+++.+.
T Consensus 464 P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 6899999999999999998774 459999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~ 901 (934)
+... ...+...-...|||||.+.-..++.++|||-||+++||++. |.-||.|-
T Consensus 543 d~~y--------------------------YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv 596 (974)
T KOG4257|consen 543 DDAY--------------------------YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV 596 (974)
T ss_pred ccch--------------------------hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc
Confidence 4332 22223334678999999999999999999999999999995 99999999
Q ss_pred CHHHHHHHHHcCC-CCCCCCCC
Q 002342 902 TRQKTFANILHKD-LKFPSSTP 922 (934)
Q Consensus 902 ~~~~~~~~i~~~~-~~~p~~~~ 922 (934)
.+.+++-.|.+|. ++.|...|
T Consensus 597 kNsDVI~~iEnGeRlP~P~nCP 618 (974)
T KOG4257|consen 597 KNSDVIGHIENGERLPCPPNCP 618 (974)
T ss_pred cccceEEEecCCCCCCCCCCCC
Confidence 9999999998887 47776653
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=269.31 Aligned_cols=218 Identities=32% Similarity=0.565 Sum_probs=189.9
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
+|.+.+.||.|+||.||++.+..++..||+|.+..... .......+.+|+++++.++|||++++++.+......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58899999999999999999998999999999876432 33555678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 750 YCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|+++++|.+++.... ...++...+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~--- 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST--- 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC---
Confidence 999999999987643 356999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
........|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..++.
T Consensus 157 ------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~ 212 (258)
T cd08215 157 ------------------------VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212 (258)
T ss_pred ------------------------cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH
Confidence 01123346899999999999988999999999999999999999999988888888
Q ss_pred HHHHcCCC
Q 002342 908 ANILHKDL 915 (934)
Q Consensus 908 ~~i~~~~~ 915 (934)
..+..+.+
T Consensus 213 ~~~~~~~~ 220 (258)
T cd08215 213 LKILKGQY 220 (258)
T ss_pred HHHhcCCC
Confidence 87776543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-29 Score=269.53 Aligned_cols=214 Identities=20% Similarity=0.285 Sum_probs=172.7
Q ss_pred cccccCCcEEEEEEEEec---CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE-eCCeEEEEEEc
Q 002342 675 KPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ-TKTHVCLITDY 750 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~---~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~~~lV~E~ 750 (934)
+.||+|+||.||++.+.. .+..+|+|.+... ........+.+|+.+++.++||||+++++++. .++..+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998754 3467999987532 23445667888999999999999999999765 45678999999
Q ss_pred cCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCC
Q 002342 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (934)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 830 (934)
+.+++|.+++.... ..++...+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++........
T Consensus 79 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~---- 153 (262)
T cd05058 79 MKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY---- 153 (262)
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc----
Confidence 99999999987543 3467778888999999999999999999999999999999999999999999854321100
Q ss_pred cchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 002342 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFAN 909 (934)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~~~~ 909 (934)
..........+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....
T Consensus 154 -------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~ 214 (262)
T cd05058 154 -------------------YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY 214 (262)
T ss_pred -------------------eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 00011123346778999999998899999999999999999998 6788888887777777
Q ss_pred HHcCC
Q 002342 910 ILHKD 914 (934)
Q Consensus 910 i~~~~ 914 (934)
+..+.
T Consensus 215 ~~~~~ 219 (262)
T cd05058 215 LLQGR 219 (262)
T ss_pred HhcCC
Confidence 76654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=286.45 Aligned_cols=216 Identities=26% Similarity=0.431 Sum_probs=179.0
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe----CCeE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----KTHV 744 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~ 744 (934)
++|++.+.||.|+||.||++.+..+++.||+|.+.+.. ........+.+|+.+|+.++||||++++++|.. ....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc-ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 68999999999999999999999999999999987542 223345667789999999999999999998863 4578
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLM-ESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehh-hhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999999 57899888654 34999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
... .........|+..|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+.
T Consensus 161 ~~~-----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 217 (334)
T cd07855 161 PTE-----------------------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217 (334)
T ss_pred CcC-----------------------CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh
Confidence 100 0111224478999999999866 4578899999999999999999999998776
Q ss_pred HHHHHHHH
Q 002342 904 QKTFANIL 911 (934)
Q Consensus 904 ~~~~~~i~ 911 (934)
...+..+.
T Consensus 218 ~~~~~~~~ 225 (334)
T cd07855 218 VHQLKLIL 225 (334)
T ss_pred HHHHHHHH
Confidence 65555443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=274.18 Aligned_cols=198 Identities=21% Similarity=0.315 Sum_probs=163.2
Q ss_pred cccccCCcEEEEEEEEec------------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 675 KPLGSGDTGSVHLVELCG------------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~------------~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
+.||.|+||.||++.... ....+++|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999998532 2335888887643 2344557788999999999999999999999989
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc-------EEEEec
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-------VSLTDF 815 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~-------vkl~DF 815 (934)
..++||||+++++|..++..+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999988876543 45899999999999999999999999999999999999987664 899999
Q ss_pred ccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc-CCCCCchhHHHHHHHHHHHHH-h
Q 002342 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEML-Y 893 (934)
Q Consensus 816 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~s~~~DiwSlG~iL~ell-t 893 (934)
|++.... ......|++.|+|||++. +..++.++|||||||++|+|+ .
T Consensus 157 g~~~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (262)
T cd05077 157 GIPITVL-------------------------------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYN 205 (262)
T ss_pred CCCcccc-------------------------------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 9884321 011235788999999986 467888999999999999998 5
Q ss_pred CCCCCCCCCHHHHH
Q 002342 894 GYTPFRGKTRQKTF 907 (934)
Q Consensus 894 G~~Pf~~~~~~~~~ 907 (934)
|..||......+..
T Consensus 206 ~~~p~~~~~~~~~~ 219 (262)
T cd05077 206 GEIPLKDKTLAEKE 219 (262)
T ss_pred CCCCCCCcchhHHH
Confidence 99999876655443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=287.31 Aligned_cols=202 Identities=32% Similarity=0.522 Sum_probs=177.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccC-----hHHHHHHHHHHHHHHhCC---CCCccceeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-----RNKVHRACAEREILDMLD---HPFVPALYASFQ 739 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~-----~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~ 739 (934)
..+|..++.||.|+||+|++|.++.+...|+||.+.|..... ..++-.+-.|+.||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 457999999999999999999999999999999998754322 222334557999999997 999999999999
Q ss_pred eCCeEEEEEEcc-CCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccC
Q 002342 740 TKTHVCLITDYC-PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (934)
Q Consensus 740 ~~~~~~lV~E~~-~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a 818 (934)
+++++||+||.. +|.+|++++..++ .+++.+++.|++|++.|+++||+.||||||||-+||.++.+|-+||+|||.|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 999999999986 5779999998764 4999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~~DiwSlG~iL~elltG~~P 897 (934)
... .++....++||..|.|||++.|.+| ...-|||+||++||.+++..-|
T Consensus 718 a~~-----------------------------ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenp 768 (772)
T KOG1152|consen 718 AYT-----------------------------KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENP 768 (772)
T ss_pred hhh-----------------------------cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCC
Confidence 542 2334467899999999999999877 5578999999999999999999
Q ss_pred CCC
Q 002342 898 FRG 900 (934)
Q Consensus 898 f~~ 900 (934)
|..
T Consensus 769 yyn 771 (772)
T KOG1152|consen 769 YYN 771 (772)
T ss_pred CcC
Confidence 963
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=279.23 Aligned_cols=204 Identities=26% Similarity=0.395 Sum_probs=170.2
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCCeEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~l 746 (934)
.++|+..+.||+|+||.||++.+..+++.||+|.+.+... ......+.+|+.++.++. ||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 4578889999999999999999999999999999875432 244567788999999995 9999999999999999999
Q ss_pred EEEccCCCCchhhh---ccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 747 ITDYCPGGELFLLL---DRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 747 V~E~~~ggsL~~~l---~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
+|||+ +++|.++. .......+++..+..++.|++.||+|||+. ||+||||||+||+++.++.++|+|||++....
T Consensus 81 ~~e~~-~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecc-cCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 99999 45655443 222335699999999999999999999985 99999999999999999999999999985321
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC---CCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~---~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
.. .......|++.|+|||++.+. .++.++|||||||++|+|++|++||.
T Consensus 160 ~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 211 (288)
T cd06616 160 DS----------------------------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211 (288)
T ss_pred cC----------------------------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence 10 011233588999999999776 68889999999999999999999997
Q ss_pred CCC
Q 002342 900 GKT 902 (934)
Q Consensus 900 ~~~ 902 (934)
...
T Consensus 212 ~~~ 214 (288)
T cd06616 212 KWN 214 (288)
T ss_pred hcc
Confidence 654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=269.83 Aligned_cols=216 Identities=30% Similarity=0.493 Sum_probs=187.3
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
+|++.+.||.|+||.||++.+..++..||+|.+.+.... ......+.+|+.+++.++|+||+++++++......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 588999999999999999999999999999998765432 3445677789999999999999999999999999999999
Q ss_pred ccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 750 YCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 750 ~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|+++++|..++... ....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 99999999988652 2245899999999999999999999999999999999999999999999999998553211
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.....
T Consensus 157 --------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~ 210 (256)
T cd08530 157 --------------------------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR 210 (256)
T ss_pred --------------------------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 111235788999999999999999999999999999999999999998888777
Q ss_pred HHHHcCCC
Q 002342 908 ANILHKDL 915 (934)
Q Consensus 908 ~~i~~~~~ 915 (934)
..+..+.+
T Consensus 211 ~~~~~~~~ 218 (256)
T cd08530 211 YKVQRGKY 218 (256)
T ss_pred HHHhcCCC
Confidence 77766554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=274.10 Aligned_cols=208 Identities=25% Similarity=0.425 Sum_probs=172.8
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeC--CeEEEE
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTK--THVCLI 747 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~--~~~~lV 747 (934)
|++++.||+|+||.||++.+..+++.||+|.+++... .... .....|+.++..+. ||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 7889999999999999999999999999999876422 2222 23457888888885 99999999999987 899999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+. ++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++. +.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--- 152 (282)
T cd07831 79 FELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--- 152 (282)
T ss_pred EecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC---
Confidence 99995 68888876543 45899999999999999999999999999999999999999 99999999998543211
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
.......+++.|+|||++.. ..++.++|+|||||++|+|++|.+||.+.+..+.
T Consensus 153 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~ 207 (282)
T cd07831 153 -------------------------PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ 207 (282)
T ss_pred -------------------------CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH
Confidence 01122457889999998754 5568899999999999999999999998887766
Q ss_pred HHHHH
Q 002342 907 FANIL 911 (934)
Q Consensus 907 ~~~i~ 911 (934)
+..+.
T Consensus 208 ~~~~~ 212 (282)
T cd07831 208 IAKIH 212 (282)
T ss_pred HHHHH
Confidence 65554
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=287.41 Aligned_cols=227 Identities=22% Similarity=0.316 Sum_probs=192.5
Q ss_pred cCCcccccccccCCcEEEEEEEEecCC---eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~---~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+...+.+.||+|.||.|+.+.++..+ ..||||++...... .....|.+|+.+|.+|+|||+++||++.-+ ...
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 456778899999999999999996532 37999999876432 267889999999999999999999999887 678
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
.||||+++.|+|.+.|.+.....|....+..|+.||+.||.||.++++|||||...|||+-....|||+|||+.+.++..
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 89999999999999998866677999999999999999999999999999999999999998899999999999765432
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~ 903 (934)
... + .......-...|+|||.+....++.++|||+|||+||||++ |..||.|...
T Consensus 266 ed~-------------------Y-----vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g 321 (1039)
T KOG0199|consen 266 EDM-------------------Y-----VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG 321 (1039)
T ss_pred Ccc-------------------e-----EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH
Confidence 211 1 11111234568999999999999999999999999999996 9999999999
Q ss_pred HHHHHHHHcCC-CCCCCCC
Q 002342 904 QKTFANILHKD-LKFPSST 921 (934)
Q Consensus 904 ~~~~~~i~~~~-~~~p~~~ 921 (934)
.+++++|..|. +.-|..+
T Consensus 322 ~qIL~~iD~~erLpRPk~c 340 (1039)
T KOG0199|consen 322 IQILKNIDAGERLPRPKYC 340 (1039)
T ss_pred HHHHHhccccccCCCCCCC
Confidence 99999998654 3555543
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=276.58 Aligned_cols=209 Identities=29% Similarity=0.482 Sum_probs=178.8
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEc
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 750 (934)
|.....||+|+||.||++.+..++..||+|.+... .......+.+|+.+++.++|+||+++++++...++.|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 44457899999999999999999999999987532 233456688899999999999999999999999999999999
Q ss_pred cCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCC
Q 002342 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (934)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 830 (934)
+++++|.+++.. ..+++..++.++.|++.+|+|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 99 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~------ 169 (292)
T cd06657 99 LEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------ 169 (292)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc------
Confidence 999999998754 24899999999999999999999999999999999999999999999999987432110
Q ss_pred cchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 002342 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910 (934)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i 910 (934)
........|++.|+|||.+.+..++.++|+||||+++|+|++|.+||.+......+..+
T Consensus 170 ---------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~ 228 (292)
T cd06657 170 ---------------------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228 (292)
T ss_pred ---------------------cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 01122346889999999998888899999999999999999999999988777666655
Q ss_pred Hc
Q 002342 911 LH 912 (934)
Q Consensus 911 ~~ 912 (934)
..
T Consensus 229 ~~ 230 (292)
T cd06657 229 RD 230 (292)
T ss_pred Hh
Confidence 43
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=272.03 Aligned_cols=218 Identities=24% Similarity=0.345 Sum_probs=177.9
Q ss_pred cccccccccCCcEEEEEEEEec---CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC-----
Q 002342 671 FRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 742 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~---~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 742 (934)
|++.+.||+|+||.||+|.+.. ++..+|||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6788999999999999998653 57899999987643 23445667889999999999999999999886432
Q ss_pred -eEEEEEEccCCCCchhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEeccc
Q 002342 743 -HVCLITDYCPGGELFLLLDRQ----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817 (934)
Q Consensus 743 -~~~lV~E~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~ 817 (934)
..+++++|+.+++|..++... ....++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 347899999999998876432 122478999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCC
Q 002342 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYT 896 (934)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~ 896 (934)
+....... .........+++.|++||.+....++.++|||||||++|+|++ |++
T Consensus 160 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~ 214 (273)
T cd05074 160 SKKIYSGD-------------------------YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214 (273)
T ss_pred cccccCCc-------------------------ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCC
Confidence 85432110 0011123346678999999999889999999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHcCC
Q 002342 897 PFRGKTRQKTFANILHKD 914 (934)
Q Consensus 897 Pf~~~~~~~~~~~i~~~~ 914 (934)
||.+.+..+.+..+..+.
T Consensus 215 p~~~~~~~~~~~~~~~~~ 232 (273)
T cd05074 215 PYAGVENSEIYNYLIKGN 232 (273)
T ss_pred CCCCCCHHHHHHHHHcCC
Confidence 999888888777776543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=295.44 Aligned_cols=234 Identities=24% Similarity=0.357 Sum_probs=199.3
Q ss_pred hcccccccccCCcccccccccCCcEEEEEEEEecCCe---EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcccee
Q 002342 659 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALY 735 (934)
Q Consensus 659 ~~~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~---~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 735 (934)
+.....+++....+|.++||.|.||.|++++.+..++ .||||.++... .......|+.|..||-+++||||++|.
T Consensus 619 vreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLE 696 (996)
T KOG0196|consen 619 VREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLE 696 (996)
T ss_pred HHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEE
Confidence 3344556777888999999999999999999987764 79999998653 445567899999999999999999999
Q ss_pred EEEEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEec
Q 002342 736 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815 (934)
Q Consensus 736 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DF 815 (934)
++......++||+|||++|+|..+|+.+.+ .|+..++..+++-|+.||+||-++|.|||||...|||++.+-.+|+.||
T Consensus 697 GVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDF 775 (996)
T KOG0196|consen 697 GVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDF 775 (996)
T ss_pred EEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccc
Confidence 999999999999999999999999988754 4999999999999999999999999999999999999999999999999
Q ss_pred ccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHH-hC
Q 002342 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG 894 (934)
Q Consensus 816 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ell-tG 894 (934)
|+++...+++.... .+..-.=...|.|||++...+++.++||||+|++|||.+ +|
T Consensus 776 GLSRvledd~~~~y------------------------tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyG 831 (996)
T KOG0196|consen 776 GLSRVLEDDPEAAY------------------------TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 831 (996)
T ss_pred cceeecccCCCccc------------------------cccCCccceeecChhHhhhcccCchhhccccceEEEEecccC
Confidence 99987654432110 000011146899999999999999999999999999988 59
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCC
Q 002342 895 YTPFRGKTRQKTFANILHKDLKFPSS 920 (934)
Q Consensus 895 ~~Pf~~~~~~~~~~~i~~~~~~~p~~ 920 (934)
..||+..+++++++.|.+| +.+|..
T Consensus 832 ERPYWdmSNQdVIkaIe~g-yRLPpP 856 (996)
T KOG0196|consen 832 ERPYWDMSNQDVIKAIEQG-YRLPPP 856 (996)
T ss_pred CCcccccchHHHHHHHHhc-cCCCCC
Confidence 9999999999999999764 445543
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=273.42 Aligned_cols=212 Identities=24% Similarity=0.434 Sum_probs=178.9
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC---CCCCccceeEEEEeCCe----
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQTKTH---- 743 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~~~~---- 743 (934)
|++.+.||.|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.+ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7889999999999999999988899999999975432 222334566788777666 69999999999988776
Q ss_pred -EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 744 -VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 744 -~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
.+++|||+. ++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999995 589888876544469999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
.. .......++..|+|||++.+..++.++|+|||||++|+|++|.+||.+.+
T Consensus 159 ~~----------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 159 FE----------------------------MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred CC----------------------------cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 11 01112357889999999999999999999999999999999999999998
Q ss_pred HHHHHHHHHc
Q 002342 903 RQKTFANILH 912 (934)
Q Consensus 903 ~~~~~~~i~~ 912 (934)
..+.+.++..
T Consensus 211 ~~~~~~~~~~ 220 (287)
T cd07838 211 EADQLDKIFD 220 (287)
T ss_pred hHHHHHHHHH
Confidence 8888777754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=283.57 Aligned_cols=211 Identities=28% Similarity=0.459 Sum_probs=176.9
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC-----Ce
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----TH 743 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~ 743 (934)
.+|.+.+.||.|+||.||++.+..++..||||.+.+.. ........+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 57999999999999999999999999999999987542 2333445677899999999999999999988643 35
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
.|+||||+ +++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 89999999 57898888654 4599999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
.. .......|+..|+|||.+.. ..++.++|+|||||++|+|++|++||.+.+
T Consensus 161 ~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 161 KG---------------------------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred Cc---------------------------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 10 11123467889999999865 468889999999999999999999998877
Q ss_pred HHHHHHHH
Q 002342 903 RQKTFANI 910 (934)
Q Consensus 903 ~~~~~~~i 910 (934)
....+..+
T Consensus 214 ~~~~~~~~ 221 (337)
T cd07858 214 YVHQLKLI 221 (337)
T ss_pred hHHHHHHH
Confidence 65555444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=273.89 Aligned_cols=213 Identities=26% Similarity=0.432 Sum_probs=180.3
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC--CeEEEEE
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVCLIT 748 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~lV~ 748 (934)
|++.+.||.|+||.||++.+..+++.+|+|.+.... ........+.+|+.+++.++|||++++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999999999999998653 2333445678899999999999999999999987 8999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||++ ++|..++.... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 80 e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 80 EYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred cccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9995 58888886542 4699999999999999999999999999999999999999999999999999854321100
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|++||.+.+....+
T Consensus 156 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~ 211 (287)
T cd07840 156 ------------------------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL 211 (287)
T ss_pred ------------------------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 01122356789999998765 45788999999999999999999999998887777
Q ss_pred HHHHc
Q 002342 908 ANILH 912 (934)
Q Consensus 908 ~~i~~ 912 (934)
..+..
T Consensus 212 ~~~~~ 216 (287)
T cd07840 212 EKIFE 216 (287)
T ss_pred HHHHH
Confidence 76654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=272.22 Aligned_cols=207 Identities=19% Similarity=0.293 Sum_probs=165.5
Q ss_pred ccccCCcEEEEEEEEecC------------------------CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCc
Q 002342 676 PLGSGDTGSVHLVELCGS------------------------GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 731 (934)
Q Consensus 676 ~LG~G~~g~Vy~a~~~~~------------------------~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~I 731 (934)
.||+|+||.||++....+ ...+|+|.+... .......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999875321 235889987643 23344567889999999999999
Q ss_pred cceeEEEEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC---
Q 002342 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG--- 808 (934)
Q Consensus 732 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~--- 808 (934)
+++++++......|+||||+++++|..++... ...+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999888653 34589999999999999999999999999999999999997644
Q ss_pred ----cEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHH
Q 002342 809 ----HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWA 883 (934)
Q Consensus 809 ----~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwS 883 (934)
.+|++|||++..... .....+++.|+|||.+.+ ..++.++||||
T Consensus 158 ~~~~~~kl~d~g~~~~~~~-------------------------------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~s 206 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS-------------------------------REERVERIPWIAPECVPGGNSLSTAADKWS 206 (274)
T ss_pred CccceeeecCCcccccccc-------------------------------ccccccCCcccCchhhcCCCCCCcHHHHHH
Confidence 489999998743210 012247788999999865 56789999999
Q ss_pred HHHHHHHHH-hCCCCCCCCCHHHHHHHHHcCCCCCC
Q 002342 884 LGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFP 918 (934)
Q Consensus 884 lG~iL~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~p 918 (934)
|||++|+|+ +|++||.+....+... +......+|
T Consensus 207 lG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~ 241 (274)
T cd05076 207 FGTTLLEICFDGEVPLKERTPSEKER-FYEKKHRLP 241 (274)
T ss_pred HHHHHHHHHhCCCCCccccChHHHHH-HHHhccCCC
Confidence 999999995 7999998876655433 333333444
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=269.72 Aligned_cols=212 Identities=17% Similarity=0.313 Sum_probs=169.3
Q ss_pred cccccCCcEEEEEEEEecC--CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccC
Q 002342 675 KPLGSGDTGSVHLVELCGS--GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 752 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~--~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 752 (934)
+.||+|+||.||++..... ...+++|.+.... .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3689999999999976433 3456677765432 23345678899999999999999999999999999999999999
Q ss_pred CCCchhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCC
Q 002342 753 GGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (934)
Q Consensus 753 ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 830 (934)
+++|.+++.... ...++...++.++.||+.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~----- 153 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED----- 153 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcch-----
Confidence 999999987542 2346777888999999999999999999999999999999999999999999874321100
Q ss_pred cchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002342 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-------AGHTSAVDWWALGILLYEMLY-GYTPFRGKT 902 (934)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~ 902 (934)
........+|++.|+|||++.. ..++.++|||||||++|+|++ |.+||...+
T Consensus 154 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 154 --------------------YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred --------------------hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 0011224568899999999853 245678999999999999996 688998888
Q ss_pred HHHHHHHHHcC
Q 002342 903 RQKTFANILHK 913 (934)
Q Consensus 903 ~~~~~~~i~~~ 913 (934)
..+.+..+..+
T Consensus 214 ~~~~~~~~~~~ 224 (268)
T cd05086 214 DREVLNHVIKD 224 (268)
T ss_pred HHHHHHHHHhh
Confidence 87777776544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=290.50 Aligned_cols=221 Identities=31% Similarity=0.460 Sum_probs=189.1
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~ 745 (934)
..+.|++...+|.|+|+.|-.+.+..+++.+++|++.+.. ....+|+.++... +||||+++++.+.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 4789999999999999999999999999999999998651 2344577666655 7999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE-ecCCcEEEEecccCcccCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl-~~~~~vkl~DFG~a~~~~~~ 824 (934)
+|||++.|+.|.+.+...+. +. ..+..|+.+|+.|+.|||.+|+|||||||+|||+ ++.|+++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999999999888876532 44 7777899999999999999999999999999999 58899999999998654211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
..+.|-|..|.|||++....|+.++||||||++||+|++|+.||......
T Consensus 470 ------------------------------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 470 ------------------------------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred ------------------------------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 22346788999999999999999999999999999999999999987666
Q ss_pred -HHHHHHHcCCCCCCCCCCCCcccCCCC
Q 002342 905 -KTFANILHKDLKFPSSTPSSCKAANVP 931 (934)
Q Consensus 905 -~~~~~i~~~~~~~p~~~~~s~~~k~l~ 931 (934)
+++.+|..+.+. ..+|..||||.
T Consensus 520 ~ei~~~i~~~~~s----~~vS~~AKdLl 543 (612)
T KOG0603|consen 520 IEIHTRIQMPKFS----ECVSDEAKDLL 543 (612)
T ss_pred HHHHHhhcCCccc----cccCHHHHHHH
Confidence 778888777666 45788888873
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=270.06 Aligned_cols=203 Identities=27% Similarity=0.391 Sum_probs=170.1
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
+.+.....||+|+||.||++.+..++..||+|.+... .......+.+|+.+++.++|+||+++++++..++..++||
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3444456799999999999999999999999988654 3345567889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-CCcEEEEecccCcccCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVL--KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l--~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-~~~vkl~DFG~a~~~~~~~ 825 (934)
||+++++|.+++.... ..+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 162 (268)
T cd06624 85 EQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI- 162 (268)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC-
Confidence 9999999999987542 234 88889999999999999999999999999999999976 679999999988542110
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~--~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
........|++.|+|||++.+.. ++.++|+||||+++|+|++|.+||....
T Consensus 163 --------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 163 --------------------------NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred --------------------------CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 00112235889999999986643 7789999999999999999999997643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=265.00 Aligned_cols=210 Identities=32% Similarity=0.537 Sum_probs=182.6
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
+|.+.+.||.|++|.||++.+..+++.+++|.+..... .....+.+|+.+++.++||||+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48889999999999999999998999999999876432 355678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+++++|.+++.... ..+++..+..++.|++.+|.|||.+|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---- 152 (253)
T cd05122 78 FCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK---- 152 (253)
T ss_pred cCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc----
Confidence 999999999987653 469999999999999999999999999999999999999999999999999885432110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~ 909 (934)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 153 ------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 208 (253)
T cd05122 153 ------------------------ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK 208 (253)
T ss_pred ------------------------cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence 02345688999999999988889999999999999999999999988765555444
Q ss_pred HH
Q 002342 910 IL 911 (934)
Q Consensus 910 i~ 911 (934)
+.
T Consensus 209 ~~ 210 (253)
T cd05122 209 IA 210 (253)
T ss_pred HH
Confidence 43
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=277.28 Aligned_cols=226 Identities=27% Similarity=0.385 Sum_probs=180.0
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC------
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 741 (934)
.++|++.+.||.|+||.||++.+..+++.||+|.+....... .......+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 579999999999999999999999999999999987543222 1223567899999999999999999987543
Q ss_pred --CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 742 --THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 742 --~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
..+|+||||+ +++|...+... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.
T Consensus 86 ~~~~~~lv~~~~-~~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 86 KRGSVYMVTPYM-DHDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred cCceEEEEEecC-CcCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 3579999999 45677766543 3469999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
........... + ............|++.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 164 ~~~~~~~~~~~----------~------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 164 PYDGPPPNPKG----------G------GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred hccCCCccccc----------C------CcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 54321110000 0 00011122345789999999998654 5788999999999999999999999
Q ss_pred CCCCHHHHHHHHHc
Q 002342 899 RGKTRQKTFANILH 912 (934)
Q Consensus 899 ~~~~~~~~~~~i~~ 912 (934)
.+.+....+..+..
T Consensus 228 ~~~~~~~~~~~~~~ 241 (311)
T cd07866 228 QGKSDIDQLHLIFK 241 (311)
T ss_pred CCCCHHHHHHHHHH
Confidence 99888877776654
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=264.36 Aligned_cols=213 Identities=27% Similarity=0.460 Sum_probs=185.0
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
+|++.+.||+|++|.||++.+..+++.|++|.+.+... .......+.+|+++++.++|||++++++++.+....+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 58899999999999999999999999999999987533 23456788999999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+++++|.+++... ..+++..+..++.|++.+|.|||++||+||||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---- 153 (254)
T cd06627 80 YAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS---- 153 (254)
T ss_pred cCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc----
Confidence 99999999998765 459999999999999999999999999999999999999999999999999985432110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~ 909 (934)
.......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........
T Consensus 154 -----------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~ 210 (254)
T cd06627 154 -----------------------KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR 210 (254)
T ss_pred -----------------------ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 012234688899999999888888999999999999999999999988776666655
Q ss_pred HHc
Q 002342 910 ILH 912 (934)
Q Consensus 910 i~~ 912 (934)
+..
T Consensus 211 ~~~ 213 (254)
T cd06627 211 IVQ 213 (254)
T ss_pred Hhc
Confidence 543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=279.08 Aligned_cols=205 Identities=28% Similarity=0.471 Sum_probs=174.3
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe-CCeEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KTHVCL 746 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~l 746 (934)
.++|++++.||.|+||.||++.+..+++.||+|.+.+.. ........+..|+.+++.++||||++++++|.. ....|+
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 578999999999999999999999999999999886542 223344667789999999999999999999875 567899
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
+|||+ +++|..++.. ..++...+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 88 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--- 160 (328)
T cd07856 88 VTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--- 160 (328)
T ss_pred Eeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---
Confidence 99999 7789888754 3488899999999999999999999999999999999999999999999998843210
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
......+++.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.....
T Consensus 161 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~ 213 (328)
T cd07856 161 ---------------------------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213 (328)
T ss_pred ---------------------------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1123467889999999866 568899999999999999999999998877644
Q ss_pred HH
Q 002342 906 TF 907 (934)
Q Consensus 906 ~~ 907 (934)
.+
T Consensus 214 ~~ 215 (328)
T cd07856 214 QF 215 (328)
T ss_pred HH
Confidence 43
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=278.49 Aligned_cols=216 Identities=25% Similarity=0.404 Sum_probs=175.8
Q ss_pred CcccccccccCCcEEEEEEEEecC--CeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEe----CC
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGS--GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT----KT 742 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~--~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~----~~ 742 (934)
+|++.+.||+|+||.||++.+..+ +..||+|.+.... ........+.+|+.+++.+ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999888 8999999986432 2233445677899999999 59999999987542 25
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
.+|++|+|+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 80 ~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 80 ELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred cEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 678999999 57899888654 459999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
.... ..........||+.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.
T Consensus 157 ~~~~-----------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 157 ENPG-----------------------ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred cccc-----------------------cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 1100 00111234578999999998866 46889999999999999999999999987
Q ss_pred CHHHHHHHHHc
Q 002342 902 TRQKTFANILH 912 (934)
Q Consensus 902 ~~~~~~~~i~~ 912 (934)
+....+..++.
T Consensus 214 ~~~~~~~~~~~ 224 (332)
T cd07857 214 DYVDQLNQILQ 224 (332)
T ss_pred CHHHHHHHHHH
Confidence 76666655543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=265.91 Aligned_cols=214 Identities=29% Similarity=0.434 Sum_probs=183.1
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC--CeEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVCLI 747 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~lV 747 (934)
+|++.+.||+|++|.||++.+..+++.+++|++..... .......+.+|+.++++++||||+++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 48889999999999999999998999999999876432 245567888999999999999999999999988 899999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+++++|.+++.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999999987653 6999999999999999999999999999999999999999999999999998554321100
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT-RQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~-~~~~ 906 (934)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ....
T Consensus 158 -------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 212 (260)
T cd06606 158 -------------------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA 212 (260)
T ss_pred -------------------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH
Confidence 01234568899999999998889999999999999999999999998766 3334
Q ss_pred HHHHH
Q 002342 907 FANIL 911 (934)
Q Consensus 907 ~~~i~ 911 (934)
...+.
T Consensus 213 ~~~~~ 217 (260)
T cd06606 213 LYKIG 217 (260)
T ss_pred HHhcc
Confidence 44443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=275.45 Aligned_cols=217 Identities=25% Similarity=0.359 Sum_probs=178.3
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC----
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT---- 742 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~---- 742 (934)
..++|++.+.||.|+||.||++.++.+++.||+|.+..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35789999999999999999999999999999999875422 2223346678999999999999999999987654
Q ss_pred ------eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecc
Q 002342 743 ------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 816 (934)
Q Consensus 743 ------~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG 816 (934)
.+|+||||+++ +|..++... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 89999999965 777777654 3459999999999999999999999999999999999999999999999999
Q ss_pred cCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCC
Q 002342 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGY 895 (934)
Q Consensus 817 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~ 895 (934)
++........ .......+++.|+|||++.+. .++.++|||||||++|+|++|+
T Consensus 162 ~~~~~~~~~~--------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 162 LARLYNSEES--------------------------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred ccccccCCcc--------------------------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 9854321110 011123467889999998653 5688999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHc
Q 002342 896 TPFRGKTRQKTFANILH 912 (934)
Q Consensus 896 ~Pf~~~~~~~~~~~i~~ 912 (934)
+||...+..+.+..+.+
T Consensus 216 ~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 216 PIFQANQELAQLELISR 232 (302)
T ss_pred CCCCCCChHHHHHHHHH
Confidence 99998877766665544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=272.92 Aligned_cols=207 Identities=25% Similarity=0.385 Sum_probs=173.6
Q ss_pred cCCcccccccccCCcEEEEEEEEe----cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe--C
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELC----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--K 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~----~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~ 741 (934)
...|++.+.||+|+||.||++... .++..||+|.+.+.... .....+.+|+++++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 357899999999999999999864 34789999998764321 356678899999999999999999999877 6
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
...+++|||+++++|.+++.... ..+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 68999999999999999997653 24999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
...... ........++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 160 ~~~~~~------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 160 PEDKDY------------------------YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccCCcc------------------------eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 211000 00111224566799999999888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=280.55 Aligned_cols=218 Identities=28% Similarity=0.458 Sum_probs=179.1
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeC--CeE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK--THV 744 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~--~~~ 744 (934)
.++|++.+.||+|+||.||++.+..++..+|+|.+.+.. ........+..|+.+++++ +||||+++++++... ...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 468999999999999999999998899999999886532 2333445677899999999 999999999998653 468
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+||||+. ++|..++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 99999995 6998888653 5889999999999999999999999999999999999999999999999998654211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
... ..........|++.|+|||.+.+ ..++.++|+||||+++|+|++|++||.+...
T Consensus 161 ~~~----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~ 218 (337)
T cd07852 161 EEN----------------------PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218 (337)
T ss_pred ccc----------------------ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence 100 00112234568999999998865 4578899999999999999999999998877
Q ss_pred HHHHHHHHc
Q 002342 904 QKTFANILH 912 (934)
Q Consensus 904 ~~~~~~i~~ 912 (934)
.+.+..+..
T Consensus 219 ~~~~~~~~~ 227 (337)
T cd07852 219 LNQLEKIIE 227 (337)
T ss_pred HHHHHHHHH
Confidence 766665544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=267.75 Aligned_cols=196 Identities=20% Similarity=0.261 Sum_probs=165.2
Q ss_pred cccccCCcEEEEEEEEecCC----------eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 675 KPLGSGDTGSVHLVELCGSG----------QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~----------~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
+.||+|+||.||++.+..++ ..+++|.+.... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998776 357888765432 115678889999999999999999999988 778
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-------cEEEEeccc
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-------HVSLTDFDL 817 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-------~vkl~DFG~ 817 (934)
++||||+++++|.+++..... .++...+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999999976532 589999999999999999999999999999999999999887 799999999
Q ss_pred CcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC--CCCchhHHHHHHHHHHHHHh-C
Q 002342 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLY-G 894 (934)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~s~~~DiwSlG~iL~ellt-G 894 (934)
+..... .....++..|+|||++.+. .++.++|+|||||++|+|++ |
T Consensus 155 a~~~~~-------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~ 203 (259)
T cd05037 155 PITVLS-------------------------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNG 203 (259)
T ss_pred cccccc-------------------------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCC
Confidence 854311 1123567789999999876 78899999999999999998 6
Q ss_pred CCCCCCCCHHHHH
Q 002342 895 YTPFRGKTRQKTF 907 (934)
Q Consensus 895 ~~Pf~~~~~~~~~ 907 (934)
..||...+.....
T Consensus 204 ~~p~~~~~~~~~~ 216 (259)
T cd05037 204 EEPLSTLSSSEKE 216 (259)
T ss_pred CCCcccCCchhHH
Confidence 8899877544433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=273.77 Aligned_cols=206 Identities=23% Similarity=0.325 Sum_probs=168.9
Q ss_pred CcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCCCchhhh
Q 002342 681 DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL 760 (934)
Q Consensus 681 ~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l 760 (934)
+++.||.+++..+++.||+|.+.... ........+.+|+.+++.++||||++++++|...+..|++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 44566677777799999999997642 24456678999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhcccc
Q 002342 761 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840 (934)
Q Consensus 761 ~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~ 840 (934)
.......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+.........
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~------------- 157 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR------------- 157 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccc-------------
Confidence 8654556899999999999999999999999999999999999999999999999988543211100
Q ss_pred CCCCcccccccccccccccCCCCccchhhhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
............++..|+|||++.+ ..++.++|+|||||++|+|++|+.||........+
T Consensus 158 -------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~ 219 (314)
T cd08216 158 -------QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML 219 (314)
T ss_pred -------ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0001112234567889999999976 35788999999999999999999999876655443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=278.42 Aligned_cols=228 Identities=24% Similarity=0.325 Sum_probs=180.2
Q ss_pred CCccc-ccccccCCcEEEEEEEEecCCeEEEEEEeecccccChH-----------HHHHHHHHHHHHHhCCCCCccceeE
Q 002342 669 QHFRP-IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN-----------KVHRACAEREILDMLDHPFVPALYA 736 (934)
Q Consensus 669 ~~y~i-~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~-----------~~~~~~~E~~il~~l~hp~Iv~l~~ 736 (934)
++|.. .+.||.|+||.||++.+..+++.||+|.+......... ....+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 56764 57799999999999999999999999998754322100 1124678999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecc
Q 002342 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 816 (934)
Q Consensus 737 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG 816 (934)
++..++..|+||||+. ++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9999999999999995 6899988654 449999999999999999999999999999999999999999999999999
Q ss_pred cCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCC
Q 002342 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGY 895 (934)
Q Consensus 817 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~ 895 (934)
++.....+....... . .. ............+++.|+|||.+.+. .++.++|+|||||++|+|++|+
T Consensus 165 ~~~~~~~~~~~~~~~-~--------~~----~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~ 231 (335)
T PTZ00024 165 LARRYGYPPYSDTLS-K--------DE----TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231 (335)
T ss_pred ceeeccccccccccc-c--------cc----cccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 986543211100000 0 00 00001112234578899999999764 4688999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHc
Q 002342 896 TPFRGKTRQKTFANILH 912 (934)
Q Consensus 896 ~Pf~~~~~~~~~~~i~~ 912 (934)
+||.+.+..+.+..+..
T Consensus 232 ~p~~~~~~~~~~~~i~~ 248 (335)
T PTZ00024 232 PLFPGENEIDQLGRIFE 248 (335)
T ss_pred CCCCCCCHHHHHHHHHH
Confidence 99999888877766644
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=271.15 Aligned_cols=222 Identities=42% Similarity=0.720 Sum_probs=179.4
Q ss_pred CcccccccccCCcEEEEEEEEe---cCCeEEEEEEeeccccc-ChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 744 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAlK~~~~~~~~-~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 744 (934)
+|++.+.||.|+||.||++.+. .++..||+|++.+.... .......+.+|+.++..+ +||||+.+++++......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 46789999998754322 223345678899999999 699999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+||||+.+++|.+++... ..+++..++.++.|++.+|.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999998754 45899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~--~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
. ........|++.|+|||.+.+.. .+.++|+||||+++|+|++|..||....
T Consensus 159 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 212 (288)
T cd05583 159 E--------------------------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212 (288)
T ss_pred c--------------------------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 0 01122356899999999997765 6789999999999999999999996432
Q ss_pred ----HHHHHHHHHcCCCCCCC
Q 002342 903 ----RQKTFANILHKDLKFPS 919 (934)
Q Consensus 903 ----~~~~~~~i~~~~~~~p~ 919 (934)
..+..+.+.......|.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd05583 213 EQNSQSEISRRILKSKPPFPK 233 (288)
T ss_pred ccchHHHHHHHHHccCCCCCc
Confidence 23444455554444443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=280.29 Aligned_cols=216 Identities=25% Similarity=0.408 Sum_probs=184.3
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC-----eE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-----HV 744 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~~ 744 (934)
+|++.+.||.|++|.||+|.+..++..||+|.+.+.. ........+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5899999999999999999999899999999987642 23445567889999999999999999999988765 78
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|++|||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 80 YIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999995 6898888664 36999999999999999999999999999999999999999999999999998653221
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
... ........+++.|+|||++.+. .++.++|+||||+++|+|++|++||.+.+.
T Consensus 157 ~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~ 212 (330)
T cd07834 157 EDE------------------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY 212 (330)
T ss_pred ccc------------------------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH
Confidence 100 0112334688999999999887 889999999999999999999999999998
Q ss_pred HHHHHHHHcC
Q 002342 904 QKTFANILHK 913 (934)
Q Consensus 904 ~~~~~~i~~~ 913 (934)
.+.+..+...
T Consensus 213 ~~~~~~i~~~ 222 (330)
T cd07834 213 IDQLNLIVEV 222 (330)
T ss_pred HHHHHHHHHh
Confidence 8888777653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=290.04 Aligned_cols=214 Identities=30% Similarity=0.467 Sum_probs=188.1
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEE-----eC
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ-----TK 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~-----~~ 741 (934)
.+.|++...||.|.+|.||+++.+.+++..|+|++.... ..-+++..|.+||+.+ +|||++.+|++|. .+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 467999999999999999999999999999999987643 2335678899999887 7999999999996 46
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
+.+|||||||.|||..++++.-.+..+.+..+..|++.++.||.+||.+.+||||||=.|||++.++.|||+|||++...
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 79999999999999999998766778999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-----CCCCchhHHHHHHHHHHHHHhCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYT 896 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~s~~~DiwSlG~iL~elltG~~ 896 (934)
....+..++++|||.|||||++.. ..|+..+|+||||++-.||.-|.|
T Consensus 174 ---------------------------dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~P 226 (953)
T KOG0587|consen 174 ---------------------------DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAP 226 (953)
T ss_pred ---------------------------ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCC
Confidence 223456678899999999999954 456779999999999999999999
Q ss_pred CCCCCCHHHHHHHHHc
Q 002342 897 PFRGKTRQKTFANILH 912 (934)
Q Consensus 897 Pf~~~~~~~~~~~i~~ 912 (934)
|+.+..+...+-+|-.
T Consensus 227 Pl~DmHPmraLF~IpR 242 (953)
T KOG0587|consen 227 PLCDMHPMRALFLIPR 242 (953)
T ss_pred CccCcchhhhhccCCC
Confidence 9998888877655543
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=279.78 Aligned_cols=209 Identities=29% Similarity=0.474 Sum_probs=174.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC------
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 741 (934)
.++|.+.+.||.|+||.||+|.+..+++.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3689999999999999999999999999999999875422 223345678899999999999999999998754
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
...|+||||+ ..+|..++. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 93 QDFYLVMPYM-QTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred ceEEEEeccc-ccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 3469999999 457766542 24899999999999999999999999999999999999999999999999998432
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.. ......|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+
T Consensus 168 ~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 168 DA------------------------------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred CC------------------------------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 10 1123467889999999876 4678899999999999999999999999
Q ss_pred CCHHHHHHHHHc
Q 002342 901 KTRQKTFANILH 912 (934)
Q Consensus 901 ~~~~~~~~~i~~ 912 (934)
.+....+..+..
T Consensus 218 ~~~~~~~~~~~~ 229 (342)
T cd07879 218 KDYLDQLTQILK 229 (342)
T ss_pred CCHHHHHHHHHH
Confidence 887766666554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=277.80 Aligned_cols=230 Identities=23% Similarity=0.317 Sum_probs=199.0
Q ss_pred cccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
..|++...+.....+||-|.||.||.+.+++-.-.||||.++.+. -.+++|..|..+|+.+.|||+|+|+++|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 456677778888899999999999999999999999999987654 4678899999999999999999999999999
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
..+|||+|||..|+|.+||.......++--.+.+++.||..||+||..+++|||||...|+|+..+..||++|||+++.|
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999998765566788888899999999999999999999999999999999999999999999887
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~ 900 (934)
..+... ...| ..=.+.|.|||-|.-..++.++|||+|||+|||+.| |..||.|
T Consensus 416 tgDTYT----------AHAG----------------AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 416 TGDTYT----------AHAG----------------AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred cCCcee----------cccC----------------ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 543221 1111 112567999999998899999999999999999996 9999999
Q ss_pred CCHHHHHHHHHcCC-CCCCCCC
Q 002342 901 KTRQKTFANILHKD-LKFPSST 921 (934)
Q Consensus 901 ~~~~~~~~~i~~~~-~~~p~~~ 921 (934)
-+..++|..+.+|. +.-|..+
T Consensus 470 idlSqVY~LLEkgyRM~~PeGC 491 (1157)
T KOG4278|consen 470 IDLSQVYGLLEKGYRMDGPEGC 491 (1157)
T ss_pred ccHHHHHHHHhccccccCCCCC
Confidence 99999998887754 2444433
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=270.25 Aligned_cols=212 Identities=27% Similarity=0.477 Sum_probs=180.5
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEc
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 750 (934)
|++.+.||.|++|.||++.+..+++.+++|.+..... .......+.+|+.+|+.++||||+++++++..++.+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6788999999999999999999999999999876432 223456778899999999999999999999999999999999
Q ss_pred cCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCC
Q 002342 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (934)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 830 (934)
+. ++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~----- 152 (283)
T cd05118 80 MD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV----- 152 (283)
T ss_pred cC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-----
Confidence 95 58888876643 469999999999999999999999999999999999999999999999999985432111
Q ss_pred cchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 002342 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (934)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~ 909 (934)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|++||.+.+..+.+..
T Consensus 153 ----------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 210 (283)
T cd05118 153 ----------------------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK 210 (283)
T ss_pred ----------------------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 011223578899999999876 788899999999999999999999998888776666
Q ss_pred HHc
Q 002342 910 ILH 912 (934)
Q Consensus 910 i~~ 912 (934)
+..
T Consensus 211 ~~~ 213 (283)
T cd05118 211 IFR 213 (283)
T ss_pred HHH
Confidence 543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=280.36 Aligned_cols=211 Identities=28% Similarity=0.480 Sum_probs=180.2
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe----
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH---- 743 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~---- 743 (934)
.++|++.+.||.|++|.||++++..++..||+|.+.... ........+.+|+.+++.++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 568999999999999999999999999999999886532 223344567789999999999999999998876554
Q ss_pred --EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 744 --VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 744 --~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
.|+|+||+ +++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 7899998865 34999999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.. ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 169 ~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 169 DD------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred cc------------------------------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 11 0123357889999999865 4678899999999999999999999998
Q ss_pred CCHHHHHHHHHcC
Q 002342 901 KTRQKTFANILHK 913 (934)
Q Consensus 901 ~~~~~~~~~i~~~ 913 (934)
......+..+.+.
T Consensus 219 ~~~~~~~~~i~~~ 231 (343)
T cd07851 219 SDHIDQLKRIMNL 231 (343)
T ss_pred CChHHHHHHHHHh
Confidence 8888777776553
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=272.85 Aligned_cols=219 Identities=28% Similarity=0.451 Sum_probs=177.0
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCC
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 742 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 742 (934)
..+..++|++.+.||.|+||.||++.+..+++.||+|.+.+.. .......+..|+.++..+ +||||+++++++....
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 4456789999999999999999999998889999999987542 223345566677766666 5999999999999999
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
..|++|||+ +++|..++.... ..+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+||+|||++...
T Consensus 88 ~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 88 DVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999999999 557777765532 368999999999999999999997 59999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC----CCchhHHHHHHHHHHHHHhCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~s~~~DiwSlG~iL~elltG~~P 897 (934)
... .......+++.|+|||++.+.. ++.++|+||||+++|+|++|+.|
T Consensus 166 ~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 217 (296)
T cd06618 166 VDS----------------------------KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217 (296)
T ss_pred cCC----------------------------CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCC
Confidence 110 0011224788999999997654 78899999999999999999999
Q ss_pred CCCCCH-HHHHHHHHcCC
Q 002342 898 FRGKTR-QKTFANILHKD 914 (934)
Q Consensus 898 f~~~~~-~~~~~~i~~~~ 914 (934)
|..... .+.+..+....
T Consensus 218 ~~~~~~~~~~~~~~~~~~ 235 (296)
T cd06618 218 YKNCKTEFEVLTKILQEE 235 (296)
T ss_pred CCcchhHHHHHHHHhcCC
Confidence 976333 45566665544
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=270.07 Aligned_cols=212 Identities=28% Similarity=0.454 Sum_probs=181.3
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEc
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 750 (934)
|++.+.||+|++|.||++.+..+++.||+|.+.... ........+..|+.+++.++|+||+++++++...+..++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677889999999999999999999999999998653 2333445677899999999999999999999999999999999
Q ss_pred cCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCC
Q 002342 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (934)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 830 (934)
+. ++|.+++.... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~----- 152 (282)
T cd07829 80 CD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL----- 152 (282)
T ss_pred cC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-----
Confidence 95 68999997653 359999999999999999999999999999999999999999999999999985432110
Q ss_pred cchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 002342 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (934)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~ 909 (934)
.......++..|+|||.+.+. .++.++|+|||||++|+|++|.+||.+.+..+.+.+
T Consensus 153 ----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 210 (282)
T cd07829 153 ----------------------RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFK 210 (282)
T ss_pred ----------------------cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 011233467889999999776 788899999999999999999999999888777666
Q ss_pred HHc
Q 002342 910 ILH 912 (934)
Q Consensus 910 i~~ 912 (934)
+..
T Consensus 211 ~~~ 213 (282)
T cd07829 211 IFQ 213 (282)
T ss_pred HHH
Confidence 643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=278.37 Aligned_cols=214 Identities=25% Similarity=0.400 Sum_probs=175.1
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC------
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 741 (934)
..+|.+.+.||.|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 368999999999999999999999999999999886542 23456678899999999999999999876543
Q ss_pred --------CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-CCcEEE
Q 002342 742 --------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSL 812 (934)
Q Consensus 742 --------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-~~~vkl 812 (934)
...|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE
Confidence 36899999995 688888754 34899999999999999999999999999999999999974 567899
Q ss_pred EecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHH
Q 002342 813 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEM 891 (934)
Q Consensus 813 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~el 891 (934)
+|||++........ .........|+..|+|||.+.+ ..++.++|||||||++|+|
T Consensus 157 ~dfg~~~~~~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 212 (342)
T cd07854 157 GDFGLARIVDPHYS------------------------HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 212 (342)
T ss_pred CCcccceecCCccc------------------------cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHH
Confidence 99999854321000 0011122357889999998754 5678899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHc
Q 002342 892 LYGYTPFRGKTRQKTFANILH 912 (934)
Q Consensus 892 ltG~~Pf~~~~~~~~~~~i~~ 912 (934)
++|+.||.+.+....+..++.
T Consensus 213 ~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 213 LTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred HhCCCCCCCCCHHHHHHHHHH
Confidence 999999998887776666654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=270.32 Aligned_cols=211 Identities=29% Similarity=0.462 Sum_probs=178.3
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCCeEEEEEE
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
|++.+.||.|++|.||++.+..+++.|+||.+.+... . .......+|+..++.++ ||||+++++++..++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY-S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc-c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 7888999999999999999988999999999875422 1 12223456899999998 9999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+ +++|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~----- 152 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR----- 152 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-----
Confidence 99 889999887765456899999999999999999999999999999999999999999999999988543210
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
.......|+..|+|||++.+ ..++.++|+||||+++|+|++|++||.+.+..+.+.
T Consensus 153 -----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~ 209 (283)
T cd07830 153 -----------------------PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY 209 (283)
T ss_pred -----------------------CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH
Confidence 01123468889999998854 457889999999999999999999999888777766
Q ss_pred HHHc
Q 002342 909 NILH 912 (934)
Q Consensus 909 ~i~~ 912 (934)
.+..
T Consensus 210 ~~~~ 213 (283)
T cd07830 210 KICS 213 (283)
T ss_pred HHHH
Confidence 6543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=266.74 Aligned_cols=217 Identities=29% Similarity=0.474 Sum_probs=180.9
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeeccccc--ChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
+|.+.+.||+|+||.||++.+...+..+++|+++..... .......+..|+.+++.++||||+++++++......|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 589999999999999999999888777777776643221 223344567799999999999999999999999999999
Q ss_pred EEccCCCCchhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 748 TDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
|||+++++|.+++.. .....+++..++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~- 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS- 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC-
Confidence 999999999988764 22356999999999999999999999999999999999999974 67999999988543211
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.....
T Consensus 159 --------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~ 212 (260)
T cd08222 159 --------------------------CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS 212 (260)
T ss_pred --------------------------cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 111224468899999999988888999999999999999999999998888777
Q ss_pred HHHHHHcCC
Q 002342 906 TFANILHKD 914 (934)
Q Consensus 906 ~~~~i~~~~ 914 (934)
....+..+.
T Consensus 213 ~~~~~~~~~ 221 (260)
T cd08222 213 VVLRIVEGP 221 (260)
T ss_pred HHHHHHcCC
Confidence 777776654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=276.63 Aligned_cols=217 Identities=24% Similarity=0.362 Sum_probs=185.4
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+..+...++++||+|.||.|.++.- ..+..||+|.++... +....+.|..|+++|.+|+||||+.|++++..++.+|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 4456788999999999999999987 336899999998754 4555688999999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
++||||++|+|.+++.......+.......|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++-...-
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg- 690 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG- 690 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC-
Confidence 9999999999999998764444455666679999999999999999999999999999999999999999999633210
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY--GYTPFRGKTR 903 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt--G~~Pf~~~~~ 903 (934)
+-.+.....+-.+.|||||.+.-++++.++|+|+||++|||+++ ..-||...+.
T Consensus 691 ------------------------~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 691 ------------------------DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred ------------------------CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 11122334566789999999999999999999999999999885 8899999998
Q ss_pred HHHHHHH
Q 002342 904 QKTFANI 910 (934)
Q Consensus 904 ~~~~~~i 910 (934)
+++....
T Consensus 747 e~vven~ 753 (807)
T KOG1094|consen 747 EQVVENA 753 (807)
T ss_pred HHHHHhh
Confidence 8887655
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=248.18 Aligned_cols=206 Identities=24% Similarity=0.418 Sum_probs=173.7
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeC--Ce
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTK--TH 743 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~--~~ 743 (934)
+.++|++++++|+|.|+.||.+....++..++||++++ ...+.+.+|++||..|. ||||++|+++..+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 45789999999999999999999999999999999875 35578999999999995 99999999999764 45
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-CcEEEEecccCcccC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLTS 822 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-~~vkl~DFG~a~~~~ 822 (934)
..|++||+++.+...+.. .++.-.++.++.+++.||.|+|++||+|||+||.|++|+.. .+++|+|+|+|....
T Consensus 110 paLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred chhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 689999999988877753 38889999999999999999999999999999999999875 579999999995432
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCC-CC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPF-RG 900 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf-~~ 900 (934)
+...-+--+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.|| .|
T Consensus 185 ----------------------------p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG 236 (338)
T KOG0668|consen 185 ----------------------------PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 236 (338)
T ss_pred ----------------------------CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC
Confidence 2222334456778899999965 45788999999999999999877775 56
Q ss_pred CCHHHHHHHHH
Q 002342 901 KTRQKTFANIL 911 (934)
Q Consensus 901 ~~~~~~~~~i~ 911 (934)
.++.+++-+|.
T Consensus 237 ~dN~DQLVkIa 247 (338)
T KOG0668|consen 237 HDNYDQLVKIA 247 (338)
T ss_pred CCCHHHHHHHH
Confidence 77777665553
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=258.26 Aligned_cols=224 Identities=24% Similarity=0.346 Sum_probs=182.8
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe------
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------ 740 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------ 740 (934)
..+.|+.+.+||+|.||.||+|+.+.+++.||+|.+--... ....-....+|++||..|.|+|++.+++++..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 46789999999999999999999999999999985432111 11223446789999999999999999887752
Q ss_pred --CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccC
Q 002342 741 --KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (934)
Q Consensus 741 --~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a 818 (934)
...+|+||.+| .-+|..++... ...|+..+++.++.+++.||.|+|.+.|+|||+||.|+||+.+|.+||+|||++
T Consensus 94 r~r~t~ylVf~~c-ehDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 94 RDRATFYLVFDFC-EHDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cccceeeeeHHHh-hhhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 34589999999 66888887654 345999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~P 897 (934)
+.++.+.... ....+..+-|++|.+||.+.+. .|+++.|+|..||++.+|++|.+.
T Consensus 172 r~fs~~~n~~-----------------------kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspi 228 (376)
T KOG0669|consen 172 RAFSTSKNVV-----------------------KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPI 228 (376)
T ss_pred cceecccccC-----------------------CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcc
Confidence 7654321110 0112334679999999999874 678899999999999999999999
Q ss_pred CCCCCHHHHHHHHHc--CCCC
Q 002342 898 FRGKTRQKTFANILH--KDLK 916 (934)
Q Consensus 898 f~~~~~~~~~~~i~~--~~~~ 916 (934)
|.+++.++++..|.. |.+.
T Consensus 229 mqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 229 MQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred ccCChHHHHHHHHHHHhccCC
Confidence 999999999988854 5543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=259.57 Aligned_cols=212 Identities=28% Similarity=0.427 Sum_probs=179.1
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC-----eEE
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-----HVC 745 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~~~ 745 (934)
.+--+.||.|+||.||.+.|..+|+.||+|.+.. .+......+++.+|+++|..++|.|++..+++.+... .+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4445689999999999999999999999998753 3445566788999999999999999999999887543 357
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
.++|+| ..+|...+-. ...++-+.++-+++||+.||+|||+.||.||||||.|+|++++-.+||||||+++....+.
T Consensus 134 V~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 889999 7788877754 4669999999999999999999999999999999999999999999999999996532111
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
....+..+-|-.|.|||.++|. .|+.++||||.||++.||+..+..|...++.
T Consensus 211 --------------------------~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi 264 (449)
T KOG0664|consen 211 --------------------------RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI 264 (449)
T ss_pred --------------------------hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH
Confidence 1222334678899999999885 6788999999999999999999999999998
Q ss_pred HHHHHHHc
Q 002342 905 KTFANILH 912 (934)
Q Consensus 905 ~~~~~i~~ 912 (934)
+.++.|.+
T Consensus 265 qQL~lItd 272 (449)
T KOG0664|consen 265 EQLQMIID 272 (449)
T ss_pred HHHHHHHH
Confidence 88887754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=258.71 Aligned_cols=181 Identities=32% Similarity=0.457 Sum_probs=155.8
Q ss_pred CCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCCCchhh
Q 002342 680 GDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 759 (934)
Q Consensus 680 G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~ 759 (934)
|.+|.||+|+++.+++.||+|.+.+.. ...+|...+....||||+++++++...+..|+||||++|++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 889999999999999999999987642 233455555666799999999999999999999999999999999
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccc
Q 002342 760 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839 (934)
Q Consensus 760 l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~ 839 (934)
+... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+.....
T Consensus 76 l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~---------------- 137 (237)
T cd05576 76 ISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED---------------- 137 (237)
T ss_pred HHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc----------------
Confidence 8764 3489999999999999999999999999999999999999999999999998743211
Q ss_pred cCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 138 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 138 --------------SCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred --------------ccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 01123456789999999888889999999999999999999998864
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-29 Score=272.14 Aligned_cols=221 Identities=27% Similarity=0.386 Sum_probs=188.2
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC------CCccceeEEEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH------PFVPALYASFQ 739 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~h------p~Iv~l~~~~~ 739 (934)
+...+|.+....|.|-||+|..|.+...|..||||++..+. ...+.=..|++||+.|+. -|++.|+-.|.
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 34589999999999999999999999999999999998653 233444679999999953 48999999999
Q ss_pred eCCeEEEEEEccCCCCchhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-CcEEEEeccc
Q 002342 740 TKTHVCLITDYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDL 817 (934)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-~~vkl~DFG~ 817 (934)
..+++|||||.+ ..+|.+++++.+ .-.|....++.|+.|+..||..|-..||+|.||||+|||++.+ ..+||||||.
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 999999999999 889999998742 2358889999999999999999999999999999999999875 4689999999
Q ss_pred CcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCC
Q 002342 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~P 897 (934)
|...+.. .-+...-+..|.|||++.|.+|++..|+||.||+||||.||+..
T Consensus 584 A~~~~en-----------------------------eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl 634 (752)
T KOG0670|consen 584 ASFASEN-----------------------------EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL 634 (752)
T ss_pred ccccccc-----------------------------cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeecccee
Confidence 8443211 11223456689999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCC
Q 002342 898 FRGKTRQKTFANILHKDLKFPSS 920 (934)
Q Consensus 898 f~~~~~~~~~~~i~~~~~~~p~~ 920 (934)
|+|.++-++++....-.-.||.-
T Consensus 635 FpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 635 FPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred cCCCCcHHHHHHHHHhcCCCcHH
Confidence 99999999998887766666653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=261.45 Aligned_cols=140 Identities=29% Similarity=0.444 Sum_probs=124.8
Q ss_pred cccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-----C---CCccc
Q 002342 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-----H---PFVPA 733 (934)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-----h---p~Iv~ 733 (934)
.+..++..+|.+.++||+|-|++||++.|..+.++||+|+.+.. ....+....||++|++++ | .+||+
T Consensus 71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 45566778999999999999999999999999999999998752 455667788999999983 3 36999
Q ss_pred eeEEEE----eCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEec
Q 002342 734 LYASFQ----TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQG 806 (934)
Q Consensus 734 l~~~~~----~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~ 806 (934)
|++.|. ++.++|||+|++ |.+|..+|.....+.++...++.|++|||.||.|||.+ ||||.||||+|||+..
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCS 223 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeec
Confidence 999997 467999999999 99999999988888899999999999999999999987 9999999999999953
|
|
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=311.93 Aligned_cols=379 Identities=15% Similarity=0.138 Sum_probs=277.4
Q ss_pred ccccccccccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHH
Q 002342 176 DEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRE 255 (934)
Q Consensus 176 ~~~~~e~aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~ 255 (934)
...+.++.+++++++|+.++++++++|+++|. +|+|+++|+++++++||+.+|++|+++..+.+|++.......+..
T Consensus 270 ~~r~~~~~l~~~e~r~~~l~e~~~~~i~~~d~---dG~i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~d~~~~~~~~~~ 346 (1092)
T PRK09776 270 AFRAERKHISESETRFRNAMEYSAIGMALVGT---EGQWLQVNKALCQFLGYSQEELRGLTFQQLTWPEDLNKDLQQVEK 346 (1092)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhCCceEEEEcC---CCcEEehhHHHHHHhCCCHHHHccCCceeccCcchhHhHHHHHHH
Confidence 34445667889999999999999999999998 788999999999999999999999998888888776666666655
Q ss_pred HHhcC-CcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhhcCCCCCchhhhHHHHHHHHH
Q 002342 256 TLQNG-QSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEM 334 (934)
Q Consensus 256 ~l~~g-~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~~~~~~l~~~l~~~~~~~~~~ 334 (934)
.+.++ ..+..+.+..++||+.+|+..+.++++|.+|.+.+++++++|||++|++|++++...
T Consensus 347 ~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~~~g~~~~~i~~~~DITerk~~e~~l~~~~----------------- 409 (1092)
T PRK09776 347 LLSGEINSYSMEKRYYRRDGEVVWALLAVSLVRDTDGTPLYFIAQIEDINELKRTEQVNERLM----------------- 409 (1092)
T ss_pred HHcCCccceeeeeEEEcCCCCEEEEEEEEEEEECCCCCEeeehhhHHhhHHHHHHHHHHHHHH-----------------
Confidence 55544 346778888999999999999999999999999999999999999999999877311
Q ss_pred hHHHHHHHHHH-ccCCCCcccCCCCCcccccCCCCchhhhcccccCCCC-C-CCCCCCCCC---CCCCcccccccccccc
Q 002342 335 ATSSVTELVQA-MKKPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKS-E-NVPPPRRNS---YGGGCRTSMQRISEVP 408 (934)
Q Consensus 335 ~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~-~-~~~~~~~~~---~~~~~~~~~~~~~~~~ 408 (934)
+....+.+. -......+.......+|....+.+|+..++..+...- . ..|+. +.. ...... .....-..+
T Consensus 410 --~~~~~~~~~~~~~i~~~d~~~~~~~~n~~~~~l~G~~~~~~~~~~~~~~~~~p~d-~~~~~~~~~~~~-~~~~~~~~e 485 (1092)
T PRK09776 410 --ERITLANEAGGIGIWEWDLKPNIISWDKRMFELYEIPPHIKPTWQVWYACLHPED-RQRVEKEIRDAL-QGRSPFKLE 485 (1092)
T ss_pred --HHHHHHHHhcCceEEEEecCCCeEeeCHHHHHHhCCCcccCCCHHHHHHhcCHhH-HHHHHHHHHHHH-hcCCCeeEE
Confidence 111112222 2223334444556667777777777776553321110 0 11110 000 000000 011222344
Q ss_pred hhcccccccccccccccccccCCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhhc-ccHHHHHHhccccEEE
Q 002342 409 EKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKG-IDLATTLERIEKNFVI 487 (934)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dv~~r~~~e~~l~~~-~~l~~i~e~~~d~i~v 487 (934)
.+...++| ..|+........+.++...... ....|||+|++.|+++++. ..++.++++++++|++
T Consensus 486 ~r~~~~dG-~~w~~~~~~~~~d~~G~~~~~i-------------g~~~DITerk~~e~~L~~~~~~l~~~l~~~~~~i~~ 551 (1092)
T PRK09776 486 FRIVVKDG-VRHIRALANRVLNKDGEVERLL-------------GINMDMTEVRQLNEALFQEKERLHITLDSIGEAVVC 551 (1092)
T ss_pred EEEEcCCc-eEEEEEeeEEEECCCCCEEEEE-------------eeeeehhHHHHHHHHHHHHHHHHHHHHhccccEEEE
Confidence 55567888 8888877777666665544332 3368999999999999776 6799999999999999
Q ss_pred EcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCC--CCHHHHHHHHHHHhcCCc--EEEEEEEEecCCcEEEEE
Q 002342 488 TDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE--TDPATVRKIRAAIDNQTD--VTVQLINYTKSGKKFWNL 563 (934)
Q Consensus 488 ~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~--~~~~~~~~i~~~l~~~~~--~~~e~~~~~kdG~~~wv~ 563 (934)
+|.+|+ |+++|+++++++||+.+|++|+++..+.+.. ........+......... ...+....+++|..+|+.
T Consensus 552 ~D~~g~---i~~~N~a~~~l~G~~~~e~iG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~~~~~~ 628 (1092)
T PRK09776 552 TDMAMK---VTFMNPVAEKMTGWTQEEALGVPLLTVLHITFGDNGPLMENIYSCLTSRSAAYLEQDVVLHCRSGGSYDVH 628 (1092)
T ss_pred ECCCCe---EEEEcHHHHHHhCCCHHHHcCCCHHHHcccccCCcchhhHHHHHHHhcCCCccccceEEEEeCCCcEEEEE
Confidence 999888 9999999999999999999999976655422 222222334444444433 456777889999999999
Q ss_pred EEEEeeecCCCCEEEEEEEEEcCCcccccccc
Q 002342 564 FHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRN 595 (934)
Q Consensus 564 ~~~~pi~de~G~v~~~vgi~rDITerk~~e~~ 595 (934)
.+..|+++.+|++.+++++++|||++|+.+++
T Consensus 629 ~~~~pi~~~~g~~~g~v~~~~DITe~k~~e~~ 660 (1092)
T PRK09776 629 YSITPLSTLDGENIGSVLVIQDVTESRKMLRQ 660 (1092)
T ss_pred EEeeeeecCCCCEEEEEEEEEecchHHHHHHH
Confidence 99999999999999999999999999986543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-27 Score=244.28 Aligned_cols=216 Identities=37% Similarity=0.602 Sum_probs=184.0
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEc
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 750 (934)
|.+.+.||.|++|.||++.+..+++.+|+|.+...... .....+.+|+..++.++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67788999999999999999888999999999865322 2567888999999999999999999999998999999999
Q ss_pred cCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCC
Q 002342 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (934)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 830 (934)
+++++|.+++..... .+++..+..++.+++.+|.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~----- 152 (225)
T smart00221 79 CEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL----- 152 (225)
T ss_pred cCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-----
Confidence 999999999876532 28899999999999999999999999999999999999999999999999986542111
Q ss_pred cchhhhccccCCCCcccccccccccccccCCCCccchhhh-cCCCCCchhHHHHHHHHHHHHHhCCCCCCC--CCHHHHH
Q 002342 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLYGYTPFRG--KTRQKTF 907 (934)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l-~~~~~s~~~DiwSlG~iL~elltG~~Pf~~--~~~~~~~ 907 (934)
........++..|++||.+ ....++.++|+||||+++++|++|+.||.+ .....+.
T Consensus 153 ---------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~ 211 (225)
T smart00221 153 ---------------------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLS 211 (225)
T ss_pred ---------------------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHH
Confidence 0012234678899999999 667778899999999999999999999987 4444778
Q ss_pred HHHHcCCC
Q 002342 908 ANILHKDL 915 (934)
Q Consensus 908 ~~i~~~~~ 915 (934)
+.|..+..
T Consensus 212 ~~~~~~~~ 219 (225)
T smart00221 212 DVWSFGVP 219 (225)
T ss_pred HHHhcCCc
Confidence 88887764
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-28 Score=249.33 Aligned_cols=210 Identities=25% Similarity=0.453 Sum_probs=182.3
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC------
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 741 (934)
..+|.-++.+|.|.- .|..+.|.-.++.+|+|.+... .......++..+|..++..+.|+||++++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 457889999999998 8888999899999999987665 33445567788999999999999999999999643
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
..+|+||||| ..+|...+.-. ++-..+..++.|+++|++|||+.||+||||||+||++..+..+||+|||+|..-
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVILME----LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 3579999999 88999888742 788999999999999999999999999999999999999999999999999542
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
.. .-..+..+.|..|.|||++.+..|...+||||+||++.||++|+..|.|.
T Consensus 169 ~~----------------------------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 169 DT----------------------------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred Cc----------------------------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 11 11234567899999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHc
Q 002342 902 TRQKTFANILH 912 (934)
Q Consensus 902 ~~~~~~~~i~~ 912 (934)
+..+++-+|.+
T Consensus 221 d~idQ~~ki~~ 231 (369)
T KOG0665|consen 221 DHIDQWNKIIE 231 (369)
T ss_pred hHHHHHHHHHH
Confidence 99988887765
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-27 Score=253.14 Aligned_cols=192 Identities=25% Similarity=0.415 Sum_probs=160.2
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHh--CCCCCccceeEEEEeCC--
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDHPFVPALYASFQTKT-- 742 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~~~~~~-- 742 (934)
+....+++..||+|.||.||++.. +++.||||++.. .....+.+|.+|.+. +.|+||++|+++-.-.+
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhc--cCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 356778889999999999999998 668999999864 345678888888775 48999999998876544
Q ss_pred --eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeecCCCCCCEEEecCCcEE
Q 002342 743 --HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ---------GIIYRDLKPENVLLQGNGHVS 811 (934)
Q Consensus 743 --~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---------giiHrDLKp~NILl~~~~~vk 811 (934)
.++||++|.+.|+|.++|+.+ .+++.....++.-|+.||+|||.. .|+|||||..|||+..|+++.
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 789999999999999999874 499999999999999999999963 599999999999999999999
Q ss_pred EEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC-C-----chhHHHHHH
Q 002342 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-T-----SAVDWWALG 885 (934)
Q Consensus 812 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s-----~~~DiwSlG 885 (934)
|+|||+|..+.+. .+...+..-+||.+|||||+|.+.-. . .+.||||+|
T Consensus 357 IaDFGLAl~~~p~-------------------------~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamg 411 (534)
T KOG3653|consen 357 IADFGLALRLEPG-------------------------KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMG 411 (534)
T ss_pred eeccceeEEecCC-------------------------CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHH
Confidence 9999999665311 11122334689999999999977522 1 279999999
Q ss_pred HHHHHHHhC
Q 002342 886 ILLYEMLYG 894 (934)
Q Consensus 886 ~iL~elltG 894 (934)
.+|||+++.
T Consensus 412 LVLWEi~SR 420 (534)
T KOG3653|consen 412 LVLWEIASR 420 (534)
T ss_pred HHHHHHHhh
Confidence 999999974
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=266.63 Aligned_cols=221 Identities=23% Similarity=0.296 Sum_probs=186.8
Q ss_pred CcccccccccCCcEEEEEEEEecCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~----~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
..+..++||+|+||+||++.+.-.|+ +||+|++.... ......++..|+-+|..|+|||+++|++++.... +.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 45667899999999999999865554 68888877542 3455678999999999999999999999998755 88
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
||++|+++|+|.++++..+ ..+.......|..||++||.|||.+++|||||...|||+..-..+||.|||+++......
T Consensus 774 lvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999999998764 458889999999999999999999999999999999999999999999999997754322
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 904 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~ 904 (934)
.. .......-.+.|||-|.+....|++++|||||||++|||+| |.-||.+....
T Consensus 853 ~e-------------------------y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~ 907 (1177)
T KOG1025|consen 853 KE-------------------------YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE 907 (1177)
T ss_pred cc-------------------------ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH
Confidence 11 11222234678999999999999999999999999999997 99999999999
Q ss_pred HHHHHHHcCCC-CCCC
Q 002342 905 KTFANILHKDL-KFPS 919 (934)
Q Consensus 905 ~~~~~i~~~~~-~~p~ 919 (934)
++-..+..|+- ..|.
T Consensus 908 eI~dlle~geRLsqPp 923 (1177)
T KOG1025|consen 908 EIPDLLEKGERLSQPP 923 (1177)
T ss_pred HhhHHHhccccCCCCC
Confidence 99888877663 4444
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=264.52 Aligned_cols=240 Identities=17% Similarity=0.167 Sum_probs=168.2
Q ss_pred ccccCCcccccccccCCcEEEEEEEEe----------------cCCeEEEEEEeecccccChH-----------HHHHHH
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELC----------------GSGQYFAMKAMDKGVMLNRN-----------KVHRAC 717 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~----------------~~~~~vAlK~~~~~~~~~~~-----------~~~~~~ 717 (934)
.+..++|.+.++||+|+||.||++.+. ..++.||||.+......... ..+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 356789999999999999999999752 24567999998643211000 112233
Q ss_pred HHHHHHHhCCCCC-----ccceeEEEEe--------CCeEEEEEEccCCCCchhhhccCCC-------------------
Q 002342 718 AEREILDMLDHPF-----VPALYASFQT--------KTHVCLITDYCPGGELFLLLDRQPT------------------- 765 (934)
Q Consensus 718 ~E~~il~~l~hp~-----Iv~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~~------------------- 765 (934)
.|+.++.++.|.+ ++.++++|.. .+..||||||+.+++|.+++.....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 4666777776554 4677777643 3568999999999999998864211
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCC
Q 002342 766 ---KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842 (934)
Q Consensus 766 ---~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~ 842 (934)
..++...++.++.|++.+|.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~----------------- 363 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI----------------- 363 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-----------------
Confidence 124567788999999999999999999999999999999999999999999985431100
Q ss_pred CCcccccccccccccccCCCCccchhhhcCCCC----------------------CchhHHHHHHHHHHHHHhCCC-CCC
Q 002342 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH----------------------TSAVDWWALGILLYEMLYGYT-PFR 899 (934)
Q Consensus 843 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~----------------------s~~~DiwSlG~iL~elltG~~-Pf~ 899 (934)
........+|+.|+|||.+..... ..+.|+||+||++|+|++|.. ||.
T Consensus 364 ---------~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 364 ---------NFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred ---------ccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 001112245889999999854321 124699999999999999875 775
Q ss_pred CCCH-----------HHHHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 900 GKTR-----------QKTFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 900 ~~~~-----------~~~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
+... ....+.+..+.+.|+.+...+..++||
T Consensus 435 ~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dL 476 (507)
T PLN03224 435 NIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDL 476 (507)
T ss_pred chhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHH
Confidence 4221 122233445666777666666666654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=237.78 Aligned_cols=205 Identities=42% Similarity=0.718 Sum_probs=175.2
Q ss_pred CcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCCCchhhh
Q 002342 681 DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL 760 (934)
Q Consensus 681 ~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l 760 (934)
+||.||++.+..+++.+|+|++........ ...+.+|+.+++.++|+||+++++++......+++|||+.+++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999998999999999876533221 578889999999999999999999999999999999999888999998
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhcccc
Q 002342 761 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840 (934)
Q Consensus 761 ~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~ 840 (934)
..... ++...+..++.+++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------------- 141 (244)
T smart00220 79 KKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------------- 141 (244)
T ss_pred HhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---------------
Confidence 76433 8999999999999999999999999999999999999999999999999985532110
Q ss_pred CCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCC
Q 002342 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG-KTRQKTFANILHKDLKF 917 (934)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~-~~~~~~~~~i~~~~~~~ 917 (934)
......|++.|++||.+.+..++.++|+||||+++|+|++|..||.. ......+..+..+....
T Consensus 142 -------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~ 206 (244)
T smart00220 142 -------------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF 206 (244)
T ss_pred -------------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC
Confidence 22344688899999999988889999999999999999999999988 55566666665555543
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-26 Score=270.93 Aligned_cols=200 Identities=18% Similarity=0.220 Sum_probs=143.5
Q ss_pred cccCCcccccccccCCcEEEEEEEEecC----CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEE----
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGS----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS---- 737 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~----~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~---- 737 (934)
...++|.+.+.||+|+||.||++.+..+ +..||+|.+.... ..+....+ .+....+.++..++..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 3567999999999999999999999888 8999999876421 11111111 1122222222222211
Q ss_pred --EEeCCeEEEEEEccCCCCchhhhccCCCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 002342 738 --FQTKTHVCLITDYCPGGELFLLLDRQPTK------------------VLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 797 (934)
Q Consensus 738 --~~~~~~~~lV~E~~~ggsL~~~l~~~~~~------------------~l~~~~~~~i~~qil~aL~yLH~~giiHrDL 797 (934)
...+...+|||||+.+++|.+++...... ......+..++.||+.||.|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 23566899999999999999998654211 1123456789999999999999999999999
Q ss_pred CCCCEEEec-CCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC--
Q 002342 798 KPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-- 874 (934)
Q Consensus 798 Kp~NILl~~-~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-- 874 (934)
||+|||++. ++.+||+|||+|...... .......++||+.|||||.+....
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~--------------------------~~~~~~~~~~t~~Y~APE~~~~~~~~ 335 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVG--------------------------INYIPKEFLLDPRYAAPEQYIMSTQT 335 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccc--------------------------cccCCcccccCCCccChHHhhccCCC
Confidence 999999986 589999999999543210 011224567899999999764322
Q ss_pred --------------------CCchhHHHHHHHHHHHHHhCCCCC
Q 002342 875 --------------------HTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 875 --------------------~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
++.++|||||||+||||+++..|+
T Consensus 336 ~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~ 379 (566)
T PLN03225 336 PSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRS 379 (566)
T ss_pred CCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCC
Confidence 334569999999999999976665
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=245.28 Aligned_cols=198 Identities=26% Similarity=0.402 Sum_probs=159.7
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHh--CCCCCccceeEEEEeC----C
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDHPFVPALYASFQTK----T 742 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~~~~~----~ 742 (934)
.+.++.+.||+|.||.||++.+ .|..||||++... .....++|.+|.+. |+|+||+.|+..-..+ .
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeeccc--cCCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 4677889999999999999998 6778999998742 23557778888765 5999999998875432 4
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCCEEEecCCcEEEEe
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLTD 814 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~--------giiHrDLKp~NILl~~~~~vkl~D 814 (934)
++|||++|.+.|||+|||.+. .++.+....++.-++.||++||-. .|.|||||..|||+.++|.+.|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 789999999999999999873 499999999999999999999953 499999999999999999999999
Q ss_pred cccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC----C--CchhHHHHHHHHH
Q 002342 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----H--TSAVDWWALGILL 888 (934)
Q Consensus 815 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~--s~~~DiwSlG~iL 888 (934)
+|+|.......... .-..+..+||..|||||++...- + -..+||||||+++
T Consensus 360 LGLAv~h~~~t~~i-----------------------di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVl 416 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTI-----------------------DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVL 416 (513)
T ss_pred ceeeEEecccCCcc-----------------------cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHH
Confidence 99996543221100 01224568999999999996532 2 1279999999999
Q ss_pred HHHHhC----------CCCCCC
Q 002342 889 YEMLYG----------YTPFRG 900 (934)
Q Consensus 889 ~elltG----------~~Pf~~ 900 (934)
||++.. ++||.+
T Consensus 417 WEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 417 WEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred HHHHHHhhcCCEehhhcCCccc
Confidence 998842 678875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=291.38 Aligned_cols=188 Identities=22% Similarity=0.362 Sum_probs=160.4
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
..|...+.||+|+||.||++.+..++..||+|.+..... ....|++++++++||||+++++++.+.+..|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 356777889999999999999999999999998864311 1124688999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH---CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
||+++|+|.++++. +++.....++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+....
T Consensus 763 Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~--- 833 (968)
T PLN00113 763 EYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC--- 833 (968)
T ss_pred eCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc---
Confidence 99999999999853 788999999999999999999 6699999999999999988887765 66542110
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
......||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus 834 ----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 834 ----------------------------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred ----------------------------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 01123688999999999999999999999999999999999999954
|
|
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=262.36 Aligned_cols=360 Identities=13% Similarity=0.041 Sum_probs=230.9
Q ss_pred HHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCC-cEEEEEEEEecC
Q 002342 195 LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ-SYCGRLLNYKKD 273 (934)
Q Consensus 195 le~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~-~~~~e~~~~~kd 273 (934)
+++++|+++++|. +|+|++||.++++++||+.+|++|+++..+++++........+...+..+. .+..+.....++
T Consensus 2 ~~~~~d~~~~~d~---~g~i~~~n~~~~~~~g~~~~el~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 78 (442)
T TIGR02040 2 LATAADVTLLLDA---EGVVREVAANPHHPSFEQLSEWEGRRWEEIVTAESVEKFELRLSEALRTGRGAVRVELNHIDPS 78 (442)
T ss_pred CcccCcEEEEECC---CCcEEEEEECCCcccccccccCCCCcHhHhhCcchHHHHHHHHHHHhccCCCcceEeeccCCCC
Confidence 5778999999999 777999999999999999999999999888888766666666666666654 455565555667
Q ss_pred CcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhhcCCCCCchhhhHHHHHHHHHhHHHHHHHHHHcc-CCCCc
Q 002342 274 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMK-KPRSL 352 (934)
Q Consensus 274 G~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~~~~~~l~~~l~~~~~~~~~~~~~~~~~l~~~~~-~~~~~ 352 (934)
|..+|+.++..++.+ + .+++++.+|||++++.+.+|......+.. +........+....++.... .....
T Consensus 79 g~~~~~~~~~~~~~~--~--~~~~~i~rDi~~~~~~~~~l~~~~~~~e~-----~~~~l~~~e~r~~~l~e~~~~~i~~~ 149 (442)
T TIGR02040 79 SFELPMRFILVRLGA--D--RGVLALGRDLRAVAELQQQLVAAQQAMER-----DYWTLREMETRYRVVLEVSSDAVLLV 149 (442)
T ss_pred CCccCeEEEEEEeCC--C--CeEEEEecccHHHHHHHHHHHHHHHHHHH-----HHHHHHHHHHHHHHHHhhCCceEEEE
Confidence 777777777776643 2 25688999999988876655211100000 00011111223333444433 33334
Q ss_pred cc-CCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCC---cccccccccccchhcccccccccccccccccc
Q 002342 353 SE-STNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGG---CRTSMQRISEVPEKKKQKSGRRSFMGLIGRKS 428 (934)
Q Consensus 353 ~~-~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 428 (934)
+. ...+..+|..+...+|+..+++.|++..+++++......... ....+. . .........+...|. ...+..
T Consensus 150 d~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~~~~~~~~~~~~~~l~~~~~~g~-~--~~~~~~~~~~~~~~~-~~~~~~ 225 (442)
T TIGR02040 150 DMSTGRIVEANSAAAALLGGVGQSLVGRAFPQEFEGRRREELMLTLRNVRATGS-A--APVRILLRRSQKRLL-VVVSVF 225 (442)
T ss_pred ECCCCEEEEEcHHHHHHhCcCHHHHcCCCHHHhCCHHHHHHHHHHHHHHHhcCC-C--cceEEEEcCCCeEEE-EEEEEE
Confidence 43 456777999999999999999999998886654221110000 000010 0 000111111111111 111111
Q ss_pred cCCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhhcccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHc
Q 002342 429 QSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELT 508 (934)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dv~~r~~~e~~l~~~~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~ 508 (934)
.. ++...+. ....|+++++..+++++ ..|+.++++++++|+++|.+|+ |+++|++|++++
T Consensus 226 ~~-~~~~~~l--------------~~~~dit~~~~~e~~~~--~~~~~l~e~~~d~I~v~D~~G~---I~~~N~a~~~l~ 285 (442)
T TIGR02040 226 RQ-DGESLFL--------------CQLSPAGATQPVGDELS--ENLARLYHEAPDAIVFSDADGT---IRGANEAFLELT 285 (442)
T ss_pred Ee-CCceEEE--------------EEEcccchhhhhhHHHH--HHHHHHHHhCCceEEEEcCCCc---EEehhHHHHHHh
Confidence 11 1111111 12356777776665543 2599999999999999999888 999999999999
Q ss_pred CCC-hhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCC
Q 002342 509 EYS-REEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587 (934)
Q Consensus 509 Gys-~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDIT 587 (934)
||+ .++++|+++..+.++.... ....+......+.....+..+.+++|..+|+.+++.|+.+..+ ..++++++|||
T Consensus 286 G~~~~~~l~G~~~~~~~~~~~~~-~~~~~~~~~~~g~~~~~~~~~~~~~G~~~~ve~s~~~i~~~~~--~~~~~v~rDIT 362 (442)
T TIGR02040 286 DSSSLEAVRGRTLDRWLGRGGVD-LRVLLSNVRRTGQVRLYATTLTGEFGAQTEVEISAAWVDQGER--PLIVLVIRDIS 362 (442)
T ss_pred CCCChHHHcCCCHHHHhCCCccc-HHHHHHHHhhcCceEEEEEEEEcCCCCEEEEEEEEEEeccCCc--eEEEEEEecch
Confidence 997 5789999977666543222 2222333334455556777888999999999999999976554 46888999999
Q ss_pred cccccc
Q 002342 588 EHLEPL 593 (934)
Q Consensus 588 erk~~e 593 (934)
+||+++
T Consensus 363 eR~~~~ 368 (442)
T TIGR02040 363 RRLTMR 368 (442)
T ss_pred hhccCC
Confidence 999874
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=234.39 Aligned_cols=198 Identities=25% Similarity=0.381 Sum_probs=161.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEE-EEeCCeEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS-FQTKTHVC 745 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~-~~~~~~~~ 745 (934)
.+.|.|.+.||+|-||.+.+|+++.++..+++|.+.+. ......|.+|..---.| .|.||+.-|++ |++.+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 47899999999999999999999999999999998764 34566778887765555 58899887765 67788899
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe--cCCcEEEEecccCcccCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~--~~~~vkl~DFG~a~~~~~ 823 (934)
++|||++-|+|..-+... .+.+.-.+.++.|+++||.|||++++||||||.+||||- +..+|||||||.+...+.
T Consensus 99 F~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred EeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999999999887653 388999999999999999999999999999999999994 345899999998844221
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-----CCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-----GHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
+ ....--+..|.+||.+... ...+.+|+|.||+++|.+++|++||
T Consensus 176 --------t----------------------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PW 225 (378)
T KOG1345|consen 176 --------T----------------------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPW 225 (378)
T ss_pred --------e----------------------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcc
Confidence 0 0111235579999988543 2356899999999999999999999
Q ss_pred CCCC
Q 002342 899 RGKT 902 (934)
Q Consensus 899 ~~~~ 902 (934)
....
T Consensus 226 Qka~ 229 (378)
T KOG1345|consen 226 QKAS 229 (378)
T ss_pred hhhh
Confidence 8543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=225.52 Aligned_cols=230 Identities=23% Similarity=0.313 Sum_probs=193.4
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC-CCccceeEEEEeCC
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH-PFVPALYASFQTKT 742 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~ 742 (934)
..+..+.|.++++||+|+||.+|++....+|..||||+-.... ....+..|.++.+.|++ ..|+.+..++....
T Consensus 10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 10 ELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred hheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 3456789999999999999999999999999999999876542 22346678999999964 67888888899999
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEEEEecccCc
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSC 819 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~~vkl~DFG~a~ 819 (934)
+-.|||+++ |.+|.+++... .+.|+..++..++.|++.-++|+|.+++|||||||+|+|+.- ..++.++|||+|+
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred cceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 999999999 99999998765 356999999999999999999999999999999999999963 3568999999997
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
..-+.... ..-+.+......||..|.+-.++.+...+.+.|+-|+|.+|.++..|..||.
T Consensus 163 ky~d~~t~--------------------~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 163 KYRDIRTR--------------------QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred hhcccccc--------------------ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccc
Confidence 65332111 1234455667889999999999999999999999999999999999999999
Q ss_pred C---CCHHHHHHHHHcCCCCCCCC
Q 002342 900 G---KTRQKTFANILHKDLKFPSS 920 (934)
Q Consensus 900 ~---~~~~~~~~~i~~~~~~~p~~ 920 (934)
| .+..+.+.+|.+.+...|..
T Consensus 223 glka~tk~QKyEkI~EkK~s~~ie 246 (341)
T KOG1163|consen 223 GLKAATKKQKYEKISEKKMSTPIE 246 (341)
T ss_pred ccchhhHHHHHHHHHHhhcCCCHH
Confidence 7 45567788999888877653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=259.66 Aligned_cols=220 Identities=27% Similarity=0.430 Sum_probs=194.6
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|+++.++|+|.||.||+++++.+++..|+|+++-. ......-+.+|+-+++.++|||||.+++.|-..+.+|+.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 46899999999999999999999999999999998743 344556678899999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||||.||+|.+..+.- +.+++.++.++++..+.+|+|||++|-+|||||=.|||+++.|.+|+.|||.+..+.
T Consensus 91 MEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit----- 163 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT----- 163 (829)
T ss_pred EEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh-----
Confidence 9999999999987653 569999999999999999999999999999999999999999999999999985432
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhh---cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII---AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l---~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
.......+++||+.|||||+- ..+.|.-.+|+|++|++-.|+--=++|-....++
T Consensus 164 ----------------------ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 164 ----------------------ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred ----------------------hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 123445678999999999997 4567888999999999999999999999899998
Q ss_pred HHHHHHHcCCCCCCC
Q 002342 905 KTFANILHKDLKFPS 919 (934)
Q Consensus 905 ~~~~~i~~~~~~~p~ 919 (934)
..+..+-.-.|+-|.
T Consensus 222 r~l~LmTkS~~qpp~ 236 (829)
T KOG0576|consen 222 RALFLMTKSGFQPPT 236 (829)
T ss_pred HHHHHhhccCCCCCc
Confidence 888888776666654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-25 Score=262.78 Aligned_cols=231 Identities=25% Similarity=0.378 Sum_probs=188.8
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEec-------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccce
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPAL 734 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~-------~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l 734 (934)
.+++..++..+.+.||+|.||.|+++.... ....||+|.++... .......+..|+++|+.+ .||||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--SSSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--CcHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 344555666777799999999999997632 14579999987653 236678899999999999 59999999
Q ss_pred eEEEEeCCeEEEEEEccCCCCchhhhccCC------------C--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 002342 735 YASFQTKTHVCLITDYCPGGELFLLLDRQP------------T--KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPE 800 (934)
Q Consensus 735 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~--~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~ 800 (934)
++.+...+.+++|+||+..|+|..++...+ . ..++......++.||+.|++||+++++|||||...
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999998754 0 13888999999999999999999999999999999
Q ss_pred CEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccC--CCCccchhhhcCCCCCch
Q 002342 801 NVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG--TEEYIAPEIIAGAGHTSA 878 (934)
Q Consensus 801 NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G--t~~y~aPE~l~~~~~s~~ 878 (934)
|||++.+..+||+|||+|+........ ......| ...|||||.+....|+.+
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y--------------------------~~~~~~~~LP~kWmApEsl~~~~ft~k 501 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYY--------------------------RTKSSAGTLPVKWMAPESLFDRVFTSK 501 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCce--------------------------EecCCCCccceeecCHHHhccCccccc
Confidence 999999999999999999643221110 0011112 345999999999999999
Q ss_pred hHHHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHHcCCC-CCCCCC
Q 002342 879 VDWWALGILLYEMLY-GYTPFRGKT-RQKTFANILHKDL-KFPSST 921 (934)
Q Consensus 879 ~DiwSlG~iL~ellt-G~~Pf~~~~-~~~~~~~i~~~~~-~~p~~~ 921 (934)
+||||||++|||+++ |..||.+-. ..++++.+.+|.. ..|...
T Consensus 502 SDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c 547 (609)
T KOG0200|consen 502 SDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHC 547 (609)
T ss_pred chhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCC
Confidence 999999999999997 999999865 6777877777764 667654
|
|
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=272.76 Aligned_cols=379 Identities=10% Similarity=0.039 Sum_probs=266.2
Q ss_pred ccccccccccchHHHH-HHHHHhccCcEEEEeCCCCCCce--EEcchHHHHHcCCChhhHcCCC--CCCCCCCCCChHHH
Q 002342 176 DEGGKEKGLPRVSDIV-KDALSTFQQTFVVSDATKPDYPI--MYASAGFFKMTGYTSKEVVGRN--CRFLQGAGTDPEDV 250 (934)
Q Consensus 176 ~~~~~e~aL~~~~~~~-~~ile~~~d~i~v~D~~~~dG~I--~~~N~a~~~l~Gys~eEllG~~--~~~l~~~~~~~~~~ 250 (934)
.++.++.+|+++++.+ +.+++++|+++++.+..+ +|.+ .++++++..++||...++++.. +..+.+|++.....
T Consensus 54 ~r~~~~~~l~~~~e~~~r~l~~~~p~~i~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~p~d~~~~~ 132 (807)
T PRK13560 54 ARAIAEAEAQDCREQCERNLKANIPGGMFLFALDG-DGTFSFPSLLDANGELAAIAKHDLMADKGLLAMLIGGDDGDFFF 132 (807)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhcCCceEEEEEEcC-ccccccceeeccchhHHHhcCcccCCccchhhhhcCCCcchhhh
Confidence 3556778888888888 999999999999988632 3443 3488888889999888877643 33566777655433
Q ss_pred -------HHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhhcCCCCCchh
Q 002342 251 -------AKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPES 323 (934)
Q Consensus 251 -------~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~~~~~~l~~~ 323 (934)
+.+..++..+.....+++.+++||+ |+.....|.++.+|.. .+.|+++|||++|++|++|+..
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~e~r~~~~dg~--~~~~~~~~~~~~~g~~-~~~g~~~DIT~rk~ae~~l~~~------- 202 (807)
T PRK13560 133 ANPFRSAETIAMALQSDDWQEEEGHFRCGDGR--FIDCCLRFERHAHADD-QVDGFAEDITERKRAEERIDEA------- 202 (807)
T ss_pred hChhhHHHHHHHHhccCcccceEEEEEeCCcc--EEEEEeeeeecCCCce-EEEEEEEccchHHHHHHHHHHH-------
Confidence 2333444455556678888999996 6677788888888875 6899999999999999988731
Q ss_pred hhHHHHHHHHHhHHHHHHHHHH-ccCCCCcccCCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCC--CCCcccc
Q 002342 324 LIRYDARQKEMATSSVTELVQA-MKKPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSY--GGGCRTS 400 (934)
Q Consensus 324 l~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~--~~~~~~~ 400 (934)
.+.+..+... -......+....++.+|..+...+|++.++++|++..++.+....... .......
T Consensus 203 ------------~~~l~~l~e~~~~~i~~~d~~g~i~~~N~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~ 270 (807)
T PRK13560 203 ------------LHFLQQLLDNIADPAFWKDEDAKVFGCNDAACLACGFRREEIIGMSIHDFAPAQPADDYQEADAAKFD 270 (807)
T ss_pred ------------HHHHHHHHhhCCCeEEEEcCCCCEEEEhHHHHHHhCCCHHHHcCCcchhcCCcchhHHHHHHHHHHhc
Confidence 1112222222 223344556668888999999999999999999999987665322111 0000011
Q ss_pred cccccccchhccccccccccccccccc--ccCCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhhc-ccHHHH
Q 002342 401 MQRISEVPEKKKQKSGRRSFMGLIGRK--SQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKG-IDLATT 477 (934)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dv~~r~~~e~~l~~~-~~l~~i 477 (934)
......++.....++|+..|+....+. ..+.++...+. .....|||+|++.|++++.. ..|+.+
T Consensus 271 ~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~~~~~g~~~g~-------------~~~~~DITerk~~e~~L~~se~~l~~l 337 (807)
T PRK13560 271 ADGSQIIEAEFQNKDGRTRPVDVIFNHAEFDDKENHCAGL-------------VGAITDISGRRAAERELLEKEDMLRAI 337 (807)
T ss_pred cCCceEEEEEEEcCCCCEEEEEEEecceEEEcCCCCEEEE-------------EEEEEechHHHHHHHHHHHHHHHHHHH
Confidence 112223444556778877755444322 22322222221 12467999999999999776 679999
Q ss_pred HHhccccEEEEcCCCCCCCEEEc-cHHHHHHcCCChhhhcCCCCcccCCCCCCHHH-----------------HHHHHHH
Q 002342 478 LERIEKNFVITDPRLPDNPIIFA-SDSFLELTEYSREEILGRNCRFLQGPETDPAT-----------------VRKIRAA 539 (934)
Q Consensus 478 ~e~~~d~i~v~D~~G~~~~I~~v-N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~-----------------~~~i~~~ 539 (934)
+++++++++++|.+|. ++++ |+++++++||+.++++|+++..+.++...... ...+...
T Consensus 338 ~~~~~~~i~~~d~~g~---i~~~nn~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (807)
T PRK13560 338 IEAAPIAAIGLDADGN---ICFVNNNAAERMLGWSAAEVMGKPLPGMDPELNEEFWCGDFQEWYPDGRPMAFDACPMAKT 414 (807)
T ss_pred HHhCcccEEEEcCCCC---EEEecCHHHHHHhCCCHHHHcCCCccccChhhhhhhhhchhhhcCCcCCcchhhhhhHHHH
Confidence 9999999999999888 9987 67888899999999999986655432211110 0112233
Q ss_pred HhcCCcE-EEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccccc
Q 002342 540 IDNQTDV-TVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 593 (934)
Q Consensus 540 l~~~~~~-~~e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e 593 (934)
+..+..+ ..++...+++|..+|+.....|++|.+|.+.+++++++|||++|++|
T Consensus 415 ~~~~~~~~~~e~~~~~~~g~~~~~~~~~~p~~d~~g~~~~~~~~~~DITerk~~E 469 (807)
T PRK13560 415 IKGGKIFDGQEVLIEREDDGPADCSAYAEPLHDADGNIIGAIALLVDITERKQVE 469 (807)
T ss_pred HhcCCcccCceEEEEcCCCCeEEEEEEEeeeECCCCCEEEEEEEeehhhhHHHHH
Confidence 4555543 35788889999999999999999999999999999999999999854
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-26 Score=260.60 Aligned_cols=226 Identities=27% Similarity=0.366 Sum_probs=174.0
Q ss_pred cccccccccCCcE-EEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEEEEE
Q 002342 671 FRPIKPLGSGDTG-SVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 671 y~i~~~LG~G~~g-~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
|.-.+.+|.|+.| .||++.. .|+.||||.+-.. ......+|+..|+.- +|||||++|+.-.+..+.||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 4455678999987 5688887 7889999987543 335677899999998 5999999999999999999999
Q ss_pred EccCCCCchhhhccC-CCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CC--cEEEEecccCccc
Q 002342 749 DYCPGGELFLLLDRQ-PTK-VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NG--HVSLTDFDLSCLT 821 (934)
Q Consensus 749 E~~~ggsL~~~l~~~-~~~-~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~--~vkl~DFG~a~~~ 821 (934)
|+| ..+|.+++... ... ....-..+.++.|++.||++||+.+||||||||.||||+. ++ .++|.|||+|+.+
T Consensus 583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999 89999999763 111 1111445678899999999999999999999999999976 33 6899999999776
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~ 900 (934)
...... ........||-+|+|||++....-..++||+||||++|+.++ |..||-.
T Consensus 662 ~~~~sS------------------------~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 662 AGGKSS------------------------FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred CCCcch------------------------hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 432211 122456679999999999999888889999999999999998 5999943
Q ss_pred CCHHHHHHHHHcCCCCCCCCC-CCCcccCCCC
Q 002342 901 KTRQKTFANILHKDLKFPSST-PSSCKAANVP 931 (934)
Q Consensus 901 ~~~~~~~~~i~~~~~~~p~~~-~~s~~~k~l~ 931 (934)
..+.-.+|+.+.+..-... ...|.|+||+
T Consensus 718 --~~~R~~NIl~~~~~L~~L~~~~d~eA~dLI 747 (903)
T KOG1027|consen 718 --SLERQANILTGNYTLVHLEPLPDCEAKDLI 747 (903)
T ss_pred --hHHhhhhhhcCccceeeeccCchHHHHHHH
Confidence 3333456777776554321 1233555553
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=223.93 Aligned_cols=226 Identities=24% Similarity=0.340 Sum_probs=191.5
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 744 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 744 (934)
+..-.|.+.++||+|+||.++++.+.-++.+||||.-... ...-.+..|....+.| ..+.|+.+|-+.+.+.+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 5567899999999999999999999999999999975432 3345567788888888 579999999888899999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-----cEEEEecccCc
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-----HVSLTDFDLSC 819 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-----~vkl~DFG~a~ 819 (934)
.||||++ |.||.+++.-. ++.|+...+..++.||+.-++|+|++.+|.|||||+|+||...+ .|.++|||+|+
T Consensus 100 iLVidLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 9999999 99999998766 45699999999999999999999999999999999999996433 58899999997
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
...+.... ..-+.+...+..||..||+-..+.+...+.+.|+-|||-++++++.|..||.
T Consensus 178 ~YrDp~Tk--------------------qHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQ 237 (449)
T KOG1165|consen 178 EYRDPKTK--------------------QHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 237 (449)
T ss_pred hhcCcccc--------------------ccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccc
Confidence 75432211 1335566778899999999999999999999999999999999999999998
Q ss_pred C---CCHHHHHHHHHcCCCCCC
Q 002342 900 G---KTRQKTFANILHKDLKFP 918 (934)
Q Consensus 900 ~---~~~~~~~~~i~~~~~~~p 918 (934)
| .+..+.+++|=..+-.-|
T Consensus 238 GLKA~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 238 GLKADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred cccCcchHHHHHHhccccccCC
Confidence 7 566778888866554433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=239.13 Aligned_cols=223 Identities=24% Similarity=0.356 Sum_probs=170.7
Q ss_pred cCCcccccccccCCcEEEEEEEEec---CCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCe
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 743 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~---~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 743 (934)
...|.++++||.|.|++||++.+.. .++.||+|.+... +...++.+|+++|..+ .+.||+.+.+.+..+++
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----cCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3579999999999999999999987 7889999987653 2345688999999999 69999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-CCcEEEEecccCcccC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTS 822 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-~~~vkl~DFG~a~~~~ 822 (934)
+++||||++..+..++... ++...++.+++.++.||.++|++|||||||||+|+|++. .++-.|+|||+|....
T Consensus 110 v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred eEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 9999999999998888754 788999999999999999999999999999999999975 5788999999997211
Q ss_pred CCC------C----CCCC-cch-hhhccccCCCCcc-ccc----ccccccccccCCCCccchhhhcCC-CCCchhHHHHH
Q 002342 823 CKP------Q----LLLP-TTN-EKKRRHKGQQNPV-FMA----EPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWAL 884 (934)
Q Consensus 823 ~~~------~----~~~~-~~~-~~~~~~~~~~~~~-~~~----~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSl 884 (934)
... . ...+ .+. .......+...+. +.. .+-.......||++|.|||++... ..++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 000 0 0000 000 0000000000000 000 011222345799999999999764 55789999999
Q ss_pred HHHHHHHHhCCCCCCC
Q 002342 885 GILLYEMLYGYTPFRG 900 (934)
Q Consensus 885 G~iL~elltG~~Pf~~ 900 (934)
|++++.++++..||-.
T Consensus 265 GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFK 280 (418)
T ss_pred cceeehhhcccccccc
Confidence 9999999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-23 Score=228.56 Aligned_cols=213 Identities=25% Similarity=0.296 Sum_probs=173.2
Q ss_pred CcccccccccCCcEEEEEEEEecCC-eEEEEEEeecccccChHHHHHHHHHHHHHHhCC----CCCccceeEEE-EeCCe
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSG-QYFAMKAMDKGVMLNRNKVHRACAEREILDMLD----HPFVPALYASF-QTKTH 743 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~-~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~----hp~Iv~l~~~~-~~~~~ 743 (934)
+|++.+.||+|+||.||+|.+..++ ..+|+|+........ ...+..|..++..+. .+++..+++.+ ..+.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999997774 789999877532111 115777899988886 36999999999 58889
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-----CcEEEEecccC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-----GHVSLTDFDLS 818 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-----~~vkl~DFG~a 818 (934)
.||||+.+ |.+|.++......+.|+...+..++.|++.+|++||+.|++||||||+|+++... ..+.|+|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 9999999876666789999999999999999999999999999999999999865 36899999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
+........ +.. ...+-.....+.||..|+++.++.+...+.+.|+||++.++.+|+.|..||
T Consensus 175 r~~~~~~~~-------------~~~----~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW 237 (322)
T KOG1164|consen 175 RRFKYVGDS-------------GGN----LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPW 237 (322)
T ss_pred ccccccCCC-------------Ccc----cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCC
Confidence 732211100 000 000001124567999999999999999999999999999999999999999
Q ss_pred CCCCH
Q 002342 899 RGKTR 903 (934)
Q Consensus 899 ~~~~~ 903 (934)
.+...
T Consensus 238 ~~~~~ 242 (322)
T KOG1164|consen 238 EALEM 242 (322)
T ss_pred ccccc
Confidence 87654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-22 Score=207.48 Aligned_cols=185 Identities=39% Similarity=0.655 Sum_probs=159.5
Q ss_pred cccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccCCCCc
Q 002342 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 756 (934)
Q Consensus 677 LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL 756 (934)
||.|++|.||++.+..+++.+++|++....... ....+.+|+.+++.+.|++|+++++++......+++|||+.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987643211 346788999999999999999999999999999999999998999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-CCcEEEEecccCcccCCCCCCCCCcchhh
Q 002342 757 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835 (934)
Q Consensus 757 ~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-~~~vkl~DFG~a~~~~~~~~~~~~~~~~~ 835 (934)
.+++.... ..++...+..++.+++.+|.|||++|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 79 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--------- 148 (215)
T cd00180 79 KDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--------- 148 (215)
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---------
Confidence 99987642 35899999999999999999999999999999999999999 89999999999854321110
Q ss_pred hccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHH
Q 002342 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEM 891 (934)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~el 891 (934)
......+...|++||.+... .++.+.|+|+||+++++|
T Consensus 149 ------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 149 ------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 12234578899999999887 788899999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=229.47 Aligned_cols=175 Identities=21% Similarity=0.191 Sum_probs=131.8
Q ss_pred cccCCcccccccccCCcEEEEEEEEec-CCeEEEEEEeecccc--cChHHHHHHHHHHHHHHhCCCCCccc-eeEEEEeC
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCG-SGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPA-LYASFQTK 741 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~-~~~~vAlK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~-l~~~~~~~ 741 (934)
...++|.+.+.||+|+||+||+|+++. +++.+|||.+..... ........+.+|+++|+.++|+|++. +++.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 346789999999999999999999876 688889998753311 12334566889999999999999985 4432
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC-CCCCEEEecCCcEEEEecccCcc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL-KPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDL-Kp~NILl~~~~~vkl~DFG~a~~ 820 (934)
+..|||||||+|++|... .. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 457999999999999632 11 11 1457889999999999999999999 99999999899999999999976
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG 872 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~ 872 (934)
........ .......-...++++.|+|||.+..
T Consensus 162 ~~~~~~~~-------------------~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALY-------------------RIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchh-------------------hhhhhhhhhhhhccCccCCcccCCh
Confidence 53211000 0000111136678999999999843
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=210.79 Aligned_cols=231 Identities=18% Similarity=0.192 Sum_probs=186.4
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCe-----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQ-----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 739 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~-----~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 739 (934)
.+...++++...+-+|.||.||.+.++.... .+-+|.++.+ ..+-++..+..|...|..+.|||+.++.++..
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 3455778899999999999999997765432 3445655433 24456677889999999999999999998875
Q ss_pred -eCCeEEEEEEccCCCCchhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEE
Q 002342 740 -TKTHVCLITDYCPGGELFLLLDR------QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 812 (934)
Q Consensus 740 -~~~~~~lV~E~~~ggsL~~~l~~------~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl 812 (934)
+....+.++.++.-|+|..++.. ...+.++..++..++.|++.|++|||+.|+||.||...|.+|++.-++||
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 45677889999989999999872 23356788888899999999999999999999999999999999999999
Q ss_pred EecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHH
Q 002342 813 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892 (934)
Q Consensus 813 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ell 892 (934)
+|-.+++..-+.... .......-...||+||.+....|+.++|+||||++||||+
T Consensus 438 tDsaLSRDLFP~DYh-------------------------cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELm 492 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYH-------------------------CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELM 492 (563)
T ss_pred ccchhccccCccccc-------------------------ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHH
Confidence 999998654221111 0111122466899999999999999999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCC
Q 002342 893 Y-GYTPFRGKTRQKTFANILHKD-LKFPSSTP 922 (934)
Q Consensus 893 t-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~ 922 (934)
| |+.||..-++.++...+++|. +..|.+.|
T Consensus 493 tlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCP 524 (563)
T KOG1024|consen 493 TLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCP 524 (563)
T ss_pred hcCCCCccccCHHHHHHHHhccceecCCCCCc
Confidence 7 999999999999999999876 46666554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-20 Score=204.22 Aligned_cols=222 Identities=37% Similarity=0.578 Sum_probs=181.8
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCC-CccceeEEEEeCCeEEEEEE
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP-FVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp-~Iv~l~~~~~~~~~~~lV~E 749 (934)
|.+...||.|+|+.||++.+. ..+++|.+.+...........+.+|+.++..+.|+ +++.+++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788899999999999999986 78999999876544444567888999999999988 79999999988888899999
Q ss_pred ccCCCCchhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-cEEEEecccCcccCCCCCC
Q 002342 750 YCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-~vkl~DFG~a~~~~~~~~~ 827 (934)
|+.+++|.+++..... ..+.......++.|++.++.|+|..|++|||+||+||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999977665421 2599999999999999999999999999999999999999888 7999999998633211100
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTR- 903 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~- 903 (934)
. .........+||..|++||.+.+ ..++...|+||+|++++++++|..||.....
T Consensus 159 ~---------------------~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~ 217 (384)
T COG0515 159 S---------------------SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS 217 (384)
T ss_pred c---------------------cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 0 00013456789999999999988 5788899999999999999999999987764
Q ss_pred ---HHHHHHHHcCCCC
Q 002342 904 ---QKTFANILHKDLK 916 (934)
Q Consensus 904 ---~~~~~~i~~~~~~ 916 (934)
......+.....+
T Consensus 218 ~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 218 SATSQTLKIILELPTP 233 (384)
T ss_pred ccHHHHHHHHHhcCCc
Confidence 4556555554443
|
|
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.3e-20 Score=231.89 Aligned_cols=241 Identities=20% Similarity=0.315 Sum_probs=198.2
Q ss_pred chHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCC----
Q 002342 186 RVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ---- 261 (934)
Q Consensus 186 ~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~---- 261 (934)
..+..+..+++.++++++++|. +|+|+++|++|++++||+.+|++|+++..+.+++........+......+.
T Consensus 9 ~~~~~~~~~le~~~~~i~~~d~---~g~i~~~N~~~~~l~G~s~eeliG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (799)
T PRK11359 9 AADGIFFPALEQNMMGAVLINE---NDEVLFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVE 85 (799)
T ss_pred hhhhhHHHHHHhhcCcEEEEcC---CCeEEEEcHHHHHHhCCCHHHHcCCCHHHhcCccccccchHHHhhhhccCCcccc
Confidence 4456778899999999999998 777999999999999999999999998877777665544455555444433
Q ss_pred cEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhhcCCCCCchhhhHHHHHHHHHhHHHHHH
Q 002342 262 SYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTE 341 (934)
Q Consensus 262 ~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~~~~~~l~~~l~~~~~~~~~~~~~~~~~ 341 (934)
.+..+++.+++||+.+|+.++..++. .+|. .+++++.+|||++++.+++++.
T Consensus 86 ~~~~e~~~~~~dG~~~~v~~~~~~~~-~~g~-~~~~~~~~DiT~~~~~~~~~~~-------------------------- 137 (799)
T PRK11359 86 GMSRELQLEKKDGSKIWTRFALSKVS-AEGK-VYYLALVRDASVEMAQKEQTRQ-------------------------- 137 (799)
T ss_pred ccceeeEEecCCcCEEEEEEEeeeec-cCCc-eEEEEEEeeccchhhhHHHHHH--------------------------
Confidence 24457888899999999999998873 4455 5678999999987766554331
Q ss_pred HHHHccCCCCcccCCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCCcccccccccccchhccccccccccc
Q 002342 342 LVQAMKKPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFM 421 (934)
Q Consensus 342 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (934)
T Consensus 138 -------------------------------------------------------------------------------- 137 (799)
T PRK11359 138 -------------------------------------------------------------------------------- 137 (799)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccccCCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhhcccHHHHHHhccccEEEEcCCCCCCCEEEcc
Q 002342 422 GLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFAS 501 (934)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dv~~r~~~e~~l~~~~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN 501 (934)
+..+++.++++++++|.+|. ++++|
T Consensus 138 ----------------------------------------------------~~~~~~~~~~~i~~~d~~g~---i~~~N 162 (799)
T PRK11359 138 ----------------------------------------------------LIIAVDHLDRPVIVLDPERR---IVQCN 162 (799)
T ss_pred ----------------------------------------------------HHHHHhcCCCcEEEEcCCCc---EEEEC
Confidence 45678889999999999888 99999
Q ss_pred HHHHHHcCCChhhhcCCCCcccCC-CCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEE
Q 002342 502 DSFLELTEYSREEILGRNCRFLQG-PETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFI 580 (934)
Q Consensus 502 ~a~~~l~Gys~eEliG~~~~~l~~-~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~v 580 (934)
+++++++||+.++++|++...+.+ +.........+...+..+..+..+.+..+++|..+|+.++..|+.+.+|.+.+++
T Consensus 163 ~~~~~l~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~v~d~~g~~~~~~ 242 (799)
T PRK11359 163 RAFTEMFGYCISEASGMQPDTLLNIPEFPADNRIRLQQLLWKTARDQDEFLLLTRTGEKIWIKASISPVYDVLAHLQNLV 242 (799)
T ss_pred hhhHhhhCCCHHHHCCCChHHhcCCCCCcHHHHHHHHHhhccCCCCcceeEEeCCCCCEEEEEeeeeeeecCCCceeEEE
Confidence 999999999999999998766654 4555555666677777777778888899999999999999999999999999999
Q ss_pred EEEEcCCccccc
Q 002342 581 GVQLDGSEHLEP 592 (934)
Q Consensus 581 gi~rDITerk~~ 592 (934)
++.+|||++|++
T Consensus 243 ~~~~DITerk~~ 254 (799)
T PRK11359 243 MTFSDITEERQI 254 (799)
T ss_pred EEeehhhhHHHH
Confidence 999999999875
|
|
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=228.14 Aligned_cols=275 Identities=19% Similarity=0.281 Sum_probs=203.5
Q ss_pred HHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEE
Q 002342 188 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 267 (934)
Q Consensus 188 ~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 267 (934)
.+.|+.++++++++++++|. +|+++|+|++|++++||++++++|++...+.++.........+...+..+..+..++
T Consensus 3 ~~~~~~i~~~~~~~i~~~d~---~g~~~~~N~~~~~~~G~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (494)
T TIGR02938 3 PEAYRQTVDQAPLAISITDL---KANILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKL 79 (494)
T ss_pred hHHHHHHHHhCCceEEEECC---CCcEEEEchhheeecCCCHHHHhCCCchhhcCCCCCHHHHHHHHHHHHhCCccccee
Confidence 46899999999999999998 677999999999999999999999987766666666666777778888888888888
Q ss_pred EEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhhcCCCCCchhhhHHHHHHHHHhHHHHHHHHHHcc
Q 002342 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMK 347 (934)
Q Consensus 268 ~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~~~~~~l~~~l~~~~~~~~~~~~~~~~~l~~~~~ 347 (934)
..++++|..+|+..++.|+++.+|.+.+++++++|||++++++++|+..
T Consensus 80 ~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIt~~k~~e~~l~~~------------------------------- 128 (494)
T TIGR02938 80 LNRRKDGELYLAELTVAPVLNEAGETTHFLGMHRDITELHRLEQVVANQ------------------------------- 128 (494)
T ss_pred eccCCCccchhhheeeEEEECCCCCEEEEEEehhhhhHHHHHHHHHHHH-------------------------------
Confidence 8889999999999999999999999999999999999999998876610
Q ss_pred CCCCcccCCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCCcccccccccccchhccccccccccccccccc
Q 002342 348 KPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRK 427 (934)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (934)
T Consensus 129 -------------------------------------------------------------------------------- 128 (494)
T TIGR02938 129 -------------------------------------------------------------------------------- 128 (494)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhhcccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHH
Q 002342 428 SQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLEL 507 (934)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dv~~r~~~e~~l~~~~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l 507 (934)
...++.++++++++++++|.+|. ++++|++|+++
T Consensus 129 -------------------------------------------~~~~~~~~~~~~~~i~~~d~~~~---i~~~N~~~~~~ 162 (494)
T TIGR02938 129 -------------------------------------------KLLIESVVDAAPVAFVLLDPTGR---VILDNQEYKKL 162 (494)
T ss_pred -------------------------------------------HHHHHHHHhcccceEEEEcCCCC---EEEechhHHHh
Confidence 01178899999999999999888 99999999999
Q ss_pred cCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcE-EEEEEEEecCCc-EEEEEEEEEeeecCCCCE---------
Q 002342 508 TEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDV-TVQLINYTKSGK-KFWNLFHLQPMRDQKGEV--------- 576 (934)
Q Consensus 508 ~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~-~~e~~~~~kdG~-~~wv~~~~~pi~de~G~v--------- 576 (934)
+|+...+..+..+..+.+++..... ......+..+ ..+......+|. .+|+.....++.+..|..
T Consensus 163 ~g~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (494)
T TIGR02938 163 ATDLRVKEPAHTVLDLLREAWREAL----AENWPQQLAFSNREARFDRGGGRPARWLSCTGSVIGMESDCADSFFCAAEQ 238 (494)
T ss_pred hchhhhhHHHHHHHHHhhHHhhhhh----hhcchhhhccccceeeeccCCCceeeEEEecCceEEeecchhhheeccCCC
Confidence 9999888777654444443332221 1111111121 223444455555 789998888887766653
Q ss_pred EEEEEEEEcCCccccccccCCchhh--HHHHHHHHHHhhhhhhhhcccCCCC
Q 002342 577 QYFIGVQLDGSEHLEPLRNSIPEAT--AEESEKLVKQTAENVNEAVKELPDA 626 (934)
Q Consensus 577 ~~~vgi~rDITerk~~e~~~~~~~~--~~e~~~~vk~~~~~v~~~~~eL~~~ 626 (934)
.+++++++|||++|++|.+.+..+. ..+.....+.+.+.+....+++..+
T Consensus 239 ~~~~~~~~DITe~k~~ee~l~~~al~~~~~~~~~~~~l~~~~~~~~h~lr~p 290 (494)
T TIGR02938 239 PYLLLTIADISNLREEQERARLSALQALMAEEERLEAIRETLSAAIHRLQGP 290 (494)
T ss_pred chheehHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcH
Confidence 3456788999999987554332211 1122233344445555555665443
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.4e-23 Score=229.78 Aligned_cols=213 Identities=43% Similarity=0.697 Sum_probs=183.5
Q ss_pred ccccCCcEEEEEEEEe---cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCCeEEEEEEcc
Q 002342 676 PLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLITDYC 751 (934)
Q Consensus 676 ~LG~G~~g~Vy~a~~~---~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lV~E~~ 751 (934)
.+|.|+||.|++++.. ..+..||+|++++......... ....|..++..++ ||+++.++..|+.+...+++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 3799999999998763 4578899999988766655555 6677889999886 999999999999999999999999
Q ss_pred CCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCc
Q 002342 752 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831 (934)
Q Consensus 752 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 831 (934)
.||.|...+... ..+.+...+.+...++.+++++|+.||+|||+|++||+++.+|++++.|||+++....
T Consensus 80 rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~-------- 149 (612)
T KOG0603|consen 80 RGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK-------- 149 (612)
T ss_pred ccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh--------
Confidence 999999888764 5699999999999999999999999999999999999999999999999999865321
Q ss_pred chhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 002342 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANIL 911 (934)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~ 911 (934)
....|||..|||||++. .+...+|+||||++.|+|++|..||.+ ++..+|+
T Consensus 150 -----------------------~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il 200 (612)
T KOG0603|consen 150 -----------------------EKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL 200 (612)
T ss_pred -----------------------hhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh
Confidence 01128999999999998 677889999999999999999999987 8899999
Q ss_pred cCCCCCCCCCCCCcccCCC
Q 002342 912 HKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 912 ~~~~~~p~~~~~s~~~k~l 930 (934)
...+.+|... +..++++
T Consensus 201 ~~~~~~p~~l--~~~a~~~ 217 (612)
T KOG0603|consen 201 KAELEMPREL--SAEARSL 217 (612)
T ss_pred hhccCCchhh--hHHHHHH
Confidence 9899888764 4444443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-21 Score=199.69 Aligned_cols=174 Identities=17% Similarity=0.142 Sum_probs=135.9
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHH------HHHHHHHHHhCCCCCccceeEEEEe
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR------ACAEREILDMLDHPFVPALYASFQT 740 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~------~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (934)
-.++|.+++.||.|+||.||++.+ ++..+|+|++............. +.+|+..+.++.||+|+.+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 357999999999999999999765 46689999998765544444444 5789999999999999999988764
Q ss_pred C--------CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEE
Q 002342 741 K--------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 812 (934)
Q Consensus 741 ~--------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl 812 (934)
. +..+|+|||++|.+|.++.. +++ ....+++.+|..||+.|++|||+||+||+++.+| ++|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence 3 35789999999999987731 333 2456999999999999999999999999999888 999
Q ss_pred EecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHH
Q 002342 813 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892 (934)
Q Consensus 813 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ell 892 (934)
+|||.+.....+. ...-.+....|..++|+||||+++..+.
T Consensus 176 iDfg~~~~~~e~~---------------------------------------a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRK---------------------------------------AKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchh---------------------------------------hHHHHHHHhHhcccccccceeEeehHHH
Confidence 9999874321100 0011344455667899999999987654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-21 Score=242.15 Aligned_cols=168 Identities=19% Similarity=0.256 Sum_probs=122.1
Q ss_pred hCCC-CCccceeEEEE-------eCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q 002342 725 MLDH-PFVPALYASFQ-------TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796 (934)
Q Consensus 725 ~l~h-p~Iv~l~~~~~-------~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrD 796 (934)
.+.| +||+.++++|. ....++++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 3445 57778888772 334678889988 77999999653 35599999999999999999999999999999
Q ss_pred CCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcc------------cc-ccc-ccccccccCCC
Q 002342 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV------------FM-AEP-MRASNSFVGTE 862 (934)
Q Consensus 797 LKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~-~~~-~~~~~~~~Gt~ 862 (934)
|||+||||+..|.+|++|||++........... +-.+.|..... .. ..+ .......+||+
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~------ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATT------KSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcc------cccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 999999998888888888887754322111000 00000000000 00 000 01112357899
Q ss_pred CccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 863 EYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 863 ~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.|||||++.+..|+.++|||||||+||||++|.+||..
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 99999999999999999999999999999999999864
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=192.85 Aligned_cols=141 Identities=16% Similarity=0.173 Sum_probs=109.9
Q ss_pred ccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHH-----------------------HHHHHHHHHHHHhCCCCC
Q 002342 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-----------------------VHRACAEREILDMLDHPF 730 (934)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~-----------------------~~~~~~E~~il~~l~hp~ 730 (934)
...||+|+||.||+|.+. +|+.||+|++++........ .....+|+++|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999996 89999999998653211110 112345999999998887
Q ss_pred ccceeEEEEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCCCEEEecCCc
Q 002342 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL-HCQGIIYRDLKPENVLLQGNGH 809 (934)
Q Consensus 731 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yL-H~~giiHrDLKp~NILl~~~~~ 809 (934)
+.....+... . .+|||||++|++|....... ..++...+..++.|++.+|.|| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec-C-CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 7544433222 2 38999999887776553332 4589999999999999999999 689999999999999998 588
Q ss_pred EEEEecccCcc
Q 002342 810 VSLTDFDLSCL 820 (934)
Q Consensus 810 vkl~DFG~a~~ 820 (934)
++|+|||+|..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999999853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-19 Score=184.37 Aligned_cols=143 Identities=17% Similarity=0.143 Sum_probs=112.1
Q ss_pred cccccccCCcEEEEEEEEecCCeEEEEEEeecccccChH-----------------------HHHHHHHHHHHHHhCCCC
Q 002342 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN-----------------------KVHRACAEREILDMLDHP 729 (934)
Q Consensus 673 i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~-----------------------~~~~~~~E~~il~~l~hp 729 (934)
+.+.||+|++|+||+|.+. +|+.||||++.+....... ....+..|...+..+.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 8999999999875321000 012235789999999999
Q ss_pred CccceeEEEEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCC
Q 002342 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNG 808 (934)
Q Consensus 730 ~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~ 808 (934)
++.....+.... .||||||++|+++....... ..++...+..++.|++.+|.+||+ +||+||||||+|||++ ++
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 885554443332 48999999887654432222 347888999999999999999999 9999999999999999 89
Q ss_pred cEEEEecccCccc
Q 002342 809 HVSLTDFDLSCLT 821 (934)
Q Consensus 809 ~vkl~DFG~a~~~ 821 (934)
.++|+|||++...
T Consensus 155 ~~~liDFG~a~~~ 167 (190)
T cd05145 155 KPYIIDVSQAVEL 167 (190)
T ss_pred CEEEEEcccceec
Confidence 9999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.7e-19 Score=180.04 Aligned_cols=203 Identities=20% Similarity=0.196 Sum_probs=143.1
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEeecccccCh-HHHHHHHHHHHHHHhCC-CCCccceeEEEEeCCeEEEEE
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-NKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~-~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
+.+...|++|+||+||++.. .+.+++.+.+........ -....+.+|+++|++|. |++|+.++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34567899999999998776 677788776654322111 11235788999999995 5889999886 4569999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC-CCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL-KPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDL-Kp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 78 eyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 78 SYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99999998754321 1 1346789999999999999999999 799999999999999999999643321100
Q ss_pred CCCcchhh-hccccCCCCcccccccccccccccCCCCccchhhhcCC-CCC-chhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 828 LLPTTNEK-KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHT-SAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 828 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s-~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
. .. ..++ ..... ..-...++.|+.|+...-- ..+ ...++++.|+-+|.++|+..|+++++.
T Consensus 149 ~-----r~L~~rD---------l~~ll-k~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 149 M-----RLLARED---------LRHLL-KHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred H-----HHHHHHH---------HHHHH-HHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 00 0000 00000 0011367889999876332 233 578999999999999999999987653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-20 Score=217.87 Aligned_cols=208 Identities=37% Similarity=0.611 Sum_probs=155.1
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
.+|..++.|..|+||-||+++++.+.+.||+|+ +++.+ +.+ +||....+|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l--------ilR--nilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL--------ILR--NILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccch--------hhh--ccccccCCccee----------------
Confidence 579999999999999999999999999999964 33221 111 166666777776
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
|+-...++..+ .++. +++.+++|||+.||+|||+||+|++|+.-|++|++|||+++...-.....
T Consensus 136 -----gDc~tllk~~g--~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -----GDCATLLKNIG--PLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -----chhhhhcccCC--CCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 33344443322 2332 33789999999999999999999999999999999999997643221111
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
...+ ..++ ....-.....||||.|.|||++...+|...+|+|++|+++|+++.|..||.|++.++.+.
T Consensus 201 l~eg-~I~k-----------~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg 268 (1205)
T KOG0606|consen 201 LKEG-HIEK-----------DTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 268 (1205)
T ss_pred hhhc-chHH-----------HHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh
Confidence 0000 0000 001122345699999999999999999999999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCC-CCCcccCCC
Q 002342 909 NILHKDLKFPSST-PSSCKAANV 930 (934)
Q Consensus 909 ~i~~~~~~~p~~~-~~s~~~k~l 930 (934)
.++.....||... ...++++||
T Consensus 269 ~visd~i~wpE~dea~p~Ea~dl 291 (1205)
T KOG0606|consen 269 QVISDDIEWPEEDEALPPEAQDL 291 (1205)
T ss_pred hhhhhhccccccCcCCCHHHHHH
Confidence 9999999999764 334444443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.3e-20 Score=219.98 Aligned_cols=211 Identities=27% Similarity=0.432 Sum_probs=167.8
Q ss_pred CCc-ccccccccCCcEEEEEEEEecCCeEEEEEEeec---ccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 669 QHF-RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDK---GVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 669 ~~y-~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~---~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
..| .....+|.|++|.|+.+........++.|.+.. ...........+..|..+-..+.|||++..+..+......
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 344 456678999999999998887777777776542 1122222333366788888889999998877777665555
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
+-.||||++ +|+.++... ..++...+..+++|++.||+|||..||.||||||+|++++.+|.+||+|||.+..+...
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 555999988 999999775 34888999999999999999999999999999999999999999999999998654321
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~-~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
. .........++|+-.|+|||++.+..|++ .+||||.|++++.|++|+.||.....
T Consensus 474 ~-----------------------e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~ 530 (601)
T KOG0590|consen 474 W-----------------------EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKK 530 (601)
T ss_pred c-----------------------chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccc
Confidence 1 11224456779999999999999999976 79999999999999999999986555
Q ss_pred HH
Q 002342 904 QK 905 (934)
Q Consensus 904 ~~ 905 (934)
.+
T Consensus 531 ~~ 532 (601)
T KOG0590|consen 531 SD 532 (601)
T ss_pred cc
Confidence 43
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7e-19 Score=212.02 Aligned_cols=199 Identities=24% Similarity=0.342 Sum_probs=161.3
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC---CCCccceeEEEEe
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD---HPFVPALYASFQT 740 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~ 740 (934)
..+....|.|-+.||.|+||+||+|.+.. |+.||||+-+.....+ +.--.+++.+|+ -+.|+.+...+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 45667899999999999999999999966 9999999877654322 222334444444 2445566666667
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-------CCcEEEE
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-------NGHVSLT 813 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-------~~~vkl~ 813 (934)
.+..+||+||.+-|+|.+++.. .+.+++..+.++..|||..|+.||..+|||+||||+|+||.. ..-++|+
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 7788999999999999999974 567999999999999999999999999999999999999952 3358999
Q ss_pred ecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh
Q 002342 814 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 893 (934)
Q Consensus 814 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt 893 (934)
|||.+..+.. ..+.......++|-.|-++|+..|..|++.+|.|.|+.+++.|+.
T Consensus 844 DfG~siDm~l-------------------------fp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLF 898 (974)
T KOG1166|consen 844 DFGRSIDMKL-------------------------FPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLF 898 (974)
T ss_pred ecccceeeeE-------------------------cCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHH
Confidence 9999865431 112234456688999999999999999999999999999999999
Q ss_pred CCC
Q 002342 894 GYT 896 (934)
Q Consensus 894 G~~ 896 (934)
|+.
T Consensus 899 G~y 901 (974)
T KOG1166|consen 899 GKY 901 (974)
T ss_pred HHH
Confidence 864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-18 Score=175.37 Aligned_cols=119 Identities=26% Similarity=0.342 Sum_probs=99.3
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcch
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 833 (934)
|+|.+++... ...+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~---------- 61 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP---------- 61 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc----------
Confidence 6888988754 345999999999999999999999998 999999999999999 998854321
Q ss_pred hhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHc
Q 002342 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR-QKTFANILH 912 (934)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~-~~~~~~i~~ 912 (934)
....||+.|||||++.+..++.++|||||||++|+|++|++||..... ...+..+..
T Consensus 62 ----------------------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 119 (176)
T smart00750 62 ----------------------EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN 119 (176)
T ss_pred ----------------------ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH
Confidence 112589999999999999999999999999999999999999976544 344555544
Q ss_pred C
Q 002342 913 K 913 (934)
Q Consensus 913 ~ 913 (934)
+
T Consensus 120 ~ 120 (176)
T smart00750 120 G 120 (176)
T ss_pred H
Confidence 3
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.3e-18 Score=175.64 Aligned_cols=135 Identities=22% Similarity=0.226 Sum_probs=106.9
Q ss_pred cccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-----CCCCccceeEEEEeCC---eE
Q 002342 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-----DHPFVPALYASFQTKT---HV 744 (934)
Q Consensus 673 i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~~~~~---~~ 744 (934)
-...||+|+||.||. ++.++.. +||++.... ....+.+.+|+.+++.+ +||||++++++++++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 346799999999995 7777666 699886532 22346789999999999 6799999999999863 44
Q ss_pred E-EEEEc--cCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHH-HHHHHCCCeecCCCCCCEEEec----CCcEEEEecc
Q 002342 745 C-LITDY--CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL-EYLHCQGIIYRDLKPENVLLQG----NGHVSLTDFD 816 (934)
Q Consensus 745 ~-lV~E~--~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL-~yLH~~giiHrDLKp~NILl~~----~~~vkl~DFG 816 (934)
+ +|||| +.+++|.+++... .+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 4 78999 5579999999653 26666 35578888887 9999999999999999999974 3379999954
Q ss_pred cC
Q 002342 817 LS 818 (934)
Q Consensus 817 ~a 818 (934)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=175.56 Aligned_cols=144 Identities=20% Similarity=0.148 Sum_probs=113.3
Q ss_pred CcccccccccCCcEEEEEEE-EecCCeEEEEEEeecccccC-------------------hH--HHHHHHHHHHHHHhCC
Q 002342 670 HFRPIKPLGSGDTGSVHLVE-LCGSGQYFAMKAMDKGVMLN-------------------RN--KVHRACAEREILDMLD 727 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~-~~~~~~~vAlK~~~~~~~~~-------------------~~--~~~~~~~E~~il~~l~ 727 (934)
.|.+.+.||.|+||.||+|. +..+|+.||+|++....... .. ....+..|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58999999999999999999 66789999999987542110 00 1123568999999997
Q ss_pred CC--CccceeEEEEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCCCCEEE
Q 002342 728 HP--FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG-IIYRDLKPENVLL 804 (934)
Q Consensus 728 hp--~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~g-iiHrDLKp~NILl 804 (934)
+. .++.++++ ...+|||||++|.+|....... ..+....+..++.||+.+|.+||+.| |+||||||+||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 53 34444432 2348999999888887665332 33666777899999999999999999 9999999999999
Q ss_pred ecCCcEEEEecccCcc
Q 002342 805 QGNGHVSLTDFDLSCL 820 (934)
Q Consensus 805 ~~~~~vkl~DFG~a~~ 820 (934)
+ ++.++|+|||.+..
T Consensus 183 ~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 183 H-DGKVVIIDVSQSVE 197 (237)
T ss_pred E-CCCEEEEEChhhhc
Confidence 9 88999999999854
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-18 Score=203.46 Aligned_cols=201 Identities=23% Similarity=0.288 Sum_probs=156.2
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeeccc-ccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~-~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
+|...+.||++.|=+|.++++.+ | .|++|++-+.. ........+...|++ ...+++||++.+......+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 68899999999999999999833 4 48999987653 222233334444555 56679999999988888888889999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
+|. .-+|+|.+..++ .+..-+.+.|+.||+.||..+|..||+|||||.+||||++-+.+.|+||..-+...-
T Consensus 101 qyv-khnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL----- 172 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYL----- 172 (1431)
T ss_pred HHH-hhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccC-----
Confidence 999 789999998764 488999999999999999999999999999999999999999999999987532211
Q ss_pred CCcchhhhccccCCCCc---ccccccccccccccCCCCccchhhhcCCC-----------CCchhHHHHHHHHHHHHHh-
Q 002342 829 LPTTNEKKRRHKGQQNP---VFMAEPMRASNSFVGTEEYIAPEIIAGAG-----------HTSAVDWWALGILLYEMLY- 893 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-----------~s~~~DiwSlG~iL~ellt- 893 (934)
+.++| .++.+.+ .--.+|+|||.+.... .+++.||||+||++.||++
T Consensus 173 ------------PeDNPadf~fFFDTS------rRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~E 234 (1431)
T KOG1240|consen 173 ------------PEDNPADFTFFFDTS------RRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLE 234 (1431)
T ss_pred ------------CCCCcccceEEEecC------CceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhc
Confidence 11111 1222222 2234899999985422 4678999999999999997
Q ss_pred CCCCCC
Q 002342 894 GYTPFR 899 (934)
Q Consensus 894 G~~Pf~ 899 (934)
|+|||.
T Consensus 235 g~PlF~ 240 (1431)
T KOG1240|consen 235 GRPLFT 240 (1431)
T ss_pred CCCccc
Confidence 899994
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.5e-17 Score=168.63 Aligned_cols=138 Identities=21% Similarity=0.236 Sum_probs=114.8
Q ss_pred ccccccCCcEEEEEEEEecCCeEEEEEEeecccccCh-----HHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-----NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~-----~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++.||+|++|.||++.+ ++..+++|.......... .....+.+|+.++..+.|++|+....++...+..+++|
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 35789999999999987 677899998654322211 12345778999999999999888777777778889999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
||++|++|.+++.... . ....++.+++.+|.+||+.|++|+|++|+|||++ ++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999986431 1 7788899999999999999999999999999999 88999999999854
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.4e-17 Score=176.36 Aligned_cols=201 Identities=23% Similarity=0.282 Sum_probs=132.6
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC----------CCCccceeEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD----------HPFVPALYASFQ 739 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~----------hp~Iv~l~~~~~ 739 (934)
.+.....||.|+++.||.|.+..+|+.+|+|++.-.........+.+.+|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4567788999999999999999999999999987554444556677777665544432 223333333332
Q ss_pred e---------C---C-----eEEEEEEccCCCCchhhhcc---CCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 002342 740 T---------K---T-----HVCLITDYCPGGELFLLLDR---QPT--KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 797 (934)
Q Consensus 740 ~---------~---~-----~~~lV~E~~~ggsL~~~l~~---~~~--~~l~~~~~~~i~~qil~aL~yLH~~giiHrDL 797 (934)
- . . ..+++|+-+ .++|.+++.. ... ..+.......+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 1 1 236788887 7888877542 111 11222333445589999999999999999999
Q ss_pred CCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC----
Q 002342 798 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA---- 873 (934)
Q Consensus 798 Kp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~---- 873 (934)
+|+|++++.+|.++|+||+.....+.. ......+..|.+||.....
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~------------------------------~~~~~~~~~~~PPe~~~~~~~~~ 221 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR------------------------------YRCSEFPVAFTPPELESCAGQFG 221 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE------------------------------EEGGGS-TTTS-HHHHHHHTSCH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce------------------------------eeccCCCcccCChhhhhhhcccC
Confidence 999999999999999999876432110 0001245789999988442
Q ss_pred ----CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 874 ----GHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 874 ----~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
.++.+.|.|+||++||.|++|..||...
T Consensus 222 ~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~ 253 (288)
T PF14531_consen 222 QNNAPYTFATDAWQLGITLYSLWCGRLPFGLS 253 (288)
T ss_dssp HSEEEE-HHHHHHHHHHHHHHHHHSS-STCCC
T ss_pred cccceeeeccCHHHHHHHHHHHHHccCCCCCC
Confidence 4678999999999999999999999743
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.7e-16 Score=161.80 Aligned_cols=133 Identities=18% Similarity=0.197 Sum_probs=107.9
Q ss_pred ccccCCcEEEEEEEEecCCeEEEEEEeecccccC-----hHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEc
Q 002342 676 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-----RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (934)
Q Consensus 676 ~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~-----~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 750 (934)
.||+|+||.||++.. ++..+++|......... ......+.+|++++..+.|+++....-++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999985 67889999865432211 11235677899999999988766555556666778999999
Q ss_pred cCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
++|++|.+++.... . .++.+++.+|.+||+.|++|+|++|+||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998875421 1 7789999999999999999999999999999 89999999999854
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2e-17 Score=167.59 Aligned_cols=224 Identities=18% Similarity=0.283 Sum_probs=175.5
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
++.....++.+|...-.|..|+++++++ .++.|++.... ......+.|..|.-.|+.+.||||+.+++.+....++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~-~t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVRE-VTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhh-cchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 4556778888999999999999999554 56677776432 23445567888888999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEecCCcEEE--EecccCccc
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSL--TDFDLSCLT 821 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~~~~vkl--~DFG~a~~~ 821 (934)
++..||+-|+|+.+++.+.+...+..++..++.+|+.|++|||+.. |.---|....|+|+.+.+.+| +|--++..
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq- 342 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ- 342 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-
Confidence 9999999999999999987777888999999999999999999983 344468888999998877655 34333311
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCc---hhHHHHHHHHHHHHHhCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS---AVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~---~~DiwSlG~iL~elltG~~Pf 898 (934)
.....-.|.||+||.+..++-+. ++|+|||.++||||.|...||
T Consensus 343 ---------------------------------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf 389 (448)
T KOG0195|consen 343 ---------------------------------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF 389 (448)
T ss_pred ---------------------------------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc
Confidence 01123578999999998876543 899999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 002342 899 RGKTRQKTFANILHKDLKFPSSTPSSCK 926 (934)
Q Consensus 899 ~~~~~~~~~~~i~~~~~~~p~~~~~s~~ 926 (934)
...++.+.-.+|.-..+.....+.+|..
T Consensus 390 adlspmecgmkialeglrv~ippgis~h 417 (448)
T KOG0195|consen 390 ADLSPMECGMKIALEGLRVHIPPGISRH 417 (448)
T ss_pred ccCCchhhhhhhhhccccccCCCCccHH
Confidence 9999998877775444433333334443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=6e-16 Score=160.25 Aligned_cols=139 Identities=21% Similarity=0.152 Sum_probs=108.6
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccCh-------------------HHHHHHHHHHHHHHhCCCC-
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-------------------NKVHRACAEREILDMLDHP- 729 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~-------------------~~~~~~~~E~~il~~l~hp- 729 (934)
.|.+.+.||.|+||.||++... +|+.||||++........ ........|..++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888899999999999999874 799999998765321000 0112356788899998777
Q ss_pred -CccceeEEEEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC
Q 002342 730 -FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 808 (934)
Q Consensus 730 -~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~ 808 (934)
.++.+++ ....++||||++|++|..+... .....++.+++.++.++|+.||+||||||+||+++.++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 4444443 2456899999999998765421 34567889999999999999999999999999999999
Q ss_pred cEEEEecccCccc
Q 002342 809 HVSLTDFDLSCLT 821 (934)
Q Consensus 809 ~vkl~DFG~a~~~ 821 (934)
.++|+|||++...
T Consensus 163 ~~~liDfg~~~~~ 175 (198)
T cd05144 163 KIYIIDWPQMVST 175 (198)
T ss_pred cEEEEECCccccC
Confidence 9999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.5e-15 Score=180.94 Aligned_cols=139 Identities=21% Similarity=0.226 Sum_probs=112.2
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeeccccc-----ChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-----NRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
..|...+.||+|+||.||++.+... .+++|........ .......+.+|+++++.++|++++..+.++.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 4567788999999999999987444 3444443222111 11234567899999999999999888777777778
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
.++||||++|++|.+++. ....++.+++.+|.|||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999998874 346789999999999999999999999999999 578999999999955
|
|
| >PF13426 PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_B 3P7N_B 1LL8_A 3MJQ_A 3BWL_A 4EET_B 4EEP_A | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.1e-15 Score=135.79 Aligned_cols=104 Identities=26% Similarity=0.564 Sum_probs=96.0
Q ss_pred cCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEEE
Q 002342 199 QQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFW 278 (934)
Q Consensus 199 ~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w 278 (934)
|++++++|. +|+|+++|++|++++||++++++|+++..++++.........+.+.+..+..+..++..++++|+.+|
T Consensus 1 p~~i~i~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~ 77 (104)
T PF13426_consen 1 PDGIFILDP---DGRILYVNPAFERLFGYSREELIGKSISDFFPEEDRPEFEEQIERALEEGGSWSGEVRLRRKDGETFW 77 (104)
T ss_dssp -SEEEEEET---TSBEEEE-HHHHHHHTS-HHHHTTSBGGGGCSTTSCHHHHHHHHHHHHHTSSEEEEEEEEETTSEEEE
T ss_pred CEEEEEECC---cCcEEehhHHHHHHHCcCHHHHcCCCcccccCcccchhhHHHHHHHHhcCCceeEEEEEEcCCCCEEE
Confidence 689999999 77799999999999999999999999998888888888889999999999999999999999999999
Q ss_pred EEEEeeeeecCCCCEEEEEEEEecchh
Q 002342 279 NLLTIAPIKDDEGKVLKFIGMQVEVSK 305 (934)
Q Consensus 279 v~~s~~pi~d~~G~v~~~v~~~~DITe 305 (934)
+.++++|+.+++|++.+++++++||||
T Consensus 78 ~~~~~~~i~~~~g~~~~~i~~~~DiTe 104 (104)
T PF13426_consen 78 VEVSASPIRDEDGEITGIIGIFRDITE 104 (104)
T ss_dssp EEEEEEEEEETTSSEEEEEEEEEEEHH
T ss_pred EEEEEEEEECCCCCEEEEEEEEEECCC
Confidence 999999999999999999999999996
|
... |
| >PF13426 PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_B 3P7N_B 1LL8_A 3MJQ_A 3BWL_A 4EET_B 4EEP_A | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.7e-15 Score=134.86 Aligned_cols=104 Identities=28% Similarity=0.460 Sum_probs=96.6
Q ss_pred cccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEE
Q 002342 482 EKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFW 561 (934)
Q Consensus 482 ~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~~w 561 (934)
|+|++++|.+|. |+++|++|++++||++++++|+++..+.+++......+.+.+.+..+..+..+..+.+++|+.+|
T Consensus 1 p~~i~i~d~~g~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~ 77 (104)
T PF13426_consen 1 PDGIFILDPDGR---ILYVNPAFERLFGYSREELIGKSISDFFPEEDRPEFEEQIERALEEGGSWSGEVRLRRKDGETFW 77 (104)
T ss_dssp -SEEEEEETTSB---EEEE-HHHHHHHTS-HHHHTTSBGGGGCSTTSCHHHHHHHHHHHHHTSSEEEEEEEEETTSEEEE
T ss_pred CEEEEEECCcCc---EEehhHHHHHHHCcCHHHHcCCCcccccCcccchhhHHHHHHHHhcCCceeEEEEEEcCCCCEEE
Confidence 689999999888 99999999999999999999999999999888888889999999988889999999999999999
Q ss_pred EEEEEEeeecCCCCEEEEEEEEEcCCc
Q 002342 562 NLFHLQPMRDQKGEVQYFIGVQLDGSE 588 (934)
Q Consensus 562 v~~~~~pi~de~G~v~~~vgi~rDITe 588 (934)
+.+++.|+.+++|++.+++++++||||
T Consensus 78 ~~~~~~~i~~~~g~~~~~i~~~~DiTe 104 (104)
T PF13426_consen 78 VEVSASPIRDEDGEITGIIGIFRDITE 104 (104)
T ss_dssp EEEEEEEEEETTSSEEEEEEEEEEEHH
T ss_pred EEEEEEEEECCCCCEEEEEEEEEECCC
Confidence 999999999999999999999999996
|
... |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.4e-15 Score=152.94 Aligned_cols=139 Identities=19% Similarity=0.177 Sum_probs=100.1
Q ss_pred cccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHH---------------------HHHHHHHHHHhCCCCC-
Q 002342 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH---------------------RACAEREILDMLDHPF- 730 (934)
Q Consensus 673 i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~---------------------~~~~E~~il~~l~hp~- 730 (934)
+.+.||+|+||.||++.+. +++.||||++.+.......... ....|...+..+.+..
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3568999999999999986 7899999998764321111111 1135666666665443
Q ss_pred -ccceeEEEEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCC
Q 002342 731 -VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNG 808 (934)
Q Consensus 731 -Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~ 808 (934)
++.++++ ...++||||++++.+........ .....++.++.+++.++.++|. .||+|+||||+||+++ ++
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhh---hhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 4555543 24589999998855432211110 1116778899999999999999 9999999999999999 89
Q ss_pred cEEEEecccCcc
Q 002342 809 HVSLTDFDLSCL 820 (934)
Q Consensus 809 ~vkl~DFG~a~~ 820 (934)
.++|+|||.+..
T Consensus 152 ~~~liDfg~a~~ 163 (187)
T cd05119 152 KVYIIDVPQAVE 163 (187)
T ss_pred cEEEEECccccc
Confidence 999999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.9e-15 Score=196.43 Aligned_cols=299 Identities=11% Similarity=0.008 Sum_probs=212.6
Q ss_pred eeeeccCCCCCcceEEecccCCCCCCCCCCcccCCCCCceEEEecccccccccccccchHHHHHHHHHhccCcEEEEeCC
Q 002342 129 LVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDAT 208 (934)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~dit~~~~~e~aL~~~~~~~~~ile~~~d~i~v~D~~ 208 (934)
..++-.+..|...|+........+..|.+. +.+..+.|||++|++|++++++++.++.+++..+++++.+|.
T Consensus 357 ~e~~~~~~dG~~~~~~~~~~~~~~~~g~~~-------~~i~~~~DITerk~~e~~l~~~~~~~~~~~~~~~~~i~~~d~- 428 (1092)
T PRK09776 357 MEKRYYRRDGEVVWALLAVSLVRDTDGTPL-------YFIAQIEDINELKRTEQVNERLMERITLANEAGGIGIWEWDL- 428 (1092)
T ss_pred eeeEEEcCCCCEEEEEEEEEEEECCCCCEe-------eehhhHHhhHHHHHHHHHHHHHHHHHHHHHHhcCceEEEEec-
Confidence 344445556666666655554444443332 244455899999999999999999999999999999999998
Q ss_pred CCCCceEEcchHHHHHcCCChhhHcCCC-CCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEeeeee
Q 002342 209 KPDYPIMYASAGFFKMTGYTSKEVVGRN-CRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIK 287 (934)
Q Consensus 209 ~~dG~I~~~N~a~~~l~Gys~eEllG~~-~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~s~~pi~ 287 (934)
+|.++++|+++++++||+.++..+.. +..+.+|++.......+...+.++..+..+++.+++|| .+|+.....+++
T Consensus 429 --~~~~~~~n~~~~~l~G~~~~~~~~~~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~e~r~~~~dG-~~w~~~~~~~~~ 505 (1092)
T PRK09776 429 --KPNIISWDKRMFELYEIPPHIKPTWQVWYACLHPEDRQRVEKEIRDALQGRSPFKLEFRIVVKDG-VRHIRALANRVL 505 (1092)
T ss_pred --CCCeEeeCHHHHHHhCCCcccCCCHHHHHHhcCHhHHHHHHHHHHHHHhcCCCeeEEEEEEcCCc-eEEEEEeeEEEE
Confidence 66799999999999999998854432 22456677777777778888888889999999999999 999999999999
Q ss_pred cCCCCEEEEEEEEecchhhHHHHHHhhcCCCCCchhhhHHHHHHHHHhHHHHHHHHHH-ccCCCCcccCCCCCcccccCC
Q 002342 288 DDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQA-MKKPRSLSESTNRPPIIRKSE 366 (934)
Q Consensus 288 d~~G~v~~~v~~~~DITerk~~e~~L~~~~~~l~~~l~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~ 366 (934)
|.+|.+.+++++.+|||++|+++++|+...+ ....+..+ -......+....+.++|..++
T Consensus 506 d~~G~~~~~ig~~~DITerk~~e~~L~~~~~-------------------~l~~~l~~~~~~i~~~D~~g~i~~~N~a~~ 566 (1092)
T PRK09776 506 NKDGEVERLLGINMDMTEVRQLNEALFQEKE-------------------RLHITLDSIGEAVVCTDMAMKVTFMNPVAE 566 (1092)
T ss_pred CCCCCEEEEEeeeeehhHHHHHHHHHHHHHH-------------------HHHHHHhccccEEEEECCCCeEEEEcHHHH
Confidence 9999999999999999999999998873111 11122222 223344555667888999999
Q ss_pred CCchhhhcccccCCCCCCCCCCCCC--CCCC---Cccccc-ccccccchhcccccccccccccccccccCCCCCCCcccc
Q 002342 367 GGVEEERAGALGRRKSENVPPPRRN--SYGG---GCRTSM-QRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENE 440 (934)
Q Consensus 367 ~~~~~~~~~~~g~~~~~~~~~~~~~--~~~~---~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (934)
...|++.++++|+...+........ .... .+.... ............++|...|+.....+..+.++...+..-
T Consensus 567 ~l~G~~~~e~iG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~ 646 (1092)
T PRK09776 567 KMTGWTQEEALGVPLLTVLHITFGDNGPLMENIYSCLTSRSAAYLEQDVVLHCRSGGSYDVHYSITPLSTLDGENIGSVL 646 (1092)
T ss_pred HHhCCCHHHHcCCCHHHHcccccCCcchhhHHHHHHHhcCCCccccceEEEEeCCCcEEEEEEEeeeeecCCCCEEEEEE
Confidence 9999999999999887654321110 0000 000000 011112223456788888888777777766655443332
Q ss_pred ccccCCCCCCCCCCCCCchhhHHHHHhhhh
Q 002342 441 IIMEGDDDYESDDERPDSVDDKVRQKEMRK 470 (934)
Q Consensus 441 ~~~~~~~~~~~~~~~~dv~~r~~~e~~l~~ 470 (934)
..+|||+|++.|++++.
T Consensus 647 -------------~~~DITe~k~~e~~L~~ 663 (1092)
T PRK09776 647 -------------VIQDVTESRKMLRQLSY 663 (1092)
T ss_pred -------------EEEecchHHHHHHHHHh
Confidence 25799999999998754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2e-14 Score=152.83 Aligned_cols=137 Identities=23% Similarity=0.341 Sum_probs=104.1
Q ss_pred cccc-cCCcEEEEEEEEecCCeEEEEEEeecccc-----c-----ChHHHHHHHHHHHHHHhCCCCCc--cceeEEEEeC
Q 002342 675 KPLG-SGDTGSVHLVELCGSGQYFAMKAMDKGVM-----L-----NRNKVHRACAEREILDMLDHPFV--PALYASFQTK 741 (934)
Q Consensus 675 ~~LG-~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~-----~-----~~~~~~~~~~E~~il~~l~hp~I--v~l~~~~~~~ 741 (934)
..|| .||.|+||.+.. .+..++||.+..... . +......+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3466 888888888877 477899998864221 0 11233567789999999998775 6677664432
Q ss_pred -C---eEEEEEEccCC-CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecc
Q 002342 742 -T---HVCLITDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 816 (934)
Q Consensus 742 -~---~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG 816 (934)
. ..++||||++| .+|.+++... .++... +.+|+.+|.+||++||+||||||.|||++.++.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 2 23599999987 6888887542 355443 5789999999999999999999999999998999999999
Q ss_pred cCcc
Q 002342 817 LSCL 820 (934)
Q Consensus 817 ~a~~ 820 (934)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8854
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.5e-15 Score=160.01 Aligned_cols=211 Identities=23% Similarity=0.298 Sum_probs=144.8
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCe-----------------------------------EEEEEEeeccc--cc
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ-----------------------------------YFAMKAMDKGV--ML 708 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~-----------------------------------~vAlK~~~~~~--~~ 708 (934)
+..++|+|...||+|....||.+....++. +.|||.+-.-. ..
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~ 233 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG 233 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence 346799999999999999999987754322 24555432110 01
Q ss_pred ChHHHHHHHHHHH-------HH-------H-------h-CCCCCccceeEEEEe--------------------------
Q 002342 709 NRNKVHRACAERE-------IL-------D-------M-LDHPFVPALYASFQT-------------------------- 740 (934)
Q Consensus 709 ~~~~~~~~~~E~~-------il-------~-------~-l~hp~Iv~l~~~~~~-------------------------- 740 (934)
+...++..-+|.- .+ + . -.|||||.++..|.+
T Consensus 234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g 313 (598)
T KOG4158|consen 234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG 313 (598)
T ss_pred hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence 1122222222221 10 1 1 259999999887732
Q ss_pred -CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe--cCC--cEEEEec
Q 002342 741 -KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ--GNG--HVSLTDF 815 (934)
Q Consensus 741 -~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~--~~~--~vkl~DF 815 (934)
...+|+||.-+ ..+|..++-.+ ..+....+.++.|+++|+.|||++||.|||+|.+|||+. +++ .+.|.||
T Consensus 314 ~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 314 EPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred CCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence 23589999988 78999998764 367778888999999999999999999999999999994 333 5789999
Q ss_pred ccCcccCCCCCCC-CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC------CchhHHHHHHHHH
Q 002342 816 DLSCLTSCKPQLL-LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH------TSAVDWWALGILL 888 (934)
Q Consensus 816 G~a~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~------s~~~DiwSlG~iL 888 (934)
|+|-. +++... .++. ...-..-|.-.-||||+....+- ..++|.|+.|.+-
T Consensus 390 GCcLA--d~~hGlqlpy~--------------------S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~Gala 447 (598)
T KOG4158|consen 390 GCCLA--DDNHGLQLPYE--------------------SDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALA 447 (598)
T ss_pred ceeee--ccccccccccc--------------------cccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhH
Confidence 98732 221111 0000 01112347778999999865321 2389999999999
Q ss_pred HHHHhCCCCCCCCC
Q 002342 889 YEMLYGYTPFRGKT 902 (934)
Q Consensus 889 ~elltG~~Pf~~~~ 902 (934)
||+++..-||.+..
T Consensus 448 YEIfg~~NPFY~rG 461 (598)
T KOG4158|consen 448 YEIFGRSNPFYKRG 461 (598)
T ss_pred HHHhccCCcccccc
Confidence 99999999998743
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.4e-14 Score=137.56 Aligned_cols=132 Identities=23% Similarity=0.245 Sum_probs=111.8
Q ss_pred cccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC--CCccceeEEEEeCCeEEEEEEc
Q 002342 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTKTHVCLITDY 750 (934)
Q Consensus 673 i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~~~~~lV~E~ 750 (934)
+++.||.|.++.||++.... ..+++|.+.+... ...+..|..+++.+.+ .++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999999843 7899999865421 3567889999999976 5899999988888899999999
Q ss_pred cCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ---GIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
+.|..+..+ +......++.+++.+|.+||.. +++|+|++|+||+++..+.++++|||.+..
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 988877554 4456677889999999999985 799999999999999989999999999854
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.8e-15 Score=166.80 Aligned_cols=128 Identities=27% Similarity=0.416 Sum_probs=108.2
Q ss_pred CeEEEEEEccCCCCchhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 742 THVCLITDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
.++||.|++|...+|.+++.+. .....+......++.|+..+++| +|.+|+|+||.||++..+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 3689999999999999999743 34457788889999999999999 9999999999999999999999999999855
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 893 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt 893 (934)
+.... .........+..+||..||+||.+.+..|+.++||||||++|+||++
T Consensus 406 ~~~~~---------------------~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 406 QDKDE---------------------TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred cccCC---------------------cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 43221 01122334556689999999999999999999999999999999997
|
|
| >PF08448 PAS_4: PAS fold; InterPro: IPR013656 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.1e-13 Score=127.88 Aligned_cols=110 Identities=25% Similarity=0.335 Sum_probs=100.1
Q ss_pred HHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCC
Q 002342 478 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSG 557 (934)
Q Consensus 478 ~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG 557 (934)
|++++++++++|.+|+ |+++|+++++++|++.++++|+++.++.++.....+...+.+++.++.....+..... +|
T Consensus 1 l~~~p~~i~v~D~~~~---i~~~N~~~~~~~~~~~~~~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 76 (110)
T PF08448_consen 1 LDSSPDGIFVIDPDGR---IVYANQAAAELFGVSPEELIGRSLFDLLPPEDREEFQAALRRALAGGEPVFFEEILLR-DG 76 (110)
T ss_dssp HHHCSSEEEEEETTSB---EEEE-HHHHHHHTSTHHHHTTSBHHHHSCCGCHHHHHHHHHHHHHHTSEEEEEEEECT-TS
T ss_pred CCCCCceeEEECCCCE---EEEEHHHHHHHhCCCHHHHhhccchhccccchhhhhHHHHHHhhccCceEEEEEEEee-cC
Confidence 6889999999999888 9999999999999999999999999999888888888899999998888777666655 99
Q ss_pred cEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccc
Q 002342 558 KKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 591 (934)
Q Consensus 558 ~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~ 591 (934)
..+|+.+++.|++|.+|++.+++++++|||++|+
T Consensus 77 ~~~~~~~~~~Pi~~~~g~~~g~~~~~~DiT~~rr 110 (110)
T PF08448_consen 77 EERWFEVSISPIFDEDGEVVGVLVIIRDITERRR 110 (110)
T ss_dssp CEEEEEEEEEEEECTTTCEEEEEEEEEEECCHHH
T ss_pred CcEEEEEEEEEeEcCCCCEEEEEEEEEECchhhC
Confidence 9999999999999999999999999999999985
|
The PAS fold appears in archaea, eubacteria and eukarya. ; PDB: 3K3D_A 3K3C_B 3KX0_X 3FC7_B 3LUQ_D 3MXQ_A 3BWL_C 3FG8_A. |
| >PF08448 PAS_4: PAS fold; InterPro: IPR013656 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.7e-13 Score=126.51 Aligned_cols=110 Identities=24% Similarity=0.365 Sum_probs=99.3
Q ss_pred HHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCC
Q 002342 195 LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDG 274 (934)
Q Consensus 195 le~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG 274 (934)
|++++++++++|. +|+|+++|+++++++|++.++++|+++..++++.........+.+++.++.....+..... +|
T Consensus 1 l~~~p~~i~v~D~---~~~i~~~N~~~~~~~~~~~~~~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 76 (110)
T PF08448_consen 1 LDSSPDGIFVIDP---DGRIVYANQAAAELFGVSPEELIGRSLFDLLPPEDREEFQAALRRALAGGEPVFFEEILLR-DG 76 (110)
T ss_dssp HHHCSSEEEEEET---TSBEEEE-HHHHHHHTSTHHHHTTSBHHHHSCCGCHHHHHHHHHHHHHHTSEEEEEEEECT-TS
T ss_pred CCCCCceeEEECC---CCEEEEEHHHHHHHhCCCHHHHhhccchhccccchhhhhHHHHHHhhccCceEEEEEEEee-cC
Confidence 6899999999999 8889999999999999999999999999888887778888899999999888776665544 99
Q ss_pred cEEEEEEEeeeeecCCCCEEEEEEEEecchhhHH
Q 002342 275 TPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308 (934)
Q Consensus 275 ~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~ 308 (934)
..+|+.+++.|++|.+|++.|++++++|||++|+
T Consensus 77 ~~~~~~~~~~Pi~~~~g~~~g~~~~~~DiT~~rr 110 (110)
T PF08448_consen 77 EERWFEVSISPIFDEDGEVVGVLVIIRDITERRR 110 (110)
T ss_dssp CEEEEEEEEEEEECTTTCEEEEEEEEEEECCHHH
T ss_pred CcEEEEEEEEEeEcCCCCEEEEEEEEEECchhhC
Confidence 9999999999999999999999999999999985
|
The PAS fold appears in archaea, eubacteria and eukarya. ; PDB: 3K3D_A 3K3C_B 3KX0_X 3FC7_B 3LUQ_D 3MXQ_A 3BWL_C 3FG8_A. |
| >PF00989 PAS: PAS fold; InterPro: IPR013767 PAS domains are involved in many signalling proteins where they are used as a signal sensor domain [] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.7e-13 Score=127.24 Aligned_cols=112 Identities=21% Similarity=0.385 Sum_probs=95.6
Q ss_pred HHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEE-EE
Q 002342 189 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG-RL 267 (934)
Q Consensus 189 ~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~-e~ 267 (934)
++|++++++++++++++|. +|+|+|+|++|+++|||+.++++|+++..+.++++.......+.+.+..+..... +.
T Consensus 1 e~~~~i~~~~~~~i~~~d~---~g~I~~~N~a~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (113)
T PF00989_consen 1 ERYRAILENSPDGIFVIDE---DGRILYVNQAAEELLGYSREELIGKSLFDLIHPEDRRELRERLRQALSQGESGESFEV 77 (113)
T ss_dssp HHHHHHHHCSSSEEEEEET---TSBEEEECHHHHHHHSS-HHHHTTSBGGGGCSGGGHHHHHHHHHHHHHHCCHECEEEE
T ss_pred CHHHHHHhcCCceEEEEeC---cCeEEEECHHHHHHHccCHHHHcCCcHHHhcCchhhHHHHHHHHHHHHcCCCceeEEE
Confidence 5789999999999999998 7779999999999999999999999998887776655677788888877766443 33
Q ss_pred EEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecc
Q 002342 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303 (934)
Q Consensus 268 ~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DI 303 (934)
....++|+.+|+.+..+|+++.+|++.+++++++||
T Consensus 78 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~DI 113 (113)
T PF00989_consen 78 RFRLRDGRPRWVEVRASPVRDEDGQIIGILVIFRDI 113 (113)
T ss_dssp EEEETTSCEEEEEEEEEEEEETTEEEEEEEEEEEE-
T ss_pred EEEecCCcEEEEEEEEEEEEeCCCCEEEEEEEEEeC
Confidence 344469999999999999999999999999999997
|
PAS domains appear in archaea, bacteria and eukaryotes. Several PAS-domain proteins are known to detect their signal by way of an associated cofactor. Haeme, flavin, and a 4-hydroxycinnamyl chromophore are used in different proteins. The PAS domain was named after three proteins that it occurs in: Per- period circadian protein Arnt- Ah receptor nuclear translocator protein Sim- single-minded protein. PAS domains are often associated with PAC domains IPR001610 from INTERPRO. It appears that these domains are directly linked, and that together they form the conserved 3D PAS fold. The division between the PAS and PAC domains is caused by major differences in sequences in the region connecting these two motifs []. In human PAS kinase, this region has been shown to be very flexible, and adopts different conformations depending on the bound ligand []. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels [].; GO: 0006355 regulation of transcription, DNA-dependent; PDB: 2GJ3_A 4F3L_B 1XFN_A 1OTD_A 2PYR_A 1KOU_A 1XFQ_A 2ZOI_A 2ZOH_A 1OTA_A .... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=9.3e-15 Score=172.85 Aligned_cols=263 Identities=30% Similarity=0.462 Sum_probs=198.6
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
..+.+.+.+.+-+|+++.++.+.-..++...+.|+..+..............+-.++-...+|.++...-.|......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 45788889999999999999999888888888887665433334444455555555555566777776666677788999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
+|+|+.+++|...++.- ++.+.+-++-+...+..+++|||...+.|+|++|.|+|+..+|..++.|||.....+..+.
T Consensus 882 ~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred hhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 99999999999998775 3578888888889999999999999999999999999999999999999995433222111
Q ss_pred CCCCcchhh--h--ccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 827 LLLPTTNEK--K--RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 827 ~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
.....+... . +.......+..............||+.|.+||.+.+......+|+|++|+++++.++|.+||...+
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 100000000 0 011111112222223355667789999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCC-CCCcccCCCC
Q 002342 903 RQKTFANILHKDLKFPSST-PSSCKAANVP 931 (934)
Q Consensus 903 ~~~~~~~i~~~~~~~p~~~-~~s~~~k~l~ 931 (934)
.+++++.|..+..++|... ..+..+++++
T Consensus 1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~ 1069 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLI 1069 (1205)
T ss_pred hhhhhhccccCCCCCCCCccccChhhhhhh
Confidence 9999999999999999763 4566666554
|
|
| >PF00989 PAS: PAS fold; InterPro: IPR013767 PAS domains are involved in many signalling proteins where they are used as a signal sensor domain [] | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.1e-13 Score=124.62 Aligned_cols=111 Identities=22% Similarity=0.331 Sum_probs=95.9
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEE-EEEE
Q 002342 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVT-VQLI 551 (934)
Q Consensus 473 ~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~-~e~~ 551 (934)
+|+.++++++++++++|.+|+ |+++|++++++|||+.++++|+++..++++++.......+...+..+.... .+..
T Consensus 2 ~~~~i~~~~~~~i~~~d~~g~---I~~~N~a~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (113)
T PF00989_consen 2 RYRAILENSPDGIFVIDEDGR---ILYVNQAAEELLGYSREELIGKSLFDLIHPEDRRELRERLRQALSQGESGESFEVR 78 (113)
T ss_dssp HHHHHHHCSSSEEEEEETTSB---EEEECHHHHHHHSS-HHHHTTSBGGGGCSGGGHHHHHHHHHHHHHHCCHECEEEEE
T ss_pred HHHHHHhcCCceEEEEeCcCe---EEEECHHHHHHHccCHHHHcCCcHHHhcCchhhHHHHHHHHHHHHcCCCceeEEEE
Confidence 489999999999999999888 999999999999999999999999999988776667777777777766543 3444
Q ss_pred EEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcC
Q 002342 552 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDG 586 (934)
Q Consensus 552 ~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDI 586 (934)
...++|..+|+.++.+|+++.+|++.+++++++||
T Consensus 79 ~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~DI 113 (113)
T PF00989_consen 79 FRLRDGRPRWVEVRASPVRDEDGQIIGILVIFRDI 113 (113)
T ss_dssp EEETTSCEEEEEEEEEEEEETTEEEEEEEEEEEE-
T ss_pred EEecCCcEEEEEEEEEEEEeCCCCEEEEEEEEEeC
Confidence 45579999999999999999999999999999997
|
PAS domains appear in archaea, bacteria and eukaryotes. Several PAS-domain proteins are known to detect their signal by way of an associated cofactor. Haeme, flavin, and a 4-hydroxycinnamyl chromophore are used in different proteins. The PAS domain was named after three proteins that it occurs in: Per- period circadian protein Arnt- Ah receptor nuclear translocator protein Sim- single-minded protein. PAS domains are often associated with PAC domains IPR001610 from INTERPRO. It appears that these domains are directly linked, and that together they form the conserved 3D PAS fold. The division between the PAS and PAC domains is caused by major differences in sequences in the region connecting these two motifs []. In human PAS kinase, this region has been shown to be very flexible, and adopts different conformations depending on the bound ligand []. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels [].; GO: 0006355 regulation of transcription, DNA-dependent; PDB: 2GJ3_A 4F3L_B 1XFN_A 1OTD_A 2PYR_A 1KOU_A 1XFQ_A 2ZOI_A 2ZOH_A 1OTA_A .... |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=9.8e-15 Score=173.56 Aligned_cols=211 Identities=25% Similarity=0.383 Sum_probs=169.5
Q ss_pred CCcccccccccCCcEEEEEEEEecC-CeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCCeEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGS-GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~-~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~l 746 (934)
..|.+.+.||.|+|+.|-++....+ ...+|.|.+.... ........+..|..+-+.+. |.|++.+++...+....++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4688889999999999998887443 4567777665432 23444555666888888886 9999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCCEEEecCC-cEEEEecccCcccCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH-CQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCK 824 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH-~~giiHrDLKp~NILl~~~~-~vkl~DFG~a~~~~~~ 824 (934)
+++|..|++++..+........+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .+++.|||+|......
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999999883222224777888899999999999999 99999999999999999999 9999999999654321
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccC-CCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG-TEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G-t~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
..........+| ++.|+|||.+.+. ......|+||+|+++..+++|..||....
T Consensus 179 ------------------------~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 179 ------------------------NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred ------------------------CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 011223344578 9999999999884 44678999999999999999999997644
Q ss_pred HH
Q 002342 903 RQ 904 (934)
Q Consensus 903 ~~ 904 (934)
..
T Consensus 235 ~~ 236 (601)
T KOG0590|consen 235 RK 236 (601)
T ss_pred cc
Confidence 43
|
|
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.2e-13 Score=159.14 Aligned_cols=258 Identities=9% Similarity=-0.003 Sum_probs=171.8
Q ss_pred CceEEEecccccccc-----------cc---cccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhh
Q 002342 166 NSVRSSGEMSDEGGK-----------EK---GLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKE 231 (934)
Q Consensus 166 ~~~~~~~dit~~~~~-----------e~---aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eE 231 (934)
+.+.+..|||+.++. |+ +|++++++|+.++++++++++++|.. +|+|+++|++|++++||+.+|
T Consensus 96 ~~~~i~rDi~~~~~~~~~l~~~~~~~e~~~~~l~~~e~r~~~l~e~~~~~i~~~d~~--~g~i~~~N~a~~~l~G~~~~e 173 (442)
T TIGR02040 96 GVLALGRDLRAVAELQQQLVAAQQAMERDYWTLREMETRYRVVLEVSSDAVLLVDMS--TGRIVEANSAAAALLGGVGQS 173 (442)
T ss_pred eEEEEecccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCCceEEEEECC--CCEEEEEcHHHHHHhCcCHHH
Confidence 355667998875543 22 67778889999999999999999972 567999999999999999999
Q ss_pred HcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHH
Q 002342 232 VVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAK 311 (934)
Q Consensus 232 llG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~ 311 (934)
++|+++..++++++.......+......+.....++. .++|...| .+.++++.. +|. ..+++.+.|||++++++.
T Consensus 174 l~g~~~~~~~~~~~~~~~~~~l~~~~~~g~~~~~~~~--~~~~~~~~-~~~~~~~~~-~~~-~~~l~~~~dit~~~~~e~ 248 (442)
T TIGR02040 174 LVGRAFPQEFEGRRREELMLTLRNVRATGSAAPVRIL--LRRSQKRL-LVVVSVFRQ-DGE-SLFLCQLSPAGATQPVGD 248 (442)
T ss_pred HcCCCHHHhCCHHHHHHHHHHHHHHHhcCCCcceEEE--EcCCCeEE-EEEEEEEEe-CCc-eEEEEEEcccchhhhhhH
Confidence 9999988777777666666777777777765554544 33444444 445666654 333 457788999999988776
Q ss_pred HhhcCCCCCchhhhHHHHHHHHHhHHHHHHHHHHccCCCCcccCCCCCcccccCCCCchhh-hcccccCCCCCCCCCCCC
Q 002342 312 DKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIRKSEGGVEEE-RAGALGRRKSENVPPPRR 390 (934)
Q Consensus 312 ~L~~~~~~l~~~l~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~g~~~~~~~~~~~~ 390 (934)
+++. .....+..+-+.+...+....+..+|..+...+|+. .++++|++...++.....
T Consensus 249 ~~~~---------------------~~~~l~e~~~d~I~v~D~~G~I~~~N~a~~~l~G~~~~~~l~G~~~~~~~~~~~~ 307 (442)
T TIGR02040 249 ELSE---------------------NLARLYHEAPDAIVFSDADGTIRGANEAFLELTDSSSLEAVRGRTLDRWLGRGGV 307 (442)
T ss_pred HHHH---------------------HHHHHHHhCCceEEEEcCCCcEEehhHHHHHHhCCCChHHHcCCCHHHHhCCCcc
Confidence 5430 011123333344455566668888999999999997 578999998776542211
Q ss_pred CC-CCCCcccccccccccchhcccccccccccccccccccCCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHH
Q 002342 391 NS-YGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQK 466 (934)
Q Consensus 391 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dv~~r~~~e~ 466 (934)
.. ..............+......++|+.+|+.....+..+.++. .... ..+|||+|++.+.
T Consensus 308 ~~~~~~~~~~~~g~~~~~~~~~~~~~G~~~~ve~s~~~i~~~~~~-~~~~--------------v~rDITeR~~~~~ 369 (442)
T TIGR02040 308 DLRVLLSNVRRTGQVRLYATTLTGEFGAQTEVEISAAWVDQGERP-LIVL--------------VIRDISRRLTMRD 369 (442)
T ss_pred cHHHHHHHHhhcCceEEEEEEEEcCCCCEEEEEEEEEEeccCCce-EEEE--------------EEecchhhccCCC
Confidence 10 000000111122234444568899999999888777664432 2222 2478898877743
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >PRK13557 histidine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.4e-12 Score=154.09 Aligned_cols=132 Identities=37% Similarity=0.739 Sum_probs=120.4
Q ss_pred cccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCc
Q 002342 183 GLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS 262 (934)
Q Consensus 183 aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~ 262 (934)
.....+..|+.++++++++|+++|..+.+|+|+|+|++|++++||+.+|++|+++..+.+++........++..+..+..
T Consensus 24 ~~~~~~~~~~~~~~~~~~~i~v~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 103 (540)
T PRK13557 24 VSDHRSDIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERRE 103 (540)
T ss_pred hhhhhhHHHHHHHHhCcCcEEEEcCCCCCCCEEEEcHHHHHHhCCCHHHhcCCChHhhcCCCCCHHHHHHHHHHHHcCCC
Confidence 34456789999999999999999987778999999999999999999999999998888887777778888888888888
Q ss_pred EEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhh
Q 002342 263 YCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (934)
Q Consensus 263 ~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~ 314 (934)
+..+++.++++|+.+|+.+++.|+.+.+|.+++++++.+|||++++++++++
T Consensus 104 ~~~~~~~~~~~G~~~~~~~~~~~i~~~~g~~~~~~~~~~dit~~~~~e~~l~ 155 (540)
T PRK13557 104 IATEILNYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSRRRDAEDALR 155 (540)
T ss_pred ceEEEEEEeCCCCEEEEEEEEEEeECCCCCEEEEEEEecChHHHHHHHHHHH
Confidence 8888888899999999999999999999999999999999999999988765
|
|
| >PRK13559 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.8e-12 Score=143.08 Aligned_cols=129 Identities=40% Similarity=0.748 Sum_probs=114.6
Q ss_pred chHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEE
Q 002342 186 RVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG 265 (934)
Q Consensus 186 ~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 265 (934)
.+.+.|+.++++++++|+++|..+.+|.|+++|++|++++||+.+|++|+++..+.++.........+...+..+..+..
T Consensus 40 ~~~~~~~~~~e~~~~~i~i~D~~~~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (361)
T PRK13559 40 ASGRLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVAKIRAAIAAEREIVV 119 (361)
T ss_pred hhhhHHHHHHHhCCCcEEEecCCCCCCcEEEEchHHHHHhCCCHHHHcCCChhhhcCCCCCHHHHHHHHHHhccCCceEE
Confidence 45677899999999999999987667889999999999999999999999988777766666667778888888888888
Q ss_pred EEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhh
Q 002342 266 RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (934)
Q Consensus 266 e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~ 314 (934)
+...+++||..+|+.+++.|+++.+|.+.+++++++|||++|+++++++
T Consensus 120 e~~~~~~dG~~~~~~~~~~~i~d~~G~~~~~v~~~~DITerk~~e~~~~ 168 (361)
T PRK13559 120 ELLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVTDIRAVRALEA 168 (361)
T ss_pred EEEEEcCCCCEEEEEEEEEEEEcCCCCEEEeeeeeeehhcchhhHHHHH
Confidence 8888999999999999999999999999999999999999998876543
|
|
| >PRK11091 aerobic respiration control sensor protein ArcB; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.1e-12 Score=164.45 Aligned_cols=140 Identities=13% Similarity=0.127 Sum_probs=128.0
Q ss_pred ecccccccccccccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHH
Q 002342 172 GEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVA 251 (934)
Q Consensus 172 ~dit~~~~~e~aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~ 251 (934)
.+|+++++++++++++++.++.++++++++++++|. +|+|+++|++|++++||+.++++|+++..+++++.......
T Consensus 138 ~~i~~r~~~~~~l~~~~~~l~~il~~~~~~i~~~D~---~g~i~~~N~a~~~l~G~~~~eliG~~~~~l~~~~~~~~~~~ 214 (779)
T PRK11091 138 NEIKEREETQIELEQQSSLLRSFLDASPDLVYYRNE---DGEFSGCNRAMELLTGKSEKQLIGLTPKDVYSPEAAEKVIE 214 (779)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhcCcceEEEECC---CCcEEeEcHHHHHHhCcCHHHHcCCChHHhCCHHHHHHHHH
Confidence 688999999999999999999999999999999998 77799999999999999999999999887777766666666
Q ss_pred HHHHHHhcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhh
Q 002342 252 KIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (934)
Q Consensus 252 ~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~ 314 (934)
.....+..+..+..+.+..++||..+|+.++..|+++.+|.+.|++++++|||++|+++++++
T Consensus 215 ~~~~~~~~~~~~~~e~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~e~~l~ 277 (779)
T PRK11091 215 TDEKVFRHNVSLTYEQWLDYPDGRKACFELRKVPFYDRVGKRHGLMGFGRDITERKRYQDALE 277 (779)
T ss_pred HHHHHHhcCCCeEEEEEEEcCCCCEEEEEEEeeeEEcCCCCEEEEEEEEeehhHHHHHHHHHH
Confidence 667778888888888888999999999999999999999999999999999999999998876
|
|
| >PRK11091 aerobic respiration control sensor protein ArcB; Provisional | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.5e-12 Score=161.10 Aligned_cols=136 Identities=14% Similarity=0.107 Sum_probs=122.7
Q ss_pred CCCchhhHHHHHhhhhc-ccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHH
Q 002342 455 RPDSVDDKVRQKEMRKG-IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATV 533 (934)
Q Consensus 455 ~~dv~~r~~~e~~l~~~-~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~ 533 (934)
.+++++|+..+++++.. ..++.++++++++|+++|.+|+ |+++|+++++++||+.++++|+++..+++++......
T Consensus 137 ~~~i~~r~~~~~~l~~~~~~l~~il~~~~~~i~~~D~~g~---i~~~N~a~~~l~G~~~~eliG~~~~~l~~~~~~~~~~ 213 (779)
T PRK11091 137 KNEIKEREETQIELEQQSSLLRSFLDASPDLVYYRNEDGE---FSGCNRAMELLTGKSEKQLIGLTPKDVYSPEAAEKVI 213 (779)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhcCcceEEEECCCCc---EEeEcHHHHHHhCcCHHHHcCCChHHhCCHHHHHHHH
Confidence 46788888888888666 6799999999999999999888 9999999999999999999999998888887666666
Q ss_pred HHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccccc
Q 002342 534 RKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 593 (934)
Q Consensus 534 ~~i~~~l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e 593 (934)
......+..+..+..+.+..+++|..+|+.++..|+++.+|.+.+++++++|||++|+++
T Consensus 214 ~~~~~~~~~~~~~~~e~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~e 273 (779)
T PRK11091 214 ETDEKVFRHNVSLTYEQWLDYPDGRKACFELRKVPFYDRVGKRHGLMGFGRDITERKRYQ 273 (779)
T ss_pred HHHHHHHhcCCCeEEEEEEEcCCCCEEEEEEEeeeEEcCCCCEEEEEEEEeehhHHHHHH
Confidence 777777888888899999999999999999999999999999999999999999999864
|
|
| >PRK13559 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.37 E-value=1e-11 Score=141.07 Aligned_cols=122 Identities=44% Similarity=0.808 Sum_probs=108.9
Q ss_pred ccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEE
Q 002342 472 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLI 551 (934)
Q Consensus 472 ~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~ 551 (934)
..|+.++++++++|+++|.+|.+++|+++|++|++++||+.++++|+++..+.++.........+...+..+..+..+..
T Consensus 43 ~~~~~~~e~~~~~i~i~D~~~~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 122 (361)
T PRK13559 43 RLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVAKIRAAIAAEREIVVELL 122 (361)
T ss_pred hHHHHHHHhCCCcEEEecCCCCCCcEEEEchHHHHHhCCCHHHHcCCChhhhcCCCCCHHHHHHHHHHhccCCceEEEEE
Confidence 34888999999999999986655669999999999999999999999988777777777767777888888888888999
Q ss_pred EEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccccc
Q 002342 552 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 593 (934)
Q Consensus 552 ~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e 593 (934)
..+++|..+|+.++..|+++.+|.+.+++++++|||++|+++
T Consensus 123 ~~~~dG~~~~~~~~~~~i~d~~G~~~~~v~~~~DITerk~~e 164 (361)
T PRK13559 123 NYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVTDIRAVR 164 (361)
T ss_pred EEcCCCCEEEEEEEEEEEEcCCCCEEEeeeeeeehhcchhhH
Confidence 999999999999999999999999999999999999999854
|
|
| >PRK13557 histidine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.36 E-value=5e-12 Score=151.36 Aligned_cols=124 Identities=43% Similarity=0.815 Sum_probs=111.9
Q ss_pred ccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEE
Q 002342 472 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLI 551 (934)
Q Consensus 472 ~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~ 551 (934)
..|..+++.++++|+++|.++.+++|+|+|++|++++||+.+|++|+++..+.+++........++..+..+..+..+.+
T Consensus 30 ~~~~~~~~~~~~~i~v~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 109 (540)
T PRK13557 30 DIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERREIATEIL 109 (540)
T ss_pred HHHHHHHHhCcCcEEEEcCCCCCCCEEEEcHHHHHHhCCCHHHhcCCChHhhcCCCCCHHHHHHHHHHHHcCCCceEEEE
Confidence 45999999999999999975555669999999999999999999999998888888877778888888888888888888
Q ss_pred EEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccccccc
Q 002342 552 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRN 595 (934)
Q Consensus 552 ~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e~~ 595 (934)
..+++|+.+|+.+++.|+++.+|.+++++++.+|||++++++..
T Consensus 110 ~~~~~G~~~~~~~~~~~i~~~~g~~~~~~~~~~dit~~~~~e~~ 153 (540)
T PRK13557 110 NYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSRRRDAEDA 153 (540)
T ss_pred EEeCCCCEEEEEEEEEEeECCCCCEEEEEEEecChHHHHHHHHH
Confidence 89999999999999999999999999999999999999986543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.4e-12 Score=148.63 Aligned_cols=142 Identities=23% Similarity=0.284 Sum_probs=98.1
Q ss_pred ccccccCCcEEEEEEEEecCCeEEEEEEeecccccCh---------------------------HHH----------HHH
Q 002342 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR---------------------------NKV----------HRA 716 (934)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~---------------------------~~~----------~~~ 716 (934)
.+.||+|++|+||+|+. .+|+.||||+.+++....- ... -.+
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 36799999999999987 5789999999876421100 000 013
Q ss_pred HHHHHHHHhCC-----CCCc--cceeEEEEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 002342 717 CAEREILDMLD-----HPFV--PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV-ALEYLH 788 (934)
Q Consensus 717 ~~E~~il~~l~-----hp~I--v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~-aL~yLH 788 (934)
.+|...+..+. +++| ++++. ...+..+|||||++|++|.++....... .. ...++.+++. .+..+|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHHHHHHHHH
Confidence 34555555542 3433 33332 2234578999999999998876532111 22 2345566655 478899
Q ss_pred HCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 789 ~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
..|++|+|+||.||+++.+|+++++|||++....
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999999986543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=6e-13 Score=155.25 Aligned_cols=147 Identities=18% Similarity=0.235 Sum_probs=97.0
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccC---------------------------h----HHHHH-
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN---------------------------R----NKVHR- 715 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~---------------------------~----~~~~~- 715 (934)
...|.. +.||+|++|+||+|+.+.+|+.||||+.+++.... . +..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456777 79999999999999998889999999998652100 0 01111
Q ss_pred -----HHHHHHHHHhC----CCCCccceeEEEE-eCCeEEEEEEccCCCCchhhh--ccCCC--CCCCHHHHHHHHHHHH
Q 002342 716 -----ACAEREILDML----DHPFVPALYASFQ-TKTHVCLITDYCPGGELFLLL--DRQPT--KVLKEDAVRFYAAEVV 781 (934)
Q Consensus 716 -----~~~E~~il~~l----~hp~Iv~l~~~~~-~~~~~~lV~E~~~ggsL~~~l--~~~~~--~~l~~~~~~~i~~qil 781 (934)
+.+|...+.++ .+...+.+-.+|. ..+..+|||||++|+.|.++. ...+. ..+.+..+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 22344444333 2333233323332 245678999999999997752 22110 124444444444444
Q ss_pred HHHHHHHHCCCeecCCCCCCEEEecCC----cEEEEecccCcccC
Q 002342 782 VALEYLHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCLTS 822 (934)
Q Consensus 782 ~aL~yLH~~giiHrDLKp~NILl~~~~----~vkl~DFG~a~~~~ 822 (934)
+..|++|+|+||.||+++.+| +++++|||++...+
T Consensus 277 ------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 458999999999999999888 99999999986543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.5e-12 Score=142.47 Aligned_cols=164 Identities=25% Similarity=0.381 Sum_probs=130.4
Q ss_pred HHhCCCCCccceeEEEEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-eecCCCCCC
Q 002342 723 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI-IYRDLKPEN 801 (934)
Q Consensus 723 l~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~gi-iHrDLKp~N 801 (934)
|+.+.|.|+.++++.+.++...++|.+||.-|+|.+.+... ...++.-....++++|+.||+|||.-.| .|+.+++.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 45789999999999999999999999999999999999763 3457777788889999999999999865 999999999
Q ss_pred EEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC-------
Q 002342 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG------- 874 (934)
Q Consensus 802 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~------- 874 (934)
.+++....+||.|||+......... ........-..-|.|||.+.+..
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~-------------------------~~~~~~~~~~~lw~aPellr~~~~~~~~~~ 134 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAE-------------------------PEAHHPIRKALLWTAPELLRGALSQSLESA 134 (484)
T ss_pred ceeeeeEEEEechhhhccccccccc-------------------------ccccchhHHHHhccCHHHhccccccccccc
Confidence 9999999999999999855422000 00001112345699999997642
Q ss_pred CCchhHHHHHHHHHHHHHhCCCCCCC----CCHHHHHHHHHc
Q 002342 875 HTSAVDWWALGILLYEMLYGYTPFRG----KTRQKTFANILH 912 (934)
Q Consensus 875 ~s~~~DiwSlG~iL~elltG~~Pf~~----~~~~~~~~~i~~ 912 (934)
.+.+.|+||||++++|+++.+.||.. ....+++.++.+
T Consensus 135 ~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~ 176 (484)
T KOG1023|consen 135 LTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK 176 (484)
T ss_pred ccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh
Confidence 35579999999999999999999975 222456667666
|
|
| >PRK13558 bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.8e-11 Score=146.88 Aligned_cols=127 Identities=39% Similarity=0.747 Sum_probs=114.7
Q ss_pred HHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEE
Q 002342 189 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLL 268 (934)
Q Consensus 189 ~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 268 (934)
..++.+++.+++++++.|..+.+|.|+|+|+++++++||+.++++|+++..+.++.........+...+..+..+..+++
T Consensus 148 r~~~~~~~~~~~gi~~~d~~~~dg~i~~~N~~~~~l~G~~~eel~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 227 (665)
T PRK13558 148 RLKERALDEAPVGITIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERPTSVELR 227 (665)
T ss_pred HHHHHHHhcCCccEEEEcCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHHHhcCCCccHHHHHHHHHHHhcCCCeEEEEE
Confidence 45678999999999999876668889999999999999999999999988777777766667778888888888889999
Q ss_pred EEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhhc
Q 002342 269 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 315 (934)
Q Consensus 269 ~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~~ 315 (934)
.+++||..+|+.++..|+.+.+|.+.+++++++|||++|++|++++.
T Consensus 228 ~~~~dG~~~~~~~~~~pi~d~~G~~~~~vgi~~DITerk~~E~~L~~ 274 (665)
T PRK13558 228 NYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKEAELALQR 274 (665)
T ss_pred EECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeCcHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999998874
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.2e-11 Score=119.98 Aligned_cols=140 Identities=14% Similarity=0.111 Sum_probs=101.7
Q ss_pred ccccccCCcEEEEEEEEec------CCeEEEEEEeecccc--c--------C---------hHHHHHHH----HHHHHHH
Q 002342 674 IKPLGSGDTGSVHLVELCG------SGQYFAMKAMDKGVM--L--------N---------RNKVHRAC----AEREILD 724 (934)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~------~~~~vAlK~~~~~~~--~--------~---------~~~~~~~~----~E~~il~ 724 (934)
...||.|.-+.||.+.... .+..+|||+++.... . + ......+. +|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998643 357999998864221 0 0 11122233 7999999
Q ss_pred hCCC--CCccceeEEEEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCCC
Q 002342 725 MLDH--PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL-HCQGIIYRDLKPEN 801 (934)
Q Consensus 725 ~l~h--p~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yL-H~~giiHrDLKp~N 801 (934)
++.. -+++.++++ ...+|||||+.+..+.....+. ..++...+..++.+++.+|..| |+.||||+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 9853 567777764 4568999999665443222121 2356667778889999999999 89999999999999
Q ss_pred EEEecCCcEEEEecccCcc
Q 002342 802 VLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 802 ILl~~~~~vkl~DFG~a~~ 820 (934)
||++ ++.+.|+|||-+..
T Consensus 156 IL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred EEEE-CCcEEEEECCCcee
Confidence 9997 57899999998844
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.1e-11 Score=121.36 Aligned_cols=127 Identities=24% Similarity=0.291 Sum_probs=96.0
Q ss_pred ccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCC-ccceeEEEEeCCeEEEEEEccC
Q 002342 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF-VPALYASFQTKTHVCLITDYCP 752 (934)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~~~~lV~E~~~ 752 (934)
++.|+.|.++.||++.. .+..|++|+...... ....+..|..+++.+.+.+ +++++.+.. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 35689999999999987 477899998765321 1224567899999886544 445655443 34579999999
Q ss_pred CCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eecCCCCCCEEEecCCcEEEEecccCc
Q 002342 753 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI-----IYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 753 ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~gi-----iHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
|.++.... . ....++.+++.+|+.||+.++ +|+|++|+||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 98876430 1 113456899999999999985 9999999999999 6789999999984
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK10060 RNase II stability modulator; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.1e-10 Score=142.84 Aligned_cols=139 Identities=12% Similarity=0.163 Sum_probs=111.6
Q ss_pred cccccccccccccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCC-CCCCCCCChHHHH
Q 002342 173 EMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCR-FLQGAGTDPEDVA 251 (934)
Q Consensus 173 dit~~~~~e~aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~-~l~~~~~~~~~~~ 251 (934)
++++.......+......++.+++.++++|+++|. +|+|+++|++|++++||+.+|++|+++. .+.+++.......
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~v~~~~~~gI~i~D~---~g~I~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~ 171 (663)
T PRK10060 95 AWHDTPSVARDLSHGLSFAEQVVSEANSVIVILDS---RGNIQRFNRLCEEYTGLKEHDVIGQSVFKLFMSRREAAASRR 171 (663)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhCCceEEEEeC---CCCEEEEcHHHHHHHCcCHHHHcCCCHHHHhCChhhHHHHHH
Confidence 34444444555667777889999999999999999 7779999999999999999999999975 4445555555667
Q ss_pred HHHHHHhcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCC-CEEEEEEEEecchhhHHHHHHhhc
Q 002342 252 KIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEG-KVLKFIGMQVEVSKHTEGAKDKML 315 (934)
Q Consensus 252 ~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G-~v~~~v~~~~DITerk~~e~~L~~ 315 (934)
.++..+..+..|.++.+.++++|..+|+.....+ .+..| ...+++++.+|||++++++++++.
T Consensus 172 ~~~~~~~~~~~~~~e~~~~~~~G~~~~~~~~~~~-~~~~g~~~~~~i~~~~DITe~k~~e~~l~~ 235 (663)
T PRK10060 172 NIRGFFRSGNAYEVERWIKTRKGQRLFLFRNKFV-HSGSGKNEIFLICSGTDITEERRAQERLRI 235 (663)
T ss_pred HHHHHHhcCCceEEEEEEEeCCCCEEEEEeeeEE-EcCCCCceEEEEEEEEechHHHHHHHHHHH
Confidence 7778888888899999999999999998766444 44444 456788999999999999988764
|
|
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=2e-10 Score=144.56 Aligned_cols=142 Identities=14% Similarity=0.182 Sum_probs=118.8
Q ss_pred CceEEEecccccccccccccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCC-CCCC
Q 002342 166 NSVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFL-QGAG 244 (934)
Q Consensus 166 ~~~~~~~dit~~~~~e~aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l-~~~~ 244 (934)
..++++.|||++++.+ +.++.+..++++++++++++|. +|+++++|+++++++||+.++++|+++..+ .++.
T Consensus 117 ~~~~~~~DiT~~~~~~----~~~~~~~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~l~G~~~~e~~g~~~~~~~~~~~ 189 (799)
T PRK11359 117 YYLALVRDASVEMAQK----EQTRQLIIAVDHLDRPVIVLDP---ERRIVQCNRAFTEMFGYCISEASGMQPDTLLNIPE 189 (799)
T ss_pred EEEEEEeeccchhhhH----HHHHHHHHHHhcCCCcEEEEcC---CCcEEEEChhhHhhhCCCHHHHCCCChHHhcCCCC
Confidence 3566779999876644 4456677889999999999998 777999999999999999999999987644 4455
Q ss_pred CChHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhh
Q 002342 245 TDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (934)
Q Consensus 245 ~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~ 314 (934)
........+...+..+..+..+++..+++|..+|+.++..|+.+.+|.+.+++++.+|||+++++++.++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~v~d~~g~~~~~~~~~~DITerk~~e~~~~ 259 (799)
T PRK11359 190 FPADNRIRLQQLLWKTARDQDEFLLLTRTGEKIWIKASISPVYDVLAHLQNLVMTFSDITEERQIRQLEG 259 (799)
T ss_pred CcHHHHHHHHHhhccCCCCcceeEEeCCCCCEEEEEeeeeeeecCCCceeEEEEEeehhhhHHHHHHHHH
Confidence 5555666677777777777888888999999999999999999999999999999999999998876543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.7e-10 Score=132.29 Aligned_cols=184 Identities=17% Similarity=0.226 Sum_probs=134.4
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEc
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 750 (934)
|++ ....-++.+..-.+..+.++.++.++.++... ........+-++-|+.++||||+++++.++.++..|||+|-
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTEr 90 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTER 90 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeec
Confidence 444 33333333322234556778888888876542 23455677888999999999999999999999999999999
Q ss_pred cCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH-CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH-~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
+ ..|..+++. ++...+...+.||+.||.||| ..+++|++|.-+.|+++..|..||++|.++......+.
T Consensus 91 V--~Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--- 160 (690)
T KOG1243|consen 91 V--RPLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--- 160 (690)
T ss_pred c--ccHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---
Confidence 8 456667765 346677778999999999998 45899999999999999999999999998844321110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhC
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 894 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG 894 (934)
.......--.|..|+.+....+ ..|.|-|||++++++.|
T Consensus 161 ------------------------~~~~~~~~~s~~~P~~~~~s~~--s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 ------------------------PAKSLYLIESFDDPEEIDPSEW--SIDSWGLGCLIEELFNG 199 (690)
T ss_pred ------------------------ccccchhhhcccChhhcCcccc--chhhhhHHHHHHHHhCc
Confidence 0011112224666766544433 46999999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2e-10 Score=112.13 Aligned_cols=146 Identities=19% Similarity=0.201 Sum_probs=110.6
Q ss_pred cccccccCCcEEEEEEEEecCCeEEEEEEee-----cccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMD-----KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 673 i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~-----~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.+..|-+|+-+.|+.+.+ .|+.++||.=- ...+..+-...+..+|+++|.++.--.|.-..=+|.+...-+|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567788999999999987 78888888422 22233344566788999999998655554444456666677899
Q ss_pred EEccCC-CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC---cEEEEecccCcc
Q 002342 748 TDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCL 820 (934)
Q Consensus 748 ~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~---~vkl~DFG~a~~ 820 (934)
|||++| .++.+++...............++.+|-..|.-||.++|||+||..+||++.++| .+.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999976 4788888765444344444477889999999999999999999999999998765 348999999854
|
|
| >PRK13558 bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.2e-10 Score=137.73 Aligned_cols=121 Identities=40% Similarity=0.759 Sum_probs=107.4
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 002342 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (934)
Q Consensus 474 l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~ 553 (934)
++.+++.+++++++.|..+.++.|+++|+++++++||+.++++|+++..+.+++........+...+..+..+..+.+.+
T Consensus 150 ~~~~~~~~~~gi~~~d~~~~dg~i~~~N~~~~~l~G~~~eel~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 229 (665)
T PRK13558 150 KERALDEAPVGITIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERPTSVELRNY 229 (665)
T ss_pred HHHHHhcCCccEEEEcCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHHHhcCCCccHHHHHHHHHHHhcCCCeEEEEEEE
Confidence 56789999999999986444455999999999999999999999998888887777666777777888888889999999
Q ss_pred ecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccccc
Q 002342 554 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLR 594 (934)
Q Consensus 554 ~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e~ 594 (934)
+++|..+|+.++..|+++.+|.+.+++++++|||++|++|.
T Consensus 230 ~~dG~~~~~~~~~~pi~d~~G~~~~~vgi~~DITerk~~E~ 270 (665)
T PRK13558 230 RKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKEAEL 270 (665)
T ss_pred CCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeCcHHHHHHH
Confidence 99999999999999999999999999999999999999644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3e-11 Score=137.56 Aligned_cols=210 Identities=23% Similarity=0.231 Sum_probs=163.9
Q ss_pred cccCCccccccccc--CCcEEEEEEEE--ecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEe
Q 002342 666 INLQHFRPIKPLGS--GDTGSVHLVEL--CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT 740 (934)
Q Consensus 666 ~~~~~y~i~~~LG~--G~~g~Vy~a~~--~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~ 740 (934)
...+.+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.. .........-.+|..-...+ .|++.++.+..+..
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCccccc
Confidence 44567888899999 99999999999 889999999974432 11222233344566666666 48999999999999
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHH----HHHHHHHCCCeecCCCCCCEEEecC-CcEEEEec
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV----ALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDF 815 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~----aL~yLH~~giiHrDLKp~NILl~~~-~~vkl~DF 815 (934)
.+..|+-+|+| +.+|..+.... ...++...++.++.+... ||.++|..+++|-|+||.||++..+ ..++++||
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 99999999999 78888887653 345889999999999999 9999999999999999999999998 78999999
Q ss_pred ccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCC
Q 002342 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 895 (934)
Q Consensus 816 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~ 895 (934)
|+...++..+.. .........-|...|++||.+.+. ++...|+++||.++.+-.+|.
T Consensus 268 ~~v~~i~~~~~~----------------------~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~ 324 (524)
T KOG0601|consen 268 GLVSKISDGNFS----------------------SVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGS 324 (524)
T ss_pred ceeEEccCCccc----------------------cceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhc
Confidence 998665432211 001111222477789999998755 678899999999999999887
Q ss_pred CCCCCC
Q 002342 896 TPFRGK 901 (934)
Q Consensus 896 ~Pf~~~ 901 (934)
.++...
T Consensus 325 ~~~~~g 330 (524)
T KOG0601|consen 325 HLPSVG 330 (524)
T ss_pred ccccCC
Confidence 766543
|
|
| >TIGR00229 sensory_box PAS domain S-box | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.8e-10 Score=100.36 Aligned_cols=121 Identities=20% Similarity=0.406 Sum_probs=98.1
Q ss_pred HHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcC-CcEEEE
Q 002342 188 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNG-QSYCGR 266 (934)
Q Consensus 188 ~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g-~~~~~e 266 (934)
++.++.+++.++++++++|. +|.++++|+++++++|++.++++|+.+..+.++.........+...+..+ ......
T Consensus 2 ~~~~~~~~~~~~~~~~~~d~---~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (124)
T TIGR00229 2 EERYRAIFESSPDAIIVIDL---EGNILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERLLEGEREPVSEE 78 (124)
T ss_pred chHHHHHHhhCCceEEEEcC---CCcEEEEchHHHHHhCCChHHhcCcchhhhcChhhhHHHHHHHHHHHcCCCCCcceE
Confidence 35788899999999999998 67799999999999999999999998876666665555555555555533 223344
Q ss_pred EEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHH
Q 002342 267 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKD 312 (934)
Q Consensus 267 ~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~ 312 (934)
+....++|..+|+..+..|+. .+|...++++++.|||++++++++
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dit~~~~~~~~ 123 (124)
T TIGR00229 79 RRVRRKDGSEIWVEVSVSPIR-TNGGELGVVGIVRDITERKQAEEA 123 (124)
T ss_pred eeeEcCCCCEEEEEEEEeehh-hCCCeeEEEEEeeehhHHHHHHhc
Confidence 555588999999999999998 788899999999999999988765
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.4e-10 Score=111.32 Aligned_cols=134 Identities=21% Similarity=0.213 Sum_probs=100.3
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeeccccc-----ChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-----NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
..+++|+-+.+|.+.+ -|..+++|.=.++..- .+-...+..+|..++..+..-.|...+=++.+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4578999999999866 4445778754333222 22334566789999999876555544445566677789999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
|++|..|.+++... ...++..+=.-+.-||..||||+||.++||+++.+ .+.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence 99999998888653 13456677777888999999999999999999855 499999999853
|
|
| >PRK10060 RNase II stability modulator; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.8e-10 Score=137.34 Aligned_cols=116 Identities=17% Similarity=0.172 Sum_probs=95.6
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccC-CCCCCHHHHHHHHHHHhcCCcEEEEEEE
Q 002342 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQ-GPETDPATVRKIRAAIDNQTDVTVQLIN 552 (934)
Q Consensus 474 l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~-~~~~~~~~~~~i~~~l~~~~~~~~e~~~ 552 (934)
++.+++.++++|+++|.+|+ |+++|+++++++||+.+|++|+++..++ ++.+.......+...+..+..+..|.++
T Consensus 113 ~~~v~~~~~~gI~i~D~~g~---I~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 189 (663)
T PRK10060 113 AEQVVSEANSVIVILDSRGN---IQRFNRLCEEYTGLKEHDVIGQSVFKLFMSRREAAASRRNIRGFFRSGNAYEVERWI 189 (663)
T ss_pred HHHHHhhCCceEEEEeCCCC---EEEEcHHHHHHHCcCHHHHcCCCHHHHhCChhhHHHHHHHHHHHHhcCCceEEEEEE
Confidence 67889999999999999888 9999999999999999999999976554 4544455566777778888889999999
Q ss_pred EecCCcEEEEEEEEEeeecCCCC-EEEEEEEEEcCCcccccc
Q 002342 553 YTKSGKKFWNLFHLQPMRDQKGE-VQYFIGVQLDGSEHLEPL 593 (934)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~de~G~-v~~~vgi~rDITerk~~e 593 (934)
.+++|..+|+..... +.+..|. ..+++++.+|||++|+++
T Consensus 190 ~~~~G~~~~~~~~~~-~~~~~g~~~~~~i~~~~DITe~k~~e 230 (663)
T PRK10060 190 KTRKGQRLFLFRNKF-VHSGSGKNEIFLICSGTDITEERRAQ 230 (663)
T ss_pred EeCCCCEEEEEeeeE-EEcCCCCceEEEEEEEEechHHHHHH
Confidence 999999999876544 4444554 467889999999999853
|
|
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.4e-10 Score=134.91 Aligned_cols=117 Identities=26% Similarity=0.438 Sum_probs=105.8
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 002342 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (934)
Q Consensus 474 l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~ 553 (934)
|+.+++.++++++++|.+|+ ++++|+++++++||++++++|++...+.++.........+...+..+..+..+....
T Consensus 6 ~~~i~~~~~~~i~~~d~~g~---~~~~N~~~~~~~G~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (494)
T TIGR02938 6 YRQTVDQAPLAISITDLKAN---ILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNR 82 (494)
T ss_pred HHHHHHhCCceEEEECCCCc---EEEEchhheeecCCCHHHHhCCCchhhcCCCCCHHHHHHHHHHHHhCCcccceeecc
Confidence 89999999999999999888 999999999999999999999987777776666666777777777788888888888
Q ss_pred ecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccccc
Q 002342 554 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 593 (934)
Q Consensus 554 ~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e 593 (934)
+++|..+|+..++.|+++.+|.+.+++++++|||++|+++
T Consensus 83 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIt~~k~~e 122 (494)
T TIGR02938 83 RKDGELYLAELTVAPVLNEAGETTHFLGMHRDITELHRLE 122 (494)
T ss_pred CCCccchhhheeeEEEECCCCCEEEEEEehhhhhHHHHHH
Confidence 9999999999999999999999999999999999999853
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >PF08447 PAS_3: PAS fold; InterPro: IPR013655 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.2e-09 Score=97.55 Aligned_cols=86 Identities=29% Similarity=0.408 Sum_probs=74.8
Q ss_pred EEEccHHHHHHcCCChhhhcCCC----CcccCCCCCCHHHHHHHHH-HHhcCCcEEEEEEEEecCCcEEEEEEEEEeeec
Q 002342 497 IIFASDSFLELTEYSREEILGRN----CRFLQGPETDPATVRKIRA-AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRD 571 (934)
Q Consensus 497 I~~vN~a~~~l~Gys~eEliG~~----~~~l~~~~~~~~~~~~i~~-~l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~d 571 (934)
|+|||+++++++||+++++ +.. +..++||++...+.+.+.. .+..+..+..++++++++|+.+|+..+..+++|
T Consensus 1 ~i~~s~~~~~i~G~~~~~~-~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~~~e~R~~~~~G~~~wi~~~~~~~~d 79 (91)
T PF08447_consen 1 IIYWSDNFYEIFGYSPEEI-GKPDFEEWLERIHPDDRERVRQAIQQAALQNGEPFEIEYRIRRKDGEYRWIEVRGRPIFD 79 (91)
T ss_dssp -EEE-THHHHHHTS-HHHH-TCBEHHHHHHHB-TTTHHHHHHHHHHHHHHTT-EEEEEEEEEGTTSTEEEEEEEEEEEET
T ss_pred CEEEeHHHHHHhCCCHHHh-ccCCHHHHHhhcCHHHHHHHHHHHHHHhhccCcceEEEEEEECCCCCEEEEEEEEEEEEC
Confidence 6899999999999999999 766 7788999999999999999 778888999999999999999999999999999
Q ss_pred CCCCEEEEEEEE
Q 002342 572 QKGEVQYFIGVQ 583 (934)
Q Consensus 572 e~G~v~~~vgi~ 583 (934)
.+|+++.++|++
T Consensus 80 ~~g~~~~~~Gv~ 91 (91)
T PF08447_consen 80 ENGKPIRIIGVI 91 (91)
T ss_dssp TTS-EEEEEEEE
T ss_pred CCCCEEEEEEEC
Confidence 999999999974
|
The PAS fold appears in archaea, eubacteria and eukarya. The PAS domain contains a sensory box, or S-box domain that occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include haem in the oxygen sensor FixL [], FAD in the redox potential sensor NifL [], and a 4-hydroxycinnamyl chromophore in photoactive yellow protein []. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. This domain has been found in the gene product of the madA gene of the filamentous zygomycete fungus Phycomyces blakesleeanus. It has been shown that MadA encodes a blue-light photoreceptor for phototropism and other light responses. The gene is involved in the phototropic responses associated with sporangiophore growth; they exhibit phototropism by bending toward near-UV and blue wavelengths and away from far-UV wavelengths in a manner that is physiologically similar to plant phototropic responses [].; GO: 0005515 protein binding; PDB: 3NJA_D 3H9W_A 3GDI_B 3ICY_A 3EEH_A 3MR0_B. |
| >TIGR00229 sensory_box PAS domain S-box | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.5e-09 Score=96.17 Aligned_cols=115 Identities=22% Similarity=0.351 Sum_probs=95.4
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcC-CcEEEEEEE
Q 002342 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ-TDVTVQLIN 552 (934)
Q Consensus 474 l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~-~~~~~e~~~ 552 (934)
++.+++.++++++++|.+|. ++++|+++++++|++.++++|+++..+.++.........+...+..+ .....+..+
T Consensus 5 ~~~~~~~~~~~~~~~d~~~~---i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (124)
T TIGR00229 5 YRAIFESSPDAIIVIDLEGN---ILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERLLEGEREPVSEERRV 81 (124)
T ss_pred HHHHHhhCCceEEEEcCCCc---EEEEchHHHHHhCCChHHhcCcchhhhcChhhhHHHHHHHHHHHcCCCCCcceEeee
Confidence 78899999999999999888 99999999999999999999999877777766655555555555533 234445555
Q ss_pred EecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccc
Q 002342 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 592 (934)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~ 592 (934)
..++|..+|+.....|+. .+|...+++++++|||+++++
T Consensus 82 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dit~~~~~ 120 (124)
T TIGR00229 82 RRKDGSEIWVEVSVSPIR-TNGGELGVVGIVRDITERKQA 120 (124)
T ss_pred EcCCCCEEEEEEEEeehh-hCCCeeEEEEEeeehhHHHHH
Confidence 688999999999999998 788899999999999999874
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. |
| >PF08447 PAS_3: PAS fold; InterPro: IPR013655 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.3e-09 Score=97.29 Aligned_cols=86 Identities=28% Similarity=0.453 Sum_probs=74.0
Q ss_pred eEEcchHHHHHcCCChhhHcCCC----CCCCCCCCCChHHHHHHHH-HHhcCCcEEEEEEEEecCCcEEEEEEEeeeeec
Q 002342 214 IMYASAGFFKMTGYTSKEVVGRN----CRFLQGAGTDPEDVAKIRE-TLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKD 288 (934)
Q Consensus 214 I~~~N~a~~~l~Gys~eEllG~~----~~~l~~~~~~~~~~~~i~~-~l~~g~~~~~e~~~~~kdG~~~wv~~s~~pi~d 288 (934)
|+|+|+.+++++||+++++ |.. +..+.+|++.......+.. .+..+..+..+++.+++||+.+|++.+..+++|
T Consensus 1 ~i~~s~~~~~i~G~~~~~~-~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~~~e~R~~~~~G~~~wi~~~~~~~~d 79 (91)
T PF08447_consen 1 IIYWSDNFYEIFGYSPEEI-GKPDFEEWLERIHPDDRERVRQAIQQAALQNGEPFEIEYRIRRKDGEYRWIEVRGRPIFD 79 (91)
T ss_dssp -EEE-THHHHHHTS-HHHH-TCBEHHHHHHHB-TTTHHHHHHHHHHHHHHTT-EEEEEEEEEGTTSTEEEEEEEEEEEET
T ss_pred CEEEeHHHHHHhCCCHHHh-ccCCHHHHHhhcCHHHHHHHHHHHHHHhhccCcceEEEEEEECCCCCEEEEEEEEEEEEC
Confidence 6899999999999999999 766 6678899999999999999 788888999999999999999999999999999
Q ss_pred CCCCEEEEEEEE
Q 002342 289 DEGKVLKFIGMQ 300 (934)
Q Consensus 289 ~~G~v~~~v~~~ 300 (934)
++|++.+++|+.
T Consensus 80 ~~g~~~~~~Gv~ 91 (91)
T PF08447_consen 80 ENGKPIRIIGVI 91 (91)
T ss_dssp TTS-EEEEEEEE
T ss_pred CCCCEEEEEEEC
Confidence 999999999874
|
The PAS fold appears in archaea, eubacteria and eukarya. The PAS domain contains a sensory box, or S-box domain that occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include haem in the oxygen sensor FixL [], FAD in the redox potential sensor NifL [], and a 4-hydroxycinnamyl chromophore in photoactive yellow protein []. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. This domain has been found in the gene product of the madA gene of the filamentous zygomycete fungus Phycomyces blakesleeanus. It has been shown that MadA encodes a blue-light photoreceptor for phototropism and other light responses. The gene is involved in the phototropic responses associated with sporangiophore growth; they exhibit phototropism by bending toward near-UV and blue wavelengths and away from far-UV wavelengths in a manner that is physiologically similar to plant phototropic responses [].; GO: 0005515 protein binding; PDB: 3NJA_D 3H9W_A 3GDI_B 3ICY_A 3EEH_A 3MR0_B. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.4e-10 Score=132.21 Aligned_cols=199 Identities=21% Similarity=0.278 Sum_probs=154.6
Q ss_pred cccCCcccccccccCCcEEEEEEEEe-cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCe
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELC-GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 743 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~-~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 743 (934)
....+|..+..||.|.|+.|+.+... .++..|++|.+.+......++.. -..|+-+...+ .|.+++.++..+....+
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCcccccc
Confidence 44678999999999999999998765 67889999988776544444433 33466666666 58999999888888888
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-CcEEEEecccCcccC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLTS 822 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-~~vkl~DFG~a~~~~ 822 (934)
.|+-.|||+++++...+.. ...+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||.+..+.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 8999999999988766632 3458888999999999999999999999999999999999876 788999999884321
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCcc--chhhhcCCCCCchhHHHHHHHHHHHHHhCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYI--APEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~--aPE~l~~~~~s~~~DiwSlG~iL~elltG~~P 897 (934)
... ..+.+.-+++ ++..+....+..+.|++|||..+.+.++|.+.
T Consensus 419 ~~~------------------------------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 419 FSS------------------------------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred eec------------------------------ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 110 1122333444 55555667788899999999999999988654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.9e-09 Score=111.82 Aligned_cols=140 Identities=23% Similarity=0.305 Sum_probs=106.9
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC--CCccceeEEEEeC---CeEEEEEE
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTK---THVCLITD 749 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~---~~~~lV~E 749 (934)
+.|+.|.++.||++... +|..|++|+....... .....+..|..+++.+.+ ..+++++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 56899999999999873 3678999987653211 134567889999999975 4467777776653 36789999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC---------------------------------------- 789 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~---------------------------------------- 789 (934)
|++|.++...+.. ..++......++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 81 RVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9999988876532 236777777778888888888873
Q ss_pred ----------------CCCeecCCCCCCEEEec--CCcEEEEecccCcc
Q 002342 790 ----------------QGIIYRDLKPENVLLQG--NGHVSLTDFDLSCL 820 (934)
Q Consensus 790 ----------------~giiHrDLKp~NILl~~--~~~vkl~DFG~a~~ 820 (934)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 56789999998843
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3829 RocR Transcriptional regulator containing PAS, AAA-type ATPase, and DNA-binding domains [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.1e-08 Score=113.39 Aligned_cols=221 Identities=18% Similarity=0.202 Sum_probs=153.2
Q ss_pred HHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEe
Q 002342 192 KDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYK 271 (934)
Q Consensus 192 ~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~ 271 (934)
+.+++.+.++++++|.. ..|..+|..+..+++-....++|+++..+.++...+.. . .+..+........
T Consensus 4 ~~~l~~~~~~~~vi~~~---~~~~~~~~~a~~~~~~~~~~~i~~~~~~i~~~~~~~~v-------~-~~~~~~~~~~~~~ 72 (560)
T COG3829 4 EGILKSILDGPVVIDKN---TGIDVANALALAKRQKNAEAVIGRPLREILETLGMERV-------E-QSRDKELTERLKL 72 (560)
T ss_pred hhhhhhcccceEEEEcC---CceeeechHHHHhhhcceEEEecccceeeccccCccee-------e-ccCccceeeeeec
Confidence 45899999999999984 44999999999999999999999988766555443221 1 2222222223333
Q ss_pred cCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhhcCCCCCchhhhHHHHHHHHHhHHHHHHHHHHccCCCC
Q 002342 272 KDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS 351 (934)
Q Consensus 272 kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~~~~~~l~~~l~~~~~~~~~~~~~~~~~l~~~~~~~~~ 351 (934)
+ + .. ..+...++.++.|+++|++.++.|+++..+.-.+..
T Consensus 73 ~-~-~~-~~~~~~~~~~~~~~~~g~~~~~~~~~e~~~~~~~~l------------------------------------- 112 (560)
T COG3829 73 K-V-KR-IVVVGKTPVDEQGRVVGVLEVFLDISEALELIEENL------------------------------------- 112 (560)
T ss_pred c-c-ee-EEEcCCceeecCCceeeeehhhhhhHHHHHHHHHHH-------------------------------------
Confidence 3 3 22 233344456778899999999999998544332210
Q ss_pred cccCCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCCcccccccccccchhcccccccccccccccccccCC
Q 002342 352 LSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQST 431 (934)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (934)
T Consensus 113 -------------------------------------------------------------------------------- 112 (560)
T COG3829 113 -------------------------------------------------------------------------------- 112 (560)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhhcccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCC
Q 002342 432 DDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYS 511 (934)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~~~dv~~r~~~e~~l~~~~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys 511 (934)
++.+ ..|+.+++.+.++++++|.+|. ++++|.++..++|++
T Consensus 113 -------------------------------~~~~-----~~l~~il~~~~~~l~vvD~~G~---~i~~N~~~~~~~gl~ 153 (560)
T COG3829 113 -------------------------------RQLR-----QRLEAILDSIDDGLLVVDEDGI---IIYYNKAYAKLLGLS 153 (560)
T ss_pred -------------------------------HHHH-----HHHHHHHhhccCceEEEcCCCc---EEEEcHHHHHHhCCC
Confidence 0001 1289999999999999999999 999999999999999
Q ss_pred hhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccc
Q 002342 512 REEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 591 (934)
Q Consensus 512 ~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~ 591 (934)
.++++|++..++.....+ ......+..+.+.......+. |... ..+..|++ .+|.+.|.+++++|+++-+.
T Consensus 154 ~e~~~gk~~~~v~~~~~~----s~~l~vl~~~kp~~~~~~~~~--~~~~--i~~~~pv~-~~g~l~G~v~~~~~~~~l~~ 224 (560)
T COG3829 154 PEEVLGKHLLDVVSAGED----STLLEVLRTGKPIRDVVQTYN--GNKI--IVNVAPVY-ADGQLIGVVGISKDVSELER 224 (560)
T ss_pred HHHHcCCcHHHHHhccCC----ceehhhhhcCCcceeeeeeec--CCce--eEeeccEe-cCCcEEEEEEeecchHHHHH
Confidence 999999997766511111 123445666766554444333 3222 34456665 56799999999999998766
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.1e-08 Score=102.01 Aligned_cols=127 Identities=24% Similarity=0.207 Sum_probs=82.3
Q ss_pred EEEEEEEecCCeEEEEEEeeccccc-----------------------ChHHHHHHHHHHHHHHhCCCC--CccceeEEE
Q 002342 684 SVHLVELCGSGQYFAMKAMDKGVML-----------------------NRNKVHRACAEREILDMLDHP--FVPALYASF 738 (934)
Q Consensus 684 ~Vy~a~~~~~~~~vAlK~~~~~~~~-----------------------~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~~ 738 (934)
.||.|.. .+|..+|||+.+..... .........+|.++|..+..- +++.++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888887 56789999988642110 011123456799999999765 567776543
Q ss_pred EeCCeEEEEEEccC--CCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHH-HHHCCCeecCCCCCCEEEecCCcEEEEec
Q 002342 739 QTKTHVCLITDYCP--GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY-LHCQGIIYRDLKPENVLLQGNGHVSLTDF 815 (934)
Q Consensus 739 ~~~~~~~lV~E~~~--ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~y-LH~~giiHrDLKp~NILl~~~~~vkl~DF 815 (934)
..+|||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 3369999997 55555443321 2244566778888885555 578999999999999999966 9999999
Q ss_pred ccCcc
Q 002342 816 DLSCL 820 (934)
Q Consensus 816 G~a~~ 820 (934)
|.+..
T Consensus 151 ~qav~ 155 (188)
T PF01163_consen 151 GQAVD 155 (188)
T ss_dssp TTEEE
T ss_pred Cccee
Confidence 98843
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.5e-08 Score=105.50 Aligned_cols=133 Identities=19% Similarity=0.060 Sum_probs=94.4
Q ss_pred EEEEEEecCCeEEEEEEeecccccC--h------HHHHHHHHHHHHHHhCCCCCc--cceeEEEEe-----CCeEEEEEE
Q 002342 685 VHLVELCGSGQYFAMKAMDKGVMLN--R------NKVHRACAEREILDMLDHPFV--PALYASFQT-----KTHVCLITD 749 (934)
Q Consensus 685 Vy~a~~~~~~~~vAlK~~~~~~~~~--~------~~~~~~~~E~~il~~l~hp~I--v~l~~~~~~-----~~~~~lV~E 749 (934)
|+.+.. .|+.|.||......... + .......+|...+..|..-+| +.+..++.. ....+||||
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 555544 67789999775332110 0 011136688888888744333 344555543 235789999
Q ss_pred ccCCC-CchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-------CCcEEEEecccCc
Q 002342 750 YCPGG-ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-------NGHVSLTDFDLSC 819 (934)
Q Consensus 750 ~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-------~~~vkl~DFG~a~ 819 (934)
++++. +|.+++........+......++.+++..+.-||..||+|+|++++|||++. ++.+.++||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99876 7888875322234667788899999999999999999999999999999985 4689999999874
|
|
| >cd00130 PAS PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.2e-07 Score=80.78 Aligned_cols=103 Identities=27% Similarity=0.422 Sum_probs=89.0
Q ss_pred ccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 002342 481 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 560 (934)
Q Consensus 481 ~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~~ 560 (934)
++++++++|.+|. ++++|+++++++|++.++++|+....++++.........+...+..+.....+......+|..+
T Consensus 1 ~~~~i~~~d~~~~---~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (103)
T cd00130 1 LPDGVIVLDLDGR---ILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGEPVTLEVRLRRKDGSVI 77 (103)
T ss_pred CCceEEEECCCCc---EEEECHHHHHHhCCCHHHHcCccHHHhcCCccchHHHHHHHHHHhcCcCeEEEEEEEccCCCEE
Confidence 3678999999888 9999999999999999999999987888877776666666666666666778888888899999
Q ss_pred EEEEEEEeeecCCCCEEEEEEEEEcC
Q 002342 561 WNLFHLQPMRDQKGEVQYFIGVQLDG 586 (934)
Q Consensus 561 wv~~~~~pi~de~G~v~~~vgi~rDI 586 (934)
|+.....++.+..|...+++++.+||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~di 103 (103)
T cd00130 78 WVLVSLTPIRDEGGEVIGLLGVVRDI 103 (103)
T ss_pred EEEEEEEEEecCCCCEEEEEEEEecC
Confidence 99999999998888999999999986
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. |
| >cd00130 PAS PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.3e-07 Score=80.54 Aligned_cols=103 Identities=24% Similarity=0.479 Sum_probs=86.8
Q ss_pred ccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 002342 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 277 (934)
Q Consensus 198 ~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 277 (934)
++++++++|. +|.++++|+++++++|++.++++|+.+..+.++.........+...+..+.....++.....+|...
T Consensus 1 ~~~~i~~~d~---~~~~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (103)
T cd00130 1 LPDGVIVLDL---DGRILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGEPVTLEVRLRRKDGSVI 77 (103)
T ss_pred CCceEEEECC---CCcEEEECHHHHHHhCCCHHHHcCccHHHhcCCccchHHHHHHHHHHhcCcCeEEEEEEEccCCCEE
Confidence 3578899998 6779999999999999999999999987677776666666666666666666777888888889999
Q ss_pred EEEEEeeeeecCCCCEEEEEEEEecc
Q 002342 278 WNLLTIAPIKDDEGKVLKFIGMQVEV 303 (934)
Q Consensus 278 wv~~s~~pi~d~~G~v~~~v~~~~DI 303 (934)
|+.+...++.+..|...+++++.+||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~di 103 (103)
T cd00130 78 WVLVSLTPIRDEGGEVIGLLGVVRDI 103 (103)
T ss_pred EEEEEEEEEecCCCCEEEEEEEEecC
Confidence 99999999999888999999999886
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=7.1e-09 Score=109.15 Aligned_cols=154 Identities=24% Similarity=0.315 Sum_probs=114.9
Q ss_pred HHHHhCCCCCccceeEEEEeCC-----eEEEEEEccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHC--C
Q 002342 721 EILDMLDHPFVPALYASFQTKT-----HVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQ--G 791 (934)
Q Consensus 721 ~il~~l~hp~Iv~l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~--g 791 (934)
.-|-++.|.|||+++.|+.+.. ...++.|||..|+|..+|++- ..+.+.....++|+.||+.||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3455668999999999987543 478999999999999999753 234588888999999999999999998 5
Q ss_pred CeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc
Q 002342 792 IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA 871 (934)
Q Consensus 792 iiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~ 871 (934)
|+|+++..+-|++..+|-+|+.--.-... .+... .+. -..+....|-++|.+||.=.
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~---h~s~~--~~~------------------~~Ek~~~~~~~g~~a~~sg~ 255 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDST---HPSVN--STR------------------EAEKSVNTSLPGFSAPESGT 255 (458)
T ss_pred cccCCcchhheeecCCceEEecccCcccc---chhhh--hhh------------------HhhhhccccCCccccCCcCc
Confidence 99999999999999888887643221100 00000 000 01112234678899999876
Q ss_pred CCCCCchhHHHHHHHHHHHHHhCCCC
Q 002342 872 GAGHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 872 ~~~~s~~~DiwSlG~iL~elltG~~P 897 (934)
....+.++|||+||.+.++|..+..-
T Consensus 256 ~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 256 TTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred ccccccchhhhhhhHHHHHHHHheec
Confidence 66777799999999999999987653
|
|
| >TIGR02966 phoR_proteo phosphate regulon sensor kinase PhoR | Back alignment and domain information |
|---|
Probab=98.76 E-value=3e-08 Score=110.56 Aligned_cols=114 Identities=15% Similarity=0.135 Sum_probs=88.7
Q ss_pred cchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEE
Q 002342 185 PRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYC 264 (934)
Q Consensus 185 ~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~ 264 (934)
....+.|+.++++++++++++|. +|.|+++|++|++++||+.++++|+++..+..+ . .+...+..+.. .
T Consensus 2 ~~~~~~l~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~---~----~~~~~l~~~~~-~ 70 (333)
T TIGR02966 2 SALLSRFRAAAQALPDAVVVLDE---EGQIEWCNPAAERLLGLRWPDDLGQRITNLIRH---P----EFVEYLAAGRF-S 70 (333)
T ss_pred hhHHHHHHHHHHhCcCcEEEECC---CCcEEEEcHHHHHHhCCChHHHcCCcHHHHccC---H----HHHHHHHhccc-C
Confidence 45668899999999999999998 777999999999999999999999997755443 1 23333433332 2
Q ss_pred EEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhh
Q 002342 265 GRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (934)
Q Consensus 265 ~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~ 314 (934)
.......++|..+|+.+++.|+.+. . ++++++|||++++.++.++
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~p~~~~--~---~~~~~~dit~~~~~~~~~~ 115 (333)
T TIGR02966 71 EPLELPSPINSERVLEIRIAPYGEE--Q---KLLVARDVTRLRRLEQMRR 115 (333)
T ss_pred CCeEeecCCCCceEEEEEEEEcCCC--c---eEEEEeCchHHHHHHHHHH
Confidence 2344556889999999999998754 2 6788999999998877654
|
Members of this protein family are the regulatory histidine kinase PhoR associated with the phosphate ABC transporter in most Proteobacteria. Related proteins from Gram-positive organisms are not included in this model. The phoR gene usually is adjacent to the response regulator phoB gene (TIGR02154). |
| >PRK11073 glnL nitrogen regulation protein NR(II); Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.4e-08 Score=111.48 Aligned_cols=111 Identities=13% Similarity=0.119 Sum_probs=87.8
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEE
Q 002342 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552 (934)
Q Consensus 473 ~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~ 552 (934)
.++.+++++++|++++|.+|+ |+++|+++++++||+.++++|+++..+.+.... ....+...+..+..+..+...
T Consensus 8 ~~~~il~~~~~gi~~~d~~~~---i~~~N~a~~~~~g~~~~~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 82 (348)
T PRK11073 8 DAGQILNSLINSILLLDDDLA---IHYANPAAQQLLAQSSRKLFGTPLPELLSYFSL--NIELMRESLQAGQGFTDNEVT 82 (348)
T ss_pred hHHHHHhcCcCeEEEECCCCe---EeeEcHHHHHHhCCCHHHHcCCCHHHHcCcchh--hHHHHHHHHHcCCcccccceE
Confidence 489999999999999999888 999999999999999999999998887765322 223444556665555444445
Q ss_pred EecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccccc
Q 002342 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 593 (934)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e 593 (934)
..++|..+|+.++..|+. . .+++..++|||++++.+
T Consensus 83 ~~~~g~~~~~~~~~~~~~--~---~~~~~~~~dit~~~~~~ 118 (348)
T PRK11073 83 LVIDGRSHILSLTAQRLP--E---GMILLEMAPMDNQRRLS 118 (348)
T ss_pred EEECCceEEEEEEEEEcc--C---ceeEEEEechhHHHHHH
Confidence 567999999999999986 2 24667789999988753
|
|
| >PRK11073 glnL nitrogen regulation protein NR(II); Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.1e-07 Score=107.33 Aligned_cols=117 Identities=17% Similarity=0.213 Sum_probs=92.2
Q ss_pred HHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEE
Q 002342 188 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 267 (934)
Q Consensus 188 ~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 267 (934)
...++.+++++++|++++|. +|+|+++|++|++++||+.++++|+++..+.+... .....+...+..+..+....
T Consensus 6 ~~~~~~il~~~~~gi~~~d~---~~~i~~~N~a~~~~~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 80 (348)
T PRK11073 6 LPDAGQILNSLINSILLLDD---DLAIHYANPAAQQLLAQSSRKLFGTPLPELLSYFS--LNIELMRESLQAGQGFTDNE 80 (348)
T ss_pred cchHHHHHhcCcCeEEEECC---CCeEeeEcHHHHHHhCCCHHHHcCCCHHHHcCcch--hhHHHHHHHHHcCCcccccc
Confidence 35678999999999999998 77799999999999999999999999886655432 22344556666666555444
Q ss_pred EEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhh
Q 002342 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (934)
Q Consensus 268 ~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~ 314 (934)
..+.+||..+|+.++.+|+. . .+++..++|||++++.++++.
T Consensus 81 ~~~~~~g~~~~~~~~~~~~~--~---~~~~~~~~dit~~~~~~~~~~ 122 (348)
T PRK11073 81 VTLVIDGRSHILSLTAQRLP--E---GMILLEMAPMDNQRRLSQEQL 122 (348)
T ss_pred eEEEECCceEEEEEEEEEcc--C---ceeEEEEechhHHHHHHHHHH
Confidence 45578999999999999986 2 346778999999998877654
|
|
| >PRK11360 sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.9e-07 Score=113.21 Aligned_cols=128 Identities=13% Similarity=0.124 Sum_probs=105.0
Q ss_pred ccccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCC
Q 002342 182 KGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ 261 (934)
Q Consensus 182 ~aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~ 261 (934)
..+...+..++.++++++++++++|. +|+|+++|+++++++||+.++++|+++..++++.. .....+...+..+.
T Consensus 255 ~~l~~~~~~~~~i~~~~~~~i~~~d~---~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~ 329 (607)
T PRK11360 255 QALRETRSLNELILESIADGVIAIDR---QGKITTMNPAAEVITGLQRHELVGKPYSELFPPNT--PFASPLLDTLEHGT 329 (607)
T ss_pred HHHHHHHHHHHHHHHhccCeEEEEcC---CCCEEEECHHHHHHhCCChHHhcCCcHHHHcCCch--hHHHHHHHHHhcCC
Confidence 45667778899999999999999998 77799999999999999999999999887766543 23344555555554
Q ss_pred c-EEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhhc
Q 002342 262 S-YCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 315 (934)
Q Consensus 262 ~-~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~~ 315 (934)
. ...++...+++|..+ +.++..|+.+.+|.+.+++++++|||++++++++++.
T Consensus 330 ~~~~~~~~~~~~~~~~~-~~~~~~~i~~~~g~~~~~i~~~~Dite~~~~e~~l~~ 383 (607)
T PRK11360 330 EHVDLEISFPGRDRTIE-LSVSTSLLHNTHGEMIGALVIFSDLTERKRLQRRVAR 383 (607)
T ss_pred CccceEEEEEcCCCcEE-EEEEEeeEEcCCCCEEEEEEEEeechHHHHHHHHHHH
Confidence 4 334566677888876 8999999999999999999999999999999988763
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.4e-07 Score=105.30 Aligned_cols=134 Identities=17% Similarity=0.253 Sum_probs=107.4
Q ss_pred cEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe----CCeEEEEEEccCC-CCc
Q 002342 682 TGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----KTHVCLITDYCPG-GEL 756 (934)
Q Consensus 682 ~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~~lV~E~~~g-gsL 756 (934)
..+.|++...-+|..|++|+++.... ........-+++++++.|+|||+|.++|.. +..+++|++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~---~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRD---QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccc---cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 35889999999999999999953321 111223346788999999999999999973 4578999999975 577
Q ss_pred hhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccC
Q 002342 757 FLLLDRQ-------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (934)
Q Consensus 757 ~~~l~~~-------------~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a 818 (934)
+++.-.. .+...++..+|.|+.|+..||.++|+.|+..+-|.|.+||++.+.+++|...|..
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccce
Confidence 7664321 1235788999999999999999999999999999999999998888988887765
|
|
| >PRK11360 sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.3e-07 Score=114.59 Aligned_cols=118 Identities=16% Similarity=0.122 Sum_probs=96.4
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCc-EEEEEE
Q 002342 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD-VTVQLI 551 (934)
Q Consensus 473 ~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~-~~~e~~ 551 (934)
.++.++++++++++++|.+|. |+++|+++++++||+.++++|+++..+.++.. .....+...+..+.. ...+..
T Consensus 263 ~~~~i~~~~~~~i~~~d~~g~---i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 337 (607)
T PRK11360 263 LNELILESIADGVIAIDRQGK---ITTMNPAAEVITGLQRHELVGKPYSELFPPNT--PFASPLLDTLEHGTEHVDLEIS 337 (607)
T ss_pred HHHHHHHhccCeEEEEcCCCC---EEEECHHHHHHhCCChHHhcCCcHHHHcCCch--hHHHHHHHHHhcCCCccceEEE
Confidence 478899999999999999888 99999999999999999999999888876542 233444455555443 345667
Q ss_pred EEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccccccC
Q 002342 552 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNS 596 (934)
Q Consensus 552 ~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e~~~ 596 (934)
..+++|..+ +.++..|+++.+|++.+++++++|||++|+++.+.
T Consensus 338 ~~~~~~~~~-~~~~~~~i~~~~g~~~~~i~~~~Dite~~~~e~~l 381 (607)
T PRK11360 338 FPGRDRTIE-LSVSTSLLHNTHGEMIGALVIFSDLTERKRLQRRV 381 (607)
T ss_pred EEcCCCcEE-EEEEEeeEEcCCCCEEEEEEEEeechHHHHHHHHH
Confidence 778888876 88999999999999999999999999999864433
|
|
| >PF13596 PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.7e-07 Score=86.56 Aligned_cols=106 Identities=15% Similarity=0.255 Sum_probs=73.5
Q ss_pred HHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEE
Q 002342 191 VKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNY 270 (934)
Q Consensus 191 ~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 270 (934)
++.++++++.+++++|. +++|.|+|+++.++++.. +..+|+++..+.++.........+ +.+..+.....+...
T Consensus 1 L~~il~s~~~~i~~vD~---~~~I~~~n~~a~~~f~~~-~~~iGr~l~~~~~~~~~~~l~~~i-~~~~~~~~~~~~~~~- 74 (106)
T PF13596_consen 1 LNNILDSMPIGIIFVDR---NLRIRYFNPAAARLFNLS-PSDIGRPLFDIHPPLSYPNLKKII-EQVRSGKEEEFEIVI- 74 (106)
T ss_dssp HHHHHHHSSSEEEEEET---TSBEEEE-SCGC-SS----GGGTTSBCCCSS-HHHHHHHHHHH-HHHHTTSBSEEEEEE-
T ss_pred ChHHHhcCCCCEEEEcC---CCeEEEeChhHhhhcCCC-hHHCCCCHHHcCCccchHHHHHHH-HHHHcCCCceEEEEe-
Confidence 46899999999999999 777999999999999976 456899999887664333333444 445555543333332
Q ss_pred ecCCcEEEEEEEeeeeecCCCCEEEEEEEEecch
Q 002342 271 KKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (934)
Q Consensus 271 ~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DIT 304 (934)
..+| .|+.+++.|++|.+|...|++.++.|||
T Consensus 75 ~~~~--~~~~~~~~P~~~~~g~~~G~v~~~~DIT 106 (106)
T PF13596_consen 75 PNGG--RWYLVRYRPYRDEDGEYAGAVITFQDIT 106 (106)
T ss_dssp EETT--EEEEEEEEEEE-TTS-EEEEEEEEEE-G
T ss_pred cCCC--EEEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 3555 3778899999999999999999999998
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.8e-07 Score=96.32 Aligned_cols=136 Identities=22% Similarity=0.203 Sum_probs=102.8
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEeeccccc------C-------------hHHHHHHHHHHHHHHhCCCC--
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML------N-------------RNKVHRACAEREILDMLDHP-- 729 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~------~-------------~~~~~~~~~E~~il~~l~hp-- 729 (934)
+.+...||-|.-|.||.+.+. .|.++|||.-+.+... . ........+|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 455678999999999999985 6889999975422110 0 01123456799999999655
Q ss_pred CccceeEEEEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc
Q 002342 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 809 (934)
Q Consensus 730 ~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~ 809 (934)
.|+..+++ +..++||||++|-.|...- ++......++..|++-+.-+-..|+||+|+.+=||+++.+|.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 77777654 5668999999988776553 133455666777777777777899999999999999999999
Q ss_pred EEEEecccC
Q 002342 810 VSLTDFDLS 818 (934)
Q Consensus 810 vkl~DFG~a 818 (934)
+.++||--+
T Consensus 241 ~~vIDwPQ~ 249 (304)
T COG0478 241 IVVIDWPQA 249 (304)
T ss_pred EEEEeCccc
Confidence 999999866
|
|
| >TIGR02966 phoR_proteo phosphate regulon sensor kinase PhoR | Back alignment and domain information |
|---|
Probab=98.59 E-value=2e-07 Score=103.93 Aligned_cols=104 Identities=11% Similarity=0.008 Sum_probs=81.6
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEE
Q 002342 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552 (934)
Q Consensus 473 ~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~ 552 (934)
+|+.++++++++|+++|.+|. |+++|++|++++||+.++++|+++..+.+++ .. ...+..+.. ......
T Consensus 7 ~l~~~~~~~~~~i~~~d~~g~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~---~~----~~~l~~~~~-~~~~~~ 75 (333)
T TIGR02966 7 RFRAAAQALPDAVVVLDEEGQ---IEWCNPAAERLLGLRWPDDLGQRITNLIRHP---EF----VEYLAAGRF-SEPLEL 75 (333)
T ss_pred HHHHHHHhCcCcEEEECCCCc---EEEEcHHHHHHhCCChHHHcCCcHHHHccCH---HH----HHHHHhccc-CCCeEe
Confidence 489999999999999999888 9999999999999999999999977776542 22 222322222 223445
Q ss_pred EecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccc
Q 002342 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 592 (934)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~ 592 (934)
..++|..+|+.+...|+.+.. ++++++|||++++.
T Consensus 76 ~~~~~~~~~~~~~~~p~~~~~-----~~~~~~dit~~~~~ 110 (333)
T TIGR02966 76 PSPINSERVLEIRIAPYGEEQ-----KLLVARDVTRLRRL 110 (333)
T ss_pred ecCCCCceEEEEEEEEcCCCc-----eEEEEeCchHHHHH
Confidence 568899999999999987542 67888999998873
|
Members of this protein family are the regulatory histidine kinase PhoR associated with the phosphate ABC transporter in most Proteobacteria. Related proteins from Gram-positive organisms are not included in this model. The phoR gene usually is adjacent to the response regulator phoB gene (TIGR02154). |
| >KOG0501 consensus K+-channel KCNQ [Inorganic ion transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.58 E-value=4.1e-07 Score=101.29 Aligned_cols=119 Identities=27% Similarity=0.600 Sum_probs=103.5
Q ss_pred HHHHHHhcc---ccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCC--CcccCCCCCCHHHHHHHHHHHhcCCcEEE
Q 002342 474 LATTLERIE---KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRN--CRFLQGPETDPATVRKIRAAIDNQTDVTV 548 (934)
Q Consensus 474 l~~i~e~~~---d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~--~~~l~~~~~~~~~~~~i~~~l~~~~~~~~ 548 (934)
++.++.... ..+++.+++-.|++|+|+|+.||++.||.+.|++.++ +.+++++-.+....+.+++.+...+.-++
T Consensus 16 LENiiRRsn~~dtsFlL~NAQiVD~PiVY~NdgFcKlsGY~RAevMQKs~tc~FMyGEltdk~ti~k~~~t~eN~~~~qf 95 (971)
T KOG0501|consen 16 LENIIRRSNNADTSFLLANAQIVDWPIVYCNDGFCKLSGYHRAEVMQKSCTCSFMYGELTDKGTIEKVRQTLENYETNQF 95 (971)
T ss_pred HHHHHhhccCCCcceeeccceeeccceEEecCcchhccCccHHHHhcccceeeeeeccccchhhHHHHHHHHHhhhhcce
Confidence 666665443 4555566666689999999999999999999999988 55667777777788888999998888899
Q ss_pred EEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccc
Q 002342 549 QLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 592 (934)
Q Consensus 549 e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~ 592 (934)
|+.++.|+.+..|..+.+.||+++...++.|+..++|||..|++
T Consensus 96 EillyKKN~TPvW~~vqiAPIrNe~d~VVLfLctFkDIT~~KQP 139 (971)
T KOG0501|consen 96 EILLYKKNRTPVWLLVQIAPIRNEKDKVVLFLCTFKDITALKQP 139 (971)
T ss_pred eeEeeecCCCceEEEEEeecccCCCceEEEEEeecccchhhcCC
Confidence 99999999999999999999999999999999999999999996
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.6e-07 Score=92.42 Aligned_cols=141 Identities=20% Similarity=0.243 Sum_probs=94.4
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHH------HHHHHHHHHhCCC---CCccceeE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR------ACAEREILDMLDH---PFVPALYA 736 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~------~~~E~~il~~l~h---p~Iv~l~~ 736 (934)
+...+|.+.+.+-......|.+..- +|..|++|............... ..+.+..+..+.. -....++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3457899999999988888888876 77899999877542211111111 1233343333322 22222222
Q ss_pred EEE-----eCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEE
Q 002342 737 SFQ-----TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 811 (934)
Q Consensus 737 ~~~-----~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vk 811 (934)
+.. .....+|+|||++|..|.++.. +++ .+...+..+|.-||+.|+.|+|.+|+|++++. +.++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~ 174 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIR 174 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEE
Confidence 222 2245679999999998877642 232 24466778899999999999999999999995 5599
Q ss_pred EEecccCc
Q 002342 812 LTDFDLSC 819 (934)
Q Consensus 812 l~DFG~a~ 819 (934)
++||+..+
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99998763
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=9.5e-07 Score=96.41 Aligned_cols=209 Identities=20% Similarity=0.290 Sum_probs=136.2
Q ss_pred cccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccc----eeEE--EEeC-CeE
Q 002342 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA----LYAS--FQTK-THV 744 (934)
Q Consensus 673 i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~----l~~~--~~~~-~~~ 744 (934)
..+.||+|+-+.+|-+.... -.+-|++++.......+ -...|... .||-+.. .... ..+. ...
T Consensus 15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~aq------k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQAQ------KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchhh---chhheeecCCCchHHHH------HHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 44679999999999765433 35678887642211111 12223333 5664322 1111 1122 236
Q ss_pred EEEEEccCCCCc-hhhh----ccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 745 CLITDYCPGGEL-FLLL----DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 745 ~lV~E~~~ggsL-~~~l----~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
.++|..+.|..= ..++ .++....+.++.+...++.++.+.+-||..|.+-+|+.++|+|+++++.|.|.|-..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 788888866421 1111 23455668899999999999999999999999999999999999999999999855321
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc-----CCCCCchhHHHHHHHHHHHHHhC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYG 894 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~~~DiwSlG~iL~elltG 894 (934)
.- .+......-+|...|.+||... +..-+...|.|.||+++|+|+.|
T Consensus 166 i~----------------------------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~g 217 (637)
T COG4248 166 IN----------------------------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFG 217 (637)
T ss_pred ec----------------------------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhc
Confidence 10 1112223457999999999875 23345578999999999999985
Q ss_pred -CCCCCCCCH----HHHH-HHHHcCCCCCC
Q 002342 895 -YTPFRGKTR----QKTF-ANILHKDLKFP 918 (934)
Q Consensus 895 -~~Pf~~~~~----~~~~-~~i~~~~~~~p 918 (934)
+.||.|--. ..-+ ..|-+|.|.+-
T Consensus 218 grHPysGI~~~~~ap~p~E~~Ia~g~f~ya 247 (637)
T COG4248 218 GRHPYSGIPLISDAPNPLETDIAHGRFAYA 247 (637)
T ss_pred CCCCCCcccccCCCCCcchhhhhcceeeec
Confidence 999986221 1122 25666666543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=9.8e-07 Score=91.89 Aligned_cols=105 Identities=28% Similarity=0.300 Sum_probs=83.1
Q ss_pred HHHHHHHHHHHhCCCC--CccceeEEEEeC----CeEEEEEEccCCC-CchhhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 002342 714 HRACAEREILDMLDHP--FVPALYASFQTK----THVCLITDYCPGG-ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786 (934)
Q Consensus 714 ~~~~~E~~il~~l~hp--~Iv~l~~~~~~~----~~~~lV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~y 786 (934)
....+|...+..|..- .++..+.+.... ...+||+|++++. +|.+++..... .+......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 4567788887777533 345666666542 2458999999874 79988876322 6677788899999999999
Q ss_pred HHHCCCeecCCCCCCEEEecCC---cEEEEecccCcc
Q 002342 787 LHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCL 820 (934)
Q Consensus 787 LH~~giiHrDLKp~NILl~~~~---~vkl~DFG~a~~ 820 (934)
||.+||+|+|++|.|||++.++ .+.++||+.+..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999887 899999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=1e-06 Score=90.17 Aligned_cols=140 Identities=14% Similarity=0.129 Sum_probs=101.7
Q ss_pred ccCCcEEEEEEEEecCCeEEEEEEeecccc---cChHHHHHHHHHHHHHHhCCCCC--ccceeEEEE---e--CCeEEEE
Q 002342 678 GSGDTGSVHLVELCGSGQYFAMKAMDKGVM---LNRNKVHRACAEREILDMLDHPF--VPALYASFQ---T--KTHVCLI 747 (934)
Q Consensus 678 G~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~---~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~~~---~--~~~~~lV 747 (934)
|+||.|.|+.... .|+.|=+|.-..... .-+.....+.+|...|..|..-+ ++++. ++. . .-..+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 7889999999876 344677886542211 11334567889999998885332 44544 332 1 1246799
Q ss_pred EEccCC-CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc--EEEEecccCcc
Q 002342 748 TDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--VSLTDFDLSCL 820 (934)
Q Consensus 748 ~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~--vkl~DFG~a~~ 820 (934)
+|-++| .+|.+++....-...+......++.+++..+.-||+.|+.|+|+-+.||+++.+|. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997743 68888876543334677778899999999999999999999999999999986677 99999997743
|
|
| >PF12860 PAS_7: PAS fold | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.9e-07 Score=86.30 Aligned_cols=105 Identities=20% Similarity=0.275 Sum_probs=74.0
Q ss_pred HHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhH-cCCCCCCCC---------CCCCChHHHHHHHHHHhcCCcEE
Q 002342 195 LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV-VGRNCRFLQ---------GAGTDPEDVAKIRETLQNGQSYC 264 (934)
Q Consensus 195 le~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEl-lG~~~~~l~---------~~~~~~~~~~~i~~~l~~g~~~~ 264 (934)
++++++||++.|. +|+++++|++|.+++|++.+.+ .|.++..+. .+.............+.......
T Consensus 1 Ld~l~~Gv~v~D~---~~rl~~~N~~~~~l~~~~~~~~~~G~~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (115)
T PF12860_consen 1 LDSLPQGVAVFDS---DGRLVFWNQRFRELFGLPPEMLRPGASFRDLLRRLAERGEFPPGDPEAWVRQRLARLRRRQPRS 77 (115)
T ss_pred CCCcCceEEEEcC---CCeEEeEcHHHHHHhCCCHHHhcCCCCHHHHHHHHHHcCCCCCCCHHHHHHHHHHHHhcCCCce
Confidence 4789999999999 7779999999999999999998 788754221 22222233333333334433333
Q ss_pred EEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHH
Q 002342 265 GRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAK 311 (934)
Q Consensus 265 ~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~ 311 (934)
.+ ....||. |++++..|+ ++| |+|.++.|||+++++|+
T Consensus 78 ~~--~~~~dgr--~l~~~~~~~--~~G---g~v~~~~DVT~~~~~E~ 115 (115)
T PF12860_consen 78 FE--LRLPDGR--WLEVRAQPL--PDG---GFVLTFTDVTERRRAEE 115 (115)
T ss_pred eE--EECCCCE--EEEEEeEEC--CCC---CEEEEEEeCCHHHHhcC
Confidence 33 3467785 678888888 456 56789999999999874
|
|
| >PF13596 PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.2e-07 Score=84.62 Aligned_cols=106 Identities=20% Similarity=0.318 Sum_probs=74.1
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 002342 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (934)
Q Consensus 474 l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~ 553 (934)
++.++++++.+++++|.+++ |.++|+++.++|+.. ...+|+++..+.++...+...+.+. .+..+.....+...
T Consensus 1 L~~il~s~~~~i~~vD~~~~---I~~~n~~a~~~f~~~-~~~iGr~l~~~~~~~~~~~l~~~i~-~~~~~~~~~~~~~~- 74 (106)
T PF13596_consen 1 LNNILDSMPIGIIFVDRNLR---IRYFNPAAARLFNLS-PSDIGRPLFDIHPPLSYPNLKKIIE-QVRSGKEEEFEIVI- 74 (106)
T ss_dssp HHHHHHHSSSEEEEEETTSB---EEEE-SCGC-SS----GGGTTSBCCCSS-HHHHHHHHHHHH-HHHTTSBSEEEEEE-
T ss_pred ChHHHhcCCCCEEEEcCCCe---EEEeChhHhhhcCCC-hHHCCCCHHHcCCccchHHHHHHHH-HHHcCCCceEEEEe-
Confidence 46789999999999999888 999999999999976 5668999988877644444444444 44455443333332
Q ss_pred ecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCC
Q 002342 554 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587 (934)
Q Consensus 554 ~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDIT 587 (934)
..+|. |+.++..|+++.+|+..|++.++.|||
T Consensus 75 ~~~~~--~~~~~~~P~~~~~g~~~G~v~~~~DIT 106 (106)
T PF13596_consen 75 PNGGR--WYLVRYRPYRDEDGEYAGAVITFQDIT 106 (106)
T ss_dssp EETTE--EEEEEEEEEE-TTS-EEEEEEEEEE-G
T ss_pred cCCCE--EEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 35555 677899999999999999999999998
|
|
| >PF12860 PAS_7: PAS fold | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.3e-07 Score=85.87 Aligned_cols=104 Identities=22% Similarity=0.284 Sum_probs=74.0
Q ss_pred HHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhh-cCCCCcccC---------CCCCCHHHHHHHHHHHhcCCcEE
Q 002342 478 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEI-LGRNCRFLQ---------GPETDPATVRKIRAAIDNQTDVT 547 (934)
Q Consensus 478 ~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEl-iG~~~~~l~---------~~~~~~~~~~~i~~~l~~~~~~~ 547 (934)
++++++||++.|.+|+ ++++|++|.+++|++.+.+ .|.++..++ .+.....................
T Consensus 1 Ld~l~~Gv~v~D~~~r---l~~~N~~~~~l~~~~~~~~~~G~~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (115)
T PF12860_consen 1 LDSLPQGVAVFDSDGR---LVFWNQRFRELFGLPPEMLRPGASFRDLLRRLAERGEFPPGDPEAWVRQRLARLRRRQPRS 77 (115)
T ss_pred CCCcCceEEEEcCCCe---EEeEcHHHHHHhCCCHHHhcCCCCHHHHHHHHHHcCCCCCCCHHHHHHHHHHHHhcCCCce
Confidence 4678999999999888 9999999999999999998 788855443 22222333333333334444333
Q ss_pred EEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccccc
Q 002342 548 VQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 593 (934)
Q Consensus 548 ~e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e 593 (934)
.+ ....||. |+.++..|+ .+| +++.++.|||++|++|
T Consensus 78 ~~--~~~~dgr--~l~~~~~~~--~~G---g~v~~~~DVT~~~~~E 114 (115)
T PF12860_consen 78 FE--LRLPDGR--WLEVRAQPL--PDG---GFVLTFTDVTERRRAE 114 (115)
T ss_pred eE--EECCCCE--EEEEEeEEC--CCC---CEEEEEEeCCHHHHhc
Confidence 33 3457787 677888888 456 5778899999999864
|
|
| >KOG0501 consensus K+-channel KCNQ [Inorganic ion transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.2e-07 Score=102.09 Aligned_cols=121 Identities=31% Similarity=0.631 Sum_probs=103.0
Q ss_pred HHHHHHHhcc--C-cEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCC--CCCCCCCChHHHHHHHHHHhcCCcEE
Q 002342 190 IVKDALSTFQ--Q-TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCR--FLQGAGTDPEDVAKIRETLQNGQSYC 264 (934)
Q Consensus 190 ~~~~ile~~~--d-~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~--~l~~~~~~~~~~~~i~~~l~~g~~~~ 264 (934)
.++.|+.-+. | .+++-+..-.|..|+|+|..||++.||.+.|+.-+++. +++.+..+....+.++++++..+.-+
T Consensus 15 FLENiiRRsn~~dtsFlL~NAQiVD~PiVY~NdgFcKlsGY~RAevMQKs~tc~FMyGEltdk~ti~k~~~t~eN~~~~q 94 (971)
T KOG0501|consen 15 FLENIIRRSNNADTSFLLANAQIVDWPIVYCNDGFCKLSGYHRAEVMQKSCTCSFMYGELTDKGTIEKVRQTLENYETNQ 94 (971)
T ss_pred HHHHHHhhccCCCcceeeccceeeccceEEecCcchhccCccHHHHhcccceeeeeeccccchhhHHHHHHHHHhhhhcc
Confidence 4444544433 3 44555555558889999999999999999999999865 78888888899999999999998888
Q ss_pred EEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHH
Q 002342 265 GRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGA 310 (934)
Q Consensus 265 ~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e 310 (934)
.|+..++|+-..+|+.+.+.||+++...++-|+++++|||..|+--
T Consensus 95 fEillyKKN~TPvW~~vqiAPIrNe~d~VVLfLctFkDIT~~KQPi 140 (971)
T KOG0501|consen 95 FEILLYKKNRTPVWLLVQIAPIRNEKDKVVLFLCTFKDITALKQPI 140 (971)
T ss_pred eeeEeeecCCCceEEEEEeecccCCCceEEEEEeecccchhhcCCC
Confidence 9999999999999999999999999999999999999999988743
|
|
| >PRK11388 DNA-binding transcriptional regulator DhaR; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=5.2e-06 Score=101.54 Aligned_cols=107 Identities=16% Similarity=0.196 Sum_probs=78.3
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 002342 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (934)
Q Consensus 474 l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~ 553 (934)
+..+++.+++||+++|.+|+ |+++|+++++++|++.++++|+++..+++.. . .+...+..+..........
T Consensus 205 ~~~il~~~~~gVl~vD~~G~---I~~~N~aa~~llg~s~~~l~G~~i~~l~~~~--~----~l~~vl~~~~~~~~~~~~l 275 (638)
T PRK11388 205 LNALLESMDDGVIAWDEQGN---LQFLNAQAARLLRLDATASQGRAITELLTLP--A----VLQQAIKQAHPLKHVEVTF 275 (638)
T ss_pred HHHHHhccCCcEEEECCCCe---EehhhHHHHHHhCcCHHHHCCCcHHHHhccc--h----HHHHHHhcCCceeeEEEEE
Confidence 56789999999999999888 9999999999999999999999977776421 1 2334455555443322223
Q ss_pred ecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccc
Q 002342 554 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 591 (934)
Q Consensus 554 ~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~ 591 (934)
..+|..+++.+++.|+.+..|. +++.+.+|++..++
T Consensus 276 ~~~g~~~~~~v~~~Pi~~~~g~--~~v~~l~~~~~~~~ 311 (638)
T PRK11388 276 ESQGQFIDAVITLKPIIEGQGT--SFILLLHPVEQMRQ 311 (638)
T ss_pred ecCCceEEEEEEEEeecccCce--EEEEEehhhHHHHH
Confidence 4567777889999999755453 35666788887543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 934 | ||||
| 2v0u_A | 146 | N- And C-terminal Helices Of Oat Lov2 (404-546) Are | 1e-67 | ||
| 2v1a_A | 144 | N- And C-Terminal Helices Of Oat Lov2 (404-546) Are | 1e-67 | ||
| 2wkp_A | 332 | Structure Of A Photoactivatable Rac1 Containing Lov | 5e-67 | ||
| 2wkq_A | 332 | Structure Of A Photoactivatable Rac1 Containing The | 7e-66 | ||
| 2wkr_A | 332 | Structure Of A Photoactivatable Rac1 Containing The | 8e-66 | ||
| 2z6c_A | 129 | Crystal Structure Of Lov1 Domain Of Phototropin1 Fr | 2e-63 | ||
| 2z6c_A | 129 | Crystal Structure Of Lov1 Domain Of Phototropin1 Fr | 4e-25 | ||
| 2z6d_A | 130 | Crystal Structure Of Lov1 Domain Of Phototropin2 Fr | 6e-55 | ||
| 2z6d_A | 130 | Crystal Structure Of Lov1 Domain Of Phototropin2 Fr | 4e-26 | ||
| 4eep_A | 115 | Crystal Structure Of Lov2 Domain Of Arabidopsis Tha | 8e-55 | ||
| 4eer_A | 115 | Crystal Structure Of Lov2 Domain Of Arabidopsis Tha | 5e-54 | ||
| 4ees_A | 115 | Crystal Structure Of Ilov Length = 115 | 4e-52 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-48 | ||
| 4eeu_A | 118 | Crystal Structure Of Philov2.1 Length = 118 | 5e-48 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-47 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-47 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-46 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-46 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-46 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-46 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-46 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-46 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-46 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-46 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-46 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-46 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-46 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-46 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-45 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-45 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-45 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-45 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-43 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-43 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-43 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-43 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-43 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-43 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-43 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-43 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-43 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-43 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-43 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-43 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-43 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-42 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-42 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-42 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-42 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-42 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-42 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-42 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-42 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-42 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-42 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-42 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-42 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-42 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-42 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-42 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-42 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-42 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-42 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-42 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-42 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-42 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-42 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-42 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-42 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-42 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-42 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-42 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-42 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-42 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-41 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-41 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-41 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-41 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-41 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-41 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-41 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-41 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-41 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-41 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-41 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-41 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-41 | ||
| 1g28_A | 104 | Structure Of A Flavin-Binding Domain, Lov2, From Th | 1e-40 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-40 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-40 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-39 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-39 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-39 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-39 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-38 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-38 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-37 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-36 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-36 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-36 | ||
| 1n9l_A | 109 | Crystal Structure Of The Phot-lov1 Domain From Chla | 2e-35 | ||
| 1n9l_A | 109 | Crystal Structure Of The Phot-lov1 Domain From Chla | 2e-24 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-35 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-35 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-35 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-35 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-35 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-35 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-35 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-34 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-34 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-34 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-34 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-34 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-34 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-34 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-34 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-34 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-34 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-34 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-34 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-34 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-34 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-34 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-34 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-34 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-34 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-34 | ||
| 3ulf_A | 170 | The Light State Structure Of The Blue-light Photore | 1e-32 | ||
| 3ue6_A | 166 | The Dark Structure Of The Blue-light Photoreceptor | 1e-32 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-32 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-31 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-31 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-30 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-30 | ||
| 3t50_A | 128 | X-Ray Structure Of The Lov Domain From The Lov-Hk S | 4e-29 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-29 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-29 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-28 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-28 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-28 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-28 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-28 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-28 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-28 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-28 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-28 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-28 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-28 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-28 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-28 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-28 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-28 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-28 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-28 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-28 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-28 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-28 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-27 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-27 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-27 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-27 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-27 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-27 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-27 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-27 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-27 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-27 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-27 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-27 | ||
| 2pr5_A | 132 | Structural Basis For Light-dependent Signaling In T | 5e-26 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-25 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-24 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-24 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-24 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-24 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-24 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-24 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-24 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-24 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-23 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-23 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-23 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-23 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-23 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-23 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-23 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-22 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-22 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-22 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-22 | ||
| 3p7n_A | 258 | Crystal Structure Of Light Activated Transcription | 4e-22 | ||
| 3p7n_A | 258 | Crystal Structure Of Light Activated Transcription | 5e-20 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-22 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-21 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-21 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-21 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-21 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-21 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-21 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-21 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-21 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-20 | ||
| 3hjk_A | 154 | 2.0 Angstrom Structure Of The Ile74val Variant Of V | 2e-20 | ||
| 3rh8_B | 148 | Crystal Structure Of The Light-State Dimer Of Funga | 2e-20 | ||
| 3is2_B | 154 | 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic | 2e-20 | ||
| 3hji_A | 154 | 1.8 Angstrom Crystal Structure Of The I74v:i85v Var | 3e-20 | ||
| 3is2_A | 154 | 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic | 3e-20 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-20 | ||
| 2pd7_A | 149 | 2.0 Angstrom Crystal Structure Of The Fungal Blue-L | 3e-20 | ||
| 2pd8_A | 149 | 1.8 Angstrom Crystal Structure Of The Cys71ser Muta | 3e-20 | ||
| 3d72_A | 149 | 1.65 Angstrom Crystal Structure Of The Cys71val Var | 4e-20 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-19 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-19 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-19 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-19 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-19 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-19 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-19 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-19 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-19 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-19 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-19 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-19 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-19 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-19 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-19 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-19 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-19 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-19 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-19 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-19 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-19 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-19 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-19 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-19 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-19 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-19 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-19 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-19 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-19 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-19 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-19 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-19 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-19 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-19 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-19 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-19 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-19 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-19 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-18 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-18 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-18 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-18 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-18 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-18 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-18 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-18 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-18 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-18 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-18 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 3sw1_A | 162 | Structure Of A Full-Length Bacterial Lov Protein Le | 2e-17 | ||
| 3sw1_A | 162 | Structure Of A Full-Length Bacterial Lov Protein Le | 2e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-17 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-17 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-17 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-17 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-17 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-17 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-17 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-16 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-16 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-15 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-15 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-15 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-14 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-11 | ||
| 4hj3_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-11 | ||
| 4hj3_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 1e-10 | ||
| 4hia_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-11 | ||
| 4hia_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 1e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-11 | ||
| 4hj6_A | 178 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-11 | ||
| 4hj6_A | 178 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 1e-10 | ||
| 4hj4_A | 177 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-11 | ||
| 4hj4_A | 177 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-08 | ||
| 2l0w_A | 138 | Solution Nmr Structure Of The N-Terminal Pas Domain | 6e-08 | ||
| 2l4r_A | 135 | Nmr Solution Structure Of The N-Terminal Pas Domain | 6e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-08 | ||
| 2l1m_A | 150 | Solution Structure Of The Eag Domain Of The Herg (K | 6e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 2gj3_A | 120 | Crystal Structure Of The Fad-Containing Pas Domain | 1e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-07 | ||
| 1byw_A | 110 | Structure Of The N-Terminal Domain Of The Human-Erg | 3e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-07 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-07 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-07 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-07 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-07 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-07 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 6e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 8e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 9e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 3ewk_A | 227 | Structure Of The Redox Sensor Domain Of Methylococc | 1e-06 | ||
| 3ewk_A | 227 | Structure Of The Redox Sensor Domain Of Methylococc | 3e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-06 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 4e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-06 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 5e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-06 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 6e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-06 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 6e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 1e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 2e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-05 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-05 |
| >pdb|2V0U|A Chain A, N- And C-terminal Helices Of Oat Lov2 (404-546) Are Involved In Light-induced Signal Transduction (cryo Dark Structure Of Lov2 (404-546)) Length = 146 | Back alignment and structure |
|
| >pdb|2V1A|A Chain A, N- And C-Terminal Helices Of Oat Lov2 (404-546) Are Involved In Light-Induced Signal Transduction (Room Temperature (293k) Dark Structure Of Lov2 (404-546)) Length = 144 | Back alignment and structure |
|
| >pdb|2WKP|A Chain A, Structure Of A Photoactivatable Rac1 Containing Lov2 Wildtype Length = 332 | Back alignment and structure |
|
| >pdb|2WKQ|A Chain A, Structure Of A Photoactivatable Rac1 Containing The Lov2 C450a Mutant Length = 332 | Back alignment and structure |
|
| >pdb|2WKR|A Chain A, Structure Of A Photoactivatable Rac1 Containing The Lov2 C450m Mutant Length = 332 | Back alignment and structure |
|
| >pdb|2Z6C|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin1 From Arabidopsis Thaliana Length = 129 | Back alignment and structure |
|
| >pdb|2Z6C|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin1 From Arabidopsis Thaliana Length = 129 | Back alignment and structure |
|
| >pdb|2Z6D|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin2 From Arabidopsis Thaliana Length = 130 | Back alignment and structure |
|
| >pdb|2Z6D|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin2 From Arabidopsis Thaliana Length = 130 | Back alignment and structure |
|
| >pdb|4EEP|A Chain A, Crystal Structure Of Lov2 Domain Of Arabidopsis Thaliana Phototropin 2 Length = 115 | Back alignment and structure |
|
| >pdb|4EER|A Chain A, Crystal Structure Of Lov2 Domain Of Arabidopsis Thaliana Phototropin 2 C426a Mutant Length = 115 | Back alignment and structure |
|
| >pdb|4EES|A Chain A, Crystal Structure Of Ilov Length = 115 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EEU|A Chain A, Crystal Structure Of Philov2.1 Length = 118 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1G28|A Chain A, Structure Of A Flavin-Binding Domain, Lov2, From The Chimeric PhytochromePHOTOTROPIN PHOTORECEPTOR PHY3 Length = 104 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1N9L|A Chain A, Crystal Structure Of The Phot-lov1 Domain From Chlamydomonas Reinhardtii In The Dark State. Length = 109 | Back alignment and structure |
|
| >pdb|1N9L|A Chain A, Crystal Structure Of The Phot-lov1 Domain From Chlamydomonas Reinhardtii In The Dark State. Length = 109 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ULF|A Chain A, The Light State Structure Of The Blue-light Photoreceptor Aureochrome1 Lov Length = 170 | Back alignment and structure |
|
| >pdb|3UE6|A Chain A, The Dark Structure Of The Blue-light Photoreceptor Aureochrome1 Lov Length = 166 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3T50|A Chain A, X-Ray Structure Of The Lov Domain From The Lov-Hk Sensory Protein From Brucella Abortus (Dark State). Length = 128 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2PR5|A Chain A, Structural Basis For Light-dependent Signaling In The Dimeric Lov Photosensor Ytva (dark Structure) Length = 132 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3P7N|A Chain A, Crystal Structure Of Light Activated Transcription Factor El222 From Erythrobacter Litoralis Length = 258 | Back alignment and structure |
|
| >pdb|3P7N|A Chain A, Crystal Structure Of Light Activated Transcription Factor El222 From Erythrobacter Litoralis Length = 258 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3HJK|A Chain A, 2.0 Angstrom Structure Of The Ile74val Variant Of Vivid (Vvd). Length = 154 | Back alignment and structure |
|
| >pdb|3RH8|B Chain B, Crystal Structure Of The Light-State Dimer Of Fungal Blue-Light Photoreceptor Vivid Length = 148 | Back alignment and structure |
|
| >pdb|3IS2|B Chain B, 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic Acid Form Of Vivid Length = 154 | Back alignment and structure |
|
| >pdb|3HJI|A Chain A, 1.8 Angstrom Crystal Structure Of The I74v:i85v Variant Of Vivid (Vvd). Length = 154 | Back alignment and structure |
|
| >pdb|3IS2|A Chain A, 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic Acid Form Of Vivid Length = 154 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2PD7|A Chain A, 2.0 Angstrom Crystal Structure Of The Fungal Blue-Light Photoreceptor Vivid Length = 149 | Back alignment and structure |
|
| >pdb|2PD8|A Chain A, 1.8 Angstrom Crystal Structure Of The Cys71ser Mutant Of Vivid Length = 149 | Back alignment and structure |
|
| >pdb|3D72|A Chain A, 1.65 Angstrom Crystal Structure Of The Cys71val Variant In The Fungal Photoreceptor Vvd Length = 149 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3SW1|A Chain A, Structure Of A Full-Length Bacterial Lov Protein Length = 162 | Back alignment and structure |
|
| >pdb|3SW1|A Chain A, Structure Of A Full-Length Bacterial Lov Protein Length = 162 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4HJ3|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|4HJ3|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|4HIA|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|4HIA|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4HJ6|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 178 | Back alignment and structure |
|
| >pdb|4HJ6|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 178 | Back alignment and structure |
|
| >pdb|4HJ4|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 177 | Back alignment and structure |
|
| >pdb|4HJ4|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 177 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2L0W|A Chain A, Solution Nmr Structure Of The N-Terminal Pas Domain Of Herg Potassium Channel Length = 138 | Back alignment and structure |
|
| >pdb|2L4R|A Chain A, Nmr Solution Structure Of The N-Terminal Pas Domain Of Herg Length = 135 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2L1M|A Chain A, Solution Structure Of The Eag Domain Of The Herg (Kv11.1) K+ Channel Length = 150 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2GJ3|A Chain A, Crystal Structure Of The Fad-Containing Pas Domain Of The Protein Nifl From Azotobacter Vinelandii. Length = 120 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1BYW|A Chain A, Structure Of The N-Terminal Domain Of The Human-Erg Potassium Channel Length = 110 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3EWK|A Chain A, Structure Of The Redox Sensor Domain Of Methylococcus Capsulatus (Bath) Mmos Length = 227 | Back alignment and structure |
|
| >pdb|3EWK|A Chain A, Structure Of The Redox Sensor Domain Of Methylococcus Capsulatus (Bath) Mmos Length = 227 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 934 | |||
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-99 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 4e-93 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 8e-93 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-92 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-92 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 8e-92 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 8e-91 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-90 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 6e-90 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-89 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 2e-89 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-89 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-89 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-88 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 6e-87 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-86 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-86 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-85 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 7e-85 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-84 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 6e-83 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 4e-80 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-76 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-76 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 7e-66 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 2e-40 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 5e-65 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 3e-54 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 8e-64 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 2e-62 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 9e-57 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-61 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-60 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 1e-59 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 8e-55 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-59 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 5e-59 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 3e-54 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-58 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-58 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 4e-58 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 8e-56 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 7e-56 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 2e-54 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-55 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 3e-55 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 7e-53 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 5e-55 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 2e-52 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 2e-53 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 2e-53 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 2e-53 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 1e-52 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 4e-53 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 3e-50 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-53 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-53 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 6e-52 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 4e-49 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 7e-52 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-51 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 7e-51 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-50 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-50 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-50 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-50 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 5e-50 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 6e-50 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 8e-50 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 8e-50 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 8e-50 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 9e-50 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-49 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-49 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-49 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-49 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-49 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-49 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-48 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-48 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 5e-48 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 5e-48 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 6e-48 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 8e-48 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 9e-48 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-47 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-47 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-47 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-47 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 6e-47 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-46 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-46 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-46 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-46 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 3e-46 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 4e-46 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 9e-46 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-45 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 7e-45 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-44 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-44 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 5e-44 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-43 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-43 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-43 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-43 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-43 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-43 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-42 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-42 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-42 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 5e-42 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-41 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-41 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-41 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-40 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-40 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 4e-40 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-38 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-38 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-38 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-06 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-37 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-35 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-35 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-33 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-33 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-33 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-33 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-32 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-32 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-32 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-32 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 7e-32 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 7e-32 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-31 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-31 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 3e-31 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 4e-31 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 9e-31 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-30 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-30 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 6e-30 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-29 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-29 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-29 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-29 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 5e-29 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 6e-29 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-27 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-26 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 6e-26 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-25 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 5e-25 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-24 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-24 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 5e-24 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 2e-23 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 3e-23 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 3e-22 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 2e-19 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-22 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 5e-22 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 8e-22 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 9e-22 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 7e-21 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 4e-16 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 9e-21 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 5e-20 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-19 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-19 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-19 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 3e-19 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 3e-17 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 4e-19 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-19 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 9e-19 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-18 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-18 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-18 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-18 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-18 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-18 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-18 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-18 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 4e-18 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-18 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 5e-18 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 5e-18 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 5e-18 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 7e-18 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 9e-18 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 9e-18 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-17 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-17 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-17 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-17 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-17 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-17 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-17 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 4e-17 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 5e-17 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 5e-17 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 6e-17 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-16 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-16 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-16 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-16 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 3e-16 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-16 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 4e-16 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 5e-16 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 6e-16 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 7e-16 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-15 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-07 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 3e-15 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 3e-15 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 4e-15 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 4e-15 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 5e-15 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 9e-15 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-14 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-14 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-14 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-14 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 3e-14 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 3e-14 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 5e-14 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 6e-14 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 9e-14 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-13 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 3e-13 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 3e-13 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 3e-13 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 4e-13 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 4e-13 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-13 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 6e-13 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 6e-13 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 9e-13 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-12 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-12 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-12 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-12 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-12 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 4e-12 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 6e-10 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-11 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-11 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-11 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-11 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 4e-11 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 4e-10 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-09 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-09 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 7e-09 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 9e-09 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-08 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-08 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-08 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-08 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 3e-08 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 3e-08 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 4e-08 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 7e-05 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 6e-08 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 7e-08 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 8e-08 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 1e-07 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 4e-05 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 1e-07 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 3e-07 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-07 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 4e-07 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 2e-04 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 5e-07 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 7e-07 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-06 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-06 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 4e-06 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 2e-05 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 5e-06 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 6e-06 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-05 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 1e-05 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 3e-05 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 2e-05 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 3e-04 | |
| 3eeh_A | 125 | Putative light and redox sensing histidine kinase; | 2e-05 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 3e-05 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 2e-04 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-04 | |
| 3kx0_X | 185 | Uncharacterized protein RV1364C/MT1410; PAS domain | 8e-04 |
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 313 bits (803), Expect = 1e-99
Identities = 83/263 (31%), Positives = 128/263 (48%), Gaps = 27/263 (10%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 723
+ + F+ K LG G +V L + + +A+K ++K ++ NKV ER+++
Sbjct: 25 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 84
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
LDHPF LY +FQ + Y GEL + + E RFY AE+V A
Sbjct: 85 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSA 142
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
LEYLH +GII+RDLKPEN+LL + H+ +TDF K +L +++ R
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT-----AK---VLSPESKQAR------ 188
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903
+NSFVGT +Y++PE++ + D WALG ++Y+++ G PFR
Sbjct: 189 -----------ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237
Query: 904 QKTFANILHKDLKFPSSTPSSCK 926
F I+ + FP +
Sbjct: 238 YLIFQKIIKLEYDFPEKFFPKAR 260
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 4e-93
Identities = 98/274 (35%), Positives = 146/274 (53%), Gaps = 33/274 (12%)
Query: 657 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKV 713
+ + E+ + F +K LG G G V LV+ + Q +AMK + K + R++V
Sbjct: 12 HHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV 71
Query: 714 HRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV 773
ER+IL ++HPF+ L+ +FQT+ + LI D+ GG+LF L ++ + E+ V
Sbjct: 72 R-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDV 128
Query: 774 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
+FY AE+ +AL++LH GIIYRDLKPEN+LL GH+ LTDF L K +
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL-----SKESIDHEKK- 182
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 893
+ SF GT EY+APE++ GHT + DWW+ G+L++EML
Sbjct: 183 ---------------------AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221
Query: 894 GYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKA 927
G PF+GK R++T IL L P ++
Sbjct: 222 GTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 255
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = 8e-93
Identities = 83/271 (30%), Positives = 135/271 (49%), Gaps = 35/271 (12%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ + + +K +G G G V LV + + +AMK + K M+ R+ ER+I+
Sbjct: 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
+ P+V L+ +FQ ++ ++ +Y PGG+L L+ + E RFY AEVV+AL
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLAL 181
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
+ +H G I+RD+KP+N+LL +GH+ L DF K +G
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC----------------MKMNKEGMVR 225
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEMLYGYTPFRG 900
++ VGT +YI+PE++ G + DWW++G+ LYEML G TPF
Sbjct: 226 ----------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275
Query: 901 KTRQKTFANILH--KDLKFPSSTPSSCKAAN 929
+ T++ I++ L FP S +A N
Sbjct: 276 DSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 306
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 294 bits (756), Expect = 2e-92
Identities = 103/275 (37%), Positives = 143/275 (52%), Gaps = 33/275 (12%)
Query: 657 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNK- 712
+ E+I + F ++ LG G G V V +G+ FAMK + K +++ K
Sbjct: 5 TSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD 64
Query: 713 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
AER IL+ + HPF+ L +FQT + LI +Y GGELF+ L+R+ + ED
Sbjct: 65 TAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDT 122
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
FY AE+ +AL +LH +GIIYRDLKPEN++L GHV LTDF L CK
Sbjct: 123 ACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL-----CK-------- 169
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
+ + ++F GT EY+APEI+ +GH AVDWW+LG L+Y+ML
Sbjct: 170 -------------ESIHDGTVT-HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDML 215
Query: 893 YGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKA 927
G PF G+ R+KT IL L P +
Sbjct: 216 TGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 250
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 4e-92
Identities = 96/262 (36%), Positives = 143/262 (54%), Gaps = 32/262 (12%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
+ +LQ F+ ++ LG+G G VHL+ +G+Y+AMK + K +++ +V ER +L
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
++ HPF+ ++ +FQ + +I DY GGELF LL + + +FYAAEV +AL
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLAL 119
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
EYLH + IIYRDLKPEN+LL NGH+ +TDF K
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGF-----AK-------------------- 154
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+ + GT +YIAPE+++ + ++DWW+ GIL+YEML GYTPF
Sbjct: 155 -----YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 209
Query: 905 KTFANILHKDLKFPSSTPSSCK 926
KT+ IL+ +L+FP K
Sbjct: 210 KTYEKILNAELRFPPFFNEDVK 231
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 8e-92
Identities = 92/263 (34%), Positives = 143/263 (54%), Gaps = 29/263 (11%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ + F +K LG G G V LV +G+Y+AMK + K V++ +++V E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
HPF+ AL +FQT +C + +Y GGELF L R+ +V E+ RFY AE+V AL
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSAL 118
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
EYLH + ++YRD+K EN++L +GH+ +TDF L CK +
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL-----CKEGI----------------- 156
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +
Sbjct: 157 -----SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211
Query: 905 KTFANILHKDLKFPSSTPSSCKA 927
+ F IL ++++FP + K+
Sbjct: 212 RLFELILMEEIRFPRTLSPEAKS 234
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 8e-91
Identities = 81/261 (31%), Positives = 129/261 (49%), Gaps = 34/261 (13%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ F +K +G G V +V++ +GQ +AMK M+K ML R +V ER++L
Sbjct: 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV 116
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
D ++ L+ +FQ + ++ L+ +Y GG+L LL + + + + RFY AE+V+A+
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAI 175
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
+ +H G ++RD+KP+N+LL GH+ L DF K R G
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC----------------LKLRADGTVR 219
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAG-------HTSAVDWWALGILLYEMLYGYTP 897
S VGT +Y++PEI+ G + DWWALG+ YEM YG TP
Sbjct: 220 ----------SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
Query: 898 FRGKTRQKTFANILHKDLKFP 918
F + +T+ I+H
Sbjct: 270 FYADSTAETYGKIVHYKEHLS 290
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 2e-90
Identities = 96/282 (34%), Positives = 137/282 (48%), Gaps = 30/282 (10%)
Query: 647 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV 706
P + I S F +K +G G G V L ++A+K + K
Sbjct: 16 APPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKA 75
Query: 707 MLNRNKVHRACAEREILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 765
+L + + +ER +L + HPF+ L+ SFQT + + DY GGELF L R+
Sbjct: 76 ILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-- 133
Query: 766 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825
+ E RFYAAE+ AL YLH I+YRDLKPEN+LL GH+ LTDF L CK
Sbjct: 134 RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL-----CKE 188
Query: 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 885
+ +T +++F GT EY+APE++ + VDWW LG
Sbjct: 189 NIEHNST----------------------TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLG 226
Query: 886 ILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKA 927
+LYEMLYG PF + + + NIL+K L+ + +S +
Sbjct: 227 AVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARH 268
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 6e-90
Identities = 86/267 (32%), Positives = 139/267 (52%), Gaps = 30/267 (11%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
++ ++ F K LG G G V L E + Q+FA+KA+ K V+L + V E+
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 722 ILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
+L + +HPF+ ++ +FQTK ++ + +Y GG+L + FYAAE+
Sbjct: 70 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEI 127
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
++ L++LH +GI+YRDLK +N+LL +GH+ + DF + CK +L
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGM-----CKENMLGDAK-------- 174
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
+N+F GT +YIAPEI+ G + +VDWW+ G+LLYEML G +PF G
Sbjct: 175 --------------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
Query: 901 KTRQKTFANILHKDLKFPSSTPSSCKA 927
+ ++ F +I + +P K
Sbjct: 221 QDEEELFHSIRMDNPFYPRWLEKEAKD 247
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 1e-89
Identities = 86/267 (32%), Positives = 134/267 (50%), Gaps = 30/267 (11%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
+ +++ L F + LG G G V L E G+ + +A+K + K V++ + V E+
Sbjct: 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 722 ILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
+L + PF+ L++ FQT + + +Y GG+L + + KE FYAAE+
Sbjct: 73 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEI 130
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+ L +L +GIIYRDLK +NV+L GH+ + DF + CK + T
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKENIWDGVT-------- 177
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
+ +F GT +YIAPEIIA + +VDWWA G+LLYEML G PF G
Sbjct: 178 --------------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223
Query: 901 KTRQKTFANILHKDLKFPSSTPSSCKA 927
+ + F +I+ ++ +P S A
Sbjct: 224 EDEDELFQSIMEHNVAYPKSMSKEAVA 250
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 287 bits (738), Expect = 2e-89
Identities = 89/267 (33%), Positives = 134/267 (50%), Gaps = 30/267 (11%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
S ++ + +F I+ LG G G V L + +G +A+K + K V+L + V E+
Sbjct: 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 722 IL-DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
IL +HPF+ L+ FQT + + ++ GG+L + + + E RFYAAE+
Sbjct: 76 ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEI 133
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+ AL +LH +GIIYRDLK +NVLL GH L DF + CK + T
Sbjct: 134 ISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM-----CKEGICNGVT-------- 180
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
+ +F GT +YIAPEI+ + AVDWWA+G+LLYEML G+ PF
Sbjct: 181 --------------TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226
Query: 901 KTRQKTFANILHKDLKFPSSTPSSCKA 927
+ F IL+ ++ +P+
Sbjct: 227 ENEDDLFEAILNDEVVYPTWLHEDATG 253
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 290 bits (743), Expect = 3e-89
Identities = 83/272 (30%), Positives = 139/272 (51%), Gaps = 34/272 (12%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 723
+++ + F +K +G G G V +V+L + + FAMK ++K ML R + ER++L
Sbjct: 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL 128
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
D ++ L+ +FQ ++ L+ DY GG+L LL + + L E+ RFY AE+V+A
Sbjct: 129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIA 187
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
++ +H ++RD+KP+N+L+ NGH+ L DF C
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS-----CLK------------------ 224
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPF 898
M + S+ VGT +YI+PEI+ + DWW+LG+ +YEMLYG TPF
Sbjct: 225 ---LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281
Query: 899 RGKTRQKTFANILHK--DLKFPSSTPSSCKAA 928
++ +T+ I++ +FP+ + A
Sbjct: 282 YAESLVETYGKIMNHKERFQFPTQVTDVSENA 313
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 3e-89
Identities = 91/265 (34%), Positives = 132/265 (49%), Gaps = 32/265 (12%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
S L F IK LG+G G V LV+ SG ++AMK +DK ++ ++ E+
Sbjct: 34 SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 722 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
IL ++ PF+ L SF+ +++ ++ +Y GGE+F L R E RFYAA++V
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIV 151
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+ EYLH +IYRDLKPEN+L+ G++ +TDF K
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF-----AK----------------- 189
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+ + GT E +APEII G+ AVDWWALG+L+YEM GY PF
Sbjct: 190 --------RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241
Query: 902 TRQKTFANILHKDLKFPSSTPSSCK 926
+ + I+ ++FPS S K
Sbjct: 242 QPIQIYEKIVSGKVRFPSHFSSDLK 266
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 2e-88
Identities = 82/274 (29%), Positives = 138/274 (50%), Gaps = 36/274 (13%)
Query: 659 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA 718
+ D E +N HF ++ +G G G V +V+ + + +AMK M+K + RN+V
Sbjct: 5 VFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
E +I+ L+HPF+ L+ SFQ + + ++ D GG+L L + KE+ V+ +
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFIC 122
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
E+V+AL+YL Q II+RD+KP+N+LL +GHV +TDF++
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNI-----AA-------------- 163
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGY 895
M + GT+ Y+APE+ + GAG++ AVDWW+LG+ YE+L G
Sbjct: 164 ---------MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
Query: 896 TPFRGKT---RQKTFANILHKDLKFPSSTPSSCK 926
P+ ++ ++ + +PS+
Sbjct: 215 RPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMV 248
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 6e-87
Identities = 102/318 (32%), Positives = 157/318 (49%), Gaps = 31/318 (9%)
Query: 611 QTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQH 670
+T E E + + A P +S + + ++ +
Sbjct: 91 ETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSP-SDNSGAEEMEVSLAKPKHRVTMNE 149
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F +K LG G G V LV+ +G+Y+AMK + K V++ +++V E +L HPF
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ AL SFQT +C + +Y GGELF L R+ +V ED RFY AE+V AL+YLH +
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSE 267
Query: 791 -GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
++YRDLK EN++L +GH+ +TDF L CK + T
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGL-----CKEGIKDGAT----------------- 305
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +K F
Sbjct: 306 -----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 360
Query: 910 ILHKDLKFPSSTPSSCKA 927
IL ++++FP + K+
Sbjct: 361 ILMEEIRFPRTLGPEAKS 378
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 1e-86
Identities = 90/276 (32%), Positives = 142/276 (51%), Gaps = 39/276 (14%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
+ + + LQ F ++ +G G V LV L + + +AMK + K ++ + + E+
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 722 ILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
+ + +HPF+ L++ FQT++ + + +Y GG+L + RQ + L E+ RFY+AE+
Sbjct: 62 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEI 119
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+AL YLH +GIIYRDLK +NVLL GH+ LTD+ + CK L
Sbjct: 120 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM-----CKEGL------------- 161
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF-- 898
P +++F GT YIAPEI+ G + +VDWWALG+L++EM+ G +PF
Sbjct: 162 ---------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212
Query: 899 -------RGKTRQKTFANILHKDLKFPSSTPSSCKA 927
T F IL K ++ P S +
Sbjct: 213 VGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS 248
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 1e-86
Identities = 98/276 (35%), Positives = 147/276 (53%), Gaps = 39/276 (14%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNK-VHRAC 717
E++ +++F +K LG+G G V LV +G+ +AMK + K ++ + K
Sbjct: 47 HAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 106
Query: 718 AEREILDMLDH-PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFY 776
ER++L+ + PF+ L+ +FQT+T + LI DY GGELF L ++ + E V+ Y
Sbjct: 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIY 164
Query: 777 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836
E+V+ALE+LH GIIYRD+K EN+LL NGHV LTDF L K
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL-----SK------------ 207
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYG 894
F+A+ + F GT EY+AP+I+ G GH AVDWW+LG+L+YE+L G
Sbjct: 208 ---------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
Query: 895 YTPF----RGKTRQKTFANILHKDLKFPSSTPSSCK 926
+PF ++ + IL + +P + K
Sbjct: 259 ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 294
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 1e-85
Identities = 90/314 (28%), Positives = 146/314 (46%), Gaps = 39/314 (12%)
Query: 624 PDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTG 683
+ N ++ ++ + + LQ F ++ +G G
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYA 66
Query: 684 SVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPALYASFQTKT 742
V LV L + + +AM+ + K ++ + + E+ + +HPF+ L++ FQT++
Sbjct: 67 KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126
Query: 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802
+ + +Y GG+L + RQ + L E+ RFY+AE+ +AL YLH +GIIYRDLK +NV
Sbjct: 127 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184
Query: 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 862
LL GH+ LTD+ + CK L P +++F GT
Sbjct: 185 LLDSEGHIKLTDYGM-----CKEGL----------------------RPGDTTSTFCGTP 217
Query: 863 EYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF---------RGKTRQKTFANILHK 913
YIAPEI+ G + +VDWWALG+L++EM+ G +PF T F IL K
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277
Query: 914 DLKFPSSTPSSCKA 927
++ P S +
Sbjct: 278 QIRIPRSLSVKAAS 291
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 286 bits (732), Expect = 7e-85
Identities = 99/412 (24%), Positives = 173/412 (41%), Gaps = 39/412 (9%)
Query: 526 PETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
P K++ D +++ + S WN +++ + + + +
Sbjct: 189 PNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDW 248
Query: 586 GSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPED---------LWAN 636
S+ +E + V + +++ E + + PE +
Sbjct: 249 DLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFER 308
Query: 637 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 696
K + + + + +++ L F + LG G G V L E G+ +
Sbjct: 309 AKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDEL 368
Query: 697 FAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGE 755
+A+K + K V++ + V E+ +L + PF+ L++ FQT + + +Y GG+
Sbjct: 369 YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD 428
Query: 756 LFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815
L + + KE FYAAE+ + L +L +GIIYRDLK +NV+L GH+ + DF
Sbjct: 429 LMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADF 486
Query: 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 875
+ CK + T + +F GT +YIAPEIIA +
Sbjct: 487 GM-----CKENIWDGVT----------------------TKTFCGTPDYIAPEIIAYQPY 519
Query: 876 TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKA 927
+VDWWA G+LLYEML G PF G+ + F +I+ ++ +P S A
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA 571
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 2e-84
Identities = 78/338 (23%), Positives = 142/338 (42%), Gaps = 39/338 (11%)
Query: 595 NSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWK 654
+ + V + + + + P L + + WK
Sbjct: 117 PQAQLFCSFLDAETVARARAGAGDGLFQ-PLLRAVLAHLGQAPFQEFLDSLYFLRFLQWK 175
Query: 655 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 714
++ + + F + LG G G V ++ +G+ +A K ++K + R
Sbjct: 176 WLEA-----QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ 230
Query: 715 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF--LLLDRQPTKVLKEDA 772
A E++IL + F+ +L +F+TKT +CL+ GG++ + + +E
Sbjct: 231 GAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR 290
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
FY A++V LE+LH + IIYRDLKPENVLL +G+V ++D L+
Sbjct: 291 AIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE------------ 338
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
A + + GT ++APE++ G + +VD++ALG+ LYEM+
Sbjct: 339 --------------LKAGQTKT-KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
Query: 893 YGYTPFRGK----TRQKTFANILHKDLKFPSSTPSSCK 926
PFR + ++ +L + + +P + K
Sbjct: 384 AARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 6e-83
Identities = 88/345 (25%), Positives = 151/345 (43%), Gaps = 44/345 (12%)
Query: 593 LRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKV-VHPKPHRKDSP 651
+N + + ++ +Q N + +++ P +L E H + V P DS
Sbjct: 106 TQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSI 165
Query: 652 ------PWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 705
WK +++ + + FR + LG G G V ++ +G+ +A K ++K
Sbjct: 166 YFNRFLQWKWLER-----QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK 220
Query: 706 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 765
+ R A E++IL+ ++ FV +L +++TK +CL+ GG+L +
Sbjct: 221 RIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ 280
Query: 766 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825
E FYAAE+ LE LH + I+YRDLKPEN+LL +GH+ ++D L
Sbjct: 281 AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL-----AVH 335
Query: 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 885
+ E VGT Y+APE++ +T + DWWALG
Sbjct: 336 ----------------------VPEGQTI-KGRVGTVGYMAPEVVKNERYTFSPDWWALG 372
Query: 886 ILLYEMLYGYTPFRGK----TRQKTFANILHKDLKFPSSTPSSCK 926
LLYEM+ G +PF+ + R++ + ++ +
Sbjct: 373 CLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQAR 417
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 4e-80
Identities = 85/338 (25%), Positives = 153/338 (45%), Gaps = 42/338 (12%)
Query: 598 PEATAEESEKLVKQTAENVNEAVKELPDANLTP--EDLWANHSKVVHPKPHRKDSPPWKA 655
+ S+ ++ ++ + K++P P E++ N V K D
Sbjct: 118 LACSHPFSKSAIEHVQGHLVK--KQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFC 175
Query: 656 IQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR 715
K ++ + + F + +G G G V+ +G+ +AMK +DK + +
Sbjct: 176 QWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL 235
Query: 716 ACAEREILDML---DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
A ER +L ++ D PF+ + +F T + I D GG+L L + V E
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEAD 293
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
+RFYAAE+++ LE++H + ++YRDLKP N+LL +GHV ++D L+
Sbjct: 294 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-------------- 339
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEM 891
K + ++ VGT Y+APE++ G + S+ DW++LG +L+++
Sbjct: 340 ---CDFSKKK------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384
Query: 892 LYGYTPFRG---KTRQKTFANILHKDLKFPSSTPSSCK 926
L G++PFR K + + L ++ P S +
Sbjct: 385 LRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 2e-76
Identities = 80/262 (30%), Positives = 110/262 (41%), Gaps = 31/262 (11%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
Q L+ F +PLG G G+V+L S A+K + K + H+ E EI
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
L HP + LY F T V LI +Y P G ++ L + E Y E+ AL
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANAL 122
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
Y H + +I+RD+KPEN+LL G + + DF S RR
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA------------PSSRRT----- 165
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
GT +Y+ PE+I G H VD W+LG+L YE L G PF T Q
Sbjct: 166 ------------DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213
Query: 905 KTFANILHKDLKFPSSTPSSCK 926
+T+ I + FP +
Sbjct: 214 ETYKRISRVEFTFPDFVTEGAR 235
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 3e-76
Identities = 73/262 (27%), Positives = 111/262 (42%), Gaps = 31/262 (11%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
+ + F +PLG G G+V+L + A+K + K + H+ E EI
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
L HP + +Y F + + L+ ++ P GEL+ L + E + E+ AL
Sbjct: 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADAL 127
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
Y H + +I+RD+KPEN+L+ G + + DF S RR
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA------------PSLRRR----- 170
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+ GT +Y+ PE+I G H VD W G+L YE L G PF +
Sbjct: 171 ------------TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 218
Query: 905 KTFANILHKDLKFPSSTPSSCK 926
+T I++ DLKFP K
Sbjct: 219 ETHRRIVNVDLKFPPFLSDGSK 240
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* Length = 332 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 7e-66
Identities = 120/236 (50%), Positives = 150/236 (63%), Gaps = 15/236 (6%)
Query: 465 QKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQ 524
LATTLERIEKNFVITDPRLPDNPIIFASDSFL+LTEYSREEILGRN RFLQ
Sbjct: 4 SHHHHHHGSLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARFLQ 63
Query: 525 GPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQL 584
GPETD ATVRKIR AIDNQT+VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQL
Sbjct: 64 GPETDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQL 123
Query: 585 DGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPK 644
DG+EH+ +++ + + + A+ + + + D + L +++ P
Sbjct: 124 DGTEHVRDAAEREGVMLIKKTAENIDEAAKELIK-CVVVGDGAVGKTCLLISYTTNAFPG 182
Query: 645 PHRKDSPPW-KAIQKILDSGEQINLQ--------HFRPIKPLGSGDTGSVHLVELC 691
+ + ++ G+ +NL + ++PL T + +C
Sbjct: 183 EYI--PTVFDNYSANVMVDGKPVNLGLWDTAGLEDYDRLRPLSYPQT---DVFLIC 233
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* Length = 332 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 48/130 (36%), Positives = 76/130 (58%)
Query: 185 PRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAG 244
+ L ++ FV++D PD PI++AS F ++T Y+ +E++GRN RFLQG
Sbjct: 7 HHHHGSLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARFLQGPE 66
Query: 245 TDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
TD V KIR+ + N +L+NY K G FWNL + P++D +G V FIG+Q++ +
Sbjct: 67 TDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGT 126
Query: 305 KHTEGAKDKM 314
+H A ++
Sbjct: 127 EHVRDAAERE 136
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* Length = 146 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 5e-65
Identities = 123/150 (82%), Positives = 133/150 (88%), Gaps = 7/150 (4%)
Query: 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATV 533
LATTLERIEKNFVITDPRLPDNPIIFASDSFL+LTEYSREEILGRNCRFLQGPETD ATV
Sbjct: 4 LATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATV 63
Query: 534 RKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 593
RKIR AIDNQT+VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH+
Sbjct: 64 RKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVR-- 121
Query: 594 RNSIPEATAEESEKLVKQTAENVNEAVKEL 623
+A E L+K+TAEN++EA KEL
Sbjct: 122 -----DAAEREGVMLIKKTAENIDEAAKEL 146
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* Length = 146 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 3e-54
Identities = 53/154 (34%), Positives = 85/154 (55%), Gaps = 9/154 (5%)
Query: 189 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPE 248
+ + L ++ FV++D PD PI++AS F ++T Y+ +E++GRNCRFLQG TD
Sbjct: 2 EFLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRA 61
Query: 249 DVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308
V KIR+ + N +L+NY K G FWNL + P++D +G V FIG+Q++ ++H
Sbjct: 62 TVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVR 121
Query: 309 GAKDKMLRPNGLPESLIRYDARQKEMATSSVTEL 342
A ++ E ++ E + EL
Sbjct: 122 DAAER--------EGVMLIKKTA-ENIDEAAKEL 146
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 8e-64
Identities = 62/326 (19%), Positives = 121/326 (37%), Gaps = 69/326 (21%)
Query: 631 EDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVEL 690
+D+ +N+S +++ + K+ + + +R I+ L G + L E
Sbjct: 7 KDILSNYSNLIYLNKYVKE--------------KDKYINDYRIIRTLNQGKFNKIILCE- 51
Query: 691 CGSGQYFAMKAMDKGVMLNRNKVHRACA--------------EREILDMLDHPFVPALYA 736
+++A+K +K ++ + ++ E +I+ + + +
Sbjct: 52 -KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110
Query: 737 SFQTKTHVCLITDYCPGGELF------LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V +I +Y + +LD+ T + ++ V+ + Y+H +
Sbjct: 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170
Query: 791 -GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
I +RD+KP N+L+ NG V L+DF S K+
Sbjct: 171 KNICHRDVKPSNILMDKNGRVKLSDFGESEYM------------VDKKIK---------- 208
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRGK-TRQKT 906
GT E++ PE + + + VD W+LGI LY M Y PF K + +
Sbjct: 209 -------GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261
Query: 907 FANILHKDLKFPSSTPSSCKAANVPP 932
F NI K++++P
Sbjct: 262 FNNIRTKNIEYPLDRNHFLYPLTNKK 287
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* Length = 130 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-62
Identities = 97/130 (74%), Positives = 112/130 (86%)
Query: 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 243
PRVS +K ALST QQTFVVSDAT+P PI+YAS+GFF MTGY+SKE+VGRNCRFLQG
Sbjct: 1 FPRVSQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGP 60
Query: 244 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
TD +VAKIR+ ++NG+SYCGRLLNYKKDGTPFWNLLT+ PIKDD+G +KFIGMQVEV
Sbjct: 61 DTDKNEVAKIRDCVKNGKSYCGRLLNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEV 120
Query: 304 SKHTEGAKDK 313
SK+TEG DK
Sbjct: 121 SKYTEGVNDK 130
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* Length = 130 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 9e-57
Identities = 53/127 (41%), Positives = 79/127 (62%)
Query: 469 RKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPET 528
R +L T L +++ FV++D P PI++AS F +T YS +EI+GRNCRFLQGP+T
Sbjct: 3 RVSQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGPDT 62
Query: 529 DPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
D V KIR + N +L+NY K G FWNL + P++D +G FIG+Q++ S+
Sbjct: 63 DKNEVAKIRDCVKNGKSYCGRLLNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEVSK 122
Query: 589 HLEPLRN 595
+ E + +
Sbjct: 123 YTEGVND 129
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 3e-61
Identities = 64/271 (23%), Positives = 112/271 (41%), Gaps = 34/271 (12%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
F I LG G G V +Y+A+K + K+ +E +L L+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLN 60
Query: 728 HPFVPALYASFQ-------------TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVR 774
H +V YA++ K+ + + +YC G L+ L+ + + D
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQRDEYW 119
Query: 775 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
+++ AL Y+H QGII+RDLKP N+ + + +V + DF L+ N
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA-------------KNV 166
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLY 893
+ + + + S +GT Y+A E++ G GH +D ++LGI+ +EM+Y
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
Query: 894 GYTPFRGKTRQKTFANILHKDLKFPSSTPSS 924
G R + ++FP +
Sbjct: 227 P--FSTGMERVNILKKLRSVSIEFPPDFDDN 255
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-60
Identities = 70/259 (27%), Positives = 108/259 (41%), Gaps = 28/259 (10%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
++ F+ LG G V+ E +G A+K +DK M V R E +I L
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
HP + LY F+ +V L+ + C GE+ L + K E+ R + +++ + YL
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYL 128
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H GI++RDL N+LL N ++ + DF L+ + T
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH--YT--------------- 171
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907
GT YI+PEI + H D W+LG + Y +L G PF T + T
Sbjct: 172 ----------LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL 221
Query: 908 ANILHKDLKFPSSTPSSCK 926
++ D + PS K
Sbjct: 222 NKVVLADYEMPSFLSIEAK 240
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* Length = 115 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-59
Identities = 96/113 (84%), Positives = 103/113 (91%)
Query: 478 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 537
E IEKNFVITDPRLPDNPIIFASD FLELTEYSREEILGRN RFLQGPETD ATV+KIR
Sbjct: 3 PEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKIR 62
Query: 538 AAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL 590
AI +Q + TVQLINYTKSGKKFWNL HLQP+RDQKGE+QYFIGVQLDGS+H+
Sbjct: 63 DAIRDQRETTVQLINYTKSGKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDHV 115
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* Length = 115 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 8e-55
Identities = 47/113 (41%), Positives = 76/113 (67%)
Query: 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 253
+ ++ FV++D PD PI++AS GF ++T Y+ +E++GRN RFLQG TD V KI
Sbjct: 2 SPEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKI 61
Query: 254 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306
R+ +++ + +L+NY K G FWNLL + P++D +G++ FIG+Q++ S H
Sbjct: 62 RDAIRDQRETTVQLINYTKSGKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDH 114
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 3e-59
Identities = 68/298 (22%), Positives = 115/298 (38%), Gaps = 31/298 (10%)
Query: 629 TPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLV 688
P D V +PP K I ++L + + + + LG G +
Sbjct: 3 APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPR--SRRRYVRGRFLGKGGFAKCFEI 60
Query: 689 ELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748
+ + FA K + K ++L ++ + E I L H V + F+ V ++
Sbjct: 61 SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120
Query: 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 808
+ C L L R+ K L E R+Y ++V+ +YLH +I+RDLK N+ L +
Sbjct: 121 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 178
Query: 809 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPE 868
V + DF L+ + GT YIAPE
Sbjct: 179 EVKIGDFGLATKVEYDGERK---------------------------KVLCGTPNYIAPE 211
Query: 869 IIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCK 926
+++ GH+ VD W++G ++Y +L G PF ++T+ I + P
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA 269
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* Length = 166 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 5e-59
Identities = 67/155 (43%), Positives = 91/155 (58%), Gaps = 3/155 (1%)
Query: 440 EIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIF 499
+I + + ++ S +++ + L L+ ++NFVITD LPDNPI++
Sbjct: 6 SLIAQCSPEADTLLTDNPSKANRILEDPDYS---LVKALQMAQQNFVITDASLPDNPIVY 62
Query: 500 ASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKK 559
AS FL LT YS ++ILGRNCRFLQGPETDP V KIR AI D +V L+NY + G
Sbjct: 63 ASRGFLTLTGYSLDQILGRNCRFLQGPETDPRAVDKIRNAITKGVDTSVCLLNYRQDGTT 122
Query: 560 FWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLR 594
FWNLF + +RD KG + ++GVQ SE L
Sbjct: 123 FWNLFFVAGLRDSKGNIVNYVGVQSKVSEDYAKLL 157
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* Length = 166 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-54
Identities = 56/143 (39%), Positives = 84/143 (58%)
Query: 166 NSVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMT 225
+ + + + L + AL QQ FV++DA+ PD PI+YAS GF +T
Sbjct: 12 SPEADTLLTDNPSKANRILEDPDYSLVKALQMAQQNFVITDASLPDNPIVYASRGFLTLT 71
Query: 226 GYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAP 285
GY+ +++GRNCRFLQG TDP V KIR + G LLNY++DGT FWNL +A
Sbjct: 72 GYSLDQILGRNCRFLQGPETDPRAVDKIRNAITKGVDTSVCLLNYRQDGTTFWNLFFVAG 131
Query: 286 IKDDEGKVLKFIGMQVEVSKHTE 308
++D +G ++ ++G+Q +VS+
Sbjct: 132 LRDSKGNIVNYVGVQSKVSEDYA 154
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 1e-58
Identities = 60/260 (23%), Positives = 104/260 (40%), Gaps = 29/260 (11%)
Query: 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML 726
+ + + + LG G + + + FA K + K ++L ++ + E I L
Sbjct: 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 72
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
H V + F+ V ++ + C L L R+ K L E R+Y ++V+ +Y
Sbjct: 73 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQY 130
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
LH +I+RDLK N+ L + V + DF L+ +
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KV-------------- 174
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
GT YIAPE+++ GH+ VD W++G ++Y +L G PF ++T
Sbjct: 175 -----------LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223
Query: 907 FANILHKDLKFPSSTPSSCK 926
+ I + P
Sbjct: 224 YLRIKKNEYSIPKHINPVAA 243
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-58
Identities = 63/294 (21%), Positives = 108/294 (36%), Gaps = 37/294 (12%)
Query: 627 NLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKIL---DSGEQINLQHFRPIKPLGSGDTG 683
+L E+L+ + P+ + +Q E Q F+ + LG G G
Sbjct: 12 DLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYG 71
Query: 684 SVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPALYASFQTKT 742
V V G+ +A+K +++ AE + HP L +++
Sbjct: 72 EVFKVRSKEDGRLYAVKRSMSPFRGPKDRAR-KLAEVGSHEKVGQHPCCVRLEQAWEEGG 130
Query: 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802
+ L T+ C G L + L E V Y + ++AL +LH QG+++ D+KP N+
Sbjct: 131 ILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANI 188
Query: 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 862
L G L DF L V + G
Sbjct: 189 FLGPRGRCKLGDFGLL---------------------------VELGTAGAG-EVQEGDP 220
Query: 863 EYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT-PFRGKTRQKTFANILHKDL 915
Y+APE++ G + +A D ++LG+ + E+ P G+ Q+ L +
Sbjct: 221 RYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF 273
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* Length = 109 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 4e-58
Identities = 65/107 (60%), Positives = 86/107 (80%)
Query: 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETL 257
+ TFVV+DAT PD P++YAS GF+ MTGY EV+G NCRFLQG GTDP++V KIR+ +
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 258 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+ G++ RLLNY+KDGTPFWNLLT+ PIK +G+V KF+G+QV+V+
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVDVT 108
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* Length = 109 | Back alignment and structure |
|---|
Score = 186 bits (476), Expect = 8e-56
Identities = 49/102 (48%), Positives = 66/102 (64%)
Query: 484 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ 543
FV+ D LPD P+++AS+ F +T Y +E+LG NCRFLQG TDP V+KIR AI
Sbjct: 5 TFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKG 64
Query: 544 TDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
+V+L+NY K G FWNL + P++ G V F+GVQ+D
Sbjct: 65 EACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVD 106
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} Length = 258 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 7e-56
Identities = 66/238 (27%), Positives = 101/238 (42%), Gaps = 21/238 (8%)
Query: 424 IGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEK 483
+GR DD D G D P + D +V + + + +E
Sbjct: 21 MGRDLYDDDDKDHP----FTMGQDRPIDGSGAPGADDTRVEVQPPAQ--WVLDLIEASPI 74
Query: 484 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ 543
V++DPRL DNP+I + +F +LT YS EE +GRNCRFL G T+P KIR +
Sbjct: 75 ASVVSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREH 134
Query: 544 TDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAE 603
V V+++NY K G F N + P+ D E+ YF+G Q++ + +
Sbjct: 135 KPVLVEILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPNM-----GMARR 189
Query: 604 ESEKLVKQTAENVNEAVKELPDANLTPEDLWAN----------HSKVVHPKPHRKDSP 651
E + +T V L + L +++ A H +V K + K S
Sbjct: 190 ERAAEMLKTLSPRQLEVTTLVASGLRNKEVAARLGLSEKTVKMHRGLVMEKLNLKTSA 247
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} Length = 258 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-54
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 144 VARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFV 203
+ R DD P T ++ + D + + V D + V
Sbjct: 21 MGRDLYDDDDKDHPFTMGQDRPIDGSGAPGADDT---RVEVQPPAQWVLDLIEASPIASV 77
Query: 204 VSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSY 263
VSD D P++ + F +TGY+ +E VGRNCRFL G+GT+P KIR+ ++ +
Sbjct: 78 VSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREHKPV 137
Query: 264 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLP-- 321
+LNYKKDGTPF N + +API DD+ ++L F+G QVEV
Sbjct: 138 LVEILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPNMGMARRERAAEMLK 197
Query: 322 ---------ESLIRYDARQKEMA 335
+L+ R KE+A
Sbjct: 198 TLSPRQLEVTTLVASGLRNKEVA 220
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-55
Identities = 57/274 (20%), Positives = 121/274 (44%), Gaps = 33/274 (12%)
Query: 641 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 700
+H H + ++ +++ + ++ +G G G LV+ G+ + +K
Sbjct: 1 MHHHHHHS-----SGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIK 55
Query: 701 AMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL 760
++ M ++ + + E +L + HP + SF+ + ++ DYC GG+LF +
Sbjct: 56 EINISRMSSKER-EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI 114
Query: 761 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820
+ Q + +ED + + ++ +AL+++H + I++RD+K +N+ L +G V L DF ++ +
Sbjct: 115 NAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174
Query: 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 880
+ +L + +GT Y++PEI + + D
Sbjct: 175 LNSTVELA---------------------------RACIGTPYYLSPEICENKPYNNKSD 207
Query: 881 WWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914
WALG +LYE+ F + + I+
Sbjct: 208 IWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS 241
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} Length = 128 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 3e-55
Identities = 54/114 (47%), Positives = 77/114 (67%)
Query: 478 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 537
E +IT+P LPDNPI+FA+ +FL+LT Y +E++GRNCRFLQG TDPA VR I+
Sbjct: 3 SEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAIK 62
Query: 538 AAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 591
+AI + + + +INY KSG+ FWN H+ P+ + G +Q+F+ QLD + L
Sbjct: 63 SAIAAEKPIDIDIINYKKSGEAFWNRLHISPVHNANGRLQHFVSSQLDVTLELV 116
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} Length = 128 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 7e-53
Identities = 43/113 (38%), Positives = 67/113 (59%)
Query: 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 253
A ++++ PD PI++A+ F K+TGY + EV+GRNCRFLQG GTDP V I
Sbjct: 2 ASEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAI 61
Query: 254 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306
+ + + ++NYKK G FWN L I+P+ + G++ F+ Q++V+
Sbjct: 62 KSAIAAEKPIDIDIINYKKSGEAFWNRLHISPVHNANGRLQHFVSSQLDVTLE 114
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A Length = 138 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 5e-55
Identities = 37/130 (28%), Positives = 59/130 (45%), Gaps = 5/130 (3%)
Query: 464 RQKEMRKGIDLATTLERIEK---NFVITDPRLPDNPIIFASDSFLELTEYSREEILGR-- 518
R + L T + + E F+I + R+ + +I+ +D F EL YSR E++ R
Sbjct: 8 RGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPC 67
Query: 519 NCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQY 578
C FL GP T +I A+ + V++ Y K G F L + P++++ G V
Sbjct: 68 TCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIM 127
Query: 579 FIGVQLDGSE 588
FI E
Sbjct: 128 FILNFEVVME 137
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A Length = 138 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-52
Identities = 32/118 (27%), Positives = 59/118 (50%), Gaps = 2/118 (1%)
Query: 189 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR--NCRFLQGAGTD 246
D + + F++++A + ++Y + GF ++ GY+ EV+ R C FL G T
Sbjct: 19 DTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQ 78
Query: 247 PEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
A+I + L + + Y+KDG+ F L+ + P+K+++G V+ FI V
Sbjct: 79 RRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVM 136
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} Length = 162 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-53
Identities = 41/135 (30%), Positives = 63/135 (46%), Gaps = 3/135 (2%)
Query: 457 DSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEIL 516
V + L + ++ V+ + D +I+ + +F LT YSR+EIL
Sbjct: 13 GLVPRGSHMINAQL---LQSMVDASNDGIVVAEKEGDDTILIYVNAAFEYLTGYSRDEIL 69
Query: 517 GRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEV 576
++CRFLQG + D +IR A+ L NY K G FWN + P++ +
Sbjct: 70 YQDCRFLQGDDRDQLGRARIRKAMAEGRPCREVLRNYRKDGSAFWNELSITPVKSDFDQR 129
Query: 577 QYFIGVQLDGSEHLE 591
YFIG+Q D S +E
Sbjct: 130 TYFIGIQKDVSRQVE 144
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} Length = 162 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-53
Identities = 42/115 (36%), Positives = 66/115 (57%)
Query: 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 253
+ VV++ D ++Y +A F +TGY+ E++ ++CRFLQG D A+I
Sbjct: 30 MVDASNDGIVVAEKEGDDTILIYVNAAFEYLTGYSRDEILYQDCRFLQGDDRDQLGRARI 89
Query: 254 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308
R+ + G+ L NY+KDG+ FWN L+I P+K D + FIG+Q +VS+ E
Sbjct: 90 RKAMAEGRPCREVLRNYRKDGSAFWNELSITPVKSDFDQRTYFIGIQKDVSRQVE 144
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 Length = 110 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-53
Identities = 33/107 (30%), Positives = 52/107 (48%), Gaps = 2/107 (1%)
Query: 484 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGR--NCRFLQGPETDPATVRKIRAAID 541
F+I + R+ + +I+ +D F EL YSR E++ R C FL GP T +I A+
Sbjct: 3 KFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALL 62
Query: 542 NQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
+ V++ Y K G F L + P++++ G V FI E
Sbjct: 63 GAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVME 109
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 Length = 110 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-52
Identities = 31/107 (28%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 200 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR--NCRFLQGAGTDPEDVAKIRETL 257
+ F++++A + ++Y + GF ++ GY+ EV+ R C FL G T A+I + L
Sbjct: 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQAL 61
Query: 258 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+ + Y+KDG+ F L+ + P+K+++G V+ FI V
Sbjct: 62 LGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVM 108
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* Length = 132 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 4e-53
Identities = 58/128 (45%), Positives = 80/128 (62%), Gaps = 5/128 (3%)
Query: 478 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 537
L+ + VITDP L DNPI++ + F+++T Y EEILG+NCRFLQG TDPA V IR
Sbjct: 5 LDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNIR 64
Query: 538 AAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL---EPLR 594
A+ N+ VTVQ+ NY K G FWN ++ PM + YF+G+Q D ++ + L
Sbjct: 65 TALQNKEPVTVQIQNYKKDGTMFWNELNIDPMEI--EDKTYFVGIQNDITKQKEYEKLLE 122
Query: 595 NSIPEATA 602
+S+ E TA
Sbjct: 123 DSLTEITA 130
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* Length = 132 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-50
Identities = 49/115 (42%), Positives = 73/115 (63%), Gaps = 2/115 (1%)
Query: 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 253
L + V++D D PI+Y + GF +MTGY ++E++G+NCRFLQG TDP +V I
Sbjct: 4 MLDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNI 63
Query: 254 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308
R LQN + ++ NYKKDGT FWN L I P++ ++ F+G+Q +++K E
Sbjct: 64 RTALQNKEPVTVQIQNYKKDGTMFWNELNIDPMEIEDKTY--FVGIQNDITKQKE 116
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 7e-53
Identities = 63/277 (22%), Positives = 106/277 (38%), Gaps = 45/277 (16%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 723
+ + + LG G T +V +G FA+K + L V E E+L
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVL 61
Query: 724 DMLDHPFVPALYASFQTKT--HVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEV 780
L+H + L+A + T H LI ++CP G L+ +L + L E +V
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836
V + +L GI++R++KP N++ G LTDF +
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA------------------ 163
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--------GHTSAVDWWALGILL 888
+ ++ S GTEEY+ P++ A + + VD W++G+
Sbjct: 164 ---RELEDDEQFV-------SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
Query: 889 YEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSC 925
Y G PFR + +++K + S S
Sbjct: 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 8e-53
Identities = 63/279 (22%), Positives = 106/279 (37%), Gaps = 45/279 (16%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
+ + + LG G T +V +G FA+K + L V E E
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFE 59
Query: 722 ILDMLDHPFVPALYASFQTKT--HVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAA 778
+L L+H + L+A + T H LI ++CP G L+ +L + L E
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
+VV + +L GI++R++KP N++ G LTDF +
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA---------------- 163
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--------GHTSAVDWWALGI 886
+ ++ S GTEEY+ P++ A + + VD W++G+
Sbjct: 164 -----RELEDDEQF-------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211
Query: 887 LLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSC 925
Y G PFR + +++K + S S
Sbjct: 212 TFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* Length = 149 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 6e-52
Identities = 48/141 (34%), Positives = 76/141 (53%), Gaps = 26/141 (18%)
Query: 471 GIDLATTLERI--EKN-------------FVITDPRLPDNPIIFASDSFLELTEYSREEI 515
G D+ L +I N ++ D + D PI++AS++FL +T YS E+
Sbjct: 9 GYDIMGYLIQIMNRPNPQVELGPVDTSVALILCDLKQKDTPIVYASEAFLYMTGYSNAEV 68
Query: 516 LGRNCRFLQGPE-----------TDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLF 564
LGRNCRFLQ P+ D T+ +R AID +V V+++N+ K+G++F N
Sbjct: 69 LGRNCRFLQSPDGMVKPKSTRKYVDSNTINTMRKAIDRNAEVQVEVVNFKKNGQRFVNFL 128
Query: 565 HLQPMRDQKGEVQYFIGVQLD 585
+ P+RD+ GE +Y +G Q +
Sbjct: 129 TMIPVRDETGEYRYSMGFQCE 149
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* Length = 149 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 4e-49
Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 11/112 (9%)
Query: 202 FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAG-----------TDPEDV 250
++ D + D PI+YAS F MTGY++ EV+GRNCRFLQ D +
Sbjct: 38 LILCDLKQKDTPIVYASEAFLYMTGYSNAEVLGRNCRFLQSPDGMVKPKSTRKYVDSNTI 97
Query: 251 AKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVE 302
+R+ + ++N+KK+G F N LT+ P++D+ G+ +G Q E
Sbjct: 98 NTMRKAIDRNAEVQVEVVNFKKNGQRFVNFLTMIPVRDETGEYRYSMGFQCE 149
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 7e-52
Identities = 65/270 (24%), Positives = 110/270 (40%), Gaps = 31/270 (11%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
I+ +H+ I+ LG G V LVE G ++A+K + +R + R E ++
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQR---EADMHR 81
Query: 725 MLDHPFVPALYASFQTKT----HVCLITDYCPGGELFLLLDRQPTKV--LKEDAVRFYAA 778
+ +HP + L A + L+ + G L+ ++R K L ED + +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+ LE +H +G +RDLKP N+LL G L D S + + +
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG-----SMNQACIHVEGSRQ--- 193
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYEMLYGY 895
A ++ + T Y APE+ + H D W+LG +LY M++G
Sbjct: 194 ----------ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
Query: 896 TPFRGKTRQ-KTFANILHKDLKFPSSTPSS 924
P+ ++ + A + L P S S
Sbjct: 244 GPYDMVFQKGDSVALAVQNQLSIPQSPRHS 273
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-51
Identities = 59/261 (22%), Positives = 102/261 (39%), Gaps = 41/261 (15%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDML 726
+ + +G G V +GQ FA+K +D + + +RE I ML
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-----QPTKVLKEDAVRFYAAEVV 781
HP + L ++ + + ++ ++ G +L V E Y +++
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLC---FEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 782 VALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
AL Y H II+RD+KP VLL + V L F ++
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA-------------------- 180
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ + E + VGT ++APE++ + VD W G++L+ +L G PF
Sbjct: 181 -------IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233
Query: 899 RGKTRQKTFANILHKDLKFPS 919
G T+++ F I+ K
Sbjct: 234 YG-TKERLFEGIIKGKYKMNP 253
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 7e-51
Identities = 74/253 (29%), Positives = 114/253 (45%), Gaps = 39/253 (15%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAERE--ILDMLDHPFV 731
+ LGSG V G+G+ +A K + K + + R V R ERE IL + HP +
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVALEYLHCQ 790
L+ F+ KT V LI + GGELF D K L ED + +++ + YLH +
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELF---DFLAEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 791 GIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
I + DLKPEN++L N + L DF ++ +
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA--HKIEAG-------------------- 165
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
+ + GT E++APEI+ D W++G++ Y +L G +PF G+T+Q+T
Sbjct: 166 ---NEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET 219
Query: 907 FANILHKDLKFPS 919
NI + F
Sbjct: 220 LTNISAVNYDFDE 232
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-50
Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 37/285 (12%)
Query: 641 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 700
+H H S E N + K LG G V +GQ +A K
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK 60
Query: 701 AMDKGVMLNRNKVHRACAERE--ILDMLDH-PFVPALYASFQTKTHVCLITDYCPGGELF 757
+ K R + RA E +L++ P V L+ ++ + + LI +Y GGE+F
Sbjct: 61 FLKKR---RRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIF 117
Query: 758 LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---GNGHVSLTD 814
L + +++ E+ V +++ + YLH I++ DLKP+N+LL G + + D
Sbjct: 118 SLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 874
F +S +R +GT EY+APEI+
Sbjct: 178 FGMS--RKIGHA-----------------------CELR---EIMGTPEYLAPEILNYDP 209
Query: 875 HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPS 919
T+A D W +GI+ Y +L +PF G+ Q+T+ NI ++ +
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 2e-50
Identities = 76/255 (29%), Positives = 118/255 (46%), Gaps = 39/255 (15%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ F ++ LGSG V LV+ +G+ FA+K + K + + E +L + H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKH 65
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYL 787
+ L +++ TH L+ GGELF DR + E +V+ A++YL
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELF---DRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 788 HCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
H GI++RDLKPEN+L N + +TDF LS K +QN
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLS---------------------KMEQN 161
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+ + GT Y+APE++A ++ AVD W++G++ Y +L GY PF +T
Sbjct: 162 GIMS--------TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES 213
Query: 905 KTFANILHKDLKFPS 919
K F I +F S
Sbjct: 214 KLFEKIKEGYYEFES 228
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 4e-50
Identities = 70/259 (27%), Positives = 108/259 (41%), Gaps = 39/259 (15%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH-RACAERE--ILDM 725
+ + LGSG V +G +A K + K + R ERE IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVAL 784
+ H V L+ ++ +T V LI + GGELF D K L E+ + +++ +
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELF---DFLAQKESLSEEEATSFIKQILDGV 128
Query: 785 EYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
YLH + I + DLKPEN++L H+ L DF L+ +
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDG-------------- 172
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
+ + GT E++APEI+ D W++G++ Y +L G +PF G
Sbjct: 173 ---------VEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 901 KTRQKTFANILHKDLKFPS 919
T+Q+T ANI F
Sbjct: 221 DTKQETLANITSVSYDFDE 239
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-50
Identities = 67/263 (25%), Positives = 109/263 (41%), Gaps = 32/263 (12%)
Query: 643 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 702
P P KA++ + L +FR K +G G V+ G A+K +
Sbjct: 9 QGPPVPQFQPQKALRPDMGYNT---LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65
Query: 703 DKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL-- 760
+++ E ++L L+HP V YASF + ++ + G+L ++
Sbjct: 66 QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH 125
Query: 761 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820
++ +++ E V Y ++ ALE++H + +++RD+KP NV + G V L D L
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185
Query: 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 880
S K +S VGT Y++PE I G+ D
Sbjct: 186 FSSKTTAA---------------------------HSLVGTPYYMSPERIHENGYNFKSD 218
Query: 881 WWALGILLYEMLYGYTPFRGKTR 903
W+LG LLYEM +PF G
Sbjct: 219 IWSLGCLLYEMAALQSPFYGDKM 241
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 5e-50
Identities = 68/269 (25%), Positives = 118/269 (43%), Gaps = 39/269 (14%)
Query: 657 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG-VMLNRNKVHR 715
++ L I+ F + LGSG G VHLVE SG +K ++K + ++
Sbjct: 11 RENLYFQGTID-DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA 69
Query: 716 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF--LLLDRQPTKVLKEDAV 773
E E+L LDHP + ++ F+ ++ ++ + C GGEL ++ + K L E V
Sbjct: 70 ---EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYV 126
Query: 774 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLP 830
+++ AL Y H Q ++++DLKPEN+L Q + + + DF L+
Sbjct: 127 AELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA------------ 174
Query: 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 890
+ S + GT Y+APE+ T D W+ G+++Y
Sbjct: 175 ---------------ELF-KSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYF 217
Query: 891 MLYGYTPFRGKTRQKTFANILHKDLKFPS 919
+L G PF G + ++ +K+ +
Sbjct: 218 LLTGCLPFTGTSLEEVQQKATYKEPNYAV 246
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 6e-50
Identities = 61/266 (22%), Positives = 106/266 (39%), Gaps = 37/266 (13%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
+ + + +G+G G + G+ K +D G M K +E +L L
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELK 63
Query: 728 HPFVPALYASFQTKT--HVCLITDYCPGGELFLLLDRQPTK--VLKEDAVRFYAAEVVVA 783
HP + Y +T + ++ +YC GG+L ++ + + L E+ V ++ +A
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 784 LEYLH-----CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
L+ H +++RDLKP NV L G +V L DF L+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA-------------------- 163
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ + A +FVGT Y++PE + + D W+LG LLYE+ PF
Sbjct: 164 -RILNHDTSFA------KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216
Query: 899 RGKTRQKTFANILHKDLKFPSSTPSS 924
++++ I + S
Sbjct: 217 TAFSQKELAGKIREGKFRRIPYRYSD 242
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 8e-50
Identities = 67/255 (26%), Positives = 109/255 (42%), Gaps = 39/255 (15%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
Q++ +G G G V + G+ A K + K + + ++ + E EI+ LDH
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ---EIEIMKSLDH 65
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYL 787
P + LY +F+ T + L+ + C GGELF +R K +E +V+ A+ Y
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELF---ERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 788 HCQGIIYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
H + +RDLKPEN L + S L DF L+
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA-------------------------- 156
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+P + + VGT Y++P+++ G + D W+ G+++Y +L GY PF T
Sbjct: 157 -ARF-KPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS 213
Query: 905 KTFANILHKDLKFPS 919
+ I FP
Sbjct: 214 EVMLKIREGTFTFPE 228
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 8e-50
Identities = 68/323 (21%), Positives = 113/323 (34%), Gaps = 70/323 (21%)
Query: 641 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 700
+H H + + S ++ + + +G G G V + + A+K
Sbjct: 1 MHHHHHHSSGR--ENLYFQGGSLLELQ-KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIK 57
Query: 701 AMDKGVMLNRNKVHRACAERE--ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF- 757
M+K + N + E ++ L HP + LY ++ + ++CL+ + C GG L
Sbjct: 58 IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLD 117
Query: 758 -------------------------------------LLLDRQPTKVLKEDAVRFYAAEV 780
V +E + ++
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
AL YLH QGI +RD+KPEN L + + L DF LS K+
Sbjct: 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLS----------------KEFY 221
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH--TSAVDWWALGILLYEMLYGYT 896
M GT ++APE++ D W+ G+LL+ +L G
Sbjct: 222 KLNNGEYYGMTT-------KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274
Query: 897 PFRGKTRQKTFANILHKDLKFPS 919
PF G T + +L+K L F +
Sbjct: 275 PFPGVNDADTISQVLNKKLCFEN 297
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 8e-50
Identities = 66/249 (26%), Positives = 106/249 (42%), Gaps = 38/249 (15%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
+ LGSG G VH +G+ F K ++ L++ V E I++ L HP + L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHHPKLINL 113
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTK--VLKEDAVRFYAAEVVVALEYLHCQGI 792
+ +F+ K + LI ++ GGELF DR + + E V Y + L+++H I
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELF---DRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170
Query: 793 IYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
++ D+KPEN++ + V + DF L+
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLAT----------------------------KLN 202
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
P T E+ APEI+ D WA+G+L Y +L G +PF G+ +T N+
Sbjct: 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 262
Query: 911 LHKDLKFPS 919
D +F
Sbjct: 263 KRCDWEFDE 271
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 9e-50
Identities = 71/253 (28%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAERE--ILDMLDHPFV 731
+ LGSG V +G +A K + K + R V R ERE IL + HP V
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVALEYLHCQ 790
L+ ++ KT V LI + GGELF D K L E+ + +++ + YLH
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 791 GIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
I + DLKPEN++L + + DF L+
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFG-------------------- 171
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
+ + GT E++APEI+ D W++G++ Y +L G +PF G T+Q+T
Sbjct: 172 ---NEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225
Query: 907 FANILHKDLKFPS 919
AN+ + +F
Sbjct: 226 LANVSAVNYEFED 238
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-49
Identities = 72/259 (27%), Positives = 111/259 (42%), Gaps = 39/259 (15%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDK-GVMLNRNKVHRACAERE--ILDM 725
+ + LGSG V +G +A K + K +R V R ERE IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVAL 784
+ HP + L+ ++ +T V LI + GGELF D K L E+ + +++ +
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELF---DFLAQKESLSEEEATSFIKQILDGV 128
Query: 785 EYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
YLH + I + DLKPEN++L H+ L DF L+ +
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDG-------------- 172
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
+ + GT E++APEI+ D W++G++ Y +L G +PF G
Sbjct: 173 ---------VEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 901 KTRQKTFANILHKDLKFPS 919
T+Q+T ANI F
Sbjct: 221 DTKQETLANITAVSYDFDE 239
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-49
Identities = 76/338 (22%), Positives = 134/338 (39%), Gaps = 47/338 (13%)
Query: 586 GSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKP 645
G+E+L S + + + + +P + L + P
Sbjct: 15 GTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFD 74
Query: 646 HRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 705
HR + A+ + + LG G G VH E +G A K +
Sbjct: 75 HRIVTAKQGAVNSFYTVSKT---------EILGGGRFGQVHKCEETATGLKLAAKIIKTR 125
Query: 706 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 765
M ++ +V E +++ LDH + LY +F++K + L+ +Y GGELF DR
Sbjct: 126 GMKDKEEVKN---EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF---DRIID 179
Query: 766 K--VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL--QGNGHVSLTDFDLSCLT 821
+ L E + ++ + ++H I++ DLKPEN+L + + + DF L+
Sbjct: 180 ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLA--- 236
Query: 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881
RR+K + E ++ GT E++APE++ + D
Sbjct: 237 ---------------RRYKPR-------EKLK---VNFGTPEFLAPEVVNYDFVSFPTDM 271
Query: 882 WALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPS 919
W++G++ Y +L G +PF G +T NIL
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED 309
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-49
Identities = 67/257 (26%), Positives = 110/257 (42%), Gaps = 40/257 (15%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN--KVHRACAEREILDML 726
++ + LG G V +G FA K ++ + R+ K+ R E I L
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKL 62
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALE 785
HP + L+ S Q ++ L+ D GGELF + + E +++ ++
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELF---EDIVAREFYSEADASHCIQQILESIA 119
Query: 786 YLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
Y H GI++R+LKPEN+LL V L DF L+
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA------------------------ 155
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902
+ + A + F GT Y++PE++ ++ VD WA G++LY +L GY PF +
Sbjct: 156 ---IEV-NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211
Query: 903 RQKTFANILHKDLKFPS 919
+ + +A I +PS
Sbjct: 212 QHRLYAQIKAGAYDYPS 228
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 3e-49
Identities = 67/255 (26%), Positives = 105/255 (41%), Gaps = 36/255 (14%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
++ + LG G G V L + +GQ A+K + K + + E ++L LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYL 787
P + LY F+ K + L+ + GGELF D K E +V+ + Y+
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELF---DEIISRKRFSEVDAARIIRQVLSGITYM 142
Query: 788 HCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
H I++RDLKPEN+LL+ + ++ + DF LS
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST------------------------- 177
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
E + +GT YIAPE++ G + D W+ G++LY +L G PF G
Sbjct: 178 ---HFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEY 233
Query: 905 KTFANILHKDLKFPS 919
+ F
Sbjct: 234 DILKKVEKGKYTFEL 248
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-49
Identities = 73/287 (25%), Positives = 115/287 (40%), Gaps = 52/287 (18%)
Query: 647 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV 706
R + P S +++ P + LG G + V + + +A+K +D
Sbjct: 2 RDAALPGS------HSTHGFY-ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTG 54
Query: 707 MLNRNKVH----RACAERE--ILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLL 759
+ + R +E IL + HP + L +++T T L+ D GELF
Sbjct: 55 GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-- 112
Query: 760 LDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818
D KV L E R ++ + LH I++RDLKPEN+LL + ++ LTDF S
Sbjct: 113 -DYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA----- 873
C P L GT Y+APEII +
Sbjct: 172 CQ--LDPGEKLREV--------------------------CGTPSYLAPEIIECSMNDNH 203
Query: 874 -GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPS 919
G+ VD W+ G+++Y +L G PF + + I+ + +F S
Sbjct: 204 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-49
Identities = 60/249 (24%), Positives = 107/249 (42%), Gaps = 39/249 (15%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
+ LG G+ G VH S + + K + ++ V + E IL++ H + L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKK---EISILNIARHRNILHL 66
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTK--VLKEDAVRFYAAEVVVALEYLHCQGI 792
+ SF++ + +I ++ G ++F +R T L E + Y +V AL++LH I
Sbjct: 67 HESFESMEELVMIFEFISGLDIF---ERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 793 IYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
+ D++PEN++ Q + + + +F + KP +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPG-----------------------D 158
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
R EY APE+ ++A D W+LG L+Y +L G PF +T Q+ NI
Sbjct: 159 NFR---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215
Query: 911 LHKDLKFPS 919
++ + F
Sbjct: 216 MNAEYTFDE 224
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-48
Identities = 68/284 (23%), Positives = 118/284 (41%), Gaps = 41/284 (14%)
Query: 642 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 701
H + + ++++ + + ++ + LG G V +G FA K
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFS-DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 702 MDKGVMLNR--NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 759
++ + R K+ R E I L HP + L+ S Q ++ L+ D GGELF
Sbjct: 62 INTKKLSARDFQKLER---EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF-- 116
Query: 760 LDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDF 815
+ + E +++ ++ Y H GI++R+LKPEN+LL V L DF
Sbjct: 117 -EDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 175
Query: 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 875
L+ + + A + F GT Y++PE++ +
Sbjct: 176 GLA---------------------------IEV-NDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 876 TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPS 919
+ VD WA G++LY +L GY PF + + + +A I +PS
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 251
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-48
Identities = 53/269 (19%), Positives = 97/269 (36%), Gaps = 55/269 (20%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
F+ I+ +GSG G V + G+ + +K + N K R E + L LD
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAER---EVKALAKLD 62
Query: 728 HPFVPALYASFQ----------------TKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
H + + + + ++C G L ++++ + L +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 772 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831
++ ++Y+H + +I RDLKP N+ L V + DF L L
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT--------SLKN 174
Query: 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891
++ GT Y++PE I+ + VD +ALG++L E+
Sbjct: 175 DGKRT--------------------RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214
Query: 892 LYGYTPFRGKTRQKTFANILHKDLKFPSS 920
L+ K F ++ +D
Sbjct: 215 LHV--CDTAFETSKFFTDL--RDGIISDI 239
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-48
Identities = 63/255 (24%), Positives = 102/255 (40%), Gaps = 37/255 (14%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ + + LG G G V + + Q +A+K ++K N++ E E+L LDH
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDH 80
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYL 787
P + L+ + + ++ + GGELF D K E +V + Y+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELF---DEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 788 HCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
H I++RDLKPEN+LL+ + + + DF LS
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-------------------------- 171
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+ +GT YIAPE++ G + D W+ G++LY +L G PF GK
Sbjct: 172 -TCF-QQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY 228
Query: 905 KTFANILHKDLKFPS 919
+ F
Sbjct: 229 DILKRVETGKYAFDL 243
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 5e-48
Identities = 64/255 (25%), Positives = 106/255 (41%), Gaps = 35/255 (13%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ ++ + LG G V +GQ +A ++ L+ + E I +L H
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINT-KKLSARDHQKLEREARICRLLKH 69
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYL 787
P + L+ S + H LI D GGELF + + E +++ A+ +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELF---EDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 788 HCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
H G+++R+LKPEN+LL V L DF L+
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA-------------------------- 160
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+ + +A F GT Y++PE++ + VD WA G++LY +L GY PF + +
Sbjct: 161 -IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH 219
Query: 905 KTFANILHKDLKFPS 919
+ + I FPS
Sbjct: 220 RLYQQIKAGAYDFPS 234
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 6e-48
Identities = 69/333 (20%), Positives = 126/333 (37%), Gaps = 51/333 (15%)
Query: 591 EPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDS 650
+P + P + K ++ +V+E K + + + +
Sbjct: 92 KPCEPTAPVLIPGDERK--RRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 651 PPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 710
+ D E+ LG+G G VH V +G FA K + ++
Sbjct: 150 IKHDHVLDHYDIHEE-----------LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK 198
Query: 711 NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK--VL 768
V + E + + +L HP + L+ +F+ + +I ++ GGELF ++ + +
Sbjct: 199 ETVRK---EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF---EKVADEHNKM 252
Query: 769 KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQ 826
ED Y +V L ++H ++ DLKPEN++ + + L DF L+
Sbjct: 253 SEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA------- 305
Query: 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 886
+P ++ GT E+ APE+ G D W++G+
Sbjct: 306 ---------------------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
Query: 887 LLYEMLYGYTPFRGKTRQKTFANILHKDLKFPS 919
L Y +L G +PF G+ +T N+ D
Sbjct: 345 LSYILLSGLSPFGGENDDETLRNVKSCDWNMDD 377
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 8e-48
Identities = 46/302 (15%), Positives = 94/302 (31%), Gaps = 49/302 (16%)
Query: 638 SKVVHPKPHRKDSPPWKAIQKILDSGEQINL--QHFRPIKPLGSGDTGSVHLVE-----L 690
S + P ++ W+ + + L + LG G V+
Sbjct: 32 SGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLND 91
Query: 691 CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750
+ Q F +K N + + E L Y++ + L+ +
Sbjct: 92 AKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGEL 148
Query: 751 CPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG- 806
G L ++ P KV+ + V +A ++ +E +H II+ D+KP+N +L
Sbjct: 149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG 208
Query: 807 ----------NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
+ ++L D S P+ +F
Sbjct: 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPK-----------------GTIF--------T 243
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 916
+ T + E+++ +D++ + +Y ML+G + L + L
Sbjct: 244 AKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP 303
Query: 917 FP 918
Sbjct: 304 HL 305
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 9e-48
Identities = 74/293 (25%), Positives = 120/293 (40%), Gaps = 49/293 (16%)
Query: 641 VHPKPHRKDSPPWKAIQKILDSGEQINL--------QHFRPIKPLGSGDTGSVHLVELCG 692
+H H Q L + + + + ++ +K LGSG G V L
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 693 SGQYFAMKAMDKGVMLNRN--KVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750
+ A+K + K + + K+ E +L +LDHP + LY F+ K + L+ +
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLE---EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117
Query: 751 CPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---G 806
GGELF D E +V+ + YLH I++RDLKPEN+LL+
Sbjct: 118 YKGGELF---DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEK 174
Query: 807 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 866
+ + + DF LS + E + +GT YIA
Sbjct: 175 DALIKIVDFGLSA----------------------------VFENQKKMKERLGTAYYIA 206
Query: 867 PEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPS 919
PE++ + D W++G++L+ +L GY PF G+T Q+ + F S
Sbjct: 207 PEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS 258
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-47
Identities = 64/257 (24%), Positives = 104/257 (40%), Gaps = 41/257 (15%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN--KVHRACAEREILDML 726
+ + + LG G G V + + Q +A+K ++K N++ + R E E+L L
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKL 78
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALE 785
DHP + L+ + + ++ + GGELF D K E +V +
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELF---DEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 786 YLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
Y+H I++RDLKPEN+LL+ + + + DF LS
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--------------------- 174
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902
+ +GT YIAPE++ G + D W+ G++LY +L G PF GK
Sbjct: 175 -------QQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN 226
Query: 903 RQKTFANILHKDLKFPS 919
+ F
Sbjct: 227 EYDILKRVETGKYAFDL 243
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-47
Identities = 67/300 (22%), Positives = 107/300 (35%), Gaps = 53/300 (17%)
Query: 641 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPI-------KPLGSGDTGSVHLVELCGS 693
+H H Q I + + I + LGSG G V L +
Sbjct: 1 MHHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNG 60
Query: 694 GQYFAMKAMDKGVMLNRNKVHRACA----------EREILDMLDHPFVPALYASFQTKTH 743
A+K + K E +L LDHP + L+ F+ K +
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 744 VCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802
L+T++ GGELF ++ E +++ + YLH I++RD+KPEN+
Sbjct: 121 FYLVTEFYEGGELF---EQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENI 177
Query: 803 LLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFV 859
LL+ ++ + DF LS +
Sbjct: 178 LLENKNSLLNIKIVDFGLSS----------------------------FFSKDYKLRDRL 209
Query: 860 GTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPS 919
GT YIAPE++ + D W+ G+++Y +L GY PF G+ Q + F
Sbjct: 210 GTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-47
Identities = 71/268 (26%), Positives = 123/268 (45%), Gaps = 36/268 (13%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAE 719
+ EQ ++ ++R +K +G G+ V L +G+ A+K +DK + + K+ R E
Sbjct: 8 ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR---E 64
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
I+ +L+HP + L+ +T+ + LI +Y GGE+F L +KE R +
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQ 122
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
+V A++Y H + I++RDLK EN+LL + ++ + DF S L
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDA-------- 172
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT-SAVDWWALGILLYEMLYGYTPF 898
F G Y APE+ G + VD W+LG++LY ++ G PF
Sbjct: 173 ------------------FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214
Query: 899 RGKTRQKTFANILHKDLKFPSSTPSSCK 926
G+ ++ +L + P + C+
Sbjct: 215 DGQNLKELRERVLRGKYRIPFYMSTDCE 242
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-47
Identities = 63/302 (20%), Positives = 112/302 (37%), Gaps = 48/302 (15%)
Query: 641 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 700
+H H S + + + +K +GSG + V V L Q +A+K
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQS-MSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIK 58
Query: 701 AMDKGVMLNRNKVHRACAEREILDMLDHP--FVPALYASFQTKTHVCLITDYCPGGELFL 758
++ + + E L+ L + LY T ++ ++ + +L
Sbjct: 59 YVNLE-EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNS 116
Query: 759 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818
L ++ K + + Y ++ A+ +H GI++ DLKP N L+ +G + L DF ++
Sbjct: 117 WLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 173
Query: 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---- 874
+ P T + +S VGT Y+ PE I
Sbjct: 174 -------NQMQPDTTSVVK------------------DSQVGTVNYMPPEAIKDMSSSRE 208
Query: 875 -------HTSAVDWWALGILLYEMLYGYTPFRGKTRQ-KTFANILHKD--LKFPSSTPSS 924
+ D W+LG +LY M YG TPF+ Q I+ + ++FP
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKD 268
Query: 925 CK 926
+
Sbjct: 269 LQ 270
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 6e-47
Identities = 73/297 (24%), Positives = 118/297 (39%), Gaps = 58/297 (19%)
Query: 661 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA-- 718
SG+ + L + +G G G V L Y+AMK + K ++ + R
Sbjct: 5 SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPR 64
Query: 719 -------------------EREI--LDMLDHPFVPALY--ASFQTKTHVCLITDYCPGGE 755
+EI L LDHP V L + H+ ++ + G
Sbjct: 65 GTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP 124
Query: 756 LFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815
+ + +P L ED RFY +++ +EYLH Q II+RD+KP N+L+ +GH+ + DF
Sbjct: 125 VMEVPTLKP---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 875
+S LL T VGT ++APE ++
Sbjct: 182 GVSNEFK-GSDALLSNT--------------------------VGTPAFMAPESLSETRK 214
Query: 876 T---SAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAAN 929
A+D WA+G+ LY ++G PF + + I + L+FP + +
Sbjct: 215 IFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKD 271
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-46
Identities = 80/342 (23%), Positives = 130/342 (38%), Gaps = 48/342 (14%)
Query: 595 NSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWK 654
N E L E ++ L D +L A K+ +P ++ ++
Sbjct: 16 NKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQ 75
Query: 655 AIQKILDSGEQINLQHFRPI----KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 710
++ + + + F +G G + V +G FA+K M+
Sbjct: 76 SMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS 135
Query: 711 NKVHRACAER-----EILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP 764
+ E IL + HP + L S+++ + + L+ D GELF D
Sbjct: 136 PEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF---DYLT 192
Query: 765 TKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
KV L E R ++ A+ +LH I++RDLKPEN+LL N + L+DF SC
Sbjct: 193 EKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH--L 250
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA------GHTS 877
+P L GT Y+APEI+ + G+
Sbjct: 251 EPGEKLRE--------------------------LCGTPGYLAPEILKCSMDETHPGYGK 284
Query: 878 AVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPS 919
VD WA G++L+ +L G PF + + I+ +F S
Sbjct: 285 EVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-46
Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 38/267 (14%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM-LNRNKVHRACAEREILDML 726
L F PI+ LG G G V + +A+K + L R KV R E + L L
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR---EVKALAKL 60
Query: 727 DHPFVPALYASFQTKT------------HVCLITDYCPGGELFLLLDRQPTKVLKEDA-V 773
+HP + + ++ K ++ + C L ++ + T +E +
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 774 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
++ A+E+LH +G+++RDLKP N+ + V + DF L +
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT--------AMDQDE 172
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 893
E++ VGT+ Y++PE I G ++ VD ++LG++L+E+LY
Sbjct: 173 EEQTVLTPMPAYARH-------TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
Query: 894 GYTPFRGKT-RQKTFANILHKDLKFPS 919
PF + R +T ++ ++LKFP
Sbjct: 226 ---PFSTQMERVRTLTDV--RNLKFPP 247
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-46
Identities = 66/257 (25%), Positives = 98/257 (38%), Gaps = 48/257 (18%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPA 733
KPLG G S Q FA+K + K E L + + HP +
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVK 70
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
L+ F + H L+ + GGELF +R + K E + ++V A+ ++H G+
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELF---ERIKKKKHFSETEASYIMRKLVSAVSHMHDVGV 127
Query: 793 IYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
++RDLKPEN+L + DF + R K N
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFA-------------------RLKPPDNQPLK- 167
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT--- 906
+ T Y APE++ G+ + D W+LG++LY ML G PF+ R T
Sbjct: 168 -------TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220
Query: 907 ----FANILHKDLKFPS 919
I D F
Sbjct: 221 AVEIMKKIKKGDFSFEG 237
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-46
Identities = 67/264 (25%), Positives = 111/264 (42%), Gaps = 31/264 (11%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 723
++ + H+ LG G G V + E +G A+K +++ + + + V + E + L
Sbjct: 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
+ HP + LY T T ++ +Y GGELF + + ++E R +++ A
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSA 123
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
++Y H +++RDLKPENVLL + + + DF LS + L T
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRT------------ 169
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKT 902
G+ Y APE+I+G VD W+ G++LY +L G PF +
Sbjct: 170 --------------SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215
Query: 903 RQKTFANILHKDLKFPSSTPSSCK 926
F I P S
Sbjct: 216 VPTLFKKIRGGVFYIPEYLNRSVA 239
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-46
Identities = 72/250 (28%), Positives = 110/250 (44%), Gaps = 41/250 (16%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
LG G T V+ + G+ + +A+K + K E +L L HP + L
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGII 793
F+T T + L+ + GGELF DR K E +++ A+ YLH GI+
Sbjct: 114 KEIFETPTEISLVLELVTGGELF---DRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 794 YRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
+RDLKPEN+L + + + DF LS + + Q+L+ T
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKT------------------- 209
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK-TFAN 909
GT Y APEI+ G + VD W++GI+ Y +L G+ PF + + F
Sbjct: 210 -------VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR 262
Query: 910 ILHKDLKFPS 919
IL+ + F S
Sbjct: 263 ILNCEYYFIS 272
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 4e-46
Identities = 61/285 (21%), Positives = 109/285 (38%), Gaps = 43/285 (15%)
Query: 649 DSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML 708
+ PP + L + E Q + + PLGSG G V + +K + K +L
Sbjct: 4 EEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVL 63
Query: 709 NRNKVHRACAER-----EILDMLDHPFVPALYASFQTKTHVCLITD-YCPGGELFLLLDR 762
+ + IL ++H + + F+ + L+ + + G +LF +DR
Sbjct: 64 EDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR 123
Query: 763 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822
P L E + ++V A+ YL + II+RD+K EN+++ + + L DF +
Sbjct: 124 HPR--LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL- 180
Query: 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT-SAVDW 881
+ L T F GT EY APE++ G + ++
Sbjct: 181 -ERGKLFYT--------------------------FCGTIEYCAPEVLMGNPYRGPELEM 213
Query: 882 WALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCK 926
W+LG+ LY +++ PF + + P
Sbjct: 214 WSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKELM 252
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 9e-46
Identities = 59/278 (21%), Positives = 107/278 (38%), Gaps = 47/278 (16%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
+ + + +K +GSG + V V L Q +A+K ++ + + E L+
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLE-EADNQTLDSYRNEIAYLN 62
Query: 725 MLDHP--FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 782
L + LY T ++ ++ + +L L ++ K + + Y ++
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKSYWKNMLE 119
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
A+ +H GI++ DLKP N L+ +G + L DF ++ + +
Sbjct: 120 AVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA------------------NQMQPD 160
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-----------HTSAVDWWALGILLYEM 891
V +S VGT Y+ PE I + D W+LG +LY M
Sbjct: 161 TTSVVK-------DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 213
Query: 892 LYGYTPFRGKTRQ-KTFANILHKD--LKFPSSTPSSCK 926
YG TPF+ Q I+ + ++FP +
Sbjct: 214 TYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 251
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-45
Identities = 75/264 (28%), Positives = 110/264 (41%), Gaps = 45/264 (17%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER-----EIL 723
+ K LGSG G V L + + A+K + K + A EIL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVV 782
L+HP + + F + ++ + GGELF D+ LKE + Y ++++
Sbjct: 70 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLL 125
Query: 783 ALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
A++YLH GII+RDLKPENVLL + + +TDF S
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS--------------------- 164
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYT 896
K M + GT Y+APE++ AG+ AVD W+LG++L+ L GY
Sbjct: 165 KILGETSLM-------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
Query: 897 PFRGKTRQKT-FANILHKDLKFPS 919
PF Q + I F
Sbjct: 218 PFSEHRTQVSLKDQITSGKYNFIP 241
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 7e-45
Identities = 66/279 (23%), Positives = 106/279 (37%), Gaps = 46/279 (16%)
Query: 650 SPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN 709
+ +I + L + + +G G + FA+K +DK +
Sbjct: 3 TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK----S 58
Query: 710 RNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKV 767
+ E EIL HP + L + +V ++T+ GGEL D+ K
Sbjct: 59 KRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELL---DKILRQKF 112
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSC 823
E + +EYLH QG+++RDLKP N+L + + DF +
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA----- 167
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 883
K+ R + + P T ++APE++ G+ +A D W+
Sbjct: 168 -----------KQLRAENG----LLMTP-------CYTANFVAPEVLERQGYDAACDIWS 205
Query: 884 LGILLYEMLYGYTPFRGK---TRQKTFANILHKDLKFPS 919
LG+LLY ML GYTPF T ++ A I
Sbjct: 206 LGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 1e-44
Identities = 64/267 (23%), Positives = 103/267 (38%), Gaps = 40/267 (14%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+ + LG+G G V +G+ A+K + L+ R C E +I+ L+HP
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ--ELSPKNRERWCLEIQIMKKLNHP 72
Query: 730 FVPALYASFQTKTHV------CLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVV 782
V + + L +YC GG+L L + LKE +R +++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
AL YLH II+RDLKPEN++LQ + D + L
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA--KELDQGELCTE-------- 182
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
FVGT +Y+APE++ +T VD+W+ G L +E + G+ PF
Sbjct: 183 ------------------FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224
Query: 900 GKTRQKTFANILHKDLKFPSSTPSSCK 926
+ + + +
Sbjct: 225 PNWQPVQWHGKVREKSNEHIVVYDDLT 251
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-44
Identities = 75/264 (28%), Positives = 111/264 (42%), Gaps = 45/264 (17%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER-----EIL 723
+ K LGSG G V L + + A++ + K + A EIL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVV 782
L+HP + + F + ++ + GGELF D+ K LKE + Y ++++
Sbjct: 195 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLL 250
Query: 783 ALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
A++YLH GII+RDLKPENVLL + + +TDF S
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS--------------------- 289
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYT 896
K M + GT Y+APE++ AG+ AVD W+LG++L+ L GY
Sbjct: 290 KILGETSLM-------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342
Query: 897 PFRGKTRQKT-FANILHKDLKFPS 919
PF Q + I F
Sbjct: 343 PFSEHRTQVSLKDQITSGKYNFIP 366
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-43
Identities = 65/270 (24%), Positives = 102/270 (37%), Gaps = 51/270 (18%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 733
LG G V + Q +A+K ++K R++V R E E+L H V
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQGHRNVLE 75
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
L F+ + L+ + GG + + E +V AL++LH +GI
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSIL---SHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 793 IYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+RDLKPEN+L + VS + DFDL
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLG-----------------SGIKLNGDCSPIST 175
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTS-----AVDWWALGILLYEMLYGYTPFRGK--- 901
+ + G+ EY+APE++ + D W+LG++LY +L GY PF G+
Sbjct: 176 PELL---TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS 232
Query: 902 ------------TRQKTFANILHKDLKFPS 919
+ F +I +FP
Sbjct: 233 DCGWDRGEACPACQNMLFESIQEGKYEFPD 262
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 63/267 (23%), Positives = 108/267 (40%), Gaps = 37/267 (13%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDML 726
++ + ++ LG G G V L + + A+K +D ++ + + E I ML
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKML 62
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALE 785
+H V Y + L +YC GGELF DR + + E + + +++ +
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL-LLPTTNEKKRRHKGQQN 844
YLH GI +RD+KPEN+LL ++ ++DF L+ + + LL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM------------ 167
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTR 903
GT Y+APE++ H VD W+ GI+L ML G P+ +
Sbjct: 168 --------------CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213
Query: 904 -QKTFANILHKDLKFPSSTPSSCKAAN 929
+ +++ K
Sbjct: 214 SCQEYSDWKEKKTYLNPWKKIDSAPLA 240
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 2e-43
Identities = 41/288 (14%), Positives = 76/288 (26%), Gaps = 73/288 (25%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL----------- 723
LG D + +G+ F + N + + E L
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 724 -----------DMLDHPFVPALYASFQTKTHVCLITDY-------CPGGELFLLLDRQPT 765
D++ P + + + +++ + +L +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 766 --KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
K L A +V+ L LH G+++ L+P +++L G V LT F+
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG- 257
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--------- 874
A + + PE+ A
Sbjct: 258 ------------------------------ARVVSSVSRGFEPPELEARRATISYHRDRR 287
Query: 875 --HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSS 920
T + D WALG+++Y + P I P
Sbjct: 288 TLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQP 335
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 2e-43
Identities = 61/263 (23%), Positives = 93/263 (35%), Gaps = 43/263 (16%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN----KVHRACAEREILDMLDHPF 730
LG G G V V + A+K + K + V + E ++L L H
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK---EIQLLRRLRHKN 67
Query: 731 VPALY--ASFQTKTHVCLITDYCPGG--ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
V L + K + ++ +YC G E+ D P K Y +++ LEY
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC-KPQLLLPTTNEKKRRHKGQQNP 845
LH QGI+++D+KP N+LL G + ++ ++ T+
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS------------- 171
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRGKTR 903
G+ + PEI G VD W+ G+ LY + G PF G
Sbjct: 172 -------------QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI 218
Query: 904 QKTFANILHKDLKFPSSTPSSCK 926
K F NI P
Sbjct: 219 YKLFENIGKGSYAIPGDCGPPLS 241
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-43
Identities = 65/322 (20%), Positives = 117/322 (36%), Gaps = 48/322 (14%)
Query: 621 KELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSG 680
+P + E A + P KA + + + + +K +GSG
Sbjct: 9 GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANEC-ISVKGRIYSILKQIGSG 67
Query: 681 DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP--FVPALYASF 738
+ V V L Q +A+K ++ + + E L+ L + LY
Sbjct: 68 GSSKVFQV-LNEKKQIYAIKYVNLE-EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 739 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLK 798
T ++ ++ + +L L ++ K + + Y ++ A+ +H GI++ DLK
Sbjct: 126 ITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 182
Query: 799 PENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSF 858
P N L+ +G + L DF ++ + P T + +S
Sbjct: 183 PANFLIV-DGMLKLIDFGIA-------NQMQPDTTSVVK------------------DSQ 216
Query: 859 VGTEEYIAPEIIAGAG-----------HTSAVDWWALGILLYEMLYGYTPFRGKTRQ-KT 906
VG Y+ PE I + D W+LG +LY M YG TPF+ Q
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 907 FANILHKD--LKFPSSTPSSCK 926
I+ + ++FP +
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQ 298
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-43
Identities = 65/264 (24%), Positives = 109/264 (41%), Gaps = 31/264 (11%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 723
++ + H+ LG G G V + + +G A+K +++ + + + V + E + L
Sbjct: 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL 70
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
+ HP + LY T + + ++ +Y GGELF + + L E R +++
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSG 128
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
++Y H +++RDLKPENVLL + + + DF LS + L T
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRT------------ 174
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKT 902
G+ Y APE+I+G VD W+ G++LY +L G PF
Sbjct: 175 --------------SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220
Query: 903 RQKTFANILHKDLKFPSSTPSSCK 926
F I P S
Sbjct: 221 VPTLFKKICDGIFYTPQYLNPSVI 244
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-42
Identities = 55/262 (20%), Positives = 95/262 (36%), Gaps = 59/262 (22%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI---LDMLDHPFV 731
+ LG G G V +GQ A+K + A +E+ P +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYD----------SPKARQEVDHHWQASGGPHI 84
Query: 732 PALYASFQTKTH----VCLITDYCPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVAL 784
+ ++ H + +I + GGELF R + + E ++ A+
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELF---SRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
++LH I +RD+KPEN+L + LTDF + K
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA---------------------KE 180
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+ T Y+APE++ + + D W+LG+++Y +L G+ PF
Sbjct: 181 TTQNALQ--------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232
Query: 902 TRQKTFANILHK----DLKFPS 919
T Q + + FP+
Sbjct: 233 TGQAISPGMKRRIRLGQYGFPN 254
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-42
Identities = 75/268 (27%), Positives = 115/268 (42%), Gaps = 36/268 (13%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
+ + ++ + + LG G G V L + Q A+K + + ++ + R ERE
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRV--ERE 59
Query: 722 I--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
I L +L HP + LY T T + ++ +Y GGELF + + K + ED R + +
Sbjct: 60 ISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQ 116
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
++ A+EY H I++RDLKPEN+LL N +V + DF LS + L T
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKT-------- 166
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPF 898
G+ Y APE+I G VD W+ GI+LY ML G PF
Sbjct: 167 ------------------SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208
Query: 899 RGKTRQKTFANILHKDLKFPSSTPSSCK 926
+ F + P +
Sbjct: 209 DDEFIPNLFKKVNSCVYVMPDFLSPGAQ 236
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 34/234 (14%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDML 726
++ + ++ LG G G V L + + A+K +D ++ + + E I ML
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKML 62
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALE 785
+H V Y + L +YC GGELF DR + + E + + +++ +
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YLH GI +RD+KPEN+LL ++ ++DF L+ + + L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------------- 166
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPF 898
GT Y+APE++ H VD W+ GI+L ML G P+
Sbjct: 167 ------------MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-42
Identities = 71/280 (25%), Positives = 106/280 (37%), Gaps = 41/280 (14%)
Query: 657 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA 716
LD + + +K +GSG+ G L+ + + A+K +++G V R
Sbjct: 8 TGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQR- 65
Query: 717 CAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFY 776
E L HP + T TH+ +I +Y GGEL+ + ED RF+
Sbjct: 66 --EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFF 121
Query: 777 AAEVVVALEYLHCQGIIYRDLKPENVLLQGN--GHVSLTDFDLSCLTSCKPQLLLPTTNE 834
+++ + Y H I +RDLK EN LL G+ + + DF S S +T
Sbjct: 122 FQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS--KSSVLHSQPKST-- 177
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLY 893
VGT YIAPE++ D W+ G+ LY ML
Sbjct: 178 ------------------------VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV 213
Query: 894 GYTPFRGKTR----QKTFANILHKDLKFPSSTPSSCKAAN 929
G PF +KT IL P S + +
Sbjct: 214 GAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH 253
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 58/274 (21%), Positives = 96/274 (35%), Gaps = 36/274 (13%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ R + L G V+ + GSG+ +A+K + + + E +
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---EVCFMK 80
Query: 725 ML-DHPFVPALYASFQTKTH--------VCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
L HP + ++ L+T+ C G + L + L D V
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 776 YAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
+ A++++H Q II+RDLK EN+LL G + L DF + S P
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYE 890
+ +N T Y PEII + D WALG +LY
Sbjct: 201 RALVEEEITRN---------------TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245
Query: 891 MLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSS 924
+ + PF + + I++ P
Sbjct: 246 LCFRQHPFEDGAKLR----IVNGKYSIPPHDTQY 275
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 67/294 (22%), Positives = 106/294 (36%), Gaps = 47/294 (15%)
Query: 643 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 702
+PP + +R LG G G+V A+K +
Sbjct: 5 KPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI 64
Query: 703 DKGVMLNRNKVHRACA-EREI--LDMLD----HPFVPALYASFQTKTHVCLITDY-CPGG 754
+ +L + + + E+ L + HP V L F+T+ L+ + P
Sbjct: 65 PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ 124
Query: 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLT 813
+LF + + L E R + +VV A+++ H +G+++RD+K EN+L+ G L
Sbjct: 125 DLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI 182
Query: 814 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA 873
DF L + F GT Y PE I+
Sbjct: 183 DFGSGALL--HDEPY---------------------------TDFDGTRVYSPPEWISRH 213
Query: 874 G-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCK 926
H W+LGILLY+M+ G PF IL +L FP+ C
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFPAHVSPDCC 261
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-41
Identities = 41/280 (14%), Positives = 74/280 (26%), Gaps = 62/280 (22%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL----------- 723
LG D + +G+ F + N + + E L
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 724 -----------DMLDHPFVPALYASFQTKTHVCLITDY-------CPGGELFLLLDRQPT 765
D++ P + + + +++ + +L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 766 --KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
K L A +V+ L LH G+++ L+P +++L G V LT F+
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---- 259
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-----TSA 878
A + E A ++ H T A
Sbjct: 260 ----------------------RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFA 297
Query: 879 VDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP 918
D W LG+ +Y + P I P
Sbjct: 298 FDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIP 337
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-40
Identities = 48/378 (12%), Positives = 101/378 (26%), Gaps = 83/378 (21%)
Query: 589 HLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRK 648
H+E + + + E E + E + E + +W +++ +
Sbjct: 3 HMEAGDSFMRDLLKREEELIGYCREEALKEPAAMV---EAVTATVWPQNAETTVDSLLSQ 59
Query: 649 DSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML 708
+ + ++PL GD V LV + FA+K G
Sbjct: 60 GE------------------RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN 101
Query: 709 NRNKVHRACAEREILDMLDHPFVPALYASFQ--------------------------TKT 742
+R+++ R L +
Sbjct: 102 SRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVA 161
Query: 743 HVCLITDYCPG--GELFLLLDRQPTK--VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLK 798
+ L+ LF LD A+ A+++ L +G+++
Sbjct: 162 NYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221
Query: 799 PENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSF 858
P+N+ + +G + L D + +
Sbjct: 222 PDNLFIMPDGRLMLGDVSAL------------------------------WKVGTRGPAS 251
Query: 859 VGTEEYIAPEII--AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 916
Y E + + A T A++ W LG+ +Y + + PF T +
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311
Query: 917 FPSSTPSSCKAANVPPVA 934
+ + + +P
Sbjct: 312 PGTDSLAFGSCTPLPDFV 329
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-40
Identities = 59/295 (20%), Positives = 103/295 (34%), Gaps = 58/295 (19%)
Query: 642 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 701
P P + P + + I + + LG G G V + + + FA+K
Sbjct: 35 PPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM 94
Query: 702 MDKGVMLNRNKVHRACAEREI---LDMLDHPFVPALYASFQT----KTHVCLITDYCPGG 754
+ A RE+ P + + ++ + + ++ + GG
Sbjct: 95 LQD----------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 144
Query: 755 ELFLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 811
ELF R + + E + A++YLH I +RD+KPEN+L +
Sbjct: 145 ELF---SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 201
Query: 812 ---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPE 868
LTDF + T+ L + T Y+APE
Sbjct: 202 ILKLTDFGFAKETTSHNSL----------------------------TTPCYTPYYVAPE 233
Query: 869 IIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT----FANILHKDLKFPS 919
++ + + D W+LG+++Y +L GY PF I +FP+
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-40
Identities = 67/297 (22%), Positives = 111/297 (37%), Gaps = 45/297 (15%)
Query: 638 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 697
S +V H A + ++ ++ LGSG GSV+
Sbjct: 12 SGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 71
Query: 698 AMKAMDKGVMLNRNKV-HRACAEREI--LDMLDH--PFVPALYASFQTKTHVCLITDYC- 751
A+K ++K + + ++ + E+ L + V L F+ LI +
Sbjct: 72 AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 131
Query: 752 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHV 810
P +LF + + L+E+ R + +V+ A+ + H G+++RD+K EN+L+ N G +
Sbjct: 132 PVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 189
Query: 811 SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII 870
L DF L K + F GT Y PE I
Sbjct: 190 KLIDFGSGALL--KDTVY---------------------------TDFDGTRVYSPPEWI 220
Query: 871 AGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCK 926
H + W+LGILLY+M+ G PF I+ + F S C+
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQRVSSECQ 271
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 57/266 (21%), Positives = 102/266 (38%), Gaps = 33/266 (12%)
Query: 634 WANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGS 693
+ + + P+ + K +D + + +G G G VH ++ +
Sbjct: 23 GSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQT 82
Query: 694 GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 753
G A+K + V E L P + LY + + V + + G
Sbjct: 83 GFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134
Query: 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSL 812
G L L+ + L ED +Y + + LEYLH + I++ D+K +NVLL +G +L
Sbjct: 135 GSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAAL 192
Query: 813 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG 872
DF + P + + + + GTE ++APE++ G
Sbjct: 193 CDFGHA----------------------LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 873 AGHTSAVDWWALGILLYEMLYGYTPF 898
+ VD W+ ++ ML G P+
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPW 256
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-38
Identities = 43/242 (17%), Positives = 85/242 (35%), Gaps = 29/242 (11%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI---LD 724
F ++ +GSG+ GSV G +A+K K + V A RE+
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA---GSVDEQNALREVYAHAV 66
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVV 782
+ H V ++++ H+ + +YC GG L + + KE ++ +V
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK-- 840
L Y+H +++ D+KP N+ + + + +++ K
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF----------KIG 176
Query: 841 --GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTP 897
G + + G ++A E++ H D +AL + +
Sbjct: 177 DLG------HVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
Query: 898 FR 899
R
Sbjct: 231 PR 232
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 3e-38
Identities = 45/253 (17%), Positives = 99/253 (39%), Gaps = 21/253 (8%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
L+H ++ + + + ++ D + + + + + +D
Sbjct: 61 LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLS-SPSPMDAPSVKIRRMDPFS 119
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEY 786
K ++ + C L ++R+ + + ++ A+E+
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
LH +G+++RDLKP N+ + V + DF L + E++
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT--------AMDQDEEEQTVLTPM---- 227
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
VGT+ Y++PE I G ++ VD ++LG++L+E+LY ++ R +
Sbjct: 228 ---PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST--QMERVRI 282
Query: 907 FANILHKDLKFPS 919
++ ++LKFP
Sbjct: 283 ITDV--RNLKFPL 293
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 20/85 (23%), Positives = 33/85 (38%), Gaps = 4/85 (4%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM-LNRNKVHRACAEREILDML 726
L F PI+ +G G G V + +A+K + L R KV R E + L L
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR---EVKALAKL 61
Query: 727 DHPFVPALYASFQTKTHVCLITDYC 751
+HP + + ++ +
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMD 86
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-37
Identities = 53/280 (18%), Positives = 96/280 (34%), Gaps = 47/280 (16%)
Query: 661 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER 720
S + F P LG G G++ + + A+K + + A+R
Sbjct: 16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECF--------SFADR 66
Query: 721 EI--LDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
E+ L D HP V + + + + + + C L ++ Q
Sbjct: 67 EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVE-QKDFAHLGLEPITLL 124
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-----VSLTDFDLSCLTSCKPQLLLPTT 832
+ L +LH I++RDLKP N+L+ ++DF L
Sbjct: 125 QQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC-------------- 170
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLY 889
K+ G+ + + GTE +IAPE+++ T VD ++ G + Y
Sbjct: 171 ---KKLAVGRHSFSRR-------SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFY 220
Query: 890 EML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAA 928
++ G PF +++ + L A
Sbjct: 221 YVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIA 260
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 1e-35
Identities = 65/288 (22%), Positives = 117/288 (40%), Gaps = 37/288 (12%)
Query: 649 DSPPWKAIQKILDSGE---QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 705
D K ++ L + ++ F I LG+G+ G V V SG A K +
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-- 67
Query: 706 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 765
+ + ++ E ++L + P++ Y +F + + + ++ GG L +L +
Sbjct: 68 LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--A 125
Query: 766 KVLKEDAVRFYAAEVVVALEYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824
+ E + + V+ L YL + I++RD+KP N+L+ G + L DF +S
Sbjct: 126 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS------ 179
Query: 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 884
GQ + + M NSFVGT Y++PE + G ++ D W++
Sbjct: 180 ----------------GQ-----LIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSM 216
Query: 885 GILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANVPP 932
G+ L EM G P ++ + + TP + P
Sbjct: 217 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-35
Identities = 63/287 (21%), Positives = 109/287 (37%), Gaps = 60/287 (20%)
Query: 660 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 719
+ + EQ K LG G +G+V G+ A+K M + A E
Sbjct: 6 IPNFEQSLKNLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLI------DFCDIALME 58
Query: 720 REILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-----QPTKVLKEDAV 773
++L D HP V Y S T + + + C L L++ + K+ KE
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 774 RFYAAEVVVALEYLHCQGIIYRDLKPENVLL-------------QGNGHVSLTDFDLSCL 820
++ + +LH II+RDLKP+N+L+ N + ++DF L
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC-- 175
Query: 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH----- 875
K+ GQ + N+ GT + APE++ + +
Sbjct: 176 ---------------KKLDSGQSS------FRTNLNNPSGTSGWRAPELLEESNNLQTKR 214
Query: 876 --TSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPS 919
T ++D +++G + Y +L G PF K ++ +NI+
Sbjct: 215 RLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDE 259
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 51/262 (19%), Positives = 85/262 (32%), Gaps = 79/262 (30%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI---LDMLDHPFV 731
+ LG G G V + + + FA+K + A RE+ P +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----------CPKARREVELHWRASQCPHI 73
Query: 732 PALYASFQT----KTHVCLITDYCPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVAL 784
+ ++ + + ++ + GGELF R + + E + A+
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELF---SRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 785 EYLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+YLH I +RD+KPEN+L N + LTDF
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------------------ 166
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
A E + + D W+LG+++Y +L GY PF
Sbjct: 167 ------------------------AKETTGE-KYDKSCDMWSLGVIMYILLCGYPPFYSN 201
Query: 902 TRQKT----FANILHKDLKFPS 919
I +FP+
Sbjct: 202 HGLAISPGMKTRIRMGQYEFPN 223
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 46/263 (17%), Positives = 105/263 (39%), Gaps = 34/263 (12%)
Query: 642 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSG--DTGSVHLVELCGSGQYFAM 699
H H ++ ++ + L G + + +G G D +V+L +G+Y +
Sbjct: 3 HHHHHHMENLYFQGMSSFLPEGG-----CYELLTVIGKGFEDLMTVNLARYKPTGEYVTV 57
Query: 700 KAMDKGVMLNRNKVHRACAEREILDM--LDHPFVPALYASFQTKTHVCLITDYCPGGELF 757
+ ++ + + + E+ +HP + A+F + ++T + G
Sbjct: 58 RRIN---LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 114
Query: 758 LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817
L+ + E A+ + V+ AL+Y+H G ++R +K ++L+ +G V L+
Sbjct: 115 DLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 174
Query: 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA--GAGH 875
+ + + +R+ P V +++PE++ G+
Sbjct: 175 NL------SM----ISHGQRQRVVHDFP----------KYSVKVLPWLSPEVLQQNLQGY 214
Query: 876 TSAVDWWALGILLYEMLYGYTPF 898
+ D +++GI E+ G+ PF
Sbjct: 215 DAKSDIYSVGITACELANGHVPF 237
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 59/226 (26%), Positives = 93/226 (41%), Gaps = 34/226 (15%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V+ + A+K + + E + L H +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIP---ERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYR 795
SF + + + PGG L LL + + E + FY +++ L+YLH I++R
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 796 DLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 854
D+K +NVL+ +G + ++DF S KR +A
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTS-----------------KR----------LAGINPC 179
Query: 855 SNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPF 898
+ +F GT +Y+APEII G+ A D W+LG + EM G PF
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 36/232 (15%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--L 726
+ F ++ +G G G V + + A+K +D L + ++EI +
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID----LEEAEDEIEDIQQEITVLSQC 77
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
D P+V Y S+ T + +I +Y GG LL+ L E + E++ L+Y
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDY 134
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
LH + I+RD+K NVLL +G V L DF ++ QL T+ + +R
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG------QL----TDTQIKR-------- 176
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
N+FVGT ++APE+I + + S D W+LGI E+ G P
Sbjct: 177 ---------NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPH 219
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 33/230 (14%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+G G TG V L SG+ A+K MD + + + E I+ H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQH 101
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
V +Y S+ + ++ ++ GG L ++ + L E+ + V+ AL YLH
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLH 158
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
QG+I+RD+K +++LL +G V L+DF Q+ + + +R
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCA------QI----SKDVPKR---------- 198
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
S VGT ++APE+I+ + + + VD W+LGI++ EM+ G P+
Sbjct: 199 -------KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 56/230 (24%), Positives = 104/230 (45%), Gaps = 33/230 (14%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ + + +G G +G+V+ +GQ A++ M+ + + K E ++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKN 76
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
P + S+ + ++ +Y GG L ++ + E + E + ALE+LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH 133
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
+I+RD+K +N+LL +G V LTDF Q+ T E+ +R
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA------QI----TPEQSKR---------- 173
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
++ VGT ++APE++ + VD W+LGI+ EM+ G P+
Sbjct: 174 -------STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 64/243 (26%), Positives = 100/243 (41%), Gaps = 37/243 (15%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
IN + + +GSG T V + A+K ++ L + + +EI M
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN----LEKCQTSMDELLKEIQAM 67
Query: 726 --LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL------DRQPTKVLKEDAVRFYA 777
HP + + Y SF K + L+ GG + ++ + VL E +
Sbjct: 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLPTTNEKK 836
EV+ LEYLH G I+RD+K N+LL +G V + DF +S L + T K
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG-----GDITRNKV 182
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGY 895
R +FVGT ++APE++ G+ D W+ GI E+ G
Sbjct: 183 R------------------KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
Query: 896 TPF 898
P+
Sbjct: 225 APY 227
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 67/253 (26%), Positives = 110/253 (43%), Gaps = 34/253 (13%)
Query: 647 RKDSPPWKAIQKILDSGEQIN-LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 705
+ +PP + ++K+ + + F ++ LG G GSV+ +GQ A+K +
Sbjct: 6 QLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-- 63
Query: 706 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 765
+ + E I+ D P V Y S+ T + ++ +YC G + ++ +
Sbjct: 64 ---VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN- 119
Query: 766 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825
K L ED + + LEYLH I+RD+K N+LL GH L DF ++
Sbjct: 120 KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG------ 173
Query: 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 885
QL T+ +R N+ +GT ++APE+I G+ D W+LG
Sbjct: 174 QL----TDTMAKR-----------------NTVIGTPFWMAPEVIQEIGYNCVADIWSLG 212
Query: 886 ILLYEMLYGYTPF 898
I EM G P+
Sbjct: 213 ITAIEMAEGKPPY 225
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 55/273 (20%), Positives = 102/273 (37%), Gaps = 47/273 (17%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
S I+ + + +G G G V + + A+K + + ++ E
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRA--KDVAIK-----QIESESERKAFIVELR 53
Query: 722 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEV 780
L ++HP + LY + VCL+ +Y GG L+ +L +P + +
Sbjct: 54 QLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 781 VVALEYLHC---QGIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLPTTNEKK 836
+ YLH + +I+RDLKP N+LL G V + DF +C
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----------------- 154
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT 896
+ M + G+ ++APE+ G+ ++ D ++ GI+L+E++
Sbjct: 155 ----------DIQTHM---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
Query: 897 PFRG-KTRQKTFANILHKDL--KFPSSTPSSCK 926
PF +H + P +
Sbjct: 202 PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 57/261 (21%), Positives = 100/261 (38%), Gaps = 20/261 (7%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
+ LG G G V +G+ MK + + + + E +++
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKVMRC 63
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
L+HP V + IT+Y GG L ++ ++ V F A ++ +
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSF-AKDIASGMA 122
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YLH II+RDL N L++ N +V + DF L+ L+ + + + P
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVADFGLAR--------LMVDEKTQPEGLRSLKKP 174
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT-RQ 904
+ + VG ++APE+I G + VD ++ GI+L E++ R
Sbjct: 175 DR-----KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229
Query: 905 KTFANILHKDLKFPSSTPSSC 925
F + L P +C
Sbjct: 230 MDFGLNVRGFLDRY--CPPNC 248
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 61/295 (20%), Positives = 107/295 (36%), Gaps = 37/295 (12%)
Query: 637 HSKVVHPKPHRKDSPPWKAIQKILDSGEQ--INLQHFRPIKPLGSGDTGSVHLVELCGSG 694
H HP + G+ I + +G+G G+VH E G
Sbjct: 3 HHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG-- 60
Query: 695 QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 754
A+K + + +V+ E I+ L HP + + ++ ++T+Y G
Sbjct: 61 SDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 755 ELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVS 811
L+ LL + L E A +V + YLH + I++R+LK N+L+ V
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVK 179
Query: 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA 871
+ DF LS A +S S GT E++APE++
Sbjct: 180 VCDFGLSR---------------------------LKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 872 GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK--FPSSTPSS 924
D ++ G++L+E+ P+ + A + K + P +
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 57/234 (24%), Positives = 103/234 (44%), Gaps = 36/234 (15%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ + + LG G G V+ + +G A K ++ + ++ E EIL DH
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCDH 75
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
P++ L ++ + ++ ++CPGG + ++ + L E ++ +++ AL +LH
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLH 134
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
+ II+RDLK NVL+ G + L DF +S + ++R
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSA------KN----LKTLQKR---------- 174
Query: 849 AEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTP 897
+SF+GT ++APE++ + D W+LGI L EM P
Sbjct: 175 -------DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 59/243 (24%), Positives = 99/243 (40%), Gaps = 37/243 (15%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-L 723
++ PI LG G G V + SGQ A+K + +N + R + +I +
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR--ATVNSQEQKRLLMDLDISM 60
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGG-ELFLLLDRQPTKVLKEDAVRFYAAEVVV 782
+D PF Y + + V + + + F + + ED + A +V
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 783 ALEYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
ALE+LH + +I+RD+KP NVL+ G V + DF +S G
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS----------------------G 158
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----AGHTSAVDWWALGILLYEMLYGYTP 897
+ + + A + G + Y+APE I G++ D W+LGI + E+ P
Sbjct: 159 Y-----LVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
Query: 898 FRG 900
+
Sbjct: 213 YDS 215
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-31
Identities = 59/255 (23%), Positives = 94/255 (36%), Gaps = 48/255 (18%)
Query: 659 ILDSGEQ---INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR 715
L G Q + + +GSG G V + +G A+K M + NK
Sbjct: 12 YLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR----RSGNKEEN 67
Query: 716 ACAEREI---LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
++ L D P++ + +F T T V + + L ++ + E
Sbjct: 68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTC--AEKLKKRMQGPIPERI 125
Query: 773 VRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLP 830
+ +V AL YL + G+I+RD+KP N+LL G + L DF +S L
Sbjct: 126 LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-------- 177
Query: 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII-----AGAGHTSAVDWWALG 885
+A + G Y+APE I + D W+LG
Sbjct: 178 ---------------------DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 216
Query: 886 ILLYEMLYGYTPFRG 900
I L E+ G P++
Sbjct: 217 ISLVELATGQFPYKN 231
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 55/276 (19%), Positives = 99/276 (35%), Gaps = 50/276 (18%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE--RE-- 721
+ K +G G G VH L A+K++ G ++ E RE
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 722 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
I+ L+HP + LY ++ ++ P G+L+ L + + +R ++
Sbjct: 76 IMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRL-MLDIA 132
Query: 782 VALEYLHCQG--IIYRDLKPENVLL-----QGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
+ +EY+ Q I++RDL+ N+ L + DF LS +
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV------------ 180
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEML 892
+ + +G +++APE I +T D ++ ++LY +L
Sbjct: 181 ------------------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222
Query: 893 YGYTPFRGKTRQK--TFANILHKDL--KFPSSTPSS 924
G PF + K I + L P P
Sbjct: 223 TGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPR 258
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 58/287 (20%), Positives = 102/287 (35%), Gaps = 43/287 (14%)
Query: 647 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMD 703
+ + D E I + +GSG G+V+ G++ A+K ++
Sbjct: 3 KGHHHHHHGSRDAADDWE-IPDGQITVGQRIGSGSFGTVYK------GKWHGDVAVKMLN 55
Query: 704 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 763
++ E +L H + T + ++T +C G L+ L
Sbjct: 56 VTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHAS 113
Query: 764 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
TK + + A + ++YLH + II+RDLK N+ L + V + DF L+ S
Sbjct: 114 ETKFEMKKLIDI-ARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS- 171
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVD 880
G+ ++APE+I + D
Sbjct: 172 ------------------------RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 881 WWALGILLYEMLYGYTPFRGKT-RQKTFANILHKDLKFPSST-PSSC 925
+A GI+LYE++ G P+ R + + L S S+C
Sbjct: 208 VYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 54/229 (23%), Positives = 96/229 (41%), Gaps = 40/229 (17%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
+G G +V+ + A + L +++ R E E+L L HP + Y
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDR-KLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 737 SF----QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG- 791
S+ + K + L+T+ G L L R KV+K +R + +++ L++LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 792 -IIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
II+RDLK +N+ + G G V + D L+ L
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS------------------------- 185
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ + +GT E++APE+ + +VD +A G+ + EM P+
Sbjct: 186 ----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY 229
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 63/273 (23%), Positives = 107/273 (39%), Gaps = 48/273 (17%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA-CAEREIL 723
+I+ + +G G G V+ G A+KA + ++ E ++
Sbjct: 3 EIDFAELTLEEIIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
ML HP + AL + ++CL+ ++ GG L +L + + D + +A ++
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARG 117
Query: 784 LEYLHCQG---IIYRDLKPENVLL--------QGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
+ YLH + II+RDLK N+L+ N + +TDF L+
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-------- 169
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
S G ++APE+I + + D W+ G+LL+E+L
Sbjct: 170 ---------------------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL 208
Query: 893 YGYTPFRGKTRQKTFANILHKDLKFPSSTPSSC 925
G PFRG + L P PS+C
Sbjct: 209 TGEVPFRGIDGLAVAYGVAMNKLALPI--PSTC 239
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 65/242 (26%), Positives = 101/242 (41%), Gaps = 43/242 (17%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLD 727
F ++ +G+G G V+ +GQ A+K MD + ++ E +L
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 728 HPFVPALYASFQTKTHVC------LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
H + Y +F K L+ ++C G + L+ LKE+ + + E++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
L +LH +I+RD+K +NVLL N V L DF +S QL RR
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------QL----DRTVGRR--- 186
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYT 896
N+F+GT ++APE+IA A + D W+LGI EM G
Sbjct: 187 --------------NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 897 PF 898
P
Sbjct: 233 PL 234
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 58/272 (21%), Positives = 103/272 (37%), Gaps = 45/272 (16%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAEREI 722
I + + +G G G V+ G++ A++ +D N +++ E
Sbjct: 30 IPFEQLEIGELIGKGRFGQVY------HGRWHGEVAIRLIDIERD-NEDQLKAFKREVMA 82
Query: 723 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 782
H V + + H+ +IT C G L+ ++ R VL + R A E+V
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVK 141
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
+ YLH +GI+++DLK +NV NG V +TDF L + +
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSI---------------SGVLQAG 185
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---------HTSAVDWWALGILLYEMLY 893
+ + G ++APEII + D +ALG + YE+
Sbjct: 186 RREDKLRIQ-------NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238
Query: 894 GYTPFRGKTRQKTFANILHKDLKFPSSTPSSC 925
PF+ + + + +K P+ +
Sbjct: 239 REWPFKTQPAEAIIWQM-GTGMK-PNLSQIGM 268
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 52/244 (21%), Positives = 90/244 (36%), Gaps = 42/244 (17%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-- 722
+ + + +G G GSV+ + SGQ A+K + ++ + ++
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR----STVDEKEQKQLLMDLDV 73
Query: 723 -LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAE 779
+ D P++ Y + + + + V+ E+ +
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 780 VVVALEYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
V AL +L II+RD+KP N+LL +G++ L DF +S QL + +
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS------GQL----VDSIAKT 183
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----AGHTSAVDWWALGILLYEMLYG 894
G Y+APE I G+ D W+LGI LYE+ G
Sbjct: 184 R------------------DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225
Query: 895 YTPF 898
P+
Sbjct: 226 RFPY 229
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 60/260 (23%), Positives = 94/260 (36%), Gaps = 38/260 (14%)
Query: 642 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 701
P R S + ++ + + F ++ +G G G+V+ + + A+K
Sbjct: 29 MPAGGRAGSLKDPDVAELFFKDD--PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKK 86
Query: 702 MDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD 761
M + K E L L HP + + L+ +YC G LL
Sbjct: 87 MSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV 146
Query: 762 RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821
+ K L+E + + L YLH +I+RD+K N+LL G V L DF +
Sbjct: 147 HK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS-- 202
Query: 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSA 878
+ NSFVGT ++APE+I +
Sbjct: 203 ----IM-------APA------------------NSFVGTPYWMAPEVILAMDEGQYDGK 233
Query: 879 VDWWALGILLYEMLYGYTPF 898
VD W+LGI E+ P
Sbjct: 234 VDVWSLGITCIELAERKPPL 253
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 40/274 (14%), Positives = 86/274 (31%), Gaps = 44/274 (16%)
Query: 660 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 719
++ I+ + + L +G + G +K + + K E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQG--NDIVVKVLKVR-DWSTRKSRDFNEE 57
Query: 720 REILDMLDHPFVPALYASFQT--KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
L + HP V + + Q+ H LIT + P G L+ +L V+ + +A
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 778 AEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
++ + +LH I L +V++ + ++ D+
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP----------- 166
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---HTSAVDWWALGILLYEML 892
+ ++APE + + + D W+ +LL+E++
Sbjct: 167 ---------------------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV 205
Query: 893 YGYTPFRGKTRQKTFANILHKDL--KFPSSTPSS 924
PF + + + + L P
Sbjct: 206 TREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 55/285 (19%), Positives = 102/285 (35%), Gaps = 44/285 (15%)
Query: 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR--ACAER 720
G+ N + I+ LG G +V L ++ AMK ++ + + A E
Sbjct: 32 GDLFN-GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK------VVKSAEHYTETALDEI 84
Query: 721 EILDML-----DHP---FVPALYASFQTK----THVCLITDYCPGGE-LFLLLDRQPTKV 767
+L + + P V L F+ TH+C++ + G L + + +
Sbjct: 85 RLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQG 142
Query: 768 LKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826
L V+ +V+ L+YLH + II+ D+KPEN+LL N +
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRAS-------------------NSFVGTEEYIAP 867
+ V EP A + T +Y +
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSL 262
Query: 868 EIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 912
E++ G+G+ + D W+ + +E+ G F + ++ + H
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 55/258 (21%), Positives = 89/258 (34%), Gaps = 61/258 (23%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI- 722
I L + +G G G V G + A+K + + E E+
Sbjct: 8 RDITLL-----ECVGKGRYGEVWRGSWQG--ENVAVK------IFSSRDEKSWFRETELY 54
Query: 723 -LDMLDHP----FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
ML H F+ + S + T + LIT Y G L+ L +R
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDT--VSCLRI-V 111
Query: 778 AEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCL-TSCKPQLL 828
+ L +LH + I +RDLK +N+L++ NG + D L+ + + QL
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA------VDWW 882
+ VGT+ Y+APE++ VD W
Sbjct: 172 VGNNPR------------------------VGTKRYMAPEVLDETIQVDCFDSYKRVDIW 207
Query: 883 ALGILLYEMLYGYTPFRG 900
A G++L+E+
Sbjct: 208 AFGLVLWEVARRMVSNGI 225
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 56/239 (23%), Positives = 96/239 (40%), Gaps = 54/239 (22%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFV 731
+ +G G G V + G + A+K + + + E EI ML H +
Sbjct: 47 QESIGKGRFGEVWRGKWRG--EEVAVK------IFSSREERSWFREAEIYQTVMLRHENI 98
Query: 732 PALYAS----FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
A+ T T + L++DY G LF L+R V E ++ A L +L
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV--EGMIKL-ALSTASGLAHL 155
Query: 788 HCQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
H + I +RDLK +N+L++ NG + D L+ RH
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA------------------VRH 197
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS------AVDWWALGILLYEML 892
+ + + A N VGT+ Y+APE++ + + D +A+G++ +E+
Sbjct: 198 DSATDTIDI-----APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 57/257 (22%), Positives = 95/257 (36%), Gaps = 53/257 (20%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--L 723
++L + + ++ +G G G+V+ L + A+K NR E+ I +
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFA---NRQNFIN---EKNIYRV 61
Query: 724 DMLDHPFVPALYA-----SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
+++H + + + L+ +Y P G L L + A
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAH 118
Query: 779 EVVVALEYLHCQ---------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829
V L YLH + I +RDL NVL++ +G ++DF LS
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR--------- 169
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-------GHTSAVDWW 882
V E A+ S VGT Y+APE++ GA VD +
Sbjct: 170 ----------LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219
Query: 883 ALGILLYEMLYGYTPFR 899
ALG++ +E+ T
Sbjct: 220 ALGLIYWEIFMRCTDLF 236
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 52/255 (20%), Positives = 99/255 (38%), Gaps = 54/255 (21%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI- 722
++ + + +K +G G G V + + G + A+K V + E EI
Sbjct: 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWRG--EKVAVK-----VFFTTEE-ASWFRETEIY 83
Query: 723 -LDMLDHPFVPALYAS----FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
++ H + A+ + T + LITDY G L+ L + + ++ A
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKL-A 140
Query: 778 AEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829
V L +LH + I +RDLK +N+L++ NG + D L+
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA----------- 189
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS------AVDWWA 883
+ N V + N+ VGT+ Y+ PE++ + + + D ++
Sbjct: 190 -------VKFISDTNEVDI-----PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237
Query: 884 LGILLYEMLYGYTPF 898
G++L+E+
Sbjct: 238 FGLILWEVARRCVSG 252
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-24
Identities = 42/197 (21%), Positives = 68/197 (34%), Gaps = 42/197 (21%)
Query: 713 VHRACAEREILDMLDHPFVPALYASFQTKTHVC-----LITDYCPGGELFLLLDRQPTKV 767
A AER+ L + HP + ++ + ++ +Y G L ++
Sbjct: 123 QAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---- 178
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827
L Y E++ AL YLH G++Y DLKPEN++L + L D
Sbjct: 179 LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGA---------- 227
Query: 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 887
+ + GT + APEI+ G T A D + +G
Sbjct: 228 ---------------------VSRINSFGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRT 265
Query: 888 LYEMLYGYTPFRGKTRQ 904
L + G+
Sbjct: 266 LAALTLDLPTRNGRYVD 282
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 27/101 (26%), Positives = 51/101 (50%)
Query: 208 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 267
T I+YA+ F ++ Y +E+VG++ R + + + T+ G + G
Sbjct: 5 TDLQGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNIWQGEF 64
Query: 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308
N +KDGT +W TI P+ D+ GK ++I ++ +++ E
Sbjct: 65 CNRRKDGTRYWVDSTIVPLMDNAGKPRQYISIRRDITAQKE 105
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-23
Identities = 37/186 (19%), Positives = 75/186 (40%), Gaps = 15/186 (8%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 545
ITD I++A+D+F ++ Y REE++G++ R + A +R + I
Sbjct: 3 SITDL---QGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNI 59
Query: 546 VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE------HLEPLRNSIPE 599
+ N K G ++W + P+ D G+ + +I ++ D + L L+ ++
Sbjct: 60 WQGEFCNRRKDGTRYWVDSTIVPLMDNAGKPRQYISIRRDITAQKEAEAQLARLKQAMDA 119
Query: 600 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLW-ANHSKVVHPKPHRKDSPPWKAIQK 658
+ N A+ + + +L + S + P D A+Q+
Sbjct: 120 NSEMILLTDRAGRIIYANPALCRF--SGMAEGELLGQSPSILDSP---LADQETLAAMQE 174
Query: 659 ILDSGE 664
L +G+
Sbjct: 175 ALQAGQ 180
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 3e-22
Identities = 27/99 (27%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 208 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 267
T I+YA+ + +G E++G++ L D E +A ++E LQ GQ + GRL
Sbjct: 127 TDRAGRIIYANPALCRFSGMAEGELLGQSPSILDSPLADQETLAAMQEALQAGQPWSGRL 186
Query: 268 LNYKK------DGTPFWNLLTIAPIKDDEGKVLKFIGMQ 300
LN ++ D +W ++ PI D ++ ++ +Q
Sbjct: 187 LNRRRTGPAPHDAEDYWAEISTTPIHTDGNGLVGYVQIQ 225
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 21/128 (16%), Positives = 53/128 (41%), Gaps = 9/128 (7%)
Query: 464 RQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFL 523
+++ + L ++ + ++TD II+A+ + + + E+LG++ L
Sbjct: 103 QKEAEAQLARLKQAMDANSEMILLTDR---AGRIIYANPALCRFSGMAEGELLGQSPSIL 159
Query: 524 QGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKK------FWNLFHLQPMRDQKGEVQ 577
P D T+ ++ A+ + +L+N ++G +W P+ +
Sbjct: 160 DSPLADQETLAAMQEALQAGQPWSGRLLNRRRTGPAPHDAEDYWAEISTTPIHTDGNGLV 219
Query: 578 YFIGVQLD 585
++ +Q D
Sbjct: 220 GYVQIQHD 227
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 52/257 (20%), Positives = 91/257 (35%), Gaps = 57/257 (22%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-- 722
+ ++ G G V +L +Y A+K ++ E E+
Sbjct: 20 YFQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQ---DKQSWQN---EYEVYS 71
Query: 723 LDMLDHP----FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
L + H F+ A + LIT + G L L + + + A
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAE 128
Query: 779 EVVVALEYLHCQ----------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828
+ L YLH I +RD+K +NVLL+ N + DF L+
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA---------- 178
Query: 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA-----VDWWA 883
+ + ++ + VGT Y+APE++ GA + +D +A
Sbjct: 179 --------LKFEAGKSAGDT-------HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223
Query: 884 LGILLYEMLYGYTPFRG 900
+G++L+E+ T G
Sbjct: 224 MGLVLWELASRCTAADG 240
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 44/177 (24%), Positives = 72/177 (40%), Gaps = 28/177 (15%)
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
L P V ++ + + + G +L +L RQ + AV ++ AL+
Sbjct: 91 LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVA-IVRQIGSALD 148
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
H G +RD+KPEN+L+ + L DF ++ T+
Sbjct: 149 AAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT----------------------- 185
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902
E + + VGT Y+APE + + T D +AL +LYE L G P++G
Sbjct: 186 ---DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 54/262 (20%), Positives = 104/262 (39%), Gaps = 32/262 (12%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
++ + LG G +V+L E A+KA+ + R E L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ ++ + L+ +Y G L ++ L D + +++ +++ H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM 130
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
I++RD+KP+N+L+ N + + DF ++ S
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--------------------------ET 164
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
+ +N +GT +Y +PE G D +++GI+LYEML G PF G+T +I
Sbjct: 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA----VSI 220
Query: 911 LHKDLKFPSSTPSSCKAANVPP 932
K ++ ++ ++P
Sbjct: 221 AIKHIQDSVPNVTTDVRKDIPQ 242
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 9e-22
Identities = 51/273 (18%), Positives = 99/273 (36%), Gaps = 59/273 (21%)
Query: 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-ACAERE 721
GE + ++ LG G +V L + + + AMK ++ A E +
Sbjct: 13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIK 67
Query: 722 ILDML-----------DHPFVPALYASFQTK----THVCLITDYCPGGELFLLLDRQPTK 766
+L + + L F K HV ++ + G L L+ + +
Sbjct: 68 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR 126
Query: 767 VLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLL------QGNGHVSLTDFDLSC 819
+ V+ + ++++ L+Y+H + GII+ D+KPENVL+ + + + D +C
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 879
+ + + T EY +PE++ GA
Sbjct: 187 WYD--------------EHY----------------TNSIQTREYRSPEVLLGAPWGCGA 216
Query: 880 DWWALGILLYEMLYGYTPFRGKTRQKTFANILH 912
D W+ L++E++ G F + H
Sbjct: 217 DIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} Length = 120 | Back alignment and structure |
|---|
Score = 87.9 bits (219), Expect = 7e-21
Identities = 29/92 (31%), Positives = 51/92 (55%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
I+YA+ F +TGY S+EV+G+N L T + L + + G L+N +KD
Sbjct: 27 ILYANRAFRTITGYGSEEVLGKNESILSNGTTPRLVYQALWGRLAQKKPWSGVLVNRRKD 86
Query: 274 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 305
T + LT+AP+ ++ G+ + ++GM + S+
Sbjct: 87 KTLYLAELTVAPVLNEAGETIYYLGMHRDTSE 118
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} Length = 120 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 4e-16
Identities = 29/116 (25%), Positives = 50/116 (43%), Gaps = 5/116 (4%)
Query: 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATV 533
T+E ITD I++A+ +F +T Y EE+LG+N L T
Sbjct: 7 FRQTVEHAPIAISITDL---KANILYANRAFRTITGYGSEEVLGKNESILSNGTTPRLVY 63
Query: 534 RKIRAAIDNQTDV-TVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
+ + + Q + L+N K + + P+ ++ GE Y++G+ D SE
Sbjct: 64 QALWGRL-AQKKPWSGVLVNRRKDKTLYLAELTVAPVLNEAGETIYYLGMHRDTSE 118
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 42/181 (23%), Positives = 75/181 (41%), Gaps = 30/181 (16%)
Query: 726 LDHPFVPALY----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
L+HP + A+Y A ++ +Y G L ++ + + A+
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADAC 126
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
AL + H GII+RD+KP N+++ V + DF ++ R
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA-------------------RAIA 167
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+ + + +GT +Y++PE G + D ++LG +LYE+L G PF G
Sbjct: 168 DS-----GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222
Query: 902 T 902
+
Sbjct: 223 S 223
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-20
Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 35/235 (14%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 728
+ I +G G G V +GQ A+K K + + V + A REI L L H
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
P + L F+ K + L+ +YC + LDR + + E V+ + + A+ + H
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH 119
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
I+RD+KPEN+L+ + + L DF + R + +
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFA-------------------RLLTGPSDYYD 160
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKT 902
E V T Y +PE++ G VD WA+G + E+L G + GK+
Sbjct: 161 DE--------VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 55/271 (20%), Positives = 99/271 (36%), Gaps = 47/271 (17%)
Query: 642 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 701
H H + + + + + + +G G G V + A+K
Sbjct: 1 HHHHHHMAAAAAAGPEMVRGQVFDV-GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK 59
Query: 702 MDKGVMLNRNKVHRACAEREI--LDMLDHP--------FVPALYASFQTKTHVCLITDYC 751
+ ++ + REI L H + V ++ D
Sbjct: 60 ISP----FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLM 112
Query: 752 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 811
+L+ LL Q L D + ++ +++ L+Y+H +++RDLKP N+LL +
Sbjct: 113 -ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 168
Query: 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA 871
+ DF L+ + + F+ E +V T Y APEI+
Sbjct: 169 ICDFGLARVAD-----------------PDHDHTGFLTE-------YVATRWYRAPEIML 204
Query: 872 GAGH-TSAVDWWALGILLYEMLYGYTPFRGK 901
+ T ++D W++G +L EML F GK
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 235
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 58/256 (22%), Positives = 101/256 (39%), Gaps = 50/256 (19%)
Query: 659 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-AC 717
I+ +GE+ + +G G G V ++ A+K ++ N+ A
Sbjct: 45 IVKNGEKWM-DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-----IIKNKKAFLNQAQ 98
Query: 718 AEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 770
E +L+++ + V L F + H+CL+ + L+ LL + +
Sbjct: 99 IEVRLLELMNKHDTEMKYYIVH-LKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSL 156
Query: 771 DAVRFYAAEVVVALEYLHCQ--GIIYRDLKPENVLL--QGNGHVSLTDFDLSCLTSCKPQ 826
+ R +A ++ AL +L II+ DLKPEN+LL + + DF SC
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC------- 209
Query: 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 886
GQ+ ++ + Y +PE++ G + A+D W+LG
Sbjct: 210 ------------QLGQR-----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGC 246
Query: 887 LLYEMLYGYTPFRGKT 902
+L EM G F G
Sbjct: 247 ILVEMHTGEPLFSGAN 262
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} Length = 124 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 3e-19
Identities = 16/86 (18%), Positives = 37/86 (43%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
I+ + G + GY+ ++ +G+ L G +++ ++N + G + KD
Sbjct: 29 IIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSEVISAVENQGKWTGEIRMLHKD 88
Query: 274 GTPFWNLLTIAPIKDDEGKVLKFIGM 299
G W PI + +++ +G+
Sbjct: 89 GHIGWIESMCVPIYGENYQMVGALGI 114
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} Length = 124 | Back alignment and structure |
|---|
Score = 77.5 bits (192), Expect = 3e-17
Identities = 22/103 (21%), Positives = 43/103 (41%), Gaps = 3/103 (2%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 545
V+TD II + L YS+E+ +G+ L P ++ +A++NQ
Sbjct: 21 VVTDL---QGFIIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSEVISAVENQGK 77
Query: 546 VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
T ++ K G W P+ + ++ +G+ D ++
Sbjct: 78 WTGEIRMLHKDGHIGWIESMCVPIYGENYQMVGALGINRDITK 120
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 4e-19
Identities = 60/254 (23%), Positives = 105/254 (41%), Gaps = 48/254 (18%)
Query: 659 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-AC 717
+ + + + + +K +G G G V Q+ A+K ++ N + HR A
Sbjct: 88 VQVPHDHVAYR-YEVLKVIGKGSFGQVVKAYDHKVHQHVALK-----MVRNEKRFHRQAA 141
Query: 718 AEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 770
E IL+ L + + +F + H+C+ + L+ L+ + +
Sbjct: 142 EEIRILEHLRKQDKDNTMNVIH-MLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSL 199
Query: 771 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--VSLTDFDLSCLTSCKPQLL 828
VR +A ++ L+ LH II+ DLKPEN+LL+ G + + DF SC
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH------ 253
Query: 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888
V+ +++ + Y APE+I GA + +D W+LG +L
Sbjct: 254 ---------------QRVY---------TYIQSRFYRAPEVILGARYGMPIDMWSLGCIL 289
Query: 889 YEMLYGYTPFRGKT 902
E+L GY G+
Sbjct: 290 AELLTGYPLLPGED 303
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-19
Identities = 64/242 (26%), Positives = 102/242 (42%), Gaps = 46/242 (19%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDML 726
+ ++ + P+GSG GSV +G A+K K ++ +H RE+ L +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 727 DHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
H V L S + V L+T G +L ++ Q L +D V+F ++
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK---LTDDHVQFLIYQI 141
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+ L+Y+H II+RDLKP N+ + + + + DF L+ RH
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA-------------------RHT 182
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR 899
M +V T Y APEI+ H VD W++G ++ E+L G T F
Sbjct: 183 AD----EMTG-------YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231
Query: 900 GK 901
G
Sbjct: 232 GT 233
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-19
Identities = 61/235 (25%), Positives = 97/235 (41%), Gaps = 35/235 (14%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 728
+ + +G G G V +G+ A+K K + + +K+ + A REI L L H
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
+ L + K L+ ++ + L+ P L V+ Y +++ + + H
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG-LDYQVVQKYLFQIINGIGFCH 141
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
II+RD+KPEN+L+ +G V L DF + R V+
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFA-------------------RTLAAPGEVYD 182
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKT 902
E V T Y APE++ G AVD WA+G L+ EM G F G +
Sbjct: 183 DE--------VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 54/245 (22%), Positives = 95/245 (38%), Gaps = 39/245 (15%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 725
F+ LG G G V +G+ A+K ++ + REI L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--PF--DKPLFALRTLREIKILKH 65
Query: 726 LDHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
H P + +F V +I + +L ++ Q L +D ++++
Sbjct: 66 FKHENIITIFNIQRPDSFENFN---EVYIIQELM-QTDLHRVISTQM---LSDDHIQYFI 118
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
+ + A++ LH +I+RDLKP N+L+ N + + DF L+ +
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID----------ESAAD 168
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYT 896
+ M E FV T Y APE++ + + A+D W+ G +L E+
Sbjct: 169 NSEPTGQQSGMVE-------FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
Query: 897 PFRGK 901
F G+
Sbjct: 222 IFPGR 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 56/242 (23%), Positives = 100/242 (41%), Gaps = 44/242 (18%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK--AMDK--GVMLNRNKVHRACAEREI- 722
++ + + LG G +V+ + + A+K ++ G A RE+
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT--------AIREVS 52
Query: 723 -LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
L L H + L+ T+ + L+ +Y +L LD + V+ + +++
Sbjct: 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI-INMHNVKLFLFQLL 110
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
L Y H Q +++RDLKP+N+L+ G + L DF L+ R K
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA-------------------RAKS 151
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRG 900
P + ++ V T Y P+I+ G+ ++ +D W +G + YEM G F G
Sbjct: 152 --------IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203
Query: 901 KT 902
T
Sbjct: 204 ST 205
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 55/242 (22%), Positives = 103/242 (42%), Gaps = 44/242 (18%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 725
L+ ++ +KP+GSG G V + A+K K +N+ H A RE+ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKC 80
Query: 726 LDHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
++H + L S + V ++ + L ++ + L + + + +
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-QME---LDHERMSYLLYQ 135
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
++ +++LH GII+RDLKP N++++ + + + DF L+
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------------- 174
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
+ M +V T Y APE+I G G+ VD W++G ++ EM+ G F
Sbjct: 175 RTAGTSFMMTP-------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 227
Query: 900 GK 901
G
Sbjct: 228 GT 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 54/242 (22%), Positives = 104/242 (42%), Gaps = 44/242 (18%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 725
L+ ++ +KP+GSG G V + A+K K +N+ H A RE+ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKC 117
Query: 726 LDHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
++H + +L + + V L+ + L ++ + L + + + +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-QME---LDHERMSYLLYQ 172
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
++ +++LH GII+RDLKP N++++ + + + DF L+
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------------- 211
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
+ M +V T Y APE+I G G+ VD W++G ++ EM+ F
Sbjct: 212 RTAGTSFMMTP-------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264
Query: 900 GK 901
G+
Sbjct: 265 GR 266
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 56/298 (18%), Positives = 108/298 (36%), Gaps = 33/298 (11%)
Query: 629 TPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLV 688
+ L + P + +A+ K D +N + + +G G+ G V
Sbjct: 77 SIPLLIDHLLSTQQPLTKKSGVVLHRAVPK--DKWV-LNHEDLVLGEQIGRGNFGEVFSG 133
Query: 689 ELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748
L A+K+ + + + + E IL HP + L K + ++
Sbjct: 134 RLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191
Query: 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 808
+ GG+ L + ++ + ++ + +EYL + I+RDL N L+
Sbjct: 192 ELVQGGDFLTFLRTEGARLRVKTLLQM-VGDAAAGMEYLESKCCIHRDLAARNCLVTEKN 250
Query: 809 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPE 868
+ ++DF +S + +Q PV ++ APE
Sbjct: 251 VLKISDFGMSREEA---------DGVYAASGGLRQVPV----------------KWTAPE 285
Query: 869 IIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPSS 924
+ ++S D W+ GILL+E G +P+ + Q+T + L P P +
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDA 343
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 63/262 (24%), Positives = 99/262 (37%), Gaps = 42/262 (16%)
Query: 659 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-AC 717
G +N F I+ +G G G V L + + +Y+A+K V+ N K R A
Sbjct: 26 SWKKGMLLN-NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVK-----VVRNIKKYTRSAK 79
Query: 718 AEREILDML------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
E +IL + ++ V + F H+CLI + G L+ ++ R +
Sbjct: 80 IEADILKKIQNDDINNNNIV-KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIE 137
Query: 772 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831
++ Y E++ AL YL + + DLKPEN+LL K Q+
Sbjct: 138 DIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 832 TNEKK-----------RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 880
+ K H S + T +Y APE+I G + D
Sbjct: 198 STGIKLIDFGCATFKSDYH----------------GSIINTRQYRAPEVILNLGWDVSSD 241
Query: 881 WWALGILLYEMLYGYTPFRGKT 902
W+ G +L E+ G FR
Sbjct: 242 MWSFGCVLAELYTGSLLFRTHE 263
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 2e-18
Identities = 46/188 (24%), Positives = 83/188 (44%), Gaps = 32/188 (17%)
Query: 718 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
REI L L H + LY TK + L+ ++ +L LLD L+ +
Sbjct: 47 TIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKS 104
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
+ +++ + Y H + +++RDLKP+N+L+ G + + DF L+
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA----------------- 147
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYG 894
R G P+R + T Y AP+++ G+ ++ +D W++G + EM+ G
Sbjct: 148 --RAFG--------IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197
Query: 895 YTPFRGKT 902
F G +
Sbjct: 198 TPLFPGVS 205
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-18
Identities = 51/250 (20%), Positives = 90/250 (36%), Gaps = 51/250 (20%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN------RNKVHRACAEREI 722
+ + + SG G+V + G A+K + V + REI
Sbjct: 22 SPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 723 --LDMLDHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
L+ HP FV + + L+T+ +L ++ V+
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMH---KLYLVTELM-RTDLAQVI-HDQRIVISPQH 135
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
++++ +++ L LH G+++RDL P N+LL N +++ DF+L+
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA-------------- 181
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEM 891
R +V Y APE++ T VD W+ G ++ EM
Sbjct: 182 -----REDTADA--NKTH-------YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
Query: 892 LYGYTPFRGK 901
FRG
Sbjct: 228 FNRKALFRGS 237
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 52/243 (21%), Positives = 94/243 (38%), Gaps = 53/243 (21%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-D 727
++ ++ LG G V + + +K +L K + E +IL+ L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKKKIKREIKILENLRG 89
Query: 728 HPFVPALYA---SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
P + L ++T L+ ++ + L L + +RFY E++ AL
Sbjct: 90 GPNIITLADIVKDPVSRTPA-LVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKAL 143
Query: 785 EYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
+Y H GI++RD+KP NV++ + + L D+ L
Sbjct: 144 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL-------------------------- 177
Query: 844 NPVFMAE---PMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP-F 898
AE P + N V + + PE++ ++D W+LG +L M++ P F
Sbjct: 178 -----AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232
Query: 899 RGK 901
G
Sbjct: 233 HGH 235
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 54/247 (21%), Positives = 99/247 (40%), Gaps = 39/247 (15%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAER 720
Q +H + ++ LG G+ GSV + A+K + + R E
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER---EI 62
Query: 721 EILDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFY 776
EIL L H + + ++ LI +Y P G L +L ++ + + + Y
Sbjct: 63 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQY 119
Query: 777 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836
+++ +EYL + I+RDL N+L++ V + DF L+ +LP E
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT--------KVLPQDKEFF 171
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGY 895
+ + ++P+F + APE + + + A D W+ G++LYE+ Y
Sbjct: 172 KVKEPGESPIF----------------WYAPESLTESKFSVASDVWSFGVVLYELFTYIE 215
Query: 896 TPFRGKT 902
Sbjct: 216 KSKSPPA 222
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 5e-18
Identities = 45/189 (23%), Positives = 83/189 (43%), Gaps = 33/189 (17%)
Query: 718 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
A REI L L H + L+ + + L+ ++C +L D L + V+
Sbjct: 48 ALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKS 105
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
+ +++ L + H + +++RDLKP+N+L+ NG + L +F L+
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA----------------- 148
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYG 894
R G P+R ++ V T Y P+++ GA ++++D W+ G + E+
Sbjct: 149 --RAFGI--------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198
Query: 895 YTP-FRGKT 902
P F G
Sbjct: 199 GRPLFPGND 207
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 59/241 (24%), Positives = 103/241 (42%), Gaps = 21/241 (8%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL---D 724
L+ + +K LG G G V +G+ A+K K +N REI+ +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIMILTE 64
Query: 725 MLDHPFVPALYASFQTKT--HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 782
+ H + L + V L+ DY +L ++ L+ ++ +++
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANI---LEPVHKQYVVYQLIK 120
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLPTTNEKKRRHKG 841
++YLH G+++RD+KP N+LL HV + DF LS + + + +
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRG 900
+ + + +V T Y APEI+ G+ T +D W+LG +L E+L G F G
Sbjct: 181 DDDQPILTD-------YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233
Query: 901 K 901
Sbjct: 234 S 234
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 44/293 (15%), Positives = 80/293 (27%), Gaps = 68/293 (23%)
Query: 643 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHL---VELCGSGQYFAM 699
+P R+ S P +Q L G +I +R + G L + A+
Sbjct: 7 REPDRESSAPPDDVQ--LVPGARIANGRYRLLIFHGGVPPLQFWQALDTAL---DRQVAL 61
Query: 700 KAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 759
+D +L + + + L +D P V + T+ ++ ++ GG L +
Sbjct: 62 TFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEV 121
Query: 760 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819
D P+ A+R + A + H G+ P V + +G V L
Sbjct: 122 ADTSPSP---VGAIR-AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP---- 173
Query: 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 879
+
Sbjct: 174 -------------------------------------------ATMPDA-------NPQD 183
Query: 880 DWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANVPP 932
D +G LY +L P + A +D P+ ++P
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRSGLA-PAERDTAGQPIEPAD-IDRDIPF 234
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 7e-18
Identities = 49/186 (26%), Positives = 89/186 (47%), Gaps = 32/186 (17%)
Query: 720 REI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
REI L L HP + +L ++ + L+ ++ +L +LD T L++ ++ Y
Sbjct: 68 REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYL 125
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
+++ + + H I++RDLKP+N+L+ +G + L DF L+
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA------------------- 166
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYT 896
R G P+R+ V T Y AP+++ G+ +++VD W++G + EM+ G
Sbjct: 167 RAFG--------IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218
Query: 897 PFRGKT 902
F G T
Sbjct: 219 LFPGVT 224
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 9e-18
Identities = 56/276 (20%), Positives = 109/276 (39%), Gaps = 40/276 (14%)
Query: 636 NHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCG--- 692
+H + + + + D + +H + ++ LG G+ GSV +
Sbjct: 9 HHDYDIPTTENLYFQGAMGSAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQD 67
Query: 693 -SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA--SFQTKTHVCLITD 749
+G+ A+K + + R E EIL L H + + ++ LI +
Sbjct: 68 NTGEVVAVKKLQHSTEEHLRDFER---EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124
Query: 750 YCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 807
Y P G L +L ++ + + + Y +++ +EYL + I+RDL N+L++
Sbjct: 125 YLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 181
Query: 808 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 867
V + DF L+ +LP E + + ++P+F + AP
Sbjct: 182 NRVKIGDFGLT--------KVLPQDKEYYKVKEPGESPIF----------------WYAP 217
Query: 868 EIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 902
E + + + A D W+ G++LYE+ Y
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 253
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 9e-18
Identities = 57/246 (23%), Positives = 97/246 (39%), Gaps = 39/246 (15%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAERE 721
+H + I LG G+ GSV L G A+K + + R E +
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR---EIQ 76
Query: 722 ILDMLDHPFVPALYA-SFQTKTH-VCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 777
IL L F+ S+ + L+ +Y P G L FL ++ L + Y+
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYS 133
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
+++ +EYL + ++RDL N+L++ HV + DF L+ LLP +
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA--------KLLPLDKDYYV 185
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 896
+ Q+P+F + APE ++ + D W+ G++LYE+ Y
Sbjct: 186 VREPGQSPIF----------------WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK 229
Query: 897 PFRGKT 902
Sbjct: 230 SCSPSA 235
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 61/242 (25%), Positives = 103/242 (42%), Gaps = 46/242 (19%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDML 726
+R ++P+GSG G+V +G A+K + + ++++ A RE+ L +
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---PFQSELFAKRAYRELRLLKHM 81
Query: 727 DHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
H V L + T L+ + G +L L+ + L ED ++F ++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK---LGEDRIQFLVYQM 137
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+ L Y+H GII+RDLKP N+ + + + + DF L+ R
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-------------------RQA 178
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR 899
M +V T Y APE+I T VD W++G ++ EM+ G T F+
Sbjct: 179 DS----EMTG-------YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227
Query: 900 GK 901
G
Sbjct: 228 GS 229
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 45/193 (23%), Positives = 86/193 (44%), Gaps = 39/193 (20%)
Query: 720 REI-----LDMLDHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLK 769
RE+ L+ +HP V L+ + +T + L+ ++ +L LD+ P +
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 118
Query: 770 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829
+ ++ +++ L++LH +++RDLKP+N+L+ +G + L DF L+
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA----------- 167
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889
R M ++ V T Y APE++ + + + VD W++G +
Sbjct: 168 --------RIYS--------FQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFA 210
Query: 890 EMLYGYTPFRGKT 902
EM FRG +
Sbjct: 211 EMFRRKPLFRGSS 223
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 48/193 (24%), Positives = 80/193 (41%), Gaps = 39/193 (20%)
Query: 720 REI-----LDMLDHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLK 769
RE+ L+ +HP V L + + V L+ ++ +L LD+ P L
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118
Query: 770 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829
+ ++ + + L++LH I++RDLKPEN+L+ G V L DF L+
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA----------- 167
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889
R M + V T Y APE++ + + + VD W++G +
Sbjct: 168 --------RIYS--------YQMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFA 210
Query: 890 EMLYGYTPFRGKT 902
EM F G +
Sbjct: 211 EMFRRKPLFCGNS 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 57/242 (23%), Positives = 103/242 (42%), Gaps = 47/242 (19%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDML 726
+ + +GSG GSV SG+ A+K + + ++++ A RE+ L +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---PFQSEIFAKRAYRELLLLKHM 80
Query: 727 DHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
H V L +S + L+ + +L ++ E+ +++ ++
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM-GLK---FSEEKIQYLVYQM 135
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+ L+Y+H G+++RDLKP N+ + + + + DF L+ RH
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA-------------------RHA 176
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR 899
+ M +V T Y APE+I H VD W++G ++ EML G T F+
Sbjct: 177 DAE----MTG-------YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225
Query: 900 GK 901
GK
Sbjct: 226 GK 227
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 68/276 (24%), Positives = 117/276 (42%), Gaps = 49/276 (17%)
Query: 639 KVVHPKPHRKDSPPWKAIQKILDSGEQINLQ---HFRPIKPLGSGDTGSVHLVELCGSGQ 695
+D K + G+ + + K +G+G G V+ +LC SG+
Sbjct: 21 SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 80
Query: 696 YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT------HVCLITD 749
A+K K V+ ++ +R E +I+ LDH + L F + ++ L+ D
Sbjct: 81 LVAIK---K-VLQDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133
Query: 750 YCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 807
Y P ++ + + L V+ Y ++ +L Y+H GI +RD+KP+N+LL +
Sbjct: 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD 192
Query: 808 -GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 866
+ L DF + + L+ EP S++ + Y A
Sbjct: 193 TAVLKLCDFGSA-------KQLVRG------------------EPNV---SYICSRYYRA 224
Query: 867 PEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGK 901
PE+I GA TS++D W+ G +L E+L G F G
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-17
Identities = 58/269 (21%), Positives = 101/269 (37%), Gaps = 33/269 (12%)
Query: 644 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 703
P K + P ++ LG G G V+ A+K +
Sbjct: 195 YPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK 254
Query: 704 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF-LLLDR 762
+ M +V E ++ + HP + L + +IT++ G L L +
Sbjct: 255 EDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 310
Query: 763 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822
+V + A ++ A+EYL + I+R+L N L+ N V + DF LS
Sbjct: 311 NRQEVSAVVLLYM-ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS---- 365
Query: 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882
+L+ T + H G + P+ + APE +A + D W
Sbjct: 366 ---RLM---TGDTYTAHAGAKFPIK----------------WTAPESLAYNKFSIKSDVW 403
Query: 883 ALGILLYEML-YGYTPFRGKTRQKTFANI 910
A G+LL+E+ YG +P+ G + + +
Sbjct: 404 AFGVLLWEIATYGMSPYPGIDLSQVYELL 432
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-17
Identities = 57/188 (30%), Positives = 83/188 (44%), Gaps = 32/188 (17%)
Query: 718 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
A REI L L HP + L +F K+++ L+ D+ +L +++ L ++
Sbjct: 59 ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV-LTPSHIKA 116
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
Y + LEYLH I++RDLKP N+LL NG + L DF L+
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA----------------- 159
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYG 894
+ G P RA V T Y APE++ GA VD WA+G +L E+L
Sbjct: 160 --KSFG--------SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209
Query: 895 YTPFRGKT 902
G +
Sbjct: 210 VPFLPGDS 217
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 48/192 (25%), Positives = 87/192 (45%), Gaps = 35/192 (18%)
Query: 718 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKED 771
A REI + L H + LY T+ + L+ ++ +L +D + L+ +
Sbjct: 50 AIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELN 108
Query: 772 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831
V+++ +++ L + H I++RDLKP+N+L+ G + L DF L+
Sbjct: 109 LVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA------------- 155
Query: 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYE 890
R G P+ +S V T Y AP+++ G+ ++++D W+ G +L E
Sbjct: 156 ------RAFG--------IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAE 201
Query: 891 MLYGYTPFRGKT 902
M+ G F G
Sbjct: 202 MITGKPLFPGTN 213
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 5e-17
Identities = 56/267 (20%), Positives = 100/267 (37%), Gaps = 23/267 (8%)
Query: 638 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 697
S+ + + S A S QI + +G+G G V +
Sbjct: 23 SQQEGQQRKQHHSSKPTASMPRPHSDWQI-PDRYEIRHLIGTGSYGHVCEAYDKLEKRVV 81
Query: 698 AMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGE 755
A+K + + + + + REI L+ L+H V + + + D E
Sbjct: 82 AIKKILR---VFEDLIDCKRILREIAILNRLNHDHVVKVL-------DIVIPKDVEKFDE 131
Query: 756 LFLLLDRQPT---------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 806
L+++L+ + L E ++ ++V ++Y+H GI++RDLKP N L+
Sbjct: 132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ 191
Query: 807 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 866
+ V + DF L+ + R V T Y A
Sbjct: 192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRA 251
Query: 867 PEIIAGAGH-TSAVDWWALGILLYEML 892
PE+I + T A+D W++G + E+L
Sbjct: 252 PELILLQENYTEAIDVWSIGCIFAELL 278
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 56/254 (22%), Positives = 106/254 (41%), Gaps = 38/254 (14%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAE 719
+ F+ IK LGSG G+V+ G+ A+K + + E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDE 67
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 777
++ +D+P V L + V LIT P G L ++ R+ + + +
Sbjct: 68 AYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWC 123
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
++ + YL + +++RDL NVL++ HV +TDF L+ +LL EK+
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA-------KLL--GAEEKEY 174
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 896
+G + P+ +++A E I +T D W+ G+ ++E++ +G
Sbjct: 175 HAEGGKVPI----------------KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 897 PFRGKTRQKTFANI 910
P+ G + + +
Sbjct: 219 PYDGIPASEISSIL 232
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 6e-17
Identities = 60/285 (21%), Positives = 107/285 (37%), Gaps = 38/285 (13%)
Query: 631 EDLWANHSKVVHPKPHRKDSPPW---KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHL 687
+ L A +SK HR + Q + +I + R LG G G V +
Sbjct: 143 QQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWM 202
Query: 688 VELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747
G+ + A+K + G M E +++ L H + LYA ++ + ++
Sbjct: 203 GTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 256
Query: 748 TDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 806
T+Y G L L + V AA++ + Y+ ++RDL+ N+L+
Sbjct: 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYVERMNYVHRDLRAANILVGE 315
Query: 807 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 866
N + DF L+ +L+ + + +G + P+ + A
Sbjct: 316 NLVCKVADFGLA-------RLI---EDNEYTARQGAKFPIK----------------WTA 349
Query: 867 PEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANI 910
PE T D W+ GILL E+ G P+ G ++ +
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-16
Identities = 60/285 (21%), Positives = 107/285 (37%), Gaps = 38/285 (13%)
Query: 631 EDLWANHSKVVHPKPHRKDSPPWK---AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHL 687
+ L A +SK HR + Q + +I + R LG G G V +
Sbjct: 226 QQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWM 285
Query: 688 VELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747
G+ + A+K + G M E +++ L H + LYA ++ + ++
Sbjct: 286 GTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 339
Query: 748 TDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 806
T+Y G L L + V AA++ + Y+ ++RDL+ N+L+
Sbjct: 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYVERMNYVHRDLRAANILVGE 398
Query: 807 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 866
N + DF L+ +L+ + + +G + P+ + A
Sbjct: 399 NLVCKVADFGLA-------RLI---EDNEYTARQGAKFPIK----------------WTA 432
Query: 867 PEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANI 910
PE T D W+ GILL E+ G P+ G ++ +
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 61/275 (22%), Positives = 112/275 (40%), Gaps = 41/275 (14%)
Query: 638 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 697
K+ P K PW+ +I + + K LG+G G V + +
Sbjct: 163 QKLSVPCMSSKPQKPWEKDAW------EIPRESLKLEKKLGAGQFGEVWMATYNKHTK-V 215
Query: 698 AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF 757
A+K M G M V AE ++ L H + L+A TK + +IT++ G L
Sbjct: 216 AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLL 270
Query: 758 -LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 816
L + +K + F +A++ + ++ + I+RDL+ N+L+ + + DF
Sbjct: 271 DFLKSDEGSKQPLPKLIDF-SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG 329
Query: 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT 876
L+ +++ + + +G + P+ ++ APE I T
Sbjct: 330 LA-------RVI---EDNEYTAREGAKFPI----------------KWTAPEAINFGSFT 363
Query: 877 SAVDWWALGILLYEML-YGYTPFRGKTRQKTFANI 910
D W+ GILL E++ YG P+ G + + +
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 61/268 (22%), Positives = 116/268 (43%), Gaps = 48/268 (17%)
Query: 644 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 703
P + K + +GEQ + + K +G+G G V +L S + A+K
Sbjct: 16 NPLDDPNKVIKVLASDGKTGEQREIA-YTNCKVIGNGSFGVVFQAKLVESDE-VAIK--- 70
Query: 704 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH------VCLITDYCPGGELF 757
K V+ ++ +R E +I+ ++ HP V L A F + + L+ +Y P ++
Sbjct: 71 K-VLQDKRFKNR---ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVY 125
Query: 758 LLLD--RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTD 814
+ + + ++ Y +++ +L Y+H GI +RD+KP+N+LL G + L D
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID 185
Query: 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 874
F + + + S++ + Y APE+I GA
Sbjct: 186 FGSA-------------------KI---------LIAGEPNVSYICSRYYRAPELIFGAT 217
Query: 875 H-TSAVDWWALGILLYEMLYGYTPFRGK 901
+ T+ +D W+ G ++ E++ G F G+
Sbjct: 218 NYTTNIDIWSTGCVMAELMQGQPLFPGE 245
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 49/252 (19%), Positives = 99/252 (39%), Gaps = 31/252 (12%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 725
++ +G G G V+L + + A+K +++ + + + REI L+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITILNR 81
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT---------KVLKEDAVRFY 776
L ++ LY + + D EL+++L+ + L E+ ++
Sbjct: 82 LKSDYIIRLY-------DLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTI 134
Query: 777 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL--SCLTSCKPQLLLPTTNE 834
+++ ++H GII+RDLKP N LL + V + DF L + + ++
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLY 893
++ + + V T Y APE+I + T ++D W+ G + E+L
Sbjct: 195 EEPGPHNKNLKKQLTS-------HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247
Query: 894 GYTPFRGKTRQK 905
+
Sbjct: 248 MLQSHINDPTNR 259
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 56/265 (21%), Positives = 88/265 (33%), Gaps = 52/265 (19%)
Query: 659 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVE---LCGSGQYFAMKAMDKGVMLNRNKVHR 715
+ G+ + + + + LG G G V VE A+K ++ N K
Sbjct: 10 VCRIGDWLQ-ERYEIVGNLGEGTFGKV--VECLDHARGKSQVALK-----IIRNVGKYRE 61
Query: 716 -ACAEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 767
A E +L + V + F H+C+ + G F L +
Sbjct: 62 AARLEINVLKKIKEKDKENKFLCV-LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQP 119
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827
VR A ++ AL +LH + + DLKPEN+L +
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILF------------------VNSEF 161
Query: 828 LLPTTNEKKRRHKGQQNPV----------FMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 877
K K +N F E + V T Y PE+I G
Sbjct: 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH---TTIVATRHYRPPEVILELGWAQ 218
Query: 878 AVDWWALGILLYEMLYGYTPFRGKT 902
D W++G +L+E G+T F+
Sbjct: 219 PCDVWSIGCILFEYYRGFTLFQTHE 243
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 56/257 (21%), Positives = 94/257 (36%), Gaps = 40/257 (15%)
Query: 652 PWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVML 708
P +++ ++ + + L ++ LG G G V E A+K + V+
Sbjct: 7 PLQSLTCLIGE-KDLRL-----LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS 60
Query: 709 NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTK 766
+ E + LDH + LY + ++T+ P G L L R+
Sbjct: 61 QPEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRL---RKHQG 116
Query: 767 VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826
+ YA +V + YL + I+RDL N+LL V + DF L
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM-------- 168
Query: 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 886
LP ++ + ++ P + APE + + A D W G+
Sbjct: 169 RALPQNDDHYVMQEHRKVPF----------------AWCAPESLKTRTFSHASDTWMFGV 212
Query: 887 LLYEML-YGYTPFRGKT 902
L+EM YG P+ G
Sbjct: 213 TLWEMFTYGQEPWIGLN 229
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 53/251 (21%), Positives = 90/251 (35%), Gaps = 44/251 (17%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAM--DKGVMLNRNKVHRACA 718
+ + I+ LG G G V L G A+K++ + G +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK----K 72
Query: 719 EREILDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 774
E EIL L H + + + LI ++ P G L +L + +
Sbjct: 73 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQL 129
Query: 775 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
YA ++ ++YL + ++RDL NVL++ V + DF L+ + T E
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT--------KAIETDKE 181
Query: 835 KKRRHKGQQNPVF-MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 892
+ +PVF APE + + A D W+ G+ L+E+L
Sbjct: 182 YYTVKDDRDSPVFWY-----------------APECLMQSKFYIASDVWSFGVTLHELLT 224
Query: 893 YGYTPFRGKTR 903
Y +
Sbjct: 225 YCDSDSSPMAL 235
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 50/248 (20%), Positives = 95/248 (38%), Gaps = 43/248 (17%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 725
+ +KPLG G G V + A+K K ++ + A REI +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---K--IVLTDPQSVKHALREIKIIRR 64
Query: 726 LDHPFVPALYASF--QTKTHVCLITDYCPGGELFLLLDRQPT--------KVLKEDAVRF 775
LDH + ++ + ++++ + T L E+ R
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL 124
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
+ +++ L+Y+H +++RDLKP N+ + + + + DF L+ +
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD------------ 172
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLY 893
+ ++E + T+ Y +P ++ + T A+D WA G + EML
Sbjct: 173 -----PHYSHKGHLSE-------GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220
Query: 894 GYTPFRGK 901
G T F G
Sbjct: 221 GKTLFAGA 228
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 56/265 (21%), Positives = 102/265 (38%), Gaps = 52/265 (19%)
Query: 659 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVE---LCGSGQYFAMKAMDKGVMLNRNKVHR 715
I SG+ ++ + + LG G G V VE G++ A+K ++ N ++
Sbjct: 5 ICQSGDVLS-ARYEIVDTLGEGAFGKV--VECIDHKAGGRHVAVK-----IVKNVDRYCE 56
Query: 716 -ACAEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 767
A +E ++L+ L V + F+ H+C++ + G + +
Sbjct: 57 AARSEIQVLEHLNTTDPNSTFRCV-QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLP 114
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827
+ D +R A ++ ++ +LH + + DLKPEN+L +
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILF------------------VQSDY 156
Query: 828 LLPTTNEKKRRHKGQQNPV----------FMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 877
+ KR + NP + E ++ V T Y APE+I G +
Sbjct: 157 TEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH---STLVSTRHYRAPEVILALGWSQ 213
Query: 878 AVDWWALGILLYEMLYGYTPFRGKT 902
D W++G +L E G+T F
Sbjct: 214 PCDVWSIGCILIEYYLGFTVFPTHD 238
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 60/258 (23%), Positives = 93/258 (36%), Gaps = 46/258 (17%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAM--DKGVMLNRNKVHRACA 718
+ ++ + I+ LG G G V L + A+KA+ D G
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK----Q 82
Query: 719 EREILDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 774
E +IL L H + + L+ +Y P G L +L L
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL---- 138
Query: 775 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
+A ++ + YLH Q I+RDL NVLL + V + DF L+ +P +E
Sbjct: 139 -FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA--------KAVPEGHE 189
Query: 835 KKRRHKGQQNPVF-MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 892
R + +PVF APE + A D W+ G+ LYE+L
Sbjct: 190 YYRVREDGDSPVFWY-----------------APECLKEYKFYYASDVWSFGVTLYELLT 232
Query: 893 YGYTPFRGKTRQKTFANI 910
+ + T+ I
Sbjct: 233 HCDSSQSPPTKFLELIGI 250
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 81.1 bits (199), Expect = 1e-15
Identities = 114/691 (16%), Positives = 190/691 (27%), Gaps = 232/691 (33%)
Query: 192 KDALSTFQQTFV-------VSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAG 244
KD LS F+ FV V D K I+ + +E+
Sbjct: 19 KDILSVFEDAFVDNFDCKDVQDMPKS---IL------------SKEEI------------ 51
Query: 245 TDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+ + ++ + + RL FW LL+ K +E V KF+
Sbjct: 52 ---DHIIMSKDAVS--GTL--RL---------FWTLLS----KQEEM-VQKFVE------ 84
Query: 305 KHTEGAKDKMLRPN-GLPESLIRYDARQKEMATSSVTELVQAMKK-PRSLSE-STNRPPI 361
++LR N S I+ + RQ M T E + + ++ + +R
Sbjct: 85 --------EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP 136
Query: 362 IRKSEGGVEEERA-------GALGRRKS-------ENVPPPRRNSYG------GGCRTSM 401
K + E R G LG K+ + + + C +
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPE 196
Query: 402 QRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDS---FENEIIMEGDDDYESDDERPDS 458
+ + QK + I S DH S I +
Sbjct: 197 TVL-----EMLQK-----LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246
Query: 459 ---VDDKVRQKEMRKGID-----LATTLERIEKNFVITDPRLPDNPIIFASDSFLE-LTE 509
+ + V+ + + L TT + +TD + D LT
Sbjct: 247 LLVLLN-VQNAKAWNAFNLSCKILLTT-----RFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 510 YSREEILGR--NCRFLQGPE----TDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNL 563
+ +L + +CR P T+P + I +I + G W+
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI--------------RDGLATWDN 346
Query: 564 FHLQPMRDQKGEVQYFIGVQLDGSEHLEP--LRNS------------IPEAT-------- 601
+ D+ + I L LEP R IP
Sbjct: 347 W-KHVNCDKLTTI---IESSL---NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDV 399
Query: 602 -AEESE----KLVKQT--AENVNEAVKELPDANL----TPEDLWANHSKVVHPKPHRKDS 650
+ KL K + + E+ +P L E+ +A H +V K
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTF 459
Query: 651 PPWKAIQKILDSGEQIN--LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML 708
I LD H +G HL + + M V L
Sbjct: 460 DSDDLIPPYLD-----QYFYSH------IGH------HLKN-IEHPERMTLFRM---VFL 498
Query: 709 N----RNKVHRA----CAEREILDML-DHPFVPALYASFQTKTH------VCLITDYCPG 753
+ K+ A IL+ L F Y + V I D+ P
Sbjct: 499 DFRFLEQKIRHDSTAWNASGSILNTLQQLKF----YKPYICDNDPKYERLVNAILDFLPK 554
Query: 754 GELFLLLDR----------QPTKVLKEDAVR 774
E L+ + + + E+A +
Sbjct: 555 IEENLICSKYTDLLRIALMAEDEAIFEEAHK 585
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 4e-07
Identities = 54/401 (13%), Positives = 114/401 (28%), Gaps = 116/401 (28%)
Query: 560 FWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEA 619
FW L + Q+ VQ F+ E L + E +Q +
Sbjct: 68 FWTL-----LSKQEEMVQKFVE------EVLRINYKFLMSPIKTEQ----RQPSMMTRMY 112
Query: 620 VKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPL-- 677
+++ + L+ N ++V K + P+ +++ L RP K +
Sbjct: 113 IEQR-------DRLY-NDNQVF-AKYNVSRLQPYLKLRQ--------ALLELRPAKNVLI 155
Query: 678 -GSGDTG-SVHLVELCGSGQYFAMKAMDKGVM-LNRNKVHRACAEREILDMLDHPFVPAL 734
G +G + +++C S Y MD + LN + +L+ML L
Sbjct: 156 DGVLGSGKTWVALDVCLS--YKVQCKMDFKIFWLNLKNCNS---PETVLEMLQ-----KL 205
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 794
++ + + + ++ + R ++ Y +C ++
Sbjct: 206 LYQIDP--------NWTSRSDHSSNI-KLRIHSIQAELRRLLKSK-----PYENCL-LVL 250
Query: 795 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK---------KRRHK--GQQ 843
+++ F+LSC ++LL TT K H
Sbjct: 251 LNVQNAKAW---------NAFNLSC------KILL-TTRFKQVTDFLSAATTTHISLDHH 294
Query: 844 NPVFM-AEPMRASNSFVGTEEY--------IAPEIIAGAG-----HTSAVDWW------A 883
+ E ++ P ++ + D W
Sbjct: 295 SMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK 354
Query: 884 LGILL---YEMLYGYTPFRGKTRQKTFANILHKDLKFPSST 921
L ++ +L P + + + P+
Sbjct: 355 LTTIIESSLNVL---EPAEYRKMFDRLS-VFPPSAHIPTIL 391
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 56/254 (22%), Positives = 100/254 (39%), Gaps = 60/254 (23%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV--HRACAEREI--- 722
+ F+ + G G G+V L + +G A+K KV RE+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK-----------KVIQDPRFRNRELQIM 70
Query: 723 --LDMLDHPFVPALYASFQTKTH-------VCLITDYCPGGELFLLLDRQPTK--VLKED 771
L +L HP + L + F T + ++ +Y P L +
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPI 129
Query: 772 AVRFYAAEVVVALEYLHCQ--GIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLL 828
++ + +++ ++ LH + +RD+KP NVL+ + +G + L DF +
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA---------- 179
Query: 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGIL 887
+ P + +++ + Y APE+I G H T+AVD W++G +
Sbjct: 180 --------K----------KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCI 221
Query: 888 LYEMLYGYTPFRGK 901
EM+ G FRG
Sbjct: 222 FAEMMLGEPIFRGD 235
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 56/254 (22%), Positives = 106/254 (41%), Gaps = 38/254 (14%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAE 719
+ F+ IK LGSG G+V+ G+ A+K + + E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDE 67
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 777
++ +D+P V L + V LIT P G L ++ R+ + + +
Sbjct: 68 AYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWC 123
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
++ + YL + +++RDL NVL++ HV +TDF L+ +LL EK+
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA-------KLL--GAEEKEY 174
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 896
+G + P+ +++A E I +T D W+ G+ ++E++ +G
Sbjct: 175 HAEGGKVPI----------------KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 897 PFRGKTRQKTFANI 910
P+ G + + +
Sbjct: 219 PYDGIPASEISSIL 232
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 63/278 (22%), Positives = 106/278 (38%), Gaps = 31/278 (11%)
Query: 637 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 696
K+ P+ + + + + +I K +GSGD+G V L GQ
Sbjct: 17 QGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQR 76
Query: 697 F---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 753
A+KA+ G + + +E I+ DHP + L ++T+Y
Sbjct: 77 DVPVAIKALKAGYTERQRR--DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMEN 134
Query: 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLT 813
G L L + V V + YL G ++RDL NVL+ N ++
Sbjct: 135 GSLDTFLRTHDGQFTIMQLVGM-LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVS 193
Query: 814 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA 873
DF LS +L + G + P+ + APE IA
Sbjct: 194 DFGLSR--------VLEDDPDAAYTTTGGKIPI----------------RWTAPEAIAFR 229
Query: 874 GHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANI 910
+SA D W+ G++++E+L YG P+ T + +++
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 44/193 (22%), Positives = 80/193 (41%), Gaps = 38/193 (19%)
Query: 718 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
A RE+ L L H + L + + LI +Y +L +D+ P + ++
Sbjct: 80 AIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP--DVSMRVIKS 136
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLL-----QGNGHVSLTDFDLSCLTSCKPQLLLP 830
+ +++ + + H + ++RDLKP+N+LL + + DF L+
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA------------ 184
Query: 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLY 889
R G P+R + T Y PEI+ G+ H +++VD W++ +
Sbjct: 185 -------RAFG--------IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWA 229
Query: 890 EMLYGYTPFRGKT 902
EML F G +
Sbjct: 230 EMLMKTPLFPGDS 242
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 55/248 (22%), Positives = 96/248 (38%), Gaps = 33/248 (13%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ LG G G V+ A+K + + M +V E ++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 64
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVA 783
+ HP + L + +IT++ G L L + +V + A ++ A
Sbjct: 65 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM-ATQISSA 123
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
+EYL + I+RDL N L+ N V + DF LS L + + H G +
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT----------GDTYTAHAGAK 173
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 902
P+ ++ APE +A + D WA G+LL+E+ YG +P+ G
Sbjct: 174 FPI----------------KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217
Query: 903 RQKTFANI 910
+ + +
Sbjct: 218 LSQVYELL 225
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 9e-15
Identities = 57/277 (20%), Positives = 109/277 (39%), Gaps = 48/277 (17%)
Query: 639 KVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFA 698
+++ PK + SG +N++ + ++ +G G+ G V L G Y
Sbjct: 166 RLIKPKVMEGTVAAQDEFYR---SGWALNMKELKLLQTIGKGEFGDVML------GDYRG 216
Query: 699 MKAMDKGVMLNRNKVHRA-CAEREILDMLDHPFVPALYA-SFQTKTHVCLITDYCPGGEL 756
K K + + +A AE ++ L H + L + K + ++T+Y G L
Sbjct: 217 NKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274
Query: 757 --FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 814
+L R + + + ++F + +V A+EYL ++RDL NVL+ + ++D
Sbjct: 275 VDYLR-SRGRSVLGGDCLLKF-SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 332
Query: 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 874
F L+ E + PV ++ APE +
Sbjct: 333 FGLTK--------------EASSTQDTGKLPV----------------KWTAPEALREKK 362
Query: 875 HTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANI 910
++ D W+ GILL+E+ +G P+ + +
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 55/241 (22%), Positives = 96/241 (39%), Gaps = 35/241 (14%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 732
K LGSG+ G+V A+K + + AE ++ LD+P++
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIV 81
Query: 733 ALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ L+ + G L +L +R +K+ + +V + ++YL
Sbjct: 82 RMIG-ICEAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES 136
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
++RDL NVLL + ++DF LS + L N K + G+
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLS-------KALRADENYYKAQTHGKW------- 182
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFAN 909
P++ + APE I +S D W+ G+L++E YG P+RG + A
Sbjct: 183 PVK----------WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 232
Query: 910 I 910
+
Sbjct: 233 L 233
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 57/280 (20%), Positives = 106/280 (37%), Gaps = 76/280 (27%)
Query: 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 722
G + + + + K LG+G G V V SG+ FA+K K V+ + +R E +I
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK---K-VLQDPRYKNR---ELDI 53
Query: 723 LDMLDHPFVPALYASFQTKTHVCLITDYCPGG--------------------------EL 756
+ +LDH + L F T P L
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 757 FLLLDRQPT-------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 803
++++ P + + + + Y ++ A+ ++H GI +RD+KP+N+L
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL 173
Query: 804 LQGN-GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 862
+ + L DF + + P S +++ +
Sbjct: 174 VNSKDNTLKLCDFGSA-------------------KK---------LIPSEPSVAYICSR 205
Query: 863 EYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGK 901
Y APE++ GA T ++D W++G + E++ G F G+
Sbjct: 206 FYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGE 245
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 2e-14
Identities = 57/285 (20%), Positives = 106/285 (37%), Gaps = 32/285 (11%)
Query: 630 PEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKP-LGSGDTGSVHLV 688
P + + P P+ +++ D + + LG G+ GSV
Sbjct: 296 PARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQG 355
Query: 689 ELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746
+ A+K + +G + E +I+ LD+P++ L + L
Sbjct: 356 VYRMRKKQIDVAIKVLKQGTEKADTE--EMMREAQIMHQLDNPYIVRLIG-VCQAEALML 412
Query: 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 806
+ + GG L L + + V +V + ++YL + ++R+L NVLL
Sbjct: 413 VMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN 471
Query: 807 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 866
+ ++DF LS + L + R G+ P++ + A
Sbjct: 472 RHYAKISDFGLS-------KALGADDSYYTARSAGKW-------PLK----------WYA 507
Query: 867 PEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANI 910
PE I +S D W+ G+ ++E L YG P++ + A I
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 57/279 (20%), Positives = 102/279 (36%), Gaps = 36/279 (12%)
Query: 637 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 696
++ ++ + P Q +L +I+ K +G+G+ G V+ L S
Sbjct: 16 TTENLYFQGAMGSDPN----QAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGK 71
Query: 697 F----AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 752
A+K + G + E I+ H + L + +IT+Y
Sbjct: 72 KEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME 129
Query: 753 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 812
G L L + + V + ++YL ++RDL N+L+ N +
Sbjct: 130 NGALDKFLREKDGEFSVLQLVGM-LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKV 188
Query: 813 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG 872
+DF LS +L E G + P+ + APE I+
Sbjct: 189 SDFGLSR--------VLEDDPEATYTTSGGKIPI----------------RWTAPEAISY 224
Query: 873 AGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANI 910
TSA D W+ GI+++E++ YG P+ + + I
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 53/247 (21%), Positives = 102/247 (41%), Gaps = 33/247 (13%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
I+ ++ +GSG G VHL + A+K + +G M E E++
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAM----SEEDFIEEAEVMM 58
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
L HP + LY + +CL+T++ G L L Q E + +V +
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM-CLDVCEGM 117
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
YL +I+RDL N L+ N + ++DF ++ +++ G +
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF----------VLDDQYTSSTGTKF 167
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 903
PV ++ +PE+ + + ++S D W+ G+L++E+ G P+ ++
Sbjct: 168 PV----------------KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211
Query: 904 QKTFANI 910
+ +I
Sbjct: 212 SEVVEDI 218
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 60/269 (22%), Positives = 110/269 (40%), Gaps = 48/269 (17%)
Query: 644 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 703
KP +D W ++ + + ++ LG+G G V + G + A+K++
Sbjct: 1 KPWWEDE--W-----------EVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLK 46
Query: 704 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL-DR 762
+G M + AE ++ L H + LYA T+ + +IT+Y G L L
Sbjct: 47 QGSMSPDAFL----AEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTP 101
Query: 763 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822
K+ + AA++ + ++ + I+RDL+ N+L+ + DF L+
Sbjct: 102 SGIKLTINKLLDM-AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA---- 156
Query: 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882
+L+ +G + P+ ++ APE I T D W
Sbjct: 157 ---RLIEDNEYT---AREGAKFPI----------------KWTAPEAINYGTFTIKSDVW 194
Query: 883 ALGILLYEML-YGYTPFRGKTRQKTFANI 910
+ GILL E++ +G P+ G T + N+
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 54/260 (20%), Positives = 103/260 (39%), Gaps = 42/260 (16%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 728
+R + +GSG G ++L +G+ A+K + K + E +I M+
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGG 64
Query: 729 PFVPALYASFQTKTHVCLITDYCPGG----ELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
+P + + ++ + G +LF R+ + LK V A +++ +
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFS--LK--TVLLLADQMISRI 118
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
EY+H + I+RD+KP+N L+ V + DF L+ + + +H
Sbjct: 119 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK----------KYRDARTHQHI- 167
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG- 900
P R + + GT Y + G + D +LG +L G P++G
Sbjct: 168 ---------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
Query: 901 --KTRQKTFANILHKDLKFP 918
T+++ + I K + P
Sbjct: 219 KAATKRQKYERISEKKMSTP 238
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 51/246 (20%), Positives = 94/246 (38%), Gaps = 42/246 (17%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAM--DKGVMLNRNKVHRACAE 719
R +K LGSG G+VH G+ +K + G +
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT----DH 65
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 777
+ LDH + L + + L+T Y P G L + RQ L + +
Sbjct: 66 MLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHV---RQHRGALGPQLLLNWG 121
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
++ + YL G+++R+L NVLL+ V + DF ++ L ++K+
Sbjct: 122 VQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP---------PDDKQL 172
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 896
+ + P+ +++A E I +T D W+ G+ ++E++ +G
Sbjct: 173 LYSEAKTPI----------------KWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
Query: 897 PFRGKT 902
P+ G
Sbjct: 217 PYAGLR 222
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 9e-14
Identities = 60/272 (22%), Positives = 104/272 (38%), Gaps = 37/272 (13%)
Query: 644 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMK 700
PH + P Q + + ++++ + K +G+G+ G V L + A+K
Sbjct: 24 DPHTFEDP----TQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 701 AMDKGVML-NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 759
+ G R E I+ DHP + L V ++T+Y G L
Sbjct: 80 TLKVGYTEKQRRDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 760 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819
L + + V + ++YL G ++RDL N+L+ N ++DF L
Sbjct: 137 LRKHDAQFTVIQLVGM-LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGR 195
Query: 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 879
+L E +G + P+ + +PE IA TSA
Sbjct: 196 --------VLEDDPEAAYTTRGGKIPI----------------RWTSPEAIAYRKFTSAS 231
Query: 880 DWWALGILLYEML-YGYTPFRGKTRQKTFANI 910
D W+ GI+L+E++ YG P+ + Q +
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 57/237 (24%), Positives = 95/237 (40%), Gaps = 44/237 (18%)
Query: 692 GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH--VCLITD 749
+ +A+K ++ + AC E +L L HP V +L F + V L+ D
Sbjct: 46 KDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100
Query: 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEV-------VVALEYLHCQGIIYRDLKPENV 802
Y +L+ ++ + V+ V + + YLH +++RDLKP N+
Sbjct: 101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANI 159
Query: 803 LLQG----NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSF 858
L+ G G V + D + R +P+ +P+ +
Sbjct: 160 LVMGEGPERGRVKIADMGFA-------------------RLFN--SPL---KPLADLDPV 195
Query: 859 VGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914
V T Y APE++ GA H T A+D WA+G + E+L F + +N H D
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 53/319 (16%), Positives = 103/319 (32%), Gaps = 43/319 (13%)
Query: 636 NHSKVVHPKPHRKDSPPWKAIQKILDSGEQ---INLQHFRPIKPLGSGDTGSVHLVELCG 692
+HS V + L +G + + ++ + G ++
Sbjct: 6 HHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTS 65
Query: 693 SG--------QYFAMK--AMDKGVMLNRNKVHRACAEREI-----LDMLDHPFVPALYAS 737
+ Q F++K A D + +N RA ++ L +P
Sbjct: 66 TLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGF 125
Query: 738 -FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
+ L+ G L LD P VL E +V A ++ ALE+LH ++ +
Sbjct: 126 GVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGN 184
Query: 797 LKPENVLL--QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 854
+ EN+ + + V+L + + + G+ +
Sbjct: 185 VTAENIFVDPEDQSQVTLAGYGFA----------------FRYCPSGKHVA----YVEGS 224
Query: 855 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG-KTRQKTFANILHK 913
+ G E+I+ ++ G G + D +LG + + LYG+ P+ + K
Sbjct: 225 RSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQK 284
Query: 914 DLKFPSSTPSSCKAANVPP 932
+ P C P
Sbjct: 285 FVDKPGPFVGPCGHWIRPS 303
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 51/247 (20%), Positives = 94/247 (38%), Gaps = 33/247 (13%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ + +K LGSG G V L + G A+K + +G M E + +
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSM----SEDEFFQEAQTMM 58
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
L HP + Y + + ++T+Y G L L + + +V +
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM-CYDVCEGM 117
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
+L I+RDL N L+ + V ++DF ++ +++ G +
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY----------VLDDQYVSSVGTKF 167
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 903
PV ++ APE+ ++S D WA GIL++E+ G P+ T
Sbjct: 168 PV----------------KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211
Query: 904 QKTFANI 910
+ +
Sbjct: 212 SEVVLKV 218
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 55/263 (20%), Positives = 101/263 (38%), Gaps = 46/263 (17%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 728
H++ + +G G G + + Q A+K + R+ + E +L
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGC 65
Query: 729 PFVPALYASFQTKTHVCLITDYCPG---GELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
+P +Y Q H L+ D G +L L R+ + +K V A +++ ++
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFS--VK--TVAMAAKQMLARVQ 120
Query: 786 YLHCQGIIYRDLKPENVLL-QGNGH----VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+H + ++YRD+KP+N L+ + N + + DF + K R
Sbjct: 121 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV----------------KFYRDP 164
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV--DWWALGILLYEMLYGYTPF 898
+ + P R + GT Y++ I G + D ALG + L G P+
Sbjct: 165 VTKQHI----PYREKKNLSGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218
Query: 899 RG---KTRQKTFANILHKDLKFP 918
+G T ++ + I K P
Sbjct: 219 QGLKAATNKQKYERIGEKKQSTP 241
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 54/238 (22%), Positives = 96/238 (40%), Gaps = 33/238 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYF--AMKAMDKGVMLNRNKVHRA-CAEREILDMLDHPFVPA 733
LG G+ GSV + A+K + +G E +I+ LD+P++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPYIVR 74
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
L Q + + L+ + GG L L + ++ + +V + ++YL + +
Sbjct: 75 LIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL-LHQVSMGMKYLEEKNFV 132
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
+RDL NVLL + ++DF LS + L + R G+ P++
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLS-------KALGADDSYYTARSAGKW-------PLK 178
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANI 910
+ APE I +S D W+ G+ ++E L YG P++ + A I
Sbjct: 179 ----------WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-13
Identities = 48/197 (24%), Positives = 73/197 (37%), Gaps = 38/197 (19%)
Query: 718 AEREI--LDMLDHPFVPALY--------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 767
A REI L +L H V L + K + L+ D+C +L LL K
Sbjct: 63 ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVK- 120
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQ 826
++ ++ L Y+H I++RD+K NVL+ +G + L DF L+ + K
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALG 885
TN V T Y PE++ G +D W G
Sbjct: 181 QPNRYTNR------------------------VVTLWYRPPELLLGERDYGPPIDLWGAG 216
Query: 886 ILLYEMLYGYTPFRGKT 902
++ EM +G T
Sbjct: 217 CIMAEMWTRSPIMQGNT 233
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 40/263 (15%), Positives = 79/263 (30%), Gaps = 52/263 (19%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF-------AMKAMDKGVMLNRNKVHRAC 717
+I + + LG G + G Y +K +DK
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE-- 61
Query: 718 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
++ L H + Y L+ ++ G L L + + + A
Sbjct: 62 -AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV-A 119
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQG--------NGHVSLTDFDLSCLTSCKPQLLL 829
++ A+ +L +I+ ++ +N+LL + L+D +S +L
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------ITVL 172
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILL 888
P ++ + ++ PE I + A D W+ G L
Sbjct: 173 PKDILQE--------------RIP----------WVPPECIENPKNLNLATDKWSFGTTL 208
Query: 889 YEML-YGYTPFRGKTRQKTFANI 910
+E+ G P Q+
Sbjct: 209 WEICSGGDKPLSALDSQRKLQFY 231
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 50/240 (20%), Positives = 93/240 (38%), Gaps = 43/240 (17%)
Query: 674 IKPLGSGDTGSVH---LVELCGSGQYFAMKAMDKGVMLNRNKVHRACA----EREILDML 726
+ +G G G V+ L++ G + A+K LNR + E I+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK------SLNRITDIGEVSQFLTEGIIMKDF 83
Query: 727 DHPFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVA 783
HP V +L +++ ++ Y G+L F+ + V +D + F +V
Sbjct: 84 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGF-GLQVAKG 140
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
++YL + ++RDL N +L V + DF L+ + + G +
Sbjct: 141 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA-------RDMYDKEYYSVHNKTGAK 193
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 902
PV +++A E + T+ D W+ G+LL+E++ G P+
Sbjct: 194 LPV----------------KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 55/261 (21%), Positives = 105/261 (40%), Gaps = 43/261 (16%)
Query: 654 KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 713
A + SG +N++ + ++ +G G+ G V L + G A+K + +
Sbjct: 6 AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVK------CIKNDAT 57
Query: 714 HRA-CAEREILDMLDHPFVPALYAS-FQTKTHVCLITDYCPGGELFLLL-DRQPTKVLKE 770
+A AE ++ L H + L + K + ++T+Y G L L R + + +
Sbjct: 58 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 117
Query: 771 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830
++F + +V A+EYL ++RDL NVL+ + ++DF L+
Sbjct: 118 CLLKF-SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT------------ 164
Query: 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 890
E + PV ++ APE + ++ D W+ GILL+E
Sbjct: 165 --KEASSTQDTGKLPV----------------KWTAPEALREKKFSTKSDVWSFGILLWE 206
Query: 891 ML-YGYTPFRGKTRQKTFANI 910
+ +G P+ + +
Sbjct: 207 IYSFGRVPYPRIPLKDVVPRV 227
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 9e-13
Identities = 62/252 (24%), Positives = 99/252 (39%), Gaps = 38/252 (15%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAERE 721
+I + + +G G G VH A+K + + + E
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE--KFLQEAL 443
Query: 722 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAE 779
+ DHP + L T+ V +I + C GEL FL + L ++ YA +
Sbjct: 444 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQ 499
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
+ AL YL + ++RD+ NVL+ N V L DF LS + + +T K +
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS-------RYMEDSTYYKASKG 552
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 898
K P++ ++APE I TSA D W G+ ++E+L +G PF
Sbjct: 553 K---------LPIK----------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593
Query: 899 RGKTRQKTFANI 910
+G I
Sbjct: 594 QGVKNNDVIGRI 605
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 59/265 (22%), Positives = 105/265 (39%), Gaps = 46/265 (17%)
Query: 649 DSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKG 705
DS ++ +L E++ + +G G G V+ E Q A+K
Sbjct: 4 DSALLAEVKDVLIPHERVVTHS---DRVIGKGHFGVVYHGEYIDQAQNRIQCAIK----- 55
Query: 706 VMLNRNKVHRACA----EREILDMLDHPFVPALYA-SFQTKTHVCLITDYCPGGEL--FL 758
L+R + E ++ L+HP V AL + ++ Y G+L F+
Sbjct: 56 -SLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI 114
Query: 759 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818
++ V +D + F +V +EYL Q ++RDL N +L + V + DF L+
Sbjct: 115 RSPQRNPTV--KDLISF-GLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
Query: 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 878
+ +L ++H+ + PV ++ A E + T+
Sbjct: 172 -------RDILDREYYSVQQHRHARLPV----------------KWTALESLQTYRFTTK 208
Query: 879 VDWWALGILLYEML-YGYTPFRGKT 902
D W+ G+LL+E+L G P+R
Sbjct: 209 SDVWSFGVLLWELLTRGAPPYRHID 233
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 49/240 (20%), Positives = 94/240 (39%), Gaps = 43/240 (17%)
Query: 674 IKPLGSGDTGSVH---LVELCGSGQYFAMKAMDKGVMLNRNKVHRACA----EREILDML 726
+ +G G G V+ L++ G + A+K LNR + E I+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK------SLNRITDIGEVSQFLTEGIIMKDF 147
Query: 727 DHPFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVA 783
HP V +L +++ ++ Y G+L F+ + V +D + F +V
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGF-GLQVAKG 204
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
+++L + ++RDL N +L V + DF L+ + + + G +
Sbjct: 205 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA-------RDMYDKEFDSVHNKTGAK 257
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 902
PV +++A E + T+ D W+ G+LL+E++ G P+
Sbjct: 258 LPV----------------KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 62/252 (24%), Positives = 99/252 (39%), Gaps = 38/252 (15%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAERE 721
+I + + +G G G VH A+K + + + E
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE--KFLQEAL 68
Query: 722 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAE 779
+ DHP + L T+ V +I + C GEL FL + L ++ YA +
Sbjct: 69 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQ 124
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
+ AL YL + ++RD+ NVL+ N V L DF LS + + +T K +
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS-------RYMEDSTYYKASKG 177
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 898
K P++ ++APE I TSA D W G+ ++E+L +G PF
Sbjct: 178 K---------LPIK----------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218
Query: 899 RGKTRQKTFANI 910
+G I
Sbjct: 219 QGVKNNDVIGRI 230
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 57/247 (23%), Positives = 100/247 (40%), Gaps = 33/247 (13%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
+I+ + +K LG+G G V + G A+K + +G M E +++
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMM 74
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
L H + LY + + +IT+Y G L L + + + +V A+
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAM 133
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
EYL + ++RDL N L+ G V ++DF LS + +L G +
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS-------RYVLDDEYT---SSVGSKF 183
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 903
PV + PE++ + +S D WA G+L++E+ G P+ T
Sbjct: 184 PV----------------RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227
Query: 904 QKTFANI 910
+T +I
Sbjct: 228 SETAEHI 234
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 4e-12
Identities = 56/257 (21%), Positives = 87/257 (33%), Gaps = 64/257 (24%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVML-NRNKVHRACAER 720
I + + LG G G V+ A+K K L N+ K E
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---EA 64
Query: 721 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAA 778
I+ LDHP + L + +I + P GEL +L + LK + Y+
Sbjct: 65 VIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSL 120
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
++ A+ YL ++RD+ N+L+ V L DF LS
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS-------------------- 160
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYI------------APEIIAGAGHTSAVDWWALGI 886
R + E+Y +PE I T+A D W +
Sbjct: 161 --------------RY----IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAV 202
Query: 887 LLYEML-YGYTPFRGKT 902
++E+L +G PF
Sbjct: 203 CMWEILSFGKQPFFWLE 219
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A Length = 120 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-12
Identities = 13/87 (14%), Positives = 30/87 (34%), Gaps = 2/87 (2%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAK-IRETLQNGQSYCGRLLNYKK 272
I + + +++GR+ L + + E + + I + SY + +
Sbjct: 24 IEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDRIMKRA 83
Query: 273 DGTPFWNLLTIAPIKDDEGKVLKFIGM 299
G FW +T + D + +
Sbjct: 84 GGELFWCHVTGRAL-DRTAPLAAGVWT 109
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A Length = 120 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 6e-10
Identities = 14/95 (14%), Positives = 30/95 (31%), Gaps = 2/95 (2%)
Query: 492 LPDNPIIFASDSFLELTEYSREEILGRNCRFLQ-GPETDPATVRKIRAAIDNQTDVTVQL 550
D I +D + +R +++GR+ L + +I +
Sbjct: 19 SRDRVIEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDR 78
Query: 551 INYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
I G+ FW + + D+ + + D
Sbjct: 79 IMKRAGGELFWCHVTGRAL-DRTAPLAAGVWTFED 112
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 57/254 (22%), Positives = 100/254 (39%), Gaps = 47/254 (18%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAER 720
+Q L + LG G+ GSV +L F A+K + ++ + + E
Sbjct: 23 QQFTL-----GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREA 76
Query: 721 EILDMLDHPFVPALYA------SFQTKTHVCLITDYCPGGEL--FLLLDR---QPTKVLK 769
+ DHP V L + +I + G+L FLL R P +
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 770 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829
+ VRF ++ +EYL + I+RDL N +L + V + DF LS +
Sbjct: 137 QTLVRF-MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS--------RKI 187
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889
+ + ++ + P++ ++A E +A +T D WA G+ ++
Sbjct: 188 YSGDYYRQGCASKL-------PVK----------WLALESLADNLYTVHSDVWAFGVTMW 230
Query: 890 EML-YGYTPFRGKT 902
E++ G TP+ G
Sbjct: 231 EIMTRGQTPYAGIE 244
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 57/312 (18%), Positives = 107/312 (34%), Gaps = 45/312 (14%)
Query: 644 KPHRKDSPPWKAIQKILDSGEQINL---QHFRPIKPLGSGDTGSVHLVEL-----CGSGQ 695
+ S + + + GE I ++ P+G G G ++L ++ GS
Sbjct: 7 AQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDA 66
Query: 696 YFAMKAM--DKGVMLNRNKVHRACAEREILDM------LDHPFVPALYAS----FQTKTH 743
+K D G + K ++ A+ E + L + VP + S K++
Sbjct: 67 PCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSY 126
Query: 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 803
+I D G +L + + + V + ++ LEY+H ++ D+K N+L
Sbjct: 127 RFMIMDRF-GSDLQKIYEANAKR-FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL 184
Query: 804 L-QGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGT 861
L N V L D+ L+ + +G GT
Sbjct: 185 LNYKNPDQVYLVDYGLA----------------YRYCPEGVHKAY----AADPKRCHDGT 224
Query: 862 EEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG-KTRQKTFANILHKDLKFPSS 920
E+ + + G + D LG + + L G+ P+ K + + + +S
Sbjct: 225 IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIAS 284
Query: 921 TPSSCKAANVPP 932
C A P
Sbjct: 285 LMDKCFPAANAP 296
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 52/314 (16%), Positives = 98/314 (31%), Gaps = 46/314 (14%)
Query: 642 HPKPHRKDSPPWKAIQKI-LDSGEQINL---QHFRPIKPLGSGDTGSVHLVELCGSGQYF 697
H Q + G+ ++ + K +GSG G ++L +
Sbjct: 6 HHSSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKD 65
Query: 698 AMKAM-----DKGVMLNRNKV-HRACAEREILDM-----LDHPFVPALYAS----FQTKT 742
A + + G + + K R + I LD+ +P Y S F+ ++
Sbjct: 66 ARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRS 125
Query: 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802
+ ++ + G +L + + T V ++ LEY+H ++ D+K N+
Sbjct: 126 YRFMVMERL-GIDLQKISGQNGTFKKS--TVLQLGIRMLDVLEYIHENEYVHGDIKAANL 182
Query: 803 LL-QGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG 860
LL N V L D+ LS + G G
Sbjct: 183 LLGYKNPDQVYLADYGLS----------------YRYCPNGNHKQY----QENPRKGHNG 222
Query: 861 TEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANIL--HKDLKFP 918
T E+ + + G + D LG + L G P+ + + + P
Sbjct: 223 TIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELP 282
Query: 919 SSTPSSCKAANVPP 932
S + +
Sbjct: 283 QSVLKWAPSGSSCC 296
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 59/262 (22%), Positives = 105/262 (40%), Gaps = 44/262 (16%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 728
+FR K +G G+ G + L + + +Y A+K + +++ + E L
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSG 64
Query: 729 PFVPALYASFQTKTHVCLITDYCPGG----ELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
+P +Y + ++ + G +LF L DR + LK V A +++ +
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFS--LK--TVLMIAIQLISRM 118
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGH-----VSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
EY+H + +IYRD+KPEN L+ G+ + + DF L+ K+
Sbjct: 119 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA----------------KEYID 162
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
+ + P R S GT Y++ G + D ALG + L G P++
Sbjct: 163 PETKKHI----PYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQ 218
Query: 900 G---KTRQKTFANILHKDLKFP 918
G T ++ + I P
Sbjct: 219 GLKADTLKERYQKIGDTKRATP 240
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 4e-11
Identities = 48/235 (20%), Positives = 92/235 (39%), Gaps = 31/235 (13%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DH 728
FR + +GSG G ++L + + A+K + + K + E +I +L
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKIYRILQGG 62
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
+P + + L+ D G L L + K+ + + A +++ +E++H
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML-ADQMINRVEFVH 120
Query: 789 CQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
+ ++RD+KP+N L+ V + DF L+ + +H
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK----------KYRDTSTHQHI----- 165
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
P R + + GT Y + G + D +LG +L L G P++G
Sbjct: 166 -----PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 60/290 (20%), Positives = 111/290 (38%), Gaps = 46/290 (15%)
Query: 637 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 696
H R ++ ++ + L K LG G+ GSV L
Sbjct: 7 HHHHSSGLVPRGSEELQNKLEDVVIDRNLLIL-----GKILGEGEFGSVMEGNLKQEDGT 61
Query: 697 F---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA-----SFQTKTHVCLIT 748
A+K M ++ ++ +E + HP V L S Q +I
Sbjct: 62 SLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120
Query: 749 DYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 803
+ G+L +LL R P + + ++F ++ + +EYL + ++RDL N +
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF-MVDIALGMEYLSNRNFLHRDLAARNCM 179
Query: 804 LQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEE 863
L+ + V + DF LS + + + ++ + P++
Sbjct: 180 LRDDMTVCVADFGLS--------KKIYSGDYYRQGRIAKM-------PVK---------- 214
Query: 864 YIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH 912
+IA E +A +TS D WA G+ ++E+ G TP+ G + + +LH
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 54/257 (21%), Positives = 92/257 (35%), Gaps = 49/257 (19%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
LG G G V L E A+KA+ + R R E E+L ML H
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTMLQH 102
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGEL--FL------------LLDRQPTKVLKEDAVR 774
+ + + ++ +Y G+L FL D P + +
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 775 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
A++V + YL ++RDL N L+ V + DF +S + +T+
Sbjct: 163 V-ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS--------RDIYSTDY 213
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 893
+ + P+R ++ PE I T+ D W+ G++L+E+ Y
Sbjct: 214 YRVGGRTML-------PIR----------WMPPESILYRKFTTESDVWSFGVVLWEIFTY 256
Query: 894 GYTPFRGKTRQKTFANI 910
G P+ + + I
Sbjct: 257 GKQPWYQLSNTEAIDCI 273
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 55/258 (21%), Positives = 93/258 (36%), Gaps = 50/258 (19%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ LG G G V L E A+KA+ + R R E E+L L H
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQH 76
Query: 729 PFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR----------- 774
+ Y + ++ +Y G+L FL +L + R
Sbjct: 77 EHIVKFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 775 -FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
A+++ + YL Q ++RDL N L+ N V + DF +S + +T+
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS--------RDVYSTD 187
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 892
+ P+R ++ PE I T+ D W+ G++L+E+
Sbjct: 188 YYRVGGHTML-------PIR----------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230
Query: 893 YGYTPFRGKTRQKTFANI 910
YG P+ + + I
Sbjct: 231 YGKQPWFQLSNTEVIECI 248
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 67/289 (23%), Positives = 111/289 (38%), Gaps = 58/289 (20%)
Query: 642 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF--AM 699
H H + P I +LD I Q +G G+ G V + G A+
Sbjct: 4 HHHHHHGKNNPDPTIYPVLDW-NDIKFQ-----DVIGEGNFGQVLKARIKKDGLRMDAAI 57
Query: 700 KAMDKGVMLNRNKVHRA-CAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGEL- 756
K M + HR E E+L L HP + L + + + ++ L +Y P G L
Sbjct: 58 KRMKEYAS---KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 114
Query: 757 -FLLLDRQPTKVLK-------------EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802
FL R + + F AA+V ++YL + I+RDL N+
Sbjct: 115 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHF-AADVARGMDYLSQKQFIHRDLAARNI 173
Query: 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 862
L+ N + DF LS ++ G+ P+R
Sbjct: 174 LVGENYVAKIADFGLS-----------RGQEVYVKKTMGRL-------PVR--------- 206
Query: 863 EYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANI 910
++A E + + +T+ D W+ G+LL+E++ G TP+ G T + + +
Sbjct: 207 -WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 9e-09
Identities = 55/258 (21%), Positives = 92/258 (35%), Gaps = 49/258 (18%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 727
++ LG G V+ L G A+K + R + E + L
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH---EAMLRARLQ 70
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF---------- 775
HP V L + +I YC G+L FL++ + V D R
Sbjct: 71 HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 776 --YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
A++ +EYL ++++DL NVL+ +V ++D L + +
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF--------REVYAAD 182
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 892
K P+R ++APE I + D W+ G++L+E+
Sbjct: 183 YYKLLGNSLL-------PIR----------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
Query: 893 YGYTPFRGKTRQKTFANI 910
YG P+ G + Q I
Sbjct: 226 YGLQPYCGYSNQDVVEMI 243
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 44/254 (17%), Positives = 93/254 (36%), Gaps = 43/254 (16%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 727
+ LG G G V+ G + A+K +++ + R + E ++ +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN---EASVMKEFN 86
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR------FYAAE 779
V L +I + G+L +L R A A E
Sbjct: 87 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
+ + YL+ ++RDL N ++ + V + DF ++ + T+ ++
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT--------RDIYETDYYRKGG 198
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 898
KG P+R +++PE + T+ D W+ G++L+E+ P+
Sbjct: 199 KGLL-------PVR----------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241
Query: 899 RGKTRQKTFANILH 912
+G + ++ ++
Sbjct: 242 QGLSNEQVLRFVME 255
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 42/207 (20%), Positives = 80/207 (38%), Gaps = 48/207 (23%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF- 775
E +L ++HP V LY + + LI +Y G L FL R+
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 776 -------------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 816
+A ++ ++YL +++RDL N+L+ + ++DF
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT 876
LS + + +R +G+ P++ ++A E + +T
Sbjct: 196 LS--------RDVYEEDSYVKRSQGR-------IPVK----------WMAIESLFDHIYT 230
Query: 877 SAVDWWALGILLYEML-YGYTPFRGKT 902
+ D W+ G+LL+E++ G P+ G
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNPYPGIP 257
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 45/201 (22%), Positives = 77/201 (38%), Gaps = 42/201 (20%)
Query: 719 EREILDMLD-HPFVPALY-ASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 774
E +IL + H V L A + + +I ++C G L +L R K
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 775 F------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822
Y+ +V +E+L + I+RDL N+LL V + DF L+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---- 195
Query: 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882
+ + R+ + P++ ++APE I +T D W
Sbjct: 196 ----RDIYKDPDYVRKGDAR-------LPLK----------WMAPETIFDRVYTIQSDVW 234
Query: 883 ALGILLYEML-YGYTPFRGKT 902
+ G+LL+E+ G +P+ G
Sbjct: 235 SFGVLLWEIFSLGASPYPGVK 255
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 57/263 (21%), Positives = 101/263 (38%), Gaps = 56/263 (21%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDML------ 726
KPLG G G V + E G + +A+ V ML + E+++ D++
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-----ATEKDLSDLVSEMEMM 94
Query: 727 ----DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----- 775
H + L + + +I +Y G L +L R P D R
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 776 -------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828
++ +EYL Q I+RDL NVL+ N + + DF L+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA--------RD 206
Query: 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888
+ + K+ G+ P++ ++APE + +T D W+ G+L+
Sbjct: 207 INNIDYYKKTTNGR-------LPVK----------WMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 889 YEML-YGYTPFRGKTRQKTFANI 910
+E+ G +P+ G ++ F +
Sbjct: 250 WEIFTLGGSPYPGIPVEELFKLL 272
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 3e-08
Identities = 49/226 (21%), Positives = 86/226 (38%), Gaps = 42/226 (18%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA-CAEREILDMLDHPFVPALY 735
+G G G V+ + + A+K + V + ++ + E +++ H + L
Sbjct: 39 MGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 736 ASFQTKTHVCLITDYCPGGEL-FLLLDRQPTKVLKED-AVRFY----AAEVVVALEYLHC 789
+CL+ Y P G L L T L +R AA + +LH
Sbjct: 97 GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL--SWHMRCKIAQGAAN---GINFLHE 151
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
I+RD+K N+LL ++DF L+ + Q +
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLA-----R---ASEK---------FAQTVM--- 191
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYG 894
++ VGT Y+APE + G T D ++ G++L E++ G
Sbjct: 192 -----TSRIVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITG 230
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 51/256 (19%), Positives = 93/256 (36%), Gaps = 47/256 (18%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 727
I+ LG G G V+ ++ G A+K + + E I+ +
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM---EALIISKFN 91
Query: 728 HPFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDR----QPTKVLKEDAVRFYAAEV 780
H + S Q+ ++ + GG+L FL R QP+ + D + A ++
Sbjct: 92 HQNIVRCIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV-ARDI 149
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
+YL I+RD+ N LL G + DF ++ + + ++
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA--------RDIYRASYYRK 201
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 896
P++ ++ PE TS D W+ G+LL+E+ GY
Sbjct: 202 GGCAML-------PVK----------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244
Query: 897 PFRGKTRQKTFANILH 912
P+ K+ Q+ +
Sbjct: 245 PYPSKSNQEVLEFVTS 260
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} Length = 114 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-08
Identities = 14/88 (15%), Positives = 29/88 (32%), Gaps = 1/88 (1%)
Query: 498 IFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSG 557
+ S + E +ILG + + PE R + + + G
Sbjct: 26 LAVSRRWREDYGLGDGDILGMSHYDI-FPEIGEEWKSVHRRGLAGEVIRVEEDCFVRADG 84
Query: 558 KKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
+ W + ++P + +G V + D
Sbjct: 85 RTQWLRWEVRPWYEGEGRVGGVVIFTED 112
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} Length = 114 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 7e-05
Identities = 13/93 (13%), Positives = 27/93 (29%), Gaps = 17/93 (18%)
Query: 215 MYASAGFFKMTGYTSKEVVGRNCRFLQGAGTD----PEDVAKIRET----LQNGQSYCGR 266
+ S + + G +++G + PE + + L
Sbjct: 26 LAVSRRWREDYGLGDGDILGM---------SHYDIFPEIGEEWKSVHRRGLAGEVIRVEE 76
Query: 267 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGM 299
+ DG W + P + EG+V +
Sbjct: 77 DCFVRADGRTQWLRWEVRPWYEGEGRVGGVVIF 109
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 57/263 (21%), Positives = 101/263 (38%), Gaps = 56/263 (21%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDML------ 726
KPLG G G V + E G + +A+ V ML + E+++ D++
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-----ATEKDLSDLVSEMEMM 140
Query: 727 ----DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----- 775
H + L + + +I +Y G L +L R P D R
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 776 -------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828
++ +EYL Q I+RDL NVL+ N + + DF L+
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA--------RD 252
Query: 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888
+ + K+ G+ P++ ++APE + +T D W+ G+L+
Sbjct: 253 INNIDYYKKTTNGR-------LPVK----------WMAPEALFDRVYTHQSDVWSFGVLM 295
Query: 889 YEML-YGYTPFRGKTRQKTFANI 910
+E+ G +P+ G ++ F +
Sbjct: 296 WEIFTLGGSPYPGIPVEELFKLL 318
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 49/253 (19%), Positives = 89/253 (35%), Gaps = 45/253 (17%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 727
I+ LG G G V+ ++ G A+K + + E I+ +
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM---EALIISKFN 132
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDR----QPTKVLKEDAVRFYAAEVV 781
H + ++ + GG+L FL R QP+ + D + A ++
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV-ARDIA 191
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+YL I+RD+ N LL G + DF ++ + ++
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA--------RDIYRAGYYRKG 243
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTP 897
P++ ++ PE TS D W+ G+LL+E+ GY P
Sbjct: 244 GCAML-------PVK----------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
Query: 898 FRGKTRQKTFANI 910
+ K+ Q+ +
Sbjct: 287 YPSKSNQEVLEFV 299
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 55/256 (21%), Positives = 92/256 (35%), Gaps = 58/256 (22%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDML------ 726
KPLG G G V L E G + + V ML + E+++ D++
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----ATEKDLSDLISEMEMM 128
Query: 727 ----DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----- 775
H + L + + +I +Y G L +L R P +
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 776 -------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828
A +V +EYL + I+RDL NVL+ + + + DF L+
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH------ 242
Query: 829 LPTTNEKKRRHKGQQNPV-FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 887
+ ++ + PV +M APE + +T D W+ G+L
Sbjct: 243 ---HIDYYKKTTNGRLPVKWM-----------------APEALFDRIYTHQSDVWSFGVL 282
Query: 888 LYEML-YGYTPFRGKT 902
L+E+ G +P+ G
Sbjct: 283 LWEIFTLGGSPYPGVP 298
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} Length = 115 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-07
Identities = 20/81 (24%), Positives = 37/81 (45%), Gaps = 2/81 (2%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
I YA+ + ++K +V ++ Q D+A + + LQ+GQS + + D
Sbjct: 29 IRYANPAAELLFSQSAKRIVEQSLS--QLIQHASLDLALLTQPLQSGQSITDSDVTFVVD 86
Query: 274 GTPFWNLLTIAPIKDDEGKVL 294
G P +T++PI +L
Sbjct: 87 GRPLMLEVTVSPITWQRQLML 107
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} Length = 115 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-05
Identities = 14/92 (15%), Positives = 35/92 (38%), Gaps = 7/92 (7%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNC-RFLQGPETDPATVRKIRAAIDNQT 544
+I D I +A+ + L S + I+ ++ + +Q D A + + +
Sbjct: 21 LILDD---GLAIRYANPAAELLFSQSAKRIVEQSLSQLIQHASLDLAL---LTQPLQSGQ 74
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEV 576
+T + + G+ + P+ Q+ +
Sbjct: 75 SITDSDVTFVVDGRPLMLEVTVSPITWQRQLM 106
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} Length = 117 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 1e-07
Identities = 13/93 (13%), Positives = 28/93 (30%), Gaps = 12/93 (12%)
Query: 210 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ---NGQSYCGR 266
+ + + GYT E + + L + D +L G+
Sbjct: 29 AEGHYLDVNPAICSAIGYTRDEFLALDWGVL----SRGVDSGWAAASLARIVGGEPLREE 84
Query: 267 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGM 299
+ ++G L+ + D K +G+
Sbjct: 85 RTVWTRNGDQLTVELSAHLLPDG-----KILGI 112
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} Length = 117 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 3e-07
Identities = 10/86 (11%), Positives = 28/86 (32%), Gaps = 6/86 (6%)
Query: 497 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKS 556
+ + + Y+R+E L + L + + + + + +T++
Sbjct: 33 YLDVNPAICSAIGYTRDEFLALDWGVLSRGVDSGWAAASLARIVGGEP-LREERTVWTRN 91
Query: 557 GKKFWNLFHLQPMRDQKGEVQYFIGV 582
G + + D K +G+
Sbjct: 92 GDQLTVELSAHLLPDGK-----ILGI 112
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 53/266 (19%), Positives = 93/266 (34%), Gaps = 57/266 (21%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 727
++ +G G G V G Y A+K + + + + R E ++ D
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---EAALMAEFD 108
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFY--------- 776
+P + L +CL+ +Y G+L FL T +
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 777 -----------AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825
A +V + YL + ++RDL N L+ N V + DF LS
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------- 221
Query: 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 885
+ + + K P+R ++ PE I +T+ D WA G
Sbjct: 222 -RNIYSADYYKADGNDAI-------PIR----------WMPPESIFYNRYTTESDVWAYG 263
Query: 886 ILLYEML-YGYTPFRGKTRQKTFANI 910
++L+E+ YG P+ G ++ +
Sbjct: 264 VVLWEIFSYGLQPYYGMAHEEVIYYV 289
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} Length = 111 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-07
Identities = 19/99 (19%), Positives = 35/99 (35%), Gaps = 9/99 (9%)
Query: 210 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG---R 266
+ I+Y SA GY E++G + ED + N R
Sbjct: 17 SNGRIIYISANSKLHLGYLQGEMIGSFLKTF----LHEEDQFLVESYFYNEHHLMPCTFR 72
Query: 267 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 305
+ KKD T W + + + + I ++++V +
Sbjct: 73 FI--KKDHTIVWVEAAVEIVTTRAERTEREIILKMKVLE 109
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} Length = 111 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 15/96 (15%), Positives = 32/96 (33%), Gaps = 3/96 (3%)
Query: 493 PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552
+ II+ S + Y + E++G + E D V + T + I
Sbjct: 17 SNGRIIYISANSKLHLGYLQGEMIGSFLKTFLHEE-DQFLVESYFYNEHHLMPCTFRFI- 74
Query: 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
K W ++ + + + I +++ E
Sbjct: 75 -KKDHTIVWVEAAVEIVTTRAERTEREIILKMKVLE 109
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} Length = 126 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 5e-07
Identities = 15/98 (15%), Positives = 26/98 (26%), Gaps = 6/98 (6%)
Query: 485 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 544
+ D D I + F Y E+LGR+ D V+ +
Sbjct: 30 IDVLDA---DGTICEVNQRFCAELGYDESEVLGRSIWEF-DLMFDAEDVQTQLSGFSVDE 85
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 582
+ + + G HL F+ +
Sbjct: 86 RRKFEGLYERRDGSTMSVEVHLLRFNL--EGEDRFLAI 121
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} Length = 126 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 7e-07
Identities = 15/81 (18%), Positives = 25/81 (30%), Gaps = 1/81 (1%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
I + F GY EV+GR+ D EDV + L ++D
Sbjct: 39 ICEVNQRFCAELGYDESEVLGRSIWEF-DLMFDAEDVQTQLSGFSVDERRKFEGLYERRD 97
Query: 274 GTPFWNLLTIAPIKDDEGKVL 294
G+ + + +
Sbjct: 98 GSTMSVEVHLLRFNLEGEDRF 118
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 44/202 (21%), Positives = 74/202 (36%), Gaps = 45/202 (22%)
Query: 718 AEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 774
+E ++L L +H + L + +IT+YC G+L FL R K
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 775 F--------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820
++ +V + +L + I+RDL N+LL + DF L+
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA-- 192
Query: 821 TSCKPQLLLPTTNEKKRRHKGQQNPV-FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 879
+ + + + PV +M APE I +T
Sbjct: 193 ------RDIKNDSNYVVKGNA-RLPVKWM-----------------APESIFNCVYTFES 228
Query: 880 DWWALGILLYEML-YGYTPFRG 900
D W+ GI L+E+ G +P+ G
Sbjct: 229 DVWSYGIFLWELFSLGSSPYPG 250
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 39/219 (17%), Positives = 78/219 (35%), Gaps = 30/219 (13%)
Query: 687 LVELCGSG--QYFAMKAMDKGVMLNRNKVHRACAER--EILDMLDHPFVPALYASFQTKT 742
+VE C G + ++ V + + + + ++ +S + +
Sbjct: 105 IVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS 164
Query: 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802
+ E + L + + Y+ +V +E+L + I+RDL N+
Sbjct: 165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 224
Query: 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 862
LL V + DF L+ + R + P+
Sbjct: 225 LLSEKNVVKICDFGLARDI---------YKDPDYVRKGDARLPL---------------- 259
Query: 863 EYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRG 900
+++APE I +T D W+ G+LL+E+ G +P+ G
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} Length = 126 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 4e-06
Identities = 12/98 (12%), Positives = 32/98 (32%), Gaps = 6/98 (6%)
Query: 485 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 544
+I + + +++A+ + + Y+ EE++ + + A KI A +
Sbjct: 12 ILIINR---EGRLLYANTAVPKKLGYTHEELMSMHILTIT-SAGKMAEGEKILAELFAGK 67
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 582
++ L K G + + +
Sbjct: 68 KESLPLSLEKKEGTSIPAKARIWQGKW--HNEPCLFAI 103
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} Length = 126 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 2e-05
Identities = 19/81 (23%), Positives = 31/81 (38%), Gaps = 1/81 (1%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
++YA+ K GYT +E++ + + + + KI L G+ L KK+
Sbjct: 21 LLYANTAVPKKLGYTHEELMSMHILTIT-SAGKMAEGEKILAELFAGKKESLPLSLEKKE 79
Query: 274 GTPFWNLLTIAPIKDDEGKVL 294
GT I K L
Sbjct: 80 GTSIPAKARIWQGKWHNEPCL 100
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 46/198 (23%), Positives = 76/198 (38%), Gaps = 43/198 (21%)
Query: 719 EREILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLK------ 769
E +I+ L H + L + V +IT+YC G+L FL + +
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 770 -----EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824
D + F +++V + +L + I+RD+ NVLL + DF L+
Sbjct: 159 STASTRDLLHF-SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA------ 211
Query: 825 PQLLLPTTNEKKRRHKGQQNPV-FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 883
+ + + + PV +M APE I +T D W+
Sbjct: 212 --RDIMNDSNYIVKGNARL-PVKWM-----------------APESIFDCVYTVQSDVWS 251
Query: 884 LGILLYEML-YGYTPFRG 900
GILL+E+ G P+ G
Sbjct: 252 YGILLWEIFSLGLNPYPG 269
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-06
Identities = 56/241 (23%), Positives = 85/241 (35%), Gaps = 50/241 (20%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA----CAEREILDML 726
F LG G G V+ L G A+K L + E E++ M
Sbjct: 32 FSNKNILGRGGFGKVYKGRL-ADGTLVAVK------RLKEERTQGGELQFQTEVEMISMA 84
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGEL-FLLLDRQPTKVLKEDAVRFY----AAEVV 781
H + L T T L+ Y G + L +R ++ + R +A
Sbjct: 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR-- 142
Query: 782 VALEYLHCQG---IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
L YLH II+RD+K N+LL + DF L+ K L+ +
Sbjct: 143 -GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-----K---LMDYKDT---- 189
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP 897
H + + GT +IAPE G + D + G++L E++ G
Sbjct: 190 H--------------VTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRA 234
Query: 898 F 898
F
Sbjct: 235 F 235
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 17/35 (48%), Positives = 23/35 (65%)
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818
L YLH + II+RD+K N+LL N +TDF +S
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} Length = 118 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 1e-05
Identities = 18/98 (18%), Positives = 37/98 (37%), Gaps = 10/98 (10%)
Query: 485 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 544
+ ++ +D+ +TEYSRE++L N + + D I +
Sbjct: 26 SFCLGD---NWQFLYVNDATCRMTEYSREQLLSMNLQDI-----DVDFALHDWEEIRQKN 77
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 582
+ T + ++SG+ F L + DQ+ +
Sbjct: 78 NYTFKTRYRSQSGRIFLVEMSLTFLEDQERR--FSCVF 113
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} Length = 118 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 12/81 (14%), Positives = 34/81 (41%), Gaps = 5/81 (6%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
+Y + +MT Y+ ++++ N + + D + E ++ +Y + +
Sbjct: 35 FLYVNDATCRMTEYSREQLLSMNLQDI-----DVDFALHDWEEIRQKNNYTFKTRYRSQS 89
Query: 274 GTPFWNLLTIAPIKDDEGKVL 294
G F +++ ++D E +
Sbjct: 90 GRIFLVEMSLTFLEDQERRFS 110
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-05
Identities = 12/86 (13%), Positives = 30/86 (34%), Gaps = 6/86 (6%)
Query: 497 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKS 556
I+ + S + ++G+ + E + ++A++N T +
Sbjct: 41 ILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLEAGKSAVENGTATRSE---DAVG 97
Query: 557 GKKFWNLFHLQPMRDQKGEVQYFIGV 582
G+ + N + P+ + F V
Sbjct: 98 GRHYHNQYI--PVDSH-RKSDTFQLV 120
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 12/86 (13%), Positives = 27/86 (31%), Gaps = 6/86 (6%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
I+ + G +VG+ + + + + + ++NG +
Sbjct: 41 ILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLEAGKSAVENGTA---TRSEDAVG 97
Query: 274 GTPFWNLLTIAPIKDDEGKVLKFIGM 299
G + N P+ D K F +
Sbjct: 98 GRHYHN--QYIPV-DSHRKSDTFQLV 120
|
| >3eeh_A Putative light and redox sensing histidine kinase; structural genomic MCSG, protein structure initiative, midwest center for STRU genomics; HET: PG5; 1.95A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 2e-05
Identities = 18/90 (20%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ---NGQSYCG--RLL 268
++ ++ + + G + ++ FL G PED +++T+Q +G+S R+
Sbjct: 34 VLVINSAYEDIWGRSVAKLRENPHDFLNG--IHPEDRELMKDTMQSLMDGESADVECRVN 91
Query: 269 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIG 298
+ W + PI +D G+ ++ G
Sbjct: 92 A--TEEYQRWVWIQGEPITNDAGETVRVAG 119
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} Length = 118 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 16/99 (16%), Positives = 28/99 (28%), Gaps = 12/99 (12%)
Query: 493 PDNPIIFASDSFLELTEYSREEILGRNCRFLQG--PETDPATVRK-IRAAIDNQTDVTVQ 549
I F +FL+ E L + D + + + +T+
Sbjct: 24 GQATIRFRPPAFLKT--LVSEHAGTTRLNTLSMIHHD-DRHMLSNAYSKLREAKHSLTLV 80
Query: 550 LINY---TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
Y T GK W H++ G G+ +
Sbjct: 81 ---YRIVTPEGKLHWIEDHMRSSFSDDGLFSGIDGILCE 116
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} Length = 118 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 12/95 (12%), Positives = 21/95 (22%), Gaps = 12/95 (12%)
Query: 210 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ----NGQSYCG 265
I + F K N + +D + S
Sbjct: 24 GQATIRFRPPAFLKTLVSEHAGTTRLNTL----SMIHHDDRHMLSNAYSKLREAKHSLTL 79
Query: 266 --RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIG 298
R++ +G W + D+G G
Sbjct: 80 VYRIVT--PEGKLHWIEDHMRSSFSDDGLFSGIDG 112
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 42/205 (20%), Positives = 78/205 (38%), Gaps = 48/205 (23%)
Query: 719 EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF 775
E +++ L H + L + + LI +YC G+L +L R+ + +
Sbjct: 98 ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 776 -------------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 816
+A +V +E+L + ++RDL NVL+ V + DF
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT 876
L+ + + + R + P++ ++APE + +T
Sbjct: 218 LA--------RDIMSDSNYVVRGNAR-------LPVK----------WMAPESLFEGIYT 252
Query: 877 SAVDWWALGILLYEML-YGYTPFRG 900
D W+ GILL+E+ G P+ G
Sbjct: 253 IKSDVWSYGILLWEIFSLGVNPYPG 277
|
| >3kx0_X Uncharacterized protein RV1364C/MT1410; PAS domain, sensory domain, mycobacteium tuberculos molecule binding domain; 2.30A {Mycobacterium tuberculosis} Length = 185 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 12/125 (9%), Positives = 40/125 (32%), Gaps = 9/125 (7%)
Query: 497 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDN-----QTDVTVQLI 551
+ + ++ + + +G+ R + + ++ +Q
Sbjct: 60 FVAVNAAYRGFSP--LLDTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQSGSEWRLQTD 117
Query: 552 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQ 611
++ + F + P R G ++ + D + + + + EA EE + +
Sbjct: 118 YDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRARQAA--EARVEELSERYRN 175
Query: 612 TAENV 616
++
Sbjct: 176 VRDSA 180
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 934 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.98 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 4f3l_A | 361 | Mclock, circadian locomoter output cycles protein | 99.8 | |
| 4f3l_B | 387 | BMAL1B; BHLH, PAS, circadian rhythm proteins, tran | 99.79 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 99.74 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 99.74 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 99.74 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 99.74 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 99.72 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 99.71 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 99.7 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 99.7 | |
| 4hia_A | 176 | LOV protein; PAS, HTH, signaling protein; HET: FMN | 99.69 | |
| 4hia_A | 176 | LOV protein; PAS, HTH, signaling protein; HET: FMN | 99.69 | |
| 3rty_A | 339 | Period circadian protein; PAS domain, signalling, | 99.68 | |
| 3mr0_A | 142 | Sensory box histidine kinase/response regulator; P | 99.68 | |
| 3f1p_B | 121 | ARYL hydrocarbon receptor nuclear translocator; PA | 99.67 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 99.67 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 99.65 | |
| 3f1p_B | 121 | ARYL hydrocarbon receptor nuclear translocator; PA | 99.65 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 99.65 | |
| 3f1p_A | 117 | Endothelial PAS domain-containing protein 1; PAS d | 99.64 | |
| 3mr0_A | 142 | Sensory box histidine kinase/response regulator; P | 99.64 | |
| 1d06_A | 130 | Nitrogen fixation regulatory protein FIXL; oxygen | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 99.62 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 99.62 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 99.62 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 99.61 | |
| 1d06_A | 130 | Nitrogen fixation regulatory protein FIXL; oxygen | 99.61 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 99.61 | |
| 3nja_A | 125 | Probable ggdef family protein; structural genomics | 99.6 | |
| 3f1p_A | 117 | Endothelial PAS domain-containing protein 1; PAS d | 99.6 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 99.6 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 99.59 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 99.59 | |
| 2vv6_A | 119 | FIXL, sensor protein FIXL; signaling protein, tran | 99.58 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 99.58 | |
| 3nja_A | 125 | Probable ggdef family protein; structural genomics | 99.58 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 99.58 | |
| 3k3c_A | 158 | Protein RV1364C/MT1410; sensor, PAS, signal transd | 99.58 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 99.56 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 99.56 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 99.55 | |
| 2vv6_A | 119 | FIXL, sensor protein FIXL; signaling protein, tran | 99.55 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 99.54 | |
| 3mxq_A | 152 | Sensor protein; PSI2, MCSG, structural genomics, p | 99.54 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 99.54 | |
| 3h9w_A | 115 | Diguanylate cyclase with PAS/PAC sensor; alpha-bet | 99.54 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 99.53 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 99.53 | |
| 3k3c_A | 158 | Protein RV1364C/MT1410; sensor, PAS, signal transd | 99.52 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 99.51 | |
| 3h9w_A | 115 | Diguanylate cyclase with PAS/PAC sensor; alpha-bet | 99.51 | |
| 3kx0_X | 185 | Uncharacterized protein RV1364C/MT1410; PAS domain | 99.51 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 99.51 | |
| 3mxq_A | 152 | Sensor protein; PSI2, MCSG, structural genomics, p | 99.5 | |
| 3eeh_A | 125 | Putative light and redox sensing histidine kinase; | 99.5 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 99.49 | |
| 4dj3_A | 317 | Period circadian protein homolog 3; PAS domain, ci | 99.49 | |
| 3kx0_X | 185 | Uncharacterized protein RV1364C/MT1410; PAS domain | 99.48 | |
| 2kdk_A | 121 | ARYL hydrocarbon receptor nuclear translocator-LI | 99.48 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 99.46 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 99.46 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 99.46 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 99.46 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 99.45 | |
| 2kdk_A | 121 | ARYL hydrocarbon receptor nuclear translocator-LI | 99.44 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 99.44 | |
| 3eeh_A | 125 | Putative light and redox sensing histidine kinase; | 99.44 | |
| 1v9y_A | 167 | Heme PAS sensor protein; signaling protein; HET: H | 99.43 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 99.41 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 99.4 | |
| 4dj2_A | 320 | Period circadian protein homolog 1; PAS domains, c | 99.4 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 99.4 | |
| 3gdi_A | 309 | Period circadian protein homolog 2; tandem PAS dom | 99.39 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 99.39 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 99.39 | |
| 1v9y_A | 167 | Heme PAS sensor protein; signaling protein; HET: H | 99.37 | |
| 4eho_A | 635 | Bacteriophytochrome, PAS/PAC sensor; photoreceptor | 99.37 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 99.36 | |
| 3mfx_A | 129 | Sensory BOX/ggdef family protein; alpha-beta prote | 99.35 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 99.35 | |
| 3vol_A | 233 | Aerotaxis transducer AER2; heme, oxygen sensor pro | 99.32 | |
| 3mfx_A | 129 | Sensory BOX/ggdef family protein; alpha-beta prote | 99.31 | |
| 4eho_A | 635 | Bacteriophytochrome, PAS/PAC sensor; photoreceptor | 99.3 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 99.24 | |
| 4hi4_A | 121 | Aerotaxis transducer AER2; PAS domain, diatomic GA | 99.23 | |
| 2qkp_A | 151 | Uncharacterized protein; structural genomics, unkn | 99.22 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 99.2 | |
| 4f3l_A | 361 | Mclock, circadian locomoter output cycles protein | 99.2 | |
| 3vol_A | 233 | Aerotaxis transducer AER2; heme, oxygen sensor pro | 99.19 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 99.18 | |
| 4hi4_A | 121 | Aerotaxis transducer AER2; PAS domain, diatomic GA | 99.16 | |
| 3fg8_A | 118 | Uncharacterized protein RHA05790; PAS domain, stru | 99.16 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 99.16 | |
| 3fg8_A | 118 | Uncharacterized protein RHA05790; PAS domain, stru | 99.16 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 99.15 | |
| 2qkp_A | 151 | Uncharacterized protein; structural genomics, unkn | 99.12 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 99.11 | |
| 4f3l_B | 387 | BMAL1B; BHLH, PAS, circadian rhythm proteins, tran | 99.11 | |
| 1ll8_A | 114 | PAS kinase; PAS domain, ligand binding, ligand scr | 99.05 | |
| 1ll8_A | 114 | PAS kinase; PAS domain, ligand binding, ligand scr | 99.03 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.03 | |
| 3a0r_A | 349 | Sensor protein; four helix bundle, PAS fold, kinas | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 2w0n_A | 118 | Sensor protein DCUS; signal transduction, two-comp | 98.96 | |
| 3cax_A | 369 | Uncharacterized protein PF0695; structural genomic | 98.96 | |
| 2ykf_A | 305 | Pdtas, probable sensor histidine kinase pdtas; tra | 98.47 | |
| 3a0r_A | 349 | Sensor protein; four helix bundle, PAS fold, kinas | 98.92 | |
| 3a0s_A | 96 | Sensor protein; PAS-fold, kinase, phosphoprotein, | 98.91 | |
| 3a0s_A | 96 | Sensor protein; PAS-fold, kinase, phosphoprotein, | 98.86 | |
| 3cax_A | 369 | Uncharacterized protein PF0695; structural genomic | 98.86 | |
| 1nwz_A | 125 | PYP, photoactive yellow protein; PAS, LOV, GAF, do | 98.84 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 2w0n_A | 118 | Sensor protein DCUS; signal transduction, two-comp | 98.83 | |
| 1mzu_A | 129 | PPR; photoactive yellow protein, PAS, PYP, signali | 98.82 | |
| 3rty_A | 339 | Period circadian protein; PAS domain, signalling, | 98.77 | |
| 2jhe_A | 190 | Transcription regulator TYRR; aromatic hydrocarbon | 98.77 | |
| 2ykf_A | 305 | Pdtas, probable sensor histidine kinase pdtas; tra | 98.25 | |
| 1nwz_A | 125 | PYP, photoactive yellow protein; PAS, LOV, GAF, do | 98.76 | |
| 1mzu_A | 129 | PPR; photoactive yellow protein, PAS, PYP, signali | 98.73 | |
| 2jhe_A | 190 | Transcription regulator TYRR; aromatic hydrocarbon | 98.71 | |
| 4dj3_A | 317 | Period circadian protein homolog 3; PAS domain, ci | 98.63 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.61 | |
| 3gdi_A | 309 | Period circadian protein homolog 2; tandem PAS dom | 98.56 | |
| 4dj2_A | 320 | Period circadian protein homolog 1; PAS domains, c | 98.52 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.38 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.01 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.97 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.92 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.85 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.55 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.23 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.2 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.18 | |
| 1oj5_A | 132 | Steroid receptor coactivator 1A; transcriptional c | 97.17 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.16 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.1 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.88 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.84 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.78 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.78 | |
| 1oj5_A | 132 | Steroid receptor coactivator 1A; transcriptional c | 96.77 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.66 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.62 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.55 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.75 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.7 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.28 | |
| 2ool_A | 337 | Sensor protein; bacteriophytochrome, photoconversi | 84.33 | |
| 2ool_A | 337 | Sensor protein; bacteriophytochrome, photoconversi | 82.35 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.8 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=447.30 Aligned_cols=234 Identities=36% Similarity=0.627 Sum_probs=211.2
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+++|+.|+|||||+++++|++++++|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999999999999999999876554555667899999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||||+||+|.+++.+. +.+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 111 mEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~-- 186 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-- 186 (311)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT--
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC--
Confidence 9999999999999875 459999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
......++|||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+++
T Consensus 187 -----------------------~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~ 243 (311)
T 4aw0_A 187 -----------------------KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF 243 (311)
T ss_dssp -----------------------TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred -----------------------CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 112345779999999999999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCCCCcccCCC
Q 002342 908 ANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 908 ~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
.+|.++.+.+|.. .|.+++||
T Consensus 244 ~~i~~~~~~~p~~--~s~~~~dl 264 (311)
T 4aw0_A 244 AKIIKLEYDFPEK--FFPKARDL 264 (311)
T ss_dssp HHHHHTCCCCCTT--CCHHHHHH
T ss_pred HHHHcCCCCCCcc--cCHHHHHH
Confidence 9999999999975 46666665
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=443.79 Aligned_cols=234 Identities=24% Similarity=0.457 Sum_probs=200.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
+++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.|+|||||+++++|.+++.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 5799999999999999999999999999999999987643 344567889999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||||+||+|.+++..+....+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~---- 177 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS---- 177 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH----
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC----
Confidence 9999999999999876666789999999999999999999999999999999999999999999999999965321
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
......+.+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+++
T Consensus 178 -----------------------~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 234 (350)
T 4b9d_A 178 -----------------------TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV 234 (350)
T ss_dssp -----------------------HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred -----------------------CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 011234568999999999999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCCCCcccCCC
Q 002342 908 ANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 908 ~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
.+|.++.++. .+...|.++++|
T Consensus 235 ~~i~~~~~~~-~~~~~s~~~~~l 256 (350)
T 4b9d_A 235 LKIISGSFPP-VSLHYSYDLRSL 256 (350)
T ss_dssp HHHHHTCCCC-CCTTSCHHHHHH
T ss_pred HHHHcCCCCC-CCccCCHHHHHH
Confidence 9999987642 223345555554
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=421.34 Aligned_cols=230 Identities=31% Similarity=0.515 Sum_probs=191.1
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 36899999999999999999999999999999999887655556667899999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||| +|+|.+++..+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---- 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---- 164 (275)
T ss_dssp EECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC----
Confidence 9999 78999999775 4599999999999999999999999999999999999999999999999999954321
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
.....+.+||+.|||||++.+..| +.++|||||||+||+|++|++||.+.+...+
T Consensus 165 ------------------------~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~ 220 (275)
T 3hyh_A 165 ------------------------GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL 220 (275)
T ss_dssp ----------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ------------------------CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 112345689999999999998876 5799999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCCCcccCCC
Q 002342 907 FANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 907 ~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
+++|.++.+.+|... |.++++|
T Consensus 221 ~~~i~~~~~~~p~~~--s~~~~~l 242 (275)
T 3hyh_A 221 FKNISNGVYTLPKFL--SPGAAGL 242 (275)
T ss_dssp HHHHHHTCCCCCTTS--CHHHHHH
T ss_pred HHHHHcCCCCCCCCC--CHHHHHH
Confidence 999999999998764 5555554
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=432.49 Aligned_cols=229 Identities=27% Similarity=0.416 Sum_probs=201.3
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
..|+++++||+|+||+||+|+++.+|+.||||++.+.... ..+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999999765332 2345788999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
|||+||+|.+++... .+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 151 Ey~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~----- 222 (346)
T 4fih_A 151 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK----- 222 (346)
T ss_dssp CCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-----
T ss_pred eCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC-----
Confidence 999999999999763 499999999999999999999999999999999999999999999999999965321
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
......+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++.
T Consensus 223 ----------------------~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~ 280 (346)
T 4fih_A 223 ----------------------EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK 280 (346)
T ss_dssp ----------------------SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred ----------------------CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence 1123456799999999999999999999999999999999999999999999999999
Q ss_pred HHHcCCC-CCCCCCCCCcccCCC
Q 002342 909 NILHKDL-KFPSSTPSSCKAANV 930 (934)
Q Consensus 909 ~i~~~~~-~~p~~~~~s~~~k~l 930 (934)
.|..+.. .++.+...|.+++||
T Consensus 281 ~i~~~~~~~~~~~~~~s~~~~dl 303 (346)
T 4fih_A 281 MIRDNLPPRLKNLHKVSPSLKGF 303 (346)
T ss_dssp HHHHSSCCCCSCGGGSCHHHHHH
T ss_pred HHHcCCCCCCCccccCCHHHHHH
Confidence 9987643 344444556666655
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=430.19 Aligned_cols=233 Identities=42% Similarity=0.734 Sum_probs=198.9
Q ss_pred cccCCcccccccccCCcEEEEEEEEe---cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
.+.++|++++.||+|+||+||+|++. .+++.||||++.+....... ...+.+|+.+|++++|||||+++++|.+++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETT
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 34568999999999999999999984 46889999999875433222 235778999999999999999999999999
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
.+|||||||+||+|.+++.+. +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999999999875 459999999999999999999999999999999999999999999999999996432
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
. ......+.+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+
T Consensus 178 ~---------------------------~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 178 D---------------------------HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp ------------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C---------------------------CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 1 1123346789999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 903 RQKTFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 903 ~~~~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
..+++.+|.++.+.+|... |.+++||
T Consensus 231 ~~~~~~~i~~~~~~~p~~~--s~~~~~l 256 (304)
T 3ubd_A 231 RKETMTMILKAKLGMPQFL--SPEAQSL 256 (304)
T ss_dssp HHHHHHHHHHCCCCCCTTS--CHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCcC--CHHHHHH
Confidence 9999999999999998753 5555554
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=434.56 Aligned_cols=229 Identities=27% Similarity=0.416 Sum_probs=201.9
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
+.|++++.||+|+||.||+|+++.+|+.||||++.+.... ..+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999999865332 2345789999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
|||+||+|.+++... .+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 228 Ey~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~----- 299 (423)
T 4fie_A 228 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK----- 299 (423)
T ss_dssp ECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS-----
T ss_pred eCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC-----
Confidence 999999999999753 499999999999999999999999999999999999999999999999999965321
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
......+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++.
T Consensus 300 ----------------------~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~ 357 (423)
T 4fie_A 300 ----------------------EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK 357 (423)
T ss_dssp ----------------------SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred ----------------------CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence 1123456799999999999999999999999999999999999999999999999999
Q ss_pred HHHcCCC-CCCCCCCCCcccCCC
Q 002342 909 NILHKDL-KFPSSTPSSCKAANV 930 (934)
Q Consensus 909 ~i~~~~~-~~p~~~~~s~~~k~l 930 (934)
.|..+.. .++.+...|..++||
T Consensus 358 ~i~~~~~~~~~~~~~~s~~~~dl 380 (423)
T 4fie_A 358 MIRDNLPPRLKNLHKVSPSLKGF 380 (423)
T ss_dssp HHHHSCCCCCSCTTSSCHHHHHH
T ss_pred HHHcCCCCCCcccccCCHHHHHH
Confidence 9987643 444445566666665
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=422.40 Aligned_cols=220 Identities=25% Similarity=0.382 Sum_probs=191.4
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
..+.|++.++||+|+||.||+|+++.+|+.||||++++... ..+|+.+|+.++|||||+++++|.+++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35679999999999999999999999999999999986532 2469999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-cEEEEecccCcccCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-~vkl~DFG~a~~~~~~~ 825 (934)
|||||+||+|.++++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+......
T Consensus 128 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp EECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999999999875 4599999999999999999999999999999999999999887 69999999997643211
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
. .........++||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+
T Consensus 206 ~----------------------~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 263 (336)
T 4g3f_A 206 L----------------------GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263 (336)
T ss_dssp ------------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC
T ss_pred c----------------------ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 0 001122345789999999999999999999999999999999999999999999888
Q ss_pred HHHHHHcCCCCCC
Q 002342 906 TFANILHKDLKFP 918 (934)
Q Consensus 906 ~~~~i~~~~~~~p 918 (934)
++.+|..+..+++
T Consensus 264 ~~~~i~~~~~~~~ 276 (336)
T 4g3f_A 264 LCLKIASEPPPIR 276 (336)
T ss_dssp CHHHHHHSCCGGG
T ss_pred HHHHHHcCCCCch
Confidence 9999998876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=403.62 Aligned_cols=227 Identities=23% Similarity=0.370 Sum_probs=189.1
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe----CCeEEE
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----KTHVCL 746 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~~l 746 (934)
|++.+.||+|+||+||+|.++.++..||+|.+.+... .......+.+|+.+|+.|+|||||+++++|.+ +.++||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 4778889999999999999999999999999986533 44556788999999999999999999999975 457899
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEec-CCcEEEEecccCcccCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~-~~~vkl~DFG~a~~~~~ 823 (934)
|||||+||+|.+++.+. +.+++..++.|+.||+.||+|||++| ||||||||+||||+. +|.+||+|||+|+...
T Consensus 107 vmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~- 183 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 183 (290)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred EEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC-
Confidence 99999999999999874 45999999999999999999999998 999999999999985 7999999999995421
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
.....+.+||+.|||||++.+ .|+.++|||||||+||+|++|++||.+.+.
T Consensus 184 ----------------------------~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~ 234 (290)
T 3fpq_A 184 ----------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN 234 (290)
T ss_dssp ----------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred ----------------------------CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence 112346789999999999875 599999999999999999999999987554
Q ss_pred -HHHHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 904 -QKTFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 904 -~~~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
..+++.+..+..+.+.+...++++++|
T Consensus 235 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l 262 (290)
T 3fpq_A 235 AAQIYRRVTSGVKPASFDKVAIPEVKEI 262 (290)
T ss_dssp HHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCCccCCHHHHHH
Confidence 556666666554322222334445443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=402.83 Aligned_cols=228 Identities=22% Similarity=0.349 Sum_probs=195.6
Q ss_pred ccccCCcccccccccCCcEEEEEEEEe-----cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 739 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 739 (934)
.+..++|.+.+.||+|+||+||+|++. .++..||||+++.. .....+.+.+|+++|++++|||||++++++.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 456678999999999999999999875 36889999999754 3455678999999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCchhhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC
Q 002342 740 TKTHVCLITDYCPGGELFLLLDRQP-----------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 808 (934)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~~-----------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~ 808 (934)
+++.+|||||||++|+|.+++.... ...+++..+..++.||+.||.|||+++||||||||+|||++.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 9999999999999999999997532 34699999999999999999999999999999999999999999
Q ss_pred cEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHH
Q 002342 809 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888 (934)
Q Consensus 809 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL 888 (934)
.+||+|||+|+..... .........+||+.|||||++.+..|+.++|||||||+|
T Consensus 166 ~~Ki~DFGla~~~~~~-------------------------~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl 220 (299)
T 4asz_A 166 LVKIGDFGMSRDVYST-------------------------DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 220 (299)
T ss_dssp CEEECCCSCHHHHTGG-------------------------GCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cEEECCcccceecCCC-------------------------CceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHH
Confidence 9999999999643211 011123345799999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCC
Q 002342 889 YEMLY-GYTPFRGKTRQKTFANILHKDL-KFPSS 920 (934)
Q Consensus 889 ~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~ 920 (934)
|||+| |++||.+.+..+++..|.++.. ++|..
T Consensus 221 ~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 254 (299)
T 4asz_A 221 WEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRT 254 (299)
T ss_dssp HHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCTT
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 99998 9999999999999999998764 55544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=396.89 Aligned_cols=226 Identities=21% Similarity=0.314 Sum_probs=187.2
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
.|++..++|++.+.||+|+||+||++++.. .||||+++.. .......+.+.+|+.+|++++|||||++++++.. +
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~-~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVV-DPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCS-SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEec-CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 456788999999999999999999998633 5999998753 2345667889999999999999999999998754 5
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
.+|||||||+||+|.+++.... ..+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+...
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred eEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 6899999999999999997653 459999999999999999999999999999999999999999999999999996532
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC---CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
.. .........+||+.|||||++.+ ..|+.++|||||||+||||++|++||.
T Consensus 184 ~~-------------------------~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~ 238 (307)
T 3omv_A 184 RW-------------------------SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS 238 (307)
T ss_dssp -----------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cC-------------------------CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC
Confidence 11 01122345689999999999964 468999999999999999999999999
Q ss_pred CCCHHHHHHHHHcCCCCCCC
Q 002342 900 GKTRQKTFANILHKDLKFPS 919 (934)
Q Consensus 900 ~~~~~~~~~~i~~~~~~~p~ 919 (934)
+.+....+..++......|.
T Consensus 239 ~~~~~~~~~~~~~~~~~~p~ 258 (307)
T 3omv_A 239 HINNRDQIIFMVGRGYASPD 258 (307)
T ss_dssp TCCCHHHHHHHHHTTCCCCC
T ss_pred CCChHHHHHHHHhcCCCCCC
Confidence 88777666666665554443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=399.28 Aligned_cols=228 Identities=22% Similarity=0.312 Sum_probs=190.9
Q ss_pred ccccCCcccccccccCCcEEEEEEEEe-----cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 739 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 739 (934)
.+..++|.+.++||+|+||+||+|++. .+++.||||+++.. .....+.+.+|+++|++++|||||++++++.
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 355678999999999999999999875 36889999999753 4455678999999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCchhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec
Q 002342 740 TKTHVCLITDYCPGGELFLLLDRQP-------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 806 (934)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~~-------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~ 806 (934)
+.+.+|||||||++|+|.+++.... ...+++..+..|+.||+.||.|||+++||||||||+|||++.
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 9999999999999999999987542 235999999999999999999999999999999999999999
Q ss_pred CCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHH
Q 002342 807 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 886 (934)
Q Consensus 807 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~ 886 (934)
++.+||+|||+|+...... ........+||+.|||||++.+..|+.++|||||||
T Consensus 194 ~~~~Ki~DFGla~~~~~~~-------------------------~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gv 248 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTD-------------------------YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGV 248 (329)
T ss_dssp TTEEEECCCC-----------------------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHH
T ss_pred CCcEEEcccccceeccCCC-------------------------cceecCcccccccccChhhhcCCCCCccccccchHH
Confidence 9999999999996532110 112234568999999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCC
Q 002342 887 LLYEMLY-GYTPFRGKTRQKTFANILHKD-LKFPSS 920 (934)
Q Consensus 887 iL~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~ 920 (934)
+||||+| |++||.+.+..+++..|.++. +.+|..
T Consensus 249 vl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~ 284 (329)
T 4aoj_A 249 VLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA 284 (329)
T ss_dssp HHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCTT
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 9999998 999999999999999998865 455553
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=396.15 Aligned_cols=229 Identities=22% Similarity=0.354 Sum_probs=195.0
Q ss_pred ccccCCcccccccccCCcEEEEEEEEe-----cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 739 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 739 (934)
++....+++.+.||+|+||+||++... .+++.||||.++... .....+.+.+|+.+|++++|||||++++++.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 355678999999999999999999863 467899999997542 3344567899999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCchhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe
Q 002342 740 TKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ 805 (934)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~ 805 (934)
+++.+|||||||++|+|.+++..+. ...+++..+..|+.||+.||+|||+++||||||||+|||++
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 9999999999999999999996532 13589999999999999999999999999999999999999
Q ss_pred cCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHH
Q 002342 806 GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 885 (934)
Q Consensus 806 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG 885 (934)
.++.+||+|||+|+..... .........+||+.|||||++.+..|+.++||||||
T Consensus 180 ~~~~~Ki~DFGlar~~~~~-------------------------~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfG 234 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAA-------------------------DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYG 234 (308)
T ss_dssp GGGCEEECCSCCBCGGGGG-------------------------GCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred CCCCEEECCcccceeccCC-------------------------CceeEecccccCCcccCHHHHhCCCCCccchhhhHH
Confidence 9999999999999653211 111233456899999999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCC
Q 002342 886 ILLYEMLY-GYTPFRGKTRQKTFANILHKDL-KFPSS 920 (934)
Q Consensus 886 ~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~ 920 (934)
|+||||+| |.+||.+.+..+++..|.++.. +.|..
T Consensus 235 vvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 271 (308)
T 4gt4_A 235 VVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDD 271 (308)
T ss_dssp HHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 99999998 9999999999999999988763 44443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=430.30 Aligned_cols=236 Identities=31% Similarity=0.561 Sum_probs=201.9
Q ss_pred cccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHH---HHHHHhCCCCCccceeEEE
Q 002342 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE---REILDMLDHPFVPALYASF 738 (934)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E---~~il~~l~hp~Iv~l~~~~ 738 (934)
....+.+++|++++.||+|+||+||+|+++.+|+.||||++.+.............+| +.+++.++|||||+++++|
T Consensus 182 ~~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f 261 (689)
T 3v5w_A 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF 261 (689)
T ss_dssp TTCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred cCCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE
Confidence 3445677899999999999999999999999999999999987544333333334444 5666677999999999999
Q ss_pred EeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccC
Q 002342 739 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (934)
Q Consensus 739 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a 818 (934)
++.+++|||||||+||+|.+++.+. +.+++..+++|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|
T Consensus 262 ~~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 262 HTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEeccccee
Confidence 9999999999999999999999875 45999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~P 897 (934)
+.... ....+.|||+.|||||++.+ ..|+.++|||||||+||+|++|++|
T Consensus 340 ~~~~~-----------------------------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~P 390 (689)
T 3v5w_A 340 CDFSK-----------------------------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390 (689)
T ss_dssp EECSS-----------------------------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred eecCC-----------------------------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 65321 12346799999999999964 6899999999999999999999999
Q ss_pred CCCC---CHHHHHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 898 FRGK---TRQKTFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 898 f~~~---~~~~~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
|.+. +..++++.+....+.+|.. .|.+++||
T Consensus 391 F~~~~~~~~~~i~~~i~~~~~~~p~~--~S~~a~dL 424 (689)
T 3v5w_A 391 FRQHKTKDKHEIDRMTLTMAVELPDS--FSPELRSL 424 (689)
T ss_dssp TCGGGCCCHHHHHHHHHHCCCCCCTT--SCHHHHHH
T ss_pred CCCCChHHHHHHHHhhcCCCCCCCcc--CCHHHHHH
Confidence 9863 4457788889999999875 46666665
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=403.12 Aligned_cols=220 Identities=25% Similarity=0.383 Sum_probs=189.9
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe------C
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------K 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------~ 741 (934)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+++|+.|+|||||++++++.. .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 368999999999999999999999999999999997643 344556778899999999999999999999864 3
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
+++||||||| +|+|.+++... +.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+..
T Consensus 132 ~~~~ivmE~~-~g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 132 KSVYVVLDLM-ESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp CCEEEEEECC-SEEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred CEEEEEEeCC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 6799999999 57899999764 45999999999999999999999999999999999999999999999999999654
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
..... .......+.+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+
T Consensus 209 ~~~~~-----------------------~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g 265 (398)
T 4b99_A 209 CTSPA-----------------------EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265 (398)
T ss_dssp ------------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred ccCcc-----------------------ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence 22110 112234567999999999999875 568999999999999999999999999
Q ss_pred CCHHHHHHHHHcCC
Q 002342 901 KTRQKTFANILHKD 914 (934)
Q Consensus 901 ~~~~~~~~~i~~~~ 914 (934)
.+..+++.+|....
T Consensus 266 ~~~~~~l~~I~~~~ 279 (398)
T 4b99_A 266 KNYVHQLQLIMMVL 279 (398)
T ss_dssp SSHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHhc
Confidence 99999999987643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=384.42 Aligned_cols=225 Identities=24% Similarity=0.383 Sum_probs=171.0
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC------
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT------ 742 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~------ 742 (934)
++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|+.|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 46999999999999999999999999999999987542 3445567889999999999999999999997544
Q ss_pred ------eEEEEEEccCCCCchhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEec
Q 002342 743 ------HVCLITDYCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815 (934)
Q Consensus 743 ------~~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DF 815 (934)
++|||||||+||+|.+++..... .......++.++.||+.||+|||++|||||||||+|||++.+|.+||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 47999999999999999976532 23556778999999999999999999999999999999999999999999
Q ss_pred ccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCC
Q 002342 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 895 (934)
Q Consensus 816 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~ 895 (934)
|+|+.......... ...........++.+||+.|||||++.+..|+.++|||||||+||||++
T Consensus 163 Gla~~~~~~~~~~~---------------~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~-- 225 (299)
T 4g31_A 163 GLVTAMDQDEEEQT---------------VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-- 225 (299)
T ss_dssp CCC-----------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS--
T ss_pred ccceecCCCccccc---------------cccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc--
Confidence 99976532211000 0000111233456789999999999999999999999999999999996
Q ss_pred CCCCCCCH-HHHHHHHHcC
Q 002342 896 TPFRGKTR-QKTFANILHK 913 (934)
Q Consensus 896 ~Pf~~~~~-~~~~~~i~~~ 913 (934)
||.+... ...+..+...
T Consensus 226 -Pf~~~~~~~~~~~~~~~~ 243 (299)
T 4g31_A 226 -PFSTQMERVRTLTDVRNL 243 (299)
T ss_dssp -CCSSHHHHHHHHHHHHTT
T ss_pred -CCCCccHHHHHHHHHhcC
Confidence 8865432 2334444443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=395.86 Aligned_cols=230 Identities=23% Similarity=0.357 Sum_probs=191.6
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCC-----eEEEEEEeecccccChHHHHHHHHHHHHHHhCCC-CCccceeEE
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH-PFVPALYAS 737 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~-----~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~ 737 (934)
|++..++|++.+.||+|+||+||+|.+..++ +.||+|.+.... .......+.+|+.+|.+++| ||||+++++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 5677789999999999999999999987643 689999987643 34456778999999999965 899999999
Q ss_pred EEe-CCeEEEEEEccCCCCchhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 002342 738 FQT-KTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802 (934)
Q Consensus 738 ~~~-~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NI 802 (934)
|.. ++.+|||||||++|+|.++++... ...+++..+..++.||+.||+|||+++||||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 865 467899999999999999997532 23589999999999999999999999999999999999
Q ss_pred EEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHH
Q 002342 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882 (934)
Q Consensus 803 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Diw 882 (934)
|++.++.+||+|||+|+...... ........+||+.|||||++.+..|+.++|||
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~-------------------------~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVw 271 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDP-------------------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 271 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCT-------------------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred eeCCCCCEEECcchhhhhcccCC-------------------------CceeeccccccccccCHHHHhcCCCCCcccEe
Confidence 99999999999999996542111 11223456899999999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHH-HHHHHHHcCC-CCCCCC
Q 002342 883 ALGILLYEMLY-GYTPFRGKTRQ-KTFANILHKD-LKFPSS 920 (934)
Q Consensus 883 SlG~iL~ellt-G~~Pf~~~~~~-~~~~~i~~~~-~~~p~~ 920 (934)
||||+||||+| |++||.+.+.. .+.+.+..+. +.+|..
T Consensus 272 S~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~ 312 (353)
T 4ase_A 272 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 312 (353)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTT
T ss_pred ehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCcc
Confidence 99999999998 99999987654 4455555553 455544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=415.99 Aligned_cols=231 Identities=27% Similarity=0.453 Sum_probs=204.9
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++++.||+|+||.||+|.++.+|+.||+|++.+. .......+.+|+.+|+.|+|||||+++++|.+.+++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999999764 234456788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC--CcEEEEecccCcccCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN--GHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~--~~vkl~DFG~a~~~~~~~ 825 (934)
||||+||+|.+++..+. ..+++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 233 ~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~-- 309 (573)
T 3uto_A 233 YEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 309 (573)
T ss_dssp EECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT--
T ss_pred EeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC--
Confidence 99999999999986543 459999999999999999999999999999999999999854 8999999999965421
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
.....+.+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+
T Consensus 310 --------------------------~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~ 363 (573)
T 3uto_A 310 --------------------------KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 363 (573)
T ss_dssp --------------------------TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred --------------------------CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 112345689999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCC--CCCCcccCCC
Q 002342 906 TFANILHKDLKFPSS--TPSSCKAANV 930 (934)
Q Consensus 906 ~~~~i~~~~~~~p~~--~~~s~~~k~l 930 (934)
++.+|.++.+.+|.. ...|..++||
T Consensus 364 ~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 364 TLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp HHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 999999998877753 3456666655
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=385.17 Aligned_cols=234 Identities=25% Similarity=0.348 Sum_probs=178.8
Q ss_pred cCCcccccccccCCcEEEEEEEEe---cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCe
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 743 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 743 (934)
.++|++.+.||+|+||+||+|+++ .+++.||+|.+.+.. ....+.+|+++|+.+ +||||++++++|.+.++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 368999999999999999999986 467899999986542 234678899999998 69999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-CcEEEEecccCcccC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLTS 822 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-~~vkl~DFG~a~~~~ 822 (934)
+|||||||+|++|.+++. .+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...
T Consensus 95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 999999999999999984 38999999999999999999999999999999999999876 899999999997654
Q ss_pred CCCCCCCCcchhhh-ccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 823 CKPQLLLPTTNEKK-RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 823 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.............. ....................+.+||+.|||||++.+. .|+.++||||+||++|+|++|++||.+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 32211100000000 0000000000011122334567899999999999875 589999999999999999999999964
Q ss_pred -CCHHHHHHHHH
Q 002342 901 -KTRQKTFANIL 911 (934)
Q Consensus 901 -~~~~~~~~~i~ 911 (934)
.+..+++.+|.
T Consensus 250 ~~~~~~~l~~I~ 261 (361)
T 4f9c_A 250 ASDDLTALAQIM 261 (361)
T ss_dssp CSSHHHHHHHHH
T ss_pred CCCHHHHHHHHH
Confidence 55556666664
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=378.38 Aligned_cols=229 Identities=38% Similarity=0.743 Sum_probs=199.1
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCC
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 742 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 742 (934)
..+..++|++++.||+|+||.||+|+++.+++.||||++.+...........+.+|..+|+.+ +||||++++++|.+.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 346678999999999999999999999999999999999876444455667788999999988 7999999999999999
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
.+|||||||+|++|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999999999765 459999999999999999999999999999999999999999999999999985321
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
. ........+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+
T Consensus 176 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 176 C---------------------------NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp C------------------------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c---------------------------CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 1 1122346689999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 002342 903 RQKTFANILHKDLKFPSST 921 (934)
Q Consensus 903 ~~~~~~~i~~~~~~~p~~~ 921 (934)
..+++.+|..+.+.+|.+.
T Consensus 229 ~~~~~~~i~~~~~~~p~~~ 247 (353)
T 3txo_A 229 EDDLFEAILNDEVVYPTWL 247 (353)
T ss_dssp HHHHHHHHHHCCCCCCTTS
T ss_pred HHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=372.02 Aligned_cols=233 Identities=39% Similarity=0.767 Sum_probs=205.6
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+..++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+|+.++||||++++++|.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 35679999999999999999999999999999999998754434445667889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
+||||++||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 82 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 157 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-- 157 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--
Confidence 999999999999999764 4599999999999999999999999999999999999999999999999999854211
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
........+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+...
T Consensus 158 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 212 (337)
T 1o6l_A 158 -------------------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212 (337)
T ss_dssp -------------------------TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH
Confidence 1112346689999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCcccCC
Q 002342 906 TFANILHKDLKFPSSTPSSCKAAN 929 (934)
Q Consensus 906 ~~~~i~~~~~~~p~~~~~s~~~k~ 929 (934)
++..|..+.+.+|... +..+++
T Consensus 213 ~~~~i~~~~~~~p~~~--s~~~~~ 234 (337)
T 1o6l_A 213 LFELILMEEIRFPRTL--SPEAKS 234 (337)
T ss_dssp HHHHHHHCCCCCCTTS--CHHHHH
T ss_pred HHHHHHcCCCCCCCCC--CHHHHH
Confidence 9999999999888653 444443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=368.92 Aligned_cols=234 Identities=35% Similarity=0.712 Sum_probs=203.9
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCe
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 743 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 743 (934)
.+..++|++.+.||+|+||.||+|+++.+++.||||++++...........+..|..+|..+ +||||++++++|.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 35678999999999999999999999999999999999875433334456778899999877 99999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999999764 3599999999999999999999999999999999999999999999999999854211
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.
T Consensus 171 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (345)
T 1xjd_A 171 ---------------------------GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223 (345)
T ss_dssp ---------------------------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH
Confidence 01123467899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCcccCC
Q 002342 904 QKTFANILHKDLKFPSSTPSSCKAAN 929 (934)
Q Consensus 904 ~~~~~~i~~~~~~~p~~~~~s~~~k~ 929 (934)
.+++.+|..+...+|.+. +..+++
T Consensus 224 ~~~~~~i~~~~~~~p~~~--s~~~~~ 247 (345)
T 1xjd_A 224 EELFHSIRMDNPFYPRWL--EKEAKD 247 (345)
T ss_dssp HHHHHHHHHCCCCCCTTS--CHHHHH
T ss_pred HHHHHHHHhCCCCCCccc--CHHHHH
Confidence 999999999998888753 444443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=365.06 Aligned_cols=223 Identities=42% Similarity=0.832 Sum_probs=201.7
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+..++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 34678999999999999999999999999999999998754333345567889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred EEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 999999999999999875 4599999999999999999999999999999999999999999999999999854311
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
...+.+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+
T Consensus 159 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 210 (318)
T 1fot_A 159 ----------------------------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210 (318)
T ss_dssp ----------------------------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ----------------------------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 1235689999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCC
Q 002342 906 TFANILHKDLKFPSS 920 (934)
Q Consensus 906 ~~~~i~~~~~~~p~~ 920 (934)
.+.+|..+.+.+|..
T Consensus 211 ~~~~i~~~~~~~p~~ 225 (318)
T 1fot_A 211 TYEKILNAELRFPPF 225 (318)
T ss_dssp HHHHHHHCCCCCCTT
T ss_pred HHHHHHhCCCCCCCC
Confidence 999999999888864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=381.74 Aligned_cols=237 Identities=35% Similarity=0.647 Sum_probs=205.3
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||++++++|.+.+++
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 35568999999999999999999999999999999999864332233334577899999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|||||||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus 145 ~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 9999999999999998753 4999999999999999999999999999999999999999999999999999653211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC----CCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
......+.+||+.|+|||++.+.. ++.++|||||||+||+|++|++||.+
T Consensus 222 --------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 275 (410)
T 3v8s_A 222 --------------------------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275 (410)
T ss_dssp --------------------------SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred --------------------------CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC
Confidence 011234668999999999998765 78899999999999999999999999
Q ss_pred CCHHHHHHHHHcCC--CCCCCCCCCCcccCCC
Q 002342 901 KTRQKTFANILHKD--LKFPSSTPSSCKAANV 930 (934)
Q Consensus 901 ~~~~~~~~~i~~~~--~~~p~~~~~s~~~k~l 930 (934)
.+..+++.+|..+. +.+|.+...|..+++|
T Consensus 276 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~l 307 (410)
T 3v8s_A 276 DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307 (410)
T ss_dssp SSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHH
T ss_pred CChhhHHHHHHhccccccCCCcccccHHHHHH
Confidence 99999999998754 6778766667776665
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=370.31 Aligned_cols=234 Identities=36% Similarity=0.675 Sum_probs=204.6
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCe
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 743 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 743 (934)
.+..++|++++.||+|+||.||+|+++.+++.||||++.+...........+..|..+|..+ +||||++++++|.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 35678999999999999999999999999999999999875443444566788899999988 89999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999999764 3499999999999999999999999999999999999999999999999999854211
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
........+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.
T Consensus 174 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 226 (353)
T 2i0e_A 174 ---------------------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226 (353)
T ss_dssp ---------------------------TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH
Confidence 01123466899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCcccCC
Q 002342 904 QKTFANILHKDLKFPSSTPSSCKAAN 929 (934)
Q Consensus 904 ~~~~~~i~~~~~~~p~~~~~s~~~k~ 929 (934)
.+++++|..+.+.+|... +..+++
T Consensus 227 ~~~~~~i~~~~~~~p~~~--s~~~~~ 250 (353)
T 2i0e_A 227 DELFQSIMEHNVAYPKSM--SKEAVA 250 (353)
T ss_dssp HHHHHHHHHCCCCCCTTS--CHHHHH
T ss_pred HHHHHHHHhCCCCCCCCC--CHHHHH
Confidence 999999999999988753 444443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=373.15 Aligned_cols=234 Identities=38% Similarity=0.718 Sum_probs=201.2
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCe
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 743 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 743 (934)
.+..++|++++.||+|+||+||+|+++.+++.||+|++++...........+.+|..+|.++ +||||++++++|.+.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 35568999999999999999999999999999999999987655555666788999999887 89999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|||||||+||+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999999875 4599999999999999999999999999999999999999999999999999854211
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK-- 901 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~-- 901 (934)
......+.+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.
T Consensus 206 ---------------------------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~ 258 (396)
T 4dc2_A 206 ---------------------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258 (396)
T ss_dssp ---------------------------TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC
T ss_pred ---------------------------CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 112345678999999999999999999999999999999999999999642
Q ss_pred -------CHHHHHHHHHcCCCCCCCCCCCCcccCC
Q 002342 902 -------TRQKTFANILHKDLKFPSSTPSSCKAAN 929 (934)
Q Consensus 902 -------~~~~~~~~i~~~~~~~p~~~~~s~~~k~ 929 (934)
....+++.|..+.+.+|... |..+++
T Consensus 259 ~~~~~~~~~~~~~~~i~~~~~~~p~~~--s~~~~~ 291 (396)
T 4dc2_A 259 SDNPDQNTEDYLFQVILEKQIRIPRSL--SVKAAS 291 (396)
T ss_dssp ------CCHHHHHHHHHHCCCCCCTTS--CHHHHH
T ss_pred ccccchhhHHHHHHHHhccccCCCCcC--CHHHHH
Confidence 34557888899999998753 444444
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=364.69 Aligned_cols=199 Identities=25% Similarity=0.342 Sum_probs=161.0
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC----eE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----HV 744 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----~~ 744 (934)
.+|.+.+.||+|+||+||++++ +|+.||||++.... ........|+.++..++|||||++++++..++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4688999999999999999987 68999999987531 22222345666667889999999999998653 68
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCCEEEecCCcEEEEecc
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLTDFD 816 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~--------giiHrDLKp~NILl~~~~~vkl~DFG 816 (934)
|||||||++|+|.+++... .+++..+..++.|++.||+|||++ |||||||||+|||++.++.+||+|||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 9999999999999999764 489999999999999999999987 99999999999999999999999999
Q ss_pred cCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC------CCCchhHHHHHHHHHHH
Q 002342 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA------GHTSAVDWWALGILLYE 890 (934)
Q Consensus 817 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~------~~s~~~DiwSlG~iL~e 890 (934)
+|+....... .........+||+.|||||++.+. .++.++|||||||+|||
T Consensus 154 la~~~~~~~~-----------------------~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~E 210 (303)
T 3hmm_A 154 LAVRHDSATD-----------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 210 (303)
T ss_dssp TCEEEETTTT-----------------------EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHH
T ss_pred CCccccCCCC-----------------------ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHH
Confidence 9965421110 001122356899999999999765 35679999999999999
Q ss_pred HHhCCCCCC
Q 002342 891 MLYGYTPFR 899 (934)
Q Consensus 891 lltG~~Pf~ 899 (934)
|++|.+||.
T Consensus 211 l~tg~~~~~ 219 (303)
T 3hmm_A 211 IARRCSIGG 219 (303)
T ss_dssp HHHTBCBTT
T ss_pred HHHCCCCCC
Confidence 999987663
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=363.42 Aligned_cols=226 Identities=38% Similarity=0.733 Sum_probs=200.9
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 744 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 744 (934)
+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|..+++.+ +||||++++++|.+.+.+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 4567999999999999999999999999999999999987666667778889999999988 899999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 86 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~- 162 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 162 (345)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC-
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC-
Confidence 9999999999999999764 4599999999999999999999999999999999999999999999999999854211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC----
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG---- 900 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~---- 900 (934)
........+||+.|+|||++.+..++.++|||||||++|+|++|++||..
T Consensus 163 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 216 (345)
T 3a8x_A 163 --------------------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 216 (345)
T ss_dssp --------------------------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-
T ss_pred --------------------------CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccc
Confidence 11223456899999999999999999999999999999999999999975
Q ss_pred -----CCHHHHHHHHHcCCCCCCCC
Q 002342 901 -----KTRQKTFANILHKDLKFPSS 920 (934)
Q Consensus 901 -----~~~~~~~~~i~~~~~~~p~~ 920 (934)
.....+++.|..+.+.+|..
T Consensus 217 ~~~~~~~~~~~~~~i~~~~~~~p~~ 241 (345)
T 3a8x_A 217 DNPDQNTEDYLFQVILEKQIRIPRS 241 (345)
T ss_dssp ------CHHHHHHHHHHCCCCCCTT
T ss_pred cccccccHHHHHHHHHcCCCCCCCC
Confidence 34456778888888888865
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=361.00 Aligned_cols=225 Identities=29% Similarity=0.536 Sum_probs=202.0
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
...++|++++.||+|+||.||+|.+..+|+.||||++.+... .......+.+|+.+|+.++||||+++++++...+.+|
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 346799999999999999999999999999999999986533 4556677889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
+||||++|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 166 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-- 166 (328)
T ss_dssp EEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS--
T ss_pred EEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC--
Confidence 999999999999999765 3499999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT-SAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s-~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|++||.+.+..
T Consensus 167 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 220 (328)
T 3fe3_A 167 --------------------------GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220 (328)
T ss_dssp --------------------------SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred --------------------------CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH
Confidence 1123456899999999999988875 7999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 002342 905 KTFANILHKDLKFPSST 921 (934)
Q Consensus 905 ~~~~~i~~~~~~~p~~~ 921 (934)
++..++..+.+.+|...
T Consensus 221 ~~~~~i~~~~~~~p~~~ 237 (328)
T 3fe3_A 221 ELRERVLRGKYRIPFYM 237 (328)
T ss_dssp HHHHHHHHCCCCCCTTS
T ss_pred HHHHHHHhCCCCCCCCC
Confidence 99999999999888753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=371.71 Aligned_cols=234 Identities=38% Similarity=0.699 Sum_probs=196.7
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHH-HHhCCCCCccceeEEEEeCCe
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-LDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~~~~~~~ 743 (934)
.+..++|++++.||+|+||.||+|+++.+++.||||++.+...........+..|..+ ++.++||||++++++|.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 3556899999999999999999999999999999999988765555556667778777 577899999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999999999764 4599999999999999999999999999999999999999999999999999854211
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.
T Consensus 192 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 244 (373)
T 2r5t_A 192 ---------------------------HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 244 (373)
T ss_dssp ---------------------------CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH
T ss_pred ---------------------------CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH
Confidence 11234567899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCcccCC
Q 002342 904 QKTFANILHKDLKFPSSTPSSCKAAN 929 (934)
Q Consensus 904 ~~~~~~i~~~~~~~p~~~~~s~~~k~ 929 (934)
.+++++|+.+.+.+|... +..+++
T Consensus 245 ~~~~~~i~~~~~~~~~~~--~~~~~~ 268 (373)
T 2r5t_A 245 AEMYDNILNKPLQLKPNI--TNSARH 268 (373)
T ss_dssp HHHHHHHHHSCCCCCSSS--CHHHHH
T ss_pred HHHHHHHHhcccCCCCCC--CHHHHH
Confidence 999999999988888643 444443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=366.58 Aligned_cols=223 Identities=39% Similarity=0.719 Sum_probs=202.2
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
...++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 44679999999999999999999999999999999998754434445677889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-- 193 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC--
Confidence 999999999999999865 3499999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+
T Consensus 194 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 245 (350)
T 1rdq_E 194 ----------------------------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245 (350)
T ss_dssp ----------------------------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ----------------------------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH
Confidence 1235689999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCC
Q 002342 906 TFANILHKDLKFPSS 920 (934)
Q Consensus 906 ~~~~i~~~~~~~p~~ 920 (934)
++.+|..+.+.+|..
T Consensus 246 ~~~~i~~~~~~~p~~ 260 (350)
T 1rdq_E 246 IYEKIVSGKVRFPSH 260 (350)
T ss_dssp HHHHHHHCCCCCCTT
T ss_pred HHHHHHcCCCCCCCC
Confidence 999999999988865
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=378.53 Aligned_cols=240 Identities=35% Similarity=0.607 Sum_probs=204.2
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
..+..++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|..++..++||||++++++|.+.+.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 34567899999999999999999999999999999999986433233333447889999999999999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|||||||+||+|.+++... ...+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|.....
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 99999999999999999764 24599999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc-----CCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
. ........+||+.|||||++. ...|+.++|||||||++|+|++|++||
T Consensus 228 ~--------------------------~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf 281 (437)
T 4aw2_A 228 D--------------------------GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281 (437)
T ss_dssp T--------------------------SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred C--------------------------CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCC
Confidence 1 011233468999999999997 567899999999999999999999999
Q ss_pred CCCCHHHHHHHHHcC--CCCCCCC-CCCCcccCCC
Q 002342 899 RGKTRQKTFANILHK--DLKFPSS-TPSSCKAANV 930 (934)
Q Consensus 899 ~~~~~~~~~~~i~~~--~~~~p~~-~~~s~~~k~l 930 (934)
.+.+..+++.+|+.. .+.+|.. ...|..+++|
T Consensus 282 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dL 316 (437)
T 4aw2_A 282 YAESLVETYGKIMNHKERFQFPTQVTDVSENAKDL 316 (437)
T ss_dssp CCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHH
T ss_pred CCCChhHHHHhhhhccccccCCcccccCCHHHHHH
Confidence 999999999999864 4677765 2355555554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=373.67 Aligned_cols=240 Identities=33% Similarity=0.588 Sum_probs=202.5
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
..+..++|++++.||+|+||.||+|+++.+++.||||++.+...........+.+|..+|..++||||++++++|.+.++
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 34567899999999999999999999999999999999986433333444567889999999999999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|||||||+||+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 999999999999999997642 3599999999999999999999999999999999999999999999999999965321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc-------CCCCCchhHHHHHHHHHHHHHhCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-------GAGHTSAVDWWALGILLYEMLYGYT 896 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-------~~~~s~~~DiwSlG~iL~elltG~~ 896 (934)
.. .......+||+.|+|||++. ...|+.++|||||||++|+|++|++
T Consensus 215 ~~--------------------------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~ 268 (412)
T 2vd5_A 215 DG--------------------------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268 (412)
T ss_dssp TS--------------------------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSC
T ss_pred CC--------------------------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCC
Confidence 10 11223568999999999997 4578999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCC--CCCCCC-CCCCcccCCC
Q 002342 897 PFRGKTRQKTFANILHKD--LKFPSS-TPSSCKAANV 930 (934)
Q Consensus 897 Pf~~~~~~~~~~~i~~~~--~~~p~~-~~~s~~~k~l 930 (934)
||.+.+..+++.+|.+.. +.+|.. ...|..+++|
T Consensus 269 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dl 305 (412)
T 2vd5_A 269 PFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDF 305 (412)
T ss_dssp TTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHH
Confidence 999999999999998643 556642 2345555544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=365.71 Aligned_cols=230 Identities=35% Similarity=0.673 Sum_probs=200.7
Q ss_pred ccccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe
Q 002342 661 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (934)
Q Consensus 661 ~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (934)
.....+..++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+|+.++||||++++++|.+
T Consensus 7 ~~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 86 (384)
T 4fr4_A 7 DENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD 86 (384)
T ss_dssp -CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CCCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 34556778999999999999999999999999999999999987544444556788899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
.+.+|+|||||.||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeee
Confidence 99999999999999999999764 4599999999999999999999999999999999999999999999999999964
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC---CCCCchhHHHHHHHHHHHHHhCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~s~~~DiwSlG~iL~elltG~~P 897 (934)
... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|++|
T Consensus 165 ~~~----------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~P 216 (384)
T 4fr4_A 165 LPR----------------------------ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216 (384)
T ss_dssp CCT----------------------------TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ccC----------------------------CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCC
Confidence 321 122345689999999999964 4688999999999999999999999
Q ss_pred CCC---CCHHHHHHHHHcCCCCCCCC
Q 002342 898 FRG---KTRQKTFANILHKDLKFPSS 920 (934)
Q Consensus 898 f~~---~~~~~~~~~i~~~~~~~p~~ 920 (934)
|.+ .....++..+......+|..
T Consensus 217 f~~~~~~~~~~~~~~~~~~~~~~p~~ 242 (384)
T 4fr4_A 217 YHIRSSTSSKEIVHTFETTVVTYPSA 242 (384)
T ss_dssp SCCCTTSCHHHHHHHHHHCCCCCCTT
T ss_pred CCCCCCccHHHHHHHHhhcccCCCCc
Confidence 974 44566777778888888765
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=359.63 Aligned_cols=233 Identities=29% Similarity=0.438 Sum_probs=202.6
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccCh---HHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR---NKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+.|++.+.||+|+||.||+|.++.+|+.||+|++.+...... .....+.+|+.+|+.++||||++++++|.+.+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 4689999999999999999999999999999999987543221 1346788999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC----cEEEEecccCcc
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCL 820 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~----~vkl~DFG~a~~ 820 (934)
|+|||||+|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999999764 4599999999999999999999999999999999999998776 799999999854
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+
T Consensus 169 ~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~ 220 (361)
T 2yab_A 169 IED----------------------------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (361)
T ss_dssp CCT----------------------------TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cCC----------------------------CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 321 1122356799999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHcCCCCCCCC--CCCCcccCCC
Q 002342 901 KTRQKTFANILHKDLKFPSS--TPSSCKAANV 930 (934)
Q Consensus 901 ~~~~~~~~~i~~~~~~~p~~--~~~s~~~k~l 930 (934)
.+..+.+..|..+.+.+|.. ...+..+++|
T Consensus 221 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 252 (361)
T 2yab_A 221 DTKQETLANITAVSYDFDEEFFSQTSELAKDF 252 (361)
T ss_dssp SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCchhccCCCHHHHHH
Confidence 99999999999998888742 3345555443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=351.44 Aligned_cols=227 Identities=44% Similarity=0.778 Sum_probs=191.2
Q ss_pred ccccCCcccccccccCCcEEEEEEEEe---cCCeEEEEEEeeccccc-ChHHHHHHHHHHHHHHhCCCCCccceeEEEEe
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAlK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (934)
.+..++|++.+.||+|+||.||+|++. .+++.||+|++.+.... .......+.+|+.+|+.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 456689999999999999999999985 68999999999865322 22344567789999999999999999999999
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
.+.+|+|||||+|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred CCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999999764 4599999999999999999999999999999999999999999999999999853
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
... ........+||+.|+|||++.+..++.++|||||||++|+|++|++||.+
T Consensus 171 ~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 171 SIH---------------------------DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223 (327)
T ss_dssp -----------------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccc---------------------------CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence 211 01122356899999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHcCCCCCCCC
Q 002342 901 KTRQKTFANILHKDLKFPSS 920 (934)
Q Consensus 901 ~~~~~~~~~i~~~~~~~p~~ 920 (934)
.+..+.+.+|..+.+.+|..
T Consensus 224 ~~~~~~~~~i~~~~~~~p~~ 243 (327)
T 3a62_A 224 ENRKKTIDKILKCKLNLPPY 243 (327)
T ss_dssp SSHHHHHHHHHHTCCCCCTT
T ss_pred CCHHHHHHHHHhCCCCCCCC
Confidence 99999999999998888864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=354.25 Aligned_cols=231 Identities=28% Similarity=0.479 Sum_probs=201.3
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3679999999999999999999999999999999986533 345567788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC---cEEEEecccCcccCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCLTSCK 824 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~---~vkl~DFG~a~~~~~~ 824 (934)
||||.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 107 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp ECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999999999998764 4599999999999999999999999999999999999997654 5999999998543211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..
T Consensus 185 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~ 236 (362)
T 2bdw_A 185 ----------------------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 236 (362)
T ss_dssp ----------------------------CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ----------------------------cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 1123457999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCC--CCCCcccCC
Q 002342 905 KTFANILHKDLKFPSS--TPSSCKAAN 929 (934)
Q Consensus 905 ~~~~~i~~~~~~~p~~--~~~s~~~k~ 929 (934)
+++..|..+.+.+|.. ...+..+++
T Consensus 237 ~~~~~i~~~~~~~~~~~~~~~~~~~~~ 263 (362)
T 2bdw_A 237 RLYAQIKAGAYDYPSPEWDTVTPEAKS 263 (362)
T ss_dssp HHHHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred HHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 9999999998888763 233444443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=372.68 Aligned_cols=235 Identities=31% Similarity=0.559 Sum_probs=203.6
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+..++|.+++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|+.++||||++++++|.+.+.+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 45679999999999999999999999999999999998754444445567889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 746 LITDYCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|||||+||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999999987643 34699999999999999999999999999999999999999999999999999965321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK-- 901 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~-- 901 (934)
. .......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.
T Consensus 342 ~---------------------------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~ 394 (543)
T 3c4z_A 342 G---------------------------QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394 (543)
T ss_dssp T---------------------------CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC
T ss_pred C---------------------------CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc
Confidence 1 11223468999999999999999999999999999999999999999875
Q ss_pred --CHHHHHHHHHcCCCCCCCCCCCCcccCC
Q 002342 902 --TRQKTFANILHKDLKFPSSTPSSCKAAN 929 (934)
Q Consensus 902 --~~~~~~~~i~~~~~~~p~~~~~s~~~k~ 929 (934)
...++.+.+..+...+|... +..+++
T Consensus 395 ~~~~~~~~~~i~~~~~~~p~~~--s~~~~~ 422 (543)
T 3c4z_A 395 KVENKELKQRVLEQAVTYPDKF--SPASKD 422 (543)
T ss_dssp CCCHHHHHHHHHHCCCCCCTTS--CHHHHH
T ss_pred chhHHHHHHHHhhcccCCCccc--CHHHHH
Confidence 45678888988888888643 444443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=363.71 Aligned_cols=233 Identities=27% Similarity=0.451 Sum_probs=201.5
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+|+.++||||+++++++.+.+..|+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999987533 334456788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe---cCCcEEEEecccCcccCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~---~~~~vkl~DFG~a~~~~~~ 824 (934)
||||.||+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 89 ~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp ECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999999999999875 4599999999999999999999999999999999999998 4578999999999543211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..
T Consensus 167 ---------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~ 219 (444)
T 3soa_A 167 ---------------------------QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH 219 (444)
T ss_dssp ---------------------------CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ---------------------------CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH
Confidence 11223467999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCC--CCCCcccCCC
Q 002342 905 KTFANILHKDLKFPSS--TPSSCKAANV 930 (934)
Q Consensus 905 ~~~~~i~~~~~~~p~~--~~~s~~~k~l 930 (934)
+++..+..+.+.+|.. ...+..+++|
T Consensus 220 ~~~~~i~~~~~~~~~~~~~~~s~~~~~l 247 (444)
T 3soa_A 220 RLYQQIKAGAYDFPSPEWDTVTPEAKDL 247 (444)
T ss_dssp HHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred HHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 9999999998877754 3445555443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=368.97 Aligned_cols=229 Identities=40% Similarity=0.780 Sum_probs=193.3
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
..+..++|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+|+.++||||++++++|...+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 34566899999999999999999999999999999999987544455556677889999999999999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
+|||||||++++|.+++... +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|....
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999999999764 459999999999999999999998 999999999999999999999999999985421
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
. ........+||+.|+|||++.+..++.++|||||||+||+|++|++||.+.+
T Consensus 301 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 301 K---------------------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp C--------------------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C---------------------------CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 1 1112345689999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 002342 903 RQKTFANILHKDLKFPSST 921 (934)
Q Consensus 903 ~~~~~~~i~~~~~~~p~~~ 921 (934)
...++..+..+.+.+|...
T Consensus 354 ~~~~~~~i~~~~~~~p~~~ 372 (446)
T 4ejn_A 354 HEKLFELILMEEIRFPRTL 372 (446)
T ss_dssp HHHHHHHHHHCCCCCCTTS
T ss_pred HHHHHHHHHhCCCCCCccC
Confidence 9999999999999888653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=385.03 Aligned_cols=235 Identities=36% Similarity=0.676 Sum_probs=206.3
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCe
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 743 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 743 (934)
.+..++|++++.||+|+||.||+|+++.+++.||||++.+...........+..|..+|..+ +||+|+.++++|.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 45678999999999999999999999999999999999875443444556788899999987 79999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+||||||++||+|..++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999999999875 3599999999999999999999999999999999999999999999999999854211
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
......+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+.
T Consensus 495 ---------------------------~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~ 547 (674)
T 3pfq_A 495 ---------------------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547 (674)
T ss_dssp ---------------------------TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH
Confidence 11223467899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 904 QKTFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 904 ~~~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
.+++++|..+.+.+|... +..+++|
T Consensus 548 ~~~~~~i~~~~~~~p~~~--s~~~~~l 572 (674)
T 3pfq_A 548 DELFQSIMEHNVAYPKSM--SKEAVAI 572 (674)
T ss_dssp HHHHHHHHSSCCCCCTTS--CHHHHHH
T ss_pred HHHHHHHHhCCCCCCccC--CHHHHHH
Confidence 999999999999999753 5555443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=340.82 Aligned_cols=221 Identities=23% Similarity=0.356 Sum_probs=191.2
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
..++|++++.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++||||+++++++...+..|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 35789999999999999999999999999999999976655566677889999999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 89 v~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 164 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-- 164 (294)
T ss_dssp EEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc--
Confidence 99999999999999765 35999999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
........+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....
T Consensus 165 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~ 220 (294)
T 4eqm_A 165 ------------------------SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220 (294)
T ss_dssp ----------------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH
T ss_pred ------------------------cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 01122345799999999999999999999999999999999999999999988877
Q ss_pred HHHHHcCCC
Q 002342 907 FANILHKDL 915 (934)
Q Consensus 907 ~~~i~~~~~ 915 (934)
......+..
T Consensus 221 ~~~~~~~~~ 229 (294)
T 4eqm_A 221 AIKHIQDSV 229 (294)
T ss_dssp HHHHHSSCC
T ss_pred HHHHhhccC
Confidence 666665543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=342.96 Aligned_cols=212 Identities=25% Similarity=0.432 Sum_probs=188.5
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||++++++|...+..|+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 4689999999999999999999999999999999875432 2345678999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||||+|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 169 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--- 169 (297)
T ss_dssp EECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST---
T ss_pred EECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc---
Confidence 9999999999999764 4999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+....+
T Consensus 170 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 225 (297)
T 3fxz_A 170 ------------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225 (297)
T ss_dssp ------------------------TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred ------------------------ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 11223557999999999999999999999999999999999999999998887777
Q ss_pred HHHHc
Q 002342 908 ANILH 912 (934)
Q Consensus 908 ~~i~~ 912 (934)
..+..
T Consensus 226 ~~~~~ 230 (297)
T 3fxz_A 226 YLIAT 230 (297)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 66654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=371.30 Aligned_cols=236 Identities=32% Similarity=0.560 Sum_probs=203.4
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+..++|++.+.||+|+||.||+|.++.+|+.||||++.+...........+.+|+.+|+.++||||++++++|.+.+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 35667899999999999999999999999999999999875443444456688999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+|||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999999998765556999999999999999999999999999999999999999999999999999543210
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC---
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK--- 901 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~--- 901 (934)
......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.
T Consensus 340 ----------------------------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~ 391 (576)
T 2acx_A 340 ----------------------------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391 (576)
T ss_dssp ----------------------------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC
T ss_pred ----------------------------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc
Confidence 1123458999999999999999999999999999999999999999875
Q ss_pred -CHHHHHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 902 -TRQKTFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 902 -~~~~~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
....+...+......+|.. .|..+++|
T Consensus 392 ~~~~~i~~~i~~~~~~~p~~--~s~~~~dL 419 (576)
T 2acx_A 392 IKREEVERLVKEVPEEYSER--FSPQARSL 419 (576)
T ss_dssp CCHHHHHHHHHHCCCCCCTT--SCHHHHHH
T ss_pred hhHHHHHHHhhcccccCCcc--CCHHHHHH
Confidence 3466777888877777754 34444443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=343.69 Aligned_cols=219 Identities=25% Similarity=0.397 Sum_probs=196.0
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++.+.||+|+||.||+|.+..+++.||+|.+... ......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 47899999999999999999999999999999998743 23445688999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec--CCcEEEEecccCcccCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG--NGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~--~~~vkl~DFG~a~~~~~~~ 825 (934)
||||+|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-- 156 (321)
T 1tki_A 80 FEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp ECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence 99999999999997642 45999999999999999999999999999999999999987 78999999999854321
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+
T Consensus 157 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 210 (321)
T 1tki_A 157 --------------------------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp --------------------------TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred --------------------------CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH
Confidence 111234579999999999999889999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCC
Q 002342 906 TFANILHKDLKFPS 919 (934)
Q Consensus 906 ~~~~i~~~~~~~p~ 919 (934)
++..+..+.+.+|.
T Consensus 211 ~~~~i~~~~~~~~~ 224 (321)
T 1tki_A 211 IIENIMNAEYTFDE 224 (321)
T ss_dssp HHHHHHHTCCCCCH
T ss_pred HHHHHHcCCCCCCh
Confidence 99999999888774
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.33 Aligned_cols=236 Identities=29% Similarity=0.513 Sum_probs=194.7
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccC-----------------------hHHHHHHHHHH
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-----------------------RNKVHRACAER 720 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~-----------------------~~~~~~~~~E~ 720 (934)
..+..++|++.+.||+|+||.||+|.+..+++.||||++.+..... ......+.+|+
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 87 (298)
T 2zv2_A 8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI 87 (298)
T ss_dssp --CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred CceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence 3455789999999999999999999999999999999997653211 12235688999
Q ss_pred HHHHhCCCCCccceeEEEEe--CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 002342 721 EILDMLDHPFVPALYASFQT--KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLK 798 (934)
Q Consensus 721 ~il~~l~hp~Iv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLK 798 (934)
.+|+.++||||+++++++.+ ...+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+|||||
T Consensus 88 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 164 (298)
T 2zv2_A 88 AILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIK 164 (298)
T ss_dssp HHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 99999999999999999986 6789999999999999987643 459999999999999999999999999999999
Q ss_pred CCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC---C
Q 002342 799 PENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---H 875 (934)
Q Consensus 799 p~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~---~ 875 (934)
|+|||++.++.+||+|||++...... .......+||+.|+|||++.+.. +
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 217 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGS---------------------------DALLSNTVGTPAFMAPESLSETRKIFS 217 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSS---------------------------SCEECCCCSCGGGCCGGGCCTTCCCEE
T ss_pred HHHEEECCCCCEEEecCCCccccccc---------------------------cccccCCcCCccccChhhhccCCCCCC
Confidence 99999999999999999998653211 01123457999999999998765 3
Q ss_pred CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccCC
Q 002342 876 TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAAN 929 (934)
Q Consensus 876 s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~k~ 929 (934)
+.++|||||||++|+|++|++||.+.........+..+.+.+|.....+..+++
T Consensus 218 ~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (298)
T 2zv2_A 218 GKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKD 271 (298)
T ss_dssp SHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHH
T ss_pred CchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHH
Confidence 678999999999999999999999999888888998888888876555555443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=353.94 Aligned_cols=222 Identities=32% Similarity=0.503 Sum_probs=192.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+..|+|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 57899999999999999999999999999999999765333333345788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+ +|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~---- 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD---- 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT----
T ss_pred EECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC----
Confidence 9999 88999988764 4599999999999999999999999999999999999999999999999999854321
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+......
T Consensus 161 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~ 216 (336)
T 3h4j_B 161 ------------------------GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL 216 (336)
T ss_dssp ------------------------SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC
T ss_pred ------------------------CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH
Confidence 112235579999999999988876 6799999999999999999999998877777
Q ss_pred HHHHHcCCCCCCCC
Q 002342 907 FANILHKDLKFPSS 920 (934)
Q Consensus 907 ~~~i~~~~~~~p~~ 920 (934)
++.+..+.+.+|..
T Consensus 217 ~~~i~~~~~~~p~~ 230 (336)
T 3h4j_B 217 FKKVNSCVYVMPDF 230 (336)
T ss_dssp BCCCCSSCCCCCTT
T ss_pred HHHHHcCCCCCccc
Confidence 66666666666654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=340.51 Aligned_cols=222 Identities=29% Similarity=0.460 Sum_probs=196.1
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccCh---HHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR---NKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+.|++.+.||+|+||.||+|.+..+++.||+|++.+...... .....+.+|+.+|+.++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3579999999999999999999999999999999986533211 1356788999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC----cEEEEecccCcc
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCL 820 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~----~vkl~DFG~a~~ 820 (934)
|+|||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999999999999764 4599999999999999999999999999999999999998877 899999999865
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+
T Consensus 168 ~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 219 (326)
T 2y0a_A 168 IDFG----------------------------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219 (326)
T ss_dssp CCTT----------------------------SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCCC----------------------------CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 3211 112345799999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHcCCCCCCC
Q 002342 901 KTRQKTFANILHKDLKFPS 919 (934)
Q Consensus 901 ~~~~~~~~~i~~~~~~~p~ 919 (934)
.+..+.+..+....+.+|.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~ 238 (326)
T 2y0a_A 220 DTKQETLANVSAVNYEFED 238 (326)
T ss_dssp SSHHHHHHHHHHTCCCCCH
T ss_pred CCHHHHHHHHHhcCCCcCc
Confidence 9999999999888777764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=362.24 Aligned_cols=227 Identities=28% Similarity=0.468 Sum_probs=201.2
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+..++|.+.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+|+.++||||+++++++...+.+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 34568999999999999999999999999999999999865433334456788999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+|||||+|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~- 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD- 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT-
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc-
Confidence 9999999999999999764 4599999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+.
T Consensus 169 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 221 (476)
T 2y94_A 169 ---------------------------GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221 (476)
T ss_dssp ---------------------------TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS
T ss_pred ---------------------------cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH
Confidence 011235589999999999998776 6799999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 002342 904 QKTFANILHKDLKFPSST 921 (934)
Q Consensus 904 ~~~~~~i~~~~~~~p~~~ 921 (934)
...+.+|..+.+.+|...
T Consensus 222 ~~~~~~i~~~~~~~p~~~ 239 (476)
T 2y94_A 222 PTLFKKICDGIFYTPQYL 239 (476)
T ss_dssp HHHHHHHHTTCCCCCTTC
T ss_pred HHHHHHHhcCCcCCCccC
Confidence 999999999988887653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=341.43 Aligned_cols=225 Identities=24% Similarity=0.367 Sum_probs=189.3
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC----e
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----H 743 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----~ 743 (934)
.++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 578999999999999999999999999999999998765556666778899999999999999999999987643 4
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
.|+||||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 59999999999999999764 3599999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
... ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 169 ~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 169 SGN------------------------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp -------------------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccc------------------------ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 110 11123345799999999999999999999999999999999999999999998
Q ss_pred HHHHHHHHcCCCCCC
Q 002342 904 QKTFANILHKDLKFP 918 (934)
Q Consensus 904 ~~~~~~i~~~~~~~p 918 (934)
......+..+....|
T Consensus 225 ~~~~~~~~~~~~~~~ 239 (311)
T 3ork_A 225 VSVAYQHVREDPIPP 239 (311)
T ss_dssp HHHHHHHHHCCCCCH
T ss_pred HHHHHHHhcCCCCCc
Confidence 888777776654443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=345.32 Aligned_cols=231 Identities=29% Similarity=0.441 Sum_probs=188.8
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
...++|++++.||+|+||.||++++..+++.||||++.+... ....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 456799999999999999999999999999999999976432 2245778999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc--EEEEecccCcccCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--VSLTDFDLSCLTSC 823 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~--vkl~DFG~a~~~~~ 823 (934)
+|||||++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 93 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 93 IIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999999998764 34999999999999999999999999999999999999987665 99999999853210
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA-VDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~-~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|++||.+..
T Consensus 171 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 171 ----------------------------HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp --------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred ----------------------------cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 111234579999999999998888765 899999999999999999998744
Q ss_pred H----HHHHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 903 R----QKTFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 903 ~----~~~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
. ...++.+....+.+|.....+..+++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 254 (361)
T 3uc3_A 223 EPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254 (361)
T ss_dssp -CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHH
T ss_pred cHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHH
Confidence 3 566777888888888776566555543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=342.58 Aligned_cols=223 Identities=27% Similarity=0.435 Sum_probs=185.3
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++++.||+|+||.||++.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999875422 22335678999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 159 (323)
T 3tki_A 84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 159 (323)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred EEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC--
Confidence 9999999999999764 459999999999999999999999999999999999999999999999999986432110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHH-H
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQ-K 905 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~~DiwSlG~iL~elltG~~Pf~~~~~~-~ 905 (934)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.... .
T Consensus 160 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 216 (323)
T 3tki_A 160 -----------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216 (323)
T ss_dssp -----------------------EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH
T ss_pred -----------------------cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 1112335689999999999988776 67899999999999999999999876554 3
Q ss_pred HHHHHHcCCCCCCC
Q 002342 906 TFANILHKDLKFPS 919 (934)
Q Consensus 906 ~~~~i~~~~~~~p~ 919 (934)
.+..+.......+.
T Consensus 217 ~~~~~~~~~~~~~~ 230 (323)
T 3tki_A 217 EYSDWKEKKTYLNP 230 (323)
T ss_dssp HHHHHHTTCTTSTT
T ss_pred HHHHHhcccccCCc
Confidence 34444444444443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=343.98 Aligned_cols=223 Identities=25% Similarity=0.430 Sum_probs=190.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccC--hHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN--RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
.+.|++.+.||+|+||.||+|.++.+++.||||++.+..... ......+.+|+.+++.++||||+++++++...+.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 468999999999999999999999999999999987532211 113467889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc---EEEEecccCcc
Q 002342 746 LITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCL 820 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~---vkl~DFG~a~~ 820 (934)
+|||||+|++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998887643 2345899999999999999999999999999999999999986654 99999999865
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.... .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+
T Consensus 183 ~~~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (351)
T 3c0i_A 183 LGES---------------------------GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235 (351)
T ss_dssp CCTT---------------------------SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred ecCC---------------------------CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence 3211 1112345799999999999999999999999999999999999999987
Q ss_pred CCHHHHHHHHHcCCCCCC
Q 002342 901 KTRQKTFANILHKDLKFP 918 (934)
Q Consensus 901 ~~~~~~~~~i~~~~~~~p 918 (934)
. ....+..+..+.+.++
T Consensus 236 ~-~~~~~~~i~~~~~~~~ 252 (351)
T 3c0i_A 236 T-KERLFEGIIKGKYKMN 252 (351)
T ss_dssp S-HHHHHHHHHHTCCCCC
T ss_pred c-HHHHHHHHHcCCCCCC
Confidence 4 5667888888877665
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=331.86 Aligned_cols=226 Identities=35% Similarity=0.568 Sum_probs=198.6
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+..++|++.+.||+|+||.||++.+..++..||+|++.+...........+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 34568999999999999999999999999999999999765433334456788999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~- 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence 9999999999999998764 3499999999999999999999999999999999999999999999999998843211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..
T Consensus 162 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 213 (279)
T 3fdn_A 162 ----------------------------SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213 (279)
T ss_dssp ----------------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ----------------------------ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH
Confidence 1123457899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 002342 905 KTFANILHKDLKFPSST 921 (934)
Q Consensus 905 ~~~~~i~~~~~~~p~~~ 921 (934)
+.+..+....+.+|...
T Consensus 214 ~~~~~~~~~~~~~~~~~ 230 (279)
T 3fdn_A 214 ETYKRISRVEFTFPDFV 230 (279)
T ss_dssp HHHHHHHHTCCCCCTTS
T ss_pred HHHHHHHhCCCCCCCcC
Confidence 99999999888888653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=337.07 Aligned_cols=222 Identities=25% Similarity=0.405 Sum_probs=185.2
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
...+..++|++.+.||+|+||.||++.+ ++..||+|++.+.. ........+.+|+.+|+.++||||+++++++...+
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC-CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 3456678999999999999999999987 68899999987653 24555678899999999999999999999999999
Q ss_pred eEEEEEEccCCCCchhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 743 HVCLITDYCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
..|+||||+++++|.+++..... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999999976421 23899999999999999999999999 9999999999999999999999999985
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
.... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 188 ~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~ 240 (309)
T 3p86_A 188 LKAS---------------------------TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240 (309)
T ss_dssp -----------------------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTT
T ss_pred cccc---------------------------cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 4211 0112234579999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHcCC
Q 002342 900 GKTRQKTFANILHKD 914 (934)
Q Consensus 900 ~~~~~~~~~~i~~~~ 914 (934)
+.+..+....+....
T Consensus 241 ~~~~~~~~~~~~~~~ 255 (309)
T 3p86_A 241 NLNPAQVVAAVGFKC 255 (309)
T ss_dssp TSCHHHHHHHHHHSC
T ss_pred CCCHHHHHHHHHhcC
Confidence 999988888775433
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=344.01 Aligned_cols=221 Identities=28% Similarity=0.434 Sum_probs=195.2
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.+.|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+|+.++||||+++++++.+...+|+|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999987642 33445788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec--CCcEEEEecccCcccCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG--NGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~--~~~vkl~DFG~a~~~~~~~ 825 (934)
||||.|++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 127 ~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 127 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 9999999999998764 245999999999999999999999999999999999999974 478999999998653211
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+
T Consensus 205 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 257 (387)
T 1kob_A 205 ---------------------------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 257 (387)
T ss_dssp ---------------------------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred ---------------------------cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH
Confidence 11223479999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCC
Q 002342 906 TFANILHKDLKFPSS 920 (934)
Q Consensus 906 ~~~~i~~~~~~~p~~ 920 (934)
.+..+..+...++..
T Consensus 258 ~~~~i~~~~~~~~~~ 272 (387)
T 1kob_A 258 TLQNVKRCDWEFDED 272 (387)
T ss_dssp HHHHHHHCCCCCCSS
T ss_pred HHHHHHhCCCCCCcc
Confidence 999999888776643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=340.59 Aligned_cols=223 Identities=25% Similarity=0.347 Sum_probs=190.8
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCC---eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~---~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (934)
..+..++|++.+.||+|+||.||++.+..++ ..||||++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 3466789999999999999999999997554 469999997542 34556778999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
.+..|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred CCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999999999654 34599999999999999999999999999999999999999999999999999965
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 899 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~ 899 (934)
....... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 201 ~~~~~~~------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 256 (325)
T 3kul_A 201 LEDDPDA------------------------AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW 256 (325)
T ss_dssp CC----C------------------------CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccCccc------------------------eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 4321110 011223356889999999999999999999999999999998 999999
Q ss_pred CCCHHHHHHHHHcC
Q 002342 900 GKTRQKTFANILHK 913 (934)
Q Consensus 900 ~~~~~~~~~~i~~~ 913 (934)
+.+..+.+..+..+
T Consensus 257 ~~~~~~~~~~~~~~ 270 (325)
T 3kul_A 257 NMTNRDVISSVEEG 270 (325)
T ss_dssp TSCHHHHHHHHHTT
T ss_pred cCCHHHHHHHHHcC
Confidence 99999999888776
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=340.22 Aligned_cols=218 Identities=27% Similarity=0.444 Sum_probs=193.2
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-----CCCccceeEEEEe
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-----HPFVPALYASFQT 740 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-----hp~Iv~l~~~~~~ 740 (934)
+..++|++++.||+|+||.||+|.+..+++.||||++... .........|+.+++.+. ||||+++++++..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 4468999999999999999999999999999999998742 344566778999999996 9999999999999
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec--------------
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-------------- 806 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-------------- 806 (934)
.+..|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 99999999999 999999998776566999999999999999999999999999999999999975
Q ss_pred -----------CCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC
Q 002342 807 -----------NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 875 (934)
Q Consensus 807 -----------~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~ 875 (934)
++.+||+|||++..... .....+||+.|+|||++.+..+
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~ 236 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSD------------------------------YHGSIINTRQYRAPEVILNLGW 236 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTS------------------------------CCCSCCSCGGGCCHHHHTTCCC
T ss_pred ccccccccccCCCCEEEEeccCceecCC------------------------------CCcCccCcccccCcHHHcCCCC
Confidence 78999999999854211 1234579999999999999999
Q ss_pred CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q 002342 876 TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP 918 (934)
Q Consensus 876 s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 918 (934)
+.++|||||||++|+|++|++||.+.+..+.+..+......+|
T Consensus 237 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p 279 (360)
T 3llt_A 237 DVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIP 279 (360)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCC
T ss_pred CCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999999888888876555554
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=349.39 Aligned_cols=227 Identities=24% Similarity=0.413 Sum_probs=183.6
Q ss_pred cCCcccc-cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHH-HhCCCCCccceeEEEEe----C
Q 002342 668 LQHFRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPALYASFQT----K 741 (934)
Q Consensus 668 ~~~y~i~-~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il-~~l~hp~Iv~l~~~~~~----~ 741 (934)
.++|.+. +.||+|+||+||++.+..+++.||||++... ..+.+|+.++ +..+||||++++++|.. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 4678887 6899999999999999999999999998642 3466788887 45589999999999876 6
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEEEEecccC
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLS 818 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~~vkl~DFG~a 818 (934)
.++|||||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 78999999999999999998765567999999999999999999999999999999999999987 789999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
..... .......+||+.|+|||++.+..++.++|||||||+||+|++|.+||
T Consensus 212 ~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 263 (400)
T 1nxk_A 212 KETTS----------------------------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263 (400)
T ss_dssp EECC---------------------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccCC----------------------------CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCC
Confidence 54321 11123568999999999999999999999999999999999999999
Q ss_pred CCCCHH----HHHHHHHcCCCCCCCC--CCCCcccCCC
Q 002342 899 RGKTRQ----KTFANILHKDLKFPSS--TPSSCKAANV 930 (934)
Q Consensus 899 ~~~~~~----~~~~~i~~~~~~~p~~--~~~s~~~k~l 930 (934)
.+.+.. .+...+..+.+.+|.. ...+..+++|
T Consensus 264 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 301 (400)
T 1nxk_A 264 YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 301 (400)
T ss_dssp CCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred CCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHH
Confidence 876543 2567777888777653 3344444443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=345.49 Aligned_cols=227 Identities=28% Similarity=0.438 Sum_probs=192.9
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~l 746 (934)
.++|++.+.||+|+||.||+|.++.+++.||||++.+... ...+|++++..+ +||||++++++|.+.+.+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 4689999999999999999999999999999999986532 234688888887 79999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC----CcEEEEecccCcccC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDFDLSCLTS 822 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~----~~vkl~DFG~a~~~~ 822 (934)
|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+... +.+||+|||++....
T Consensus 94 v~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999999765 459999999999999999999999999999999999998543 359999999986432
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC--
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG-- 900 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~-- 900 (934)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+
T Consensus 172 ~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 224 (342)
T 2qr7_A 172 AE---------------------------NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224 (342)
T ss_dssp CT---------------------------TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST
T ss_pred CC---------------------------CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC
Confidence 11 1123356899999999999988889999999999999999999999986
Q ss_pred -CCHHHHHHHHHcCCCCCCCC--CCCCcccCCC
Q 002342 901 -KTRQKTFANILHKDLKFPSS--TPSSCKAANV 930 (934)
Q Consensus 901 -~~~~~~~~~i~~~~~~~p~~--~~~s~~~k~l 930 (934)
.+..+++..|..+.+.++.. ...|..+++|
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 257 (342)
T 2qr7_A 225 DDTPEEILARIGSGKFSLSGGYWNSVSDTAKDL 257 (342)
T ss_dssp TSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHH
T ss_pred cCCHHHHHHHHccCCcccCccccccCCHHHHHH
Confidence 56678899999999887753 3345555443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=345.41 Aligned_cols=228 Identities=19% Similarity=0.312 Sum_probs=192.2
Q ss_pred ccCCcccccccccC--CcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 667 NLQHFRPIKPLGSG--DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 667 ~~~~y~i~~~LG~G--~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
..++|++++.||+| +||.||++++..+++.||||++..... .......+.+|+.+|+.++||||++++++|.+.+.+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 46789999999999 999999999999999999999986532 445667788999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+|||||++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 99999999999999998765566999999999999999999999999999999999999999999999999988543211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
... ...........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+
T Consensus 182 ~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 182 GQR--------------------QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp TEE--------------------CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccc--------------------ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 000 0000112234579999999999987 678999999999999999999999999988
Q ss_pred HHHHHHHHHcCCC
Q 002342 903 RQKTFANILHKDL 915 (934)
Q Consensus 903 ~~~~~~~i~~~~~ 915 (934)
..+.+..+..+.+
T Consensus 242 ~~~~~~~~~~~~~ 254 (389)
T 3gni_B 242 ATQMLLEKLNGTV 254 (389)
T ss_dssp STTHHHHC-----
T ss_pred HHHHHHHHhcCCC
Confidence 7777766665543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=328.96 Aligned_cols=224 Identities=31% Similarity=0.557 Sum_probs=199.0
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+..++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 45679999999999999999999999999999999997643323333467889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~-- 166 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-- 166 (284)
T ss_dssp EEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS--
T ss_pred EEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc--
Confidence 999999999999999765 3499999999999999999999999999999999999999999999999999844211
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
......+|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+
T Consensus 167 ---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 219 (284)
T 2vgo_A 167 ---------------------------LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219 (284)
T ss_dssp ---------------------------SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ---------------------------cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH
Confidence 11234579999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCC
Q 002342 906 TFANILHKDLKFPSS 920 (934)
Q Consensus 906 ~~~~i~~~~~~~p~~ 920 (934)
....+....+.+|..
T Consensus 220 ~~~~~~~~~~~~~~~ 234 (284)
T 2vgo_A 220 THRRIVNVDLKFPPF 234 (284)
T ss_dssp HHHHHHTTCCCCCTT
T ss_pred HHHHHhccccCCCCc
Confidence 999999988888764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=340.14 Aligned_cols=223 Identities=22% Similarity=0.336 Sum_probs=192.5
Q ss_pred ccccCCcccccccccCCcEEEEEEEEe-------cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 736 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~-------~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 736 (934)
.+..++|++.+.||+|+||.||+|++. .++..||+|++... ........+.+|+.+|+.+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 455689999999999999999999985 34568999999764 2445567889999999999 8999999999
Q ss_pred EEEeCCeEEEEEEccCCCCchhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 002342 737 SFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802 (934)
Q Consensus 737 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NI 802 (934)
++...+.+|+||||+++|+|.+++.... ...++...+..++.||+.||.|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999997643 23589999999999999999999999999999999999
Q ss_pred EEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHH
Q 002342 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882 (934)
Q Consensus 803 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Diw 882 (934)
|++.++.+||+|||++........ ........||+.|+|||++.+..++.++|||
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~-------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvw 289 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDY-------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 289 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCT-------------------------TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHH
T ss_pred EECCCCCEEEccccCCcccCcccc-------------------------eecccCCCcccceECHhHhcCCCCCcHHHHH
Confidence 999999999999999964321110 1122344678999999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 002342 883 ALGILLYEMLY-GYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 883 SlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~ 914 (934)
||||++|+|++ |.+||.+....+++..+..+.
T Consensus 290 slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 322 (370)
T 2psq_A 290 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 322 (370)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 99999999998 999999999988888887765
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=326.04 Aligned_cols=225 Identities=27% Similarity=0.479 Sum_probs=201.3
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
..++|.+.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 35789999999999999999999999999999999987655566677788999999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 168 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-- 168 (294)
T ss_dssp EEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC--
Confidence 99999999999998764 35999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+....+.
T Consensus 169 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 223 (294)
T 2rku_A 169 -------------------------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223 (294)
T ss_dssp -------------------------TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred -------------------------ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 1112345799999999999999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCC
Q 002342 907 FANILHKDLKFPSS 920 (934)
Q Consensus 907 ~~~i~~~~~~~p~~ 920 (934)
+..+..+.+.+|..
T Consensus 224 ~~~~~~~~~~~~~~ 237 (294)
T 2rku_A 224 YLRIKKNEYSIPKH 237 (294)
T ss_dssp HHHHHTTCCCCCTT
T ss_pred HHHHhhccCCCccc
Confidence 98898888877764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=360.00 Aligned_cols=233 Identities=29% Similarity=0.457 Sum_probs=202.2
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
..++|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+|+.++||||+++++++...+.+|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 34689999999999999999999999999999999987655445556788999999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---ecCCcEEEEecccCcccCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl---~~~~~vkl~DFG~a~~~~~ 823 (934)
|||||.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999999999998764 459999999999999999999999999999999999999 4678999999999854321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
. ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.
T Consensus 182 ~----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 232 (484)
T 3nyv_A 182 S----------------------------KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE 232 (484)
T ss_dssp C----------------------------CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred c----------------------------cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH
Confidence 1 11234579999999999977 689999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCC--CCCCCcccCCC
Q 002342 904 QKTFANILHKDLKFPS--STPSSCKAANV 930 (934)
Q Consensus 904 ~~~~~~i~~~~~~~p~--~~~~s~~~k~l 930 (934)
.+++..+..+.+.++. +...|..+++|
T Consensus 233 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 261 (484)
T 3nyv_A 233 YDILKKVEKGKYTFELPQWKKVSESAKDL 261 (484)
T ss_dssp HHHHHHHHHCCCCCCSGGGGGSCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCcccccCCHHHHHH
Confidence 9999999998876653 33445554443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=343.02 Aligned_cols=239 Identities=27% Similarity=0.431 Sum_probs=181.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCC--eE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKT--HV 744 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~--~~ 744 (934)
.++|++++.||+|+||.||+|.+..+++.||||.+.+. .........+.+|+.+|+.+. ||||+++++++...+ .+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 57899999999999999999999999999999998754 334556677889999999997 999999999997544 79
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+|||||+ ++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 87 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 99999995 689998876 35999999999999999999999999999999999999999999999999999765321
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
......... ...................+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.
T Consensus 163 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 163 RRVTNNIPL------SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp CCCCCCGGG------CCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccc------cccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 111000000 000000001111233456689999999999987 6789999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCC
Q 002342 904 QKTFANILHKDLKFP 918 (934)
Q Consensus 904 ~~~~~~i~~~~~~~p 918 (934)
.+.+.+|.. .+.+|
T Consensus 237 ~~~~~~i~~-~~~~p 250 (388)
T 3oz6_A 237 MNQLERIIG-VIDFP 250 (388)
T ss_dssp HHHHHHHHH-HHCCC
T ss_pred HHHHHHHHH-hcCCC
Confidence 999888873 33444
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=333.69 Aligned_cols=225 Identities=27% Similarity=0.479 Sum_probs=201.7
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
..++|.+.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999987655566677888999999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 119 v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-- 194 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-- 194 (335)
T ss_dssp EECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred EEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC--
Confidence 99999999999998764 45999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.
T Consensus 195 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 249 (335)
T 2owb_A 195 -------------------------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 249 (335)
T ss_dssp -------------------------TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred -------------------------cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence 1112345799999999999999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCC
Q 002342 907 FANILHKDLKFPSS 920 (934)
Q Consensus 907 ~~~i~~~~~~~p~~ 920 (934)
+..+..+.+.+|..
T Consensus 250 ~~~~~~~~~~~~~~ 263 (335)
T 2owb_A 250 YLRIKKNEYSIPKH 263 (335)
T ss_dssp HHHHHHTCCCCCTT
T ss_pred HHHHhcCCCCCCcc
Confidence 88888888877764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.38 Aligned_cols=222 Identities=29% Similarity=0.498 Sum_probs=197.5
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4789999999999999999999999999999999976533 445567788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc---EEEEecccCcccCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCK 824 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~---vkl~DFG~a~~~~~~ 824 (934)
|||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++......
T Consensus 84 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999999999988765 45999999999999999999999999999999999999986655 999999998543211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..
T Consensus 162 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 213 (284)
T 3kk8_A 162 ----------------------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 213 (284)
T ss_dssp ----------------------------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ----------------------------ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh
Confidence 1123457999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCC
Q 002342 905 KTFANILHKDLKFPSS 920 (934)
Q Consensus 905 ~~~~~i~~~~~~~p~~ 920 (934)
.....+..+.+.+|..
T Consensus 214 ~~~~~~~~~~~~~~~~ 229 (284)
T 3kk8_A 214 RLYAQIKAGAYDYPSP 229 (284)
T ss_dssp HHHHHHHHTCCCCCTT
T ss_pred HHHHHHHhccccCCch
Confidence 9999999988877754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=350.23 Aligned_cols=211 Identities=25% Similarity=0.453 Sum_probs=181.7
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC------
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 741 (934)
.++|++++.||+|+||.||+|.+..+++.||||++.+. .........+.+|+.+|+.++||||++++++|...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 57899999999999999999999999999999999864 33455667888999999999999999999999654
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
..+|||||||+ ++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 140 ~~~~lv~E~~~-~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 140 QDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp CEEEEEEECCS-EEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred CeEEEEEeCCC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 46799999995 557666643 3899999999999999999999999999999999999999999999999999543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
.. .......+||+.|+|||++.+..|+.++|||||||+||+|++|++||.+.
T Consensus 215 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 215 GT----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp ------------------------------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CC----------------------------CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 11234568999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHc
Q 002342 902 TRQKTFANILH 912 (934)
Q Consensus 902 ~~~~~~~~i~~ 912 (934)
+..+++.+|.+
T Consensus 267 ~~~~~~~~i~~ 277 (464)
T 3ttj_A 267 DYIDQWNKVIE 277 (464)
T ss_dssp SHHHHHHHHHH
T ss_pred CHHHHHHHHHH
Confidence 99888888765
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=341.22 Aligned_cols=218 Identities=27% Similarity=0.455 Sum_probs=186.0
Q ss_pred Cccc--ccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 670 HFRP--IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 670 ~y~i--~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.|.+ .+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+|+.++||||+++++++...+.+|||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc---ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4444 67899999999999999999999999999764 234556788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE--ecCCcEEEEecccCcccCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL--QGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl--~~~~~vkl~DFG~a~~~~~~~ 825 (934)
||||++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 165 ~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~- 242 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR- 242 (373)
T ss_dssp EECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-
T ss_pred EeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-
Confidence 9999999999988654 2459999999999999999999999999999999999999 45678999999998653211
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus 243 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 295 (373)
T 2x4f_A 243 ---------------------------EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE 295 (373)
T ss_dssp ---------------------------CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ---------------------------cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 11234479999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCC
Q 002342 906 TFANILHKDLKFPS 919 (934)
Q Consensus 906 ~~~~i~~~~~~~p~ 919 (934)
.+..|..+...++.
T Consensus 296 ~~~~i~~~~~~~~~ 309 (373)
T 2x4f_A 296 TLNNILACRWDLED 309 (373)
T ss_dssp HHHHHHHTCCCSCS
T ss_pred HHHHHHhccCCCCh
Confidence 99999988776664
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=335.89 Aligned_cols=215 Identities=27% Similarity=0.418 Sum_probs=188.8
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
+.|.+++.||+|+||.||+|.+..+++.||||++.............+.+|+.+|+.++||||+++++++...+..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 46999999999999999999999999999999998654444556678899999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||+. |+|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~------ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------ 205 (348)
T ss_dssp ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS------
T ss_pred ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC------
Confidence 9995 6888887543 2459999999999999999999999999999999999999999999999999985431
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
.....+||+.|+|||++. ...++.++|||||||++|+|++|++||.+.+...
T Consensus 206 -------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 260 (348)
T 1u5q_A 206 -------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 260 (348)
T ss_dssp -------------------------SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred -------------------------CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 112457999999999995 5678899999999999999999999999998888
Q ss_pred HHHHHHcCCCC
Q 002342 906 TFANILHKDLK 916 (934)
Q Consensus 906 ~~~~i~~~~~~ 916 (934)
.+..+..+..+
T Consensus 261 ~~~~~~~~~~~ 271 (348)
T 1u5q_A 261 ALYHIAQNESP 271 (348)
T ss_dssp HHHHHHHSCCC
T ss_pred HHHHHHhcCCC
Confidence 88777776543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=327.19 Aligned_cols=214 Identities=22% Similarity=0.401 Sum_probs=183.3
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++++.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC-CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 68999999999999999999999999999999998653 23445567889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
|||+ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 154 (292)
T 3o0g_A 81 EFCD-QDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP---- 154 (292)
T ss_dssp ECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC----
T ss_pred ecCC-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc----
Confidence 9995 4666666543 245999999999999999999999999999999999999999999999999999653211
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCC-CCCCCHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTP-FRGKTRQKT 906 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~s~~~DiwSlG~iL~elltG~~P-f~~~~~~~~ 906 (934)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+.
T Consensus 155 -----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~ 211 (292)
T 3o0g_A 155 -----------------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_dssp -----------------------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH
T ss_pred -----------------------cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence 11223457899999999998765 79999999999999999976665 677777777
Q ss_pred HHHHHc
Q 002342 907 FANILH 912 (934)
Q Consensus 907 ~~~i~~ 912 (934)
+..+..
T Consensus 212 ~~~i~~ 217 (292)
T 3o0g_A 212 LKRIFR 217 (292)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=338.53 Aligned_cols=218 Identities=31% Similarity=0.490 Sum_probs=177.8
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
..+.|++.+.||+|+||.||+|.+..+++.||||++.+.. ....+.+|+.+|+.++||||+++++++...+..|+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 3478999999999999999999999999999999987542 23567789999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEEEEecccCcccCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~~vkl~DFG~a~~~~~ 823 (934)
||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 126 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999999998764 45999999999999999999999999999999999999975 88999999999854321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 204 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 255 (349)
T 2w4o_A 204 ----------------------------QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255 (349)
T ss_dssp -------------------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC
T ss_pred ----------------------------ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 0112345799999999999999999999999999999999999999987665
Q ss_pred HH-HHHHHHcCCCCCCC
Q 002342 904 QK-TFANILHKDLKFPS 919 (934)
Q Consensus 904 ~~-~~~~i~~~~~~~p~ 919 (934)
.. ++..+..+.+.++.
T Consensus 256 ~~~~~~~i~~~~~~~~~ 272 (349)
T 2w4o_A 256 DQFMFRRILNCEYYFIS 272 (349)
T ss_dssp HHHHHHHHHTTCCCCCT
T ss_pred cHHHHHHHHhCCCccCC
Confidence 54 77888887776654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=334.92 Aligned_cols=224 Identities=24% Similarity=0.334 Sum_probs=187.8
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 744 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 744 (934)
+..++|++.+.||+|+||.||++.+..+++.||||++..... ...+.+|+.+++.+ +||||+++++++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 445789999999999999999999999999999999875421 23577899999999 999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc-----EEEEecccCc
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-----VSLTDFDLSC 819 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~-----vkl~DFG~a~ 819 (934)
|+||||+ +++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 9999999 99999999864 346999999999999999999999999999999999999998887 9999999996
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
........ ...+.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.
T Consensus 159 ~~~~~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~ 218 (330)
T 2izr_A 159 EYIDPETK--------------------KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQ 218 (330)
T ss_dssp ESBCTTTC--------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred eeecCCCC--------------------ccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcc
Confidence 54321110 0011223456789999999999999999999999999999999999999998
Q ss_pred C---CCHHHHHHHHHcCCCC
Q 002342 900 G---KTRQKTFANILHKDLK 916 (934)
Q Consensus 900 ~---~~~~~~~~~i~~~~~~ 916 (934)
+ ....+.+..+......
T Consensus 219 ~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 219 GLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp TCCCSSHHHHHHHHHHHHHH
T ss_pred ccccccHHHHHHHHHhhhcc
Confidence 7 3444556666544433
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=330.89 Aligned_cols=222 Identities=30% Similarity=0.449 Sum_probs=196.0
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccCh---HHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR---NKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+...... .....+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4679999999999999999999999999999999986533221 1356788999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC----cEEEEecccCcc
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCL 820 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~----~vkl~DFG~a~~ 820 (934)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999999764 4599999999999999999999999999999999999999887 799999999854
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 169 ~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 220 (321)
T 2a2a_A 169 IEDG----------------------------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (321)
T ss_dssp CCTT----------------------------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cCcc----------------------------ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence 3211 112345699999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHcCCCCCCC
Q 002342 901 KTRQKTFANILHKDLKFPS 919 (934)
Q Consensus 901 ~~~~~~~~~i~~~~~~~p~ 919 (934)
.+..+.+..+..+.+.+|.
T Consensus 221 ~~~~~~~~~i~~~~~~~~~ 239 (321)
T 2a2a_A 221 DTKQETLANITSVSYDFDE 239 (321)
T ss_dssp SSHHHHHHHHHTTCCCCCH
T ss_pred CCHHHHHHHHHhcccccCh
Confidence 9999999999888777664
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=332.80 Aligned_cols=215 Identities=25% Similarity=0.426 Sum_probs=172.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+|+.++||||+++++++..++..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 468999999999999999999999999999999997543 222335678899999999999999999999999999999
Q ss_pred EEccCCCCchhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 748 TDYCPGGELFLLLDRQ----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
|||++ ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99996 6999888643 123589999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+
T Consensus 161 ~---------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 161 P---------------------------VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp C---------------------------CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred C---------------------------cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 111234578999999999986 468999999999999999999999999999
Q ss_pred HHHHHHHHHc
Q 002342 903 RQKTFANILH 912 (934)
Q Consensus 903 ~~~~~~~i~~ 912 (934)
..+.+..|.+
T Consensus 214 ~~~~~~~i~~ 223 (317)
T 2pmi_A 214 DEEQLKLIFD 223 (317)
T ss_dssp HHHHHHHHHH
T ss_pred hHHHHHHHHH
Confidence 9888887765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=330.82 Aligned_cols=217 Identities=24% Similarity=0.426 Sum_probs=182.6
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
+...++|++++.||+|+||.||+|.+ .+++.||+|++.... ........+.+|+.+|+.++||||+++++++.+++..
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEE-TTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEE-CCCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence 34468999999999999999999998 458999999987542 2333456788999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+|||||+ ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 95 TLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99999995 58888876543 45999999999999999999999999999999999999999999999999999653211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.
T Consensus 173 ---------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (311)
T 3niz_A 173 ---------------------------VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225 (311)
T ss_dssp ---------------------------CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST
T ss_pred ---------------------------cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh
Confidence 112234578999999999976 5689999999999999999999999999888
Q ss_pred HHHHHHHHc
Q 002342 904 QKTFANILH 912 (934)
Q Consensus 904 ~~~~~~i~~ 912 (934)
.+.+..+..
T Consensus 226 ~~~~~~i~~ 234 (311)
T 3niz_A 226 DDQLPKIFS 234 (311)
T ss_dssp TTHHHHHHH
T ss_pred HHHHHHHHH
Confidence 777776654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=356.36 Aligned_cols=231 Identities=27% Similarity=0.446 Sum_probs=197.2
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++++.||+|+||.||+|.+..+++.||||++.+.... ......+.+|+.+|+.++||||+++++++.+...+|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 36899999999999999999999999999999999764322 22346788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe---cCCcEEEEecccCcccCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~---~~~~vkl~DFG~a~~~~~~ 824 (934)
||||.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 100 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999999999998765 4599999999999999999999999999999999999995 4567999999998643211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..
T Consensus 178 ----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 228 (486)
T 3mwu_A 178 ----------------------------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY 228 (486)
T ss_dssp --------------------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ----------------------------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 11234579999999999986 4899999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCC--CCCCCcccCCC
Q 002342 905 KTFANILHKDLKFPS--STPSSCKAANV 930 (934)
Q Consensus 905 ~~~~~i~~~~~~~p~--~~~~s~~~k~l 930 (934)
+++..+..+.+.++. +...|..+++|
T Consensus 229 ~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 229 DILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp HHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred HHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 999999998876653 33455555443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=329.59 Aligned_cols=218 Identities=27% Similarity=0.417 Sum_probs=183.4
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeeccccc--ChHHHHHHHHHHHHHHhC---CCCCccceeEEEEe
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDML---DHPFVPALYASFQT 740 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~--~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~ 740 (934)
+..++|++++.||+|+||.||+|++..+++.||||++...... .......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467999999999999999999999999999999998753211 111123455677777666 59999999999987
Q ss_pred CC-----eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEec
Q 002342 741 KT-----HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815 (934)
Q Consensus 741 ~~-----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DF 815 (934)
.. .+++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 54 5899999994 69999998776566999999999999999999999999999999999999999999999999
Q ss_pred ccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCC
Q 002342 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 895 (934)
Q Consensus 816 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~ 895 (934)
|++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 165 g~a~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 216 (308)
T 3g33_A 165 GLARIYSY----------------------------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216 (308)
T ss_dssp SCTTTSTT----------------------------CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSS
T ss_pred ccccccCC----------------------------CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCC
Confidence 99854321 11223457999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHc
Q 002342 896 TPFRGKTRQKTFANILH 912 (934)
Q Consensus 896 ~Pf~~~~~~~~~~~i~~ 912 (934)
+||.+.+..+.+.++.+
T Consensus 217 ~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 217 PLFCGNSEADQLGKIFD 233 (308)
T ss_dssp CSCCCSSHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHH
Confidence 99999999988888865
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=333.09 Aligned_cols=216 Identities=29% Similarity=0.490 Sum_probs=168.5
Q ss_pred CCcccc---cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCCeE
Q 002342 669 QHFRPI---KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHV 744 (934)
Q Consensus 669 ~~y~i~---~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~ 744 (934)
++|.+. +.||+|+||.||++.+..+++.||||++.+. ....+.+|+.+++.+. ||||+++++++.+....
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 345554 7899999999999999999999999998753 3356778999999996 99999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC---cEEEEecccCccc
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCLT 821 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~---~vkl~DFG~a~~~ 821 (934)
|+|||||++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999999875 4599999999999999999999999999999999999998766 8999999998643
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.
T Consensus 160 ~~~---------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 160 PPD---------------------------NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp CC-------------------------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCC---------------------------CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 211 11223457899999999999999999999999999999999999999864
Q ss_pred C-------HHHHHHHHHcCCCCCCC
Q 002342 902 T-------RQKTFANILHKDLKFPS 919 (934)
Q Consensus 902 ~-------~~~~~~~i~~~~~~~p~ 919 (934)
+ ..+++..+..+.+.++.
T Consensus 213 ~~~~~~~~~~~~~~~i~~~~~~~~~ 237 (325)
T 3kn6_A 213 DRSLTCTSAVEIMKKIKKGDFSFEG 237 (325)
T ss_dssp -----CCCHHHHHHHHTTTCCCCCS
T ss_pred ccccccccHHHHHHHHHcCCCCCCc
Confidence 3 35778888888877664
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.55 Aligned_cols=218 Identities=22% Similarity=0.313 Sum_probs=182.7
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+..++|.+.+.||+|+||.||++.+..+++.||+|.+... .......+.+|+.+++.++||||+++++++.+++..|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 4567999999999999999999999999999999988643 4566678899999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
+||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999999997643 459999999999999999999999999999999999999999999999999997643221
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
...... ..............+||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 163 ~~~~~~-------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~ 224 (310)
T 3s95_A 163 TQPEGL-------------RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224 (310)
T ss_dssp ------------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred cccccc-------------ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence 110000 00000111223356899999999999999999999999999999999999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.04 Aligned_cols=218 Identities=30% Similarity=0.529 Sum_probs=193.7
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++.+.||+|+||.||++.+..++..+|+|.+.+... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 3579999999999999999999999999999999876432 2346788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---ecCCcEEEEecccCcccCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl---~~~~~vkl~DFG~a~~~~~~ 824 (934)
|||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 85 MELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred EeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999999998764 449999999999999999999999999999999999999 77889999999998543211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
.......||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+.+..
T Consensus 163 ----------------------------~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 213 (277)
T 3f3z_A 163 ----------------------------KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS 213 (277)
T ss_dssp ----------------------------SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ----------------------------cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH
Confidence 122345799999999998765 889999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCC
Q 002342 905 KTFANILHKDLKFPS 919 (934)
Q Consensus 905 ~~~~~i~~~~~~~p~ 919 (934)
+....+..+.+.+|.
T Consensus 214 ~~~~~~~~~~~~~~~ 228 (277)
T 3f3z_A 214 EVMLKIREGTFTFPE 228 (277)
T ss_dssp HHHHHHHHCCCCCCH
T ss_pred HHHHHHHhCCCCCCc
Confidence 999999999888775
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=331.66 Aligned_cols=213 Identities=29% Similarity=0.461 Sum_probs=188.1
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
.|...+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4778889999999999999999999999999987542 2334568899999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
|+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 123 ~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----- 194 (321)
T 2c30_A 123 FLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----- 194 (321)
T ss_dssp CCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-----
T ss_pred cCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC-----
Confidence 9999999999865 34999999999999999999999999999999999999999999999999998543211
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~ 909 (934)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..
T Consensus 195 ----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~ 252 (321)
T 2c30_A 195 ----------------------VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252 (321)
T ss_dssp ----------------------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred ----------------------ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1112345799999999999999999999999999999999999999999998888888
Q ss_pred HHcCCC
Q 002342 910 ILHKDL 915 (934)
Q Consensus 910 i~~~~~ 915 (934)
+.....
T Consensus 253 ~~~~~~ 258 (321)
T 2c30_A 253 LRDSPP 258 (321)
T ss_dssp HHHSSC
T ss_pred HhcCCC
Confidence 876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=322.56 Aligned_cols=219 Identities=22% Similarity=0.370 Sum_probs=190.9
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
+.+..++|++.+.||+|+||.||++.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 4466789999999999999999999985 577899999976432 23568899999999999999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
.|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred eEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999999999999997643 4599999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~ 902 (934)
. .........||+.|+|||++.+..++.++||||||+++|+|++ |.+||.+.+
T Consensus 159 ~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 159 D--------------------------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp H--------------------------HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred c--------------------------ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 0 0111223457889999999999999999999999999999999 999999999
Q ss_pred HHHHHHHHHcCC
Q 002342 903 RQKTFANILHKD 914 (934)
Q Consensus 903 ~~~~~~~i~~~~ 914 (934)
..+....+..+.
T Consensus 213 ~~~~~~~~~~~~ 224 (269)
T 4hcu_A 213 NSEVVEDISTGF 224 (269)
T ss_dssp HHHHHHHHHTTC
T ss_pred HHHHHHHHhcCc
Confidence 999998888764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=326.38 Aligned_cols=213 Identities=24% Similarity=0.411 Sum_probs=180.7
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++++.||+|+||.||+|.+ .+++.||+|.+..... .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 6899999999999999999998 7789999999875432 2223356788999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||++ ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 153 (288)
T 1ob3_A 80 EHLD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP---- 153 (288)
T ss_dssp ECCS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EecC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc----
Confidence 9995 58998887643 45999999999999999999999999999999999999999999999999998543210
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+
T Consensus 154 -----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 210 (288)
T 1ob3_A 154 -----------------------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210 (288)
T ss_dssp -------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred -----------------------ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 1112344789999999999764 5899999999999999999999999999988887
Q ss_pred HHHHc
Q 002342 908 ANILH 912 (934)
Q Consensus 908 ~~i~~ 912 (934)
..+.+
T Consensus 211 ~~~~~ 215 (288)
T 1ob3_A 211 MRIFR 215 (288)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=352.03 Aligned_cols=230 Identities=30% Similarity=0.492 Sum_probs=192.9
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++++.||+|+||.||+|+++.++..||+|++.+.... ......+.+|+.+|+.++||||++++++|.+...+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999999999999999999865322 223467889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC---CcEEEEecccCcccCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~---~~vkl~DFG~a~~~~~~~ 825 (934)
|||.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++.....
T Consensus 116 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~-- 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN-- 191 (494)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT--
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC--
Confidence 999999999988765 449999999999999999999999999999999999999764 4599999999855321
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
.......+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+..+
T Consensus 192 --------------------------~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 244 (494)
T 3lij_A 192 --------------------------QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244 (494)
T ss_dssp --------------------------TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred --------------------------CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 11223457999999999986 468999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCC--CCCCcccCCC
Q 002342 906 TFANILHKDLKFPSS--TPSSCKAANV 930 (934)
Q Consensus 906 ~~~~i~~~~~~~p~~--~~~s~~~k~l 930 (934)
++..+..+.+.++.. ...|..+++|
T Consensus 245 ~~~~i~~~~~~~~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 245 ILRKVEKGKYTFDSPEWKNVSEGAKDL 271 (494)
T ss_dssp HHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred HHHHHHhCCCCCCchhcccCCHHHHHH
Confidence 999999998877643 3345444443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=349.76 Aligned_cols=232 Identities=28% Similarity=0.457 Sum_probs=195.9
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccCh----------HHHHHHHHHHHHHHhCCCCCccceeEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR----------NKVHRACAEREILDMLDHPFVPALYAS 737 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~----------~~~~~~~~E~~il~~l~hp~Iv~l~~~ 737 (934)
.++|.+++.||+|+||.||+|.++.+++.||+|++.+...... .....+.+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 5789999999999999999999999999999999986533211 235678899999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC---cEEEEe
Q 002342 738 FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTD 814 (934)
Q Consensus 738 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~---~vkl~D 814 (934)
+.+...+|+|||||+|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999998764 4499999999999999999999999999999999999998776 699999
Q ss_pred cccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhC
Q 002342 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 894 (934)
Q Consensus 815 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG 894 (934)
||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|
T Consensus 193 fg~a~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g 243 (504)
T 3q5i_A 193 FGLSSFFSKD----------------------------YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG 243 (504)
T ss_dssp CTTCEECCTT----------------------------SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHS
T ss_pred CCCCEEcCCC----------------------------CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhC
Confidence 9999653211 12234579999999999874 689999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCC--CCCCCcccCCC
Q 002342 895 YTPFRGKTRQKTFANILHKDLKFPS--STPSSCKAANV 930 (934)
Q Consensus 895 ~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~s~~~k~l 930 (934)
.+||.+.+..+++..+..+.+.++. +...|..+++|
T Consensus 244 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 281 (504)
T 3q5i_A 244 YPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKEL 281 (504)
T ss_dssp SCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHH
Confidence 9999999999999999999887763 23345554443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=337.53 Aligned_cols=230 Identities=29% Similarity=0.472 Sum_probs=191.2
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeeccccc--ChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
.++|++.+.||+|+||.||++.+..+++.||+|++.+.... .......+.+|+.+++.++||||+++++++.+.+..|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 46899999999999999999999999999999999764321 2345678889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccC--------------------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 002342 746 LITDYCPGGELFLLLDRQ--------------------------------------PTKVLKEDAVRFYAAEVVVALEYL 787 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~qil~aL~yL 787 (934)
+|||||+|++|.+++... ....+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998521 012346788899999999999999
Q ss_pred HHCCCeecCCCCCCEEEecCC--cEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCcc
Q 002342 788 HCQGIIYRDLKPENVLLQGNG--HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYI 865 (934)
Q Consensus 788 H~~giiHrDLKp~NILl~~~~--~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~ 865 (934)
|++||+||||||+|||++.++ .+||+|||++........ ..........||+.|+
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~-----------------------~~~~~~~~~~gt~~y~ 241 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN-----------------------GEYYGMTTKAGTPYFV 241 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC-----------------------C--------CCCGGGC
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCc-----------------------cccccccccCCCcccc
Confidence 999999999999999998766 899999999864321100 0011223557999999
Q ss_pred chhhhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 002342 866 APEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSS 920 (934)
Q Consensus 866 aPE~l~~--~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~ 920 (934)
|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..+...++..
T Consensus 242 aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 298 (345)
T 3hko_A 242 APEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP 298 (345)
T ss_dssp CHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG
T ss_pred CchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc
Confidence 9999975 678899999999999999999999999999999999999888766643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=346.16 Aligned_cols=231 Identities=21% Similarity=0.264 Sum_probs=165.5
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe-----CC
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-----KT 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~ 742 (934)
.++|++++.||+|+||.||+|.+..+++.||||++.+. .........+.+|+.+|+.++||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 47899999999999999999999999999999998764 3355566788999999999999999999999943 35
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
.+|+||||+ +++|..++... ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred eEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 799999998 78999998764 459999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhh-cCCCCCchhHHHHHHHHHHHHHh--------
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLY-------- 893 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l-~~~~~s~~~DiwSlG~iL~ellt-------- 893 (934)
....................................+||+.|+|||++ .+..|+.++|||||||+||||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 321110000000000000000000000011234566899999999987 45679999999999999999998
Q ss_pred ---CCCCCCCCC
Q 002342 894 ---GYTPFRGKT 902 (934)
Q Consensus 894 ---G~~Pf~~~~ 902 (934)
|++||.+.+
T Consensus 288 ~~~~~p~f~g~~ 299 (458)
T 3rp9_A 288 HADRGPLFPGSS 299 (458)
T ss_dssp GGGCCCSCC---
T ss_pred cccccccCCCCc
Confidence 888888765
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=339.69 Aligned_cols=223 Identities=24% Similarity=0.370 Sum_probs=185.8
Q ss_pred ccccccCCcccccccccCCcEEEEEEEE-----ecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeE
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 736 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~-----~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 736 (934)
.+.+..++|++.+.||+|+||.||++.+ ..+++.||||++.... .......+.+|+.+++.+ +||||+++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 3456678999999999999999999994 4567899999997542 344557789999999999 7899999999
Q ss_pred EEEeCC-eEEEEEEccCCCCchhhhccCCC--------------------------------------------------
Q 002342 737 SFQTKT-HVCLITDYCPGGELFLLLDRQPT-------------------------------------------------- 765 (934)
Q Consensus 737 ~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~-------------------------------------------------- 765 (934)
++...+ .+|+|||||++|+|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 998754 48999999999999999976432
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCc
Q 002342 766 --------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831 (934)
Q Consensus 766 --------------~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 831 (934)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~----- 248 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD----- 248 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-----
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-----
Confidence 1289999999999999999999999999999999999999999999999999965321110
Q ss_pred chhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 002342 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANI 910 (934)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i 910 (934)
........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+....+.+...
T Consensus 249 --------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 308 (359)
T 3vhe_A 249 --------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 308 (359)
T ss_dssp --------------------CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred --------------------chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH
Confidence 112234578999999999999999999999999999999998 99999987765544444
Q ss_pred Hc
Q 002342 911 LH 912 (934)
Q Consensus 911 ~~ 912 (934)
..
T Consensus 309 ~~ 310 (359)
T 3vhe_A 309 LK 310 (359)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=326.07 Aligned_cols=225 Identities=30% Similarity=0.522 Sum_probs=170.6
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35899999999999999999999999999999999764332333456788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~--- 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--- 165 (278)
T ss_dssp EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC---
Confidence 9999999999998764 345999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
.......+||+.|+|||++.+..++.++||||||+++|+|++|++||...+....+
T Consensus 166 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 221 (278)
T 3cok_A 166 ------------------------HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL 221 (278)
T ss_dssp --------------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---
T ss_pred ------------------------CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH
Confidence 01122457899999999999999999999999999999999999999988777777
Q ss_pred HHHHcCCCCCCCC
Q 002342 908 ANILHKDLKFPSS 920 (934)
Q Consensus 908 ~~i~~~~~~~p~~ 920 (934)
..+....+.+|..
T Consensus 222 ~~~~~~~~~~~~~ 234 (278)
T 3cok_A 222 NKVVLADYEMPSF 234 (278)
T ss_dssp --CCSSCCCCCTT
T ss_pred HHHhhcccCCccc
Confidence 7666666655543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=338.12 Aligned_cols=224 Identities=20% Similarity=0.272 Sum_probs=190.0
Q ss_pred ccccCCcccccccccCCcEEEEEEE-----EecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVE-----LCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 739 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~-----~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 739 (934)
.+..++|++.+.||+|+||.||+|. +..+++.||||.+... ........+.+|+.+++.++||||+++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4556789999999999999999999 4557889999998643 23445567889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCchhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC---cEE
Q 002342 740 TKTHVCLITDYCPGGELFLLLDRQP-----TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVS 811 (934)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~~-----~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~---~vk 811 (934)
.....|+|||||++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999997642 23589999999999999999999999999999999999998555 599
Q ss_pred EEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHH
Q 002342 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891 (934)
Q Consensus 812 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~el 891 (934)
|+|||+++..... ..........||+.|+|||++.+..++.++|||||||++|+|
T Consensus 225 L~DFG~a~~~~~~-------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el 279 (367)
T 3l9p_A 225 IGDFGMARDIYRA-------------------------GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279 (367)
T ss_dssp ECCCHHHHHHHHH-------------------------SSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ECCCccccccccc-------------------------cccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 9999998532110 011223345789999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCC
Q 002342 892 LY-GYTPFRGKTRQKTFANILHKDL 915 (934)
Q Consensus 892 lt-G~~Pf~~~~~~~~~~~i~~~~~ 915 (934)
++ |.+||.+.+..+++..+..+..
T Consensus 280 lt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 280 FSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 98 9999999999999998887663
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=338.30 Aligned_cols=206 Identities=18% Similarity=0.230 Sum_probs=175.4
Q ss_pred cccccCCcccccccccCCcEEEEEE-----EEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC---CCCcccee
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLV-----ELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD---HPFVPALY 735 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a-----~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~ 735 (934)
..+..++|.+.+.||+|+||.||+| .+..+++.||+|++.+. ....+..|+.+++.+. |+||+.++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 3456788999999999999999999 46778999999998754 2345777888888886 89999999
Q ss_pred EEEEeCCeEEEEEEccCCCCchhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec------
Q 002342 736 ASFQTKTHVCLITDYCPGGELFLLLDRQ---PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG------ 806 (934)
Q Consensus 736 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~---~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~------ 806 (934)
+++...+..|||||||++|+|.+++... ....+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 9999999999999999999999999742 2356999999999999999999999999999999999999998
Q ss_pred -----CCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHH
Q 002342 807 -----NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (934)
Q Consensus 807 -----~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Di 881 (934)
++.+||+|||+|..+... .........+||+.|||||++.+..++.++||
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 268 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLF-------------------------PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDY 268 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGS-------------------------CTTEEECCSSCTTSCCCHHHHTTCCBSTHHHH
T ss_pred ccccccCCEEEeeCchhhhhhcc-------------------------CCCceeeeecCCCCCCChHHhcCCCCCccccH
Confidence 899999999999543211 11122345689999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCC
Q 002342 882 WALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 882 wSlG~iL~elltG~~Pf~~ 900 (934)
|||||++|+|++|++||..
T Consensus 269 wslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 269 FGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp HHHHHHHHHHHHSSCCCEE
T ss_pred HHHHHHHHHHHhCCCcccc
Confidence 9999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=330.52 Aligned_cols=224 Identities=21% Similarity=0.307 Sum_probs=193.1
Q ss_pred ccccCCcccccccccCCcEEEEEEEEe-----cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 739 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 739 (934)
.+..++|++.+.||+|+||.||++.+. .+++.||+|++.+.. .......+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 455689999999999999999999997 355899999997642 3455677899999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCchhhhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 002342 740 TKTHVCLITDYCPGGELFLLLDRQP----------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 797 (934)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDL 797 (934)
..+..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 9999999999999999999997642 146999999999999999999999999999999
Q ss_pred CCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCc
Q 002342 798 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 877 (934)
Q Consensus 798 Kp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ 877 (934)
||+|||++.++.+||+|||++....... .........||+.|+|||++.+..++.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~ 255 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSAD-------------------------YYKADGNDAIPIRWMPPESIFYNRYTT 255 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGG-------------------------CBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred CcceEEECCCCeEEEeecCCCcccccCc-------------------------cccccCCCcccceecChhhhccCCcCc
Confidence 9999999999999999999985432110 011223446899999999999999999
Q ss_pred hhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC
Q 002342 878 AVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDL 915 (934)
Q Consensus 878 ~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 915 (934)
++|||||||++|+|++ |..||.+.+..++...+..+..
T Consensus 256 ~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 294 (343)
T 1luf_A 256 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI 294 (343)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred ccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCc
Confidence 9999999999999998 9999999999999988888765
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=325.24 Aligned_cols=215 Identities=27% Similarity=0.391 Sum_probs=182.5
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++++.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++++...+..|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 468999999999999999999999999999999987642 3444556788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+++++|..++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 155 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--- 155 (311)
T ss_dssp EECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc---
Confidence 9999999999888654 45999999999999999999999999999999999999999999999999998653211
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 156 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 211 (311)
T 4agu_A 156 ------------------------SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ 211 (311)
T ss_dssp ----------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 111234578999999999976 6779999999999999999999999999988877
Q ss_pred HHHHHc
Q 002342 907 FANILH 912 (934)
Q Consensus 907 ~~~i~~ 912 (934)
+..+..
T Consensus 212 ~~~~~~ 217 (311)
T 4agu_A 212 LYLIRK 217 (311)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 766643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.44 Aligned_cols=226 Identities=29% Similarity=0.480 Sum_probs=190.8
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+..++|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 34568999999999999999999999999999999999764333334456788999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999999999765 34999999999999999999999999999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.
T Consensus 165 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 216 (276)
T 2h6d_A 165 ----------------------------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216 (276)
T ss_dssp ----------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ----------------------------cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence 11123468999999999988766 5799999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCC
Q 002342 904 QKTFANILHKDLKFPSS 920 (934)
Q Consensus 904 ~~~~~~i~~~~~~~p~~ 920 (934)
...++.+..+.+.+|..
T Consensus 217 ~~~~~~~~~~~~~~~~~ 233 (276)
T 2h6d_A 217 PTLFKKIRGGVFYIPEY 233 (276)
T ss_dssp HHHHHHHHHCCCCCCTT
T ss_pred HHHHHHhhcCcccCchh
Confidence 99999998888777754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.81 Aligned_cols=217 Identities=25% Similarity=0.308 Sum_probs=180.1
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
..++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 35799999999999999999999999999999999987655555666788999999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 112 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-- 187 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE-- 187 (309)
T ss_dssp EEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc--
Confidence 99999999999999764 35999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+...+
T Consensus 188 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (309)
T 2h34_A 188 ------------------------KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM 243 (309)
T ss_dssp ---------------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH
T ss_pred ------------------------ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH
Confidence 01112345699999999999999999999999999999999999999988776644
Q ss_pred HHHHH
Q 002342 907 FANIL 911 (934)
Q Consensus 907 ~~~i~ 911 (934)
...+.
T Consensus 244 ~~~~~ 248 (309)
T 2h34_A 244 GAHIN 248 (309)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 44443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=324.89 Aligned_cols=219 Identities=33% Similarity=0.530 Sum_probs=191.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 368999999999999999999999999999999998642 22335678999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---ecCCcEEEEecccCcccCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl---~~~~~vkl~DFG~a~~~~~~ 824 (934)
|||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 85 MQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161 (304)
T ss_dssp ECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred EEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence 9999999999998764 349999999999999999999999999999999999999 6788999999999853210
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..
T Consensus 162 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 213 (304)
T 2jam_A 162 ----------------------------GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES 213 (304)
T ss_dssp ----------------------------BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred ----------------------------CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 1122346999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCC
Q 002342 905 KTFANILHKDLKFPSS 920 (934)
Q Consensus 905 ~~~~~i~~~~~~~p~~ 920 (934)
..+..+.++.+.++..
T Consensus 214 ~~~~~i~~~~~~~~~~ 229 (304)
T 2jam_A 214 KLFEKIKEGYYEFESP 229 (304)
T ss_dssp HHHHHHHHCCCCCCTT
T ss_pred HHHHHHHcCCCCCCcc
Confidence 9999999988776653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=327.16 Aligned_cols=224 Identities=28% Similarity=0.459 Sum_probs=193.5
Q ss_pred cCCcccc-cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEE
Q 002342 668 LQHFRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 668 ~~~y~i~-~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~ 745 (934)
.+.|.+. +.||+|+||.||++.+..+++.||+|++.+... .......+.+|+.+++.+ .||||+++++++...+..|
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 3568887 889999999999999999999999999986532 233456788999999999 5699999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEEEEecccCcccC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTS 822 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~~vkl~DFG~a~~~~ 822 (934)
+|||||.+++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 9999999999999997665567999999999999999999999999999999999999987 7899999999996532
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 186 ~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 186 HA----------------------------CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp ------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cc----------------------------cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11 11234579999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCC
Q 002342 903 RQKTFANILHKDLKFPSS 920 (934)
Q Consensus 903 ~~~~~~~i~~~~~~~p~~ 920 (934)
..+.+..+......++..
T Consensus 238 ~~~~~~~i~~~~~~~~~~ 255 (327)
T 3lm5_A 238 NQETYLNISQVNVDYSEE 255 (327)
T ss_dssp HHHHHHHHHHTCCCCCTT
T ss_pred chHHHHHHHhcccccCch
Confidence 999999888877766654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=327.85 Aligned_cols=218 Identities=27% Similarity=0.430 Sum_probs=183.9
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC--eE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT--HV 744 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~ 744 (934)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++.... ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 45789999999999999999999999999999999975432 223466789999999999999999999998655 88
Q ss_pred EEEEEccCCCCchhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE----ecCCcEEEEecccCc
Q 002342 745 CLITDYCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL----QGNGHVSLTDFDLSC 819 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl----~~~~~vkl~DFG~a~ 819 (934)
|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999999976422 239999999999999999999999999999999999999 677789999999996
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc--------CCCCCchhHHHHHHHHHHHH
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA--------GAGHTSAVDWWALGILLYEM 891 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~~s~~~DiwSlG~iL~el 891 (934)
..... ......+||+.|+|||++. +..++.++|||||||++|+|
T Consensus 165 ~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el 216 (319)
T 4euu_A 165 ELEDD----------------------------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (319)
T ss_dssp ECCTT----------------------------CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHH
T ss_pred ecCCC----------------------------CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHH
Confidence 53211 1123457999999999996 57888999999999999999
Q ss_pred HhCCCCCCCC----CHHHHHHHHHcCC
Q 002342 892 LYGYTPFRGK----TRQKTFANILHKD 914 (934)
Q Consensus 892 ltG~~Pf~~~----~~~~~~~~i~~~~ 914 (934)
++|+.||... ...+++..+..+.
T Consensus 217 ~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 217 ATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp HHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred HhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 9999999743 3355666666654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=334.12 Aligned_cols=230 Identities=23% Similarity=0.349 Sum_probs=190.1
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEe-----cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeE
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 736 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 736 (934)
.+.+..++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+|+.+ +||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 35567789999999999999999999983 466789999997542 233456788999999999 8999999999
Q ss_pred EEEeCCeEEEEEEccCCCCchhhhccCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 002342 737 SFQTKTHVCLITDYCPGGELFLLLDRQPT---------------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795 (934)
Q Consensus 737 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------~~l~~~~~~~i~~qil~aL~yLH~~giiHr 795 (934)
++...+..|+||||+++++|.+++..... ..+++..+..++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99999999999999999999999976532 237999999999999999999999999999
Q ss_pred CCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC
Q 002342 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 875 (934)
Q Consensus 796 DLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~ 875 (934)
||||+|||++.++.+||+|||++....... .........||+.|+|||++.+..+
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~ 251 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDS-------------------------NYVVRGNARLPVKWMAPESLFEGIY 251 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCT-------------------------TSEEETTEEECGGGCCHHHHHHCCC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCc-------------------------cceeccCccCccCccCHHHhccCCC
Confidence 999999999999999999999986432110 0112234467899999999999999
Q ss_pred CchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCC
Q 002342 876 TSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPS 919 (934)
Q Consensus 876 s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~ 919 (934)
+.++|||||||++|+|++ |.+||.+......+..+.......+.
T Consensus 252 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (344)
T 1rjb_A 252 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ 296 (344)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCC
T ss_pred ChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCC
Confidence 999999999999999998 99999988877666666665544433
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=331.99 Aligned_cols=224 Identities=23% Similarity=0.343 Sum_probs=193.8
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecC-------CeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcccee
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGS-------GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 735 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~-------~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~ 735 (934)
+.+..++|.+.+.||+|+||.||+|.+..+ +..||+|++... ........+.+|+.+++.+ +||||++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 446678999999999999999999998643 368999999764 2445567889999999999 999999999
Q ss_pred EEEEeCCeEEEEEEccCCCCchhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 002342 736 ASFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801 (934)
Q Consensus 736 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~N 801 (934)
+++...+..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999997653 2359999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHH
Q 002342 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (934)
Q Consensus 802 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Di 881 (934)
||++.++.+||+|||++....... .........||+.|+|||++.+..++.++||
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 276 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHID-------------------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 276 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCC-------------------------TTCCCTTCCCGGGGSCHHHHHSCCCCHHHHH
T ss_pred EEEcCCCcEEEcccCccccccccc-------------------------ccccccCCCCCcceeCHHHhcCCCCCchhHH
Confidence 999999999999999996542111 0112234467899999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 002342 882 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 882 wSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~ 914 (934)
|||||++|+|++ |..||.+.+..++...+..+.
T Consensus 277 wslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 310 (382)
T 3tt0_A 277 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 310 (382)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999999999 999999999999888887764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.32 Aligned_cols=226 Identities=21% Similarity=0.309 Sum_probs=194.4
Q ss_pred cccccccCCcccccccccCCcEEEEEEEEe-----cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeE
Q 002342 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736 (934)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 736 (934)
+.+.+..++|.+.+.||+|+||.||++.+. .++..||+|++.... .......+.+|+.+|+.++||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 445667789999999999999999999984 455899999987542 4556678899999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCchhhhccCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 002342 737 SFQTKTHVCLITDYCPGGELFLLLDRQPT----------------------KVLKEDAVRFYAAEVVVALEYLHCQGIIY 794 (934)
Q Consensus 737 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~----------------------~~l~~~~~~~i~~qil~aL~yLH~~giiH 794 (934)
++...+..|+||||+++++|.+++..... ..+++..+..++.||+.||.|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 99999999999999999999999976432 34899999999999999999999999999
Q ss_pred cCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC
Q 002342 795 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 874 (934)
Q Consensus 795 rDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~ 874 (934)
|||||+|||++.++.+||+|||++........ ........||+.|+|||++.+..
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~ 228 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDS-------------------------YVKRSQGRIPVKWMAIESLFDHI 228 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSC-------------------------EECSSCCCSCGGGCCHHHHHHCE
T ss_pred cccchheEEEcCCCCEEEcccccccccccccc-------------------------ceeccCCCCcccccChhhhcCCC
Confidence 99999999999999999999999865321110 11123346788999999999999
Q ss_pred CCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 002342 875 HTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 875 ~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~ 914 (934)
++.++|||||||++|+|++ |..||.+.+...+...+..+.
T Consensus 229 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 269 (314)
T 2ivs_A 229 YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH 269 (314)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred cCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCC
Confidence 9999999999999999999 999999999888888877654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=322.27 Aligned_cols=221 Identities=23% Similarity=0.325 Sum_probs=194.9
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
.+.+..++|++.+.||+|+||.||++.+..++..||+|.+... ......+.+|+.+++.++||||+++++++...+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 3456778999999999999999999999999999999998753 334567889999999999999999999999999
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
..|+||||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999999999987666679999999999999999999999999999999999999999999999999986542
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~ 901 (934)
... ........||+.|+|||++.+..++.++||||||+++|+|++ |.+||.+.
T Consensus 163 ~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~ 216 (288)
T 3kfa_A 163 GDT--------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216 (288)
T ss_dssp SSS--------------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCc--------------------------cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 111 111223457889999999999999999999999999999999 99999998
Q ss_pred CHHHHHHHHHcC
Q 002342 902 TRQKTFANILHK 913 (934)
Q Consensus 902 ~~~~~~~~i~~~ 913 (934)
+.......+..+
T Consensus 217 ~~~~~~~~~~~~ 228 (288)
T 3kfa_A 217 DLSQVYELLEKD 228 (288)
T ss_dssp CGGGHHHHHHTT
T ss_pred CHHHHHHHHhcc
Confidence 888887777654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.03 Aligned_cols=227 Identities=27% Similarity=0.433 Sum_probs=183.4
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccC-hHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
+..++|++.+.||+|+||.||++.+ ++..||+|++....... ......+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 4568999999999999999999998 58899999987643222 23356788999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCCCCEEEec--------CCcEEEE
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG---IIYRDLKPENVLLQG--------NGHVSLT 813 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~g---iiHrDLKp~NILl~~--------~~~vkl~ 813 (934)
|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++| |+||||||+|||++. ++.+||+
T Consensus 82 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999999864 35999999999999999999999999 999999999999985 6789999
Q ss_pred ecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh
Q 002342 814 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 893 (934)
Q Consensus 814 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt 893 (934)
|||++...... ......||+.|+|||++.+..++.++||||||+++|+|++
T Consensus 159 Dfg~~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 209 (271)
T 3dtc_A 159 DFGLAREWHRT-----------------------------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT 209 (271)
T ss_dssp CCCC------------------------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHH
T ss_pred cCCcccccccc-----------------------------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 99998543210 1123468999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 002342 894 GYTPFRGKTRQKTFANILHKDLKFPSSTPSSCK 926 (934)
Q Consensus 894 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~ 926 (934)
|+.||.+.+.......+..+....+.....+..
T Consensus 210 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (271)
T 3dtc_A 210 GEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEP 242 (271)
T ss_dssp CCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred CCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHH
Confidence 999999999988888887777655544333333
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=318.54 Aligned_cols=221 Identities=31% Similarity=0.506 Sum_probs=192.2
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccCh---HHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR---NKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.++|++.+.||+|+||.||++.+..+++.||+|++.+...... .....+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3579999999999999999999999999999999986533221 1356788999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC----cEEEEecccCcc
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCL 820 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~----~vkl~DFG~a~~ 820 (934)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 84 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999999764 4599999999999999999999999999999999999998877 899999999854
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+
T Consensus 162 ~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 213 (283)
T 3bhy_A 162 IEAG----------------------------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213 (283)
T ss_dssp CC------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccCC----------------------------CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence 3211 111234689999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHcCCCCCC
Q 002342 901 KTRQKTFANILHKDLKFP 918 (934)
Q Consensus 901 ~~~~~~~~~i~~~~~~~p 918 (934)
.+..+.+..+......++
T Consensus 214 ~~~~~~~~~~~~~~~~~~ 231 (283)
T 3bhy_A 214 ETKQETLTNISAVNYDFD 231 (283)
T ss_dssp SSHHHHHHHHHTTCCCCC
T ss_pred cchHHHHHHhHhcccCCc
Confidence 999999998888777665
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=336.96 Aligned_cols=225 Identities=22% Similarity=0.323 Sum_probs=182.7
Q ss_pred cccccccCCcccccccccCCcEEEEEEEEe---cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEE
Q 002342 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF 738 (934)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 738 (934)
....+..++|.+.+.||+|+||.||++++. .++..||||.+.... .......+.+|+.+|++++||||+++++++
T Consensus 38 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 115 (373)
T 2qol_A 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVV 115 (373)
T ss_dssp TSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred HHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 344567789999999999999999999987 467789999987542 345567789999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccC
Q 002342 739 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (934)
Q Consensus 739 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a 818 (934)
...+..|+|||||++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 116 ~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 116 TKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred eeCCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence 9999999999999999999999764 345999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTP 897 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~P 897 (934)
......... ........+++.|+|||++.+..++.++|||||||++|+|++ |+.|
T Consensus 195 ~~~~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P 250 (373)
T 2qol_A 195 RVLEDDPEA------------------------AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250 (373)
T ss_dssp -------------------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CT
T ss_pred cccccCCcc------------------------ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCC
Confidence 654321100 011112346789999999999999999999999999999997 9999
Q ss_pred CCCCCHHHHHHHHHcC
Q 002342 898 FRGKTRQKTFANILHK 913 (934)
Q Consensus 898 f~~~~~~~~~~~i~~~ 913 (934)
|.+.+..+++..+..+
T Consensus 251 ~~~~~~~~~~~~i~~~ 266 (373)
T 2qol_A 251 YWEMSNQDVIKAVDEG 266 (373)
T ss_dssp TTTCCHHHHHHHHHTT
T ss_pred CCCCCHHHHHHHHHcC
Confidence 9999999888888665
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=326.86 Aligned_cols=228 Identities=21% Similarity=0.336 Sum_probs=192.0
Q ss_pred cccccCCcccccccccCCcEEEEEEEE-----ecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEE
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS 737 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~-----~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 737 (934)
+.+..++|++.+.||+|+||.||++.+ ..+++.||+|++.... .......+.+|+.+++.+ +||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 456678999999999999999999996 3467899999997542 334557788999999999 99999999999
Q ss_pred EEeCCeEEEEEEccCCCCchhhhccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 002342 738 FQTKTHVCLITDYCPGGELFLLLDRQPT----------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801 (934)
Q Consensus 738 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~N 801 (934)
+...+..|+||||+++++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 9999999999999999999999976532 248999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHH
Q 002342 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (934)
Q Consensus 802 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Di 881 (934)
||++.++.+||+|||++........ ........||+.|+|||++.+..++.++||
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 230 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSN-------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDV 230 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT-------------------------SEECSSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred EEEcCCCCEEEcccccccccccccc-------------------------ceeccCCCCcceeeChHHhcCCCCChHHHH
Confidence 9999999999999999865422110 111234467889999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCC
Q 002342 882 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFP 918 (934)
Q Consensus 882 wSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p 918 (934)
|||||++|+|++ |.+||.+......+..+.......+
T Consensus 231 ~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 268 (313)
T 1t46_A 231 WSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML 268 (313)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC
T ss_pred HHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC
Confidence 999999999998 9999998777666555555444433
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=329.65 Aligned_cols=216 Identities=22% Similarity=0.344 Sum_probs=178.1
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
...++|++++.||+|+||.||++.+..+++.||||++.... ........+.+|+.+|+.++||||+++++++...+.+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc-cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 34679999999999999999999999999999999997643 23334456778999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe-----cCCcEEEEecccCcc
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-----GNGHVSLTDFDLSCL 820 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~-----~~~~vkl~DFG~a~~ 820 (934)
+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||++..
T Consensus 110 lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999995 6999999775 3499999999999999999999999999999999999995 445699999999854
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.
T Consensus 187 ~~~~---------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 239 (329)
T 3gbz_A 187 FGIP---------------------------IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239 (329)
T ss_dssp HC--------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCc---------------------------ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 3211 1122345789999999999875 48999999999999999999999999
Q ss_pred CCCHHHHHHHHHc
Q 002342 900 GKTRQKTFANILH 912 (934)
Q Consensus 900 ~~~~~~~~~~i~~ 912 (934)
+.+..+.+..+..
T Consensus 240 ~~~~~~~~~~~~~ 252 (329)
T 3gbz_A 240 GDSEIDQLFKIFE 252 (329)
T ss_dssp CSSHHHHHHHHHH
T ss_pred CCCHHHHHHHHHH
Confidence 9999888887765
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=322.66 Aligned_cols=222 Identities=30% Similarity=0.445 Sum_probs=180.6
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
..++|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 45789999999999999999999999999999999986544556667788999999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 747 ITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
||||+++++|.+++... ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 99999999999998641 2355999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--C
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK--T 902 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~--~ 902 (934)
........|++.|+|||++.+..++.++||||||+++|+|++|..||.+. .
T Consensus 190 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 242 (310)
T 2wqm_A 190 ---------------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 242 (310)
T ss_dssp ------------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC
T ss_pred ---------------------------CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh
Confidence 01122457899999999999999999999999999999999999999764 3
Q ss_pred HHHHHHHHHcCCC
Q 002342 903 RQKTFANILHKDL 915 (934)
Q Consensus 903 ~~~~~~~i~~~~~ 915 (934)
.......+..+.+
T Consensus 243 ~~~~~~~~~~~~~ 255 (310)
T 2wqm_A 243 LYSLCKKIEQCDY 255 (310)
T ss_dssp HHHHHHHHHTTCS
T ss_pred HHHHHHHhhcccC
Confidence 3455666666554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=331.09 Aligned_cols=212 Identities=25% Similarity=0.456 Sum_probs=179.1
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC-----
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 742 (934)
.++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 579999999999999999999999999999999997642 34455677889999999999999999999998654
Q ss_pred -eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 743 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 743 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
..|+|||||+ ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred cceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 7899999995 678888753 3899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.
T Consensus 178 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 178 GT----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp ----------------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cc----------------------------ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 21 01123457999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHcC
Q 002342 902 TRQKTFANILHK 913 (934)
Q Consensus 902 ~~~~~~~~i~~~ 913 (934)
+..+.+..+.+.
T Consensus 230 ~~~~~~~~i~~~ 241 (371)
T 2xrw_A 230 DHIDQWNKVIEQ 241 (371)
T ss_dssp SHHHHHHHHHC-
T ss_pred CHHHHHHHHHHH
Confidence 998888888764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=337.89 Aligned_cols=229 Identities=21% Similarity=0.319 Sum_probs=194.2
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
.+.+..++|++.+.||+|+||.||++.+..+++.||||++.... .......+.+|+.+|+.++||||+++++++...+
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 34567789999999999999999999999899999999987542 3445567889999999999999999999999999
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
..|+|||||++++|.+++... ...++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred CcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 999999999999999999764 2358999999999999999999999999999999999999999999999999985422
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~ 901 (934)
.... ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 265 ~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~ 319 (377)
T 3cbl_A 265 DGVY-------------------------AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319 (377)
T ss_dssp TSEE-------------------------ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred CCce-------------------------eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1000 001112245778999999998889999999999999999998 99999999
Q ss_pred CHHHHHHHHHcCC-CCCCC
Q 002342 902 TRQKTFANILHKD-LKFPS 919 (934)
Q Consensus 902 ~~~~~~~~i~~~~-~~~p~ 919 (934)
+..+....+..+. +++|.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~ 338 (377)
T 3cbl_A 320 SNQQTREFVEKGGRLPCPE 338 (377)
T ss_dssp CHHHHHHHHHTTCCCCCCT
T ss_pred CHHHHHHHHHcCCCCCCCC
Confidence 9988887776653 34443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.37 Aligned_cols=219 Identities=18% Similarity=0.308 Sum_probs=190.1
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC--C
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--T 742 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~ 742 (934)
.+..++|++.+.||+|+||.||++.+ ++..||+|++.... ........+.+|+.+++.++||||+++++++.+. .
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 45678999999999999999999998 58899999998643 2445557789999999999999999999999876 7
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
..++||||+++++|.+++.......+++..+..++.||+.||.|||++| |+||||||+||+++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 8899999999999999998765556999999999999999999999999 99999999999999999999999998733
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCc---hhHHHHHHHHHHHHHhCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS---AVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~---~~DiwSlG~iL~elltG~~P 897 (934)
.. .....||+.|+|||++.+..++. ++|||||||++|+|++|+.|
T Consensus 163 ~~--------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 210 (271)
T 3kmu_A 163 FQ--------------------------------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210 (271)
T ss_dssp TS--------------------------------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCT
T ss_pred ec--------------------------------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 11 12346899999999998765544 89999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCC
Q 002342 898 FRGKTRQKTFANILHKDLKFP 918 (934)
Q Consensus 898 f~~~~~~~~~~~i~~~~~~~p 918 (934)
|.+.+..+....+.......+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~ 231 (271)
T 3kmu_A 211 FADLSNMEIGMKVALEGLRPT 231 (271)
T ss_dssp TTTSCHHHHHHHHHHSCCCCC
T ss_pred ccccChHHHHHHHHhcCCCCC
Confidence 999999888888876654433
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=321.52 Aligned_cols=220 Identities=30% Similarity=0.504 Sum_probs=187.7
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|.+.+.||+|+||.||+|.+..++..+|+|++.+.. .......+.+|+.+|+.++||||+++++++.+....|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 68999999999999999999999999999999998653 2233567889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---ecCCcEEEEecccCcccCC
Q 002342 749 DYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 749 E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl---~~~~~vkl~DFG~a~~~~~ 823 (934)
||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999999999988542 23559999999999999999999999999999999999999 4567899999999854321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
. ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 180 ~----------------------------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~ 230 (285)
T 3is5_A 180 D----------------------------EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230 (285)
T ss_dssp -----------------------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred c----------------------------ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH
Confidence 1 1123457999999999986 5688999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCC
Q 002342 904 QKTFANILHKDLKFPS 919 (934)
Q Consensus 904 ~~~~~~i~~~~~~~p~ 919 (934)
.+....+..+...++.
T Consensus 231 ~~~~~~~~~~~~~~~~ 246 (285)
T 3is5_A 231 EEVQQKATYKEPNYAV 246 (285)
T ss_dssp HHHHHHHHHCCCCCCC
T ss_pred HHHHhhhccCCccccc
Confidence 8888888776665554
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=333.92 Aligned_cols=210 Identities=29% Similarity=0.479 Sum_probs=180.2
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC------
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 741 (934)
.++|++++.||+|+||.||+|.+..+|+.||||.+... .........+.+|+.+|+.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSST-TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcc-ccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 47899999999999999999999999999999998654 23445567788999999999999999999999865
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 3469999999 8999999876 34999999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+
T Consensus 179 ~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 179 DS------------------------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp CS------------------------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cc------------------------------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 11 1234578999999999987 7889999999999999999999999999
Q ss_pred CCHHHHHHHHHc
Q 002342 901 KTRQKTFANILH 912 (934)
Q Consensus 901 ~~~~~~~~~i~~ 912 (934)
.+..+.+..|.+
T Consensus 229 ~~~~~~l~~i~~ 240 (367)
T 1cm8_A 229 SDHLDQLKEIMK 240 (367)
T ss_dssp SSHHHHHHHHHH
T ss_pred CCHHHHHHHHHH
Confidence 999888887765
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=324.41 Aligned_cols=227 Identities=27% Similarity=0.443 Sum_probs=184.6
Q ss_pred cCCcccc-cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEE
Q 002342 668 LQHFRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 668 ~~~y~i~-~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~ 745 (934)
.+.|++. +.||+|+||.||+|.+..+++.||||++.+.. ......+.+|+.+|.++ +||||+++++++.+.+.+|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4679986 78999999999999999999999999997642 23346788999999985 7999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc---EEEEecccCcccC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTS 822 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~---vkl~DFG~a~~~~ 822 (934)
+|||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 88 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 999999999999999765 45999999999999999999999999999999999999988765 9999999986432
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-----CCCCchhHHHHHHHHHHHHHhCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~s~~~DiwSlG~iL~elltG~~P 897 (934)
..... ...........+||+.|+|||++.+ ..++.++|||||||++|+|++|++|
T Consensus 166 ~~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~p 225 (316)
T 2ac3_A 166 LNGDC--------------------SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225 (316)
T ss_dssp ------------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCS
T ss_pred cCCcc--------------------ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCC
Confidence 11000 0000112234579999999999975 5578899999999999999999999
Q ss_pred CCCCC---------------HHHHHHHHHcCCCCCCC
Q 002342 898 FRGKT---------------RQKTFANILHKDLKFPS 919 (934)
Q Consensus 898 f~~~~---------------~~~~~~~i~~~~~~~p~ 919 (934)
|.+.+ ...++..+..+.+.+|.
T Consensus 226 f~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 262 (316)
T 2ac3_A 226 FVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPD 262 (316)
T ss_dssp CCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCH
T ss_pred CcccccccccccccccchhHHHHHHHHHhccCcccCc
Confidence 98765 24567788888887774
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=330.98 Aligned_cols=213 Identities=25% Similarity=0.402 Sum_probs=178.3
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++++.||+|+||.||++.+..+++.||+|++..... ......+.+|+.+|+.++||||+++++++...+..|+||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 689999999999999999999999999999999875321 111123457999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~---- 153 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---- 153 (324)
T ss_dssp ECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC----
Confidence 9995 6899988765 345999999999999999999999999999999999999999999999999998543211
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+
T Consensus 154 -----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 210 (324)
T 3mtl_A 154 -----------------------TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL 210 (324)
T ss_dssp --------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred -----------------------ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 111234478999999999987 56899999999999999999999999999998888
Q ss_pred HHHHc
Q 002342 908 ANILH 912 (934)
Q Consensus 908 ~~i~~ 912 (934)
..+..
T Consensus 211 ~~i~~ 215 (324)
T 3mtl_A 211 HFIFR 215 (324)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87765
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=329.59 Aligned_cols=222 Identities=30% Similarity=0.508 Sum_probs=192.9
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeeccccc-----ChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeC
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-----NRNKVHRACAEREILDML-DHPFVPALYASFQTK 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~-----~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~ 741 (934)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... .......+.+|+.+++.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 35799999999999999999999989999999998764311 112245678899999999 899999999999999
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
+..|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 9999999999999999999764 45999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC------CCCCchhHHHHHHHHHHHHHhCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG------AGHTSAVDWWALGILLYEMLYGY 895 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~~s~~~DiwSlG~iL~elltG~ 895 (934)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 251 ~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~ 302 (365)
T 2y7j_A 251 EPG----------------------------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS 302 (365)
T ss_dssp CTT----------------------------CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred CCC----------------------------cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCC
Confidence 211 11234579999999999963 35788999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCC
Q 002342 896 TPFRGKTRQKTFANILHKDLKFPS 919 (934)
Q Consensus 896 ~Pf~~~~~~~~~~~i~~~~~~~p~ 919 (934)
+||.+.+....+..+..+.+.++.
T Consensus 303 ~pf~~~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 303 PPFWHRRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCC
Confidence 999999999999999888877653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=337.22 Aligned_cols=211 Identities=27% Similarity=0.458 Sum_probs=186.9
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC------CCCCccceeEEEEe
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML------DHPFVPALYASFQT 740 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l------~hp~Iv~l~~~~~~ 740 (934)
...+|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+ +|+||+.+++++..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 357899999999999999999999999999999998753 34456677888888877 57799999999999
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc--EEEEecccC
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--VSLTDFDLS 818 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~--vkl~DFG~a 818 (934)
.+++|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 171 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999999999 579999998776566999999999999999999999999999999999999999887 999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
.... ......+||+.|+|||++.+..++.++|||||||+||+|++|.+||
T Consensus 250 ~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf 299 (429)
T 3kvw_A 250 CYEH------------------------------QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLL 299 (429)
T ss_dssp EETT------------------------------CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred eecC------------------------------CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCC
Confidence 5421 1123457999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHc
Q 002342 899 RGKTRQKTFANILH 912 (934)
Q Consensus 899 ~~~~~~~~~~~i~~ 912 (934)
.+.+..+.+..+..
T Consensus 300 ~~~~~~~~l~~i~~ 313 (429)
T 3kvw_A 300 PGEDEGDQLACMIE 313 (429)
T ss_dssp CCSSHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHH
Confidence 99999888877764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=316.41 Aligned_cols=221 Identities=24% Similarity=0.356 Sum_probs=188.6
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
.+.+..++|++++.||+|+||.||++.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 45577889999999999999999999874 678899999986432 2356889999999999999999999999999
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999999999999999997632 459999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~ 901 (934)
.. .........||+.|+|||++.+..++.++||||||+++|+|++ |++||.+.
T Consensus 172 ~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 172 DD--------------------------EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp CH--------------------------HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cc--------------------------ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 10 0011223357889999999999999999999999999999998 99999999
Q ss_pred CHHHHHHHHHcCCC
Q 002342 902 TRQKTFANILHKDL 915 (934)
Q Consensus 902 ~~~~~~~~i~~~~~ 915 (934)
+..+....+..+..
T Consensus 226 ~~~~~~~~~~~~~~ 239 (283)
T 3gen_A 226 TNSETAEHIAQGLR 239 (283)
T ss_dssp CHHHHHHHHHTTCC
T ss_pred ChhHHHHHHhcccC
Confidence 99999988887654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=324.62 Aligned_cols=216 Identities=25% Similarity=0.357 Sum_probs=185.0
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
..++|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...+..|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 4679999999999999999999999999999999987642 344455667899999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 102 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 177 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-- 177 (331)
T ss_dssp EEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--
Confidence 99999999888876654 34999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+
T Consensus 178 -------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 232 (331)
T 4aaa_A 178 -------------------------GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID 232 (331)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -------------------------ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 1112345789999999999875 78899999999999999999999999998887
Q ss_pred HHHHHHc
Q 002342 906 TFANILH 912 (934)
Q Consensus 906 ~~~~i~~ 912 (934)
.+..+..
T Consensus 233 ~~~~~~~ 239 (331)
T 4aaa_A 233 QLYHIMM 239 (331)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7766653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=327.44 Aligned_cols=219 Identities=25% Similarity=0.376 Sum_probs=179.2
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC--CCccceeEEEEeCCe
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTKTH 743 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~~~ 743 (934)
+..+.|++++.||+|+||.||++.+ .+++.||+|++.... ........+.+|+.+|+.++| |||+++++++.....
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 4567899999999999999999988 568899999997643 345556788999999999976 999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|+|||+. +++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 84 ~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 84 IYMVMECG-NIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEEECCC-SEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEEeCC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99999954 89999999875 4599999999999999999999999999999999999997 68999999999965421
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-----------CCCCchhHHHHHHHHHHHHH
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----------AGHTSAVDWWALGILLYEML 892 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----------~~~s~~~DiwSlG~iL~ell 892 (934)
.. ........+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 160 ~~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell 214 (343)
T 3dbq_A 160 DT-------------------------TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 214 (343)
T ss_dssp -----------------------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHH
T ss_pred cc-------------------------ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHH
Confidence 11 0112235579999999999965 67888999999999999999
Q ss_pred hCCCCCCCCCH-HHHHHHHHcCCC
Q 002342 893 YGYTPFRGKTR-QKTFANILHKDL 915 (934)
Q Consensus 893 tG~~Pf~~~~~-~~~~~~i~~~~~ 915 (934)
+|++||.+... ...+..+.....
T Consensus 215 ~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 215 YGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp HSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred hCCCcchhhhhHHHHHHHHhcCCc
Confidence 99999987443 355555655433
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=320.34 Aligned_cols=220 Identities=18% Similarity=0.265 Sum_probs=184.2
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCC-------eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSG-------QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS 737 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~-------~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 737 (934)
.+..++|++.+.||+|+||.||++.+..++ ..||+|++.+. .......+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 355679999999999999999999998877 57999998754 33455678899999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc--------
Q 002342 738 FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-------- 809 (934)
Q Consensus 738 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~-------- 809 (934)
+...+..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999999997652 44999999999999999999999999999999999999998887
Q ss_pred EEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHH
Q 002342 810 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILL 888 (934)
Q Consensus 810 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL 888 (934)
+||+|||++.... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 160 ~kl~Dfg~~~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 208 (289)
T 4fvq_A 160 IKLSDPGISITVL-------------------------------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTL 208 (289)
T ss_dssp EEECCCCSCTTTS-------------------------------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHH
T ss_pred eeeccCccccccc-------------------------------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHH
Confidence 9999999984321 1123458899999999987 7789999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 002342 889 YEMLY-GYTPFRGKTRQKTFANILHKDLKFPSS 920 (934)
Q Consensus 889 ~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 920 (934)
|+|++ |.+||......... .+......+|..
T Consensus 209 ~el~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~ 240 (289)
T 4fvq_A 209 WEICSGGDKPLSALDSQRKL-QFYEDRHQLPAP 240 (289)
T ss_dssp HHHHTTTCCTTTTSCHHHHH-HHHHTTCCCCCC
T ss_pred HHHHcCCCCCccccchHHHH-HHhhccCCCCCC
Confidence 99999 55556555554444 444455555543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=328.41 Aligned_cols=222 Identities=21% Similarity=0.327 Sum_probs=184.7
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeE----EEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY----FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 739 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~----vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 739 (934)
..+..++|++++.||+|+||.||+|.+..++.. ||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 345678999999999999999999999888876 6666654321 1222345678999999999999999999886
Q ss_pred eCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 740 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
+...++||||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred -CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence 46789999999999999999764 3458999999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPF 898 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf 898 (934)
....... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 164 ~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 218 (325)
T 3kex_A 164 LLPPDDK-------------------------QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218 (325)
T ss_dssp GSCCCTT-------------------------CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccCcccc-------------------------cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCc
Confidence 5432111 112234568889999999999999999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHcCC
Q 002342 899 RGKTRQKTFANILHKD 914 (934)
Q Consensus 899 ~~~~~~~~~~~i~~~~ 914 (934)
.+.+..++...+..+.
T Consensus 219 ~~~~~~~~~~~~~~~~ 234 (325)
T 3kex_A 219 AGLRLAEVPDLLEKGE 234 (325)
T ss_dssp TTSCTTHHHHHHHTTC
T ss_pred cccCHHHHHHHHHcCC
Confidence 9998888888887764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=325.31 Aligned_cols=218 Identities=28% Similarity=0.431 Sum_probs=183.0
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEe-----
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT----- 740 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~----- 740 (934)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 4678999999999999999999999999999999987542 2335678899999999 89999999999986
Q ss_pred -CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 741 -KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 741 -~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
.+.+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 5689999999999999999987655569999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc-----CCCCCchhHHHHHHHHHHHHHhC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYG 894 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~~~DiwSlG~iL~elltG 894 (934)
..... ........||+.|+|||++. +..++.++|||||||++|+|++|
T Consensus 178 ~~~~~---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g 230 (326)
T 2x7f_A 178 QLDRT---------------------------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230 (326)
T ss_dssp ----------------------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHS
T ss_pred ecCcC---------------------------ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhC
Confidence 43210 11123457999999999997 56788999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCC
Q 002342 895 YTPFRGKTRQKTFANILHKDL 915 (934)
Q Consensus 895 ~~Pf~~~~~~~~~~~i~~~~~ 915 (934)
.+||.+.+....+..+.....
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~ 251 (326)
T 2x7f_A 231 APPLCDMHPMRALFLIPRNPA 251 (326)
T ss_dssp SCTTTTSCHHHHHHHHHHSCC
T ss_pred CCCCCCCcHHHHHHHhhcCcc
Confidence 999999888887777766544
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=338.86 Aligned_cols=217 Identities=24% Similarity=0.408 Sum_probs=189.8
Q ss_pred ccccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe
Q 002342 661 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (934)
Q Consensus 661 ~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (934)
...+.+..++|++.+.||+|+||.||++.+ .++.||||+++... ....+.+|+.+|++++||||+++++++..
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 257 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVE 257 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence 456778889999999999999999999988 47899999987542 34578899999999999999999999876
Q ss_pred CC-eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 741 KT-HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 741 ~~-~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
.. .+|+|||||++|+|.+++.......++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 258 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337 (450)
T ss_dssp TTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence 54 79999999999999999987655558999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPF 898 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf 898 (934)
.... ......+++.|+|||++.+..++.++|||||||+||+|++ |..||
T Consensus 338 ~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~ 387 (450)
T 1k9a_A 338 EASS------------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387 (450)
T ss_dssp ECC------------------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cccc------------------------------cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 3211 0112257889999999999999999999999999999998 99999
Q ss_pred CCCCHHHHHHHHHcCC
Q 002342 899 RGKTRQKTFANILHKD 914 (934)
Q Consensus 899 ~~~~~~~~~~~i~~~~ 914 (934)
.+.+..+++..+..+.
T Consensus 388 ~~~~~~~~~~~i~~~~ 403 (450)
T 1k9a_A 388 PRIPLKDVVPRVEKGY 403 (450)
T ss_dssp TTSCTTTHHHHHHTTC
T ss_pred CCCCHHHHHHHHHcCC
Confidence 9998888888887763
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=315.62 Aligned_cols=221 Identities=23% Similarity=0.335 Sum_probs=190.7
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+..++|++.+.||+|+||.||++.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 456789999999999999999999774 677899999976432 235688999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999999999764 245999999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~ 903 (934)
. ........||+.|+|||++.+..++.++||||||+++|+|++ |.+||.+.+.
T Consensus 158 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (268)
T 3sxs_A 158 Q--------------------------YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211 (268)
T ss_dssp C--------------------------EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred h--------------------------hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh
Confidence 0 011223356788999999999889999999999999999998 9999999999
Q ss_pred HHHHHHHHcCCCCC
Q 002342 904 QKTFANILHKDLKF 917 (934)
Q Consensus 904 ~~~~~~i~~~~~~~ 917 (934)
......+..+....
T Consensus 212 ~~~~~~~~~~~~~~ 225 (268)
T 3sxs_A 212 SEVVLKVSQGHRLY 225 (268)
T ss_dssp HHHHHHHHTTCCCC
T ss_pred HHHHHHHHcCCCCC
Confidence 98888888766443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=319.36 Aligned_cols=221 Identities=25% Similarity=0.372 Sum_probs=180.5
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecC---CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (934)
..+..++|++.+.||+|+||.||++.+..+ +..||+|.+... ........+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 345678999999999999999999998654 567999998653 23455677889999999999999999999985
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
++..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 467899999999999999997653 4599999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 899 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~ 899 (934)
..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.
T Consensus 166 ~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~ 219 (281)
T 1mp8_A 166 MEDST--------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219 (281)
T ss_dssp ---------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCccc--------------------------ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCC
Confidence 32110 011223357889999999999999999999999999999996 999999
Q ss_pred CCCHHHHHHHHHcCC
Q 002342 900 GKTRQKTFANILHKD 914 (934)
Q Consensus 900 ~~~~~~~~~~i~~~~ 914 (934)
+.+..+.+..+..+.
T Consensus 220 ~~~~~~~~~~i~~~~ 234 (281)
T 1mp8_A 220 GVKNNDVIGRIENGE 234 (281)
T ss_dssp TCCGGGHHHHHHTTC
T ss_pred cCCHHHHHHHHHcCC
Confidence 999888888887764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=333.57 Aligned_cols=222 Identities=24% Similarity=0.367 Sum_probs=182.6
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC--CCCccceeEEEEeCCe
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD--HPFVPALYASFQTKTH 743 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~~ 743 (934)
+....|++++.||+|+||.||++.+.. ++.||||++.+... .......+.+|+.+|+.+. ||||+++++++...+.
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 345679999999999999999999854 89999999976432 4556678899999999996 5999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|||||+ .+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 131 ~~lv~E~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 131 IYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEEEC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEEEEec-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9999994 589999999875 3589999999999999999999999999999999999995 68999999999965321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-----------CCCCchhHHHHHHHHHHHHH
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----------AGHTSAVDWWALGILLYEML 892 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----------~~~s~~~DiwSlG~iL~ell 892 (934)
.. ........+||+.|+|||++.+ ..++.++|||||||+||+|+
T Consensus 207 ~~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell 261 (390)
T 2zmd_A 207 DT-------------------------TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 261 (390)
T ss_dssp --------------------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHH
T ss_pred CC-------------------------ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHH
Confidence 10 0112235579999999999975 46888999999999999999
Q ss_pred hCCCCCCCCC-HHHHHHHHHcCCCCCC
Q 002342 893 YGYTPFRGKT-RQKTFANILHKDLKFP 918 (934)
Q Consensus 893 tG~~Pf~~~~-~~~~~~~i~~~~~~~p 918 (934)
+|++||.+.. ....+..++.....++
T Consensus 262 ~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 262 YGKTPFQQIINQISKLHAIIDPNHEIE 288 (390)
T ss_dssp HSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred HCCCcchhhhHHHHHHHHHhCccccCC
Confidence 9999998754 3466777776554433
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=327.46 Aligned_cols=222 Identities=25% Similarity=0.324 Sum_probs=186.3
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe-------
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------- 740 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------- 740 (934)
.++|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 5789999999999999999999999999999999876432 22333567789999999999999999999986
Q ss_pred -CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 741 -KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 741 -~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
.+.+|+|||||. ++|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 95 CKGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp --CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 457899999995 57777776543 459999999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
....... .........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||
T Consensus 173 ~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 229 (351)
T 3mi9_A 173 AFSLAKN-----------------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229 (351)
T ss_dssp ECCCCSS-----------------------SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccc-----------------------ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 5431110 01122345578999999999976 45799999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCC
Q 002342 899 RGKTRQKTFANILHKDL 915 (934)
Q Consensus 899 ~~~~~~~~~~~i~~~~~ 915 (934)
.+.+....+..+.....
T Consensus 230 ~~~~~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 230 QGNTEQHQLALISQLCG 246 (351)
T ss_dssp CCSSHHHHHHHHHHHHC
T ss_pred CCCChHHHHHHHHHHhC
Confidence 99999988888865433
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=330.83 Aligned_cols=210 Identities=29% Similarity=0.461 Sum_probs=170.1
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC------
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 741 (934)
.++|++++.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+|+.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSST-TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcc-ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 47999999999999999999999999999999998754 23445567788999999999999999999999754
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
...|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred CeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 5689999999 8999998865 34999999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+
T Consensus 183 ~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 183 AD------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp --------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cc------------------------------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 10 1234579999999999987 6789999999999999999999999999
Q ss_pred CCHHHHHHHHHc
Q 002342 901 KTRQKTFANILH 912 (934)
Q Consensus 901 ~~~~~~~~~i~~ 912 (934)
.+..+.+..|.+
T Consensus 233 ~~~~~~l~~i~~ 244 (367)
T 2fst_X 233 TDHIDQLKLILR 244 (367)
T ss_dssp SSHHHHHHHHHH
T ss_pred CCHHHHHHHHHH
Confidence 999888877765
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=320.24 Aligned_cols=227 Identities=26% Similarity=0.389 Sum_probs=190.6
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeeccccc-ChHHHHHHHHHHHHHHhCCCCCccceeEEEE--eCCeE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDHPFVPALYASFQ--TKTHV 744 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~ 744 (934)
.++|++.+.||+|+||.||++.+..+++.||+|++.+.... .......+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999999999999999999764321 1334567889999999999999999999984 45689
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+||||+.++ |.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999665 777777655567999999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC--CchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH--TSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~--s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
. .........||+.|+|||++.+... +.++|||||||++|+|++|..||.+.+
T Consensus 163 ~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 163 A-------------------------ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp C-------------------------SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c-------------------------cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 0 0111234569999999999986543 679999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCC
Q 002342 903 RQKTFANILHKDLKFPSS 920 (934)
Q Consensus 903 ~~~~~~~i~~~~~~~p~~ 920 (934)
..+.+..+..+.+.+|..
T Consensus 218 ~~~~~~~i~~~~~~~~~~ 235 (305)
T 2wtk_C 218 IYKLFENIGKGSYAIPGD 235 (305)
T ss_dssp HHHHHHHHHHCCCCCCSS
T ss_pred HHHHHHHHhcCCCCCCCc
Confidence 999999999888877754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=328.03 Aligned_cols=221 Identities=24% Similarity=0.333 Sum_probs=179.7
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEE----EEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~v----AlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (934)
.+..++|++.+.||+|+||.||+|.+..+++.+ |+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 355688999999999999999999998887755 666665321 23345678899999999999999999999987
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
.. .++||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred CC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 54 789999999999999997753 4599999999999999999999999999999999999999999999999999965
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 899 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~ 899 (934)
...... ........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.
T Consensus 167 ~~~~~~-------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 221 (327)
T 3poz_A 167 LGAEEK-------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp HTTTCC--------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCCcc-------------------------cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCcc
Confidence 432111 111223457889999999999999999999999999999999 999999
Q ss_pred CCCHHHHHHHHHcCC
Q 002342 900 GKTRQKTFANILHKD 914 (934)
Q Consensus 900 ~~~~~~~~~~i~~~~ 914 (934)
+.+...+...+..+.
T Consensus 222 ~~~~~~~~~~~~~~~ 236 (327)
T 3poz_A 222 GIPASEISSILEKGE 236 (327)
T ss_dssp TCCGGGHHHHHHTTC
T ss_pred CCCHHHHHHHHHcCC
Confidence 988888777776554
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=331.22 Aligned_cols=227 Identities=41% Similarity=0.747 Sum_probs=187.6
Q ss_pred cccCCcccccccccCCcEEEEEEEEe---cCCeEEEEEEeeccccc-ChHHHHHHHHHHHHHHhC-CCCCccceeEEEEe
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDML-DHPFVPALYASFQT 740 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAlK~~~~~~~~-~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~ 740 (934)
+..++|++.+.||+|+||.||+|++. .+++.||||++.+.... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 45679999999999999999999995 58999999998754321 122334566799999999 79999999999999
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
.+.+|+|||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999999764 3599999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC--CCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
.... ........+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||
T Consensus 209 ~~~~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf 262 (355)
T 1vzo_A 209 FVAD--------------------------ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262 (355)
T ss_dssp CCGG--------------------------GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccC--------------------------CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 3210 1112234679999999999986 35788999999999999999999999
Q ss_pred CCC----CHHHHHHHHHcCCCCCCCC
Q 002342 899 RGK----TRQKTFANILHKDLKFPSS 920 (934)
Q Consensus 899 ~~~----~~~~~~~~i~~~~~~~p~~ 920 (934)
... ....+.+.+......+|..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (355)
T 1vzo_A 263 TVDGEKNSQAEISRRILKSEPPYPQE 288 (355)
T ss_dssp SCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred ccCCccchHHHHHHHHhccCCCCCcc
Confidence 753 3456666777776666654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=315.97 Aligned_cols=224 Identities=29% Similarity=0.444 Sum_probs=194.8
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeeccccc------ChHHHHHHHHHHHHHHhCC-CCCccceeEEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML------NRNKVHRACAEREILDMLD-HPFVPALYASFQ 739 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~------~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~ 739 (934)
..++|++.+.||+|+||.||++.+..+++.||||++...... .......+.+|+.+++.+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 357999999999999999999999999999999999754211 1233466788999999995 999999999999
Q ss_pred eCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 740 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
..+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 999999999999999999999764 459999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc------CCCCCchhHHHHHHHHHHHHHh
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA------GAGHTSAVDWWALGILLYEMLY 893 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~~s~~~DiwSlG~iL~ellt 893 (934)
..... .......||+.|+|||++. ...++.++||||||+++|+|++
T Consensus 173 ~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~ 224 (298)
T 1phk_A 173 QLDPG----------------------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224 (298)
T ss_dssp ECCTT----------------------------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred hcCCC----------------------------cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHH
Confidence 43211 1123457999999999985 4567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 002342 894 GYTPFRGKTRQKTFANILHKDLKFPSS 920 (934)
Q Consensus 894 G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 920 (934)
|..||.+.+.......+..+.+.++..
T Consensus 225 g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 225 GSPPFWHRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred CCCCCcCccHHHHHHHHhcCCcccCcc
Confidence 999999999999999999988777653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=316.99 Aligned_cols=222 Identities=27% Similarity=0.437 Sum_probs=186.9
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG--CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc--chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 357999999999999999999999999999999987543 233456788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-- 159 (276)
T 2yex_A 84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 159 (276)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred EEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc--
Confidence 9999999999999754 459999999999999999999999999999999999999999999999999985432110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHH-H
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQ-K 905 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~~DiwSlG~iL~elltG~~Pf~~~~~~-~ 905 (934)
........+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.... .
T Consensus 160 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 216 (276)
T 2yex_A 160 -----------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216 (276)
T ss_dssp -----------------------EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH
T ss_pred -----------------------chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 0112234579999999999988765 67899999999999999999999876553 3
Q ss_pred HHHHHHcCCCCCC
Q 002342 906 TFANILHKDLKFP 918 (934)
Q Consensus 906 ~~~~i~~~~~~~p 918 (934)
.+..+..+...++
T Consensus 217 ~~~~~~~~~~~~~ 229 (276)
T 2yex_A 217 EYSDWKEKKTYLN 229 (276)
T ss_dssp HHHHHHTTCTTST
T ss_pred HHHHhhhcccccC
Confidence 4445554444333
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=326.81 Aligned_cols=223 Identities=23% Similarity=0.340 Sum_probs=174.4
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCe---EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~---~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
+..++|++.+.||+|+||.||+|.+..++. .||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 456789999999999999999999877765 899999876432 3345678899999999999999999999998766
Q ss_pred eE------EEEEEccCCCCchhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEE
Q 002342 743 HV------CLITDYCPGGELFLLLDRQP----TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 812 (934)
Q Consensus 743 ~~------~lV~E~~~ggsL~~~l~~~~----~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl 812 (934)
.. |+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence 55 99999999999999986431 125999999999999999999999999999999999999999999999
Q ss_pred EecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHH
Q 002342 813 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892 (934)
Q Consensus 813 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ell 892 (934)
+|||++........ ........+++.|+|||++.+..++.++|||||||++|+|+
T Consensus 179 ~Dfg~a~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 233 (323)
T 3qup_A 179 ADFGLSRKIYSGDY-------------------------YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233 (323)
T ss_dssp CCCCC------------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred eecccccccccccc-------------------------ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHH
Confidence 99999865321110 11122345788999999999999999999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCC
Q 002342 893 Y-GYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 893 t-G~~Pf~~~~~~~~~~~i~~~~ 914 (934)
+ |.+||.+.+..+.+..+..+.
T Consensus 234 ~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 234 TRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp TTSCCTTTTCCGGGHHHHHHTTC
T ss_pred hCCCCCccccChHHHHHHHhcCC
Confidence 9 999999999998888887765
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=342.14 Aligned_cols=220 Identities=23% Similarity=0.338 Sum_probs=189.5
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
.+.+..++|++.+.||+|+||.||++.+. ++..||||.++... ...+.+.+|+.+|+.++||||+++++++. ..
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 45677789999999999999999999984 57789999997643 23567889999999999999999999986 56
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
..|+|||||++|+|.+++.......++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 78999999999999999976433458999999999999999999999999999999999999999999999999996532
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~ 901 (934)
.. .........+++.|+|||++....++.++|||||||+||+|++ |++||.+.
T Consensus 336 ~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~ 389 (454)
T 1qcf_A 336 DN--------------------------EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389 (454)
T ss_dssp CH--------------------------HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CC--------------------------ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 10 0011123346889999999998999999999999999999999 99999999
Q ss_pred CHHHHHHHHHcCC
Q 002342 902 TRQKTFANILHKD 914 (934)
Q Consensus 902 ~~~~~~~~i~~~~ 914 (934)
+..+++..+..+.
T Consensus 390 ~~~~~~~~i~~~~ 402 (454)
T 1qcf_A 390 SNPEVIRALERGY 402 (454)
T ss_dssp CHHHHHHHHHHTC
T ss_pred CHHHHHHHHHcCC
Confidence 9999998887753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=321.70 Aligned_cols=209 Identities=23% Similarity=0.387 Sum_probs=176.3
Q ss_pred cccccCCcccccccccCCcEEEEEEE----EecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVE----LCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 739 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~----~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 739 (934)
..+..++|++++.||+|+||.||+++ +..+++.||+|++... .......+.+|+.+|+.++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34667899999999999999999998 5678999999998754 4455677889999999999999999999986
Q ss_pred e--CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEeccc
Q 002342 740 T--KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817 (934)
Q Consensus 740 ~--~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~ 817 (934)
. ...+|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 4 456899999999999999997653 3599999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCC
Q 002342 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~P 897 (934)
+........ .........|++.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 161 ~~~~~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 216 (295)
T 3ugc_A 161 TKVLPQDKE------------------------FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 216 (295)
T ss_dssp CC-------------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCT
T ss_pred cccccCCcc------------------------eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccc
Confidence 965432110 01112234578889999999999999999999999999999999999
Q ss_pred CCC
Q 002342 898 FRG 900 (934)
Q Consensus 898 f~~ 900 (934)
|..
T Consensus 217 ~~~ 219 (295)
T 3ugc_A 217 SKS 219 (295)
T ss_dssp TCS
T ss_pred cCC
Confidence 864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=317.91 Aligned_cols=217 Identities=24% Similarity=0.388 Sum_probs=181.4
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHH----HHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV----HRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~----~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
+..++|++.+.||+|+||.||++.+..+++.||+|++........... ..+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 556899999999999999999999999999999999876433222221 6788999999999999999999999766
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEecCCc-----EEEEe
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGH-----VSLTD 814 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~~~~-----vkl~D 814 (934)
. ++||||+++++|.+++... ...+++..+..++.|++.||.|||++| |+||||||+|||++.++. +||+|
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred C--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 5 6999999999999988664 346999999999999999999999999 999999999999988776 99999
Q ss_pred cccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhh--cCCCCCchhHHHHHHHHHHHHH
Q 002342 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII--AGAGHTSAVDWWALGILLYEML 892 (934)
Q Consensus 815 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l--~~~~~s~~~DiwSlG~iL~ell 892 (934)
||++.... .......||+.|+|||++ ....++.++|||||||++|+|+
T Consensus 173 fg~~~~~~------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~ 222 (287)
T 4f0f_A 173 FGLSQQSV------------------------------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222 (287)
T ss_dssp CTTCBCCS------------------------------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHH
T ss_pred CCcccccc------------------------------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHH
Confidence 99985321 112345799999999999 4456788999999999999999
Q ss_pred hCCCCCCCCCHHHH--HHHHHcCCC
Q 002342 893 YGYTPFRGKTRQKT--FANILHKDL 915 (934)
Q Consensus 893 tG~~Pf~~~~~~~~--~~~i~~~~~ 915 (934)
+|+.||.+.+.... ...+.....
T Consensus 223 ~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 223 TGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp HSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred cCCCCCccccccHHHHHHHHhccCC
Confidence 99999987655433 455554443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=344.34 Aligned_cols=221 Identities=22% Similarity=0.321 Sum_probs=193.8
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
.+.+...+|++.+.||+|+||.||++.+..++..||||.+.... .....+.+|+.+|+.++||||+++++++....
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 35567788999999999999999999999999999999987642 23567889999999999999999999999999
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
.+|||||||++|+|.+++.......++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999999999987655679999999999999999999999999999999999999999999999999986542
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~ 901 (934)
... ........+++.|+|||++.+..++.++|||||||+||+|++ |..||.+.
T Consensus 370 ~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 370 GDT--------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp TCC--------------------------EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCc--------------------------eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 110 011123356789999999999999999999999999999998 99999999
Q ss_pred CHHHHHHHHHcC
Q 002342 902 TRQKTFANILHK 913 (934)
Q Consensus 902 ~~~~~~~~i~~~ 913 (934)
+..+++..+..+
T Consensus 424 ~~~~~~~~~~~~ 435 (495)
T 1opk_A 424 DLSQVYELLEKD 435 (495)
T ss_dssp CGGGHHHHHHTT
T ss_pred CHHHHHHHHHcC
Confidence 888888777654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=328.40 Aligned_cols=227 Identities=23% Similarity=0.363 Sum_probs=191.1
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCe-----EEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEE
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ-----YFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS 737 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~-----~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 737 (934)
..+..++|++.+.||+|+||.||++.+..+++ .||+|.+.... .......+.+|+.+++.+ +||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 45667899999999999999999999977654 79999987542 344567788999999999 89999999999
Q ss_pred EEeCCeEEEEEEccCCCCchhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe
Q 002342 738 FQTKTHVCLITDYCPGGELFLLLDRQP------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ 805 (934)
Q Consensus 738 ~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~ 805 (934)
+...+..|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 999999999999999999999987531 23589999999999999999999999999999999999999
Q ss_pred cCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHH
Q 002342 806 GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 885 (934)
Q Consensus 806 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG 885 (934)
.++.+||+|||++....... .........||+.|+|||++.+..++.++||||||
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 253 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDS-------------------------NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 253 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCT-------------------------TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHH
T ss_pred CCCeEEECcccccccccccc-------------------------ceeecCCCCCCccccCHHHhccCCCChHHHHHHHH
Confidence 99999999999986432110 01112344678899999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCC
Q 002342 886 ILLYEMLY-GYTPFRGKTRQKTFANILHKDLKF 917 (934)
Q Consensus 886 ~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~ 917 (934)
|++|+|++ |.+||.+......+..+.......
T Consensus 254 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 286 (333)
T 2i1m_A 254 ILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 286 (333)
T ss_dssp HHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCC
T ss_pred HHHHHHHcCCCCCCcccchhHHHHHHHhcCCCC
Confidence 99999998 999999887766666666554443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=316.23 Aligned_cols=216 Identities=24% Similarity=0.384 Sum_probs=183.8
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe----C
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----K 741 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~ 741 (934)
.....|++.+.||+|+||.||+|.+..++..||+|.+..... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 445679999999999999999999999999999999876433 44556788999999999999999999999875 4
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEe-cCCcEEEEecccC
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQ-GNGHVSLTDFDLS 818 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~-~~~~vkl~DFG~a 818 (934)
..+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred ceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 6789999999999999999764 45999999999999999999999999 99999999999997 7899999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
..... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||
T Consensus 180 ~~~~~-----------------------------~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf 229 (290)
T 1t4h_A 180 TLKRA-----------------------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY 229 (290)
T ss_dssp GGCCT-----------------------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccccc-----------------------------cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCC
Confidence 53211 11234579999999998875 5899999999999999999999999
Q ss_pred CCCCH-HHHHHHHHcCC
Q 002342 899 RGKTR-QKTFANILHKD 914 (934)
Q Consensus 899 ~~~~~-~~~~~~i~~~~ 914 (934)
.+... ...+..+..+.
T Consensus 230 ~~~~~~~~~~~~~~~~~ 246 (290)
T 1t4h_A 230 SECQNAAQIYRRVTSGV 246 (290)
T ss_dssp TTCSSHHHHHHHHTTTC
T ss_pred CCcCcHHHHHHHHhccC
Confidence 88444 45555555543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=327.38 Aligned_cols=216 Identities=29% Similarity=0.430 Sum_probs=179.7
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccC--hHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN--RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
.++|++.+.||+|+||.||++.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++...+..|
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 478999999999999999999999999999999987542211 112246778999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
+||||++ ++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 89 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~- 165 (346)
T 1ua2_A 89 LVFDFME-TDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP- 165 (346)
T ss_dssp EEEECCS-EEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-
T ss_pred EEEEcCC-CCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC-
Confidence 9999996 4888888654 345899999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..
T Consensus 166 --------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~ 219 (346)
T 1ua2_A 166 --------------------------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 219 (346)
T ss_dssp --------------------------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred --------------------------cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence 1122345799999999999764 5789999999999999999999999999999
Q ss_pred HHHHHHHc
Q 002342 905 KTFANILH 912 (934)
Q Consensus 905 ~~~~~i~~ 912 (934)
+.+.++..
T Consensus 220 ~~~~~i~~ 227 (346)
T 1ua2_A 220 DQLTRIFE 227 (346)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 88888865
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.77 Aligned_cols=221 Identities=22% Similarity=0.309 Sum_probs=185.8
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 744 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 744 (934)
+..++|++.+.||+|+||.||++.+..+++.||+|++.... ....+.+|+.+++.+ +|+|++.+++++......
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 45678999999999999999999999999999999986532 223577899999999 799999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc-----EEEEecccCc
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-----VSLTDFDLSC 819 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~-----vkl~DFG~a~ 819 (934)
|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 9999999 999999998653 45999999999999999999999999999999999999987776 9999999996
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
........ ...+........||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 160 ~~~~~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 219 (298)
T 1csn_A 160 FYRDPVTK--------------------QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 219 (298)
T ss_dssp ESBCTTTC--------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cccccccc--------------------ccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcc
Confidence 54321110 0011123456689999999999999999999999999999999999999998
Q ss_pred CC---CHHHHHHHHHcC
Q 002342 900 GK---TRQKTFANILHK 913 (934)
Q Consensus 900 ~~---~~~~~~~~i~~~ 913 (934)
+. .....+..+..+
T Consensus 220 ~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 220 GLKAATNKQKYERIGEK 236 (298)
T ss_dssp SCCSCCHHHHHHHHHHH
T ss_pred hhhccccHHHHHHHHhh
Confidence 74 344555555443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=324.83 Aligned_cols=225 Identities=21% Similarity=0.332 Sum_probs=191.4
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEe-------cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccce
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPAL 734 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~-------~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l 734 (934)
.+.+..++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.+ +||||+++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 34566789999999999999999999985 457789999987542 345567788999999999 89999999
Q ss_pred eEEEEeCCeEEEEEEccCCCCchhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 002342 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPT--------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPE 800 (934)
Q Consensus 735 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~ 800 (934)
++++...+..|+||||+++++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 9999999999999999999999999976431 24899999999999999999999999999999999
Q ss_pred CEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhH
Q 002342 801 NVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 880 (934)
Q Consensus 801 NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~D 880 (934)
|||++.++.+||+|||++........ ........||+.|+|||++.+..++.++|
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 241 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDY-------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSD 241 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSS-------------------------EECCSCCCCCGGGCCHHHHHHCEECHHHH
T ss_pred eEEEcCCCCEEEcccccccccccccc-------------------------ccccCCCCcccceeChHHhcCCCcChHHH
Confidence 99999999999999999865321110 01122345788999999999888999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 002342 881 WWALGILLYEMLY-GYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 881 iwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~ 914 (934)
||||||++|+|++ |..||.+.+..+++..+..+.
T Consensus 242 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 276 (334)
T 2pvf_A 242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 276 (334)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCC
Confidence 9999999999999 999999999998888887765
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=322.52 Aligned_cols=214 Identities=23% Similarity=0.381 Sum_probs=173.6
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC-----
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 742 (934)
.++|++.+.||+|+||.||+|+++.+++.||||++.... .......+.+|+.+|+.++||||++++++|....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 357999999999999999999999999999999997543 3345577899999999999999999999986533
Q ss_pred ----------------------------------------------------eEEEEEEccCCCCchhhhccCCC-CCCC
Q 002342 743 ----------------------------------------------------HVCLITDYCPGGELFLLLDRQPT-KVLK 769 (934)
Q Consensus 743 ----------------------------------------------------~~~lV~E~~~ggsL~~~l~~~~~-~~l~ 769 (934)
+.|+|||||++++|.+++..... ...+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 48999999999999999976532 3356
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCccccc
Q 002342 770 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849 (934)
Q Consensus 770 ~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (934)
...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++............ ....
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~---------------~~~~ 227 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV---------------LTPM 227 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------------------------
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc---------------cccc
Confidence 6678999999999999999999999999999999999999999999999765432111000 0000
Q ss_pred ccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 850 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..|+
T Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 228 PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp ----CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred cccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 1112334568999999999999999999999999999999999998876
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=329.38 Aligned_cols=211 Identities=27% Similarity=0.443 Sum_probs=177.3
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe-----
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----- 740 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----- 740 (934)
...++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+|+.+|+.++||||++++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 345789999999999999999999999999999999875421 22369999999999999999999843
Q ss_pred ---------------------------------CCeEEEEEEccCCCCchhhhcc--CCCCCCCHHHHHHHHHHHHHHHH
Q 002342 741 ---------------------------------KTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALE 785 (934)
Q Consensus 741 ---------------------------------~~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~ 785 (934)
..++++|||||+ ++|.+.+.. .....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 345899999996 687777653 23456999999999999999999
Q ss_pred HHHHCCCeecCCCCCCEEEe-cCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCc
Q 002342 786 YLHCQGIIYRDLKPENVLLQ-GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEY 864 (934)
Q Consensus 786 yLH~~giiHrDLKp~NILl~-~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y 864 (934)
|||++||+||||||+|||++ .++.+||+|||+|...... ......+||+.|
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~----------------------------~~~~~~~~t~~y 207 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS----------------------------EPSVAYICSRFY 207 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT----------------------------SCCCCCCCCSSC
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC----------------------------CCCcCcccCCCc
Confidence 99999999999999999998 5889999999999643211 122345789999
Q ss_pred cchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Q 002342 865 IAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 912 (934)
Q Consensus 865 ~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~ 912 (934)
+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..|.+
T Consensus 208 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 256 (383)
T 3eb0_A 208 RAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQ 256 (383)
T ss_dssp CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999875 489999999999999999999999999999888877764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=335.80 Aligned_cols=220 Identities=33% Similarity=0.521 Sum_probs=177.0
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeeccccc-----ChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-----NRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.+.... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 46899999999999999999999999999999999865322 11223357789999999999999999999865 5
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC---cEEEEecccCc
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSC 819 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~---~vkl~DFG~a~ 819 (934)
..|+|||||++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 589999999999999998764 4599999999999999999999999999999999999997544 59999999996
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC---CCCCchhHHHHHHHHHHHHHhCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYT 896 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~s~~~DiwSlG~iL~elltG~~ 896 (934)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+
T Consensus 291 ~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~ 342 (419)
T 3i6u_A 291 ILGET----------------------------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342 (419)
T ss_dssp SCC---------------------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCC----------------------------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 53211 12235679999999999864 567889999999999999999999
Q ss_pred CCCCCCHH-HHHHHHHcCCCCCC
Q 002342 897 PFRGKTRQ-KTFANILHKDLKFP 918 (934)
Q Consensus 897 Pf~~~~~~-~~~~~i~~~~~~~p 918 (934)
||.+.... .....+..+.+.++
T Consensus 343 pf~~~~~~~~~~~~i~~~~~~~~ 365 (419)
T 3i6u_A 343 PFSEHRTQVSLKDQITSGKYNFI 365 (419)
T ss_dssp SSCCCSSSCCHHHHHHTTCCCCC
T ss_pred CCCCCcchHHHHHHHhcCCCCCC
Confidence 99875443 45566667766654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=328.32 Aligned_cols=223 Identities=26% Similarity=0.473 Sum_probs=194.2
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChH--------------HHHHHHHHHHHHHhCCCCCc
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN--------------KVHRACAEREILDMLDHPFV 731 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~--------------~~~~~~~E~~il~~l~hp~I 731 (934)
...++|++.+.||+|+||.||+|.+ +++.||+|++......... ....+.+|+.+++.++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 4467999999999999999999999 9999999999764322211 12678899999999999999
Q ss_pred cceeEEEEeCCeEEEEEEccCCCCchhh------hccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEE
Q 002342 732 PALYASFQTKTHVCLITDYCPGGELFLL------LDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLL 804 (934)
Q Consensus 732 v~l~~~~~~~~~~~lV~E~~~ggsL~~~------l~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl 804 (934)
+++++++.+.+..|+||||+++++|.++ +.......+++..++.++.||+.||.|||+ +||+||||||+||++
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999999999999999999999999999 665445679999999999999999999999 999999999999999
Q ss_pred ecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCc-hhHHH
Q 002342 805 QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTS-AVDWW 882 (934)
Q Consensus 805 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~-~~Diw 882 (934)
+.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~ 236 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK-----------------------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIW 236 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT-----------------------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHH
T ss_pred cCCCcEEEeccccccccccc-----------------------------cccCCCCCcCccCchhhcCCCCCCcchhhHH
Confidence 99999999999998543210 12345699999999999887 6666 99999
Q ss_pred HHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCCC
Q 002342 883 ALGILLYEMLYGYTPFRGKTR-QKTFANILHKDLKFPS 919 (934)
Q Consensus 883 SlG~iL~elltG~~Pf~~~~~-~~~~~~i~~~~~~~p~ 919 (934)
||||++|+|++|.+||.+.+. .+.+..+..+.+.+|.
T Consensus 237 slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~ 274 (348)
T 2pml_X 237 SLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPL 274 (348)
T ss_dssp HHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCC
T ss_pred HHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCcc
Confidence 999999999999999998877 7888899888888885
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=324.04 Aligned_cols=226 Identities=19% Similarity=0.258 Sum_probs=186.8
Q ss_pred ccccccCCcccccccccCCcEEEEEEE-----EecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEE
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVE-----LCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS 737 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~-----~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 737 (934)
-..+..++|++.+.||+|+||.||++. +..++..||+|.+... ........+.+|+.+++.++||||++++++
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGV 101 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 345667899999999999999999999 5567889999998643 234455678899999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCchhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCc
Q 002342 738 FQTKTHVCLITDYCPGGELFLLLDRQPT-----KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGH 809 (934)
Q Consensus 738 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~~ 809 (934)
+......|+||||+++++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 9999999999999999999999976532 34899999999999999999999999999999999999984 446
Q ss_pred EEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHH
Q 002342 810 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889 (934)
Q Consensus 810 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ 889 (934)
+||+|||++....... .........||+.|+|||++.+..++.++|||||||++|
T Consensus 182 ~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 236 (327)
T 2yfx_A 182 AKIGDFGMARDIYRAS-------------------------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 236 (327)
T ss_dssp EEECCCHHHHHHHC-------------------------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred EEECcccccccccccc-------------------------ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHH
Confidence 9999999985431110 011223456899999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCC
Q 002342 890 EMLY-GYTPFRGKTRQKTFANILHKDL 915 (934)
Q Consensus 890 ellt-G~~Pf~~~~~~~~~~~i~~~~~ 915 (934)
+|++ |.+||.+.+..+.+..+..+..
T Consensus 237 ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 237 EIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp HHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred HHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 9998 9999999999888888877654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.22 Aligned_cols=220 Identities=23% Similarity=0.372 Sum_probs=190.9
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
+.++.++|++.+.||+|+||.||++.+. ++..||+|.+.+... ....+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3466789999999999999999999985 678899999986432 23568899999999999999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
.|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred eEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999999999999997653 4589999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~ 902 (934)
. .........|++.|+|||++.+..++.++||||||+++|+|++ |++||.+.+
T Consensus 157 ~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 157 D--------------------------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp H--------------------------HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred c--------------------------cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 0 0011223457889999999999999999999999999999999 999999999
Q ss_pred HHHHHHHHHcCCC
Q 002342 903 RQKTFANILHKDL 915 (934)
Q Consensus 903 ~~~~~~~i~~~~~ 915 (934)
..+....+..+..
T Consensus 211 ~~~~~~~i~~~~~ 223 (267)
T 3t9t_A 211 NSEVVEDISTGFR 223 (267)
T ss_dssp HHHHHHHHHTTCC
T ss_pred HHHHHHHHhcCCc
Confidence 9999988887643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=322.11 Aligned_cols=224 Identities=22% Similarity=0.292 Sum_probs=186.2
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecCC----eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEE
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSG----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF 738 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~----~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 738 (934)
...+...+|++.+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+++.++||||+++++++
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34567789999999999999999999987653 469999987542 344556788999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccC
Q 002342 739 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (934)
Q Consensus 739 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a 818 (934)
...+..|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 9999999999999999999999764 345999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTP 897 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~P 897 (934)
......... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 195 ~~~~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 250 (333)
T 1mqb_A 195 RVLEDDPEA------------------------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250 (333)
T ss_dssp ----------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred hhhcccccc------------------------ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 654221100 011122356889999999999999999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHcC
Q 002342 898 FRGKTRQKTFANILHK 913 (934)
Q Consensus 898 f~~~~~~~~~~~i~~~ 913 (934)
|.+.+..+++..+..+
T Consensus 251 f~~~~~~~~~~~~~~~ 266 (333)
T 1mqb_A 251 YWELSNHEVMKAINDG 266 (333)
T ss_dssp TTTCCHHHHHHHHHTT
T ss_pred cccCCHHHHHHHHHCC
Confidence 9999998888888765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=330.26 Aligned_cols=214 Identities=19% Similarity=0.215 Sum_probs=171.9
Q ss_pred cccCCcccccccccCCcEEEEEEEEecC-----CeEEEEEEeecccccChHH--------HHHHHHHHHHHHhCCCCCcc
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNK--------VHRACAEREILDMLDHPFVP 732 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~vAlK~~~~~~~~~~~~--------~~~~~~E~~il~~l~hp~Iv 732 (934)
+..++|++.+.||+|+||.||+|.+..+ ++.||||++.......... ......|+.+++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 3456899999999999999999999765 5889999987642110000 11223455567778899999
Q ss_pred ceeEEEEeC----CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe--c
Q 002342 733 ALYASFQTK----THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ--G 806 (934)
Q Consensus 733 ~l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~--~ 806 (934)
++++++... .+.||||||| |++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 999998764 5689999999 99999999764 35699999999999999999999999999999999999999 8
Q ss_pred CCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHH
Q 002342 807 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 886 (934)
Q Consensus 807 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~ 886 (934)
++.+||+|||++......... ...........+||+.|+|||++.+..++.++|||||||
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 249 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVH--------------------KAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGY 249 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCC--------------------CCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred CCeEEEEECCcceecccCCcc--------------------cccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHH
Confidence 899999999999654321100 001112234567999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 002342 887 LLYEMLYGYTPFRGK 901 (934)
Q Consensus 887 iL~elltG~~Pf~~~ 901 (934)
+||+|++|+.||.+.
T Consensus 250 ~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 250 CMIQWLTGHLPWEDN 264 (364)
T ss_dssp HHHHHHHSCCTTGGG
T ss_pred HHHHHHhCCCCcccc
Confidence 999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=325.36 Aligned_cols=221 Identities=24% Similarity=0.331 Sum_probs=181.5
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEE----EEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~v----AlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (934)
.+..++|++++.||+|+||.||+|.+..+++.+ |+|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 355689999999999999999999998888765 55555432 123345678899999999999999999999987
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
.. .++||+|+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred CC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 55 789999999999999997653 4599999999999999999999999999999999999999999999999999965
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 899 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~ 899 (934)
...... ........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.
T Consensus 167 ~~~~~~-------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 221 (327)
T 3lzb_A 167 LGAEEK-------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp --------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCccc-------------------------cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCC
Confidence 421110 011223457889999999999999999999999999999999 999999
Q ss_pred CCCHHHHHHHHHcCC
Q 002342 900 GKTRQKTFANILHKD 914 (934)
Q Consensus 900 ~~~~~~~~~~i~~~~ 914 (934)
+....++...+..+.
T Consensus 222 ~~~~~~~~~~~~~~~ 236 (327)
T 3lzb_A 222 GIPASEISSILEKGE 236 (327)
T ss_dssp TCCGGGHHHHHHTTC
T ss_pred CCCHHHHHHHHHcCC
Confidence 988888877776654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.63 Aligned_cols=227 Identities=16% Similarity=0.241 Sum_probs=193.7
Q ss_pred cccccccCCcccccccccCCcEEEEEEEEe-----cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeE
Q 002342 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736 (934)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 736 (934)
..+.+..++|++.+.||+|+||.||+|.+. .+++.||+|.+.... .......+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 344566789999999999999999999987 467899999987542 3445567889999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCchhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC
Q 002342 737 SFQTKTHVCLITDYCPGGELFLLLDRQP--------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 808 (934)
Q Consensus 737 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~ 808 (934)
++...+..|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 9999999999999999999999987531 13478999999999999999999999999999999999999999
Q ss_pred cEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHH
Q 002342 809 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888 (934)
Q Consensus 809 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL 888 (934)
.+||+|||++...... ..........||+.|+|||++.+..++.++|||||||++
T Consensus 176 ~~kl~Dfg~~~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 230 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYET-------------------------DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230 (322)
T ss_dssp CEEECCTTCCCGGGGG-------------------------GCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred eEEECcCccccccccc-------------------------cccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHH
Confidence 9999999998543210 001122344678999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCC
Q 002342 889 YEMLY-GYTPFRGKTRQKTFANILHKDL 915 (934)
Q Consensus 889 ~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 915 (934)
|+|++ |.+||.+.+..+....+..+..
T Consensus 231 ~el~~~g~~p~~~~~~~~~~~~~~~~~~ 258 (322)
T 1p4o_A 231 WEIATLAEQPYQGLSNEQVLRFVMEGGL 258 (322)
T ss_dssp HHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred HHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence 99999 9999999999999888887654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=324.00 Aligned_cols=218 Identities=24% Similarity=0.374 Sum_probs=186.0
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEE--EEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCC
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 742 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~v--AlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 742 (934)
+..++|++.+.||+|+||.||+|.+..++..+ |+|.+... ........+.+|+.+++.+ +||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 55689999999999999999999999999865 99988753 2334456788999999999 8999999999999999
Q ss_pred eEEEEEEccCCCCchhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC
Q 002342 743 HVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 808 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~ 808 (934)
..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997642 23699999999999999999999999999999999999999999
Q ss_pred cEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHH
Q 002342 809 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888 (934)
Q Consensus 809 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL 888 (934)
.+||+|||++..... ........+++.|+|||++.+..++.++|||||||++
T Consensus 180 ~~kL~Dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 231 (327)
T 1fvr_A 180 VAKIADFGLSRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 231 (327)
T ss_dssp CEEECCTTCEESSCE----------------------------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred eEEEcccCcCccccc----------------------------cccccCCCCCccccChhhhccccCCchhcchHHHHHH
Confidence 999999999853210 0112234578899999999988899999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcC
Q 002342 889 YEMLY-GYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 889 ~ellt-G~~Pf~~~~~~~~~~~i~~~ 913 (934)
|+|++ |.+||.+.+..+.+..+..+
T Consensus 232 ~ellt~g~~pf~~~~~~~~~~~~~~~ 257 (327)
T 1fvr_A 232 WEIVSLGGTPYCGMTCAELYEKLPQG 257 (327)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred HHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence 99998 99999999999888888765
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=328.34 Aligned_cols=203 Identities=27% Similarity=0.465 Sum_probs=177.3
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccCh-----HHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-----NKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~-----~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
.++|++++.||+|+||.||+|.+..+++.||||++.+...... .....+.+|+.+|+.++||||++++++|.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 3689999999999999999999999999999999987532221 13345677999999999999999999999999
Q ss_pred eEEEEEEccCCC-CchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 743 HVCLITDYCPGG-ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 743 ~~~lV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
..++||||+.+| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 999999999766 999998764 35999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus 181 ~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 181 ERG----------------------------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp CTT----------------------------CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred CCC----------------------------CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 211 11234579999999999998877 7899999999999999999999965
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=327.37 Aligned_cols=213 Identities=26% Similarity=0.441 Sum_probs=187.0
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+..++|++++.||+|+||.||++.+..+++.||+|++.... .......+.+|+.+|+.++||||+++++++...+..
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 455689999999999999999999999999999999998642 445567789999999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 107 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999999999765 3499999999999999999999996 999999999999999999999999999843210
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 185 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 185 -----------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp -----------------------------HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred -----------------------------ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 112345799999999999999999999999999999999999999998887
Q ss_pred HHHHHHH
Q 002342 904 QKTFANI 910 (934)
Q Consensus 904 ~~~~~~i 910 (934)
.+....+
T Consensus 236 ~~~~~~~ 242 (360)
T 3eqc_A 236 KELELMF 242 (360)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 7655443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=311.20 Aligned_cols=222 Identities=23% Similarity=0.333 Sum_probs=188.8
Q ss_pred ccccCCccccc-ccccCCcEEEEEEEEe--cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 665 QINLQHFRPIK-PLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 665 ~~~~~~y~i~~-~LG~G~~g~Vy~a~~~--~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
.+..++|.+.+ .||+|+||.||++.+. .++..||+|++... ........+.+|+.+++.++||||+++++++ ..
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 35567888887 9999999999999864 46889999999764 2455667889999999999999999999999 45
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
+..|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 6789999999999999998654 345999999999999999999999999999999999999999999999999999654
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~ 900 (934)
...... ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+
T Consensus 161 ~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 216 (287)
T 1u59_A 161 GADDSY------------------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216 (287)
T ss_dssp TTCSCE------------------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccCcce------------------------eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 321110 011223457899999999998889999999999999999998 9999999
Q ss_pred CCHHHHHHHHHcCC
Q 002342 901 KTRQKTFANILHKD 914 (934)
Q Consensus 901 ~~~~~~~~~i~~~~ 914 (934)
.+..+....+..+.
T Consensus 217 ~~~~~~~~~i~~~~ 230 (287)
T 1u59_A 217 MKGPEVMAFIEQGK 230 (287)
T ss_dssp CCTHHHHHHHHTTC
T ss_pred CCHHHHHHHHhcCC
Confidence 99888888887765
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=332.31 Aligned_cols=226 Identities=23% Similarity=0.342 Sum_probs=175.5
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC-----C
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----T 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~ 742 (934)
.++|++++.||+|+||.||+|.+..+++.||||++.+. .........+.+|+.+|+.++||||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 57899999999999999999999999999999999764 33555667889999999999999999999999766 5
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
.+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 104 ELYIVLEIA-DSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CEEEEEECC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred eEEEEEecC-CcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 799999999 57999999764 459999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhh-cCCCCCchhHHHHHHHHHHHHHh--------
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLY-------- 893 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l-~~~~~s~~~DiwSlG~iL~ellt-------- 893 (934)
............. ..................+||+.|+|||++ ....++.++|||||||+||+|++
T Consensus 181 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 181 SEKDTNIVNDLEE-----NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp -----------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred ccccccccccccc-----cccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 2211000000000 000000000001234567899999999997 55679999999999999999998
Q ss_pred ---CCCCCCCCC
Q 002342 894 ---GYTPFRGKT 902 (934)
Q Consensus 894 ---G~~Pf~~~~ 902 (934)
|.++|.+.+
T Consensus 256 ~~~~~p~f~g~~ 267 (432)
T 3n9x_A 256 PTNRFPLFPGSS 267 (432)
T ss_dssp GGGCCCSCCCSC
T ss_pred cccccccCCCcc
Confidence 666666654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=320.05 Aligned_cols=202 Identities=27% Similarity=0.378 Sum_probs=169.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHh-CCCCCccceeEEEEeCCeEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~~~~~~l 746 (934)
.++|++++.||+|+||+||+|.+..+++.||||++..... ..........|+..+.. .+||||+++++++...+.+|+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 4689999999999999999999999999999999876433 23333444555555554 499999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 135 v~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-- 210 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-- 210 (311)
T ss_dssp EEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC--
Confidence 99999 789999887653 45999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.
T Consensus 211 --------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~ 258 (311)
T 3p1a_A 211 --------------------------GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG 258 (311)
T ss_dssp ------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred --------------------------CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 11234469999999999986 6899999999999999999997777543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=315.85 Aligned_cols=221 Identities=24% Similarity=0.353 Sum_probs=189.1
Q ss_pred cccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
..+.+..++|++.+.||+|+||.||++.+ .++..||+|.+.... .....+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 79 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCc----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-
Confidence 45667778999999999999999999997 457789999987542 124568899999999999999999999874
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
+..|+||||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 56899999999999999997643335999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~ 900 (934)
.... ........|++.|+|||++.+..++.++||||||+++|+|++ |.+||.+
T Consensus 160 ~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 213 (279)
T 1qpc_A 160 EDNE--------------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (279)
T ss_dssp SSSC--------------------------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cCcc--------------------------cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence 2110 011223457889999999998889999999999999999999 9999999
Q ss_pred CCHHHHHHHHHcCC
Q 002342 901 KTRQKTFANILHKD 914 (934)
Q Consensus 901 ~~~~~~~~~i~~~~ 914 (934)
.+..+.+..+..+.
T Consensus 214 ~~~~~~~~~~~~~~ 227 (279)
T 1qpc_A 214 MTNPEVIQNLERGY 227 (279)
T ss_dssp CCHHHHHHHHHTTC
T ss_pred cCHHHHHHHHhccc
Confidence 99998888887653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=314.18 Aligned_cols=215 Identities=29% Similarity=0.445 Sum_probs=190.3
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.+.|++++.||+|+||.||++.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++......|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 3579999999999999999999999999999999976432 33457788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 99 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--- 172 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--- 172 (303)
T ss_dssp EECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT---
T ss_pred EEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc---
Confidence 999999999999865 35999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
........||+.|+|||++.+..++.++|||||||++|+|++|.+||.........
T Consensus 173 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 228 (303)
T 3a7i_A 173 ------------------------QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL 228 (303)
T ss_dssp ------------------------BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred ------------------------ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH
Confidence 01123457999999999999999999999999999999999999999998888887
Q ss_pred HHHHcCC
Q 002342 908 ANILHKD 914 (934)
Q Consensus 908 ~~i~~~~ 914 (934)
..+..+.
T Consensus 229 ~~~~~~~ 235 (303)
T 3a7i_A 229 FLIPKNN 235 (303)
T ss_dssp HHHHHSC
T ss_pred HHhhcCC
Confidence 7776654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=320.21 Aligned_cols=208 Identities=25% Similarity=0.289 Sum_probs=180.3
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
..++|++.+.||+|+||.||++.+ .+++.||+|.+... .......+.+|+.+++.++||||+++++++...+..|+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE---SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 457999999999999999999996 56899999988754 23456678899999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 747 ITDYCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999999997543 235899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
. .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 193 ~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 193 D-------------------------QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp S-------------------------CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred c-------------------------ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 0 01122345699999999999999999999999999999999999999986543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.63 Aligned_cols=220 Identities=26% Similarity=0.402 Sum_probs=170.2
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
++..++|++++.||+|+||.||++.+..+++.||+|++.... ........+.++...++.++||||+++++++...+..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 355689999999999999999999999999999999987642 1223333444555567888999999999999999999
Q ss_pred EEEEEccCCCCchhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 745 CLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
|+||||++ ++|.+++.. .....+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999995 588777653 1235699999999999999999999998 9999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhh----cCCCCCchhHHHHHHHHHHHHHhCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII----AGAGHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l----~~~~~s~~~DiwSlG~iL~elltG~~P 897 (934)
... .......||+.|+|||++ .+..++.++|||||||++|+|++|..|
T Consensus 161 ~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 212 (290)
T 3fme_A 161 VDD----------------------------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212 (290)
T ss_dssp -------------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCS
T ss_pred ccc----------------------------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 211 112234699999999996 566788999999999999999999999
Q ss_pred CCC-CCHHHHHHHHHcCC
Q 002342 898 FRG-KTRQKTFANILHKD 914 (934)
Q Consensus 898 f~~-~~~~~~~~~i~~~~ 914 (934)
|.. ......+..+....
T Consensus 213 ~~~~~~~~~~~~~~~~~~ 230 (290)
T 3fme_A 213 YDSWGTPFQQLKQVVEEP 230 (290)
T ss_dssp SCCCSCHHHHHHHHHHSC
T ss_pred ccccCchHHHHHHHhccC
Confidence 986 44444454444433
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=315.47 Aligned_cols=220 Identities=27% Similarity=0.493 Sum_probs=189.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE--eCCeEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ--TKTHVC 745 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~~ 745 (934)
.++|++.+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++. .....|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4689999999999999999999999999999999986532 3455677889999999999999999999885 467899
Q ss_pred EEEEccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCCCCEEEecCCcEEEEecccC
Q 002342 746 LITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQG-----IIYRDLKPENVLLQGNGHVSLTDFDLS 818 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~g-----iiHrDLKp~NILl~~~~~vkl~DFG~a 818 (934)
+||||+++++|.+++... ....+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999998753 2245999999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
...... ........||+.|+|||++.+..++.++||||||+++|+|++|.+||
T Consensus 164 ~~~~~~---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 216 (279)
T 2w5a_A 164 RILNHD---------------------------TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216 (279)
T ss_dssp HHC------------------------------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred eeeccc---------------------------cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 543211 00112346899999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCC
Q 002342 899 RGKTRQKTFANILHKDL 915 (934)
Q Consensus 899 ~~~~~~~~~~~i~~~~~ 915 (934)
.+.+..++...+..+.+
T Consensus 217 ~~~~~~~~~~~i~~~~~ 233 (279)
T 2w5a_A 217 TAFSQKELAGKIREGKF 233 (279)
T ss_dssp CCSSHHHHHHHHHHTCC
T ss_pred cccCHHHHHHHHhhccc
Confidence 99999888888888765
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=324.27 Aligned_cols=215 Identities=25% Similarity=0.392 Sum_probs=184.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC-----C
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----T 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~ 742 (934)
.++|++++.||+|+||.||+|.+..+++.||||++... ........+.+|+.+|+.++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 46899999999999999999999999999999998753 2445557788999999999999999999999764 4
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
..|+||||+ +++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~~iv~e~~-~~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 104 DVYIVQDLM-ETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp CEEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEccc-CcCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 789999999 46999998763 49999999999999999999999999999999999999999999999999996532
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
... .........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.
T Consensus 180 ~~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 235 (364)
T 3qyz_A 180 PDH------------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 235 (364)
T ss_dssp GGG------------------------CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCC------------------------CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence 110 00111234589999999998765 45899999999999999999999999999
Q ss_pred CHHHHHHHHHc
Q 002342 902 TRQKTFANILH 912 (934)
Q Consensus 902 ~~~~~~~~i~~ 912 (934)
+..+.+..|..
T Consensus 236 ~~~~~~~~i~~ 246 (364)
T 3qyz_A 236 HYLDQLNHILG 246 (364)
T ss_dssp SGGGHHHHHHH
T ss_pred ChHHHHHHHHH
Confidence 88888777753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=322.76 Aligned_cols=223 Identities=23% Similarity=0.354 Sum_probs=185.3
Q ss_pred cccccCCcccccccccCCcEEEEEEEEe-----cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEE
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS 737 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 737 (934)
+.+..++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+ +||||++++++
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 3456789999999999999999999964 467899999997642 344556788999999999 79999999999
Q ss_pred EEeCC-eEEEEEEccCCCCchhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 002342 738 FQTKT-HVCLITDYCPGGELFLLLDRQPT--------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802 (934)
Q Consensus 738 ~~~~~-~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NI 802 (934)
+...+ .+|+||||+++++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 87654 58999999999999999976532 1289999999999999999999999999999999999
Q ss_pred EEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHH
Q 002342 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882 (934)
Q Consensus 803 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Diw 882 (934)
+++.++.+||+|||++........ ........||+.|+|||++.+..++.++|||
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~-------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 234 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPD-------------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVW 234 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT-------------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred EECCCCCEEECCCccccccccCcc-------------------------ceeccCCCcceeecCchhhccccccchhHHH
Confidence 999999999999999865321110 1122345688999999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHH-HHHHHcC
Q 002342 883 ALGILLYEMLY-GYTPFRGKTRQKT-FANILHK 913 (934)
Q Consensus 883 SlG~iL~ellt-G~~Pf~~~~~~~~-~~~i~~~ 913 (934)
||||++|+|++ |..||.+...... ...+..+
T Consensus 235 slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~ 267 (316)
T 2xir_A 235 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267 (316)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCcccchhHHHHHHhccC
Confidence 99999999998 9999988765444 4444443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=332.97 Aligned_cols=219 Identities=27% Similarity=0.428 Sum_probs=184.0
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC--eE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT--HV 744 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~ 744 (934)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++...+ ..
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 35789999999999999999999999999999999975432 223456788999999999999999999998655 78
Q ss_pred EEEEEccCCCCchhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE----ecCCcEEEEecccCc
Q 002342 745 CLITDYCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL----QGNGHVSLTDFDLSC 819 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl----~~~~~vkl~DFG~a~ 819 (934)
|+|||||++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999999976422 239999999999999999999999999999999999999 667789999999996
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC--------CCCCchhHHHHHHHHHHHH
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--------AGHTSAVDWWALGILLYEM 891 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--------~~~s~~~DiwSlG~iL~el 891 (934)
.... .......+||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 165 ~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el 216 (396)
T 4eut_A 165 ELED----------------------------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (396)
T ss_dssp ECCC----------------------------GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHH
T ss_pred EccC----------------------------CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHH
Confidence 4321 111234579999999999865 5667899999999999999
Q ss_pred HhCCCCCCC----CCHHHHHHHHHcCCC
Q 002342 892 LYGYTPFRG----KTRQKTFANILHKDL 915 (934)
Q Consensus 892 ltG~~Pf~~----~~~~~~~~~i~~~~~ 915 (934)
++|+.||.+ ....+++..+..+..
T Consensus 217 ~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 217 ATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp HHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred HHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 999999974 334566777776543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=318.96 Aligned_cols=212 Identities=23% Similarity=0.393 Sum_probs=185.1
Q ss_pred ccCCcccccccccCCcEEEEEEEE-ecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCC------CccceeEEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVEL-CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP------FVPALYASFQ 739 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~-~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp------~Iv~l~~~~~ 739 (934)
..++|++.+.||+|+||.||++.+ ..+++.||+|++... ......+.+|+.+++.++|+ +|+++++++.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 357999999999999999999998 568999999998643 34456788899999988655 4999999999
Q ss_pred eCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-------------
Q 002342 740 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG------------- 806 (934)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~------------- 806 (934)
..++.|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999999 999999998776557999999999999999999999999999999999999987
Q ss_pred ------CCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhH
Q 002342 807 ------NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 880 (934)
Q Consensus 807 ------~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~D 880 (934)
++.+||+|||++..... .....+||+.|+|||++.+..++.++|
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 216 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE------------------------------HHSTLVSTRHYRAPEVILALGWSQPCD 216 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS------------------------------CCCSSCSCGGGCCHHHHTTSCCCTHHH
T ss_pred ccccccCCCceEeeCcccccCcc------------------------------ccccccCCccccChHHhhCCCCCcchh
Confidence 66899999999854211 123457999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 002342 881 WWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 881 iwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~ 913 (934)
||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 217 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 249 (339)
T 1z57_A 217 VWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249 (339)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999999999999999999998888777666543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=339.32 Aligned_cols=211 Identities=18% Similarity=0.147 Sum_probs=169.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHH---HHhCCCCCcccee-------EE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI---LDMLDHPFVPALY-------AS 737 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~i---l~~l~hp~Iv~l~-------~~ 737 (934)
.++|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+ |+.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4689999999999999999999999999999999986544455667788999954 5555899999998 77
Q ss_pred EEeCC-----------------eEEEEEEccCCCCchhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 002342 738 FQTKT-----------------HVCLITDYCPGGELFLLLDRQPT-----KVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795 (934)
Q Consensus 738 ~~~~~-----------------~~~lV~E~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qil~aL~yLH~~giiHr 795 (934)
+...+ ..||||||+ +|+|.+++..... ..+++..+..++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 76554 389999999 7899999976421 123348888899999999999999999999
Q ss_pred CCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC--
Q 002342 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-- 873 (934)
Q Consensus 796 DLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-- 873 (934)
||||+|||++.++.+||+|||+|.... ......+| +.|+|||++.+.
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~------------------------------~~~~~~~g-~~y~aPE~~~~~~~ 279 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDG------------------------------ARVVSSVS-RGFEPPELEARRAT 279 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT------------------------------CEEECCCC-TTCCCHHHHHHHTS
T ss_pred CCCHHHEEEcCCCCEEEEechhheecC------------------------------CcccCCCC-cCccChhhhccccc
Confidence 999999999999999999999985321 11234578 999999999887
Q ss_pred ---------CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 002342 874 ---------GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910 (934)
Q Consensus 874 ---------~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i 910 (934)
.++.++|||||||+||+|++|++||.+.+....+..+
T Consensus 280 ~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~ 325 (377)
T 3byv_A 280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI 325 (377)
T ss_dssp THHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGG
T ss_pred ccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhh
Confidence 8999999999999999999999999876654444333
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=312.79 Aligned_cols=223 Identities=22% Similarity=0.329 Sum_probs=175.3
Q ss_pred cccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
...++..++|++.+.||+|+||.||++.+. ..+|+|+++.. .........+.+|+.+|+.++||||++++++. ..
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCS-SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEecc-CCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 345677889999999999999999999863 35999998764 23456667889999999999999999999965 55
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
...++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred CccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 6789999999999999998654 355999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
.... .........||+.|+|||++. +..++.++|||||||++|+|++|+.||
T Consensus 171 ~~~~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 225 (289)
T 3og7_A 171 SRWS-------------------------GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225 (289)
T ss_dssp --------------------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccc-------------------------ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCc
Confidence 2110 011223457999999999996 667888999999999999999999999
Q ss_pred CCCCHHH-HHHHHHcCCC
Q 002342 899 RGKTRQK-TFANILHKDL 915 (934)
Q Consensus 899 ~~~~~~~-~~~~i~~~~~ 915 (934)
.+....+ ....+..+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~ 243 (289)
T 3og7_A 226 SNINNRDQIIEMVGRGSL 243 (289)
T ss_dssp SSCCCHHHHHHHHHHTSC
T ss_pred cccchHHHHHHHhccccc
Confidence 8865554 4444545544
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=318.13 Aligned_cols=237 Identities=24% Similarity=0.333 Sum_probs=186.5
Q ss_pred ccccCCcccccccccCCcEEEEEEEEec-CC--eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCG-SG--QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~-~~--~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
.+..++|++.+.||+|+||.||++.+.. ++ ..||+|++.............+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 4556799999999999999999998754 33 36999998865544556677889999999999999999999999876
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
. .++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred C-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 5 889999999999999987642 45999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~ 900 (934)
..... .........||+.|+|||++.+..++.++||||||+++|+|++ |.+||.+
T Consensus 172 ~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 227 (291)
T 1u46_A 172 PQNDD------------------------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227 (291)
T ss_dssp CC-CC------------------------EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccc------------------------chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 22110 0011223467889999999998889999999999999999999 9999999
Q ss_pred CCHHHHHHHHHcCCCCCCCCCCCCccc
Q 002342 901 KTRQKTFANILHKDLKFPSSTPSSCKA 927 (934)
Q Consensus 901 ~~~~~~~~~i~~~~~~~p~~~~~s~~~ 927 (934)
.+..+.+..+......+|.....+..+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (291)
T 1u46_A 228 LNGSQILHKIDKEGERLPRPEDCPQDI 254 (291)
T ss_dssp CCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CCHHHHHHHHHccCCCCCCCcCcCHHH
Confidence 999999999987766665543334333
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=333.49 Aligned_cols=209 Identities=29% Similarity=0.465 Sum_probs=174.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe------C
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------K 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------~ 741 (934)
..+|++.+.||+|+||.||++.+..+++.||||.+.+.. ....+|+++|+.++||||++++++|.. .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 347999999999999999999999999999999987532 123469999999999999999999853 2
Q ss_pred CeEEEEEEccCCCCchhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-CcEEEEecccC
Q 002342 742 THVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLS 818 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-~~vkl~DFG~a 818 (934)
.++++||||++ ++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 126 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 126 VYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 35789999995 466666542 223569999999999999999999999999999999999999965 67899999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~P 897 (934)
+..... ......+||+.|+|||++.+. .++.++|||||||+||+|++|++|
T Consensus 205 ~~~~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~p 256 (420)
T 1j1b_A 205 KQLVRG----------------------------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 256 (420)
T ss_dssp EECCTT----------------------------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred hhcccC----------------------------CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 643211 112345789999999999765 789999999999999999999999
Q ss_pred CCCCCHHHHHHHHHc
Q 002342 898 FRGKTRQKTFANILH 912 (934)
Q Consensus 898 f~~~~~~~~~~~i~~ 912 (934)
|.+.+..+.+..|++
T Consensus 257 f~~~~~~~~l~~i~~ 271 (420)
T 1j1b_A 257 FPGDSGVDQLVEIIK 271 (420)
T ss_dssp SCCSSHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHH
Confidence 999998877777654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=313.06 Aligned_cols=223 Identities=22% Similarity=0.313 Sum_probs=186.4
Q ss_pred cccccCCccccc-ccccCCcEEEEEEEE--ecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe
Q 002342 664 EQINLQHFRPIK-PLGSGDTGSVHLVEL--CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (934)
Q Consensus 664 ~~~~~~~y~i~~-~LG~G~~g~Vy~a~~--~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (934)
..+..++|++.+ .||+|+||.||++.+ ..+++.||+|++.... ........+.+|+.+++.++||||+++++++ .
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 345667899998 999999999999955 5567899999997642 2344467789999999999999999999999 5
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
.+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 67789999999999999999874 4599999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 899 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~ 899 (934)
....... ........|++.|+|||++.+..++.++||||||+++|+|++ |+.||.
T Consensus 167 ~~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 222 (291)
T 1xbb_A 167 LRADENY------------------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 222 (291)
T ss_dssp CCTTCSE------------------------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred eccCCCc------------------------ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCC
Confidence 4221100 011123357889999999998889999999999999999999 999999
Q ss_pred CCCHHHHHHHHHcCC
Q 002342 900 GKTRQKTFANILHKD 914 (934)
Q Consensus 900 ~~~~~~~~~~i~~~~ 914 (934)
+.+..++...+..+.
T Consensus 223 ~~~~~~~~~~~~~~~ 237 (291)
T 1xbb_A 223 GMKGSEVTAMLEKGE 237 (291)
T ss_dssp TCCHHHHHHHHHTTC
T ss_pred CCCHHHHHHHHHcCC
Confidence 999988888887754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=323.45 Aligned_cols=205 Identities=25% Similarity=0.342 Sum_probs=173.3
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
...+..++|++.+.||+|+||.||++++ .++.||||++... ........+|+.+|+.++||||+++++++....
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred ccccchhhchhhheecccCceEEEEEEE--CCCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 3446678999999999999999999987 4899999998653 233445566899999999999999999998743
Q ss_pred ----eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CCeecCCCCCCEEEecCC
Q 002342 743 ----HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ----------GIIYRDLKPENVLLQGNG 808 (934)
Q Consensus 743 ----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~----------giiHrDLKp~NILl~~~~ 808 (934)
.+|+|||||++++|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred CCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence 479999999999999999763 399999999999999999999999 999999999999999999
Q ss_pred cEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-----CCCchhHHHH
Q 002342 809 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-----GHTSAVDWWA 883 (934)
Q Consensus 809 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----~~s~~~DiwS 883 (934)
.+||+|||++........ .......+||+.|+|||++.+. .++.++||||
T Consensus 169 ~~kL~DFg~a~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diws 223 (322)
T 3soc_A 169 TACIADFGLALKFEAGKS-------------------------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223 (322)
T ss_dssp CEEECCCTTCEEECTTSC-------------------------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHH
T ss_pred eEEEccCCcccccccccC-------------------------ccccccCccCccccCHhhcccccccCcCCCccchhHH
Confidence 999999999965432110 1122345799999999999873 4456889999
Q ss_pred HHHHHHHHHhCCCCCCCC
Q 002342 884 LGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 884 lG~iL~elltG~~Pf~~~ 901 (934)
|||++|+|++|++||.+.
T Consensus 224 lG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 224 MGLVLWELASRCTAADGP 241 (322)
T ss_dssp HHHHHHHHHTTBTTSSSC
T ss_pred HHHHHHHHHhCCCCCCCC
Confidence 999999999999999764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=323.62 Aligned_cols=209 Identities=26% Similarity=0.432 Sum_probs=181.7
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE---
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV--- 744 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~--- 744 (934)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 479999999999999999999999999999999997642 3445567788999999999999999999999876654
Q ss_pred ---EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 745 ---CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 745 ---~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
|+||||+ +++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 120 ~~~~lv~e~~-~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 120 YDFYLVMPFM-QTDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCCEEEEECC-CEEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eeEEEEEccc-cccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 9999999 4788887743 3999999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+
T Consensus 195 ~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 195 DA------------------------------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp -----------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cc------------------------------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 11 1234578999999999987 7889999999999999999999999999
Q ss_pred CCHHHHHHHHHc
Q 002342 901 KTRQKTFANILH 912 (934)
Q Consensus 901 ~~~~~~~~~i~~ 912 (934)
.+..+.+..+..
T Consensus 245 ~~~~~~~~~i~~ 256 (371)
T 4exu_A 245 KDYLDQLTQILK 256 (371)
T ss_dssp SSHHHHHHHHHH
T ss_pred CChHHHHHHHHH
Confidence 998888877754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=336.92 Aligned_cols=220 Identities=24% Similarity=0.346 Sum_probs=185.6
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
.+.+..++|++.+.||+|+||.||++.+.. +..||||+++.... ..+.+.+|+.+|+.++||||+++++++.. +
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 455677899999999999999999999854 46799999976432 23568899999999999999999999876 6
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
..|+|||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 78999999999999999976444569999999999999999999999999999999999999999999999999996532
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~ 901 (934)
... ........+++.|+|||++.+..++.++|||||||+||+|++ |.+||.+.
T Consensus 332 ~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 332 DNE--------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp -------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CCc--------------------------eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 110 011123357889999999999999999999999999999999 99999999
Q ss_pred CHHHHHHHHHcCC
Q 002342 902 TRQKTFANILHKD 914 (934)
Q Consensus 902 ~~~~~~~~i~~~~ 914 (934)
+..+++..+..+.
T Consensus 386 ~~~~~~~~i~~~~ 398 (452)
T 1fmk_A 386 VNREVLDQVERGY 398 (452)
T ss_dssp CHHHHHHHHHTTC
T ss_pred CHHHHHHHHHcCC
Confidence 9999988887653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=312.98 Aligned_cols=195 Identities=24% Similarity=0.397 Sum_probs=172.5
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEe--CCe
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQT--KTH 743 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~--~~~ 743 (934)
+.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+|+.+. ||||+++++++.. ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 457899999999999999999999999999999998753 2356889999999997 9999999999987 678
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-cEEEEecccCcccC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTS 822 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-~vkl~DFG~a~~~~ 822 (934)
.++||||+.+++|.+++.. +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 108 ~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999999998853 89999999999999999999999999999999999999776 89999999985432
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 183 ~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 183 PG----------------------------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp TT----------------------------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CC----------------------------CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 11 11234578999999999987 6789999999999999999999999954
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=316.72 Aligned_cols=214 Identities=29% Similarity=0.461 Sum_probs=181.9
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
..++|++.+.||+|+||.||++.+..+++.||+|.+.... ....+.+|+.+++.++||||+++++++...+..|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3578999999999999999999999999999999987532 23567889999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||||+++++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 102 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-- 178 (314)
T ss_dssp EEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred EeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence 99999999999998643 245999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....
T Consensus 179 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 233 (314)
T 3com_A 179 -------------------------MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA 233 (314)
T ss_dssp -------------------------BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred -------------------------ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 1122345799999999999999999999999999999999999999998887776
Q ss_pred HHHHHcC
Q 002342 907 FANILHK 913 (934)
Q Consensus 907 ~~~i~~~ 913 (934)
...+...
T Consensus 234 ~~~~~~~ 240 (314)
T 3com_A 234 IFMIPTN 240 (314)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 6666544
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=316.51 Aligned_cols=224 Identities=24% Similarity=0.315 Sum_probs=181.7
Q ss_pred ccccCCcccccccccCCcEEEEEEEEec---CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~---~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
.+..++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ........+.+|+.+++.++||||+++++++...
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 4556899999999999999999998876 56689999987642 2445567789999999999999999999999865
Q ss_pred C-----eEEEEEEccCCCCchhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEE
Q 002342 742 T-----HVCLITDYCPGGELFLLLDR----QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 812 (934)
Q Consensus 742 ~-----~~~lV~E~~~ggsL~~~l~~----~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl 812 (934)
+ ..|+||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence 4 45999999999999999843 22356999999999999999999999999999999999999999999999
Q ss_pred EecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHH
Q 002342 813 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892 (934)
Q Consensus 813 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ell 892 (934)
+|||++....... .........+++.|+|||++.+..++.++|||||||++|+|+
T Consensus 189 ~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 243 (313)
T 3brb_A 189 ADFGLSKKIYSGD-------------------------YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243 (313)
T ss_dssp CSCSCC-----------------------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHH
T ss_pred eecCcceeccccc-------------------------ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHH
Confidence 9999985432110 001122345788999999999999999999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCC
Q 002342 893 Y-GYTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 893 t-G~~Pf~~~~~~~~~~~i~~~~ 914 (934)
+ |.+||.+.........+..+.
T Consensus 244 ~~g~~p~~~~~~~~~~~~~~~~~ 266 (313)
T 3brb_A 244 TRGMTPYPGVQNHEMYDYLLHGH 266 (313)
T ss_dssp TTSCCSSTTCCGGGHHHHHHTTC
T ss_pred hcCCCCCccCCHHHHHHHHHcCC
Confidence 9 999999999988888887764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=315.80 Aligned_cols=217 Identities=27% Similarity=0.471 Sum_probs=183.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.+.|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 46899999999999999999999999999999998754 233456788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 95 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~----- 168 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL----- 168 (302)
T ss_dssp EECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH-----
T ss_pred EEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccc-----
Confidence 9999999999988653 2459999999999999999999999999999999999999999999999999873210
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhh-----cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII-----AGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l-----~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
..........||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+
T Consensus 169 ----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 169 ----------------------KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp ----------------------HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ----------------------ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 001112345799999999998 36778899999999999999999999999998
Q ss_pred HHHHHHHHHcCCC
Q 002342 903 RQKTFANILHKDL 915 (934)
Q Consensus 903 ~~~~~~~i~~~~~ 915 (934)
....+..+..+..
T Consensus 227 ~~~~~~~~~~~~~ 239 (302)
T 2j7t_A 227 PMRVLLKIAKSDP 239 (302)
T ss_dssp HHHHHHHHHHSCC
T ss_pred HHHHHHHHhccCC
Confidence 8888877776554
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=326.23 Aligned_cols=200 Identities=25% Similarity=0.413 Sum_probs=175.2
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC--------CCCccceeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD--------HPFVPALYASFQ 739 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~--------hp~Iv~l~~~~~ 739 (934)
.++|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+|+.+. ||||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 57899999999999999999999999999999998753 345567889999999985 788999999998
Q ss_pred ----eCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCC------
Q 002342 740 ----TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNG------ 808 (934)
Q Consensus 740 ----~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~------ 808 (934)
...++|+||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence 566899999999 77777777665556699999999999999999999999 999999999999998775
Q ss_pred -------------------------------------------cEEEEecccCcccCCCCCCCCCcchhhhccccCCCCc
Q 002342 809 -------------------------------------------HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845 (934)
Q Consensus 809 -------------------------------------------~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (934)
.+||+|||++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~---------------------- 248 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---------------------- 248 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB----------------------
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc----------------------
Confidence 799999999854321
Q ss_pred ccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 846 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
.....+||+.|+|||++.+..++.++|||||||+||+|++|++||.+.+
T Consensus 249 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 249 --------HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp --------CSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred --------cCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1223479999999999999999999999999999999999999998755
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.34 Aligned_cols=217 Identities=24% Similarity=0.412 Sum_probs=180.8
Q ss_pred cccccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE
Q 002342 660 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 739 (934)
Q Consensus 660 ~~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 739 (934)
....+.+..++|++.+.||+|+||.||++.+ +++.||+|++... ...+.+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (278)
T 1byg_A 12 YRSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIV 84 (278)
T ss_dssp ---CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred hhccccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch-----hHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3455667889999999999999999999987 5889999998753 24467889999999999999999999975
Q ss_pred e-CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccC
Q 002342 740 T-KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (934)
Q Consensus 740 ~-~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a 818 (934)
. .+..|+||||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp CC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred cCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccc
Confidence 4 457899999999999999997653334899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTP 897 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~P 897 (934)
..... ......+++.|+|||++.+..++.++||||||+++|+|++ |.+|
T Consensus 165 ~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p 214 (278)
T 1byg_A 165 KEASS------------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214 (278)
T ss_dssp -----------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccc------------------------------cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCC
Confidence 53211 0112357889999999999999999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHcC
Q 002342 898 FRGKTRQKTFANILHK 913 (934)
Q Consensus 898 f~~~~~~~~~~~i~~~ 913 (934)
|...+..+....+..+
T Consensus 215 ~~~~~~~~~~~~~~~~ 230 (278)
T 1byg_A 215 YPRIPLKDVVPRVEKG 230 (278)
T ss_dssp CTTSCGGGHHHHHTTT
T ss_pred CCCCCHHHHHHHHhcC
Confidence 9998888888887665
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=315.44 Aligned_cols=207 Identities=23% Similarity=0.324 Sum_probs=174.7
Q ss_pred cccCCcccccccccCCcEEEEEEE----EecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVE----LCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~----~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
+....|++++.||+|+||.||+|. +..+++.||+|++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 445679999999999999999999 56789999999987542 233456788999999999999999999999876
Q ss_pred --CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 742 --THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 742 --~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
..+|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 67899999999999999996543 459999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
....... .........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 175 ~~~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 175 AIETDKE------------------------YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp ECCTTCC------------------------EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccCCCc------------------------ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 5432110 0112234568889999999999999999999999999999999998763
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=311.01 Aligned_cols=220 Identities=28% Similarity=0.475 Sum_probs=191.3
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 4689999999999999999999999999999999976533 233456788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC---CcEEEEecccCcccCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~---~~vkl~DFG~a~~~~~~ 824 (934)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 100 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 100 GELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 9999999999988764 359999999999999999999999999999999999999754 46999999998543211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
.......||+.|+|||++.+. ++.++||||||+++|+|++|.+||.+.+..
T Consensus 178 ----------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (287)
T 2wei_A 178 ----------------------------TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY 228 (287)
T ss_dssp ----------------------------SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ----------------------------CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence 111234689999999998764 889999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCC
Q 002342 905 KTFANILHKDLKFPS 919 (934)
Q Consensus 905 ~~~~~i~~~~~~~p~ 919 (934)
++...+..+.+.++.
T Consensus 229 ~~~~~~~~~~~~~~~ 243 (287)
T 2wei_A 229 DILKRVETGKYAFDL 243 (287)
T ss_dssp HHHHHHHHCCCCCCS
T ss_pred HHHHHHHcCCCCCCc
Confidence 999999988876553
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=311.46 Aligned_cols=220 Identities=24% Similarity=0.312 Sum_probs=185.2
Q ss_pred ccccCCcccccccccCCcEEEEEEEEec---CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~---~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
.+..++|++.+.||+|+||.||++.+.. ++..||+|.+.+.. .......+.+|+.+++.++||||+++++++..+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 4567899999999999999999999754 34579999987642 344567788999999999999999999998754
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 5689999999999999997643 45999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~ 900 (934)
.... ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||..
T Consensus 164 ~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~ 217 (281)
T 3cc6_A 164 EDED--------------------------YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217 (281)
T ss_dssp -----------------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cccc--------------------------ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence 2110 011223457889999999999999999999999999999998 9999998
Q ss_pred CCHHHHHHHHHcCC
Q 002342 901 KTRQKTFANILHKD 914 (934)
Q Consensus 901 ~~~~~~~~~i~~~~ 914 (934)
....+....+..+.
T Consensus 218 ~~~~~~~~~~~~~~ 231 (281)
T 3cc6_A 218 LENKDVIGVLEKGD 231 (281)
T ss_dssp SCGGGHHHHHHHTC
T ss_pred CChHHHHHHHhcCC
Confidence 88888877776654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=318.35 Aligned_cols=219 Identities=33% Similarity=0.531 Sum_probs=179.0
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeeccccc-----ChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-----NRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
++|++.+.||+|+||.||+|.+..+++.||||++.+.... .......+.+|+.+|+.++||||+++++++..++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999999999999999998764321 1223345788999999999999999999997765
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc---EEEEecccCcc
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCL 820 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~---vkl~DFG~a~~ 820 (934)
.|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 89999999999999998764 45999999999999999999999999999999999999987664 99999999854
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~s~~~DiwSlG~iL~elltG~~P 897 (934)
.... ......+||+.|+|||++. ...++.++|||||||++|+|++|.+|
T Consensus 167 ~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 218 (322)
T 2ycf_A 167 LGET----------------------------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218 (322)
T ss_dssp CCCC----------------------------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccc----------------------------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 3210 0112356999999999984 56788999999999999999999999
Q ss_pred CCCCCHH-HHHHHHHcCCCCCC
Q 002342 898 FRGKTRQ-KTFANILHKDLKFP 918 (934)
Q Consensus 898 f~~~~~~-~~~~~i~~~~~~~p 918 (934)
|.+.... .....+..+.+.++
T Consensus 219 f~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T 2ycf_A 219 FSEHRTQVSLKDQITSGKYNFI 240 (322)
T ss_dssp SCSTTCSSCHHHHHHHTCCCCC
T ss_pred CcccchHHHHHHHHHhCccccC
Confidence 9875543 44555666665543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.39 Aligned_cols=227 Identities=26% Similarity=0.435 Sum_probs=169.2
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
+.+..++|++.+.||+|+||.||++.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh--cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 4466789999999999999999999999999999999886532 22345667889999999999999999999999999
Q ss_pred EEEEEEccCCCCchhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEeccc
Q 002342 744 VCLITDYCPGGELFLLLDR------QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~------~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~ 817 (934)
.|+||||+++++|.+++.. .....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999864 1234599999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCC
Q 002342 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYT 896 (934)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~ 896 (934)
+........ ...........||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 168 ~~~~~~~~~----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 225 (303)
T 2vwi_A 168 SAFLATGGD----------------------ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225 (303)
T ss_dssp HHHCC-------------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred hheeccCCC----------------------ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 854321100 001112234579999999999976 568899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCC
Q 002342 897 PFRGKTRQKTFANILHKD 914 (934)
Q Consensus 897 Pf~~~~~~~~~~~i~~~~ 914 (934)
||.+......+.....+.
T Consensus 226 pf~~~~~~~~~~~~~~~~ 243 (303)
T 2vwi_A 226 PYHKYPPMKVLMLTLQND 243 (303)
T ss_dssp TTTTSCGGGHHHHHHTSS
T ss_pred CCccCchhhHHHHHhccC
Confidence 999888777666665544
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=319.93 Aligned_cols=212 Identities=23% Similarity=0.372 Sum_probs=181.4
Q ss_pred ccccccCCcccccccccCCcEEEEEEE----EecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEE
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVE----LCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF 738 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~----~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 738 (934)
...+..++|++++.||+|+||.||+++ +..+++.||+|++... .......+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 344667899999999999999999999 4678999999998754 345567789999999999999999999998
Q ss_pred E--eCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecc
Q 002342 739 Q--TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 816 (934)
Q Consensus 739 ~--~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG 816 (934)
. ....+|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccc
Confidence 6 4567999999999999999997642 349999999999999999999999999999999999999999999999999
Q ss_pred cCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCC
Q 002342 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT 896 (934)
Q Consensus 817 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~ 896 (934)
++........ .........||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 173 ~~~~~~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~ 228 (327)
T 3lxl_A 173 LAKLLPLDKD------------------------YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228 (327)
T ss_dssp GCEECCTTCS------------------------EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred cceecccCCc------------------------cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 9965432110 0112234468899999999999989999999999999999999999
Q ss_pred CCCCCC
Q 002342 897 PFRGKT 902 (934)
Q Consensus 897 Pf~~~~ 902 (934)
||....
T Consensus 229 p~~~~~ 234 (327)
T 3lxl_A 229 KSCSPS 234 (327)
T ss_dssp GGGSHH
T ss_pred CCcccc
Confidence 996543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=315.19 Aligned_cols=215 Identities=26% Similarity=0.434 Sum_probs=183.1
Q ss_pred cCCcccccccccCCcEEEEEEEEe-cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC---CCCCccceeEEEE----
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELC-GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQ---- 739 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~-~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~---- 739 (934)
.++|++.+.||+|+||.||+|.+. .+++.||+|++...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 478999999999999999999995 67899999998754321 11123455677777665 8999999999987
Q ss_pred -eCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccC
Q 002342 740 -TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (934)
Q Consensus 740 -~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a 818 (934)
.....++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 5678899999996 69999998765566999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|++||
T Consensus 168 ~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 219 (326)
T 1blx_A 168 RIYSF----------------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219 (326)
T ss_dssp CCCCG----------------------------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccC----------------------------CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCC
Confidence 54321 01123457899999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHc
Q 002342 899 RGKTRQKTFANILH 912 (934)
Q Consensus 899 ~~~~~~~~~~~i~~ 912 (934)
.+.+..+.+..+..
T Consensus 220 ~~~~~~~~~~~i~~ 233 (326)
T 1blx_A 220 RGSSDVDQLGKILD 233 (326)
T ss_dssp CCSSHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHH
Confidence 99999888887764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.25 Aligned_cols=224 Identities=19% Similarity=0.255 Sum_probs=185.5
Q ss_pred cCCcccccccccCCcEEEEEEEEecC---CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEE-EeCCe
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF-QTKTH 743 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-~~~~~ 743 (934)
...|++.+.||+|+||.||++.+..+ ...+|+|.+... ........+.+|+.+++.++||||+++++++ ..++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 45799999999999999999997543 346899998753 3455667889999999999999999999985 45678
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
.|+||||+++++|.+++... ...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred eEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 89999999999999999764 35589999999999999999999999999999999999999999999999999965421
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~ 902 (934)
... ..........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+
T Consensus 181 ~~~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 237 (298)
T 3f66_A 181 KEY-----------------------YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237 (298)
T ss_dssp GGG-----------------------CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred cch-----------------------hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence 110 01122234568899999999999999999999999999999999 888898888
Q ss_pred HHHHHHHHHcCCCCC
Q 002342 903 RQKTFANILHKDLKF 917 (934)
Q Consensus 903 ~~~~~~~i~~~~~~~ 917 (934)
..+....+..+....
T Consensus 238 ~~~~~~~~~~~~~~~ 252 (298)
T 3f66_A 238 TFDITVYLLQGRRLL 252 (298)
T ss_dssp TTTHHHHHHTTCCCC
T ss_pred HHHHHHHHhcCCCCC
Confidence 888888887766543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=310.62 Aligned_cols=215 Identities=25% Similarity=0.395 Sum_probs=177.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE--------
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ-------- 739 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-------- 739 (934)
.++|++++.||+|+||.||++.+..+++.||+|.+... .......+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 57899999999999999999999999999999998753 4556678889999999999999999999873
Q ss_pred ------eCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe-cCCcEEE
Q 002342 740 ------TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-GNGHVSL 812 (934)
Q Consensus 740 ------~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~-~~~~vkl 812 (934)
.....|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 3468899999995 699999864 3489999999999999999999999999999999999997 4679999
Q ss_pred EecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHH
Q 002342 813 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEM 891 (934)
Q Consensus 813 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~el 891 (934)
+|||++........ .........||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 163 ~Dfg~~~~~~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el 218 (320)
T 2i6l_A 163 GDFGLARIMDPHYS------------------------HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218 (320)
T ss_dssp CCCTTCBCC--------------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHH
T ss_pred ccCccccccCCCcc------------------------cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHH
Confidence 99999865321100 0112234468999999999876 6788999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcC
Q 002342 892 LYGYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 892 ltG~~Pf~~~~~~~~~~~i~~~ 913 (934)
++|+.||.+.+..+.+..+...
T Consensus 219 ~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 219 LTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999999988888877653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=309.99 Aligned_cols=220 Identities=21% Similarity=0.263 Sum_probs=184.3
Q ss_pred CCcccccccccCCcEEEEEEEEecCCe---EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE-
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV- 744 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~---~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~- 744 (934)
-.|.+.+.||+|+||.||++.+..++. .||+|.+... ........+.+|+.+++.++||||+++++++.+.+..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 357778999999999999999866554 7999998753 3455667888999999999999999999999876655
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
++||||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp EEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999999764 356899999999999999999999999999999999999999999999999999643211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~ 903 (934)
. ...........||+.|+|||.+.+..++.++|||||||++|+|++ |.+||.+.+.
T Consensus 178 ~-----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~ 234 (298)
T 3pls_A 178 E-----------------------YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234 (298)
T ss_dssp G-----------------------GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG
T ss_pred c-----------------------ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH
Confidence 0 001122334578999999999999999999999999999999999 6777777777
Q ss_pred HHHHHHHHcCC
Q 002342 904 QKTFANILHKD 914 (934)
Q Consensus 904 ~~~~~~i~~~~ 914 (934)
.+....+..+.
T Consensus 235 ~~~~~~~~~~~ 245 (298)
T 3pls_A 235 FDLTHFLAQGR 245 (298)
T ss_dssp GGHHHHHHTTC
T ss_pred HHHHHHhhcCC
Confidence 77777776654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=317.63 Aligned_cols=209 Identities=26% Similarity=0.430 Sum_probs=180.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe----
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH---- 743 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~---- 743 (934)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 478999999999999999999999999999999997642 344556778899999999999999999999987653
Q ss_pred --EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 744 --VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 744 --~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
.|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999995 788888743 3999999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+
T Consensus 177 ~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 226 (353)
T 3coi_A 177 DA------------------------------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226 (353)
T ss_dssp -------------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred CC------------------------------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 10 1123478999999999987 6788999999999999999999999999
Q ss_pred CCHHHHHHHHHc
Q 002342 901 KTRQKTFANILH 912 (934)
Q Consensus 901 ~~~~~~~~~i~~ 912 (934)
.+..+.+..+..
T Consensus 227 ~~~~~~~~~i~~ 238 (353)
T 3coi_A 227 KDYLDQLTQILK 238 (353)
T ss_dssp SCHHHHHHHHHH
T ss_pred CCHHHHHHHHHH
Confidence 988877777654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=317.17 Aligned_cols=217 Identities=23% Similarity=0.356 Sum_probs=185.4
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCC-eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCC------ccceeEEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSG-QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF------VPALYASFQ 739 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~-~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~------Iv~l~~~~~ 739 (934)
..++|++.+.||+|+||.||+|.+..++ ..||+|++... ......+.+|+.+++.+.|++ ++.+++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 3579999999999999999999998776 79999998753 344567788999999987655 899999999
Q ss_pred eCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---------------
Q 002342 740 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL--------------- 804 (934)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl--------------- 804 (934)
..++.|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 999999999999 7788888776655569999999999999999999999999999999999999
Q ss_pred ----ecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhH
Q 002342 805 ----QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 880 (934)
Q Consensus 805 ----~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~D 880 (934)
+.++.+||+|||++..... .....+||+.|+|||++.+..++.++|
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 221 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE------------------------------HHTTIVATRHYRPPEVILELGWAQPCD 221 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS------------------------------CCCSSCSCGGGCCHHHHTTCCCCTHHH
T ss_pred cccccCCCcEEEeecCccccccc------------------------------cccCCcCCCcccCCeeeecCCCCCccc
Confidence 6678999999999854211 123457999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q 002342 881 WWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP 918 (934)
Q Consensus 881 iwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 918 (934)
||||||++|+|++|.+||.+.+..+.+..+......+|
T Consensus 222 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p 259 (355)
T 2eu9_A 222 VWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIP 259 (355)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCc
Confidence 99999999999999999999888877766654333333
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=323.79 Aligned_cols=206 Identities=20% Similarity=0.262 Sum_probs=174.0
Q ss_pred cCCcccccccccCCcEEEEEEEEec--------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccc------
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCG--------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA------ 733 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~--------~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~------ 733 (934)
.++|++.+.||+|+||.||+|.+.. +++.||+|++.+. ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 4799999999999999999999987 4889999998754 35778999999999998887
Q ss_pred ---------eeEEEEe-CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 002342 734 ---------LYASFQT-KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 803 (934)
Q Consensus 734 ---------l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NIL 803 (934)
+++++.. ....|+||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6777776 78899999999 999999998764456999999999999999999999999999999999999
Q ss_pred EecCC--cEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHH
Q 002342 804 LQGNG--HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (934)
Q Consensus 804 l~~~~--~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Di 881 (934)
++.++ .+||+|||++......... ............||+.|+|||++.+..++.++||
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 251 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKH--------------------VAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDL 251 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCC--------------------CCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred EcCCCCceEEEecCcceeeccCCCcc--------------------ccccccccccccCCccccCHHHHccCCCCchhhH
Confidence 99988 8999999999654321100 0001112244589999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCC
Q 002342 882 WALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 882 wSlG~iL~elltG~~Pf~~~~ 902 (934)
|||||+||+|++|+.||.+..
T Consensus 252 ~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 252 QSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp HHHHHHHHHHHHSCCTTGGGT
T ss_pred HHHHHHHHHHHhCCCCcccCC
Confidence 999999999999999998764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=321.77 Aligned_cols=211 Identities=25% Similarity=0.426 Sum_probs=184.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CC-----CccceeEEEEeC
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HP-----FVPALYASFQTK 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp-----~Iv~l~~~~~~~ 741 (934)
.++|++.+.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.+. |+ +|+.+++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 57999999999999999999999999999999998743 344566778999988885 54 499999999999
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCCCCEEEe--cCCcEEEEeccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH--CQGIIYRDLKPENVLLQ--GNGHVSLTDFDL 817 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH--~~giiHrDLKp~NILl~--~~~~vkl~DFG~ 817 (934)
+..|+||||+ +++|.+++.......+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|||+
T Consensus 129 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 129 NHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CceEEEEecC-CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999999 569999998765566999999999999999999999 57999999999999995 467899999999
Q ss_pred CcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCC
Q 002342 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~P 897 (934)
+..... .....+||+.|+|||++.+..++.++|||||||++|+|++|++|
T Consensus 208 a~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 257 (382)
T 2vx3_A 208 SCQLGQ------------------------------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPL 257 (382)
T ss_dssp CEETTC------------------------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ceeccc------------------------------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 854321 12245799999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcC
Q 002342 898 FRGKTRQKTFANILHK 913 (934)
Q Consensus 898 f~~~~~~~~~~~i~~~ 913 (934)
|.+.+..+.+..|...
T Consensus 258 f~~~~~~~~~~~i~~~ 273 (382)
T 2vx3_A 258 FSGANEVDQMNKIVEV 273 (382)
T ss_dssp SCCSSHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHH
Confidence 9999999888888753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=316.81 Aligned_cols=221 Identities=23% Similarity=0.355 Sum_probs=182.6
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC-----C
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----T 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~ 742 (934)
.++|++.+.||+|+||.||++.+..+++.||||++... ........+.+|+.+++.++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 47899999999999999999999999999999998643 2445556788999999999999999999988754 6
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
..|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 7899999994 799998876 349999999999999999999999999999999999999999999999999996543
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
........ ...........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.
T Consensus 164 ~~~~~~~~-----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 164 ESAADNSE-----------------PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp ---------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccC-----------------ccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 21110000 0001112235689999999999865 77899999999999999999999999999
Q ss_pred CHHHHHHHHH
Q 002342 902 TRQKTFANIL 911 (934)
Q Consensus 902 ~~~~~~~~i~ 911 (934)
+..+.+..+.
T Consensus 227 ~~~~~~~~~~ 236 (353)
T 2b9h_A 227 DYRHQLLLIF 236 (353)
T ss_dssp SHHHHHHHHH
T ss_pred CcHHHHHHHH
Confidence 8877766654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=339.38 Aligned_cols=226 Identities=23% Similarity=0.348 Sum_probs=185.4
Q ss_pred cccCCccccc-ccccCCcEEEEEEEEec--CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 666 INLQHFRPIK-PLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 666 ~~~~~y~i~~-~LG~G~~g~Vy~a~~~~--~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
+..+.|.+.+ .||+|+||.||++.+.. ++..||||++++.. .......+.+|+.+|+.++||||+++++++.. +
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 3445566666 79999999999998863 56789999997642 33455778999999999999999999999976 5
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
.+|||||||++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 699999999999999999754 3459999999999999999999999999999999999999999999999999996542
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~ 901 (934)
..... ........+++.|+|||++.+..++.++|||||||+||||++ |+.||.+.
T Consensus 488 ~~~~~------------------------~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 543 (613)
T 2ozo_A 488 ADDSY------------------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543 (613)
T ss_dssp --------------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCce------------------------eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 11100 011122346789999999999999999999999999999998 99999999
Q ss_pred CHHHHHHHHHcCC-CCCCC
Q 002342 902 TRQKTFANILHKD-LKFPS 919 (934)
Q Consensus 902 ~~~~~~~~i~~~~-~~~p~ 919 (934)
+..+++..|..+. +.+|.
T Consensus 544 ~~~~~~~~i~~~~~~~~p~ 562 (613)
T 2ozo_A 544 KGPEVMAFIEQGKRMECPP 562 (613)
T ss_dssp CSHHHHHHHHTTCCCCCCT
T ss_pred CHHHHHHHHHcCCCCCCCC
Confidence 9999999988765 34444
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=308.63 Aligned_cols=213 Identities=21% Similarity=0.310 Sum_probs=178.6
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~l 746 (934)
.++|++.+.||+|+||.||++.+..+++.||+|++.+... .......+.+|+.++..+ +||||+++++++...+..|+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3679999999999999999999999999999999986533 334456788899999999 99999999999999999999
Q ss_pred EEEccCCCCchhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-----------------
Q 002342 747 ITDYCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----------------- 807 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~----------------- 807 (934)
||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 999999999999997531 1458999999999999999999999999999999999999844
Q ss_pred --CcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHH
Q 002342 808 --GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWAL 884 (934)
Q Consensus 808 --~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSl 884 (934)
..+||+|||++..... .....||+.|+|||++.+. .++.++|||||
T Consensus 169 ~~~~~kl~Dfg~~~~~~~-------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 217 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISS-------------------------------PQVEEGDSRFLANEVLQENYTHLPKADIFAL 217 (289)
T ss_dssp -CCCEEECCCTTCEETTC-------------------------------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHH
T ss_pred CceEEEEcccccccccCC-------------------------------ccccCCCccccChhHhcCCCCCCchhhHHHH
Confidence 4799999999854321 1123589999999999876 55679999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Q 002342 885 GILLYEMLYGYTPFRGKTRQKTFANILHKDL 915 (934)
Q Consensus 885 G~iL~elltG~~Pf~~~~~~~~~~~i~~~~~ 915 (934)
||++|+|++|.+||.... ....+..+.+
T Consensus 218 G~il~~l~~~~~~~~~~~---~~~~~~~~~~ 245 (289)
T 1x8b_A 218 ALTVVCAAGAEPLPRNGD---QWHEIRQGRL 245 (289)
T ss_dssp HHHHHHHTTCCCCCSSSH---HHHHHHTTCC
T ss_pred HHHHHHHhcCCCCCcchh---HHHHHHcCCC
Confidence 999999999998885443 3445555544
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=340.56 Aligned_cols=220 Identities=24% Similarity=0.346 Sum_probs=189.0
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
.+.+..++|++.+.||+|+||.||++.+.. +..||||+++.... ..+.+.+|+.+|+.++||||+++++++.. .
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 455777899999999999999999999854 46799999976432 23568899999999999999999999876 6
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
.+|||||||.+++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 78999999999999999976434569999999999999999999999999999999999999999999999999996432
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~ 901 (934)
.. .........+++.|+|||++.+..++.++|||||||+||+|++ |+.||.+.
T Consensus 415 ~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 415 DN--------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp CH--------------------------HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred CC--------------------------ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 10 0011123357889999999999999999999999999999999 99999999
Q ss_pred CHHHHHHHHHcCC
Q 002342 902 TRQKTFANILHKD 914 (934)
Q Consensus 902 ~~~~~~~~i~~~~ 914 (934)
...+++..+..+.
T Consensus 469 ~~~~~~~~i~~~~ 481 (535)
T 2h8h_A 469 VNREVLDQVERGY 481 (535)
T ss_dssp CHHHHHHHHHTTC
T ss_pred CHHHHHHHHHcCC
Confidence 9999998887653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=307.59 Aligned_cols=223 Identities=21% Similarity=0.280 Sum_probs=180.5
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEE-EeCCeEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF-QTKTHVCL 746 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-~~~~~~~l 746 (934)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ...+.+|+.+++.+.|++++..+..+ ...+..|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 4789999999999999999999999999999999875422 23578899999999988765555544 67788899
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe---cCCcEEEEecccCcccCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~---~~~~vkl~DFG~a~~~~~ 823 (934)
||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99999 999999997542 4599999999999999999999999999999999999994 788999999999965432
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT- 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~- 902 (934)
.... ...+........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 161 ~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 3uzp_A 161 ARTH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp TTTC--------------------CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccc--------------------cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence 2110 0011123346689999999999999999999999999999999999999998733
Q ss_pred --HHHHHHHHHcCCCCC
Q 002342 903 --RQKTFANILHKDLKF 917 (934)
Q Consensus 903 --~~~~~~~i~~~~~~~ 917 (934)
..+.+..+..+.+..
T Consensus 221 ~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 221 ATKRQKYERISEKKMST 237 (296)
T ss_dssp SSSSSHHHHHHHHHHHS
T ss_pred hhhhhhhhhhcccccCC
Confidence 233444444443333
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=322.10 Aligned_cols=208 Identities=26% Similarity=0.454 Sum_probs=171.2
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC-----
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 742 (934)
..+|++.+.||+|+||.||+|++..++. +|+|.+..... ...+|+.+|+.++||||++++++|...+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 4679999999999999999999977766 77887654321 1236999999999999999999996433
Q ss_pred -eEEEEEEccCCCCchhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe-cCCcEEEEecccC
Q 002342 743 -HVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-GNGHVSLTDFDLS 818 (934)
Q Consensus 743 -~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~-~~~~vkl~DFG~a 818 (934)
++|+|||||+++ +...+.. .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|
T Consensus 111 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 111 VFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 488999999654 4433321 1235699999999999999999999999999999999999999 7899999999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~P 897 (934)
+..... ......+||+.|+|||++.+. .++.++|||||||++|+|++|++|
T Consensus 190 ~~~~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 241 (394)
T 4e7w_A 190 KILIAG----------------------------EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPL 241 (394)
T ss_dssp EECCTT----------------------------CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccCC----------------------------CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 653211 112345789999999999765 589999999999999999999999
Q ss_pred CCCCCHHHHHHHHHc
Q 002342 898 FRGKTRQKTFANILH 912 (934)
Q Consensus 898 f~~~~~~~~~~~i~~ 912 (934)
|.+.+..+.+..|.+
T Consensus 242 f~~~~~~~~l~~i~~ 256 (394)
T 4e7w_A 242 FPGESGIDQLVEIIK 256 (394)
T ss_dssp SCCSSHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHH
Confidence 999998888777754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=317.38 Aligned_cols=214 Identities=25% Similarity=0.402 Sum_probs=176.5
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccc--------cChHHHHHHHHHHHHHHhCCCCCccceeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--------LNRNKVHRACAEREILDMLDHPFVPALYASFQ 739 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~--------~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 739 (934)
.++|++.+.||+|+||.||++.+.. ++.||||.+..... ........+.+|+.+|+.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 5789999999999999999999854 89999999865322 22334578899999999999999999999985
Q ss_pred e-----CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEe
Q 002342 740 T-----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 814 (934)
Q Consensus 740 ~-----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~D 814 (934)
. ...+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 3 347899999995 7888888754 34699999999999999999999999999999999999999999999999
Q ss_pred cccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHh
Q 002342 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLY 893 (934)
Q Consensus 815 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~ellt 893 (934)
||++..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 178 fg~~~~~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 229 (362)
T 3pg1_A 178 FNLAREDTA----------------------------DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229 (362)
T ss_dssp TTC-------------------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH
T ss_pred cCccccccc----------------------------ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHh
Confidence 999853211 111234578999999999987 678999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHc
Q 002342 894 GYTPFRGKTRQKTFANILH 912 (934)
Q Consensus 894 G~~Pf~~~~~~~~~~~i~~ 912 (934)
|++||.+.+..+.+..+..
T Consensus 230 g~~pf~~~~~~~~~~~i~~ 248 (362)
T 3pg1_A 230 RKALFRGSTFYNQLNKIVE 248 (362)
T ss_dssp SSCSCCCSSHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHH
Confidence 9999999998888877754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=317.84 Aligned_cols=212 Identities=19% Similarity=0.183 Sum_probs=170.5
Q ss_pred cccCCcccccccccCCcEEEEEEEEec---CCeEEEEEEeecccccChH--------HHHHHHHHHHHHHhCCCCCccce
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRN--------KVHRACAEREILDMLDHPFVPAL 734 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~---~~~~vAlK~~~~~~~~~~~--------~~~~~~~E~~il~~l~hp~Iv~l 734 (934)
+..++|++.+.||+|+||.||+|.+.. ++..+|+|++......... ....+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 345789999999999999999999987 7889999998764211101 11235578889999999999999
Q ss_pred eEEEEe----CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC--
Q 002342 735 YASFQT----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-- 808 (934)
Q Consensus 735 ~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-- 808 (934)
++++.. ....|+||||| +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 999987 78899999999 999999997653 699999999999999999999999999999999999999877
Q ss_pred cEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHH
Q 002342 809 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888 (934)
Q Consensus 809 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL 888 (934)
.+||+|||++......... ............||+.|+|||++.+..++.++|||||||++
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 250 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNH--------------------KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCM 250 (345)
T ss_dssp SEEECCCTTCEESSGGGCC--------------------CCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHH
T ss_pred cEEEEeCCCceeccccccc--------------------ccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHH
Confidence 9999999999654321100 00011122456899999999999999999999999999999
Q ss_pred HHHHhCCCCCCC
Q 002342 889 YEMLYGYTPFRG 900 (934)
Q Consensus 889 ~elltG~~Pf~~ 900 (934)
|+|++|+.||.+
T Consensus 251 ~ell~g~~pf~~ 262 (345)
T 2v62_A 251 LRWLCGKLPWEQ 262 (345)
T ss_dssp HHHHHSSCTTGG
T ss_pred HHHHhCCCCccc
Confidence 999999999965
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=307.53 Aligned_cols=209 Identities=23% Similarity=0.364 Sum_probs=178.5
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe-------
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------- 740 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------- 740 (934)
..+|++++.||+|+||.||++.+..+++.||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 367999999999999999999999899999999987542 246689999999999999999999864
Q ss_pred ---------CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEE
Q 002342 741 ---------KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 811 (934)
Q Consensus 741 ---------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vk 811 (934)
...+|+||||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 45689999999999999999765455699999999999999999999999999999999999999999999
Q ss_pred EEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHH
Q 002342 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891 (934)
Q Consensus 812 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~el 891 (934)
|+|||++...... .......||+.|+|||++.+..++.++||||||+++|+|
T Consensus 163 l~Dfg~~~~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 214 (284)
T 2a19_B 163 IGDFGLVTSLKND----------------------------GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214 (284)
T ss_dssp ECCCTTCEESSCC----------------------------SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHH
T ss_pred ECcchhheecccc----------------------------ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHH
Confidence 9999998543211 112234699999999999999999999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcC
Q 002342 892 LYGYTPFRGKTRQKTFANILHK 913 (934)
Q Consensus 892 ltG~~Pf~~~~~~~~~~~i~~~ 913 (934)
++|..||.. .......+..+
T Consensus 215 ~~~~~~~~~--~~~~~~~~~~~ 234 (284)
T 2a19_B 215 LHVCDTAFE--TSKFFTDLRDG 234 (284)
T ss_dssp HSCCSSHHH--HHHHHHHHHTT
T ss_pred HhcCCcchh--HHHHHHHhhcc
Confidence 999999853 23334444443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=316.24 Aligned_cols=217 Identities=25% Similarity=0.407 Sum_probs=152.7
Q ss_pred ccCCccccc-ccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe----C
Q 002342 667 NLQHFRPIK-PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----K 741 (934)
Q Consensus 667 ~~~~y~i~~-~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~ 741 (934)
..++|.+.+ .||+|+||.||++.+..+++.||||++... .. ........++.++||||+++++++.. .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 357899966 599999999999999999999999998753 11 12223334667799999999999976 5
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEEEEecccC
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLS 818 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~~vkl~DFG~a 818 (934)
..+|+|||||+|++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 56899999999999999998776567999999999999999999999999999999999999976 445999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||
T Consensus 179 ~~~~~-----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 229 (336)
T 3fhr_A 179 KETTQ-----------------------------NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229 (336)
T ss_dssp EEC---------------------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred eeccc-----------------------------cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 54321 1123457899999999999888999999999999999999999999
Q ss_pred CCCCHHHH----HHHHHcCCCCCCC
Q 002342 899 RGKTRQKT----FANILHKDLKFPS 919 (934)
Q Consensus 899 ~~~~~~~~----~~~i~~~~~~~p~ 919 (934)
.+...... ...+..+.+.+|.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (336)
T 3fhr_A 230 YSNTGQAISPGMKRRIRLGQYGFPN 254 (336)
T ss_dssp ---------------------CCCT
T ss_pred CCccchhhhhhHHHhhhccccccCc
Confidence 87665543 3344444444443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=317.85 Aligned_cols=206 Identities=26% Similarity=0.334 Sum_probs=176.5
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeE
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (934)
.+..++|.+.+.||+|+||.||++.+ .+++.||+|++..... ......+.+|+.+++.++||||+++++++...+..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccC--chHHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 34568999999999999999999985 4689999999876432 11223578899999999999999999999999999
Q ss_pred EEEEEccCCCCchhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 745 CLITDYCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQ---GIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~yLH~~---giiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
++||||+++++|.+++.... ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 99999999999999997643 23499999999999999999999999 99999999999999999999999999996
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 183 ~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 183 LMDYKD--------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp ECCSSS--------------------------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccCccc--------------------------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 542111 112234569999999999998889999999999999999999999995
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=339.40 Aligned_cols=217 Identities=23% Similarity=0.339 Sum_probs=180.6
Q ss_pred cccccCCcEEEEEEEE--ecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccC
Q 002342 675 KPLGSGDTGSVHLVEL--CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 752 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~--~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 752 (934)
+.||+|+||.||++.+ ..+++.||||+++... ........+.+|+.+|+.++||||+++++++.. +..+||||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4799999999999965 4567899999997642 344456789999999999999999999999975 56899999999
Q ss_pred CCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcc
Q 002342 753 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832 (934)
Q Consensus 753 ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 832 (934)
+++|.+++... +.+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.......
T Consensus 453 ~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~------ 524 (635)
T 4fl3_A 453 LGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN------ 524 (635)
T ss_dssp TEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc------
Confidence 99999999764 4599999999999999999999999999999999999999999999999999965432110
Q ss_pred hhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 002342 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANIL 911 (934)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~ 911 (934)
.........||+.|+|||++.+..++.++|||||||+||+|++ |+.||.+.+..++...+.
T Consensus 525 ------------------~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~ 586 (635)
T 4fl3_A 525 ------------------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 586 (635)
T ss_dssp ----------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred ------------------ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 0011223457889999999999999999999999999999998 999999999999998888
Q ss_pred cCCC-CCCC
Q 002342 912 HKDL-KFPS 919 (934)
Q Consensus 912 ~~~~-~~p~ 919 (934)
.+.. .+|.
T Consensus 587 ~~~~~~~p~ 595 (635)
T 4fl3_A 587 KGERMGCPA 595 (635)
T ss_dssp TTCCCCCCT
T ss_pred cCCCCCCCC
Confidence 7653 4443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=315.63 Aligned_cols=235 Identities=25% Similarity=0.359 Sum_probs=165.3
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEE---
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQ--- 739 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~--- 739 (934)
..+...+|++.+.||+|+||.||++.+..+++.||+|++.+. .......+.+|+.+++.+. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 345567899999999999999999999999999999998653 4455667889999999995 999999999994
Q ss_pred -----eCCeEEEEEEccCCCCchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEecCCcEE
Q 002342 740 -----TKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVS 811 (934)
Q Consensus 740 -----~~~~~~lV~E~~~ggsL~~~l~~-~~~~~l~~~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~~~~vk 811 (934)
....+++||||+ +|+|.+++.. .....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred cccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence 345689999999 5799888864 22345999999999999999999999999 99999999999999999999
Q ss_pred EEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhh---cCCCCCchhHHHHHHHHH
Q 002342 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII---AGAGHTSAVDWWALGILL 888 (934)
Q Consensus 812 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l---~~~~~s~~~DiwSlG~iL 888 (934)
|+|||++............. ............+||+.|+|||++ .+..++.++|||||||++
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il 243 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSA---------------QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243 (337)
T ss_dssp BCCCTTCBCCSSCC----------------------------------------------CCTTSCSSHHHHHHHHHHHH
T ss_pred EecCccceeccccCcccccc---------------cccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHH
Confidence 99999997654321110000 000001122355799999999999 566788899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 002342 889 YEMLYGYTPFRGKTRQKTFANILHKDLKFPSST 921 (934)
Q Consensus 889 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 921 (934)
|+|++|+.||.+..... +..+.+.+|...
T Consensus 244 ~el~~g~~p~~~~~~~~----~~~~~~~~~~~~ 272 (337)
T 3ll6_A 244 YLLCFRQHPFEDGAKLR----IVNGKYSIPPHD 272 (337)
T ss_dssp HHHHHSSCCC----------------CCCCTTC
T ss_pred HHHHhCCCCCcchhHHH----hhcCcccCCccc
Confidence 99999999997655543 334444444433
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=314.55 Aligned_cols=207 Identities=26% Similarity=0.362 Sum_probs=174.4
Q ss_pred cccCCcccccccccCCcEEEEEEEE----ecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe-
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVEL----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT- 740 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~----~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~- 740 (934)
+....|++++.||+|+||.||++.. ..+++.||||++... ........+.+|+.+|+.++||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 3334459999999999999988754 457899999999864 244556778999999999999999999999987
Q ss_pred -CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 741 -KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 741 -~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
...+|+||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred CCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 46889999999999999999764 39999999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
....... .........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 183 ~~~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 238 (318)
T 3lxp_A 183 AVPEGHE------------------------YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238 (318)
T ss_dssp ECCTTCS------------------------EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ccccccc------------------------ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence 5432110 0112234468889999999999899999999999999999999999997
Q ss_pred CC
Q 002342 900 GK 901 (934)
Q Consensus 900 ~~ 901 (934)
..
T Consensus 239 ~~ 240 (318)
T 3lxp_A 239 SP 240 (318)
T ss_dssp SH
T ss_pred cc
Confidence 53
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.73 Aligned_cols=215 Identities=27% Similarity=0.408 Sum_probs=175.6
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE----e
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ----T 740 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~----~ 740 (934)
.+..++|++.+.||+|+||.||++.+..+++.||+|++... .......+.+|+.+++.++||||+++++++. .
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 34567899999999999999999999999999999998653 4456677889999999999999999999987 3
Q ss_pred CCeEEEEEEccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccC
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a 818 (934)
....|+||||+.+++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 45789999999999999998752 2356999999999999999999999999999999999999999999999999988
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC---CCchhHHHHHHHHHHHHHhCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---HTSAVDWWALGILLYEMLYGY 895 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~---~s~~~DiwSlG~iL~elltG~ 895 (934)
......... .. ............||+.|+|||++.+.. ++.++|||||||++|+|++|+
T Consensus 182 ~~~~~~~~~-----~~-------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 243 (317)
T 2buj_A 182 NQACIHVEG-----SR-------------QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243 (317)
T ss_dssp EESCEEEES-----HH-------------HHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSS
T ss_pred hhccccccc-----cc-------------ccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCC
Confidence 543210000 00 000001112346899999999997654 688999999999999999999
Q ss_pred CCCCC
Q 002342 896 TPFRG 900 (934)
Q Consensus 896 ~Pf~~ 900 (934)
.||..
T Consensus 244 ~p~~~ 248 (317)
T 2buj_A 244 GPYDM 248 (317)
T ss_dssp CTTHH
T ss_pred CChhh
Confidence 99964
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=316.62 Aligned_cols=213 Identities=25% Similarity=0.401 Sum_probs=167.4
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC----
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT---- 742 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~---- 742 (934)
..++|++.+.||+|+||.||++.+..+++.||||++.... .......+++..++.++||||++++++|...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP----RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCT----TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc----cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 3579999999999999999999999999999999986542 22234567888889999999999999997533
Q ss_pred ---eEEEEEEccCCCCchhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCCCCEEEec-CCcEEEEe
Q 002342 743 ---HVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLH--CQGIIYRDLKPENVLLQG-NGHVSLTD 814 (934)
Q Consensus 743 ---~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~yLH--~~giiHrDLKp~NILl~~-~~~vkl~D 814 (934)
++|+||||+.+ +|...+.. .....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||+|
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 38999999965 55444332 23456899999999999999999999 999999999999999997 89999999
Q ss_pred cccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC-CCchhHHHHHHHHHHHHHh
Q 002342 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLY 893 (934)
Q Consensus 815 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~s~~~DiwSlG~iL~ellt 893 (934)
||++...... ......+||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 176 fg~a~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~ 227 (360)
T 3e3p_A 176 FGSAKKLSPS----------------------------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227 (360)
T ss_dssp CTTCBCCCTT----------------------------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CCCceecCCC----------------------------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 9999653211 1123457899999999997654 8999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHc
Q 002342 894 GYTPFRGKTRQKTFANILH 912 (934)
Q Consensus 894 G~~Pf~~~~~~~~~~~i~~ 912 (934)
|++||.+.+....+..+..
T Consensus 228 g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 228 GEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp SSCSSCCSSHHHHHHHHHH
T ss_pred CCCCcCCCChHHHHHHHHH
Confidence 9999999999888887765
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=306.17 Aligned_cols=232 Identities=27% Similarity=0.494 Sum_probs=180.4
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe--------
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-------- 740 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-------- 740 (934)
++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 5799999999999999999999999999999998642 3456778899999999999999999998864
Q ss_pred -----CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEec
Q 002342 741 -----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815 (934)
Q Consensus 741 -----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DF 815 (934)
.+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 46789999999999999999764 345889999999999999999999999999999999999999999999999
Q ss_pred ccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhC
Q 002342 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG 894 (934)
Q Consensus 816 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG 894 (934)
|++............. ...............||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 161 g~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~- 226 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLD-------------SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY- 226 (303)
T ss_dssp CCCSCTTC--------------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS-
T ss_pred cchhhcccccchhccc-------------cccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh-
Confidence 9986543211100000 00000111233456799999999999865 68999999999999999998
Q ss_pred CCCCCC-CCHHHHHHHHHcCCCCCCCCC
Q 002342 895 YTPFRG-KTRQKTFANILHKDLKFPSST 921 (934)
Q Consensus 895 ~~Pf~~-~~~~~~~~~i~~~~~~~p~~~ 921 (934)
||.. .+....+..+......+|...
T Consensus 227 --p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (303)
T 1zy4_A 227 --PFSTGMERVNILKKLRSVSIEFPPDF 252 (303)
T ss_dssp --CCSSHHHHHHHHHHHHSTTCCCCTTC
T ss_pred --ccCCchhHHHHHHhccccccccCccc
Confidence 5543 444567777777777777643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=324.85 Aligned_cols=203 Identities=20% Similarity=0.278 Sum_probs=159.0
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC--CCCCcccee-------EEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML--DHPFVPALY-------ASFQ 739 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l--~hp~Iv~l~-------~~~~ 739 (934)
..|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4599999999999999999999999999999999986544556667778886555555 699977755 5554
Q ss_pred eC-----------------CeEEEEEEccCCCCchhhhccCCCCCCCHHHH------HHHHHHHHHHHHHHHHCCCeecC
Q 002342 740 TK-----------------THVCLITDYCPGGELFLLLDRQPTKVLKEDAV------RFYAAEVVVALEYLHCQGIIYRD 796 (934)
Q Consensus 740 ~~-----------------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~------~~i~~qil~aL~yLH~~giiHrD 796 (934)
.. ..+|||||||+ ++|.+++.... ..+..... ..++.||+.||+|||++||+|||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 33 34899999997 89999997642 22444444 56779999999999999999999
Q ss_pred CCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC--CC
Q 002342 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AG 874 (934)
Q Consensus 797 LKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~ 874 (934)
|||+|||++.+|.+||+|||+|..... ......||+.|+|||++.+ ..
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~ 269 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT------------------------------RGPASSVPVTYAPREFLNASTAT 269 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC------------------------------EEEGGGSCGGGCCHHHHTCSEEE
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC------------------------------CccCccCCcCCcChhhccCCCCC
Confidence 999999999999999999999854321 0113357799999999987 77
Q ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 875 HTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 875 ~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
++.++|||||||+||+|++|++||.+...
T Consensus 270 ~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 270 FTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred cCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 89999999999999999999999987643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=320.66 Aligned_cols=221 Identities=19% Similarity=0.261 Sum_probs=177.2
Q ss_pred CCcccccccccCCcEEEEEEEEecCC---eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE-eCCeE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ-TKTHV 744 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~---~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~~ 744 (934)
..|++.+.||+|+||.||++.+..++ ..||+|.+... ........+.+|+.+++.++||||+++++++. .++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 35889999999999999999986543 46899988653 34456678899999999999999999999865 45688
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
|+||||+++++|.+++... ...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 167 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999999999764 345899999999999999999999999999999999999999999999999999643211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~ 903 (934)
.. ..........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+.
T Consensus 246 ~~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~ 302 (373)
T 3c1x_A 246 EF-----------------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302 (373)
T ss_dssp -----------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS
T ss_pred cc-----------------------ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH
Confidence 00 00111233467889999999999999999999999999999999 8999998888
Q ss_pred HHHHHHHHcCCC
Q 002342 904 QKTFANILHKDL 915 (934)
Q Consensus 904 ~~~~~~i~~~~~ 915 (934)
.+....+..+..
T Consensus 303 ~~~~~~~~~~~~ 314 (373)
T 3c1x_A 303 FDITVYLLQGRR 314 (373)
T ss_dssp SCHHHHHHTTCC
T ss_pred HHHHHHHHcCCC
Confidence 777777777654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=306.45 Aligned_cols=208 Identities=26% Similarity=0.383 Sum_probs=176.2
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
...++|.....||+|+||.||++.+..+++.||+|.+... .......+.+|+.+++.++||||+++++++...+..+
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC---CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC---chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 4456777778999999999999999999999999998754 2344567889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-CCcEEEEecccCcccCC
Q 002342 746 LITDYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-~~~vkl~DFG~a~~~~~ 823 (934)
+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999999999997652 235779999999999999999999999999999999999997 89999999999854321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC--CCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~--~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
. ........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...
T Consensus 176 ~---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 176 I---------------------------NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp --------------------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred C---------------------------CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 1 01123457999999999997643 788999999999999999999999764
Q ss_pred CH
Q 002342 902 TR 903 (934)
Q Consensus 902 ~~ 903 (934)
..
T Consensus 229 ~~ 230 (295)
T 2clq_A 229 GE 230 (295)
T ss_dssp SS
T ss_pred Cc
Confidence 43
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=304.14 Aligned_cols=208 Identities=22% Similarity=0.276 Sum_probs=171.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEE-EEeCCeEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS-FQTKTHVCL 746 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-~~~~~~~~l 746 (934)
.++|++.+.||+|+||.||++.+..+++.||+|++.... ....+.+|+.+++.+.|++++..+.. +...+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 478999999999999999999999999999999876532 22347789999999988776655554 467888999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---ecCCcEEEEecccCcccCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl---~~~~~vkl~DFG~a~~~~~ 823 (934)
||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 99999 999999987542 459999999999999999999999999999999999999 7889999999999965432
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
.... ...+........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 161 ~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 161 ARTH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp TTTC--------------------CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccC--------------------ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 1110 0011223346689999999999999999999999999999999999999998743
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=307.29 Aligned_cols=200 Identities=28% Similarity=0.398 Sum_probs=167.1
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHh--CCCCCccceeEEEEe----
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDHPFVPALYASFQT---- 740 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~~~~---- 740 (934)
..++|++.+.||+|+||.||++.+ +++.||||++... ....+..|.+++.. ++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHS 77 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence 457899999999999999999987 7899999998653 23455667777776 799999999998654
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeecCCCCCCEEEecCCcEEE
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH--------CQGIIYRDLKPENVLLQGNGHVSL 812 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH--------~~giiHrDLKp~NILl~~~~~vkl 812 (934)
...+|+||||+++++|.++++. ..+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3568999999999999999964 35999999999999999999999 999999999999999999999999
Q ss_pred EecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC------CCCchhHHHHHHH
Q 002342 813 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA------GHTSAVDWWALGI 886 (934)
Q Consensus 813 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~------~~s~~~DiwSlG~ 886 (934)
+|||++......... ........+||+.|+|||++.+. .++.++|||||||
T Consensus 155 ~Dfg~a~~~~~~~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~ 211 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQ-----------------------LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGL 211 (301)
T ss_dssp CCCTTCEEEETTTTE-----------------------EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHH
T ss_pred eeCCCeeeccccccc-----------------------ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHH
Confidence 999998653221100 00112345799999999999876 4456999999999
Q ss_pred HHHHHHhC----------CCCCCC
Q 002342 887 LLYEMLYG----------YTPFRG 900 (934)
Q Consensus 887 iL~elltG----------~~Pf~~ 900 (934)
++|+|++| .+||..
T Consensus 212 il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 212 VLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred HHHHHHhhhcCccccccccccccc
Confidence 99999999 899965
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=315.70 Aligned_cols=229 Identities=24% Similarity=0.310 Sum_probs=186.4
Q ss_pred cccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
..+.+..++|++.+.||+|+||.||++.+.. .+|+|++..... .......+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 4456778999999999999999999999854 499999875422 222334567899999999999999999999999
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred CceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 99999999999999999997643 4599999999999999999999999999999999999998 789999999998543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC---------CCCCchhHHHHHHHHHHHHH
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---------AGHTSAVDWWALGILLYEML 892 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---------~~~s~~~DiwSlG~iL~ell 892 (934)
..... ...........||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 180 ~~~~~----------------------~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~ 237 (319)
T 2y4i_B 180 GVLQA----------------------GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237 (319)
T ss_dssp ------------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHH
T ss_pred ccccc----------------------cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHH
Confidence 21100 001122234569999999999975 45788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCC
Q 002342 893 YGYTPFRGKTRQKTFANILHKDLKFP 918 (934)
Q Consensus 893 tG~~Pf~~~~~~~~~~~i~~~~~~~p 918 (934)
+|..||.+.+.......+..+.....
T Consensus 238 ~g~~p~~~~~~~~~~~~~~~~~~~~~ 263 (319)
T 2y4i_B 238 AREWPFKTQPAEAIIWQMGTGMKPNL 263 (319)
T ss_dssp HSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred hCCCCCCCCCHHHHHHHhccCCCCCC
Confidence 99999999999988888877655433
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=317.80 Aligned_cols=205 Identities=24% Similarity=0.401 Sum_probs=175.2
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-----------CCCc
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-----------HPFV 731 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-----------hp~I 731 (934)
+..+..++|++.+.||+|+||.||+|.+..+++.||||++.+. ......+.+|+.+++.+. ||||
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i 88 (373)
T 1q8y_A 13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 88 (373)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchH
Confidence 3445668999999999999999999999999999999998753 334566788999998886 8999
Q ss_pred cceeEEEEeCC----eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEec
Q 002342 732 PALYASFQTKT----HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQG 806 (934)
Q Consensus 732 v~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~ 806 (934)
+++++++...+ ++++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 167 (373)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEec
Confidence 99999998654 789999999 99999999876556699999999999999999999998 9999999999999954
Q ss_pred C------CcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhH
Q 002342 807 N------GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 880 (934)
Q Consensus 807 ~------~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~D 880 (934)
+ +.+||+|||++..... .....+||+.|+|||++.+..++.++|
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~D 217 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDE------------------------------HYTNSIQTREYRSPEVLLGAPWGCGAD 217 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTB------------------------------CCCSCCSCGGGCCHHHHHTCCCCTHHH
T ss_pred cCCCcCcceEEEcccccccccCC------------------------------CCCCCCCCccccCcHHHhCCCCCchHh
Confidence 3 3799999999854321 112347899999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCC
Q 002342 881 WWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 881 iwSlG~iL~elltG~~Pf~~~~ 902 (934)
||||||++|+|++|.+||.+.+
T Consensus 218 i~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 218 IWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp HHHHHHHHHHHHHSSCCC----
T ss_pred HHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999999999999998755
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=322.45 Aligned_cols=205 Identities=27% Similarity=0.434 Sum_probs=157.8
Q ss_pred CCcccc-cccccCCcEEEEEEEEe--cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe--CCe
Q 002342 669 QHFRPI-KPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTH 743 (934)
Q Consensus 669 ~~y~i~-~~LG~G~~g~Vy~a~~~--~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~ 743 (934)
+.|.+. ++||+|+||.||+|.++ .+++.||||++..... ...+.+|+.+|+.++||||++++++|.. ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 457774 57999999999999976 5788999999875421 2357789999999999999999999954 678
Q ss_pred EEEEEEccCCCCchhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE----ecCCcEEE
Q 002342 744 VCLITDYCPGGELFLLLDRQ-------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL----QGNGHVSL 812 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~-------~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl----~~~~~vkl 812 (934)
+|+||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 95 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECC-SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCC-CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 99999999 56888877532 12249999999999999999999999999999999999999 66789999
Q ss_pred EecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHH
Q 002342 813 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEM 891 (934)
Q Consensus 813 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~el 891 (934)
+|||+|....... .........+||+.|+|||++.+. .++.++|||||||+||+|
T Consensus 174 ~Dfg~a~~~~~~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 229 (405)
T 3rgf_A 174 ADMGFARLFNSPL------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 229 (405)
T ss_dssp CCTTCCC----------------------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHH
T ss_pred EECCCceecCCCC------------------------cccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHH
Confidence 9999996542110 011223456899999999999874 589999999999999999
Q ss_pred HhCCCCCCCCCH
Q 002342 892 LYGYTPFRGKTR 903 (934)
Q Consensus 892 ltG~~Pf~~~~~ 903 (934)
++|++||.+...
T Consensus 230 l~g~~pf~~~~~ 241 (405)
T 3rgf_A 230 LTSEPIFHCRQE 241 (405)
T ss_dssp HHSSCTTCCCC-
T ss_pred HhCCCCCCCccc
Confidence 999999987654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-33 Score=323.18 Aligned_cols=208 Identities=23% Similarity=0.296 Sum_probs=176.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC-CCccceeEEEEeCCeEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH-PFVPALYASFQTKTHVCL 746 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~l 746 (934)
.++|++.+.||+|+||.||++.+..+++.||||++..... ...+.+|+++++.+.| ++|+.+..++...+..||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 5789999999999999999999999999999998875432 1246789999999976 566677777778889999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---ecCCcEEEEecccCcccCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl---~~~~~vkl~DFG~a~~~~~ 823 (934)
||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++....
T Consensus 81 vme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99999 999999997542 459999999999999999999999999999999999999 5789999999999965432
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
.... ...+.......+||+.|+|||++.+..++.++|||||||+||+|++|+.||.+..
T Consensus 159 ~~~~--------------------~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~ 217 (483)
T 3sv0_A 159 TSTH--------------------QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (483)
T ss_dssp TTTC--------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred Cccc--------------------cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 1110 0111233446789999999999999999999999999999999999999998743
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=305.57 Aligned_cols=209 Identities=23% Similarity=0.442 Sum_probs=171.6
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
++.++|++.+.||+|+||.||++.+ .++.||+|.+... .....+.+|+.+|+.++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 4567899999999999999999987 5789999998642 345678899999999999999999998764 478
Q ss_pred EEEEccCCCCchhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCCCCEEEecCCc-EEEEecccCcc
Q 002342 746 LITDYCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVVALEYLHC---QGIIYRDLKPENVLLQGNGH-VSLTDFDLSCL 820 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~yLH~---~giiHrDLKp~NILl~~~~~-vkl~DFG~a~~ 820 (934)
+||||+++++|.+++..... ..++...+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999999999999976432 247899999999999999999999 89999999999999998886 79999999853
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 156 ~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 205 (307)
T 2eva_A 156 IQT------------------------------HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205 (307)
T ss_dssp ---------------------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred ccc------------------------------ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence 211 01233589999999999999999999999999999999999999985
Q ss_pred CC--HHHHHHHHHcC
Q 002342 901 KT--RQKTFANILHK 913 (934)
Q Consensus 901 ~~--~~~~~~~i~~~ 913 (934)
.. .......+..+
T Consensus 206 ~~~~~~~~~~~~~~~ 220 (307)
T 2eva_A 206 IGGPAFRIMWAVHNG 220 (307)
T ss_dssp TCSSHHHHHHHHHTT
T ss_pred hCccHHHHHHHHhcC
Confidence 43 33444444443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-33 Score=306.36 Aligned_cols=222 Identities=24% Similarity=0.366 Sum_probs=179.6
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC--CCCccceeEEEEe
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD--HPFVPALYASFQT 740 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~ 740 (934)
...+..++|++++.||+|+||.||++.+. +++.||+|++.... ........+.+|+.+++.+. ||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 34456778999999999999999999984 58899999997643 24556678899999999997 5999999999999
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
.+..|+|||+ .+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 100 ~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 100 DQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 175 (313)
T ss_dssp SSEEEEEECC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred CCEEEEEEec-CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccc
Confidence 9999999995 489999999875 4599999999999999999999999999999999999996 58999999999865
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-----------CCCCchhHHHHHHHHHH
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----------AGHTSAVDWWALGILLY 889 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----------~~~s~~~DiwSlG~iL~ 889 (934)
...... .......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 176 ~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~ 230 (313)
T 3cek_A 176 MQPDTT-------------------------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230 (313)
T ss_dssp ---------------------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHH
T ss_pred ccCccc-------------------------cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHH
Confidence 321100 011234579999999999976 46788999999999999
Q ss_pred HHHhCCCCCCCCC-HHHHHHHHHcCCC
Q 002342 890 EMLYGYTPFRGKT-RQKTFANILHKDL 915 (934)
Q Consensus 890 elltG~~Pf~~~~-~~~~~~~i~~~~~ 915 (934)
+|++|..||.... ....+..+.....
T Consensus 231 el~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (313)
T 3cek_A 231 YMTYGKTPFQQIINQISKLHAIIDPNH 257 (313)
T ss_dssp HHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred HHHhCCCchhhHHHHHHHHHHHHhccc
Confidence 9999999998754 3445555655443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=307.13 Aligned_cols=207 Identities=23% Similarity=0.280 Sum_probs=175.0
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccc-cChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM-LNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
..|...+.||+|+||.||++.+ ++..||+|.+..... ........+.+|+.+++.++||||+++++++...+..|+|
T Consensus 31 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 108 (307)
T 2nru_A 31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108 (307)
T ss_dssp BTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEE
Confidence 3466679999999999999986 688999999875432 2344567788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 748 TDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
|||+++++|.+++... ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence 9999999999998643 234599999999999999999999999999999999999999999999999999854321100
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+...
T Consensus 189 -------------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 189 -------------------------TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp -------------------------CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred -------------------------cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 111234579999999999875 478899999999999999999999987544
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=306.45 Aligned_cols=221 Identities=27% Similarity=0.424 Sum_probs=168.3
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
.....++|++++.||+|+||.||+|.+..+++.||||++..... .......+..+..+++.++||||+++++++...+.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence 34567899999999999999999999999999999999976432 22233344455567888899999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
.|+||||+ ++.+..+.... ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 99999999 66565555432 34599999999999999999999996 99999999999999999999999999985432
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc-----CCCCCchhHHHHHHHHHHHHHhCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~~~DiwSlG~iL~elltG~~P 897 (934)
.. .......||+.|+|||++. ...++.++|||||||++|+|++|+.|
T Consensus 177 ~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (318)
T 2dyl_A 177 DD----------------------------KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228 (318)
T ss_dssp --------------------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CC----------------------------ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCC
Confidence 11 1112346999999999994 56788899999999999999999999
Q ss_pred CCC-CCHHHHHHHHHcCCC
Q 002342 898 FRG-KTRQKTFANILHKDL 915 (934)
Q Consensus 898 f~~-~~~~~~~~~i~~~~~ 915 (934)
|.. ....+.+..+..+..
T Consensus 229 f~~~~~~~~~~~~~~~~~~ 247 (318)
T 2dyl_A 229 YKNCKTDFEVLTKVLQEEP 247 (318)
T ss_dssp TTTCCSHHHHHHHHHHSCC
T ss_pred CCCCCccHHHHHHHhccCC
Confidence 987 455677777776553
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=310.07 Aligned_cols=205 Identities=27% Similarity=0.358 Sum_probs=175.3
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccCh---HHHHHHHHHHHHHHhCC--CCCccceeEEEEe
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR---NKVHRACAEREILDMLD--HPFVPALYASFQT 740 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~---~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~ 740 (934)
...++|++.+.||+|+||.||++.+..+++.||||++.+...... .....+.+|+.+++.+. ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 346789999999999999999999999999999999986533221 12234567999999996 5999999999999
Q ss_pred CCeEEEEEEccCC-CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe-cCCcEEEEecccC
Q 002342 741 KTHVCLITDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-GNGHVSLTDFDLS 818 (934)
Q Consensus 741 ~~~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~-~~~~vkl~DFG~a 818 (934)
.+..++||||+.+ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 9999999999976 8999998764 4599999999999999999999999999999999999999 7899999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~~DiwSlG~iL~elltG~~P 897 (934)
..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.|
T Consensus 198 ~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 248 (320)
T 3a99_A 198 ALLKD-----------------------------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248 (320)
T ss_dssp EECCS-----------------------------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccc-----------------------------ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCC
Confidence 54321 11224569999999999987666 6789999999999999999999
Q ss_pred CCCC
Q 002342 898 FRGK 901 (934)
Q Consensus 898 f~~~ 901 (934)
|...
T Consensus 249 f~~~ 252 (320)
T 3a99_A 249 FEHD 252 (320)
T ss_dssp CCSH
T ss_pred CCCh
Confidence 9653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=309.74 Aligned_cols=209 Identities=23% Similarity=0.381 Sum_probs=177.3
Q ss_pred cccccCCcccccccccCCcEEEEEEEE----ecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEE
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVEL----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 739 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~----~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 739 (934)
..+..++|++++.||+|+||.||++++ ..+++.||+|.+... .......+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 345567899999999999999999984 568999999998753 3455677899999999999999999999987
Q ss_pred eCC--eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEeccc
Q 002342 740 TKT--HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817 (934)
Q Consensus 740 ~~~--~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~ 817 (934)
..+ .+++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 543 7899999999999999997753 4599999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCC
Q 002342 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~P 897 (934)
+........ .........+++.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 192 ~~~~~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~ 247 (326)
T 2w1i_A 192 TKVLPQDKE------------------------YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 247 (326)
T ss_dssp CEECCSSCS------------------------EEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCG
T ss_pred hhhcccccc------------------------ccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCC
Confidence 865432110 00112234578889999999988899999999999999999999999
Q ss_pred CCC
Q 002342 898 FRG 900 (934)
Q Consensus 898 f~~ 900 (934)
|..
T Consensus 248 ~~~ 250 (326)
T 2w1i_A 248 SKS 250 (326)
T ss_dssp GGS
T ss_pred CCC
Confidence 864
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-31 Score=276.71 Aligned_cols=220 Identities=22% Similarity=0.444 Sum_probs=205.9
Q ss_pred EEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEE
Q 002342 202 FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLL 281 (934)
Q Consensus 202 i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~ 281 (934)
|+++|. +|+|+++|++|++++||+++|++|+++..+.++.........++..+..+..+.++++.+++||+.+|+.+
T Consensus 2 i~i~D~---~g~i~~~N~a~~~l~Gy~~~el~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~ 78 (227)
T 3ewk_A 2 VSITDL---QGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNIWQGEFCNRRKDGTRYWVDS 78 (227)
T ss_dssp EEEEET---TCBEEEECHHHHHHTTCCHHHHTTSBGGGGCCSCSCHHHHHHHHHHHTTTCCEEEEEEEECSSSCEEEEEE
T ss_pred EEEECC---CCcEEehHHHHHHHHCcCHHHHcCCCHHHcCCCCCCHHHHHHHHHHHHcCCeEEEEEEEEcCCCCEEeeee
Confidence 678898 77899999999999999999999999888877777777888888999999999999999999999999999
Q ss_pred EeeeeecCCCCEEEEEEEEecchhhHHHHHHhhcCCCCCchhhhHHHHHHHHHhHHHHHHHHHHccCCCCcccCCCCCcc
Q 002342 282 TIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPI 361 (934)
Q Consensus 282 s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~~~~~~l~~~l~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 361 (934)
++.|++|.+|.+.+++++.+|||++|+++++|+.
T Consensus 79 ~~~p~~d~~g~~~~~~~~~~DIT~~k~~e~~l~~---------------------------------------------- 112 (227)
T 3ewk_A 79 TIVPLMDNAGKPRQYISIRRDITAQKEAEAQLAR---------------------------------------------- 112 (227)
T ss_dssp EEEEEECSSSCEEEEEEEEEECTTTTHHHHHHHH----------------------------------------------
T ss_pred EEEEEEcCCCCEEEEEEEEEehhhHHHHHHHHHH----------------------------------------------
Confidence 9999999999999999999999999999988762
Q ss_pred cccCCCCchhhhcccccCCCCCCCCCCCCCCCCCCcccccccccccchhcccccccccccccccccccCCCCCCCccccc
Q 002342 362 IRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEI 441 (934)
Q Consensus 362 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (934)
T Consensus 113 -------------------------------------------------------------------------------- 112 (227)
T 3ewk_A 113 -------------------------------------------------------------------------------- 112 (227)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccCCCCCCCCCCCCCchhhHHHHHhhhhcccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCc
Q 002342 442 IMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCR 521 (934)
Q Consensus 442 ~~~~~~~~~~~~~~~dv~~r~~~e~~l~~~~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~ 521 (934)
++.++++++++|+++|.+|+ |+++|++|++++||+.+|++|+++.
T Consensus 113 --------------------------------~~~~~~~~~~~i~~~d~~g~---i~~~N~~~~~~~G~~~~e~~g~~~~ 157 (227)
T 3ewk_A 113 --------------------------------LKQAMDANSEMILLTDRAGR---IIYANPALCRFSGMAEGELLGQSPS 157 (227)
T ss_dssp --------------------------------HHHHHHTCCSEEEEECTTSC---EEEECHHHHHHHTCCTHHHHSSCGG
T ss_pred --------------------------------HHHHHhcCcCeEEEEcCCCc---EEEEchHHHHHhCCCHHHHcCCChh
Confidence 66788899999999999888 9999999999999999999999999
Q ss_pred ccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCc------EEEEEEEEEeeecCCCCEEEEEEEEEc
Q 002342 522 FLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGK------KFWNLFHLQPMRDQKGEVQYFIGVQLD 585 (934)
Q Consensus 522 ~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~------~~wv~~~~~pi~de~G~v~~~vgi~rD 585 (934)
.+.++.........+++.+..+..+.+|+..++++|. .+|+++++.|++|.+|.+++++++++|
T Consensus 158 ~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~k~G~~~~dg~~~~~~~~~~pi~d~~g~~~~~v~i~~D 227 (227)
T 3ewk_A 158 ILDSPLADQETLAAMQEALQAGQPWSGRLLNRRRTGPAPHDAEDYWAEISTTPIHTDGNGLVGYVQIQHD 227 (227)
T ss_dssp GGBCTTSCHHHHHHHHHHHHHTCCEECCEEEEEECCSSSSCEEEEEEEEEEEEEECSSSCEEEEEEEEEC
T ss_pred hccCCCCCHHHHHHHHHHHHcCCceeEEEEEECCCCCcCcccceEEEEEEEEEEECCCCCEEEEEEEecC
Confidence 9999988888899999999999999999999999997 899999999999999999999999998
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-32 Score=330.03 Aligned_cols=225 Identities=26% Similarity=0.388 Sum_probs=187.9
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecC---CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
.+..++|++.+.||+|+||.||++.+..+ +..||+|.+... ........+.+|+.+|+.++||||+++++++. +
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 34567899999999999999999998653 568999988653 23455577889999999999999999999985 4
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
+..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred CceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 67899999999999999997653 45999999999999999999999999999999999999999999999999999654
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~ 900 (934)
.... ........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+
T Consensus 542 ~~~~--------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 595 (656)
T 2j0j_A 542 EDST--------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595 (656)
T ss_dssp CC------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCCc--------------------------ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 2110 011223457889999999999999999999999999999997 9999999
Q ss_pred CCHHHHHHHHHcCC-CCCCC
Q 002342 901 KTRQKTFANILHKD-LKFPS 919 (934)
Q Consensus 901 ~~~~~~~~~i~~~~-~~~p~ 919 (934)
.+..+.+..+..+. ..+|.
T Consensus 596 ~~~~~~~~~i~~~~~~~~~~ 615 (656)
T 2j0j_A 596 VKNNDVIGRIENGERLPMPP 615 (656)
T ss_dssp CCHHHHHHHHHHTCCCCCCT
T ss_pred CCHHHHHHHHHcCCCCCCCc
Confidence 99999998888765 34444
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-32 Score=303.58 Aligned_cols=209 Identities=25% Similarity=0.387 Sum_probs=158.1
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHH-HHHhCCCCCccceeEEEEeC
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~ 741 (934)
.+.+..++|++++.||+|+||.||++.+..+++.||||++.... .......+..|+. +++.++||||+++++++...
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 34566789999999999999999999999999999999997642 2334445556665 67778999999999999999
Q ss_pred CeEEEEEEccCCCCchhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEeccc
Q 002342 742 THVCLITDYCPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDL 817 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~---~~~~~l~~~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFG~ 817 (934)
+..|+||||+. ++|.+++.. .....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 94 GDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp SEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred CceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence 99999999995 588777652 2235699999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhh----cCCCCCchhHHHHHHHHHHHHHh
Q 002342 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII----AGAGHTSAVDWWALGILLYEMLY 893 (934)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l----~~~~~s~~~DiwSlG~iL~ellt 893 (934)
+...... .......||+.|+|||++ .+..++.++|||||||++|+|++
T Consensus 173 ~~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~ 224 (327)
T 3aln_A 173 SGQLVDS----------------------------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELAT 224 (327)
T ss_dssp SCC----------------------------------------------------------CCSHHHHHHHHHHHHHHHH
T ss_pred ceecccc----------------------------cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHH
Confidence 8543211 111233699999999999 56678999999999999999999
Q ss_pred CCCCCCCCC
Q 002342 894 GYTPFRGKT 902 (934)
Q Consensus 894 G~~Pf~~~~ 902 (934)
|..||.+..
T Consensus 225 g~~pf~~~~ 233 (327)
T 3aln_A 225 GRFPYPKWN 233 (327)
T ss_dssp SCCCSSCC-
T ss_pred CCCCCCCcc
Confidence 999998754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=306.89 Aligned_cols=204 Identities=28% Similarity=0.415 Sum_probs=166.1
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccCh---HHHHHHHHHHHHHHhC----CCCCccceeEEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR---NKVHRACAEREILDML----DHPFVPALYASF 738 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~---~~~~~~~~E~~il~~l----~hp~Iv~l~~~~ 738 (934)
...++|++.+.||+|+||.||++.+..+++.||+|++........ .....+.+|+.+++.+ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 345789999999999999999999999999999999976432221 1223455799999998 899999999999
Q ss_pred EeCCeEEEEEEc-cCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe-cCCcEEEEecc
Q 002342 739 QTKTHVCLITDY-CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-GNGHVSLTDFD 816 (934)
Q Consensus 739 ~~~~~~~lV~E~-~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~-~~~~vkl~DFG 816 (934)
...+..++|||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 999999999999 7899999999764 3499999999999999999999999999999999999999 78999999999
Q ss_pred cCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCC-chhHHHHHHHHHHHHHhCC
Q 002342 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT-SAVDWWALGILLYEMLYGY 895 (934)
Q Consensus 817 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s-~~~DiwSlG~iL~elltG~ 895 (934)
++...... ......||+.|+|||++.+..+. .++|||||||++|+|++|+
T Consensus 186 ~~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 236 (312)
T 2iwi_A 186 SGALLHDE-----------------------------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236 (312)
T ss_dssp SCEECCSS-----------------------------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred hhhhcccC-----------------------------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCC
Confidence 98553211 12345699999999999877664 4899999999999999999
Q ss_pred CCCCC
Q 002342 896 TPFRG 900 (934)
Q Consensus 896 ~Pf~~ 900 (934)
.||.+
T Consensus 237 ~pf~~ 241 (312)
T 2iwi_A 237 IPFER 241 (312)
T ss_dssp CSCCS
T ss_pred CCCCC
Confidence 99965
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=310.16 Aligned_cols=206 Identities=26% Similarity=0.397 Sum_probs=162.5
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHH--HHhCCCCCccceeEEEEe-
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFVPALYASFQT- 740 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~i--l~~l~hp~Iv~l~~~~~~- 740 (934)
..+..++|++.+.||+|+||.||++.+ +++.||||++.... ...+..|.++ +..++||||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 346778999999999999999999976 78999999987531 2333444444 455899999999986542
Q ss_pred ----CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeecCCCCCCEEEecC
Q 002342 741 ----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ---------GIIYRDLKPENVLLQGN 807 (934)
Q Consensus 741 ----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---------giiHrDLKp~NILl~~~ 807 (934)
...+|+|||||++++|.+++... .+++..+..++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence 33679999999999999999764 268899999999999999999999 99999999999999999
Q ss_pred CcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-------CCCCchhH
Q 002342 808 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-------AGHTSAVD 880 (934)
Q Consensus 808 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~~s~~~D 880 (934)
+.+||+|||++.......... ...........+||+.|+|||++.+ ..++.++|
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~-------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D 217 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVR-------------------PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVD 217 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC----------------------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHH
T ss_pred CcEEEeeccceeecccccccC-------------------ccccccccccCCCccceeCchhhcCCcccccccccccccc
Confidence 999999999996543221100 0011122335579999999999987 35567899
Q ss_pred HHHHHHHHHHHHhCCCCCC
Q 002342 881 WWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 881 iwSlG~iL~elltG~~Pf~ 899 (934)
||||||++|+|++|..||.
T Consensus 218 iwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 218 MYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp HHHHHHHHHHHHTTBGGGS
T ss_pred hHHHHHHHHHHHhcCCcCC
Confidence 9999999999999966653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-32 Score=303.08 Aligned_cols=199 Identities=26% Similarity=0.391 Sum_probs=164.7
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC--CCCCccceeEEEEeC----
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML--DHPFVPALYASFQTK---- 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l--~hp~Iv~l~~~~~~~---- 741 (934)
.++|++.+.||+|+||.||++.+ +++.||||++... .......|.+++..+ +||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 46899999999999999999988 4899999998643 223445566666554 899999999999877
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCCEEEecCCcEEEE
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLT 813 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~--------giiHrDLKp~NILl~~~~~vkl~ 813 (934)
..+|+|||||++++|.+++... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 7899999999999999999763 499999999999999999999999 99999999999999999999999
Q ss_pred ecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCch------hHHHHHHHH
Q 002342 814 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA------VDWWALGIL 887 (934)
Q Consensus 814 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~------~DiwSlG~i 887 (934)
|||++......... ........+||+.|+|||++.+..++.. +|||||||+
T Consensus 185 Dfg~a~~~~~~~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~i 241 (337)
T 3mdy_A 185 DLGLAVKFISDTNE-----------------------VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLI 241 (337)
T ss_dssp CCTTCEECC--------------------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHH
T ss_pred eCCCceeecccccc-----------------------ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHH
Confidence 99998654221100 0011234579999999999988766654 999999999
Q ss_pred HHHHHhC----------CCCCCC
Q 002342 888 LYEMLYG----------YTPFRG 900 (934)
Q Consensus 888 L~elltG----------~~Pf~~ 900 (934)
+|+|++| ..||..
T Consensus 242 l~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 242 LWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp HHHHHTTBCBTTBCCCCCCTTTT
T ss_pred HHHHHhccCcccccccccccHhh
Confidence 9999999 778865
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-32 Score=295.01 Aligned_cols=185 Identities=16% Similarity=0.161 Sum_probs=163.1
Q ss_pred cccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
.+..+..++|++.+.||+|+||.||++.+..+++.||||++.............+.+|+.+++.++||||+++++++...
T Consensus 24 ~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 103 (286)
T 3uqc_A 24 PGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR 103 (286)
T ss_dssp TTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC
Confidence 34435568899999999999999999999999999999999876555566678899999999999999999999999999
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
+..|+||||++|++|.+++... .....+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|.
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~---- 175 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT---- 175 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC----
T ss_pred CcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc----
Confidence 9999999999999999998542 35567888999999999999999999999999999999999999985542
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
++ .++.++|||||||+||+|++|+.||.+.
T Consensus 176 -------------------------------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~ 205 (286)
T 3uqc_A 176 -------------------------------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEA 205 (286)
T ss_dssp -------------------------------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCC
T ss_pred -------------------------------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 22 2678999999999999999999999876
Q ss_pred CHH
Q 002342 902 TRQ 904 (934)
Q Consensus 902 ~~~ 904 (934)
+..
T Consensus 206 ~~~ 208 (286)
T 3uqc_A 206 GVR 208 (286)
T ss_dssp SBC
T ss_pred Ccc
Confidence 543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-33 Score=314.27 Aligned_cols=197 Identities=17% Similarity=0.180 Sum_probs=164.8
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeeccccc-----ChHHHHHHHHHHHHHHhCC---------CCCc
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-----NRNKVHRACAEREILDMLD---------HPFV 731 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~-----~~~~~~~~~~E~~il~~l~---------hp~I 731 (934)
+..++|++.+.||+|+||+||+|++ +++.||||++.+.... .......+.+|+.+|+.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 4467899999999999999999998 7899999999865321 2233467889999998885 7777
Q ss_pred cceeEEEE-----------------e-------------CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHH
Q 002342 732 PALYASFQ-----------------T-------------KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781 (934)
Q Consensus 732 v~l~~~~~-----------------~-------------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil 781 (934)
+.+++++. + .+.+|||||||++|++.+.+.+ +.+++..++.++.||+
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLT 171 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHH
Confidence 77766542 2 6889999999999987777744 4589999999999999
Q ss_pred HHHHHHH-HCCCeecCCCCCCEEEecCC--------------------cEEEEecccCcccCCCCCCCCCcchhhhcccc
Q 002342 782 VALEYLH-CQGIIYRDLKPENVLLQGNG--------------------HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840 (934)
Q Consensus 782 ~aL~yLH-~~giiHrDLKp~NILl~~~~--------------------~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~ 840 (934)
.||.||| ++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~------------------ 233 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER------------------ 233 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE------------------
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC------------------
Confidence 9999999 99999999999999999887 89999999995431
Q ss_pred CCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHH-HHHHHhCCCCCCC
Q 002342 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL-LYEMLYGYTPFRG 900 (934)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~i-L~elltG~~Pf~~ 900 (934)
....+||+.|||||++.+.. +.++||||||++ .++++.|..||.+
T Consensus 234 --------------~~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 234 --------------DGIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp --------------TTEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred --------------CCcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 11347999999999998776 889999998877 7778889999954
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=301.03 Aligned_cols=213 Identities=23% Similarity=0.346 Sum_probs=175.1
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHh--CCCCCccceeEEEEeCC---
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDHPFVPALYASFQTKT--- 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~~~~~~--- 742 (934)
.++|++.+.||+|+||.||++.+ +++.||||++... ....+.+|.+++.. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 36899999999999999999998 6899999998643 23567789999988 78999999999998775
Q ss_pred -eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeecCCCCCCEEEecCCcEEEE
Q 002342 743 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH--------CQGIIYRDLKPENVLLQGNGHVSLT 813 (934)
Q Consensus 743 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH--------~~giiHrDLKp~NILl~~~~~vkl~ 813 (934)
..|+||||+++++|.+++... .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred ceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 899999999999999999763 4999999999999999999999 8999999999999999999999999
Q ss_pred ecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC------CCchhHHHHHHHH
Q 002342 814 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG------HTSAVDWWALGIL 887 (934)
Q Consensus 814 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~------~s~~~DiwSlG~i 887 (934)
|||++......... .........||+.|+|||++.+.. ++.++|||||||+
T Consensus 190 Dfg~~~~~~~~~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~i 246 (342)
T 1b6c_B 190 DLGLAVRHDSATDT-----------------------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 246 (342)
T ss_dssp CCTTCEEEETTTTE-----------------------EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHH
T ss_pred ECCCceeccccccc-----------------------cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHH
Confidence 99998553211100 001223457999999999998763 2368999999999
Q ss_pred HHHHHhC----------CCCCCCC-----CHHHHHHHHHcCC
Q 002342 888 LYEMLYG----------YTPFRGK-----TRQKTFANILHKD 914 (934)
Q Consensus 888 L~elltG----------~~Pf~~~-----~~~~~~~~i~~~~ 914 (934)
+|+|++| ..||... ........+..+.
T Consensus 247 l~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (342)
T 1b6c_B 247 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK 288 (342)
T ss_dssp HHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC
T ss_pred HHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHH
Confidence 9999999 8899764 2344455554443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=310.13 Aligned_cols=220 Identities=25% Similarity=0.311 Sum_probs=166.9
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~l 746 (934)
.+.|.+.+.||+|+||+||.+ ...+|+.||||.+... ....+.+|+.+|+.+ +||||+++++++.+.+.+||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 355667789999999999875 4568999999998653 234567899999876 89999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-------------C
Q 002342 747 ITDYCPGGELFLLLDRQPTKV-----LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-------------G 808 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~-----l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-------------~ 808 (934)
||||| +++|.+++....... .++..+..++.||+.||.|||++||+||||||+|||++.+ +
T Consensus 87 v~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 99999 579999997643211 1233456799999999999999999999999999999754 4
Q ss_pred cEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-------CCCCchhHH
Q 002342 809 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-------AGHTSAVDW 881 (934)
Q Consensus 809 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~~s~~~Di 881 (934)
.+||+|||++......... ........+||+.|+|||++.+ ..++.++||
T Consensus 166 ~~kL~DFG~a~~~~~~~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di 222 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSS-----------------------FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI 222 (434)
T ss_dssp EEEECCCTTCEECCC-------------------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHH
T ss_pred EEEEcccccceecCCCCcc-----------------------ceeeecCCCCCCCccCHHHhccccccccccCcchhhhh
Confidence 8999999999654321100 0011234579999999999976 678899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 002342 882 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSS 920 (934)
Q Consensus 882 wSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 920 (934)
|||||++|+|++ |.+||.+..... ..+..+.+.++..
T Consensus 223 wSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~ 260 (434)
T 2rio_A 223 FSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEM 260 (434)
T ss_dssp HHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCC
T ss_pred HhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccc
Confidence 999999999998 999997655443 4566666655543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=328.39 Aligned_cols=195 Identities=24% Similarity=0.346 Sum_probs=168.1
Q ss_pred ccCCcccccccccCCcEEEEEEEEec-CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe--
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCG-SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH-- 743 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~-~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~-- 743 (934)
..++|++.+.||+|+||.||++.+.. +++.||||++... ........+.+|+.+|+.++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 35899999999999999999999976 7999999998653 234555678899999999999999999999987655
Q ss_pred ---EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 744 ---VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 744 ---~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
.||||||++|++|.+++.. .+++..+..++.||+.||.|||++|||||||||+|||++.+ .+||+|||++..
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp CEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999988754 49999999999999999999999999999999999999874 999999999854
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
... ....+||+.|+|||++.+.. +.++|||||||+||+|++|.+||.+
T Consensus 231 ~~~-------------------------------~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 231 INS-------------------------------FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp TTC-------------------------------CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred ccc-------------------------------CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 311 13457999999999997654 8899999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-32 Score=323.98 Aligned_cols=207 Identities=30% Similarity=0.471 Sum_probs=177.2
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe------C
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------K 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------~ 741 (934)
.++|++.+.||+|+||.||++.+..+|+.||||++... ........+.+|+.+|+.++||||+++++++.. .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 47899999999999999999999999999999998754 245556778999999999999999999998765 6
Q ss_pred CeEEEEEEccCCCCchhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc---EEEEeccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDL 817 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~---vkl~DFG~ 817 (934)
+..|+|||||+|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 78899999999999999997643 235899999999999999999999999999999999999997765 99999999
Q ss_pred CcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCC
Q 002342 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897 (934)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~P 897 (934)
+...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 171 a~~~~~~----------------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~P 222 (676)
T 3qa8_A 171 AKELDQG----------------------------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222 (676)
T ss_dssp CCBTTSC----------------------------CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSS
T ss_pred ccccccc----------------------------cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 8643211 112345799999999999999999999999999999999999999
Q ss_pred CCCCCHH
Q 002342 898 FRGKTRQ 904 (934)
Q Consensus 898 f~~~~~~ 904 (934)
|.+....
T Consensus 223 f~~~~~~ 229 (676)
T 3qa8_A 223 FLPNWQP 229 (676)
T ss_dssp CCSSCHH
T ss_pred CCcccch
Confidence 9875443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=308.02 Aligned_cols=207 Identities=22% Similarity=0.323 Sum_probs=162.8
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 744 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 744 (934)
+...+|.+.+.||+|+||+||. ....+++.||||.+.+... ....+|+.+|+.+ +||||+++++++.+....
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 3445799999999999999764 4557899999999875432 2245799999999 799999999999999999
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---C--CcEEEEecccCc
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---N--GHVSLTDFDLSC 819 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~--~~vkl~DFG~a~ 819 (934)
||||||| +++|.+++.... ..+....+..++.||+.||.|||++||+||||||+|||++. + .++||+|||+|.
T Consensus 94 ~lv~E~~-~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 94 YIAIELC-AATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEEECC-SEEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEEECC-CCCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9999999 579999997653 23555567789999999999999999999999999999953 2 358899999996
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc---CCCCCchhHHHHHHHHHHHHHh-CC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLY-GY 895 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~s~~~DiwSlG~iL~ellt-G~ 895 (934)
....... ........+||+.|+|||++. ...++.++|||||||++|+|++ |.
T Consensus 172 ~~~~~~~------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~ 227 (432)
T 3p23_A 172 KLAVGRH------------------------SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS 227 (432)
T ss_dssp CC------------------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSC
T ss_pred eccCCCc------------------------ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCC
Confidence 5421100 011234567999999999997 4567789999999999999999 99
Q ss_pred CCCCCCCHHH
Q 002342 896 TPFRGKTRQK 905 (934)
Q Consensus 896 ~Pf~~~~~~~ 905 (934)
+||.......
T Consensus 228 ~pf~~~~~~~ 237 (432)
T 3p23_A 228 HPFGKSLQRQ 237 (432)
T ss_dssp BTTBSTTTHH
T ss_pred CCcchhhHHH
Confidence 9996654443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-32 Score=310.13 Aligned_cols=213 Identities=18% Similarity=0.149 Sum_probs=164.7
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC-CCc---------cc----
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH-PFV---------PA---- 733 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~I---------v~---- 733 (934)
...|.+.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+.| .|. +.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3468889999999999999999999999999999885433333446778899999999977 221 11
Q ss_pred --------eeEEEEe-----CCeEEEEEEccCCCCchhhhc-----cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 002342 734 --------LYASFQT-----KTHVCLITDYCPGGELFLLLD-----RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795 (934)
Q Consensus 734 --------l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~-----~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHr 795 (934)
+..++.. ....+++|+++ +++|.+++. ......+++..+..++.||+.||+|||++||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1111111 23467888877 899999985 2223458888999999999999999999999999
Q ss_pred CCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhh-----
Q 002342 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII----- 870 (934)
Q Consensus 796 DLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l----- 870 (934)
||||+|||++.++.+||+|||+++.... .....+| +.|+|||++
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~------------------------------~~~~~~g-~~y~aPE~~~~~~~ 284 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGA------------------------------SAVSPIG-RGFAPPETTAERML 284 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTE------------------------------EECCCCC-TTTCCHHHHHHHTS
T ss_pred CcccceEEEecCCeEEEEeccceeecCC------------------------------ccccCCC-CceeCchhhhcccc
Confidence 9999999999999999999999854211 1234578 999999999
Q ss_pred -----cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Q 002342 871 -----AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 912 (934)
Q Consensus 871 -----~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~i~~ 912 (934)
.+..++.++|||||||+||+|++|+.||.+.+.......+..
T Consensus 285 ~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~ 331 (413)
T 3dzo_A 285 PFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR 331 (413)
T ss_dssp TTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS
T ss_pred ccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh
Confidence 555688899999999999999999999988766554444443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-31 Score=288.20 Aligned_cols=181 Identities=26% Similarity=0.467 Sum_probs=156.3
Q ss_pred cCCcccc-cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHH-HhCCCCCccceeEEEEe----C
Q 002342 668 LQHFRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPALYASFQT----K 741 (934)
Q Consensus 668 ~~~y~i~-~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il-~~l~hp~Iv~l~~~~~~----~ 741 (934)
.++|.+. +.||+|+||.||++.+..+++.||+|++... ....+|+.++ +.++||||+++++++.. .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4678888 7799999999999999999999999998643 3566788888 66699999999999987 7
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEEEEecccC
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLS 818 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~~vkl~DFG~a 818 (934)
..+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 78999999999999999998876567999999999999999999999999999999999999998 788999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
.... +..++.++|||||||++|+|++|.+||
T Consensus 168 ~~~~-------------------------------------------------~~~~~~~~DiwslG~il~el~tg~~pf 198 (299)
T 3m2w_A 168 KETT-------------------------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPF 198 (299)
T ss_dssp EECT-------------------------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccc-------------------------------------------------cccCCchhhHHHHHHHHHHHHHCCCCC
Confidence 4311 134667899999999999999999999
Q ss_pred CCCCHHH
Q 002342 899 RGKTRQK 905 (934)
Q Consensus 899 ~~~~~~~ 905 (934)
.+.+...
T Consensus 199 ~~~~~~~ 205 (299)
T 3m2w_A 199 YSNHGLA 205 (299)
T ss_dssp CC-----
T ss_pred CCCcchh
Confidence 8765544
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-30 Score=304.17 Aligned_cols=188 Identities=16% Similarity=0.122 Sum_probs=134.1
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeeccccc-------ChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCCeEEE
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-------NRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~-------~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~l 746 (934)
..++.|++|.+..++....|..||+|++.+.... .....+.+.+|+++|+++ .|+||+++++++++++.+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3567888888888888888999999999865321 123346688999999999 79999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
|||||+|++|.+++... +.++.. .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 320 VMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--- 391 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--- 391 (569)
T ss_dssp EEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred EEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC---
Confidence 99999999999999875 346654 4789999999999999999999999999999999999999999865321
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCC
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 895 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~ 895 (934)
......+.+||+.|||||++.+. +..++|+||+|++++.|.++.
T Consensus 392 ------------------------~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 392 ------------------------DCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp --------------------------CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred ------------------------CCccccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 11223467899999999999764 567899999999887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-25 Score=261.92 Aligned_cols=194 Identities=16% Similarity=0.164 Sum_probs=146.7
Q ss_pred ccccccccCCcEEEEEEEEecCCeEEEEEEeecccccCh-----HHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 672 RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-----NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 672 ~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~-----~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
...+.||+|+||.||++. ..+..+++|.......... ...+.+.+|+++|++++||||+.+..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 445689999999999994 4678899998765333222 224557899999999999999966666667777899
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
|||||+|++|.+++.. +..++.||+.+|.|||++||+||||||+|||++. .+||+|||+|+.......
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999999865 4578999999999999999999999999999998 999999999965421100
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC--CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
. . ........+++||+.|||||++.. ..|+..+|+||..+-.++-+.++.+|.
T Consensus 485 --------~-~-----------~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 --------K-A-----------VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp --------H-H-----------HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred --------c-c-----------cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 0 0 000011236689999999999977 567778999999999999988887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6e-23 Score=223.18 Aligned_cols=135 Identities=17% Similarity=0.107 Sum_probs=109.9
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccCh---------------HHHHHHHHHHHHHHhCCCCCccc
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR---------------NKVHRACAEREILDMLDHPFVPA 733 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~---------------~~~~~~~~E~~il~~l~hp~Iv~ 733 (934)
..|.+.+.||+|+||.||+|.+ .+|+.||||++........ .....+.+|+.+|+.++ | +.
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 4466669999999999999999 8899999999875321110 23456889999999999 4 56
Q ss_pred eeEEEEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEE
Q 002342 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLT 813 (934)
Q Consensus 734 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~ 813 (934)
+++++.. +..|+|||||+|++|.+ +.. .....++.|++.||.|||++||+||||||+|||++ +|.+||+
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 6665544 45699999999999998 422 13456899999999999999999999999999999 9999999
Q ss_pred ecccC
Q 002342 814 DFDLS 818 (934)
Q Consensus 814 DFG~a 818 (934)
|||+|
T Consensus 235 DFG~a 239 (282)
T 1zar_A 235 DFPQS 239 (282)
T ss_dssp CCTTC
T ss_pred ECCCC
Confidence 99998
|
| >4f3l_A Mclock, circadian locomoter output cycles protein kaput; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-19 Score=204.61 Aligned_cols=107 Identities=11% Similarity=0.010 Sum_probs=98.4
Q ss_pred cccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEE
Q 002342 482 EKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFW 561 (934)
Q Consensus 482 ~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~~w 561 (934)
.+.++..|.+|. |+|||++++.++||+++|++|+++..++||++.......+...+..|.....+++++++||..+|
T Consensus 251 ~~f~~~~~~dg~---~~~vn~~~~~ilGY~~eEl~g~~~~~~iHpdD~~~~~~~~~~~l~~g~~~~~eyR~~~kdG~~vW 327 (361)
T 4f3l_A 251 EEFTSRHSLEWK---FLFLDHRAPPIIGYLPFEVLGTSGYDYYHVDDLENLAKCHEHLMQYGKGKSCYYRFLTKGQQWIW 327 (361)
T ss_dssp CEEEEEECTTSB---EEEECTTSHHHHCCCHHHHTTSBGGGGBCHHHHHHHHHHHHHHHHHSEEECCCEEEECTTSEEEE
T ss_pred ceeEEEEcCCce---EEEECChhhhhhCcCHHHHcCCCHHHeECHHHHHHHHHHHHHHHhCCCcceEEEEEEecCCCEEE
Confidence 456777888777 99999999999999999999999999999999888888888888888877889999999999999
Q ss_pred EEEEEEeeecC-CCCEEEEEEEEEcCCcccc
Q 002342 562 NLFHLQPMRDQ-KGEVQYFIGVQLDGSEHLE 591 (934)
Q Consensus 562 v~~~~~pi~de-~G~v~~~vgi~rDITerk~ 591 (934)
+..+..|++|. .|++.+++|+.+|||+++.
T Consensus 328 v~~~~~~v~~~~~g~~~~iv~~~~dITe~~~ 358 (361)
T 4f3l_A 328 LQTHYYITYHQWNSRPEFIVCTHTVVSYAEV 358 (361)
T ss_dssp EEEEEEEEECTTTCCEEEEEEEEEECCHHHH
T ss_pred EEEEEEEEEcCCCCCeeEEEEEEEECChhHh
Confidence 99999999998 7999999999999999876
|
| >4f3l_B BMAL1B; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=4e-19 Score=201.43 Aligned_cols=108 Identities=12% Similarity=0.062 Sum_probs=93.6
Q ss_pred ccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCc-EEEEEEEEecCCcE
Q 002342 481 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD-VTVQLINYTKSGKK 559 (934)
Q Consensus 481 ~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~-~~~e~~~~~kdG~~ 559 (934)
..+.++..|.+|. ++|||++++.++||+++|++|+++..++||++...+.+.+...+..+.. ...+++++++||.+
T Consensus 277 ~~~fi~~~~~dg~---~~~vn~~~~~ilGY~~eEl~g~~~~~~iHpdD~~~~~~~~~~~l~~~~~~~~~eyR~~~kdG~~ 353 (387)
T 4f3l_B 277 SMEYVSRHAIDGK---FVFVDQRATAILAYLPQELLGTSCYEYFHQDDIGHLAECHRQVLQTREKITTNCYKFKIKDGSF 353 (387)
T ss_dssp CCEEEEEECTTSB---EEEECTHHHHHHCCCHHHHTTSBGGGTBCHHHHHHHHHHHHHHTTCSSCEECCCEEEECTTSCE
T ss_pred CceEEEEECCCCE---EEEECCCcccccCCCHHHHcCCcHHHeeCHHHHHHHHHHHHHHHhcCCCeeeEEEEEEccCCCE
Confidence 4567888899888 9999999999999999999999999999999988888888777766554 56799999999999
Q ss_pred EEEEEEEEeeecC-CCCEEEEEEEEEcCCcccc
Q 002342 560 FWNLFHLQPMRDQ-KGEVQYFIGVQLDGSEHLE 591 (934)
Q Consensus 560 ~wv~~~~~pi~de-~G~v~~~vgi~rDITerk~ 591 (934)
+|+..+..+++|. .|++.+++|+.+|||+||+
T Consensus 354 vWv~~~~~~~~~~~~g~~~~ivg~~~dIT~Rk~ 386 (387)
T 4f3l_B 354 ITLRSRWFSFMNPWTKEVEYIVSTNTVVLANVL 386 (387)
T ss_dssp EEEEEEEEEEEETTTTEEEEEEEEEEECC----
T ss_pred EEEEEEEEEEECCCCCCEEEEEEEEEEcchhhc
Confidence 9999999999997 7899999999999999985
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} | Back alignment and structure |
|---|
Probab=99.77 E-value=4.7e-18 Score=158.55 Aligned_cols=119 Identities=26% Similarity=0.460 Sum_probs=109.1
Q ss_pred chHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEE
Q 002342 186 RVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG 265 (934)
Q Consensus 186 ~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 265 (934)
+++++|+.++++++++|+++|. +|+|+|+|++|++++||+.+|++|+++..+.++.........++..+..+..+.+
T Consensus 2 ~~~~~~~~~~~~~~~~i~~~d~---~g~i~~~N~a~~~~~G~~~~elig~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (120)
T 2gj3_A 2 LLPEIFRQTVEHAPIAISITDL---KANILYANRAFRTITGYGSEEVLGKNESILSNGTTPRLVYQALWGRLAQKKPWSG 78 (120)
T ss_dssp CCHHHHHHHHHHCSSEEEEECT---TCBEEEECHHHHHHHCCCTTGGGGCBGGGGCCTTSCHHHHHHHHHHHHTTCCEEE
T ss_pred hhHHHHHHHHHhCCCeEEEECC---CCCEEeehHHHHHHHCcCHHHHcCCCHHHcCCCCCCHHHHHHHHHHHHcCCCEEE
Confidence 4567899999999999999998 7779999999999999999999999988887777766667788888888999999
Q ss_pred EEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhH
Q 002342 266 RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHT 307 (934)
Q Consensus 266 e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk 307 (934)
++..+++||+.+|+.+++.|++|.+|.+.+++++++|||++|
T Consensus 79 e~~~~~~dG~~~~~~~~~~pi~~~~g~~~~~v~~~~DITe~k 120 (120)
T 2gj3_A 79 VLVNRRKDKTLYLAELTVAPVLNEAGETIYYLGMHRDTSELH 120 (120)
T ss_dssp EEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCSCC
T ss_pred EEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEeccCcccC
Confidence 999999999999999999999999999999999999999975
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=6.3e-19 Score=188.93 Aligned_cols=140 Identities=18% Similarity=0.108 Sum_probs=108.5
Q ss_pred CcccccccccCCcEEEEEEEEecCCeE--EEEEEeecccccC---------------------hHHHHHHHHHHHHHHhC
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQY--FAMKAMDKGVMLN---------------------RNKVHRACAEREILDML 726 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~--vAlK~~~~~~~~~---------------------~~~~~~~~~E~~il~~l 726 (934)
-|.+.+.||+|+||.||+|.+..+|+. ||||+++.....- ......+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378899999999999999999888999 9999976532110 01123577899999999
Q ss_pred CCCCc--cceeEEEEeCCeEEEEEEccCC-C----CchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCC
Q 002342 727 DHPFV--PALYASFQTKTHVCLITDYCPG-G----ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH-CQGIIYRDLK 798 (934)
Q Consensus 727 ~hp~I--v~l~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH-~~giiHrDLK 798 (934)
.|+++ +.+++. +..||||||+.+ | +|.++... .++..+..++.||+.+|.||| +.||+|||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 88754 444432 356899999932 3 55555422 234567889999999999999 9999999999
Q ss_pred CCCEEEecCCcEEEEecccCcc
Q 002342 799 PENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 799 p~NILl~~~~~vkl~DFG~a~~ 820 (934)
|+|||++. .++|+|||+|..
T Consensus 199 p~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEE
T ss_pred HHHEEEcC--cEEEEECccccc
Confidence 99999997 999999999854
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.5e-17 Score=153.61 Aligned_cols=115 Identities=24% Similarity=0.388 Sum_probs=107.0
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEE
Q 002342 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552 (934)
Q Consensus 473 ~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~ 552 (934)
.|+.++++++++|+++|.+|+ |+|+|++|++++||+.+|++|++...+.+++........+...+..+..+..+++.
T Consensus 6 ~~~~~~~~~~~~i~~~d~~g~---i~~~N~a~~~~~G~~~~elig~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 82 (120)
T 2gj3_A 6 IFRQTVEHAPIAISITDLKAN---ILYANRAFRTITGYGSEEVLGKNESILSNGTTPRLVYQALWGRLAQKKPWSGVLVN 82 (120)
T ss_dssp HHHHHHHHCSSEEEEECTTCB---EEEECHHHHHHHCCCTTGGGGCBGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEE
T ss_pred HHHHHHHhCCCeEEEECCCCC---EEeehHHHHHHHCcCHHHHcCCCHHHcCCCCCCHHHHHHHHHHHHcCCCEEEEEEE
Confidence 488999999999999999888 99999999999999999999999888888777776777788888888899999999
Q ss_pred EecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccc
Q 002342 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL 590 (934)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk 590 (934)
+++||+.+|+.+++.|++|.+|.+.+++++++|||++|
T Consensus 83 ~~~dG~~~~~~~~~~pi~~~~g~~~~~v~~~~DITe~k 120 (120)
T 2gj3_A 83 RRKDKTLYLAELTVAPVLNEAGETIYYLGMHRDTSELH 120 (120)
T ss_dssp ECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCSCC
T ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEeccCcccC
Confidence 99999999999999999999999999999999999986
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.7e-17 Score=173.80 Aligned_cols=162 Identities=23% Similarity=0.442 Sum_probs=138.9
Q ss_pred hceeeeccCCCCCcceEEecccCCCCCCCCCCcccCCCCCceEEEecccccccccccccchHHHHHHHHHhccCcEEEEe
Q 002342 127 WGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSD 206 (934)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~dit~~~~~e~aL~~~~~~~~~ile~~~d~i~v~D 206 (934)
|...+.-.+..|..-|+........+.+|.+. +.+++..|||++|+++++|+ .++.++++++++|+++|
T Consensus 60 ~~~e~~~~~~dG~~~~~~~~~~p~~d~~g~~~-------~~~~~~~DIT~~k~~e~~l~----~~~~~~~~~~~~i~~~d 128 (227)
T 3ewk_A 60 WQGEFCNRRKDGTRYWVDSTIVPLMDNAGKPR-------QYISIRRDITAQKEAEAQLA----RLKQAMDANSEMILLTD 128 (227)
T ss_dssp EEEEEEEECSSSCEEEEEEEEEEEECSSSCEE-------EEEEEEEECTTTTHHHHHHH----HHHHHHHTCCSEEEEEC
T ss_pred EEEEEEEEcCCCCEEeeeeEEEEEEcCCCCEE-------EEEEEEEehhhHHHHHHHHH----HHHHHHhcCcCeEEEEc
Confidence 44445556677777777766666555555433 36677799999999888774 56778999999999999
Q ss_pred CCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCc------EEEEE
Q 002342 207 ATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGT------PFWNL 280 (934)
Q Consensus 207 ~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~------~~wv~ 280 (934)
. +|+|+++|++|++++||+.+|++|+++..+.++.........+++.+..+..|.+++..++|||+ .+|++
T Consensus 129 ~---~g~i~~~N~~~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~k~G~~~~dg~~~~~~ 205 (227)
T 3ewk_A 129 R---AGRIIYANPALCRFSGMAEGELLGQSPSILDSPLADQETLAAMQEALQAGQPWSGRLLNRRRTGPAPHDAEDYWAE 205 (227)
T ss_dssp T---TSCEEEECHHHHHHHTCCTHHHHSSCGGGGBCTTSCHHHHHHHHHHHHHTCCEECCEEEEEECCSSSSCEEEEEEE
T ss_pred C---CCcEEEEchHHHHHhCCCHHHHcCCChhhccCCCCCHHHHHHHHHHHHcCCceeEEEEEECCCCCcCcccceEEEE
Confidence 8 77799999999999999999999999998888888888999999999999999999999999997 89999
Q ss_pred EEeeeeecCCCCEEEEEEEEec
Q 002342 281 LTIAPIKDDEGKVLKFIGMQVE 302 (934)
Q Consensus 281 ~s~~pi~d~~G~v~~~v~~~~D 302 (934)
++++|++|.+|.+.+++++++|
T Consensus 206 ~~~~pi~d~~g~~~~~v~i~~D 227 (227)
T 3ewk_A 206 ISTTPIHTDGNGLVGYVQIQHD 227 (227)
T ss_dssp EEEEEEECSSSCEEEEEEEEEC
T ss_pred EEEEEEECCCCCEEEEEEEecC
Confidence 9999999999999999999988
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.4e-17 Score=156.48 Aligned_cols=121 Identities=41% Similarity=0.739 Sum_probs=105.8
Q ss_pred HHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEe
Q 002342 192 KDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYK 271 (934)
Q Consensus 192 ~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~ 271 (934)
+.++++++++|+++|..+.+|+|+|+|++|++++||+.+|++|+++..+.+++........++..+..+..+..+++.++
T Consensus 2 ~~~~~~~~~~i~~~d~~g~~~~i~~~N~a~~~~~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 81 (132)
T 2pr5_A 2 SHMLDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNIRTALQNKEPVTVQIQNYK 81 (132)
T ss_dssp ----CCCCCEEEEECTTSTTCCEEEECHHHHHHHSCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEEC
T ss_pred hhHHhcCCCcEEEEeCCCCCCcEEEECHHHHHHhCcCHHHHcCCChhhhCCCCCCHHHHHHHHHHHHcCCCeEEEEEEEe
Confidence 35789999999999985545589999999999999999999999988777777777777788888888888999999999
Q ss_pred cCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhh
Q 002342 272 KDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (934)
Q Consensus 272 kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~ 314 (934)
+||+.+|+.+++.|+.+.+ +.+++++++|||++|++|++|+
T Consensus 82 kdG~~~~~~~~~~~~~~~~--~~~~~~~~~DITe~k~~e~~l~ 122 (132)
T 2pr5_A 82 KDGTMFWNELNIDPMEIED--KTYFVGIQNDITKQKEYEKLLE 122 (132)
T ss_dssp TTSCEEEEEEEEEEEEETT--EEEEEEEEEECHHHHHHHHHHH
T ss_pred cCCCeeeeEEEEEeccCCC--eeEEEEEEEeCcHHHHHHHHHH
Confidence 9999999999999998765 8899999999999999999987
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=3e-17 Score=150.73 Aligned_cols=108 Identities=60% Similarity=1.139 Sum_probs=100.6
Q ss_pred ccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 002342 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 277 (934)
Q Consensus 198 ~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 277 (934)
++++|+++|....+|+|+|+|++|++++||+.+|++|+++..+.++.........++.++..+..+.++++.++|||+.+
T Consensus 2 ~~~~i~i~d~~~~~g~i~~~N~a~~~l~Gy~~~e~~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~ 81 (109)
T 1n9l_A 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred CccEEEEEcCCCCCCeEEEEchHHHHHHCcCHHHHcCCCchhcCCCCCCHHHHHHHHHHHHcCCcEEEEEEEEcCCCCEE
Confidence 67899999976668899999999999999999999999988888887777778889999999999999999999999999
Q ss_pred EEEEEeeeeecCCCCEEEEEEEEecchh
Q 002342 278 WNLLTIAPIKDDEGKVLKFIGMQVEVSK 305 (934)
Q Consensus 278 wv~~s~~pi~d~~G~v~~~v~~~~DITe 305 (934)
|++++++|++|++|.+.+++++++|||+
T Consensus 82 ~~~~~~~pi~d~~G~~~~~v~~~~DITe 109 (109)
T 1n9l_A 82 WNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEeCCC
Confidence 9999999999999999999999999995
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=8.9e-17 Score=157.74 Aligned_cols=141 Identities=40% Similarity=0.715 Sum_probs=119.3
Q ss_pred ccccccccccccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHH
Q 002342 174 MSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 253 (934)
Q Consensus 174 it~~~~~e~aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i 253 (934)
..+++++++++...++.|+.++++++++|+++|....+|+|+++|++|++++||+.++++|+++..+.+++........+
T Consensus 20 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~G~~~~e~~g~~~~~l~~~~~~~~~~~~~ 99 (166)
T 3ue6_A 20 TDNPSKANRILEDPDYSLVKALQMAQQNFVITDASLPDNPIVYASRGFLTLTGYSLDQILGRNCRFLQGPETDPRAVDKI 99 (166)
T ss_dssp -----------CCCCCHHHHHHHHTTSCEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHH
T ss_pred ehhhhHHHHHHHHHHHHHHHHHhcCCceEEEEEccCCCCcEEEECHHHHHHhCcCHHHHcCCCHhheeCCCCCHHHHHHH
Confidence 44566778889999999999999999999999974335779999999999999999999999988888888888888888
Q ss_pred HHHHhcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhh
Q 002342 254 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (934)
Q Consensus 254 ~~~l~~g~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~ 314 (934)
...+..+..+..++..++++|..+|+.+++.|+.+.+|.+.+++++++|||++|+++...+
T Consensus 100 ~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k~~~~~~e 160 (166)
T 3ue6_A 100 RNAITKGVDTSVCLLNYRQDGTTFWNLFFVAGLRDSKGNIVNYVGVQSKVSEDYAKLLVNE 160 (166)
T ss_dssp HHHHHHTCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEECCBCCHHHHHHHHHH
T ss_pred HHHHhcCCceEEEEEEEcCCCCEEEEEEEEEeeeCCCCCEEEEEEEEEechHHHHHHHHHh
Confidence 8999999999999999999999999999999999999999999999999999999876644
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} | Back alignment and structure |
|---|
Probab=99.71 E-value=6e-17 Score=172.96 Aligned_cols=136 Identities=38% Similarity=0.609 Sum_probs=110.8
Q ss_pred cccccccccccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHH
Q 002342 175 SDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIR 254 (934)
Q Consensus 175 t~~~~~e~aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~ 254 (934)
.....++++++++++.|+.++++++++|+++|..+.+|+|+|+|++|++++||+++|++|+++..+.+++........+.
T Consensus 49 ~~~~~~~~~l~~~~~~~~~i~~~~~~~i~~~d~~~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~~~~~~~~~~~ 128 (258)
T 3p7n_A 49 PGADDTRVEVQPPAQWVLDLIEASPIASVVSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIR 128 (258)
T ss_dssp ------------CCHHHHHHHHTCSSEEEEECTTSTTCCEEEECHHHHHHHCCCGGGTTTSCGGGGCCTTCCHHHHHHHH
T ss_pred CcchhhHHHHHhHHHHHHHHHhcCCccEEEEcCCCCCCcEEEEhHHHHHHcCCCHHHHCCCChhhccCCCCchhHHHHHH
Confidence 34444566799999999999999999999999855567799999999999999999999999998888888888888899
Q ss_pred HHHhcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHH
Q 002342 255 ETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGA 310 (934)
Q Consensus 255 ~~l~~g~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e 310 (934)
..+..+..+..+++.+++||+.+|+.+++.|++|++|.+.+++++++|||++|+.+
T Consensus 129 ~~l~~~~~~~~e~~~~~~dG~~~~~~~~~~pi~d~~g~~~~~v~~~~DITerk~~~ 184 (258)
T 3p7n_A 129 QGVREHKPVLVEILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPNM 184 (258)
T ss_dssp HHHHHTCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCSEEEEEEEEEC-------
T ss_pred HHHHcCCCeEEEEEEEcCCCCEEEEeeEEEEEEcCCCCEEEEEEEeeecchhhhhh
Confidence 99999999999999999999999999999999999999999999999999995443
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-16 Score=151.16 Aligned_cols=116 Identities=47% Similarity=0.848 Sum_probs=100.7
Q ss_pred HHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEe
Q 002342 475 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYT 554 (934)
Q Consensus 475 ~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~ 554 (934)
+.++++++++|+++|.+|.+++|+|+|++|++++||+.+|++|+++..+.+++........+...+..+..+..+++.++
T Consensus 2 ~~~~~~~~~~i~~~d~~g~~~~i~~~N~a~~~~~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 81 (132)
T 2pr5_A 2 SHMLDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNIRTALQNKEPVTVQIQNYK 81 (132)
T ss_dssp ----CCCCCEEEEECTTSTTCCEEEECHHHHHHHSCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEEC
T ss_pred hhHHhcCCCcEEEEeCCCCCCcEEEECHHHHHHhCcCHHHHcCCChhhhCCCCCCHHHHHHHHHHHHcCCCeEEEEEEEe
Confidence 35788999999999997733459999999999999999999999988888887777777788888888888999999999
Q ss_pred cCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccc
Q 002342 555 KSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 592 (934)
Q Consensus 555 kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~ 592 (934)
+||+.+|+.+++.|+++++ +.+++++++|||++|++
T Consensus 82 kdG~~~~~~~~~~~~~~~~--~~~~~~~~~DITe~k~~ 117 (132)
T 2pr5_A 82 KDGTMFWNELNIDPMEIED--KTYFVGIQNDITKQKEY 117 (132)
T ss_dssp TTSCEEEEEEEEEEEEETT--EEEEEEEEEECHHHHHH
T ss_pred cCCCeeeeEEEEEeccCCC--eeEEEEEEEeCcHHHHH
Confidence 9999999999999999765 78899999999999984
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.6e-16 Score=144.43 Aligned_cols=108 Identities=45% Similarity=0.912 Sum_probs=98.1
Q ss_pred ccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 002342 481 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 560 (934)
Q Consensus 481 ~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~~ 560 (934)
++++|+++|....+++|+|+|++|++++||+.+|++|+++..+.++.......+.++..+..+..+..+++.++|||+.+
T Consensus 2 ~~~~i~i~d~~~~~g~i~~~N~a~~~l~Gy~~~e~~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~ 81 (109)
T 1n9l_A 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred CccEEEEEcCCCCCCeEEEEchHHHHHHCcCHHHHcCCCchhcCCCCCCHHHHHHHHHHHHcCCcEEEEEEEEcCCCCEE
Confidence 57899999964333449999999999999999999999988888888777778888999999999999999999999999
Q ss_pred EEEEEEEeeecCCCCEEEEEEEEEcCCc
Q 002342 561 WNLFHLQPMRDQKGEVQYFIGVQLDGSE 588 (934)
Q Consensus 561 wv~~~~~pi~de~G~v~~~vgi~rDITe 588 (934)
|+.+++.|++|++|++.+++++++|||+
T Consensus 82 ~~~~~~~pi~d~~G~~~~~v~~~~DITe 109 (109)
T 1n9l_A 82 WNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEeCCC
Confidence 9999999999999999999999999996
|
| >4hia_A LOV protein; PAS, HTH, signaling protein; HET: FMN; 1.95A {Rhodobacter sphaeroides} PDB: 4hnb_A* 4hj4_A* 4hj6_A* 4hj3_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.4e-16 Score=158.85 Aligned_cols=128 Identities=27% Similarity=0.501 Sum_probs=116.8
Q ss_pred hHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEE
Q 002342 187 VSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGR 266 (934)
Q Consensus 187 ~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e 266 (934)
..+.|+.++++++++|+++|....+|+|+++|++|++++||+.+|++|+++..+.+++........+...+..+..+..+
T Consensus 5 ~~~~~~~~~~~~~~~i~~~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 84 (176)
T 4hia_A 5 QFEKIRAVFDRSGVALTLVDMSLPEQPVVLANPPFLRMTGYTEGQILGFNCRFLQRGDENAQARADIRDALKLGRELQVV 84 (176)
T ss_dssp HHHHHHHHHHHCSSCCEEEETTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEE
T ss_pred HHHHHHHHHhcCCCcEEEEecCCCCCcEEEECHHHHHHHCcCHHHHcCCCcceeeCCCCCHHHHHHHHHHHHcCCceEEE
Confidence 44688999999999999999842238899999999999999999999999888888888888888899999999999999
Q ss_pred EEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhh
Q 002342 267 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (934)
Q Consensus 267 ~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~ 314 (934)
++.+++||+.+|+.+++.|++|.+|.+.+++++++|||++|++|++++
T Consensus 85 ~~~~~~dG~~~~~~~~~~pi~~~~g~~~~~~~~~~DITe~k~~e~~~~ 132 (176)
T 4hia_A 85 LRNYRANDEPFDNLLFLHPVGGRPDAPDYFLGSQFELGRSGNSEEAAA 132 (176)
T ss_dssp EEEECTTCCEEEEEEEEEEESSBTTBCSEEEEEEEEESSSGGGHHHHH
T ss_pred EEEEcCCCCEEEEEEEEEEeeCCCCCeEEEEEEEEECcHhhHHHHHHH
Confidence 999999999999999999999999999999999999999999988843
|
| >4hia_A LOV protein; PAS, HTH, signaling protein; HET: FMN; 1.95A {Rhodobacter sphaeroides} PDB: 4hnb_A* 4hj4_A* 4hj6_A* 4hj3_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=2.4e-16 Score=157.08 Aligned_cols=120 Identities=28% Similarity=0.504 Sum_probs=112.6
Q ss_pred cHHHHHHhccccEEEEcCC---CCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEE
Q 002342 473 DLATTLERIEKNFVITDPR---LPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQ 549 (934)
Q Consensus 473 ~l~~i~e~~~d~i~v~D~~---G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e 549 (934)
.|+.++++++++|+++|.+ |+ |+++|++|++++||+.++++|+++..+.+++........+...+..+..+..+
T Consensus 8 ~~~~~~~~~~~~i~~~d~~~~~g~---i~~~N~a~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 84 (176)
T 4hia_A 8 KIRAVFDRSGVALTLVDMSLPEQP---VVLANPPFLRMTGYTEGQILGFNCRFLQRGDENAQARADIRDALKLGRELQVV 84 (176)
T ss_dssp HHHHHHHHCSSCCEEEETTSTTCC---EEEECHHHHHHHTCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEE
T ss_pred HHHHHHhcCCCcEEEEecCCCCCc---EEEECHHHHHHHCcCHHHHcCCCcceeeCCCCCHHHHHHHHHHHHcCCceEEE
Confidence 3899999999999999998 77 99999999999999999999999998999988888888888999999999999
Q ss_pred EEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccccccc
Q 002342 550 LINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRN 595 (934)
Q Consensus 550 ~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e~~ 595 (934)
++..+++|..+|+.+++.|+++.+|.+.+++++++|||++|++|.+
T Consensus 85 ~~~~~~dG~~~~~~~~~~pi~~~~g~~~~~~~~~~DITe~k~~e~~ 130 (176)
T 4hia_A 85 LRNYRANDEPFDNLLFLHPVGGRPDAPDYFLGSQFELGRSGNSEEA 130 (176)
T ss_dssp EEEECTTCCEEEEEEEEEEESSBTTBCSEEEEEEEEESSSGGGHHH
T ss_pred EEEEcCCCCEEEEEEEEEEeeCCCCCeEEEEEEEEECcHhhHHHHH
Confidence 9999999999999999999999999999999999999999997655
|
| >3rty_A Period circadian protein; PAS domain, signalling, timeless, circadian clock protein; 2.85A {Drosophila melanogaster} PDB: 1wa9_A 3gec_A | Back alignment and structure |
|---|
Probab=99.68 E-value=4.1e-16 Score=172.26 Aligned_cols=108 Identities=7% Similarity=0.003 Sum_probs=94.5
Q ss_pred cccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCc-----EEEEEEEEecC
Q 002342 482 EKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD-----VTVQLINYTKS 556 (934)
Q Consensus 482 ~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~-----~~~e~~~~~kd 556 (934)
.+.++..|.+|. ++|+|+++..++||+++|++|+++..++||++.....+.+...+..|.. ...+++++++|
T Consensus 154 ~~fi~r~~~dG~---~~yvn~~~~~lLGY~peELiG~s~~~~vHPdD~~~~~~~~~~~l~~G~~~~~~~~s~~yR~~~kd 230 (339)
T 3rty_A 154 PKFAIRHTATGI---ISHVDSAAVSALGYLPQDLIGRSIMDFYHHEDLSVMKETYETVMKKGQTAGASFCSKPYRFLIQN 230 (339)
T ss_dssp CEEEEEEETTCB---EEEECTTHHHHHCCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHHHHTTSTTCCCBCCCEEEECTT
T ss_pred ceEEEEECCCCe---EEEcChhhhcccCCCHHHHcCCcHHHEECHHHHHHHHHHHHHHHHcCCcccccccceEEEEEccC
Confidence 456778899888 9999999999999999999999999999999988888888888876664 35789999999
Q ss_pred CcEEEEEEEEEeeecCC-CCEEEEEEEEEcCCccccc
Q 002342 557 GKKFWNLFHLQPMRDQK-GEVQYFIGVQLDGSEHLEP 592 (934)
Q Consensus 557 G~~~wv~~~~~pi~de~-G~v~~~vgi~rDITerk~~ 592 (934)
|..+|++.+.++++|.. +++.+++|+-+.|+.....
T Consensus 231 G~~vWlet~~~~~~np~s~~~~~II~~h~vi~~p~~~ 267 (339)
T 3rty_A 231 GCYVLLETEWTSFVNPWSRKLEFVVGHHRVFQGPKQC 267 (339)
T ss_dssp SCEEEEEEEEEEEECTTTCSEEEEEEEEEEEECCSSS
T ss_pred CCEEEEEEEEEEEECCCCCCeeEEEEEEEECCCCCCC
Confidence 99999999999999865 5777899999998887653
|
| >3mr0_A Sensory box histidine kinase/response regulator; PAS fold, structural genomics, PSI-2; HET: PG5; 1.49A {Burkholderia thailandensis} | Back alignment and structure |
|---|
Probab=99.68 E-value=3.2e-16 Score=151.00 Aligned_cols=131 Identities=15% Similarity=0.195 Sum_probs=112.8
Q ss_pred ccccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCC--CCCCCCCCCCChHHHHHHHHHHhc
Q 002342 182 KGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR--NCRFLQGAGTDPEDVAKIRETLQN 259 (934)
Q Consensus 182 ~aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~--~~~~l~~~~~~~~~~~~i~~~l~~ 259 (934)
++|++++++|+.+++++++++|.+|. ++.++++|+++++++||+.+++.+. .+..++||++.......+...+..
T Consensus 2 ~aL~~se~rl~~~~~~~~~g~w~~d~---~~~~~~~s~~~~~~~G~~~~~~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~ 78 (142)
T 3mr0_A 2 NALSASEERFQLAVSGASAGLWDWNP---KTGAMYLSPHFKKIMGYEDHELPDEITGHRESIHPDDRARVLAALKAHLEH 78 (142)
T ss_dssp -------CCHHHHHHHTTCEEEEECT---TTCCEEECHHHHHHTTCCGGGSCSEEC---CCBCTTTHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCcEEEEEEc---CCCeEEECHHHHHHhCCCccccCCCHHHHHhhcCHHHHHHHHHHHHHHHhC
Confidence 46888999999999999999999998 5669999999999999999998773 345678899888888888889998
Q ss_pred CCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhhc
Q 002342 260 GQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 315 (934)
Q Consensus 260 g~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~~ 315 (934)
+..+..+++.+++||..+|+.....|++|.+|.+.+++|+++|||++|++|++|+.
T Consensus 79 ~~~~~~e~r~~~~~G~~~w~~~~~~~~~d~~g~~~~~~G~~~DITerk~~E~~L~~ 134 (142)
T 3mr0_A 79 RDTYDVEYRVRTRSGDFRWIQSRGQALWNSAGEPYRMVGWIMDVTDRKRDEDALRV 134 (142)
T ss_dssp CCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHHHHHHHHH
T ss_pred CCceEEEEEEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEcCchHHHHHHHHHH
Confidence 88999999999999999999999999999999999999999999999999999874
|
| >3f1p_B ARYL hydrocarbon receptor nuclear translocator; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.0 PDB: 3f1o_B* 3f1n_B 3h7w_B* 3h82_B* 1x0o_A 2hv1_A 4h6j_B 2b02_A* 2k7s_A 2a24_B | Back alignment and structure |
|---|
Probab=99.67 E-value=1.8e-16 Score=147.62 Aligned_cols=115 Identities=12% Similarity=0.166 Sum_probs=101.0
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHh-cCCcEEEEEEE
Q 002342 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAID-NQTDVTVQLIN 552 (934)
Q Consensus 474 l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~-~~~~~~~e~~~ 552 (934)
+..+++++++.|+++|.+|+ |+|+|+++++++||+++|++|+++..++||++.....+.+...+. .+..+..|+++
T Consensus 4 ~~ll~e~~~d~i~~~d~~g~---i~~~n~~~~~~~G~~~~el~g~~~~~~i~p~d~~~~~~~~~~~~~~~~~~~~~e~r~ 80 (121)
T 3f1p_B 4 KGLNVCQPTRFISRHNIEGI---FTFVDHRCVATVGYQPQELLGKNIVEFCHPEDQQLLRDSFQQVVKLKGQVLSVMFRF 80 (121)
T ss_dssp ----CCCCCEEEEEECTTSB---EEEECTTHHHHHSCCGGGTTTSBGGGGBCTTTHHHHHHHHHHHTTSTTCCEEEEEEE
T ss_pred ccceecCCCceEEEECCCce---EEEECcchhhhhCCChHHHcCCCHHHeECHHHHHHHHHHHHHHHhcCCCcccEEEEE
Confidence 45678999999999999888 999999999999999999999999999999998888888877774 45578999999
Q ss_pred EecCCcEEEEEEEEEeeecC-CCCEEEEEEEEEcCCcccc
Q 002342 553 YTKSGKKFWNLFHLQPMRDQ-KGEVQYFIGVQLDGSEHLE 591 (934)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~de-~G~v~~~vgi~rDITerk~ 591 (934)
+++||+.+|+.++..|++|. .|.+.+++|+.+|||++|+
T Consensus 81 ~~~dG~~~w~~~~~~~~~~~~~g~~~~iv~~~~DIT~~kq 120 (121)
T 3f1p_B 81 RSKNQEWLWMRTSSFTFQNPYSDEIEYIICTNTNVKNSSQ 120 (121)
T ss_dssp ECTTSCEEEEEEEEEEECCTTCCCCCEEEEEEEECCCC--
T ss_pred EecCCCEEEEEEEEEEEECCCCCceeEEEEEeEEcccccC
Confidence 99999999999999999987 7889999999999999987
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.4e-16 Score=167.06 Aligned_cols=132 Identities=32% Similarity=0.547 Sum_probs=107.3
Q ss_pred CchhhHHHHHhhhhc-ccHHHHHHhccccEEEEcC---CCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHH
Q 002342 457 DSVDDKVRQKEMRKG-IDLATTLERIEKNFVITDP---RLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPAT 532 (934)
Q Consensus 457 dv~~r~~~e~~l~~~-~~l~~i~e~~~d~i~v~D~---~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~ 532 (934)
.+..+...+++++.. ..|+.++++++++|+++|. +|+ |++||++|++++||+.+|++|+++..+.++++....
T Consensus 47 ~~~~~~~~~~~l~~~~~~~~~i~~~~~~~i~~~d~~~~~g~---i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~~~~~~ 123 (258)
T 3p7n_A 47 GAPGADDTRVEVQPPAQWVLDLIEASPIASVVSDPRLADNP---LIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWL 123 (258)
T ss_dssp --------------CCHHHHHHHHTCSSEEEEECTTSTTCC---EEEECHHHHHHHCCCGGGTTTSCGGGGCCTTCCHHH
T ss_pred cCCcchhhHHHHHhHHHHHHHHHhcCCccEEEEcCCCCCCc---EEEEhHHHHHHcCCCHHHHCCCChhhccCCCCchhH
Confidence 344445555666555 5699999999999999999 666 999999999999999999999999999999988888
Q ss_pred HHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccc
Q 002342 533 VRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 591 (934)
Q Consensus 533 ~~~i~~~l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~ 591 (934)
...+...+..+..+..+++.+++||..+|+.+++.|++|++|.+.+++++++|||++|+
T Consensus 124 ~~~~~~~l~~~~~~~~e~~~~~~dG~~~~~~~~~~pi~d~~g~~~~~v~~~~DITerk~ 182 (258)
T 3p7n_A 124 TDKIRQGVREHKPVLVEILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQP 182 (258)
T ss_dssp HHHHHHHHHHTCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCSEEEEEEEEEC-----
T ss_pred HHHHHHHHHcCCCeEEEEEEEcCCCCEEEEeeEEEEEEcCCCCEEEEEEEeeecchhhh
Confidence 88889999999999999999999999999999999999999999999999999999965
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} | Back alignment and structure |
|---|
Probab=99.65 E-value=7.8e-16 Score=143.91 Aligned_cols=122 Identities=35% Similarity=0.679 Sum_probs=105.8
Q ss_pred HHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecC
Q 002342 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273 (934)
Q Consensus 194 ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kd 273 (934)
++++++++|+++|..+.+|+|+++|++|++++||+.++++|+++..+.++.........+...+..+..+..+++..+++
T Consensus 2 ~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~g~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 81 (128)
T 3t50_A 2 ASEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAIKSAIAAEKPIDIDIINYKKS 81 (128)
T ss_dssp CCCCCSSCEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEECTT
T ss_pred ccccCcccEEEecCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHhhhcCCccCHHHHHHHHHHHHcCCCceeEEEEEcCC
Confidence 46788999999997443667999999999999999999999998888888888888888889999999999999999999
Q ss_pred CcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhhc
Q 002342 274 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 315 (934)
Q Consensus 274 G~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~~ 315 (934)
|..+|+.+++.|+.+.+|.+.+++++++|||++|+++++.+.
T Consensus 82 g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k~~e~~~~~ 123 (128)
T 3t50_A 82 GEAFWNRLHISPVHNANGRLQHFVSSQLDVTLELVPRGSLEH 123 (128)
T ss_dssp CCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHC-------
T ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEEcchhhhhhhhhhh
Confidence 999999999999999999999999999999999999988663
|
| >3f1p_B ARYL hydrocarbon receptor nuclear translocator; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.0 PDB: 3f1o_B* 3f1n_B 3h7w_B* 3h82_B* 1x0o_A 2hv1_A 4h6j_B 2b02_A* 2k7s_A 2a24_B | Back alignment and structure |
|---|
Probab=99.65 E-value=2.3e-16 Score=146.96 Aligned_cols=116 Identities=9% Similarity=0.109 Sum_probs=99.8
Q ss_pred HHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHh-cCCcEEEEEE
Q 002342 190 IVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ-NGQSYCGRLL 268 (934)
Q Consensus 190 ~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~-~g~~~~~e~~ 268 (934)
.+..+++++++.|+++|. +|+|+|+|+++++++||+++|++|+++..+++|++.......+...+. .+..+..+++
T Consensus 3 ~~~ll~e~~~d~i~~~d~---~g~i~~~n~~~~~~~G~~~~el~g~~~~~~i~p~d~~~~~~~~~~~~~~~~~~~~~e~r 79 (121)
T 3f1p_B 3 FKGLNVCQPTRFISRHNI---EGIFTFVDHRCVATVGYQPQELLGKNIVEFCHPEDQQLLRDSFQQVVKLKGQVLSVMFR 79 (121)
T ss_dssp -----CCCCCEEEEEECT---TSBEEEECTTHHHHHSCCGGGTTTSBGGGGBCTTTHHHHHHHHHHHTTSTTCCEEEEEE
T ss_pred cccceecCCCceEEEECC---CceEEEECcchhhhhCCChHHHcCCCHHHeECHHHHHHHHHHHHHHHhcCCCcccEEEE
Confidence 345688999999999998 778999999999999999999999999888999988877788877774 4557889999
Q ss_pred EEecCCcEEEEEEEeeeeecC-CCCEEEEEEEEecchhhHH
Q 002342 269 NYKKDGTPFWNLLTIAPIKDD-EGKVLKFIGMQVEVSKHTE 308 (934)
Q Consensus 269 ~~~kdG~~~wv~~s~~pi~d~-~G~v~~~v~~~~DITerk~ 308 (934)
.+++||+.+|++++..|++|. +|.+.+++++.+|||++|+
T Consensus 80 ~~~~dG~~~w~~~~~~~~~~~~~g~~~~iv~~~~DIT~~kq 120 (121)
T 3f1p_B 80 FRSKNQEWLWMRTSSFTFQNPYSDEIEYIICTNTNVKNSSQ 120 (121)
T ss_dssp EECTTSCEEEEEEEEEEECCTTCCCCCEEEEEEEECCCC--
T ss_pred EEecCCCEEEEEEEEEEEECCCCCceeEEEEEeEEcccccC
Confidence 999999999999999999987 7888999999999999886
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=6.6e-16 Score=151.45 Aligned_cols=129 Identities=47% Similarity=0.796 Sum_probs=112.3
Q ss_pred hHHHHHhhhhc-ccHHHHHHhccccEEEEcC---CCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHH
Q 002342 461 DKVRQKEMRKG-IDLATTLERIEKNFVITDP---RLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKI 536 (934)
Q Consensus 461 r~~~e~~l~~~-~~l~~i~e~~~d~i~v~D~---~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i 536 (934)
+...+++++.. ..|+.++++++++|+++|. +|. |+++|++|++++||+.++++|+++..+.+++........+
T Consensus 23 ~~~~~~~l~~~~~~~~~~~~~~~~~i~~~d~~~~~g~---i~~~N~~~~~l~G~~~~e~~g~~~~~l~~~~~~~~~~~~~ 99 (166)
T 3ue6_A 23 PSKANRILEDPDYSLVKALQMAQQNFVITDASLPDNP---IVYASRGFLTLTGYSLDQILGRNCRFLQGPETDPRAVDKI 99 (166)
T ss_dssp --------CCCCCHHHHHHHHTTSCEEEEETTSTTCC---EEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHH
T ss_pred hhHHHHHHHHHHHHHHHHHhcCCceEEEEEccCCCCc---EEEECHHHHHHhCcCHHHHcCCCHhheeCCCCCHHHHHHH
Confidence 34445555544 5699999999999999999 688 9999999999999999999999998888888888888888
Q ss_pred HHHHhcCCcEEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccc
Q 002342 537 RAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 592 (934)
Q Consensus 537 ~~~l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~ 592 (934)
...+..+..+..++...+++|..+|+.+++.|+++++|.+.+++++++|||++|++
T Consensus 100 ~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k~~ 155 (166)
T 3ue6_A 100 RNAITKGVDTSVCLLNYRQDGTTFWNLFFVAGLRDSKGNIVNYVGVQSKVSEDYAK 155 (166)
T ss_dssp HHHHHHTCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEECCBCCHHHHH
T ss_pred HHHHhcCCceEEEEEEEcCCCCEEEEEEEEEeeeCCCCCEEEEEEEEEechHHHHH
Confidence 88888999999999999999999999999999999999999999999999999984
|
| >3f1p_A Endothelial PAS domain-containing protein 1; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.7 PDB: 3f1o_A* 3f1n_A 3h7w_A* 3h82_A* 1p97_A 2a24_A 4h6j_A | Back alignment and structure |
|---|
Probab=99.64 E-value=5.4e-16 Score=143.35 Aligned_cols=109 Identities=17% Similarity=0.125 Sum_probs=101.5
Q ss_pred hccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcE
Q 002342 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKK 559 (934)
Q Consensus 480 ~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~ 559 (934)
++++.|+++|.+|+ |+|+|+++++++||+++|++|+++..++||++.....+.+...+..+..+..|++++++||+.
T Consensus 7 ~~~~~i~~~d~~g~---i~~~n~~~~~~~Gy~~~el~g~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~ 83 (117)
T 3f1p_A 7 DSKTFLSEHSMDMK---FTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGY 83 (117)
T ss_dssp GGGEEEEEECTTCB---EEEECTHHHHHHCCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHHHHSEEECCCEEEECTTSSE
T ss_pred CCccEEEEECCCce---EEEECcChhhhhCCCHHHHcCCchhheECHHHHHHHHHHHHHHHhCCCeeeeEEEEEecCCCE
Confidence 35789999999888 999999999999999999999999999999998888888888888888888899999999999
Q ss_pred EEEEEEEEeeecC-CCCEEEEEEEEEcCCcccc
Q 002342 560 FWNLFHLQPMRDQ-KGEVQYFIGVQLDGSEHLE 591 (934)
Q Consensus 560 ~wv~~~~~pi~de-~G~v~~~vgi~rDITerk~ 591 (934)
+|+.++..|++|+ +|.+.+++|+.+|||++|+
T Consensus 84 ~w~~~~~~~~~d~~~g~~~~iv~~~~DITer~~ 116 (117)
T 3f1p_A 84 VWLETQGTVIYNPRNLQPQCIMCVNYVLSEIEK 116 (117)
T ss_dssp EEEEEEEEEEEETTTTEEEEEEEEEEECSCCBC
T ss_pred EEEEEeeEEEECCCCCCceEEEEEeeecccccc
Confidence 9999999999998 8899999999999999987
|
| >3mr0_A Sensory box histidine kinase/response regulator; PAS fold, structural genomics, PSI-2; HET: PG5; 1.49A {Burkholderia thailandensis} | Back alignment and structure |
|---|
Probab=99.64 E-value=2.5e-15 Score=144.69 Aligned_cols=120 Identities=15% Similarity=0.217 Sum_probs=108.4
Q ss_pred cccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCC--CCcccCCCCCCHHHHHHHHHHHhcCCcEEE
Q 002342 471 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGR--NCRFLQGPETDPATVRKIRAAIDNQTDVTV 548 (934)
Q Consensus 471 ~~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~--~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~ 548 (934)
+..|+.+++.+++++|.+|..+. ++++|+++++++||+.+++.+. .+..++||++...+...+...+..+..+..
T Consensus 8 e~rl~~~~~~~~~g~w~~d~~~~---~~~~s~~~~~~~G~~~~~~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~~ 84 (142)
T 3mr0_A 8 EERFQLAVSGASAGLWDWNPKTG---AMYLSPHFKKIMGYEDHELPDEITGHRESIHPDDRARVLAALKAHLEHRDTYDV 84 (142)
T ss_dssp -CCHHHHHHHTTCEEEEECTTTC---CEEECHHHHHHTTCCGGGSCSEEC---CCBCTTTHHHHHHHHHHHHHHCCCEEE
T ss_pred HHHHHHHHHhCCcEEEEEEcCCC---eEEECHHHHHHhCCCccccCCCHHHHHhhcCHHHHHHHHHHHHHHHhCCCceEE
Confidence 36699999999999999999888 9999999999999999998873 466788999998888888888988889999
Q ss_pred EEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccccc
Q 002342 549 QLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 593 (934)
Q Consensus 549 e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e 593 (934)
|+++.+++|..+|+.....|++|.+|.+.+++|+++|||++|++|
T Consensus 85 e~r~~~~~G~~~w~~~~~~~~~d~~g~~~~~~G~~~DITerk~~E 129 (142)
T 3mr0_A 85 EYRVRTRSGDFRWIQSRGQALWNSAGEPYRMVGWIMDVTDRKRDE 129 (142)
T ss_dssp EEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHHHH
T ss_pred EEEEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEcCchHHHHH
Confidence 999999999999999999999999999999999999999999953
|
| >1d06_A Nitrogen fixation regulatory protein FIXL; oxygen sensor, histidine kinase, PAS, high-resolution, two-C system, signaling protein; HET: HEM; 1.40A {Sinorhizobium meliloti} SCOP: d.110.3.2 PDB: 1ew0_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=3.8e-16 Score=147.70 Aligned_cols=125 Identities=22% Similarity=0.264 Sum_probs=101.4
Q ss_pred cccccccccccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHH
Q 002342 175 SDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIR 254 (934)
Q Consensus 175 t~~~~~e~aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~ 254 (934)
|+++++|++|+++++.|+.++++++++|+++|. +|+|+++|++|++++||+.+|++|+++..+.++.........+.
T Consensus 2 ~~~~~~e~~l~~~~~~~~~l~~~~~d~i~~~d~---~g~i~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~ 78 (130)
T 1d06_A 2 SHMLETEDVVRARDAHLRSILDTVPDATVVSAT---DGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQ 78 (130)
T ss_dssp CHHHHHHHHHHHHTSCHHHHHTTCSSEEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHHHHHhhCcCeEEEECC---CCeEEEEcHHHHHHHCCCHHHHcCCcHHHHCCchhHHHHHHHHH
Confidence 456788899999999999999999999999998 77799999999999999999999999887776655444344444
Q ss_pred HHHhcCCc----EEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecch
Q 002342 255 ETLQNGQS----YCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (934)
Q Consensus 255 ~~l~~g~~----~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DIT 304 (934)
.....+.. ...++..++|||+.+|+++++.|+.+. ...+++++++|||
T Consensus 79 ~~~~~~~~~~~~~~~e~~~~~kdG~~~~~~~~~~~~~~~--~~~~~~~~~~DIT 130 (130)
T 1d06_A 79 RYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSG--GERFFTGFIRDLT 130 (130)
T ss_dssp HHHHHCCCSSTTSCEEEEEECTTSCEEEEEEEEEEEEET--TEEEEEEEEEECC
T ss_pred HHHhcCCccccCCeeEEEEEeCCCCEEEEEEEEEEEEEC--CeEEEEEEEEECc
Confidence 44444332 234667789999999999999999763 4456899999997
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=5e-16 Score=173.49 Aligned_cols=140 Identities=14% Similarity=0.126 Sum_probs=102.2
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeeccccc------------C--h-HH--H--HHHHHHHHHHHhCCCCC
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML------------N--R-NK--V--HRACAEREILDMLDHPF 730 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~------------~--~-~~--~--~~~~~E~~il~~l~hp~ 730 (934)
-|.+.++||.|+||.||+|.+ .+|+.||||+++..... . . .. . -....|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 399999999999999999998 56999999998643110 0 0 00 0 01235777788775554
Q ss_pred ccceeEEEEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC--
Q 002342 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-- 808 (934)
Q Consensus 731 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-- 808 (934)
+....-+... ..+|||||++|++|..+... .....++.||+.+|.|||++|||||||||.|||++.+|
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 4322222222 23799999999998766432 23456789999999999999999999999999998776
Q ss_pred --------cEEEEecccCcc
Q 002342 809 --------HVSLTDFDLSCL 820 (934)
Q Consensus 809 --------~vkl~DFG~a~~ 820 (934)
.+.|+||+-+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 389999997754
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} | Back alignment and structure |
|---|
Probab=99.62 E-value=4.7e-15 Score=144.84 Aligned_cols=132 Identities=31% Similarity=0.552 Sum_probs=119.4
Q ss_pred cchHHHHHHHHHhccCcEEEEeCCCCCC---ceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCC
Q 002342 185 PRVSDIVKDALSTFQQTFVVSDATKPDY---PIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ 261 (934)
Q Consensus 185 ~~~~~~~~~ile~~~d~i~v~D~~~~dG---~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~ 261 (934)
..+++.++.++++++++++++|. +| +|+++|++|++++||+.++++|+++..+.++.........+...+..+.
T Consensus 21 ~~~~~~~~~i~~~~~~~i~~~d~---~~~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (162)
T 3sw1_A 21 MINAQLLQSMVDASNDGIVVAEK---EGDDTILIYVNAAFEYLTGYSRDEILYQDCRFLQGDDRDQLGRARIRKAMAEGR 97 (162)
T ss_dssp CCCHHHHHHHHHTCSSEEEEEEE---ETTEEEEEEECHHHHHHHTCCHHHHTTSBGGGGTTTCCCCHHHHHHHHHHHHTC
T ss_pred cchHHHHHHHHhhccCcEEEEeC---CCCccEEEEECHHHHHHHCCCHHHHcCCCcceecCCCcCHHHHHHHHHHHhcCC
Confidence 35568899999999999999998 66 7999999999999999999999999888888777778888888899999
Q ss_pred cEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhhcCCCC
Q 002342 262 SYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNG 319 (934)
Q Consensus 262 ~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~~~~~~ 319 (934)
.+..++...+++|..+|+.+++.|+.+.+|.+.+++++++|||++++++++|+.....
T Consensus 98 ~~~~~~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DiTe~k~~e~~l~~~~~~ 155 (162)
T 3sw1_A 98 PCREVLRNYRKDGSAFWNELSITPVKSDFDQRTYFIGIQKDVSRQVELERELAELRAR 155 (162)
T ss_dssp CEEEEEEEECTTCCEEEEEEEEEEEECSSSSCEEEEEEEEECHHHHHHHHHHHHHTC-
T ss_pred CCcceEEEECCCCCEEEEEEEEEEeecCCCCEEEEEEEEEeCcHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999999999999998854443
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} | Back alignment and structure |
|---|
Probab=99.62 E-value=2.4e-15 Score=140.56 Aligned_cols=117 Identities=44% Similarity=0.791 Sum_probs=105.0
Q ss_pred HHHhccccEEEEcC---CCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 002342 477 TLERIEKNFVITDP---RLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (934)
Q Consensus 477 i~e~~~d~i~v~D~---~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~ 553 (934)
++++++++|+++|. +|+ |+++|++|++++||+.++++|+++..+.+++........+...+..+..+..+++..
T Consensus 2 ~~~~~~~~i~~~d~~~~~g~---i~~~N~~~~~l~g~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 78 (128)
T 3t50_A 2 ASEFTLMPMLITNPHLPDNP---IVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAIKSAIAAEKPIDIDIINY 78 (128)
T ss_dssp CCCCCSSCEEEECTTSTTCC---EEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEE
T ss_pred ccccCcccEEEecCCCCCCc---EEEEcHHHHHHhCcCHHHHcCCCHhhhcCCccCHHHHHHHHHHHHcCCCceeEEEEE
Confidence 46788999999999 667 999999999999999999999999888888888888888888899999999999999
Q ss_pred ecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccccccC
Q 002342 554 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNS 596 (934)
Q Consensus 554 ~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e~~~ 596 (934)
+++|..+|+.+++.|+.+.+|.+.+++++++|||++|+++...
T Consensus 79 ~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k~~e~~~ 121 (128)
T 3t50_A 79 KKSGEAFWNRLHISPVHNANGRLQHFVSSQLDVTLELVPRGSL 121 (128)
T ss_dssp CTTCCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHC-----
T ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEEcchhhhhhhhh
Confidence 9999999999999999999999999999999999999965443
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} | Back alignment and structure |
|---|
Probab=99.62 E-value=4.9e-15 Score=137.64 Aligned_cols=114 Identities=16% Similarity=0.196 Sum_probs=93.3
Q ss_pred ccccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCC
Q 002342 182 KGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ 261 (934)
Q Consensus 182 ~aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~ 261 (934)
+.|+++++.|+.++++++++|+++|. +|+|+++|++|++++||+.+|++|+++..+.++.... ........+..+.
T Consensus 4 ~~l~~se~~~~~l~e~~~d~i~~~d~---~g~i~~vN~a~~~l~Gy~~~el~g~~~~~~~~~~~~~-~~~~~~~~~~~~~ 79 (117)
T 2r78_A 4 ENLYFQSNAYRALFEHAIDGIFIMDA---EGHYLDVNPAICSAIGYTRDEFLALDWGVLSRGVDSG-WAAASLARIVGGE 79 (117)
T ss_dssp CSHHHHHHHHHHHHHHCSSEEEEECT---TSBEEEECHHHHHHHCCCHHHHTTCBTTTTTTCSTTS-HHHHHHHHHHTTC
T ss_pred hHHHHhHHHHHHHHhcCCceEEEECC---CCCEEEecHHHHHHHCcCHHHHcCCCHHHhCCccchh-HHHHHHHHHHcCC
Confidence 45788999999999999999999998 7779999999999999999999999877665443322 2334455666777
Q ss_pred cEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecch
Q 002342 262 SYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (934)
Q Consensus 262 ~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DIT 304 (934)
.+..+.+.++|||+.+|+++++.|+. +|. ++++++|||
T Consensus 80 ~~~~e~~~~~kdG~~~~v~~~~~~~~--~g~---~~~i~~DIT 117 (117)
T 2r78_A 80 PLREERTVWTRNGDQLTVELSAHLLP--DGK---ILGIARDVS 117 (117)
T ss_dssp CEEEEEEEECTTSCEEEEEEEEEECT--TSC---EEEEEEC--
T ss_pred cEEEEEEEEecCCCEEEEEEEEEEec--CCe---EEEEEEeCC
Confidence 78889999999999999999999985 565 678999997
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.1e-14 Score=132.40 Aligned_cols=111 Identities=82% Similarity=1.236 Sum_probs=102.0
Q ss_pred HHHhccccEEEEcC---CCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 002342 477 TLERIEKNFVITDP---RLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (934)
Q Consensus 477 i~e~~~d~i~v~D~---~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~ 553 (934)
.+++++++|+++|. +|+ |+++|+++++++||+.++++|+++..+.+++........+...+..+..+..+.+..
T Consensus 2 ~l~~~~~~i~~~d~~~~~g~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (115)
T 4eet_B 2 SPEFIEKNFVITDPRLPDNP---IIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKIRDAIRDQRETTVQLINY 78 (115)
T ss_dssp ---CCCCSEEEECTTSTTCC---EEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEE
T ss_pred ccccCCCcEEEEcCCCCCCc---EEEEcHHHHHHHCcCHHHHhCCCHHHhcCCCCChHHHHHHHHHHHcCCCcceEEEEe
Confidence 46789999999999 888 999999999999999999999998888888888888888888899999999999999
Q ss_pred ecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccc
Q 002342 554 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL 590 (934)
Q Consensus 554 ~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk 590 (934)
+++|..+|+.+++.|+++.+|.+.+++++++|||+++
T Consensus 79 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DITer~ 115 (115)
T 4eet_B 79 TKSGKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDHV 115 (115)
T ss_dssp CTTCCEEEEEEEEEEEECTTSCEEEEEEEEEECSCCC
T ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeecccC
Confidence 9999999999999999999999999999999999985
|
| >1d06_A Nitrogen fixation regulatory protein FIXL; oxygen sensor, histidine kinase, PAS, high-resolution, two-C system, signaling protein; HET: HEM; 1.40A {Sinorhizobium meliloti} SCOP: d.110.3.2 PDB: 1ew0_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=4.2e-15 Score=140.45 Aligned_cols=124 Identities=16% Similarity=0.202 Sum_probs=100.8
Q ss_pred hhhHHHHHhhhhc-ccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHH
Q 002342 459 VDDKVRQKEMRKG-IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 537 (934)
Q Consensus 459 ~~r~~~e~~l~~~-~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~ 537 (934)
|++++.|++++.. ..|+.++++++++|+++|.+|. |+++|+++++++||+.+|++|+++..+++++........+.
T Consensus 2 ~~~~~~e~~l~~~~~~~~~l~~~~~d~i~~~d~~g~---i~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~ 78 (130)
T 1d06_A 2 SHMLETEDVVRARDAHLRSILDTVPDATVVSATDGT---IVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQ 78 (130)
T ss_dssp CHHHHHHHHHHHHTSCHHHHHTTCSSEEEEEETTSB---EEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHHHHHhhCcCeEEEECCCCe---EEEEcHHHHHHHCCCHHHHcCCcHHHHCCchhHHHHHHHHH
Confidence 5678888888766 6799999999999999999888 99999999999999999999999888887765544444444
Q ss_pred HHHhcCCc----EEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCC
Q 002342 538 AAIDNQTD----VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587 (934)
Q Consensus 538 ~~l~~~~~----~~~e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDIT 587 (934)
.....+.. ...++..+++||+.+|+.+++.|+.+. ...+++++++|||
T Consensus 79 ~~~~~~~~~~~~~~~e~~~~~kdG~~~~~~~~~~~~~~~--~~~~~~~~~~DIT 130 (130)
T 1d06_A 79 RYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSG--GERFFTGFIRDLT 130 (130)
T ss_dssp HHHHHCCCSSTTSCEEEEEECTTSCEEEEEEEEEEEEET--TEEEEEEEEEECC
T ss_pred HHHhcCCccccCCeeEEEEEeCCCCEEEEEEEEEEEEEC--CeEEEEEEEEECc
Confidence 44433332 245778899999999999999999764 3356899999998
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=7.8e-15 Score=133.34 Aligned_cols=114 Identities=41% Similarity=0.829 Sum_probs=101.7
Q ss_pred HHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecC
Q 002342 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273 (934)
Q Consensus 194 ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kd 273 (934)
++++++++++++|....+|+|+++|++|++++||+.++++|+++..+.++.........+...+..+..+..+++.++++
T Consensus 2 ~l~~~~~~i~~~d~~~~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (115)
T 4eet_B 2 SPEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKIRDAIRDQRETTVQLINYTKS 81 (115)
T ss_dssp ---CCCCSEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEECTT
T ss_pred ccccCCCcEEEEcCCCCCCcEEEEcHHHHHHHCcCHHHHhCCCHHHhcCCCCChHHHHHHHHHHHcCCCcceEEEEecCC
Confidence 57889999999998333566999999999999999999999998888888888888888889999999999999999999
Q ss_pred CcEEEEEEEeeeeecCCCCEEEEEEEEecchhhH
Q 002342 274 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHT 307 (934)
Q Consensus 274 G~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk 307 (934)
|+.+|+.+++.|+.+.+|.+.+++++++|||+++
T Consensus 82 g~~~~~~~~~~~~~~~~g~~~~~~~~~~DITer~ 115 (115)
T 4eet_B 82 GKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDHV 115 (115)
T ss_dssp CCEEEEEEEEEEEECTTSCEEEEEEEEEECSCCC
T ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEeecccC
Confidence 9999999999999999999999999999999874
|
| >3nja_A Probable ggdef family protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; 2.37A {Chromobacterium violaceum} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.1e-15 Score=139.31 Aligned_cols=123 Identities=11% Similarity=0.015 Sum_probs=94.7
Q ss_pred cccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcC--CCCCCCCCCCCChHHHHHHHHHHhcC
Q 002342 183 GLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVG--RNCRFLQGAGTDPEDVAKIRETLQNG 260 (934)
Q Consensus 183 aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG--~~~~~l~~~~~~~~~~~~i~~~l~~g 260 (934)
+|+++++.|+.++++++++++++|. +|.++++|+++++++||+.++++| ..+..+.+|++.......+...+..+
T Consensus 1 al~~~~~~l~~~~~~~~~~i~~~d~---~~~~~~~n~~~~~~~G~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 77 (125)
T 3nja_A 1 SNAMAEKLLHTAESDAGIGSWVLHM---ESGRLEWSQAVHDIFGTDSATFDATEDAYFQRVHPDDRARVRRELDRHVLGD 77 (125)
T ss_dssp ----------------CCEEEEEET---TTTEEEECHHHHHHHTCCTTTCCCBHHHHHHHBCTTTHHHHHHHHHHHHHSC
T ss_pred CcHHHHHHHHHHHHhCCeeEEEEEc---CCCcEEECHHHHHHhCCCcccccccHHHHHhhcChhHHHHHHHHHHHHHhcC
Confidence 3677888999999999999999998 666999999999999999999999 44445677888777788888888988
Q ss_pred CcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHH
Q 002342 261 QSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308 (934)
Q Consensus 261 ~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~ 308 (934)
..+..+++..+++|..+|+.++..|+.+.+|.+.+++++++|||++|+
T Consensus 78 ~~~~~e~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~g~~~DITe~k~ 125 (125)
T 3nja_A 78 RPFDVEYRIVRPDGQVRELLERNHIQRQASGQVDHLWGTVIDMTEHKQ 125 (125)
T ss_dssp CCEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCC---
T ss_pred CCceEEEEEECCCCCEEEEEEeeEEEECCCCCEEEEEEEEEecccccC
Confidence 889999999999999999999999999999999999999999999875
|
| >3f1p_A Endothelial PAS domain-containing protein 1; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.7 PDB: 3f1o_A* 3f1n_A 3h7w_A* 3h82_A* 1p97_A 2a24_A 4h6j_A | Back alignment and structure |
|---|
Probab=99.60 E-value=9.5e-16 Score=141.65 Aligned_cols=108 Identities=15% Similarity=0.156 Sum_probs=98.6
Q ss_pred ccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 002342 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 277 (934)
Q Consensus 198 ~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 277 (934)
.++.|+++|. +|+|+|+|+++++++||+++|++|+++..+.+|++.......+...+..+..+..+++.+++||+.+
T Consensus 8 ~~~~i~~~d~---~g~i~~~n~~~~~~~Gy~~~el~g~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~~ 84 (117)
T 3f1p_A 8 SKTFLSEHSM---DMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYV 84 (117)
T ss_dssp GGEEEEEECT---TCBEEEECTHHHHHHCCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHHHHSEEECCCEEEECTTSSEE
T ss_pred CccEEEEECC---CceEEEECcChhhhhCCCHHHHcCCchhheECHHHHHHHHHHHHHHHhCCCeeeeEEEEEecCCCEE
Confidence 4577888888 7889999999999999999999999998889998888888888888888888888999999999999
Q ss_pred EEEEEeeeeecC-CCCEEEEEEEEecchhhHH
Q 002342 278 WNLLTIAPIKDD-EGKVLKFIGMQVEVSKHTE 308 (934)
Q Consensus 278 wv~~s~~pi~d~-~G~v~~~v~~~~DITerk~ 308 (934)
|++++..|++|+ +|.+.+++++.+|||++|+
T Consensus 85 w~~~~~~~~~d~~~g~~~~iv~~~~DITer~~ 116 (117)
T 3f1p_A 85 WLETQGTVIYNPRNLQPQCIMCVNYVLSEIEK 116 (117)
T ss_dssp EEEEEEEEEEETTTTEEEEEEEEEEECSCCBC
T ss_pred EEEEeeEEEECCCCCCceEEEEEeeecccccc
Confidence 999999999998 7889999999999999875
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.6e-15 Score=140.95 Aligned_cols=115 Identities=15% Similarity=0.141 Sum_probs=93.5
Q ss_pred HHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCC-hHHHHHHHHHHhcCCcEEEEEE
Q 002342 190 IVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTD-PEDVAKIRETLQNGQSYCGRLL 268 (934)
Q Consensus 190 ~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~-~~~~~~i~~~l~~g~~~~~e~~ 268 (934)
.|+.+|++++++|+ +|. +|+|+++|++|++++||+++|++|+++..+++++.. ......+...+..+..+..+++
T Consensus 4 ~~~~~~~~~~~~i~-~~~---~g~i~~~N~a~~~l~G~~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 79 (120)
T 3mqq_A 4 DYKTAFHLAPIGLV-LSR---DRVIEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDRI 79 (120)
T ss_dssp CHHHHHHHCSSEEE-EEE---TTEEEEECHHHHHHTTSCHHHHTTCBGGGGSSSHHHHHHHHHHHHHHHHHHSCEEEEEE
T ss_pred hHHHHHhcCCceEE-Eec---CCEEHHHHHHHHHHhCcCHHHhCCCchhhccCChhhHHHHHHHHHHHHhcCCcceEEEE
Confidence 47899999999996 465 788999999999999999999999998876655332 3444556667777788899999
Q ss_pred EEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHH
Q 002342 269 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEG 309 (934)
Q Consensus 269 ~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~ 309 (934)
.+++||+.+|+.++..|+ +.+|...+++++++|||++|++
T Consensus 80 ~~~~dG~~~~~~~~~~~~-~~~~~~~~~v~~~~DITerk~~ 119 (120)
T 3mqq_A 80 MKRAGGELFWCHVTGRAL-DRTAPLAAGVWTFEDLSATRRV 119 (120)
T ss_dssp EECTTSCEEEEEEEEEES-STTSTTSSEEEEEEESCC----
T ss_pred EEeCCCCEEEEEEEEEEC-CCCCCceeEEEEEEcccHhhcc
Confidence 999999999999999998 5666677899999999999975
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A | Back alignment and structure |
|---|
Probab=99.59 E-value=2.1e-15 Score=140.09 Aligned_cols=116 Identities=16% Similarity=0.170 Sum_probs=94.4
Q ss_pred ccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCC-HHHHHHHHHHHhcCCcEEEEE
Q 002342 472 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD-PATVRKIRAAIDNQTDVTVQL 550 (934)
Q Consensus 472 ~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~-~~~~~~i~~~l~~~~~~~~e~ 550 (934)
.+|+.+|++++++|++ |.+|+ |+++|++|++++||+++|++|+++..+.+++.. ......+...+..+..+..|+
T Consensus 3 ~~~~~~~~~~~~~i~~-~~~g~---i~~~N~a~~~l~G~~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 78 (120)
T 3mqq_A 3 IDYKTAFHLAPIGLVL-SRDRV---IEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDR 78 (120)
T ss_dssp CCHHHHHHHCSSEEEE-EETTE---EEEECHHHHHHTTSCHHHHTTCBGGGGSSSHHHHHHHHHHHHHHHHHHSCEEEEE
T ss_pred chHHHHHhcCCceEEE-ecCCE---EHHHHHHHHHHhCcCHHHhCCCchhhccCChhhHHHHHHHHHHHHhcCCcceEEE
Confidence 3589999999999965 66777 999999999999999999999998877765432 334555666677778889999
Q ss_pred EEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccc
Q 002342 551 INYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 592 (934)
Q Consensus 551 ~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~ 592 (934)
++.++||+.+|+.++..|+ +.+|...+++++++|||++|+.
T Consensus 79 ~~~~~dG~~~~~~~~~~~~-~~~~~~~~~v~~~~DITerk~~ 119 (120)
T 3mqq_A 79 IMKRAGGELFWCHVTGRAL-DRTAPLAAGVWTFEDLSATRRV 119 (120)
T ss_dssp EEECTTSCEEEEEEEEEES-STTSTTSSEEEEEEESCC----
T ss_pred EEEeCCCCEEEEEEEEEEC-CCCCCceeEEEEEEcccHhhcc
Confidence 9999999999999999999 5566667889999999999983
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.7e-14 Score=132.61 Aligned_cols=127 Identities=75% Similarity=1.225 Sum_probs=107.3
Q ss_pred chHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEE
Q 002342 186 RVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG 265 (934)
Q Consensus 186 ~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 265 (934)
+.++.++.++++++++++++|..+.+|.|+++|+++++++||+.++++|+++..+.++.........+...+..+..+..
T Consensus 3 ~~~~~~~~~~~~~~~~i~~~d~~d~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (130)
T 2z6d_A 3 RVSQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGPDTDKNEVAKIRDCVKNGKSYCG 82 (130)
T ss_dssp ----CHHHHHHHTTCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEE
T ss_pred hHHHHHHHHHHhcccceeeeeccCCCCcEEEecHHHHHHhCcCHHHHcCCChhhccCCCCCchHHHHHHHHHHcCCccee
Confidence 44567899999999999999932227789999999999999999999999988888887777777888888888888888
Q ss_pred EEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHH
Q 002342 266 RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKD 312 (934)
Q Consensus 266 e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~ 312 (934)
++...+++|..+|+.+++.|+.+.+|.+.+++++++|||++++++++
T Consensus 83 ~~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~~e~e 129 (130)
T 2z6d_A 83 RLLNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEVSKYTEGVND 129 (130)
T ss_dssp EEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCTTC-----
T ss_pred EEEEEcCCCcEEEEEEEEEEEECCCCCeeEEEEEEecchHHHHhhcc
Confidence 88889999999999999999999999999999999999999988764
|
| >2vv6_A FIXL, sensor protein FIXL; signaling protein, transferase, phosphoprotein, nitrogen FIX PER-ARNT-SIM, metal-binding, PAS, iron, heme; HET: HEM; 1.5A {Bradyrhizobium japonicum} PDB: 1xj6_A* 1xj4_A* 2vv7_A* 2vv8_A* 1lsw_A* 1dp8_A* 1dp9_A* 1drm_A* 1lsv_A* 1dp6_A* 1lsx_A* 1lt0_A* 1y28_A* 2cmn_A* 1xj3_A* 1xj2_A* 2owh_A* 2owj_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=5.8e-15 Score=137.04 Aligned_cols=113 Identities=18% Similarity=0.232 Sum_probs=80.0
Q ss_pred hccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCc----EEEEEEEEec
Q 002342 197 TFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS----YCGRLLNYKK 272 (934)
Q Consensus 197 ~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~~~~k 272 (934)
+++++|+++|. +|+|+++|++|++++||+++|++|+++..+.++.........+......+.. ...++..+++
T Consensus 1 ~~~d~i~~~d~---~g~i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (119)
T 2vv6_A 1 TIPDAMIVIDG---HGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRR 77 (119)
T ss_dssp -CCCEEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECT
T ss_pred CCcceEEEECC---CCeEEEEhHHHHHHhCCCHHHHcCCCHHHhCCchHHHHHHHHHHHHhcCCCcccCCCceEEEEEeC
Confidence 36889999998 7779999999999999999999999988777665443333344444444332 2346677899
Q ss_pred CCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhh
Q 002342 273 DGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (934)
Q Consensus 273 dG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~ 314 (934)
||+.+|++++++|+.+. ...+++++++|||++|++|++|+
T Consensus 78 dG~~~~~~~~~~~~~~~--~~~~~~~~~~DITerk~~e~~l~ 117 (119)
T 2vv6_A 78 DGTTFPMHLSIGEMQSG--GEPYFTGFVRDLTEHQQTQARLQ 117 (119)
T ss_dssp TSCEEEEEEEEEEEEET--TEEEEEEEEEECC----------
T ss_pred CCCEEEEEEEEEEEEEC--CeEEEEEEEEEcHHHHHHHHHHH
Confidence 99999999999999764 34578999999999999999876
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.8e-14 Score=131.51 Aligned_cols=121 Identities=17% Similarity=0.293 Sum_probs=107.8
Q ss_pred chHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEE
Q 002342 186 RVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG 265 (934)
Q Consensus 186 ~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 265 (934)
++++.++.++++++++++++|. +|+|+++|+++++++|++.++++|+++..+.+++........+...+..+..+..
T Consensus 4 ~~~~~~~~~~~~~~~~i~~~d~---~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (124)
T 3lyx_A 4 DILKQRAKAFDYVFDAIVVTDL---QGFIIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSEVISAVENQGKWTG 80 (124)
T ss_dssp CHHHHHHHGGGTCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTHHHHHHHHHHHHHHTSCEEE
T ss_pred hHHHHHHHHHhhcCceEEEECC---CCcEeehhhHHHHHhCCCHHHHcCCCHHHhcCcchhhHHHHHHHHHHHcCCcccc
Confidence 5668899999999999999998 7779999999999999999999999988777776666667778888888888999
Q ss_pred EEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHH
Q 002342 266 RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEG 309 (934)
Q Consensus 266 e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~ 309 (934)
++...+++|..+|+.+++.|+.+.+|.+.+++++++|||+++++
T Consensus 81 ~~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~l 124 (124)
T 3lyx_A 81 EIRMLHKDGHIGWIESMCVPIYGENYQMVGALGINRDITKRKKE 124 (124)
T ss_dssp EEEEECTTSCEEEEEEEEEEEECSTTCEEEEEEEEEECSCC---
T ss_pred eEEEEccCCCEEEEEEEEEEEECCCCCEEEEEEEEecchhhhcC
Confidence 99999999999999999999999999999999999999998763
|
| >3nja_A Probable ggdef family protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; 2.37A {Chromobacterium violaceum} | Back alignment and structure |
|---|
Probab=99.58 E-value=7.1e-15 Score=135.78 Aligned_cols=117 Identities=13% Similarity=0.021 Sum_probs=96.7
Q ss_pred ccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcC--CCCcccCCCCCCHHHHHHHHHHHhcCCcEEEE
Q 002342 472 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILG--RNCRFLQGPETDPATVRKIRAAIDNQTDVTVQ 549 (934)
Q Consensus 472 ~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG--~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e 549 (934)
..|+.+++.+++++|++|.+|. ++++|+++++++||+.++++| ..+..+++|++.......+...+..+..+..+
T Consensus 7 ~~l~~~~~~~~~~i~~~d~~~~---~~~~n~~~~~~~G~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~e 83 (125)
T 3nja_A 7 KLLHTAESDAGIGSWVLHMESG---RLEWSQAVHDIFGTDSATFDATEDAYFQRVHPDDRARVRRELDRHVLGDRPFDVE 83 (125)
T ss_dssp ----------CCEEEEEETTTT---EEEECHHHHHHHTCCTTTCCCBHHHHHHHBCTTTHHHHHHHHHHHHHSCCCEEEE
T ss_pred HHHHHHHHhCCeeEEEEEcCCC---cEEECHHHHHHhCCCcccccccHHHHHhhcChhHHHHHHHHHHHHHhcCCCceEE
Confidence 4588999999999999999888 999999999999999999999 44566788888888888888888888889999
Q ss_pred EEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccc
Q 002342 550 LINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 591 (934)
Q Consensus 550 ~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~ 591 (934)
+++.+++|..+|+.++..|+++.+|.+.+++|+++|||++|+
T Consensus 84 ~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~g~~~DITe~k~ 125 (125)
T 3nja_A 84 YRIVRPDGQVRELLERNHIQRQASGQVDHLWGTVIDMTEHKQ 125 (125)
T ss_dssp EEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCC---
T ss_pred EEEECCCCCEEEEEEeeEEEECCCCCEEEEEEEEEecccccC
Confidence 999999999999999999999999999999999999999985
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=2.7e-14 Score=134.64 Aligned_cols=139 Identities=84% Similarity=1.238 Sum_probs=118.9
Q ss_pred HHHHHHhccccEEEEcC---CCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEE
Q 002342 474 LATTLERIEKNFVITDP---RLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQL 550 (934)
Q Consensus 474 l~~i~e~~~d~i~v~D~---~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~ 550 (934)
|+.++++++++++++|. +|. |+++|+++++++||+.++++|+++..+.+++........+...+..+..+..++
T Consensus 4 l~~~~~~~~~~i~~~d~~~~~~~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (146)
T 2v0u_A 4 LATTLERIEKNFVITDPRLPDNP---IIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATVRKIRDAIDNQTEVTVQL 80 (146)
T ss_dssp CCCTGGGSSSCEEEECTTSTTCC---EEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEE
T ss_pred HHHHHhcCCCcEEEEcCCCCCce---EEEEcHHHHHHHCcCHHHHcCCCHHHhcCCcCChHHHHHHHHHHhcCCCcceEE
Confidence 56678999999999999 888 999999999999999999999999888888888888888888888899999999
Q ss_pred EEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccccccCCchhhHHHHHHHHHHhhhhhhhhccc
Q 002342 551 INYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKE 622 (934)
Q Consensus 551 ~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e~~~~~~~~~~e~~~~vk~~~~~v~~~~~e 622 (934)
...+++|..+|+.++..|+.+.+|.+.+++++++|||++|+. +...+....++.+..++...+++
T Consensus 81 ~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 145 (146)
T 2v0u_A 81 INYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRD-------AAEREGVMLIKKTAENIDEAAKE 145 (146)
T ss_dssp EEECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEEESSCCCH-------HHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCCcEEEEEEEEEEeECCCCCEEEEEEEEeechHHHHH-------HHHHHHHHHHHHHHhccHhhHhc
Confidence 999999999999999999999999999999999999999872 22333444555555555555543
|
| >3k3c_A Protein RV1364C/MT1410; sensor, PAS, signal transduction, fatty-acid binding, sigma regulator, signaling protein; HET: PLM; 1.62A {Mycobacterium tuberculosis} PDB: 3k3d_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.5e-15 Score=146.69 Aligned_cols=125 Identities=10% Similarity=0.099 Sum_probs=105.9
Q ss_pred cchHHHHHHHHHhccCcEEEEe-CCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcE
Q 002342 185 PRVSDIVKDALSTFQQTFVVSD-ATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSY 263 (934)
Q Consensus 185 ~~~~~~~~~ile~~~d~i~v~D-~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~ 263 (934)
..+++.|+.++++++++|+++| . +|+|+++|++|++++||+ +++|+++..++++.........+.+++..+...
T Consensus 13 ~~~~~~~~~~~~~~~~~i~~~d~~---~~~i~~~N~~~~~~~g~~--~~~G~~~~~~~~~~~~~~~~~~~~~~~~~g~~~ 87 (158)
T 3k3c_A 13 VGAAEDVRRIFEHIPAILVGLEGP---DHRFVAVNAAYRGFSPLL--DTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQ 87 (158)
T ss_dssp TCCHHHHHHHHHHCSSEEEEEETT---TTEEEEECHHHHHHCTTC--CSTTSBHHHHSGGGGGTTHHHHHHHHHHHCCCE
T ss_pred HHHHHHHHHHHhcCCceEEEEECC---CcEeHHHHHHHHHHcCCc--hhcCCcHHHhCCchhHHHHHHHHHHHHHhCCcc
Confidence 4556789999999999999999 7 788999999999999999 999999887777766556677888888888875
Q ss_pred EEEEE-E--Ee-cC-CcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhh
Q 002342 264 CGRLL-N--YK-KD-GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (934)
Q Consensus 264 ~~e~~-~--~~-kd-G~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~ 314 (934)
..+.. . .+ .+ |..+|+.+++.|+++.+|.+.|++++++|||++|++|++|+
T Consensus 88 ~~~~~~~~~~~~~~~g~~~~~~~~~~pi~~~~g~~~g~~~~~~DITe~k~~e~~l~ 143 (158)
T 3k3c_A 88 SGSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRARQAAE 143 (158)
T ss_dssp EEEEEEEEEESSSSCEEEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHHHHHHHH
T ss_pred cccceeEEeccCCCCcceEEEEEEEEEeECCCCCEEEEEEEEEehhHHHHHHHHHH
Confidence 54322 2 22 22 77899999999999999999999999999999999999986
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=9.2e-14 Score=127.67 Aligned_cols=119 Identities=44% Similarity=0.843 Sum_probs=107.3
Q ss_pred ccHHHHHHhccccEEEEc---CCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEE
Q 002342 472 IDLATTLERIEKNFVITD---PRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTV 548 (934)
Q Consensus 472 ~~l~~i~e~~~d~i~v~D---~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~ 548 (934)
..++.++++++++++++| .+|. |+++|+++++++||+.++++|+++..+.++.........+...+..+..+..
T Consensus 6 ~~~~~~~~~~~~~i~~~d~~d~~~~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (130)
T 2z6d_A 6 QELKTALSTLQQTFVVSDATQPHCP---IVYASSGFFTMTGYSSKEIVGRNCRFLQGPDTDKNEVAKIRDCVKNGKSYCG 82 (130)
T ss_dssp -CHHHHHHHTTCEEEEEETTSTTCC---EEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEE
T ss_pred HHHHHHHHhcccceeeeeccCCCCc---EEEecHHHHHHhCcCHHHHcCCChhhccCCCCCchHHHHHHHHHHcCCccee
Confidence 348999999999999999 8777 9999999999999999999999998888888888777888888888888888
Q ss_pred EEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccccc
Q 002342 549 QLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 593 (934)
Q Consensus 549 e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e 593 (934)
+....+++|..+|+.+...|+.+.+|.+.+++++++|||++|+++
T Consensus 83 ~~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~~e 127 (130)
T 2z6d_A 83 RLLNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEVSKYTEGV 127 (130)
T ss_dssp EEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCTTC---
T ss_pred EEEEEcCCCcEEEEEEEEEEEECCCCCeeEEEEEEecchHHHHhh
Confidence 999999999999999999999999999999999999999999854
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} | Back alignment and structure |
|---|
Probab=99.56 E-value=1e-14 Score=136.24 Aligned_cols=124 Identities=17% Similarity=0.159 Sum_probs=94.8
Q ss_pred cccccccccccccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHc--CCCCCCCCCCCCChHHH
Q 002342 173 EMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVV--GRNCRFLQGAGTDPEDV 250 (934)
Q Consensus 173 dit~~~~~e~aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEll--G~~~~~l~~~~~~~~~~ 250 (934)
+||++++++++|+++++.|+.++++++++|+++|. +|+|+++|++|++++||+.+|++ |+++..+.+ +.....
T Consensus 1 ~~t~r~~~e~~L~~~~~~~~~l~e~~~~~i~~~d~---~g~i~~~N~a~~~~~G~~~~el~g~g~~~~~~~~--~~~~~~ 75 (126)
T 3bwl_A 1 SNAERKRREKRLEETSSRLEALFENSPDMIDVLDA---DGTICEVNQRFCAELGYDESEVLGRSIWEFDLMF--DAEDVQ 75 (126)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHCSSEEEEECT---TCBEEEECHHHHHHHTCCGGGTTTSBGGGTBTTC--CHHHHH
T ss_pred CchhHHHHHHHHHHHHHHHHHHHhhCCcEEEEEcC---CCCEEEEcHHHHHHhCCCHHHHhhCCCchhhccC--CHHHHH
Confidence 57899999999999999999999999999999998 77899999999999999999994 566655554 222221
Q ss_pred HHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecch
Q 002342 251 AKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (934)
Q Consensus 251 ~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DIT 304 (934)
..+.. ...+.....+....++||+.+|+.++..++.+ +|. .+++++++|||
T Consensus 76 ~~~~~-~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~-~~~-~~~~~~~~DIT 126 (126)
T 3bwl_A 76 TQLSG-FSVDERRKFEGLYERRDGSTMSVEVHLLRFNL-EGE-DRFLAISRDIT 126 (126)
T ss_dssp HHHHT-CCTTCEEEEEEEEECTTSCEEEEEEEEEEEEE-TTE-EEEEEEEEEC-
T ss_pred HHHHH-HhcCCCcceEEEEEeCCCCEEEEEEEeEEEec-CCc-EEEEEEEEeCC
Confidence 11111 12233445566778999999999998888743 343 46789999998
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} | Back alignment and structure |
|---|
Probab=99.55 E-value=5.2e-14 Score=130.62 Aligned_cols=107 Identities=15% Similarity=0.153 Sum_probs=87.0
Q ss_pred ccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEE
Q 002342 472 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLI 551 (934)
Q Consensus 472 ~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~ 551 (934)
..|+.++++++++|+++|.+|+ |++||+++++++||+++|++|+++..+.++.... ........+..+..+..|.+
T Consensus 11 ~~~~~l~e~~~d~i~~~d~~g~---i~~vN~a~~~l~Gy~~~el~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~e~~ 86 (117)
T 2r78_A 11 NAYRALFEHAIDGIFIMDAEGH---YLDVNPAICSAIGYTRDEFLALDWGVLSRGVDSG-WAAASLARIVGGEPLREERT 86 (117)
T ss_dssp HHHHHHHHHCSSEEEEECTTSB---EEEECHHHHHHHCCCHHHHTTCBTTTTTTCSTTS-HHHHHHHHHHTTCCEEEEEE
T ss_pred HHHHHHHhcCCceEEEECCCCC---EEEecHHHHHHHCcCHHHHcCCCHHHhCCccchh-HHHHHHHHHHcCCcEEEEEE
Confidence 3499999999999999999888 9999999999999999999999877665443322 22334455666777888999
Q ss_pred EEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCC
Q 002342 552 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587 (934)
Q Consensus 552 ~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDIT 587 (934)
++++||+.+|+.+++.|+. +|. ++++++|||
T Consensus 87 ~~~kdG~~~~v~~~~~~~~--~g~---~~~i~~DIT 117 (117)
T 2r78_A 87 VWTRNGDQLTVELSAHLLP--DGK---ILGIARDVS 117 (117)
T ss_dssp EECTTSCEEEEEEEEEECT--TSC---EEEEEEC--
T ss_pred EEecCCCEEEEEEEEEEec--CCe---EEEEEEeCC
Confidence 9999999999999999985 565 678999998
|
| >2vv6_A FIXL, sensor protein FIXL; signaling protein, transferase, phosphoprotein, nitrogen FIX PER-ARNT-SIM, metal-binding, PAS, iron, heme; HET: HEM; 1.5A {Bradyrhizobium japonicum} PDB: 1xj6_A* 1xj4_A* 2vv7_A* 2vv8_A* 1lsw_A* 1dp8_A* 1dp9_A* 1drm_A* 1lsv_A* 1dp6_A* 1lsx_A* 1lt0_A* 1y28_A* 2cmn_A* 1xj3_A* 1xj2_A* 2owh_A* 2owj_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.9e-14 Score=133.51 Aligned_cols=110 Identities=18% Similarity=0.191 Sum_probs=81.6
Q ss_pred ccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCc----EEEEEEEEecC
Q 002342 481 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD----VTVQLINYTKS 556 (934)
Q Consensus 481 ~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~----~~~e~~~~~kd 556 (934)
++++|+++|.+|. |+++|+++++++||+++|++|+++..+++++........+......+.. ...++..+++|
T Consensus 2 ~~d~i~~~d~~g~---i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 78 (119)
T 2vv6_A 2 IPDAMIVIDGHGI---IQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRD 78 (119)
T ss_dssp CCCEEEEEETTSB---EEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTT
T ss_pred CcceEEEECCCCe---EEEEhHHHHHHhCCCHHHHcCCCHHHhCCchHHHHHHHHHHHHhcCCCcccCCCceEEEEEeCC
Confidence 6899999999888 9999999999999999999999988887776544433444444433332 24577788999
Q ss_pred CcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccccccc
Q 002342 557 GKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRN 595 (934)
Q Consensus 557 G~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e~~ 595 (934)
|+.+|+.++++|+.+. ...+++++++|||++|++|++
T Consensus 79 G~~~~~~~~~~~~~~~--~~~~~~~~~~DITerk~~e~~ 115 (119)
T 2vv6_A 79 GTTFPMHLSIGEMQSG--GEPYFTGFVRDLTEHQQTQAR 115 (119)
T ss_dssp SCEEEEEEEEEEEEET--TEEEEEEEEEECC--------
T ss_pred CCEEEEEEEEEEEEEC--CeEEEEEEEEEcHHHHHHHHH
Confidence 9999999999999864 335689999999999996543
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} | Back alignment and structure |
|---|
Probab=99.54 E-value=5.4e-14 Score=128.29 Aligned_cols=116 Identities=20% Similarity=0.224 Sum_probs=104.8
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEE
Q 002342 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552 (934)
Q Consensus 473 ~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~ 552 (934)
.++.++++++++++++|.+|. |+++|+++++++|++.++++|+++..+.+++........+...+..+..+..+...
T Consensus 8 ~~~~~~~~~~~~i~~~d~~~~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (124)
T 3lyx_A 8 QRAKAFDYVFDAIVVTDLQGF---IIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSEVISAVENQGKWTGEIRM 84 (124)
T ss_dssp HHHHGGGTCSSEEEEEETTCB---EEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTHHHHHHHHHHHHHHTSCEEEEEEE
T ss_pred HHHHHHhhcCceEEEECCCCc---EeehhhHHHHHhCCCHHHHcCCCHHHhcCcchhhHHHHHHHHHHHcCCcccceEEE
Confidence 488999999999999999888 99999999999999999999999887767766666677788888888889999999
Q ss_pred EecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccc
Q 002342 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 591 (934)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~ 591 (934)
.+++|..+|+.+++.|+.+.+|.+.+++++++|||++|+
T Consensus 85 ~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~ 123 (124)
T 3lyx_A 85 LHKDGHIGWIESMCVPIYGENYQMVGALGINRDITKRKK 123 (124)
T ss_dssp ECTTSCEEEEEEEEEEEECSTTCEEEEEEEEEECSCC--
T ss_pred EccCCCEEEEEEEEEEEECCCCCEEEEEEEEecchhhhc
Confidence 999999999999999999999999999999999999986
|
| >3mxq_A Sensor protein; PSI2, MCSG, structural genomics, protein structure initiativ midwest center for structural genomics; 2.78A {Vibrio cholerae o1 biovar el tor} | Back alignment and structure |
|---|
Probab=99.54 E-value=6.4e-15 Score=144.07 Aligned_cols=125 Identities=14% Similarity=0.177 Sum_probs=99.5
Q ss_pred ccccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCC
Q 002342 182 KGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ 261 (934)
Q Consensus 182 ~aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~ 261 (934)
+++++++.+|+.+++++++||+++|. +|+|++||+++++++|++++|++|+++..+++. ........++.++..|.
T Consensus 15 ~~~~~~~~~l~~il~~~~~gi~v~D~---~g~I~~~N~a~~~~~G~~~~eviG~~~~~~~p~-~~~~~~~~l~~vl~~G~ 90 (152)
T 3mxq_A 15 NAMAKSRLLLSELLDQLSFALCIVRN---DYVIVKVNEYFESRVIFDGETMQGKNILELFPE-SADYLKRKIDTALVIES 90 (152)
T ss_dssp HHHHHHHHHHHHHHHHHCCEEEEEET---TSBEEEECHHHHHTSSSCHHHHTTSBHHHHSGG-GHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHHHHHhcCCCCEEEEcC---CCEEEEECHHHHHHHCcCHHHHCCCCHHHhcCC-hHHHHHHHHHHHHhcCC
Confidence 35778888899999999999999998 788999999999999999999999999877777 55556677888898887
Q ss_pred cEEEE---------EE---EEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHH
Q 002342 262 SYCGR---------LL---NYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGA 310 (934)
Q Consensus 262 ~~~~e---------~~---~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e 310 (934)
+.... +. ...++|..+|..++++|++|++|.+.|++.+++|||+++.+.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ti~Pl~d~~G~v~gv~~ii~DVTe~~~a~ 151 (152)
T 3mxq_A 91 SSFSSWEQKPHLLPFKSSRPVSGEEEQMYQNLEVIPIHSEDGTIEHVCLCVYDVTIQASQQ 151 (152)
T ss_dssp CEEEECCSSSCSSCC----------CCEEEEEEEEEEECTTSCEEEEEEEEEEEECC----
T ss_pred ceeeecccccccccccccCCCCCCCcEEEEEEEEEEEECCCCCEEEEEEEEEECCHHHhcc
Confidence 53221 11 123677888999999999999999999999999999998753
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=4.2e-14 Score=156.75 Aligned_cols=116 Identities=89% Similarity=1.304 Sum_probs=108.4
Q ss_pred HHHHHhccccEEEEcC---CCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEE
Q 002342 475 ATTLERIEKNFVITDP---RLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLI 551 (934)
Q Consensus 475 ~~i~e~~~d~i~v~D~---~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~ 551 (934)
..++++++++|+++|. +|+ |+++|++|++++||+++|++|+++..+.+++......+.+...+..+..+..+++
T Consensus 14 ~~~~~~~~~~i~~~D~~~~~g~---i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 90 (332)
T 2wkq_A 14 ATTLERIEKNFVITDPRLPDNP---IIFASDSFLQLTEYSREEILGRNARFLQGPETDRATVRKIRDAIDNQTEVTVQLI 90 (332)
T ss_dssp CCCGGGCCSEEEEECTTSTTCC---EEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEE
T ss_pred HhHhhcCCCcEEEecCCCCCCC---EEEeehHHHHHhCCCHHHHcCCCchhhcCCCCCHHHHHHHHHHHHcCCeeEEEEE
Confidence 3467889999999999 888 9999999999999999999999999999988888888888999999999999999
Q ss_pred EEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccccc
Q 002342 552 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 593 (934)
Q Consensus 552 ~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e 593 (934)
.+++||+.+|+.+++.|++|.+|.+.+++++++|||++|+.+
T Consensus 91 ~~~~dG~~~~~~~~~~pi~d~~g~~~~~v~~~~DITe~k~~e 132 (332)
T 2wkq_A 91 NYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRDA 132 (332)
T ss_dssp EECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEEESSCCCHH
T ss_pred EEcCCCCEEEEeeEEEEeEcCCCCEEEEEEEeccCchhhhhh
Confidence 999999999999999999999999999999999999999854
|
| >3h9w_A Diguanylate cyclase with PAS/PAC sensor; alpha-beta protein., structural genomics, PSI-2, protein STR initiative; 1.90A {Marinobacter aquaeolei} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.2e-14 Score=133.79 Aligned_cols=110 Identities=15% Similarity=0.103 Sum_probs=97.4
Q ss_pred ccccEEEEcC-CCCCCCEEEccHHHHHHcCCChhhhcCCC-CcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCc
Q 002342 481 IEKNFVITDP-RLPDNPIIFASDSFLELTEYSREEILGRN-CRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGK 558 (934)
Q Consensus 481 ~~d~i~v~D~-~G~~~~I~~vN~a~~~l~Gys~eEliG~~-~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~ 558 (934)
+++++|.+|. .|. ++|+|+++++++||++++++|.. +..++||++...+...+...+..+..+..|++++++||+
T Consensus 2 a~~giw~~d~~~~~---~~~~n~~~~~l~G~~~~e~~~~~~~~~~ihpdd~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~ 78 (115)
T 3h9w_A 2 TKAIPWKINWQTMA---FEYIGPQIEALLGWPQGSWKSVEDWATRMHPEDQEWVVNFCVKQSECGVDHEADYRALHRDGH 78 (115)
T ss_dssp -CCEEEEEETTTTE---EEEECTHHHHHHCSCGGGCCBHHHHHHSBCHHHHHHHHHHHHHHHHTTCCEEEEEEEECTTSC
T ss_pred cceEEEEEEcCCCc---EEEEChhHHHHhCCChHHccCHHHHHHhcCHHHHHHHHHHHHHHHhcCCcccEEEEEEcCCCC
Confidence 5789999994 455 99999999999999999999832 356789998888888888889888899999999999999
Q ss_pred EEEEEEEEEeeecCCCCEEEEEEEEEcCCcccccc
Q 002342 559 KFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 593 (934)
Q Consensus 559 ~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e 593 (934)
.+|+..+..|++|++|++++++|++.|||++|++|
T Consensus 79 ~~w~~~~~~~~~d~~G~~~~~~G~~~Dit~~k~~~ 113 (115)
T 3h9w_A 79 YVWIRDVVHVVRDDSGEVEALIGFMFDISLEHHHH 113 (115)
T ss_dssp EEEEEEEEEEEECTTSCEEEEEEEEEECGGGGC--
T ss_pred EEEEEEEEEEEECCCCCEEEEEEEEeccCcccccc
Confidence 99999999999999999999999999999999964
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=3.9e-14 Score=157.02 Aligned_cols=122 Identities=39% Similarity=0.789 Sum_probs=111.8
Q ss_pred HHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEec
Q 002342 193 DALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKK 272 (934)
Q Consensus 193 ~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~k 272 (934)
.++++++++|+++|....+|+|+|+|++|++++||+++|++|+++..+.+++........+...+..+..+..+++.+++
T Consensus 15 ~~~~~~~~~i~~~D~~~~~g~i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 94 (332)
T 2wkq_A 15 TTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARFLQGPETDRATVRKIRDAIDNQTEVTVQLINYTK 94 (332)
T ss_dssp CCGGGCCSEEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECT
T ss_pred hHhhcCCCcEEEecCCCCCCCEEEeehHHHHHhCCCHHHHcCCCchhhcCCCCCHHHHHHHHHHHHcCCeeEEEEEEEcC
Confidence 35789999999999844466799999999999999999999999998888888888888899999999999999999999
Q ss_pred CCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhh
Q 002342 273 DGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (934)
Q Consensus 273 dG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~ 314 (934)
||+.+|+++++.|++|.+|.+.+++++++|||++++.+++++
T Consensus 95 dG~~~~~~~~~~pi~d~~g~~~~~v~~~~DITe~k~~e~~~~ 136 (332)
T 2wkq_A 95 SGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRDAAERE 136 (332)
T ss_dssp TCCEEEEEEEEEEEECTTSCEEEEEEEEEEESSCCCHHHHHH
T ss_pred CCCEEEEeeEEEEeEcCCCCEEEEEEEeccCchhhhhhhhcc
Confidence 999999999999999999999999999999999999887765
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} | Back alignment and structure |
|---|
Probab=99.53 E-value=6.7e-14 Score=127.02 Aligned_cols=113 Identities=12% Similarity=0.119 Sum_probs=93.1
Q ss_pred HHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEE
Q 002342 188 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 267 (934)
Q Consensus 188 ~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 267 (934)
+++|+.++++++++++++|. +|+|+++|++|++++||+.++++|+++..++ ++........+...+.++.....+.
T Consensus 2 e~~~~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (114)
T 3luq_A 2 DERLRLFTEHAPAALAMFDR---EMRYLAVSRRWREDYGLGDGDILGMSHYDIF-PEIGEEWKSVHRRGLAGEVIRVEED 77 (114)
T ss_dssp CHHHHHHHHTCSSEEEEEET---TCBEEEECHHHHHHTTCCSSCCTTCBHHHHC-TTCCHHHHHHHHHHHTTCCEEEEEE
T ss_pred hHHHHHHHhcCCceEEEEcC---CcEEEEECHHHHHHHCCCHHHHcCCcHHHHC-CccHHHHHHHHHHHhcCCcceeeee
Confidence 57899999999999999998 7779999999999999999999999987666 4555555555555555443333344
Q ss_pred EEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecch
Q 002342 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (934)
Q Consensus 268 ~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DIT 304 (934)
...+++|..+|+.++..|+++.+|.+.+++++++|||
T Consensus 78 ~~~~~~g~~~~~~~~~~p~~~~~g~~~~~~~~~~DIT 114 (114)
T 3luq_A 78 CFVRADGRTQWLRWEVRPWYEGEGRVGGVVIFTEDIT 114 (114)
T ss_dssp EEEC--CCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEEcCCCcEEEEEEEEEEeECCCCCEEEEEEEEeeCC
Confidence 7788999999999999999999999999999999997
|
| >3k3c_A Protein RV1364C/MT1410; sensor, PAS, signal transduction, fatty-acid binding, sigma regulator, signaling protein; HET: PLM; 1.62A {Mycobacterium tuberculosis} PDB: 3k3d_A | Back alignment and structure |
|---|
Probab=99.52 E-value=2.7e-14 Score=139.28 Aligned_cols=120 Identities=10% Similarity=0.084 Sum_probs=101.1
Q ss_pred hhhcccHHHHHHhccccEEEEc-CCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcE
Q 002342 468 MRKGIDLATTLERIEKNFVITD-PRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDV 546 (934)
Q Consensus 468 l~~~~~l~~i~e~~~d~i~v~D-~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~ 546 (934)
++....|+.++++++++|+++| .+|+ |+++|+++++++||+ +++|+++..++++.........+...+..+...
T Consensus 13 ~~~~~~~~~~~~~~~~~i~~~d~~~~~---i~~~N~~~~~~~g~~--~~~G~~~~~~~~~~~~~~~~~~~~~~~~~g~~~ 87 (158)
T 3k3c_A 13 VGAAEDVRRIFEHIPAILVGLEGPDHR---FVAVNAAYRGFSPLL--DTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQ 87 (158)
T ss_dssp TCCHHHHHHHHHHCSSEEEEEETTTTE---EEEECHHHHHHCTTC--CSTTSBHHHHSGGGGGTTHHHHHHHHHHHCCCE
T ss_pred HHHHHHHHHHHhcCCceEEEEECCCcE---eHHHHHHHHHHcCCc--hhcCCcHHHhCCchhHHHHHHHHHHHHHhCCcc
Confidence 5555679999999999999999 8777 999999999999999 999999888888766655667778888778775
Q ss_pred EEEEE-E--EecC--CcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccc
Q 002342 547 TVQLI-N--YTKS--GKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 592 (934)
Q Consensus 547 ~~e~~-~--~~kd--G~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~ 592 (934)
..+.. . .+.+ |..+|+.+++.|+++.+|.+.+++++++|||++|++
T Consensus 88 ~~~~~~~~~~~~~~~g~~~~~~~~~~pi~~~~g~~~g~~~~~~DITe~k~~ 138 (158)
T 3k3c_A 88 SGSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRA 138 (158)
T ss_dssp EEEEEEEEEESSSSCEEEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHHH
T ss_pred cccceeEEeccCCCCcceEEEEEEEEEeECCCCCEEEEEEEEEehhHHHHH
Confidence 54432 2 2222 778999999999999999999999999999999984
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} | Back alignment and structure |
|---|
Probab=99.51 E-value=5.8e-14 Score=137.04 Aligned_cols=118 Identities=33% Similarity=0.571 Sum_probs=109.6
Q ss_pred ccHHHHHHhccccEEEEcCCC---CCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEE
Q 002342 472 IDLATTLERIEKNFVITDPRL---PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTV 548 (934)
Q Consensus 472 ~~l~~i~e~~~d~i~v~D~~G---~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~ 548 (934)
..++.++++++++|+++|.+| + |+++|+++++++||+.++++|+++..+.++.........+...+..+..+..
T Consensus 25 ~~~~~i~~~~~~~i~~~d~~~~~~~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 101 (162)
T 3sw1_A 25 QLLQSMVDASNDGIVVAEKEGDDTI---LIYVNAAFEYLTGYSRDEILYQDCRFLQGDDRDQLGRARIRKAMAEGRPCRE 101 (162)
T ss_dssp HHHHHHHHTCSSEEEEEEEETTEEE---EEEECHHHHHHHTCCHHHHTTSBGGGGTTTCCCCHHHHHHHHHHHHTCCEEE
T ss_pred HHHHHHHhhccCcEEEEeCCCCccE---EEEECHHHHHHHCCCHHHHcCCCcceecCCCcCHHHHHHHHHHHhcCCCCcc
Confidence 348999999999999999988 7 9999999999999999999999998888888777777888888888999999
Q ss_pred EEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccc
Q 002342 549 QLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 592 (934)
Q Consensus 549 e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~ 592 (934)
++...+++|..+|+.+++.|+.+.+|.+.+++++++|||++|++
T Consensus 102 ~~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DiTe~k~~ 145 (162)
T 3sw1_A 102 VLRNYRKDGSAFWNELSITPVKSDFDQRTYFIGIQKDVSRQVEL 145 (162)
T ss_dssp EEEEECTTCCEEEEEEEEEEEECSSSSCEEEEEEEEECHHHHHH
T ss_pred eEEEECCCCCEEEEEEEEEEeecCCCCEEEEEEEEEeCcHHHHH
Confidence 99999999999999999999999999999999999999999984
|
| >3h9w_A Diguanylate cyclase with PAS/PAC sensor; alpha-beta protein., structural genomics, PSI-2, protein STR initiative; 1.90A {Marinobacter aquaeolei} | Back alignment and structure |
|---|
Probab=99.51 E-value=2.4e-14 Score=131.78 Aligned_cols=112 Identities=13% Similarity=0.100 Sum_probs=97.1
Q ss_pred ccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCC-CCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcE
Q 002342 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRN-CRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTP 276 (934)
Q Consensus 198 ~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~-~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~ 276 (934)
+++++|.+|.. +|+++|+|+++++++||++++++|.. +..+++|++.......+...+..+..+..+++.+++||+.
T Consensus 2 a~~giw~~d~~--~~~~~~~n~~~~~l~G~~~~e~~~~~~~~~~ihpdd~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~ 79 (115)
T 3h9w_A 2 TKAIPWKINWQ--TMAFEYIGPQIEALLGWPQGSWKSVEDWATRMHPEDQEWVVNFCVKQSECGVDHEADYRALHRDGHY 79 (115)
T ss_dssp -CCEEEEEETT--TTEEEEECTHHHHHHCSCGGGCCBHHHHHHSBCHHHHHHHHHHHHHHHHTTCCEEEEEEEECTTSCE
T ss_pred cceEEEEEEcC--CCcEEEEChhHHHHhCCChHHccCHHHHHHhcCHHHHHHHHHHHHHHHhcCCcccEEEEEEcCCCCE
Confidence 46889999953 67799999999999999999999832 2357788888888888888899888899999999999999
Q ss_pred EEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHH
Q 002342 277 FWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAK 311 (934)
Q Consensus 277 ~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~ 311 (934)
+|+..+..|++|++|.+.+++|++.|||++|++|+
T Consensus 80 ~w~~~~~~~~~d~~G~~~~~~G~~~Dit~~k~~~~ 114 (115)
T 3h9w_A 80 VWIRDVVHVVRDDSGEVEALIGFMFDISLEHHHHH 114 (115)
T ss_dssp EEEEEEEEEEECTTSCEEEEEEEEEECGGGGC---
T ss_pred EEEEEEEEEEECCCCCEEEEEEEEeccCccccccc
Confidence 99999999999999999999999999999999875
|
| >3kx0_X Uncharacterized protein RV1364C/MT1410; PAS domain, sensory domain, mycobacteium tuberculos molecule binding domain; 2.30A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.51 E-value=3.4e-14 Score=143.46 Aligned_cols=124 Identities=10% Similarity=0.125 Sum_probs=102.7
Q ss_pred cchHHHHHHHHHhccCcEEEEe-CCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcE
Q 002342 185 PRVSDIVKDALSTFQQTFVVSD-ATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSY 263 (934)
Q Consensus 185 ~~~~~~~~~ile~~~d~i~v~D-~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~ 263 (934)
..+++.|+.++++++++|+++| . +|+|+++|++|++++||+ +++|+++..++++.........+..++..|...
T Consensus 33 ~~~~~~l~~l~~~~~~~i~~~d~~---~g~i~~~N~a~~~l~G~~--~~~G~~~~~~~~~~~~~~~~~~~~~~~~~g~~~ 107 (185)
T 3kx0_X 33 VGAAEDVRRIFEHIPAILVGLEGP---DHRFVAVNAAYRGFSPLL--DTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQ 107 (185)
T ss_dssp TCCHHHHHHHHHHCSSEEEEEETT---TTEEEEECHHHHHHCCCC--SCTTSBHHHHCTTSCSSSSHHHHHHHHHHCCCE
T ss_pred hhhHHHHHHHHhcCCceEEEEECC---CcEEEEEcHHHHHHcCCc--cccCCcHHHHCCchhhhhHHHHHHHHHHcCCcc
Confidence 5667899999999999999999 7 788999999999999999 999999887777766655667788888888876
Q ss_pred EEEEEEE---ecC--CcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHh
Q 002342 264 CGRLLNY---KKD--GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDK 313 (934)
Q Consensus 264 ~~e~~~~---~kd--G~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L 313 (934)
..+.... +++ |..+|+.+++.|++|.+|.+.+++++++|||++|++|+++
T Consensus 108 ~~~~~~~~~~~~~~gg~~~~~~~~~~pi~~~~g~~~g~~~~~~DITerk~~e~~~ 162 (185)
T 3kx0_X 108 SGSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRARQAA 162 (185)
T ss_dssp EEEEEEEC--------CCEEEEEEEEEEECTTSCEEEEEEEEEECHHHHTTCC--
T ss_pred cccceeEEeeccCCCCccEEEEEEEEEEECCCCCEEEEEEEEEeCCHHHHHHHHH
Confidence 5543222 222 7789999999999999999999999999999999999983
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.1e-13 Score=129.15 Aligned_cols=123 Identities=15% Similarity=0.127 Sum_probs=94.2
Q ss_pred CchhhHHHHHhhhhc-ccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhh--cCCCCcccCCCCCCHHHH
Q 002342 457 DSVDDKVRQKEMRKG-IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEI--LGRNCRFLQGPETDPATV 533 (934)
Q Consensus 457 dv~~r~~~e~~l~~~-~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEl--iG~~~~~l~~~~~~~~~~ 533 (934)
++|+|++.|++|+.. ..|+.++++++++|+++|.+|+ |+++|+++++++||+.+|+ +|++...+.+ +.....
T Consensus 1 ~~t~r~~~e~~L~~~~~~~~~l~e~~~~~i~~~d~~g~---i~~~N~a~~~~~G~~~~el~g~g~~~~~~~~--~~~~~~ 75 (126)
T 3bwl_A 1 SNAERKRREKRLEETSSRLEALFENSPDMIDVLDADGT---ICEVNQRFCAELGYDESEVLGRSIWEFDLMF--DAEDVQ 75 (126)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHCSSEEEEECTTCB---EEEECHHHHHHHTCCGGGTTTSBGGGTBTTC--CHHHHH
T ss_pred CchhHHHHHHHHHHHHHHHHHHHhhCCcEEEEEcCCCC---EEEEcHHHHHHhCCCHHHHhhCCCchhhccC--CHHHHH
Confidence 478999999999766 6799999999999999999888 9999999999999999999 5676666665 222222
Q ss_pred HHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCC
Q 002342 534 RKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587 (934)
Q Consensus 534 ~~i~~~l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDIT 587 (934)
..+. ....+.....+.++.++||..+|+.++..++.+ +|. ..++++++|||
T Consensus 76 ~~~~-~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~-~~~-~~~~~~~~DIT 126 (126)
T 3bwl_A 76 TQLS-GFSVDERRKFEGLYERRDGSTMSVEVHLLRFNL-EGE-DRFLAISRDIT 126 (126)
T ss_dssp HHHH-TCCTTCEEEEEEEEECTTSCEEEEEEEEEEEEE-TTE-EEEEEEEEEC-
T ss_pred HHHH-HHhcCCCcceEEEEEeCCCCEEEEEEEeEEEec-CCc-EEEEEEEEeCC
Confidence 2211 112334456677788999999999988888743 444 45789999998
|
| >3mxq_A Sensor protein; PSI2, MCSG, structural genomics, protein structure initiativ midwest center for structural genomics; 2.78A {Vibrio cholerae o1 biovar el tor} | Back alignment and structure |
|---|
Probab=99.50 E-value=2.5e-14 Score=139.87 Aligned_cols=122 Identities=15% Similarity=0.193 Sum_probs=95.9
Q ss_pred hhhhc-ccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCc
Q 002342 467 EMRKG-IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 545 (934)
Q Consensus 467 ~l~~~-~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~ 545 (934)
++++. ..|+.+++++++||+++|.+|+ |++||+++++++|++++|++|+++.+++++ ....+...+..++..|.+
T Consensus 16 ~~~~~~~~l~~il~~~~~gi~v~D~~g~---I~~~N~a~~~~~G~~~~eviG~~~~~~~p~-~~~~~~~~l~~vl~~G~~ 91 (152)
T 3mxq_A 16 AMAKSRLLLSELLDQLSFALCIVRNDYV---IVKVNEYFESRVIFDGETMQGKNILELFPE-SADYLKRKIDTALVIESS 91 (152)
T ss_dssp HHHHHHHHHHHHHHHHCCEEEEEETTSB---EEEECHHHHHTSSSCHHHHTTSBHHHHSGG-GHHHHHHHHHHHHHHTSC
T ss_pred HHHHHHHHHHHHHhcCCCCEEEEcCCCE---EEEECHHHHHHHCcCHHHHCCCCHHHhcCC-hHHHHHHHHHHHHhcCCc
Confidence 34433 3489999999999999999888 999999999999999999999999888877 555566778888887765
Q ss_pred EEEE---------EEE---EecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccc
Q 002342 546 VTVQ---------LIN---YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 592 (934)
Q Consensus 546 ~~~e---------~~~---~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~ 592 (934)
.... +.. ..++|..+|..+++.|++|++|++.+++++++|||+++++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ti~Pl~d~~G~v~gv~~ii~DVTe~~~a 150 (152)
T 3mxq_A 92 SFSSWEQKPHLLPFKSSRPVSGEEEQMYQNLEVIPIHSEDGTIEHVCLCVYDVTIQASQ 150 (152)
T ss_dssp EEEECCSSSCSSCC----------CCEEEEEEEEEEECTTSCEEEEEEEEEEEECC---
T ss_pred eeeecccccccccccccCCCCCCCcEEEEEEEEEEEECCCCCEEEEEEEEEECCHHHhc
Confidence 3221 111 2356778899999999999999999999999999999873
|
| >3eeh_A Putative light and redox sensing histidine kinase; structural genomic MCSG, protein structure initiative, midwest center for STRU genomics; HET: PG5; 1.95A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.50 E-value=5.6e-14 Score=128.83 Aligned_cols=121 Identities=11% Similarity=0.133 Sum_probs=98.1
Q ss_pred ccccccchHHHHHHHHHhccCcEEEEeCCCCC-CceEEcchHHHHHcCCChhhHcCCC--CCCCCCCCCChHHHHHHHHH
Q 002342 180 KEKGLPRVSDIVKDALSTFQQTFVVSDATKPD-YPIMYASAGFFKMTGYTSKEVVGRN--CRFLQGAGTDPEDVAKIRET 256 (934)
Q Consensus 180 ~e~aL~~~~~~~~~ile~~~d~i~v~D~~~~d-G~I~~~N~a~~~l~Gys~eEllG~~--~~~l~~~~~~~~~~~~i~~~ 256 (934)
++++|+++++.|+.++++++++++++|. + |+++++|+++++++||+.++++|.. +..+.++++.......+..
T Consensus 2 ~e~~l~~~~~~~~~~~~~~~~~i~~~d~---~~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 77 (125)
T 3eeh_A 2 AKQQAAKSERRVRELTEATNDILWEFTA---DLSEVLVINSAYEDIWGRSVAKLRENPHDFLNGIHPEDRELMKDTMQS- 77 (125)
T ss_dssp --------CHHHHHHHSCCCCEEEEEET---TSSCEEEECTHHHHHHSSCHHHHHHCGGGGGGGBCHHHHHHHHHHHHH-
T ss_pred hHHHHHHHHHHHHHHHhcCCceEEEEEc---CCCcEEEecHHHHHHHCCCHHHHccCcHHHHHhcCHHHHHHHHHHHHH-
Confidence 5677889999999999999999999998 5 7799999999999999999999987 3445566554444455544
Q ss_pred HhcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecch
Q 002342 257 LQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (934)
Q Consensus 257 l~~g~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DIT 304 (934)
+..+..+..+++..+++|..+|+.++..|+.+.+|.+.+++++++|||
T Consensus 78 ~~~~~~~~~e~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIT 125 (125)
T 3eeh_A 78 LMDGESADVECRVNATEEYQRWVWIQGEPITNDAGETVRVAGFARDIT 125 (125)
T ss_dssp HHTTCCEEEEEEECGGGTTCEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred HHcCCCccEEEEEEcCCCCEEEEEEecEEEECCCCCEEEEEEEEEecC
Confidence 667777888999999999999999999999999999999999999997
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} | Back alignment and structure |
|---|
Probab=99.49 E-value=2e-13 Score=123.80 Aligned_cols=111 Identities=15% Similarity=0.140 Sum_probs=92.8
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEE
Q 002342 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552 (934)
Q Consensus 473 ~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~ 552 (934)
.|+.++++++++|+++|.+|+ |+++|+++++++||+.++++|+++..++ |+........+...+.++.....+..+
T Consensus 4 ~~~~~~~~~~~~i~~~d~~g~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (114)
T 3luq_A 4 RLRLFTEHAPAALAMFDREMR---YLAVSRRWREDYGLGDGDILGMSHYDIF-PEIGEEWKSVHRRGLAGEVIRVEEDCF 79 (114)
T ss_dssp HHHHHHHTCSSEEEEEETTCB---EEEECHHHHHHTTCCSSCCTTCBHHHHC-TTCCHHHHHHHHHHHTTCCEEEEEEEE
T ss_pred HHHHHHhcCCceEEEEcCCcE---EEEECHHHHHHHCCCHHHHcCCcHHHHC-CccHHHHHHHHHHHhcCCcceeeeeEE
Confidence 488999999999999999888 9999999999999999999999988777 555565555666655544433444478
Q ss_pred EecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCC
Q 002342 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587 (934)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDIT 587 (934)
.+++|..+|+.++..|+++.+|.+.+++++++|||
T Consensus 80 ~~~~g~~~~~~~~~~p~~~~~g~~~~~~~~~~DIT 114 (114)
T 3luq_A 80 VRADGRTQWLRWEVRPWYEGEGRVGGVVIFTEDIT 114 (114)
T ss_dssp EC--CCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EcCCCcEEEEEEEEEEeECCCCCEEEEEEEEeeCC
Confidence 89999999999999999999999999999999998
|
| >4dj3_A Period circadian protein homolog 3; PAS domain, circadian rhythm, protein binding; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.6e-12 Score=142.06 Aligned_cols=106 Identities=13% Similarity=0.134 Sum_probs=89.9
Q ss_pred ccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCc---EEEEEEEEecCCcE
Q 002342 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD---VTVQLINYTKSGKK 559 (934)
Q Consensus 483 d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~---~~~e~~~~~kdG~~ 559 (934)
+-+...+.+|+ ++|+|+++..++||.++|++|+++..++||++.....+.+...+..+.. ...+++++++||..
T Consensus 175 ~Fitrh~~dG~---~~yvs~~~~~lLGY~peELig~s~~~~vHPdD~~~~~~~~~~~l~~~~~~~f~s~~yR~~~kdG~~ 251 (317)
T 4dj3_A 175 IFTTTHTPGCV---FLEVDERAVPLLGYLPQDLIGTSILTYLHPEDRPLMVAIHQKVLKYAGHPPFEHSPVRFCTQNGEY 251 (317)
T ss_dssp EEEEEECTTSB---EEEECTTHHHHHSCCHHHHTTSBGGGGBCTTTTTHHHHHHHHHHHTTTSCCEECCCEEEECTTSCE
T ss_pred ceEEEecCCCe---EEEEChHHhhhcCcChHHHcCCCHHHeECHHHHHHHHHHHHHHHHcCCCccccceEEEEEccCCCE
Confidence 45666778777 9999999999999999999999999999999999888888888887654 35789999999999
Q ss_pred EEEEEEEEeeecC-CCCEEEEEEEEEcCCcccc
Q 002342 560 FWNLFHLQPMRDQ-KGEVQYFIGVQLDGSEHLE 591 (934)
Q Consensus 560 ~wv~~~~~pi~de-~G~v~~~vgi~rDITerk~ 591 (934)
+|++....+++|. .+++.+++|.-+-|+....
T Consensus 252 vwvet~~~~~~np~s~~~e~II~~h~v~~~p~~ 284 (317)
T 4dj3_A 252 VILDSSWSSFVNPWSRKVSFIIGRHKVRTSPLN 284 (317)
T ss_dssp EEEEEEEEEEECSSSCCEEEEEEEEEECCCCSS
T ss_pred EEEEEEEEEEECCCCCcccEEEEEEEeccCCCC
Confidence 9999999999986 4667788888775555443
|
| >3kx0_X Uncharacterized protein RV1364C/MT1410; PAS domain, sensory domain, mycobacteium tuberculos molecule binding domain; 2.30A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.48 E-value=5.5e-14 Score=141.91 Aligned_cols=141 Identities=11% Similarity=0.123 Sum_probs=100.5
Q ss_pred hhhcccHHHHHHhccccEEEEc-CCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcE
Q 002342 468 MRKGIDLATTLERIEKNFVITD-PRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDV 546 (934)
Q Consensus 468 l~~~~~l~~i~e~~~d~i~v~D-~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~ 546 (934)
++....|+.++++++++|+++| .+|+ |+++|+++++++||+ +++|+++..++++.........+..++..+...
T Consensus 33 ~~~~~~l~~l~~~~~~~i~~~d~~~g~---i~~~N~a~~~l~G~~--~~~G~~~~~~~~~~~~~~~~~~~~~~~~~g~~~ 107 (185)
T 3kx0_X 33 VGAAEDVRRIFEHIPAILVGLEGPDHR---FVAVNAAYRGFSPLL--DTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQ 107 (185)
T ss_dssp TCCHHHHHHHHHHCSSEEEEEETTTTE---EEEECHHHHHHCCCC--SCTTSBHHHHCTTSCSSSSHHHHHHHHHHCCCE
T ss_pred hhhHHHHHHHHhcCCceEEEEECCCcE---EEEEcHHHHHHcCCc--cccCCcHHHHCCchhhhhHHHHHHHHHHcCCcc
Confidence 4444669999999999999999 8777 999999999999999 999999888888776655566777788778776
Q ss_pred EEEEEEE---ecC--CcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccccccCCchhhHHHHHHHHHHhhhh
Q 002342 547 TVQLINY---TKS--GKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAEN 615 (934)
Q Consensus 547 ~~e~~~~---~kd--G~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e~~~~~~~~~~e~~~~vk~~~~~ 615 (934)
..+.... +++ |..+|+.+++.|+++.+|.+.+++++++|||++|++|++. ...+++.++.++.+..+
T Consensus 108 ~~~~~~~~~~~~~~gg~~~~~~~~~~pi~~~~g~~~g~~~~~~DITerk~~e~~~--~~ll~~~~~~l~~~~~~ 179 (185)
T 3kx0_X 108 SGSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRARQAA--EARVEELSERYRNVRDS 179 (185)
T ss_dssp EEEEEEEC--------CCEEEEEEEEEEECTTSCEEEEEEEEEECHHHHTTCC---------------------
T ss_pred cccceeEEeeccCCCCccEEEEEEEEEEECCCCCEEEEEEEEEeCCHHHHHHHHH--HHHHHHHHHHHHHHHhh
Confidence 5543222 222 7889999999999999999999999999999999975542 12344455554444443
|
| >2kdk_A ARYL hydrocarbon receptor nuclear translocator-LI 2; circadian clock, PAS domain, transcription, activator, biolo rhythms, DNA-binding, nucleus; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=2.2e-13 Score=126.06 Aligned_cols=114 Identities=13% Similarity=0.110 Sum_probs=98.7
Q ss_pred HHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhc-CCcEEEEEEEE
Q 002342 475 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDN-QTDVTVQLINY 553 (934)
Q Consensus 475 ~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~-~~~~~~e~~~~ 553 (934)
.+++++++++|+++|.+|+ |+++|+++++++||+.+|++|+++..+++|++.......+...+.. +.....+++++
T Consensus 6 ~~~~~~~~~~i~~~d~~g~---i~~~N~~~~~~~G~~~~el~g~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~e~r~~ 82 (121)
T 2kdk_A 6 GEINVKPTEFITRFAVNGK---FVYVDQRATAILGYLPQELLGTSCYEYFHQDDHNNLTDKHKAVLQSKEKILTDSYKFR 82 (121)
T ss_dssp TCCCCCSSEEEEEECTTSB---EEEECTHHHHHTCCCTTTSBTSBTTTTBCSSSHHHHHHHHHHHHTSSSCEEEEEEEEE
T ss_pred cccccCCccEEEEECCCee---EEEEChhHHHHHCCCHHHHcCCcHHHeeCHHHHHHHHHHHHHHHhCCCCCccEEEEEE
Confidence 3466788999999999888 9999999999999999999999988899998877777777776765 44468899999
Q ss_pred ecCCcEEEEEEEEEeeecCC-CCEEEEEEEEEcCCcccc
Q 002342 554 TKSGKKFWNLFHLQPMRDQK-GEVQYFIGVQLDGSEHLE 591 (934)
Q Consensus 554 ~kdG~~~wv~~~~~pi~de~-G~v~~~vgi~rDITerk~ 591 (934)
++||+.+|+.++..|++|.. |.+.+++++.+||++.++
T Consensus 83 ~~dG~~~~~~~~~~~~~d~~~~~~~~~v~~~~~i~~~~~ 121 (121)
T 2kdk_A 83 AKDGSFVTLKSQWFSFTNPDTKELEYIVSVNTLVLGHSE 121 (121)
T ss_dssp CSSSCEEEEEEEEEEEECCSSSCEEEEEEEEECCSSCCC
T ss_pred EcCCCEEEEEEEEEEEECCCCCeeeEEEEEEEeccccCC
Confidence 99999999999999999886 567789999999999763
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=6.1e-13 Score=125.22 Aligned_cols=121 Identities=40% Similarity=0.821 Sum_probs=107.2
Q ss_pred HHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEE
Q 002342 191 VKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNY 270 (934)
Q Consensus 191 ~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 270 (934)
|+.++++++++++++|....+|.|+++|+++++++||+.++++|+++..+.++.........+...+..+..+..++...
T Consensus 4 l~~~~~~~~~~i~~~d~~~~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (146)
T 2v0u_A 4 LATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATVRKIRDAIDNQTEVTVQLINY 83 (146)
T ss_dssp CCCTGGGSSSCEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEE
T ss_pred HHHHHhcCCCcEEEEcCCCCCceEEEEcHHHHHHHCcCHHHHcCCCHHHhcCCcCChHHHHHHHHHHhcCCCcceEEEEE
Confidence 34578999999999997322456999999999999999999999998888888887777888888899999999999999
Q ss_pred ecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHH
Q 002342 271 KKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAK 311 (934)
Q Consensus 271 ~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~ 311 (934)
+++|..+|+.++..|+.+.+|.+.+++++++|||++++.++
T Consensus 84 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~~~~ 124 (146)
T 2v0u_A 84 TKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRDAA 124 (146)
T ss_dssp CTTCCEEEEEEEEEEEECTTSCEEEEEEEEEEESSCCCHHH
T ss_pred ecCCcEEEEEEEEEEeECCCCCEEEEEEEEeechHHHHHHH
Confidence 99999999999999999999999999999999999998443
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} | Back alignment and structure |
|---|
Probab=99.46 E-value=7.9e-14 Score=127.75 Aligned_cols=115 Identities=9% Similarity=-0.035 Sum_probs=104.7
Q ss_pred hHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCC--CCCCCCCCChHHHHHHHHHHhcCCcEE
Q 002342 187 VSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNC--RFLQGAGTDPEDVAKIRETLQNGQSYC 264 (934)
Q Consensus 187 ~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~--~~l~~~~~~~~~~~~i~~~l~~g~~~~ 264 (934)
++++|+.++++++++++.+|. +|.++++|+++++++||+.++++|... ..+.+|++.......+...+..+..+.
T Consensus 2 s~~~~~~l~~~~~~~i~~~d~---~~~~~~~n~~~~~~~G~~~~~~~~~~~~~~~~i~p~d~~~~~~~~~~~~~~~~~~~ 78 (118)
T 3icy_A 2 NAEELQALVDNIPAAIYHLDV---SGQATIRFRPPAFLKTLVSEHAGTTRLNTLSMIHHDDRHMLSNAYSKLREAKHSLT 78 (118)
T ss_dssp HHHHHHHHHTTCCCCCEEECT---TSCEEECCCCCGGGGGGEEEETTEEEEGGGGGBCGGGHHHHHHHHHHHHHSCCEEE
T ss_pred cHHHHHHHHhcCCceEEEEEc---CCCceEEechhHhhcCCCHHHccCChhHHHHHcCHHHHHHHHHHHHHHHhcCCCce
Confidence 568899999999999999998 677999999999999999999988754 457788887788888888888888899
Q ss_pred EEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecch
Q 002342 265 GRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (934)
Q Consensus 265 ~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DIT 304 (934)
.+++.++++|+.+|+..+..|+++++|.+.+++|+++|||
T Consensus 79 ~e~r~~~~~g~~~w~~~~~~~~~~~~g~~~~~~g~~~DIT 118 (118)
T 3icy_A 79 LVYRIVTPEGKLHWIEDHMRSSFSDDGLFSGIDGILCEVT 118 (118)
T ss_dssp EEEEEECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEEEEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 9999999999999999999999999999999999999998
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 | Back alignment and structure |
|---|
Probab=99.46 E-value=1e-12 Score=116.86 Aligned_cols=107 Identities=29% Similarity=0.579 Sum_probs=94.6
Q ss_pred CcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCC--CCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 002342 200 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRN--CRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 277 (934)
Q Consensus 200 d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~--~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 277 (934)
.+|+++|....+|+|+++|++|++++||+.++++|++ ...+.++.........+...+..+..+..++..++++|..+
T Consensus 2 ~~i~i~d~~~~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~ 81 (110)
T 1byw_A 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCF 81 (110)
T ss_dssp CEEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEE
T ss_pred CCEEEEeccCCCCcEEEECHHHHHHhCCCHHHHccCCCccccccCCcCCHHHHHHHHHHHhcCCCceEEEEEEcCCCCEE
Confidence 5889999866678999999999999999999999998 45666666666667778888888888888888899999999
Q ss_pred EEEEEeeeeecCCCCEEEEEEEEecchhh
Q 002342 278 WNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306 (934)
Q Consensus 278 wv~~s~~pi~d~~G~v~~~v~~~~DITer 306 (934)
|+.+++.|+.+.+|.+.+++++++|||++
T Consensus 82 ~~~~~~~~~~~~~g~~~~~~~~~~DiTe~ 110 (110)
T 1byw_A 82 LCLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred EEEEEEEEeecCCCCEEEEEEEEEeccCC
Confidence 99999999999999999999999999975
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} | Back alignment and structure |
|---|
Probab=99.46 E-value=7.5e-14 Score=127.91 Aligned_cols=113 Identities=12% Similarity=0.027 Sum_probs=104.1
Q ss_pred ccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCC--CcccCCCCCCHHHHHHHHHHHhcCCcEEEE
Q 002342 472 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRN--CRFLQGPETDPATVRKIRAAIDNQTDVTVQ 549 (934)
Q Consensus 472 ~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~--~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e 549 (934)
.+|+.++++++++++.+|.+|. ++++|+++++++||+.++++|.. +..+++|++.....+.+...+..+..+..|
T Consensus 4 ~~~~~l~~~~~~~i~~~d~~~~---~~~~n~~~~~~~G~~~~~~~~~~~~~~~~i~p~d~~~~~~~~~~~~~~~~~~~~e 80 (118)
T 3icy_A 4 EELQALVDNIPAAIYHLDVSGQ---ATIRFRPPAFLKTLVSEHAGTTRLNTLSMIHHDDRHMLSNAYSKLREAKHSLTLV 80 (118)
T ss_dssp HHHHHHHTTCCCCCEEECTTSC---EEECCCCCGGGGGGEEEETTEEEEGGGGGBCGGGHHHHHHHHHHHHHSCCEEEEE
T ss_pred HHHHHHHhcCCceEEEEEcCCC---ceEEechhHhhcCCCHHHccCChhHHHHHcCHHHHHHHHHHHHHHHhcCCCceEE
Confidence 3489999999999999999888 99999999999999999998875 356789998888888888888888899999
Q ss_pred EEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCC
Q 002342 550 LINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587 (934)
Q Consensus 550 ~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDIT 587 (934)
+++.+++|..+|+.....|+++++|.+.+++|+++|||
T Consensus 81 ~r~~~~~g~~~w~~~~~~~~~~~~g~~~~~~g~~~DIT 118 (118)
T 3icy_A 81 YRIVTPEGKLHWIEDHMRSSFSDDGLFSGIDGILCEVT 118 (118)
T ss_dssp EEEECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 99999999999999999999999999999999999998
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.3e-13 Score=123.55 Aligned_cols=114 Identities=11% Similarity=0.098 Sum_probs=90.7
Q ss_pred cccccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcC
Q 002342 181 EKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNG 260 (934)
Q Consensus 181 e~aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g 260 (934)
++.+++..+.++.++++++++|+++|. +|+|+++|++|++++||+++|++|+++..+.++..... +..+..+
T Consensus 5 ~~~~e~~~~~~~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~~~~~-----~~~~~~~ 76 (118)
T 3olo_A 5 NIQSELEFKFAHYLINNAVEASFCLGD---NWQFLYVNDATCRMTEYSREQLLSMNLQDIDVDFALHD-----WEEIRQK 76 (118)
T ss_dssp --CHHHHHHHHHHHHHHCSSEEEEECT---TSBEEEECHHHHHHHCCCHHHHTTCBGGGTBTTGGGSC-----HHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCceEEEECC---CCcEEEEHHHHHHHHCCCHHHHhCCChhhcccccCHHH-----HHHHHhc
Confidence 344566667889999999999999998 77799999999999999999999999886665433222 2334445
Q ss_pred CcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecch
Q 002342 261 QSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (934)
Q Consensus 261 ~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DIT 304 (934)
..+..+.+.++++|+.+|+.++..|+.+.+ ..+++++++|||
T Consensus 77 ~~~~~e~~~~~~~g~~~~~~~~~~~~~~~~--~~~~~~~~~DIT 118 (118)
T 3olo_A 77 NNYTFKTRYRSQSGRIFLVEMSLTFLEDQE--RRFSCVFVREKS 118 (118)
T ss_dssp SEEEEEEEEECTTCCEEEEEEEEEEEEETT--EEEEEEEEEEC-
T ss_pred CcEEEEEEEEccCCCEEEEEEEEEEEEECC--ccEEEEEEEeCC
Confidence 677788888999999999999999997643 356789999997
|
| >2kdk_A ARYL hydrocarbon receptor nuclear translocator-LI 2; circadian clock, PAS domain, transcription, activator, biolo rhythms, DNA-binding, nucleus; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.7e-13 Score=125.53 Aligned_cols=111 Identities=13% Similarity=0.098 Sum_probs=95.2
Q ss_pred HHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCC-cEEEEEEEEec
Q 002342 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ-SYCGRLLNYKK 272 (934)
Q Consensus 194 ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~-~~~~e~~~~~k 272 (934)
++++++++|+++|. +|+|+|+|+++++++||+++|++|+++..+.+|++.......+...+..+. .+..+++.+++
T Consensus 8 ~~~~~~~~i~~~d~---~g~i~~~N~~~~~~~G~~~~el~g~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~e~r~~~~ 84 (121)
T 2kdk_A 8 INVKPTEFITRFAV---NGKFVYVDQRATAILGYLPQELLGTSCYEYFHQDDHNNLTDKHKAVLQSKEKILTDSYKFRAK 84 (121)
T ss_dssp CCCCSSEEEEEECT---TSBEEEECTHHHHHTCCCTTTSBTSBTTTTBCSSSHHHHHHHHHHHHTSSSCEEEEEEEEECS
T ss_pred cccCCccEEEEECC---CeeEEEEChhHHHHHCCCHHHHcCCcHHHeeCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Confidence 56778999999998 777999999999999999999999998888888877766677777776544 45788999999
Q ss_pred CCcEEEEEEEeeeeecCC-CCEEEEEEEEecchhhH
Q 002342 273 DGTPFWNLLTIAPIKDDE-GKVLKFIGMQVEVSKHT 307 (934)
Q Consensus 273 dG~~~wv~~s~~pi~d~~-G~v~~~v~~~~DITerk 307 (934)
||+.+|++++..|++|.. |.+.+++++.+||++.+
T Consensus 85 dG~~~~~~~~~~~~~d~~~~~~~~~v~~~~~i~~~~ 120 (121)
T 2kdk_A 85 DGSFVTLKSQWFSFTNPDTKELEYIVSVNTLVLGHS 120 (121)
T ss_dssp SSCEEEEEEEEEEEECCSSSCEEEEEEEEECCSSCC
T ss_pred CCCEEEEEEEEEEEECCCCCeeeEEEEEEEeccccC
Confidence 999999999999999886 46778899999999864
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* | Back alignment and structure |
|---|
Probab=99.44 E-value=5.5e-13 Score=128.32 Aligned_cols=127 Identities=31% Similarity=0.581 Sum_probs=105.3
Q ss_pred ceEEEecccccccccccccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCC-
Q 002342 167 SVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGT- 245 (934)
Q Consensus 167 ~~~~~~dit~~~~~e~aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~- 245 (934)
.++...||+.++..+..+ .++++. ++|+++|..+.+|+|+++|++|++++||+.+|++|+++..+.+++.
T Consensus 12 ~~~~~~~~~~r~~~~~~~--------~~~~~~-~~i~~~d~~d~~g~i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~~~ 82 (149)
T 3d72_A 12 IMGYLIQIMNRPNPQVEL--------GPVDTS-VALILCDLKQKDTPIVYASEAFLYMTGYSNAEVLGRNCRFLQSPDGM 82 (149)
T ss_dssp HHHHHHHHHHCSSCSSCC--------CSCCTT-SCEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGGSTTSC
T ss_pred eeeeeehhhhCcchhHHH--------HhhcCC-ccEEEEeccCCCCcEEEECHHHHHHHCcCHHHHcCCChhHhCCcccc
Confidence 334457777776654332 345664 8999999544488899999999999999999999999887777764
Q ss_pred ----------ChHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEec
Q 002342 246 ----------DPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVE 302 (934)
Q Consensus 246 ----------~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~D 302 (934)
.......+...+..+..+..++..+++||+.+|+.+++.|+++.+|.+.+++++++|
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~i~~~~g~~~~~v~~~~D 149 (149)
T 3d72_A 83 VKPKSTRKYVDSNTINTMRKAIDRNAEVQVEVVNFKKNGQRFVNFLTMIPVRDETGEYRYSMGFQCE 149 (149)
T ss_dssp CCTTCCCSSSCHHHHHHHHHHHHHTCCEEEEEEEECTTCCEEEEEEEEEEEECTTSSEEEEEEECCC
T ss_pred ccccccccccChHHHHHHHHHHHCCCceEEEEEEECCCCCEEEEEEEEEEEEcCCCCEEEEEEEEeC
Confidence 666677788888888899999999999999999999999999999999999999887
|
| >3eeh_A Putative light and redox sensing histidine kinase; structural genomic MCSG, protein structure initiative, midwest center for STRU genomics; HET: PG5; 1.95A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.6e-13 Score=124.37 Aligned_cols=112 Identities=10% Similarity=0.085 Sum_probs=99.0
Q ss_pred ccHHHHHHhccccEEEEcCC-CCCCCEEEccHHHHHHcCCChhhhcCCC--CcccCCCCCCHHHHHHHHHHHhcCCcEEE
Q 002342 472 IDLATTLERIEKNFVITDPR-LPDNPIIFASDSFLELTEYSREEILGRN--CRFLQGPETDPATVRKIRAAIDNQTDVTV 548 (934)
Q Consensus 472 ~~l~~i~e~~~d~i~v~D~~-G~~~~I~~vN~a~~~l~Gys~eEliG~~--~~~l~~~~~~~~~~~~i~~~l~~~~~~~~ 548 (934)
..|+.++++++++++++|.+ |. ++++|+++++++||+.++++|.+ +..++++++.......+.. +..+..+..
T Consensus 11 ~~~~~~~~~~~~~i~~~d~~~~~---i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 86 (125)
T 3eeh_A 11 RRVRELTEATNDILWEFTADLSE---VLVINSAYEDIWGRSVAKLRENPHDFLNGIHPEDRELMKDTMQS-LMDGESADV 86 (125)
T ss_dssp HHHHHHHSCCCCEEEEEETTSSC---EEEECTHHHHHHSSCHHHHHHCGGGGGGGBCHHHHHHHHHHHHH-HHTTCCEEE
T ss_pred HHHHHHHhcCCceEEEEEcCCCc---EEEecHHHHHHHCCCHHHHccCcHHHHHhcCHHHHHHHHHHHHH-HHcCCCccE
Confidence 56999999999999999998 77 99999999999999999999987 5566777766655555555 667778889
Q ss_pred EEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCC
Q 002342 549 QLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587 (934)
Q Consensus 549 e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDIT 587 (934)
++++.+++|..+|+.++..|+.+.+|.+.+++++++|||
T Consensus 87 e~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIT 125 (125)
T 3eeh_A 87 ECRVNATEEYQRWVWIQGEPITNDAGETVRVAGFARDIT 125 (125)
T ss_dssp EEEECGGGTTCEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEEEEcCCCCEEEEEEecEEEECCCCCEEEEEEEEEecC
Confidence 999999999999999999999999999999999999998
|
| >1v9y_A Heme PAS sensor protein; signaling protein; HET: HEM; 1.32A {Escherichia coli} SCOP: d.110.3.2 PDB: 1v9z_A* 1vb6_A* 1s67_L* 1s66_L* | Back alignment and structure |
|---|
Probab=99.43 E-value=2.4e-13 Score=132.70 Aligned_cols=139 Identities=20% Similarity=0.278 Sum_probs=87.7
Q ss_pred EecccccccccccccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHH
Q 002342 171 SGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDV 250 (934)
Q Consensus 171 ~~dit~~~~~e~aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~ 250 (934)
..+++...+..+++...++.|+.++++++++++++|. +|.|+++|+++++++||+.++++|+++..++++.......
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~i~~~d~---~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~ 98 (167)
T 1v9y_A 22 RQDAEVIMKLTDADNAADGIFFPALEQNMMGAVLINE---NDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHP 98 (167)
T ss_dssp ------------------CCHHHHHHTCSSEEEEECT---TSBEEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHH
T ss_pred HhhHHHHHHHHHHHhhhhHHHHHHHHhCCCCEEEECC---CCcEEEECHHHHHHhCCCHHHHcCCChhhccCccccchHH
Confidence 3677777888888889999999999999999999998 7779999999999999999999999988777766655555
Q ss_pred HHHHHHHhcCCc----EEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhh
Q 002342 251 AKIRETLQNGQS----YCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (934)
Q Consensus 251 ~~i~~~l~~g~~----~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~ 314 (934)
..+......+.. +..++...+++|..+|+.+++.|+ +.+|.+ +++++++|||++++++++|+
T Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~-~~~g~~-~~~~~~~DiT~~~~~e~~l~ 164 (167)
T 1v9y_A 99 EYIRHNREGGKARVEGMSRELQLEKKDGSKIWTRFALSKV-SAEGKV-YYLALVRDASVEMAQKEQTR 164 (167)
T ss_dssp HHHHHHHC----------CEEEEECTTSCEEEEEEEEEEE-EETTEE-EEEEEEEC------------
T ss_pred HHHHHHhhcCCCcccccceEEEEEcCCCcEEEEEEEEEEE-ecCCCE-EEEEEEecCcHHHHHHHHHH
Confidence 555555554433 455777789999999999999999 455655 48999999999999998876
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A | Back alignment and structure |
|---|
Probab=99.41 E-value=3.8e-12 Score=118.60 Aligned_cols=118 Identities=27% Similarity=0.537 Sum_probs=101.1
Q ss_pred HHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCC--CCCCCCCCCChHHHHHHHHHHhcCCcEEEE
Q 002342 189 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRN--CRFLQGAGTDPEDVAKIRETLQNGQSYCGR 266 (934)
Q Consensus 189 ~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~--~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e 266 (934)
+.+...+++++++++++|....+|+|+++|++|++++||+.++++|++ +..+.+++........+...+..+..+..+
T Consensus 19 ~~~~~~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (138)
T 2l0w_A 19 DTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVE 98 (138)
T ss_dssp HHHHHHHTTTTSEEEEEESSSTTCBEEEECSHHHHHHSCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHTTCSSCEEEE
T ss_pred HHHHHHHhcCCCCEEEEecCCCCCEEEEeCHHHHHHhCCCHHHHcCCCCcccccCCcccchhHHHHHHHHHhhcCCceeE
Confidence 445566677999999999733346699999999999999999999998 556777776666677788888888888888
Q ss_pred EEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhh
Q 002342 267 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306 (934)
Q Consensus 267 ~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITer 306 (934)
+..++++|..+|+.+++.|+.+.+|.+.+++++++|||++
T Consensus 99 ~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~ 138 (138)
T 2l0w_A 99 IAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEK 138 (138)
T ss_dssp EEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEEEEEC
T ss_pred EEEECCCCCEEEEEEEEEEEeCCCCCEEEEEEEEEeccCC
Confidence 8888999999999999999999999999999999999974
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} | Back alignment and structure |
|---|
Probab=99.40 E-value=4.2e-13 Score=124.24 Aligned_cols=118 Identities=19% Similarity=0.202 Sum_probs=90.1
Q ss_pred HHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEE
Q 002342 191 VKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNY 270 (934)
Q Consensus 191 ~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 270 (934)
|+.++++++++++++|. +|+|+++|+++++++||+.++++|+++..+.+++........+...+.++.. ..++...
T Consensus 1 ~~~l~~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 76 (126)
T 3mjq_A 1 MKNFLETIEDMILIINR---EGRLLYANTAVPKKLGYTHEELMSMHILTITSAGKMAEGEKILAELFAGKKE-SLPLSLE 76 (126)
T ss_dssp -CTTGGGCSSEEEEEET---TSBEEEECTHHHHHHSCCHHHHHHSBHHHHHCTTCHHHHHHHHHHHHHTCCS-EEEEEEE
T ss_pred ChhHHhhCCceEEEEeC---CCcEEEEcHHHHHHHCCCHHHHcCCCHHHHcCchhHHHHHHHHHHHHhCCCc-eeEEEEE
Confidence 34678999999999998 7779999999999999999999999988777777666666666666666655 6778888
Q ss_pred ecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhh
Q 002342 271 KKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (934)
Q Consensus 271 ~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~ 314 (934)
+++|..+|+.++..|+.+ +...+++++++|||+++++++++.
T Consensus 77 ~~~g~~~~~~~~~~~~~~--~~~~~~~~~~~DITe~k~a~~~~~ 118 (126)
T 3mjq_A 77 KKEGTSIPAKARIWQGKW--HNEPCLFAIIKDLSKEERASSPPF 118 (126)
T ss_dssp CTTSCEEEEEEEEEEEES--SSSEEEEEEEEECC----------
T ss_pred ccCCCEEEEEEEEEeeeE--CCceEEEEEEEechHHHHhhcccc
Confidence 999999999999988764 345789999999999999998866
|
| >4dj2_A Period circadian protein homolog 1; PAS domains, circadian clock protein, protein binding; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.7e-12 Score=142.14 Aligned_cols=108 Identities=11% Similarity=0.095 Sum_probs=92.0
Q ss_pred cccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhc-CCcE-EEEEEEEecCCcE
Q 002342 482 EKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDN-QTDV-TVQLINYTKSGKK 559 (934)
Q Consensus 482 ~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~-~~~~-~~e~~~~~kdG~~ 559 (934)
.+-+...+.+|+ ++|+|+++..++||.++|++|+++..++||++.....+.+...+.. +... ..++|++++||..
T Consensus 176 ~~Fitrh~~dG~---~~yvd~~~~~lLGY~peELig~s~~~~vHPdD~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~ 252 (320)
T 4dj2_A 176 RIFTTRHTPSCL---FQDVDERAAPLLGYLPQDLLGAPVLLFLHPEDRPLMLAIHKKILQLAGQPFDHSPIRFCARNGEY 252 (320)
T ss_dssp CEEEEEECTTCB---EEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHTTSSSCCEECCCEEEECSSSCE
T ss_pred ceEEEEecCCce---EEEcCcceeccCCcChHHHcCCcHHHhCCHHHHHHHHHHHHHHHhcCCCcccceEEEEEccCCCE
Confidence 345667788777 9999999999999999999999999999999988888888777774 4455 4699999999999
Q ss_pred EEEEEEEEeeecC-CCCEEEEEEEEEcCCccccc
Q 002342 560 FWNLFHLQPMRDQ-KGEVQYFIGVQLDGSEHLEP 592 (934)
Q Consensus 560 ~wv~~~~~pi~de-~G~v~~~vgi~rDITerk~~ 592 (934)
+|++...++++|. .+++.+++|.-+-|+.....
T Consensus 253 vwvet~~~~~~np~s~~~e~II~~h~v~~gp~~~ 286 (320)
T 4dj2_A 253 VTMDTSWAGFVHPWSRKVAFVLGRHKVRTAPLNE 286 (320)
T ss_dssp EEEECEEEEEECTTTCSEEEEEEEEEESSCCSSC
T ss_pred EEEEEEEEEEECCCCCCccEEEEEEEEccCCCCC
Confidence 9999999999885 57888999998888886653
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} | Back alignment and structure |
|---|
Probab=99.40 E-value=4.8e-13 Score=123.85 Aligned_cols=116 Identities=12% Similarity=0.115 Sum_probs=91.6
Q ss_pred HHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEe
Q 002342 475 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYT 554 (934)
Q Consensus 475 ~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~ 554 (934)
+.++++++++|+++|.+|. |+++|+++++++||+.++++|+++..++++++.......+...+.++.. ..++.+.+
T Consensus 2 ~~l~~~~~~~i~~~d~~g~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 77 (126)
T 3mjq_A 2 KNFLETIEDMILIINREGR---LLYANTAVPKKLGYTHEELMSMHILTITSAGKMAEGEKILAELFAGKKE-SLPLSLEK 77 (126)
T ss_dssp CTTGGGCSSEEEEEETTSB---EEEECTHHHHHHSCCHHHHHHSBHHHHHCTTCHHHHHHHHHHHHHTCCS-EEEEEEEC
T ss_pred hhHHhhCCceEEEEeCCCc---EEEEcHHHHHHHCCCHHHHcCCCHHHHcCchhHHHHHHHHHHHHhCCCc-eeEEEEEc
Confidence 4578899999999999888 9999999999999999999999988888887776666667666666655 77888889
Q ss_pred cCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccccccC
Q 002342 555 KSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNS 596 (934)
Q Consensus 555 kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e~~~ 596 (934)
++|..+|+.++..|+.+ +...+++++++|||++|+++...
T Consensus 78 ~~g~~~~~~~~~~~~~~--~~~~~~~~~~~DITe~k~a~~~~ 117 (126)
T 3mjq_A 78 KEGTSIPAKARIWQGKW--HNEPCLFAIIKDLSKEERASSPP 117 (126)
T ss_dssp TTSCEEEEEEEEEEEES--SSSEEEEEEEEECC---------
T ss_pred cCCCEEEEEEEEEeeeE--CCceEEEEEEEechHHHHhhccc
Confidence 99999999999987764 34568999999999999965443
|
| >3gdi_A Period circadian protein homolog 2; tandem PAS domains, biological rhythms, cytoplasm, nucleus, phosphoprotein, transcription; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.39 E-value=2.3e-12 Score=140.37 Aligned_cols=106 Identities=9% Similarity=0.084 Sum_probs=90.2
Q ss_pred ccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCC-cEE-EEEEEEecCCcEE
Q 002342 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT-DVT-VQLINYTKSGKKF 560 (934)
Q Consensus 483 d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~-~~~-~e~~~~~kdG~~~ 560 (934)
.-+...+.+|+ ++|+|+++..++||.++|++|+++..++||++.....+.+...+..+. ... .+++++++||..+
T Consensus 166 ~Fitrh~~dG~---~~yvd~~~~~lLGY~peELig~s~~~~iHpdD~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~v 242 (309)
T 3gdi_A 166 IFTTTHTPNCL---FQAVDERAVPLLGYLPQDLIETPVLVQLHPSDRPLMLAIHKKILQAGGQPFDYSPIRFRTRNGEYI 242 (309)
T ss_dssp EEEEEECTTCB---EEEECTTHHHHHSCCHHHHTTSBHHHHBCTTSHHHHHHHHHHHHHTTTCCEEEEEEEEECTTSCEE
T ss_pred eEEEEecCCCe---EEEECcccccccCcCHHHHcCCCHHHhCCHHHHHHHHHHHHHHHhcCCceeeceEEEEEccCCCEE
Confidence 45667788777 999999999999999999999999999999998888888888887544 455 6999999999999
Q ss_pred EEEEEEEeeecC-CCCEEEEEEEEEcCCcccc
Q 002342 561 WNLFHLQPMRDQ-KGEVQYFIGVQLDGSEHLE 591 (934)
Q Consensus 561 wv~~~~~pi~de-~G~v~~~vgi~rDITerk~ 591 (934)
|++....++.|. .+++.+++|+-+-|+....
T Consensus 243 wvet~~~~~~np~s~~~e~ii~~h~v~~gp~~ 274 (309)
T 3gdi_A 243 TLDTSWSSFINPWSRKISFIIGRHKVRVGPLN 274 (309)
T ss_dssp EEEEEEEEEECTTTCCEEEEEEEEEEEECCSS
T ss_pred EEEEEEEEEECCCCCcccEEEEEEEEccCCCC
Confidence 999999999886 5778888998888776544
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 | Back alignment and structure |
|---|
Probab=99.39 E-value=5.2e-12 Score=112.25 Aligned_cols=107 Identities=31% Similarity=0.551 Sum_probs=92.3
Q ss_pred ccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCC--CcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 002342 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRN--CRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 560 (934)
Q Consensus 483 d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~--~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~~ 560 (934)
.+|+++|....+++|+++|+++++++||+.++++|++ ...+.+++........+...+..+..+..+....+++|..+
T Consensus 2 ~~i~i~d~~~~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~ 81 (110)
T 1byw_A 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCF 81 (110)
T ss_dssp CEEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEE
T ss_pred CCEEEEeccCCCCcEEEECHHHHHHhCCCHHHHccCCCccccccCCcCCHHHHHHHHHHHhcCCCceEEEEEEcCCCCEE
Confidence 6889999752234499999999999999999999998 55566666666667777888888888899999999999999
Q ss_pred EEEEEEEeeecCCCCEEEEEEEEEcCCcc
Q 002342 561 WNLFHLQPMRDQKGEVQYFIGVQLDGSEH 589 (934)
Q Consensus 561 wv~~~~~pi~de~G~v~~~vgi~rDITer 589 (934)
|+.++..|+.+.+|.+.+++++++|||++
T Consensus 82 ~~~~~~~~~~~~~g~~~~~~~~~~DiTe~ 110 (110)
T 1byw_A 82 LCLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred EEEEEEEEeecCCCCEEEEEEEEEeccCC
Confidence 99999999999999999999999999985
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.1e-12 Score=119.89 Aligned_cols=105 Identities=17% Similarity=0.164 Sum_probs=86.2
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEE
Q 002342 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552 (934)
Q Consensus 473 ~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~ 552 (934)
.++.++++++++|+++|.+|+ |+++|+++++++||++++++|+++..+.++..... ...+..+..+..|.++
T Consensus 14 ~~~~~~~~~~~~i~~~d~~g~---i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~~~~~-----~~~~~~~~~~~~e~~~ 85 (118)
T 3olo_A 14 FAHYLINNAVEASFCLGDNWQ---FLYVNDATCRMTEYSREQLLSMNLQDIDVDFALHD-----WEEIRQKNNYTFKTRY 85 (118)
T ss_dssp HHHHHHHHCSSEEEEECTTSB---EEEECHHHHHHHCCCHHHHTTCBGGGTBTTGGGSC-----HHHHHHHSEEEEEEEE
T ss_pred HHHHHHhcCCceEEEECCCCc---EEEEHHHHHHHHCCCHHHHhCCChhhcccccCHHH-----HHHHHhcCcEEEEEEE
Confidence 378999999999999999888 99999999999999999999999887775443222 2233445677889999
Q ss_pred EecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCC
Q 002342 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587 (934)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDIT 587 (934)
.+++|..+|+.++..|+.+.. ..+++++++|||
T Consensus 86 ~~~~g~~~~~~~~~~~~~~~~--~~~~~~~~~DIT 118 (118)
T 3olo_A 86 RSQSGRIFLVEMSLTFLEDQE--RRFSCVFVREKS 118 (118)
T ss_dssp ECTTCCEEEEEEEEEEEEETT--EEEEEEEEEEC-
T ss_pred EccCCCEEEEEEEEEEEEECC--ccEEEEEEEeCC
Confidence 999999999999999997643 346789999997
|
| >1v9y_A Heme PAS sensor protein; signaling protein; HET: HEM; 1.32A {Escherichia coli} SCOP: d.110.3.2 PDB: 1v9z_A* 1vb6_A* 1s67_L* 1s66_L* | Back alignment and structure |
|---|
Probab=99.37 E-value=1.8e-12 Score=126.39 Aligned_cols=136 Identities=22% Similarity=0.298 Sum_probs=88.1
Q ss_pred CCCchhhHHHHHhhhhc-ccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHH
Q 002342 455 RPDSVDDKVRQKEMRKG-IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATV 533 (934)
Q Consensus 455 ~~dv~~r~~~e~~l~~~-~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~ 533 (934)
+.++.+.+...++++.. ..|..++++++++|+++|.+|. |+++|+++++++||+.++++|+++..++++.......
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~i~~~d~~g~---i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~ 98 (167)
T 1v9y_A 22 RQDAEVIMKLTDADNAADGIFFPALEQNMMGAVLINENDE---VMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHP 98 (167)
T ss_dssp ------------------CCHHHHHHTCSSEEEEECTTSB---EEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHH
T ss_pred HhhHHHHHHHHHHHhhhhHHHHHHHHhCCCCEEEECCCCc---EEEECHHHHHHhCCCHHHHcCCChhhccCccccchHH
Confidence 44555555555555444 5799999999999999999888 9999999999999999999999988888776655554
Q ss_pred HHHHHHHhcCCc----EEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcccccccc
Q 002342 534 RKIRAAIDNQTD----VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRN 595 (934)
Q Consensus 534 ~~i~~~l~~~~~----~~~e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e~~ 595 (934)
..+......+.. +..+....+++|..+|+.++..|+ +.+|.+ +++++++|||++|+++.+
T Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~-~~~g~~-~~~~~~~DiT~~~~~e~~ 162 (167)
T 1v9y_A 99 EYIRHNREGGKARVEGMSRELQLEKKDGSKIWTRFALSKV-SAEGKV-YYLALVRDASVEMAQKEQ 162 (167)
T ss_dssp HHHHHHHC----------CEEEEECTTSCEEEEEEEEEEE-EETTEE-EEEEEEEC----------
T ss_pred HHHHHHhhcCCCcccccceEEEEEcCCCcEEEEEEEEEEE-ecCCCE-EEEEEEecCcHHHHHHHH
Confidence 555555544433 455788889999999999999999 456666 499999999999986443
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A | Back alignment and structure |
|---|
Probab=99.36 E-value=7.2e-12 Score=116.70 Aligned_cols=113 Identities=29% Similarity=0.523 Sum_probs=100.0
Q ss_pred HHHHHHhccccEEEEcC---CCCCCCEEEccHHHHHHcCCChhhhcCCC--CcccCCCCCCHHHHHHHHHHHhcCCcEEE
Q 002342 474 LATTLERIEKNFVITDP---RLPDNPIIFASDSFLELTEYSREEILGRN--CRFLQGPETDPATVRKIRAAIDNQTDVTV 548 (934)
Q Consensus 474 l~~i~e~~~d~i~v~D~---~G~~~~I~~vN~a~~~l~Gys~eEliG~~--~~~l~~~~~~~~~~~~i~~~l~~~~~~~~ 548 (934)
+...+++++++|+++|. +|. |+++|+++++++||+.++++|++ +..+.+++........+...+..+..+..
T Consensus 21 ~~~~~~~~~~~i~~~d~~~~~g~---i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (138)
T 2l0w_A 21 IIRKFEGQSRKFIIANARVENCA---VIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKV 97 (138)
T ss_dssp HHHHHTTTTSEEEEEESSSTTCB---EEEECSHHHHHHSCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHTTCSSCEEE
T ss_pred HHHHHhcCCCCEEEEecCCCCCE---EEEeCHHHHHHhCCCHHHHcCCCCcccccCCcccchhHHHHHHHHHhhcCCcee
Confidence 45556779999999999 888 99999999999999999999998 56666777777667777788888888888
Q ss_pred EEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcc
Q 002342 549 QLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH 589 (934)
Q Consensus 549 e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITer 589 (934)
+....+++|..+|+.+++.|+.+.+|.+.+++++++|||++
T Consensus 98 ~~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~ 138 (138)
T 2l0w_A 98 EIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEK 138 (138)
T ss_dssp EEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEEEEEC
T ss_pred EEEEECCCCCEEEEEEEEEEEeCCCCCEEEEEEEEEeccCC
Confidence 99999999999999999999999999999999999999985
|
| >3mfx_A Sensory BOX/ggdef family protein; alpha-beta protein, structural genomics, PSI-2, protein structure initiative; 2.40A {Shewanella oneidensis} | Back alignment and structure |
|---|
Probab=99.35 E-value=2.1e-12 Score=122.60 Aligned_cols=112 Identities=11% Similarity=0.065 Sum_probs=84.7
Q ss_pred HHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcC-------
Q 002342 188 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNG------- 260 (934)
Q Consensus 188 ~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g------- 260 (934)
.+.++.++++++++|+++|. +|+|+++|++|++++||+++|++|+++..++++.........+......+
T Consensus 6 ~~~l~~i~~~~~d~i~~~D~---~g~I~~~N~aa~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (129)
T 3mfx_A 6 LETIELFIQHLTEAMILVNA---NGFIRSCNQRSAELLDCPQVSLKGQDWRNFLTEHHQARYDNLLSHDVQLGTNCGQPV 82 (129)
T ss_dssp HHHHHHHHTTCSSEEEEEET---TSBEEEECHHHHHHTTSCHHHHTTSBGGGGBCTTCCGGGGCTTC----------CCS
T ss_pred HHHHHHHHhcCCceEEEECC---CCEEEeEhHHHHHHHCcCHHHHcCCcHHHHcChHhHHHHHHHHHHHHhcCccccccc
Confidence 36789999999999999998 77799999999999999999999999987777766543222222111111
Q ss_pred CcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchh
Q 002342 261 QSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 305 (934)
Q Consensus 261 ~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITe 305 (934)
..+..++..+++||+.+|++++++|+.+ ++. .|+++++|+..
T Consensus 83 ~~~~~E~~~~rkdG~~~~velsis~i~~--~~~-~~v~~~~~~~~ 124 (129)
T 3mfx_A 83 QHPAQETTLICASGKAKDVELSISYIPG--HEP-MFVMVMHDLEH 124 (129)
T ss_dssp CEEEEEEEEECTTSCEEEEEEEEEEECS--SSC-EEEEEEEEC--
T ss_pred CCCceEEEEEcCCCCEEEEEEEEEEecC--CCc-EEEEEEechhh
Confidence 1245788889999999999999999973 333 37899999753
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* | Back alignment and structure |
|---|
Probab=99.35 E-value=3.6e-12 Score=122.54 Aligned_cols=108 Identities=39% Similarity=0.784 Sum_probs=95.5
Q ss_pred HHHHHHhccccEEEEc---CCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCC-----------CHHHHHHHHHH
Q 002342 474 LATTLERIEKNFVITD---PRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPET-----------DPATVRKIRAA 539 (934)
Q Consensus 474 l~~i~e~~~d~i~v~D---~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~-----------~~~~~~~i~~~ 539 (934)
+..+++.. ++|+++| .+|+ |+++|+++++++||+.+|++|+++..+.+++. .......+...
T Consensus 28 ~~~~~~~~-~~i~~~d~~d~~g~---i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 103 (149)
T 3d72_A 28 ELGPVDTS-VALILCDLKQKDTP---IVYASEAFLYMTGYSNAEVLGRNCRFLQSPDGMVKPKSTRKYVDSNTINTMRKA 103 (149)
T ss_dssp CCCSCCTT-SCEEEEETTSTTCC---EEEECHHHHHHHCCCHHHHTTSCGGGGGSTTSCCCTTCCCSSSCHHHHHHHHHH
T ss_pred HHHhhcCC-ccEEEEeccCCCCc---EEEECHHHHHHHCcCHHHHcCCChhHhCCccccccccccccccChHHHHHHHHH
Confidence 33456664 9999999 6777 99999999999999999999999888887764 66677778888
Q ss_pred HhcCCcEEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEc
Q 002342 540 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585 (934)
Q Consensus 540 l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rD 585 (934)
+..+..+..+++..+++|..+|+.+++.|+++++|++.+++++++|
T Consensus 104 ~~~~~~~~~e~~~~~~dG~~~~~~~~~~~i~~~~g~~~~~v~~~~D 149 (149)
T 3d72_A 104 IDRNAEVQVEVVNFKKNGQRFVNFLTMIPVRDETGEYRYSMGFQCE 149 (149)
T ss_dssp HHHTCCEEEEEEEECTTCCEEEEEEEEEEEECTTSSEEEEEEECCC
T ss_pred HHCCCceEEEEEEECCCCCEEEEEEEEEEEEcCCCCEEEEEEEEeC
Confidence 8888889999999999999999999999999999999999999887
|
| >3vol_A Aerotaxis transducer AER2; heme, oxygen sensor protein, PAS, HAMP, cyanoMet, CN-bound, protein; HET: HEM; 2.40A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.32 E-value=9.3e-12 Score=130.86 Aligned_cols=118 Identities=15% Similarity=0.216 Sum_probs=94.0
Q ss_pred ccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHc------------CCChhhHcCCCCCCCCCCCCChHHHH
Q 002342 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMT------------GYTSKEVVGRNCRFLQGAGTDPEDVA 251 (934)
Q Consensus 184 L~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~------------Gys~eEllG~~~~~l~~~~~~~~~~~ 251 (934)
+.....+++.++++++++|+++|. +|+|+|+|++|++++ ||++++++|+++..+++. .....
T Consensus 17 ~~~e~~~l~~iLd~~~~~vii~D~---~g~I~~~N~a~~~ll~~~~~~~~~~l~G~~~~eliG~~~~~~~~~---~~~~~ 90 (233)
T 3vol_A 17 RGSHMARIKSALDNVSANVMIADN---DLNIIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFHKN---PAHQR 90 (233)
T ss_dssp -CTHHHHHHHHHTTSSSEEEEEET---TSBEEEECHHHHHHHHHTHHHHHTTCTTCCTTSCTTCBGGGGSSS---HHHHH
T ss_pred hHHHHHHHHHHHhcCCCcEEEECC---CCcEEEecHHHHHHHHHHHHHHHhhcCCCCHHHHcCCCHHHHcCC---HHHHH
Confidence 345557889999999999999998 778999999999999 899999999998866542 33333
Q ss_pred HHHHHHhcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhh
Q 002342 252 KIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (934)
Q Consensus 252 ~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~ 314 (934)
.++..+. ..+..++. .+|. |+.++++|++|++|.+.|++++++|||++++++++++
T Consensus 91 ~~~~~~~--~~~~~~~~---~~g~--~~~~~~~Pi~d~~G~~~g~v~~~~DITe~~~~e~ei~ 146 (233)
T 3vol_A 91 HLLANLT--GVHKAELN---LGGR--RFSLDVVPVFNDANERLGSAVQWTDRTEEHRAEQEVS 146 (233)
T ss_dssp HHHHTCC--SCEEEEEE---ETTE--EEEEEEEEEECTTCCEEEEEEEEEECHHHHHHHHHHH
T ss_pred HHHHhcc--cceeEEEE---ECCE--EEEEEEEEEECCCCCEEEEEEEEehhhHHHHHHHHHH
Confidence 4444332 23444443 3553 7799999999999999999999999999999998876
|
| >3mfx_A Sensory BOX/ggdef family protein; alpha-beta protein, structural genomics, PSI-2, protein structure initiative; 2.40A {Shewanella oneidensis} | Back alignment and structure |
|---|
Probab=99.31 E-value=4.4e-12 Score=120.38 Aligned_cols=111 Identities=12% Similarity=0.093 Sum_probs=85.0
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcC-------Cc
Q 002342 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ-------TD 545 (934)
Q Consensus 473 ~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~-------~~ 545 (934)
.++.++++++++|+++|.+|+ |+++|+++++++||++++++|+++..++++++.......+......+ ..
T Consensus 8 ~l~~i~~~~~d~i~~~D~~g~---I~~~N~aa~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (129)
T 3mfx_A 8 TIELFIQHLTEAMILVNANGF---IRSCNQRSAELLDCPQVSLKGQDWRNFLTEHHQARYDNLLSHDVQLGTNCGQPVQH 84 (129)
T ss_dssp HHHHHHTTCSSEEEEEETTSB---EEEECHHHHHHTTSCHHHHTTSBGGGGBCTTCCGGGGCTTC----------CCSCE
T ss_pred HHHHHHhcCCceEEEECCCCE---EEeEhHHHHHHHCcCHHHHcCCcHHHHcChHhHHHHHHHHHHHHhcCcccccccCC
Confidence 389999999999999999888 99999999999999999999999998888876543222222111111 12
Q ss_pred EEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcc
Q 002342 546 VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH 589 (934)
Q Consensus 546 ~~~e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITer 589 (934)
...|+..+++||+.+|++++++|+.+ |+. .|+++++|+...
T Consensus 85 ~~~E~~~~rkdG~~~~velsis~i~~--~~~-~~v~~~~~~~~~ 125 (129)
T 3mfx_A 85 PAQETTLICASGKAKDVELSISYIPG--HEP-MFVMVMHDLEHH 125 (129)
T ss_dssp EEEEEEEECTTSCEEEEEEEEEEECS--SSC-EEEEEEEEC---
T ss_pred CceEEEEEcCCCCEEEEEEEEEEecC--CCc-EEEEEEechhhh
Confidence 45789999999999999999999973 333 478999997543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=1.6e-11 Score=131.24 Aligned_cols=140 Identities=13% Similarity=0.080 Sum_probs=112.1
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCCeEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~l 746 (934)
...|++...++.|+.+.||++.. .+..+++|+....... ....+.+|..+|+.+. +..++++++++...+..|+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 35799999999999999999975 4678999998643111 1235788999999984 6778899999999899999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC------------------------------------- 789 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~------------------------------------- 789 (934)
||||++|.+|.+.+.. ......++.++..+|..||+
T Consensus 88 v~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999998876321 12234678899999999998
Q ss_pred ----------------------CCCeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 790 ----------------------QGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 790 ----------------------~giiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999865556799999874
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.24 E-value=4.8e-12 Score=117.11 Aligned_cols=108 Identities=11% Similarity=0.125 Sum_probs=76.4
Q ss_pred hHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEE
Q 002342 187 VSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGR 266 (934)
Q Consensus 187 ~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e 266 (934)
+++.|+.++++++++|+++|. +|+|+++|++|++++||+.++++|+++..+.+++...............+...
T Consensus 17 ~~~~~~~i~~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 90 (125)
T 3fc7_A 17 TRKKFESLVSDSPDGIVHLTT---NGTILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLEAGKSAVENGTAT--- 90 (125)
T ss_dssp ---------CCSCCEEEEEET---TSBEEEECHHHHHHHTSCHHHHTTSBGGGSSCHHHHHHHHHHHHHHHHHTSCE---
T ss_pred HHHHHHHHHhcCCCeEEEEcC---CCeEEEECHHHHHHhCCCHHHHcCccHHHhCCHHHHHHHHHHHHHHhcCCCeE---
Confidence 778999999999999999998 77799999999999999999999999887663332222223334555666543
Q ss_pred EEEEecCCc-EEEEEEEeeeeecCCCCEEEEEEEEecch
Q 002342 267 LLNYKKDGT-PFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (934)
Q Consensus 267 ~~~~~kdG~-~~wv~~s~~pi~d~~G~v~~~v~~~~DIT 304 (934)
..++|. .+|+.+++.|+.+. |...+++++++|||
T Consensus 91 ---~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~~DIT 125 (125)
T 3fc7_A 91 ---RSEDAVGGRHYHNQYIPVDSH-RKSDTFQLVSRDIT 125 (125)
T ss_dssp ---EEEEEETTEEEEEEEEESSTT-TTTTEEEEEEEECC
T ss_pred ---EeEcCCCcEEEEEEEEeEecC-CCeEEEEEEEecCC
Confidence 234455 67999999998765 66678999999997
|
| >4hi4_A Aerotaxis transducer AER2; PAS domain, diatomic GAS sensor, signaling protein; HET: HEM GOL; 2.30A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.23 E-value=5.7e-11 Score=110.69 Aligned_cols=106 Identities=17% Similarity=0.256 Sum_probs=80.4
Q ss_pred HHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcC------------CChhhHcCCCCCCCCCCCCChHHHHHHHH
Q 002342 188 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTG------------YTSKEVVGRNCRFLQGAGTDPEDVAKIRE 255 (934)
Q Consensus 188 ~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~G------------ys~eEllG~~~~~l~~~~~~~~~~~~i~~ 255 (934)
..++++++++++++|+++|. +|+|+|+|++|++++| |++++++|+++..+.+. ......+..
T Consensus 4 ~~rl~~il~~~~~gviv~D~---~g~I~~~N~a~~~llg~~~~~i~~~~~g~~~~~~~G~~~~~~~~~---~~~~~~~~~ 77 (121)
T 4hi4_A 4 MARIASALDNVSANVMIADN---DLNIIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFHKN---PAHQRHLLA 77 (121)
T ss_dssp HHHHHHHHTTSSSEEEEEET---TCBEEEECHHHHHHHHHTHHHHHHHCTTCCGGGCTTCBGGGGCSS---HHHHHHHHH
T ss_pred HHHHHHHHhcCCccEEEEcC---CCeEEEecHHHHHHHHHHHHHHHHhcCCCChHHhcCCCHHHhcCC---HHHHHHHHh
Confidence 36789999999999999998 7779999999999995 89999999998866542 222223333
Q ss_pred HHhcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhh
Q 002342 256 TLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306 (934)
Q Consensus 256 ~l~~g~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITer 306 (934)
.+. ..+..++. .+|. ++.++++|++|.+|.+.|++++++|||++
T Consensus 78 ~~~--~~~~~~~~---~~~~--~~~~~~~pi~~~~g~~~g~v~~~~DiTee 121 (121)
T 4hi4_A 78 NLT--GVHKAELN---LGGR--RFSLDVVPVFNDANARLGSAVQWTDRTEE 121 (121)
T ss_dssp HCS--SCEEEEEE---ETTE--EEEEEEEEEECTTSCEEEEEEEEEECC--
T ss_pred CcC--CCcEEEEE---ECCE--EEEEEEEEEECCCCCEEEEEEEEEEecCC
Confidence 222 33444433 3554 56789999999999999999999999974
|
| >2qkp_A Uncharacterized protein; structural genomics, unknown function, PSI-2, protein struct initiative; 1.75A {Streptococcus mutans} | Back alignment and structure |
|---|
Probab=99.22 E-value=2.2e-11 Score=118.78 Aligned_cols=122 Identities=16% Similarity=0.127 Sum_probs=95.7
Q ss_pred hHHHHHHHHHhccCcEEEEeCCCCCCceEEcchH---HHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcE
Q 002342 187 VSDIVKDALSTFQQTFVVSDATKPDYPIMYASAG---FFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSY 263 (934)
Q Consensus 187 ~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a---~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~ 263 (934)
+.+.+.++|++++++|+++|. +|+|+|+|++ +++++| ..++++|+++..+.++. .....+.+...++++...
T Consensus 17 ~~~~l~~IL~~~~~gI~~vD~---~g~I~~~N~a~~~~~~i~g-~~~~~iGr~v~~~~~~~-~~~~v~~i~~~l~~g~~~ 91 (151)
T 2qkp_A 17 SVEQANLILNHLPLEITFVNK---DDIFQYYNDSVPAAEMVFK-RTPSQVGRNVELCHPPK-VLDKVKKVFELLRNGQRD 91 (151)
T ss_dssp CHHHHHHHHHHSSSEEEEEET---TSBEEEECCCSCGGGCSSC-CCGGGTTSBGGGSSCHH-HHHHHHHHHHHHHTTSBS
T ss_pred cHHHHHHHHHhCCCceEEEcC---CCeEEEEeCCCchhhhhcC-CCHHHcCCCHHHhCCHH-HHHHHHHHHHHHHcCCcc
Confidence 346789999999999999999 7779999999 999999 56789999998765532 233345567778878776
Q ss_pred EEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhh
Q 002342 264 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (934)
Q Consensus 264 ~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~ 314 (934)
..++.....+ ...++.++..|++|++|.+.|++.+++|||+.++++++++
T Consensus 92 ~~~~~~~~~~-~~~~v~v~~~Pi~d~~G~~~G~vev~~Dit~l~~le~~r~ 141 (151)
T 2qkp_A 92 KVNMWFQSER-LGKFVYVTYAAVRDQAGDFQGVLEYVQDIKPFFELDSEFN 141 (151)
T ss_dssp EEEEEEEETT-TTEEEEEEEEEEECTTCCEEEEEEEEEECGGGGGGGGC--
T ss_pred EEEEEEecCC-CCeEEEEEEEEEECCCCCEEEEEEEEEECHHHHhhhhhhh
Confidence 6665543332 1246788999999999999999999999999998887754
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.20 E-value=1e-11 Score=114.94 Aligned_cols=108 Identities=11% Similarity=0.086 Sum_probs=77.0
Q ss_pred hcccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEE
Q 002342 470 KGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQ 549 (934)
Q Consensus 470 ~~~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e 549 (934)
....|+.++++++++|+++|.+|+ |+++|+++++++||+.++++|+++..+++++...............+...
T Consensus 17 ~~~~~~~i~~~~~~~i~~~d~~g~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 90 (125)
T 3fc7_A 17 TRKKFESLVSDSPDGIVHLTTNGT---ILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLEAGKSAVENGTAT--- 90 (125)
T ss_dssp ---------CCSCCEEEEEETTSB---EEEECHHHHHHHTSCHHHHTTSBGGGSSCHHHHHHHHHHHHHHHHHTSCE---
T ss_pred HHHHHHHHHhcCCCeEEEEcCCCe---EEEECHHHHHHhCCCHHHHcCccHHHhCCHHHHHHHHHHHHHHhcCCCeE---
Confidence 445699999999999999999888 99999999999999999999999888874332222333334555555543
Q ss_pred EEEEecCCc-EEEEEEEEEeeecCCCCEEEEEEEEEcCC
Q 002342 550 LINYTKSGK-KFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587 (934)
Q Consensus 550 ~~~~~kdG~-~~wv~~~~~pi~de~G~v~~~vgi~rDIT 587 (934)
..++|. .+|+.+++.|+.+. |...+++++++|||
T Consensus 91 ---~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~~DIT 125 (125)
T 3fc7_A 91 ---RSEDAVGGRHYHNQYIPVDSH-RKSDTFQLVSRDIT 125 (125)
T ss_dssp ---EEEEEETTEEEEEEEEESSTT-TTTTEEEEEEEECC
T ss_pred ---EeEcCCCcEEEEEEEEeEecC-CCeEEEEEEEecCC
Confidence 234455 67999999998765 66678999999998
|
| >4f3l_A Mclock, circadian locomoter output cycles protein kaput; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.6e-11 Score=137.77 Aligned_cols=108 Identities=11% Similarity=0.011 Sum_probs=97.0
Q ss_pred CcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEE
Q 002342 200 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWN 279 (934)
Q Consensus 200 d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~wv 279 (934)
..++..|. ||+|+|+|++++.++||+++|++|+++..++||++.......++..+..|..+..++++++|||+.+|+
T Consensus 252 ~f~~~~~~---dg~~~~vn~~~~~ilGY~~eEl~g~~~~~~iHpdD~~~~~~~~~~~l~~g~~~~~eyR~~~kdG~~vWv 328 (361)
T 4f3l_A 252 EFTSRHSL---EWKFLFLDHRAPPIIGYLPFEVLGTSGYDYYHVDDLENLAKCHEHLMQYGKGKSCYYRFLTKGQQWIWL 328 (361)
T ss_dssp EEEEEECT---TSBEEEECTTSHHHHCCCHHHHTTSBGGGGBCHHHHHHHHHHHHHHHHHSEEECCCEEEECTTSEEEEE
T ss_pred eeEEEEcC---CceEEEECChhhhhhCcCHHHHcCCCHHHeECHHHHHHHHHHHHHHHhCCCcceEEEEEEecCCCEEEE
Confidence 34555555 888999999999999999999999999999999988888888888888888777889999999999999
Q ss_pred EEEeeeeecC-CCCEEEEEEEEecchhhHHHH
Q 002342 280 LLTIAPIKDD-EGKVLKFIGMQVEVSKHTEGA 310 (934)
Q Consensus 280 ~~s~~pi~d~-~G~v~~~v~~~~DITerk~~e 310 (934)
+.+..|++|. +|.+.+++++.+|||+++..+
T Consensus 329 ~~~~~~v~~~~~g~~~~iv~~~~dITe~~~~~ 360 (361)
T 4f3l_A 329 QTHYYITYHQWNSRPEFIVCTHTVVSYAEVRA 360 (361)
T ss_dssp EEEEEEEECTTTCCEEEEEEEEEECCHHHHHH
T ss_pred EEEEEEEEcCCCCCeeEEEEEEEECChhHhhc
Confidence 9999999998 799999999999999998765
|
| >3vol_A Aerotaxis transducer AER2; heme, oxygen sensor protein, PAS, HAMP, cyanoMet, CN-bound, protein; HET: HEM; 2.40A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.19 E-value=7.6e-11 Score=123.87 Aligned_cols=107 Identities=19% Similarity=0.280 Sum_probs=85.5
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHc------------CCChhhhcCCCCcccCCCCCCHHHHHHHHHHH
Q 002342 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELT------------EYSREEILGRNCRFLQGPETDPATVRKIRAAI 540 (934)
Q Consensus 473 ~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~------------Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l 540 (934)
++..++++++++|+++|.+|+ |+|+|++|++++ ||++++++|+++..+.+. ......+...+
T Consensus 23 ~l~~iLd~~~~~vii~D~~g~---I~~~N~a~~~ll~~~~~~~~~~l~G~~~~eliG~~~~~~~~~---~~~~~~~~~~~ 96 (233)
T 3vol_A 23 RIKSALDNVSANVMIADNDLN---IIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFHKN---PAHQRHLLANL 96 (233)
T ss_dssp HHHHHHTTSSSEEEEEETTSB---EEEECHHHHHHHHHTHHHHHTTCTTCCTTSCTTCBGGGGSSS---HHHHHHHHHTC
T ss_pred HHHHHHhcCCCcEEEECCCCc---EEEecHHHHHHHHHHHHHHHhhcCCCCHHHHcCCCHHHHcCC---HHHHHHHHHhc
Confidence 388999999999999999888 999999999998 899999999998877653 23333333332
Q ss_pred hcCCcEEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccc
Q 002342 541 DNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 592 (934)
Q Consensus 541 ~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~ 592 (934)
. ..+..++. .+|. |+.+++.|++|++|++.+++++++|||+++++
T Consensus 97 ~--~~~~~~~~---~~g~--~~~~~~~Pi~d~~G~~~g~v~~~~DITe~~~~ 141 (233)
T 3vol_A 97 T--GVHKAELN---LGGR--RFSLDVVPVFNDANERLGSAVQWTDRTEEHRA 141 (233)
T ss_dssp C--SCEEEEEE---ETTE--EEEEEEEEEECTTCCEEEEEEEEEECHHHHHH
T ss_pred c--cceeEEEE---ECCE--EEEEEEEEEECCCCCEEEEEEEEehhhHHHHH
Confidence 2 23444442 3564 77899999999999999999999999999983
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=99.18 E-value=2.3e-11 Score=112.18 Aligned_cols=94 Identities=17% Similarity=0.104 Sum_probs=68.7
Q ss_pred HHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEec
Q 002342 193 DALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKK 272 (934)
Q Consensus 193 ~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~k 272 (934)
.+++++++.|+++|. +|+|+|+|+++++++||+++|++|+++..+.||++.......+. ..+.....+++.++|
T Consensus 3 ~lle~~~d~i~v~d~---~G~i~yvn~~~~~~lGy~~~el~G~~~~~~ihp~D~~~~~~~~~---~~~~~~~~e~r~~~k 76 (111)
T 2vlg_A 3 FPLQTKTDIHAVLAS---NGRIIYISANSKLHLGYLQGEMIGSFLKTFLHEEDQFLVESYFY---NEHHLMPCTFRFIKK 76 (111)
T ss_dssp ------CCEEEEECT---TSBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHHHHHHH---CSCCSSCEEEEEECT
T ss_pred chhhcCCCEEEEEcC---CCeEEEEChHHHHHhCCCHHHHcCCcHHHeECHhHHHHHHHHHh---ccCCCccEEEEEEcC
Confidence 578999999999998 78899999999999999999999999988888887665544332 223334567888999
Q ss_pred CCcEEEEEEEeeeeecCCCC
Q 002342 273 DGTPFWNLLTIAPIKDDEGK 292 (934)
Q Consensus 273 dG~~~wv~~s~~pi~d~~G~ 292 (934)
||+.+|++++++++.+..+.
T Consensus 77 dG~~~wve~~~~~v~~~~~~ 96 (111)
T 2vlg_A 77 DHTIVWVEAAVEIVTTRAER 96 (111)
T ss_dssp TSCEEEEEEEEEEC------
T ss_pred CCCEEEEEEEEEEEecccCC
Confidence 99999999999999987653
|
| >4hi4_A Aerotaxis transducer AER2; PAS domain, diatomic GAS sensor, signaling protein; HET: HEM GOL; 2.30A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.7e-10 Score=107.39 Aligned_cols=104 Identities=19% Similarity=0.284 Sum_probs=79.2
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcC------------CChhhhcCCCCcccCCCCCCHHHHHHHHHHH
Q 002342 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTE------------YSREEILGRNCRFLQGPETDPATVRKIRAAI 540 (934)
Q Consensus 473 ~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~G------------ys~eEliG~~~~~l~~~~~~~~~~~~i~~~l 540 (934)
+++.+++++++||+++|.+|+ |+++|++|++++| |+.++++|++...+.+. ......+....
T Consensus 6 rl~~il~~~~~gviv~D~~g~---I~~~N~a~~~llg~~~~~i~~~~~g~~~~~~~G~~~~~~~~~---~~~~~~~~~~~ 79 (121)
T 4hi4_A 6 RIASALDNVSANVMIADNDLN---IIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFHKN---PAHQRHLLANL 79 (121)
T ss_dssp HHHHHHTTSSSEEEEEETTCB---EEEECHHHHHHHHHTHHHHHHHCTTCCGGGCTTCBGGGGCSS---HHHHHHHHHHC
T ss_pred HHHHHHhcCCccEEEEcCCCe---EEEecHHHHHHHHHHHHHHHHhcCCCChHHhcCCCHHHhcCC---HHHHHHHHhCc
Confidence 489999999999999999888 9999999999995 89999999998777643 22222222222
Q ss_pred hcCCcEEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcc
Q 002342 541 DNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH 589 (934)
Q Consensus 541 ~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITer 589 (934)
. ..+..++. .+|. ++.++++|++|.+|++.|++++++|||++
T Consensus 80 ~--~~~~~~~~---~~~~--~~~~~~~pi~~~~g~~~g~v~~~~DiTee 121 (121)
T 4hi4_A 80 T--GVHKAELN---LGGR--RFSLDVVPVFNDANARLGSAVQWTDRTEE 121 (121)
T ss_dssp S--SCEEEEEE---ETTE--EEEEEEEEEECTTSCEEEEEEEEEECC--
T ss_pred C--CCcEEEEE---ECCE--EEEEEEEEEECCCCCEEEEEEEEEEecCC
Confidence 2 33444433 3554 55788999999999999999999999984
|
| >3fg8_A Uncharacterized protein RHA05790; PAS domain, structural genomics, PS protein structure initiative, midwest center for structural genomics, MCSG; HET: 3PB; 1.80A {Rhodococcus SP} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.5e-11 Score=114.09 Aligned_cols=107 Identities=14% Similarity=0.086 Sum_probs=87.7
Q ss_pred ccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEE
Q 002342 472 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLI 551 (934)
Q Consensus 472 ~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~ 551 (934)
.+++.++++++++|+++|.+|+ |+++|+++++++|++.++++|+++..++++.........+...+..+.....++.
T Consensus 12 ~~~~~il~~~~~~i~~~D~~g~---i~~~N~a~~~l~g~~~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (118)
T 3fg8_A 12 SGRENLYFQGGLGFMALDEDLR---IIYVNSGCLRHVRRSRDELLGRVVTEVLPETQGSYFDALCRKVLATGREQQTRVD 88 (118)
T ss_dssp -CCCCSSSCTTCEEEEECTTCB---EEEECHHHHHHHTCCHHHHTTSBHHHHCGGGTTSHHHHHHHHHHHHCCCEEEEEE
T ss_pred chHHHHHhhCCceEEEECCCCe---EEEECHHHHHHhCCCHHHHcCCcHHHHcCccchHHHHHHHHHHHHcCCceEEEEE
Confidence 3477889999999999999888 9999999999999999999999988888776666677778888888888777544
Q ss_pred EEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCcc
Q 002342 552 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH 589 (934)
Q Consensus 552 ~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITer 589 (934)
....+| .|+.+++.|+.+ | ++++++|||+|
T Consensus 89 ~~~~~g--~~~~~~~~p~~~--g----~v~~~~DITer 118 (118)
T 3fg8_A 89 SLYSPG--MTIEVTAAADSG--A----LVVHFRDVTAE 118 (118)
T ss_dssp CSSSTT--CEEEEEEEEETT--E----EEEEEEECSCC
T ss_pred EEcCCC--eEEEEEEEEcCC--c----EEEEEEeccCC
Confidence 333466 478888888743 3 78889999986
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=99.16 E-value=3.7e-11 Score=110.77 Aligned_cols=93 Identities=11% Similarity=0.061 Sum_probs=70.7
Q ss_pred HHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEec
Q 002342 476 TTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTK 555 (934)
Q Consensus 476 ~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~k 555 (934)
.++++++++|+++|.+|+ |+|+|+++++++||+++|++|+++..++||++.....+.+. ..+.....+++++++
T Consensus 3 ~lle~~~d~i~v~d~~G~---i~yvn~~~~~~lGy~~~el~G~~~~~~ihp~D~~~~~~~~~---~~~~~~~~e~r~~~k 76 (111)
T 2vlg_A 3 FPLQTKTDIHAVLASNGR---IIYISANSKLHLGYLQGEMIGSFLKTFLHEEDQFLVESYFY---NEHHLMPCTFRFIKK 76 (111)
T ss_dssp ------CCEEEEECTTSB---EEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHHHHHHH---CSCCSSCEEEEEECT
T ss_pred chhhcCCCEEEEEcCCCe---EEEEChHHHHHhCCCHHHHcCCcHHHeECHhHHHHHHHHHh---ccCCCccEEEEEEcC
Confidence 468899999999999888 99999999999999999999999999999998776544332 223334568889999
Q ss_pred CCcEEEEEEEEEeeecCCC
Q 002342 556 SGKKFWNLFHLQPMRDQKG 574 (934)
Q Consensus 556 dG~~~wv~~~~~pi~de~G 574 (934)
||+.+|++++++++.+..+
T Consensus 77 dG~~~wve~~~~~v~~~~~ 95 (111)
T 2vlg_A 77 DHTIVWVEAAVEIVTTRAE 95 (111)
T ss_dssp TSCEEEEEEEEEEC-----
T ss_pred CCCEEEEEEEEEEEecccC
Confidence 9999999999999988655
|
| >3fg8_A Uncharacterized protein RHA05790; PAS domain, structural genomics, PS protein structure initiative, midwest center for structural genomics, MCSG; HET: 3PB; 1.80A {Rhodococcus SP} | Back alignment and structure |
|---|
Probab=99.16 E-value=9.9e-12 Score=115.24 Aligned_cols=112 Identities=17% Similarity=0.121 Sum_probs=86.9
Q ss_pred ccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcE
Q 002342 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSY 263 (934)
Q Consensus 184 L~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~ 263 (934)
+....+.+++++++++++|+++|. +|+|+++|+++++++||+.++++|+++..++++.........+..++..+...
T Consensus 7 ~~~~~~~~~~il~~~~~~i~~~D~---~g~i~~~N~a~~~l~g~~~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (118)
T 3fg8_A 7 HHHHSSGRENLYFQGGLGFMALDE---DLRIIYVNSGCLRHVRRSRDELLGRVVTEVLPETQGSYFDALCRKVLATGREQ 83 (118)
T ss_dssp ------CCCCSSSCTTCEEEEECT---TCBEEEECHHHHHHHTCCHHHHTTSBHHHHCGGGTTSHHHHHHHHHHHHCCCE
T ss_pred cccccchHHHHHhhCCceEEEECC---CCeEEEECHHHHHHhCCCHHHHcCCcHHHHcCccchHHHHHHHHHHHHcCCce
Confidence 334455667789999999999998 78899999999999999999999999887777666666777888888888887
Q ss_pred EEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhh
Q 002342 264 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306 (934)
Q Consensus 264 ~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITer 306 (934)
..++.....+| .|+.+++.|+.+ +++++++|||++
T Consensus 84 ~~~~~~~~~~g--~~~~~~~~p~~~------g~v~~~~DITer 118 (118)
T 3fg8_A 84 QTRVDSLYSPG--MTIEVTAAADSG------ALVVHFRDVTAE 118 (118)
T ss_dssp EEEEECSSSTT--CEEEEEEEEETT------EEEEEEEECSCC
T ss_pred EEEEEEEcCCC--eEEEEEEEEcCC------cEEEEEEeccCC
Confidence 76443333466 578888889743 378899999985
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} | Back alignment and structure |
|---|
Probab=99.15 E-value=1.2e-10 Score=106.60 Aligned_cols=107 Identities=21% Similarity=0.254 Sum_probs=83.6
Q ss_pred HHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcE-EEEEE
Q 002342 190 IVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSY-CGRLL 268 (934)
Q Consensus 190 ~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~-~~e~~ 268 (934)
+...++++++++++++|. +|+|+++|+++++++||+.++++|+++..+.++... ....+..++..+... ..++.
T Consensus 8 l~~~il~~~~~~i~~~D~---~g~I~~~N~aa~~l~g~~~~~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 82 (115)
T 3b33_A 8 LPSAILNNMVTATLILDD---GLAIRYANPAAELLFSQSAKRIVEQSLSQLIQHASL--DLALLTQPLQSGQSITDSDVT 82 (115)
T ss_dssp HHHHHHHHCSSEEEEECT---TCBEEEECHHHHHHTTSCHHHHTTCBHHHHCSEEEC--CTHHHHHHHHHCCCEEEEEEE
T ss_pred cHHHHHhhcCceEEEECC---CCcEEEECHHHHHHhCCCHHHHhCCCHHHHhCccch--hhHHHHHHHHcCCcccCCceE
Confidence 456699999999999998 777999999999999999999999997755443221 123445566666654 34555
Q ss_pred EEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecch
Q 002342 269 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (934)
Q Consensus 269 ~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DIT 304 (934)
.. ++|..+|+.+++.|+.+ +|. .+++.+++||+
T Consensus 83 ~~-~~g~~~~~~~~~~pi~~-~g~-~~~l~~~~Di~ 115 (115)
T 3b33_A 83 FV-VDGRPLMLEVTVSPITW-QRQ-LMLLVEMRKID 115 (115)
T ss_dssp EE-ETTEEEEEEEEEEEEEE-TTE-EEEEEEEEEC-
T ss_pred Ee-cCCCEEEEEEEEEEeec-CCc-eEEEEEEEeCC
Confidence 55 78999999999999998 776 68899999985
|
| >2qkp_A Uncharacterized protein; structural genomics, unknown function, PSI-2, protein struct initiative; 1.75A {Streptococcus mutans} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.7e-10 Score=112.46 Aligned_cols=117 Identities=15% Similarity=0.132 Sum_probs=92.2
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEEccHH---HHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEE
Q 002342 474 LATTLERIEKNFVITDPRLPDNPIIFASDS---FLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQL 550 (934)
Q Consensus 474 l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a---~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~ 550 (934)
|..++++++++|+++|.+|+ |+|+|++ +++++| ..++++|+++..+.++. .....+.+...++.+.....+.
T Consensus 21 l~~IL~~~~~gI~~vD~~g~---I~~~N~a~~~~~~i~g-~~~~~iGr~v~~~~~~~-~~~~v~~i~~~l~~g~~~~~~~ 95 (151)
T 2qkp_A 21 ANLILNHLPLEITFVNKDDI---FQYYNDSVPAAEMVFK-RTPSQVGRNVELCHPPK-VLDKVKKVFELLRNGQRDKVNM 95 (151)
T ss_dssp HHHHHHHSSSEEEEEETTSB---EEEECCCSCGGGCSSC-CCGGGTTSBGGGSSCHH-HHHHHHHHHHHHHTTSBSEEEE
T ss_pred HHHHHHhCCCceEEEcCCCe---EEEEeCCCchhhhhcC-CCHHHcCCCHHHhCCHH-HHHHHHHHHHHHHcCCccEEEE
Confidence 88999999999999999888 9999999 999999 56789999988775533 2333455667777777766666
Q ss_pred EEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccccccC
Q 002342 551 INYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNS 596 (934)
Q Consensus 551 ~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e~~~ 596 (934)
.....+ ...++.++..|++|++|++.|++.+++|||+.++.+..+
T Consensus 96 ~~~~~~-~~~~v~v~~~Pi~d~~G~~~G~vev~~Dit~l~~le~~r 140 (151)
T 2qkp_A 96 WFQSER-LGKFVYVTYAAVRDQAGDFQGVLEYVQDIKPFFELDSEF 140 (151)
T ss_dssp EEEETT-TTEEEEEEEEEEECTTCCEEEEEEEEEECGGGGGGGGC-
T ss_pred EEecCC-CCeEEEEEEEEEECCCCCEEEEEEEEEECHHHHhhhhhh
Confidence 553332 124678889999999999999999999999998865443
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} | Back alignment and structure |
|---|
Probab=99.11 E-value=2.6e-10 Score=104.25 Aligned_cols=106 Identities=11% Similarity=0.084 Sum_probs=84.1
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCc-EEEEEEE
Q 002342 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD-VTVQLIN 552 (934)
Q Consensus 474 l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~-~~~e~~~ 552 (934)
...++++++++|+++|.+|+ |+++|+++++++|++.++++|+++..+.++... ....+...+..+.. ...+..+
T Consensus 9 ~~~il~~~~~~i~~~D~~g~---I~~~N~aa~~l~g~~~~~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 83 (115)
T 3b33_A 9 PSAILNNMVTATLILDDGLA---IRYANPAAELLFSQSAKRIVEQSLSQLIQHASL--DLALLTQPLQSGQSITDSDVTF 83 (115)
T ss_dssp HHHHHHHCSSEEEEECTTCB---EEEECHHHHHHTTSCHHHHTTCBHHHHCSEEEC--CTHHHHHHHHHCCCEEEEEEEE
T ss_pred HHHHHhhcCceEEEECCCCc---EEEECHHHHHHhCCCHHHHhCCCHHHHhCccch--hhHHHHHHHHcCCcccCCceEE
Confidence 56699999999999999888 999999999999999999999997777654321 12234445555555 3456666
Q ss_pred EecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCC
Q 002342 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587 (934)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDIT 587 (934)
. ++|..+|+.+++.|+.+ +|. .+++.+++||+
T Consensus 84 ~-~~g~~~~~~~~~~pi~~-~g~-~~~l~~~~Di~ 115 (115)
T 3b33_A 84 V-VDGRPLMLEVTVSPITW-QRQ-LMLLVEMRKID 115 (115)
T ss_dssp E-ETTEEEEEEEEEEEEEE-TTE-EEEEEEEEEC-
T ss_pred e-cCCCEEEEEEEEEEeec-CCc-eEEEEEEEeCC
Confidence 5 89999999999999998 776 68899999985
|
| >4f3l_B BMAL1B; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.11 E-value=7e-11 Score=133.67 Aligned_cols=108 Identities=12% Similarity=0.025 Sum_probs=91.1
Q ss_pred ccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCc-EEEEEEEEecCCcE
Q 002342 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS-YCGRLLNYKKDGTP 276 (934)
Q Consensus 198 ~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~-~~~e~~~~~kdG~~ 276 (934)
..+.++..|. ||+++|+|++++.++||+++|++|+++..++||++.......+...+..+.. +..++++++|||+.
T Consensus 277 ~~~fi~~~~~---dg~~~~vn~~~~~ilGY~~eEl~g~~~~~~iHpdD~~~~~~~~~~~l~~~~~~~~~eyR~~~kdG~~ 353 (387)
T 4f3l_B 277 SMEYVSRHAI---DGKFVFVDQRATAILAYLPQELLGTSCYEYFHQDDIGHLAECHRQVLQTREKITTNCYKFKIKDGSF 353 (387)
T ss_dssp CCEEEEEECT---TSBEEEECTHHHHHHCCCHHHHTTSBGGGTBCHHHHHHHHHHHHHHTTCSSCEECCCEEEECTTSCE
T ss_pred CceEEEEECC---CCEEEEECCCcccccCCCHHHHcCCcHHHeeCHHHHHHHHHHHHHHHhcCCCeeeEEEEEEccCCCE
Confidence 4455666666 8889999999999999999999999999899998887777778777766554 55789999999999
Q ss_pred EEEEEEeeeeecC-CCCEEEEEEEEecchhhHH
Q 002342 277 FWNLLTIAPIKDD-EGKVLKFIGMQVEVSKHTE 308 (934)
Q Consensus 277 ~wv~~s~~pi~d~-~G~v~~~v~~~~DITerk~ 308 (934)
+|++.+..+++|. .|.+.+++|+.+|||+||+
T Consensus 354 vWv~~~~~~~~~~~~g~~~~ivg~~~dIT~Rk~ 386 (387)
T 4f3l_B 354 ITLRSRWFSFMNPWTKEVEYIVSTNTVVLANVL 386 (387)
T ss_dssp EEEEEEEEEEEETTTTEEEEEEEEEEECC----
T ss_pred EEEEEEEEEEECCCCCCEEEEEEEEEEcchhhc
Confidence 9999999999997 7889999999999999874
|
| >1ll8_A PAS kinase; PAS domain, ligand binding, ligand screening, kinase regulation, transferase; NMR {Homo sapiens} SCOP: d.110.3.5 | Back alignment and structure |
|---|
Probab=99.05 E-value=6.2e-11 Score=108.61 Aligned_cols=102 Identities=15% Similarity=0.209 Sum_probs=75.3
Q ss_pred hccCcEEEEeCCCCC-CceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHH-HHhc-CCcE---EEEEEEE
Q 002342 197 TFQQTFVVSDATKPD-YPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRE-TLQN-GQSY---CGRLLNY 270 (934)
Q Consensus 197 ~~~d~i~v~D~~~~d-G~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~-~l~~-g~~~---~~e~~~~ 270 (934)
+.+++|+++|. + |+|+++|++|+++|||+.+|++|+++..+.++..... ...+.. .+.. +... ..++..+
T Consensus 6 ~~~~~i~~~d~---~~g~I~~~N~aa~~l~G~~~~el~g~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (114)
T 1ll8_A 6 EFNKAIFTVDA---KTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDV-VEALSEEHMEADGHAAVVFGTVVDII 81 (114)
T ss_dssp TTTCEEEEEET---TTCBEEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTHH-HHHTTSSTTSSSSCSSCCCSSSEEEC
T ss_pred CCCceEEEEEC---CCCeEEEehHHHHHHhCCCHHHHcCCCHHHhcCcchhHH-HHHHHHHhhccCCcceeccCcEEEEE
Confidence 34579999998 6 7799999999999999999999999987777654332 222222 1111 1111 2345667
Q ss_pred ecCCcEEEEEEEeeeeecCCCCEEEEEEEEecch
Q 002342 271 KKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (934)
Q Consensus 271 ~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DIT 304 (934)
++||+.+|++++++|+.+.++ .+++++++|++
T Consensus 82 ~~dG~~~~v~~~~~~~~~~~~--~~~v~~~~~~~ 113 (114)
T 1ll8_A 82 SRSGEKIPVSVWMKRMRQERR--LCCVVVLEPVE 113 (114)
T ss_dssp CTTCCCEEEECCEECCBSSSS--BEEEEEEEECC
T ss_pred ecCCCEEEEEEEEEeeccCCc--cEEEEEEeecC
Confidence 999999999999999987654 36789999986
|
| >1ll8_A PAS kinase; PAS domain, ligand binding, ligand screening, kinase regulation, transferase; NMR {Homo sapiens} SCOP: d.110.3.5 | Back alignment and structure |
|---|
Probab=99.03 E-value=8.3e-11 Score=107.74 Aligned_cols=103 Identities=16% Similarity=0.201 Sum_probs=77.9
Q ss_pred hccccEEEEcCC-CCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHH-Hhc-CCc---EEEEEEEE
Q 002342 480 RIEKNFVITDPR-LPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA-IDN-QTD---VTVQLINY 553 (934)
Q Consensus 480 ~~~d~i~v~D~~-G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~-l~~-~~~---~~~e~~~~ 553 (934)
+.+++|+++|.+ |+ |+++|++++++|||+++|++|+++..+++++.... ...+... +.. +.. ...+...+
T Consensus 6 ~~~~~i~~~d~~~g~---I~~~N~aa~~l~G~~~~el~g~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (114)
T 1ll8_A 6 EFNKAIFTVDAKTTE---ILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDV-VEALSEEHMEADGHAAVVFGTVVDII 81 (114)
T ss_dssp TTTCEEEEEETTTCB---EEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTHH-HHHTTSSTTSSSSCSSCCCSSSEEEC
T ss_pred CCCceEEEEECCCCe---EEEehHHHHHHhCCCHHHHcCCCHHHhcCcchhHH-HHHHHHHhhccCCcceeccCcEEEEE
Confidence 356899999998 88 99999999999999999999999988888765443 2222221 111 111 13356778
Q ss_pred ecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCc
Q 002342 554 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588 (934)
Q Consensus 554 ~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITe 588 (934)
++||+.+|+.++++|+.+..+ .+++++++|++.
T Consensus 82 ~~dG~~~~v~~~~~~~~~~~~--~~~v~~~~~~~~ 114 (114)
T 1ll8_A 82 SRSGEKIPVSVWMKRMRQERR--LCCVVVLEPVER 114 (114)
T ss_dssp CTTCCCEEEECCEECCBSSSS--BEEEEEEEECCC
T ss_pred ecCCCEEEEEEEEEeeccCCc--cEEEEEEeecCC
Confidence 999999999999999987654 367899999863
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.03 E-value=4.7e-10 Score=119.06 Aligned_cols=135 Identities=13% Similarity=0.084 Sum_probs=100.4
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCC--ccceeEEEEeCCeEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF--VPALYASFQTKTHVCL 746 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~~~~~~~~~l 746 (934)
..|.+....+.|..+.||++.. .+|..|++|+.... ....+.+|..+++.+.+.+ +++++.++..++..|+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 4566554445666799999964 56778999987643 1234678999999885433 6678998888888999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------------------
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG----------------------------------- 791 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~g----------------------------------- 791 (934)
||||++|.+|. ... .+ ...++.+++..|..||+..
T Consensus 93 v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 93 LLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 99999998884 211 11 1256677888888888753
Q ss_pred -----------------------CeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 792 -----------------------IIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 792 -----------------------iiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
++|+|++|.|||++.++.+.|+|||.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998766667999999843
|
| >3a0r_A Sensor protein; four helix bundle, PAS fold, kinase, phosphoprotein, transfe two-component regulatory system; 3.80A {Thermotoga maritima} | Back alignment and structure |
|---|
Probab=99.02 E-value=2.4e-10 Score=127.05 Aligned_cols=137 Identities=15% Similarity=0.109 Sum_probs=99.9
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEE
Q 002342 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552 (934)
Q Consensus 473 ~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~ 552 (934)
.++.++++++++|+++|.+|+ |+++|+++++++||+.++++|+++..+.+++ .....+...+..+.....+.
T Consensus 9 ~~~~i~~~~~~~i~~~d~~g~---i~~~N~a~~~l~G~~~~e~~G~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~-- 80 (349)
T 3a0r_A 9 FSESILESLETAIITLSKDGR---ITEWNKKAEQLFGLKKENVLGRRLKDLPDFE---EIGSVAESVFENKEPVFLNF-- 80 (349)
T ss_dssp CCCSSGGGSSSEEEEEESSSB---CSCBCHHHHHHHSCCSTTTTTCBSTTSTTTT---HHHHHHHHHHHHCCCCEEEC--
T ss_pred HHHHHHhhhcCeEEEECCCCC---EEeeHHHHHHHhCCCHHHHcCcCHHHCcChh---HHHHHHHHHHhcCCceeecc--
Confidence 477899999999999999888 9999999999999999999999988773332 23344455555555433221
Q ss_pred EecCCcEEEEEEEEEeeecCCCCE-EEEEEEEEcCCccccccccCCchhhHHHHHHHHHHhhhhhhhh
Q 002342 553 YTKSGKKFWNLFHLQPMRDQKGEV-QYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEA 619 (934)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~de~G~v-~~~vgi~rDITerk~~e~~~~~~~~~~e~~~~vk~~~~~v~~~ 619 (934)
..+..+|+.++..|+++..|.. .+++++++|||++|+++.+....+...++......+++.+...
T Consensus 81 --~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~DiTe~~~~e~~~~~~~~~~~~~~~~~~i~Helr~p 146 (349)
T 3a0r_A 81 --YKFGERYFNIRFSPFRNAKTQLLEGVIITIDDVTELYKYEEERKRRERLSILGEMTARVAHEIRNP 146 (349)
T ss_dssp --CCBTTBCCEEEEEEECCTTTTSSCEEEEEEECCSTTTTTTTTTTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred --cccCceEEEEEEEEEEcCCCceeeEEEEEEEechHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcch
Confidence 2223358888999999888775 5899999999999998777765555555555555555444433
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.2e-09 Score=122.47 Aligned_cols=142 Identities=18% Similarity=0.263 Sum_probs=107.2
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEee--cccccChHHHHHHHHHHHHHHhCC--CCCccceeEEEEeC---Ce
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD--KGVMLNRNKVHRACAEREILDMLD--HPFVPALYASFQTK---TH 743 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~--~~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~---~~ 743 (934)
...++.|+.|.++.||++.. .+..+++|+.. .... ......+.+|..+++.|. +..+++++.++.+. +.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 34467789999999999986 34678899765 3211 112346778999999996 45678899888766 45
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC---------------------------------- 789 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~---------------------------------- 789 (934)
.|+||||++|..+.+... ..++......++.+++..|..||+
T Consensus 116 ~~~vme~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp CEEEEECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred eEEEEEecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 899999999988854321 237788888999999999999997
Q ss_pred ------------------------CCCeecCCCCCCEEEecCCc--EEEEecccCcc
Q 002342 790 ------------------------QGIIYRDLKPENVLLQGNGH--VSLTDFDLSCL 820 (934)
Q Consensus 790 ------------------------~giiHrDLKp~NILl~~~~~--vkl~DFG~a~~ 820 (934)
.+++|+|++|.|||++.++. +.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999997653 68999999854
|
| >2w0n_A Sensor protein DCUS; signal transduction, two-component regulatory system, PAS, kinase, membrane, transferase, solid state cell inner membrane; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=98.96 E-value=1.6e-10 Score=105.28 Aligned_cols=109 Identities=11% Similarity=0.153 Sum_probs=85.3
Q ss_pred cccccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCC---ChhhHcCCCCCCCCCCCCChHHHHHHHHHH
Q 002342 181 EKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGY---TSKEVVGRNCRFLQGAGTDPEDVAKIRETL 257 (934)
Q Consensus 181 e~aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gy---s~eEllG~~~~~l~~~~~~~~~~~~i~~~l 257 (934)
.++++..++.++.++++++++++++|. +|+|+++|++|++++|| +.++++|+++..+.++.. +...+
T Consensus 7 ~~~l~~~~~~~~~il~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~~~~g~~~~~~~~~~~-------~~~~~ 76 (118)
T 2w0n_A 7 PYEISTLFEQRQAMLQSIKEGVVAVDD---RGEVTLINDAAQELLNYRKSQDDEKLSTLSHSWSQVVD-------VSEVL 76 (118)
T ss_dssp HHHHCTTHHHHHHHHHCCCCCCEEEBT---TTBCCCBCHHHHHHHCSCTTTTTSSCCCTTCCCSCTHH-------HHHHH
T ss_pred HHHHHHHHHHHHHHHhhccccEEEECC---CCcEeehhHHHHHHhCCCccChhhhhccCcccccCchh-------HHHHh
Confidence 456777888999999999999999998 77799999999999998 889999999876655431 44455
Q ss_pred hcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecch
Q 002342 258 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (934)
Q Consensus 258 ~~g~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DIT 304 (934)
..+....... ...+| .|+.++..|+.+ +|.+.|++++++|||
T Consensus 77 ~~~~~~~~~~--~~~~~--~~~~~~~~p~~~-~g~~~g~v~~~~DiT 118 (118)
T 2w0n_A 77 RDGTPRRDEE--ITIKD--RLLLINTVPVRS-NGVIIGAISTFRDKT 118 (118)
T ss_dssp HTTCCCCCCC--EESSS--CEECCCEECCCC-SSCCCCEEECCCCCC
T ss_pred ccCceeccEE--EEECC--EEEEEeeceeee-CCEEEEEEEEEEeCC
Confidence 5554432211 23456 478888999987 788889999999997
|
| >3cax_A Uncharacterized protein PF0695; structural genomics, unknown function, PSI-2, protein struct initiative; 2.43A {Pyrococcus furiosus dsm 3638} | Back alignment and structure |
|---|
Probab=98.96 E-value=9e-10 Score=123.72 Aligned_cols=122 Identities=13% Similarity=0.181 Sum_probs=98.0
Q ss_pred ccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcE
Q 002342 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSY 263 (934)
Q Consensus 184 L~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~ 263 (934)
.....+.++++++++++||+++|. +|+|+|+|++ ++++ ++.++++|+++..++++. .......+..++.+|...
T Consensus 234 g~~~~~~l~~IL~~l~dgIivvD~---~g~I~~~N~a-e~i~-~~~~e~iGr~v~~~~p~~-~~~~~~~l~~~l~~g~~~ 307 (369)
T 3cax_A 234 GYLNIEELKAIFEALPVDVTFIDK---DDRVRFFSPG-ERIF-TRTPSVLGRPVQLCHPPK-SVYVVNKILKAFKEGRKK 307 (369)
T ss_dssp CEECHHHHHHHHHHSSSEEEEECT---TSBEEEECCS-SCSS-CCCGGGTTCBTTTSSCGG-GHHHHHHHHHHHHHTSCS
T ss_pred chhhHHHHHHHHHhCCCcEEEECC---CCcEEEEcCH-HHcc-CChHHHcCCcHHHHCChh-hHHHHHHHHHHHHcCCce
Confidence 345557889999999999999999 7779999999 9999 999999999998776543 233445566777777765
Q ss_pred EEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhh
Q 002342 264 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (934)
Q Consensus 264 ~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~ 314 (934)
..+... .++| .++.++..|++|.+|.+.|++.+++|||+.++++++.+
T Consensus 308 ~~~~~~-~~~g--~~v~v~~~PI~d~~G~~~G~v~v~~DITe~~~le~~rr 355 (369)
T 3cax_A 308 EATFWL-RLRE--KYVYIKYVPLFNEKGEYIGTLEMTMDIAPYKKIEGEKR 355 (369)
T ss_dssp CEEEEE-EETT--EEEEEEEEEEECTTSCEEEEEEEEEECHHHHTCCSCCC
T ss_pred EEEEEE-eeCC--EEEEEEEEEEECCCCCEEEEEEEEEcCHHHHHHHHHhH
Confidence 444443 3456 47889999999999999999999999999988776543
|
| >2ykf_A Pdtas, probable sensor histidine kinase pdtas; transferase, two-component system, GAF domain, PAS domain; 2.00A {Mycobacterium tuberculosis} PDB: 2ykh_A | Back alignment and structure |
|---|
Probab=98.47 E-value=9.8e-11 Score=127.88 Aligned_cols=112 Identities=15% Similarity=0.070 Sum_probs=78.0
Q ss_pred HHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcC---CChhhhcCCCCcccCCCC---CCH--HHHHHHHHHHhc-CCc
Q 002342 475 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTE---YSREEILGRNCRFLQGPE---TDP--ATVRKIRAAIDN-QTD 545 (934)
Q Consensus 475 ~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~G---ys~eEliG~~~~~l~~~~---~~~--~~~~~i~~~l~~-~~~ 545 (934)
+.+++++++||+++|.+|+ |+++|++++++|| ++ ++++|+++..+.+.. ... .+...+...+.+ +..
T Consensus 173 ~~~~~~~~dGIivvD~~G~---Ii~~N~aA~~ll~~lG~~-~~~iGk~l~el~~~~~~~~~~~~~~~~~l~~vl~~~~~~ 248 (305)
T 2ykf_A 173 SRSSPRAGDGFIRLDVDGV---VSYASPNALSAYHRMGLT-TELEGVNLIDATRPLISDPFEAHEVDEHVQDLLAGDGKG 248 (305)
Confidence 4568889999999999888 9999999999985 54 789999988776543 110 112222223333 333
Q ss_pred EEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccccccC
Q 002342 546 VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNS 596 (934)
Q Consensus 546 ~~~e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e~~~ 596 (934)
...+.. .+| +++.++..|+++ +|++.|++.+++|||++++.|++.
T Consensus 249 ~~~ei~---~~~--~~l~v~~~Pi~~-~g~~~G~Vvv~rDITE~~~lE~eL 293 (305)
T 2ykf_A 249 MRMEVD---AGG--ATVLLRTLPLVV-AGRNVGAAILIRDVTEVKRRDRAL 293 (305)
Confidence 222221 123 467788899986 588889999999999999965544
|
| >3a0r_A Sensor protein; four helix bundle, PAS fold, kinase, phosphoprotein, transfe two-component regulatory system; 3.80A {Thermotoga maritima} | Back alignment and structure |
|---|
Probab=98.92 E-value=3.4e-10 Score=125.76 Aligned_cols=121 Identities=11% Similarity=0.112 Sum_probs=89.9
Q ss_pred ccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcE
Q 002342 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSY 263 (934)
Q Consensus 184 L~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~ 263 (934)
++.+++.++.++++++++|+++|. +|+|+++|++|++++||+.+|++|+++..+.++ ......+...+..+...
T Consensus 3 l~~~~~~~~~i~~~~~~~i~~~d~---~g~i~~~N~a~~~l~G~~~~e~~G~~~~~~~~~---~~~~~~~~~~~~~~~~~ 76 (349)
T 3a0r_A 3 VEHLRNFSESILESLETAIITLSK---DGRITEWNKKAEQLFGLKKENVLGRRLKDLPDF---EEIGSVAESVFENKEPV 76 (349)
T ss_dssp ------CCCSSGGGSSSEEEEEES---SSBCSCBCHHHHHHHSCCSTTTTTCBSTTSTTT---THHHHHHHHHHHHCCCC
T ss_pred hHHHHHHHHHHHhhhcCeEEEECC---CCCEEeeHHHHHHHhCCCHHHHcCcCHHHCcCh---hHHHHHHHHHHhcCCce
Confidence 445566788899999999999998 778999999999999999999999998876332 23334455556666543
Q ss_pred EEEEEEEecCCcEEEEEEEeeeeecCCCCE-EEEEEEEecchhhHHHHHHhh
Q 002342 264 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKV-LKFIGMQVEVSKHTEGAKDKM 314 (934)
Q Consensus 264 ~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v-~~~v~~~~DITerk~~e~~L~ 314 (934)
.... ..+..+|+.+++.|+.+.+|.. .|++++++|||++++++++++
T Consensus 77 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~DiTe~~~~e~~~~ 124 (349)
T 3a0r_A 77 FLNF----YKFGERYFNIRFSPFRNAKTQLLEGVIITIDDVTELYKYEEERK 124 (349)
T ss_dssp EEEC----CCBTTBCCEEEEEEECCTTTTSSCEEEEEEECCSTTTTTTTTTT
T ss_pred eecc----cccCceEEEEEEEEEEcCCCceeeEEEEEEEechHHHHHHHHHH
Confidence 3221 2223358889999999888775 589999999999999887765
|
| >3a0s_A Sensor protein; PAS-fold, kinase, phosphoprotein, transferase, two-component regulatory system; HET: PG4 PGE; 1.47A {Thermotoga maritima} PDB: 3a0v_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=9.9e-09 Score=88.43 Aligned_cols=95 Identities=12% Similarity=0.046 Sum_probs=72.8
Q ss_pred ccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 002342 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 277 (934)
Q Consensus 198 ~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 277 (934)
++++|+++|. +|+|+++|+++++++||+.++++|+++..+ +. .......+...+..+..+.. .. .+|..+
T Consensus 1 ~~~~i~~~d~---~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~--~~--~~~~~~ 70 (96)
T 3a0s_A 1 METAIITLSK---DGRITEWNKKAEQLFGLKKENVLGRRLKDL--PD-FEEIGSVAESVFENKEPVFL--NF--YKFGER 70 (96)
T ss_dssp CCCEEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGS--TT-CHHHHHHHHHHHHHTCCEEE--EE--EEETTE
T ss_pred CCceEEEEcC---CCCEeehhHHHHHHhCCCHHHhcCCCHHHC--cc-hHHHHHHHHHHhccCCeEEE--EE--EcCCcE
Confidence 4789999998 777999999999999999999999998766 22 23444556666666665532 22 234456
Q ss_pred EEEEEeeeeecCCCC-EEEEEEEEec
Q 002342 278 WNLLTIAPIKDDEGK-VLKFIGMQVE 302 (934)
Q Consensus 278 wv~~s~~pi~d~~G~-v~~~v~~~~D 302 (934)
|+.+++.|+.+.+|+ +.+++++++|
T Consensus 71 ~~~~~~~p~~~~~~~~~~g~v~~~~D 96 (96)
T 3a0s_A 71 YFNIRFSPFRNAKTQLLEGVIITIDD 96 (96)
T ss_dssp EEEEEEEEEECTTTCCEEEEEEEEEC
T ss_pred EEEEEEEEeEcCCCCeeeEEEEEecC
Confidence 999999999988665 6789999887
|
| >3a0s_A Sensor protein; PAS-fold, kinase, phosphoprotein, transferase, two-component regulatory system; HET: PG4 PGE; 1.47A {Thermotoga maritima} PDB: 3a0v_A* | Back alignment and structure |
|---|
Probab=98.86 E-value=1.6e-08 Score=87.06 Aligned_cols=95 Identities=17% Similarity=0.150 Sum_probs=73.0
Q ss_pred ccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 002342 481 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 560 (934)
Q Consensus 481 ~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~~ 560 (934)
++++|+++|.+|+ |+++|+++++++||+.++++|+++..+ +. .......+...+..+..+..+ . .+|..+
T Consensus 1 ~~~~i~~~d~~g~---i~~~N~~~~~l~g~~~~~~~g~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~--~--~~~~~~ 70 (96)
T 3a0s_A 1 METAIITLSKDGR---ITEWNKKAEQLFGLKKENVLGRRLKDL--PD-FEEIGSVAESVFENKEPVFLN--F--YKFGER 70 (96)
T ss_dssp CCCEEEEEETTSB---EEEECHHHHHHHCCCHHHHTTSBGGGS--TT-CHHHHHHHHHHHHHTCCEEEE--E--EEETTE
T ss_pred CCceEEEEcCCCC---EeehhHHHHHHhCCCHHHhcCCCHHHC--cc-hHHHHHHHHHHhccCCeEEEE--E--EcCCcE
Confidence 4789999999888 999999999999999999999998777 32 244445556666666655322 2 234446
Q ss_pred EEEEEEEeeecCCCC-EEEEEEEEEc
Q 002342 561 WNLFHLQPMRDQKGE-VQYFIGVQLD 585 (934)
Q Consensus 561 wv~~~~~pi~de~G~-v~~~vgi~rD 585 (934)
|+.+++.|+.+.+|. +.+++++++|
T Consensus 71 ~~~~~~~p~~~~~~~~~~g~v~~~~D 96 (96)
T 3a0s_A 71 YFNIRFSPFRNAKTQLLEGVIITIDD 96 (96)
T ss_dssp EEEEEEEEEECTTTCCEEEEEEEEEC
T ss_pred EEEEEEEEeEcCCCCeeeEEEEEecC
Confidence 899999999988665 6789999887
|
| >3cax_A Uncharacterized protein PF0695; structural genomics, unknown function, PSI-2, protein struct initiative; 2.43A {Pyrococcus furiosus dsm 3638} | Back alignment and structure |
|---|
Probab=98.86 E-value=4e-09 Score=118.45 Aligned_cols=116 Identities=16% Similarity=0.157 Sum_probs=93.9
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEE
Q 002342 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552 (934)
Q Consensus 473 ~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~ 552 (934)
.|..+++++++||+++|.+|+ |+++|++ +++| ++.++++|+++..++++. .....+.+...+..+.....+...
T Consensus 240 ~l~~IL~~l~dgIivvD~~g~---I~~~N~a-e~i~-~~~~e~iGr~v~~~~p~~-~~~~~~~l~~~l~~g~~~~~~~~~ 313 (369)
T 3cax_A 240 ELKAIFEALPVDVTFIDKDDR---VRFFSPG-ERIF-TRTPSVLGRPVQLCHPPK-SVYVVNKILKAFKEGRKKEATFWL 313 (369)
T ss_dssp HHHHHHHHSSSEEEEECTTSB---EEEECCS-SCSS-CCCGGGTTCBTTTSSCGG-GHHHHHHHHHHHHHTSCSCEEEEE
T ss_pred HHHHHHHhCCCcEEEECCCCc---EEEEcCH-HHcc-CChHHHcCCcHHHHCChh-hHHHHHHHHHHHHcCCceEEEEEE
Confidence 488999999999999999888 9999999 9999 999999999988877643 333445566667777665455544
Q ss_pred EecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCCccccccccCC
Q 002342 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSI 597 (934)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDITerk~~e~~~~ 597 (934)
. .+| +++.++..|++|.+|++.|++++++|||+.++.+..++
T Consensus 314 ~-~~g--~~v~v~~~PI~d~~G~~~G~v~v~~DITe~~~le~~rr 355 (369)
T 3cax_A 314 R-LRE--KYVYIKYVPLFNEKGEYIGTLEMTMDIAPYKKIEGEKR 355 (369)
T ss_dssp E-ETT--EEEEEEEEEEECTTSCEEEEEEEEEECHHHHTCCSCCC
T ss_pred e-eCC--EEEEEEEEEEECCCCCEEEEEEEEEcCHHHHHHHHHhH
Confidence 3 456 47888999999999999999999999999988655543
|
| >1nwz_A PYP, photoactive yellow protein; PAS, LOV, GAF, domains fold, signaling protein; HET: HC4; 0.82A {Halorhodospira halophila} SCOP: d.110.3.1 PDB: 1kou_A* 1ot9_A* 1otb_A* 1s4r_A* 1s4s_A* 1ts0_A* 1ts6_A* 1ts7_A* 1ts8_A* 1uwn_X* 1uwp_X* 2d01_A* 2phy_A* 2pyp_A* 2pyr_A* 2qj5_A* 2qj7_A* 2qws_A* 2zoh_A* 2zoi_A* ... | Back alignment and structure |
|---|
Probab=98.84 E-value=2e-08 Score=93.27 Aligned_cols=100 Identities=20% Similarity=0.202 Sum_probs=78.2
Q ss_pred HHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCC-CCCCCCChHHHHHHHHHHhcCCcEEEEEEE-
Q 002342 192 KDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRF-LQGAGTDPEDVAKIRETLQNGQSYCGRLLN- 269 (934)
Q Consensus 192 ~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~-l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~- 269 (934)
..++++++.|++++|. +|+|++||+++++++||++++++|+++.. +.+......+...+.+.+..|. +..++.+
T Consensus 20 ~~~ld~l~~Gii~lD~---~g~I~~~N~~~e~~sG~~~~eviGk~~f~~~~~~~~~~~f~~rf~~~~~~g~-l~~~~~~v 95 (125)
T 1nwz_A 20 DGQLDGLAFGAIQLDG---DGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGN-LNTMFEYT 95 (125)
T ss_dssp HHHHTTCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTC-CEEEEEEE
T ss_pred HHHHhccCceEEEECC---CCEEEEEHHHHHHHhCCCHHHHcCCchhhhccchhcccHHHHHHHHHHhcCc-eeEEEEEE
Confidence 4579999999999998 77899999999999999999999999975 4444456667788888888776 4444444
Q ss_pred EecCCcEEEEEEEeeeeecCCCCEEEEE
Q 002342 270 YKKDGTPFWNLLTIAPIKDDEGKVLKFI 297 (934)
Q Consensus 270 ~~kdG~~~wv~~s~~pi~d~~G~v~~~v 297 (934)
.+++|+. +.++++...+++|...++.
T Consensus 96 ~~~~~~p--~~v~i~l~~~~~~~~~~i~ 121 (125)
T 1nwz_A 96 FDYQMTP--TKVKVHMKKALSGDSYWVF 121 (125)
T ss_dssp ECTTSCC--EEEEEEEEECSSSSEEEEE
T ss_pred EcCCCCE--EEEEEEEEEcCCCCEEEEE
Confidence 4899995 4555566677888876543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=1.3e-09 Score=119.09 Aligned_cols=197 Identities=16% Similarity=0.209 Sum_probs=124.6
Q ss_pred ccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCC--ccceeEEEEeCC---eEEEE
Q 002342 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPF--VPALYASFQTKT---HVCLI 747 (934)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~--Iv~l~~~~~~~~---~~~lV 747 (934)
++.++.|.++.||++. ..+++|+... ......+.+|..+|+.+ .+.. ++.++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3458999999999874 3588998643 23456788999999888 3333 445555443333 34899
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-------------------------------------- 789 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~-------------------------------------- 789 (934)
|++++|.+|...... .++......++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999999998764332 27777888888999999999986
Q ss_pred --------------------CCCeecCCCCCCEEEec--CCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCccc
Q 002342 790 --------------------QGIIYRDLKPENVLLQG--NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847 (934)
Q Consensus 790 --------------------~giiHrDLKp~NILl~~--~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (934)
..++|+|++|.||+++. ++.+.|+||+.+.......... ...... ..
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~--------~~~~~~--~~- 239 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI--------SLMEDD--EE- 239 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH--------TTCCTT--TS-
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH--------HHHhhc--cc-
Confidence 13699999999999998 4567899999985432110000 000000 00
Q ss_pred ccccccccccccCCCCccc-hhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 848 MAEPMRASNSFVGTEEYIA-PEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 848 ~~~~~~~~~~~~Gt~~y~a-PE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
. .......+........ |+..... ....+.|++|.++|.+.+|.++|.
T Consensus 240 ~--~~~~~~~~l~~Y~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 240 Y--GMEFVSKILNHYKHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp C--CHHHHHHHHHHHTCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred c--CHHHHHHHHHHcCCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0 0000000111111222 3333211 224689999999999999999884
|
| >2w0n_A Sensor protein DCUS; signal transduction, two-component regulatory system, PAS, kinase, membrane, transferase, solid state cell inner membrane; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=98.83 E-value=6.6e-10 Score=101.06 Aligned_cols=101 Identities=19% Similarity=0.175 Sum_probs=78.9
Q ss_pred ccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCC---ChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEE
Q 002342 472 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEY---SREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTV 548 (934)
Q Consensus 472 ~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gy---s~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~ 548 (934)
..++.++++++++|+++|.+|+ |+++|+++++++|| +.++++|+++..+.++.. +...+..+.....
T Consensus 15 ~~~~~il~~~~~~i~~~d~~g~---i~~~N~~~~~~~g~~~~~~~~~~g~~~~~~~~~~~-------~~~~~~~~~~~~~ 84 (118)
T 2w0n_A 15 EQRQAMLQSIKEGVVAVDDRGE---VTLINDAAQELLNYRKSQDDEKLSTLSHSWSQVVD-------VSEVLRDGTPRRD 84 (118)
T ss_dssp HHHHHHHHCCCCCCEEEBTTTB---CCCBCHHHHHHHCSCTTTTTSSCCCTTCCCSCTHH-------HHHHHHTTCCCCC
T ss_pred HHHHHHHhhccccEEEECCCCc---EeehhHHHHHHhCCCccChhhhhccCcccccCchh-------HHHHhccCceecc
Confidence 4588999999999999999888 99999999999998 889999999887775532 3344444443221
Q ss_pred EEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCC
Q 002342 549 QLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587 (934)
Q Consensus 549 e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDIT 587 (934)
+. ...+| .|+.++..|+.+ +|++.+++++++|||
T Consensus 85 ~~--~~~~~--~~~~~~~~p~~~-~g~~~g~v~~~~DiT 118 (118)
T 2w0n_A 85 EE--ITIKD--RLLLINTVPVRS-NGVIIGAISTFRDKT 118 (118)
T ss_dssp CC--EESSS--CEECCCEECCCC-SSCCCCEEECCCCCC
T ss_pred EE--EEECC--EEEEEeeceeee-CCEEEEEEEEEEeCC
Confidence 11 23456 477888899987 788889999999998
|
| >1mzu_A PPR; photoactive yellow protein, PAS, PYP, signaling protein; HET: HC4; 2.00A {Rhodospirillum centenum} SCOP: d.110.3.1 | Back alignment and structure |
|---|
Probab=98.82 E-value=1.8e-08 Score=93.68 Aligned_cols=99 Identities=12% Similarity=0.093 Sum_probs=77.5
Q ss_pred HHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCC-CCCCCCChHHHHHHHHHHhcCCcEEEEEEE-E
Q 002342 193 DALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRF-LQGAGTDPEDVAKIRETLQNGQSYCGRLLN-Y 270 (934)
Q Consensus 193 ~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~-l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~-~ 270 (934)
.++++++.|++++|. +|+|++||+++++++||++++++|+++.. +.+......+...+.+.+..|. +..++.+ .
T Consensus 26 ~~ld~l~~GiivlD~---dg~I~~~N~~~e~isG~s~eeviGk~~f~~~~p~~~~~~f~grf~~~~~~G~-l~~~~~yv~ 101 (129)
T 1mzu_A 26 AEFDALPVGAIQVDG---SGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGT-LDARFDFVF 101 (129)
T ss_dssp TTGGGCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSC-CEEEEEEEE
T ss_pred HHHhccCceEEEECC---CCeEEEEHHHHHHHhCCCHHHHcCCchhhhccchhcccHHHHHHHHHHhcCc-eeEEEEEEE
Confidence 369999999999998 77799999999999999999999999975 3444456667788888888766 4444444 4
Q ss_pred ecCCcEEEEEEEeeeeecCCCCEEEEE
Q 002342 271 KKDGTPFWNLLTIAPIKDDEGKVLKFI 297 (934)
Q Consensus 271 ~kdG~~~wv~~s~~pi~d~~G~v~~~v 297 (934)
+++|+. +.++++...+.+|...++.
T Consensus 102 ~~~~~p--~~v~i~l~~~~~~~~~~i~ 126 (129)
T 1mzu_A 102 DFQMAP--VRVQIRMQNAGVPDRYWIF 126 (129)
T ss_dssp ECSSCE--EEEEEEEEECSSTTEEEEE
T ss_pred cCCCCE--EEEEEEEEEcCCCCEEEEE
Confidence 899995 5555566777888876543
|
| >3rty_A Period circadian protein; PAS domain, signalling, timeless, circadian clock protein; 2.85A {Drosophila melanogaster} PDB: 1wa9_A 3gec_A | Back alignment and structure |
|---|
Probab=98.77 E-value=1.2e-08 Score=112.42 Aligned_cols=106 Identities=10% Similarity=0.030 Sum_probs=91.0
Q ss_pred cCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCc-----EEEEEEEEecC
Q 002342 199 QQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS-----YCGRLLNYKKD 273 (934)
Q Consensus 199 ~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~-----~~~e~~~~~kd 273 (934)
.+.++..+. ||+++|+|+++..++||+++|++|+++..++||++.....+.++..+..|.. ...+++++++|
T Consensus 154 ~~fi~r~~~---dG~~~yvn~~~~~lLGY~peELiG~s~~~~vHPdD~~~~~~~~~~~l~~G~~~~~~~~s~~yR~~~kd 230 (339)
T 3rty_A 154 PKFAIRHTA---TGIISHVDSAAVSALGYLPQDLIGRSIMDFYHHEDLSVMKETYETVMKKGQTAGASFCSKPYRFLIQN 230 (339)
T ss_dssp CEEEEEEET---TCBEEEECTTHHHHHCCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHHHHTTSTTCCCBCCCEEEECTT
T ss_pred ceEEEEECC---CCeEEEcChhhhcccCCCHHHHcCCcHHHEECHHHHHHHHHHHHHHHHcCCcccccccceEEEEEccC
Confidence 456666776 8889999999999999999999999999999999988888888888877664 35689999999
Q ss_pred CcEEEEEEEeeeeecCC-CCEEEEEEEEecchhhH
Q 002342 274 GTPFWNLLTIAPIKDDE-GKVLKFIGMQVEVSKHT 307 (934)
Q Consensus 274 G~~~wv~~s~~pi~d~~-G~v~~~v~~~~DITerk 307 (934)
|+.+|++.+.++++|.. +.+.+++++.+.|+...
T Consensus 231 G~~vWlet~~~~~~np~s~~~~~II~~h~vi~~p~ 265 (339)
T 3rty_A 231 GCYVLLETEWTSFVNPWSRKLEFVVGHHRVFQGPK 265 (339)
T ss_dssp SCEEEEEEEEEEEECTTTCSEEEEEEEEEEEECCS
T ss_pred CCEEEEEEEEEEEECCCCCCeeEEEEEEEECCCCC
Confidence 99999999999999875 56778889988888753
|
| >2jhe_A Transcription regulator TYRR; aromatic hydrocarbons catabolism, TYRR protei nucleotide-binding, transcription regulation, activator; HET: PG4; 2.30A {Escherichia coli} | Back alignment and structure |
|---|
Probab=98.77 E-value=5.5e-09 Score=105.23 Aligned_cols=108 Identities=12% Similarity=0.095 Sum_probs=81.3
Q ss_pred cchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCC--c
Q 002342 185 PRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ--S 262 (934)
Q Consensus 185 ~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~--~ 262 (934)
++..+.++.+++++++|++++|. +|+|+++|+++++++|++.++++|+++..+.++.. +...+..+. .
T Consensus 76 ~~~~~~l~~il~~~~~gvi~~D~---~g~I~~~N~aa~~llg~~~~~~~g~~~~~~~~~~~-------~~~~~~~~~~~~ 145 (190)
T 2jhe_A 76 EREHLALSALLEALPEPVLSVDM---KSKVDMANPASCQLFGQKLDRLRNHTAAQLINGFN-------FLRWLESEPQDS 145 (190)
T ss_dssp THHHHHHHHHHHHCSSCEEEECT---TCBEEEECHHHHHHHTSCHHHHTTSBGGGTSTTCC-------HHHHHHTCCCSC
T ss_pred HHHHHHHHHHHHhCCCcEEEEcC---CCCEEEEcHHHHHHhCCCHHHhcCccHHHHhCCCC-------HHHHHhcCCCCC
Confidence 44557899999999999999998 77799999999999999999999999887766542 122344443 2
Q ss_pred EEEEEEEEecCCcEEEEEEEeeeeecCCCC----EEEEEEEEecchhhH
Q 002342 263 YCGRLLNYKKDGTPFWNLLTIAPIKDDEGK----VLKFIGMQVEVSKHT 307 (934)
Q Consensus 263 ~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~----v~~~v~~~~DITerk 307 (934)
...++. .+|. ++.++++|+.+.+|. +.|++.+++|||+++
T Consensus 146 ~~~~~~---~~g~--~~~~~~~pi~~~~~~~~~~~~g~v~~~~DiTe~~ 189 (190)
T 2jhe_A 146 HNEHVV---INGQ--NFLMEITPVYLQDENDQHVLTGAVVMLRSTIRMG 189 (190)
T ss_dssp EEEEEE---ETTE--EEEEEEEEETTTTEEEEEEEE-HHHHHHHHTTTC
T ss_pred cceEEE---ECCe--EEEEEEEEEEecCCCCcceEEeEEEEEeccchhc
Confidence 333332 2675 456778899875665 788899999999875
|
| >2ykf_A Pdtas, probable sensor histidine kinase pdtas; transferase, two-component system, GAF domain, PAS domain; 2.00A {Mycobacterium tuberculosis} PDB: 2ykh_A | Back alignment and structure |
|---|
Probab=98.25 E-value=7.8e-10 Score=120.74 Aligned_cols=181 Identities=14% Similarity=0.100 Sum_probs=117.4
Q ss_pred HHHHHHHhceeeeccCCC-CCcceEEecccCCCCCCCCCCcccCCCCCceEEEe-ccccc---ccccccccchHHHHHHH
Q 002342 120 AAQRAAEWGLVLKTDTET-GKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSG-EMSDE---GGKEKGLPRVSDIVKDA 194 (934)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~-dit~~---~~~e~aL~~~~~~~~~i 194 (934)
+..+|.+-|..++..... ++ ..|..+ +..+..|+.......+.++... |+++. +..|.+..+..+.|..+
T Consensus 84 ~v~~~~~~g~~~~~~~~~~~~----~~~~~~-v~~~~~Pi~~~g~vigvl~~~~~di~~~~~~~~~e~~~~~~~~~L~~m 158 (305)
T 2ykf_A 84 LVAATFSGGVPGREGAVGQQN----SCQHDG-HSVEVSPVRFGDQVVAVLTRHQPELAARRRSGHLETAYRLCATDLLRM 158 (305)
Confidence 456677777555333221 00 113333 5566677776544445556668 99986 44555555666666666
Q ss_pred H-----------------HhccCcEEEEeCCCCCCceEEcchHHHHHcC---CChhhHcCCCCCCCCCCC---C-Ch-HH
Q 002342 195 L-----------------STFQQTFVVSDATKPDYPIMYASAGFFKMTG---YTSKEVVGRNCRFLQGAG---T-DP-ED 249 (934)
Q Consensus 195 l-----------------e~~~d~i~v~D~~~~dG~I~~~N~a~~~l~G---ys~eEllG~~~~~l~~~~---~-~~-~~ 249 (934)
+ +++++||+++|. +|+|+++|++++++|| +. ++++|+++..+.+.. . .. ..
T Consensus 159 i~~~~~~~~~~~~~~~~~~~~~dGIivvD~---~G~Ii~~N~aA~~ll~~lG~~-~~~iGk~l~el~~~~~~~~~~~~~~ 234 (305)
T 2ykf_A 159 LAEGTFPDAGDVAMSRSSPRAGDGFIRLDV---DGVVSYASPNALSAYHRMGLT-TELEGVNLIDATRPLISDPFEAHEV 234 (305)
Confidence 5 489999999998 7779999999999985 55 789999988665432 1 00 12
Q ss_pred HHHHHHHHhc-CCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhHHHHHHhhc
Q 002342 250 VAKIRETLQN-GQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 315 (934)
Q Consensus 250 ~~~i~~~l~~-g~~~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DITerk~~e~~L~~ 315 (934)
...+..++.+ +.....++. .+| .++.++..|+.+ +|.+.|++.+++|||+.++.+++|+.
T Consensus 235 ~~~l~~vl~~~~~~~~~ei~---~~~--~~l~v~~~Pi~~-~g~~~G~Vvv~rDITE~~~lE~eL~~ 295 (305)
T 2ykf_A 235 DEHVQDLLAGDGKGMRMEVD---AGG--ATVLLRTLPLVV-AGRNVGAAILIRDVTEVKRRDRALIS 295 (305)
Confidence 2222234443 333222221 223 467888899986 57888999999999999999999874
|
| >1nwz_A PYP, photoactive yellow protein; PAS, LOV, GAF, domains fold, signaling protein; HET: HC4; 0.82A {Halorhodospira halophila} SCOP: d.110.3.1 PDB: 1kou_A* 1ot9_A* 1otb_A* 1s4r_A* 1s4s_A* 1ts0_A* 1ts6_A* 1ts7_A* 1ts8_A* 1uwn_X* 1uwp_X* 2d01_A* 2phy_A* 2pyp_A* 2pyr_A* 2qj5_A* 2qj7_A* 2qws_A* 2zoh_A* 2zoi_A* ... | Back alignment and structure |
|---|
Probab=98.76 E-value=4.6e-08 Score=90.82 Aligned_cols=100 Identities=9% Similarity=0.080 Sum_probs=78.3
Q ss_pred HHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccC-CCCCCHHHHHHHHHHHhcCCcEEEEEEE-
Q 002342 475 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQ-GPETDPATVRKIRAAIDNQTDVTVQLIN- 552 (934)
Q Consensus 475 ~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~-~~~~~~~~~~~i~~~l~~~~~~~~e~~~- 552 (934)
..++++++.|++++|.+|+ |++||+++++++||++++++|+++...+ +......+...+.+.+..|. ...+...
T Consensus 20 ~~~ld~l~~Gii~lD~~g~---I~~~N~~~e~~sG~~~~eviGk~~f~~~~~~~~~~~f~~rf~~~~~~g~-l~~~~~~v 95 (125)
T 1nwz_A 20 DGQLDGLAFGAIQLDGDGN---ILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGN-LNTMFEYT 95 (125)
T ss_dssp HHHHTTCSSEEEEEETTCB---EEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTC-CEEEEEEE
T ss_pred HHHHhccCceEEEECCCCE---EEEEHHHHHHHhCCCHHHHcCCchhhhccchhcccHHHHHHHHHHhcCc-eeEEEEEE
Confidence 6689999999999999888 9999999999999999999999987644 44555666777888777666 4444444
Q ss_pred EecCCcEEEEEEEEEeeecCCCCEEEEE
Q 002342 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFI 580 (934)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~de~G~v~~~v 580 (934)
.+++|+ ++.++++...+.+|...+++
T Consensus 96 ~~~~~~--p~~v~i~l~~~~~~~~~~i~ 121 (125)
T 1nwz_A 96 FDYQMT--PTKVKVHMKKALSGDSYWVF 121 (125)
T ss_dssp ECTTSC--CEEEEEEEEECSSSSEEEEE
T ss_pred EcCCCC--EEEEEEEEEEcCCCCEEEEE
Confidence 489999 45556666777888776553
|
| >1mzu_A PPR; photoactive yellow protein, PAS, PYP, signaling protein; HET: HC4; 2.00A {Rhodospirillum centenum} SCOP: d.110.3.1 | Back alignment and structure |
|---|
Probab=98.73 E-value=5.8e-08 Score=90.28 Aligned_cols=100 Identities=10% Similarity=0.019 Sum_probs=77.6
Q ss_pred HHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccC-CCCCCHHHHHHHHHHHhcCCcEEEEEEE-
Q 002342 475 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQ-GPETDPATVRKIRAAIDNQTDVTVQLIN- 552 (934)
Q Consensus 475 ~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~-~~~~~~~~~~~i~~~l~~~~~~~~e~~~- 552 (934)
..++++++.||+++|.+|+ |++||.++++++||++++++|+++...+ +......+...+.+.+..|. ...+...
T Consensus 25 ~~~ld~l~~GiivlD~dg~---I~~~N~~~e~isG~s~eeviGk~~f~~~~p~~~~~~f~grf~~~~~~G~-l~~~~~yv 100 (129)
T 1mzu_A 25 TAEFDALPVGAIQVDGSGV---IHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGT-LDARFDFV 100 (129)
T ss_dssp CTTGGGCSSEEEEEETTCB---EEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSC-CEEEEEEE
T ss_pred HHHHhccCceEEEECCCCe---EEEEHHHHHHHhCCCHHHHcCCchhhhccchhcccHHHHHHHHHHhcCc-eeEEEEEE
Confidence 3468999999999999888 9999999999999999999999987644 44555666777888888666 4444444
Q ss_pred EecCCcEEEEEEEEEeeecCCCCEEEEE
Q 002342 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFI 580 (934)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~de~G~v~~~v 580 (934)
.+++|+ ++.++++...+.+|...+++
T Consensus 101 ~~~~~~--p~~v~i~l~~~~~~~~~~i~ 126 (129)
T 1mzu_A 101 FDFQMA--PVRVQIRMQNAGVPDRYWIF 126 (129)
T ss_dssp EECSSC--EEEEEEEEEECSSTTEEEEE
T ss_pred EcCCCC--EEEEEEEEEEcCCCCEEEEE
Confidence 489999 45556666777888776543
|
| >2jhe_A Transcription regulator TYRR; aromatic hydrocarbons catabolism, TYRR protei nucleotide-binding, transcription regulation, activator; HET: PG4; 2.30A {Escherichia coli} | Back alignment and structure |
|---|
Probab=98.71 E-value=9.2e-09 Score=103.61 Aligned_cols=104 Identities=11% Similarity=0.056 Sum_probs=79.6
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCC--cEEEEE
Q 002342 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT--DVTVQL 550 (934)
Q Consensus 473 ~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~--~~~~e~ 550 (934)
.++.+++++++||+++|.+|+ |+++|++++++||++.++++|+++..+.++... ...+..+. ....++
T Consensus 81 ~l~~il~~~~~gvi~~D~~g~---I~~~N~aa~~llg~~~~~~~g~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~ 150 (190)
T 2jhe_A 81 ALSALLEALPEPVLSVDMKSK---VDMANPASCQLFGQKLDRLRNHTAAQLINGFNF-------LRWLESEPQDSHNEHV 150 (190)
T ss_dssp HHHHHHHHCSSCEEEECTTCB---EEEECHHHHHHHTSCHHHHTTSBGGGTSTTCCH-------HHHHHTCCCSCEEEEE
T ss_pred HHHHHHHhCCCcEEEEcCCCC---EEEEcHHHHHHhCCCHHHhcCccHHHHhCCCCH-------HHHHhcCCCCCcceEE
Confidence 489999999999999999888 999999999999999999999998888766432 12333333 233333
Q ss_pred EEEecCCcEEEEEEEEEeeecCCCC----EEEEEEEEEcCCcccc
Q 002342 551 INYTKSGKKFWNLFHLQPMRDQKGE----VQYFIGVQLDGSEHLE 591 (934)
Q Consensus 551 ~~~~kdG~~~wv~~~~~pi~de~G~----v~~~vgi~rDITerk~ 591 (934)
.. +|. ++.+++.|+.+.+|+ +.|++++++|||++++
T Consensus 151 ~~---~g~--~~~~~~~pi~~~~~~~~~~~~g~v~~~~DiTe~~~ 190 (190)
T 2jhe_A 151 VI---NGQ--NFLMEITPVYLQDENDQHVLTGAVVMLRSTIRMGR 190 (190)
T ss_dssp EE---TTE--EEEEEEEEETTTTEEEEEEEE-HHHHHHHHTTTCC
T ss_pred EE---CCe--EEEEEEEEEEecCCCCcceEEeEEEEEeccchhcC
Confidence 32 675 456778899875665 7888889999999874
|
| >4dj3_A Period circadian protein homolog 3; PAS domain, circadian rhythm, protein binding; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.63 E-value=1.3e-07 Score=103.30 Aligned_cols=97 Identities=13% Similarity=0.113 Sum_probs=83.2
Q ss_pred CCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCc---EEEEEEEEecCCcEEEEEEEeee
Q 002342 209 KPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS---YCGRLLNYKKDGTPFWNLLTIAP 285 (934)
Q Consensus 209 ~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~---~~~e~~~~~kdG~~~wv~~s~~p 285 (934)
..||+++|+|+++..++||.++|++|+++..++||++.....+.+.+.+..+.. ...+++.++|||+.+|++.+.++
T Consensus 181 ~~dG~~~yvs~~~~~lLGY~peELig~s~~~~vHPdD~~~~~~~~~~~l~~~~~~~f~s~~yR~~~kdG~~vwvet~~~~ 260 (317)
T 4dj3_A 181 TPGCVFLEVDERAVPLLGYLPQDLIGTSILTYLHPEDRPLMVAIHQKVLKYAGHPPFEHSPVRFCTQNGEYVILDSSWSS 260 (317)
T ss_dssp CTTSBEEEECTTHHHHHSCCHHHHTTSBGGGGBCTTTTTHHHHHHHHHHHTTTSCCEECCCEEEECTTSCEEEEEEEEEE
T ss_pred cCCCeEEEEChHHhhhcCcChHHHcCCCHHHeECHHHHHHHHHHHHHHHHcCCCccccceEEEEEccCCCEEEEEEEEEE
Confidence 448999999999999999999999999999999999988888888888887654 35789999999999999999999
Q ss_pred eecC-CCCEEEEEEEEecchh
Q 002342 286 IKDD-EGKVLKFIGMQVEVSK 305 (934)
Q Consensus 286 i~d~-~G~v~~~v~~~~DITe 305 (934)
++|. .+++.++++..+-++.
T Consensus 261 ~~np~s~~~e~II~~h~v~~~ 281 (317)
T 4dj3_A 261 FVNPWSRKVSFIIGRHKVRTS 281 (317)
T ss_dssp EECSSSCCEEEEEEEEEECCC
T ss_pred EECCCCCcccEEEEEEEeccC
Confidence 9987 4566677777775544
|
| >3gdi_A Period circadian protein homolog 2; tandem PAS domains, biological rhythms, cytoplasm, nucleus, phosphoprotein, transcription; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.56 E-value=2.3e-07 Score=100.95 Aligned_cols=98 Identities=12% Similarity=0.117 Sum_probs=84.6
Q ss_pred CCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCC-cEE-EEEEEEecCCcEEEEEEEeeee
Q 002342 209 KPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ-SYC-GRLLNYKKDGTPFWNLLTIAPI 286 (934)
Q Consensus 209 ~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~-~~~-~e~~~~~kdG~~~wv~~s~~pi 286 (934)
..||+++|+|+++..++||.++|++|+++..++||++.....+.+.+.+..++ ... .+++.++|||..+|++.+.+++
T Consensus 172 ~~dG~~~yvd~~~~~lLGY~peELig~s~~~~iHpdD~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~vwvet~~~~~ 251 (309)
T 3gdi_A 172 TPNCLFQAVDERAVPLLGYLPQDLIETPVLVQLHPSDRPLMLAIHKKILQAGGQPFDYSPIRFRTRNGEYITLDTSWSSF 251 (309)
T ss_dssp CTTCBEEEECTTHHHHHSCCHHHHTTSBHHHHBCTTSHHHHHHHHHHHHHTTTCCEEEEEEEEECTTSCEEEEEEEEEEE
T ss_pred cCCCeEEEECcccccccCcCHHHHcCCCHHHhCCHHHHHHHHHHHHHHHhcCCceeeceEEEEEccCCCEEEEEEEEEEE
Confidence 34899999999999999999999999999889999998877788888887554 455 5899999999999999999999
Q ss_pred ecC-CCCEEEEEEEEecchhh
Q 002342 287 KDD-EGKVLKFIGMQVEVSKH 306 (934)
Q Consensus 287 ~d~-~G~v~~~v~~~~DITer 306 (934)
.|. .+++.++++..+-|+..
T Consensus 252 ~np~s~~~e~ii~~h~v~~gp 272 (309)
T 3gdi_A 252 INPWSRKISFIIGRHKVRVGP 272 (309)
T ss_dssp ECTTTCCEEEEEEEEEEEECC
T ss_pred ECCCCCcccEEEEEEEEccCC
Confidence 886 56778889988888764
|
| >4dj2_A Period circadian protein homolog 1; PAS domains, circadian clock protein, protein binding; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.52 E-value=1.8e-07 Score=102.18 Aligned_cols=98 Identities=15% Similarity=0.148 Sum_probs=84.0
Q ss_pred CCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhc-CCcE-EEEEEEEecCCcEEEEEEEeeee
Q 002342 209 KPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQN-GQSY-CGRLLNYKKDGTPFWNLLTIAPI 286 (934)
Q Consensus 209 ~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~-g~~~-~~e~~~~~kdG~~~wv~~s~~pi 286 (934)
+.||+++|+|+++..++||.++|++|+++..++||++.....+.+...+.. |... ..++|+++|||..+|++.+.+++
T Consensus 183 ~~dG~~~yvd~~~~~lLGY~peELig~s~~~~vHPdD~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~vwvet~~~~~ 262 (320)
T 4dj2_A 183 TPSCLFQDVDERAAPLLGYLPQDLLGAPVLLFLHPEDRPLMLAIHKKILQLAGQPFDHSPIRFCARNGEYVTMDTSWAGF 262 (320)
T ss_dssp CTTCBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHTTSSSCCEECCCEEEECSSSCEEEEECEEEEE
T ss_pred cCCceEEEcCcceeccCCcChHHHcCCcHHHhCCHHHHHHHHHHHHHHHhcCCCcccceEEEEEccCCCEEEEEEEEEEE
Confidence 348999999999999999999999999999999999887777777777774 4445 36899999999999999999999
Q ss_pred ecC-CCCEEEEEEEEecchhh
Q 002342 287 KDD-EGKVLKFIGMQVEVSKH 306 (934)
Q Consensus 287 ~d~-~G~v~~~v~~~~DITer 306 (934)
.|. .+++.++++..+-|+..
T Consensus 263 ~np~s~~~e~II~~h~v~~gp 283 (320)
T 4dj2_A 263 VHPWSRKVAFVLGRHKVRTAP 283 (320)
T ss_dssp ECTTTCSEEEEEEEEEESSCC
T ss_pred ECCCCCCccEEEEEEEEccCC
Confidence 886 57788889988887764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=2.2e-06 Score=93.49 Aligned_cols=133 Identities=18% Similarity=0.146 Sum_probs=95.8
Q ss_pred ccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCC---CccceeEEEE-eCCeEEEEEE
Q 002342 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP---FVPALYASFQ-TKTHVCLITD 749 (934)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp---~Iv~l~~~~~-~~~~~~lV~E 749 (934)
+..++.|....||++ +..+++|+.. .......+.+|..+|+.|.+. .++.++.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456789999999998 4568899853 223456788999999999642 3667777764 4566889999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ--------------------------------------- 790 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~--------------------------------------- 790 (934)
|++|.+|....-. .++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9999888763211 144555555566666666666642
Q ss_pred ---------------------CCeecCCCCCCEEEec---CCc-EEEEecccCcc
Q 002342 791 ---------------------GIIYRDLKPENVLLQG---NGH-VSLTDFDLSCL 820 (934)
Q Consensus 791 ---------------------giiHrDLKp~NILl~~---~~~-vkl~DFG~a~~ 820 (934)
.++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 455 48999998854
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=4.7e-06 Score=88.85 Aligned_cols=132 Identities=17% Similarity=0.176 Sum_probs=96.1
Q ss_pred cccCCcE-EEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCCeEEEEEEccCCC
Q 002342 677 LGSGDTG-SVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLITDYCPGG 754 (934)
Q Consensus 677 LG~G~~g-~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lV~E~~~gg 754 (934)
+..|..+ .||.+.....+..+++|+.... ....+.+|..+|+.+. +--|++++.++.+.+..|+|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 3444444 7999888777888999986532 3456788999999884 334778999999999999999999998
Q ss_pred CchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------------
Q 002342 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-------------------------------------------- 790 (934)
Q Consensus 755 sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-------------------------------------------- 790 (934)
++.+..... ......++.++...|..||..
T Consensus 106 ~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 106 TAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp EHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 877654321 112233455566666666631
Q ss_pred --------------CCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 791 --------------GIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 791 --------------giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 168999999999999776677999998854
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=1.2e-05 Score=90.86 Aligned_cols=81 Identities=15% Similarity=0.119 Sum_probs=51.0
Q ss_pred cccccccCCcEEEEEEEEecCCeEEEEEEeecccc--cC--hHHHHHHHHHHHHHHhCCC--C-CccceeEEEEeCCeEE
Q 002342 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LN--RNKVHRACAEREILDMLDH--P-FVPALYASFQTKTHVC 745 (934)
Q Consensus 673 i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~--~~--~~~~~~~~~E~~il~~l~h--p-~Iv~l~~~~~~~~~~~ 745 (934)
..+.||.|.++.||++....+++.|++|....... .. .....++..|.++|+.+.. | .++.++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35678999999999997655678899998653211 00 0123456778899888742 3 45566643 344568
Q ss_pred EEEEccCCCC
Q 002342 746 LITDYCPGGE 755 (934)
Q Consensus 746 lV~E~~~ggs 755 (934)
+||||++|..
T Consensus 112 lvmE~l~g~~ 121 (397)
T 2olc_A 112 TVMEDLSHLK 121 (397)
T ss_dssp EEECCCTTSE
T ss_pred EEEEeCCCcc
Confidence 9999997643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=4.9e-05 Score=84.46 Aligned_cols=86 Identities=12% Similarity=0.004 Sum_probs=57.6
Q ss_pred ccccc-ccCCcEEEEEEEEe--c----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-C--CCccceeEEEEeC-
Q 002342 673 PIKPL-GSGDTGSVHLVELC--G----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-H--PFVPALYASFQTK- 741 (934)
Q Consensus 673 i~~~L-G~G~~g~Vy~a~~~--~----~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-h--p~Iv~l~~~~~~~- 741 (934)
..+.| +.|..+.+|++... . ++..+++|+..............+.+|..+|+.|. + -.+++++.+..+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34667 88999999998763 1 26689999865432000000134677888888874 2 3577888877655
Q ss_pred --CeEEEEEEccCCCCchh
Q 002342 742 --THVCLITDYCPGGELFL 758 (934)
Q Consensus 742 --~~~~lV~E~~~ggsL~~ 758 (934)
+..|+||||++|..+.+
T Consensus 104 ~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTSSCEEEEECCCCBCCCB
T ss_pred ccCCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.85 E-value=9.3e-05 Score=81.36 Aligned_cols=138 Identities=14% Similarity=0.125 Sum_probs=79.0
Q ss_pred ccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC--CCCccceeE------EEEeCCeEE
Q 002342 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD--HPFVPALYA------SFQTKTHVC 745 (934)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~------~~~~~~~~~ 745 (934)
+..|+.|..+.||++.. .+..+++|+.... . ..+..|..+++.|. .-.++.++. +....+..+
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 34566777899999976 3345899988652 1 23334555555442 113344433 123467789
Q ss_pred EEEEccCCCCchh-----------h---hcc--CCC--C-C-------CCHH--------H-------------------
Q 002342 746 LITDYCPGGELFL-----------L---LDR--QPT--K-V-------LKED--------A------------------- 772 (934)
Q Consensus 746 lV~E~~~ggsL~~-----------~---l~~--~~~--~-~-------l~~~--------~------------------- 772 (934)
++|+|++|.++.. . ++. ... . . .... .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 9999999876530 0 111 000 0 0 0000 0
Q ss_pred ----HHHHHHHHHHHHHHHHH-------------CCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 773 ----VRFYAAEVVVALEYLHC-------------QGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 773 ----~~~i~~qil~aL~yLH~-------------~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
+..+..++..++.+|+. .+++|+|++|.|||++.++.+.|+||+.+..
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11112233445666652 5799999999999998888999999998854
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00057 Score=74.38 Aligned_cols=76 Identities=20% Similarity=0.173 Sum_probs=60.8
Q ss_pred cccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC---CCCccceeEEEEeCCeEEEEEE
Q 002342 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD---HPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 673 i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
-...|+.|....+|++.. ++..|++|+.... ....+..|...|+.|. ...+++++.+....+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 346789999999999975 5678889987542 2456788999888883 3678899998888889999999
Q ss_pred ccCCCCc
Q 002342 750 YCPGGEL 756 (934)
Q Consensus 750 ~~~ggsL 756 (934)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998865
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00068 Score=77.14 Aligned_cols=77 Identities=23% Similarity=0.192 Sum_probs=45.7
Q ss_pred cccccccCCcEEEEEEEEecCCeEEEEEEeecccc--cC--hHHHHHHHHHHHHHHhC---CCCCccceeEEEEeCCeEE
Q 002342 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LN--RNKVHRACAEREILDML---DHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 673 i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~--~~--~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~~~~~~ 745 (934)
-++.||.|..+.||++.. +++.++||....... .. .........|.+++..+ ....+++++.+. ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 356789999999999964 567899994332110 00 00001122233333322 335677777665 46678
Q ss_pred EEEEcc-CC
Q 002342 746 LITDYC-PG 753 (934)
Q Consensus 746 lV~E~~-~g 753 (934)
+||||+ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 77
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00037 Score=75.46 Aligned_cols=72 Identities=14% Similarity=0.032 Sum_probs=46.0
Q ss_pred ccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCc-cceeEEEEeCCeEEEEEEcc-
Q 002342 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV-PALYASFQTKTHVCLITDYC- 751 (934)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~I-v~l~~~~~~~~~~~lV~E~~- 751 (934)
++.|+.|....+|++ ..|++|+...... ......+|..+++.+....+ ++++..+ .+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 678999999999999 4588998765311 11123457777777642222 5666543 33457899999
Q ss_pred CCCCch
Q 002342 752 PGGELF 757 (934)
Q Consensus 752 ~ggsL~ 757 (934)
+|.+|.
T Consensus 91 ~g~~l~ 96 (301)
T 3dxq_A 91 GAQTMS 96 (301)
T ss_dssp TCEECC
T ss_pred CCccCC
Confidence 766653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0008 Score=75.23 Aligned_cols=138 Identities=18% Similarity=0.218 Sum_probs=84.1
Q ss_pred cccccCCcEEEEEEEEec-------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCCeEEE
Q 002342 675 KPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~-------~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~l 746 (934)
+.|..|-...+|++.... +++.|++|+.-.. ......+.+|..+++.|. +.-.+++++.+.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 467778888999998742 3578999986432 112345668999998874 3334677776654 29
Q ss_pred EEEccCCCCchhhh-----------------ccC---CCCCC--CHHHHHHHHHHHHH-------------------HHH
Q 002342 747 ITDYCPGGELFLLL-----------------DRQ---PTKVL--KEDAVRFYAAEVVV-------------------ALE 785 (934)
Q Consensus 747 V~E~~~ggsL~~~l-----------------~~~---~~~~l--~~~~~~~i~~qil~-------------------aL~ 785 (934)
||||++|.+|..-- +.. ..+.. -...+..+..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999987664210 000 01112 23455555544422 233
Q ss_pred HHH----HC----CCeecCCCCCCEEEecC----CcEEEEecccCcc
Q 002342 786 YLH----CQ----GIIYRDLKPENVLLQGN----GHVSLTDFDLSCL 820 (934)
Q Consensus 786 yLH----~~----giiHrDLKp~NILl~~~----~~vkl~DFG~a~~ 820 (934)
.|. .. .++|+|+.+.|||++.+ +.+.|+||.+|..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 333 22 59999999999999876 7899999999854
|
| >1oj5_A Steroid receptor coactivator 1A; transcriptional coactivator, complex, LXXLL motif, transcriptional regulation; 2.2A {Mus musculus} SCOP: d.110.3.8 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00032 Score=64.79 Aligned_cols=97 Identities=8% Similarity=-0.000 Sum_probs=76.6
Q ss_pred CCCCCceEEcchHHHHHcCCCh--hhHcCCCCCCCCCCCCCh--HHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEe
Q 002342 208 TKPDYPIMYASAGFFKMTGYTS--KEVVGRNCRFLQGAGTDP--EDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTI 283 (934)
Q Consensus 208 ~~~dG~I~~~N~a~~~l~Gys~--eEllG~~~~~l~~~~~~~--~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~s~ 283 (934)
.+.||+|+++..... ..+|.. +||+|+.+..++|+++.. ...+.+..++..|...+.-++.+.|+|..+|++...
T Consensus 13 h~~dGKf~~vDq~~~-r~~~~~g~qdLlGrsiy~f~H~~D~~~s~l~~h~~~vl~~Gq~~S~~YRfr~k~g~~V~~qT~s 91 (132)
T 1oj5_A 13 QDTTGKIISIDTSSL-RAAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSAHTRC 91 (132)
T ss_dssp ECTTCCEEEEECHHH-HTTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEEEEEEE
T ss_pred ecCCCcEEEEecccc-cccccccHHHHHHHHHHHHhCcccchHHHHHHHHHHHHHcCCccccceEEEecCCcEEEEEEEE
Confidence 344899999999987 478888 999999999888988855 778888889988888888899999999999999998
Q ss_pred eeeecCC-CCEEEEEEEEecchh
Q 002342 284 APIKDDE-GKVLKFIGMQVEVSK 305 (934)
Q Consensus 284 ~pi~d~~-G~v~~~v~~~~DITe 305 (934)
..+++.. .++-+++++-.=+.+
T Consensus 92 k~f~np~t~e~e~Ivs~n~v~r~ 114 (132)
T 1oj5_A 92 KLCYPQSPDMQPFIMGIHIIDRE 114 (132)
T ss_dssp EEECC----CCCEEEEEEEEECC
T ss_pred EEecCCCCCCCCEEEEEEEEEcC
Confidence 8888752 344555665544443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00093 Score=72.78 Aligned_cols=141 Identities=19% Similarity=0.235 Sum_probs=79.0
Q ss_pred cccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCC--CccceeEE------EEeCCeE
Q 002342 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP--FVPALYAS------FQTKTHV 744 (934)
Q Consensus 673 i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~------~~~~~~~ 744 (934)
-++.|+.|....+|++... ++ .|++|+..... ....+..|..+++.|... .++.++.. ....+..
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 3566788988999999763 33 68899887521 112345677777666321 13333321 1234677
Q ss_pred EEEEEccCCCCchhh--------------hcc--CC--CC---CCCHHHHHH---------------HHHHHHHHHHHHH
Q 002342 745 CLITDYCPGGELFLL--------------LDR--QP--TK---VLKEDAVRF---------------YAAEVVVALEYLH 788 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~--------------l~~--~~--~~---~l~~~~~~~---------------i~~qil~aL~yLH 788 (934)
+++|+|++|..+... ++. .. .. ......... +...+...+++++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 999999988764210 111 00 00 011110010 0011334455555
Q ss_pred H-------CCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 789 C-------QGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 789 ~-------~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
. .+++|+|++|.|||++.++.+.|+||+.+..
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3 3699999999999999765568999998854
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0013 Score=74.91 Aligned_cols=75 Identities=20% Similarity=0.290 Sum_probs=51.3
Q ss_pred ccccccCCcEEEEEEEEec-------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCCeEE
Q 002342 674 IKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVC 745 (934)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~-------~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~ 745 (934)
++.|+.|-...||++.... ++..|++|+.... .. ...+..|..+++.|. +...+++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 4578889999999998753 2578999988431 11 134457888888884 3334677776543 2
Q ss_pred EEEEccCCCCch
Q 002342 746 LITDYCPGGELF 757 (934)
Q Consensus 746 lV~E~~~ggsL~ 757 (934)
+||||++|.+|.
T Consensus 149 ~v~e~l~G~~l~ 160 (429)
T 1nw1_A 149 RLEEYIPSRPLS 160 (429)
T ss_dssp EEECCCCEEECC
T ss_pred EEEEEeCCcccC
Confidence 899999875553
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.002 Score=71.71 Aligned_cols=75 Identities=21% Similarity=0.255 Sum_probs=45.8
Q ss_pred ccccccCCcEEEEEEEEec--------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCC-ccceeEEEEeCCeE
Q 002342 674 IKPLGSGDTGSVHLVELCG--------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF-VPALYASFQTKTHV 744 (934)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~--------~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~~~ 744 (934)
+..|+.|....+|++.... .+..|++|+..... ........|..+++.+...+ +++++..+ .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 4567888889999998743 13688999876431 11112356888888774223 55777654 22
Q ss_pred EEEEEccCCCCc
Q 002342 745 CLITDYCPGGEL 756 (934)
Q Consensus 745 ~lV~E~~~ggsL 756 (934)
++||||++|.++
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999988654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0058 Score=70.03 Aligned_cols=76 Identities=14% Similarity=0.166 Sum_probs=50.1
Q ss_pred ccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCc-cceeEEEEeCCeEEEEEEccC
Q 002342 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV-PALYASFQTKTHVCLITDYCP 752 (934)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~I-v~l~~~~~~~~~~~lV~E~~~ 752 (934)
++.|+.|-...+|++.....+..|++|+...... . .-...+|..+++.|...++ +++++.+. + .+||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---E-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---S-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---h-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 4578889999999998754458899998754321 1 1112578999998864444 67777763 2 25999998
Q ss_pred CCCch
Q 002342 753 GGELF 757 (934)
Q Consensus 753 ggsL~ 757 (934)
|.+|.
T Consensus 185 G~~l~ 189 (458)
T 2qg7_A 185 GYALS 189 (458)
T ss_dssp SEECC
T ss_pred CccCC
Confidence 86653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0058 Score=65.42 Aligned_cols=81 Identities=19% Similarity=0.081 Sum_probs=56.5
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC---CCccceeEEEEeCCeE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH---PFVPALYASFQTKTHV 744 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~h---p~Iv~l~~~~~~~~~~ 744 (934)
.....-+..+|.|..+.||++.. .+|+.|.+|+...... .....+..|...|+.|.. -.+++++.+. ..
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~ 85 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DR 85 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TT
T ss_pred CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEecc----Cc
Confidence 34556678899999999999986 6788999998654321 122346789999998842 2355665542 23
Q ss_pred EEEEEccCCCCc
Q 002342 745 CLITDYCPGGEL 756 (934)
Q Consensus 745 ~lV~E~~~ggsL 756 (934)
++||||++++..
T Consensus 86 ~lv~e~l~~~~~ 97 (288)
T 3f7w_A 86 TLAMEWVDERPP 97 (288)
T ss_dssp EEEEECCCCCCC
T ss_pred eEEEEeecccCC
Confidence 789999987654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0021 Score=70.43 Aligned_cols=138 Identities=13% Similarity=0.161 Sum_probs=71.7
Q ss_pred cccccCCcEE-EEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC--CCccceeEEEEeCCeEEEEEEcc
Q 002342 675 KPLGSGDTGS-VHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTKTHVCLITDYC 751 (934)
Q Consensus 675 ~~LG~G~~g~-Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~~~~~lV~E~~ 751 (934)
+.|+.|+... +|++.. .++..+++|...... ...+..|..+++.+.. -.+++++.+....+ +++||++
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 3465555554 666653 236677888654321 0234456777766632 24566776533333 7899999
Q ss_pred CCCCchhhhccC---------------------C---CCCCCHHHHH-------H-HH------------HHHHHHHHHH
Q 002342 752 PGGELFLLLDRQ---------------------P---TKVLKEDAVR-------F-YA------------AEVVVALEYL 787 (934)
Q Consensus 752 ~ggsL~~~l~~~---------------------~---~~~l~~~~~~-------~-i~------------~qil~aL~yL 787 (934)
.+..+.+.+... . ...++..... . +. ..+...+..|
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 766654332210 0 0112221111 0 00 0111222333
Q ss_pred ------HHCCCeecCCCCCCEEEecC----CcEEEEecccCccc
Q 002342 788 ------HCQGIIYRDLKPENVLLQGN----GHVSLTDFDLSCLT 821 (934)
Q Consensus 788 ------H~~giiHrDLKp~NILl~~~----~~vkl~DFG~a~~~ 821 (934)
+...++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 12469999999999999874 68999999998653
|
| >1oj5_A Steroid receptor coactivator 1A; transcriptional coactivator, complex, LXXLL motif, transcriptional regulation; 2.2A {Mus musculus} SCOP: d.110.3.8 | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0014 Score=60.56 Aligned_cols=102 Identities=12% Similarity=0.078 Sum_probs=79.4
Q ss_pred ccEEEEcCCCCCCCEEEccHHHHHHcCCCh--hhhcCCCCcccCCCCCCH--HHHHHHHHHHhcCCcEEEEEEEEecCCc
Q 002342 483 KNFVITDPRLPDNPIIFASDSFLELTEYSR--EEILGRNCRFLQGPETDP--ATVRKIRAAIDNQTDVTVQLINYTKSGK 558 (934)
Q Consensus 483 d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~--eEliG~~~~~l~~~~~~~--~~~~~i~~~l~~~~~~~~e~~~~~kdG~ 558 (934)
.-+.-.|.+|+ |++|.....+ .+|.. +||+|+.+.+++|+++.. ...+.+.+++..|.....-++++.++|.
T Consensus 8 ~F~sRh~~dGK---f~~vDq~~~r-~~~~~g~qdLlGrsiy~f~H~~D~~~s~l~~h~~~vl~~Gq~~S~~YRfr~k~g~ 83 (132)
T 1oj5_A 8 SFMTKQDTTGK---IISIDTSSLR-AAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGT 83 (132)
T ss_dssp EEEEEECTTCC---EEEEECHHHH-TTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSC
T ss_pred eeEEeecCCCc---EEEEeccccc-ccccccHHHHHHHHHHHHhCcccchHHHHHHHHHHHHHcCCccccceEEEecCCc
Confidence 44566788888 9999998874 77788 999999999999999865 7778888888888777778999999999
Q ss_pred EEEEEEEEEeeecCC-CCEEEEEEEEEcCCc
Q 002342 559 KFWNLFHLQPMRDQK-GEVQYFIGVQLDGSE 588 (934)
Q Consensus 559 ~~wv~~~~~pi~de~-G~v~~~vgi~rDITe 588 (934)
.+|+......+++.. .++-+++++-.=|.+
T Consensus 84 ~V~~qT~sk~f~np~t~e~e~Ivs~n~v~r~ 114 (132)
T 1oj5_A 84 MLSAHTRCKLCYPQSPDMQPFIMGIHIIDRE 114 (132)
T ss_dssp EEEEEEEEEEECC----CCCEEEEEEEEECC
T ss_pred EEEEEEEEEEecCCCCCCCCEEEEEEEEEcC
Confidence 999999888887742 345556655443443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0064 Score=66.89 Aligned_cols=31 Identities=23% Similarity=0.338 Sum_probs=27.6
Q ss_pred CCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 790 ~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
..++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999888899999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0065 Score=66.18 Aligned_cols=138 Identities=14% Similarity=0.061 Sum_probs=78.7
Q ss_pred cccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC--CCccceeEE-----EEeCCeEEEE
Q 002342 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYAS-----FQTKTHVCLI 747 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~-----~~~~~~~~lV 747 (934)
..|+ |....||++.. .+|+.|++|+...... ....+..|..+++.|.. -.++.++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 78889998865 3466799999864311 12355667787777632 123444432 2235667899
Q ss_pred EEccCCCCchh-----------h---hcc----CC---CCCCCHHHH----------------------HHHHHHHHHHH
Q 002342 748 TDYCPGGELFL-----------L---LDR----QP---TKVLKEDAV----------------------RFYAAEVVVAL 784 (934)
Q Consensus 748 ~E~~~ggsL~~-----------~---l~~----~~---~~~l~~~~~----------------------~~i~~qil~aL 784 (934)
|+|++|..+.. . ++. .. ...++.... ...+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 99998765431 0 000 00 011221111 01111222222
Q ss_pred HHH----HHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 785 EYL----HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 785 ~yL----H~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
.-+ +...++|+|++|.|||++ + .+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 211 123589999999999998 4 899999998854
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.75 E-value=0.017 Score=65.46 Aligned_cols=75 Identities=21% Similarity=0.321 Sum_probs=49.6
Q ss_pred ccccccCCcEEEEEEEEecC-------CeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCCeEE
Q 002342 674 IKPLGSGDTGSVHLVELCGS-------GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVC 745 (934)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~~-------~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~ 745 (934)
++.|..|-...+|++..... +..|++|+..... .......+|..+++.+. +.-.+++++.+. + +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADFP--E--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--C
Confidence 35677888889999987521 5789999875432 11112356888888774 334567775442 2 6
Q ss_pred EEEEccCCCCc
Q 002342 746 LITDYCPGGEL 756 (934)
Q Consensus 746 lV~E~~~ggsL 756 (934)
+||+|++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.70 E-value=0.067 Score=54.09 Aligned_cols=104 Identities=16% Similarity=0.126 Sum_probs=68.1
Q ss_pred CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcc
Q 002342 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832 (934)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 832 (934)
-+|.++|... +.+++++++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence 3688888765 4679999999999999999877622 2222344457899999999987764 2210
Q ss_pred hhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHH-hCCCCCC
Q 002342 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFR 899 (934)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ell-tG~~Pf~ 899 (934)
.....|.|||.+. ...+.+.=|||||++||.-+ .|-++=.
T Consensus 98 --------------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e 138 (229)
T 2yle_A 98 --------------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE 138 (229)
T ss_dssp -----------------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE
T ss_pred --------------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc
Confidence 0122466777763 34456888999999999999 4665543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.28 E-value=0.17 Score=56.68 Aligned_cols=29 Identities=28% Similarity=0.401 Sum_probs=25.0
Q ss_pred CeecCCCCCCEEEe------cCCcEEEEecccCcc
Q 002342 792 IIYRDLKPENVLLQ------GNGHVSLTDFDLSCL 820 (934)
Q Consensus 792 iiHrDLKp~NILl~------~~~~vkl~DFG~a~~ 820 (934)
++|+|+.+.|||+. .++.+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 68999999999994 456799999999854
|
| >2ool_A Sensor protein; bacteriophytochrome, photoconversion, photoreceptor, biliver signaling protein; HET: LBV; 2.20A {Rhodopseudomonas palustris} SCOP: d.110.2.1 d.110.3.9 | Back alignment and structure |
|---|
Probab=84.33 E-value=0.61 Score=50.66 Aligned_cols=77 Identities=13% Similarity=0.151 Sum_probs=49.2
Q ss_pred cEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCc---EEEEEEEEec-CCcE
Q 002342 484 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD---VTVQLINYTK-SGKK 559 (934)
Q Consensus 484 ~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~---~~~e~~~~~k-dG~~ 559 (934)
.++++|.. +++|+.+|..+++++|+++++++|+++..+++++. ...+...+..+.. ...++..... +|..
T Consensus 44 ~Ll~~~~~--~~~i~~~S~N~~~~lg~~~~~llG~~l~~ll~~~~----~~~l~~~l~~~~~~~~~p~~~~~~~~~~~~~ 117 (337)
T 2ool_A 44 YLFVVSET--DLRIASVSANVEDLLRQPPASLLNVPIAHYLTAAS----AARLTHALHGGDPAAINPIRLDVVTPDGERA 117 (337)
T ss_dssp EEEEECTT--TCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCHHH----HHHHHHHHCC----CCCSEEEEEEETTEEEE
T ss_pred EEEEEECC--CCEEEEEehhHHHHHCcCHHHHcCCCHHHHcCHHH----HHHHHHHHhcCCccccCcEEEEEeccCCCeE
Confidence 34456654 45599999999999999999999999988887643 3344444433221 2234444333 3556
Q ss_pred EEEEEEE
Q 002342 560 FWNLFHL 566 (934)
Q Consensus 560 ~wv~~~~ 566 (934)
+|+.++.
T Consensus 118 f~~~~Hr 124 (337)
T 2ool_A 118 FNGILHR 124 (337)
T ss_dssp EEEEEEE
T ss_pred EEEEEEE
Confidence 6665543
|
| >2ool_A Sensor protein; bacteriophytochrome, photoconversion, photoreceptor, biliver signaling protein; HET: LBV; 2.20A {Rhodopseudomonas palustris} SCOP: d.110.2.1 d.110.3.9 | Back alignment and structure |
|---|
Probab=82.35 E-value=1.6 Score=47.37 Aligned_cols=77 Identities=17% Similarity=0.168 Sum_probs=48.2
Q ss_pred CcE-EEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCc---EEEEEEEEec-CC
Q 002342 200 QTF-VVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS---YCGRLLNYKK-DG 274 (934)
Q Consensus 200 d~i-~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~---~~~e~~~~~k-dG 274 (934)
.|+ +++|. .+++|+.+|..+++++|+++++++|+++..+++++ ....++..+..+.. ....++.... +|
T Consensus 42 ~G~Ll~~~~--~~~~i~~~S~N~~~~lg~~~~~llG~~l~~ll~~~----~~~~l~~~l~~~~~~~~~p~~~~~~~~~~~ 115 (337)
T 2ool_A 42 HGYLFVVSE--TDLRIASVSANVEDLLRQPPASLLNVPIAHYLTAA----SAARLTHALHGGDPAAINPIRLDVVTPDGE 115 (337)
T ss_dssp TSEEEEECT--TTCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCHH----HHHHHHHHHCC----CCCSEEEEEEETTEE
T ss_pred CEEEEEEEC--CCCEEEEEehhHHHHHCcCHHHHcCCCHHHHcCHH----HHHHHHHHHhcCCccccCcEEEEEeccCCC
Confidence 344 44553 26889999999999999999999999988777653 33445555544321 1123333333 35
Q ss_pred cEEEEEEE
Q 002342 275 TPFWNLLT 282 (934)
Q Consensus 275 ~~~wv~~s 282 (934)
..+|+.+.
T Consensus 116 ~~f~~~~H 123 (337)
T 2ool_A 116 RAFNGILH 123 (337)
T ss_dssp EEEEEEEE
T ss_pred eEEEEEEE
Confidence 56665543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.80 E-value=4.4 Score=40.73 Aligned_cols=84 Identities=11% Similarity=0.062 Sum_probs=60.5
Q ss_pred CCCCccceeEEEEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec
Q 002342 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 806 (934)
Q Consensus 727 ~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~ 806 (934)
.||+++.. .+-..++.+.+.++.-+.+.=+..++ .++....+.++.+|+....+++ .-+|--|+|+||+++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTR 114 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcC
Confidence 68888877 56667777767666543222222232 2778888888888888774443 3477789999999999
Q ss_pred CCcEEEEecccC
Q 002342 807 NGHVSLTDFDLS 818 (934)
Q Consensus 807 ~~~vkl~DFG~a 818 (934)
++.+++.=.|+-
T Consensus 115 ~~~p~i~~RGik 126 (215)
T 4ann_A 115 DGLPIAKTRGLQ 126 (215)
T ss_dssp TSCEEESCCEET
T ss_pred CCCEEEEEccCc
Confidence 999999988875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 934 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-62 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-56 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-55 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-53 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-53 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-53 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-53 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-50 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-48 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-48 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-45 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-34 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-26 | |
| d1n9la_ | 109 | d.110.3.6 (A:) Putative blue light receptor, phot- | 1e-24 | |
| d1n9la_ | 109 | d.110.3.6 (A:) Putative blue light receptor, phot- | 2e-24 | |
| d1jnua_ | 104 | d.110.3.6 (A:) Photoreceptor phy3 flavin-binding d | 3e-23 | |
| d1jnua_ | 104 | d.110.3.6 (A:) Photoreceptor phy3 flavin-binding d | 4e-21 | |
| d1bywa_ | 110 | d.110.3.6 (A:) Erg potassium channel, N-terminal d | 4e-16 | |
| d1bywa_ | 110 | d.110.3.6 (A:) Erg potassium channel, N-terminal d | 6e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-13 | |
| d1xj3a1 | 106 | d.110.3.2 (A:154-259) Histidine kinase FixL heme d | 7e-07 | |
| d1xj3a1 | 106 | d.110.3.2 (A:154-259) Histidine kinase FixL heme d | 7e-06 | |
| d1ew0a_ | 130 | d.110.3.2 (A:) Histidine kinase FixL heme domain { | 6e-06 | |
| d1ew0a_ | 130 | d.110.3.2 (A:) Histidine kinase FixL heme domain { | 3e-05 | |
| d1ll8a_ | 114 | d.110.3.5 (A:) N-terminal PAS domain of Pas kinase | 7e-05 | |
| d1p97a_ | 114 | d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-t | 3e-04 | |
| d1p97a_ | 114 | d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-t | 0.001 | |
| d1mzua_ | 110 | d.110.3.1 (A:) PYP domain of sensor histidine kina | 0.001 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 2e-62
Identities = 78/259 (30%), Positives = 109/259 (42%), Gaps = 31/259 (11%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
L+ F +PLG G G+V+L S A+K + K + H+ E EI L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
HP + LY F T V LI +Y P G ++ L + E Y E+ AL Y
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYC 122
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H + +I+RD+KPEN+LL G + + DF S
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA-------------------------- 156
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907
P + GT +Y+ PE+I G H VD W+LG+L YE L G PF T Q+T+
Sbjct: 157 ---PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 213
Query: 908 ANILHKDLKFPSSTPSSCK 926
I + FP +
Sbjct: 214 KRISRVEFTFPDFVTEGAR 232
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 6e-61
Identities = 81/257 (31%), Positives = 123/257 (47%), Gaps = 27/257 (10%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
F+ K LG G +V L + + +A+K ++K ++ NKV ER+++ LDHP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
F LY +FQ + Y GEL + + E RFY AE+V ALEYLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 126
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+GII+RDLKPEN+LL + H+ +TDF + + S +
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------------------------- 161
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+NSFVGT +Y++PE++ + D WALG ++Y+++ G PFR F
Sbjct: 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK 221
Query: 910 ILHKDLKFPSSTPSSCK 926
I+ + FP +
Sbjct: 222 IIKLEYDFPEKFFPKAR 238
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-56
Identities = 62/265 (23%), Positives = 106/265 (40%), Gaps = 39/265 (14%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+ I LG G G V+ + + A K +D + ++ E +IL DHP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHP 69
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+ L +F + ++ ++ ++C GG + ++ + L E ++ + + AL YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD 128
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
II+RDLK N+L +G + L DF +S
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSA---------------------------KNT 161
Query: 850 EPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
++ +SF+GT ++APE++ + D W+LGI L EM P
Sbjct: 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221
Query: 905 KTFANILHKD---LKFPSSTPSSCK 926
+ I + L PS S+ K
Sbjct: 222 RVLLKIAKSEPPTLAQPSRWSSNFK 246
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 4e-56
Identities = 59/268 (22%), Positives = 105/268 (39%), Gaps = 34/268 (12%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ F I LG+G+ G V V SG A K + + ++ E ++L
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLH 59
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
+ P++ Y +F + + + ++ GG L +L + + E + + V+ L
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 117
Query: 785 EYLH-CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
YL I++RD+KP N+L+ G + L DF +S
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---------------------- 155
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903
+NSFVGT Y++PE + G ++ D W++G+ L EM G P
Sbjct: 156 -------IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208
Query: 904 QKTFANILHKDLKFPSSTPSSCKAANVP 931
++ + + TP + P
Sbjct: 209 KELELMFGCQVEGDAAETPPRPRTPGRP 236
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 195 bits (496), Expect = 5e-56
Identities = 66/260 (25%), Positives = 112/260 (43%), Gaps = 34/260 (13%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
L H+ + LG+G G VH V +G FA K + ++ V + E + + +L
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLR 81
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
HP + L+ +F+ + +I ++ GGELF + + K + ED Y +V L ++
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHM 140
Query: 788 HCQGIIYRDLKPENVLL--QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
H ++ DLKPEN++ + + + L DF L+
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-------------------------- 174
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
+P ++ GT E+ APE+ G D W++G+L Y +L G +PF G+ +
Sbjct: 175 --HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232
Query: 906 TFANILHKDLKFPSSTPSSC 925
T N+ D S S
Sbjct: 233 TLRNVKSCDWNMDDSAFSGI 252
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 193 bits (492), Expect = 2e-55
Identities = 67/260 (25%), Positives = 112/260 (43%), Gaps = 34/260 (13%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
++ ++ LGSG G VH +G+ F K ++ L++ V E I++ L
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLH 84
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
HP + L+ +F+ K + LI ++ GGELF + + K + E V Y + L+++
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHM 143
Query: 788 HCQGIIYRDLKPENVLL--QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
H I++ D+KPEN++ + V + DF L+ +
Sbjct: 144 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN----------------------- 180
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
P T E+ APEI+ D WA+G+L Y +L G +PF G+ +
Sbjct: 181 -----PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 235
Query: 906 TFANILHKDLKFPSSTPSSC 925
T N+ D +F SS
Sbjct: 236 TLQNVKRCDWEFDEDAFSSV 255
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-54
Identities = 83/260 (31%), Positives = 133/260 (51%), Gaps = 30/260 (11%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-L 726
++ F K LG G G V L E + Q+FA+KA+ K V+L + V E+ +L +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
+HPF+ ++ +FQTK ++ + +Y GG+L + FYAAE+++ L++
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQF 118
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
LH +GI+YRDLK +N+LL +GH+ + DF +
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--------------------------- 151
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
+N+F GT +YIAPEI+ G + +VDWW+ G+LLYEML G +PF G+ ++
Sbjct: 152 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 211
Query: 907 FANILHKDLKFPSSTPSSCK 926
F +I + +P K
Sbjct: 212 FHSIRMDNPFYPRWLEKEAK 231
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (475), Expect = 1e-53
Identities = 62/265 (23%), Positives = 94/265 (35%), Gaps = 36/265 (13%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ F ++ +G G G+V+ + + A+K M + K E L L H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
P + + L+ +YC G LL + K L+E + + L YLH
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH 132
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
+I+RD+K N+LL G V L DF + +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI---------------------------- 164
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
M +NSFVGT ++APE+I VD W+LGI E+ P
Sbjct: 165 ---MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221
Query: 906 TFANILHKDLKFPSSTPSSCKAANV 930
+I + S S N
Sbjct: 222 ALYHIAQNESPALQSGHWSEYFRNF 246
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 187 bits (475), Expect = 1e-53
Identities = 95/259 (36%), Positives = 139/259 (53%), Gaps = 32/259 (12%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
LQ F+ ++ LG+G G VHL+ +G+Y+AMK + K +++ +V ER +L ++
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
HPF+ ++ +FQ + +I DY GGELF LL + +FYAAEV +ALEYL
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLALEYL 120
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H + IIYRDLKPEN+LL NGH+ +TDF +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---------------------- 158
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907
+ GT +YIAPE+++ + ++DWW+ GIL+YEML GYTPF KT+
Sbjct: 159 --------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210
Query: 908 ANILHKDLKFPSSTPSSCK 926
IL+ +L+FP K
Sbjct: 211 EKILNAELRFPPFFNEDVK 229
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 3e-53
Identities = 54/261 (20%), Positives = 105/261 (40%), Gaps = 36/261 (13%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ + + +G G +G+V+ +GQ A++ M+ + + E ++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKN 76
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
P + S+ + ++ +Y GG L ++ E + E + ALE+LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLH 133
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
+I+RD+K +N+LL +G V LTDF +
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA---------------------------QI 166
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908
++ VGT ++APE++ + VD W+LGI+ EM+ G P+ + +
Sbjct: 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
Query: 909 NILHK---DLKFPSSTPSSCK 926
I +L+ P + +
Sbjct: 227 LIATNGTPELQNPEKLSAIFR 247
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 184 bits (468), Expect = 4e-53
Identities = 67/270 (24%), Positives = 110/270 (40%), Gaps = 43/270 (15%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK------VHRACAEREI 722
+++ P + LG G + V + + +A+K +D + + E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 723 LDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
L + HP + L +++T T L+ D GELF L + T L E R ++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALL 120
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+ LH I++RDLKPEN+LL + ++ LTDF SC
Sbjct: 121 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--------------------- 159
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA------GHTSAVDWWALGILLYEMLYGY 895
+P GT Y+APEII + G+ VD W+ G+++Y +L G
Sbjct: 160 -------LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
Query: 896 TPFRGKTRQKTFANILHKDLKFPSSTPSSC 925
PF + + I+ + +F S
Sbjct: 213 PPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 242
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 5e-53
Identities = 60/266 (22%), Positives = 107/266 (40%), Gaps = 38/266 (14%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+ + +G+G G + G+ K +D G M + +E +L L HP
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPN 64
Query: 731 VPALYASF--QTKTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEY 786
+ Y +T T + ++ +YC GG+L ++ + + + L E+ V ++ +AL+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 787 LHCQG-----IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
H + +++RDLKP NV L G +V L DF L+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR---------------------- 162
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+ + +FVGT Y++PE + + D W+LG LLYE+ PF
Sbjct: 163 -----ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217
Query: 902 TRQKTFANILHKDL-KFPSSTPSSCK 926
++++ I + P
Sbjct: 218 SQKELAGKIREGKFRRIPYRYSDELN 243
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (469), Expect = 9e-53
Identities = 73/276 (26%), Positives = 117/276 (42%), Gaps = 43/276 (15%)
Query: 653 WKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK 712
WK + I D + LG+G V L E + + A+K + K + K
Sbjct: 1 WKQAEDIRD--------IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGK 50
Query: 713 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
E +L + HP + AL +++ H+ LI GGELF + + E
Sbjct: 51 EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERD 108
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSCKPQLLL 829
+V+ A++YLH GI++RDLKPEN+L + + ++DF LS +
Sbjct: 109 ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED------- 161
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889
P ++ GT Y+APE++A ++ AVD W++G++ Y
Sbjct: 162 ---------------------PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAY 200
Query: 890 EMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSC 925
+L GY PF + K F IL + +F S
Sbjct: 201 ILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-52
Identities = 89/261 (34%), Positives = 136/261 (52%), Gaps = 29/261 (11%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
+ + F +K LG G G V LV +G+Y+AMK + K V++ +++V E +L
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
HPF+ AL +FQT +C + +Y GGELF L R+ E+ RFY AE+V ALE
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALE 119
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YLH + ++YRD+K EN++L +GH+ +TDF L
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-------------------------- 153
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + ++
Sbjct: 154 -EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
Query: 906 TFANILHKDLKFPSSTPSSCK 926
F IL ++++FP + K
Sbjct: 213 LFELILMEEIRFPRTLSPEAK 233
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-51
Identities = 60/257 (23%), Positives = 105/257 (40%), Gaps = 30/257 (11%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
++ + ++ LG G G V L + + A+K +D ++ + E I ML+
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLN 61
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
H V Y + L +YC GGELF ++ + E + + +++ + YL
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYL 119
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H GI +RD+KPEN+LL ++ ++DF L+ + +
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--------------------- 158
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
R N GT Y+APE++ H VD W+ GI+L ML G P+ +
Sbjct: 159 ----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214
Query: 907 FANILHKDLKFPSSTPS 923
+ + + +
Sbjct: 215 EYSDWKEKKTYLNPWKK 231
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 179 bits (454), Expect = 3e-51
Identities = 54/260 (20%), Positives = 103/260 (39%), Gaps = 30/260 (11%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+ + LG G VHL + A+K + + + + R E + L+HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 730 FVPALYASFQTKTH----VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
+ A+Y + + +T ++ +Y G L ++ + + A+ AL
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALN 125
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
+ H GII+RD+KP N+++ V + DF ++ +
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN------------------- 166
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
+ + + +GT +Y++PE G + D ++LG +LYE+L G PF G +
Sbjct: 167 -----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221
Query: 906 TFANILHKDLKFPSSTPSSC 925
+ +D PS+
Sbjct: 222 VAYQHVREDPIPPSARHEGL 241
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 3e-50
Identities = 54/258 (20%), Positives = 100/258 (38%), Gaps = 35/258 (13%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+ + LG G+ G VH S + + K + E IL++ H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHR 61
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+ L+ SF++ + +I ++ G ++F ++ + L E + Y +V AL++LH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS 120
Query: 790 QGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
I + D++PEN++ Q + + + +F +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-------------------- 160
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907
EY APE+ ++A D W+LG L+Y +L G PF +T Q+
Sbjct: 161 --------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
Query: 908 ANILHKDLKFPSSTPSSC 925
NI++ + F
Sbjct: 213 ENIMNAEYTFDEEAFKEI 230
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 7e-49
Identities = 55/265 (20%), Positives = 101/265 (38%), Gaps = 36/265 (13%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
I + +GSG G+V+ + G A+K ++ ++ E +L
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLRK 60
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
H + + T + ++T +C G L+ L TK + + A + ++
Sbjct: 61 TRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMD 118
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YLH + II+RDLK N+ L + V + DF L+ + S
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS----------------------- 155
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAG---HTSAVDWWALGILLYEMLYGYTPFRGKT 902
G+ ++APE+I ++ D +A GI+LYE++ G P+
Sbjct: 156 --RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213
Query: 903 RQKTFANILHKDLKFP--SSTPSSC 925
+ ++ + P S S+C
Sbjct: 214 NRDQIIFMVGRGYLSPDLSKVRSNC 238
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 174 bits (443), Expect = 1e-48
Identities = 76/268 (28%), Positives = 130/268 (48%), Gaps = 38/268 (14%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
+ + F + +G G G V+ +G+ +AMK +DK + + A ER +L +
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 726 L---DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 782
+ D PF+ + +F T + I D GG+L L + E +RFYAAE+++
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIIL 118
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
LE++H + ++YRDLKP N+LL +GHV ++D L+C S K
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----------------- 161
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRG- 900
++ VGT Y+APE++ G + S+ DW++LG +L+++L G++PFR
Sbjct: 162 ------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209
Query: 901 --KTRQKTFANILHKDLKFPSSTPSSCK 926
K + + L ++ P S +
Sbjct: 210 KTKDKHEIDRMTLTMAVELPDSFSPELR 237
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-48
Identities = 57/273 (20%), Positives = 107/273 (39%), Gaps = 40/273 (14%)
Query: 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 722
G + + + +G G +V+ + A + L +++ R E E+
Sbjct: 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR-KLTKSERQRFKEEAEM 61
Query: 723 LDMLDHPFVPALYASFQT----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
L L HP + Y S+++ K + L+T+ G L L R KV+K +R +
Sbjct: 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCR 119
Query: 779 EVVVALEYLHCQG--IIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
+++ L++LH + II+RDLK +N+ + G G V + D L+ L
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--------------- 164
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 895
+ + + +GT E++APE+ + +VD +A G+ + EM
Sbjct: 165 --------------KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE 209
Query: 896 TPFRGKTRQKTFANILHKDLKFPSSTPSSCKAA 928
P+ + +K S +
Sbjct: 210 YPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 9e-48
Identities = 99/275 (36%), Positives = 146/275 (53%), Gaps = 35/275 (12%)
Query: 658 KILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNK-V 713
+ E++ +++F +K LG+G G V LV +G+ +AMK + K ++ + K
Sbjct: 13 NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 72
Query: 714 HRACAEREILDMLDH-PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
ER++L+ + PF+ L+ +FQT+T + LI DY GGELF L ++ E
Sbjct: 73 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHE 130
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
V+ Y E+V+ALE+LH GIIYRD+K EN+LL NGHV LTDF LS
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK------------- 177
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYE 890
F+A+ + F GT EY+AP+I+ G +GH AVDWW+LG+L+YE
Sbjct: 178 -------------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 224
Query: 891 MLYGYTPFRGKTRQKTFANILHKDLKFPSSTPSSC 925
+L G +PF + + A I + LK P
Sbjct: 225 LLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (434), Expect = 1e-47
Identities = 89/262 (33%), Positives = 131/262 (50%), Gaps = 32/262 (12%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
L F IK LG+G G V LV+ SG ++AMK +DK ++ ++ E+ IL
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
++ PF+ L SF+ +++ ++ +Y GGE+F L R E RFYAA++V+
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTF 154
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
EYLH +IYRDLKPEN+L+ G++ +TDF +
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------------- 189
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+ + GT E +APEII G+ AVDWWALG+L+YEM GY PF
Sbjct: 190 -----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 905 KTFANILHKDLKFPSSTPSSCK 926
+ + I+ ++FPS S K
Sbjct: 245 QIYEKIVSGKVRFPSHFSSDLK 266
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 4e-47
Identities = 72/269 (26%), Positives = 117/269 (43%), Gaps = 38/269 (14%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-NRNKVHRACAERE- 721
E ++ ++ + LGSG V +G +A K + K +R V R ERE
Sbjct: 6 ENVD-DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 722 -ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
IL + HP V L+ ++ KT V LI + GGELF L + + L E+ + ++
Sbjct: 65 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQI 122
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCLTSCKPQLLLPTTNEKK 836
+ + YLH I + DLKPEN++L + + DF L+
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------------- 165
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT 896
+ + GT E++APEI+ D W++G++ Y +L G +
Sbjct: 166 -----------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 214
Query: 897 PFRGKTRQKTFANILHKDLKFPSSTPSSC 925
PF G T+Q+T AN+ + +F S+
Sbjct: 215 PFLGDTKQETLANVSAVNYEFEDEYFSNT 243
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 7e-47
Identities = 53/267 (19%), Positives = 101/267 (37%), Gaps = 40/267 (14%)
Query: 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 722
G +N++ + ++ +G G+ G V L + G A+K + AE +
Sbjct: 1 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN-----DATAQAFLAEASV 53
Query: 723 LDMLDHPFVPALYASF-QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
+ L H + L + K + ++T+Y G L L + VL D + ++ +V
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
A+EYL ++RDL NVL+ + ++DF L+ S
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----------------- 156
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRG 900
++ ++ APE + ++ D W+ GILL+E+ +G P+
Sbjct: 157 -------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203
Query: 901 KTRQKTFANILH-KDLKFPSSTPSSCK 926
+ + + P P +
Sbjct: 204 IPLKDVVPRVEKGYKMDAPDGCPPAVY 230
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-46
Identities = 56/263 (21%), Positives = 98/263 (37%), Gaps = 34/263 (12%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
I+ + +K LG+G G V + G A+K + +G M E +++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED----EFIEEAKVMMN 55
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
L H + LY + + +IT+Y G L L + + + +V A+E
Sbjct: 56 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAME 114
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YL + ++RDL N L+ G V ++DF LS
Sbjct: 115 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY------------------------- 149
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQ 904
+ + +S + PE++ + +S D WA G+L++E+ G P+ T
Sbjct: 150 -VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208
Query: 905 KTFANILH-KDLKFPSSTPSSCK 926
+T +I L P
Sbjct: 209 ETAEHIAQGLRLYRPHLASEKVY 231
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 7e-46
Identities = 58/269 (21%), Positives = 89/269 (33%), Gaps = 30/269 (11%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREI 722
I + R ++ LG G G V E G A+K + V+ + E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 723 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 782
+ LDH + LY T + ++T+ P G L L + + YA +V
Sbjct: 65 MHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAE 122
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
+ YL + I+RDL N+LL V + DF L
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN------------------ 164
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGK 901
+ + APE + + A D W G+ L+EM YG P+ G
Sbjct: 165 ------DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218
Query: 902 TRQKTFANILHKDLKFPSSTPSSCKAANV 930
+ I + + P NV
Sbjct: 219 NGSQILHKIDKEGERLPRPEDCPQDIYNV 247
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 4e-45
Identities = 55/255 (21%), Positives = 95/255 (37%), Gaps = 32/255 (12%)
Query: 677 LGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
LG G+ GSV A+K + +G + E +I+ LD+P++ L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 794
Q + + L+ + GG L L + + V +V + ++YL + ++
Sbjct: 75 IGVCQAE-ALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 132
Query: 795 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 854
RDL NVLL + ++DF LS +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS---------------------- 170
Query: 855 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH- 912
+ ++ APE I +S D W+ G+ ++E L YG P++ + A I
Sbjct: 171 --AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 228
Query: 913 KDLKFPSSTPSSCKA 927
K ++ P P A
Sbjct: 229 KRMECPPECPPELYA 243
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 6e-45
Identities = 52/256 (20%), Positives = 96/256 (37%), Gaps = 32/256 (12%)
Query: 675 KPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 732
K LGSG+ G+V + A+K + + AE ++ LD+P++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIV 71
Query: 733 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
+ + ++ L+ + G L L + +K+ + +V + ++YL
Sbjct: 72 RMIGICEAESW-MLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNF 128
Query: 793 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
++RDL NVLL + ++DF LS
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN------------------------YY 164
Query: 853 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANIL 911
+A ++ APE I +S D W+ G+L++E YG P+RG + A +
Sbjct: 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224
Query: 912 H-KDLKFPSSTPSSCK 926
+ + P+ P
Sbjct: 225 KGERMGCPAGCPREMY 240
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 3e-44
Identities = 65/249 (26%), Positives = 96/249 (38%), Gaps = 32/249 (12%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLDHPFV 731
+ LG G +V+ + Q A+K + G A RE +L L HP +
Sbjct: 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 791
L +F K+++ L+ D+ ++ D VL ++ Y + LEYLH
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 792 IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEP 851
I++RDLKP N+LL NG + L DF L+ P
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK---------------------------SFGSP 153
Query: 852 MRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
RA V T Y APE++ GA + VD WA+G +L E+L G + I
Sbjct: 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213
Query: 911 LHKDLKFPS 919
Sbjct: 214 FETLGTPTE 222
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 7e-44
Identities = 61/285 (21%), Positives = 106/285 (37%), Gaps = 47/285 (16%)
Query: 644 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 703
KP +D W ++ + + ++ LG+G G V + G A+K++
Sbjct: 1 KPWWEDE--W-----------EVPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLK 46
Query: 704 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 763
+G M AE ++ L H + LYA T+ + +IT+Y G L L
Sbjct: 47 QGSM----SPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTP 101
Query: 764 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
L + + AA++ + ++ + I+RDL+ N+L+ + DF L+ L
Sbjct: 102 SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL--- 158
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 883
A ++ APE I T D W+
Sbjct: 159 -----------------------IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 884 LGILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPSSCK 926
GILL E++ +G P+ G T + N+ + P + P
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-43
Identities = 59/264 (22%), Positives = 97/264 (36%), Gaps = 43/264 (16%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH---RACAEREILDML 726
++ LGSG GSV+ A+K ++K + + ++ R E +L +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 727 D--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
V L F+ LI + + + L+E+ R + +V+ A+
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 123
Query: 785 EYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
+ H G+++RD+K EN+L+ N G + L DF L
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----------------- 166
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEMLYGYTPFRGKT 902
F GT Y PE I + + W+LGILLY+M+ G PF
Sbjct: 167 ------------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214
Query: 903 RQKTFANILHKDLKFPSSTPSSCK 926
I+ + F S C+
Sbjct: 215 ------EIIRGQVFFRQRVSSECQ 232
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (396), Expect = 4e-43
Identities = 59/268 (22%), Positives = 99/268 (36%), Gaps = 30/268 (11%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAER 720
++I++ + + +G+G+ G V L G+ + A+K + G + +E
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEA 78
Query: 721 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
I+ DHP V L T V +IT++ G L RQ + +
Sbjct: 79 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-LRQNDGQFTVIQLVGMLRGI 137
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
++YL ++RDL N+L+ N ++DF LS
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD------------- 184
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFR 899
++ + APE I TSA D W+ GI+++E++ YG P+
Sbjct: 185 ---------PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235
Query: 900 GKTRQKTFANILH-KDLKFPSSTPSSCK 926
T Q I L P PS+
Sbjct: 236 DMTNQDVINAIEQDYRLPPPMDCPSALH 263
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 7e-43
Identities = 54/263 (20%), Positives = 96/263 (36%), Gaps = 48/263 (18%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 733
+ LG G G V + + + FA+K + R E E+ P +
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVR 69
Query: 734 LYASFQT----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+ ++ + + ++ + GGELF + + + E + A++YLH
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 790 QGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
I +RD+KPEN+L + N + LTDF +
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--------------------------- 162
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
+ + T Y+APE++ + + D W+LG+++Y +L GY PF
Sbjct: 163 -ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221
Query: 907 ----FANILHKDLKFPSSTPSSC 925
I +FP+ S
Sbjct: 222 SPGMKTRIRMGQYEFPNPEWSEV 244
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-42
Identities = 54/293 (18%), Positives = 102/293 (34%), Gaps = 55/293 (18%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ-----YFAMKAMDKGVMLNRNKVHRACAER 720
++ K LGSG G V G + A+K + + + ++ +E
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSEL 91
Query: 721 EILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK------------- 766
+++ L H + L + + LI +YC G+L L + K
Sbjct: 92 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 767 --------VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818
VL + + +A +V +E+L + ++RDL NVL+ V + DF L+
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 878
++ +++APE + +T
Sbjct: 212 RDIMSDSNYVVRGN-------------------------ARLPVKWMAPESLFEGIYTIK 246
Query: 879 VDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANV 930
D W+ GILL+E+ G P+ G F ++ K ++ + +
Sbjct: 247 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYII 299
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (388), Expect = 3e-42
Identities = 51/266 (19%), Positives = 89/266 (33%), Gaps = 30/266 (11%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ LG G G V+ A+K + + + +V E ++
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMK 68
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
+ HP + L + +IT++ G L L + + + + A ++ A+
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
EYL + I+RDL N L+ N V + DF LS L
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------------------------ 164
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+ A ++ APE +A + D WA G+LL+E+
Sbjct: 165 --MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222
Query: 905 KTFANILHKDLKFPSSTPSSCKAANV 930
+L KD + K +
Sbjct: 223 SQVYELLEKDYRMERPEGCPEKVYEL 248
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 3e-42
Identities = 50/263 (19%), Positives = 103/263 (39%), Gaps = 34/263 (12%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
I+ ++ +GSG G VHL + A+K + +G M + + E E++
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIE----EAEVMMK 56
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
L HP + LY + +CL+ ++ G L R + + + +V +
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YL +I+RDL N L+ N + ++DF ++
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF------------------------- 150
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQ 904
+ + +S ++ +PE+ + + ++S D W+ G+L++E+ G P+ ++
Sbjct: 151 -VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209
Query: 905 KTFANILH-KDLKFPSSTPSSCK 926
+ +I L P +
Sbjct: 210 EVVEDISTGFRLYKPRLASTHVY 232
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 4e-42
Identities = 56/263 (21%), Positives = 95/263 (36%), Gaps = 34/263 (12%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
I + R LG G G V + G+ + A+K + G M E +++
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE----AFLQEAQVMKK 68
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
L H + LYA ++ + ++T+Y G L L + K L+ + AA++ +
Sbjct: 69 LRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
Y+ ++RDL+ N+L+ N + DF L+ L
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARL------------------------- 162
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQ 904
A ++ APE T D W+ GILL E+ G P+ G +
Sbjct: 163 -IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221
Query: 905 KTFANILH-KDLKFPSSTPSSCK 926
+ + + P P S
Sbjct: 222 EVLDQVERGYRMPCPPECPESLH 244
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 152 bits (385), Expect = 9e-42
Identities = 50/269 (18%), Positives = 90/269 (33%), Gaps = 34/269 (12%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 728
H++ + +G G G + + Q A+K + R+ + E +L
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGC 60
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
+P +Y Q H L+ D LL + V A +++ ++ +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 789 CQGIIYRDLKPENVLL-----QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
+ ++YRD+KP+N L+ + + + DF +
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR--------------------D 158
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903
P R + GT Y++ G + D ALG + L G P++G
Sbjct: 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK- 217
Query: 904 QKTFANILHKDLKFPSSTPSSCKAANVPP 932
T + + STP A P
Sbjct: 218 AATNKQKYERIGEKKQSTPLRELCAGFPE 246
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-41
Identities = 56/260 (21%), Positives = 99/260 (38%), Gaps = 30/260 (11%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
+++F+ ++ +G G G V+ +G+ A+K + A E +L L+
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN 59
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
HP + L T+ + L+ ++ L +D + ++ Y +++ L +
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H +++RDLKP+N+L+ G + L DF L+
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---------------------------A 151
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEMLYGYTPFRGKTRQKT 906
P+R V T Y APEI+ G + S AVD W+LG + EM+ F G +
Sbjct: 152 FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211
Query: 907 FANILHKDLKFPSSTPSSCK 926
I
Sbjct: 212 LFRIFRTLGTPDEVVWPGVT 231
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-40
Identities = 55/266 (20%), Positives = 89/266 (33%), Gaps = 35/266 (13%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+ + +G G G V +GQ A+K + A E +IL +L H
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME-NEKEGFPITALREIKILQLLKHE 69
Query: 730 FVPALYASFQTKT--------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
V L +TK + L+ D+C LL + ++ ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLL 127
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
L Y+H I++RD+K NVL+ +G + L DF L+ S
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN--------------- 172
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRG 900
+ V T Y PE++ G + +D W G ++ EM +G
Sbjct: 173 --------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224
Query: 901 KTRQKTFANILHKDLKFPSSTPSSCK 926
T Q A I +
Sbjct: 225 NTEQHQLALISQLCGSITPEVWPNVD 250
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-40
Identities = 56/253 (22%), Positives = 101/253 (39%), Gaps = 39/253 (15%)
Query: 669 QHFRPIKPLGSGDTGSVHLV-ELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML- 726
Q + + +G G G V +L G++ A+K + E +L L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLE 65
Query: 727 --DHPFVPALYASFQT-----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
+HP V L+ +T + L+ ++ L D+ P + + ++ +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL-DKVPEPGVPTETIKDMMFQ 124
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
++ L++LH +++RDLKP+N+L+ +G + L DF L+ + S
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS----------------- 167
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
A S V T Y APE++ + + + VD W++G + EM FR
Sbjct: 168 -----------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216
Query: 900 GKTRQKTFANILH 912
G + IL
Sbjct: 217 GSSDVDQLGKILD 229
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 5e-40
Identities = 52/279 (18%), Positives = 96/279 (34%), Gaps = 45/279 (16%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ + +G G+ G V + G +++ E E+L
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65
Query: 725 ML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLL--------------DRQPTKVLK 769
L HP + L + + + ++ L +Y P G L L L
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 770 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829
+ +AA+V ++YL + I+RDL N+L+ N + DF LS
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS----------- 174
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889
E ++A E + + +T+ D W+ G+LL+
Sbjct: 175 -----------------RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217
Query: 890 EML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPSSCK 926
E++ G TP+ G T + + + L+ P +
Sbjct: 218 EIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVY 256
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (372), Expect = 6e-40
Identities = 52/291 (17%), Positives = 96/291 (32%), Gaps = 56/291 (19%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAE 719
+ + ++ +G G G V G A+K + + + + E
Sbjct: 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQRE 66
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ---------------- 763
++ D+P + L +CL+ +Y G+L L
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 764 ------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817
L A +V + YL + ++RDL N L+ N V + DF L
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 877
S ++ A+ +A + ++ PE I +T+
Sbjct: 187 SRN-------------------------IYSADYYKADGNDAIPIRWMPPESIFYNRYTT 221
Query: 878 AVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPSSCK 926
D WA G++L+E+ YG P+ G ++ + + L P + P
Sbjct: 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELY 272
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (366), Expect = 4e-39
Identities = 50/267 (18%), Positives = 92/267 (34%), Gaps = 32/267 (11%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+R + +GSG G ++L +G+ A+K + + K + E +I M+
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQGG 62
Query: 730 -FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
+P + + ++ + L ++ V A +++ +EY+H
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDL--FNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 789 CQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
+ I+RD+KP+N L+ V + DF L+ K +
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK--------------------KYRDAR 160
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
P R + + GT Y + G + D +LG +L G P++G
Sbjct: 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220
Query: 906 TFANILHKDLKFPSSTPSSCKAANVPP 932
K STP P
Sbjct: 221 KRQKYERISEKKM-STPIEVLCKGYPS 246
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 144 bits (363), Expect = 7e-39
Identities = 51/253 (20%), Positives = 101/253 (39%), Gaps = 32/253 (12%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
++ + ++ +G G G V+ + G+ FA+K + + E IL L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLE-KEDEGIPSTTIREISILKELK 58
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
H + LY TK + L+ ++ LL + L+ + + +++ + Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYC 116
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H + +++RDLKP+N+L+ G + + DF L+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLAR---------------------------A 149
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
P+R + T Y AP+++ G+ +++ +D W++G + EM+ G F G +
Sbjct: 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ 209
Query: 907 FANILHKDLKFPS 919
I S
Sbjct: 210 LMRIFRILGTPNS 222
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-38
Identities = 60/267 (22%), Positives = 98/267 (36%), Gaps = 35/267 (13%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREI 722
I + + +G G G VH A+K + + + E
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--CTSDSVREKFLQEALT 61
Query: 723 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 782
+ DHP + L T+ V +I + C GEL L + L ++ YA ++
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLST 119
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
AL YL + ++RD+ NVL+ N V L DF LS
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-------------------- 159
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGK 901
++ +++APE I TSA D W G+ ++E+L +G PF+G
Sbjct: 160 ------DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213
Query: 902 TRQKTFANILHKD-LKFPSSTPSSCKA 927
I + + L P + P + +
Sbjct: 214 KNNDVIGRIENGERLPMPPNCPPTLYS 240
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-38
Identities = 54/254 (21%), Positives = 96/254 (37%), Gaps = 34/254 (13%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+ + +G G G V + A+K + ++ R E +IL H
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHE 66
Query: 730 FVPALYASFQTKTHV----CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
+ + + T + + G +L+ LL Q L D + ++ +++ L+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLK 123
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
Y+H +++RDLKP N+LL + + DF L+ +
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-------------------- 163
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+ +V T Y APEI+ G+T ++D W++G +L EML F GK
Sbjct: 164 ----DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 219
Query: 905 KTFANILHKDLKFP 918
+IL
Sbjct: 220 DQLNHILGILGSPS 233
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-38
Identities = 57/276 (20%), Positives = 103/276 (37%), Gaps = 37/276 (13%)
Query: 655 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-- 712
A+ +IL E F+ IK LGSG G+V+ G+ + K + +
Sbjct: 1 ALLRILKETE------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 54
Query: 713 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
E ++ +D+P V L T T LIT P G L + +
Sbjct: 55 NKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI-GSQY 112
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
+ + ++ + YL + +++RDL NVL++ HV +TDF L+ L
Sbjct: 113 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL------------ 160
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
+ E + +++A E I +T D W+ G+ ++E++
Sbjct: 161 -------------LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 207
Query: 893 -YGYTPFRGKTRQKTFANIL-HKDLKFPSSTPSSCK 926
+G P+ G + + + + L P
Sbjct: 208 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 243
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-38
Identities = 58/250 (23%), Positives = 101/250 (40%), Gaps = 44/250 (17%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+ K +G+G G V+ +LC SG+ A+K + + E +I+ LDH
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 74
Query: 731 VPALYASFQT------KTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVA 783
+ L F + + ++ L+ DY P + + + L V+ Y ++ +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
L Y+H GI +RD+KP+N+LL + V L DF +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-------------------- 174
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAP-EIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+ S++ + Y AP I +TS++D W+ G +L E+L G F G
Sbjct: 175 --------RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226
Query: 902 TRQKTFANIL 911
+ I+
Sbjct: 227 SGVDQLVEII 236
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-38
Identities = 53/297 (17%), Positives = 100/297 (33%), Gaps = 50/297 (16%)
Query: 657 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRN 711
Q D + K LG+G G V G + A+K + +
Sbjct: 11 QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLT 68
Query: 712 KVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ------- 763
+ +E ++L L +H + L + +IT+YC G+L L R+
Sbjct: 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 764 ---------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 814
L + + ++ +V + +L + I+RDL N+LL + D
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 874
F L+ + +++APE I
Sbjct: 189 FGLARDIKND-------------------------SNYVVKGNARLPVKWMAPESIFNCV 223
Query: 875 HTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANV 930
+T D W+ GI L+E+ G +P+ G F ++ + + S + + ++
Sbjct: 224 YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDI 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 7e-38
Identities = 48/259 (18%), Positives = 99/259 (38%), Gaps = 32/259 (12%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
+Q + ++ +G G G+V + + + A+K + + A E +L L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK 59
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
H + L+ + + L+ ++C L + V+ + +++ L +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY--FDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H + +++RDLKP+N+L+ NG + L +F L+
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARA--------------------------- 150
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTP-FRGKTRQK 905
P+R ++ V T Y P+++ GA +++++D W+ G + E+ P F G
Sbjct: 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
Query: 906 TFANILHKDLKFPSSTPSS 924
I S
Sbjct: 211 QLKRIFRLLGTPTEEQWPS 229
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 8e-37
Identities = 55/285 (19%), Positives = 100/285 (35%), Gaps = 51/285 (17%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACA 718
+ KPLG G G V L E G A+K + + +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLIS 67
Query: 719 EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLL--------------DRQ 763
E E++ M+ H + L + + +I +Y G L L
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 764 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
P + L + A +V +EYL + I+RDL NVL+ + + + DF L+
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH- 186
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 883
+ + + + +++APE + +T D W+
Sbjct: 187 ------------------------HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 222
Query: 884 LGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPSSCK 926
G+LL+E+ G +P+ G ++ F + + PS+ +
Sbjct: 223 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELY 267
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-36
Identities = 50/257 (19%), Positives = 103/257 (40%), Gaps = 40/257 (15%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
L+ ++ +KP+GSG G V + A+K + + N+ RA E ++ ++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN 74
Query: 728 HPFVPALYASFQTK------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
H + +L F + V L+ + ++ + + + +++
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQML 129
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+++LH GII+RDLKP N++++ + + + DF L+ +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-------------- 175
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+V T Y APE+I G G+ VD W++G ++ EM+ F G+
Sbjct: 176 --------------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 902 TRQKTFANILHKDLKFP 918
+ ++ +
Sbjct: 222 DYIDQWNKVIEQLGTPC 238
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 137 bits (346), Expect = 3e-36
Identities = 53/286 (18%), Positives = 103/286 (36%), Gaps = 47/286 (16%)
Query: 638 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 697
++V + W +++ G N ++ ++ LG G V + +
Sbjct: 7 ARVYTDVNTHRPREYWDYESHVVEWG---NQDDYQLVRKLGRGKYSEVFEAINITNNEKV 63
Query: 698 AMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH--VCLITDYCPGG 754
+K + K + E +IL+ L P + L + L+ ++
Sbjct: 64 VVKILKP------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117
Query: 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLT 813
+ L L + +RFY E++ AL+Y H GI++RD+KP NV++ + + L
Sbjct: 118 DFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 172
Query: 814 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA 873
D+ L+ P + N V + + PE++
Sbjct: 173 DWGLAE----------------------------FYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 874 -GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP 918
+ ++D W+LG +L M++ PF + K L
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 9e-36
Identities = 53/292 (18%), Positives = 110/292 (37%), Gaps = 35/292 (11%)
Query: 641 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYF 697
VH + +A+Q ++ + + HF + +G G G V+ L G +
Sbjct: 2 VHIDLSALNPELVQAVQHVVIGPSSLIV-HFNEV--IGRGHFGCVYHGTLLDNDGKKIHC 58
Query: 698 AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALY-ASFQTKTHVCLITDYCPGGEL 756
A+K++++ + + +V + E I+ HP V +L +++ ++ Y G+L
Sbjct: 59 AVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 116
Query: 757 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 816
+ + +D + F +V +++L + ++RDL N +L V + DF
Sbjct: 117 RNFIRNETHNPTVKDLIGF-GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 175
Query: 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT 876
L+ K + + +++A E + T
Sbjct: 176 LARDMYDK-----------------------EFDSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 877 SAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPSSCK 926
+ D W+ G+LL+E++ G P+ +L + L P P
Sbjct: 213 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 9e-36
Identities = 60/261 (22%), Positives = 101/261 (38%), Gaps = 34/261 (13%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+R ++P+GSG G+V +G A+K + + + RA E +L + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRH 76
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
V L F + TD+ L + L ED ++F +++ L Y
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
+H GII+RDLKP N+ + + + + DF L+ +
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---------------------- 174
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
+V T Y APE+I +T VD W++G ++ EM+ G T F+G
Sbjct: 175 --------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226
Query: 906 TFANILHKDLKFPSSTPSSCK 926
I+ P+ +
Sbjct: 227 QLKEIMKVTGTPPAEFVQRLQ 247
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 4e-35
Identities = 47/270 (17%), Positives = 89/270 (32%), Gaps = 31/270 (11%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAER 720
+I+ K +G+G+ G V+ L S A+K + G + E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEA 60
Query: 721 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
I+ H + L + +IT+Y G R+ + +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENG-ALDKFLREKDGEFSVLQLVGMLRGI 119
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
++YL ++RDL N+L+ N ++DF LS + P+ T+
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-------- 171
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
+ APE I+ TSA D W+ GI+++E++
Sbjct: 172 ----------------GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215
Query: 901 KTRQKTFANILHKDLKFPSSTPSSCKAANV 930
+ ++ + P+ +
Sbjct: 216 ELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-34
Identities = 39/276 (14%), Positives = 87/276 (31%), Gaps = 42/276 (15%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAER 720
+ + + LG G G V+ G A+K +++ + E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEA 74
Query: 721 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL--------DRQPTKVLKEDA 772
++ + V L +I + G+L L +
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
+ A E+ + YL+ ++RDL N ++ + V +
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG------------------- 175
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
G ++ + R + +++PE + T+ D W+ G++L+E+
Sbjct: 176 ------DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229
Query: 893 -YGYTPFRGKTRQKTFANILHKD-LKFPSSTPSSCK 926
P++G + ++ ++ L P + P
Sbjct: 230 TLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 9e-34
Identities = 51/251 (20%), Positives = 92/251 (36%), Gaps = 54/251 (21%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDHPFVP 732
+ +G G G V + G+ A+K + + + E EI L H +
Sbjct: 9 ESIGKGRFGEVWRGKW--RGEEVAVK------IFSSREERSWFREAEIYQTVMLRHENIL 60
Query: 733 ALYASFQ----TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
A+ T T + L++DY G LF L+R + + + A L +LH
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLH 117
Query: 789 CQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+ I +RDLK +N+L++ NG + D L+ +
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI------------ 165
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH------TSAVDWWALGILLYEMLYG 894
A N VGT+ Y+APE++ + + D +A+G++ +E+
Sbjct: 166 -----------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214
Query: 895 YTPFRGKTRQK 905
+ +
Sbjct: 215 CSIGGIHEDYQ 225
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 9e-34
Identities = 54/288 (18%), Positives = 104/288 (36%), Gaps = 49/288 (17%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAE 719
+ + KPLG G G V + G + + A+K + +G + ++ + E
Sbjct: 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS--E 66
Query: 720 REILDMLDHPF--VPALYASFQTKTHVCLITDYCPGGELFLLLDRQ-------------- 763
+IL + H V L A + + +I ++C G L L +
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 764 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
L + + Y+ +V +E+L + I+RDL N+LL V + DF L+
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD--- 183
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 883
++ +++APE I +T D W+
Sbjct: 184 ----------------------IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 221
Query: 884 LGILLYEMLYGY-TPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANV 930
G+LL+E+ +P+ G + F L + + + ++ +
Sbjct: 222 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 269
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 3e-33
Identities = 59/263 (22%), Positives = 100/263 (38%), Gaps = 40/263 (15%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
++ + P+GSG GSV +G A+K + + + R E +L + H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHE 77
Query: 730 FVPALYASFQTKTHVC-----LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
V L F + + + G +L ++ Q L +D V+F +++ L
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGL 134
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
+Y+H II+RDLKP N+ + + + + DF L+ T +
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM------------------- 175
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEMLYGYTPFRGKTR 903
+V T Y APEI+ H + VD W++G ++ E+L G T F G
Sbjct: 176 -----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224
Query: 904 QKTFANILHKDLKFPSSTPSSCK 926
IL +
Sbjct: 225 IDQLKLILRLVGTPGAELLKKIS 247
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (275), Expect = 1e-26
Identities = 47/262 (17%), Positives = 93/262 (35%), Gaps = 37/262 (14%)
Query: 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 722
GE + ++ LG G +V L + + + AMK + + + +
Sbjct: 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 66
Query: 723 -------LDMLDHPFVPALYASFQTKT---HVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
D + + L F K ++ G L L+ + + +
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 773 VRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLP 830
V+ + ++++ L+Y+H + GII+ D+KPENVL++ L ++ L +
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC------ 180
Query: 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 890
+ + T EY +PE++ GA D W+ L++E
Sbjct: 181 -------------------WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 221
Query: 891 MLYGYTPFRGKTRQKTFANILH 912
++ G F + H
Sbjct: 222 LITGDFLFEPDEGHSYTKDDDH 243
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 109 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 97.2 bits (241), Expect = 1e-24
Identities = 65/107 (60%), Positives = 86/107 (80%)
Query: 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETL 257
+ TFVV+DAT PD P++YAS GF+ MTGY EV+G NCRFLQG GTDP++V KIR+ +
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 258 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+ G++ RLLNY+KDGTPFWNLLT+ PIK +G+V KF+G+QV+V+
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVDVT 108
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 109 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 96.9 bits (240), Expect = 2e-24
Identities = 49/105 (46%), Positives = 67/105 (63%)
Query: 481 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAI 540
+ FV+ D LPD P+++AS+ F +T Y +E+LG NCRFLQG TDP V+KIR AI
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 541 DNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
+V+L+NY K G FWNL + P++ G V F+GVQ+D
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVD 106
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Score = 92.7 bits (229), Expect = 3e-23
Identities = 75/103 (72%), Positives = 86/103 (83%)
Query: 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDN 542
K+FVITDPRLPDNPIIFASD FLELTEY+REE+LG NCRFLQG TD V+ IR A+
Sbjct: 1 KSFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKE 60
Query: 543 QTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
Q DVTVQ++NYTK G+ FWNLFHLQ MRD+ G+VQYFIGVQ +
Sbjct: 61 QRDVTVQVLNYTKGGRAFWNLFHLQVMRDENGDVQYFIGVQQE 103
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Score = 86.9 bits (214), Expect = 4e-21
Identities = 46/104 (44%), Positives = 69/104 (66%)
Query: 200 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQN 259
++FV++D PD PI++AS F ++T YT +EV+G NCRFLQG GTD + V IR+ ++
Sbjct: 1 KSFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKE 60
Query: 260 GQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
+ ++LNY K G FWNL + ++D+ G V FIG+Q E+
Sbjct: 61 QRDVTVQVLNYTKGGRAFWNLFHLQVMRDENGDVQYFIGVQQEM 104
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.2 bits (178), Expect = 4e-16
Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 2/108 (1%)
Query: 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNC--RFLQGPETDPATVRKIRAAI 540
+ F+I + R+ + +I+ +D F EL YSR E++ R C FL GP T +I A+
Sbjct: 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQAL 61
Query: 541 DNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
+ V++ Y K G F L + P++++ G V FI E
Sbjct: 62 LGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVME 109
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.9 bits (154), Expect = 6e-13
Identities = 31/107 (28%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 200 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNC--RFLQGAGTDPEDVAKIRETL 257
+ F++++A + ++Y + GF ++ GY+ EV+ R C FL G T A+I + L
Sbjct: 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQAL 61
Query: 258 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+ + Y+KDG+ F L+ + P+K+++G V+ FI V
Sbjct: 62 LGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVM 108
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 68.3 bits (166), Expect = 1e-13
Identities = 25/159 (15%), Positives = 46/159 (28%), Gaps = 30/159 (18%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN-KVHRACAERE------------ 721
K +G G +V +K G + K R +
Sbjct: 6 KLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 722 --ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
L L VP +YA ++ + ++ +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGN----AVLMELIDAK---------ELYRVRVENPDEVLDM 111
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818
++ + + +GI++ DL NVL+ G + DF S
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEGIW-IIDFPQS 149
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} Length = 106 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Score = 46.3 bits (108), Expect = 7e-07
Identities = 20/108 (18%), Positives = 34/108 (31%), Gaps = 9/108 (8%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKI----RAAID 541
++ D I S + L +S E +G+N L I +
Sbjct: 4 IVIDG---HGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDP 60
Query: 542 NQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH 589
+ + + + G F + M+ G YF G D +EH
Sbjct: 61 HIIGIGRIVTGKRRDGTTFPMHLSIGEMQS--GGEPYFTGFVRDLTEH 106
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} Length = 106 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Score = 43.6 bits (101), Expect = 7e-06
Identities = 17/103 (16%), Positives = 36/103 (34%), Gaps = 6/103 (5%)
Query: 208 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI----RETLQNGQSY 263
I S ++ G++ E +G+N L + I + +
Sbjct: 6 IDGHGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGI 65
Query: 264 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306
+ ++DGT F L+I ++ F G ++++H
Sbjct: 66 GRIVTGKRRDGTTFPMHLSIGEMQSGGEPY--FTGFVRDLTEH 106
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Score = 44.3 bits (103), Expect = 6e-06
Identities = 20/101 (19%), Positives = 41/101 (40%), Gaps = 6/101 (5%)
Query: 208 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ----SY 263
+ D I+ +A + GY +EV+G+N R L E ++ + G+
Sbjct: 32 SATDGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQRYMATGEKRIIGI 91
Query: 264 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+ +KDG+ F L + ++ + F G +++
Sbjct: 92 DRVVSGQRKDGSTFPMKLAVGEMRSGGERF--FTGFIRDLT 130
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Score = 42.3 bits (98), Expect = 3e-05
Identities = 27/129 (20%), Positives = 48/129 (37%), Gaps = 13/129 (10%)
Query: 461 DKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNC 520
D VR ++ L + L+ + V++ D I+ + + + Y+ EE++G+N
Sbjct: 9 DVVRARDAH----LRSILDTVPDATVVSAT---DGTIVSFNAAAVRQFGYAEEEVIGQNL 61
Query: 521 RFLQG----PETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEV 576
R L E D R + + + K G F + MR G
Sbjct: 62 RILMPEPYRHEHDGYLQRYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRS--GGE 119
Query: 577 QYFIGVQLD 585
++F G D
Sbjct: 120 RFFTGFIRD 128
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (95), Expect = 7e-05
Identities = 15/101 (14%), Positives = 34/101 (33%), Gaps = 8/101 (7%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 545
D + I+ A+D L YS ++++G+ ++
Sbjct: 12 FTVDAK--TTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGH 69
Query: 546 VTV----QLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 582
V + ++SG+K ++ MR ++ + V
Sbjct: 70 AAVVFGTVVDIISRSGEKIPVSVWMKRMRQERRL--CCVVV 108
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 3e-04
Identities = 19/97 (19%), Positives = 30/97 (30%), Gaps = 1/97 (1%)
Query: 493 PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552
D + D EL Y EE+LGR+ + + V+ Q
Sbjct: 14 MDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRM 73
Query: 553 YTKSGKKFWNLFHLQPMRDQK-GEVQYFIGVQLDGSE 588
K G W + + + + Q + V SE
Sbjct: 74 LAKHGGYVWLETQGTVIYNPRNLQPQCIMCVNYVLSE 110
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.7 bits (86), Expect = 0.001
Identities = 18/107 (16%), Positives = 33/107 (30%), Gaps = 3/107 (2%)
Query: 199 QQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ 258
+TF+ D Y ++ GY +E++GR+ A +
Sbjct: 5 SKTFLSR--HSMDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCT 62
Query: 259 NGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDE-GKVLKFIGMQVEVS 304
GQ G+ K G W I + + + + +S
Sbjct: 63 KGQVVSGQYRMLAKHGGYVWLETQGTVIYNPRNLQPQCIMCVNYVLS 109
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Score = 37.4 bits (86), Expect = 0.001
Identities = 12/96 (12%), Positives = 25/96 (26%), Gaps = 5/96 (5%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR-KIRAAIDNQT 544
+ D I + + L+ E ++GRN P T+ + + + T
Sbjct: 17 IQVDG---SGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGT 73
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFI 580
+ +Q F+
Sbjct: 74 LDARFDFVFDFQMAPVRVQIRMQNAGVP-DRYWIFV 108
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 934 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.98 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1n9la_ | 109 | Putative blue light receptor, phot-lov1 domain {Gr | 99.8 | |
| d1n9la_ | 109 | Putative blue light receptor, phot-lov1 domain {Gr | 99.77 | |
| d1bywa_ | 110 | Erg potassium channel, N-terminal domain {Human (H | 99.73 | |
| d1jnua_ | 104 | Photoreceptor phy3 flavin-binding domain, lov2 {Ma | 99.71 | |
| d1bywa_ | 110 | Erg potassium channel, N-terminal domain {Human (H | 99.71 | |
| d1jnua_ | 104 | Photoreceptor phy3 flavin-binding domain, lov2 {Ma | 99.68 | |
| d1ew0a_ | 130 | Histidine kinase FixL heme domain {Rhizobium melil | 99.68 | |
| d1ew0a_ | 130 | Histidine kinase FixL heme domain {Rhizobium melil | 99.63 | |
| d1p97a_ | 114 | Hypoxia-inducible factor Hif2a, C-terminal domain | 99.55 | |
| d1p97a_ | 114 | Hypoxia-inducible factor Hif2a, C-terminal domain | 99.54 | |
| d1v9ya_ | 113 | Direct oxygen sensor protein, DOS {Escherichia col | 99.49 | |
| d1xj3a1 | 106 | Histidine kinase FixL heme domain {Bradyrhizobium | 99.49 | |
| d1xj3a1 | 106 | Histidine kinase FixL heme domain {Bradyrhizobium | 99.49 | |
| d1v9ya_ | 113 | Direct oxygen sensor protein, DOS {Escherichia col | 99.47 | |
| d1nwza_ | 125 | Photoactive yellow protein, PYP {Ectothiorhodospir | 99.29 | |
| d1mzua_ | 110 | PYP domain of sensor histidine kinase Ppr {Rhodosp | 99.28 | |
| d1nwza_ | 125 | Photoactive yellow protein, PYP {Ectothiorhodospir | 99.23 | |
| d1mzua_ | 110 | PYP domain of sensor histidine kinase Ppr {Rhodosp | 99.18 | |
| d1ll8a_ | 114 | N-terminal PAS domain of Pas kinase {Human (Homo s | 99.17 | |
| d1ll8a_ | 114 | N-terminal PAS domain of Pas kinase {Human (Homo s | 99.12 | |
| d1oj5a_ | 109 | PAS domain of steroid receptor coactivator 1A, NCo | 98.85 | |
| d1oj5a_ | 109 | PAS domain of steroid receptor coactivator 1A, NCo | 98.79 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.29 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.76 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.71 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.91 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.22 | |
| d2oola2 | 114 | Sensor protein PhyB2 {Rhodopseudomonas palustris [ | 96.06 | |
| d2oola2 | 114 | Sensor protein PhyB2 {Rhodopseudomonas palustris [ | 95.97 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.67 | |
| d2veaa3 | 127 | Phytochrome-like protein Cph1 {Synechocystis sp. p | 88.74 | |
| d2veaa3 | 127 | Phytochrome-like protein Cph1 {Synechocystis sp. p | 88.73 | |
| d2o9ca2 | 127 | Bacteriophytochrome BphP {Deinococcus radiodurans | 87.05 | |
| d2o9ca2 | 127 | Bacteriophytochrome BphP {Deinococcus radiodurans | 86.65 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=411.85 Aligned_cols=230 Identities=34% Similarity=0.563 Sum_probs=206.0
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++.+.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+++.+|||
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 56899999999999999999999999999999999875444445567788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 85 mEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---- 158 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 158 (263)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC----
T ss_pred EeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC----
Confidence 9999999999999764 4599999999999999999999999999999999999999999999999999954321
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
......+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+++
T Consensus 159 -------------------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~ 213 (263)
T d2j4za1 159 -------------------------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 213 (263)
T ss_dssp -------------------------CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred -------------------------CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH
Confidence 1223567999999999999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCCCCcccCCC
Q 002342 908 ANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 908 ~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
.+|.++.+.+|... |..+++|
T Consensus 214 ~~i~~~~~~~p~~~--s~~~~~l 234 (263)
T d2j4za1 214 KRISRVEFTFPDFV--TEGARDL 234 (263)
T ss_dssp HHHHTTCCCCCTTS--CHHHHHH
T ss_pred HHHHcCCCCCCccC--CHHHHHH
Confidence 99999999988753 5555443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=415.53 Aligned_cols=234 Identities=35% Similarity=0.623 Sum_probs=205.5
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++.+.||+|+||+||+|+++.+++.||||++.+...........+.+|+++|++++||||++++++|.+++.+|||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999875544455567889999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 87 mEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~-- 162 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-- 162 (288)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC--
Confidence 9999999999998765 459999999999999999999999999999999999999999999999999996543211
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
......+.+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+++
T Consensus 163 -----------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~ 219 (288)
T d1uu3a_ 163 -----------------------KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 219 (288)
T ss_dssp ------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred -----------------------cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH
Confidence 112234568999999999999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCCCCcccCCC
Q 002342 908 ANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 908 ~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
++|.++.+.+|.. .|.+++||
T Consensus 220 ~~i~~~~~~~p~~--~s~~~~~l 240 (288)
T d1uu3a_ 220 QKIIKLEYDFPEK--FFPKARDL 240 (288)
T ss_dssp HHHHTTCCCCCTT--CCHHHHHH
T ss_pred HHHHcCCCCCCcc--CCHHHHHH
Confidence 9999999999875 35555554
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=421.19 Aligned_cols=234 Identities=39% Similarity=0.765 Sum_probs=210.8
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+.+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++||||++++++|.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 45678999999999999999999999999999999998765545556678889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
+|||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 82 iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~-- 157 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-- 157 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred cceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--
Confidence 999999999999999875 4599999999999999999999999999999999999999999999999999964321
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
........+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+
T Consensus 158 -------------------------~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 212 (337)
T d1o6la_ 158 -------------------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212 (337)
T ss_dssp -------------------------TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH
Confidence 1122346789999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 906 TFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 906 ~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
+++++..+.+.+|.. .|++++||
T Consensus 213 ~~~~i~~~~~~~p~~--~s~~~~dl 235 (337)
T d1o6la_ 213 LFELILMEEIRFPRT--LSPEAKSL 235 (337)
T ss_dssp HHHHHHHCCCCCCTT--SCHHHHHH
T ss_pred HHHHHhcCCCCCCcc--CCHHHHHH
Confidence 999999999999976 46666665
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-46 Score=402.78 Aligned_cols=229 Identities=24% Similarity=0.403 Sum_probs=198.2
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
++|++++.||+|+||+||+|.++.+|+.||||++.+... ...+.+.+|+.+|+.++||||++++++|.+++++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 579999999999999999999999999999999986532 23456889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
|||+||+|.+++... .+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 97 Ey~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~---- 169 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 169 (293)
T ss_dssp ECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST----
T ss_pred EecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc----
Confidence 999999999988653 4999999999999999999999999999999999999999999999999999654211
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~ 908 (934)
.......+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+.+.
T Consensus 170 -----------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 226 (293)
T d1yhwa1 170 -----------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (293)
T ss_dssp -----------------------TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred -----------------------cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH
Confidence 112345689999999999999999999999999999999999999999999888877
Q ss_pred HHHcC-CCCCCCCCCCCcccCCC
Q 002342 909 NILHK-DLKFPSSTPSSCKAANV 930 (934)
Q Consensus 909 ~i~~~-~~~~p~~~~~s~~~k~l 930 (934)
.+..+ ...++.+...|..+++|
T Consensus 227 ~~~~~~~~~~~~~~~~s~~~~~l 249 (293)
T d1yhwa1 227 LIATNGTPELQNPEKLSAIFRDF 249 (293)
T ss_dssp HHHHHCSCCCSSGGGSCHHHHHH
T ss_pred HHHhCCCCCCCCcccCCHHHHHH
Confidence 77654 33444433455555554
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-46 Score=409.62 Aligned_cols=228 Identities=41% Similarity=0.811 Sum_probs=205.2
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46899999999999999999999999999999999876544445567888999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||||.||+|..++... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 83 mE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---- 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 156 (316)
T ss_dssp ECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred eeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc----
Confidence 9999999999998775 4589999999999999999999999999999999999999999999999999965321
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
...+.+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+++
T Consensus 157 --------------------------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 210 (316)
T d1fota_ 157 --------------------------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210 (316)
T ss_dssp --------------------------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred --------------------------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH
Confidence 123568999999999999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCCCCcccCC
Q 002342 908 ANILHKDLKFPSSTPSSCKAAN 929 (934)
Q Consensus 908 ~~i~~~~~~~p~~~~~s~~~k~ 929 (934)
.+|.++.+.+|... |.++++
T Consensus 211 ~~i~~~~~~~p~~~--s~~~~~ 230 (316)
T d1fota_ 211 EKILNAELRFPPFF--NEDVKD 230 (316)
T ss_dssp HHHHHCCCCCCTTS--CHHHHH
T ss_pred HHHHcCCCCCCCCC--CHHHHH
Confidence 99999999888753 444443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=400.87 Aligned_cols=234 Identities=26% Similarity=0.408 Sum_probs=193.2
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ....+.+.+|+.+|+.++||||+++++++.+++.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 4689999999999999999999999999999999976432 23345688999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 82 mEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~-- 157 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 157 (271)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred EeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC--
Confidence 9999999999999764 459999999999999999999999999999999999999999999999999996542111
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHH-H
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQ-K 905 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~~DiwSlG~iL~elltG~~Pf~~~~~~-~ 905 (934)
........+||+.|||||++.+..+ +.++|||||||+||+|++|++||.+.+.. .
T Consensus 158 -----------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~ 214 (271)
T d1nvra_ 158 -----------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214 (271)
T ss_dssp -----------------------EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH
T ss_pred -----------------------ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH
Confidence 1122345689999999999988876 56899999999999999999999876554 4
Q ss_pred HHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 906 TFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 906 ~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
.+..+.......+.+...|..+++|
T Consensus 215 ~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 215 EYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp HHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred HHHHHhcCCCCCCccccCCHHHHHH
Confidence 4445555544444444456555544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-45 Score=400.18 Aligned_cols=228 Identities=27% Similarity=0.375 Sum_probs=201.1
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEE
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 749 (934)
.|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999987655556667789999999999999999999999999999999999
Q ss_pred ccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCC
Q 002342 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (934)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 829 (934)
||.+|+|..++... +.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|....
T Consensus 96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~------- 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 166 (309)
T ss_dssp CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-------
T ss_pred ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC-------
Confidence 99999998776554 459999999999999999999999999999999999999999999999999985421
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
.....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.
T Consensus 167 ------------------------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~ 222 (309)
T d1u5ra_ 167 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (309)
T ss_dssp ------------------------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ------------------------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 1234579999999999964 4688999999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCCCcccCCC
Q 002342 907 FANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 907 ~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
+.++..+....+.....|..+++|
T Consensus 223 ~~~i~~~~~~~~~~~~~s~~~~~l 246 (309)
T d1u5ra_ 223 LYHIAQNESPALQSGHWSEYFRNF 246 (309)
T ss_dssp HHHHHHSCCCCCSCTTSCHHHHHH
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHH
Confidence 999988876655544556666554
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-45 Score=401.77 Aligned_cols=231 Identities=30% Similarity=0.467 Sum_probs=187.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.+.|++.+.||+|+||+||+|+++.+++.||||++.+..... ....+.+|+.+|+.++||||++++++|.+++.+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367999999999999999999999999999999998754322 235677899999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe---cCCcEEEEecccCcccCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~---~~~~vkl~DFG~a~~~~~~ 824 (934)
||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+....
T Consensus 86 mE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~- 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP- 162 (307)
T ss_dssp ECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC-
Confidence 9999999999999764 4599999999999999999999999999999999999995 478999999999954321
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
.....+.+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..
T Consensus 163 ---------------------------~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~ 215 (307)
T d1a06a_ 163 ---------------------------GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 215 (307)
T ss_dssp -------------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ---------------------------CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH
Confidence 11234568999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCC--CCCCcccCCC
Q 002342 905 KTFANILHKDLKFPSS--TPSSCKAANV 930 (934)
Q Consensus 905 ~~~~~i~~~~~~~p~~--~~~s~~~k~l 930 (934)
+++.+|.++.+.+|.. ...|.++++|
T Consensus 216 ~~~~~i~~~~~~~~~~~~~~~s~~~~~l 243 (307)
T d1a06a_ 216 KLFEQILKAEYEFDSPYWDDISDSAKDF 243 (307)
T ss_dssp HHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred HHHHHHhccCCCCCCccccCCCHHHHHH
Confidence 9999999988877654 3345555443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=400.23 Aligned_cols=231 Identities=25% Similarity=0.405 Sum_probs=197.4
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 748 (934)
+.|++++.||+|+||+||+|+++.+++.||+|++.+. .....+.+.+|+++|++++|||||++++++.+++.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 4699999999999999999999999999999999764 2344567889999999999999999999999999999999
Q ss_pred EccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCC
Q 002342 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (934)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 828 (934)
|||+||+|.+++... .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 89 Ey~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~----- 162 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR----- 162 (288)
T ss_dssp ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH-----
T ss_pred ecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC-----
Confidence 999999999987654 34599999999999999999999999999999999999999999999999999854210
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
......+.+||+.|||||++. +..|+.++|||||||+||+|++|++||.+.+.
T Consensus 163 ----------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~ 220 (288)
T d2jfla1 163 ----------------------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220 (288)
T ss_dssp ----------------------HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred ----------------------CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH
Confidence 011233568999999999994 45688999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCC-CCCCCCcccCCC
Q 002342 904 QKTFANILHKDLKFP-SSTPSSCKAANV 930 (934)
Q Consensus 904 ~~~~~~i~~~~~~~p-~~~~~s~~~k~l 930 (934)
.+++.+|.++..+.. .....|.++++|
T Consensus 221 ~~~~~~i~~~~~~~~~~~~~~s~~~~~l 248 (288)
T d2jfla1 221 MRVLLKIAKSEPPTLAQPSRWSSNFKDF 248 (288)
T ss_dssp GGHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence 999999988765332 223345555443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=396.00 Aligned_cols=232 Identities=26% Similarity=0.478 Sum_probs=189.8
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe--CCeEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVCL 746 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~l 746 (934)
++|++++.||+|+||+||+|+++.+|+.||+|.+.+... .......+.+|+++|++++||||+++++++.+ .+.+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 579999999999999999999999999999999987643 44556778999999999999999999999864 567899
Q ss_pred EEEccCCCCchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 747 ITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQG-----IIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~g-----iiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
|||||+||+|.+++... ....+++..++.++.||+.||+|||++| ||||||||+|||++.+|.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998642 2356999999999999999999999976 9999999999999999999999999996
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
..... .......+||+.|||||++.+..|+.++|||||||+||+|++|++||.
T Consensus 163 ~~~~~---------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~ 215 (269)
T d2java1 163 ILNHD---------------------------TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215 (269)
T ss_dssp HC--------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ecccC---------------------------CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCC
Confidence 53211 112345689999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHcCCCC-CCCCCCCCcccCCC
Q 002342 900 GKTRQKTFANILHKDLK-FPSSTPSSCKAANV 930 (934)
Q Consensus 900 ~~~~~~~~~~i~~~~~~-~p~~~~~s~~~k~l 930 (934)
+.+..+++.+|.++.+. +|. ..|.++++|
T Consensus 216 ~~~~~~~~~~i~~~~~~~~~~--~~s~~l~~l 245 (269)
T d2java1 216 AFSQKELAGKIREGKFRRIPY--RYSDELNEI 245 (269)
T ss_dssp CSSHHHHHHHHHHTCCCCCCT--TSCHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCCc--ccCHHHHHH
Confidence 99999999999988764 333 234444443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-45 Score=408.78 Aligned_cols=229 Identities=38% Similarity=0.704 Sum_probs=205.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
+++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|+.++||||++++++|.+...+|+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 56899999999999999999999999999999999865444445567788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+.||+|..++... +.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 120 ~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---- 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred cccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc----
Confidence 9999999999999775 3599999999999999999999999999999999999999999999999999965321
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~ 907 (934)
...+.+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+...++
T Consensus 194 --------------------------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 247 (350)
T d1rdqe_ 194 --------------------------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247 (350)
T ss_dssp --------------------------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred --------------------------ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH
Confidence 123568999999999999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCCCCcccCCC
Q 002342 908 ANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 908 ~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
.+|..+.+.+|... |.++++|
T Consensus 248 ~~i~~~~~~~p~~~--s~~~~~l 268 (350)
T d1rdqe_ 248 EKIVSGKVRFPSHF--SSDLKDL 268 (350)
T ss_dssp HHHHHCCCCCCTTC--CHHHHHH
T ss_pred HHHhcCCCCCCccC--CHHHHHH
Confidence 99999998888753 4454443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-44 Score=402.48 Aligned_cols=231 Identities=27% Similarity=0.418 Sum_probs=203.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ......+.+|+.+|++++|||||+++++|.+++++|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 368999999999999999999999999999999987642 33446778999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe--cCCcEEEEecccCcccCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~--~~~~vkl~DFG~a~~~~~~~ 825 (934)
||||+||+|.+++... ...+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|.....
T Consensus 105 mE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~-- 181 (352)
T d1koba_ 105 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-- 181 (352)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT--
T ss_pred EEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC--
Confidence 9999999999987654 34599999999999999999999999999999999999997 578999999999965421
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
.......+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+
T Consensus 182 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 235 (352)
T d1koba_ 182 --------------------------DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 235 (352)
T ss_dssp --------------------------TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred --------------------------CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 122345679999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCC--CCCCcccCCC
Q 002342 906 TFANILHKDLKFPSS--TPSSCKAANV 930 (934)
Q Consensus 906 ~~~~i~~~~~~~p~~--~~~s~~~k~l 930 (934)
++.+|.++.+.+|.. ...|..+++|
T Consensus 236 ~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 236 TLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp HHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 999999999887754 3455555554
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-44 Score=402.40 Aligned_cols=231 Identities=27% Similarity=0.454 Sum_probs=202.7
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
+++|++++.||+|+||.||+|+++.+|+.||||++.+. .....+.+.+|+.+|+.++|||||+++++|.+++++|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999764 234456788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec--CCcEEEEecccCcccCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG--NGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~--~~~vkl~DFG~a~~~~~~~ 825 (934)
||||+||+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||+|.....
T Consensus 102 mE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~-- 178 (350)
T d1koaa2 102 YEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 178 (350)
T ss_dssp ECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT--
T ss_pred EEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc--
Confidence 99999999999986543 45999999999999999999999999999999999999964 57899999999965321
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
.....+.+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+
T Consensus 179 --------------------------~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 232 (350)
T d1koaa2 179 --------------------------KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232 (350)
T ss_dssp --------------------------TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred --------------------------ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 112335689999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCC--CCCCcccCCC
Q 002342 906 TFANILHKDLKFPSS--TPSSCKAANV 930 (934)
Q Consensus 906 ~~~~i~~~~~~~p~~--~~~s~~~k~l 930 (934)
++.+|.++.+.+|.. ...|..+++|
T Consensus 233 ~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 233 TLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp HHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 999999998877754 2345555544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=397.96 Aligned_cols=232 Identities=36% Similarity=0.710 Sum_probs=203.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHH-hCCCCCccceeEEEEeCCeEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD-MLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
+++|++.+.||+|+||+||+|.++.+++.||||++.+...........+..|..++. .++||||+++++++.+++++||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 368999999999999999999999999999999998754433444556677777765 6899999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
|||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 81 vmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-- 156 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-- 156 (320)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--
T ss_pred EEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc--
Confidence 99999999999999764 45999999999999999999999999999999999999999999999999999643211
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
.......+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..++
T Consensus 157 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~ 211 (320)
T d1xjda_ 157 -------------------------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 211 (320)
T ss_dssp -------------------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -------------------------cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence 1223446899999999999999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCCCcccCCC
Q 002342 907 FANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 907 ~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
+.+|..+.+.+|... |..++||
T Consensus 212 ~~~i~~~~~~~p~~~--s~~~~dl 233 (320)
T d1xjda_ 212 FHSIRMDNPFYPRWL--EKEAKDL 233 (320)
T ss_dssp HHHHHHCCCCCCTTS--CHHHHHH
T ss_pred HHHHHcCCCCCCccC--CHHHHHH
Confidence 999999999888753 5555554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=397.44 Aligned_cols=207 Identities=27% Similarity=0.463 Sum_probs=183.5
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
+..++|++++.||+|+||+||+|+++.+|+.||+|++++.. .......+.+|+.+|+.++|||||+++++|.+++++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 44578999999999999999999999999999999997643 3344567889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecccCcccCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~ 824 (934)
||||||+||+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|....
T Consensus 81 iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~-- 156 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-- 156 (322)
T ss_dssp EEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH--
T ss_pred EEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccC--
Confidence 999999999999999765 459999999999999999999997 599999999999999999999999999995421
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..
T Consensus 157 ---------------------------~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 157 ---------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp ---------------------------HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred ---------------------------CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 01224568999999999999999999999999999999999999999886654
Q ss_pred H
Q 002342 905 K 905 (934)
Q Consensus 905 ~ 905 (934)
.
T Consensus 210 ~ 210 (322)
T d1s9ja_ 210 E 210 (322)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-44 Score=382.09 Aligned_cols=230 Identities=23% Similarity=0.349 Sum_probs=188.9
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe----CC
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----KT 742 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~ 742 (934)
+...|++.+.||+|+||+||+|.++.+++.||+|.+.+... .......+.+|+++|++++|||||+++++|.+ +.
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence 33335788899999999999999999999999999886533 44556778999999999999999999999875 45
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEe-cCCcEEEEecccCc
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQ-GNGHVSLTDFDLSC 819 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~-~~~~vkl~DFG~a~ 819 (934)
.+|||||||++|+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|+
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 689999999999999999765 45999999999999999999999998 99999999999997 47899999999995
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~ 899 (934)
.... ....+.+||+.|||||++.+ .|+.++|||||||+||+|++|++||.
T Consensus 164 ~~~~-----------------------------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~ 213 (270)
T d1t4ha_ 164 LKRA-----------------------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 213 (270)
T ss_dssp GCCT-----------------------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred eccC-----------------------------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCC
Confidence 4211 12235689999999999876 59999999999999999999999998
Q ss_pred CCC-HHHHHHHHHcCCCCCCCCCCCCcccCC
Q 002342 900 GKT-RQKTFANILHKDLKFPSSTPSSCKAAN 929 (934)
Q Consensus 900 ~~~-~~~~~~~i~~~~~~~p~~~~~s~~~k~ 929 (934)
+.. ...+++.+..+..+.+.+...+.++++
T Consensus 214 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (270)
T d1t4ha_ 214 ECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244 (270)
T ss_dssp TCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred CcccHHHHHHHHHcCCCCcccCccCCHHHHH
Confidence 755 455667776654433222223444443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=385.10 Aligned_cols=232 Identities=29% Similarity=0.452 Sum_probs=202.5
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccC---hHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN---RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
++|++.+.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.+|++++|||||+++++|.+.+++|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 67999999999999999999999999999999998654322 223567889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC----cEEEEecccCccc
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCLT 821 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~----~vkl~DFG~a~~~ 821 (934)
||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|...
T Consensus 90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999999765 3599999999999999999999999999999999999998776 5999999998653
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
.. .....+.+||+.|||||++.+..++.++|||||||+||+|++|++||.+.
T Consensus 168 ~~----------------------------~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 219 (293)
T d1jksa_ 168 DF----------------------------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219 (293)
T ss_dssp TT----------------------------SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CC----------------------------CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence 21 11233567999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHcCCCCCCCC--CCCCcccCCC
Q 002342 902 TRQKTFANILHKDLKFPSS--TPSSCKAANV 930 (934)
Q Consensus 902 ~~~~~~~~i~~~~~~~p~~--~~~s~~~k~l 930 (934)
+..+++..|..+.+.+|.. ...|..++||
T Consensus 220 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 250 (293)
T d1jksa_ 220 TKQETLANVSAVNYEFEDEYFSNTSALAKDF 250 (293)
T ss_dssp SHHHHHHHHHTTCCCCCHHHHTTSCHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCchhcCCCCHHHHHH
Confidence 9999999999998877743 2345555443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-44 Score=388.58 Aligned_cols=235 Identities=21% Similarity=0.289 Sum_probs=195.1
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
|++..++|++.+.||+|+||+||+|.++.+++.||||++++.. ...+.+.+|+.+|+.++|||||++++++.+++.
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 4567789999999999999999999999999999999987642 234568899999999999999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|||||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999999999876667799999999999999999999999999999999999999999999999999965432
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY-TPFRGKT 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~-~Pf~~~~ 902 (934)
.. ........||+.|||||++.+..|+.++|||||||++|||++|. +||.+.+
T Consensus 168 ~~--------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~ 221 (287)
T d1opja_ 168 DT--------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 221 (287)
T ss_dssp SS--------------------------SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CC--------------------------ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch
Confidence 11 11122345899999999999999999999999999999999955 4555666
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCcccCC
Q 002342 903 RQKTFANILHKDLKFPSSTPSSCKAAN 929 (934)
Q Consensus 903 ~~~~~~~i~~~~~~~p~~~~~s~~~k~ 929 (934)
...+++.+..+ +..+.....+..+++
T Consensus 222 ~~~~~~~i~~~-~~~~~~~~~~~~l~~ 247 (287)
T d1opja_ 222 LSQVYELLEKD-YRMERPEGCPEKVYE 247 (287)
T ss_dssp HHHHHHHHHTT-CCCCCCTTCCHHHHH
T ss_pred HHHHHHHHhcC-CCCCCCccchHHHHH
Confidence 66666555443 333332233444443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.2e-43 Score=379.10 Aligned_cols=226 Identities=24% Similarity=0.365 Sum_probs=192.7
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC----e
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----H 743 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----~ 743 (934)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+....+......+.+|+.+|+.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367999999999999999999999999999999998876666777788999999999999999999999998653 4
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|||||||+|++|..++... +.+++..++.++.||+.||+|||++|||||||||+|||++.++.++|+|||.+.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 89999999999999988765 4599999999999999999999999999999999999999999999999998854321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~ 903 (934)
.. .........+||+.|||||++.+..++.++|||||||+||+|++|++||.+.+.
T Consensus 164 ~~------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 219 (277)
T d1o6ya_ 164 SG------------------------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 219 (277)
T ss_dssp ---------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cc------------------------ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH
Confidence 11 111233456899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCC
Q 002342 904 QKTFANILHKDLKFPS 919 (934)
Q Consensus 904 ~~~~~~i~~~~~~~p~ 919 (934)
.+.+.+++.+....|.
T Consensus 220 ~~~~~~~~~~~~~~~~ 235 (277)
T d1o6ya_ 220 VSVAYQHVREDPIPPS 235 (277)
T ss_dssp HHHHHHHHHCCCCCGG
T ss_pred HHHHHHHHhcCCCCCc
Confidence 9999999887766554
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=388.36 Aligned_cols=230 Identities=24% Similarity=0.381 Sum_probs=201.6
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
.++|++++.||+|+||+||+|.++.+++.||+|++.+.. .....+.+|+++|+.++||||++++++|.+++++|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999999999999999997642 2334578999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC--CcEEEEecccCcccCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN--GHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~--~~vkl~DFG~a~~~~~~~ 825 (934)
||||+|++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 80 mE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-- 156 (321)
T d1tkia_ 80 FEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp ECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc--
Confidence 99999999999997653 359999999999999999999999999999999999999854 4899999999854321
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~ 905 (934)
.......+||+.|+|||.+.+..|+.++|||||||++|+|++|++||.+.+..+
T Consensus 157 --------------------------~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~ 210 (321)
T d1tkia_ 157 --------------------------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp --------------------------TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred --------------------------CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH
Confidence 112335579999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCC--CCCCcccCCC
Q 002342 906 TFANILHKDLKFPSS--TPSSCKAANV 930 (934)
Q Consensus 906 ~~~~i~~~~~~~p~~--~~~s~~~k~l 930 (934)
++.+|.++.+.+|.. ...|.+++||
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 211 IIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred HHHHHHhCCCCCChhhccCCCHHHHHH
Confidence 999999999888753 2345555554
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6e-43 Score=376.99 Aligned_cols=233 Identities=28% Similarity=0.435 Sum_probs=201.5
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccC------hHHHHHHHHHHHHHHhCC-CCCccceeEEEEe
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN------RNKVHRACAEREILDMLD-HPFVPALYASFQT 740 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~------~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~ 740 (934)
.++|++.+.||+|+||+||+|+++.+++.||||++.+..... ....+.+.+|+.+|+.++ ||||++++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999999999999999998754322 223456789999999996 9999999999999
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
++++|||||||+||+|.+++..+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999999999765 4599999999999999999999999999999999999999999999999999965
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC------CCCCchhHHHHHHHHHHHHHhC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG------AGHTSAVDWWALGILLYEMLYG 894 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~~s~~~DiwSlG~iL~elltG 894 (934)
.... ......+||+.|+|||.+.+ ..++.++|||||||+||+|++|
T Consensus 160 ~~~~----------------------------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g 211 (277)
T d1phka_ 160 LDPG----------------------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211 (277)
T ss_dssp CCTT----------------------------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred ccCC----------------------------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccC
Confidence 4211 12234579999999999953 4567899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCC--CCCcccCCC
Q 002342 895 YTPFRGKTRQKTFANILHKDLKFPSST--PSSCKAANV 930 (934)
Q Consensus 895 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~--~~s~~~k~l 930 (934)
++||.+.+....+++|.++...+|... ..|.+++||
T Consensus 212 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 249 (277)
T d1phka_ 212 SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDL 249 (277)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHH
Confidence 999999999999999999988766542 355555554
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-43 Score=395.47 Aligned_cols=231 Identities=31% Similarity=0.562 Sum_probs=190.8
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHH---HHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC---AEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~---~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
.+++|++++.||+|+||.||+|+++.+|+.||||++.+...........+. +++.+++.++|||||+++++|.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 467999999999999999999999999999999999765433222223333 44667777889999999999999999
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|||||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999999775 4589999999999999999999999999999999999999999999999999964321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
......+||+.|||||++.. ..|+.++|||||||+||+|++|++||.+.+
T Consensus 160 -----------------------------~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 160 -----------------------------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp -----------------------------SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred -----------------------------CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 12235579999999999964 578999999999999999999999998755
Q ss_pred HH---HHHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 903 RQ---KTFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 903 ~~---~~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
.. .+.+.+......+|.. .|..+++|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~--~s~~~~~l 239 (364)
T d1omwa3 211 TKDKHEIDRMTLTMAVELPDS--FSPELRSL 239 (364)
T ss_dssp SSCHHHHHHHSSSCCCCCCSS--SCHHHHHH
T ss_pred HHHHHHHHHhcccCCCCCCCC--CCHHHHHH
Confidence 43 3444555555566553 35555544
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-43 Score=376.68 Aligned_cols=222 Identities=21% Similarity=0.308 Sum_probs=182.6
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCe
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (934)
|++..++|++.+.||+|+||+||+++.. ..||||+++.... .....+.+.+|+.+|++++|||||++++++. ++.
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence 5677889999999999999999999753 3599999976533 4456678999999999999999999999865 456
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
+|||||||+||+|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 899999999999999997543 4599999999999999999999999999999999999999999999999999965421
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC---CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.. ........+||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+
T Consensus 157 ~~-------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~ 211 (276)
T d1uwha_ 157 WS-------------------------GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211 (276)
T ss_dssp ----------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cC-------------------------CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC
Confidence 10 1122345689999999999964 3578899999999999999999999998
Q ss_pred CCHHHHHHHHHcCCCC
Q 002342 901 KTRQKTFANILHKDLK 916 (934)
Q Consensus 901 ~~~~~~~~~i~~~~~~ 916 (934)
.+....+..+......
T Consensus 212 ~~~~~~~~~~~~~~~~ 227 (276)
T d1uwha_ 212 INNRDQIIFMVGRGYL 227 (276)
T ss_dssp CCCHHHHHHHHHHTSC
T ss_pred CChHHHHHHHHhcCCC
Confidence 7776665555544433
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=388.79 Aligned_cols=241 Identities=22% Similarity=0.327 Sum_probs=197.3
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecCCe-----EEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeE
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ-----YFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 736 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~-----~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 736 (934)
.|++..++|++.+.||+|+||+||+|++..+++ .||+|.+.+.. .......+.+|+.+|.++ +|||||++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 355677899999999999999999999976553 69999887542 233445788999999998 8999999999
Q ss_pred EEEeCCeEEEEEEccCCCCchhhhccCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 002342 737 SFQTKTHVCLITDYCPGGELFLLLDRQPT---------------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795 (934)
Q Consensus 737 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------~~l~~~~~~~i~~qil~aL~yLH~~giiHr 795 (934)
++.+.+.+|||||||++|+|.+++..+.. ..+++..++.++.||+.||+|||++|||||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 99999999999999999999999976432 348999999999999999999999999999
Q ss_pred CCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC
Q 002342 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 875 (934)
Q Consensus 796 DLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~ 875 (934)
||||+|||++.++.+||+|||+|+...... ......+.+||+.|||||++.+..|
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~-------------------------~~~~~~~~~gt~~y~aPE~l~~~~~ 243 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDS-------------------------NYVVRGNARLPVKWMAPESLFEGIY 243 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCT-------------------------TSEEETTEEECGGGCCHHHHHHCCC
T ss_pred cCchhccccccCCeEEEeeccccccccCCC-------------------------ceeeeccccCCCccCChHHHcCCCC
Confidence 999999999999999999999996532111 1112234578999999999999999
Q ss_pred CchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 876 TSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 876 s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
+.++|||||||+||||++ |.+||.+.+..+.+.+++.+.+.+|.+...+..+++|
T Consensus 244 ~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~l 299 (325)
T d1rjba_ 244 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYII 299 (325)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred CcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 999999999999999997 9999999888777777877766555444445555443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-42 Score=379.53 Aligned_cols=225 Identities=24% Similarity=0.331 Sum_probs=182.4
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCCe---EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~---~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (934)
.+..+.|++.+.||+|+||+||+|+++.+++ .||||.+.... .....+.+.+|+.+|++++|||||++++++...
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4566789999999999999999999977664 68899876532 345567789999999999999999999999999
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
+.+|+|||||++|+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999999999988764 345999999999999999999999999999999999999999999999999999654
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~ 900 (934)
...... ..........||+.|||||++.+..++.++|||||||+||||++ |++||.+
T Consensus 179 ~~~~~~----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 179 EDDTSD----------------------PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp ---------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCCCCc----------------------ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence 321110 00111223468999999999999999999999999999999998 9999999
Q ss_pred CCHHHHHHHHHcCC
Q 002342 901 KTRQKTFANILHKD 914 (934)
Q Consensus 901 ~~~~~~~~~i~~~~ 914 (934)
.+..+++..|.++.
T Consensus 237 ~~~~~~~~~i~~~~ 250 (299)
T d1jpaa_ 237 MTNQDVINAIEQDY 250 (299)
T ss_dssp CCHHHHHHHHHTTC
T ss_pred CCHHHHHHHHHcCC
Confidence 99999999887754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=373.06 Aligned_cols=222 Identities=23% Similarity=0.352 Sum_probs=190.2
Q ss_pred ccccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe
Q 002342 661 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (934)
Q Consensus 661 ~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (934)
...|++..++|++.+.||+|+||.||+|.++ ++..||||++.+.. ...+.+.+|+.+|++++|||||++++++.+
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 79 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence 3456677789999999999999999999974 67889999997643 223568999999999999999999998754
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
+.+|||||||++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 80 -~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEE
Confidence 5679999999999999988765445699999999999999999999999999999999999999999999999999965
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 899 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~ 899 (934)
..... ........||+.|||||++.+..++.++|||||||+||||++ |.+||.
T Consensus 159 ~~~~~--------------------------~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~ 212 (272)
T d1qpca_ 159 IEDNE--------------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212 (272)
T ss_dssp CSSSC--------------------------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccCCc--------------------------cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 43111 112234579999999999999999999999999999999998 677788
Q ss_pred CCCHHHHHHHHHcCC
Q 002342 900 GKTRQKTFANILHKD 914 (934)
Q Consensus 900 ~~~~~~~~~~i~~~~ 914 (934)
..+..++++.+..+.
T Consensus 213 ~~~~~~~~~~i~~~~ 227 (272)
T d1qpca_ 213 GMTNPEVIQNLERGY 227 (272)
T ss_dssp TCCHHHHHHHHHTTC
T ss_pred CCCHHHHHHHHHhcC
Confidence 888888888887764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=368.06 Aligned_cols=227 Identities=23% Similarity=0.343 Sum_probs=191.3
Q ss_pred cccCCcccccc-cccCCcEEEEEEEEec--CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 666 INLQHFRPIKP-LGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 666 ~~~~~y~i~~~-LG~G~~g~Vy~a~~~~--~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
+..++|.+.+. ||+|+||+||+|.++. ++..||||++++.. .......+.+|+++|++++|||||++++++.+ +
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 34467888884 9999999999998754 45689999997642 45566789999999999999999999999875 4
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
.+|||||||++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred eEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 689999999999999987654 2459999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~ 901 (934)
.... ........+||+.|||||++.+..++.++|||||||++|||++ |++||.+.
T Consensus 161 ~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~ 216 (285)
T d1u59a_ 161 ADDS------------------------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216 (285)
T ss_dssp TCSC------------------------EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccc------------------------ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC
Confidence 2111 0112234579999999999999999999999999999999997 99999999
Q ss_pred CHHHHHHHHHcCC-CCCCCC
Q 002342 902 TRQKTFANILHKD-LKFPSS 920 (934)
Q Consensus 902 ~~~~~~~~i~~~~-~~~p~~ 920 (934)
+..+++..|.++. +.+|..
T Consensus 217 ~~~~~~~~i~~~~~~~~p~~ 236 (285)
T d1u59a_ 217 KGPEVMAFIEQGKRMECPPE 236 (285)
T ss_dssp CTHHHHHHHHTTCCCCCCTT
T ss_pred CHHHHHHHHHcCCCCCCCCc
Confidence 9999999998875 355543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=364.84 Aligned_cols=218 Identities=22% Similarity=0.378 Sum_probs=182.2
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEE
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (934)
++.++|++++.||+|+||.||+|.+. ++..||||.+.+... ..+.+.+|+++++.++||||+++++++..++..|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence 34578999999999999999999985 577899999876432 2356889999999999999999999999999999
Q ss_pred EEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCC
Q 002342 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (934)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~ 825 (934)
+|||||++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 77 lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred EEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 999999999999998765 3458999999999999999999999999999999999999999999999999996542111
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHH
Q 002342 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 904 (934)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~ 904 (934)
........||+.|||||++.+..|+.++|||||||+||||++ |.+||.+.+..
T Consensus 156 --------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~ 209 (263)
T d1sm2a_ 156 --------------------------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209 (263)
T ss_dssp -----------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH
T ss_pred --------------------------ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH
Confidence 111234579999999999999999999999999999999998 78889888999
Q ss_pred HHHHHHHcCCC
Q 002342 905 KTFANILHKDL 915 (934)
Q Consensus 905 ~~~~~i~~~~~ 915 (934)
+++..+..+..
T Consensus 210 ~~~~~i~~~~~ 220 (263)
T d1sm2a_ 210 EVVEDISTGFR 220 (263)
T ss_dssp HHHHHHHHTCC
T ss_pred HHHHHHHhcCC
Confidence 99999887643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=362.54 Aligned_cols=217 Identities=24% Similarity=0.361 Sum_probs=191.3
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEE
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 746 (934)
+.++|++.+.||+|+||.||++++ .+++.||||.+++... ..+.+.+|+.++++++||||+++++++.+++.+++
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 457899999999999999999998 5788999999987532 23568899999999999999999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCC
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 826 (934)
||||+++|+|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 77 v~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~- 154 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 154 (258)
T ss_dssp EEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-
T ss_pred EEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC-
Confidence 999999999999976543 458999999999999999999999999999999999999999999999999996542211
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 002342 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK 905 (934)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~ 905 (934)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+
T Consensus 155 -------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~ 209 (258)
T d1k2pa_ 155 -------------------------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209 (258)
T ss_dssp -------------------------CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred -------------------------ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence 112234579999999999999999999999999999999998 899999999999
Q ss_pred HHHHHHcCCC
Q 002342 906 TFANILHKDL 915 (934)
Q Consensus 906 ~~~~i~~~~~ 915 (934)
+..+|.++..
T Consensus 210 ~~~~i~~~~~ 219 (258)
T d1k2pa_ 210 TAEHIAQGLR 219 (258)
T ss_dssp HHHHHHTTCC
T ss_pred HHHHHHhCCC
Confidence 9999988653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=382.53 Aligned_cols=227 Identities=24% Similarity=0.407 Sum_probs=187.2
Q ss_pred cCCccccc-ccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHh-CCCCCccceeEEEEe----C
Q 002342 668 LQHFRPIK-PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPALYASFQT----K 741 (934)
Q Consensus 668 ~~~y~i~~-~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~----~ 741 (934)
.++|+++. .||+|+||+||+|++..+++.||||++.+. ..+.+|+.++.+ ++|||||+++++|.+ +
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 56899886 599999999999999999999999998753 356789998755 589999999999975 4
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEEEEecccC
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLS 818 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~~vkl~DFG~a 818 (934)
.++|||||||+||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 67899999999999999998765567999999999999999999999999999999999999975 467999999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
+..... ......+||+.|||||++.+..|+.++|||||||+||+|++|++||
T Consensus 162 ~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf 213 (335)
T d2ozaa1 162 KETTSH----------------------------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213 (335)
T ss_dssp EECCCC----------------------------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSC
T ss_pred eeccCC----------------------------CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCC
Confidence 653211 1223567999999999999999999999999999999999999999
Q ss_pred CCCCHHHHH----HHHHcCCCCCCCC--CCCCcccCCC
Q 002342 899 RGKTRQKTF----ANILHKDLKFPSS--TPSSCKAANV 930 (934)
Q Consensus 899 ~~~~~~~~~----~~i~~~~~~~p~~--~~~s~~~k~l 930 (934)
.+.+..... .++..+.+.+|.. ...|.+++||
T Consensus 214 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 251 (335)
T d2ozaa1 214 YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 251 (335)
T ss_dssp EETTCC--------CCCSCSSSCCTTHHHHSCHHHHHH
T ss_pred CCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHH
Confidence 887755443 4445566666653 2244444443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-41 Score=369.63 Aligned_cols=211 Identities=29% Similarity=0.413 Sum_probs=178.8
Q ss_pred cccccccCCcEEEEEEEEecCCeEEEEEEeecccccC--hHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEc
Q 002342 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN--RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (934)
Q Consensus 673 i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 750 (934)
.++.||+|+||+||+|+++.+|+.||||++.+..... ......+.+|+.+|+.++|||||+++++|.+++++||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4678999999999999999999999999987643221 11234678999999999999999999999999999999999
Q ss_pred cCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCC
Q 002342 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (934)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 830 (934)
|.++++..+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~------ 153 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP------ 153 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC------
T ss_pred hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC------
Confidence 988877766644 356999999999999999999999999999999999999999999999999999543211
Q ss_pred cchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 002342 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (934)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~~~~ 909 (934)
.......+||+.|||||++.. ..|+.++|||||||++|+|++|.+||.+.+..+++.+
T Consensus 154 ---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~ 212 (299)
T d1ua2a_ 154 ---------------------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 212 (299)
T ss_dssp ---------------------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ---------------------cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHH
Confidence 122335689999999999975 4678999999999999999999999999999999988
Q ss_pred HHc
Q 002342 910 ILH 912 (934)
Q Consensus 910 i~~ 912 (934)
|.+
T Consensus 213 i~~ 215 (299)
T d1ua2a_ 213 IFE 215 (299)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-41 Score=363.08 Aligned_cols=218 Identities=23% Similarity=0.342 Sum_probs=181.6
Q ss_pred cccccCCcEEEEEEEEec--CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEEEEccC
Q 002342 675 KPLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 752 (934)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~--~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 752 (934)
+.||+|+||+||+|.+.. +++.||||+++... .+....+.+.+|+.+|++++|||||++++++.. +..|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 469999999999998754 56789999997543 344556789999999999999999999999975 45789999999
Q ss_pred CCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCCCCCcc
Q 002342 753 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832 (934)
Q Consensus 753 ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 832 (934)
+|+|.+++... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.......
T Consensus 91 ~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~------ 162 (277)
T d1xbba_ 91 LGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN------ 162 (277)
T ss_dssp TEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS------
T ss_pred CCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccc------
Confidence 99999999764 4599999999999999999999999999999999999999999999999999965421110
Q ss_pred hhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 002342 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANIL 911 (934)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~ 911 (934)
.........||+.|||||++.+..++.++|||||||++|||++ |++||.+.+..++...|.
T Consensus 163 ------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~ 224 (277)
T d1xbba_ 163 ------------------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224 (277)
T ss_dssp ------------------EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred ------------------ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH
Confidence 0112234579999999999999999999999999999999997 999999999999998888
Q ss_pred cCC-CCCCCC
Q 002342 912 HKD-LKFPSS 920 (934)
Q Consensus 912 ~~~-~~~p~~ 920 (934)
++. +++|..
T Consensus 225 ~~~~~~~p~~ 234 (277)
T d1xbba_ 225 KGERMGCPAG 234 (277)
T ss_dssp TTCCCCCCTT
T ss_pred cCCCCCCCcc
Confidence 765 455543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=368.67 Aligned_cols=216 Identities=25% Similarity=0.428 Sum_probs=184.5
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
+++|++++.||+|+||+||+|.+..+|+.||||++..... .......+.+|+++|++++||||++++++|.+.+++|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 3689999999999999999999999999999999976432 233456788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||||. +++.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 80 ~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~---- 154 (298)
T d1gz8a_ 80 FEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---- 154 (298)
T ss_dssp EECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC----
T ss_pred EeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC----
Confidence 99995 5566666555456799999999999999999999999999999999999999999999999999865321
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
........+||+.|+|||++....+ +.++|||||||++|+|++|++||.+.+..+.
T Consensus 155 -----------------------~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~ 211 (298)
T d1gz8a_ 155 -----------------------PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211 (298)
T ss_dssp -----------------------CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred -----------------------CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH
Confidence 1122345579999999999877654 7899999999999999999999999999888
Q ss_pred HHHHHc
Q 002342 907 FANILH 912 (934)
Q Consensus 907 ~~~i~~ 912 (934)
+.++.+
T Consensus 212 ~~~i~~ 217 (298)
T d1gz8a_ 212 LFRIFR 217 (298)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 877764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=364.01 Aligned_cols=234 Identities=24% Similarity=0.355 Sum_probs=187.5
Q ss_pred cccccCCcccccccccCCcEEEEEEEEecC---CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (934)
+++..++|++.+.||+|+||.||+|.+..+ +..||||.+... ........+.+|+.+|++++||||+++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 446668999999999999999999998654 357889987643 24555677899999999999999999999996
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
++.+|+|||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+.
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred cCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhee
Confidence 467899999999999999876543 4599999999999999999999999999999999999999999999999999965
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 899 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~ 899 (934)
.... .........||+.|+|||++.+..++.++|||||||+||||++ |.+||.
T Consensus 158 ~~~~--------------------------~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~ 211 (273)
T d1mp8a_ 158 MEDS--------------------------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 211 (273)
T ss_dssp ---------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCC--------------------------cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCC
Confidence 3211 1112334568999999999999999999999999999999997 999999
Q ss_pred CCCHHHHHHHHHcCCC-CCCCCCCCCcccCC
Q 002342 900 GKTRQKTFANILHKDL-KFPSSTPSSCKAAN 929 (934)
Q Consensus 900 ~~~~~~~~~~i~~~~~-~~p~~~~~s~~~k~ 929 (934)
+.+..+++.++.++.. ++|.. .+.++++
T Consensus 212 ~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~ 240 (273)
T d1mp8a_ 212 GVKNNDVIGRIENGERLPMPPN--CPPTLYS 240 (273)
T ss_dssp TCCGGGHHHHHHTTCCCCCCTT--CCHHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCCCC--CCHHHHH
Confidence 9999999999988763 44443 3444443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=365.39 Aligned_cols=239 Identities=23% Similarity=0.326 Sum_probs=189.7
Q ss_pred cccCCcccccccccCCcEEEEEEEEecC---CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
++.++|++++.||+|+||.||+|++..+ ...||||++.+.........+.+.+|+.+|++++||||+++++++.+ .
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 4457899999999999999999987543 24789999987666666777889999999999999999999999976 4
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
..++|||||++++|.+++..+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 6789999999999998877643 459999999999999999999999999999999999999999999999999996543
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~ 901 (934)
.... .........|++.|+|||++.+..++.++|||||||++|||++ |++||.+.
T Consensus 163 ~~~~------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 163 QNDD------------------------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp C-CC------------------------EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCCC------------------------cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence 2111 1112234468889999999999999999999999999999997 99999999
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 902 TRQKTFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 902 ~~~~~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
+..+++.+|.+....+|.....+..+++|
T Consensus 219 ~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 247 (273)
T d1u46a_ 219 NGSQILHKIDKEGERLPRPEDCPQDIYNV 247 (273)
T ss_dssp CHHHHHHHHHTSCCCCCCCTTCCHHHHHH
T ss_pred CHHHHHHHHHhCCCCCCCcccccHHHHHH
Confidence 99999999988877666554455554443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=361.34 Aligned_cols=223 Identities=22% Similarity=0.290 Sum_probs=183.0
Q ss_pred ccccCCcccccccccCCcEEEEEEEEecCC----eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe
Q 002342 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSG----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (934)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~----~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (934)
++..+.|++.+.||+|+||.||+|.++.++ ..||||.+.... .......+.+|+.+|++++|||||++++++..
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 455678999999999999999999987654 479999987542 34445678899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
.+..++|||||.+++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999999999887655 35699999999999999999999999999999999999999999999999999965
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 899 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~ 899 (934)
...... .........||+.|||||++.+..++.++|||||||+||||++ |.+||.
T Consensus 160 ~~~~~~------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 160 LEDDPE------------------------ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp --------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCCCc------------------------cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 432110 0112234468999999999999999999999999999999998 566777
Q ss_pred CCCHHHHHHHHHcCC
Q 002342 900 GKTRQKTFANILHKD 914 (934)
Q Consensus 900 ~~~~~~~~~~i~~~~ 914 (934)
+.+..++++.+.++.
T Consensus 216 ~~~~~~~~~~i~~~~ 230 (283)
T d1mqba_ 216 ELSNHEVMKAINDGF 230 (283)
T ss_dssp TCCHHHHHHHHHTTC
T ss_pred cCCHHHHHHHHhccC
Confidence 778888888877653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=363.18 Aligned_cols=223 Identities=26% Similarity=0.366 Sum_probs=184.9
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChH---HHHHHHHHHHHHHhCC--CCCccceeEEEEeCCe
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN---KVHRACAEREILDMLD--HPFVPALYASFQTKTH 743 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~---~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~~ 743 (934)
++|++.+.||+|+||+||+|+++.+|+.||||++.+....... ....+.+|+.+|++++ ||||++++++|.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5899999999999999999999999999999999865432211 1233568999999996 8999999999999999
Q ss_pred EEEEEEccCC-CCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-CCcEEEEecccCccc
Q 002342 744 VCLITDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLT 821 (934)
Q Consensus 744 ~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-~~~vkl~DFG~a~~~ 821 (934)
.|+||||+.+ +++.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|...
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999999976 5777777664 45999999999999999999999999999999999999985 479999999998543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
.. ....+.+||+.|||||++.+..+ +.++|||||||+||+|++|++||.+
T Consensus 162 ~~-----------------------------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 162 KD-----------------------------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp CS-----------------------------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred cc-----------------------------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 21 12235689999999999987665 5679999999999999999999975
Q ss_pred CCHHHHHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 901 KTRQKTFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 901 ~~~~~~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
. ..+..+...+|... |.++++|
T Consensus 213 ~------~~i~~~~~~~~~~~--s~~~~~l 234 (273)
T d1xwsa_ 213 D------EEIIRGQVFFRQRV--SSECQHL 234 (273)
T ss_dssp H------HHHHHCCCCCSSCC--CHHHHHH
T ss_pred c------hHHhhcccCCCCCC--CHHHHHH
Confidence 3 24667777777643 5555544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-41 Score=359.44 Aligned_cols=220 Identities=24% Similarity=0.414 Sum_probs=185.4
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe-C
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-K 741 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~ 741 (934)
+|.++.++|++.+.||+|+||.||+|.+ +|..||||++++. ...+.+.+|+++|++++||||+++++++.+ .
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 5678889999999999999999999998 5789999998753 234678899999999999999999999854 5
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
+.+||||||+++|+|.+++.......+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++..
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceec
Confidence 67899999999999999997654445899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~ 900 (934)
.. ......+|+.|+|||++.+..++.++|||||||++|||++ |++||.+
T Consensus 154 ~~------------------------------~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~ 203 (262)
T d1byga_ 154 SS------------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203 (262)
T ss_dssp --------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred CC------------------------------CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC
Confidence 21 1223468999999999999999999999999999999998 8999999
Q ss_pred CCHHHHHHHHHcCC-CCCCC
Q 002342 901 KTRQKTFANILHKD-LKFPS 919 (934)
Q Consensus 901 ~~~~~~~~~i~~~~-~~~p~ 919 (934)
.+..+++..|.++. +++|.
T Consensus 204 ~~~~~~~~~i~~~~~~~~~~ 223 (262)
T d1byga_ 204 IPLKDVVPRVEKGYKMDAPD 223 (262)
T ss_dssp SCGGGHHHHHTTTCCCCCCT
T ss_pred CCHHHHHHHHHcCCCCCCCc
Confidence 99999999987653 34444
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-40 Score=362.33 Aligned_cols=224 Identities=24% Similarity=0.336 Sum_probs=183.1
Q ss_pred ccCCcccccccccCCcEEEEEEEEecCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~----~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
..++|++++.||+|+||+||+|.+..+|+ .||+|.+.... .....+.+.+|+.+|++++|||||++++++.++
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 34679999999999999999999988876 57777775432 333456789999999999999999999999875
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
..+++|||+.+++|.+++... ...+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred CeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 567889999999999988765 3569999999999999999999999999999999999999999999999999996543
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~ 901 (934)
.... ........||+.|||||++.+..|+.++|||||||+||||+| |.+||.+.
T Consensus 163 ~~~~-------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~ 217 (317)
T d1xkka_ 163 AEEK-------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217 (317)
T ss_dssp TTCC---------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cccc-------------------------cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 2110 112234468999999999999999999999999999999998 89999999
Q ss_pred CHHHHHHHHHcCC-CCCCC
Q 002342 902 TRQKTFANILHKD-LKFPS 919 (934)
Q Consensus 902 ~~~~~~~~i~~~~-~~~p~ 919 (934)
+..++...+..+. +++|.
T Consensus 218 ~~~~~~~~i~~~~~~~~p~ 236 (317)
T d1xkka_ 218 PASEISSILEKGERLPQPP 236 (317)
T ss_dssp CGGGHHHHHHHTCCCCCCT
T ss_pred CHHHHHHHHHcCCCCCCCc
Confidence 9888888887765 34444
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-41 Score=361.18 Aligned_cols=220 Identities=24% Similarity=0.350 Sum_probs=183.5
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (934)
.|++..++|++.+.||+|+||+||+|++..+ ..||||++..... ..+.+.+|+.+|++++|||||++++++.+ +
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 3456678999999999999999999998654 6799999875432 23568899999999999999999999865 5
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
.+|+|||||++|+|..++.......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence 67999999999999999876545569999999999999999999999999999999999999999999999999996532
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ellt-G~~Pf~~~ 901 (934)
... ........||+.|+|||++....++.++|||||||+||||++ |.+||.+.
T Consensus 165 ~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~ 218 (285)
T d1fmka3 165 DNE--------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 218 (285)
T ss_dssp -------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CCC--------------------------ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC
Confidence 110 112234579999999999999999999999999999999998 67777788
Q ss_pred CHHHHHHHHHcCC
Q 002342 902 TRQKTFANILHKD 914 (934)
Q Consensus 902 ~~~~~~~~i~~~~ 914 (934)
...+++..+.++.
T Consensus 219 ~~~~~~~~i~~~~ 231 (285)
T d1fmka3 219 VNREVLDQVERGY 231 (285)
T ss_dssp CHHHHHHHHHTTC
T ss_pred CHHHHHHHHHhcC
Confidence 8888888887654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-40 Score=358.53 Aligned_cols=231 Identities=23% Similarity=0.358 Sum_probs=191.5
Q ss_pred cccccccCCcccccccccCCcEEEEEEEEecCC-------eEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccc
Q 002342 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSG-------QYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 733 (934)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~-------~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~ 733 (934)
+.|.+..++|++.+.||+|+||.||+|++..++ ..||||.+++.. .......+.+|..++.++ +|||||+
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 345577889999999999999999999986654 479999997643 344556788899988888 8999999
Q ss_pred eeEEEEeCCeEEEEEEccCCCCchhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 002342 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKP 799 (934)
Q Consensus 734 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp 799 (934)
+++++.+++.+|+|||||++|+|.+++..+. ...+++..+..++.||+.||+|||++|||||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 9999999999999999999999999997543 23589999999999999999999999999999999
Q ss_pred CCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchh
Q 002342 800 ENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 879 (934)
Q Consensus 800 ~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~ 879 (934)
+|||++.++.+||+|||+++..... .........+||+.|+|||++.+..|+.++
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~ 218 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHI-------------------------DYYKKTTNGRLPVKWMAPEALFDRIYTHQS 218 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGC-------------------------CTTCCCTTSCCGGGGSCHHHHHHCCCCHHH
T ss_pred cceeecCCCCeEeccchhhcccccc-------------------------ccccccccCCCChhhhhhhHhcCCCCCchh
Confidence 9999999999999999999654211 111233456799999999999999999999
Q ss_pred HHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCC
Q 002342 880 DWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKD-LKFPS 919 (934)
Q Consensus 880 DiwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 919 (934)
|||||||++|+|++ |.+||.+.+..++++.+.++. +.+|.
T Consensus 219 DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~ 260 (299)
T d1fgka_ 219 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS 260 (299)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCS
T ss_pred hhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 99999999999997 899999999999888887754 34443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-40 Score=359.29 Aligned_cols=215 Identities=25% Similarity=0.402 Sum_probs=179.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecC-CeEEEEEEeecccccChHHHHHHHHHHHHHHhC---CCCCccceeEEEEe---
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGS-GQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQT--- 740 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~-~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~--- 740 (934)
.++|++++.||+|+||+||+|++..+ ++.||||++.+..... .....+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 47899999999999999999999765 6789999987643222 2223455677776665 89999999999853
Q ss_pred --CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccC
Q 002342 741 --KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (934)
Q Consensus 741 --~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a 818 (934)
..++|++||||.++.+..... .....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred ccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 357899999997776654443 33456999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
..... .......+||+.|||||++.+..|+.++|||||||++|+|++|++||
T Consensus 164 ~~~~~----------------------------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf 215 (305)
T d1blxa_ 164 RIYSF----------------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 215 (305)
T ss_dssp CCCCG----------------------------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred hhhcc----------------------------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCC
Confidence 54211 11234568999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHc
Q 002342 899 RGKTRQKTFANILH 912 (934)
Q Consensus 899 ~~~~~~~~~~~i~~ 912 (934)
.+.+..+++.+|.+
T Consensus 216 ~~~~~~~~~~~i~~ 229 (305)
T d1blxa_ 216 RGSSDVDQLGKILD 229 (305)
T ss_dssp CCSSHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHH
Confidence 99999998888865
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-40 Score=359.77 Aligned_cols=222 Identities=24% Similarity=0.364 Sum_probs=174.9
Q ss_pred cccccCCcccccccccCCcEEEEEEEEec-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEE
Q 002342 664 EQINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS 737 (934)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 737 (934)
+++..++|++.+.||+|+||.||+|.+.. +++.||||.++... .......+.+|..++.++ +|+||+.++++
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 34666789999999999999999999865 35789999987542 344456677888888776 68999999998
Q ss_pred EEe-CCeEEEEEEccCCCCchhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 002342 738 FQT-KTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802 (934)
Q Consensus 738 ~~~-~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NI 802 (934)
+.. +..+++|||||++|+|.+++.... ...+++..+..++.||+.||.|||++|||||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 765 456899999999999999986532 23489999999999999999999999999999999999
Q ss_pred EEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHH
Q 002342 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882 (934)
Q Consensus 803 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Diw 882 (934)
|++.++.+||+|||+|+....... .......+||+.|||||++.+..++.++|||
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~-------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiw 220 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPD-------------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVW 220 (299)
T ss_dssp EECGGGCEEECC------CCSCTT-------------------------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHH
T ss_pred eECCCCcEEEccCcchhhcccccc-------------------------ccccCceeeCccccchhHhhcCCCCccccee
Confidence 999999999999999965322111 1223456899999999999999999999999
Q ss_pred HHHHHHHHHHhC-CCCCCCCCHHHHHHHHHc
Q 002342 883 ALGILLYEMLYG-YTPFRGKTRQKTFANILH 912 (934)
Q Consensus 883 SlG~iL~elltG-~~Pf~~~~~~~~~~~i~~ 912 (934)
||||++|||++| .+||.+.+..+.+..++.
T Consensus 221 S~Gvil~ellt~~~~p~~~~~~~~~~~~~~~ 251 (299)
T d1ywna1 221 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251 (299)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred ehHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 999999999985 678988766555544443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9e-40 Score=357.10 Aligned_cols=223 Identities=21% Similarity=0.306 Sum_probs=191.4
Q ss_pred cccCCcccccccccCCcEEEEEEEEec-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (934)
+..++|++.+.||+|+||+||+|+++. +++.||||++++.. .......+.+|+.+|+.++||||+++++++..
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 345689999999999999999999864 56899999987542 34556778999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCchhhhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQP----------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLK 798 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLK 798 (934)
.+..+++|||+++|+|.+++.... ...++...+..++.||+.||+|||++||||||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 999999999999999999986421 2248899999999999999999999999999999
Q ss_pred CCCEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCch
Q 002342 799 PENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 878 (934)
Q Consensus 799 p~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~ 878 (934)
|+|||++.++.+||+|||+|+..... .......+.+||+.|||||++.+..|+.+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~t~k 222 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSA-------------------------DYYKADGNDAIPIRWMPPESIFYNRYTTE 222 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGG-------------------------GCBC----CCBCGGGCCHHHHHHCCCCHH
T ss_pred ccceEECCCCcEEEccchhheeccCC-------------------------ccccccCCCCcCcCcCCHHHHccCCCChh
Confidence 99999999999999999998643211 11123345679999999999999999999
Q ss_pred hHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCC
Q 002342 879 VDWWALGILLYEMLYG-YTPFRGKTRQKTFANILHKDL 915 (934)
Q Consensus 879 ~DiwSlG~iL~elltG-~~Pf~~~~~~~~~~~i~~~~~ 915 (934)
+|||||||+||||++| .+||.+.+..+++..+.++..
T Consensus 223 sDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~ 260 (301)
T d1lufa_ 223 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI 260 (301)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred hhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999999999999987 578999999999999988774
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-40 Score=358.78 Aligned_cols=219 Identities=23% Similarity=0.347 Sum_probs=185.4
Q ss_pred cccCCcccccccccCCcEEEEEEEEecCCeE--EEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeEEEEeCC
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 742 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~--vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 742 (934)
++.++|++.+.||+|+||.||+|.++.++.. ||||.+... ........+.+|+++|+.+ +||||+++++++.+++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4568999999999999999999999998875 667776543 2334456789999999998 7999999999999999
Q ss_pred eEEEEEEccCCCCchhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC
Q 002342 743 HVCLITDYCPGGELFLLLDRQ--------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 808 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~ 808 (934)
.+|+|||||++|+|.++++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999998753 235699999999999999999999999999999999999999999
Q ss_pred cEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHH
Q 002342 809 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888 (934)
Q Consensus 809 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL 888 (934)
.+||+|||+|+.... ........||+.|+|||.+.+..++.++|||||||++
T Consensus 165 ~~kl~DfG~a~~~~~----------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil 216 (309)
T d1fvra_ 165 VAKIADFGLSRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 216 (309)
T ss_dssp CEEECCTTCEESSCE----------------------------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred ceEEccccccccccc----------------------------cccccceecCCcccchHHhccCCCCccceeehhHHHH
Confidence 999999999854221 1122345699999999999999999999999999999
Q ss_pred HHHHhC-CCCCCCCCHHHHHHHHHcCC
Q 002342 889 YEMLYG-YTPFRGKTRQKTFANILHKD 914 (934)
Q Consensus 889 ~elltG-~~Pf~~~~~~~~~~~i~~~~ 914 (934)
|||++| .+||.+.+..+++..|.++.
T Consensus 217 ~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 217 WEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 999995 57899999999999988764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=357.41 Aligned_cols=241 Identities=21% Similarity=0.323 Sum_probs=200.1
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEe-----cCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccceeE
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 736 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 736 (934)
.|++..++|++.+.||+|+||.||+|.+. .+++.||||.+++.. .......+.+|+.+++.+ +|||||++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 45566789999999999999999999874 466799999997643 345556788999999999 7999999999
Q ss_pred EEEeCCeEEEEEEccCCCCchhhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 002342 737 SFQTKTHVCLITDYCPGGELFLLLDRQP----------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPE 800 (934)
Q Consensus 737 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~ 800 (934)
++.+.+.+|||||||++|+|.+++.... ...+++..+..++.||+.||+|||++|||||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999987542 125899999999999999999999999999999999
Q ss_pred CEEEecCCcEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhH
Q 002342 801 NVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 880 (934)
Q Consensus 801 NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~D 880 (934)
|||++.++.+|++|||+++...... ........+||+.|+|||++.+..++.++|
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 229 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDS-------------------------NYVVKGNARLPVKWMAPESIFNCVYTFESD 229 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCT-------------------------TSEECSSSEECGGGCCHHHHHHCCCCHHHH
T ss_pred cccccccCcccccccchheeccCCC-------------------------cceEeeecccChHHcCHHHhcCCCCCCccc
Confidence 9999999999999999996543211 112234568999999999999999999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccCCC
Q 002342 881 WWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPSSCKAANV 930 (934)
Q Consensus 881 iwSlG~iL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~k~l 930 (934)
||||||+||||++ |.+||.+.+..+.+.+++...+..+.....+..+++|
T Consensus 230 IwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~L 280 (311)
T d1t46a_ 230 VWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDI 280 (311)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred ccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHH
Confidence 9999999999998 8888888888777777766655444443345554443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-39 Score=353.28 Aligned_cols=214 Identities=23% Similarity=0.385 Sum_probs=181.9
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
+++|++++.||+|+||+||+|+++ +|+.||||++..... .......+.+|+.+|+.++||||++++++|..++..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 368999999999999999999984 789999999976532 333456788999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|||+.++.+..+.... +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|......
T Consensus 79 ~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--- 153 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--- 153 (286)
T ss_dssp EECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC---
Confidence 9999777666665543 56999999999999999999999999999999999999999999999999998653211
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~~~ 906 (934)
........|++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+..++
T Consensus 154 ------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~ 209 (286)
T d1ob3a_ 154 ------------------------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ 209 (286)
T ss_dssp --------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH
Confidence 1123345789999999999764 568999999999999999999999999998888
Q ss_pred HHHHHc
Q 002342 907 FANILH 912 (934)
Q Consensus 907 ~~~i~~ 912 (934)
+.++..
T Consensus 210 ~~~i~~ 215 (286)
T d1ob3a_ 210 LMRIFR 215 (286)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-39 Score=354.34 Aligned_cols=225 Identities=24% Similarity=0.309 Sum_probs=183.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe-------
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------- 740 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------- 740 (934)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+++|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 5799999999999999999999999999999999876433 23344667899999999999999999999854
Q ss_pred -CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCc
Q 002342 741 -KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (934)
Q Consensus 741 -~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~ 819 (934)
++++|+|||||.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 4568999999976666544433 3569999999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
....... .......+.+||+.|+|||++.+. .|+.++|||||||++|+|++|++||
T Consensus 166 ~~~~~~~-----------------------~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf 222 (318)
T d3blha1 166 AFSLAKN-----------------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222 (318)
T ss_dssp ECCC----------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ecccccc-----------------------cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC
Confidence 5432110 111223356899999999999765 6889999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCC
Q 002342 899 RGKTRQKTFANILHKDLKFP 918 (934)
Q Consensus 899 ~~~~~~~~~~~i~~~~~~~p 918 (934)
.+.+....+.++.+....++
T Consensus 223 ~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 223 QGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp CCSSHHHHHHHHHHHHCCCC
T ss_pred CCCCHHHHHHHHHHhcCCCC
Confidence 99999888888766443333
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-39 Score=358.83 Aligned_cols=210 Identities=29% Similarity=0.467 Sum_probs=178.8
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC-----
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 742 (934)
.++|++++.||+|+||+||+|.++.+|+.||||++.+.. ......+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 479999999999999999999999999999999997643 35556678899999999999999999999998654
Q ss_pred -eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 743 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 743 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
++|+||||| +.+|..+++. ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+|++|||+|...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 579999999 7788887754 34999999999999999999999999999999999999999999999999999543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
. ...+..+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+
T Consensus 172 ~------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 172 D------------------------------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp C------------------------------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred C------------------------------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence 2 112355799999999999764 568899999999999999999999999
Q ss_pred CCHHHHHHHHHc
Q 002342 901 KTRQKTFANILH 912 (934)
Q Consensus 901 ~~~~~~~~~i~~ 912 (934)
.+....+..+..
T Consensus 222 ~~~~~~~~~~~~ 233 (346)
T d1cm8a_ 222 SDHLDQLKEIMK 233 (346)
T ss_dssp SSHHHHHHHHHH
T ss_pred CChHHHHHHHHh
Confidence 998888777655
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-39 Score=350.22 Aligned_cols=226 Identities=17% Similarity=0.244 Sum_probs=194.6
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEec-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEE
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS 737 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 737 (934)
.|++..++|++.+.||+|+||.||+|.+.. ++..||||.+++.. .......+.+|+.++++++||||++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 356777899999999999999999999853 35789999997542 34455678899999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCchhhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc
Q 002342 738 FQTKTHVCLITDYCPGGELFLLLDRQ--------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 809 (934)
Q Consensus 738 ~~~~~~~~lV~E~~~ggsL~~~l~~~--------~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~ 809 (934)
+..++..++|||||++|+|.+++... ....++...+..++.|++.||.|||+++|+||||||+|||++.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 99999999999999999999987642 1134788999999999999999999999999999999999999999
Q ss_pred EEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHH
Q 002342 810 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889 (934)
Q Consensus 810 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~ 889 (934)
+||+|||+|+..... .........+||+.|+|||.+.+..++.++|||||||+||
T Consensus 172 ~Kl~DFGla~~~~~~-------------------------~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~ 226 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYET-------------------------DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 226 (308)
T ss_dssp EEECCTTCCCGGGGG-------------------------GCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred EEEeecccceeccCC-------------------------cceeeccceecccccCCHHHHccCCCCcccccccHHHHHH
Confidence 999999999654211 1112234457999999999999999999999999999999
Q ss_pred HHHhC-CCCCCCCCHHHHHHHHHcCCC
Q 002342 890 EMLYG-YTPFRGKTRQKTFANILHKDL 915 (934)
Q Consensus 890 elltG-~~Pf~~~~~~~~~~~i~~~~~ 915 (934)
||++| .+||.+.+..+++..+.++..
T Consensus 227 El~t~~~~p~~~~~~~~~~~~i~~~~~ 253 (308)
T d1p4oa_ 227 EIATLAEQPYQGLSNEQVLRFVMEGGL 253 (308)
T ss_dssp HHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence 99997 699999999999999988664
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-38 Score=345.73 Aligned_cols=218 Identities=22% Similarity=0.297 Sum_probs=182.5
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC-CCccceeEEEEeCCeEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH-PFVPALYASFQTKTHVCL 746 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~l 746 (934)
.++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.+.| +|++.+++++......|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 4789999999999999999999999999999999865421 2346778999999965 899999999999999999
Q ss_pred EEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-----CCcEEEEecccCccc
Q 002342 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-----NGHVSLTDFDLSCLT 821 (934)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-----~~~vkl~DFG~a~~~ 821 (934)
||||| +++|.+++... ...++...+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 79 vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99999 89999998765 356999999999999999999999999999999999999964 578999999999765
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
...... ...+.......+||+.|||||++.+..++.++|||||||++|+|++|++||.+.
T Consensus 157 ~~~~~~--------------------~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~ 216 (293)
T d1csna_ 157 RDPVTK--------------------QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216 (293)
T ss_dssp BCTTTC--------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccCccc--------------------cceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence 322111 011223345678999999999999999999999999999999999999999864
Q ss_pred C---HHHHHHHHHc
Q 002342 902 T---RQKTFANILH 912 (934)
Q Consensus 902 ~---~~~~~~~i~~ 912 (934)
. ....+.++..
T Consensus 217 ~~~~~~~~~~~i~~ 230 (293)
T d1csna_ 217 KAATNKQKYERIGE 230 (293)
T ss_dssp CSCCHHHHHHHHHH
T ss_pred cchhHHHHHHHHHh
Confidence 3 3344444443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=353.98 Aligned_cols=208 Identities=28% Similarity=0.444 Sum_probs=174.7
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe------CCe
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------KTH 743 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------~~~ 743 (934)
+|+.+++||+|+||+||+|+++.+|+.||||++.+... ...+|+.+|+.++||||++++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 69999999999999999999999999999999976421 23469999999999999999999853 346
Q ss_pred EEEEEEccCCCCchhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-cEEEEecccCccc
Q 002342 744 VCLITDYCPGGELFLLLD-RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLT 821 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~-~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-~vkl~DFG~a~~~ 821 (934)
+|||||||+++.+..+.. ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 899999996554333322 12345699999999999999999999999999999999999999775 8999999998653
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~~DiwSlG~iL~elltG~~Pf~~ 900 (934)
... ....+.+||+.|+|||.+.+ ..|+.++|||||||++|||++|++||.+
T Consensus 174 ~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 174 VRG----------------------------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp CTT----------------------------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cCC----------------------------cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence 211 12234579999999999875 5789999999999999999999999999
Q ss_pred CCHHHHHHHHHc
Q 002342 901 KTRQKTFANILH 912 (934)
Q Consensus 901 ~~~~~~~~~i~~ 912 (934)
.+..+.+..|.+
T Consensus 226 ~~~~~~l~~i~~ 237 (350)
T d1q5ka_ 226 DSGVDQLVEIIK 237 (350)
T ss_dssp SSHHHHHHHHHH
T ss_pred CCHHHHHHHHHH
Confidence 998888877753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-39 Score=355.87 Aligned_cols=227 Identities=41% Similarity=0.746 Sum_probs=187.4
Q ss_pred cccCCcccccccccCCcEEEEEEEEe---cCCeEEEEEEeeccccc-ChHHHHHHHHHHHHHHhCCC-CCccceeEEEEe
Q 002342 666 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDH-PFVPALYASFQT 740 (934)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vAlK~~~~~~~~-~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~ 740 (934)
+..++|++++.||+|+||+||+|++. .+|+.||||++.+.... +......+.+|+++|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 45678999999999999999999984 46899999998764332 22334567889999999976 899999999999
Q ss_pred CCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
...+|++||||.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999999775 4488999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC--CCCchhHHHHHHHHHHHHHhCCCCC
Q 002342 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPF 898 (934)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~s~~~DiwSlG~iL~elltG~~Pf 898 (934)
.... ......+..|++.|+|||.+.+. .++.++|||||||+||+|++|+.||
T Consensus 179 ~~~~--------------------------~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF 232 (322)
T d1vzoa_ 179 FVAD--------------------------ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 232 (322)
T ss_dssp CCGG--------------------------GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred hccc--------------------------ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 4211 11223456799999999999764 4677999999999999999999999
Q ss_pred CCCCHHHH----HHHHHcCCCCCCCC
Q 002342 899 RGKTRQKT----FANILHKDLKFPSS 920 (934)
Q Consensus 899 ~~~~~~~~----~~~i~~~~~~~p~~ 920 (934)
.+.+..+. .+........+|..
T Consensus 233 ~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 233 TVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp SCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred CCCCHHHHHHHHHHhcccCCCCCccc
Confidence 88655444 34444555566553
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-38 Score=351.03 Aligned_cols=213 Identities=26% Similarity=0.409 Sum_probs=177.5
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC-----e
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-----H 743 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~ 743 (934)
++|++++.||+|+||+||+|.+..+|+.||||++.+.. .....+.+.+|+.+|++++||||+++++++.... +
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 57999999999999999999999999999999997532 4555677889999999999999999999997543 3
Q ss_pred EEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCC
Q 002342 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (934)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~ 823 (934)
.|++ +|+.+++|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|.....
T Consensus 86 ~~l~-~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEE-EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEE-EeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 4555 455699999999763 499999999999999999999999999999999999999999999999999965422
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
... ........+||+.|+|||++. +..++.++||||+||++|+|++|++||.+.+
T Consensus 162 ~~~------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 162 DHD------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp GGC------------------------BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCc------------------------cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 110 111234568999999999984 4567889999999999999999999999988
Q ss_pred HHHHHHHHH
Q 002342 903 RQKTFANIL 911 (934)
Q Consensus 903 ~~~~~~~i~ 911 (934)
..++...+.
T Consensus 218 ~~~~~~~~~ 226 (345)
T d1pmea_ 218 YLDQLNHIL 226 (345)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 877766654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-38 Score=351.61 Aligned_cols=211 Identities=25% Similarity=0.442 Sum_probs=175.4
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe------C
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------K 741 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------~ 741 (934)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||++++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 378999999999999999999999999999999998753 345566778899999999999999999999963 4
Q ss_pred CeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCccc
Q 002342 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~ 821 (934)
.++|+|||||.++ +...+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++...
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp CEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred ceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 7899999999554 444443 34899999999999999999999999999999999999999999999999988543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
.. .......+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.
T Consensus 170 ~~----------------------------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 170 GT----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp ---------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cc----------------------------ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 21 12234557999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHc
Q 002342 902 TRQKTFANILH 912 (934)
Q Consensus 902 ~~~~~~~~i~~ 912 (934)
+......++..
T Consensus 222 ~~~~~~~~i~~ 232 (355)
T d2b1pa1 222 DYIDQWNKVIE 232 (355)
T ss_dssp SHHHHHHHHHH
T ss_pred CHHHHHHHHHH
Confidence 98888777754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=338.02 Aligned_cols=215 Identities=21% Similarity=0.377 Sum_probs=186.0
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCCeEEEE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 747 (934)
+++|++++.||+|+||+||+|+++.+++.||||+++... ........+.+|+.+|+.++||||+++++++.+..+.++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 368999999999999999999999999999999997653 3445667889999999999999999999999999999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
|+++.+++|..++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|......
T Consensus 80 ~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--- 154 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--- 154 (292)
T ss_dssp EECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC---
T ss_pred eeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC---
Confidence 9999999988887654 56999999999999999999999999999999999999999999999999999654321
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCC-CCCCCHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTP-FRGKTRQK 905 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~s~~~DiwSlG~iL~elltG~~P-f~~~~~~~ 905 (934)
........+++.|+|||++.... ++.++|||||||++|+|++|+.| |.+.+..+
T Consensus 155 ------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 210 (292)
T d1unla_ 155 ------------------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210 (292)
T ss_dssp ------------------------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH
T ss_pred ------------------------CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH
Confidence 11223346788999999997765 68899999999999999998887 55667777
Q ss_pred HHHHHHc
Q 002342 906 TFANILH 912 (934)
Q Consensus 906 ~~~~i~~ 912 (934)
.+.++..
T Consensus 211 ~~~~~~~ 217 (292)
T d1unla_ 211 QLKRIFR 217 (292)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 7777654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-37 Score=342.75 Aligned_cols=196 Identities=23% Similarity=0.380 Sum_probs=170.6
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEe--CCeE
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQT--KTHV 744 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~--~~~~ 744 (934)
.++|++++.||+|+||+||+|+++.+|+.||||++++. ....+.+|+.+|+.+. ||||++++++|.. ..++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 46899999999999999999999999999999998753 2356789999999995 9999999999984 4579
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-cEEEEecccCcccCC
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSC 823 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-~vkl~DFG~a~~~~~ 823 (934)
|+|||||.+++|..+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999999997764 3499999999999999999999999999999999999998755 699999999964321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002342 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~~DiwSlG~iL~elltG~~Pf~~~~ 902 (934)
.......+||+.|+|||.+.+. .++.++|||||||++|+|++|+.||....
T Consensus 183 ----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 183 ----------------------------GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp ----------------------------TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ----------------------------CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 1123455799999999998775 47999999999999999999999997654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-38 Score=350.55 Aligned_cols=214 Identities=27% Similarity=0.400 Sum_probs=181.6
Q ss_pred cCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeC-----C
Q 002342 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----T 742 (934)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~ 742 (934)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||++++++|... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 478999999999999999999999999999999998653 3445566788999999999999999999999643 3
Q ss_pred eEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccC
Q 002342 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (934)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~ 822 (934)
..+++|+|+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred ceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 34566677779999999865 349999999999999999999999999999999999999999999999999985421
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002342 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGK 901 (934)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~s~~~DiwSlG~iL~elltG~~Pf~~~ 901 (934)
....+..||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.
T Consensus 173 ------------------------------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 173 ------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp ------------------------------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ------------------------------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 1223457999999999987754 578999999999999999999999999
Q ss_pred CHHHHHHHHHcCCC
Q 002342 902 TRQKTFANILHKDL 915 (934)
Q Consensus 902 ~~~~~~~~i~~~~~ 915 (934)
+.......|.....
T Consensus 223 ~~~~~~~~i~~~~~ 236 (348)
T d2gfsa1 223 DHIDQLKLILRLVG 236 (348)
T ss_dssp SHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHhcC
Confidence 99988888876443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-37 Score=337.66 Aligned_cols=211 Identities=21% Similarity=0.295 Sum_probs=172.3
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCC-ccceeEEEEeCCeEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF-VPALYASFQTKTHVCLI 747 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~~~~lV 747 (934)
++|++.+.||+|+||.||+|++..+|+.||||++..... ...+..|+++++.++|++ |+.+++++...+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 579999999999999999999999999999999876422 134678999999997665 55666777888999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEEEEecccCcccCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCK 824 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~~vkl~DFG~a~~~~~~ 824 (934)
|||| +++|...+... .+.+++..+..++.|++.||+|||++|||||||||+|||++. +..+||+|||+|+.....
T Consensus 82 me~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9999 67777666543 356999999999999999999999999999999999999863 457999999999765322
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 002342 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (934)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~~~~~~ 904 (934)
... ...........+||+.|||||++.+..++.++|||||||++|||++|++||.+....
T Consensus 160 ~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~ 219 (299)
T d1ckia_ 160 RTH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219 (299)
T ss_dssp TTC--------------------CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred ccc--------------------cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchH
Confidence 110 011123345678999999999999999999999999999999999999999876654
Q ss_pred HH
Q 002342 905 KT 906 (934)
Q Consensus 905 ~~ 906 (934)
..
T Consensus 220 ~~ 221 (299)
T d1ckia_ 220 TK 221 (299)
T ss_dssp --
T ss_pred HH
Confidence 43
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-37 Score=336.35 Aligned_cols=217 Identities=19% Similarity=0.234 Sum_probs=175.5
Q ss_pred ccccccccCCcEEEEEEEEecCC---eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEe-CCeEEEE
Q 002342 672 RPIKPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KTHVCLI 747 (934)
Q Consensus 672 ~i~~~LG~G~~g~Vy~a~~~~~~---~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lV 747 (934)
.+.+.||+|+||+||+|.+..++ ..||||.+++. ........+.+|+++|++++||||+++++++.. ++..++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 33578999999999999986643 36999998743 356667889999999999999999999999765 5689999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecccCcccCCCCCC
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 827 (934)
||||++++|.+++... ...++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 108 ~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 9999999999998765 345888889999999999999999999999999999999999999999999999764322110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCCHHHH
Q 002342 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR-GKTRQKT 906 (934)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~DiwSlG~iL~elltG~~Pf~-~~~~~~~ 906 (934)
.........||+.|+|||.+....++.++||||||++||||++|..||. ..+..++
T Consensus 187 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~ 243 (311)
T d1r0pa_ 187 -----------------------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 243 (311)
T ss_dssp -----------------------CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C
T ss_pred -----------------------cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH
Confidence 1112234578999999999999999999999999999999999666655 4555667
Q ss_pred HHHHHcCC
Q 002342 907 FANILHKD 914 (934)
Q Consensus 907 ~~~i~~~~ 914 (934)
...+.++.
T Consensus 244 ~~~i~~g~ 251 (311)
T d1r0pa_ 244 TVYLLQGR 251 (311)
T ss_dssp HHHHHTTC
T ss_pred HHHHHcCC
Confidence 77777765
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=332.62 Aligned_cols=199 Identities=25% Similarity=0.330 Sum_probs=160.8
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCccceeEEEEeCC----eE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----HV 744 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----~~ 744 (934)
.+|.+.+.||+|+||.||+|++ +|+.||||++.... ........|+..+..++||||+++++++..++ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4688999999999999999986 78999999986431 12122234555556789999999999997643 68
Q ss_pred EEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCeecCCCCCCEEEecCCcEEEEecc
Q 002342 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC--------QGIIYRDLKPENVLLQGNGHVSLTDFD 816 (934)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~--------~giiHrDLKp~NILl~~~~~vkl~DFG 816 (934)
|+|||||++|+|.+++++. .+++.....++.|++.||.|||+ +|||||||||+|||++.++.+||+|||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999999864 48999999999999999999996 599999999999999999999999999
Q ss_pred cCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCC------CCchhHHHHHHHHHHH
Q 002342 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG------HTSAVDWWALGILLYE 890 (934)
Q Consensus 817 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~------~s~~~DiwSlG~iL~e 890 (934)
++......... ........+||+.|||||++.+.. ++.++|||||||+|||
T Consensus 154 l~~~~~~~~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~e 210 (303)
T d1vjya_ 154 LAVRHDSATDT-----------------------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 210 (303)
T ss_dssp TCEEEETTTTE-----------------------ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccCCCcc-----------------------eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHH
Confidence 99654321110 011233568999999999997653 4568999999999999
Q ss_pred HHhCCCCCC
Q 002342 891 MLYGYTPFR 899 (934)
Q Consensus 891 lltG~~Pf~ 899 (934)
|++|.+||.
T Consensus 211 l~tg~~~~~ 219 (303)
T d1vjya_ 211 IARRCSIGG 219 (303)
T ss_dssp HHHTBCBTT
T ss_pred HhhCCCCCC
Confidence 999988874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.98 E-value=1.5e-32 Score=307.52 Aligned_cols=206 Identities=23% Similarity=0.372 Sum_probs=166.9
Q ss_pred ccccccCCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-----------CCCc
Q 002342 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-----------HPFV 731 (934)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-----------hp~I 731 (934)
++.+..++|++++.||+|+||+||+|+++.+|+.||||++++. ....+.+.+|+.+++.++ |+||
T Consensus 7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 5555556799999999999999999999999999999999764 234456778999888775 5789
Q ss_pred cceeEEEEe--CCeEEEEEEccCCCCch-hhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecC
Q 002342 732 PALYASFQT--KTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGN 807 (934)
Q Consensus 732 v~l~~~~~~--~~~~~lV~E~~~ggsL~-~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~ 807 (934)
+++++++.. ....+++|+++..+... ..........+++..++.++.||+.||+|||+ .||+||||||+|||++.+
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence 999998864 45677777776554433 33334445679999999999999999999998 899999999999999866
Q ss_pred C------cEEEEecccCcccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCCCccchhhhcCCCCCchhHH
Q 002342 808 G------HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (934)
Q Consensus 808 ~------~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~~Di 881 (934)
+ .++++|||.|.... ......+||+.|+|||++.+..++.++|+
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 212 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYD------------------------------EHYTNSIQTREYRSPEVLLGAPWGCGADI 212 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETT------------------------------BCCCSCCSCGGGCCHHHHHTCCCCTHHHH
T ss_pred CcccccceeeEeecccccccc------------------------------cccccccccccccChhhccccCCCccccc
Confidence 5 39999999985422 11234579999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCC
Q 002342 882 WALGILLYEMLYGYTPFRGKT 902 (934)
Q Consensus 882 wSlG~iL~elltG~~Pf~~~~ 902 (934)
|||||++++|++|+.||.+..
T Consensus 213 wSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 213 WSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp HHHHHHHHHHHHSSCCC----
T ss_pred cchHHHHHHHHHCCCCCCCCc
Confidence 999999999999999998644
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.6e-22 Score=204.31 Aligned_cols=135 Identities=19% Similarity=0.143 Sum_probs=105.3
Q ss_pred cccccccccCCcEEEEEEEEecCCeEEEEEEeeccccc---------------ChHHHHHHHHHHHHHHhCCCCCcccee
Q 002342 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML---------------NRNKVHRACAEREILDMLDHPFVPALY 735 (934)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~---------------~~~~~~~~~~E~~il~~l~hp~Iv~l~ 735 (934)
|.+.++||+|+||.||+|.+ .+|+.||||+++..... ..........|..++..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 45788999999999999998 57899999987642110 011123345688899999999999887
Q ss_pred EEEEeCCeEEEEEEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEec
Q 002342 736 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815 (934)
Q Consensus 736 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DF 815 (934)
++.. .+++|||+++..+.. ++...+..++.|++.+|.|||++||+||||||+|||+++ +.++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~-~~~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-EGIWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET-TEEEECCC
T ss_pred EecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC-CCEEEEEC
Confidence 6532 379999997766543 333456788999999999999999999999999999995 45899999
Q ss_pred ccCcc
Q 002342 816 DLSCL 820 (934)
Q Consensus 816 G~a~~ 820 (934)
|.|..
T Consensus 147 G~a~~ 151 (191)
T d1zara2 147 PQSVE 151 (191)
T ss_dssp TTCEE
T ss_pred CCccc
Confidence 99854
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.80 E-value=2.8e-19 Score=162.82 Aligned_cols=108 Identities=60% Similarity=1.139 Sum_probs=102.2
Q ss_pred ccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 002342 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 277 (934)
Q Consensus 198 ~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 277 (934)
+.++++++|+..+||+|+|||++|++++||+++|++|+++..+.+++......+.++..+..+..+.++++.++|||+.+
T Consensus 2 i~~~~vi~Da~~pdg~Ii~vN~a~~~~~Gy~~~El~G~~~~~l~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~kdG~~~ 81 (109)
T d1n9la_ 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred ccceEEEEeCCCCCCeEEEEcHHHHHHHCcCHHHHcCCcceeeecccCCHHHhhhhhhHhhcCCceeeeEEEEecCCeEE
Confidence 57899999987679999999999999999999999999999888888888889999999999999999999999999999
Q ss_pred EEEEEeeeeecCCCCEEEEEEEEecchh
Q 002342 278 WNLLTIAPIKDDEGKVLKFIGMQVEVSK 305 (934)
Q Consensus 278 wv~~s~~pi~d~~G~v~~~v~~~~DITe 305 (934)
|++++++|++|++|.+.+++++++|||.
T Consensus 82 w~~~~~~pi~d~~G~v~~~v~~~~DITa 109 (109)
T d1n9la_ 82 WNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECCC
Confidence 9999999999999999999999999984
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.77 E-value=2.9e-18 Score=156.02 Aligned_cols=108 Identities=45% Similarity=0.912 Sum_probs=99.7
Q ss_pred ccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 002342 481 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 560 (934)
Q Consensus 481 ~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~~ 560 (934)
+.++++++|+..+|++|+|||++|++++||+++|++|+++..+.+++..+...+.+...+..+..+.+|+++++|||+.+
T Consensus 2 i~~~~vi~Da~~pdg~Ii~vN~a~~~~~Gy~~~El~G~~~~~l~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~kdG~~~ 81 (109)
T d1n9la_ 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred ccceEEEEeCCCCCCeEEEEcHHHHHHHCcCHHHHcCCcceeeecccCCHHHhhhhhhHhhcCCceeeeEEEEecCCeEE
Confidence 46899999964334559999999999999999999999999999888888888999999999999999999999999999
Q ss_pred EEEEEEEeeecCCCCEEEEEEEEEcCCc
Q 002342 561 WNLFHLQPMRDQKGEVQYFIGVQLDGSE 588 (934)
Q Consensus 561 wv~~~~~pi~de~G~v~~~vgi~rDITe 588 (934)
|+.+++.|++|++|++.+++++++|||.
T Consensus 82 w~~~~~~pi~d~~G~v~~~v~~~~DITa 109 (109)
T d1n9la_ 82 WNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECCC
Confidence 9999999999999999999999999994
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=1.8e-17 Score=150.74 Aligned_cols=107 Identities=29% Similarity=0.579 Sum_probs=98.4
Q ss_pred CcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCC--CCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 002342 200 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCR--FLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 277 (934)
Q Consensus 200 d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~--~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 277 (934)
..++++|....|++|+|+|++|++++||+++|++|+++. ++.+++........+..++..+..+..+++.++++|+.+
T Consensus 2 ~~f~i~~~~~~d~~I~~~N~a~~~l~G~~~~eiiG~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~~~g~~~ 81 (110)
T d1bywa_ 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCF 81 (110)
T ss_dssp CEEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEE
T ss_pred ceEEEEcCCCCCCEEEEEcHHHHHHhCCCHHHhcccCcccccceeeheecccccccchhhcccccccceeeeeeccccee
Confidence 357889987789999999999999999999999999876 345677778888999999999999999999999999999
Q ss_pred EEEEEeeeeecCCCCEEEEEEEEecchhh
Q 002342 278 WNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306 (934)
Q Consensus 278 wv~~s~~pi~d~~G~v~~~v~~~~DITer 306 (934)
|+.++++|++|++|++++++++++|||||
T Consensus 82 w~~~~~~pi~d~~G~v~~~i~~~~DITer 110 (110)
T d1bywa_ 82 LCLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred eeeeeEEEEECCCCCEEEEEEEEEECCCC
Confidence 99999999999999999999999999986
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Probab=99.71 E-value=2.5e-17 Score=148.13 Aligned_cols=103 Identities=45% Similarity=0.866 Sum_probs=98.6
Q ss_pred cEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEE
Q 002342 201 TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNL 280 (934)
Q Consensus 201 ~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~ 280 (934)
.++++|+..+||+|+|+|++|++++||+.+|++|+++..+.+++......+.+...+..+..+.++++.+++||+.+|++
T Consensus 2 ~fvi~d~~~pd~~I~y~N~a~~~~~G~s~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~~~ 81 (104)
T d1jnua_ 2 SFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTKGGRAFWNL 81 (104)
T ss_dssp EEEEECTTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEcCCCCCCEEEEEcHHHHHHHCcCHHHHCCccceeccccccchHHHhhhhhhhhcCceeEeEEEEEecccceEEEE
Confidence 47899987779999999999999999999999999999899999999999999999999999999999999999999999
Q ss_pred EEeeeeecCCCCEEEEEEEEecc
Q 002342 281 LTIAPIKDDEGKVLKFIGMQVEV 303 (934)
Q Consensus 281 ~s~~pi~d~~G~v~~~v~~~~DI 303 (934)
++++|++|++|++.+++++.+||
T Consensus 82 ~~~~pi~d~~G~v~~~i~i~~DI 104 (104)
T d1jnua_ 82 FHLQVMRDENGDVQYFIGVQQEM 104 (104)
T ss_dssp EEEEEECTTTSSCCEEEEEEEEC
T ss_pred EEEEEEECCCCCEEEEEEEEEcC
Confidence 99999999999999999999998
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=4.7e-17 Score=147.95 Aligned_cols=107 Identities=30% Similarity=0.527 Sum_probs=97.9
Q ss_pred ccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcc--cCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 002342 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF--LQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 560 (934)
Q Consensus 483 d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~--l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~~ 560 (934)
..++++|+++.|++|+|+|++|++++||+.+|++|+++.. +.+++........+...+..+..+..|++.++++|+.+
T Consensus 2 ~~f~i~~~~~~d~~I~~~N~a~~~l~G~~~~eiiG~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~~~g~~~ 81 (110)
T d1bywa_ 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCF 81 (110)
T ss_dssp CEEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEE
T ss_pred ceEEEEcCCCCCCEEEEEcHHHHHHhCCCHHHhcccCcccccceeeheecccccccchhhcccccccceeeeeeccccee
Confidence 3578899888888899999999999999999999998654 44677778888999999999999999999999999999
Q ss_pred EEEEEEEeeecCCCCEEEEEEEEEcCCcc
Q 002342 561 WNLFHLQPMRDQKGEVQYFIGVQLDGSEH 589 (934)
Q Consensus 561 wv~~~~~pi~de~G~v~~~vgi~rDITer 589 (934)
|+.++++|++|++|++++++++++|||||
T Consensus 82 w~~~~~~pi~d~~G~v~~~i~~~~DITer 110 (110)
T d1bywa_ 82 LCLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred eeeeeEEEEECCCCCEEEEEEEEEECCCC
Confidence 99999999999999999999999999996
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Probab=99.68 E-value=1.7e-16 Score=142.63 Aligned_cols=103 Identities=72% Similarity=1.188 Sum_probs=96.8
Q ss_pred cEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEE
Q 002342 484 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNL 563 (934)
Q Consensus 484 ~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~~wv~ 563 (934)
.++++|+...|++|+|+|++|++++||+.+|++|+++..+.+++......+.+...+..+..+.+|++++++||+.+|+.
T Consensus 2 ~fvi~d~~~pd~~I~y~N~a~~~~~G~s~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~~~ 81 (104)
T d1jnua_ 2 SFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTKGGRAFWNL 81 (104)
T ss_dssp EEEEECTTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEcCCCCCCEEEEEcHHHHHHHCcCHHHHCCccceeccccccchHHHhhhhhhhhcCceeEeEEEEEecccceEEEE
Confidence 47899965555669999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeeecCCCCEEEEEEEEEcC
Q 002342 564 FHLQPMRDQKGEVQYFIGVQLDG 586 (934)
Q Consensus 564 ~~~~pi~de~G~v~~~vgi~rDI 586 (934)
+++.|++|++|++++++++++||
T Consensus 82 ~~~~pi~d~~G~v~~~i~i~~DI 104 (104)
T d1jnua_ 82 FHLQVMRDENGDVQYFIGVQQEM 104 (104)
T ss_dssp EEEEEECTTTSSCCEEEEEEEEC
T ss_pred EEEEEEECCCCCEEEEEEEEEcC
Confidence 99999999999999999999998
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Probab=99.68 E-value=2.9e-17 Score=153.82 Aligned_cols=125 Identities=22% Similarity=0.267 Sum_probs=107.5
Q ss_pred cccccccccccchHHHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHH
Q 002342 175 SDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIR 254 (934)
Q Consensus 175 t~~~~~e~aL~~~~~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~ 254 (934)
|+.++++++|++++++|+.++++++++|+++|. +|+|+++|++|++++||+++|++|+++..+.++.........+.
T Consensus 2 s~l~~~e~~l~~~e~~~~~i~~~~~~~i~~~d~---~g~i~~~N~~~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~ 78 (130)
T d1ew0a_ 2 SHMLETEDVVRARDAHLRSILDTVPDATVVSAT---DGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQ 78 (130)
T ss_dssp CHHHHHHHHHHHHTSCHHHHHTTCSSEEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTGGGHHHHHH
T ss_pred ChHHHHHHHHHHHHHHHHHHHHcCCCeEEEEeC---CccEEEEHHHHHHhhcCCHHHhcCCccccccccchhHHHHHHHH
Confidence 456778899999999999999999999999998 77899999999999999999999999988888877776666666
Q ss_pred HHHhcCCc----EEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecch
Q 002342 255 ETLQNGQS----YCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (934)
Q Consensus 255 ~~l~~g~~----~~~e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DIT 304 (934)
..+..+.. ...++..+++||+.+|++++++|+.+.++ .+++++++|||
T Consensus 79 ~~~~~~~~~~~~~~~e~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~i~rDIT 130 (130)
T d1ew0a_ 79 RYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGE--RFFTGFIRDLT 130 (130)
T ss_dssp HHHHHCCCSSTTSCEEEEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEECC
T ss_pred HHHHhCCCccccceeeEEEEcCCCCEEEEEEEEEEEEECCe--EEEEEEEEECC
Confidence 66665543 45678888999999999999999987544 45889999998
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Probab=99.63 E-value=7.1e-16 Score=144.15 Aligned_cols=124 Identities=16% Similarity=0.204 Sum_probs=105.0
Q ss_pred hhhHHHHHhhhhc-ccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHH
Q 002342 459 VDDKVRQKEMRKG-IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 537 (934)
Q Consensus 459 ~~r~~~e~~l~~~-~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~ 537 (934)
++.+..|++|++. .+|+.++++++++|+++|.+|+ |+++|+++++++||+++|++|+++..+.++.........+.
T Consensus 2 s~l~~~e~~l~~~e~~~~~i~~~~~~~i~~~d~~g~---i~~~N~~~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~ 78 (130)
T d1ew0a_ 2 SHMLETEDVVRARDAHLRSILDTVPDATVVSATDGT---IVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQ 78 (130)
T ss_dssp CHHHHHHHHHHHHTSCHHHHHTTCSSEEEEEETTSB---EEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTGGGHHHHHH
T ss_pred ChHHHHHHHHHHHHHHHHHHHHcCCCeEEEEeCCcc---EEEEHHHHHHhhcCCHHHhcCCccccccccchhHHHHHHHH
Confidence 3556778888766 7899999999999999999888 99999999999999999999999988888877766666666
Q ss_pred HHHhcCCc----EEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCC
Q 002342 538 AAIDNQTD----VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587 (934)
Q Consensus 538 ~~l~~~~~----~~~e~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDIT 587 (934)
..+..+.. ...++...++||+.+|+.++++|+.+.++ ..++++++|||
T Consensus 79 ~~~~~~~~~~~~~~~e~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~i~rDIT 130 (130)
T d1ew0a_ 79 RYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGE--RFFTGFIRDLT 130 (130)
T ss_dssp HHHHHCCCSSTTSCEEEEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEECC
T ss_pred HHHHhCCCccccceeeEEEEcCCCCEEEEEEEEEEEEECCe--EEEEEEEEECC
Confidence 66654443 56788889999999999999999987544 45889999998
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=3.6e-15 Score=136.07 Aligned_cols=107 Identities=17% Similarity=0.134 Sum_probs=96.4
Q ss_pred cccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEE
Q 002342 482 EKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFW 561 (934)
Q Consensus 482 ~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~~w 561 (934)
++.|+..|++|+ |+|+|+++++++||+.+|++|+++..+++|++.....+.+...+..+..+..|++++++||+.+|
T Consensus 6 ~~fi~r~~~dG~---i~~~N~~~~~~~G~~~~el~g~~~~~~~~~ed~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~w 82 (114)
T d1p97a_ 6 KTFLSRHSMDMK---FTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYVW 82 (114)
T ss_dssp EEEEEEECTTTS---CSEECTTHHHHTSSCHHHHTTSCHHHHSCSSSHHHHHHHHHHHTTTSEEEEEEEEEECTTSCEEE
T ss_pred CEEEEEECCCCc---EEEECHHHHHHcCCCccccccccccccccccccccceeeeeecccccceeecceeeeeecCcceE
Confidence 344555699888 99999999999999999999999998999998888888887777777778999999999999999
Q ss_pred EEEEEEeeecC-CCCEEEEEEEEEcCCcccc
Q 002342 562 NLFHLQPMRDQ-KGEVQYFIGVQLDGSEHLE 591 (934)
Q Consensus 562 v~~~~~pi~de-~G~v~~~vgi~rDITerk~ 591 (934)
+.++.+|++|. +|++.+++++.+||||+|+
T Consensus 83 v~~~~~~~~~~~~~~~~~ii~~~~dite~k~ 113 (114)
T d1p97a_ 83 LETQGTVIYNPRNLQPQCIMCVNYVLSEIEK 113 (114)
T ss_dssp EEEEEEEEECTTTCSEEEEEEEEEEEEEEEC
T ss_pred EEEEEEEEEeCCCCCEEEEEEEEEECChhhc
Confidence 99999999987 6899999999999999997
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=3.4e-15 Score=136.25 Aligned_cols=106 Identities=15% Similarity=0.173 Sum_probs=93.4
Q ss_pred CcEEE--EeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 002342 200 QTFVV--SDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 277 (934)
Q Consensus 200 d~i~v--~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 277 (934)
...++ .|. ||+|+|+|+++++++||+.+|++|+++..+.+|++.....+.+...+..+..+..+++.+++||+.+
T Consensus 5 ~~~fi~r~~~---dG~i~~~N~~~~~~~G~~~~el~g~~~~~~~~~ed~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~ 81 (114)
T d1p97a_ 5 SKTFLSRHSM---DMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYV 81 (114)
T ss_dssp CEEEEEEECT---TTSCSEECTTHHHHTSSCHHHHTTSCHHHHSCSSSHHHHHHHHHHHTTTSEEEEEEEEEECTTSCEE
T ss_pred cCEEEEEECC---CCcEEEECHHHHHHcCCCccccccccccccccccccccceeeeeecccccceeecceeeeeecCcce
Confidence 34444 455 8889999999999999999999999988888888877777777777777777889999999999999
Q ss_pred EEEEEeeeeecC-CCCEEEEEEEEecchhhHH
Q 002342 278 WNLLTIAPIKDD-EGKVLKFIGMQVEVSKHTE 308 (934)
Q Consensus 278 wv~~s~~pi~d~-~G~v~~~v~~~~DITerk~ 308 (934)
|++++.+|++|+ +|.+.+++++.+||||+|+
T Consensus 82 wv~~~~~~~~~~~~~~~~~ii~~~~dite~k~ 113 (114)
T d1p97a_ 82 WLETQGTVIYNPRNLQPQCIMCVNYVLSEIEK 113 (114)
T ss_dssp EEEEEEEEEECTTTCSEEEEEEEEEEEEEEEC
T ss_pred EEEEEEEEEEeCCCCCEEEEEEEEEECChhhc
Confidence 999999999997 6899999999999999985
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Probab=99.49 E-value=3.6e-14 Score=128.43 Aligned_cols=108 Identities=21% Similarity=0.358 Sum_probs=85.9
Q ss_pred HHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCC----cEEE
Q 002342 190 IVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ----SYCG 265 (934)
Q Consensus 190 ~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~----~~~~ 265 (934)
.|.++|++++++|+++|. +|+|+++|++|++++||+++|++|+++..+.++.........+...+..+. ....
T Consensus 2 ~~~~~~e~~~d~i~~~d~---~g~i~~~N~~~~~l~Gy~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (113)
T d1v9ya_ 2 IFFPALEQNMMGAVLINE---NDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSR 78 (113)
T ss_dssp CHHHHHHTCSSEEEEECT---TSBEEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------C
T ss_pred HHHHHHHcCcCcEEEEeC---CCCEEEEchhHhhhhccchhhhcCcceecccccccccccccccccccccccccccccce
Confidence 478999999999999998 777999999999999999999999998877766665555555554444332 2456
Q ss_pred EEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEec
Q 002342 266 RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVE 302 (934)
Q Consensus 266 e~~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~D 302 (934)
+...++|||+.+|++++++|+.+++| .+++++++|
T Consensus 79 e~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~v~rD 113 (113)
T d1v9ya_ 79 ELQLEKKDGSKIWTRFALSKVSAEGK--VYYLALVRD 113 (113)
T ss_dssp EEEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEC
T ss_pred eeeeccccceeEEEEEEEEEEEECCe--EEEEEEEEC
Confidence 77888999999999999999998654 447888887
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Probab=99.49 E-value=5.2e-14 Score=125.67 Aligned_cols=102 Identities=19% Similarity=0.262 Sum_probs=84.0
Q ss_pred CcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCc----EEEEEEEEecCCc
Q 002342 200 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS----YCGRLLNYKKDGT 275 (934)
Q Consensus 200 d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~~~~kdG~ 275 (934)
|||+++|. +|+|+++|++|++++||+.+|++|+++..+.++.........+...+..... ...++..+++||+
T Consensus 1 dgi~~~D~---~G~I~~~N~a~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~ 77 (106)
T d1xj3a1 1 DAMIVIDG---HGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGT 77 (106)
T ss_dssp CCEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSC
T ss_pred CEEEEECC---CCcEEEEcHHHHHHhhhchHhhcCCCcccccccccccchhhhhhhhhhhcccccccccceeeeeeccce
Confidence 68999998 7779999999999999999999999988888877666655555554444332 4467888999999
Q ss_pred EEEEEEEeeeeecCCCCEEEEEEEEecchhh
Q 002342 276 PFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306 (934)
Q Consensus 276 ~~wv~~s~~pi~d~~G~v~~~v~~~~DITer 306 (934)
.+|++++++|+.+.++ .+++++++||||.
T Consensus 78 ~~~v~~~~~~~~~~~~--~~~~~~~~DITE~ 106 (106)
T d1xj3a1 78 TFPMHLSIGEMQSGGE--PYFTGFVRDLTEH 106 (106)
T ss_dssp EEEEEEEEEEEEETTE--EEEEEEEEECHHH
T ss_pred EEEEEEEEEEEEECCe--EEEEEEEEeCCCC
Confidence 9999999999988544 5689999999974
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Probab=99.49 E-value=3.4e-14 Score=126.85 Aligned_cols=102 Identities=19% Similarity=0.205 Sum_probs=85.5
Q ss_pred ccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCC----cEEEEEEEEecCCc
Q 002342 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT----DVTVQLINYTKSGK 558 (934)
Q Consensus 483 d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~----~~~~e~~~~~kdG~ 558 (934)
|||+++|.+|+ |+++|+++++++||+.+|++|+++..+.++.........+...+.... ....+....++||.
T Consensus 1 dgi~~~D~~G~---I~~~N~a~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~ 77 (106)
T d1xj3a1 1 DAMIVIDGHGI---IQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGT 77 (106)
T ss_dssp CCEEEEETTSB---EEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSC
T ss_pred CEEEEECCCCc---EEEEcHHHHHHhhhchHhhcCCCcccccccccccchhhhhhhhhhhcccccccccceeeeeeccce
Confidence 68999999888 999999999999999999999999888888776665555555444333 24578889999999
Q ss_pred EEEEEEEEEeeecCCCCEEEEEEEEEcCCcc
Q 002342 559 KFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH 589 (934)
Q Consensus 559 ~~wv~~~~~pi~de~G~v~~~vgi~rDITer 589 (934)
.+|++++++|+.+.++ .+++++++||||+
T Consensus 78 ~~~v~~~~~~~~~~~~--~~~~~~~~DITE~ 106 (106)
T d1xj3a1 78 TFPMHLSIGEMQSGGE--PYFTGFVRDLTEH 106 (106)
T ss_dssp EEEEEEEEEEEEETTE--EEEEEEEEECHHH
T ss_pred EEEEEEEEEEEEECCe--EEEEEEEEeCCCC
Confidence 9999999999988554 4689999999974
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Probab=99.47 E-value=8.6e-14 Score=125.87 Aligned_cols=107 Identities=23% Similarity=0.366 Sum_probs=86.1
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcC----CcEEEE
Q 002342 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ----TDVTVQ 549 (934)
Q Consensus 474 l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~----~~~~~e 549 (934)
|.++++++++||+++|.+|+ |+++|+++++++||+++|++|++...+.++.........+...+... .....|
T Consensus 3 ~~~~~e~~~d~i~~~d~~g~---i~~~N~~~~~l~Gy~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 79 (113)
T d1v9ya_ 3 FFPALEQNMMGAVLINENDE---VMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSRE 79 (113)
T ss_dssp HHHHHHTCSSEEEEECTTSB---EEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------CE
T ss_pred HHHHHHcCcCcEEEEeCCCC---EEEEchhHhhhhccchhhhcCcceeccccccccccccccccccccccccccccccee
Confidence 78999999999999999888 99999999999999999999999888877665555444444444332 235668
Q ss_pred EEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEc
Q 002342 550 LINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585 (934)
Q Consensus 550 ~~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rD 585 (934)
...+++||+.+|+++++.|+.+++| ..+++++||
T Consensus 80 ~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~v~rD 113 (113)
T d1v9ya_ 80 LQLEKKDGSKIWTRFALSKVSAEGK--VYYLALVRD 113 (113)
T ss_dssp EEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEC
T ss_pred eeeccccceeEEEEEEEEEEEECCe--EEEEEEEEC
Confidence 8889999999999999999998654 348889998
|
| >d1nwza_ d.110.3.1 (A:) Photoactive yellow protein, PYP {Ectothiorhodospira halophila [TaxId: 1053]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: Photoactive yellow protein, PYP species: Ectothiorhodospira halophila [TaxId: 1053]
Probab=99.29 E-value=3.6e-12 Score=118.01 Aligned_cols=108 Identities=19% Similarity=0.123 Sum_probs=87.9
Q ss_pred HHHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCC-CCCCChHHHHHHHHHHhcCCcEEEEE
Q 002342 189 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQ-GAGTDPEDVAKIRETLQNGQSYCGRL 267 (934)
Q Consensus 189 ~~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~-~~~~~~~~~~~i~~~l~~g~~~~~e~ 267 (934)
..+..++|++++|++++|. +|+|+++|+++++++||+++|++|+++..++ ++.........+.+++.++.....+.
T Consensus 17 ~~~d~~ld~~p~gi~~lD~---~G~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~ 93 (125)
T d1nwza_ 17 KMDDGQLDGLAFGAIQLDG---DGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGNLNTMFE 93 (125)
T ss_dssp TCCHHHHTTCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTCCEEEEE
T ss_pred HHHHHHHhCCCccEEEEeC---CCCEEEEcHHHHHhhccchHhhcCCCHHHccCchhhhhheeeeceeeeecCCcceEEE
Confidence 4567899999999999999 7789999999999999999999999976544 44455566777888888888777776
Q ss_pred EEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecc
Q 002342 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303 (934)
Q Consensus 268 ~~~~kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DI 303 (934)
..++++|+.+|+++++.++. +|+-. ..+++||
T Consensus 94 ~~~~~~G~~~~v~v~l~~~~--~g~~~--~v~V~di 125 (125)
T d1nwza_ 94 YTFDYQMTPTKVKVHMKKAL--SGDSY--WVFVKRV 125 (125)
T ss_dssp EEECTTSCCEEEEEEEEECS--SSSEE--EEEEEEC
T ss_pred EEeccCCcEEEEEEEEEEec--CCCEE--EEEEEEC
Confidence 67899999999999988774 44433 3566775
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Probab=99.28 E-value=6.7e-12 Score=113.32 Aligned_cols=96 Identities=10% Similarity=0.065 Sum_probs=78.6
Q ss_pred HHHHHHHhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCC-CCCCCCCChHHHHHHHHHHhcCCcEEEEEE
Q 002342 190 IVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCR-FLQGAGTDPEDVAKIRETLQNGQSYCGRLL 268 (934)
Q Consensus 190 ~~~~ile~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~-~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 268 (934)
.++++||++|+||+++|. +|+|++||+++++|+||+++|++|+++. .+.++.........+.+.+.+|......-.
T Consensus 4 ~~~A~ld~~p~gvi~~D~---~G~I~~~N~aa~~~~G~~~eellG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~ 80 (110)
T d1mzua_ 4 MGTAEFDALPVGAIQVDG---SGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGTLDARFDF 80 (110)
T ss_dssp --CTTGGGCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSCCEEEEEE
T ss_pred HHHHHHhCCCcEEEEEcC---CCCEEEeHHHHHHHHcCCHHHHcCCCHHHhcCChhhhHHHHHHHHHHHhccccCcceEE
Confidence 356789999999999998 7889999999999999999999999986 455555566778888899999876544334
Q ss_pred EEecCCcEEEEEEEeeeeec
Q 002342 269 NYKKDGTPFWNLLTIAPIKD 288 (934)
Q Consensus 269 ~~~kdG~~~wv~~s~~pi~d 288 (934)
..+++|..+++++++.+..+
T Consensus 81 ~l~~~G~~~~v~v~~~~~~~ 100 (110)
T d1mzua_ 81 VFDFQMAPVRVQIRMQNAGV 100 (110)
T ss_dssp EEECSSCEEEEEEEEEECSS
T ss_pred EEecCCceEEEEEEEEEecC
Confidence 46899999999999888743
|
| >d1nwza_ d.110.3.1 (A:) Photoactive yellow protein, PYP {Ectothiorhodospira halophila [TaxId: 1053]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: Photoactive yellow protein, PYP species: Ectothiorhodospira halophila [TaxId: 1053]
Probab=99.23 E-value=1.8e-11 Score=113.12 Aligned_cols=108 Identities=11% Similarity=0.009 Sum_probs=88.5
Q ss_pred ccHHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCC-CCHHHHHHHHHHHhcCCcEEEEE
Q 002342 472 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE-TDPATVRKIRAAIDNQTDVTVQL 550 (934)
Q Consensus 472 ~~l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~-~~~~~~~~i~~~l~~~~~~~~e~ 550 (934)
..+..+++++|+||+++|.+|+ |+++|+++++++||+++|++|+++..+++|+ ....+...+.+.+..+.....+.
T Consensus 17 ~~~d~~ld~~p~gi~~lD~~G~---i~~~N~a~~~l~G~~~~e~iG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~ 93 (125)
T d1nwza_ 17 KMDDGQLDGLAFGAIQLDGDGN---ILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGNLNTMFE 93 (125)
T ss_dssp TCCHHHHTTCSSEEEEEETTCB---EEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTCCEEEEE
T ss_pred HHHHHHHhCCCccEEEEeCCCC---EEEEcHHHHHhhccchHhhcCCCHHHccCchhhhhheeeeceeeeecCCcceEEE
Confidence 3478899999999999999888 9999999999999999999999986666544 44556677788888888877777
Q ss_pred EEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcC
Q 002342 551 INYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDG 586 (934)
Q Consensus 551 ~~~~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDI 586 (934)
..++++|..+|+.+++.++. +|+-+ ..+++||
T Consensus 94 ~~~~~~G~~~~v~v~l~~~~--~g~~~--~v~V~di 125 (125)
T d1nwza_ 94 YTFDYQMTPTKVKVHMKKAL--SGDSY--WVFVKRV 125 (125)
T ss_dssp EEECTTSCCEEEEEEEEECS--SSSEE--EEEEEEC
T ss_pred EEeccCCcEEEEEEEEEEec--CCCEE--EEEEEEC
Confidence 77899999999999988875 44433 3466776
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Probab=99.18 E-value=3.5e-11 Score=108.47 Aligned_cols=95 Identities=12% Similarity=-0.032 Sum_probs=78.2
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCC-CCCCHHHHHHHHHHHhcCCcEEEEEEE
Q 002342 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQG-PETDPATVRKIRAAIDNQTDVTVQLIN 552 (934)
Q Consensus 474 l~~i~e~~~d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~-~~~~~~~~~~i~~~l~~~~~~~~e~~~ 552 (934)
+.++++++|+||+++|.+|+ |+++|+++++++||+++|++|+++..++. +...+.+...+.+.+..|.........
T Consensus 5 ~~A~ld~~p~gvi~~D~~G~---I~~~N~aa~~~~G~~~eellG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~ 81 (110)
T d1mzua_ 5 GTAEFDALPVGAIQVDGSGV---IHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGTLDARFDFV 81 (110)
T ss_dssp -CTTGGGCSSEEEEEETTCB---EEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSCCEEEEEEE
T ss_pred HHHHHhCCCcEEEEEcCCCC---EEEeHHHHHHHHcCCHHHHcCCCHHHhcCChhhhHHHHHHHHHHHhccccCcceEEE
Confidence 67789999999999999888 99999999999999999999999765554 445566777888888888765444444
Q ss_pred EecCCcEEEEEEEEEeeec
Q 002342 553 YTKSGKKFWNLFHLQPMRD 571 (934)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~d 571 (934)
.+++|..+++++++.+..+
T Consensus 82 l~~~G~~~~v~v~~~~~~~ 100 (110)
T d1mzua_ 82 FDFQMAPVRVQIRMQNAGV 100 (110)
T ss_dssp EECSSCEEEEEEEEEECSS
T ss_pred EecCCceEEEEEEEEEecC
Confidence 6889999999999888753
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.17 E-value=4e-12 Score=115.52 Aligned_cols=105 Identities=12% Similarity=0.159 Sum_probs=84.1
Q ss_pred HhccCcEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCc----EEEEEEEEe
Q 002342 196 STFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS----YCGRLLNYK 271 (934)
Q Consensus 196 e~~~d~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~~~~ 271 (934)
+.+.+||+++|.. +|+|+++|++++++|||+.+|++|+++..+.++.........+...+.++.. +..++..++
T Consensus 5 ~~~n~AI~~id~~--~G~I~~~N~a~~~l~Gy~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 82 (114)
T d1ll8a_ 5 PEFNKAIFTVDAK--TTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGHAAVVFGTVVDIIS 82 (114)
T ss_dssp TTTTCEEEEEETT--TCBEEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTHHHHHTTSSTTSSSSCSSCCCSSSEEECC
T ss_pred hhcCcEEEEEECC--CCEEEEECHHHHHhhcCCHHHHcCCCeeeecCcccHHHHHHHHHHHHhcCCCccceeeEEEEEEc
Confidence 5678899999963 6789999999999999999999999999888887776665555555554432 223577789
Q ss_pred cCCcEEEEEEEeeeeecCCCCEEEEEEEEecch
Q 002342 272 KDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (934)
Q Consensus 272 kdG~~~wv~~s~~pi~d~~G~v~~~v~~~~DIT 304 (934)
++|+.+|++++++++..+ |+. .++++++||+
T Consensus 83 ~~G~~~pvevs~~~i~~~-~~~-~~l~vi~dV~ 113 (114)
T d1ll8a_ 83 RSGEKIPVSVWMKRMRQE-RRL-CCVVVLEPVE 113 (114)
T ss_dssp TTCCCEEEECCEECCBSS-SSB-EEEEEEEECC
T ss_pred cCCcEEEEEEEEEEEEEC-CeE-EEEEEEEECc
Confidence 999999999999999764 444 4789999994
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.12 E-value=9.3e-12 Score=113.04 Aligned_cols=104 Identities=14% Similarity=0.164 Sum_probs=83.9
Q ss_pred HhccccEEEEcCC-CCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCCc----EEEEEEEE
Q 002342 479 ERIEKNFVITDPR-LPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD----VTVQLINY 553 (934)
Q Consensus 479 e~~~d~i~v~D~~-G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~~----~~~e~~~~ 553 (934)
+.+.++|+++|.+ |+ |+++|++++++|||+++|++|+++..++++++.......+...+..+.. +..+...+
T Consensus 5 ~~~n~AI~~id~~~G~---I~~~N~a~~~l~Gy~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 81 (114)
T d1ll8a_ 5 PEFNKAIFTVDAKTTE---ILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGHAAVVFGTVVDII 81 (114)
T ss_dssp TTTTCEEEEEETTTCB---EEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTHHHHHTTSSTTSSSSCSSCCCSSSEEEC
T ss_pred hhcCcEEEEEECCCCE---EEEECHHHHHhhcCCHHHHcCCCeeeecCcccHHHHHHHHHHHHhcCCCccceeeEEEEEE
Confidence 3567899999964 66 9999999999999999999999999999988877665555555544432 33478888
Q ss_pred ecCCcEEEEEEEEEeeecCCCCEEEEEEEEEcCC
Q 002342 554 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587 (934)
Q Consensus 554 ~kdG~~~wv~~~~~pi~de~G~v~~~vgi~rDIT 587 (934)
+++|+.+|++++++++..+ |+. .++++++||+
T Consensus 82 ~~~G~~~pvevs~~~i~~~-~~~-~~l~vi~dV~ 113 (114)
T d1ll8a_ 82 SRSGEKIPVSVWMKRMRQE-RRL-CCVVVLEPVE 113 (114)
T ss_dssp CTTCCCEEEECCEECCBSS-SSB-EEEEEEEECC
T ss_pred ccCCcEEEEEEEEEEEEEC-CeE-EEEEEEEECc
Confidence 9999999999999999754 444 4789999994
|
| >d1oj5a_ d.110.3.8 (A:) PAS domain of steroid receptor coactivator 1A, NCo-A1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PAS domain of steroid receptor coactivator 1A, NCo-A1 domain: PAS domain of steroid receptor coactivator 1A, NCo-A1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.85 E-value=6.4e-10 Score=99.76 Aligned_cols=89 Identities=11% Similarity=0.064 Sum_probs=71.6
Q ss_pred CCceEEcchHHHHHcCCCh-hhHcCCCCCCCCCCCCCh--HHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEeeeee
Q 002342 211 DYPIMYASAGFFKMTGYTS-KEVVGRNCRFLQGAGTDP--EDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIK 287 (934)
Q Consensus 211 dG~I~~~N~a~~~l~Gys~-eEllG~~~~~l~~~~~~~--~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~s~~pi~ 287 (934)
+|+|+++|+++++++||.+ +|++|+++..++||++.+ .....+...+..|.....++++++|||+.+|++.+..+++
T Consensus 11 ~g~~~~vd~~~~~~~gy~~~eelig~s~~~f~HPeD~~~~~~~~~~~~~~~~g~~~~~~yR~~~kdG~~vWv~t~~~~~~ 90 (109)
T d1oj5a_ 11 TGKIISIDTSSLRAAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSAHTRCKLCY 90 (109)
T ss_dssp TCCEEEEECHHHHTTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEEEEEEEEEEC
T ss_pred CceEEEECHHHhhHhhcCCHHHHcCCcHHHeECcccchHHHhhHHHHHHHhhcccchhhhhhhhccCcEEEEEEEEEEEE
Confidence 8889999999999999985 999999999889998854 2334456777888888889999999999999999999999
Q ss_pred cCCCCEE-EEEEE
Q 002342 288 DDEGKVL-KFIGM 299 (934)
Q Consensus 288 d~~G~v~-~~v~~ 299 (934)
|+.|+.. +++++
T Consensus 91 ~~~~~~~~~Ii~~ 103 (109)
T d1oj5a_ 91 PQSPDMQPFIMGI 103 (109)
T ss_dssp C----CCCEEEEE
T ss_pred CCCCCcccEEEEE
Confidence 8765443 44443
|
| >d1oj5a_ d.110.3.8 (A:) PAS domain of steroid receptor coactivator 1A, NCo-A1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PAS domain of steroid receptor coactivator 1A, NCo-A1 domain: PAS domain of steroid receptor coactivator 1A, NCo-A1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.79 E-value=1.5e-09 Score=97.21 Aligned_cols=94 Identities=12% Similarity=0.105 Sum_probs=75.1
Q ss_pred EEEEcCCCCCCCEEEccHHHHHHcCCCh-hhhcCCCCcccCCCCCCHH--HHHHHHHHHhcCCcEEEEEEEEecCCcEEE
Q 002342 485 FVITDPRLPDNPIIFASDSFLELTEYSR-EEILGRNCRFLQGPETDPA--TVRKIRAAIDNQTDVTVQLINYTKSGKKFW 561 (934)
Q Consensus 485 i~v~D~~G~~~~I~~vN~a~~~l~Gys~-eEliG~~~~~l~~~~~~~~--~~~~i~~~l~~~~~~~~e~~~~~kdG~~~w 561 (934)
+.-.|.+|+ |+++|+++.+++||.. +|++|+++.+++||+|.+. ........+..|.....++++++|||..+|
T Consensus 5 ~trh~~~g~---~~~vd~~~~~~~gy~~~eelig~s~~~f~HPeD~~~~~~~~~~~~~~~~g~~~~~~yR~~~kdG~~vW 81 (109)
T d1oj5a_ 5 MTKQDTTGK---IISIDTSSLRAAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLS 81 (109)
T ss_dssp EEEECTTCC---EEEEECHHHHTTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEE
T ss_pred EEEECCCce---EEEECHHHhhHhhcCCHHHHcCCcHHHeECcccchHHHhhHHHHHHHhhcccchhhhhhhhccCcEEE
Confidence 345688888 9999999999999985 9999999999999998652 334456677788888999999999999999
Q ss_pred EEEEEEeeecCCCCE-EEEEE
Q 002342 562 NLFHLQPMRDQKGEV-QYFIG 581 (934)
Q Consensus 562 v~~~~~pi~de~G~v-~~~vg 581 (934)
+..+..+++|..|.. .+++|
T Consensus 82 v~t~~~~~~~~~~~~~~~Ii~ 102 (109)
T d1oj5a_ 82 AHTRCKLCYPQSPDMQPFIMG 102 (109)
T ss_dssp EEEEEEEECC----CCCEEEE
T ss_pred EEEEEEEEECCCCCcccEEEE
Confidence 999999999875543 33444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.29 E-value=9.4e-07 Score=91.23 Aligned_cols=140 Identities=13% Similarity=0.103 Sum_probs=94.7
Q ss_pred CCcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCCeEEEE
Q 002342 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLI 747 (934)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lV 747 (934)
..|+.++..+.++.+.||++. .++..+++|....... .....+.+|..++..+. +--+++++.+...++..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 467777776666668999886 3666778898764322 12234667888888774 44467888888888999999
Q ss_pred EEccCCCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 002342 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-------------------------------------- 789 (934)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~yLH~-------------------------------------- 789 (934)
|++++|.++....... . ....++.++...+..||+
T Consensus 89 ~~~l~G~~~~~~~~~~----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHTTTC----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEeccccccccccccc----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 9999988876543211 1 111223333334444442
Q ss_pred ---------------C------CCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 790 ---------------Q------GIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 790 ---------------~------giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
. .++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1 279999999999999766667999998843
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.76 E-value=3.4e-05 Score=78.63 Aligned_cols=74 Identities=16% Similarity=0.130 Sum_probs=52.6
Q ss_pred ccCC-cEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC--CCccceeEEEEeCCeEEEEEEccCCC
Q 002342 678 GSGD-TGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTKTHVCLITDYCPGG 754 (934)
Q Consensus 678 G~G~-~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~~~~~lV~E~~~gg 754 (934)
..|. .+.||++.. ..+..+++|...... ...+..|...|+.+.. -.+++++.+..+++..++||++++|.
T Consensus 19 ~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp SCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred CCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4444 368999876 456678899866442 1246678888877743 33677888888888999999999887
Q ss_pred Cchh
Q 002342 755 ELFL 758 (934)
Q Consensus 755 sL~~ 758 (934)
++..
T Consensus 92 ~~~~ 95 (255)
T d1nd4a_ 92 DLLS 95 (255)
T ss_dssp ETTT
T ss_pred cccc
Confidence 7643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.71 E-value=2.5e-05 Score=85.50 Aligned_cols=81 Identities=15% Similarity=0.125 Sum_probs=51.1
Q ss_pred ccccccCCcEEEEEEEEecCCeEEEEEEeeccccc----ChHHHHHHHHHHHHHHhCC-C--CCccceeEEEEeCCeEEE
Q 002342 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML----NRNKVHRACAEREILDMLD-H--PFVPALYASFQTKTHVCL 746 (934)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~----~~~~~~~~~~E~~il~~l~-h--p~Iv~l~~~~~~~~~~~l 746 (934)
.+.||.|....||++.+..+++.+++|.-....-. -+....+...|.++|+.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 44689999999999998777889999975432110 0112344567888887763 2 346666644 4455679
Q ss_pred EEEccCCCCc
Q 002342 747 ITDYCPGGEL 756 (934)
Q Consensus 747 V~E~~~ggsL 756 (934)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976554
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.91 E-value=0.0012 Score=71.84 Aligned_cols=75 Identities=20% Similarity=0.304 Sum_probs=52.5
Q ss_pred ccccccCCcEEEEEEEEec-------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCccceeEEEEeCCeEE
Q 002342 674 IKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVC 745 (934)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~-------~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~ 745 (934)
++.|+.|-.-.+|++.... ..+.|.+++.-.. .......+|..+++.+. +.-.+++++++.+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-----chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 3578999999999998753 2456778876521 12234567999998884 4445688877753 5
Q ss_pred EEEEccCCCCch
Q 002342 746 LITDYCPGGELF 757 (934)
Q Consensus 746 lV~E~~~ggsL~ 757 (934)
+||||++|..|.
T Consensus 118 ~I~efi~g~~l~ 129 (395)
T d1nw1a_ 118 RLEEYIPSRPLS 129 (395)
T ss_dssp EEECCCCEEECC
T ss_pred eEEEEeccccCC
Confidence 899999876554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.22 E-value=0.0037 Score=65.75 Aligned_cols=70 Identities=11% Similarity=0.017 Sum_probs=45.1
Q ss_pred cEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCc--ccee-----EEEEeCCeEEEEEEccCCC
Q 002342 682 TGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV--PALY-----ASFQTKTHVCLITDYCPGG 754 (934)
Q Consensus 682 ~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~I--v~l~-----~~~~~~~~~~lV~E~~~gg 754 (934)
-..||++.. .+|..|++|+.+.+. .....+..|...+..|....| +..+ ..+...+..+.++++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 368999987 678889999987642 123456678888777632111 1111 1234567789999999765
Q ss_pred Cc
Q 002342 755 EL 756 (934)
Q Consensus 755 sL 756 (934)
.+
T Consensus 110 ~~ 111 (325)
T d1zyla1 110 QF 111 (325)
T ss_dssp EC
T ss_pred CC
Confidence 44
|
| >d2oola2 d.110.3.9 (A:26-139) Sensor protein PhyB2 {Rhodopseudomonas palustris [TaxId: 1076]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Sensor protein PhyB2 species: Rhodopseudomonas palustris [TaxId: 1076]
Probab=96.06 E-value=0.002 Score=56.59 Aligned_cols=47 Identities=11% Similarity=0.064 Sum_probs=38.0
Q ss_pred ccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHH
Q 002342 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPA 531 (934)
Q Consensus 483 d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~ 531 (934)
-.++++|.. +++|+++++....++|+++++++|+++.+++++++...
T Consensus 18 G~Llvld~~--d~~I~~vS~N~~~lLG~~~~~llG~~l~dll~~~~~~~ 64 (114)
T d2oola2 18 GYLFVVSET--DLRIASVSANVEDLLRQPPASLLNVPIAHYLTAASAAR 64 (114)
T ss_dssp SEEEEECTT--TCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCHHHHHH
T ss_pred cEEEEEECC--CCEEEEEcCCHHHHhCCChHHHcCCCHHHhCCHHHHHH
Confidence 456677753 33499999999999999999999999999988765443
|
| >d2oola2 d.110.3.9 (A:26-139) Sensor protein PhyB2 {Rhodopseudomonas palustris [TaxId: 1076]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Sensor protein PhyB2 species: Rhodopseudomonas palustris [TaxId: 1076]
Probab=95.97 E-value=0.0018 Score=56.92 Aligned_cols=53 Identities=17% Similarity=0.172 Sum_probs=40.6
Q ss_pred cEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhc
Q 002342 201 TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQN 259 (934)
Q Consensus 201 ~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~ 259 (934)
.++++|.. +|+|+|++++...++|+++++++|+++..++++++ ...+++.+..
T Consensus 19 ~Llvld~~--d~~I~~vS~N~~~lLG~~~~~llG~~l~dll~~~~----~~~i~~~l~~ 71 (114)
T d2oola2 19 YLFVVSET--DLRIASVSANVEDLLRQPPASLLNVPIAHYLTAAS----AARLTHALHG 71 (114)
T ss_dssp EEEEECTT--TCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCHHH----HHHHHHHHCC
T ss_pred EEEEEECC--CCEEEEEcCCHHHHhCCChHHHcCCCHHHhCCHHH----HHHHHHHHhc
Confidence 34566643 78899999999999999999999999988877654 3445555543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.67 E-value=0.0038 Score=65.12 Aligned_cols=144 Identities=17% Similarity=0.154 Sum_probs=74.4
Q ss_pred CcccccccccCCcEEEEEEEEecCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC-----CCcccee---EEEEeC
Q 002342 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH-----PFVPALY---ASFQTK 741 (934)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~vAlK~~~~~~~~~~~~~~~~~~E~~il~~l~h-----p~Iv~l~---~~~~~~ 741 (934)
...-.+.|..|--.+.|++... +| .|++|++.+.. ....+..|++++..|.. |..+... .+....
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~-----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~ 91 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 91 (316)
T ss_dssp CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred CceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC-----CHHHHHHHHHHHHhhhhccccccccceecCCCcceeee
Confidence 3444455677888899999863 34 58999986531 12344556666666532 2221110 011234
Q ss_pred CeEEEEEEccCCCCchhhhcc----------------C-----CCCCCCHHH------------------HHHHHHHHHH
Q 002342 742 THVCLITDYCPGGELFLLLDR----------------Q-----PTKVLKEDA------------------VRFYAAEVVV 782 (934)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~----------------~-----~~~~l~~~~------------------~~~i~~qil~ 782 (934)
...+.++.++.|......... . ......... ....+..+..
T Consensus 92 ~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 171 (316)
T d2ppqa1 92 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 171 (316)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred cccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHH
Confidence 566777777766544211000 0 000001110 1111222222
Q ss_pred HHHHHHH----CCCeecCCCCCCEEEecCCcEEEEecccCcc
Q 002342 783 ALEYLHC----QGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (934)
Q Consensus 783 aL~yLH~----~giiHrDLKp~NILl~~~~~vkl~DFG~a~~ 820 (934)
.+.-.+. .|+||+|+.++||+++.++.+-|+||+.|..
T Consensus 172 ~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 172 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 2222222 3799999999999999877778999999854
|
| >d2veaa3 d.110.3.9 (A:4-130) Phytochrome-like protein Cph1 {Synechocystis sp. pcc 6803 [TaxId: 1148]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Phytochrome-like protein Cph1 species: Synechocystis sp. pcc 6803 [TaxId: 1148]
Probab=88.74 E-value=0.12 Score=45.67 Aligned_cols=47 Identities=19% Similarity=0.084 Sum_probs=35.8
Q ss_pred ccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHH
Q 002342 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPA 531 (934)
Q Consensus 483 d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~ 531 (934)
-.++++|.. +++|..++.....++|+++++++|+++..++.++....
T Consensus 27 G~LLald~~--~~~I~~aS~N~~~~lG~~~~~lLG~~l~~ll~~~~~~~ 73 (127)
T d2veaa3 27 GLVVVLQEP--DLTISQISANCTGILGRSPEDLLGRTLGEVFDSFQIDP 73 (127)
T ss_dssp SEEEEEETT--TTEEEEEETTHHHHTSCCTTTSSTTTTTTTSBCC----
T ss_pred eEEEEEECC--CCEEEEEcCCHHHHhCcChHHHcCCCHHHHCCHHHHHH
Confidence 345566753 44599999999999999999999999999887765443
|
| >d2veaa3 d.110.3.9 (A:4-130) Phytochrome-like protein Cph1 {Synechocystis sp. pcc 6803 [TaxId: 1148]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Phytochrome-like protein Cph1 species: Synechocystis sp. pcc 6803 [TaxId: 1148]
Probab=88.73 E-value=0.12 Score=45.67 Aligned_cols=44 Identities=23% Similarity=0.234 Sum_probs=35.0
Q ss_pred EEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCCh
Q 002342 202 FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDP 247 (934)
Q Consensus 202 i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~ 247 (934)
++++|. .+++|+.++.....++|+++++++|+++..++.+....
T Consensus 29 LLald~--~~~~I~~aS~N~~~~lG~~~~~lLG~~l~~ll~~~~~~ 72 (127)
T d2veaa3 29 VVVLQE--PDLTISQISANCTGILGRSPEDLLGRTLGEVFDSFQID 72 (127)
T ss_dssp EEEEET--TTTEEEEEETTHHHHTSCCTTTSSTTTTTTTSBCC---
T ss_pred EEEEEC--CCCEEEEEcCCHHHHhCcChHHHcCCCHHHHCCHHHHH
Confidence 455664 27889999999999999999999999998877665433
|
| >d2o9ca2 d.110.3.9 (A:4-130) Bacteriophytochrome BphP {Deinococcus radiodurans [TaxId: 1299]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Deinococcus radiodurans [TaxId: 1299]
Probab=87.05 E-value=0.45 Score=41.74 Aligned_cols=77 Identities=9% Similarity=-0.003 Sum_probs=49.2
Q ss_pred ccEEEEcCCCCCCCEEEccHHHHHHcCCChhhhcCCCCcccCCCCCCHHHHHHHHHHHhcCC--cEEEEEEEEecCCcEE
Q 002342 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT--DVTVQLINYTKSGKKF 560 (934)
Q Consensus 483 d~i~v~D~~G~~~~I~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~~~--~~~~e~~~~~kdG~~~ 560 (934)
-.++++|.. ++.|+.++....+++|++.++++|++...+.+.. . ..+...+.... ...........+|..+
T Consensus 36 G~LLald~~--~~~I~~~S~N~~~~lG~~~~~llG~~l~~ll~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~f 108 (127)
T d2o9ca2 36 GALLTADGH--SGEVLQMSLNAATFLGQEPTVLRGQTLAALLPEQ-W----PALQAALPPGCPDALQYRATLDWPAAGHL 108 (127)
T ss_dssp SEEEEEETT--TCBEEEEETTHHHHHSSCHHHHTTCBHHHHCTTT-H----HHHHHHSCTTCCTTCCEEEEECCSSSSEE
T ss_pred eEEEEEECC--CCEEEEECCCHHHHhCCChHHHcCCCHHHHCCHH-H----HHHHHHhhhcCcccccceeeeecCCCceE
Confidence 345566753 4459999999999999999999999988887542 1 22233332222 2233334445567777
Q ss_pred EEEEEE
Q 002342 561 WNLFHL 566 (934)
Q Consensus 561 wv~~~~ 566 (934)
++.++.
T Consensus 109 ~~~~Hr 114 (127)
T d2o9ca2 109 SLTVHR 114 (127)
T ss_dssp EEEEEE
T ss_pred EEEEEE
Confidence 666553
|
| >d2o9ca2 d.110.3.9 (A:4-130) Bacteriophytochrome BphP {Deinococcus radiodurans [TaxId: 1299]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Deinococcus radiodurans [TaxId: 1299]
Probab=86.65 E-value=0.47 Score=41.58 Aligned_cols=75 Identities=11% Similarity=0.019 Sum_probs=47.4
Q ss_pred cEEEEeCCCCCCceEEcchHHHHHcCCChhhHcCCCCCCCCCCCCChHHHHHHHHHHhcCCc--EEEEEEEEecCCcEEE
Q 002342 201 TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS--YCGRLLNYKKDGTPFW 278 (934)
Q Consensus 201 ~i~v~D~~~~dG~I~~~N~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~--~~~e~~~~~kdG~~~w 278 (934)
.++++|.. ++.|+.++.....++|++.++++|+++..+++.. ...+...+..... ..........+|..+|
T Consensus 37 ~LLald~~--~~~I~~~S~N~~~~lG~~~~~llG~~l~~ll~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~ 109 (127)
T d2o9ca2 37 ALLTADGH--SGEVLQMSLNAATFLGQEPTVLRGQTLAALLPEQ-----WPALQAALPPGCPDALQYRATLDWPAAGHLS 109 (127)
T ss_dssp EEEEEETT--TCBEEEEETTHHHHHSSCHHHHTTCBHHHHCTTT-----HHHHHHHSCTTCCTTCCEEEEECCSSSSEEE
T ss_pred EEEEEECC--CCEEEEECCCHHHHhCCChHHHcCCCHHHHCCHH-----HHHHHHHhhhcCcccccceeeeecCCCceEE
Confidence 34556653 7889999999999999999999999988776432 1223333332221 2233333345666666
Q ss_pred EEEE
Q 002342 279 NLLT 282 (934)
Q Consensus 279 v~~s 282 (934)
+.+.
T Consensus 110 ~~~H 113 (127)
T d2o9ca2 110 LTVH 113 (127)
T ss_dssp EEEE
T ss_pred EEEE
Confidence 5554
|